PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Brune, M; Muller, M; Melino, G; Bierhaus, A; Schilling, T; Nawroth, PP				Brune, M.; Mueller, M.; Melino, G.; Bierhaus, A.; Schilling, T.; Nawroth, P. P.			Depletion of the receptor for advanced glycation end products (RAGE) sensitizes towards apoptosis via p53 and p73 posttranslational regulation	ONCOGENE			English	Article						RAGE; apoptosis; CD95; p53; p73	FACTOR-KAPPA-B; HEPATOCELLULAR-CARCINOMA; TRANSCRIPTION FACTOR; BINDING-PROTEINS; CELL-SURFACE; EXPRESSION; MOUSE; CANCER; DEATH; INFLAMMATION	The receptor for advanced glycation endproduct (RAGE) is involved in diabetic complications and chronic inflammation, conditions known to affect the sensitivity towards apoptosis. Here, we studied the effect of genetically depleting RAGE on the susceptibility towards apoptosis. In murine osteoblastic cells, RAGE knockout increased both spontaneous and induced apoptosis. Decreased levels of B-cell lymphoma 2 protein and increased intrinsic apoptosis were observed in Rage(-/-) cells. Furthermore, loss of RAGE increased expression of the death receptor CD95 (Fas, Apo-1), CD95-dependent caspase activation and extrinsic apoptosis, whereas NF-kB-p65 nuclear translocation was diminished. Importantly, depletion of RAGE reduced the ubiquitination and degradation of p53 and p73 and increased their nuclear translocation. The increase of p53 and p73 transactivational activity was essential for the RAGE-dependent regulation of apoptosis, because knockdown of p53 and p73 significantly decreased apoptosis in RAGE-deficient but not in RAGE-expressing cells. Thus, the RAGE-mediated posttranslational regulation of p53 and p73 orchestrates a sequence of events culminating in control of intrinsic and extrinsic apoptosis signaling pathways. Oncogene (2013) 32, 1460-1468; doi:10.1038/onc.2012.150; published online 30 April 2012	[Brune, M.; Bierhaus, A.; Schilling, T.; Nawroth, P. P.] Heidelberg Univ, Dept Internal Med & Clin Chem 1, D-69120 Heidelberg, Germany; [Mueller, M.] Heidelberg Univ, Dept Internal Med 4, D-69120 Heidelberg, Germany; [Mueller, M.] Univ Regensburg, Dept Internal Med 1, D-93053 Regensburg, Germany; [Melino, G.] MRC, Toxicol Unit, Leicester, Leics, England; [Melino, G.] Univ Rome, Dept Expt Med & Biochem Sci, IDI IRCCS, Biochem Lab, Rome, Italy	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Regensburg; University of Leicester; IRCCS Istituto Dermopatico dell'Immacolata (IDI); Sapienza University Rome	Brune, M (corresponding author), Heidelberg Univ, Dept Internal Med & Clin Chem 1, Neuenheimer Feld 410, D-69120 Heidelberg, Germany.	maik.brune@med.uni-heidelberg.de	Martina, Mueller-Schilling/R-4162-2016		Dietmar Hopp Stiftung 'Altern-Mobilitat erhalten, Regeneration ermoglichen'; Deutsche Forschungsgemeinschaft [SFB938]; Deutsche Forschungsgemeinschaft, Transregional Collaborative Research Centre [SFB/TRR77]; Tumorzentrum Heidelberg/Mannheim; Helmholtz Alliance on Immunotherapy of Cancer; Initiative and Networking Fund of the Helmholtz Association; Medical Research Council [MC_U132670600] Funding Source: researchfish; MRC [MC_U132670600] Funding Source: UKRI	Dietmar Hopp Stiftung 'Altern-Mobilitat erhalten, Regeneration ermoglichen'; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft, Transregional Collaborative Research Centre(German Research Foundation (DFG)); Tumorzentrum Heidelberg/Mannheim; Helmholtz Alliance on Immunotherapy of Cancer; Initiative and Networking Fund of the Helmholtz Association; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Dr Subrata Biswas for isolation of MOC, Thomas Fleming for assistance with chromatin immunoprecipitation and electroporation, Dr Andreas Koch for assistance with flow cytometry, as well as Katja Lorenz and Petra Hill for expert technical assistance. This work was supported by a grant of the Dietmar Hopp Stiftung 'Altern-Mobilitat erhalten, Regeneration ermoglichen' to MB, PN, AB and TS, by a grant of the Deutsche Forschungsgemeinschaft SFB938 to AB and by the grant of the Deutsche Forschungsgemeinschaft, Transregional Collaborative Research Centre SFB/TRR77, the Tumorzentrum Heidelberg/Mannheim and the Helmholtz Alliance on Immunotherapy of Cancer funded by the Initiative and Networking Fund of the Helmholtz Association to MM.	Alikhani M, 2007, BONE, V40, P345, DOI 10.1016/j.bone.2006.09.011; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bentires-Alj M, 2001, ONCOGENE, V20, P2805, DOI 10.1038/sj.onc.1204343; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Bierhaus A, 2009, DIABETOLOGIA, V52, P2251, DOI 10.1007/s00125-009-1458-9; Borcsok I, 1998, J EXP MED, V188, P1563, DOI 10.1084/jem.188.9.1563; Chan H, 1999, MOL CELL BIOL, V19, P2098, DOI 10.1128/mcb.19.3.2098; Cheng B, 2011, EXP CLIN ENDOCR DIAB, V119, P480, DOI 10.1055/s-0031-1279714; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; Ding KH, 2006, BIOCHEM BIOPH RES CO, V340, P1091, DOI 10.1016/j.bbrc.2005.12.107; Dudley E, 1999, EUR J IMMUNOL, V29, P878, DOI 10.1002/(SICI)1521-4141(199903)29:03<878::AID-IMMU878>3.0.CO;2-9; Eggers K, 2011, EXP CLIN ENDOCR DIAB, V119, P353, DOI 10.1055/s-0030-1268426; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Gebhardt C, 2008, J EXP MED, V205, P275, DOI 10.1084/jem.20070679; Gulcelik NE, 2011, EXP CLIN ENDOCR DIAB, V119, P414, DOI 10.1055/s-0030-1270466; Hiwatashi K, 2009, ANTICANCER RES, V29, P1287; Hofbauer LC, 2007, J BONE MINER RES, V22, P1317, DOI 10.1359/JBMR.070510; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Ishihara K, 2003, FEBS LETT, V550, P107, DOI 10.1016/S0014-5793(03)00846-9; Kang R, 2010, CELL DEATH DIFFER, V17, P666, DOI 10.1038/cdd.2009.149; Kang R, 2011, AUTOPHAGY, V7, P442, DOI 10.4161/auto.7.4.14681; Kang R, 2011, AUTOPHAGY, V7, P91, DOI [10.4161/auto.7.1.13852, 10.1038/cdd.2009.149]; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kikuchi H, 2006, ONCOGENE, V25, P7608, DOI 10.1038/sj.onc.1209748; Lavrik IN, 2007, J BIOL CHEM, V282, P13664, DOI 10.1074/jbc.M700434200; Lavrik IN, 2006, BLOOD, V108, P559, DOI 10.1182/blood-2005-07-007096; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Muller M, 2005, CELL DEATH DIFFER, V12, P1564, DOI 10.1038/sj.cdd.4401774; Mundt HM, 2010, BIOCHEM BIOPH RES CO, V396, P335, DOI 10.1016/j.bbrc.2010.04.093; Munsch D, 2000, J BIOL CHEM, V275, P3867, DOI 10.1074/jbc.275.6.3867; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Paul RG, 1996, INT J BIOCHEM CELL B, V28, P1297, DOI 10.1016/S1357-2725(96)00079-9; RENSINGEHL A, 1995, J INFLAMM, V45, P161; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Seitz SJ, 2010, INT J CANCER, V126, P2049, DOI 10.1002/ijc.24861; Soro-Paavonen A, 2008, DIABETES, V57, P2461, DOI 10.2337/db07-1808; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Stolzing A, 2010, CELLS TISSUES ORGANS, V191, P453, DOI 10.1159/000281826; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Tsoporis JN, 2010, CIRC RES, V106, P93, DOI 10.1161/CIRCRESAHA.109.195834; Villa-Morales M, 2006, ONCOGENE, V25, P2022, DOI 10.1038/sj.onc.1209234; Zhou Z, 2006, J EXP MED, V203, P1067, DOI 10.1084/jem.20051947	44	10	10	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 14	2013	32	11					1460	1468		10.1038/onc.2012.150	http://dx.doi.org/10.1038/onc.2012.150			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110OZ	22543586				2022-12-25	WOS:000316455600012
J	Trauner, A; Lougheed, KEA; Bennett, MH; Hingley-Wilson, SM; Williams, HD				Trauner, Andrej; Lougheed, Kathryn E. A.; Bennett, Mark H.; Hingley-Wilson, Suzanne M.; Williams, Huw D.			The Dormancy Regulator DosR Controls Ribosome Stability in Hypoxic Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIBERNATION PROMOTING FACTOR; MODULATION FACTOR; ESCHERICHIA-COLI; STATIONARY-PHASE; PROTEIN EXPRESSION; GENE-EXPRESSION; TUBERCULOSIS; STARVATION; SENSOR; DEVS	It is thought that during latent infection, Mycobacterium tuberculosis bacilli are retained within granulomas in a low-oxygen environment. The dormancy survival (Dos) regulon, regulated by the response regulator DosR, appears to be essential for hypoxic survival in M. tuberculosis, but it is not known how the regulon promotes survival. Here we report that mycobacteria, in contrast to enteric bacteria, do not form higher-order structures (e.g. ribosomal dimers) upon entry into stasis. Instead, ribosomes are stabilized in the associated form (70S). Using a strategy incorporating microfluidic, proteomic, and ribosomal profiling techniques to elucidate the fate of mycobacterial ribosomes during hypoxic stasis, we show that the dormancy regulator DosR is required for optimal ribosome stabilization. We present evidence that the majority of this effect is mediated by the DosR-regulated protein MSMEG_3935 (a S30AE domain protein), which is associated with the ribosome under hypoxic conditions. A Delta 3935 mutant phenocopies the Delta dosR mutant during hypoxia, and complementation of Delta dosR with the MSMEG_3935 gene leads to complete recovery of dosR mutant phenotypes during hypoxia. We suggest that this protein is named ribosome-associated factor under hypoxia (RafH) and that it is the major factor responsible for DosR-mediated hypoxic survival in mycobacteria.	[Trauner, Andrej; Lougheed, Kathryn E. A.; Bennett, Mark H.; Hingley-Wilson, Suzanne M.; Williams, Huw D.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Div Cell & Mol Biol, London SW7 2AZ, England	Imperial College London	Williams, HD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Div Cell & Mol Biol, Sir Alexander Fleming Bldg,Exhibit Rd, London SW7 2AZ, England.	h.d.williams@imperial.ac.uk		Williams, Huw/0000-0003-2225-6413; Trauner, Andrej/0000-0002-6260-9829; Hingley-Wilson, Suzie/0000-0002-6514-1424	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust.	Agafonov DE, 2001, EMBO REP, V2, P399; Atkins JF, 2009, MICROBIOL MOL BIOL R, V73, P178, DOI 10.1128/MMBR.00010-08; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Belisle JT, 1998, METH MOL B, V101, P31, DOI 10.1385/0-89603-471-2:31; Berney M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008614; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Boon C, 2002, J BACTERIOL, V184, P6760, DOI 10.1128/JB.184.24.6760-6767.2002; Dasgupta N, 2000, TUBERCLE LUNG DIS, V80, P141, DOI 10.1054/tuld.2000.0240; DAVIS BD, 1986, J BACTERIOL, V166, P439, DOI 10.1128/jb.166.2.439-445.1986; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; El-Sharoud WM, 2007, MICROBIOL-SGM, V153, P247, DOI 10.1099/mic.0.2006/001552-0; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gengenbacher M, 2010, MICROBIOL-SGM, V156, P81, DOI 10.1099/mic.0.033084-0; Hingley-Wilson SM, 2010, TUBERCULOSIS, V90, P236, DOI 10.1016/j.tube.2010.03.013; Honaker RW, 2009, INFECT IMMUN, V77, P3258, DOI 10.1128/IAI.01449-08; Ioanoviciu A, 2007, BIOCHEMISTRY-US, V46, P4250, DOI 10.1021/bi602422p; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Keer J, 2001, MICROBIOL-SGM, V147, P473, DOI 10.1099/00221287-147-2-473; Klotzsche M, 2009, NUCLEIC ACIDS RES, V37, P1778, DOI 10.1093/nar/gkp015; Krab IM, 1998, BBA-GENE STRUCT EXPR, V1443, P1, DOI 10.1016/S0167-4781(98)00169-9; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Leistikow RL, 2010, J BACTERIOL, V192, P1662, DOI 10.1128/JB.00926-09; Lillebaek T, 2003, J INFECT DIS, V188, P1032, DOI 10.1086/378240; Niven GW, 2004, ARCH MICROBIOL, V182, P60, DOI 10.1007/s00203-004-0698-9; O'Toole R, 2003, J BACTERIOL, V185, P1543, DOI 10.1128/JB.185.5.1543-1554.2003; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Rao SPS, 2008, P NATL ACAD SCI USA, V105, P11945, DOI 10.1073/pnas.0711697105; Reddy TBK, 2009, NUCLEIC ACIDS RES, V37, pD499, DOI 10.1093/nar/gkn652; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Rustad TR, 2009, CELL MICROBIOL, V11, P1151, DOI 10.1111/j.1462-5822.2009.01325.x; Rustad Tige R., 2008, V465, P13, DOI 10.1007/978-1-59745-207-6_2; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shleeva M, 2004, MICROBIOL-SGM, V150, P1687, DOI 10.1099/mic.0.26893-0; Smeulders MJ, 1999, J BACTERIOL, V181, P270, DOI 10.1128/JB.181.1.270-283.1999; Sousa EHS, 2007, PROTEIN SCI, V16, P1708, DOI 10.1110/ps.072897707; Stallings CL, 2009, CELL, V138, P146, DOI 10.1016/j.cell.2009.04.041; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; TAN XL, 1994, J BIOL CHEM, V269, P20905; Timm J, 2003, P NATL ACAD SCI USA, V100, P14321, DOI 10.1073/pnas.2436197100; Trauner A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016273; Ueta M, 2008, J BIOCHEM, V143, P425, DOI 10.1093/jb/mvm243; Ueta M, 2010, GENES CELLS, V15, P43, DOI 10.1111/j.1365-2443.2009.01364.x; Uicker WC, 2007, J BACTERIOL, V189, P2926, DOI 10.1128/JB.01654-06; Unwin RD, 2009, NAT PROTOC, V4, P870, DOI 10.1038/nprot.2009.57; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Vesper O, 2011, CELL, V147, P147, DOI 10.1016/j.cell.2011.07.047; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Vila-Sanjurjo A, 2004, NAT STRUCT MOL BIOL, V11, P1054, DOI 10.1038/nsmb850; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Vynnycky E, 1997, INT J TUBERC LUNG D, V1, P389; WADA A, 1995, BIOCHEM BIOPH RES CO, V214, P410, DOI 10.1006/bbrc.1995.2302; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Wilson DN, 2004, NAT STRUCT MOL BIOL, V11, P1026, DOI 10.1038/nsmb1104-1026; Yoshida H, 2002, J BIOCHEM, V132, P983, DOI 10.1093/oxfordjournals.jbchem.a003313; Yukl ET, 2007, BIOCHEMISTRY-US, V46, P9728, DOI 10.1021/bi7008695; Zundel MA, 2009, RNA, V15, P977, DOI 10.1261/rna.1381309	63	47	49	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					24053	24063		10.1074/jbc.M112.364851	http://dx.doi.org/10.1074/jbc.M112.364851			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22544737	Green Published, hybrid			2022-12-25	WOS:000306511300073
J	Irving, M; Zoete, V; Hebeisen, M; Schmid, D; Baumgartner, P; Guillaume, P; Romero, P; Speiser, D; Luescher, I; Rufer, N; Michielin, O				Irving, Melita; Zoete, Vincent; Hebeisen, Michael; Schmid, Daphne; Baumgartner, Petra; Guillaume, Philippe; Romero, Pedro; Speiser, Daniel; Luescher, Immanuel; Rufer, Nathalie; Michielin, Olivier			Interplay between T Cell Receptor Binding Kinetics and the Level of Cognate Peptide Presented by Major Histocompatibility Complexes Governs CD8(+) T Cell Responsiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE-ENERGY DECOMPOSITION; HIGH-AFFINITY; DWELL-TIME; MM-GBSA; TCR; ANTIGEN; MHC; ACTIVATION; LIGANDS; IMPACT	Through a rational design approach, we generated a panel of HLA-A*0201/NY-ESO-1(157-165)-specific T cell receptors (TCR) with increasing affinities of up to 150-fold from the wild-type TCR. Using these TCR variants which extend just beyond the natural affinity range, along with an extreme supraphysiologic one having 1400-fold enhanced affinity, and a low-binding one, we sought to determine the effect of TCR binding properties along with cognate peptide concentration on CD8(+) T cell responsiveness. Major histocompatibility complexes (MHC) expressed on the surface of various antigen presenting cells were peptide-pulsed and used to stimulate human CD8(+) T cells expressing the different TCR via lentiviral transduction. At intermediate peptide concentration we measured maximum cytokine/chemokine secretion, cytotoxicity, and Ca2+ flux for CD8(+) T cells expressing TCR within a dissociation constant (K-D) range of similar to 1-5 mu M. Under these same conditions there was a gradual attenuation in activity for supraphysiologic affinity TCR with K-D < similar to 1 mu M, irrespective of CD8 co-engagement and of half-life (t(1/2) = ln 2/k(off)) values. With increased peptide concentration, however, the activity levels of CD8(+) T cells expressing supraphysiologic affinity TCR were gradually restored. Together our data support the productive hit rate model of T cell activation arguing that it is not the absolute number of TCR/pMHC complexes formed at equilibrium, but rather their productive turnover, that controls levels of biological activity. Our findings have important implications for various immunotherapies under development such as adoptive cell transfer of TCR-engineered CD8(+) T cells, as well as for peptide vaccination strategies.	[Irving, Melita; Schmid, Daphne; Rufer, Nathalie; Michielin, Olivier] Multidisciplinary Oncol Ctr CePO, Div Expt Oncol, Lausanne, Switzerland; [Michielin, Olivier] Quartier UNIL Sorge, Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Hebeisen, Michael] Univ Hosp Ctr, Dept Res, CH-1011 Lausanne, Switzerland; [Hebeisen, Michael] Univ Lausanne, Lausanne, Switzerland; [Baumgartner, Petra; Guillaume, Philippe; Romero, Pedro; Speiser, Daniel; Luescher, Immanuel; Rufer, Nathalie; Michielin, Olivier] Univ Lausanne LICR UNIL, Ludwig Ctr Canc Res, Lausanne, Switzerland	Swiss Institute of Bioinformatics; University of Lausanne	Luescher, I (corresponding author), Univ Lausanne, Ludwig Ctr Canc Res, Chemin Boveresses 155, CH-1044 Epalinges, Switzerland.	Immanuel.Luescher@unil.ch; Nathalie.Rufer@unil.ch; Olivier.Michielin@unil.ch	Romero, Pedro/S-6015-2017; Speiser, Daniel E./F-2173-2013; Michielin, Olivier/ABE-7924-2020	Romero, Pedro/0000-0002-9688-2882; 	Swiss National Center of Competence in Research; Swiss National Science foundation [3200B0-103173, 3200B0-118123]; OncoSuisse [OCS 01381-08-2003, 02555-02-2010]	Swiss National Center of Competence in Research(Swiss National Science Foundation (SNSF)); Swiss National Science foundation(Swiss National Science Foundation (SNSF)European Commission); OncoSuisse	This work was supported by the Swiss National Center of Competence in Research and the Swiss National Science foundation Grants 3200B0-103173 (to O. M.) and 3200B0-118123 (to N. R.) and by OncoSuisse Grants OCS 01381-08-2003 (to O. M.) and 02555-02-2010 (to O. M. and V. Z.).	Aleksic M, 2010, IMMUNITY, V32, P163, DOI 10.1016/j.immuni.2009.11.013; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Barde I., 2010, CURRENT PROTOCOLS NE, P21; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Carreno LJ, 2010, P NATL ACAD SCI USA, V107, P210, DOI 10.1073/pnas.0911258107; CHANG HC, 1994, P NATL ACAD SCI USA, V91, P11408, DOI 10.1073/pnas.91.24.11408; Chen JL, 2000, J IMMUNOL, V165, P948, DOI 10.4049/jimmunol.165.2.948; Chen JL, 2005, J EXP MED, V201, P1243, DOI 10.1084/jem.20042323; Chervin AS, 2009, J IMMUNOL, V183, P1166, DOI 10.4049/jimmunol.0900054; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; Corse E, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000481; Derre L, 2008, P NATL ACAD SCI USA, V105, P15010, DOI 10.1073/pnas.0807954105; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Dunn SM, 2006, PROTEIN SCI, V15, P710, DOI 10.1110/ps.051936406; Dushek O, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001430; Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295; Gonzalez PA, 2005, P NATL ACAD SCI USA, V102, P4824, DOI 10.1073/pnas.0500922102; Govern CC, 2010, P NATL ACAD SCI USA, V107, P8724, DOI 10.1073/pnas.1000966107; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Holler PD, 2003, IMMUNITY, V18, P255, DOI 10.1016/S1074-7613(03)00019-0; Holler PD, 2003, NAT IMMUNOL, V4, P55, DOI 10.1038/ni863; Jiang N, 2011, IMMUNITY, V34, P13, DOI 10.1016/j.immuni.2010.12.017; Kalergis AM, 2001, NAT IMMUNOL, V2, P229, DOI 10.1038/85286; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Krogsgaard M, 2005, NAT IMMUNOL, V6, P239, DOI 10.1038/ni1173; Kuhns MS, 2010, P NATL ACAD SCI USA, V107, P5094, DOI 10.1073/pnas.1000925107; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; McMahan RH, 2006, J CLIN INVEST, V116, P2543, DOI 10.1172/JCI26936; Molloy PE, 2005, CURR OPIN PHARMACOL, V5, P438, DOI 10.1016/j.coph.2005.02.004; Naeher D, 2007, J EXP MED, V204, P2553, DOI 10.1084/jem.20070254; Nicholson LB, 1998, P NATL ACAD SCI USA, V95, P264, DOI 10.1073/pnas.95.1.264; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qi SY, 2006, P NATL ACAD SCI USA, V103, P4416, DOI 10.1073/pnas.0510991103; Robbins PF, 2008, J IMMUNOL, V180, P6116, DOI 10.4049/jimmunol.180.9.6116; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Rosette C, 2001, IMMUNITY, V15, P59, DOI 10.1016/S1074-7613(01)00173-X; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sami M, 2007, PROTEIN ENG DES SEL, V20, P397, DOI 10.1093/protein/gzm033; Schmid DA, 2010, J IMMUNOL, V184, P4936, DOI 10.4049/jimmunol.1000173; SMITH SD, 1984, CANCER RES, V44, P5657; Speiser DE, 2008, P NATL ACAD SCI USA, V105, P3849, DOI 10.1073/pnas.0800080105; Stone JD, 2009, IMMUNOLOGY, V126, P165, DOI 10.1111/j.1365-2567.2008.03015.x; Thomas S, 2011, BLOOD, V118, P319, DOI 10.1182/blood-2010-12-326736; Tian S, 2007, J IMMUNOL, V179, P2952, DOI 10.4049/jimmunol.179.5.2952; Udyavar A, 2009, J IMMUNOL, V182, P4439, DOI 10.4049/jimmunol.0804377; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Varela-Rohena A, 2008, NAT MED, V14, P1390, DOI 10.1038/nm.1779; Zhao Y, 2007, J IMMUNOL, V179, P5845, DOI 10.4049/jimmunol.179.9.5845; Zoete V, 2005, PROTEINS, V61, P79, DOI 10.1002/prot.20528; Zoete V, 2010, J MOL RECOGNIT, V23, P142, DOI 10.1002/jmr.1005; Zoete V, 2007, PROTEINS, V67, P1026, DOI 10.1002/prot.21395	54	86	88	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23068	23078		10.1074/jbc.M112.357673	http://dx.doi.org/10.1074/jbc.M112.357673			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22549784	Green Published, hybrid			2022-12-25	WOS:000306495000063
J	Xu, J; Kurup, P; Bartos, JA; Patriarchi, T; Hell, JW; Lombroso, PJ				Xu, Jian; Kurup, Pradeep; Bartos, Jason A.; Patriarchi, Tommaso; Hell, Johannes W.; Lombroso, Paul J.			Striatal-enriched Protein-tyrosine Phosphatase (STEP) Regulates Pyk2 Kinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; D-ASPARTATE RECEPTOR; NMDA RECEPTORS; HIPPOCAMPAL SLICES; CEREBRAL-ISCHEMIA; MOLECULAR CHARACTERIZATION; DIFFERENTIAL REGULATION; SIGNAL-TRANSDUCTION; RAT HIPPOCAMPUS; NERVOUS-SYSTEM	Proline-rich tyrosine kinase 2 (Pyk2) is a member of the focal adhesion kinase family and is highly expressed in brain and hematopoietic cells. Pyk2 plays diverse functions in cells, including the regulation of cell adhesion, migration, and cytoskeletal reorganization. In the brain, it is involved in the induction of long term potentiation through regulation of N-methyl-D-aspartate receptor trafficking. This occurs through the phosphorylation and activation of Src family tyrosine kinase members, such as Fyn, that phosphorylate GluN2B at Tyr(1472). Phosphorylation at this site leads to exocytosis of GluN1-GluN2B receptors to synaptic membranes. Pyk2 activity is modulated by phosphorylation at several critical tyrosine sites, including Tyr(402). In this study, we report that Pyk2 is a substrate of striatal-enriched protein-tyrosine phosphatase (STEP). STEP binds to and dephosphorylates Pyk2 at Tyr(402). STEP KO mice showed enhanced phosphorylation of Pyk2 at Tyr(402) and of the Pyk2 substrates paxillin and ASAP1. Functional studies indicated that STEP opposes Pyk2 activation after KCl depolarization of cortical slices and blocks Pyk2 translocation to postsynaptic densities, a key step required for Pyk2 activation and function. This is the first study to identify Pyk2 as a substrate for STEP.	[Xu, Jian; Kurup, Pradeep; Hell, Johannes W.; Lombroso, Paul J.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06520 USA; [Lombroso, Paul J.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; [Lombroso, Paul J.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; [Bartos, Jason A.; Patriarchi, Tommaso; Hell, Johannes W.] Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA; [Hell, Johannes W.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95615 USA	Yale University; Yale University; Yale University; University of Iowa; University of California System; University of California Davis	Xu, J (corresponding author), Yale Univ, Sch Med, Ctr Child Study, 230 S Frontage Rd,SHMI 269, New Haven, CT 06519 USA.	jian.xu@yale.edu; jwhell@ucdavis.edu	Hell, Johannes W./P-5085-2019; Patriarchi, Tommaso/AAK-8653-2020; Kurup, Pradeep/F-1291-2010; XU, JIAN/E-6915-2010	Patriarchi, Tommaso/0000-0001-9351-3734; Bartos, Jason/0000-0003-0113-5305	National Institutes of Health [MH052711, MH091037, AG017502]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052711, R01MH091037, R29MH052711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG017502, R01AG017502] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants MH052711 and MH091037 (to P. J. L.) and AG017502 (to J. W. H.).	ADACHI M, 1992, BIOCHEM BIOPH RES CO, V186, P1607, DOI 10.1016/S0006-291X(05)81592-X; Andreev J, 1999, MOL CELL BIOL, V19, P2338; Andreev J, 2001, J BIOL CHEM, V276, P20130, DOI 10.1074/jbc.M102307200; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Bartos JA, 2010, J NEUROSCI, V30, P449, DOI 10.1523/JNEUROSCI.4992-08.2010; Baum Matthew L, 2010, Commun Integr Biol, V3, P419, DOI 10.4161/cib.3.5.12692; Blaukat A, 1999, J BIOL CHEM, V274, P14893, DOI 10.1074/jbc.274.21.14893; BOULANGER LM, 1995, J NEUROSCI, V15, P1532; Braithwaite SP, 2006, TRENDS NEUROSCI, V29, P452, DOI 10.1016/j.tins.2006.06.007; Collins M, 2010, J LEUKOCYTE BIOL, V87, P691, DOI 10.1189/jlb.0409227; Corvol JC, 2005, J BIOL CHEM, V280, P660, DOI 10.1074/jbc.M411312200; Davidson D, 2001, EMBO J, V20, P3414, DOI 10.1093/emboj/20.13.3414; Derkinderen P, 1998, EUR J NEUROSCI, V10, P1667, DOI 10.1046/j.1460-9568.1998.00174.x; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Du QS, 2001, J CELL SCI, V114, P2977; Dunah AW, 2004, MOL PHARMACOL, V65, P121, DOI 10.1124/mol.65.1.121; Eminaga S, 2008, J BIOL CHEM, V283, P15328, DOI 10.1074/jbc.M801382200; Gingrich JR, 2004, P NATL ACAD SCI USA, V101, P6237, DOI 10.1073/pnas.0401413101; Girault JA, 1999, TRENDS NEUROSCI, V22, P257, DOI 10.1016/S0166-2236(98)01358-7; Goebel-Goody SM, 2009, NEUROSCIENCE, V158, P1446, DOI 10.1016/j.neuroscience.2008.11.006; Guo J, 2004, NEUROSCI LETT, V355, P177, DOI 10.1016/j.neulet.2003.10.076; Haglund K, 2004, J CELL SCI, V117, P2557, DOI 10.1242/jcs.01148; Halfter UM, 2005, BIOCHEM J, V388, P17, DOI 10.1042/BJ20041236; Hallett PJ, 2006, J NEUROSCI, V26, P4690, DOI 10.1523/JNEUROSCI.0792-06.2006; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; Huang YQ, 2001, NEURON, V29, P485, DOI 10.1016/S0896-6273(01)00220-3; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kruljac-Letunic A, 2003, J BIOL CHEM, V278, P29560, DOI 10.1074/jbc.M302278200; Kumar S, 1999, J BIOL CHEM, V274, P30657, DOI 10.1074/jbc.274.43.30657; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Lim IA, 2002, J BIOL CHEM, V277, P21697, DOI 10.1074/jbc.M112339200; Liu Y, 2001, BRAIN RES, V909, P51, DOI 10.1016/S0006-8993(01)02619-1; LOMBROSO PJ, 1991, P NATL ACAD SCI USA, V88, P7242, DOI 10.1073/pnas.88.16.7242; Lu WY, 2000, J NEUROSCI, V20, P4452, DOI 10.1523/JNEUROSCI.20-12-04452.2000; Lyons PD, 2001, J BIOL CHEM, V276, P24422, DOI 10.1074/jbc.M011080200; Ma J, 2004, NEUROSCI RES, V49, P357, DOI 10.1016/j.neures.2004.04.004; Menegon A, 1999, EUR J NEUROSCI, V11, P3777, DOI 10.1046/j.1460-9568.1999.00798.x; Munoz JJ, 2003, BIOCHEM J, V372, P193, DOI 10.1042/BJ20021941; Nguyen TH, 2002, J BIOL CHEM, V277, P24274, DOI 10.1074/jbc.M111683200; Nishi A, 1999, J NEUROCHEM, V72, P2015, DOI 10.1046/j.1471-4159.1999.0722015.x; Ostergaard HL, 1998, J BIOL CHEM, V273, P5692, DOI 10.1074/jbc.273.10.5692; OYAMA T, 1995, NEUROSCIENCE, V69, P869, DOI 10.1016/0306-4522(95)00278-Q; Park SY, 2004, J BIOL CHEM, V279, P33315, DOI 10.1074/jbc.M313527200; Paul S, 2003, NAT NEUROSCI, V6, P34, DOI 10.1038/nn989; Paul S, 2000, J NEUROSCI, V20, P5630, DOI 10.1523/JNEUROSCI.20-15-05630.2000; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; Qian DP, 1997, J EXP MED, V185, P1253, DOI 10.1084/jem.185.7.1253; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Sabri A, 1998, CIRC RES, V83, P841, DOI 10.1161/01.RES.83.8.841; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; Schaller Michael D, 2008, Biochem J, V410, pe3, DOI 10.1042/BJ20080133; Schauwienold D, 2008, J BIOL CHEM, V283, P27748, DOI 10.1074/jbc.M801431200; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2; Seabold GK, 2003, J BIOL CHEM, V278, P15040, DOI 10.1074/jbc.M212825200; SHIOZUKA K, 1995, GENE, V162, P279, DOI 10.1016/0378-1119(95)00306-Q; Siciliano JC, 1996, J BIOL CHEM, V271, P28942, DOI 10.1074/jbc.271.46.28942; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Venkitaramani DV, 2009, SYNAPSE, V63, P69, DOI 10.1002/syn.20608; Villasana LE, 2006, J NEUROSCI METH, V158, P30, DOI 10.1016/j.jneumeth.2006.05.008; Xu J, 2009, J NEUROSCI, V29, P9330, DOI 10.1523/JNEUROSCI.2212-09.2009; Zhang Y, 2008, J NEUROSCI, V28, P10561, DOI 10.1523/JNEUROSCI.2666-08.2008; Zhang YF, 2010, P NATL ACAD SCI USA, V107, P19014, DOI 10.1073/pnas.1013543107	67	60	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20942	20956		10.1074/jbc.M112.368654	http://dx.doi.org/10.1074/jbc.M112.368654			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22544749	hybrid, Green Published			2022-12-25	WOS:000306416800016
J	Zhang, J; Ying, ZZ; Tang, ZL; Long, LQ; Li, K				Zhang, Jing; Ying, Zheng-zhou; Tang, Zhong-lin; Long, Liang-qi; Li, Kui			MicroRNA-148a Promotes Myogenic Differentiation by Targeting the ROCK1 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; BINDING PROTEIN RHO; MYOBLAST DIFFERENTIATION; C2C12 MYOBLASTS; OBLIGATORY ROLE; DOWN-REGULATION; CELL-CYCLE; EXPRESSION; KINASE; MIR-148A	MicroRNAs are evolutionarily conserved small RNAs that post-transcriptionally regulate gene expression and have emerged as critical regulators of skeletal muscle development. Here, we identified miR-148a as a novel myogenic microRNA that mediated myogenic differentiation. The expression levels of miR-148a increased during C2C12 myoblast differentiation. Overexpression of miR-148a significantly promoted myogenic differentiation of both C2C12 myoblast and primary muscle cells. Blocking the function of miR-148a with a 2'-O-methylated antisense oligonucleotide inhibitor repressed C2C12 myoblast differentiation. Using a bioinformatics approach, we identified Rho-associated coiled-coil containing protein kinase 1 (ROCK1), a known inhibitor of myogenesis, as a target of miR-148a. A dual-luciferase reporter assay was used to demonstrate that miR-148a directly targeted the 3'-UTR of ROCK1. In addition, the overexpression of miR-148a decreased the protein expression of ROCK1 in C2C12 myoblast and primary muscle cells. Furthermore, ROCK1 inhibition with specific siRNA leaded to accelerated myogenic differentiation progression, underscoring a negative regulatory function of ROCK1 in myogenesis. Therefore, our results revealed a novel mechanism in which miR-148a positively regulates myogenic differentiation via ROCK1 down-regulation.	[Tang, Zhong-lin] Chinese Acad Agr Sci, Dept Gene & Cell Engn, State Key Lab Anim Nutr,Minist Agr China,Inst Ani, IAS,Key Lab Domest Anim Genet Resources & Breedin, Beijing 100193, Peoples R China; [Zhang, Jing; Long, Liang-qi] Huazhong Agr Univ, Sch Anim Vet Med, Wuhan 430070, Peoples R China	Chinese Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University	Tang, ZL (corresponding author), Chinese Acad Agr Sci, Dept Gene & Cell Engn, State Key Lab Anim Nutr,Minist Agr China,Inst Ani, IAS,Key Lab Domest Anim Genet Resources & Breedin, Beijing 100193, Peoples R China.	zhonglinqy_99@sina.com; wulong491024@mail.hzau.edu.cn	Ying, ZZ/ABF-7816-2021	Tang, Zhonglin/0000-0002-4538-4349	National Natural Science Foundation of China [30830080, 31171192]; National Basic Research Program of China [2009CB941604]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (No. 30830080, No. 31171192) and National Basic Research Program of China (No. 2009CB941604).	Beqaj S, 2002, J CELL BIOL, V156, P893, DOI 10.1083/jcb.200107049; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bois PRJ, 2003, EMBO J, V22, P1147, DOI 10.1093/emboj/cdg116; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Callis TE, 2007, DNA CELL BIOL, V26, P219, DOI 10.1089/dna.2006.0556; Cardinali B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007607; Castellani L, 2006, J BIOL CHEM, V281, P15249, DOI 10.1074/jbc.M601390200; Charrasse S, 2002, J CELL BIOL, V158, P953, DOI 10.1083/jcb.200202034; Charrasse S, 2006, MOL BIOL CELL, V17, P749, DOI 10.1091/mbc.E05-04-0284; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen Y, 2010, J GASTROINTEST SURG, V14, P1170, DOI 10.1007/s11605-010-1202-2; Cloutier M, 2010, PEDIATR PULM, V45, P966, DOI 10.1002/ppul.21266; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Fujita Y, 2010, J BIOL CHEM, V285, P19076, DOI 10.1074/jbc.M109.079525; Gagan J, 2011, J BIOL CHEM, V286, P19431, DOI 10.1074/jbc.M111.219006; Gerlach D, 2009, NUCLEIC ACIDS RES, V37, pD111, DOI 10.1093/nar/gkn707; Guo SL, 2011, INT J BIOL SCI, V7, P567, DOI 10.7150/ijbs.7.567; Hummel R, 2011, J GASTROINTEST SURG, V15, P429, DOI 10.1007/s11605-011-1418-9; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Iwasaki K, 2008, J BIOL CHEM, V283, P21230, DOI 10.1074/jbc.M710525200; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Lim MJ, 2007, MOL ENDOCRINOL, V21, P2282, DOI 10.1210/me.2007-0114; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Meriane M, 2000, MOL BIOL CELL, V11, P2513, DOI 10.1091/mbc.11.8.2513; Merlie J P, 1977, Curr Top Dev Biol, V11, P61, DOI 10.1016/S0070-2153(08)60743-7; Murata T, 2010, PROSTATE CANCER P D, V13, P356, DOI 10.1038/pcan.2010.32; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Nishiyama T, 2004, J BIOL CHEM, V279, P47311, DOI 10.1074/jbc.M403546200; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; Pelosi M, 2007, MOL CELL BIOL, V27, P6163, DOI 10.1128/MCB.01735-06; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Sarkar S, 2010, MOL BIOL CELL, V21, P2138, DOI 10.1091/mbc.E10-01-0062; Shu LL, 2009, MOL CELL BIOL, V29, P4691, DOI 10.1128/MCB.00764-09; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Takagi S, 2008, J BIOL CHEM, V283, P9674, DOI 10.1074/jbc.M709382200; Takano H, 1998, MOL CELL BIOL, V18, P1580, DOI 10.1128/MCB.18.3.1580; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wei L, 2001, DEVELOPMENT, V128, P2953; Wei L, 2000, AM J PHYSIOL-HEART C, V278, pH1736, DOI 10.1152/ajpheart.2000.278.6.H1736; Wei L, 1998, J BIOL CHEM, V273, P30287, DOI 10.1074/jbc.273.46.30287; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	58	105	120	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21093	21101		10.1074/jbc.M111.330381	http://dx.doi.org/10.1074/jbc.M111.330381			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22547064	Green Published, hybrid			2022-12-25	WOS:000306416800030
J	Almeida, SCP; de Oliveira, VL; Ventura, S; Bofill, M; Parkhouse, RME				Paiva Almeida, Silvia Cristina; de Oliveira, Vivian Leite; Ventura, Sonia; Bofill, Margarita; Evans Parkhouse, Robert Michael			Neoplastic Transformation of T Lymphocytes through Transgenic Expression of a Virus Host Modification Protein	PLOS ONE			English	Article							NF-KAPPA-B; CELLULAR PHOSPHATASE CALCINEURIN; NUCLEAR-FACTOR; TRANSCRIPTIONAL COACTIVATORS; TARGETED DISRUPTION; IMMUNE-RESPONSES; MICE LACKING; CELLS; EVASION; P300	Virus host evasion genes are ready-made tools for gene manipulation and therapy. In this work we have assessed the impact in vivo of the evasion gene A238L of the African Swine Fever Virus, a gene which inhibits transcription mediated by both NF-kappa B and NFAT. The A238L gene has been selectively expressed in mouse T lymphocytes using tissue specific promoter, enhancer and locus control region sequences for CD2. The resulting two independently derived transgenic mice expressed the transgene and developed a metastasic, angiogenic and transplantable CD4(+)CD8(+)CD69(-) lymphoma. The CD4(+)CD8(+)CD69(-) cells also grew vigorously in vitro. The absence of CD69 from the tumour cells suggests that they were derived from T cells at a stage prior to positive selection. In contrast, transgenic mice similarly expressing a mutant A238L, solely inhibiting transcription mediated by NF-kappa B, were indistinguishable from wild type mice. Expression of Rag1, Rag2, TCR beta-V8.2, CD25, FoxP3, Bcl3, Bcl2 l14, Myc, IL-2, NFAT1 and Itk, by purified CD4(+)CD8(+)CD69(-) thymocytes from A238L transgenic mice was consistent with the phenotype. Similarly evaluated expression profiles of CD4(+)CD8(+)CD69(-) thymocytes from the mutant A238L transgenic mice were comparable to those of wild type mice. These features, together with the demonstration of (mono-) oligoclonality, suggest a transgene-NFAT-dependent transformation yielding a lymphoma with a phenotype reminiscent of some acute lymphoblastic lymphomas.	[Paiva Almeida, Silvia Cristina; de Oliveira, Vivian Leite; Ventura, Sonia; Evans Parkhouse, Robert Michael] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Bofill, Margarita] IrsiCaixa, Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Instituto Gulbenkian de Ciencia; ICREA; Institut de Recerca de la Sida - IrsiCaixa	Almeida, SCP (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal.	scpalmeida@gmail.com; parkhous@igc.gulbenkian.pt	de Oliveira, Vivian Leite/AAJ-9491-2020; Almeida, Sílvia C.P./L-3171-2014; de Paiva e Almeida, Silvia Cristina/F-2547-2011	de Oliveira, Vivian Leite/0000-0003-2523-0374; Almeida, Sílvia C.P./0000-0002-2400-6090; de Paiva e Almeida, Silvia Cristina/0000-0002-2400-6090; Parkhouse, Michael/0000-0001-5967-3291	Fundacao para a Ciencia e Tecnologia; Ministerio da Ciencia e Ensino Superior [SFRH/BD/882/2000, POCTI/2000/MGI/36403]; Wellcome Trust [WT075813MA]; ICREA Funding Source: Custom	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Ministerio da Ciencia e Ensino Superior; Wellcome Trust(Wellcome TrustEuropean Commission); ICREA(ICREA)	This work was supported by Fundacao para a Ciencia e Tecnologia, Ministerio da Ciencia e Ensino Superior (SFRH/BD/882/2000; POCTI/2000/MGI/36403) and the Wellcome Trust project WT075813MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bonjardim CA, 2009, IMMUNOL LETT, V122, P1, DOI 10.1016/j.imlet.2008.11.002; Bopp T, 2005, J EXP MED, V201, P181, DOI 10.1084/jem.20041538; BORN W, 1985, P NATL ACAD SCI USA, V82, P2925, DOI 10.1073/pnas.82.9.2925; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P9398, DOI 10.1073/pnas.152665399; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Chang PY, 2006, CANCER RES, V66, P6008, DOI 10.1158/0008-5472.CAN-06-0194; Esslinger CW, 1997, J IMMUNOL, V158, P5075; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Garcia-Rodriguez C, 1998, J EXP MED, V187, P2031, DOI 10.1084/jem.187.12.2031; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Glud SZ, 2005, BLOOD, V106, P3546, DOI 10.1182/blood-2005-02-0493; Granja AG, 2006, J IMMUNOL, V176, P451, DOI 10.4049/jimmunol.176.1.451; Granja AG, 2004, J BIOL CHEM, V279, P53736, DOI 10.1074/jbc.M406620200; Granja AG, J VIROLOGY, V83, P969; Granja AG, 2008, J IMMUNOL, V180, P2429, DOI 10.4049/jimmunol.180.4.2429; Granja AG, 2006, J VIROL, V80, P10487, DOI 10.1128/JVI.00862-06; Guo B, 2001, J BIOL CHEM, V276, P2780, DOI 10.1074/jbc.M005889200; Jonjic S, 2008, CURR OPIN IMMUNOL, V20, P30, DOI 10.1016/j.coi.2007.11.002; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; LEONARDI E, 1992, J CLIN PATHOL, V45, P416, DOI 10.1136/jcp.45.5.416; Loo YM, 2007, CURR TOP MICROBIOL, V316, P295; Luo N, 2009, CLIN IMMUNOL, V132, P349, DOI 10.1016/j.clim.2009.05.010; Medyouf H, 2007, NAT MED, V13, P736, DOI 10.1038/nm1588; Miskin JE, 2000, J VIROL, V74, P9412, DOI 10.1128/JVI.74.20.9412-9420.2000; Miskin JE, 1998, SCIENCE, V281, P562, DOI 10.1126/science.281.5376.562; Ohno H, 2005, INT J HEMATOL, V82, P397, DOI 10.1532/IJH97.05045; Oukka M, 1998, IMMUNITY, V9, P295, DOI 10.1016/S1074-7613(00)80612-3; PALMER MS, 1989, NUCLEIC ACIDS RES, V17, P2353, DOI 10.1093/nar/17.6.2353; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Powell PP, 1996, J VIROL, V70, P8527, DOI 10.1128/JVI.70.12.8527-8533.1996; Readinger JA, 2009, IMMUNOL REV, V228, P93, DOI 10.1111/j.1600-065X.2008.00757.x; Revilla Y, 1998, J BIOL CHEM, V273, P5405, DOI 10.1074/jbc.273.9.5405; Revilla Y, 2009, CRIT REV IMMUNOL, V29, P131, DOI 10.1615/CritRevImmunol.v29.i2.30; Rudensky AY, 2006, IMMUNOL REV, V241, P260; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; SPANOPOULOU E, 1989, NATURE, V342, P185, DOI 10.1038/342185a0; Tait SW, 2005, J BIOL CHEM, V275, P34656; Unterholzner L, 2008, BIOCHEM PHARMACOL, V75, P589, DOI 10.1016/j.bcp.2007.07.043; Vischer HF, 2006, CURR TOP MICROBIOL, V303, P121, DOI 10.1007/978-3-540-33397-5_6; Wang CG, 2011, CANCER BIOL THER, V11, P615, DOI 10.4161/cbt.11.7.14688; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; WULCZYN FG, 1992, NATURE, V358, P597, DOI 10.1038/358597a0; Zhou F, 2009, INT REV IMMUNOL, V28, P376, DOI 10.1080/08830180903013034; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	46	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e34140	10.1371/journal.pone.0034140	http://dx.doi.org/10.1371/journal.pone.0034140			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558084	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000010
J	Eriksson, ME; Terfelt, F				Eriksson, Mats E.; Terfelt, Fredrik			Exceptionally Preserved Cambrian Trilobite Digestive System Revealed in 3D by Synchrotron-Radiation X-Ray Tomographic Microscopy	PLOS ONE			English	Article							CRUSTACEA; ANATOMY; ORIGIN; LARVAE	The Cambrian 'Orsten' fauna comprises exceptionally preserved and phosphatised microscopic arthropods. The external morphology of these fossils is well known, but their internal soft-tissue anatomy has remained virtually unknown. Here, we report the first non-biomineralised tissues from a juvenile polymerid trilobite, represented by digestive structures, glands, and connective strands harboured in a hypostome from the Swedish 'Orsten' fauna. Synchrotron-radiation X-ray tomographic microscopy enabled three-dimensional internal recordings at sub-micrometre resolution. The specimen provides the first unambiguous evidence for a J-shaped anterior gut and the presence of a crop with a constricted alimentary tract in the Trilobita. Moreover, the gut is Y-shaped in cross section, probably due to a collapsed lumen of that shape, another feature which has not previously been observed in trilobites. The combination of anatomical features suggests that the trilobite hypostome is functionally analogous to the labrum of euarthropods and that it was a sophisticated element closely integrated with the digestive system. This study also briefly addresses the preservational bias of the 'Orsten' fauna, particularly the near-absence of polymerid trilobites, and the taphonomy of the soft-tissue-harbouring hypostome.	[Eriksson, Mats E.; Terfelt, Fredrik] Lund Univ, Dept Geol, Lund, Sweden	Lund University	Eriksson, ME (corresponding author), Lund Univ, Dept Geol, Lund, Sweden.	fredrik.terfelt@geol.lu.se			Swedish Research Council; Royal Physiographic Society, Lund; Faculty of Science, Lund University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Physiographic Society, Lund; Faculty of Science, Lund University	The Swedish Research Council, the Royal Physiographic Society, Lund, and the Faculty of Science, Lund University, funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwmark C, 2011, METEORIT PLANET SCI, V46, P1071, DOI 10.1111/j.1945-5100.2011.01214.x; BITSCH J, 1994, ANN SOC ENTOMOL FR, V30, P103; Butterfield NJ, 2002, PALEOBIOLOGY, V28, P155, DOI 10.1666/0094-8373(2002)028<0155:LGATIO>2.0.CO;2; CHATTERTON BDE, 1994, J PALEONTOL, V68, P294, DOI 10.1017/S0022336000022897; CHATTERTON BDE, 1990, J PALEONTOL, V64, P255, DOI 10.1017/S0022336000018424; Chatterton Brian D.E., 1997, P173; CISNE J L, 1975, Fossils and Strata, V4, P45; Cisne J. L., 1981, PALAEONTOGRAPHICA AM, V9, P95; CISNE JL, 1974, SCIENCE, V186, P13, DOI 10.1126/science.186.4158.13; Dewel RA, 1999, ZOOL ANZ, V238, P191; ELDREDGE N, 1971, Journal of Paleontology, V45, P52; ELOFSSON R, 1992, J CRUSTACEAN BIOL, V12, P571, DOI 10.2307/1548838; Felgenhauer Bruce E., 1999, P223; Fortey RA, 1999, PALAEONTOLOGY, V42, P429, DOI 10.1111/1475-4983.00080; Henningsmoen G., 1957, MATEMATISK NATURVIDE, V1, P1; HerreraAlvarez L, 1996, J MORPHOL, V230, P199, DOI 10.1002/(SICI)1097-4687(199611)230:2<199::AID-JMOR7>3.0.CO;2-C; ICELY JD, 1984, PHILOS T ROY SOC B, V306, P49, DOI 10.1098/rstb.1984.0081; Jeppsson L, 1999, J PALEONTOL, V73, P964, DOI 10.1017/S0022336000040798; Lerosey-Aubril R, 2006, GEOL MAG, V143, P89, DOI 10.1017/S0016756805001421; Lerosey-Aubril R, 2005, J PALEONTOL, V79, P702, DOI 10.1666/0022-3360(2005)079[0702:FCPLT]2.0.CO;2; Lerosey-Aubril R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032934; Lerosey-Aubril R, 2011, LETHAIA, V44, P166, DOI 10.1111/j.1502-3931.2010.00233.x; Maas Andreas, 2003, Fossils and Strata, V49, P1; Maas Andreas, 2006, Palaeoworld, V15, P266, DOI 10.1016/j.palwor.2006.10.005; Maeda H, 2011, PALAIOS, V26, P225, DOI 10.2110/palo.2010.p10-042r; Marone F, 2010, PROC SPIE, V7804, DOI 10.1117/12.859703; MULLER KJ, 1979, LETHAIA, V12, P1, DOI 10.1111/j.1502-3931.1979.tb01234.x; Olesen J, 2005, J MORPHOL, V264, P131, DOI 10.1002/jmor.10202; Richter R., 1923, PALAEONTOLOGIA HUNGA, V1, P77; Robison Richard A., 2011, Paleontological Contributions, P1; SCHMITZ EH, 1967, AM MIDL NAT, V78, P1, DOI 10.2307/2423369; Speyer S.E., 1989, Historical Biology, V3, P27; Stampanoni M, 2006, PROC SPIE, V6318, DOI 10.1117/12.679497; Terfelt F, 2011, LETHAIA, V44, P8, DOI 10.1111/j.1502-3931.2009.00211.x; WALOSSEK D, 1992, ACTA ZOOL-STOCKHOLM, V73, P305, DOI 10.1111/j.1463-6395.1992.tb01096.x; Walossek D, 1987, FOSSILS STRATA, V19, P1; Waloszek Dieter, 2003, Paleontological Research, V7, P71, DOI 10.2517/prpsj.7.71	37	16	20	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35625	10.1371/journal.pone.0035625	http://dx.doi.org/10.1371/journal.pone.0035625			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558180	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345200055
J	Fang, D; Pan, C; Lin, HJ; Lin, Y; Xu, GR; Zhang, GY; Wang, HZ; Xie, LP; Zhang, RQ				Fang, Dong; Pan, Cong; Lin, Huijuan; Lin, Ya; Xu, Guangrui; Zhang, Guiyou; Wang, Hongzhong; Xie, Liping; Zhang, Rongqing			Ubiquitylation Functions in the Calcium Carbonate Biomineralization in the Extracellular Matrix	PLOS ONE			English	Article							OYSTER-PINCTADA-FUCATA; PRISMATIC LAYER FORMATION; PEARL OYSTER; PROTEIN FAMILY; MECHANICAL CHARACTERIZATION; FRAMEWORK FORMATION; SHELL PROTEINS; NACREOUS LAYER; CORTICAL BONE; DUAL ROLE	Mollusks shell formation is mediated by matrix proteins and many of these proteins have been identified and characterized. However, the mechanisms of protein control remain unknown. Here, we report the ubiquitylation of matrix proteins in the prismatic layer of the pearl oyster, Pinctada fucata. The presence of ubiquitylated proteins in the prismatic layer of the shell was detected with a combination of western blot and immunogold assays. The coupled ubiquitins were separated and identified by Edman degradation and liquid chromatography/mass spectrometry (LC/MS). Antibody injection in vivo resulted in large amounts of calcium carbonate randomly accumulating on the surface of the nacreous layer. These ubiquitylated proteins could bind to specific faces of calcite and aragonite, which are the two main mineral components of the shell. In the in vitro calcium carbonate crystallization assay, they could reduce the rate of calcium carbonate precipitation and induce the calcite formation. Furthermore, when the attached ubiquitins were removed, the functions of the EDTA-soluble matrix of the prismatic layer were changed. Their potency to inhibit precipitation of calcium carbonate was decreased and their influence on the morphology of calcium carbonate crystals was changed. Taken together, ubiquitylation is involved in shell formation. Although the ubiquitylation is supposed to be involved in every aspect of biophysical processes, our work connected the biomineralization-related proteins and the ubiquitylation mechanism in the extracellular matrix for the first time. This would promote our understanding of the shell biomineralization and the ubiquitylation processes.	[Fang, Dong; Pan, Cong; Lin, Huijuan; Lin, Ya; Xu, Guangrui; Zhang, Guiyou; Wang, Hongzhong; Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Sch Life Sci, Inst Marine Biotechnol, Beijing 100084, Peoples R China; [Zhang, Guiyou; Wang, Hongzhong; Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Prot Sci Lab, Minist Educ, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Fang, D (corresponding author), Tsinghua Univ, Sch Life Sci, Inst Marine Biotechnol, Beijing 100084, Peoples R China.	lpxie@mail.tsinghua.edu.cn; rqzhang@mail.tsinghua.edu.cn			National Basic Research Program of China [2010CB126405]; National High Technology Research and Development Program of China [2010AA09Z405]; National Natural Science Foundation of China [31172382, 21176138, 40876068, 30871911, U0831001]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20090002110055]; Independent Research Projects of Tsinghua University [20111080964]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Independent Research Projects of Tsinghua University	This work was supported by the National Basic Research Program of China 2010CB126405, the National High Technology Research and Development Program of China 2010AA09Z405, National Natural Science Foundation of China Grants 31172382, 21176138, 40876068, 30871911, U0831001 (Joint Fund with Guangdong), the Specialized Research Fund for the Doctoral Program of Higher Education of China 20090002110055, and the Independent Research Projects of Tsinghua University 20111080964. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDADI L, 1992, ANGEW CHEM INT EDIT, V31, P153, DOI 10.1002/anie.199201531; Barthelat F, 2007, J MECH PHYS SOLIDS, V55, P306, DOI 10.1016/j.jmps.2006.07.007; Bedouet L, 2007, MAR BIOTECHNOL, V9, P638, DOI 10.1007/s10126-007-9017-1; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Chan K, 2005, J MATER RES, V20, P1097; Chan XY, 2011, DEV BIOL, V349, P102, DOI 10.1016/j.ydbio.2010.10.001; Clark MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-362; CLEGG WJ, 1990, NATURE, V347, P455, DOI 10.1038/347455a0; Contri MB, 1996, AM J PATHOL, V148, P569; CURREY JD, 1974, CALC TISS RES, V15, P173, DOI 10.1007/BF02059054; CURREY JD, 1976, J ZOOL, V180, P445; Davis JB, 2000, J EUR CERAM SOC, V20, P583, DOI 10.1016/S0955-2219(99)00256-3; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P306, DOI 10.1038/nrm2685; DiMasi E, 2004, J MATER RES, V19, P1471, DOI 10.1557/JMR.2004.0196; Dunlop JWC, 2010, ANNU REV MATER RES, V40, P1, DOI 10.1146/annurev-matsci-070909-104421; Evans AG, 1997, ACTA MATER, V45, P23, DOI 10.1016/S1359-6454(96)00143-7; EVANS AG, 1994, J MATER SCI, V29, P3857, DOI 10.1007/BF00355946; Feng QL, 1999, J MATER SCI LETT, V18, P1547, DOI 10.1023/A:1006687627323; Fondrk MT, 1999, J BIOMECH ENG-T ASME, V121, P616, DOI 10.1115/1.2800862; Ghosh P, 2007, BIOMACROMOLECULES, V8, P851, DOI 10.1021/bm060942h; Green DJ, 1999, SCIENCE, V283, P1295, DOI 10.1126/science.283.5406.1295; Hazelaar S, 2003, BIOMOL ENG, V20, P163, DOI 10.1016/S1389-0344(03)00044-3; HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311; Inoue H, 2004, BIOCHEM BIOPH RES CO, V318, P649, DOI 10.1016/j.bbrc.2004.04.075; JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056; Kasapi MA, 1997, J EXP BIOL, V200, P1639; Kong YW, 2009, J BIOL CHEM, V284, P10841, DOI 10.1074/jbc.M808357200; Leu JH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-120; Levi CG, 1998, J AM CERAM SOC, V81, P2077; Li XD, 2004, NANO LETT, V4, P613, DOI 10.1021/nl049962k; Li XD, 2007, JOM-US, V59, P71, DOI 10.1007/s11837-007-0043-2; LOWENSTAM HA, 1981, SCIENCE, V211, P1126, DOI 10.1126/science.7008198; Ma ZJ, 2007, J BIOL CHEM, V282, P23253, DOI 10.1074/jbc.M700001200; Marin F, 2005, J BIOL CHEM, V280, P33895, DOI 10.1074/jbc.M506526200; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Marshall DB, 2008, ANNU REV MATER RES, V38, P425, DOI 10.1146/annurev.matsci.38.060407.130214; Mayer G, 2002, EXP MECH, V42, P395, DOI 10.1007/BF02412144; MCMEEKING RM, 1982, J AM CERAM SOC, V65, P242, DOI 10.1111/j.1151-2916.1982.tb10426.x; McNulty JC, 1999, J AM CERAM SOC, V82, P1217, DOI 10.1111/j.1151-2916.1999.tb01899.x; Menig R, 2000, ACTA MATER, V48, P2383, DOI 10.1016/S1359-6454(99)00443-7; Mercer C, 2006, ACTA BIOMATER, V2, P59, DOI 10.1016/j.actbio.2005.08.004; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Oaki K, 2005, ANGEW CHEM INT EDIT, V44, P6571, DOI 10.1002/anie.200500338; Patwardhan SV, 2011, CHEM COMMUN, V47, P7567, DOI 10.1039/c0cc05648k; Ramanathan R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017707; REILLY DT, 1975, J BIOMECH, V8, P393, DOI 10.1016/0021-9290(75)90075-5; Rousseau M, 2005, BIOMATERIALS, V26, P6254, DOI 10.1016/j.biomaterials.2005.03.028; ROWCLIFFE DJ, 1977, J MATER SCI, V12, P35, DOI 10.1007/BF00738469; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; Shechter A, 2008, P NATL ACAD SCI USA, V105, P7129, DOI 10.1073/pnas.0800193105; Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607; Song F, 2003, J MATER RES, V18, P1741, DOI 10.1557/JMR.2003.0239; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Sumitomo T, 2008, J MATER RES, V23, P1466, DOI 10.1557/JMR.2008.0184; Suzuki M, 2004, BIOCHEM J, V382, P205, DOI 10.1042/BJ20040319; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Takagi R, 2010, ZOOL SCI, V27, P416, DOI 10.2108/zsj.27.416; Takahashi T, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-240; Tsukamoto D, 2004, BIOCHEM BIOPH RES CO, V320, P1175, DOI 10.1016/j.bbrc.2004.06.072; Veis A., 1990, SCIENCE, V247, P1129; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang RZ, 2011, ANNU REV MATER RES, V41, P41, DOI 10.1146/annurev-matsci-062910-095806; Wang RZ, 1998, J BIOMECH, V31, P135, DOI 10.1016/S0021-9290(97)00131-0; WEINER S, 1986, CRC CR REV BIOCH MOL, V20, P365, DOI 10.3109/10409238609081998; Wilkinson KD, 2009, J CELL SCI, V122, P2325, DOI 10.1242/jcs.041046; Yano M, 2007, BIOCHEM BIOPH RES CO, V362, P158, DOI 10.1016/j.bbrc.2007.07.172; Yao N, 2009, J R SOC INTERFACE, V6, P367, DOI 10.1098/rsif.2008.0316; Zhang C, 2006, MAR BIOTECHNOL, V8, P624, DOI 10.1007/s10126-006-6037-1; Zhang C, 2006, BIOCHEM BIOPH RES CO, V344, P735, DOI 10.1016/j.bbrc.2006.03.179; Zhang Y, 2003, COMP BIOCHEM PHYS B, V135, P565, DOI 10.1016/S1096-4959(03)00138-6	70	10	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35715	10.1371/journal.pone.0035715	http://dx.doi.org/10.1371/journal.pone.0035715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558208	Green Submitted, gold, Green Published			2022-12-25	WOS:000305345200070
J	Oppert, B; Dowd, SE; Bouffard, P; Li, L; Conesa, A; Lorenzen, MD; Toutges, M; Marshall, J; Huestis, DL; Fabrick, J; Oppert, C; Jurat-Fuentes, JL				Oppert, Brenda; Dowd, Scot E.; Bouffard, Pascal; Li, Lewyn; Conesa, Ana; Lorenzen, Marce D.; Toutges, Michelle; Marshall, Jeremy; Huestis, Diana L.; Fabrick, Jeff; Oppert, Cris; Jurat-Fuentes, Juan Luis			Transcriptome Profiling of the Intoxication Response of Tenebrio molitor Larvae to Bacillus thuringiensis Cry3Aa Protoxin	PLOS ONE			English	Article							TRIBOLIUM-CASTANEUM; CHORISTONEURA-FUMIFERANA; CRYSTAL PROTEINS; DELTA-ENDOTOXIN; CRY1AB TOXIN; RECEPTOR; IDENTIFICATION; RESISTANCE; SEQUENCE; MIDGUT	Bacillus thuringiensis (Bt) crystal (Cry) proteins are effective against a select number of insect pests, but improvements are needed to increase efficacy and decrease time to mortality for coleopteran pests. To gain insight into the Bt intoxication process in Coleoptera, we performed RNA-Seq on cDNA generated from the guts of Tenebrio molitor larvae that consumed either a control diet or a diet containing Cry3Aa protoxin. Approximately 134,090 and 124,287 sequence reads from the control and Cry3Aa-treated groups were assembled into 1,318 and 1,140 contigs, respectively. Enrichment analyses indicated that functions associated with mitochondrial respiration, signalling, maintenance of cell structure, membrane integrity, protein recycling/synthesis, and glycosyl hydrolases were significantly increased in Cry3Aa-treated larvae, whereas functions associated with many metabolic processes were reduced, especially glycolysis, tricarboxylic acid cycle, and fatty acid synthesis. Microarray analysis was used to evaluate temporal changes in gene expression after 6, 12 or 24 h of Cry3Aa exposure. Overall, microarray analysis indicated that transcripts related to allergens, chitin-binding proteins, glycosyl hydrolases, and tubulins were induced, and those related to immunity and metabolism were repressed in Cry3Aa-intoxicated larvae. The 24 h microarray data validated most of the RNA-Seq data. Of the three intoxication intervals, larvae demonstrated more differential expression of transcripts after 12 h exposure to Cry3Aa. Gene expression examined by three different methods in control vs. Cry3Aa-treated larvae at the 24 h time point indicated that transcripts encoding proteins with chitin-binding domain 3 were the most differentially expressed in Cry3Aa-intoxicated larvae. Overall, the data suggest that T. molitor larvae mount a complex response to Cry3Aa during the initial 24 h of intoxication. Data from this study represent the largest genetic sequence dataset for T. molitor to date. Furthermore, the methods in this study are useful for comparative analyses in organisms lacking a sequenced genome.	[Oppert, Brenda; Toutges, Michelle] USDA ARS, Ctr Grain & Anim Hlth Res, Manhattan, KS USA; [Dowd, Scot E.] Mol Res LP, Shallowater, TX USA; [Bouffard, Pascal; Li, Lewyn] 454 Life Sci, Branford, CT USA; [Conesa, Ana] Ctr Invest Principe Felipe, Bioinformat & Genom Dept, Valencia, Spain; [Lorenzen, Marce D.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Marshall, Jeremy; Huestis, Diana L.] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA; [Fabrick, Jeff] USDA ARS, US Arid Land Agr Res Ctr, Maricopa, AZ USA; [Oppert, Cris; Jurat-Fuentes, Juan Luis] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA	United States Department of Agriculture (USDA); Prince Felipe Research Center; University of North Carolina; North Carolina State University; Kansas State University; United States Department of Agriculture (USDA); University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Oppert, B (corresponding author), USDA ARS, Ctr Grain & Anim Hlth Res, Manhattan, KS USA.	bso@ksu.edu	Cegarra, Ana V Conesa/A-9559-2014; Jurat-Fuentes, Juan Luis/A-5104-2014; Dowd, Scot E/M-5386-2017; moreno manzano, Victoria/B-4175-2014	Cegarra, Ana V Conesa/0000-0001-9597-311X; Jurat-Fuentes, Juan Luis/0000-0002-8945-1814; Dowd, Scot E/0000-0002-6296-1427; Lorenzen, Marce/0000-0003-2318-1388; Huestis, Diana/0000-0001-6649-4785; moreno manzano, Victoria/0000-0002-6035-9491; Fabrick, Jeffrey/0000-0002-3893-9545	USDA National Institute of Food and Agriculture [2008-39211-19577]	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	CO was supported by Biotechnology Risk Assessment Program Competitive Grant no. 2008-39211-19577 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altincicek B, 2008, DEV COMP IMMUNOL, V32, P585, DOI 10.1016/j.dci.2007.09.005; Annaert WG, 1997, J CELL BIOL, V139, P1397, DOI 10.1083/jcb.139.6.1397; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bellier A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000689; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Cancino-Rodezno A, 2010, INSECT BIOCHEM MOLEC, V40, P58, DOI 10.1016/j.ibmb.2009.12.010; CARROLL J, 1989, BIOCHEM J, V261, P99, DOI 10.1042/bj2610099; Chen CS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009494; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crickmore N, 2011, BACILLUS THURINGIENS; Cristofoletti PT, 2005, INSECT BIOCHEM MOLEC, V35, P883, DOI 10.1016/j.ibmb.2005.03.006; Rodriguez MD, 2007, MOL BIOCHEM PARASIT, V153, P167, DOI 10.1016/j.molbiopara.2007.03.002; Eriksson TLJ, 1999, INT ARCH ALLERGY IMM, V119, P275, DOI 10.1159/000024204; Fabrick J, 2009, J BIOL CHEM, V284, P18401, DOI 10.1074/jbc.M109.001651; Fischer HM, 2008, MOL BIOL EVOL, V25, P809, DOI 10.1093/molbev/msn014; Heckel DG, 2007, J INVERTEBR PATHOL, V95, P192, DOI 10.1016/j.jip.2007.03.008; Hernandez-Martinez P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012795; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Johannessen BR, 2005, FEBS LETT, V579, P1208, DOI 10.1016/j.febslet.2004.11.115; Jurat-Fuentes JL, 2004, EUR J BIOCHEM, V271, P3127, DOI 10.1111/j.1432-1033.2004.04238.x; Kao CY, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001314; Khajuria C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-286; Lee KH, 1998, BIOCHEM J, V334, P99, DOI 10.1042/bj3340099; Levashina EA, 2004, INSECT BIOCHEM MOLEC, V34, P673, DOI 10.1016/j.ibmb.2004.03.020; Meunier L, 2006, INSECT MOL BIOL, V15, P475, DOI 10.1111/j.1365-2583.2006.00659.x; MORGAN NS, 1995, DEV BIOL, V172, P51, DOI 10.1006/dbio.1995.0005; Morris K, 2009, J PROTEOME RES, V8, P3889, DOI 10.1021/pr900168z; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Nguyen M, 2000, MOL CELL BIOL, V20, P6731, DOI 10.1128/MCB.20.18.6731-6740.2000; Ochoa-Campuzano C, 2007, BIOCHEM BIOPH RES CO, V362, P437, DOI 10.1016/j.bbrc.2007.07.197; Oppert B, 2011, PEST MANAG SCI, V67, P568, DOI 10.1002/ps.2099; Paris M, 2011, J INVERTEBR PATHOL; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Prabhakar S, 2007, INSECT MOL BIOL, V16, P455, DOI 10.1111/j.1365-2583.2007.00740.x; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Sayed A, 2010, INSECT MOL BIOL, V19, P381, DOI 10.1111/j.1365-2583.2010.00998.x; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309; Sugarbaker DJ, 2008, P NATL ACAD SCI USA, V105, P3521, DOI 10.1073/pnas.0712399105; Tiewsiri K, 2011, P NATL ACAD SCI USA, V108, P14037, DOI 10.1073/pnas.1102555108; van Frankenhuyzen K, 2009, J INVERTEBR PATHOL, V101, P1, DOI 10.1016/j.jip.2009.02.009; van Munster M, 2007, INSECT MOL BIOL, V16, P25, DOI 10.1111/j.1365-2583.2006.00692.x; Vinokurov KS, 2006, COMP BIOCHEM PHYS B, V145, P126, DOI 10.1016/j.cbpb.2006.05.005; Weers PMM, 2006, INSECT BIOCHEM MOLEC, V36, P231, DOI 10.1016/j.ibmb.2006.01.001; Wu SJ, 1996, J MOL BIOL, V255, P628, DOI 10.1006/jmbi.1996.0052; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103; Zhao MY, 2005, J BIOL CHEM, V280, P24744, DOI 10.1074/jbc.M504173200; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177	55	44	47	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e34624	10.1371/journal.pone.0034624	http://dx.doi.org/10.1371/journal.pone.0034624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558093	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345200011
J	Song, P; Pimplikar, SW				Song, Ping; Pimplikar, Sanjay W.			Knockdown of Amyloid Precursor Protein in Zebrafish Causes Defects in Motor Axon Outgrowth	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; GENE-EXPRESSION; CYTOSKELETAL DYNAMICS; APP; NEURONS; BIOLOGY; ALPHA	Amyloid precursor protein (APP) plays a pivotal role in Alzheimer's disease (AD) pathogenesis, but its normal physiological functions are less clear. Combined deletion of the APP and APP-like protein 2 (APLP2) genes in mice results in post-natal lethality, suggesting that APP performs an essential, if redundant, function during embryogenesis. We previously showed that injection of antisense morpholino to reduce APP levels in zebrafish embryos caused convergent-extension defects. Here we report that a reduction in APP levels causes defective axonal outgrowth of facial branchiomotor and spinal motor neurons, which involves disorganized axonal cytoskeletal elements. The defective outgrowth is caused in a cell-autonomous manner and both extracellular and intracellular domains of human APP are required to rescue the defective phenotype. Interestingly, wild-type human APP rescues the defective phenotype but APPswe mutation, which causes familial AD, does not. Our results show that the zebrafish model provides a powerful system to delineate APP functions in vivo and to study the biological effects of APP mutations.	[Song, Ping; Pimplikar, Sanjay W.] Cleveland Clin, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Song, P (corresponding author), Cleveland Clin, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44106 USA.	pimplis@ccf.org			Cleveland Clinic	Cleveland Clinic	These studies were funded by funds from Cleveland Clinic and Anonymous Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; Barbagallo APM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018006; Barbagallo APM, 2011, J BIOL CHEM, V286, P8717, DOI 10.1074/jbc.C111.219873; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Boon KL, 2009, HUM MOL GENET, V18, P3615, DOI 10.1093/hmg/ddp310; Crews L, 2010, BRAIN STRUCT FUNCT, V214, P111, DOI 10.1007/s00429-009-0232-6; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; Gakhar-Koppole N, 2008, EUR J NEUROSCI, V28, P871, DOI 10.1111/j.1460-9568.2008.06398.x; Ghosal K, 2009, P NATL ACAD SCI USA, V106, P18367, DOI 10.1073/pnas.0907652106; Guo QX, 2012, CELL RES, V22, P78, DOI 10.1038/cr.2011.116; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Hornsten A, 2007, P NATL ACAD SCI USA, V104, P1971, DOI 10.1073/pnas.0603997104; Joshi P, 2009, DEV BIOL, V335, P1, DOI 10.1016/j.ydbio.2009.07.041; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; Li HM, 2010, P NATL ACAD SCI USA, V107, P17362, DOI 10.1073/pnas.1012568107; Muller T, 2008, PROG NEUROBIOL, V85, P393, DOI 10.1016/j.pneurobio.2008.05.002; Muller T, 2007, MOL BIOL CELL, V18, P201, DOI 10.1091/mbc.E06-04-0283; Musa A, 2001, DEV GENES EVOL, V211, P563, DOI 10.1007/s00427-001-0189-9; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Nornes S, 2009, EXP CELL RES, V315, P2791, DOI 10.1016/j.yexcr.2009.06.023; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Russo C, 2005, BRAIN RES REV, V48, P257, DOI 10.1016/j.brainresrev.2004.12.016; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Steinbach JP, 1998, CELL DEATH DIFFER, V5, P858, DOI 10.1038/sj.cdd.4400391; Uemura O, 2005, DEV BIOL, V278, P587, DOI 10.1016/j.ydbio.2004.11.031; van Tijn P, 2011, PROG NEUROBIOL, V93, P149, DOI 10.1016/j.pneurobio.2010.10.008; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Xia WM, 2010, J ALZHEIMERS DIS, V20, P981, DOI 10.3233/JAD-2010-1412; Young-Pearse TL, 2011, CELL RES        0719, DOI [10.1038/cr.2011.116, DOI 10.1038/CR.2011.116]; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zheng H, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-5; Zheng H, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-27	33	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e34209	10.1371/journal.pone.0034209	http://dx.doi.org/10.1371/journal.pone.0034209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545081	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343200004
J	Rachwal, PA; Rose, HL; Cox, V; Lukaszewski, RA; Murch, AL; Weller, SA				Rachwal, Phillip A.; Rose, Helen L.; Cox, Victoria; Lukaszewski, Roman A.; Murch, Amber L.; Weller, Simon A.			The Potential of TaqMan Array Cards for Detection of Multiple Biological Agents by Real-Time PCR	PLOS ONE			English	Article							YERSINIA-PESTIS; GENES	The TaqMan Array Card architecture, normally used for gene expression studies, was evaluated for its potential to detect multiple bacterial agents by real-time PCR. Ten PCR assays targeting five biological agents (Bacillus anthracis, Burkholderia mallei, Burkholderia pseudomallei, Francisella tularensis, and Yersinia pestis) were incorporated onto Array Cards. A comparison of PCR performance of each PCR in Array Card and singleplex format was conducted using DNA extracted from pure bacterial cultures. When 100 fg of agent DNA was added to Array Card channels the following levels of agent detection (where at least one agent PCR replicate returned a positive result) were observed: Y. pestis 100%, B. mallei & F. tularensis 93%; B. anthracis 71%; B. pseudomallei 43%. For B. mallei & pseudomallei detection the BPM2 PCR, which detects both species, outperformed PCR assays specific to each organism indicating identification of the respective species would not be reproducible at the 100 fg level. Near 100% levels of detection were observed when 100 fg of DNA was added to each PCR in singleplex format with singleplex PCRs also returning sporadic positives at the 10 fg per PCR level. Before evaluating the use of Array Cards for the testing of environmental and clinical sample types, with potential levels of background DNA and PCR inhibitors, users would therefore have to accept a 10-fold reduction in sensitivity of PCR assays on the Array Card format, in order to benefit for the capacity to test multiple samples for multiple agents. A two PCR per agent strategy would allow the testing of 7 samples for the presence of 11 biological agents or 3 samples for 23 biological agents per card (with negative control channels).	[Rachwal, Phillip A.; Rose, Helen L.; Cox, Victoria; Lukaszewski, Roman A.; Murch, Amber L.; Weller, Simon A.] Def Sci & Technol Lab, Salisbury, Wilts, England	Defence Science & Technology Laboratory	Rachwal, PA (corresponding author), Def Sci & Technol Lab, Salisbury, Wilts, England.	sweller@mail.dstl.gov.uk		Weller, Simon/0000-0001-9286-2991	UK Ministry of Defence (Programme Office)	UK Ministry of Defence (Programme Office)	This study was funded by the UK Ministry of Defence (Programme Office). The funding body appproved submission of the manuscript for publication but had no role in study design, data collection and analysis, or preparation of the manuscript.	Cho HB, 2005, P NATL ACAD SCI USA, V102, P14843, DOI 10.1073/pnas.0503458102; Hondow HL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-265; Janse I, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-314; Kodani M, 2011, J CLIN MICROBIOL, V49, P2175, DOI 10.1128/JCM.02270-10; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Merritt AJ, 2010, J CLIN MICROBIOL, V48, P3758, DOI 10.1128/JCM.00471-10; Mitchell JL, 2010, MOL CELL PROBE, V24, P72, DOI 10.1016/j.mcp.2009.10.004; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Pel J, 2009, P NATL ACAD SCI USA, V106, P14796, DOI 10.1073/pnas.0907402106; Picard FJ, 2009, J CLIN MICROBIOL, V47, P751, DOI 10.1128/JCM.01746-08; Rangel-Moreno J, 2006, J CLIN INVEST, V116, P3183, DOI 10.1172/JCI28756; Riehm JM, 2011, MOL CELL PROBE, V25, P8, DOI 10.1016/j.mcp.2010.09.002; Rose HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022668; Tarberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189; Thurman KA, 2011, DIAGN MICR INFEC DIS, V70, P1, DOI 10.1016/j.diagmicrobio.2010.11.014; Wittwer CT., 2004, MOL MICROBIOLOGY DIA, P71; Worsham PL, 2003, ADV EXP MED BIOL, V529, P129; Zhou ZX, 2010, J APPL MICROBIOL, V108, P898, DOI 10.1111/j.1365-2672.2009.04482.x	18	32	34	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35971	10.1371/journal.pone.0035971	http://dx.doi.org/10.1371/journal.pone.0035971			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540014	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341000080
J	Stoeckli, S; Hirschi, M; Spirig, C; Calanca, P; Rotach, MW; Samietz, J				Stoeckli, Sibylle; Hirschi, Martin; Spirig, Christoph; Calanca, Pierluigi; Rotach, Mathias W.; Samietz, Joerg			Impact of Climate Change on Voltinism and Prospective Diapause Induction of a Global Pest Insect - Cydia pomonella ( L.)	PLOS ONE			English	Article							CODLING MOTH; PHENOLOGY; LEPIDOPTERA; TEMPERATURE; POPULATIONS; RESISTANCE; EUROPE; MODELS; WALNUT	Global warming will lead to earlier beginnings and prolongation of growing seasons in temperate regions and will have pronounced effects on phenology and life-history adaptation in many species. These changes were not easy to simulate for actual phenologies because of the rudimentary temporal (season) and spatial (regional) resolution of climate model projections. We investigate the effect of climate change on the regional incidence of a pest insect with nearly worldwide distribution and very high potential for adaptation to season length and temperature - the Codling Moth, Cydia pomonella. Seasonal and regional climate change signals were downscaled to the hourly temporal scale of a pest phenology model and the spatial scale of pest habitats using a stochastic weather generator operating at daily scale in combination with a re-sampling approach for simulation of hourly weather data. Under future conditions of increased temperatures (2045-2074), the present risk of below 20% for a pronounced second generation (peak larval emergence) in Switzerland will increase to 70-100%. The risk of an additional third generation will increase from presently 0-2% to 100%. We identified a significant two-week shift to earlier dates in phenological stages, such as overwintering adult flight. The relative extent (magnitude) of first generation pupae and all later stages will significantly increase. The presence of first generation pupae and later stages will be prolonged. A significant decrease in the length of overlap of first and second generation larval emergence was identified. Such shifts in phenology may induce changes in life-history traits regulating the life cycle. An accordingly life-history adaptation in photoperiodic diapause induction to shorter day-length is expected and would thereby even more increase the risk of an additional generation. With respect to Codling Moth management, the shifts in phenology and voltinism projected here will require adaptations of plant protection strategies to maintain their sustainability.	[Stoeckli, Sibylle; Samietz, Joerg] ACW, Agroscope Changins Wadenswil Res Stn, Wadenswil, Switzerland; [Hirschi, Martin; Spirig, Christoph; Rotach, Mathias W.] Fed Off Meteorol & Climatol MeteoSwiss, Zurich, Switzerland; [Calanca, Pierluigi] Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland; [Rotach, Mathias W.] Univ Innsbruck, Inst Meteorol & Geophys, A-6020 Innsbruck, Austria	Swiss Federal Research Station Agroscope; Federal Office of Meteorology & Climatology (MeteoSwiss); Swiss Federal Research Station Agroscope; Swiss Federal Research Station for Agroecology & Agriculture; University of Innsbruck	Stoeckli, S (corresponding author), ACW, Agroscope Changins Wadenswil Res Stn, Wadenswil, Switzerland.	sibylle.stoeckli@acw.admin.ch	Rotach, Mathias/E-9938-2018; Spirig, Christoph/D-2471-2014; Hirschi, Martin/ABF-1564-2020	Rotach, Mathias/0000-0003-2283-309X; Spirig, Christoph/0000-0001-9535-7333; Hirschi, Martin/0000-0001-9154-756X	Swiss State Secretariat for Education and Research SER [C09.0052]; National Centre of Competence in Research on Climate (NCCR Climate) of the Swiss National Science Foundation	Swiss State Secretariat for Education and Research SER; National Centre of Competence in Research on Climate (NCCR Climate) of the Swiss National Science Foundation	The project was funded by the Swiss State Secretariat for Education and Research SER (grant number C09.0052) in the framework of COST 734 (Impacts of Climate Change and Variability on European Agriculture - CLIVAGRI). The contribution of MeteoSwiss was additionally funded by the National Centre of Competence in Research on Climate (NCCR Climate) of the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford D. V, 2007, PESTS FRUIT CROPS CO; Altermatt F, 2010, P ROY SOC B-BIOL SCI, V277, P1281, DOI 10.1098/rspb.2009.1910; Asser-Kaiser S, 2007, SCIENCE, V317, P1916, DOI 10.1126/science.1146542; Beers Elizabeth H., 2003, P489, DOI 10.1079/9780851995922.0489; Bradshaw WE, 2001, P NATL ACAD SCI USA, V98, P14509, DOI 10.1073/pnas.241391498; Calanca P., 2009, SURVEY AGROMETOEORLO, P237; Charmillot P. J., 2007, Revue Suisse de Viticulture, Arboriculture et Horticulture, V39, P385; Danilevskii A. S., 1961, PHOTOPERIODISM SEASO; Dubrovsky M, 2004, CLIMATIC CHANGE, V63, P145, DOI 10.1023/B:CLIM.0000018504.99914.60; Dubrovsky M, 2011, GEOPH RES ABSTR, V13, P496; Fischer AM, 2012, INT J CLIMATOL, V32, P2348, DOI 10.1002/joc.3396; GARCIASALAZAR C, 1988, ENVIRON ENTOMOL, V17, P626, DOI 10.1093/ee/17.4.626; Gomi T, 2007, ENTOMOL EXP APPL, V125, P179, DOI 10.1111/j.1570-7458.2007.00616.x; Harada T, 2005, APPL ENTOMOL ZOOL, V40, P461, DOI 10.1303/aez.2005.461; Hewitt C. D., 2005, EGGS NEWSLETT, V13, P22; Hill M. G., 1989, IMPACT CLIMATE CHANG; Hirschi M, 2012, EARTH SYST DYNAM, V3, P33, DOI 10.5194/esd-3-33-2012; Hohn H, 2010, PFLANZENSCHUTZEMPFEH; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Jepsen JU, 2011, GLOBAL CHANGE BIOL, V17, P2071, DOI 10.1111/j.1365-2486.2010.02370.x; JERMY T., 1967, ACTA PHYTOPATHOL ACAD SCI HUNG, V2, P49; Legave JM, 2009, ACTA HORTIC, V838, P21; Luedeling E, 2011, GLOBAL CHANGE BIOL, V17, P228, DOI 10.1111/j.1365-2486.2010.02227.x; MANETSCH TJ, 1976, IEEE T SYST MAN CYB, V6, P547, DOI 10.1109/TSMC.1976.4309549; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Morin X, 2009, GLOBAL CHANGE BIOL, V15, P961, DOI 10.1111/j.1365-2486.2008.01735.x; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; PETERSON DM, 1968, J INSECT PHYSIOL, V14, P519, DOI 10.1016/0022-1910(68)90067-X; PHILLIPS PA, 1975, ANN ENTOMOL SOC AM, V68, P1053, DOI 10.1093/aesa/68.6.1053; Reyes M, 2007, PEST MANAG SCI, V63, P890, DOI 10.1002/ps.1421; RICHARDSON CW, 1981, WATER RESOUR RES, V17, P182, DOI 10.1029/WR017i001p00182; RIEDL H, 1978, CAN ENTOMOL, V110, P455, DOI 10.4039/Ent110455-5; Riedl H., 1983, Diapause and life cycle strategies in insects, P233; Samietz J., 2007, Bulletin OEPP, V37, P255, DOI 10.1111/j.1365-2338.2007.01121.x; Scoble M. J., 1995, LEPIDOPTERA FORM FUN; Shel'deshova GG, 1965, AKAD NAUK SSSR T ZOO, V36, P5; Stoeckli S, 2012, ACTA HORT IN PRESS; Tobin PC, 2008, GLOBAL CHANGE BIOL, V14, P951, DOI 10.1111/j.1365-2486.2008.01561.x; VANSICKLE J, 1977, IEEE T SYST MAN CYB, V7, P635, DOI 10.1109/TSMC.1977.4309800; Visser ME, 2001, P ROY SOC B-BIOL SCI, V268, P289, DOI 10.1098/rspb.2000.1363; Vitasse Y, 2011, AGR FOREST METEOROL, V151, P969, DOI 10.1016/j.agrformet.2011.03.003; WILDBOLZ T, 1969, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V42, P58; Willmer P., 2000, ENV PHYSL ANIMALS	44	49	48	1	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35723	10.1371/journal.pone.0035723	http://dx.doi.org/10.1371/journal.pone.0035723			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539997	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341000063
J	Ni, SW; Hong, F; Haldeman, BD; Baker, JE; Facemyer, KC; Cremo, CR				Ni, Shaowei; Hong, Feng; Haldeman, Brian D.; Baker, Josh E.; Facemyer, Kevin C.; Cremo, Christine R.			Modification of Interface between Regulatory and Essential Light Chains Hampers Phosphorylation-dependent Activation of Smooth Muscle Myosin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-MEROMYOSIN; SCALLOP MYOSIN; ANGSTROM RESOLUTION; CALCIUM-BINDING; RECOVERY STROKE; ATPASE ACTIVITY; GIZZARD MYOSIN; MOTOR DOMAIN; POWER STROKE; IN-VITRO	We examined the regulatory importance of interactions between regulatory light chain (RLC), essential light chain (ELC), and adjacent heavy chain (HC) in the regulatory domain of smooth muscle heavy meromyosin. After mutating the HC, RLC, and/or ELC to disrupt their predicted interactions (using scallop myosin coordinates), we measured basal ATPase, V-max, and K-ATPase of actin-activated ATPase, actin-sliding velocities, rigor binding to actin, and kinetics of ATP binding and ADP release. If unphosphorylated, all mutants were similar to wild type showing turned-off behaviors. In contrast, if phosphorylated, mutation of RLC residues smM129Q and smG130C in the F-G helix linker, which interact with the ELC (Ca2+ binding in scallop), was sufficient to abolish motility and diminish ATPase activity, without altering other parameters. ELC mutations within this interacting ELC loop (smR20M and smK25A) were normal, but smM129Q/G130C-R20M or -K25A showed a partially recovered phenotype suggesting that interaction between the RLC and ELC is important. A molecular dynamics study suggested that breaking the RLC/ELC interface leads to increased flexibility at the interface and ELC-binding site of the HC. We hypothesize that this leads to hampered activation by allowing a pre-existing equilibrium between activated and inhibited structural distributions (Vileno, B., Chamoun, J., Liang, H., Brewer, P., Haldeman, B. D., Facemyer, K. C., Salzameda, B., Song, L., Li, H. C., Cremo, C. R., and Fajer, P. G. (2011) Broad disorder and the allosteric mechanism of myosin II regulation by phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 108, 8218-8223) to be biased strongly toward the inhibited distribution even when the RLC is phosphorylated. We propose that an important structural function of RLC phosphorylation is to promote or assist in the maintenance of an intact RLC/ELC interface. If the RLC/ELC interface is broken, the off-state structures are no longer destabilized by phosphorylation.	[Ni, Shaowei; Hong, Feng; Haldeman, Brian D.; Baker, Josh E.; Facemyer, Kevin C.; Cremo, Christine R.] Univ Nevada, Sch Med, Dept Biochem & Mol Biol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Cremo, CR (corresponding author), Univ Nevada, Sch Med, Dept Biochem & Mol Biol, 1664 N Virginia St, Reno, NV 89557 USA.	cremo@unr.edu			National Institutes of Health Grant from NIAMS [RO1 AR040917]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040917] Funding Source: NIH RePORTER	National Institutes of Health Grant from NIAMS; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AR040917 from NIAMS (to C. R. C. and K. C. F.).	Baumann BAJ, 2012, J MOL BIOL, V415, P274, DOI 10.1016/j.jmb.2011.10.047; Camps J, 2009, BIOINFORMATICS, V25, P1709, DOI 10.1093/bioinformatics/btp304; Cremo CR, 2001, J BIOL CHEM, V276, P41465, DOI 10.1074/jbc.M107103200; Cremo CR, 1998, BIOCHEMISTRY-US, V37, P1969, DOI 10.1021/bi9722406; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; Cuda G, 1997, BIOPHYS J, V72, P1767, DOI 10.1016/S0006-3495(97)78823-4; Ellison PA, 2000, J BIOL CHEM, V275, P15142, DOI 10.1074/jbc.275.20.15142; Ellison PA, 2003, J BIOL CHEM, V278, P4410, DOI 10.1074/jbc.M211016200; Fischer S, 2005, P NATL ACAD SCI USA, V102, P6873, DOI 10.1073/pnas.0408784102; Fiske CH, 1925, J BIOL CHEM, V66, P375; GEEVES MA, 1991, BIOCHEM J, V274, P1; Gourinath S, 2003, STRUCTURE, V11, P1621, DOI 10.1016/j.str.2003.10.013; Gyimesi M, 2008, J BIOL CHEM, V283, P8153, DOI 10.1074/jbc.M708863200; Himmel DM, 2009, J MOL BIOL, V394, P496, DOI 10.1016/j.jmb.2009.09.035; Holmes KC, 2000, PHILOS T R SOC B, V355, P419, DOI 10.1098/rstb.2000.0583; Houdusse A, 1996, STRUCTURE, V4, P1475, DOI 10.1016/S0969-2126(96)00154-2; Houdusse A, 1996, STRUCTURE, V4, P21, DOI 10.1016/S0969-2126(96)00006-8; Howard J, 2001, MECH MOTOR PROTEINS; IKEBE M, 1985, BIOCHEMISTRY-US, V24, P2380, DOI 10.1021/bi00330a038; JANCSO A, 1994, P NATL ACAD SCI USA, V91, P8762, DOI 10.1073/pnas.91.19.8762; Katoh T, 1996, J BIOL CHEM, V271, P9992, DOI 10.1074/jbc.271.17.9992; Katoh T, 2002, J BIOCHEM, V131, P641, DOI 10.1093/oxfordjournals.jbchem.a003146; Khromov AS, 1998, J PHYSIOL-LONDON, V512, P345, DOI 10.1111/j.1469-7793.1998.345be.x; Kurzawa SE, 1996, J MUSCLE RES CELL M, V17, P669, DOI 10.1007/BF00154061; KWON H, 1990, P NATL ACAD SCI USA, V87, P4771, DOI 10.1073/pnas.87.12.4771; KWON H, 1992, J MUSCLE RES CELL M, V13, P315, DOI 10.1007/BF01766459; LOWEY S, 1969, J MOL BIOL, V42, P1, DOI 10.1016/0022-2836(69)90483-5; Lowey S, 2010, J BIOL CHEM, V285, P16403, DOI 10.1074/jbc.R109.025551; Malnasi-Csizmadia A, 1999, EUR J BIOCHEM, V261, P452, DOI 10.1046/j.1432-1327.1999.00290.x; Mesentean S, 2007, J MOL BIOL, V367, P591, DOI 10.1016/j.jmb.2006.12.058; Ni SW, 2009, BBA-PROTEINS PROTEOM, V1794, P1599, DOI 10.1016/j.bbapap.2009.07.009; Onishi H, 2008, BIOCHEM BIOPH RES CO, V369, P115, DOI 10.1016/j.bbrc.2007.11.148; Ruff C, 2001, NAT STRUCT BIOL, V8, P226, DOI 10.1038/84962; SEIDEL JC, 1980, J BIOL CHEM, V255, P4355; SELLERS JR, 1985, J BIOL CHEM, V260, P5815; Sherwood JJ, 2004, P NATL ACAD SCI USA, V101, P10973, DOI 10.1073/pnas.0401699101; SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Szent-Gyorgyi AG, 2007, ADV EXP MED BIOL, V592, P253; SZENTGYORGYI AG, 1994, MYOLOGY, P506; TAYLOR EW, 1979, CRC CR REV BIOCH MOL, V6, P103, DOI 10.3109/10409237909102562; TRYBUS KM, 1994, J CELL BIOL, V124, P963, DOI 10.1083/jcb.124.6.963; TRYBUS KM, 1994, J BIOL CHEM, V269, P20819; Tyska MJ, 2002, CELL MOTIL CYTOSKEL, V51, P1, DOI 10.1002/cm.10014; Uyeda TQP, 1996, P NATL ACAD SCI USA, V93, P4459, DOI 10.1073/pnas.93.9.4459; VANBUREN P, 1994, P NATL ACAD SCI USA, V91, P12403, DOI 10.1073/pnas.91.26.12403; Vileno B, 2011, P NATL ACAD SCI USA, V108, P8218, DOI 10.1073/pnas.1014137108; Warshaw DM, 2000, J BIOL CHEM, V275, P37167, DOI 10.1074/jbc.M006438200; WARSHAW DM, 1990, J CELL BIOL, V111, P453, DOI 10.1083/jcb.111.2.453; WARSHAW DM, 1991, J BIOL CHEM, V266, P24339; Wendt T, 2001, P NATL ACAD SCI USA, V98, P4361, DOI 10.1073/pnas.071051098; XIE X, 1994, NATURE, V368, P306, DOI 10.1038/368306a0	52	10	11	3	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22068	22079		10.1074/jbc.M112.343491	http://dx.doi.org/10.1074/jbc.M112.343491			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22549781	hybrid, Green Published			2022-12-25	WOS:000306418600044
J	Poulsen, AH; Stenager, E; Johansen, C; Bentzen, J; Friis, S; Schuz, J				Poulsen, Aslak Harbo; Stenager, Egon; Johansen, Christoffer; Bentzen, Joan; Friis, Soren; Schuez, Joachim			Mobile Phones and Multiple Sclerosis - A Nationwide Cohort Study in Denmark	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; CELLULAR TELEPHONE USE; ELECTROMAGNETIC-FIELDS; OCULAR SYMPTOMS; RADIOFREQUENCY; EXPOSURE; PERMEABILITY; PREVALENCE; RADIATION; USERS	We investigated the risk of, prognosis of and symptoms of multiple sclerosis (MS) among all Danish residents who owned a mobile phone subscription before 1996. Using the Danish Multiple Sclerosis Registry and Civil Registration System, study subjects were followed up for MS through 2004. Poisson models were used to calculate incidence rate ratios (IRR, age range: 18-64 years) and mortality rate ratios (MRR, age range: 18+) and to compare presenting symptoms among subscribers and all non-subscribers. A total of 405 971 subscription holders accrued four million years of follow up, with men accounting for 86% of the observation time. Among subscription holding men, the IRR of MS was close to unity, overall as well as 13+ years after first subscription (IRR 1.02, 95% CI: 0.48-2.16). Among women, the IRR was 3.43 (95% CI: 0.86-13.72) 13+ years after first subscription, however, based on only two cases. Presenting symptoms of MS differed between subscribers and nonsubscribers (p = 0.03), with slightly increased risk of diplopia in both genders (IRR: 1.38, 95% CI: 1.02-1.86), an increased risk of fatigue among women (IRR: 3.02, 95% CI: 1.45-6.28), and of optic neuritis among men (IRR: 1.38, 95% CI: 1.03-1.86). Overall the MRR was close to one (MRR: 0.91, 95% CI 0.70-1.19) among MS-patients with a subscription and although we observed some increased MRR estimates among women, these were based on small numbers. In conclusion, we found little evidence for a pronounced association between mobile phone use and risk of MS or mortality rate among MS patients. Symptoms of MS differed between subscribers and nonsubscribers for symptoms previously suggested to be associated with mobile phone use. This deserves further attention, as does the increased long-term risk of MS among female subscribers, although small numbers and lack of consistency between genders prevent causal interpretation.	[Poulsen, Aslak Harbo; Johansen, Christoffer; Friis, Soren] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Stenager, Egon] Copenhagen Univ Hosp, Danish MS Registry, Copenhagen, Denmark; [Bentzen, Joan] Univ So Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Schuez, Joachim] IARC, Sect Environm & Radiat, Lyon, France; [Stenager, Egon] Univ So Denmark, Inst Reg Hlth Serv, Odense, Denmark; [Stenager, Egon] Sonderborg Hosp, MS Clin So Jutland Sonderborg Vejle Esbjerg, Sonderborg, Denmark	Danish Cancer Society; University of Copenhagen; University of Southern Denmark; World Health Organization; International Agency for Research on Cancer (IARC); University of Southern Denmark	Poulsen, AH (corresponding author), Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark.	Aslak@Cancer.DK	Johansen, Christoffer/AAG-7916-2020; Stenager, Egon/AAU-4463-2020; Stenager, Egon/O-2275-2017	Johansen, Christoffer/0000-0002-4384-206X; stenager, egon/0000-0002-4877-5193	Danish Graduate School in Public Health Science; Sonofon and TeleDenmark Mobile; Danish Multiple Sclerosis Society; Bayer Schering; Merck Serono; Biogen Idec; Sanofi Aventis; Novartis	Danish Graduate School in Public Health Science; Sonofon and TeleDenmark Mobile; Danish Multiple Sclerosis Society; Bayer Schering(Bayer AG); Merck Serono(Merck & Company); Biogen Idec(Biogen); Sanofi Aventis(Sanofi-Aventis); Novartis(Novartis)	AHP was supported by a stipend for PhD students from the Danish Graduate School in Public Health Science. All other authors contributed to this work based on their respective core budget positions. The establishment of the original cohort of subscription holders was supported by Sonofon and TeleDenmark Mobile. The Danish MS Registry is funded by the Danish Multiple Sclerosis Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Since 1994, CJ has been a Consultant to the Danish National Board of Health in the area electromagnetic fields and health and received support from Sonofon and TeleDenmark Mobile for the establishment of the nationwide cohort in 1999. ES has received financial support for congress participation from Bayer Schering, Merck Serono, Biogen Idec, Sanofi Aventis and Novartis and unrestricted research grants from Bayer Schering, Merck Serono, and Biogen Idec. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Baan R, 2011, LANCET ONCOL, V12, P624, DOI 10.1016/S1470-2045(11)70147-4; Balik HH, 2005, PATHOL BIOL, V53, P88, DOI 10.1016/j.patbio.2004.03.012; Bentzen J, 2010, MULT SCLER J, V16, P520, DOI 10.1177/1352458510364197; Bronnum-Hansen H, 2004, BRAIN, V127, P844, DOI 10.1093/brain/awh104; Bronnum-Hansen H, 2011, SCAND J PUBLIC HEALT, V39, P62, DOI 10.1177/1403494810390729; Cardis E, 2008, PHYS MED BIOL, V53, P2771, DOI 10.1088/0031-9155/53/11/001; Chia SE, 2000, ENVIRON HEALTH PERSP, V108, P1059, DOI 10.2307/3434959; Davis SL, 2010, J APPL PHYSIOL, V109, P1531, DOI 10.1152/japplphysiol.00460.2010; de Gannes FP, 2009, RADIAT RES, V172, P359, DOI 10.1667/RR1578.1; DIMBYLOW PJ, 1994, PHYS MED BIOL, V39, P1537, DOI 10.1088/0031-9155/39/10/003; Eberhardt JL, 2008, ELECTROMAGN BIOL MED, V27, P215, DOI 10.1080/15368370802344037; Frei P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6387; Greer JM, 2011, J NEUROIMMUNOL, V234, P7, DOI 10.1016/j.jneuroim.2011.03.003; GUTHRIE TC, 1995, J NEUROL SCI, V129, P1, DOI 10.1016/0022-510X(94)00248-M; Huss A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-267; Johansen C, 2001, JNCI-J NATL CANCER I, V93, P203, DOI 10.1093/jnci/93.3.203; Kister I, 2010, CURR PAIN HEADACHE R, V14, P441, DOI 10.1007/s11916-010-0143-5; Kleinlogel H, 2008, BIOELECTROMAGNETICS, V29, P488, DOI 10.1002/bem.20418; Koch-Henriksen N, 2001, DAN MED BULL, V48, P91; Kucer N, 2008, ELECTROMAGN BIOL MED, V27, P205, DOI 10.1080/15368370802072174; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mason K, 2011, ACTA NEUROL SCAND; Masuda H, 2009, RADIAT RES, V172, P66, DOI 10.1667/RR1542.1; McQuade JMS, 2009, RADIAT RES, V171, P615, DOI 10.1667/RR1507.1; Meo Sultan A., 2005, International Journal of Occupational Medicine and Environmental Health, V18, P53; National IT and Telecom Agency D, 2003, TEL YB 2002; Nittby H, 2008, ELECTROMAGN BIOL MED, V27, P103, DOI 10.1080/15368370802061995; Nittby Henrietta, 2009, Pathophysiology, V16, P103, DOI 10.1016/j.pathophys.2009.01.001; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; SALFORD LG, 1994, MICROSC RES TECHNIQ, V27, P535, DOI 10.1002/jemt.1070270608; Schreier N, 2006, SOZ PRAVENTIV MED, V51, P202, DOI 10.1007/s00038-006-5061-2; Schuz J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004389; Schuz J, 2010, CANC EPIDEMIOL; Schuz J, 2006, JNCI-J NATL CANCER I, V98, P1707, DOI 10.1093/jnci/djj464; Schuz J, 2007, BIOELECTROMAGNETICS, V28, P130, DOI 10.1002/bem.20297; Stam R, 2010, BRAIN RES REV, V65, P80, DOI 10.1016/j.brainresrev.2010.06.001; van Rongen E, 2009, J TOXICOL ENV HEAL B, V12, P572, DOI 10.1080/10937400903458940	39	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e34453	10.1371/journal.pone.0034453	http://dx.doi.org/10.1371/journal.pone.0034453			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558088	Green Submitted, Green Published, gold			2022-12-25	WOS:000305340200005
J	Walton, NM; Shin, R; Tajinda, K; Heusner, CL; Kogan, JH; Miyake, S; Chen, Q; Tamura, K; Matsumoto, M				Walton, Noah M.; Shin, Rick; Tajinda, Katsunori; Heusner, Carrie L.; Kogan, Jeffrey H.; Miyake, Shinichi; Chen, Qian; Tamura, Kouichi; Matsumoto, Mitsuyuki			Adult Neurogenesis Transiently Generates Oxidative Stress	PLOS ONE			English	Article							NEURAL STEM-CELLS; MILD COGNITIVE IMPAIRMENT; MOUSE DENTATE GYRUS; II MUTANT MICE; ALZHEIMERS-DISEASE; HIPPOCAMPAL NEUROGENESIS; MAMMALIAN BRAIN; DNA-DAMAGE; OXYGEN; CYCLE	An increasing body of evidence suggests that alterations in neurogenesis and oxidative stress are associated with a wide variety of CNS diseases, including Alzheimer's disease, schizophrenia and Parkinson's disease, as well as routine loss of function accompanying aging. Interestingly, the association between neurogenesis and the production of reactive oxidative species (ROS) remains largely unexamined. The adult CNS harbors two regions of persistent lifelong neurogenesis: the subventricular zone and the dentate gyrus (DG). These regions contain populations of quiescent neural stem cells (NSCs) that generate mature progeny via rapidly-dividing progenitor cells. We hypothesized that the energetic demands of highly proliferative progenitors generates localized oxidative stress that contributes to ROS-mediated damage within the neuropoietic microenvironment. In vivo examination of germinal niches in adult rodents revealed increases in oxidized DNA and lipid markers, particularly in the subgranular zone (SGZ) of the dentate gyrus. To further pinpoint the cell types responsible for oxidative stress, we employed an in vitro cell culture model allowing for the synchronous terminal differentiation of primary hippocampal NSCs. Inducing differentiation in primary NSCs resulted in an immediate increase in total mitochondria number and overall ROS production, suggesting oxidative stress is generated during a transient window of elevated neurogenesis accompanying normal neurogenesis. To confirm these findings in vivo, we identified a set of oxidation-responsive genes, which respond to antioxidant administration and are significantly elevated in genetic-and exercise-induced model of hyperactive hippocampal neurogenesis. While no direct evidence exists coupling neurogenesis-associated stress to CNS disease, our data suggest that oxidative stress is produced as a result of routine adult neurogenesis.	[Walton, Noah M.; Shin, Rick; Tajinda, Katsunori; Heusner, Carrie L.; Kogan, Jeffrey H.; Miyake, Shinichi; Chen, Qian; Tamura, Kouichi; Matsumoto, Mitsuyuki] Astellas Res Inst Amer LLC, CNS, Skokie, IL 60077 USA	Astellas Pharmaceuticals	Walton, NM (corresponding author), Astellas Res Inst Amer LLC, CNS, Skokie, IL 60077 USA.	noah.walton@us.astellas.com	Matsumoto, Mitsuyuki/G-3207-2012	Matsumoto, Mitsuyuki/0000-0002-1172-2354				Acharya MM, 2010, FREE RADICAL BIO MED, V49, P1846, DOI 10.1016/j.freeradbiomed.2010.08.021; Adibhatla RM, 2008, BMB REP, V41, P560, DOI 10.5483/BMBRep.2008.41.8.560; Alam ZI, 1997, J NEUROCHEM, V69, P1196, DOI 10.1046/j.1471-4159.1997.69031196.x; Anantharam V, 2007, NEUROCHEM INT, V50, P834, DOI 10.1016/j.neuint.2007.02.003; Babu H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000388; Babu H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00089; Beal MF, 2005, NEUROBIOL AGING, V26, P585, DOI 10.1016/j.neurobiolaging.2004.09.022; Bitanihirwe BKY, 2011, NEUROSCI BIOBEHAV R, V35, P878, DOI 10.1016/j.neubiorev.2010.10.008; Bradley MA, 2010, NEUROBIOL AGING; Che Y, 2010, J PSYCHIATR NEUROSCI, V35, P296, DOI 10.1503/jpn.090083; Chen QM, 2000, BIOCHEM J, V347, P543, DOI 10.1042/0264-6021:3470543; Chen SC, 2007, TRANSL RES, V149, P274, DOI 10.1016/j.trsl.2006.08.005; Clay HB, 2011, INT J DEV NEUROSCI, V29, P311, DOI 10.1016/j.ijdevneu.2010.08.007; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Curtis MA, 2011, EUR J NEUROSCI, V33, P1170, DOI 10.1111/j.1460-9568.2011.07616.x; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Fiskum G, 2004, J BIOENERG BIOMEMBR, V36, P347, DOI 10.1023/B:JOBB.0000041766.71376.81; Gallagher J, 2003, FEBS LETT, V551, P8, DOI 10.1016/S0014-5793(03)00823-8; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; INCE PG, 1994, NEUROSCI LETT, V182, P87, DOI 10.1016/0304-3940(94)90213-5; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Kannan, 2000, Pathophysiology, V7, P153, DOI 10.1016/S0928-4680(00)00053-5; Kapogiannis D, 2011, LANCET NEUROL, V10, P187, DOI 10.1016/S1474-4422(10)70277-5; Klein JA, 2003, J CLIN INVEST, V111, P785, DOI 10.1172/JCI200318182; Li Y, 2009, CURR TOP DEV BIOL, V87, P149, DOI 10.1016/S0070-2153(09)01205-8; Lovell MA, 2007, J NEUROSCI RES, V85, P3036, DOI 10.1002/jnr.21346; Madhavan L, 2005, ANN NY ACAD SCI, V1049, P185, DOI 10.1196/annals.1334.017; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; Moh C, 2011, RESULTS PROBL CELL D, V53, P565, DOI 10.1007/978-3-642-19065-0_23; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Moser KV, 2004, BRAIN RES, V1017, P53, DOI 10.1016/j.brainres.2004.05.013; PERO RW, 1990, CANCER RES, V50, P4619; Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005; Scheffler B, 2005, P NATL ACAD SCI USA, V102, P9353, DOI 10.1073/pnas.0503965102; SCOTT ID, 1980, BIOCHEM J, V186, P21, DOI 10.1042/bj1860021; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Studer L, 2000, J NEUROSCI, V20, P7377; Sugawara T, 2003, ANTIOXID REDOX SIGN, V5, P597, DOI 10.1089/152308603770310266; Taupin Philippe, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P16; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Wang XK, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-12; Yamasaki N, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-6; Yang AH, 2003, J NEUROSCI, V23, P10454; Zalba G, 2005, ANTIOXID REDOX SIGN, V7, P1327, DOI 10.1089/ars.2005.7.1327	49	77	79	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35264	10.1371/journal.pone.0035264	http://dx.doi.org/10.1371/journal.pone.0035264			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558133	Green Submitted, gold, Green Published			2022-12-25	WOS:000305340200011
J	Baamrane, MAA; Shehzad, W; Ouhammou, A; Abbad, A; Naimi, M; Coissac, E; Taberlet, P; Znari, M				Baamrane, Moulay Abdeljalil Ait; Shehzad, Wasim; Ouhammou, Ahmed; Abbad, Abdelaziz; Naimi, Mohamed; Coissac, Eric; Taberlet, Pierre; Znari, Mohammed			Assessment of the Food Habits of the Moroccan Dorcas Gazelle in M'Sabih Talaa, West Central Morocco, Using the trnL Approach	PLOS ONE			English	Article							DIET COMPOSITION; INSECT HERBIVORE; CO2 ENRICHMENT; MOUNTAIN HARES; PAPER BIRCH; PLANT; GROWTH; NUTRITION; AVAILABILITY; SPECTROSCOPY	Food habits of the Moroccan dorcas gazelle, Gazella dorcas massaesyla, previously investigated in the 1980s using microhistological fecal analysis, in the M'Sabih Talaa Reserve, west central Morocco, were re-evaluated over three seasons (spring, summer and autumn 2009) using the trnL approach to determine the diet composition and its seasonal variation from fecal samples. Taxonomic identification was carried out using the identification originating from the database built from EMBL and the list of plant species within the reserve. The total taxonomic richness in the reserve was 130 instead of 171 species in the 1980s. The diet composition revealed to be much more diversified (71 plant taxa belonging to 57 genus and 29 families) than it was 22 years ago (29 identified taxa). Thirty-four taxa were newly identified in the diet while 13 reported in 1986-87 were not found. Moroccan dorcas gazelle showed a high preference to Acacia gummifera, Anagallis arvensis, Glebionis coronaria, Cladanthus arabicus, Diplotaxis tenuisiliqua, Erodium salzmannii, Limonium thouini, Lotus arenarius and Zizyphus lotus. Seasonal variations occurred in both number (40-41 taxa in spring-summer and 49 taxa in autumn vs. respectively 23-22 and 26 in 1986-1987) and taxonomic type of eaten plant taxa. This dietary diversification could be attributed either to the difference in methods of analysis, trnL approach having a higher taxonomic resolution, or a potential change in nutritional quality of plants over time.	[Baamrane, Moulay Abdeljalil Ait; Naimi, Mohamed; Znari, Mohammed] Univ Cadi Ayyad, Fac Sci Semlalia, Lab Biodivers & Dynam Ecosyst BioDEcos, Marrakech, Morocco; [Shehzad, Wasim; Coissac, Eric; Taberlet, Pierre] Univ Grenoble 1, CNRS UMR 5553, Lab Ecol Alpine LECA, Grenoble, France; [Ouhammou, Ahmed] Univ Cadi Ayyad, Fac Sci Semlalia, L2E, Marrakech, Morocco; [Abbad, Abdelaziz] Univ Cadi Ayyad, Fac Sci Semlalia, Lab Biotechnol Protect & Valorisat Ressources Veg, Marrakech, Morocco	Cadi Ayyad University of Marrakech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; Cadi Ayyad University of Marrakech; Cadi Ayyad University of Marrakech	Baamrane, MAA (corresponding author), Univ Cadi Ayyad, Fac Sci Semlalia, Lab Biodivers & Dynam Ecosyst BioDEcos, Marrakech, Morocco.	znarim@gmail.com	Taberlet, Pierre/D-1178-2010; baamrane, moulay abdeljalil ait/AAH-4252-2021; Coissac, Éric/AAE-8735-2019	Taberlet, Pierre/0000-0002-3554-5954; baamrane, moulay abdeljalil ait/0000-0003-0980-6345; Coissac, Éric/0000-0001-7507-6729; OUHAMMOU, Ahmed/0000-0001-9206-1617	People's Trust for Endangered Species (PTES, UK); Laboratory of Alpine Ecology (LECA), Joseph Fourier University, Grenoble, France	People's Trust for Endangered Species (PTES, UK); Laboratory of Alpine Ecology (LECA), Joseph Fourier University, Grenoble, France	The present work has been funded by People's Trust for Endangered Species (PTES, UK) (Project titled: Conservation and management of an isolated population of Moroccan Dorcas gazelles north west of the Atlas mountains, awarded on November 2008. www.ptes.org/files/853_record_of_historic_grants_awarded_2000.pdf). Molecular analyses were funded by the Laboratory of Alpine Ecology (LECA), Joseph Fourier University, Grenoble, France, http://www-leca.ujf-grenoble.fr/equipes/emabio_composition.htm, in collaboration with one of the co-authors, Dr. Taberlet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait Baamrane MA, 2009, 2 DIVERSITAS OP SCI; ALADOS CL, 1987, ISRAEL J ZOOL, V34, P33; AYRES MP, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P75; BELOVSKY GE, 1981, ECOLOGY, V62, P1020, DOI 10.2307/1937001; Bradley BJ, 2007, AM J PRIMATOL, V69, P699, DOI 10.1002/ajp.20384; Brownstein MJ, 1996, MODULATION NONTEMPLA, P1004; Bugalho MN, 2001, J ZOOL, V255, P285, DOI 10.1017/S0952836901001376; Coley PD, 1998, CLIMATIC CHANGE, V39, P455, DOI 10.1023/A:1005307620024; Cristobal-Azkarate J, 2007, AM J PRIMATOL, V69, P1013, DOI 10.1002/ajp.20420; Cuzin F, 1996, MAMMALIA, V60, P101, DOI 10.1515/mamm.1996.60.1.101; Cuzin F, 2007, ETUDE ELABORATION LI; Cuzin F, 2003, THESIS EPHE MONTPELL; Dove H, 1996, J NUTR, V126, P13, DOI 10.1093/jn/126.1.13; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Duncan AJ, 1999, J AGR SCI, V132, P233, DOI 10.1017/S0021859698006303; FAJER ED, 1989, SCIENCE, V243, P1198, DOI 10.1126/science.243.4895.1198; Fennane M, 2007, TRAV I SCI RABAT, V2, P1; Fennane M, 1999, TRAV I SCI RABAT, V1, P1; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Foley WJ, 1998, OECOLOGIA, V116, P293, DOI 10.1007/s004420050591; Forshaw D, 2000, ANIMAL HLTH ANIMAL D; FREELAND WJ, 1974, AM NAT, V108, P269, DOI 10.1086/282907; GORDON IJ, 1995, SMALL RUMINANT RES, V16, P203, DOI 10.1016/0921-4488(95)00635-X; Halsey LA, 1998, FLORIDA BEEF CATTLE, P99; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Henley S. R., 2006, African Journal of Range & Forage Science, V23, P185, DOI 10.2989/10220110609485903; HOLECHEK JL, 1982, J RANGE MANAGE, V35, P309, DOI 10.2307/3898308; HOSS M, 1992, NATURE, V359, P199, DOI 10.1038/359199a0; Hulbert IAR, 2001, OECOLOGIA, V129, P197, DOI 10.1007/s004420100725; Hutchings MR, 2000, J AGR SCI, V135, P65, DOI 10.1017/S002185969900790X; IUCN S, 2010, IUCN 2010 IUCN RED L; JOHNSON MK, 1981, J RANGE MANAGE, V34, P232, DOI 10.2307/3898049; Kaneko H, 2006, MAR MAMMAL SCI, V22, P261, DOI 10.1111/j.1748-7692.2006.00030.x; Kinney KK, 1997, ECOLOGY, V78, P215; Knight AP, 2002, PLANT POISONING ANIM, P41; Korfhage RC, 1974, THESIS WASHINGTON ST; Kowalczyk R, 2011, FOREST ECOL MANAG, V261, P821, DOI 10.1016/j.foreco.2010.11.026; Lagarde FR, 2003, ECOGRAPHY, V26, P236, DOI 10.1034/j.1600-0587.2003.03365.x; LINCOLN DE, 1986, OECOLOGIA, V69, P556, DOI 10.1007/BF00410362; LINCOLN DE, 1984, ENVIRON ENTOMOL, V13, P1527, DOI 10.1093/ee/13.6.1527; LINCOLN DE, 1993, TRENDS ECOL EVOL, V8, P64, DOI 10.1016/0169-5347(93)90161-H; LINDROTH RL, 1995, FUNCT ECOL, V9, P306, DOI 10.2307/2390578; LOGGERS C, 1991, MAMMALIA, V55, P255, DOI 10.1515/mamm.1991.55.2.255; LOGGERS CO, 1992, AFR J ECOL, V30, P301, DOI 10.1111/j.1365-2028.1992.tb00506.x; Magnuson VL, 1996, BIOTECHNIQUES, V21, P700, DOI 10.2144/96214rr03; Marraha Mustapha, 1996, Annales de la Recherche Forestiere au Maroc, V29, P40; Mason Mervyn C., 1999, Chelonian Conservation and Biology, V3, P435; MCINNIS ML, 1983, J RANGE MANAGE, V36, P302, DOI 10.2307/3898474; MORENO-BLACK G, 1978, Primates, V19, P215, DOI 10.1007/BF02373239; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; MOSKOVITS DK, 1990, HERPETOLOGICA, V46, P207; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Negre R, 1962, PETITE FLORE REGIONS, V2, P566; Negre R, 1961, PETITE FLORE REGIONS, V1, P413; NORBY RJ, 1986, PLANT PHYSIOL, V82, P83, DOI 10.1104/pp.82.1.83; OBERBAUER SF, 1986, CAN J BOT, V64, P2993, DOI 10.1139/b86-396; OSBRINK WLA, 1987, ENVIRON ENTOMOL, V16, P639, DOI 10.1093/ee/16.3.639; OWENSMITH N, 1982, AM NAT, V119, P151, DOI 10.1086/283902; Pegard A, 2009, J AGR FOOD CHEM, V57, P5700, DOI 10.1021/jf803680c; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Quezel P, 1962, NOUVELLE FLORE ALGER, V1, P1; Quezel P, 1963, NOUVELLE FLORE ALGER, V2, P571; Rao SJ, 2003, CAN J ZOOL, V81, P1047, DOI 10.1139/Z03-093; Raye G, 2011, ECOL RES, V26, P265, DOI 10.1007/s11284-010-0780-5; REEKIE EG, 1989, OECOLOGIA, V79, P212, DOI 10.1007/BF00388481; ROTH SK, 1994, BIOCHEM SYST ECOL, V22, P341, DOI 10.1016/0305-1978(94)90025-6; ROTH SK, 1994, OECOLOGIA, V98, P133, DOI 10.1007/BF00341464; SALT CA, 1992, J APPL ECOL, V29, P378, DOI 10.2307/2404507; SLATER J, 1971, J AUST I AGR SCI, V37, P238; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Valdes B, 2002, CHEKLIST VASCULAR PL; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; van Wyk JH, 2000, AFR ZOOL, V35, P9; VAVRA M, 1978, J RANGE MANAGE, V31, P11, DOI 10.2307/3897623; Ward D, 1997, J CHEM ECOL, V23, P333, DOI 10.1023/B:JOEC.0000006363.34360.9d; WESTOBY M, 1978, AM NAT, V112, P627, DOI 10.1086/283303; WILLIAMS RS, 1994, OECOLOGIA, V98, P64, DOI 10.1007/BF00326091; WILLIAMS WE, 1986, OECOLOGIA, V69, P454, DOI 10.1007/BF00377068; WONG SC, 1979, OECOLOGIA, V44, P68, DOI 10.1007/BF00346400	83	46	47	5	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35643	10.1371/journal.pone.0035643	http://dx.doi.org/10.1371/journal.pone.0035643			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558187	gold, Green Published			2022-12-25	WOS:000305336000042
J	van de Waal, E; Krutzen, M; Hula, J; Goudet, J; Bshary, R				van de Waal, Erica; Kruetzen, Michael; Hula, Josephine; Goudet, Jerome; Bshary, Redouan			Similarity in Food Cleaning Techniques within Matrilines in Wild Vervet Monkeys	PLOS ONE			English	Article							CULTURAL TRANSMISSION; VOCAL TRADITIONS; CHLOROCEBUS-AETHIOPS; SOCIAL TRANSMISSION; JAPANESE MACAQUES; LEARNING-STRATEGY; CAPUCHIN MONKEYS; FIELD EXPERIMENT; MACACA-FUSCATA; ORCINUS-ORCA	Social learning and the formation of traditions rely on the ability and willingness to copy one another. A central question is under which conditions individuals adapt behaviour to social influences. Here, we demonstrate that similarities in food processing techniques emerge on the level of matrilines (mother - offspring) but not on the group level in an experiment on six groups of wild vervet monkeys that involved grapes covered with sand. Monkeys regularly ate unclean grapes but also used four cleaning techniques more similarly within matrilines: rubbing in hands, rubbing on substrate, open with mouth, and open with hands. Individual cleaning techniques evolved over time as they converged within matrilines, stabilised at the end and remained stable in a follow-up session more than one year later. The similarity within matrilines persisted when we analyzed only foraging events of individuals in the absence of other matriline members and matriline members used more similar methods than adult full sisters. Thus, momentary conversion or purely genetic causation are unlikely explanations, favouring social learning as mechanism for within matriline similarities. The restriction of traditions to matriline membership rather than to the group level may restrict the development of culture in monkeys relative to apes or humans.	[van de Waal, Erica; Bshary, Redouan] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland; [van de Waal, Erica; Hula, Josephine; Bshary, Redouan] Univ S Africa, Appl Behav Ecol & Ecosyst Res Unit, Florida, South Africa; [van de Waal, Erica] Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland; [Kruetzen, Michael; Hula, Josephine] Univ Zurich, Evolutionary Genet Grp, Anthropol Inst & Museum, Zurich, Switzerland; [Goudet, Jerome] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland	University of Neuchatel; University of South Africa; University of St Andrews; University of Zurich; University of Lausanne	van de Waal, E (corresponding author), Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland.	erica.vandewaal@unine.ch	Krutzen, Michael C/D-9550-2011; Goudet, Jerome/A-9730-2012	Goudet, Jerome/0000-0002-5318-7601; Krutzen, Michael/0000-0003-1055-5299; van de Waal, Erica/0000-0001-7778-418X; Bshary, Redouan/0000-0001-7198-8472	Swiss Science Foundation; Fonds Marguerite Wutrich et A. Mathey-Dupraz from the University of Neuchatel	Swiss Science Foundation(Swiss National Science Foundation (SNSF)); Fonds Marguerite Wutrich et A. Mathey-Dupraz from the University of Neuchatel	The project was funded by the Swiss Science Foundation (grant to RB) and the Fonds Marguerite Wutrich et A. Mathey-Dupraz from the University of Neuchatel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D, IME4 LINEAR MIXED EF; Bonnie KE, 2007, P ROY SOC B-BIOL SCI, V274, P367, DOI 10.1098/rspb.2006.3733; Boyd R., 1985, CULTURE EVOLUTIONARY; Boyd R., 2005, ORIGIN EVOLUTION CUL; Claidiere N, 2012, PSYCHOL B IN PRESS; Csillery K, 2006, GENETICS, V173, P2091, DOI 10.1534/genetics.106.057331; de Waal F., 2001, APE SUSHI MASTER CUL; Dindo M, 2008, P ROY SOC B-BIOL SCI, V275, P187, DOI 10.1098/rspb.2007.1318; Filatova OA, 2010, BIOL BULL+, V37, P965, DOI 10.1134/S1062359010090104; FORD JKB, 1991, CAN J ZOOL, V69, P1454, DOI 10.1139/z91-206; Fruteau C, 2009, P NATL ACAD SCI USA, V106, P12007, DOI 10.1073/pnas.0812280106; Gajdon GK, 2004, LEARN BEHAV, V32, P62; Giraldeau LA, 2002, PHILOS T R SOC B, V357, P1559, DOI 10.1098/rstb.2002.1065; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; HIKAMI K, 1990, J COMP PSYCHOL, V104, P233, DOI 10.1037/0735-7036.104.3.233; Hoppitt W, 2008, ADV STUD BEHAV, V38, P105, DOI 10.1016/S0065-3454(08)00003-X; Horner V, 2006, P NATL ACAD SCI USA, V103, P13878, DOI 10.1073/pnas.0606015103; Jaeggi AV, 2010, AM J PRIMATOL, V72, P62, DOI 10.1002/ajp.20752; Kendal JR, 2009, BEHAV ECOL, V20, P238, DOI 10.1093/beheco/arp016; Kwai M., 1965, PRIMATES, V6, P1, DOI DOI 10.1007/BF01794457; LALAND KN, 1990, ANIM LEARN BEHAV, V18, P246, DOI 10.3758/BF03205282; Laland KN, 2004, LEARN BEHAV, V32, P4; Langen TA, 1996, ETHOLOGY, V102, P157; Leca JB, 2010, ANIM BEHAV, V79, P117, DOI 10.1016/j.anbehav.2009.09.035; LEFEBVRE L, 1986, ETHOLOGY, V71, P295; Lehmann L, 2008, THEOR POPUL BIOL, V73, P506, DOI 10.1016/j.tpb.2008.02.004; Mesoudi A, 2008, EVOL HUM BEHAV, V29, P350, DOI 10.1016/j.evolhumbehav.2008.04.005; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; Muller CA, 2010, CURR BIOL, V20, P1171, DOI 10.1016/j.cub.2010.04.037; Newman TK, 2002, AM J PRIMATOL, V56, P237, DOI 10.1002/ajp.1078; Perry S, 2003, CURR ANTHROPOL, V44, P241, DOI 10.1086/345825; Perry S, 2009, ANIM COGN, V12, P705, DOI 10.1007/s10071-009-0230-3; Pesendorfer MB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004472; Price JJ, 1998, P ROY SOC B-BIOL SCI, V265, P497, DOI 10.1098/rspb.1998.0322; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Santorelli CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016863; Tanaka I, 1998, ANIM BEHAV, V56, P1229, DOI 10.1006/anbe.1998.0891; Thornton A, 2009, P ROY SOC B-BIOL SCI, V276, P1269, DOI 10.1098/rspb.2008.1794; van de Waal E, 2011, ANIM BEHAV, V81, P433, DOI 10.1016/j.anbehav.2010.11.013; van de Waal E, 2010, FOLIA PRIMATOL, V81, P282, DOI 10.1159/000322628; van de Waal E, 2010, P ROY SOC B-BIOL SCI, V277, P2105, DOI 10.1098/rspb.2009.2260; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; Voelkl B, 2000, ANIM BEHAV, V60, P195, DOI 10.1006/anbe.2000.1457; Wang JL, 2002, GENETICS, V160, P1203; Wang Y, 2006, THESIS U SYDNEY AUST; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; WHITEN A, 2009, QUESTION ANIMAL CULT, P99; Whiten A, 2007, PHILOS T R SOC B, V362, P603, DOI 10.1098/rstb.2006.1998; Whiten A, 2011, PHILOS T R SOC B, V366, P938, DOI 10.1098/rstb.2010.0372; Yeaman S, 2011, ANIM BEHAV, V82, P101, DOI 10.1016/j.anbehav.2011.04.004	54	29	29	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35694	10.1371/journal.pone.0035694	http://dx.doi.org/10.1371/journal.pone.0035694			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558201	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000305345200068
J	Drannik, AG; Nag, K; Yao, XD; Henrick, BM; Sallenave, JM; Rosenthal, KL				Drannik, Anna G.; Nag, Kakon; Yao, Xiao-Dan; Henrick, Bethany M.; Sallenave, Jean-Michel; Rosenthal, Kenneth L.			Trappin-2/Elafin Modulate Innate Immune Responses of Human Endometrial Epithelial Cells to PolyI:C	PLOS ONE			English	Article							ELASTASE-SPECIFIC INHIBITOR; LEUKOCYTE PROTEASE INHIBITOR; FEMALE REPRODUCTIVE-TRACT; DOUBLE-STRANDED-RNA; NF-KAPPA-B; HERPES-SIMPLEX-VIRUS; ADENOVIRUS-MEDIATED EXPRESSION; TOLL-LIKE RECEPTOR-3; HUMAN BETA-DEFENSINS; INDUCIBLE GENE-I	Background: Upon viral recognition, innate and adaptive antiviral immune responses are initiated by genital epithelial cells (ECs) to eradicate or contain viral infection. Such responses, however, are often accompanied by inflammation that contributes to acquisition and progression of sexually transmitted infections (STIs). Hence, interventions/factors enhancing antiviral protection while reducing inflammation may prove beneficial in controlling the spread of STIs. Serine antiprotease trappin-2 (Tr) and its cleaved form, elafin (E), are alarm antimicrobials secreted by multiple cells, including genital epithelia. Methodology and Principal Findings: We investigated whether and how each Tr and E (Tr/E) contribute to antiviral defenses against a synthetic mimic of viral dsRNA, polyinosine-polycytidylic acid (polyI:C) and vesicular stomatitis virus. We show that delivery of a replication-deficient adenovector expressing Tr gene (Ad/Tr) to human endometrial epithelial cells, HEC-1A, resulted in secretion of functional Tr, whereas both Tr/E were detected in response to polyI: C. Moreover, Tr/E were found to significantly reduce viral replication by either acting directly on virus or through enhancing polyI: C-driven antiviral protection. The latter was associated with reduced levels of pro-inflammatory factors IL-8, IL-6, TNF alpha, lowered expression of RIG-I, MDA5 and attenuated NF-kappa B activation. Interestingly, enhanced polyI: C-driven antiviral protection of HEC-Ad/Tr cells was partially mediated through IRF3 activation, but not associated with higher induction of IFN beta, suggesting multiple antiviral mechanisms of Tr/E and the involvement of alternative factors or pathways. Conclusions and Significance: This is the first evidence of both Tr/E altering viral binding/entry, innate recognition and mounting of antiviral and inflammatory responses in genital ECs that could have significant implications for homeostasis of the female genital tract.	[Drannik, Anna G.; Nag, Kakon; Yao, Xiao-Dan; Henrick, Bethany M.; Rosenthal, Kenneth L.] McMaster Univ, Dept Pathol & Mol Med, McMaster Immunol Res Ctr, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Sallenave, Jean-Michel] Inst Pasteur, Unite Def Innee & Inflammat, Paris, France; [Sallenave, Jean-Michel] INSERM, Unite U874, Paris, France; [Sallenave, Jean-Michel] Univ Paris 07, Paris, France	McMaster University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Drannik, AG (corresponding author), McMaster Univ, Dept Pathol & Mol Med, McMaster Immunol Res Ctr, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada.	rosenthl@mcmaster.ca	SALLENAVE, Jean-Michel/J-3746-2017; Henrick, Bethany/P-7388-2016	SALLENAVE, Jean-Michel/0000-0002-8595-6970; Henrick, Bethany/0000-0003-1883-6749	Comprehensive T Cell Vaccine Immune Monitoring Consortium (CTC-VIMC), a key component of the Collaboration for AIDS Vaccine Development (CAVD); Bill & Melinda Gates Foundation; Ontario HIV Treatment Network (OHTN)	Comprehensive T Cell Vaccine Immune Monitoring Consortium (CTC-VIMC), a key component of the Collaboration for AIDS Vaccine Development (CAVD); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Ontario HIV Treatment Network (OHTN)	This work was supported by a grant as part of the Comprehensive T Cell Vaccine Immune Monitoring Consortium (CTC-VIMC), a key component of the Collaboration for AIDS Vaccine Development (CAVD) funded by the Bill & Melinda Gates Foundation. A. G. D. was supported by a Studentship and K. L. R. by a Career Scientist Award from the Ontario HIV Treatment Network (OHTN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam SR, 2012, BIOCHEM PHARMACOL, V83, P695, DOI 10.1016/j.bcp.2011.11.003; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Alvarez R, 2008, J VIROL, V82, P471, DOI 10.1128/JVI.00939-07; Ashkar AA, 2004, J INFECT DIS, V190, P1841, DOI 10.1086/425079; Baranger K, 2008, FEBS J, V275, P2008, DOI 10.1111/j.1742-4658.2008.06355.x; Bauer CMT, 2008, J INTERF CYTOK RES, V28, P167, DOI 10.1089/jir.2007.0054; Bellemare A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-253; BETT AJ, 1994, P NATL ACAD SCI USA, V91, P8802, DOI 10.1073/pnas.91.19.8802; Bingle CD, 2008, TRENDS IMMUNOL, V29, P444, DOI 10.1016/j.it.2008.07.001; Butler MW, 2006, J BIOL CHEM, V281, P34730, DOI 10.1074/jbc.M604844200; Dogusan Z, 2008, DIABETES, V57, P1236, DOI 10.2337/db07-0844; Drannik AG, 2011, BIOCHEM SOC T, V39, P1427, DOI 10.1042/BST0391427; DRENTH J, 1980, J BIOL CHEM, V255, P2652; Erhart W, 2011, J INFECT DIS, V204, P391, DOI 10.1093/infdis/jir079; Fahey JV, 2011, AM J REPROD IMMUNOL, V65, P334, DOI 10.1111/j.1600-0897.2010.00949.x; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Ghosh M, 2010, IMMUNOLOGY, V129, P207, DOI 10.1111/j.1365-2567.2009.03165.x; Guo JJ, 2000, VIROLOGY, V267, P209, DOI 10.1006/viro.1999.0135; Guyot N, 2005, BIOCHEMISTRY-US, V44, P15610, DOI 10.1021/bi051418i; Guyot N, 2005, BIOL CHEM, V386, P391, DOI 10.1515/BC.2005.047; Guyot N, 2010, BIOL CHEM, V391, P705, DOI 10.1515/BC.2010.066; Harty RN, 2009, J INNATE IMMUN, V1, P397, DOI 10.1159/000226245; Hasan M, 2011, J IMMUNOL, V187, P5653, DOI 10.4049/jimmunol.1102144; Hazrati E, 2006, J IMMUNOL, V177, P8658, DOI 10.4049/jimmunol.177.12.8658; Henriksen PA, 2004, J IMMUNOL, V172, P4535, DOI 10.4049/jimmunol.172.7.4535; HOBBS DS, 1982, J BIOL CHEM, V257, P4071; Iqbal SM, 2009, AIDS, V23, P1669, DOI 10.1097/QAD.0b013e32832ea643; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; King AE, 2007, PLACENTA, V28, P161, DOI 10.1016/j.placenta.2006.01.006; King AE, 2003, J CLIN ENDOCR METAB, V88, P4426, DOI 10.1210/jc.2003-030239; Lester RT, 2008, AIDS, V22, P685, DOI 10.1097/QAD.0b013e3282f4de35; Lester RT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005644; Li Y, 2009, P NATL ACAD SCI USA, V106, P7945, DOI 10.1073/pnas.0900818106; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Ma G, 2004, J EXP MED, V200, P1337, DOI 10.1084/jem.20041115; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; MasCasullo V, 2005, VIRAL IMMUNOL, V18, P595, DOI 10.1089/vim.2005.18.595; McAlhany SJ, 2004, PROSTATE, V61, P182, DOI 10.1002/pros.20085; MCELVANEY NG, 1993, AM REV RESPIR DIS, V148, P1056, DOI 10.1164/ajrccm/148.4_Pt_1.1056; McLaren PJ, 2010, J INFECT DIS, V202, pS339, DOI 10.1086/655968; McMichael JW, 2005, AM J RESP CELL MOL, V32, P443, DOI 10.1165/rcmb.2004-0250OC; Moreau T, 2008, BIOCHIMIE, V90, P284, DOI 10.1016/j.biochi.2007.09.007; Mossman KL, 2001, J VIROL, V75, P750, DOI 10.1128/JVI.75.2.750-758.2001; Motta JP, 2011, GASTROENTEROLOGY, V140, P1272, DOI 10.1053/j.gastro.2010.12.050; Mulligan MS, 2000, AM J PATHOL, V156, P1033, DOI 10.1016/S0002-9440(10)64971-1; NARA K, 1994, J BIOCHEM, V115, P441, DOI 10.1093/oxfordjournals.jbchem.a124357; Nazli A, 2009, ANTIVIR RES, V81, P103, DOI 10.1016/j.antiviral.2008.10.005; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Noyce RS, 2006, J VIROL, V80, P226, DOI 10.1128/JVI.80.1.226-235.2006; Paladino P, 2006, J IMMUNOL, V177, P8008, DOI 10.4049/jimmunol.177.11.8008; Pfundt R, 2000, ARCH DERMATOL RES, V292, P180, DOI 10.1007/s004030050475; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; PILETZ JE, 1981, J BIOL CHEM, V256, P1509; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Rapista A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-45; Rebbapragada A, 2007, AIDS, V21, P589, DOI 10.1097/QAD.0b013e328012b896; Roghanian A, 2006, AM J RESP CELL MOL, V34, P634, DOI 10.1165/rcmb.2005-0405OC; Sakurai H, 2008, INT J PHARMACEUT, V354, P9, DOI 10.1016/j.ijpharm.2007.06.012; Sallenave JM, 2010, AM J RESP CELL MOL, V42, P635, DOI 10.1165/rcmb.2010-0095RT; Sallenave JM, 1998, GENE THER, V5, P352, DOI 10.1038/sj.gt.3300610; Sallenave JM, 1997, CHEST, V111, pS128, DOI 10.1378/chest.111.6_Supplement.128S; SALLENAVE JM, 1994, AM J RESP CELL MOL, V11, P733, DOI 10.1165/ajrcmb.11.6.7946401; SALLENAVE JM, 1992, BIOL CHEM H-S, V373, P27, DOI 10.1515/bchm3.1992.373.1.27; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schaefer TM, 2005, J IMMUNOL, V174, P992, DOI 10.4049/jimmunol.174.2.992; Schalkwijk J, 1999, BIOCHEM J, V340, P569, DOI 10.1042/0264-6021:3400569; SCHALKWIJK J, 1991, BIOCHIM BIOPHYS ACTA, V1096, P148, DOI 10.1016/0925-4439(91)90053-C; SCHALKWIJK J, 1990, BRIT J DERMATOL, V122, P631, DOI 10.1111/j.1365-2133.1990.tb07285.x; Semple F, 2011, EUR J IMMUNOL, V41, P3291, DOI 10.1002/eji.201141648; Shaw L, 2011, BIOCHEM SOC T, V39, P1450, DOI 10.1042/BST0391450; Simpson AJ, 1999, FEBS LETT, V452, P309, DOI 10.1016/S0014-5793(99)00670-5; Simpson AJ, 2001, HUM GENE THER, V12, P1395, DOI 10.1089/104303401750298553; Simpson AJ, 2001, J IMMUNOL, V167, P1778, DOI 10.4049/jimmunol.167.3.1778; Steinstraesser L, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-2; Taggart CC, 2005, J EXP MED, V202, P1659, DOI 10.1084/jem.20050768; Terenzi F, 2006, J BIOL CHEM, V281, P34064, DOI 10.1074/jbc.M605771200; Tsunemi M, 1996, BIOCHEMISTRY-US, V35, P11570, DOI 10.1021/bi960900l; Vandermeeren M, 2001, ARCH DERMATOL RES, V293, P343, DOI 10.1007/s004030100238; Vergnolle NSJ-M, 2011, RECOMBINANT PROBIOTI; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; WIEDOW O, 1990, J BIOL CHEM, V265, P14791; Wilkinson TS, 2009, AM J PATHOL, V174, P1338, DOI 10.2353/ajpath.2009.080746; Wira CR, 2005, AM J REPROD IMMUNOL, V53, P65, DOI 10.1111/j.1600-0897.2004.00248.x; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Zani ML, 2011, BIOCHEM SOC T, V39, P1441, DOI 10.1042/BST0391441; Zapata W, 2008, CURR HIV RES, V6, P531, DOI 10.2174/157016208786501463	90	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35866	10.1371/journal.pone.0035866	http://dx.doi.org/10.1371/journal.pone.0035866			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545145	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343200065
J	Hahn, DL; Schure, A; Patel, K; Childs, T; Drizik, E; Webley, W				Hahn, David L.; Schure, Allison; Patel, Katir; Childs, Tawanna; Drizik, Eduard; Webley, Wilmore			Chlamydia pneumoniae-Specific IgE Is Prevalent in Asthma and Is Associated with Disease Severity	PLOS ONE			English	Article							CHLAMYDOPHILA-PNEUMONIAE; MYCOPLASMA-PNEUMONIAE; AIRWAY INFLAMMATION; INFECTION; CELLS; COPD; LUNG; TRACHOMATIS; MEMBRANE; PROTEINS	Background: Several Chlamydia pneumoniae (Cp) biomarkers have been associated with asthma but Cp-specific IgE (Cp IgE) has not been investigated extensively. Our objective was to investigate Cp IgE in community adult asthma patients. Methods: (1) Prevalence of Cp IgE (measured by immunoblotting) and Cp DNA (by polymerase chain reaction) in peripheral blood, and biomarker associations with asthma severity. (2) Case-control studies of Cp IgE association with asthma using healthy blood donor (study 1) and non-asthmatic clinic patient (study 2) controls. Results: Of 66 asthma subjects (mean age 40.9 years, range 5-75, 59% male, 45% ever-smokers) 33 (50%) were Cp IgE positive and 16 (24%) were Cp DNA positive (P = 0.001 for association of Cp IgE and DNA). Cp IgE was detected in 21% of mild intermittent asthma v 79% of severe persistent asthma (test for trend over severity categories, P = 0.002). Cp IgE detection was significantly (P = 0.001) associated with asthma when compared to healthy blood donor controls but not when compared to clinic controls. Conclusions: Half of this sample of community asthma patients had detectable IgE against C. pneumoniae. Cp IgE was strongly and positively associated with asthma severity and with asthma when healthy blood donor controls were used. These results support the inclusion of Cp IgE as a biomarker in future studies of infectious contributions to asthma pathogenesis.	[Hahn, David L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Family Med, Madison, WI 53706 USA; [Hahn, David L.] Univ Wisconsin, Dean Clin, Madison, WI USA; [Schure, Allison; Patel, Katir; Childs, Tawanna; Drizik, Eduard; Webley, Wilmore] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Massachusetts System; University of Massachusetts Amherst	Hahn, DL (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Family Med, Madison, WI 53706 USA.	wilmore@microbio.umass.edu	Webley, Wilmore/I-7145-2012	Webley, Wilmore/0000-0003-4490-395X	Dean Foundation for Health Research and Education, Madison, Wisconsin	Dean Foundation for Health Research and Education, Madison, Wisconsin	The Dean Foundation for Health Research and Education, Madison, Wisconsin funded the study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEGRA L, 1994, EUR RESPIR J, V7, P2165, DOI 10.1183/09031936.94.07122165; Altenburg J, 2011, RESPIRATION, V81, P67, DOI 10.1159/000320319; [Anonymous], 2007, 3 US DEP HLTH HUM SE; Asquith KL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001339; Beigelman A, 2009, CHEST, V136, P498, DOI 10.1378/chest.08-3056; Birmingham N, 2003, J IMMUNOL METHODS, V275, P89, DOI 10.1016/S0022-1759(03)00008-5; Blasi F, 2000, CHLAMYDIA PNEUMONIAE; Blasi F, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-83; Burian K, 2003, IMMUNOL LETT, V89, P229, DOI 10.1016/S0165-2478(03)00154-8; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Chen CZ, 2009, J FORMOS MED ASSOC, V108, P45, DOI 10.1016/S0929-6646(09)60031-0; CHOBOT R, 1951, J ALLERGY, V22, P106, DOI 10.1016/0021-8707(51)90049-4; CIOCCA DR, 1983, J HISTOCHEM CYTOCHEM, V31, P691, DOI 10.1177/31.5.6341459; da Costa CP, 2002, EUR J IMMUNOL, V32, P2460, DOI 10.1002/1521-4141(200209)32:9<2460::AID-IMMU2460>3.0.CO;2-M; DeGraves FJ, 2003, BIOTECHNIQUES, V34, P106, DOI 10.2144/03341rr01; EMRE U, 1995, J INFECT DIS, V172, P265, DOI 10.1093/infdis/172.1.265; Gaydos CA, 1992, ABSTR AM SOC MICR D, VD-132, P118; Gern JE, 2000, J ALLERGY CLIN IMMUN, V106, P201, DOI 10.1067/mai.2000.108604; Gibson PG, 2009, THORAX, V64, P728, DOI 10.1136/thx.2008.108027; Global Initiative for Asthma (GINA), 2007, GLOB STRAT ASTHM MAN; Hahn DL, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010011; Hahn DL, 2008, ANN ALLERG ASTHMA IM, V101, P614, DOI 10.1016/S1081-1206(10)60224-4; Hahn DL, 2000, ANN ALLERG ASTHMA IM, V84, P227, DOI 10.1016/S1081-1206(10)62760-3; Hahn DL, 1999, ANN ALLERG ASTHMA IM, V83, P271, DOI 10.1016/S1081-1206(10)62666-X; HAHN DL, 1995, J FAM PRACTICE, V41, P345; Hahn DL, 2002, FRONT BIOSCI-LANDMRK, V7, pE66, DOI 10.2741/hahn; Hahn DL, 2004, INFEC AGENT, P239; Hamilton RG, 2010, J ALLERGY CLIN IMMUN, V125, pS284, DOI 10.1016/j.jaci.2009.09.055; Hansbro PM, 2004, PHARMACOL THERAPEUT, V101, P193, DOI 10.1016/j.pharmthera.2003.10.007; Henderson CE, 1998, J IMMUNOL METHODS, V213, P99, DOI 10.1016/S0022-1759(98)00014-3; Herland K, 2005, RESP MED, V99, P11, DOI 10.1016/j.rmed.2004.03.026; Hollams EM, 2010, EUR RESPIR J, V36, P509, DOI 10.1183/09031936.00184109; Horvat JC, 2007, AM J RESP CRIT CARE, V176, P556, DOI 10.1164/rccm.200607-1005OC; Horvat JC, 2010, J ALLERGY CLIN IMMUN, V125, P617, DOI 10.1016/j.jaci.2009.10.018; Horvat JC, 2010, J IMMUNOL, DOI 10,4049/jimmunol.0902287; Ikezawa Shigeru, 2001, Kurume Medical Journal, V48, P165, DOI 10.2739/kurumemedj.48.165; Jahn HU, 2000, J INFECT DIS, V182, P1678, DOI 10.1086/317608; Johnston SL, 2005, AM J RESP CRIT CARE, V172, P1078, DOI 10.1164/rccm.200412-1743PP; Kadooka Y, 2000, INT ARCH ALLERGY IMM, V122, P264, DOI 10.1159/000024408; Kaiko GE, 2008, J IMMUNOL, V180, P2225, DOI 10.4049/jimmunol.180.4.2225; Martin RJ, 2001, J ALLERGY CLIN IMMUN, V107, P595, DOI 10.1067/mai.2001.113563; Montigiani S, 2002, INFECT IMMUN, V70, P368, DOI 10.1128/IAI.70.1.368-379.2002; Morinaga Y, 2009, PULM PHARMACOL THER, V22, P580, DOI 10.1016/j.pupt.2009.08.004; Peters J, 2011, CHEST, V140, P401, DOI 10.1378/chest.11-0221; Redecke V, 1998, AM J RESP CELL MOL, V19, P721, DOI 10.1165/ajrcmb.19.5.3072; Rizzo A, 2011, CYTOKINE, V56, P450, DOI 10.1016/j.cyto.2011.06.027; SAIKKU P, 1993, EUR HEART J, V14, P62; Schroeder NWJ, 2008, J ALLERGY CLIN IMMUN, V122, P595, DOI 10.1016/j.jaci.2008.06.038; SEGGEV JS, 1992, J ALLERGY CLIN IMMUN, V89, P230; SHEMERAVNI Y, 1995, J INFECT DIS, V171, P1274, DOI 10.1093/infdis/171.5.1274; Simpson JL, 2008, AM J RESP CRIT CARE, V177, P148, DOI 10.1164/rccm.200707-1134OC; Souza-Atta MLB, 1999, BRAZ J MED BIOL RES, V32, P1101, DOI 10.1590/S0100-879X1999000900008; Stone KD, 2010, J ALLERGY CLIN IMMUN, V125, pS73, DOI 10.1016/j.jaci.2009.11.017; Tanzer RJ, 2001, J BACTERIOL, V183, P2686, DOI 10.1128/JB.183.8.2686-2690.2001; von Hertzen L, 2002, SCAND J INFECT DIS, V34, P22, DOI 10.1080/00365540110077155; Webley WC, 2009, EUR RESPIR J, V33, P360, DOI 10.1183/09031936.00019508; WELLIVER RC, 1980, NEW ENGL J MED, V303, P1198, DOI 10.1056/NEJM198011203032103; WELLIVER RC, 1982, J PEDIATR-US, V101, P889, DOI 10.1016/S0022-3476(82)80005-X; Wolf K, 2009, CELL MICROBIOL, V11, P769, DOI 10.1111/j.1462-5822.2009.01290.x; YANO T, 1992, American Review of Respiratory Disease, V145, pA497	61	53	55	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35945	10.1371/journal.pone.0035945	http://dx.doi.org/10.1371/journal.pone.0035945			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545149	Green Published, gold			2022-12-25	WOS:000305343200069
J	Rius, M; Turon, X; Ordonez, V; Pascual, M				Rius, Marc; Turon, Xavier; Ordonez, Victor; Pascual, Marta			Tracking Invasion Histories in the Sea: Facing Complex Scenarios Using Multilocus Data	PLOS ONE			English	Article							MICROCOSMUS-SQUAMIGER ASCIDIACEA; GENETIC DIVERSITY; BIOLOGICAL INVASIONS; INTRODUCED POPULATIONS; SPINY LOBSTERS; MICROSATELLITE; PHYLOGEOGRAPHY; CONSEQUENCES; SOFTWARE; SUCCESS	In recent years, new analytical tools have allowed researchers to extract historical information contained in molecular data, which has fundamentally transformed our understanding of processes ruling biological invasions. However, the use of these new analytical tools has been largely restricted to studies of terrestrial organisms despite the growing recognition that the sea contains ecosystems that are amongst the most heavily affected by biological invasions, and that marine invasion histories are often remarkably complex. Here, we studied the routes of invasion and colonisation histories of an invasive marine invertebrate Microcosmus squamiger (Ascidiacea) using microsatellite loci, mitochondrial DNA sequence data and 11 worldwide populations. Discriminant analysis of principal components, clustering methods and approximate Bayesian computation (ABC) methods showed that the most likely source of the introduced populations was a single admixture event that involved populations from two genetically differentiated ancestral regions - the western and eastern coasts of Australia. The ABC analyses revealed that colonisation of the introduced range of M. squamiger consisted of a series of non-independent introductions along the coastlines of Africa, North America and Europe. Furthermore, we inferred that the sequence of colonisation across continents was in line with historical taxonomic records - first the Mediterranean Sea and South Africa from an unsampled ancestral population, followed by sequential introductions in California and, more recently, the NE Atlantic Ocean. We revealed the most likely invasion history for world populations of M. squamiger, which is broadly characterized by the presence of multiple ancestral sources and non-independent introductions within the introduced range. The results presented here illustrate the complexity of marine invasion routes and identify a cause-effect relationship between human-mediated transport and the success of widespread marine non-indigenous species, which benefit from stepping-stone invasions and admixture processes involving different sources for the spread and expansion of their range.	[Rius, Marc] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Turon, Xavier] CSIC, CEAB, Blanes, Spain; [Ordonez, Victor; Pascual, Marta] Univ Barcelona, Dept Genet, Barcelona, Spain; [Ordonez, Victor; Pascual, Marta] Univ Barcelona, IRBio, Barcelona, Spain	University of California System; University of California Davis; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of Barcelona; University of Barcelona	Rius, M (corresponding author), Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA.	mrius@ucdavis.edu	Pascual, Marta/M-7626-2015; Turon, Xavier/J-9211-2012; Rius, Marc/C-5088-2011; Pascual, Marta/ABG-3782-2020	Pascual, Marta/0000-0002-6189-0612; Turon, Xavier/0000-0002-9229-5541; Rius, Marc/0000-0002-2195-6605; Pascual, Marta/0000-0002-6189-0612	Marie Curie International Outgoing fellowship (EU - FP7 - PEOPLE - IOF) from the European Community's Seventh Framework Programme [254634]; Spanish Government [CTM2010 - 22218]; Fundacion Banco Bilbao Vizcaya Argentaria (FBBVA) [BIOCON08-187]; FPU (Formacion del Profesorado Universitario) scholarship from the Spanish Ministerio de Educacion [AP2008 - 04209, 2009]; COCONET, EU - FP7 [287844]	Marie Curie International Outgoing fellowship (EU - FP7 - PEOPLE - IOF) from the European Community's Seventh Framework Programme; Spanish Government(Spanish GovernmentEuropean Commission); Fundacion Banco Bilbao Vizcaya Argentaria (FBBVA); FPU (Formacion del Profesorado Universitario) scholarship from the Spanish Ministerio de Educacion(German Research Foundation (DFG)); COCONET, EU - FP7	M.R. was supported by a Marie Curie International Outgoing fellowship (EU - FP7 - PEOPLE - 2009 - IOF, 254634) from the European Community's Seventh Framework Programme. This research was funded by projects CTM2010 - 22218 of the Spanish Government, project 287844 (COCONET, EU - FP7), BIOCON08-187 from the Fundacion Banco Bilbao Vizcaya Argentaria (FBBVA) and a FPU (Formacion del Profesorado Universitario) scholarship to V.O. (AP2008 - 04209, 2009) from the Spanish Ministerio de Educacion. The authors are part of the research groups 2009SGR - 636, and 2009SGR - 484 of the Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul JAH, 2007, J EXP MAR BIOL ECOL, V342, P189, DOI 10.1016/j.jembe.2006.10.041; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Bach J., 1976, MARITIME HIST AUSTR; Barrows TT, 2004, QUATERNARY SCI REV, V23, P697, DOI 10.1016/j.quascirev.2003.10.011; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Beaumont MA, 2004, NAT REV GENET, V5, P251, DOI 10.1038/nrg1318; Beaumont MA, 2002, GENETICS, V162, P2025; Beheregaray LB, 2008, MOL ECOL, V17, P3754, DOI 10.1111/j.1365-294X.2008.03857.x; Belkhir K, 9060 CNRS UPR U MONT; Benjamini Y, 2001, ANN STAT, V29, P1165; Boero F, 2002, CIESM WORKSHOP MONOG, P87; Borsa P, 1997, MAR BIOL, V129, P233, DOI 10.1007/s002270050164; Bryja J, 2010, MOL ECOL, V19, P4708, DOI 10.1111/j.1365-294X.2010.04844.x; Byrnes JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000295; CARLTON JT, 1993, SCIENCE, V261, P78, DOI 10.1126/science.261.5117.78; Carlton JT, 1996, BIOL CONSERV, V78, P97, DOI 10.1016/0006-3207(96)00020-1; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Cohen AN, 1998, SCIENCE, V279, P555, DOI 10.1126/science.279.5350.555; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Cornuet JM, 1996, GENETICS, V144, P2001; Coutts ADM, 2007, MAR POLLUT BULL, V54, P875, DOI 10.1016/j.marpolbul.2007.03.011; Csillery K, 2010, TRENDS ECOL EVOL, V25, P410, DOI 10.1016/j.tree.2010.04.001; deMenocal P, 2000, SCIENCE, V288, P2198, DOI 10.1126/science.288.5474.2198; Dupont L, 2010, BIOL INVASIONS, V12, P2707, DOI 10.1007/s10530-009-9676-0; Estoup A, 2004, EVOLUTION, V58, P2021, DOI 10.1111/j.0014-3820.2004.tb00487.x; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fenwick G., 2005, 200512 MIN AGR FOR; Fitzpatrick BM, 2012, BIOL INVASIONS, V14, P245, DOI 10.1007/s10530-011-0064-1; Galarza JA, 2009, P NATL ACAD SCI USA, V106, P1473, DOI 10.1073/pnas.0806804106; Galil Bella S., 2000, Biological Invasions, V2, P177, DOI 10.1023/A:1010057010476; Geller JB, 2010, ANNU REV MAR SCI, V2, P367, DOI 10.1146/annurev.marine.010908.163745; Gerlach G, 2010, MOL ECOL, V19, P3845, DOI 10.1111/j.1365-294X.2010.04784.x; Gillis NK, 2009, DIVERS DISTRIB, V15, P784, DOI 10.1111/j.1472-4642.2009.00591.x; Goldstien SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016755; Grosholz E, 2002, TRENDS ECOL EVOL, V17, P22, DOI 10.1016/S0169-5347(01)02358-8; Grosholz ED, 2005, P NATL ACAD SCI USA, V102, P1088, DOI 10.1073/pnas.0308547102; Guillemaud T, 2010, HEREDITY, V104, P88, DOI 10.1038/hdy.2009.92; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; Holland BS, 2000, HYDROBIOLOGIA, V420, P63, DOI 10.1023/A:1003929519809; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Ilves KL, 2010, MOL ECOL, V19, P4505, DOI 10.1111/j.1365-294X.2010.04790.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T., 2010, BMC GENET, V11, P1, DOI [10.1186/1471-2156-11-94, DOI 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kaluza P, 2010, J R SOC INTERFACE, V7, P1093, DOI 10.1098/rsif.2009.0495; Keller RP, 2011, DIVERS DISTRIB, V17, P93, DOI 10.1111/j.1472-4642.2010.00696.x; Keller SR, 2010, J EVOLUTION BIOL, V23, P1720, DOI 10.1111/j.1420-9101.2010.02037.x; Kirkpatrick M, 2006, GENETICS, V173, P419, DOI 10.1534/genetics.105.047985; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; KOTT P, 1985, Memoirs of the Queensland Museum, V23, P1; Lambert CC, 1998, MAR BIOL, V130, P675, DOI 10.1007/s002270050289; Lambert CC, 2003, MAR ECOL PROG SER, V259, P145, DOI 10.3354/meps259145; Lambert G, 2007, J EXP MAR BIOL ECOL, V342, P3, DOI 10.1016/j.jembe.2006.10.009; Lambert Gretchen, 2002, Pacific Science, V56, P291, DOI 10.1353/psc.2002.0026; Lindholm AK, 2005, MOL ECOL, V14, P3671, DOI 10.1111/j.1365-294X.2005.02697.x; Liu TK, 2011, MAR POLLUT BULL, V62, P602, DOI 10.1016/j.marpolbul.2010.11.016; Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mastrototaro F, 2008, J MAR BIOL ASSOC UK, V88, P1053, DOI 10.1017/S0025315408001392; Mastrototaro F., 2008, MAR BIODIVERS REC, V1, P12, DOI [DOI 10.1017/S1755267205001247, 10.1017/S1755267205001247]; Mead A, 2011, BIOL INVASIONS, V13, P1991, DOI 10.1007/s10530-011-0016-9; MICHAELSEN W., 1927, ZOOL ANZEIGER, V71, P193; Millar B. H., 1962, Annals of the South African Museum, V46, P113; MILLAR R. H., 1955, PROC ZOOL SOC LONDON, V125, P169; MILLAR RH, 1971, ADV MAR BIOL, V9, P1, DOI 10.1016/S0065-2881(08)60341-7; Miller N, 2005, SCIENCE, V310, P992, DOI 10.1126/science.1115871; MONNIOT C, 1981, Tethys, V10, P59; Monniot Claude, 2001, Annals of the South African Museum, V108, P1; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Naranjo S. A., 1994, Graellsia, V50, P57; Naranjo SA, 1996, MAR ECOL PROG SER, V144, P119, DOI 10.3354/meps144119; Naranjo SA, 1995, THESIS U SEVILLA SEV; OLSON RR, 1985, ECOLOGY, V66, P30, DOI 10.2307/1941304; Palero F, 2010, J CRUSTACEAN BIOL, V30, P658, DOI 10.1651/09-3192.1; Palero F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-263; Pascual M, 2007, MOL ECOL, V16, P3069, DOI 10.1111/j.1365-294X.2007.03336.x; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pineda MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025495; Pritchard JK, 2000, GENETICS, V155, P945; Ranasinghe JA, 2005, BIOL INVASIONS, V7, P679, DOI 10.1007/s10530-004-5857-z; Ricciardi A, 2007, CONSERV BIOL, V21, P329, DOI 10.1111/j.1523-1739.2006.00615.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rius M, 2008, MOL ECOL RESOUR, V8, P1405, DOI 10.1111/j.1755-0998.2008.02311.x; Rius M, 2008, DIVERS DISTRIB, V14, P818, DOI 10.1111/j.1472-4642.2008.00485.x; Rius M, 2010, FUNCT ECOL, V24, P685, DOI 10.1111/j.1365-2435.2009.01668.x; Rius M, 2009, BIOL INVASIONS, V11, P2181, DOI 10.1007/s10530-008-9375-2; Rolshausen G, 2009, CURR BIOL, V19, P2097, DOI 10.1016/j.cub.2009.10.061; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Roman J, 2006, P ROY SOC B-BIOL SCI, V273, P2453, DOI 10.1098/rspb.2006.3597; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rovito SM, 2010, MOL ECOL, V19, P4554, DOI 10.1111/j.1365-294X.2010.04825.x; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Simon-Bouhet B, 2006, MOL ECOL, V15, P1699, DOI 10.1111/j.1365-294X.2006.02881.x; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Svane I., 1989, Oceanography and Marine Biology an Annual Review, V27, P45; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Turon X, 2007, J EXP MAR BIOL ECOL, V342, P185, DOI 10.1016/j.jembe.2006.10.040; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wasson K, 2001, BIOL CONSERV, V102, P143, DOI 10.1016/S0006-3207(01)00098-2; Whitlock MC, 2011, MOL ECOL, V20, P1083, DOI 10.1111/j.1365-294X.2010.04996.x; Wonham MJ, 2005, BIOL INVASIONS, V7, P369, DOI 10.1007/s10530-004-2581-7; Zepeda-Paulo FA, 2010, MOL ECOL, V19, P4738, DOI 10.1111/j.1365-294X.2010.04857.x; Zhan AB, 2010, MOL ECOL, V19, P4678, DOI 10.1111/j.1365-294X.2010.04837.x	110	49	49	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35815	10.1371/journal.pone.0035815	http://dx.doi.org/10.1371/journal.pone.0035815			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545140	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000305343200060
J	McIver, SC; Stanger, SJ; Santarelli, DM; Roman, SD; Nixon, B; McLaughlin, EA				McIver, Skye C.; Stanger, Simone J.; Santarelli, Danielle M.; Roman, Shaun D.; Nixon, Brett; McLaughlin, Eileen A.			A Unique Combination of Male Germ Cell miRNAs Coordinates Gonocyte Differentiation	PLOS ONE			English	Article							SPERMATOGONIAL STEM-CELLS; TESTICULAR EMBRYONAL CARCINOMA; MOUSE SPERMATOGENESIS; SELF-RENEWAL; MICRORNA EXPRESSION; TESTIS TISSUES; UP-REGULATION; TUMORS; PROLIFERATION; TRANSITION	The last 100 years have seen a concerning decline in male reproductive health associated with decreased sperm production, sperm function and male fertility. Concomitantly, the incidence of defects in reproductive development, such as undescended testes, hypospadias and testicular cancer has increased. Indeed testicular cancer is now recognised as the most common malignancy in young men. Such cancers develop from the pre-invasive lesion Carcinoma in Situ (CIS), a dysfunctional precursor germ cell or gonocyte which has failed to successfully differentiate into a spermatogonium. It is therefore essential to understand the cellular transition from gonocytes to spermatogonia, in order to gain a better understanding of the aetiology of testicular germ cell tumours. MicroRNA (miRNA) are important regulators of gene expression in differentiation and development and thus highly likely to play a role in the differentiation of gonocytes. In this study we have examined the miRNA profiles of highly enriched populations of gonocytes and spermatogonia, using microarray technology. We identified seven differentially expressed miRNAs between gonocytes and spermatogonia (down-regulated: miR-293, 291a-5p, 290-5p and 294*, up-regulated: miR-136, 743a and 463*). Target prediction software identified many potential targets of several differentially expressed miRNA implicated in germ cell development, including members of the PTEN, and Wnt signalling pathways. These targets converge on the key downstream cell cycle regulator Cyclin D1, indicating that a unique combination of male germ cell miRNAs coordinate the differentiation and maintenance of pluripotency in germ cells.	[McIver, Skye C.; Stanger, Simone J.; Roman, Shaun D.; Nixon, Brett; McLaughlin, Eileen A.] Univ Newcastle, ARC Ctr Excellence Biotechnol & Dev, Discipline Biol Sci, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia; [Santarelli, Danielle M.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia	University of Newcastle; University of Newcastle	McLaughlin, EA (corresponding author), Univ Newcastle, ARC Ctr Excellence Biotechnol & Dev, Discipline Biol Sci, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia.	eileen.mclaughlin@newcastle.edu.au	McLaughlin, Eileen A/G-7620-2013; Roman, Shaun/AFR-5087-2022; Nixon, Brett/B-5121-2012; McLaughlin, Eileen/AAF-5588-2021; ROMAN, SHAUN/G-7047-2013	Nixon, Brett/0000-0003-2745-8188; McLaughlin, Eileen/0000-0002-5837-3876; Santarelli, Danielle/0000-0002-2756-3327; ROMAN, SHAUN/0000-0002-7758-7757	Australian Research Council; National Health and Medical Research Council; University of Newcastle; Australian Postgraduate Award PhD scholarship; Australian Research Council Centre of Excellence in Biotechnology and Development [CE0348239]; University of Newcastle Vice Chancellors Post Graduate Award	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of Newcastle; Australian Postgraduate Award PhD scholarship; Australian Research Council Centre of Excellence in Biotechnology and Development(Australian Research Council); University of Newcastle Vice Chancellors Post Graduate Award	The authors gratefully acknowledge the financial assistance to EAM, SDR and BN by the Australian Research Council, National Health and Medical Research Council and the University of Newcastle. SCM is the recipient of an Australian Postgraduate Award PhD scholarship and a University of Newcastle Vice Chancellors Post Graduate Award. This work was supported by the Australian Research Council Centre of Excellence in Biotechnology and Development (CE0348239) to EAM and SDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baleato RM, 2005, DEV BIOL, V286, P78, DOI 10.1016/j.ydbio.2005.07.009; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beumer TL, 2000, BIOL REPROD, V63, P1893, DOI 10.1095/biolreprod63.6.1893; Buchold GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015317; Cao X, 2011, MED ONCOLOGY; Conrotto P, 2011, MOL ONCOLOGY; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Cui Y, 2011, J CELL PHYSL; Culty M, 2009, BIRTH DEFECTS RES C, V87, P1, DOI 10.1002/bdrc.20142; Dai L, 2011, J BIOL CHEM; Dalgaard MD, 2011, J MED GENETICS; de Jong Jeroen, 2006, Critical Reviews in Oncogenesis, V12, P171; Di Vizio D, 2005, ONCOGENE, V24, P1882, DOI 10.1038/sj.onc.1208368; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Feng M, 2011, ONCOGENE, V30, P2242, DOI 10.1038/onc.2010.602; Freemantle SJ, 2007, INT J ONCOL, V30, P333; Gilbert D, 2011, NAT REV CANCER, V11, P278, DOI 10.1038/nrc3021; Gilbert DC, 2011, GENE CHROMOSOME CANC, V50, P186, DOI 10.1002/gcc.20843; Gillis AJM, 2007, J PATHOL, V213, P319, DOI 10.1002/path.2230; Giwercman A, 2011, BEST PRACT RES CL EN, V25, P391, DOI 10.1016/j.beem.2010.09.011; Goddard NC, 2007, INT J ANDROL, V30, P337, DOI 10.1111/j.1365-2605.2007.00769.x; Golestaneh N, 2009, REPRODUCTION, V138, P151, DOI 10.1530/REP-08-0510; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; Huang Y, 2011, CELL BIOL INT, V35, P905, DOI 10.1042/CBI20110161; Jin X, 2011, CANCER RES, V71, P3066, DOI 10.1158/0008-5472.CAN-10-1495; Joffe M, 2010, HUM REPROD, V25, P295, DOI 10.1093/humrep/dep390; Kocer A, 2009, MOL HUM REPROD, V15, P205, DOI 10.1093/molehr/gap008; Kotlabova K, 2011, J REPROD IMMUNOL, V89, P185, DOI 10.1016/j.jri.2011.02.006; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Larson BL, 2010, TISSUE ENG PT A, V16, P3385, DOI 10.1089/ten.tea.2010.0085; Lee J, 2007, DEVELOPMENT, V134, P1853, DOI 10.1242/dev.003004; Lee TL, 2009, BIRTH DEFECTS RES C, V87, P43, DOI 10.1002/bdrc.20147; Li Q, 2005, J BIOL CHEM, V280, P2831, DOI 10.1074/jbc.M405680200; Lian J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.70; Lian J, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-13; Linsen SEV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-249; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lize M, 2010, CELL DEATH DIFFER, V17, P452, DOI 10.1038/cdd.2009.188; Luo JP, 2009, J CELL PHYSIOL, V220, P460, DOI 10.1002/jcp.21789; Luo LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011744; Ma PP, 2006, MOL REPROD DEV, V73, P774, DOI 10.1002/mrd.20468; Maatouk DM, 2008, BIOL REPROD, V79, P696, DOI 10.1095/biolreprod.108.067827; Marcon E, 2008, CHROMOSOME RES, V16, P243, DOI 10.1007/s10577-007-1190-6; McIver SC, 2012, HUM REPROD UPDATE, V18, P44, DOI 10.1093/humupd/dmr041; Medeiros LA, 2011, P NATL ACAD SCI USA, V108, P14163, DOI 10.1073/pnas.1111241108; Meyts ERD, 2007, ANN NY ACAD SCI, V1120, P168, DOI 10.1196/annals.1411.013; Niu ZY, 2011, P NATL ACAD SCI USA, V108, P12740, DOI 10.1073/pnas.1109987108; Noel EE, 2010, AM J PATHOL, V176, P2607, DOI 10.2353/ajpath.2010.090780; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Oatley JM, 2006, METHOD ENZYMOL, V419, P259, DOI 10.1016/S0076-6879(06)19011-4; Papaioannou MD, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M900587-MCP200; Papaioannou MD, 2010, J ANDROL, V31, P26, DOI 10.2164/jandrol.109.008128; Pode-Shakked N, 2011, ONCOGENE, V30, P1664, DOI 10.1038/onc.2010.549; Povey AC, 2010, HUM FERTIL, V13, P182, DOI 10.3109/14647273.2010.515700; Ro S, 2007, DEV BIOL, V311, P592, DOI 10.1016/j.ydbio.2007.09.009; Ruprecht-Karles-Universitat, 2010, MIRWALK DAT PRED VAL; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shi QL, 2011, J NEUROCHEM, V118, P440, DOI 10.1111/j.1471-4159.2011.07333.x; Skakkebek NE, 2007, INT J ANDROL, V30, P198, DOI 10.1111/j.1365-2605.2007.00776.x; Sonne SB, 2009, CANCER RES, V69, P5241, DOI 10.1158/0008-5472.CAN-08-4554; Suzuki H, 2011, DEV BIOL; Tanwar PS, 2010, BIOL REPROD, V82, P422, DOI 10.1095/biolreprod.109.079335; Tong MH, 2011, BIOL REPROD; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Wu X, 2011, BIOL REPROD, V85, P1114, DOI 10.1095/biolreprod.111.091793; Yan NH, 2007, REPRODUCTION, V134, P73, DOI 10.1530/REP-07-0056; Yan NH, 2009, J ASSIST REPROD GEN, V26, P179, DOI 10.1007/s10815-009-9305-y; Yang L, 2011, ONCOGENE; Yu ZR, 2005, BIOL REPROD, V73, P427, DOI 10.1095/biolreprod.105.040998; Zhang BH, 2009, ENVIRON HEALTH PERSP, V117, P231, DOI 10.1289/ehp.11841; Zheng GXY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002054; Zovoilis A, 2008, MOL HUM REPROD, V14, P521, DOI 10.1093/molehr/gan044; Zovoilis A, 2010, MOL HUM REPROD, V16, P793, DOI 10.1093/molehr/gaq053	77	59	62	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35553	10.1371/journal.pone.0035553	http://dx.doi.org/10.1371/journal.pone.0035553			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536405	Green Published, gold			2022-12-25	WOS:000305339200078
J	Momke, S; Sickinger, M; Rehage, J; Doll, K; Distl, O				Moemke, Stefanie; Sickinger, Marlene; Rehage, Juergen; Doll, Klaus; Distl, Ottmar			Transcription Factor Binding Site Polymorphism in the Motilin Gene Associated with Left-Sided Displacement of the Abomasum in German Holstein Cattle	PLOS ONE			English	Article							GASTRIC DILATATION; MILK-PRODUCTION	Left-sided displacement of the abomasum (LDA) is a common disease in many dairy cattle breeds. A genome-wide screen for QTL for LDA in German Holstein (GH) cows indicated motilin (MLN) as a candidate gene on bovine chromosome 23. Genomic DNA sequence analysis of MLN revealed a total of 32 polymorphisms. All informative polymorphisms used for association analyses in a random sample of 1,136 GH cows confirmed MLN as a candidate for LDA. A single nucleotide polymorphism (FN298674:g.90T>C) located within the first non-coding exon of bovine MLN affects a NKX2-5 transcription factor binding site and showed significant associations (ORallele = 0.64; -log(10)P(allele) = 6.8, -log(10)P(genotype) = 7.0) with LDA. An expression study gave evidence of a significantly decreased MLN expression in cows carrying the mutant allele (C). In individuals heterozygous or homozygous for the mutation, MLN expression was decreased by 89% relative to the wildtype. FN298674:g.90T>C may therefore play a role in bovine LDA via the motility of the abomasum. This MLN SNP appears useful to reduce the incidence of LDA in German Holstein cattle and provides a first step towards a deeper understanding of the genetics of LDA.	[Moemke, Stefanie; Distl, Ottmar] Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany; [Sickinger, Marlene; Doll, Klaus] Univ Giessen, Fac Vet Med, Clin Ruminants & Swine, Giessen, Germany; [Rehage, Juergen] Univ Vet Med Hannover, Clin Cattle, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; Justus Liebig University Giessen; University of Veterinary Medicine Hannover, Foundation	Distl, O (corresponding author), Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany.	ottmar.distl@tiho-hannover.de			German Research Foundation (Deutsche Forschungsgemeinschaft, DFG), Bonn [MO1691/1-2, MO1691/2-1]	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG), Bonn(German Research Foundation (DFG))	The project and SM were supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG), Bonn (MO1691/1-2 and 2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; BETHLEHEM M, 1987, TIJDSCHR DIERGENEESK, V112, P1101; Bredal WP, 1996, ACTA VET SCAND, V37, P445; Doll K, 2009, VET J, V181, P90, DOI 10.1016/j.tvjl.2008.01.013; Geishauser T, 1998, NEUROGASTROENT MOTIL, V10, P395; GRYMER J, 1982, NORD VET MED, V34, P412; Hamann H, 2004, J VET MED A, V51, P203, DOI 10.1111/j.1439-0442.2004.00626.x; Hudson NPH, 2008, EQUINE VET J, V40, P422, DOI 10.2746/042516408X312932; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCallum RW, 2007, ALIMENT PHARM THER, V26, P1121, DOI 10.1111/j.1365-2036.2007.03461.x; McCallum RW, 2007, ALIMENT PHARM THER, V26, P107, DOI 10.1111/j.1365-2036.2007.03346.x; Momke S, 2008, J DAIRY SCI, V91, P4383, DOI 10.3168/jds.2008-1260; Monnet E, 2003, VET CLIN N AM-SMALL, V33, P987, DOI 10.1016/S0195-5616(03)00059-7; Oishi T, 2008, J HUM GENET, V53, P151, DOI 10.1007/s10038-007-0233-3; Poitras P, 2008, CURR OPIN ENDOCRINOL, V15, P54, DOI 10.1097/MED.0b013e3282f370af; Riazi AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005698; Rohrbach BW, 1999, J AM VET MED ASSOC, V214, P1660; Tsai JJ, 2009, J GASTROEN HEPATOL, V24, P1306, DOI 10.1111/j.1440-1746.2009.05956.x; Tsutsui C, 2009, PEPTIDES, V30, P318, DOI 10.1016/j.peptides.2008.10.006; Wierup N, 2007, J CLIN ENDOCR METAB, V92, P3573, DOI 10.1210/jc.2006-2756; Willemse A, 1975, Tijdschr Diergeneeskd, V100, P840; Wittek T, 2008, VET SURG, V37, P537, DOI 10.1111/j.1532-950X.2008.00401.x; Wolf V, 2001, DEUT TIERARZTL WOCH, V108, P403; Zhang ZH, 2008, HEPATOB PANCREAT DIS, V7, P58	26	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35562	10.1371/journal.pone.0035562	http://dx.doi.org/10.1371/journal.pone.0035562			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536407	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339200080
J	de Hevia, MD; Vanderslice, M; Spelke, ES				de Hevia, Maria Dolores; Vanderslice, Monica; Spelke, Elizabeth S.			Cross-Dimensional Mapping of Number, Length and Brightness by Preschool Children	PLOS ONE			English	Article							MENTAL REPRESENTATION; DISCRIMINATION; MAGNITUDE; SPACE; DISTANCE; QUANTITY; DISCRETE; MODEL; TIME; PROXIMITIES	Human adults in diverse cultures, children, infants, and non-human primates relate number to space, but it is not clear whether this ability reflects a specific and privileged number-space mapping. To investigate this possibility, we tested preschool children in matching tasks where the dimensions of number and length were mapped both to one another and to a third dimension, brightness. Children detected variation on all three dimensions, and they reliably performed mappings between number and length, and partially between brightness and length, but not between number and brightness. Moreover, children showed reliably better mapping of number onto the dimension of length than onto the dimension of brightness. These findings suggest that number establishes a privileged mapping with the dimension of length, and that other dimensions, including brightness, can be mapped onto length, although less efficiently. Children's adeptness at number-length mappings suggests that these two dimensions are intuitively related by the end of the preschool years.	[de Hevia, Maria Dolores] Univ Paris 05, Lab Psychol Percept, CNRS, UMR 8158, Paris, France; [Vanderslice, Monica; Spelke, Elizabeth S.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Harvard University	de Hevia, MD (corresponding author), Univ Paris 05, Lab Psychol Percept, CNRS, UMR 8158, Paris, France.	dehevialola@gmail.com			ESS from NIH [HD23103]; Harvard Mind, Brain and Behavior; Jacobs Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD023103] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD023103] Funding Source: NIH RePORTER	ESS from NIH; Harvard Mind, Brain and Behavior; Jacobs Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research has been supported by a grant to ESS from NIH (HD23103), and by a Harvard Mind, Brain and Behavior Postdoctoral Fellowship, and a Jacobs Foundation grant to MDdH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres M, 2004, NEUROREPORT, V15, P2773; Bachtold D, 1998, NEUROPSYCHOLOGIA, V36, P731, DOI 10.1016/S0028-3932(98)00002-5; BAIRD JC, 1980, J EXP PSYCHOL HUMAN, V6, P277, DOI 10.1037/0096-1523.6.2.277; BANKS WP, 1977, J EXP PSYCHOL HUMAN, V3, P278, DOI 10.1037/0096-1523.3.2.278; Berch DB, 1999, J EXP CHILD PSYCHOL, V74, P286, DOI 10.1006/jecp.1999.2518; Brannon EM, 2007, DEVELOPMENTAL SCI, V10, P770, DOI 10.1111/j.1467-7687.2007.00635.x; Brannon EM, 2006, DEVELOPMENTAL SCI, V9, pF59, DOI 10.1111/j.1467-7687.2006.00530.x; Brannon EM, 2004, COGNITION, V93, pB59, DOI 10.1016/j.cognition.2004.01.004; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; Castelli F, 2006, P NATL ACAD SCI USA, V103, P4693, DOI 10.1073/pnas.0600444103; Kadosh RC, 2006, EXP PSYCHOL, V53, P87, DOI 10.1027/1618-3769.53.2.87; Cordes S, 2009, DEVELOPMENTAL SCI, V12, P453, DOI 10.1111/j.1467-7687.2008.00781.x; de Hevia MD, 2010, PSYCHOL SCI, V21, P653, DOI 10.1177/0956797610366091; de Hevia MD, 2008, Q J EXP PSYCHOL, V61, P1496, DOI 10.1080/17470210701560674; de Hevia MD, 2009, COGNITION, V110, P198, DOI 10.1016/j.cognition.2008.11.003; de Hevia MD, 2006, EXP BRAIN RES, V168, P254, DOI 10.1007/s00221-005-0084-0; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Dehaene S, 2008, SCIENCE, V320, P1217, DOI 10.1126/science.1156540; Fias W, 2001, PSYCHOL RES-PSYCH FO, V65, P250, DOI 10.1007/s004260100065; Fias W., 1996, MATH COGNITION, V2, P95, DOI [DOI 10.1080/135467996387552, 10.1080/135467996387552]; Fischer MH, 2010, BRAIN COGNITION, V72, P333, DOI 10.1016/j.bandc.2009.10.010; Fischer MH, 2003, NAT NEUROSCI, V6, P555, DOI 10.1038/nn1066; Galton F., 1880, NATURE, V21, P252, DOI [10.1038/021252a0, DOI 10.1038/021252A0]; Gebuis T, 2011, ATTEN PERCEPT PSYCHO, V73, P259, DOI 10.3758/s13414-010-0002-9; Gevers W, 2003, COGNITION, V87, pB87, DOI 10.1016/S0010-0277(02)00234-2; Gevers Wim, 2004, Cortex, V40, P171, DOI 10.1016/S0010-9452(08)70938-9; Holloway ID, 2008, DEVELOPMENTAL SCI, V11, P644, DOI 10.1111/j.1467-7687.2008.00712.x; Holloway ID, 2009, J EXP CHILD PSYCHOL, V103, P17, DOI 10.1016/j.jecp.2008.04.001; Izard V, 2009, P NATL ACAD SCI USA, V106, P10382, DOI 10.1073/pnas.0812142106; JOHNSON DM, 1939, ARCH PSYCHOL, V34, P1; Kadosh RC, 2008, CEREB CORTEX, V18, P337, DOI 10.1093/cercor/bhm058; Knops A, 2009, SCIENCE, V324, P1583, DOI 10.1126/science.1171599; Kotovsky L, 1996, CHILD DEV, V67, P2797, DOI 10.1111/j.1467-8624.1996.tb01889.x; Lipton JS, 2003, PSYCHOL SCI, V14, P396, DOI 10.1111/1467-9280.01453; Lourenco SF, 2010, PSYCHOL SCI, V21, P873, DOI 10.1177/0956797610370158; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; MOYER RS, 1973, PERCEPT PSYCHOPHYS, V13, P180, DOI 10.3758/BF03214124; Munshell AH, 1912, AM J PSYCHOL, V23, P236, DOI 10.2307/1412843; Opfer JE, 2008, CHILD DEV, V79, P788, DOI 10.1111/j.1467-8624.2008.01158.x; Opfer JE, 2007, COGNITIVE PSYCHOL, V55, P169, DOI 10.1016/j.cogpsych.2006.09.002; Opfer JE, 2010, DEVELOPMENTAL SCI, V13, P761, DOI 10.1111/j.1467-7687.2009.00934.x; PAIVIO A, 1975, MEM COGNITION, V3, P635, DOI 10.3758/BF03198229; Pinel P, 2004, NEURON, V41, P983, DOI 10.1016/S0896-6273(04)00107-2; Previtali P, 2010, EXP BRAIN RES, V201, P599, DOI 10.1007/s00221-009-2063-3; Roitman JD, 2007, ACTA PSYCHOL, V124, P296, DOI 10.1016/j.actpsy.2006.03.008; Rusconi E, 2006, COGNITION, V99, P113, DOI 10.1016/j.cognition.2005.01.004; SHEPARD RN, 1982, PSYCHOL REV, V89, P305, DOI 10.1037/0033-295X.89.4.305; SHEPARD RN, 1958, J EXP PSYCHOL, V55, P509, DOI 10.1037/h0042354; SHEPARD RN, 1962, PSYCHOMETRIKA, V27, P125, DOI 10.1007/BF02289630; SHEPARD RN, 1962, PSYCHOMETRIKA, V27, P219, DOI 10.1007/BF02289621; SHEPARD RN, 1987, SCIENCE, V237, P1317, DOI 10.1126/science.3629243; Siegler RS, 2003, PSYCHOL SCI, V14, P237, DOI 10.1111/1467-9280.02438; Srinivasan M, 2010, COGNITION, V116, P217, DOI 10.1016/j.cognition.2010.05.005; STEVENS JC, 1965, P NATL ACAD SCI USA, V54, P407, DOI 10.1073/pnas.54.2.407; STEVENS SS, 1957, PSYCHOL REV, V64, P153, DOI 10.1037/h0046162; Tudusciuc O, 2007, P NATL ACAD SCI USA, V104, P14513, DOI 10.1073/pnas.0705495104; TVERSKY A, 1977, PSYCHOL REV, V84, P327, DOI 10.1037/h0026750; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; van Galen MS, 2008, J EXP CHILD PSYCHOL, V101, P99, DOI 10.1016/j.jecp.2008.05.001; Vanmarle K, 2006, DEVELOPMENTAL SCI, V9, pF41, DOI 10.1111/j.1467-7687.2006.00508.x; VANOEFFELEN MP, 1982, PERCEPT PSYCHOPHYS, V32, P163, DOI 10.3758/BF03204275; Vuilleumier P, 2004, CORTEX, V40, P399, DOI 10.1016/S0010-9452(08)70134-5; Walker P, 2010, PSYCHOL SCI, V21, P21, DOI 10.1177/0956797609354734; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9; Zebian S, 2005, J COGN CULT, V5, P165, DOI 10.1163/1568537054068660; Zorzi M, 2002, NATURE, V417, P138, DOI 10.1038/417138a	68	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35530	10.1371/journal.pone.0035530	http://dx.doi.org/10.1371/journal.pone.0035530			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TL	22536399	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336200051
J	DeAndrade, MP; Zhang, L; Doroodchi, A; Yokoi, F; Cheetham, CC; Chen, HX; Roper, SN; Sweatt, JD; Li, YQ				DeAndrade, Mark P.; Zhang, Li; Doroodchi, Atbin; Yokoi, Fumiaki; Cheetham, Chad C.; Chen, Huan-Xin; Roper, Steven N.; Sweatt, J. David; Li, Yuqing			Enhanced Hippocampal Long-Term Potentiation and Fear Memory in Btbd9 Mutant Mice	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; DEFICITS; PROTEIN; DOMAIN; INHIBITOR	Polymorphisms in BTBD9 have recently been associated with higher risk of restless legs syndrome (RLS), a neurological disorder characterized by uncomfortable sensations in the legs at rest that are relieved by movement. The BTBD9 protein contains a BTB/POZ domain and a BACK domain, but its function is unknown. To elucidate its function and potential role in the pathophysiology of RLS, we generated a line of mutant Btbd9 mice derived from a commercial gene-trap embryonic stem cell clone. Btbd9 is the mouse homolog of the human BTBD9. Proteins that contain a BTB/POZ domain have been reported to be associated with synaptic transmission and plasticity. We found that Btbd9 is naturally expressed in the hippocampus of our mutant mice, a region critical for learning and memory. As electrophysiological characteristics of CA3-CA1 synapses of the hippocampus are well characterized, we performed electrophysiological recordings in this region. The mutant mice showed normal input-output relationship, a significant impairment in pre-synaptic activity, and an enhanced long-term potentiation. We further performed an analysis of fear memory and found the mutant mice had an enhanced cued and contextual fear memory. To elucidate a possible molecular basis for these enhancements, we analyzed proteins that have been associated with synaptic plasticity. We found an elevated level of dynamin 1, an enzyme associated with endocytosis, in the mutant mice. These results suggest the first identified function of Btbd9 as being involved in regulating synaptic plasticity and memory. Recent studies have suggested that enhanced synaptic plasticity, analogous to what we have observed, in other regions of the brain could enhance sensory perception similar to what is seen in RLS patients. Further analyses of the mutant mice will help shine light on the function of BTBD9 and its role in RLS.	[DeAndrade, Mark P.] Univ Florida, Coll Med, Interdisciplinary Program Biomed Sci, Gainesville, FL 32610 USA; [DeAndrade, Mark P.; Yokoi, Fumiaki; Li, Yuqing] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA; [Zhang, Li; Doroodchi, Atbin; Cheetham, Chad C.] Univ Alabama Birmingham, Dept Neurol, Sch Med, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA; [Chen, Huan-Xin; Roper, Steven N.] Univ Florida, Coll Med, Dept Neurosurg, Gainesville, FL USA; [Sweatt, J. David] Univ Alabama Birmingham, Sch Med, Dept Neurobiol, Birmingham, AL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Alabama System; University of Alabama Birmingham; State University System of Florida; University of Florida; University of Alabama System; University of Alabama Birmingham	Li, YQ (corresponding author), Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA.	yuqing.li@neurology.ufl.edu	Li, Yuqing/G-1596-2011; Li, Yuqing/AAR-9383-2021; DeAndrade, Mark/G-4930-2011	Li, Yuqing/0000-0003-1211-5529; Li, Yuqing/0000-0003-1211-5529; Tilahin, Shimelis/0000-0001-8975-8026; Sweatt, J. David/0000-0003-3567-485X; DeAndrade, Mark/0000-0003-3610-6459	National Institutes of Health [NS37409, NS47466, NS47692, NS54246, NS57098, NS65273, NS72872, NS74423]; Department of Neurology (University of Alabama at Birmingham); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS037409, P30NS047466, R01NS054246, R21NS065273, R21NS072872, R21NS047692, P50NS037409, R03NS074423, P30NS057098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Neurology (University of Alabama at Birmingham); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (grants NS37409, NS47466, NS47692, NS54246, NS57098, NS65273, NS72872, and NS74423) and the Department of Neurology (University of Alabama at Birmingham). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson DT, 2011, NEUROPHARMACOLOGY; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Chen Y, 2002, J BIOL CHEM, V277, P30495, DOI 10.1074/jbc.M202076200; Dang MT, 2012, BEHAV BRAIN RES, V226, P465, DOI 10.1016/j.bbr.2011.10.002; Djagaeva I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007598; Edwards RR, 2011, SLEEP MED, V12, P603, DOI 10.1016/j.sleep.2010.09.018; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Frey U, 1996, J PHYSIOL-LONDON, V490, P703, DOI 10.1113/jphysiol.1996.sp021179; Gong QJ, 2010, BRAIN RES, V1361, P23, DOI 10.1016/j.brainres.2010.09.034; Goosens KA, 2011, CURR OPIN NEUROBIOL; Hallett Penelope J, 2008, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0116s42; Hornyak M, 2007, SLEEP MED, V9, P22, DOI 10.1016/j.sleep.2006.09.010; HU S, 1995, GENE DEV, V9, P2936, DOI 10.1101/gad.9.23.2936; Ikeda H, 2003, SCIENCE, V299, P1237, DOI 10.1126/science.1080659; Ito Y, 2001, PHARMACOL BIOCHEM BE, V70, P353, DOI 10.1016/S0091-3057(01)00618-9; Jellen LC, 2009, BIOCHIMIE, V91, P1255, DOI 10.1016/j.biochi.2009.04.009; Kavalali ET, 2011, PHYSIOLOGY, V26, P45, DOI 10.1152/physiol.00040.2010; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Kothapalli KSD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000370; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Li WJ, 2004, NEURON, V43, P823, DOI 10.1016/j.neuron.2004.08.040; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; Molinaro P, 2011, J NEUROSCI, V31, P7312, DOI 10.1523/JNEUROSCI.6296-10.2011; Nakamura H, 2010, BMC NEUROSCI ENGLAND; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pohlack ST, 2011, HUM BRAIN MAPP; Polter A, 2010, NEUROPSYCHOPHARMACOL, V35, P1761, DOI 10.1038/npp.2010.43; Priller C, 2006, J NEUROSCI, V26, P7212, DOI 10.1523/JNEUROSCI.1450-06.2006; Ruscheweyh R, 2011, MOL PAIN ENGLAND; Salinas GD, 2006, J BIOL CHEM, V281, P40164, DOI 10.1074/jbc.M608194200; Schaefer H, 2006, MOL BIOL CELL, V17, P1250, DOI 10.1091/mbc.E05-08-0794; Schrenk-Siemens K, 2008, STEM CELLS; Shalin SC, 2006, NEURON, V50, P765, DOI 10.1016/j.neuron.2006.04.029; Song S, 2007, MOL THER, V15, P1432, DOI 10.1038/sj.mt.6300199; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stefansson H, 2007, NEW ENGL J MED, V357, P639, DOI 10.1056/NEJMoa072743; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Stogios PJ, 2004, TRENDS BIOCHEM SCI, V29, P634, DOI 10.1016/j.tibs.2004.10.003; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Walters AS, 2003, SLEEP MED, V4, P121, DOI 10.1016/S1389-9457(02)00258-7; Watanabe T, 2010, J NEUROSCI RES, V88, P1908, DOI 10.1002/jnr.22346; Winkelmann J, 2007, NAT GENET, V39, P1000, DOI 10.1038/ng2099; Yokoi F, 2012, HUM MOL GENET, V21, P916, DOI 10.1093/hmg/ddr528; Yokoi F, 2010, J BIOCHEM, V148, P459, DOI 10.1093/jb/mvq078; Yokoi F, 2009, NEUROSCI RES, V65, P228, DOI 10.1016/j.neures.2009.07.004; Youdim KA, 2000, INT J DEV NEUROSCI, V18, P383, DOI 10.1016/S0736-5748(00)00013-7	50	27	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35518	10.1371/journal.pone.0035518	http://dx.doi.org/10.1371/journal.pone.0035518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536397	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336200050
J	Burrack, S; Aberle, D; Burck, J; Ulrich, AS; Meyers, G				Burrack, Sandra; Aberle, Daniel; Buerck, Jochen; Ulrich, Anne S.; Meyers, Gregor			A new type of intracellular retention signal identified in a pestivirus structural glycoprotein	FASEB JOURNAL			English	Article						viral RNase; classical swine fever virus; amphopathic helix; Erns protein; protein sorting; innate immune evasion	VIRAL-DIARRHEA-VIRUS; HEPATITIS-C VIRUS; SWINE-FEVER VIRUS; PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; HOG-CHOLERA VIRUS; DOUBLE-STRANDED-RNA; ENDOPLASMIC-RETICULUM; TRANSMEMBRANE DOMAIN; NUCLEOTIDE-SEQUENCE	Sorting of membrane proteins into intracellular organelles is crucial for cell function. Viruses exploit intracellular transport and retention systems to concentrate envelope proteins at the site of virus budding. In pestiviruses, a group of important pathogens of pigs and ruminants closely related to human hepatitis C virus, the E-rns protein translated from the viral RNA is secreted from the infected cells and found in the serum of infected animals. Secretion of the protein is regarded as crucial for its function as a viral virulence factor associated with its RNase activity. However, similar to 95% of the E-rns molecules are retained within the infected cell. Fusion of different Erns fragments to the C terminus of CD72 allowed identification of a retention signal within the C-terminal 65 aa of the viral protein. This C-terminal sequence represents its membrane anchor and folds into an amphipathic helix binding in-plane to the membrane surface. Residues L183, I190, and L208 are important for intracellular location of E-rns. Presentation of the retention signal on the cytoplasmic instead of the luminal face of the ER membrane in CD8 alpha fusion proteins still led to retention. Thus, E-rns contains in its C-terminal amphipathic helix an intracellular retention signal that is active on both faces of the membrane.-Burrack, S., Aberle, D., Burck, J., Ulrich, A. S., Meyers, G. A new type of intracellular retention signal identified in a pestivirus structural glycoprotein. FASEB J. 26, 3292-3305 (2012). www.fasebj.org	[Burrack, Sandra; Aberle, Daniel; Meyers, Gregor] Friedrich Loeffler Inst, Inst Immunol, Insel Riems, Germany; [Buerck, Jochen; Ulrich, Anne S.] Karlsruhe Inst Technol, Inst Biol Grenzflachen, Karlsruhe, Germany; [Ulrich, Anne S.] Karlsruhe Inst Technol, Inst Organ Chem, Karlsruhe, Germany	Friedrich Loeffler Institute; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology	Meyers, G (corresponding author), Friedrich Loeffler Inst, Inst Immunol, Sudufer 10, D-17493 Greifswald, Germany.	gregor.meyers@fli.bund.de	Ulrich, Anne S/H-5519-2013	Ulrich, Anne S/0000-0001-5571-9483	Deutsche Forschungsgemeinschaft [DFG-ME1367/4]; Boehringer Ingelheim Vetmedica GmbH (Ingelheim, Germany)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Boehringer Ingelheim Vetmedica GmbH (Ingelheim, Germany)(Boehringer Ingelheim)	The authors thank Gaby Stooss, Petra Wulle, Maren Ziegler, and Bianca Posselt for excellent technical assistance. The authors are especially grateful to Annette Vogel for help with the FACS analyses. This study was supported by grants from the Deutsche Forschungsgemeinschaft (DFG-ME1367/4) and Boehringer Ingelheim Vetmedica GmbH (Ingelheim, Germany).	Balali-Mood K, 2009, BIOCHEMISTRY-US, V48, P2135, DOI 10.1021/bi8017398; Bintintan I, 2010, J BIOL CHEM, V285, P8572, DOI 10.1074/jbc.M109.083394; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; Brass V, 2007, J VIROL, V81, P2745, DOI 10.1128/JVI.01279-06; Brass V, 2010, J VIROL, V84, P11580, DOI 10.1128/JVI.01519-10; Ciczora Y, 2010, J GEN VIROL, V91, P404, DOI 10.1099/vir.0.015339-0; Cocquerel L, 2000, J VIROL, V74, P3623, DOI 10.1128/JVI.74.8.3623-3633.2000; Cocquerel L, 1998, J VIROL, V72, P2183, DOI 10.1128/JVI.72.3.2183-2191.1998; Cocquerel L, 1999, J VIROL, V73, P2641, DOI 10.1128/JVI.73.4.2641-2649.1999; COLLETT MS, 1988, VIROLOGY, V165, P191, DOI 10.1016/0042-6822(88)90672-1; Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675; DEMOERLOOZE L, 1993, J GEN VIROL, V74, P1433, DOI 10.1099/0022-1317-74-7-1433; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; Fetzer C, 2005, J VIROL, V79, P11901, DOI 10.1128/JVI.79.18.11901-11913.2005; Gouttenoire J, 2010, REV MED VIROL, V20, P117, DOI 10.1002/rmv.640; Gouttenoire J, 2009, J VIROL, V83, P11378, DOI 10.1128/JVI.01122-09; Grummer B, 2001, J GEN VIROL, V82, P2597, DOI 10.1099/0022-1317-82-11-2597; Hausmann Y, 2004, J VIROL, V78, P5507, DOI 10.1128/JVI.78.10.5507-5512.2004; HEINZ FX, 2000, VIRUS TAXONOMY, P859; Heyden ABV, 2011, EMBO J, V30, P3217, DOI 10.1038/emboj.2011.233; Hilton L, 2006, J VIROL, V80, P11723, DOI 10.1128/JVI.01145-06; Hobman TC, 1997, J VIROL, V71, P7670, DOI 10.1128/JVI.71.10.7670-7680.1997; HORIUCHI H, 1988, J BIOCHEM-TOKYO, V103, P408, DOI 10.1093/oxfordjournals.jbchem.a122284; HULST MM, 1994, VIROLOGY, V200, P558, DOI 10.1006/viro.1994.1218; Iqbal M, 2004, J VIROL, V78, P136, DOI 10.1128/JVI.78.1.136-145.2004; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Kohl W, 2004, J GEN VIROL, V85, P1101, DOI 10.1099/vir.0.19740-0; Kummerer BM, 1998, J VIROL, V72, P4127; Li Y, 1998, J BIOL CHEM, V273, P29830, DOI 10.1074/jbc.273.45.29830; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Magkouras I, 2008, J GEN VIROL, V89, P2501, DOI 10.1099/vir.0.2008/003749-0; Marks MS, 1997, TRENDS CELL BIOL, V7, P124, DOI 10.1016/S0962-8924(96)10057-X; Matzener P, 2009, VIRUS RES, V140, P15, DOI 10.1016/j.virusres.2008.10.015; Meyer C, 2002, J VIROL, V76, P8494, DOI 10.1128/JVI.76.16.8494-8503.2002; Meyers G, 1999, J VIROL, V73, P10224, DOI 10.1128/JVI.73.12.10224-10235.1999; MEYERS G, 1989, VIROLOGY, V171, P555, DOI 10.1016/0042-6822(89)90625-9; Meyers G, 1996, J VIROL, V70, P8606, DOI 10.1128/JVI.70.12.8606-8613.1996; Meyers G, 2007, J VIROL, V81, P3327, DOI 10.1128/JVI.02372-06; Moormann RJM, 1996, J VIROL, V70, P763, DOI 10.1128/JVI.70.2.763-770.1996; MOORMANN RJM, 1990, VIROLOGY, V177, P184, DOI 10.1016/0042-6822(90)90472-4; Morikawa K, 2011, J VIRAL HEPATITIS, V18, P305, DOI 10.1111/j.1365-2893.2011.01451.x; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nair R, 2003, PROTEINS, V53, P917, DOI 10.1002/prot.10507; Nakai K, 2001, J STRUCT BIOL, V134, P103, DOI 10.1006/jsbi.2001.4378; Nina M, 2000, EUR BIOPHYS J BIOPHY, V29, P439, DOI 10.1007/PL00006649; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pagny S, 1999, J EXP BOT, V50, P157, DOI 10.1093/jexbot/50.331.157; PELHAM HRB, 1993, CELL, V75, P603, DOI 10.1016/0092-8674(93)90479-A; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Picot D, 1997, ADV EXP MED BIOL, V400, P107; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Reimann I, 2007, VIROLOGY, V366, P377, DOI 10.1016/j.virol.2007.05.006; Ronchi P, 2008, J CELL BIOL, V181, P105, DOI 10.1083/jcb.200710093; Ruggli N, 2005, VIROLOGY, V340, P265, DOI 10.1016/j.virol.2005.06.033; RUMENAPF T, 1993, J VIROL, V67, P3288; Sainz IF, 2008, VIROLOGY, V370, P122, DOI 10.1016/j.virol.2007.08.028; Sapay N, 2006, BIOCHEMISTRY-US, V45, P2221, DOI 10.1021/bi0517685; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHNEIDER R, 1993, SCIENCE, V261, P1169, DOI 10.1126/science.8356450; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 1999, PROTEIN SCI, V8, P370; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Strandberg E, 2004, CONCEPT MAGN RESON A, V23A, P89, DOI 10.1002/cmr.a.20024; Tews BA, 2007, J BIOL CHEM, V282, P32730, DOI 10.1074/jbc.M706803200; Thor F, 2009, TRAFFIC, V10, P1819, DOI 10.1111/j.1600-0854.2009.00989.x; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Wan SZ, 2009, J COMPUT CHEM, V30, P1038, DOI 10.1002/jcc.21130; WEILAND E, 1992, J VIROL, V66, P3677, DOI 10.1128/JVI.66.6.3677-3682.1992; Weiland F, 1999, J GEN VIROL, V80, P1157, DOI 10.1099/0022-1317-80-5-1157; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Widjojoatmodjo MN, 2000, J VIROL, V74, P2973, DOI 10.1128/JVI.74.7.2973-2980.2000; Windisch JM, 1996, J VIROL, V70, P352, DOI 10.1128/JVI.70.1.352-358.1996; WYATT LS, 1995, VIROLOGY, V210, P202, DOI 10.1006/viro.1995.1332	76	22	22	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2012	26	8					3292	3305		10.1096/fj.12-207191	http://dx.doi.org/10.1096/fj.12-207191			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22549508				2022-12-25	WOS:000307162800020
J	Becker, D; Richter, J; Tocilescu, MA; Przedborski, S; Voos, W				Becker, Dorothea; Richter, Judith; Tocilescu, Maja A.; Przedborski, Serge; Voos, Wolfgang			Pink1 Kinase and Its Membrane Potential (Delta psi)-dependent Cleavage Product Both Localize to Outer Mitochondrial Membrane by Unique Targeting Mode	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY-ONSET PARKINSONISM; INTRAMEMBRANE PROTEOLYSIS; SACCHAROMYCES-CEREVISIAE; SUBCELLULAR-DISTRIBUTION; RECESSIVE PARKINSONISM; PROTEASE PARL; 2 LOCATIONS; IMPORT; DISEASE; MUTATIONS	The Parkinson disease-associated kinase Pink1 is targeted to mitochondria where it is thought to regulate mitochondrial quality control by promoting the selective autophagic removal of dysfunctional mitochondria. Nevertheless, the targeting mode of Pink1 and its submitochondrial localization are still not conclusively resolved. The aim of this study was to dissect the mitochondrial import pathway of Pink1 by use of a highly sensitive in vitro assay. Mutational analysis of the Pink1 sequence revealed that its N terminus acts as a genuine matrix localization sequence that mediates the initial membrane potential (Delta psi)-dependent targeting of the Pink1 precursor to the inner mitochondrial membrane, but it is dispensable for Pink1 import or processing. A hydrophobic segment downstream of the signal sequence impeded complete translocation of Pink1 across the mitochondrial inner membrane. Additionally, the C-terminal end of the protein promoted the retention of Pink1 at the outer membrane. Thus, multiple targeting signals featured by the Pink1 sequence result in the final localization of both the full-length protein and its major Delta psi-dependent cleavage product to the cytosolic face of the outer mitochondrial membrane. Full-length Pink1 and deletion constructs resembling the natural Pink1 processing product were found to assemble into membrane potential-sensitive high molecular weight protein complexes at the mitochondrial surface and displayed similar cytoprotective effects when expressed in vivo, indicating that both species are functionally relevant.	[Becker, Dorothea; Richter, Judith; Voos, Wolfgang] Univ Bonn, IBMB, D-53115 Bonn, Germany; [Tocilescu, Maja A.; Przedborski, Serge] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Tocilescu, Maja A.; Przedborski, Serge] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Tocilescu, Maja A.; Przedborski, Serge] Columbia Univ, Dept Cell Biol, New York, NY 10032 USA; [Tocilescu, Maja A.; Przedborski, Serge] Columbia Univ, Ctr Motor Neuron Biol & Dis, New York, NY 10032 USA	University of Bonn; Columbia University; Columbia University; Columbia University; Columbia University	Voos, W (corresponding author), Univ Bonn, IBMB, Nussallee 11, D-53115 Bonn, Germany.	wolfgang.voos@uni-bonn.de			National Institutes of Health [NS042269, NS064191, NS38370, NS070276, NS072182]; Medical Faculty of the University of Bonn; United States Department of Defense [W81XWH-08-1-0522, W81XWH-08-1-0465, W81XWH-09-1-0245]; Parkinson's Disease Foundation; Thomas Hartman Foundation For Parkinson's Research; Project A.L.S.; Muscular Dystrophy Association; P2ALS; Deutsche Forschungsgemeinschaft [805231]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042269, R21NS064191, P50NS038370, R21NS072182, RC2NS070276] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Faculty of the University of Bonn; United States Department of Defense(United States Department of Defense); Parkinson's Disease Foundation; Thomas Hartman Foundation For Parkinson's Research; Project A.L.S.; Muscular Dystrophy Association(Muscular Dystrophy Association); P2ALS; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS042269, NS064191, NS38370, NS070276, and NS072182. This work was also supported by a grant from the BONFOR program of the Medical Faculty of the University of Bonn (to W. V.); United States Department of Defense Grants W81XWH-08-1-0522, W81XWH-08-1-0465, and W81XWH-09-1-0245; the Parkinson's Disease Foundation; the Thomas Hartman Foundation For Parkinson's Research; Project A.L.S.; the Muscular Dystrophy Association and P2ALS (to S. P.); and Deutsche Forschungsgemeinschaft Grant 805231 (to M. A. T.).	Becker T, 2008, BBA-BIOENERGETICS, V1777, P557, DOI 10.1016/j.bbabio.2008.03.017; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Ben-Menachem R, 2011, J MOL BIOL, V409, P113, DOI 10.1016/j.jmb.2011.03.045; Bentivoglio AR, 2001, MOVEMENT DISORD, V16, P999, DOI 10.1002/mds.10034; Bohnert M, 2010, CURR BIOL, V20, P1227, DOI 10.1016/j.cub.2010.05.058; Bomer U, 1998, EMBO J, V17, P4226, DOI 10.1093/emboj/17.15.4226; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chu CT, 2010, BBA-MOL BASIS DIS, V1802, P20, DOI 10.1016/j.bbadis.2009.06.012; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Deas E, 2011, BBA-MOL CELL RES, V1813, P623, DOI 10.1016/j.bbamcr.2010.08.007; Deas E, 2011, HUM MOL GENET, V20, P867, DOI 10.1093/hmg/ddq526; Deas E, 2009, EMBO MOL MED, V1, P152, DOI 10.1002/emmm.200900024; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; Freeman M, 2008, ANNU REV GENET, V42, P191, DOI 10.1146/annurev.genet.42.110807.091628; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Gandhi S, 2006, BRAIN, V129, P1720, DOI 10.1093/brain/awl114; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; HAHNE K, 1994, CELL, V79, P829, DOI 10.1016/0092-8674(94)90072-8; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; Haucke V, 1997, MOL CELL BIOL, V17, P4024, DOI 10.1128/MCB.17.7.4024; Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Johnston AJ, 2002, J BIOL CHEM, V277, P42197, DOI 10.1074/jbc.M205613200; Knox C, 1998, J BIOL CHEM, V273, P25587, DOI 10.1074/jbc.273.40.25587; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Lin W, 2008, J NEUROCHEM, V106, P464, DOI 10.1111/j.1471-4159.2008.05398.x; Lin W, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-90; Liu WC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004597; Luciano P, 1998, J MOL BIOL, V280, P193, DOI 10.1006/jmbi.1998.1858; Marongiu R, 2009, J NEUROCHEM, V108, P1561, DOI 10.1111/j.1471-4159.2009.05932.x; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Meier S, 2005, J CELL BIOL, V170, P881, DOI 10.1083/jcb.200505126; Meineke B, 2008, FEBS LETT, V582, P855, DOI 10.1016/j.febslet.2008.02.009; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; Muqit MMK, 2006, J NEUROCHEM, V98, P156, DOI 10.1111/j.1471-4159.2006.03845.x; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nett JH, 1996, J BIOL CHEM, V271, P26713, DOI 10.1074/jbc.271.43.26713; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Regev-Rudzki N, 2005, MOL BIOL CELL, V16, P4163, DOI 10.1091/mbc.e04-11-1028; Sass E, 2003, J BIOL CHEM, V278, P45109, DOI 10.1074/jbc.M302344200; Schagger H, 2001, METHOD CELL BIOL, V65, P231, DOI 10.1016/S0091-679X(01)65014-3; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; STEIN I, 1994, MOL CELL BIOL, V14, P4770, DOI 10.1128/MCB.14.7.4770; Strisovsky K, 2009, MOL CELL, V36, P1048, DOI 10.1016/j.molcel.2009.11.006; Takatori S, 2008, NEUROSCI LETT, V430, P13, DOI 10.1016/j.neulet.2007.10.019; Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430; Unoki M, 2001, ONCOGENE, V20, P4457, DOI 10.1038/sj.onc.1204608; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Valente EM, 2001, AM J HUM GENET, V68, P895, DOI 10.1086/319522; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Voisine C, 1999, CELL, V97, P565, DOI 10.1016/S0092-8674(00)80768-0; Weihofen A, 2008, HUM MOL GENET, V17, P602, DOI 10.1093/hmg/ddm334; Wiedemann N, 2007, J CELL BIOL, V179, P1115, DOI 10.1083/jcb.200709087; Yogev O, 2011, FEBS J, V278, P4230, DOI 10.1111/j.1742-4658.2011.08359.x; Yogev O, 2011, BBA-BIOMEMBRANES, V1808, P1012, DOI 10.1016/j.bbamem.2010.07.004; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105	64	59	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22969	22987		10.1074/jbc.M112.365700	http://dx.doi.org/10.1074/jbc.M112.365700			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22547060	Green Published, hybrid			2022-12-25	WOS:000306495000054
J	Tadjuidje, E; Sen Wang, T; Pandey, RN; Sumanas, S; Lang, RA; Hegde, RS				Tadjuidje, Emmanuel; Sen Wang, Tim; Pandey, Ram Naresh; Sumanas, Saulius; Lang, Richard A.; Hegde, Rashmi S.			The EYA Tyrosine Phosphatase Activity Is Pro-Angiogenic and Is Inhibited by Benzbromarone	PLOS ONE			English	Article							BRANCHIOOTORENAL BOR SYNDROME; EYES-ABSENT; HUMAN HOMOLOG; MUTATIONS; MODEL; PROLIFERATION; APOPTOSIS; SURVIVAL; H2AX	Eyes Absents (EYA) are multifunctional proteins best known for their role in organogenesis. There is accumulating evidence that overexpression of EYAs in breast and ovarian cancers, and in malignant peripheral nerve sheath tumors, correlates with tumor growth and increased metastasis. The EYA protein is both a transcriptional activator and a tyrosine phosphatase, and the tyrosine phosphatase activity promotes single cell motility of mammary epithelial cells. Since EYAs are expressed in vascular endothelial cells and cell motility is a critical feature of angiogenesis we investigated the role of EYAs in this process. Using RNA interference techniques we show that EYA3 depletion in human umbilical vein endothelial cells inhibits transwell migration as well as Matrigel-induced tube formation. To specifically query the role of the EYA tyrosine phosphatase activity we employed a chemical biology approach. Through an experimental screen the uricosuric agents Benzbromarone and Benzarone were found to be potent EYA inhibitors, and Benzarone in particular exhibited selectivity towards EYA versus a representative classical protein tyrosine phosphatase, PTP1B. These compounds inhibit the motility of mammary epithelial cells over-expressing EYA2 as well as the motility of endothelial cells. Furthermore, they attenuate tubulogenesis in matrigel and sprouting angiogenesis in the ex vivo aortic ring assay in a dose-dependent fashion. The anti-angiogenic effect of the inhibitors was also demonstrated in vivo, as treatment of zebrafish embryos led to significant and dose-dependent defects in the developing vasculature. Taken together our results demonstrate that the EYA tyrosine phosphatase activity is pro-angiogenic and that Benzbromarone and Benzarone are attractive candidates for repurposing as drugs for the treatment of cancer metastasis, tumor angiogenesis, and vasculopathies.	[Tadjuidje, Emmanuel; Sen Wang, Tim; Pandey, Ram Naresh; Sumanas, Saulius; Lang, Richard A.; Hegde, Rashmi S.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH USA; [Lang, Richard A.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Ophthalmol, Visual Syst Grp, Cincinnati, OH USA; [Hegde, Rashmi S.] Univ Cincinnati, Dept Pediat, Cincinnati, OH 45221 USA; [Lang, Richard A.] Univ Cincinnati, Dept Ophthalmol, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Tadjuidje, E (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH USA.	rashmi.hegde@cchmc.org		Wang, Tim/0000-0001-5518-508X; Lang, Richard/0000-0002-5212-254X	National Institutes of Health [RO1 EY014648, R21 EY019125]; NATIONAL EYE INSTITUTE [R01EY014648, R21EY019125] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grants RO1 EY014648 to RSH and R21 EY019125 to RSH and RAL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Abdelhak S, 1997, HUM MOL GENET, V6, P2247, DOI 10.1093/hmg/6.13.2247; Abdelhak S, 1997, NAT GENET, V15, P157, DOI 10.1038/ng0297-157; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andreu I, 2009, CURR DRUG METAB, V10, P947, DOI 10.2174/138920009790711823; Aplin AC, 2008, METHOD ENZYMOL, V443, P119, DOI 10.1016/S0076-6879(08)02007-7; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Azuma N, 2000, HUM MOL GENET, V9, P363, DOI 10.1093/hmg/9.3.363; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Economopoulou M, 2009, NAT MED, V15, P553, DOI 10.1038/nm.1947; El-Hashash AHK, 2011, DEV BIOL, V350, P112, DOI 10.1016/j.ydbio.2010.11.022; Farabaugh SM, 2011, ONCOGENE; Gerhardt H, 2005, EXP SUPPL, V94, P3; Guo CS, 2011, J CLIN INVEST, V121, P1585, DOI 10.1172/JCI44630; Ikeda K, 2002, MOL CELL BIOL, V22, P6759, DOI 10.1128/MCB.22.19.6759-6766.2002; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Jung SK, 2009, FASEB J; Krishnan N, 2009, J BIOL CHEM; Langheinrich U, 2003, BIOESSAYS, V25, P904, DOI 10.1002/bies.10326; Lee MHH, 2008, DRUG SAFETY, V31, P643, DOI 10.2165/00002018-200831080-00002; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; Melo F, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P187; Miller SJ, 2010, ONCOGENE, V29, P368, DOI 10.1038/onc.2009.360; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Okabe Y, 2009, NATURE, V460, P520, DOI 10.1038/nature08138; Pandey RN, 2010, ONCOGENE, V29, P3715, DOI 10.1038/onc.2010.122; Pandey RN, 2010, ONCOGENE; Park H, 2011, CHEM BIOL DRUG DES, V78, P642, DOI 10.1111/j.1747-0285.2011.01192.x; Rayapureddi JP, 2006, FEBS LETT, V580, P3853, DOI 10.1016/j.febslet.2006.06.009; Rayapureddi JP, 2005, BIOCHEMISTRY-US, V44, P751, DOI 10.1021/bi0481794; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Reed May J, 2011, Open Circ Vasc J, V4, P12; Ryan AJ, 2003, J MED CHEM, V46, P3448, DOI 10.1021/jm0340896; Sapieha P, 2010, J CLIN INVEST, V120, P3022, DOI 10.1172/JCI42142; Schonberger J, 2005, NAT GENET; Shimasaki N, 2004, PEDIATR CARDIOL, V25, P411, DOI 10.1007/s00246-003-0271-3; Shin HJ, 2011, NEPHROLOGY, V16, P156, DOI 10.1111/j.1440-1797.2010.01368.x; Soker T, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-118; Staton CA, 2009, INT J EXP PATHOL, V90, P195, DOI 10.1111/j.1365-2613.2008.00633.x; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Tran JC, 2011, NATURE; WALTERSACK I, 1990, EUR J CLIN PHARMACOL, V39, P577, DOI 10.1007/BF00316099; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; Wayne S, 2001, HUM MOL GENET, V10, P195, DOI 10.1093/hmg/10.3.195; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803; Wrobel J, 1999, J MED CHEM, V42, P3199, DOI 10.1021/jm990260v; Xiao A, 2009, NATURE, V457, P57, DOI 10.1038/nature07668; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722; Zhang L, 2005, CANCER RES, V65, P925	50	37	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e34806	10.1371/journal.pone.0034806	http://dx.doi.org/10.1371/journal.pone.0034806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545090	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343200013
J	Lacruz, RS; Nakayama, Y; Holcroft, J; Nguyen, V; Somogyi-Ganss, E; Snead, ML; White, SN; Paine, ML; Ganss, B				Lacruz, Rodrigo S.; Nakayama, Yohei; Holcroft, James; Van Nguyen; Somogyi-Ganss, Eszter; Snead, Malcolm L.; White, Shane N.; Paine, Michael L.; Ganss, Bernhard			Targeted Overexpression of Amelotin Disrupts the Microstructure of Dental Enamel	PLOS ONE			English	Article							AMELOGENESIS IMPERFECTA; PROTEIN; EXPRESSION; SIALOPROTEIN; BINDING; MATRIX; HYDROXYAPATITE; AMELOBLASTS; GENE; MICE	We have previously identified amelotin (AMTN) as a novel protein expressed predominantly during the late stages of dental enamel formation, but its role during amelogenesis remains to be determined. In this study we generated transgenic mice that produce AMTN under the amelogenin (Amel) gene promoter to study the effect of AMTN overexpression on enamel formation in vivo. The specific overexpression of AMTN in secretory stage ameloblasts was confirmed by Western blot and immunohistochemistry. The gross histological appearance of ameloblasts or supporting cellular structures as well as the expression of the enamel proteins amelogenin (AMEL) and ameloblastin (AMBN) was not altered by AMTN overexpression, suggesting that protein production, processing and secretion occurred normally in transgenic mice. The expression of Odontogenic, Ameloblast-Associated (ODAM) was slightly increased in secretory stage ameloblasts of transgenic animals. The enamel in AMTN-overexpressing mice was much thinner and displayed a highly irregular surface structure compared to wild type littermates. Teeth of transgenic animals underwent rapid attrition due to the brittleness of the enamel layer. The microstructure of enamel, normally a highly ordered arrangement of hydroxyapatite crystals, was completely disorganized. Tomes' process, the hallmark of secretory stage ameloblasts, did not form in transgenic mice. Collectively our data demonstrate that the overexpression of amelotin has a profound effect on enamel structure by disrupting the formation of Tomes' process and the orderly growth of enamel prisms.	[Lacruz, Rodrigo S.; Snead, Malcolm L.; Paine, Michael L.] Univ So Calif, Ctr Craniofacial Mol Biol, Sch Dent, Los Angeles, CA 90033 USA; [Nakayama, Yohei; Holcroft, James; Van Nguyen; Somogyi-Ganss, Eszter; Ganss, Bernhard] Univ Toronto, Fac Dent, Matrix Dynam Grp, Toronto, ON, Canada; [White, Shane N.] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA	University of Southern California; University of Toronto; University of California System; University of California Los Angeles	Lacruz, RS (corresponding author), Univ So Calif, Ctr Craniofacial Mol Biol, Sch Dent, 2250 Alcazar St, Los Angeles, CA 90033 USA.	b.ganss@utoronto.ca	Lacruz, Rodrigo/AGY-8090-2022	LACRUZ, RODRIGO/0000-0002-0776-6143	NIDCR, National Institutes of Health [DE006988, DE013045, DE013404, DE019629, DE014189]; Canadian Institutes of Health Research (CIHR) [MOP-79449]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE006988, R01DE013045, R01DE019629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE013045, R01DE013404, K22DE014189] Funding Source: NIH RePORTER	NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Grants DE006988 and DE013045 (MLS), DE013404 and DE019629 (MLP) and DE014189 (SNW) from the NIDCR, National Institutes of Health and by an Operating Grant MOP-79449 (BG) from the Canadian Institutes of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fong CD, 1998, EUR J ORAL SCI, V106, P324, DOI 10.1111/j.1600-0722.1998.tb02193.x; Goldberg HA, 2001, CONNECT TISSUE RES, V42, P25, DOI 10.3109/03008200109014246; Hu JCC, 2007, CELLS TISSUES ORGANS, V186, P78, DOI 10.1159/000102683; IGNELZI MA, 1995, CRIT REV ORAL BIOL M, V6, P181, DOI 10.1177/10454411950060030201; INAGE T, 1990, Journal of Nihon University School of Dentistry, V32, P259; Iwasaki K, 2005, J DENT RES, V84, P1127, DOI 10.1177/154405910508401207; KALLENBACH E, 1973, TISSUE CELL, V5, P501, DOI 10.1016/S0040-8166(73)80041-2; Kestler DP, 2008, MOL MED, V14, P318, DOI 10.2119/2008-00010.Kestler; Lacruz RS, 2011, J DENT RES, V90, P1228, DOI 10.1177/0022034511418231; Lu Y, 2008, BIOL CHEM, V389, P695, DOI 10.1515/BC.2008.080; Luo W, 2004, CELLS TISSUES ORGANS, V177, P212, DOI 10.1159/000080134; Moffatt P, 2008, J CELL BIOCHEM, V103, P941, DOI 10.1002/jcb.21465; Moffatt P, 2006, BIOCHEM J, V399, P37, DOI 10.1042/BJ20060662; Moinichen CB, 1996, J ANAT, V189, P325; Nagy A., 2003, MANIPULATING MOUSE E; Nanci A, 2008, 10 CATES ORAL HISTOL, P141; Paine ML, 2003, J BIOL CHEM, V278, P19447, DOI 10.1074/jbc.M300445200; Paine ML, 2005, J BIOL CHEM, V280, P31991, DOI 10.1074/jbc.M502991200; Paine ML, 2004, CELLS TISSUES ORGANS, V176, P7, DOI 10.1159/000075023; Sire JY, 2007, CELLS TISSUES ORGANS, V186, P25, DOI 10.1159/000102679; Snead ML, 1996, CONNECT TISSUE RES, V35, P41, DOI 10.3109/03008209609029173; Somogyi E, 2003, MATRIX BIOL, V22, P179, DOI 10.1016/S0945-053X(02)00117-8; Somogyi-Ganss E., 2011, CELLS TISSUES ORGANS; WEILE V, 1993, CALCIFIED TISSUE INT, V52, P318, DOI 10.1007/BF00296658; Wen X, 2008, ANAT REC, V291, P1246, DOI 10.1002/ar.20751; White SN, 2007, J BIOL CHEM, V282, P5340, DOI 10.1074/jbc.M604814200; White SN, 2001, J DENT RES, V80, P321, DOI 10.1177/00220345010800010501; Zhou YL, 2000, J BIOL CHEM, V275, P12273, DOI 10.1074/jbc.275.16.12273	28	53	54	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35200	10.1371/journal.pone.0035200	http://dx.doi.org/10.1371/journal.pone.0035200			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539960	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341000024
J	Mohanty, P; Patel, A; Bhardwaj, AK				Mohanty, Priyabrata; Patel, Arati; Bhardwaj, Ashima Kushwaha			Role of H- and D- MATE-Type Transporters from Multidrug Resistant Clinical Isolates of Vibrio fluvialis in Conferring Fluoroquinolone Resistance	PLOS ONE			English	Article							AMINO-ACID-RESIDUES; EFFLUX PUMPS; DRUG-RESISTANCE; ACTIVE EFFLUX; NORM; MECHANISM; GENE; PARAHAEMOLYTICUS; IDENTIFICATION; DETERMINANTS	Background: The study seeks to understand the role of efflux pumps in multidrug resistance displayed by the clinical isolates of Vibrio fluvialis, a pathogen known to cause cholera-like diarrhoea. Methodology: Two putative MATE family efflux pumps (H- and D-type) were PCR amplified from clinical isolates of V. fluvialis obtained from Kolkata, India, in 2006 and sequenced. Bioinformatic analysis of these proteins was done to predict protein structures. Subsequently, the genes were cloned and expressed in a drug hypersusceptible Escherichia coli strain KAM32 using the vector pBR322. The recombinant clones were tested for the functionality of the efflux pump proteins by MIC determination and drug transport assays using fluorimeter. Results: The sequences of the genes were found to be around 99% identical to their counterparts in V. cholerae. Protein structure predicting servers TMHMM and I-TASSER depicted ten-twelve membrane helical structures for both type of pumps. Real time PCR showed that these genes were expressed in the native V. fluvialis isolates. In the drug transport assays, the V. fluvialis clinical isolates as well as recombinant E. coli harbouring the efflux pump genes showed the energy-dependent and sodium ion-dependent drug transport activity. KAM32 cells harbouring the recombinant plasmids showed elevated MIC to the fluoroquinolones, norfloxacin and ciprofloxacin but H- type pumps VCH and VFH from V. cholerae and V. fluvialis respectively, showed decreased MIC to aminoglycosides like gentamicin, kanamycin and streptomycin. Decrease in MIC was also observed for acriflavin, ethidium bromide, safranin and nalidixic acid. Significance: Increased resistance towards fluoroquinolones exhibited due to these efflux pumps from multidrug resistant clinical isolates of V. fluvialis implies that treatment procedure may become more elaborate for this simple but highly infectious disease. To the best of our knowledge, this is the first report of cloning and characterization of efflux pumps from multidrug resistant clinical isolates of V. fluvialis.	[Mohanty, Priyabrata; Patel, Arati; Bhardwaj, Ashima Kushwaha] Indian Inst Adv Res, Dept Human Hlth & Dis, Gandhinagar, Gujarat, India		Mohanty, P (corresponding author), Indian Inst Adv Res, Dept Human Hlth & Dis, Gandhinagar, Gujarat, India.	ashima.bhardwaj@gmail.com		Mohanty, Pryabrata/0000-0001-9339-9935	Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India [BT/PR10304/GBD/27/95/2008, BT/PR/11634/INF/22/104/2008]; Puri Foundation for Education in India; DBT [BT/PR10304/GBD/27/95/2008]	Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Puri Foundation for Education in India; DBT(Department of Biotechnology (DBT) India)	This work was supported by the grants BT/PR10304/GBD/27/95/2008 and BT/PR/11634/INF/22/104/2008 from Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India. The authors thankfully acknowledge the partial funding received from Puri Foundation for Education in India (www.iiar.res.in). Mr. P. B. Mohanty is a recipient of Junior Research Fellowship from the DBT grant BT/PR10304/GBD/27/95/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 2005, FEMS MICROBIOL LETT, V242, P241, DOI 10.1016/j.femsle.2004.11.012; Ahmed AM, 2004, J ANTIMICROB CHEMOTH, V53, P947, DOI 10.1093/jac/dkh221; Baranwal S, 2002, ANTIMICROB AGENTS CH, V46, P2676, DOI 10.1128/AAC.46.8.2676-2678.2002; Begum A, 2005, MICROBIOL IMMUNOL, V49, P951; Bhardwaj AK, 2012, RECENT PAT IN PRESS; Chen J, 2002, J BACTERIOL, V184, P572, DOI 10.1128/JB.184.2.572-576.2002; He XA, 2010, NATURE, V467, P991, DOI 10.1038/nature09408; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Long F, 2008, ANTIMICROB AGENTS CH, V52, P3052, DOI 10.1128/AAC.00475-08; Ma JY, 2009, ANTIMICROB AGENTS CH, V53, P519, DOI 10.1128/AAC.00886-08; MCMURRY L, 1980, P NATL ACAD SCI-BIOL, V77, P3974, DOI 10.1073/pnas.77.7.3974; Misra R, 2009, BBA-PROTEINS PROTEOM, V1794, P817, DOI 10.1016/j.bbapap.2009.02.017; Morita Y, 1998, ANTIMICROB AGENTS CH, V42, P1778, DOI 10.1128/AAC.42.7.1778; Morita Y, 2000, J BACTERIOL, V182, P6694, DOI 10.1128/JB.182.23.6694-6697.2000; Otsuka M, 2005, J BACTERIOL, V187, P1552, DOI 10.1128/JB.187.5.1552-1558.2005; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Rajpara N, 2009, INT J ANTIMICROB AG, V34, P220, DOI 10.1016/j.ijantimicag.2009.03.020; Singh AK, 2006, ANTIMICROB AGENTS CH, V50, P3717, DOI 10.1128/AAC.00460-06; Singh R, 2011, J MED MICROBIOL, V61, P369; Srinivasan VB, 2006, ANTIMICROB AGENTS CH, V50, P2428, DOI 10.1128/AAC.01561-05; Thungapathra M, 2002, ANTIMICROB AGENTS CH, V46, P2948, DOI 10.1128/AAC.46.9.2948-2955.2002; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702	23	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35752	10.1371/journal.pone.0035752	http://dx.doi.org/10.1371/journal.pone.0035752			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540001	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341000067
J	Zhang, J; Lazarenko, OP; Wu, XL; Tong, YD; Blackburn, ML; Gomez-Acevedo, H; Shankar, K; Badger, TM; Ronis, MJJ; Chen, JR				Zhang, Jian; Lazarenko, Oxana P.; Wu, Xianli; Tong, Yudong; Blackburn, Michael L.; Gomez-Acevedo, Horatio; Shankar, Kartik; Badger, Thomas M.; Ronis, Martin J. J.; Chen, Jin-Ran			Differential Effects of Short Term Feeding of a Soy Protein Isolate Diet and Estrogen Treatment on Bone in the Pre-Pubertal Rat	PLOS ONE			English	Article							FEMALE RATS; CONSUMPTION; ISOFLAVONES; EXPRESSION; DIFFERS; HEALTH; WOMEN; BETA; SIZE; MASS	Background: Previous reports suggest that beneficial effects of soy on bone quality are due to the estrogenic actions of isoflavone phytochemicals associated with the protein. However, mechanistic studies comparing the effects of soy diet and estrogens on bone, particularly in rapidly growing animals are lacking. Methodology and Principal Findings: We studied the effects of short term feeding of soy protein isolate (SPI) on bone in comparison to the effects of 17 beta-estradiol (E2) in pre-pubertal rats. Female rats were weaned to one of 4 treatments: 1) a control casein-based diet (CAS); 2) CAS with subcutaneous E2 (10 mg/kg/d) (CAS+E2); 3) a SPI-containing diet (SPI); or 4) SPI with subcutaneous E2 (SPI) or SPI with 10 mu g/kg/d E2 (SPI+E2) for 14 days beginning on postnatal day 20. SPI increased while E2 decreased bone turnover compared to CAS. In contrast, both treatments decreased serum sclerostin levels. Microarray analysis of RNA isolated from bone revealed 652 genes regulated by SPI, 491 genes regulated by E2, and 266 genes regulated by both SPI diet and E2 compared to CAS. The expression of caveolin-1, a protein localized in the cell membrane, was down-regulated (p < 0.05) in rats fed SPI, but not by E2 compared to rats fed casein. Down-regulation of caveolin-1 by SPI was associated with increased BMP2, Smad and Runx2 expression in bone and osteoblasts (p < 0.05). Conclusions/Significance: These results suggest SPI and E2 have different effects on bone turnover prior to puberty. Approximately half of the genes are regulated in the same direction by E2 or SPI, but in combination, SPI blocks the estrogen effects and returns the profile towards control levels. In addition, there are E2 specific and SPI-specific gene changes related to regulation of bone formation.	[Zhang, Jian; Lazarenko, Oxana P.; Wu, Xianli; Tong, Yudong; Blackburn, Michael L.; Gomez-Acevedo, Horatio; Shankar, Kartik; Badger, Thomas M.; Ronis, Martin J. J.; Chen, Jin-Ran] Arkansas Childrens Nutr Ctr, Little Rock, AR USA; [Zhang, Jian; Shankar, Kartik; Badger, Thomas M.; Ronis, Martin J. J.; Chen, Jin-Ran] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Lazarenko, Oxana P.; Wu, Xianli; Blackburn, Michael L.; Badger, Thomas M.] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; [Ronis, Martin J. J.] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Chen, JR (corresponding author), Arkansas Childrens Nutr Ctr, Little Rock, AR USA.	chenjinran@uams.edu	Gomez-Acevedo, Horacio/AAR-8783-2021	Gomez-Acevedo, Horacio/0000-0002-1570-1606; Shankar, Kartik/0000-0002-7964-9026	United States Department of Agriculture/Agriculture Research Service (USDA/ARS) [6251-51000-005-03S]	United States Department of Agriculture/Agriculture Research Service (USDA/ARS)(United States Department of Agriculture (USDA))	This work was supported by United States Department of Agriculture/Agriculture Research Service (USDA/ARS) #6251-51000-005-03S to the Arkansas Children's Nutrition Center (JRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjmandi BH, 1996, J NUTR, V126, P161, DOI 10.1093/jn/126.1.161; Badger TM, 2002, J NUTR, V132, p559S, DOI 10.1093/jn/132.3.559S; Bhangu PS, 2001, BONE, V29, P16, DOI 10.1016/S8756-3282(01)00482-3; Bitto A, 2010, CURR MED CHEM, V17, P3007, DOI 10.2174/092986710791959738; Chen JR, 2008, EXP BIOL MED, V233, P1348, DOI 10.3181/0802-RM-63; Chen JR, 2009, J NUTR, V139, P1839, DOI 10.3945/jn.109.109041; Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X; Gu LW, 2006, J NUTR, V136, P1215, DOI 10.1093/jn/136.5.1215; Ho SC, 2001, J BONE MINER RES, V16, P1363, DOI 10.1359/jbmr.2001.16.7.1363; Kaludjerovic J, 2010, J NUTR, V140, P766, DOI 10.3945/jn.109.116343; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kurzer M. S., 2008, Inflammopharmacology, V16, P227, DOI 10.1007/s10787-008-8021-z; Meksem K., 2001, Journal of Biomedicine and Biotechnology, V1, P38, DOI 10.1155/S1110724301000110; Messina M, 2010, J NUTR, V140, p2289S, DOI 10.3945/jn.110.124107; Mughal MZ, 2011, CURR OPIN ENDOCRINOL, V18, P28, DOI 10.1097/MED.0b013e3283416441; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Reinwald S, 2006, J NAT PROD, V69, P450, DOI 10.1021/np058104g; Ronis MJ, 2001, J NUTR, V131, P1180, DOI 10.1093/jn/131.4.1180; Rubin J, 2007, J BONE MINER RES, V22, P1408, DOI 10.1359/jbmr.070601; Sacco SM, 2009, MENOPAUSE, V16, P545, DOI 10.1097/gme.0b013e31818fc00a; Setchell KDR, 2001, J AM COLL NUTR, V20, p354S, DOI 10.1080/07315724.2001.10719168; Shankar K, 2010, ENDOCRINOLOGY, V151, P153, DOI 10.1210/en.2009-0840; Shupnik MA, 1998, J CLIN ENDOCR METAB, V83, P3965, DOI 10.1210/jc.83.11.3965; Singhal R, 2009, J ENDOCRINOL, V202, P141, DOI 10.1677/JOE-09-0059; Tylavsky FA, 2004, AM J CLIN NUTR, V79, P311; Warri A, 2008, BRIT J CANCER, V98, P1485, DOI 10.1038/sj.bjc.6604321; Wrana JL, 2000, CELL, V100, P189, DOI 10.1016/S0092-8674(00)81556-1	29	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35736	10.1371/journal.pone.0035736	http://dx.doi.org/10.1371/journal.pone.0035736			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536432	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339200104
J	O'Sullivan, VJ; Barrette-Ng, I; Hommema, E; Hermanson, GT; Schofield, M; Wu, SC; Honetschlaeger, C; Ng, KKS; Wong, SL				O'Sullivan, Valerie J.; Barrette-Ng, Isabelle; Hommema, Eric; Hermanson, Greg T.; Schofield, Mark; Wu, Sau-Ching; Honetschlaeger, Claudia; Ng, Kenneth K. -S.; Wong, Sui-Lam			Development of a Tetrameric Streptavidin Mutein with Reversible Biotin Binding Capability: Engineering a Mobile Loop as an Exit Door for Biotin	PLOS ONE			English	Article							MONOMERIC STREPTAVIDIN; SECRETORY PRODUCTION; BACILLUS-SUBTILIS; AVIDIN; DISSOCIATION; DIFFRACTION; COMPLEX; TOOLS	A novel form of tetrameric streptavidin has been engineered to have reversible biotin binding capability. In wild-type streptavidin, loop(3-4) functions as a lid for the entry and exit of biotin. When biotin is bound, interactions between biotin and key residues in loop(3-4) keep this lid in the closed state. In the engineered mutein, a second biotin exit door is created by changing the amino acid sequence of loop(7-8). This door is mobile even in the presence of the bound biotin and can facilitate the release of biotin from the mutein. Since loop(7-8) is involved in subunit interactions, alteration of this loop in the engineered mutein results in an 11 degrees rotation between the two dimers in reference to wild-type streptavidin. The tetrameric state of the engineered mutein is stabilized by a H127C mutation, which leads to the formation of inter-subunit disulfide bonds. The biotin binding kinetic parameters (k(off) of 4.28 x 10(-4) s(-1) and K-d of 1.9 x 10(-8) M) make this engineered mutein a superb affinity agent for the purification of biotinylated biomolecules. Affinity matrices can be regenerated using gentle procedures, and regenerated matrices can be reused at least ten times without any observable reduction in binding capacity. With the combination of both the engineered mutein and wild-type streptavidin, biotinylated biomolecules can easily be affinity purified to high purity and immobilized to desirable platforms without any leakage concerns. Other potential biotechnological applications, such as development of an automated high-throughput protein purification system, are feasible.	[O'Sullivan, Valerie J.; Hommema, Eric; Hermanson, Greg T.; Schofield, Mark] Thermo Fisher Sci Inc, Pierce Prot Res, Rockford, IL USA; [Barrette-Ng, Isabelle; Wu, Sau-Ching; Honetschlaeger, Claudia; Ng, Kenneth K. -S.; Wong, Sui-Lam] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	Thermo Fisher Scientific; University of Calgary	O'Sullivan, VJ (corresponding author), Thermo Fisher Sci Inc, Pierce Prot Res, Rockford, IL USA.	slwong@ucalgary.ca		Ng, Kenneth K.S./0000-0001-7280-8445	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The work was supported by Natural Sciences and Engineering Research Council of Canada, http://www.nserc-crsng.gc.ca/Index_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer EA, 1996, ELECTROPHORESIS, V17, P1319, DOI 10.1002/elps.1150170808; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHILKOTI A, 1995, P NATL ACAD SCI USA, V92, P1754, DOI 10.1073/pnas.92.5.1754; CHILKOTI A, 1995, BIO-TECHNOL, V13, P1198, DOI 10.1038/nbt1195-1198; Chivers CE, 2011, BIOCHEM J, V435, P55, DOI 10.1042/BJ20101593; Chivers CE, 2010, NAT METHODS, V7, P391, DOI [10.1038/nmeth.1450, 10.1038/NMETH.1450]; Chu V, 1998, PROTEIN SCI, V7, P848; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freitag S, 1998, J MOL BIOL, V279, P211, DOI 10.1006/jmbi.1998.1735; Freitag S, 1999, P NATL ACAD SCI USA, V96, P8384, DOI 10.1073/pnas.96.15.8384; Freitag S, 1997, PROTEIN SCI, V6, P1157, DOI 10.1002/pro.5560060604; GREEN NM, 1990, METHOD ENZYMOL, V184, P51; HENDRICKSON WA, 1989, P NATL ACAD SCI USA, V86, P2190, DOI 10.1073/pnas.86.7.2190; Huang W, 1997, ANAL CHEM, V69, P4601, DOI 10.1021/ac970390g; Katz BA, 1997, J MOL BIOL, V274, P776, DOI 10.1006/jmbi.1997.1444; KOHANSKI RA, 1990, METHOD ENZYMOL, V184, P194; Kopetzki E, 2001, US, Patent No. [6312916 B1, 6312916]; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Laitinen OH, 2007, TRENDS BIOTECHNOL, V25, P269, DOI 10.1016/j.tibtech.2007.04.001; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le Trong I, 2011, ACTA CRYSTALLOGR D, V67, P813, DOI 10.1107/S0907444911027806; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qureshi MH, 2001, J BIOL CHEM, V276, P46422, DOI 10.1074/jbc.M107398200; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Reznik GO, 1996, NAT BIOTECHNOL, V14, P1007, DOI 10.1038/nbt0896-1007; Reznik GO, 2001, BIOCONJUGATE CHEM, V12, P1000, DOI 10.1021/bc015507t; SANO T, 1995, P NATL ACAD SCI USA, V92, P3180, DOI 10.1073/pnas.92.8.3180; Stayton PS, 1999, BIOMOL ENG, V16, P39, DOI 10.1016/S1050-3862(99)00042-X; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Waner MJ, 2004, BIOPHYS J, V87, P2701, DOI 10.1529/biophysj.104.047266; WEBER PC, 1989, SCIENCE, V243, P85, DOI 10.1126/science.2911722; WILCHEK M, 1990, METHOD ENZYMOL, V184, P5; WILMOT CM, 1988, J MOL BIOL, V203, P221, DOI 10.1016/0022-2836(88)90103-9; Wu SC, 2006, PROTEIN EXPRES PURIF, V46, P268, DOI 10.1016/j.pep.2005.10.006; Wu SC, 2005, J BIOL CHEM, V280, P23225, DOI 10.1074/jbc.M501733200; Wu SC, 2002, APPL ENVIRON MICROB, V68, P3261, DOI 10.1128/AEM.68.7.3261-3269.2002; Wu SC, 2002, PROTEIN EXPRES PURIF, V24, P348, DOI 10.1006/prep.2001.1582; Wu SC, 2002, APPL ENVIRON MICROB, V68, P1102, DOI 10.1128/AEM.68.3.1102-1108.2002	41	20	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35203	10.1371/journal.pone.0035203	http://dx.doi.org/10.1371/journal.pone.0035203			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536357	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336200028
J	Lohmiller, T; Cox, N; Su, JH; Messinger, J; Lubitz, W				Lohmiller, Thomas; Cox, Nicholas; Su, Ji-Hu; Messinger, Johannes; Lubitz, Wolfgang			The Basic Properties of the Electronic Structure of the Oxygen-evolving Complex of Photosystem II Are Not Perturbed by Ca2+ Removal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINACH THYLAKOID MEMBRANES; WATER-OXIDIZING COMPLEX; STATE MULTILINE SIGNAL; KDA EXTRINSIC PROTEIN; CALCIUM-BINDING SITE; MANGANESE CLUSTER; S-2 STATE; PARAMAGNETIC-RES; CRYSTAL-STRUCTURE; PULSE EPR	Ca2+ is an integral component of the Mn4O5Ca cluster of the oxygen-evolving complex in photosystem II (PS II). Its removal leads to the loss of the water oxidizing functionality. The S-2' state of the Ca2+-depleted cluster from spinach is examined by X-and Q-band EPR and Mn-55 electron nuclear double resonance (ENDOR) spectroscopy. Spectral simulations demonstrate that upon Ca2+ removal, its electronic structure remains essentially unaltered, i.e. that of a manganese tetramer. No redistribution of the manganese valence states and only minor perturbation of the exchange interactions between the manganese ions were found. Interestingly, the S-2' state in spinach PS II is very similar to the native S-2 state of Thermosynechococcus elongatus in terms of spin state energies and insensitivity to methanol addition. These results assign the Ca2+ a functional as opposed to a structural role in water splitting catalysis, such as (i) being essential for efficient proton-coupled electron transfer between Y-Z and the manganese cluster and/or (ii) providing an initial binding site for substrate water. Additionally, a novel Mn-55(2+) signal, detected by Q-band pulse EPR and ENDOR, was observed in Ca2+-depleted PS II. Mn2+ titration, monitored by Mn-55 ENDOR, revealed a specific Mn2+ binding site with a submicromolar K-D. Ca2+ titration of Mn2+-loaded, Ca2+-depleted PS II demonstrated that the site is reversibly made accessible to Mn2+ by Ca2+ depletion and reconstitution. Mn2+ is proposed to bind at one of the extrinsic subunits. This process is possibly relevant for the formation of the Mn4O5Ca cluster during photoassembly and/or D1 repair.	[Lohmiller, Thomas; Cox, Nicholas; Su, Ji-Hu; Lubitz, Wolfgang] Max Planck Inst Bioanorgan Chem, D-45470 Mulheim, Germany; [Messinger, Johannes] Umea Univ, Dept Chem, Chem Biol Ctr KBC, S-90187 Umea, Sweden	Max Planck Society; Umea University	Lubitz, W (corresponding author), Max Planck Inst Bioanorgan Chem, Stiftstr 34-36, D-45470 Mulheim, Germany.	wolfgang.lubitz@mpi-mail.mpg.de	Cox, Nicholas/J-8047-2014; Messinger, Johannes/AAC-4221-2019	Cox, Nicholas/0000-0002-7815-6115; Messinger, Johannes/0000-0003-2790-7721; Lohmiller, Thomas/0000-0003-0373-1506	Max Planck Gesellschaft; EU/Energy Network project SOLAR-H2 (FP7) [212508]; Federal Ministry of Education and Research of Germany (BMBF) [03SF0355C]; National Natural Science Foundation of China [31070211]; Vetenskapsradet, Umea University (Solar Fuels Strong Research Environment); K&A Wallenberg foundation (Artificial Leaf project Umea); Kempe foundation	Max Planck Gesellschaft(Max Planck Society); EU/Energy Network project SOLAR-H2 (FP7); Federal Ministry of Education and Research of Germany (BMBF)(Federal Ministry of Education & Research (BMBF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Vetenskapsradet, Umea University (Solar Fuels Strong Research Environment); K&A Wallenberg foundation (Artificial Leaf project Umea); Kempe foundation	This work was supported by Max Planck Gesellschaft and the EU/Energy Network project SOLAR-H2 (FP7 Contract 212508).; Supported by the Federal Ministry of Education and Research of Germany (BMBF) in the framework of the Bio-H2 project (03SF0355C).; Supported by the National Natural Science Foundation of China (31070211). Present address: Dept. of Modern Physics, University of Science and Technology of China, Hefei, Anhui 230026, China.; Supported by Vetenskapsradet, Umea University (Solar Fuels Strong Research Environment), the K&A Wallenberg foundation (Artificial Leaf project Umea), and the Kempe foundation.	ABRAMOWICZ DA, 1984, BIOCHIM BIOPHYS ACTA, V765, P318, DOI 10.1016/0005-2728(84)90172-5; Ahrling KA, 1998, BIOCHEMISTRY-US, V37, P8115, DOI 10.1021/bi980117o; Ahrling KA, 2004, BBA-BIOENERGETICS, V1656, P66, DOI 10.1016/j.bbabio.2004.01.006; Ahrling KA, 2006, BIOCHEMISTRY-US, V45, P7069, DOI 10.1021/bi052146m; Ames W, 2011, J AM CHEM SOC, V133, P19743, DOI 10.1021/ja2041805; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BALDWIN MJ, 1994, J AM CHEM SOC, V116, P11349, DOI 10.1021/ja00104a014; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Bondarava N, 2005, BBA-BIOENERGETICS, V1708, P63, DOI 10.1016/j.bbabio.2005.01.005; Bondarava N, 2007, BBA-BIOENERGETICS, V1767, P583, DOI 10.1016/j.bbabio.2007.01.001; Booth PJ, 1996, BBA-BIOENERGETICS, V1277, P127, DOI 10.1016/S0005-2728(96)00094-1; Boussac A, 2004, J BIOL CHEM, V279, P22809, DOI 10.1074/jbc.M401677200; BOUSSAC A, 1989, BIOCHEMISTRY-US, V28, P8984, DOI 10.1021/bi00449a005; Boussac A, 1997, J BIOL INORG CHEM, V2, P580, DOI 10.1007/s007750050172; BOUSSAC A, 1988, BIOCHEMISTRY-US, V27, P3476, DOI 10.1021/bi00409a052; BOUSSAC A, 1988, FEBS LETT, V236, P432, DOI 10.1016/0014-5793(88)80071-1; BOUSSAC A, 1985, BIOCHIM BIOPHYS ACTA, V808, P231, DOI 10.1016/0005-2728(85)90004-0; Bricker TM, 2011, J PHOTOCH PHOTOBIO B, V104, P165, DOI 10.1016/j.jphotobiol.2011.01.025; Campbell KA, 2000, J AM CHEM SOC, V122, P3754, DOI 10.1021/ja000142t; CASEY JL, 1984, BIOCHIM BIOPHYS ACTA, V767, P21, DOI 10.1016/0005-2728(84)90075-6; Charlot MF, 2005, BBA-BIOENERGETICS, V1708, P120, DOI 10.1016/j.bbabio.2005.01.006; Cinco RM, 1998, J PHYS CHEM B, V102, P8248, DOI 10.1021/jp981658q; Cox N, 2011, J AM CHEM SOC, V133, P3635, DOI 10.1021/ja110145v; Dasgupta J, 2008, COORDIN CHEM REV, V252, P347, DOI 10.1016/j.ccr.2007.08.022; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; Dau H, 2009, ACCOUNTS CHEM RES, V42, P1861, DOI 10.1021/ar900225y; Diner BA, 2005, ADV PHOTO RESPIRAT, V22, P207; DISMUKES GC, 1981, P NATL ACAD SCI-BIOL, V78, P274, DOI 10.1073/pnas.78.1.274; Epel B, 2005, CONCEPT MAGN RESON B, V26B, P36, DOI 10.1002/cmr.b.20037; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Force DA, 1998, J AM CHEM SOC, V120, P13321, DOI 10.1021/ja982713b; GERRITSEN HJ, 1963, PHYS REV, V132, P1507, DOI 10.1103/PhysRev.132.1507; GHANOTAKIS DF, 1984, FEBS LETT, V167, P127, DOI 10.1016/0014-5793(84)80846-7; GHANOTAKIS DF, 1984, FEBS LETT, V170, P169, DOI 10.1016/0014-5793(84)81393-9; Grasse N, 2011, J BIOL CHEM, V286, P29548, DOI 10.1074/jbc.M111.238394; Griffith J., 2009, THEORY TRANSITION ME; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Heredia P, 2003, BIOCHEMISTRY-US, V42, P11831, DOI 10.1021/bi034582j; Hillier W, 2005, ADV PHOTO RESPIRAT, V22, P567; Hillier W, 2008, COORDIN CHEM REV, V252, P306, DOI 10.1016/j.ccr.2007.09.004; Horner O, 1998, J AM CHEM SOC, V120, P7924, DOI 10.1021/ja981330a; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Komenda J., 2011, SELF HEALING NANOSCA, P3; Kruk J, 2003, BIOCHEMISTRY-US, V42, P14862, DOI 10.1021/bi0351413; Kulik L, 2005, PHOTOSYNTH RES, V84, P347, DOI 10.1007/s11120-005-2438-7; Kulik LV, 2007, J AM CHEM SOC, V129, P13421, DOI 10.1021/ja071487f; Kulik LV, 2005, J AM CHEM SOC, V127, P2392, DOI 10.1021/ja043012j; KUSUNOKI M, 1992, CHEM PHYS LETT, V197, P108, DOI 10.1016/0009-2614(92)86031-C; Kusunoki M, 2007, BBA-BIOENERGETICS, V1767, P484, DOI 10.1016/j.bbabio.2007.03.012; Latimer MJ, 1998, J PHYS CHEM B, V102, P8257, DOI 10.1021/jp981668r; LAVERGNE J, 1993, PHOTOSYNTH RES, V38, P279, DOI 10.1007/BF00046752; Lohmiller T., 2010, P 15 INT C PHOT BEIJ; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; LORIGAN GA, 1994, BIOCHEMISTRY-US, V33, P12072, DOI 10.1021/bi00206a009; Lu YK, 2005, PLANT CELL PHYSIOL, V46, P1944, DOI 10.1093/pcp/pci209; Lubitz W, 2008, ENERG ENVIRON SCI, V1, P15, DOI 10.1039/b808792j; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; Messinger J, 2001, J AM CHEM SOC, V123, P7804, DOI 10.1021/ja004307+; MESSINGER J, 1995, P NATL ACAD SCI USA, V92, P3209, DOI 10.1073/pnas.92.8.3209; Messinger J., 2008, PRIMARY PROCESSES PH, P291; Messinger J, 2011, RSC ENERGY ENVIRON S, P163; Michoux F, 2010, BIOCHEMISTRY-US, V49, P7411, DOI 10.1021/bi1011145; Miqyass M, 2007, PHOTOSYNTH RES, V92, P275, DOI 10.1007/s11120-006-9124-2; Mulo P, 2008, PHOTOSYNTH RES, V98, P489, DOI 10.1007/s11120-008-9320-3; Murray JW, 2006, BIOCHEMISTRY-US, V45, P4128, DOI 10.1021/bi052503t; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; ONO T, 1988, FEBS LETT, V227, P147, DOI 10.1016/0014-5793(88)80886-X; ONO TA, 1989, ARCH BIOCHEM BIOPHYS, V275, P440, DOI 10.1016/0003-9861(89)90390-1; PACE RJ, 1991, BIOCHIM BIOPHYS ACTA, V1058, P161, DOI 10.1016/S0005-2728(05)80233-6; Pantazis DA, 2009, PHYS CHEM CHEM PHYS, V11, P6788, DOI 10.1039/b907038a; Pecoraro VL, 1998, PURE APPL CHEM, V70, P925, DOI 10.1351/pac199870040925; Peloquin JM, 2000, J AM CHEM SOC, V122, P10926, DOI 10.1021/ja002104f; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Pushkar Y, 2007, J BIOL CHEM, V282, P7198, DOI 10.1074/jbc.M610505200; Reijerse E, 2012, J MAGN RESON, V214, P237, DOI 10.1016/j.jmr.2011.11.011; Renger G, 2008, PHOTOSYNTH RES, V98, P53, DOI 10.1007/s11120-008-9345-7; Roberts AG, 2003, BBA-BIOENERGETICS, V1604, P23, DOI 10.1016/S0005-2728(03)00021-5; RUTHERFORD AW, 1984, BIOCHIM BIOPHYS ACTA, V767, P168, DOI 10.1016/0005-2728(84)90092-6; Siegbahn PEM, 2009, ACCOUNTS CHEM RES, V42, P1871, DOI 10.1021/ar900117k; Siegbahn PEM, 2009, DALTON T, P10063, DOI 10.1039/b909470a; SIVARAJA M, 1989, BIOCHEMISTRY-US, V28, P9459, DOI 10.1021/bi00450a032; Stich TA, 2011, BIOCHEMISTRY-US, V50, P7390, DOI 10.1021/bi2010703; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; STURGEON BE, 1994, J PHYS CHEM-US, V98, P12871, DOI 10.1021/j100100a012; Su JH, 2011, BBA-BIOENERGETICS, V1807, P829, DOI 10.1016/j.bbabio.2011.03.002; Teutloff C, 2006, FEBS LETT, V580, P3605, DOI 10.1016/j.febslet.2006.05.039; Teutloff C, 2009, PHYS CHEM CHEM PHYS, V11, P6715, DOI 10.1039/b908093g; TSO J, 1991, BIOCHEMISTRY-US, V30, P4734, DOI 10.1021/bi00233a014; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Vrettos JS, 2001, BIOCHEMISTRY-US, V40, P7937, DOI 10.1021/bi010679z; Yachandra VK, 2011, J PHOTOCH PHOTOBIO B, V104, P51, DOI 10.1016/j.jphotobiol.2011.02.019; Yachandra VK, 2005, ADV PHOTO RESPIRAT, V22, P235; YAMAMOTO Y, 1984, FEBS LETT, V175, P429, DOI 10.1016/0014-5793(84)80782-6; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Yano J, 2006, SCIENCE, V314, P821, DOI 10.1126/science.1128186; Yocum CF, 2008, COORDIN CHEM REV, V252, P296, DOI 10.1016/j.ccr.2007.08.010; Zhang LX, 1996, PHOTOSYNTH RES, V48, P379, DOI 10.1007/BF00029470; Zheng M, 1996, INORG CHEM, V35, P3307, DOI 10.1021/ic9512340; ZIMMERMANN JL, 1984, BIOCHIM BIOPHYS ACTA, V767, P160, DOI 10.1016/0005-2728(84)90091-4; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	100	53	53	1	59	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24721	24733		10.1074/jbc.M112.365288	http://dx.doi.org/10.1074/jbc.M112.365288			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22549771	Green Published, hybrid			2022-12-25	WOS:000306651100065
J	Nin, V; Escande, C; Chini, CC; Giri, S; Camacho-Pereira, J; Matalonga, J; Lou, ZK; Chini, EN				Nin, Veronica; Escande, Carlos; Chini, Claudia C.; Giri, Shailendra; Camacho-Pereira, Juliana; Matalonga, Jonathan; Lou, Zhenkun; Chini, Eduardo N.			Role of Deleted in Breast Cancer 1 (DBC1) Protein in SIRT1 Deacetylase Activation Induced by Protein Kinase A and AMP-activated Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; INSULIN-SECRETION; SIGNALING PATHWAY; CELLULAR-RESPONSE; MAMMALIAN TARGET; TUMOR-SUPPRESSOR; NAD; PHOSPHORYLATION; RESVERATROL; GLUCOSE	The NAD(+)-dependent deacetylase SIRT1 is a key regulator of several aspects of metabolism and aging. SIRT1 activation is beneficial for several human diseases, including metabolic syndrome, diabetes, obesity, liver steatosis, and Alzheimer disease. We have recently shown that the protein deleted in breast cancer 1 (DBC1) is a key regulator of SIRT1 activity in vivo. Furthermore, SIRT1 and DBC1 form a dynamic complex that is regulated by the energetic state of the organism. Understanding how the interaction between SIRT1 and DBC1 is regulated is therefore essential to design strategies aimed to activate SIRT1. Here, we investigated which pathways can lead to the dissociation of SIRT1 and DBC1 and consequently to SIRT1 activation. We observed that PKA activation leads to a fast and transient activation of SIRT1 that is DBC1-dependent. In fact, an increase in cAMP/PKA activity resulted in the dissociation of SIRT1 and DBC1 in an AMP-activated protein kinase (AMPK)-dependent manner. Pharmacological AMPK activation led to SIRT1 activation by a DBC1-dependent mechanism. Indeed, we found that AMPK activators promote SIRT1-DBC1 dissociation in cells, resulting in an increase in SIRT1 activity. In addition, we observed that the SIRT1 activation promoted by PKA and AMPK occurs without changes in the intracellular levels of NAD(+). We propose that PKA and AMPK can acutely activate SIRT1 by inducing dissociation of SIRT1 from its endogenous inhibitor DBC1. Our experiments provide new insight on the in vivo mechanism of SIRT1 regulation and a new avenue for the development of pharmacological SIRT1 activators targeted at the dissociation of the SIRT1-DBC1 complex.	[Chini, Eduardo N.] Mayo Clin, Dept Anesthesiol, Lab Signal Transduct, Rochester, MN 55905 USA; [Nin, Veronica; Escande, Carlos; Chini, Claudia C.; Camacho-Pereira, Juliana; Matalonga, Jonathan; Chini, Eduardo N.] Mayo Clin, Kogod Aging Ctr, Rochester, MN 55905 USA; [Giri, Shailendra] Mayo Clin, Dept Expt Pathol, Rochester, MN 55905 USA; [Lou, Zhenkun] Mayo Clin, Dept Oncol, Div Oncol Res, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Chini, EN (corresponding author), Mayo Clin, Dept Anesthesiol, Lab Signal Transduct, Rochester, MN 55905 USA.	chini.eduardo@mayo.edu	Camacho-Pereira, Juliana/AAZ-6174-2021	Camacho-Pereira, Juliana/0000-0002-4247-2140	NIDDK, National Institutes of Health [DK-084055]; American Federation of Aging Research; Mayo Foundation; Strickland Career Development Award; American Heart Association Postdoctoral Fellowship Award [11POST7320060]; Fundacao de Amparo A Pesquisa do Estado do Rio de Janeiro, Brazil; NATIONAL CANCER INSTITUTE [P50CA108961, R01CA129344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084055] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Federation of Aging Research; Mayo Foundation; Strickland Career Development Award; American Heart Association Postdoctoral Fellowship Award(American Heart Association); Fundacao de Amparo A Pesquisa do Estado do Rio de Janeiro, Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-084055 from the NIDDK. This work was also supported by grants from the American Federation of Aging Research and the Mayo Foundation and by the Strickland Career Development Award.; Supported by American Heart Association Postdoctoral Fellowship Award 11POST7320060.; Supported by Fundacao de Amparo A Pesquisa do Estado do Rio de Janeiro, Brazil.	Aksoy P, 2006, BIOCHEM BIOPH RES CO, V349, P353, DOI 10.1016/j.bbrc.2006.08.066; Aksoy P, 2006, BIOCHEM BIOPH RES CO, V345, P1386, DOI 10.1016/j.bbrc.2006.05.042; Barata H, 2004, ENDOCRINOLOGY, V145, P881, DOI 10.1210/en.2003-0774; Barbosa MTP, 2007, FASEB J, V21, P3629, DOI 10.1096/fj.07-8290com; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Canto C, 2012, PHARMACOL REV, V64, P166, DOI 10.1124/pr.110.003905; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; CARLING D, 1989, BIOCHIM BIOPHYS ACTA, V1012, P81, DOI 10.1016/0167-4889(89)90014-1; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Chini CCS, 2010, J BIOL CHEM, V285, P40830, DOI 10.1074/jbc.M110.153270; Chini EN, 2009, CURR PHARM DESIGN, V15, P57, DOI 10.2174/138161209787185788; Chini EN, 2005, BIOCHEM J, V389, P269, DOI 10.1042/BJ20041971; Collins SP, 2000, BIOCHEM J, V345, P673, DOI 10.1042/0264-6021:3450673; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; Escande C, 2010, J CLIN INVEST, V120, P545, DOI 10.1172/JCI39319; Farci P, 2010, P NATL ACAD SCI USA, V107, P8766, DOI [10.1073/pnas.1003854107, 10.1073/pnas.1003833107]; Fu JJ, 2009, J BIOL CHEM, V284, P6832, DOI 10.1074/jbc.M808988200; Gao ZG, 2011, J BIOL CHEM, V286, P22227, DOI 10.1074/jbc.M111.228874; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P13632, DOI 10.1073/pnas.0706290104; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Hiraike H, 2010, BRIT J CANCER, V102, P1061, DOI 10.1038/sj.bjc.6605577; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; Kang H, 2011, MOL CELL, V44, P203, DOI 10.1016/j.molcel.2011.07.038; Kang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006611; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200; Koyama S, 2010, BIOCHEM BIOPH RES CO, V392, P357, DOI 10.1016/j.bbrc.2010.01.025; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Moreno D, 2008, FEBS LETT, V582, P2650, DOI 10.1016/j.febslet.2008.06.044; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Nagamune K, 2008, NATURE, V451, P207, DOI 10.1038/nature06478; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Revollo JR, 2007, CURR OPIN GASTROEN, V23, P164, DOI 10.1097/MOG.0b013e32801b3c8f; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Schenk S, 2011, J CLIN INVEST, V121, P4281, DOI 10.1172/JCI58554; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Trauernicht AM, 2007, MOL ENDOCRINOL, V21, P1526, DOI 10.1210/me.2007-0064; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Williamson DL, 2006, J PHYSIOL-LONDON, V573, P497, DOI 10.1113/jphysiol.2005.103481; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Wu HM, 2011, MOL PHARMACOL, V80, P859, DOI 10.1124/mol.111.072769; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; Yin W, 2003, J BIOL CHEM, V278, P43074, DOI 10.1074/jbc.M308484200; Yuan J, 2012, GENE DEV, V26, P791, DOI 10.1101/gad.188482.112; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; Zschoernig B, 2009, BIOCHEM BIOPH RES CO, V381, P372, DOI 10.1016/j.bbrc.2009.02.085	71	85	95	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23489	23501		10.1074/jbc.M112.365874	http://dx.doi.org/10.1074/jbc.M112.365874			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22553202	Green Published, hybrid			2022-12-25	WOS:000306511300021
J	Magnone, M; Bauer, I; Poggi, A; Mannino, E; Sturla, L; Brini, M; Zocchi, E; De Flora, A; Nencioni, A; Bruzzone, S				Magnone, Mirko; Bauer, Inga; Poggi, Alessandro; Mannino, Elena; Sturla, Laura; Brini, Marisa; Zocchi, Elena; De Flora, Antonio; Nencioni, Alessio; Bruzzone, Santina			NAD(+) Levels Control Ca2+ Store Replenishment and Mitogen-induced Increase of Cytosolic Ca2+ by Cyclic ADP-ribose-dependent TRPM2 Channel Gating in Human T Lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; CALCIUM; 2ND-MESSENGER; CD38; ACTIVATION; CELLS; BCL-2; INHIBITION; INFLUX; PROLIFERATION	Intracellular NAD(+) levels ([NAD(+)](i)) are important in regulating human T lymphocyte survival, cytokine secretion, and the capacity to respond to antigenic stimuli. NAD(+)-derived Ca2+-mobilizing second messengers, produced by CD38, play a pivotal role in T cell activation. Here we demonstrate that [NAD(+)] i modifications in T lymphocytes affect intracellular Ca2+ homeostasis both in terms of mitogen-induced [Ca2+](i) increase and of endoplasmic reticulum Ca2+ store replenishment. Lowering [NAD(+)](i) by FK866-mediated nicotinamide phosphoribosyltransferase inhibition decreased the mitogen-induced [Ca2+](i) rise in Jurkat cells and in activated T lymphocytes. Accordingly, the Ca2+ content of thapsigargin-sensitive Ca2+ stores was greatly reduced in these cells in the presence of FK866. When NAD(+) levels were increased by supplementing peripheral blood lymphocytes with the NAD(+) precursors nicotinamide, nicotinic acid, or nicotinamide mononucleotide, the Ca2+ content of thapsigargin-sensitive Ca2+ stores as well as cell responsiveness to mitogens in terms of [Ca2+](i) elevation were up-regulated. The use of specific siRNA showed that the changes of Ca2+ homeostasis induced by NAD(+) precursors are mediated by CD38 and the consequent ADPR-mediated TRPM2 gating. Finally, the presence of NAD(+) precursors up-regulated important T cell functions, such as proliferation and IL-2 release in response to mitogens.	[Bauer, Inga; Nencioni, Alessio] Univ Genoa, Dept Internal Med, I-16132 Genoa, Italy; [Magnone, Mirko; Mannino, Elena; Sturla, Laura; Zocchi, Elena; De Flora, Antonio; Bruzzone, Santina] Univ Genoa, Dept Expt Med, Biochem Sect, I-16132 Genoa, Italy; [Magnone, Mirko; Mannino, Elena; Sturla, Laura; De Flora, Antonio; Nencioni, Alessio] Univ Genoa, Ctr Excellence Biomed Res, I-16132 Genoa, Italy; [Poggi, Alessandro] IRCCS AOU San Martino IST Natl Inst Canc Res, Mol Oncol & Angiogenesis Unit, I-16132 Genoa, Italy; [Zocchi, Elena; Bruzzone, Santina] Adv Biotechnol Ctr, I-16132 Genoa, Italy; [Brini, Marisa] Univ Padua, Dept Comparat Biomed & Food Sci, I-35131 Padua, Italy	University of Genoa; University of Genoa; University of Genoa; University of Genoa; IRCCS AOU San Martino IST; University of Padua	Nencioni, A (corresponding author), Univ Genoa, Dept Internal Med, Viale Benedetto 15,6, I-16132 Genoa, Italy.	alessio.nencioni@unige.it; santina.bruzzone@unige.it	Poggi, Alessandro/K-6664-2016; Bruzzone, Santina/A-4264-2015; Nencioni, Alessio/K-3692-2018; Brini, Marisa/K-5189-2016	Poggi, Alessandro/0000-0002-1860-430X; Bruzzone, Santina/0000-0003-2034-3716; Brini, Marisa/0000-0001-5141-0243; NENCIONI, ALESSIO/0000-0001-5068-8884	Italian Ministry of Education, University and Scientific Research; Italian Ministry of Health; University of Genova; Fondazione CARIGE; Compagnia di S. Paolo; Regione Liguria; Fondazione Italiana Sclerosi Multipla (FISM); Associazione Italiana per la Ricerca sul Cancro (AIRC) [8761]	Italian Ministry of Education, University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health(Ministry of Health, Italy); University of Genova; Fondazione CARIGE(Fondazione Carige); Compagnia di S. Paolo(Compagnia di San Paolo); Regione Liguria(Regione Liguria); Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Italian Ministry of Education, University and Scientific Research, the Italian Ministry of Health, the University of Genova, the Fondazione CARIGE, the Compagnia di S. Paolo, the Regione Liguria, the Fondazione Italiana Sclerosi Multipla (FISM), and the Associazione Italiana per la Ricerca sul Cancro (AIRC, START-UP grant (to A. N.) and AIRC n.8761 (to A. P.)).	Basile G, 2005, P NATL ACAD SCI USA, V102, P14509, DOI 10.1073/pnas.0503691102; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Belka C, 2000, ONCOGENE, V19, P1181, DOI 10.1038/sj.onc.1203401; BERGER SJ, 1987, EXP CELL RES, V169, P149, DOI 10.1016/0014-4827(87)90233-3; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Bogan KL, 2009, J BIOL CHEM, V284, P34861, DOI 10.1074/jbc.M109.056689; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Brini M, 2008, METHODS, V46, P160, DOI 10.1016/j.ymeth.2008.09.011; Bruzzone S, 2003, BIOCHEM J, V375, P395, DOI 10.1042/BJ20030556; Bruzzone S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007897; Buelow Ben, 2008, J Biol Chem, V283, P24571, DOI 10.1074/jbc.M802673200; Carafoli E, 2003, NAT REV MOL CELL BIO, V4, P326, DOI 10.1038/nrm1073; Carafoli E, 2001, CRIT REV BIOCHEM MOL, V36, P107, DOI 10.1080/20014091074183; De Flora A, 2004, ANN NY ACAD SCI, V1028, P176, DOI 10.1196/annals.1322.021; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Fliegert R, 2007, BIOCHEM SOC T, V35, P109, DOI 10.1042/BST0350109; Galli M, 2010, CANCER RES, V70, P8, DOI 10.1158/0008-5472.CAN-09-2465; Garavaglia S, 2012, BIOCHEM J, V441, P131, DOI 10.1042/BJ20111263; Gasser A, 2006, J BIOL CHEM, V281, P2489, DOI 10.1074/jbc.M506525200; Guse AH, 2005, FEBS J, V272, P4590, DOI 10.1111/j.1742-4658.2005.04863.x; Guse AH, 2004, CURR MOL MED, V4, P239, DOI 10.2174/1566524043360771; Guse AH, 1999, NATURE, V398, P70, DOI 10.1038/18024; Hanson CJ, 2008, CELL CALCIUM, V44, P324, DOI 10.1016/j.ceca.2008.01.003; Hasmann M, 2003, CANCER RES, V63, P7436; Holen K, 2008, INVEST NEW DRUG, V26, P45, DOI 10.1007/s10637-007-9083-2; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Imai SI, 2010, PHARMACOL RES, V62, P42, DOI 10.1016/j.phrs.2010.01.006; INESI G, 1992, ARCH BIOCHEM BIOPHYS, V298, P313, DOI 10.1016/0003-9861(92)90416-T; Khan JA, 2006, NAT STRUCT MOL BIOL, V13, P582, DOI 10.1038/nsmb1105; Lange I, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000278; Lau C, 2009, FRONT BIOSCI-LANDMRK, V14, P410, DOI 10.2741/3252; Lee HC, 2004, CURR MOL MED, V4, P227, DOI 10.2174/1566524043360753; LEE HC, 1989, J BIOL CHEM, V264, P1608; Lee HC, 2011, SCI CHINA LIFE SCI, V54, P699, DOI 10.1007/s11427-011-4197-3; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Musso A, 2011, HAEMATOL-HEMATOL J, V96, P16, DOI 10.3324/haematol.2010.031633; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Partida-Sanchez S, 2007, J IMMUNOL, V179, P7827, DOI 10.4049/jimmunol.179.11.7827; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Pinton P, 2006, CELL DEATH DIFFER, V13, P1409, DOI 10.1038/sj.cdd.4401960; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Rong YP, 2008, MOL CELL, V31, P255, DOI 10.1016/j.molcel.2008.06.014; Rong YP, 2009, P NATL ACAD SCI USA, V106, P14397, DOI 10.1073/pnas.0907555106; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; Rongvaux A, 2008, J IMMUNOL, V181, P4685, DOI 10.4049/jimmunol.181.7.4685; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Sauve AA, 1998, BIOCHEMISTRY-US, V37, P13239, DOI 10.1021/bi981248s; Sestini S, 2000, ARCH BIOCHEM BIOPHYS, V379, P277, DOI 10.1006/abbi.2000.1888; Shaffer AL, 2001, IMMUNITY, V15, P375, DOI 10.1016/S1074-7613(01)00194-7; Stahlberg A, 2005, EXPERT REV MOL DIAGN, V5, P221, DOI 10.1586/14737159.5.2.221; Sumoza-Toledo A, 2011, J PHYSIOL-LONDON, V589, P1515, DOI 10.1113/jphysiol.2010.201855; Tempel W, 2007, PLOS BIOL, V5, P2220, DOI 10.1371/journal.pbio.0050263; Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906; Wosikowski K, 2002, CANCER RES, V62, P1057; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zocchi E, 1998, J BIOL CHEM, V273, P8017, DOI 10.1074/jbc.273.14.8017; ZOCCHI E, 1993, BIOCHEM BIOPH RES CO, V196, P1459, DOI 10.1006/bbrc.1993.2416	65	43	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21067	21081		10.1074/jbc.M111.324269	http://dx.doi.org/10.1074/jbc.M111.324269			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22547068	hybrid, Green Published			2022-12-25	WOS:000306416800028
J	Burns, F; Edwards, SG; Woods, J; Haidari, G; Calderon, Y; Leider, J; Morris, S; Tobin, R; Cartledge, J; Brown, M				Burns, Fiona; Edwards, Simon G.; Woods, Jeremy; Haidari, Golaleh; Calderon, Yvette; Leider, Jason; Morris, Stephen; Tobin, Rose; Cartledge, Jonathan; Brown, Michael			Acceptability and Feasibility of Universal Offer of Rapid Point of Care Testing for HIV in an Acute Admissions Unit: Results of the RAPID Project	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT; ENGLAND; WALES; UK	Background: UK guidance recommend all acute medical admissions be offered an HIV test. Our aim was to determine whether a dedicated staff member using a multimedia tool, a model found to be effective in the USA, is an acceptable, feasible, and cost-effective model when translated to a UK setting. Design: Between 14th Jan to 12th May 2010, a Health advisor (HA) approached 19-65 year olds at a central London acute medical admissions unit (AAU) and offered a rapid HIV point of care test (POCT) with the aid of an educational video. Patients with negative results had the option to watch a post-test video providing risk-reduction information. For reactive results the HA arranged a confirmatory test, and ensured linkage into HIV specialist care. Feasibility and acceptability were assessed through surveys and uptake rates. Costs per case of HIV identified were established. Results: Of the 606 eligible people admitted during the pilot period, 324 (53.5%) could not be approached or testing was deemed inappropriate. In total 23.0% of eligible admissions had an HIV POCT. Of the patients who watched the video and had not recently tested for HIV, 93.6% (131/140) agreed to an HIV test; four further patients had an HIV test but did not watch the video. Three tests (2.2%, 3/135) were reactive and all were confirmed HIV positive on laboratory testing. 97.5% felt HIV testing in this setting was appropriate, and 90.1% liked receiving the information via video. The cost per patient of the intervention was 21 pound. Discussion: Universal POCT HIV testing in an acute medical setting, facilitated by an educational video and dedicated staff appears to be acceptable, feasible, effective, and low cost. These findings support the recommendation of HIV testing all admissions to AAU in high prevalence settings, although with the model used a significant proportion remained untested.	[Burns, Fiona] UCL, Res Dept Infect & Populat Hlth, London, England; [Edwards, Simon G.; Woods, Jeremy; Tobin, Rose; Cartledge, Jonathan] Cent & N W London Fdn Trust, Mortimer Market Ctr, London, England; [Haidari, Golaleh; Brown, Michael] Univ Coll London Hosp Natl Hlth Serv Fdn Trust, London, England; [Calderon, Yvette; Leider, Jason] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Morris, Stephen] UCL, Univ Coll London Ctr Appl Hlth Res, London, England; [Brown, Michael] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England	University of London; University College London; University of London; University College London; Yeshiva University; Albert Einstein College of Medicine; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Burns, F (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	f.burns@ucl.ac.uk			Gilead's United Kingdom; Ireland Fellowship Programme; Camden's & Islington's Provider Services; Department of Health's National Institutes of Health Research Biomedical Research Centres funding scheme; United Kingdom and Ireland Fellowship Programme; Gilead	Gilead's United Kingdom; Ireland Fellowship Programme; Camden's & Islington's Provider Services; Department of Health's National Institutes of Health Research Biomedical Research Centres funding scheme; United Kingdom and Ireland Fellowship Programme; Gilead(Gilead Sciences)	Gilead's United Kingdom and Ireland Fellowship Programme and Camden's & Islington's Provider Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was undertaken at University College London Hospital/University College London who received a proportion of funding from the Department of Health's National Institutes of Health Research Biomedical Research Centres funding scheme.; University College London Hospital has received free INSTI-60 second tests from Pasante Healthcare for another testing pilot within the Trust. Gilead funded part of this work through an unrestricted educational grant via their United Kingdom and Ireland Fellowship Programme. JL & YC received funding for HIV testing from Gilead. JC, SE and FB have received funding from various pharmaceutical companies to attend conferences and/or been paid to lecture at educational meetings. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	[Anonymous], 2011, NIC PUBL HLTH GUID 3; [Anonymous], 2021, HIV TESTING NEW HIV; BHIVA Audit & Standards Sub-Committee, 2006, MORT AUD; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Calderon Y, 2006, ANN EMERG MED, V48, P21, DOI 10.1016/j.annemergmed.2006.01.003; Calderon Y, 2009, AIDS PATIENT CARE ST, V23, P749, DOI 10.1089/apc.2008.0270; Chadborn TR, 2006, AIDS, V20, P2371, DOI 10.1097/QAD.0b013e32801138f7; Chadborn TR, 2005, AIDS, V19, P513, DOI 10.1097/01.aids.0000162340.43310.08; Curtis L., 2010, UNIT COSTS HLTH SOCI; De Cock KM, 1998, BMJ-BRIT MED J, V316, P290, DOI 10.1136/bmj.316.7127.290; Department of Health, 2003, SCREEN INF DIS PREGN; Fonseca K, 2004, 15 INT AIDS C 2004 B; Health Protection Agency, 2009, HIV UK 2009 REP; Krentz HB, 2004, HIV MED, V5, P93, DOI 10.1111/j.1468-1293.2004.00193.x; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; National Institute for Health and Clinical Excellence, 2011, INCR UPT HIV TEST ME; Peck L, 2010, QJM-INT J MED, V103, P147, DOI 10.1093/qjmed/hcp185; Simpson WM, 1998, BRIT MED J, V316, P262, DOI 10.1136/bmj.316.7127.262; Streetly A., 2002, POLICY DECISION IMPL; Sullivan AK, 2005, BRIT MED J, V330, P1301, DOI 10.1136/bmj.38398.590602.E0; WILSON JMG, 1968, WHO CHRON, V22, P473	21	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35212	10.1371/journal.pone.0035212	http://dx.doi.org/10.1371/journal.pone.0035212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558129	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000305336000026
J	Gonzalez-Caro, S; Parra, JL; Graham, CH; McGuire, JA; Cadena, CD				Gonzalez-Caro, Sebastian; Parra, Juan L.; Graham, Catherine H.; McGuire, Jimmy A.; Daniel Cadena, Carlos			Sensitivity of Metrics of Phylogenetic Structure to Scale, Source of Data and Species Pool of Hummingbird Assemblages along Elevational Gradients	PLOS ONE			English	Article							COMMUNITY STRUCTURE; PATTERNS; TRAIT; DIVERSITY; ECOLOGY; COMPETITION; RICHNESS; EXAMPLE; MODEL; SIZE	Patterns of phylogenetic structure of assemblages are increasingly used to gain insight into the ecological and evolutionary processes involved in the assembly of co-occurring species. Metrics of phylogenetic structure can be sensitive to scaling issues and data availability. Here we empirically assess the sensitivity of four metrics of phylogenetic structure of assemblages to changes in (i) the source of data, (ii) the spatial grain at which assemblages are defined, and (iii) the definition of species pools using hummingbird (Trochilidae) assemblages along an elevational gradient in Colombia. We also discuss some of the implications in terms of the potential mechanisms driving these patterns. To explore how source of data influence phylogenetic structure we defined assemblages using three sources of data: field inventories, museum specimens, and range maps. Assemblages were defined at two spatial grains: coarse-grained (elevational bands of 800-m width) and fine-grained (1-km(2) plots). We used three different species pools: all species contained in assemblages, all species within half-degree quadrats, and all species either above or below 2000 m elevation. Metrics considering phylogenetic relationships among all species within assemblages showed phylogenetic clustering at high elevations and phylogenetic evenness in the lowlands, whereas those metrics considering only the closest co-occurring relatives showed the opposite trend. This result suggests that using multiple metrics of phylogenetic structure should provide greater insight into the mechanisms shaping assemblage structure. The source and spatial grain of data had important influences on estimates of both richness and phylogenetic structure. Metrics considering the co-occurrence of close relatives were particularly sensitive to changes in the spatial grain. Assemblages based on range maps included more species and showed less phylogenetic structure than assemblages based on museum or field inventories. Coarse-grained assemblages included more distantly related species and thus showed a more even phylogenetic structure than fine-grained assemblages. Our results emphasize the importance of carefully selecting the scale, source of data and metric used in analysis of the phylogenetic structure of assemblages.	[Gonzalez-Caro, Sebastian; Daniel Cadena, Carlos] Univ Los Andes, Dept Ciencias Biol, Lab Biol Evolut Vertebrados, Bogota, Colombia; [Parra, Juan L.] Univ Antioquia, Fac Ciencias Exactas & Nat, Inst Biol, Medellin, Colombia; [Parra, Juan L.; Graham, Catherine H.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [McGuire, Jimmy A.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	Universidad de los Andes (Colombia); Universidad de Antioquia; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of California System; University of California Berkeley	Gonzalez-Caro, S (corresponding author), Univ Los Andes, Dept Ciencias Biol, Lab Biol Evolut Vertebrados, Bogota, Colombia.	juanluisparra@gmail.com	Graham, Catherine/A-9560-2011; Graham, Catherine/AAN-1237-2020; McGuire, Jimmy/N-7357-2019; Gonzalez-Caro, Sebastian/T-3532-2019	Graham, Catherine/0000-0001-9267-7948; Graham, Catherine/0000-0001-9267-7948; 	National Science Foundation [DEB-563 0820490]	National Science Foundation(National Science Foundation (NSF))	Funding for this work was provided by the National Science Foundation through DEB-563 0820490 to CHG and JLP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DL, 2002, J EXP BIOL, V205, P2325; Bleiweiss R, 1998, BIOL J LINN SOC, V65, P77, DOI 10.1111/j.1095-8312.1998.tb00352.x; Boakes EH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000385; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1549, DOI 10.1098/rspb.2008.0262; Cavender-Bares J, 2006, ECOLOGY, V87, pS109, DOI 10.1890/0012-9658(2006)87[109:PSOFPC]2.0.CO;2; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Colwell R.K., 1984, NULL MODEL NULL MODE, P344; Elias M, 2008, PLOS BIOL, V6, P2642, DOI 10.1371/journal.pbio.0060300; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; Fosberg F, 1967, IBP HDB, V4, P73; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Graham CH, 2006, GLOBAL ECOL BIOGEOGR, V15, P578, DOI 10.1111/j.1466-8238.2006.00257.x; Graham CH, 2009, P NATL ACAD SCI USA, V106, P19673, DOI 10.1073/pnas.0901649106; He FL, 2002, ECOLOGY, V83, P1185, DOI 10.1890/0012-9658(2002)083[1185:SDPDFS]2.0.CO;2; Heard SB, 2007, AM NAT, V169, pE107, DOI 10.1086/512690; Helmus MR, 2007, AM NAT, V169, pE68, DOI 10.1086/511334; Hurlbert AH, 2005, ECOL LETT, V8, P319, DOI 10.1111/j.1461-0248.2005.00726.x; Jetz W, 2012, TRENDS ECOL EVOL, V27, P151, DOI 10.1016/j.tree.2011.09.007; Kadmon R, 2004, ECOL APPL, V14, P401, DOI 10.1890/02-5364; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kembel SW, 2009, ECOL LETT, V12, P949, DOI 10.1111/j.1461-0248.2009.01354.x; Kraft NJB, 2007, AM NAT, V170, P271, DOI 10.1086/519400; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Lennon JJ, 2001, J ANIM ECOL, V70, P966, DOI 10.1046/j.0021-8790.2001.00563.x; Lessard JP, 2012, P ROY SOC B-BIOL SCI, V279, P266, DOI 10.1098/rspb.2011.0552; Lovette IJ, 2006, ECOLOGY, V87, pS14, DOI 10.1890/0012-9658(2006)87[14:SEOPNC]2.0.CO;2; MACARTHUR RH, 1958, ECOLOGY, V39, P599, DOI 10.2307/1931600; McGuire JA, 2007, SYST BIOL, V56, P837, DOI 10.1080/10635150701656360; McPherson JM, 2007, GLOBAL ECOL BIOGEOGR, V16, P657, DOI 10.1111/j.1466-8238.2007.00318.x; Gomez JP, 2010, J ANIM ECOL, V79, P1181, DOI 10.1111/j.1365-2656.2010.01725.x; Parra JL, 2010, AM NAT, V176, P573, DOI 10.1086/656619; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; R Development Core Team, 2005, R LANG ENV STAT COMP; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; SIH A, 1985, ANNU REV ECOL SYST, V16, P269, DOI 10.1146/annurev.es.16.110185.001413; Stiles FG, 2008, ORNITOL NEOTROP, V19, P511; Stiles FG, 2004, ORNITOL NEOTROP, V15, P191; Swenson NG, 2007, ECOLOGY, V88, P1770, DOI 10.1890/06-1499.1; Swenson NG, 2006, ECOLOGY, V87, P2418, DOI 10.1890/0012-9658(2006)87[2418:TPAPOS]2.0.CO;2; Swenson NG, 2009, ECOLOGY, V90, P2161, DOI 10.1890/08-1025.1; TERBORGH J, 1990, ECOL MONOGR, V60, P213, DOI 10.2307/1943045; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Vamosi JC, 2007, DIVERS DISTRIB, V13, P1, DOI 10.1111/j.1472-4642.2006.00299.x; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; WEIHER E, 1995, OIKOS, V74, P159, DOI 10.2307/3545686; WIENS JA, 1981, ECOL MONOGR, V51, P21, DOI 10.2307/2937305; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612	51	17	17	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35472	10.1371/journal.pone.0035472	http://dx.doi.org/10.1371/journal.pone.0035472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558157	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336000032
J	Osman, W; Okada, Y; Kamatani, Y; Kubo, M; Matsuda, K; Nakamura, Y				Osman, Wael; Okada, Yukinori; Kamatani, Yoichiro; Kubo, Michiaki; Matsuda, Koichi; Nakamura, Yusuke			Association of Common Variants in TNFRSF13B, TNFSF13, and ANXA3 with Serum Levels of Non-Albumin Protein and Immunoglobulin Isotypes in Japanese	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; C-REACTIVE PROTEIN; APRIL; TACI; POPULATION; ANNEXINS; GENE; RECEPTORS; TRAITS; CELLS	We performed a genome-wide association study (GWAS) on levels of serum total protein (TP), albumin (ALB), and nonalbumin protein (NAP). We analyzed SNPs on autosomal chromosomes using data from 9,103 Japanese individuals, followed by a replication study of 1,600 additional individuals. We confirmed the previously-reported association of GCKR on chromosome 2p23.3 with serum ALB (rs1260326, P-meta = 3.1x10(-9)), and additionally identified the significant genome-wide association of rs4985726 in TNFRSF13B on 17p11.2 with both TP and NAP ( P-meta = 1.2x10(-14) and 7.1x10(-24), respectively). For NAP, rs3803800 and rs11552708 in TNFSF13 on 17p13.1 (P-meta = 7.2x10(-15) and 7.5x10(-10), respectively) as well as rs10007186 on 4q21.2 near ANXA3 (Pmeta = 1.3x10(-9)) also indicated significant associations. Interestingly, TNFRSF13B and TNFSF13 encode a tumor necrosis factor (TNF) receptor and its ligand, which together constitute an important receptor-ligand axis for B-cell homeostasis and immunoglobulin production. Furthermore, three SNPs, rs4985726, rs3803800, and rs11552708 in TNFRSF13B and TNFSF13, were indicated to be associated with serum levels of IgG (P<2.3x10(-3)) and IgM (P<0.018), while rs3803800 and rs11552708 were associated with IgA (P<0.013). Rs10007186 in 4q21.2 was associated with serum levels of IgA (P = 0.036), IgM (P = 0.019), and IgE (P = 4.9x10(-4)). Our results should add interesting knowledge about the regulation of major serum components.	[Osman, Wael; Matsuda, Koichi; Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Mol Med Lab, Tokyo, Japan; [Okada, Yukinori] RIKEN, Ctr Genom Med, Inst Phys & Chem Res, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Okada, Yukinori] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan; [Kamatani, Yoichiro] Ctr Etud Polymorphisme Humain, F-75010 Paris, France; [Kubo, Michiaki] RIKEN, Ctr Genom Med, Lab Genotyping Dev, Yokohama, Kanagawa, Japan	University of Tokyo; RIKEN; University of Tokyo; RIKEN	Osman, W (corresponding author), Univ Tokyo, Inst Med Sci, Mol Med Lab, Tokyo, Japan.	yusuke@ims.u-tokyo.ac.jp	Osman, Wael/H-3362-2012; Kamatani, Yoichiro/N-5513-2015; Kubo, Michiaki/N-7947-2015; Matsuda, Koichi/D-4597-2011	OSMAN, WAEL/0000-0002-1921-8021; Matsuda, Koichi/0000-0001-7292-2686	Leading Project for Personalized Medicine in the Ministry of Education, Culture, Sports, Science and Technology, Japan	Leading Project for Personalized Medicine in the Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported by Leading Project for Personalized Medicine in the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bossen C, 2006, SEMIN IMMUNOL, V18, P263, DOI 10.1016/j.smim.2006.04.006; Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Koyama T, 2003, RHEUMATOLOGY, V42, P980, DOI 10.1093/rheumatology/keg270; Larsson M, 1997, IMMUNOLOGY, V92, P501, DOI 10.1046/j.1365-2567.1997.00377.x; Lopez-Fraga M, 2001, EMBO REP, V2, P945, DOI 10.1093/embo-reports/kve198; Mackay F, 2002, CURR OPIN IMMUNOL, V14, P783, DOI 10.1016/S0952-7915(02)00407-7; Mackay F, 2008, CYTOKINE GROWTH F R, V19, P263, DOI 10.1016/j.cytogfr.2008.04.006; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Okada Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002067; Olivier M, 2005, MUTAT RES-FUND MOL M, V573, P103, DOI 10.1016/j.mrfmmm.2004.08.016; Orho-Melander M, 2008, DIABETES, V57, P3112, DOI 10.2337/db08-0516; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rahmioglu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004435; Ridker PM, 2008, AM J HUM GENET, V82, P1185, DOI 10.1016/j.ajhg.2008.03.015; Rosales JL, 1997, J IMMUNOL, V159, P6195; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Sakurai D, 2007, BLOOD, V109, P2961, DOI 10.1182/blood-2006-08-041772; Weidinger S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000166; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290	27	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e32683	10.1371/journal.pone.0032683	http://dx.doi.org/10.1371/journal.pone.0032683			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558069	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000003
J	Rhein, C; Tripal, P; Seebahn, A; Konrad, A; Kramer, M; Nagel, C; Kemper, J; Bode, J; Muhle, C; Gulbins, E; Reichel, M; Becker, CM; Kornhuber, J				Rhein, Cosima; Tripal, Philipp; Seebahn, Angela; Konrad, Alice; Kramer, Marcel; Nagel, Christine; Kemper, Jonas; Bode, Jens; Muehle, Christiane; Gulbins, Erich; Reichel, Martin; Becker, Cord-Michael; Kornhuber, Johannes			Functional Implications of Novel Human Acid Sphingomyelinase Splice Variants	PLOS ONE			English	Article							NIEMANN-PICK-DISEASE; LEUKEMIA-CELL LINE; ENDOTHELIAL APOPTOSIS; MOUSE TRANSCRIPTOME; MASS-SPECTROMETRY; FULL-LENGTH; GENE; IDENTIFICATION; DEFICIENCY; EXPRESSION	Background: Acid sphingomyelinase (ASM) hydrolyses sphingomyelin and generates the lipid messenger ceramide, which mediates a variety of stress-related cellular processes. The pathological effects of dysregulated ASM activity are evident in several human diseases and indicate an important functional role for ASM regulation. We investigated alternative splicing as a possible mechanism for regulating cellular ASM activity. Methodology/Principal Findings: We identified three novel ASM splice variants in human cells, termed ASM-5, -6 and -7, which lack portions of the catalytic- and/or carboxy-terminal domains in comparison to full-length ASM-1. Differential expression patterns in primary blood cells indicated that ASM splicing might be subject to regulatory processes. The newly identified ASM splice variants were catalytically inactive in biochemical in vitro assays, but they decreased the relative cellular ceramide content in overexpression studies and exerted a dominant-negative effect on ASM activity in physiological cell models. Conclusions/Significance: These findings indicate that alternative splicing of ASM is of functional significance for the cellular stress response, possibly representing a mechanism for maintaining constant levels of cellular ASM enzyme activity.	[Rhein, Cosima; Tripal, Philipp; Konrad, Alice; Nagel, Christine; Kemper, Jonas; Bode, Jens; Muehle, Christiane; Reichel, Martin; Kornhuber, Johannes] Univ Erlangen Nurnberg, Univ Hosp, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany; [Seebahn, Angela; Becker, Cord-Michael] Univ Erlangen Nurnberg, Inst Biochem, Emil Fischer Ctr, D-91054 Erlangen, Germany; [Gulbins, Erich] Univ Duisburg Essen, Dept Mol Biol, Essen, Germany; [Kramer, Marcel] Jena Univ Hosp, Leibniz Inst Age Res, Fritz Lipmann Inst, Jena, Germany; [Kramer, Marcel] Jena Univ Hosp, Ctr Sepsis Control & Care, Jena, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Duisburg Essen; Friedrich Schiller University of Jena; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Friedrich Schiller University of Jena	Rhein, C (corresponding author), Univ Erlangen Nurnberg, Univ Hosp, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany.	Johannes.Kornhuber@uk-erlangen.de	Kornhuber, Johannes/B-9613-2014; Gulbins, Erich/L-6989-2014; MÃhle, Christiane/AAE-7043-2019	Kornhuber, Johannes/0000-0002-8096-3987; Gulbins, Erich/0000-0002-3117-1342; Muhle, Christiane/0000-0001-7517-9154; Tripal, Philipp/0000-0003-0568-1725; Reichel, Martin/0000-0001-7886-2784; Rhein, Cosima/0000-0002-3010-2169	ELAN fonds (Erlanger leistungsbezogene Anschubfinanzierung und Nachwuchsforderung) [09.03.22.1]; Deutsche Forschungsgemeinschaft DFG [GU 335/23-1, KO 947/11-1]; University Erlangen-Nuremberg	ELAN fonds (Erlanger leistungsbezogene Anschubfinanzierung und Nachwuchsforderung); Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); University Erlangen-Nuremberg	This work was supported by grants from ELAN fonds (Erlanger leistungsbezogene Anschubfinanzierung und Nachwuchsforderung/09.03.22.1; to PT) and from the Deutsche Forschungsgemeinschaft DFG (GU 335/23-1, KO 947/11-1, to EG and JKo), and by the Scholarship Programme 'Equality for Women in Research and Teaching', University Erlangen-Nuremberg (to CR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; BRADY RO, 1966, P NATL ACAD SCI USA, V55, P366, DOI 10.1073/pnas.55.2.366; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Calarco JA, 2007, GENE DEV, V21, P2963, DOI 10.1101/gad.1606907; FERLINZ K, 1991, BIOCHEM BIOPH RES CO, V179, P1187, DOI 10.1016/0006-291X(91)91697-B; FERLINZ K, 1995, AM J HUM GENET, V56, P1343; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garcia-Ruiz C, 2003, J CLIN INVEST, V111, P197, DOI 10.1172/JCI200316010; Grabowski PJ, 2001, PROG NEUROBIOL, V65, P289, DOI 10.1016/S0301-0082(01)00007-7; Gulbins E, 2000, METHOD ENZYMOL, V322, P382; HaimovitzFriedman A, 1997, J EXP MED, V186, P1831, DOI 10.1084/jem.186.11.1831; HE X, 2008, NEUROBIOL AGING; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Kornhuber J, 2005, J NEURAL TRANSM, V112, P1583, DOI 10.1007/s00702-005-0374-5; Kramer M, 2011, GENETICS, V187, P761, DOI 10.1534/genetics.110.125096; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langmann T, 1999, J LIPID RES, V40, P870; LeckaCzernik B, 1996, EXP GERONTOL, V31, P159, DOI 10.1016/0531-5565(95)02014-4; Lehner M, 2007, LEUKEMIA RES, V31, P1729, DOI 10.1016/j.leukres.2007.05.001; LEVRAN O, 1993, HUM MUTAT, V2, P317, DOI 10.1002/humu.1380020414; LEVRAN O, 1991, J CLIN INVEST, V88, P806, DOI 10.1172/JCI115380; LEVRAN O, 1992, BLOOD, V80, P2081; Lin T, 2000, J BIOL CHEM, V275, P8657, DOI 10.1074/jbc.275.12.8657; Lohmann C, 2010, J NEUROCHEM, V114, P1119, DOI 10.1111/j.1471-4159.2010.06836.x; Mikati MA, 2008, EPILEPSY RES, V81, P161, DOI 10.1016/j.eplepsyres.2008.05.009; Murate T, 2002, J BIOL CHEM, V277, P9936, DOI 10.1074/jbc.M111594200; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Pick M, 2004, ANN NY ACAD SCI, V1018, P85, DOI 10.1196/annals.1296.010; Qiu HW, 2003, J BIOL CHEM, V278, P32744, DOI 10.1074/jbc.M303022200; QUINTERN LE, 1989, EMBO J, V8, P2469, DOI 10.1002/j.1460-2075.1989.tb08382.x; QUINTERN LE, 1987, BIOCHIM BIOPHYS ACTA, V922, P323, DOI 10.1016/0005-2760(87)90055-5; Rebillard A, 2008, ONCOGENE, V27, P6590, DOI 10.1038/onc.2008.257; Reichel M, 2010, ALCOHOL CLIN EXP RES, V34, P46, DOI 10.1111/j.1530-0277.2009.01064.x; Rodriguez-Pascau L, 2009, HUM MUTAT, V30, P1117, DOI 10.1002/humu.21018; Schiller J, 2004, PROG LIPID RES, V43, P449, DOI 10.1016/j.plipres.2004.08.001; Schissel SL, 1998, J BIOL CHEM, V273, P18250, DOI 10.1074/jbc.273.29.18250; SCHUCHMAN EH, 1991, J BIOL CHEM, V266, P8531; Shah C, 2008, J BIOL CHEM, V283, P13538, DOI 10.1074/jbc.M709950200; Simonaro CM, 2002, AM J HUM GENET, V71, P1413, DOI 10.1086/345074; Skandalis A, 2010, RNA, V16, P2014, DOI 10.1261/rna.2127910; Spassieva SD, 2012, J LIPID RES; Spiegel S, 1998, ANN NY ACAD SCI, V845, P11, DOI 10.1111/j.1749-6632.1998.tb09658.x; Spiegel S, 1996, FASEB J, V10, P1388, DOI 10.1096/fasebj.10.12.8903509; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; TAKAHASHI T, 1992, J BIOL CHEM, V267, P12552; Takahashi Tsutomu, 1992, Human Mutation, V1, P70, DOI 10.1002/humu.1380010111; Truman JP, 2011, CELL MOL LIFE SCI, V68, P3293, DOI 10.1007/s00018-011-0686-6; Wu J, 2005, J LIPID RES, V46, P1944, DOI 10.1194/jlr.M500118-JLR200; Xu Q, 2002, NUCLEIC ACIDS RES, V30, P3754, DOI 10.1093/nar/gkf492; Zavolan M, 2003, GENOME RES, V13, P1290, DOI 10.1101/gr.1017303; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200	52	21	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35467	10.1371/journal.pone.0035467	http://dx.doi.org/10.1371/journal.pone.0035467			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558155	Green Published, gold			2022-12-25	WOS:000305336000031
J	Wheeler, TJ; Chien, S				Wheeler, Thomas J.; Chien, Sufan			Protection of Rat Cardiac Myocytes by Fructose-1,6-Bisphosphate and 2,3-Butanedione	PLOS ONE			English	Article							HEART PRESERVATION; INTRACELLULAR CA2+; EXCESS ACTIVATION; FRUCTOSE-1,6-DIPHOSPHATE; METABOLISM; INJURY; HYPOXIA; 6-DIPHOSPHATE; REPERFUSION; FRUCTOSE-1	Earlier studies by our group showed that fructose- 1,6-bisphosphate (FBP) enhances the hypothermic preservation of rat cardiac myocytes and the functional recovery of animal hearts after hypothermic storage. However, the mechanisms involved were not clear. We extended the cardiomyocyte studies by testing whether the FBP effects were due to chelation of extracellular calcium, leading to lower intracellular levels. We also tested effects of 2,3-butanedione monoxime (BDM), pyruvate, and adenine nucleotide precursors. Cardiomyocytes were incubated in ischemic suspension at 3 degrees C, and aliquots examined over 48 to 72 hours for retention of rod-shaped morphology, a measure of viability. Cytosolic Ca2+ levels were measured in some experiments. FBP at 5 mM reduced the death rate even when added after one or two days of incubation. It caused cytosolic calcium levels that were 33% lower than controls in freshly-isolated cells and 70% lower after one day of incubation. EGTA protected against cell death similarly to FBP. These results indicated that one of the mechanisms by which FBP exerts protective effects is through chelation of extracellular calcium. BDM was strongly protective and reduced cytosolic calcium by 30% after one day of incubation. As with FBP, BDM was effective when added after one or two days of incubation. BDM may be useful in combination with FBP in preserving heart tissue. Pyruvate, adenine, and ribose provided little or no protection during hypothermia.	[Wheeler, Thomas J.] Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40292 USA; [Chien, Sufan] Univ Louisville, Sch Med, Dept Surg, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Wheeler, TJ (corresponding author), Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40292 USA.	sufanc@aim.com			National Institutes of Health [HL64186, T35HL071486]; University of Louisville School; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064186, T35HL071486] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Louisville School; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the National Institutes of Health (HL64186, to SC and TJW) and the University of Louisville School of Medicine Summer Research Scholars Program (Paul D. Kelsey and Bradley W. Richmond), with support to PDK coming from National Institutes of Health grant T35HL071486. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azambuja AA, 2011, INFLAMMATION, V34, P67, DOI 10.1007/s10753-010-9212-5; BICKLER PE, 1992, STROKE, V23, P1617, DOI 10.1161/01.STR.23.11.1617; Bickler PE, 1996, J NEUROCHEM, V67, P1463; Calafell R, 2009, EUR J PHARMACOL, V610, P128, DOI 10.1016/j.ejphar.2009.03.044; CAVALLINI L, 1992, BIOCHEM PHARMACOL, V43, P1539, DOI 10.1016/0006-2952(92)90212-2; Chien S, 2000, J HEART LUNG TRANSPL, V19, P277, DOI 10.1016/S1053-2498(99)00142-4; Chu SJ, 2002, CRIT CARE MED, V30, P1605, DOI 10.1097/00003246-200207000-00034; Cobert ML, 2011, J SURG RES IN PRESS; Colston VL, 2001, LIFE SCI, V69, P2383, DOI 10.1016/S0024-3205(01)01325-X; DIDLAKE R, 1985, CIRC SHOCK, V16, P205; Ding Y, 2010, NEUROSCI LETT, V477, P33, DOI 10.1016/j.neulet.2010.04.030; Donohoe PH, 2001, BRAIN RES, V917, P158, DOI 10.1016/S0006-8993(01)02849-9; DOW JW, 1981, CARDIOVASC RES, V15, P483, DOI 10.1093/cvr/15.9.483; Ehringer WD, 2001, MOL CELL BIOCHEM, V221, P33, DOI 10.1023/A:1010973806747; Fahlman CS, 2002, BRAIN RES, V958, P43, DOI 10.1016/S0006-8993(02)03433-9; FISCHER Y, 1991, LIFE SCI, V49, P1679, DOI 10.1016/0024-3205(91)90310-8; Gal J, 2007, J CARDIOVASC SURG, V48, P751; Gawarammana I, 2010, BMC EMERG MED, V10, DOI 10.1186/1471-227X-10-15; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HARDIN CD, 1994, AM J PHYSIOL-HEART C, V267, pH2325, DOI 10.1152/ajpheart.1994.267.6.H2325; HASSINEN IE, 1991, CIRCULATION, V83, P584, DOI 10.1161/01.CIR.83.2.584; Hirokawa F, 2002, TRANSPLANTATION, V74, P779, DOI 10.1097/00007890-200209270-00008; Hua DP, 2003, J HEART LUNG TRANSPL, V22, P574, DOI 10.1016/S1053-2498(02)00661-7; KIVISTO T, 1995, JPN J PHYSIOL, V45, P203, DOI 10.2170/jjphysiol.45.203; Mallet RT, 2000, P SOC EXP BIOL MED, V223, P136, DOI 10.1046/j.1525-1373.2000.22319.x; Niu WY, 1999, J SURG RES, V85, P120, DOI 10.1006/jsre.1999.5658; Poston RS, 2004, ANN THORAC SURG, V78, P1362, DOI 10.1016/j.athoracsur.2004.02.143; Riedel BJ, 2004, ANESTH ANALG, V98, P20, DOI 10.1213/01.ANE.0000094336.97693.90; SELLIN LC, 1994, PHARMACOL TOXICOL, V74, P305, DOI 10.1111/j.1600-0773.1994.tb01365.x; STRINGHAM JC, 1992, TRANSPLANTATION, V53, P287, DOI 10.1097/00007890-199202010-00007; SUN JX, 1990, GASTROENTEROLOGY, V98, P117, DOI 10.1016/0016-5085(90)91299-L; Tamaki T, 2002, DIGEST DIS SCI, V47, P2179, DOI 10.1023/A:1020118823672; Thum T, 2001, Cardiovasc Toxicol, V1, P61, DOI 10.1385/CT:1:1:61; Toledo-Pereyra L.H., 2010, ORGAN PROCUREMENT PR, P82; Wan TC, 2003, PLATELETS, V14, P295, DOI 10.1080/0953710031000154713; Wheeler TJ, 2005, J HEART LUNG TRANSPL, V24, P1378, DOI 10.1016/j.healun.2004.08.013; Wheeler TJ, 2004, MOL CELL BIOCHEM, V259, P105, DOI 10.1023/B:MCBI.0000021356.89867.0d; Xu M, 2010, EXP CLIN ENDOCR DIAB, V118, P459, DOI 10.1055/s-0030-1248325; Yin H, 2008, INT IMMUNOPHARMACOL, V8, P1842, DOI 10.1016/j.intimp.2008.09.004; Zeng Fan-xin, 2003, Yaoxue Xuebao, V38, P325; Zhang J, 1997, ANN THORAC SURG, V63, P388; Zimmer HG, 1996, MOL CELL BIOCHEM, V161, P101, DOI 10.1007/BF00240038	42	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35023	10.1371/journal.pone.0035023	http://dx.doi.org/10.1371/journal.pone.0035023			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558110	Green Submitted, gold, Green Published			2022-12-25	WOS:000305336000022
J	Nishi, D; Koido, Y; Nakaya, N; Sone, T; Noguchi, H; Hamazaki, K; Hamazaki, T; Matsuoka, Y				Nishi, Daisuke; Koido, Yuichi; Nakaya, Naoki; Sone, Toshimasa; Noguchi, Hiroko; Hamazaki, Kei; Hamazaki, Tomohito; Matsuoka, Yutaka			Peritraumatic Distress, Watching Television, and Posttraumatic Stress Symptoms among Rescue Workers after the Great East Japan Earthquake	PLOS ONE			English	Article							TERRORIST ATTACKS; DISORDER; INVENTORY; SEPTEMBER-11; DISASTER; METAANALYSIS; RELIABILITY; VALIDITY; VERSION; IMAGES	Background: The Great East Japan Earthquake of March 11, 2001 left around 20,000 dead or missing. Previous studies showed that rescue workers, as well as survivors, of disasters are at high risk for posttraumatic stress disorder (PTSD). This study examined the predictive usefulness of the Peritraumatic Distress Inventory (PDI) among rescue workers of Disaster Medical Assistance Teams (DMATs) deployed during the acute disaster phase of the Great East Japan Earthquake. Methodology/Principal Findings: In this prospective observational study, the DMAT members recruited were assessed 1 month after the earthquake on the PDI and 4 months after the earthquake on the Impact of Event Scale-Revised to determine PTSD symptoms. The predictive value of the PDI at initial assessment for PTSD symptoms at the follow-up assessment was examined by univariate and multiple linear regression analysis. Of the 254 rescue workers who participated in the initial assessment, 173 completed the follow-up assessment. Univariate regression analysis revealed that PDI total score and most individual item scores predicted PTSD symptoms. In particular, high predictive values were seen for peritraumatic emotional distress such as losing control of emotions and being ashamed of emotional reactions. In multiple linear regression analysis, PDI total score was an independent predictor for PTSD symptoms after adjusting for covariates. As for covariates specifically, watching earthquake television news reports for more than 4 hours per day predicted PTSD symptoms. Conclusions/Significance: The PDI predicted PTSD symptoms in rescue workers after the Great East Japan Earthquake. Peritraumatic emotional distress appears to be an important factor to screen for individuals at risk for developing PTSD among medical rescue workers. In addition, watching television for extended period of time might require attention at a time of crisis.	[Nishi, Daisuke; Matsuoka, Yutaka] Natl Disaster Med Ctr, Dept Psychiat, Tachikawa, Tokyo, Japan; [Nishi, Daisuke; Koido, Yuichi; Noguchi, Hiroko; Matsuoka, Yutaka] Natl Disaster Med Ctr, Clin Res Inst, Tachikawa, Tokyo, Japan; [Nishi, Daisuke; Nakaya, Naoki; Sone, Toshimasa; Noguchi, Hiroko; Hamazaki, Kei; Hamazaki, Tomohito; Matsuoka, Yutaka] Japan Sci & Technol Agcy, CREST, Tachikawa, Tokyo, Japan; [Koido, Yuichi] Japan Disaster Med Assistance Team, Head Off, Tachikawa, Tokyo, Japan; [Nakaya, Naoki] Kamakura Womens Univ, Fac Family & Consumer Sci, Dept Nutr & Dietet, Kamakura, Kanagawa, Japan; [Sone, Toshimasa] Tohoku Fukushi Univ, Fac Hlth Sci, Dept Rehabil, Sendai, Miyagi, Japan; [Noguchi, Hiroko; Matsuoka, Yutaka] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Adult Mental Hlth, Kodaira, Tokyo, Japan; [Hamazaki, Kei] Toyama Univ, Fac Med, Dept Publ Hlth, Toyama 930, Japan; [Hamazaki, Tomohito] Toyama Univ, Inst Nat Med, Dept Clin Sci, Toyama 930, Japan; [Matsuoka, Yutaka] Natl Ctr Neurol & Psychiat, Translat Med Ctr, Clin Res Training & Consultat Program, Kodaira, Tokyo, Japan	Japan Science & Technology Agency (JST); Kamakura Women's University; National Center for Neurology & Psychiatry - Japan; University of Toyama; University of Toyama; National Center for Neurology & Psychiatry - Japan	Nishi, D (corresponding author), Natl Disaster Med Ctr, Dept Psychiat, Tachikawa, Tokyo, Japan.	yutaka@ncnp.go.jp	Nishi, Daisuke/AAH-7211-2019; Matsuoka, Yutaka/N-1588-2019	Nishi, Daisuke/0000-0001-9349-3294; Matsuoka, Yutaka/0000-0002-8690-8129	Core Research for Evolutional Science and Technology (CREST), the Japan Science and Technology Agency (JST); Ministry of Health, Labor, and Welfare of Japan; Eli Lilly Japan; Toray Industries, Inc.; Foundation for Total Health Promotion; Qol Co., Ltd.; Japan Society for the Promotion of Science; Tamura Foundation for Promotion of Science and Technology; Ichiro Kanehara Foundation for Promotion of Medical Sciences and Medical Care; Polyene Project, Inc.; Otsuka Pharmaceutical Co., Ltd.; Nippon Suisan Kaisha, Ltd.; Open Research Center for Lipid Nutrition (Kinjo Gakuin University); Mochida Pharmaceutical Co., Ltd.; Ono Pharmaceutical Co., Ltd.; Astrazeneca K.K.; Bristol-Myers Squibb Company; National Center of Global Health and Medicine	Core Research for Evolutional Science and Technology (CREST), the Japan Science and Technology Agency (JST); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Eli Lilly Japan(Eli Lilly); Toray Industries, Inc.(Toray Industries, Inc.); Foundation for Total Health Promotion(Foundation for Total Health Promotion); Qol Co., Ltd.; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tamura Foundation for Promotion of Science and Technology; Ichiro Kanehara Foundation for Promotion of Medical Sciences and Medical Care; Polyene Project, Inc.; Otsuka Pharmaceutical Co., Ltd.(Otsuka Pharmaceutical); Nippon Suisan Kaisha, Ltd.; Open Research Center for Lipid Nutrition (Kinjo Gakuin University); Mochida Pharmaceutical Co., Ltd.; Ono Pharmaceutical Co., Ltd.(Ono Pharmaceutical Co Ltd); Astrazeneca K.K.(AstraZeneca); Bristol-Myers Squibb Company(Bristol-Myers Squibb); National Center of Global Health and Medicine	This work was supported by Core Research for Evolutional Science and Technology (CREST), the Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; YM has received another research support from the Ministry of Health, Labor, and Welfare of Japan and a lecture fee from Eli Lilly Japan. DN has received research support from Toray Industries, Inc., and the Foundation for Total Health Promotion and a lecture fee from Qol Co., Ltd. KH has received research support from the Japan Society for the Promotion of Science, the Tamura Foundation for Promotion of Science and Technology, and the Ichiro Kanehara Foundation for Promotion of Medical Sciences and Medical Care, and consultant fees from Polyene Project, Inc., and Otsuka Pharmaceutical Co., Ltd., and a lecture fee from Nippon Suisan Kaisha, Ltd. TM has received research support from the Japan Society for the Promotion of Science, Open Research Center for Lipid Nutrition (Kinjo Gakuin University, and Nippon Suisan Kaisha, Ltd., and consultant fees from Polyene Project, Inc., and Otsuka Pharmaceutical Co., Ltd., and lecture fees from Mochida Pharmaceutical Co., Ltd.) YK has received research support from the Ministry of Health, Labor, and Welfare of Japan, Ono Pharmaceutical Co., Ltd., Astrazeneca K.K., Bristol-Myers Squibb Company, and National Center of Global Health and Medicine. All other authors declare that they have no competing interests. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ahern J, 2004, J NERV MENT DIS, V192, P217, DOI 10.1097/01.nmd.0000116465.99830.ca; Ahern J, 2002, PSYCHIATRY, V65, P289, DOI 10.1521/psyc.65.4.289.20240; American Psychiatric Association, 2017, DIAGN STAT MAN MENT, V5th; Asukai N, 2002, J NERV MENT DIS, V190, P175, DOI 10.1097/00005053-200203000-00006; Bedard-Gilligan M, 2008, BEHAV RES THER, V46, P1062, DOI 10.1016/j.brat.2008.06.009; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Brunet A, 2001, AM J PSYCHIAT, V158, P1480, DOI 10.1176/appi.ajp.158.9.1480; CHARNEY DS, 1993, ARCH GEN PSYCHIAT, V50, P294; DAVIDSON JRT, 1991, PSYCHOL MED, V21, P713, DOI 10.1017/S0033291700022352; Epstein RS, 1998, AM J PSYCHIAT, V155, P934, DOI 10.1176/ajp.155.7.934; Fullerton CS, 2004, AM J PSYCHIAT, V161, P1370, DOI 10.1176/appi.ajp.161.8.1370; Jehel L, 2005, CAN J PSYCHIAT, V50, P67, DOI 10.1177/070674370505000112; Matsuoka Y, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-132; Nishi D, 2012, POSTTRAUMATIC STRESS, P97; Nishi D, 2010, PSYCHIAT CLIN NEUROS, V64, P149, DOI 10.1111/j.1440-1819.2010.02065.x; Nishi D, 2009, GEN HOSP PSYCHIAT, V31, P75, DOI 10.1016/j.genhosppsych.2008.09.002; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Schlenger WE, 2002, JAMA-J AM MED ASSOC, V288, P581, DOI 10.1001/jama.288.5.581; Schnurr P, 2002, J CLIN GEROPSYCHOL, V8, P175, DOI [DOI 10.1023/A:1015992110544, 10.1023/A:1015992110544]; Silver RC, 2002, JAMA-J AM MED ASSOC, V288, P1235, DOI 10.1001/jama.288.10.1235; Walker EA, 2003, ARCH GEN PSYCHIAT, V60, P369, DOI 10.1001/archpsyc.60.4.369; Weiss DS., 2004, IMPACT EVENT SCALE R, P168	23	57	57	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35248	10.1371/journal.pone.0035248	http://dx.doi.org/10.1371/journal.pone.0035248			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VP	22558130	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345200030
J	Cheadle, C; Berger, AE; Mathai, SC; Grigoryev, DN; Watkins, TN; Sugawara, Y; Barkataki, S; Fan, JS; Boorgula, M; Hummers, L; Zaiman, AL; Girgis, R; McDevitt, MA; Johns, RA; Wigley, F; Barnes, KC; Hassoun, PM				Cheadle, Chris; Berger, Alan E.; Mathai, Stephen C.; Grigoryev, Dmitry N.; Watkins, Tonya N.; Sugawara, Yumiko; Barkataki, Sangjucta; Fan, Jinshui; Boorgula, Meher; Hummers, Laura; Zaiman, Ari L.; Girgis, Reda; McDevitt, Michael A.; Johns, Roger A.; Wigley, Frederick; Barnes, Kathleen C.; Hassoun, Paul M.			Erythroid-Specific Transcriptional Changes in PBMCs from Pulmonary Hypertension Patients	PLOS ONE			English	Article							PERIPHERAL-BLOOD CELLS; EXPERT CONSENSUS DOCUMENTS; FOUNDATION TASK-FORCE; GENE-EXPRESSION; ARTERIAL-HYPERTENSION; SYSTEMIC-SCLEROSIS; IN-VITRO; INTERFERON; LUNG; DIFFERENTIATION	Background: Gene expression profiling of peripheral blood mononuclear cells (PBMCs) is a powerful tool for the identification of surrogate markers involved in disease processes. The hypothesis tested in this study was that chronic exposure of PBMCs to a hypertensive environment in remodeled pulmonary vessels would be reflected by specific transcriptional changes in these cells. Methodology/Principal Findings: The transcript profiles of PBMCs from 30 idiopathic pulmonary arterial hypertension patients (IPAH), 19 patients with systemic sclerosis without pulmonary hypertension (SSc), 42 scleroderma-associated pulmonary arterial hypertensio patients (SSc-PAH), and 8 patients with SSc complicated by interstitial lung disease and pulmonary hypertension (SSc-PH-ILD) were compared to the gene expression profiles of PBMCs from 41 healthy individuals. Multiple gene expression signatures were identified which could distinguish various disease groups from controls. One of these signatures, specific for erythrocyte maturation, is enriched specifically in patients with PH. This association was validated in multiple published datasets. The erythropoiesis signature was strongly correlated with hemodynamic measures of increasing disease severity in IPAH patients. No significant correlation of the same type was noted for SSc-PAH patients, this despite a clear signature enrichment within this group overall. These findings suggest an association of the erythropoiesis signature in PBMCs from patients with PH with a variable presentation among different subtypes of disease. Conclusions/Significance: In PH, the expansion of immature red blood cell precursors may constitute a response to the increasingly hypoxic conditions prevalent in this syndrome. A correlation of this erythrocyte signature with more severe hypertension cases may provide an important biomarker of disease progression.	[Cheadle, Chris; Berger, Alan E.; Watkins, Tonya N.; Sugawara, Yumiko; Barkataki, Sangjucta; Fan, Jinshui; Boorgula, Meher; Barnes, Kathleen C.] Johns Hopkins Univ, Sch Med, Div Allergy & Clin Immunol, Baltimore, MD 21218 USA; [Mathai, Stephen C.; Zaiman, Ari L.; Girgis, Reda; Hassoun, Paul M.] Johns Hopkins Univ, Sch Med, Div Pulm Crit Care Med, Baltimore, MD USA; [Grigoryev, Dmitry N.] Childrens Mercy Hosp & Clin, Med Genet Core, Kansas City, MO USA; [Hummers, Laura; Wigley, Frederick] Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD USA; [McDevitt, Michael A.] Johns Hopkins Univ, Sch Med, Div Hematol, Baltimore, MD USA; [Johns, Roger A.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Children's Mercy Hospital; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Cheadle, C (corresponding author), Johns Hopkins Univ, Sch Med, Div Allergy & Clin Immunol, Baltimore, MD 21218 USA.	ccheadl1@jhmi.edu; phassou1@jhmi.edu	Boorgula, Meher Preethi/AAC-6252-2022; Grigoryev, Dmitry/C-9422-2015	Hummers, Laura/0000-0002-4864-4011; Grigoryev, Dmitry/0000-0002-1849-1763	NHLBI (Specialized Center for Clinically-Oriented Research) [P50 Grant HL084946]; Mary Beryl Patch Turnbull Scholar Program; Scleroderma Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084946] Funding Source: NIH RePORTER	NHLBI (Specialized Center for Clinically-Oriented Research); Mary Beryl Patch Turnbull Scholar Program; Scleroderma Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by NHLBI P50 Grant HL084946 (Specialized Center for Clinically-Oriented Research, to P. M. H.). Supported in part by the Mary Beryl Patch Turnbull Scholar Program (to K. C. B.). The Scleroderma Research Foundation has provided support for the Johns Hopkins Scleroderma Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baechler EC, 2004, GENES IMMUN, V5, P347, DOI 10.1038/sj.gene.6364098; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bendayan D, 2006, ISR MED ASSOC J, V8, P252; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Bull TM, 2004, AM J RESP CRIT CARE, V170, P911, DOI 10.1164/rccm.200312-1686OC; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Burczynski ME, 2006, PHARMACOGENOMICS, V7, P187, DOI 10.2217/14622416.7.2.187; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Cheadle Chris, 2003, Appl Bioinformatics, V2, P209; Cheadle C, 2010, ARTHRITIS RHEUM-US, V62, P1744, DOI 10.1002/art.27398; Christmann RB, 2011, ARTHRITIS RHEUM-US, V63, P1718, DOI 10.1002/art.30318; CRAPO RO, 1982, B EUR PHYSIOPATH RES, V18, P419; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P185; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; De S, 2010, PHYSIOL GENOMICS, V42A, P162, DOI 10.1152/physiolgenomics.00008.2010; Ebert BL, 2008, PLOS MED, V5, P312, DOI 10.1371/journal.pmed.0050035; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fagan KA, 2002, PROG CARDIOVASC DIS, V45, P225, DOI 10.1053/pcad.2002.129975; Fall N, 2007, ARTHRITIS RHEUM-US, V56, P3793, DOI 10.1002/art.22981; Filippone C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009496; Fisher MR, 2006, ARTHRITIS RHEUM-US, V54, P3043, DOI 10.1002/art.22069; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; Gaine SP, 1998, LANCET, V352, P719, DOI 10.1016/S0140-6736(98)02111-4; Ghosh S, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-56; Girgis RE, 2007, ANN RHEUM DIS, V66, P1467, DOI 10.1136/ard.2007.069609; Goh SH, 2007, PHYSIOL GENOMICS, V30, P172, DOI 10.1152/physiolgenomics.00247.2006; Greer JP, 2009, WINTROBES CLIN HEMAT; Grigoryev DN, 2008, TRANSL RES, V151, P197, DOI 10.1016/j.trsl.2007.12.010; Hachulla E, 2005, ARTHRITIS RHEUM-US, V52, P3792, DOI 10.1002/art.21433; Harigae H, 1998, BLOOD, V91, P798, DOI 10.1182/blood.V91.3.798.798_798_805; Hassoun Paul M, 2009, Expert Rev Respir Med, V3, P187, DOI 10.1586/ers.09.5; Hassoun PM, 2011, PRESSE MED, V40, pe3, DOI DOI 10.1016/J.LPM.2010.08.006; Hinze CH, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3061; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kaneko K, 2009, FEBS J, V276, P1370, DOI 10.1111/j.1742-4658.2009.06878.x; Le Payec J, 2010, AM J RESP CRIT CARE, V181, P1285, DOI 10.1164/rccm.200909-1331PP; LEROY EC, 1988, J RHEUMATOL, V15, P202; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; MacDonald SLS, 2001, RADIOLOGY, V221, P600, DOI 10.1148/radiol.2213010158; Martinelli S, 2004, J BIOL CHEM, V279, P44123, DOI 10.1074/jbc.M405883200; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; McCall MN, 2011, NUCLEIC ACIDS RES, V39, pD1011, DOI 10.1093/nar/gkq1259; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Nadon R, 2002, CEL MOL NEU; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; Ohneda K, 2002, ACTA HAEMATOL-BASEL, V108, P237, DOI 10.1159/000065660; Pan W, 2002, BIOINFORMATICS, V18, P546, DOI 10.1093/bioinformatics/18.4.546; PATERAKIS GS, 1993, ACTA HAEMATOL-BASEL, V90, P182; Pendergrass SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012106; Rajkumar R, 2010, AM J PHYSIOL-HEART C, V298, pH1235, DOI 10.1152/ajpheart.00254.2009; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; Risbano MG, 2010, CTS-CLIN TRANSL SCI, V3, P210, DOI 10.1111/j.1752-8062.2010.00218.x; Simonneau G, 2002, AM J RESP CRIT CARE, V165, P800, DOI 10.1164/ajrccm.165.6.2106079; Steen VD, 2005, JCR-J CLIN RHEUMATOL, V11, P40, DOI 10.1097/01.rhu.0000152147.38706.db; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van den Akker E, 2010, HAEMATOL-HEMATOL J, V95, P1594, DOI 10.3324/haematol.2009.019828; Yu X, 2009, BLOOD, V113, P5961, DOI 10.1182/blood-2008-12-196030; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	61	46	46	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e34951	10.1371/journal.pone.0034951	http://dx.doi.org/10.1371/journal.pone.0034951			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545094	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343200016
J	Sanchez, A; Contreras, C; Martinez, MP; Climent, B; Benedito, S; Garcia-Sacristan, A; Hernandez, M; Prieto, D				Sanchez, Ana; Contreras, Cristina; Martinez, Maria Pilar; Climent, Belen; Benedito, Sara; Garcia-Sacristan, Albino; Hernandez, Medardo; Prieto, Dolores			Role of Neural NO Synthase (nNOS) Uncoupling in the Dysfunctional Nitrergic Vasorelaxation of Penile Arteries from Insulin-Resistant Obese Zucker Rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ENDOTHELIUM-DEPENDENT RELAXATION; KINASE SIGNALING PATHWAY; ALPHA-LIPOIC ACID; CORPUS-CAVERNOSUM; ERECTILE DYSFUNCTION; DIABETES-MELLITUS; CA2+ SENSITIZATION; MOUSE PENIS; K+ CHANNELS	Objective: Erectile dysfunction (ED) is considered as an early sign of vascular disease due to its high prevalence in patients with cardiovascular risk factors. Endothelial and neural dysfunction involving nitric oxide (NO) are usually implicated in the pathophysiology of the diabetic ED, but the underlying mechanisms are unclear. The present study assessed the role of oxidative stress in the dysfunctional neural vasodilator responses of penile arteries in the obese Zucker rat (OZR), an experimental model of metabolic syndrome/prediabetes. Methods and Results: Electrical field stimulation (EFS) under non-adrenergic non-cholinergic (NANC) conditions evoked relaxations that were significantly reduced in penile arteries of OZR compared with those of lean Zucker rats (LZR). Blockade of NO synthase (NOS) inhibited neural relaxations in both LZR and OZR, while saturating concentrations of the NOS substrate L-arginine reversed the inhibition and restored relaxations in OZR to levels in arteries from LZR. nNOS expression was unchanged in arteries from OZR compared to LZR and nNOS selective inhibition decreased the EFS relaxations in LZR but not in OZR, while endothelium removal did not alter these responses in either strain. Superoxide anion production and nitro-tyrosine immunostaining were elevated in the erectile tissue from OZR. Treatment with the NADPH oxidase inhibitor apocynin or acute incubation with the NOS cofactor tetrahydrobiopterin (BH4) restored neural relaxations in OZR to levels in control arteries, while inhibition of the enzyme of BH4 synthesis GTP-cyclohydrolase (GCH) reduced neural relaxations in arteries from LZR but not OZR. The NO donor SNAP induced decreases in intracellular calcium that were impaired in arteries from OZR compared to controls. Conclusions: The present study demonstrates nitrergic dysfunction and impaired neural NO signalling due to oxidative stress and nNOS uncoupling in penile arteries under conditions of insulin resistance. This dysfunction likely contributes to the metabolic syndrome-associated ED, along with the endothelial dysfunction also involving altered NO signalling.	[Sanchez, Ana; Contreras, Cristina; Climent, Belen; Benedito, Sara; Garcia-Sacristan, Albino; Hernandez, Medardo; Prieto, Dolores] Univ Complutense Madrid, Fac Farm, Dept Fisiol, Madrid, Spain; [Martinez, Maria Pilar] Univ Complutense Madrid, Fac Farm, Dept Anat & Anat Patol Comparadas, Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid	Sanchez, A (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Fisiol, Madrid, Spain.	dprieto@farm.ucm.es	Contreras, Cristina/N-7257-2019; BENEDITO, SARA/H-9730-2015; Pilar Martinez, P Martinez/E-8591-2016; Climent, Belen/P-2416-2015; PRIETO, DOLORES/S-8172-2018	Contreras, Cristina/0000-0002-7015-7922; BENEDITO, SARA/0000-0001-9660-2409; Pilar Martinez, P Martinez/0000-0001-9063-3191; Climent, Belen/0000-0003-0852-9227; PRIETO, DOLORES/0000-0001-7049-5991	Spanish Minister of Science and Innovation [SAF2009-10448]	Spanish Minister of Science and Innovation(Spanish Government)	This study was supported by Grant no SAF2009-10448 from the Spanish Minister of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON KE, 1995, PHYSIOL REV, V75, P191, DOI 10.1152/physrev.1995.75.1.191; Andersson KE, 2003, J UROLOGY, V170, pS6, DOI 10.1097/01.ju.0000075362.08363.a4; AZADZOI KM, 1992, J UROLOGY, V148, P1587, DOI 10.1016/S0022-5347(17)36975-6; Bivalacqua TJ, 2004, P NATL ACAD SCI USA, V101, P9121, DOI 10.1073/pnas.0400520101; Bivalacqua TJ, 2007, AM J PHYSIOL-HEART C, V292, pH1340, DOI 10.1152/ajpheart.00121.2005; Cameron NE, 2001, DIABETOLOGIA, V44, P1973, DOI 10.1007/s001250100001; Carneiro FS, 2010, J SEX MED, V7, P3620, DOI 10.1111/j.1743-6109.2010.02000.x; Carneiro FS, 2008, J SEX MED, V5, P1156, DOI 10.1111/j.1743-6109.2007.00752.x; Cellek S, 2003, DIABETES, V52, P2353, DOI 10.2337/diabetes.52.9.2353; Cellek S, 1997, P NATL ACAD SCI USA, V94, P8226, DOI 10.1073/pnas.94.15.8226; Cellek S, 1999, BRIT J PHARMACOL, V128, P1804, DOI 10.1038/sj.bjp.0702981; Contreras C, 2010, BRIT J PHARMACOL, V161, P350, DOI 10.1111/j.1476-5381.2010.00825.x; DETEJADA IS, 1989, NEW ENGL J MED, V320, P1025, DOI 10.1056/NEJM198904203201601; Feldman EL, 2003, J CLIN INVEST, V111, P431, DOI 10.1172/JCI200317863; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; GRILL V, 1992, METABOLISM, V41, P28, DOI 10.1016/0026-0495(92)90186-E; Gur S, 2007, J UROLOGY, V178, P1543, DOI 10.1016/j.juro.2007.05.121; Guzik TJ, 2002, CIRCULATION, V105, P1656, DOI 10.1161/01.CIR.0000012748.58444.08; Hakim LS, 1996, ENDOCRIN METAB CLIN, V25, P379, DOI 10.1016/S0889-8529(05)70329-7; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Hurt KJ, 2002, P NATL ACAD SCI USA, V99, P4061, DOI 10.1073/pnas.052712499; Jin LM, 2004, AM J PHYSIOL-HEART C, V287, pH1495, DOI 10.1152/ajpheart.01006.2003; Johnson JM, 2011, INT J IMPOT RES, V23, P43, DOI 10.1038/ijir.2011.2; Katakam PV, 2012, J CEREB BLOOD F 0111; Keegan A, 1999, DIABETOLOGIA, V42, P343, DOI 10.1007/s001250051161; Keegan A, 2001, DIABETES-METAB RES, V17, P380, DOI 10.1002/dmrr.215; Li HW, 2004, DIABETES, V53, P2436, DOI 10.2337/diabetes.53.9.2436; Liu YP, 2002, CIRC RES, V91, P1070, DOI 10.1161/01.RES.0000046003.14031.98; Luttrell IP, 2008, AM J PHYSIOL-HEART C, V294, pH2204, DOI 10.1152/ajpheart.00027.2008; Montorsi F, 2003, EUR UROL, V44, P360, DOI 10.1016/S0302-2838(03)00305-1; Moody JA, 1997, J UROLOGY, V158, P942, DOI 10.1016/S0022-5347(01)64368-4; Musicki B, 2007, INT J IMPOT RES, V19, P129, DOI 10.1038/sj.ijir.3901494; Musicki B, 2005, P NATL ACAD SCI USA, V102, P11870, DOI 10.1073/pnas.0502488102; Musicki B, 2010, J SEX MED, V7, P3023, DOI 10.1111/j.1743-6109.2010.01880.x; Nangle MR, 2004, PFLUG ARCH EUR J PHY, V448, P139, DOI 10.1007/s00424-003-1232-7; Nangle MR, 2003, NITRIC OXIDE-BIOL CH, V9, P194, DOI 10.1016/j.niox.2004.01.006; Pieper GM, 1997, J PHARMACOL EXP THER, V283, P684; Podlasek CA, 2001, J UROLOGY, V166, P746, DOI 10.1016/S0022-5347(05)66054-5; Prieto D, 2008, INT J IMPOT RES, V20, P17, DOI 10.1038/sj.ijir.3901581; Prieto D, 1998, BRIT J PHARMACOL, V123, P1609, DOI 10.1038/sj.bjp.0701780; Prieto D, 2010, AM J PHYSIOL-HEART C, V299, pH915, DOI 10.1152/ajpheart.00382.2010; SAENZ DE, 2005, J SEX MED, V2, P26; Sanchez A, 2008, EUR J PHARMACOL, V586, P283, DOI 10.1016/j.ejphar.2008.03.002; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Schmidt TS, 2007, CLIN SCI, V113, P47, DOI 10.1042/CS20070108; Sullivan ME, 1999, CARDIOVASC RES, V43, P658, DOI 10.1016/S0008-6363(99)00135-2; Touyz RM, 2011, HYPERTENS RES, V34, P5, DOI 10.1038/hr.2010.201; Venardos K, 2009, INT J BIOCHEM CELL B, V41, P2522, DOI 10.1016/j.biocel.2009.08.008; VERNET D, 1995, ENDOCRINOLOGY, V136, P5709, DOI 10.1210/en.136.12.5709; Vickers MA, 2004, AM J MANAG CARE, V10, pS3; Villalba N, 2007, AM J PHYSIOL-HEART C, V292, pH1157, DOI 10.1152/ajpheart.01034.2006; Villalba N, 2011, AM J PHYSIOL-HEART C, V300, pH2044, DOI 10.1152/ajpheart.01204.2010; Villalba N, 2009, AM J PHYSIOL-HEART C, V297, pH696, DOI 10.1152/ajpheart.01308.2008; Wingard C, 2007, J SEX MED, V4, P348, DOI 10.1111/j.1743-6109.2007.00439.x; Xu J, 2007, CIRCULATION, V116, P944, DOI 10.1161/CIRCULATIONAHA.106.684795	55	38	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e36027	10.1371/journal.pone.0036027	http://dx.doi.org/10.1371/journal.pone.0036027			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540017	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341000083
J	Nguyen, T; Jagannathan, M; Shire, K; Frappier, L				Tin Nguyen; Jagannathan, Madhav; Shire, Kathy; Frappier, Lori			Interactions of the Human MCM-BP Protein with MCM Complex Components and Dbf4	PLOS ONE			English	Article							MINICHROMOSOME MAINTENANCE PROTEINS; MCM4,6,7 HELICASE ACTIVITY; DNA-REPLICATION; S-PHASE; SCHIZOSACCHAROMYCES-POMBE; KINASE COMPLEX; ACTIVE-SITES; HUMAN-CELLS; PHOSPHORYLATION; CDC7	MCM-BP was discovered as a protein that co-purified from human cells with MCM proteins 3 through 7; results which were recapitulated in frogs, yeast and plants. Evidence in all of these organisms supports an important role for MCM-BP in DNA replication, including contributions to MCM complex unloading. However the mechanisms by which MCM-BP functions and associates with MCM complexes are not well understood. Here we show that human MCM-BP is capable of interacting with individual MCM proteins 2 through 7 when co-expressed in insect cells and can greatly increase the recovery of some recombinant MCM proteins. Glycerol gradient sedimentation analysis indicated that MCM-BP interacts most strongly with MCM4 and MCM7. Similar gradient analyses of human cell lysates showed that only a small amount of MCM-BP overlapped with the migration of MCM complexes and that MCM complexes were disrupted by exogenous MCM-BP. In addition, large complexes containing MCM-BP and MCM proteins were detected at mid to late S phase, suggesting that the formation of specific MCM-BP complexes is cell cycle regulated. We also identified an interaction between MCM-BP and the Dbf4 regulatory component of the DDK kinase in both yeast 2-hybrid and insect cell co-expression assays, and this interaction was verified by co-immunoprecipitation of endogenous proteins from human cells. In vitro kinase assays showed that MCM-BP was not a substrate for DDK but could inhibit DDK phosphorylation of MCM4,6,7 within MCM4,6,7 or MCM2-7 complexes, with little effect on DDK phosphorylation of MCM2. Since DDK is known to activate DNA replication through phosphorylation of these MCM proteins, our results suggest that MCM-BP may affect DNA replication in part by regulating MCM phosphorylation by DDK.	[Tin Nguyen; Jagannathan, Madhav; Shire, Kathy; Frappier, Lori] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto	Nguyen, T (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	lori.frappier@utoronto.ca	Jagannathan, Madhav/AAF-8137-2019	Jagannathan, Madhav/0000-0003-3428-6812	Canadian Institutes of Health Research (CIHR) [84306]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by operating grant 84306 from the Canadian Institutes of Health Research (CIHR) to L.F. L.F. is a tier 1 Canada Research Chair in Molecular Virology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bochman ML, 2008, MOL CELL BIOL, V28, P5865, DOI 10.1128/MCB.00161-08; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bochman ML, 2010, NUCLEIC ACIDS RES, V38, P6078, DOI 10.1093/nar/gkq422; Chibazakura T, 2011, MOL CELL BIOL, V31, P248, DOI 10.1128/MCB.00630-10; Cho WH, 2006, P NATL ACAD SCI USA, V103, P11521, DOI 10.1073/pnas.0604990103; Chuang LC, 2009, MOL CELL, V35, P206, DOI 10.1016/j.molcel.2009.06.014; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Ding L, 2011, J BIOL CHEM, V286, P32918, DOI 10.1074/jbc.M111.282541; Duch A, 2011, J BIOL CHEM, V286, P2486, DOI 10.1074/jbc.M110.190843; Duncker BP, 2003, MUTAT RES-FUND MOL M, V532, P21, DOI 10.1016/j.mrfmmm.2003.08.007; Ferguson RL, 2008, J CELL SCI, V121, P3224, DOI 10.1242/jcs.034702; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Furuya K, 2010, MOL CELL, V40, P606, DOI 10.1016/j.molcel.2010.10.026; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Hubbi ME, 2011, MOL CELL, V42, P700, DOI 10.1016/j.molcel.2011.03.029; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Ishimi Y, 2000, J BIOL CHEM, V275, P16235, DOI 10.1074/jbc.M909040199; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Ishimi Y, 2001, J BIOL CHEM, V276, P34428, DOI 10.1074/jbc.M104480200; Jagannathan M, 2012, J CELL SCI, V125, P133, DOI 10.1242/jcs.089938; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; Jones DR, 2010, CELL CYCLE, V9, P2018, DOI 10.4161/cc.9.10.11752; Kanter DM, 2008, J BIOL CHEM, V283, P31172, DOI 10.1074/jbc.M804686200; Kneissl M, 2003, J MOL BIOL, V327, P111, DOI 10.1016/S0022-2836(03)00079-2; Lee JK, 2000, J BIOL CHEM, V275, P18871, DOI 10.1074/jbc.M001118200; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; Li JJ, 2011, FEBS LETT, V585, P3850, DOI 10.1016/j.febslet.2011.10.033; Maiorano D, 2006, CURR OPIN CELL BIOL, V18, P130, DOI 10.1016/j.ceb.2006.02.006; Masai H, 2000, J BIOL CHEM, V275, P29042, DOI 10.1074/jbc.M002713200; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Nayyar VK, 2009, J CELL SCI, V122, P4341, DOI 10.1242/jcs.060913; Nishiyama A, 2011, GENE DEV, V25, P165, DOI 10.1101/gad.614411; Prokhorova TA, 2000, J BIOL CHEM, V275, P2491, DOI 10.1074/jbc.275.4.2491; Sakwe AM, 2007, MOL CELL BIOL, V27, P3044, DOI 10.1128/MCB.02384-06; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Shire K, 2006, J VIROL, V80, P5261, DOI 10.1128/JVI.02682-05; Sterner JM, 1998, MOL CELL BIOL, V18, P2748, DOI 10.1128/MCB.18.5.2748; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Takahashi N, 2008, EMBO J, V27, P1840, DOI 10.1038/emboj.2008.107; Takahashi N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000817; Tenca P, 2007, J BIOL CHEM, V282, P208, DOI 10.1074/jbc.M604457200; Tsao CC, 2004, EMBO J, V23, P4660, DOI 10.1038/sj.emboj.7600463; Tsuji T, 2008, MOL CELL, V32, P862, DOI 10.1016/j.molcel.2008.12.005; Tsuji T, 2006, MOL BIOL CELL, V17, P4459, DOI 10.1091/mbc.E06-03-0241; Varrin AE, 2005, MOL CELL BIOL, V25, P7494, DOI 10.1128/MCB.25.17.7494-7504.2005; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Yu ZL, 2004, J MOL BIOL, V340, P1197, DOI 10.1016/j.jmb.2004.05.024	54	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35931	10.1371/journal.pone.0035931	http://dx.doi.org/10.1371/journal.pone.0035931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540012	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341000078
J	Radigan, KA; Urich, D; Misharin, AV; Chiarella, SE; Soberanes, S; Gonzalez, A; Perlman, H; Wunderink, RG; Budinger, GRS; Mutlu, GM				Radigan, Kathryn A.; Urich, Daniela; Misharin, Alexander V.; Chiarella, Sergio E.; Soberanes, Saul; Gonzalez, Angel; Perlman, Harris; Wunderink, Richard G.; Budinger, G. R. Scott; Mutlu, Goekhan M.			The Effect of Rosuvastatin in a Murine Model of Influenza A Infection	PLOS ONE			English	Article							POPULATION-BASED COHORT; CARDIOVASCULAR-DISEASE; STATIN THERAPY; PANDEMIC INFLUENZA; UNITED-STATES; SEVERE SEPSIS; PNEUMONIA; MORTALITY; VIRUS; INHIBITORS	Rationale: HMG-CoA reductase inhibitors such as rosuvastatin may have immunomodulatory and anti-inflammatory effects that may reduce the severity of influenza A infection. We hypothesized that rosuvastatin would decrease viral replication, attenuate lung injury, and improve mortality following influenza A infection in mice. Methods: C57Bl/6 mice were treated daily with rosuvastatin (10 mg/kg/day) supplemented in chow (or control chow) beginning three days prior to infection with either A//Udorn/72 [H3N2] or A/WSN/33 [H1N1] influenza A virus (1 x 10(5) pfu/mouse). Plaque assays were used to examine the effect of rosuvastatin on viral replication in vitro and in the lungs of infected mice. We measured cell count with differential, protein and cytokines in the bronchoalveolar lavage (BAL) fluid, histologic evidence of lung injury, and wet-to-dry ratio on Day 1, 2, 4, and 6. We also recorded daily weights and mortality. Results: The administration of rosuvastatin had no effect on viral clearance of influenza A after infection. Weight loss, lung inflammation and lung injury severity were similar in the rosuvastatin and control treated mice. In the mice infected with influenza A (A/WSN/33), mortality was unaffected by treatment with rosuvastatin. Conclusions: Statins did not alter the replication of influenza A in vitro or enhance its clearance from the lung in vivo. Statins neither attenuated the severity of influenza A-induced lung injury nor had an effect on influenza A-related mortality. Our data suggest that the association between HMG CoA reductase inhibitors and improved outcomes in patients with sepsis and pneumonia are not attributable to their effects on influenza A infection.	[Radigan, Kathryn A.; Urich, Daniela; Chiarella, Sergio E.; Soberanes, Saul; Gonzalez, Angel; Wunderink, Richard G.; Budinger, G. R. Scott; Mutlu, Goekhan M.] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA; [Misharin, Alexander V.; Perlman, Harris] Northwestern Univ, Feinberg Sch Med, Div Rheumatol, Chicago, IL 60611 USA; [Budinger, G. R. Scott] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Radigan, KA (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA.	k-radigan@northwestern.edu	Misharin, Alexander/AAD-6456-2019	Chiarella, Sergio/0000-0002-0445-4929; Wunderink, Richard/0000-0002-8527-4195; Misharin, Alexander/0000-0003-2879-3789	National Institutes of Health [F32AI094976, T32HL076139, ES015024, ES013995, P01HL071643]; Veterans Administration [5I01BX000201]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL071643, T32HL076139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI094976] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015024, R01ES013995] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Veterans Affairs(US Department of Veterans Affairs)	Funding was provided by National Institutes of Health F32AI094976, T32HL076139, ES015024, ES013995, and P01HL071643 and Veterans Administration 5I01BX000201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa M, 2001, CIRCULATION, V103, P276; Almog Y, 2004, CIRCULATION, V110, P880, DOI 10.1161/01.CIR.0000138932.17956.F1; Almog Y, 2007, CRIT CARE MED, V35, P372, DOI 10.1097/01.CCM.0000253397.42079.D5; BEUTLER B, 1987, NEW ENGL J MED, V316, P379; Blanco-Colio LM, 2003, KIDNEY INT, V63, P12, DOI 10.1046/j.1523-1755.2003.00744.x; Brammer L., 2009, Morbidity and Mortality Weekly Report, V58, P115; Catron DM, 2004, INFECT IMMUN, V72, P1036, DOI 10.1128/IAI.72.2.1036-1042.2004; Chalmers JD, 2008, AM J MED, V121, P1002, DOI 10.1016/j.amjmed.2008.06.030; del Real G, 2004, J EXP MED, V200, P541, DOI 10.1084/jem.20040061; Desjardins F, 2008, EUR HEART J, V29, P128, DOI 10.1093/eurheartj/ehm540; Fedson David S, 2007, Perm J, V11, P63; Giguere JF, 2004, J VIROL, V78, P12062, DOI 10.1128/JVI.78.21.12062-12065.2004; Guo HY, 2009, ARCH MED RES, V40, P345, DOI 10.1016/j.arcmed.2009.07.006; Gupta R, 2007, JAMA-J AM MED ASSOC, V297, P1455, DOI 10.1001/jama.297.13.1455; Hackam DG, 2006, LANCET, V367, P413, DOI 10.1016/S0140-6736(06)68041-0; Hamilton BE, 2007, PEDIATRICS, V119, P345, DOI 10.1542/peds.2006-3226; Hayden FG, 2006, J INFECT DIS, V194, pS119, DOI 10.1086/507552; Hurt A, 2011, EURO SURVEILL, V16; Jing XH, 2008, P NATL ACAD SCI USA, V105, P10967, DOI 10.1073/pnas.0804958105; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kaiser L, 2001, J MED VIROL, V64, P262, DOI 10.1002/jmv.1045; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Liao JK, 2002, J CLIN INVEST, V110, P285, DOI 10.1172/JCI200216421; Lippi G, 2010, SEMIN THROMB HEMOST, V36, P49, DOI 10.1055/s-0030-1248724; Macreadie IG, 2006, FEMS MICROBIOL LETT, V262, P9, DOI 10.1111/j.1574-6968.2006.00370.x; Madjid M, 2004, TEX HEART I J, V31, P4; Makris D, 2011, CRIT CARE MED, V39, P2440, DOI 10.1097/CCM.0b013e318225742c; Martin CP, 2007, PHARMACOTHERAPY, V27, P20, DOI 10.1592/phco.27.1.20; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Mortensen EM, 2008, EUR RESPIR J, V31, P611, DOI 10.1183/09031936.00162006; Mortensen EM, 2007, PHARMACOTHERAPY, V27, P1619, DOI 10.1592/phco.27.12.1619; Mortensen EM, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-45; Mutlu GM, 2007, J CLIN INVEST, V117, P2952, DOI 10.1172/JCI30639; Node K, 2003, CIRCULATION, V108, P839, DOI 10.1161/01.CIR.0000084539.58092.DE; Pastey MK, 2000, NAT MED, V6, P35, DOI 10.1038/71503; Puig-Barbera J, 2007, VACCINE, V25, P7313, DOI 10.1016/j.vaccine.2007.08.039; Schafer K, 2005, THROMB HAEMOSTASIS, V93, P145, DOI 10.1160/TH04-07-0415; Schlienger RG, 2007, PHARMACOTHERAPY, V27, P325, DOI 10.1592/phco.27.3.325; Schonbeck U, 2004, CIRCULATION, V109, P18, DOI 10.1161/01.CIR.0000129505.34151.23; Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Thomsen RW, 2008, PHARMACOEPIDEM DR S, V17, pS234; van de Garde EMW, 2006, THORAX, V61, P957, DOI 10.1136/thx.2006.062885; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058; Yeh SS, 2008, J AM MED DIR ASSOC, V9, P221, DOI 10.1016/j.jamda.2008.01.003; Zarogiannis SG, 2012, LIFE SCI	47	39	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35788	10.1371/journal.pone.0035788	http://dx.doi.org/10.1371/journal.pone.0035788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536437	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339200111
J	Scalliet, G; Bowler, J; Luksch, T; Kirchhofer-Allan, L; Steinhauer, D; Ward, K; Niklaus, M; Verras, A; Csukai, M; Daina, A; Fonne-Pfister, R				Scalliet, Gabriel; Bowler, Judith; Luksch, Torsten; Kirchhofer-Allan, Lucy; Steinhauer, Diana; Ward, Keith; Niklaus, Michael; Verras, Andreas; Csukai, Michael; Daina, Antoine; Fonne-Pfister, Raymonde			Mutagenesis and Functional Studies with Succinate Dehydrogenase Inhibitors in the Wheat Pathogen Mycosphaerella graminicola	PLOS ONE			English	Article							UBIQUINONE-BINDING SITE; COMPLEX-II SUCCINATE; IRON-SULFUR SUBUNIT; CARBOXIN RESISTANCE; ELECTRON-TRANSFER; ESCHERICHIA-COLI; BOSCALID RESISTANCE; OXIDATIVE STRESS; BOTRYTIS-CINEREA; OXIDOREDUCTASE	A range of novel carboxamide fungicides, inhibitors of the succinate dehydrogenase enzyme (SDH, EC 1.3.5.1) is currently being introduced to the crop protection market. The aim of this study was to explore the impact of structurally distinct carboxamides on target site resistance development and to assess possible impact on fitness. We used a UV mutagenesis approach in Mycosphaerella graminicola, a key pathogen of wheat to compare the nature, frequencies and impact of target mutations towards five subclasses of carboxamides. From this screen we identified 27 amino acid substitutions occurring at 18 different positions on the 3 subunits constituting the ubiquinone binding (Qp) site of the enzyme. The nature of substitutions and cross resistance profiles indicated significant differences in the binding interaction to the enzyme across the different inhibitors. Pharmacophore elucidation followed by docking studies in a tridimensional SDH model allowed us to propose rational hypotheses explaining some of the differential behaviors for the first time. Interestingly all the characterized substitutions had a negative impact on enzyme efficiency, however very low levels of enzyme activity appeared to be sufficient for cell survival. In order to explore the impact of mutations on pathogen fitness in vivo and in planta, homologous recombinants were generated for a selection of mutation types. In vivo, in contrast to previous studies performed in yeast and other organisms, SDH mutations did not result in a major increase of reactive oxygen species levels and did not display any significant fitness penalty. However, a number of Qp site mutations affecting enzyme efficiency were shown to have a biological impact in planta. Using the combined approaches described here, we have significantly improved our understanding of possible resistance mechanisms to carboxamides and performed preliminary fitness penalty assessment in an economically important plant pathogen years ahead of possible resistance development in the field.	[Scalliet, Gabriel; Luksch, Torsten; Kirchhofer-Allan, Lucy; Steinhauer, Diana; Niklaus, Michael; Verras, Andreas; Daina, Antoine; Fonne-Pfister, Raymonde] Syngenta Crop Protect Munchwilen AG, Stein, Switzerland; [Bowler, Judith; Ward, Keith; Csukai, Michael] Syngenta Jealotts Hill Int Res Ctr, Bracknell, Berks, England	Syngenta; Syngenta	Scalliet, G (corresponding author), Syngenta Crop Protect Munchwilen AG, Stein, Switzerland.	gabriel.scalliet@syngenta.com		Niklaus, Michael/0000-0003-4713-261X; Csukai, Michael/0000-0003-0615-7802				Amand O., 2003, Communications in Agricultural and Applied Biological Sciences, V68, P519; Anderson RF, 2005, J BIOL CHEM, V280, P33331, DOI 10.1074/jbc.M506002200; [Anonymous], 2005, PHYTOPATHOL MEDITERR, V44, P216; [Anonymous], 1995, FUNGICIDE RESISTANCE; Avenot H, 2009, PLANT PATHOL, V58, P1134, DOI 10.1111/j.1365-3059.2009.02154.x; Avenot HF, 2008, PHYTOPATHOLOGY, V98, P736, DOI 10.1094/PHYTO-98-6-0736; BAGINSKY ML, 1969, J BIOL CHEM, V244, P5313; Bowler J, 2010, MOL PLANT PATHOL, V11, P691, DOI [10.1111/J.1364-3703.2010.00629.X, 10.1111/j.1364-3703.2010.00629.x]; BROOMFIELD PLE, 1992, CURR GENET, V22, P117, DOI 10.1007/BF00351470; Cheng VWT, 2006, J BIOL CHEM, V281, P27662, DOI 10.1074/jbc.M604900200; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Eyal Z., 1987, SEPTORIA DIS WHEAT C; Fraaije BA, 2005, PHYTOPATHOLOGY, V95, P933, DOI 10.1094/PHYTO-95-0933; Fraaije BA, 2012, MOL PLANT PATHOL, V13, P263, DOI 10.1111/j.1364-3703.2011.00746.x; GERBER PR, 1995, J COMPUT AID MOL DES, V9, P251, DOI 10.1007/BF00124456; Gisi U, 2002, PEST MANAG SCI, V58, P859, DOI 10.1002/ps.565; Goodwin SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002070; Grasso V, 2006, PEST MANAG SCI, V62, P465, DOI 10.1002/ps.1236; Guo J, 2003, J BIOL CHEM, V278, P47629, DOI 10.1074/jbc.M306312200; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; Hellens R, 2000, TRENDS PLANT SCI, V5, P446, DOI 10.1016/S1360-1385(00)01740-4; Heller J, 2011, ANNU REV PHYTOPATHOL, V49, P369, DOI 10.1146/annurev-phyto-072910-095355; HENDERSON PJ, 1972, BIOCHEM J, V127, P321, DOI 10.1042/bj1270321; Hobbelen PHF, 2011, PLANT PATHOL, V60, P304, DOI 10.1111/j.1365-3059.2010.02380.x; Honda Y, 2000, CURR GENET, V37, P209, DOI 10.1007/s002940050521; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; Horsefield R, 2006, J BIOL CHEM, V281, P7309, DOI 10.1074/jbc.M508173200; Huang JZ, 2009, J MOL BIOL, V387, P559, DOI 10.1016/j.jmb.2009.02.028; Huang LS, 2006, J BIOL CHEM, V281, P5965, DOI 10.1074/jbc.M511270200; Ishii H, 2011, PEST MANAG SCI, V67, P474, DOI 10.1002/ps.2092; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Ishii T, 2005, CANCER RES, V65, P203; Ito Y, 2004, MOL GENET GENOMICS, V272, P328, DOI 10.1007/s00438-004-1060-2; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; KEARNEY EB, 1960, J BIOL CHEM, V235, P865; Keon J, 2005, FUNGAL GENET BIOL, V42, P376, DOI 10.1016/j.fgb.2004.12.005; Keon J, 2007, MOL PLANT MICROBE IN, V20, P178, DOI 10.1094/MPMI-20-2-0178; KEON JPR, 1991, CURR GENET, V19, P475, DOI 10.1007/BF00312739; Kilaru S, 2009, CURR GENET, V55, P543, DOI 10.1007/s00294-009-0266-6; KISTLER WA, 1971, J BACTERIOL, V108, P1224, DOI 10.1128/JB.108.3.1224-1234.1971; Leroux P, 2007, PEST MANAG SCI, V63, P688, DOI 10.1002/ps.1390; Leroux P, 2010, APPL ENVIRON MICROB, V76, P6615, DOI 10.1128/AEM.00931-10; Li X, 2004, PROTEINS, V55, P368, DOI 10.1002/prot.20014; Maklashina E, 2001, J BIOL CHEM, V276, P18968, DOI 10.1074/jbc.M011270200; Mehrabi R, 2006, MOL PLANT MICROBE IN, V19, P1262, DOI 10.1094/MPMI-19-1262; Newcombe G, 2000, PHYTOPATHOLOGY, V90, P179, DOI 10.1094/PHYTO.2000.90.2.179; Oyedotun KS, 2004, J BIOL CHEM, V279, P9432, DOI 10.1074/jbc.M311877200; Oyedotun KS, 1999, J BIOL CHEM, V274, P23956, DOI 10.1074/jbc.274.34.23956; Oyedotun KS, 1997, J BIOL CHEM, V272, P31382, DOI 10.1074/jbc.272.50.31382; Parnell S, 2008, PLANT PATHOL, V57, P509, DOI 10.1111/j.1365-3059.2007.01786.x; PAZOUR GJ, 1992, J BACTERIOL, V174, P4169, DOI 10.1128/jb.174.12.4169-4174.1992; Pollastri G, 2002, PROTEINS, V47, P228, DOI 10.1002/prot.10082; POLLEY RW, 1991, ANN APPL BIOL, V119, P1, DOI 10.1111/j.1744-7348.1991.tb04839.x; Ruprecht J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.209874; Ruprecht J, 2009, J BIOL CHEM, V284, P29836, DOI 10.1074/jbc.M109.010058; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Scalliet G., 2011, Modern fungicides and antifungal compounds VI. 16th International Reinhardsbrunn Symposium, Friedrichroda, Germany, April 25-29, 2010, P171; SCHEERENGROOT EP, 1994, J BACTERIOL, V176, P6418, DOI 10.1128/JB.176.21.6418-6426.1994; Shima Y, 2009, FUNGAL GENET BIOL, V46, P67, DOI 10.1016/j.fgb.2008.10.005; Sierotzki H., 2011, Modern fungicides and antifungal compounds VI. 16th International Reinhardsbrunn Symposium, Friedrichroda, Germany, April 25-29, 2010, P179; Singer TP, 1971, METHODS ENZYMOL    B, V18, P416; Singer TP, 1980, METHOD ENZYMOL, V66, P354; Sitkin Y, 2007, BBA-BIOENERGETICS, V1767, P143, DOI 10.1016/j.bbabio.2006.11.017; Skinner T, 1998, CURR GENET, V34, P393, DOI 10.1007/s002940050412; SNEL M, 1970, PHYTOPATHOLOGY, V60, P1164, DOI [10.1094/Phyto-60-1164, 10.1094/Phyto-60-1708]; Stammler G., 2008, ABSTRACTS 18 S RES C, P30; Stergiopoulos I, 2003, MOL PLANT MICROBE IN, V16, P689, DOI 10.1094/MPMI.2003.16.8.689; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Szeto SSW, 2007, J BIOL CHEM, V282, P27518, DOI 10.1074/jbc.M700601200; Szeto SSW, 2010, J PROTEOME RES, V9, P6729, DOI 10.1021/pr100880y; Tran QM, 2006, J BIOL CHEM, V281, P32310, DOI 10.1074/jbc.M607476200; Vibat CRT, 1998, BIOCHEMISTRY-US, V37, P4148, DOI 10.1021/bi9716635; VONSCHME.B, 1966, SCIENCE, V152, P659, DOI 10.1126/science.152.3722.659; Walker DW, 2006, P NATL ACAD SCI USA, V103, P16382, DOI 10.1073/pnas.0607918103; WHITE GA, 1978, PESTIC BIOCHEM PHYS, V9, P165, DOI 10.1016/0048-3575(78)90077-9; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605; Yin YN, 2011, PHYTOPATHOLOGY, V101, P986, DOI 10.1094/PHYTO-01-11-0016	78	129	131	7	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35429	10.1371/journal.pone.0035429	http://dx.doi.org/10.1371/journal.pone.0035429			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536383	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336200040
J	Du, W; Wright, BM; Li, X; Finke, J; Rini, BI; Zhou, M; He, H; Lal, P; Welford, SM				Du, W.; Wright, B. M.; Li, X.; Finke, J.; Rini, B. I.; Zhou, M.; He, H.; Lal, P.; Welford, S. M.			Tumor-derived macrophage migration inhibitory factor promotes an autocrine loop that enhances renal cell carcinoma	ONCOGENE			English	Article						renal cell carcinoma; macrophage migration inhibitory factor; MIF; src; p27; autocrine signaling	HYPOXIA-INDUCIBLE FACTORS; FACTOR MIF; GASTRIC-CANCER; UP-REGULATION; EXPRESSION; ACTIVATION; GENE; SRC; ANGIOGENESIS; PROGNOSIS	The macrophage migration inhibitory factor (MIF) is a hypoxia regulated gene that has a variety of tumorigenic functions. In clear cell renal carcinoma (CCRC), hypoxic signaling is constitutively active because of the frequent loss of function of the von Hippel-Lindau tumor suppressor protein. We therefore sought to assess the expression of MIF in CCRC and its biological functions. We stained tumor tissue microarrays comprising sections of 128 CCRC tumors and found MIF to be moderately or highly expressed in >98%. MIF expression was further found to be dramatically elevated in blood plasma of individuals with CCRC compared with healthy controls, suggesting that measurement of MIF levels in the blood may have utility as a diagnostic marker in CCRC. At a functional level, MIF has been reported to engage the CD74 and CD44 receptors and induce signal transduction. In CCRC cell lines, depletion of MIF, CD74 or CD44 by small hairpin RNA led to a significant reduction in growth rate, and clonogenic survival, coinciding with the degree of knockdown. Interruption of the MIF pathway also decreased tumorigenic potential. Biochemically, we found that in CCRC cells MIF signaling leads to activation of the mitogen-activated protein kinase pathway and to Src phosphorylation, which is critical for regulation of p27. Together, our studies establish MIF as a protumorigenic signaling molecule that functions in an autocrine fashion to promote renal cell carcinoma and may be useful as a minimally invasive marker of disease status. Oncogene (2013) 32, 1469-1474; doi:10.1038/onc.2012.143; published online 30 April 2012	[Du, W.; Wright, B. M.; Li, X.; Welford, S. M.] Case Western Reserve Univ, Sch Med, Dept Radiat Oncol, Cleveland, OH 44106 USA; [Finke, J.] Dept Mol Med, Cleveland, OH USA; [Rini, B. I.] Dept Solid Tumor Oncol, Cleveland, OH USA; [Zhou, M.; He, H.] Cleveland Clin Fdn, Dept Anat Pathol & Canc Biol, Cleveland, OH 44195 USA; [Lal, P.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA	Case Western Reserve University; Cleveland Clinic Foundation; University of Pennsylvania	Welford, SM (corresponding author), Case Western Reserve Univ, Sch Med, Dept Radiat Oncol, BRB325,10900 Euclid Ave, Cleveland, OH 44106 USA.	scott.welford@case.edu			RSG from the American Cancer Society [121762-RSG-12-097-01-CCG];  [CA147387];  [P30CA43703]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER	RSG from the American Cancer Society; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by CA147387, and by an RSG from the American Cancer Society (121762-RSG-12-097-01-CCG) to SMW. We thank Drs Amato Giaccia and Haifeng Yang for cell lines. Flow cytometry was performed in the CASE Comprehensive Cancer Center Cytometry and Microscopy Core facility, which is supported by P30CA43703.	American Cancer Society, 2011, CANC FACTS FIG 2011; Amin MA, 2006, BLOOD, V107, P2252, DOI 10.1182/blood-2005-05-2011; Bach JP, 2008, ONCOLOGY-BASEL, V75, P127, DOI 10.1159/000155223; Bacher M, 2003, AM J PATHOL, V162, P11, DOI 10.1016/S0002-9440(10)63793-5; Baugh JA, 2006, BIOCHEM BIOPH RES CO, V347, P895, DOI 10.1016/j.bbrc.2006.06.148; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; He XX, 2006, GUT, V55, P797, DOI 10.1136/gut.2005.078113; He XX, 2009, MOL MED, V15, P1, DOI 10.2119/molmed.2008.00107; Hira E, 2005, CANCER, V103, P588, DOI 10.1002/cncr.20818; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kamimura A, 2000, CANCER, V89, P334, DOI 10.1002/1097-0142(20000715)89:2<334::AID-CNCR18>3.0.CO;2-N; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Koong AC, 2000, CANCER RES, V60, P883; Krieg M, 2000, ONCOGENE, V19, P5435, DOI 10.1038/sj.onc.1203938; Legendre H, 2003, MODERN PATHOL, V16, P491, DOI 10.1097/01.MP.0000068235.45178.C1; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Li GQ, 2009, WORLD J GASTROENTERO, V15, P5541, DOI 10.3748/wjg.15.5541; Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200; Lue H, 2007, ONCOGENE, V26, P5046, DOI 10.1038/sj.onc.1210318; Lue HQ, 2006, CELL SIGNAL, V18, P688, DOI 10.1016/j.cellsig.2005.06.013; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Meyer-Siegler KL, 2002, CANCER-AM CANCER SOC, V94, P1449, DOI 10.1002/cncr.10354; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Nguyen MT, 2003, J IMMUNOL, V170, P3337, DOI 10.4049/jimmunol.170.6.3337; Onodera S, 2002, J BIOL CHEM, V277, P7865, DOI 10.1074/jbc.M106020200; Schrader J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-464; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Shimizu T, 1999, BIOCHEM BIOPH RES CO, V264, P751, DOI 10.1006/bbrc.1999.1584; Welford SM, 2006, GENE DEV, V20, P3366, DOI 10.1101/gad.1471106; Xia HHX, 2009, CANCER-AM CANCER SOC, V115, P5441, DOI 10.1002/cncr.24609	36	28	29	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 14	2013	32	11					1469	1474		10.1038/onc.2012.143	http://dx.doi.org/10.1038/onc.2012.143			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110OZ	22543583				2022-12-25	WOS:000316455600013
J	Ahmed, A; Gaadhe, K; Sharma, GP; Kumar, N; Neculai, M; Hui, R; Mohanty, D; Sharma, P				Ahmed, Anwar; Gaadhe, Kavita; Sharma, Guru Prasad; Kumar, Narendra; Neculai, Mirela; Hui, Raymond; Mohanty, Debasisa; Sharma, Pushkar			Novel insights into the regulation of malarial calcium-dependent protein kinase 1	FASEB JOURNAL			English	Article						autophosphorylation; structure-function	PARASITE PLASMODIUM-FALCIPARUM; CALMODULIN-LIKE DOMAIN; ACTIVATION; SUBSTRATE; MOTILITY; INVASION; COMPLEX	Calcium-dependent protein kinases (CDPKs) are major effectors of calcium signaling in apicomplexan parasites like Toxoplasma and Plasmodium and control important processes of the parasite life cycle. Despite recently reported crystal structures of Toxoplasma gondii (Tg)CDPKs, several important questions about their regulation remain unanswered. Plasmodium falciparum (Pf)CDPK1 has emerged as a key player in the life cycle of the malaria parasite, as it may be involved in the invasion of the host cells. Molecular modeling and site-directed mutagenesis studies on PfCDPK1 suggested that several residues in the regulatory domain play a dual role, as they seem to contribute to the stabilization of both the active and inactive kinase. Mass spectrometry revealed that PfCDPK1 was autophosphorylated at several sites; some of these were placed at strategic locations and therefore were found to be critical for kinase activation. The N-terminal extension of PfCDPK1 was found to be important for PfCDPK1 activation. Unexpectedly, an ATP binding site in the NTE of PfCDPK1 was identified. Our studies highlight several novel features of PfCDPK1 regulation, which may be shared by other members of the CDPK family. These findings may also aid design of inhibitors against these important targets, which are absent from the host.-Ahmed, A., Gaadhe, K., Sharma, G. P., Kumar, N., Neculai, M., Hui, R., Mohanty, D., Sharma, P. Novel insights into the regulation of malarial calcium-dependent protein kinase 1. FASEB J. 26, 3212-3221 (2012). www.fasebj.org	[Ahmed, Anwar; Gaadhe, Kavita; Sharma, Guru Prasad; Sharma, Pushkar] Natl Inst Immunol, Eukaryot Gene Express Lab, New Delhi 110067, India; [Kumar, Narendra; Mohanty, Debasisa] Natl Inst Immunol, Bioinformat Ctr, New Delhi 110067, India; [Neculai, Mirela; Hui, Raymond] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; National Institute of Immunology (NII); University of Toronto; Structural Genomics Consortium	Sharma, P (corresponding author), Natl Inst Immunol, Eukaryot Gene Express Lab, New Delhi 110067, India.	pushkar@nii.ac.in	Ahmed, Anwar/ADH-1445-2022; Ahmed, Anwar/AAL-7789-2021; Sharma, Guruprasad/M-5256-2017; Mohanty, Debasisa/A-1428-2009	Ahmed, Anwar/0000-0001-8147-714X; Sharma, Guruprasad/0000-0003-3197-4396; MOHANTY, DEBASISA/0000-0002-3374-0588; Kumar, Narendra/0000-0002-3978-8742	Department of Science and Technology, India; Signalling in Life Cycle Stages of Malaria Parasites (MALSIG) project; European Union under FP7; U.S. National Institutes of Health grant from the National Institute of Allergy and Infectious Diseases [R01AI075459]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075459] Funding Source: NIH RePORTER	Department of Science and Technology, India(Department of Science & Technology (India)); Signalling in Life Cycle Stages of Malaria Parasites (MALSIG) project; European Union under FP7; U.S. National Institutes of Health grant from the National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	P.S. received a Swarnajayanti Fellowship grant from the Department of Science and Technology, India, and his laboratory is supported by the Signalling in Life Cycle Stages of Malaria Parasites (MALSIG) project funded by the European Union under FP7. This work was also supported in part by U.S. National Institutes of Health grant R01AI075459 from the National Institute of Allergy and Infectious Diseases. The assistance rendered by Shivang Vachharajani, Ashutosh Upadhyay and Sudhir Kumar in generating constructs, protein expression and kinase assays is acknowledged.	Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Doerig C, 2009, PARASITE, V16, P169, DOI 10.1051/parasite/2009163169; Doerig C, 2008, TRENDS PARASITOL, V24, P570, DOI 10.1016/j.pt.2008.08.007; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Fieulaine S, 2002, P NATL ACAD SCI USA, V99, P13437, DOI 10.1073/pnas.192368699; Garcia CRS, 1999, PARASITOL TODAY, V15, P488, DOI 10.1016/S0169-4758(99)01571-9; Gazarini ML, 2004, BIOCHEM BIOPH RES CO, V321, P138, DOI 10.1016/j.bbrc.2004.06.141; Green JL, 2008, J BIOL CHEM, V283, P30980, DOI 10.1074/jbc.M803129200; Harper JF, 2005, NAT REV MOL CELL BIO, V6, P555, DOI 10.1038/nrm1679; Hegeman AD, 2006, PROTEOMICS, V6, P3649, DOI 10.1002/pmic.200500926; HUANG CYF, 1995, J BIOL CHEM, V270, P7183, DOI 10.1074/jbc.270.13.7183; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Kato N, 2008, NAT CHEM BIOL, V4, P347, DOI 10.1038/nchembio.87; Koyama FC, 2009, MOL BIOCHEM PARASIT, V165, P1, DOI 10.1016/j.molbiopara.2009.01.003; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Nagamune Kisaburo, 2008, V47, P70; Ojo KK, 2010, NAT STRUCT MOL BIOL, V17, P602, DOI 10.1038/nsmb.1818; Ranjan R, 2009, J BIOL CHEM, V284, P15267, DOI 10.1074/jbc.M900656200; Rellos P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000426; Siden-Kiamos I, 2006, MOL MICROBIOL, V60, P1355, DOI 10.1111/j.1365-2958.2006.05189.x; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Vaid A, 2008, J BIOL CHEM, V283, P5589, DOI 10.1074/jbc.M708465200; Vitart V, 2000, BIOCHEMISTRY-US, V39, P4004, DOI 10.1021/bi992373m; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Wernimont AK, 2011, PROTEINS, V79, P803, DOI 10.1002/prot.22919; Wernimont AK, 2010, NAT STRUCT MOL BIOL, V17, P596, DOI 10.1038/nsmb.1795; Yoo BC, 1996, BIOCHEMISTRY-US, V35, P12029, DOI 10.1021/bi9606612	28	20	20	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2012	26	8					3212	3221		10.1096/fj.12-203877	http://dx.doi.org/10.1096/fj.12-203877			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22539638	Green Published			2022-12-25	WOS:000307162800012
J	Petrik, D; Jiang, YD; Birnbaum, SG; Powell, CM; Kim, MS; Hsieh, J; Eisch, AJ				Petrik, David; Jiang, Yindi; Birnbaum, Shari G.; Powell, Craig M.; Kim, Mi-Sung; Hsieh, Jenny; Eisch, Amelia J.			Functional and mechanistic exploration of an adult neurogenesis-promoting small molecule	FASEB JOURNAL			English	Article						neural stem cells; dendrites; chemical biology; Morris water maze; Mef2	NEURAL STEM-CELL; GENERATED GRANULE CELLS; HIPPOCAMPAL NEUROGENESIS; SYNAPTIC PLASTICITY; TRANSCRIPTION FACTOR; DENTATE GYRUS; PROLIFERATING CELLS; PHYSICAL-ACTIVITY; PROGENITOR CELLS; CHRONIC MORPHINE	Adult neurogenesis occurs throughout life in the mammalian hippocampus and is essential for memory and mood control. There is significant interest in identifying ways to promote neurogenesis and ensure maintenance of these hippocampal functions. Previous work with a synthetic small molecule, isoxazole 9 (Isx-9), highlighted its neuronal-differentiating properties in vitro. However, the ability of Isx-9 to drive neurogenesis in vivo or improve hippocampal function was unknown. Here we show that Isx-9 promotes neurogenesis in vivo, enhancing the proliferation and differentiation of hippocampal subgranular zone (SGZ) neuroblasts, and the dendritic arborization of adult-generated dentate gyrus neurons. Isx-9 also improves hippocampal function, enhancing memory in the Morris water maze. Notably, Isx-9 enhances neurogenesis and memory without detectable increases in cellular or animal activity or vascularization. Molecular exploration of Isx-9-induced regulation of neurogenesis (via FACS and microarray of SGZ stem and progenitor cells) suggested the involvement of the myocyte-enhancer family of proteins (Mef2). Indeed, transgenic-mediated inducible knockout of all brain-enriched Mef2 isoforms (Mef2a/c/d) specifically from neural stem cells and their progeny confirmed Mef2's requirement for Isx-9-induced increase in hippocampal neurogenesis. Thus, Isx-9 enhances hippocampal neurogenesis and memory in vivo, and its effects are reliant on Mef2, revealing a novel cell-intrinsic molecular pathway regulating adult neurogenesis.-Petrik, D., Jiang, Y., Birnbaum, S. G., Powell, C. M., Kim, M.-S., Hsieh, J., Eisch, A. J. Functional and mechanistic exploration of an adult neurogenesis-promoting small molecule. FASEB J. 26, 3148-3162 (2012). www.fasebj.org	[Jiang, Yindi; Kim, Mi-Sung; Hsieh, Jenny] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Petrik, David; Birnbaum, Shari G.; Eisch, Amelia J.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Powell, Craig M.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hsieh, J (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	jenny.hsieh@utsouthwestern.edu; amelia.eisch@utsouthwestern.edu		Petrik, David/0000-0003-3026-0770; Eisch, Amelia/0000-0001-6476-5385; Powell, Craig/0000-0001-5451-2165	NIH [R01 DA016765, K02 DA023555, R21 DA023701, R01 AG032383]; National Alliance for Research on Schizophrenia and Depression; Welch Foundation [I-1660]; Cancer Prevention and Research Institute of Texas [RP100674]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093697, R01MH081164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA023555, R01DA016765, R21DA023701] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research on Schizophrenia and Depression(NARSAD); Welch Foundation(The Welch Foundation); Cancer Prevention and Research Institute of Texas; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank Eric N. Olson (University of Texas Southwestern Medical Center) for providing the Mef2a/c/d<SUP>flox/flox</SUP> mice and Paul Worley (Johns Hopkins University, Baltimore, MD, USA) for the anti-Arc antibody. The authors also thank Masahiro Yamaguchi (University of Tokyo, Tokyo, Japan) for providing the initial nestin-GFP breeders that helped establish the colony at University of Texas Southwestern. The authors also thank Haley Speed, Noelle Williams, and Kerstin Ure for helpful comments on the experiments, and the U. S. National Institutes of Health (NIH) Neuroscience Consortium for the microarray help. This work was supported in part by grants from the NIH (R01 DA016765, K02 DA023555, and R21 DA023701 to A.J.E.; R01 AG032383 to J.H.), the National Alliance for Research on Schizophrenia and Depression (Independent Investigator Award to A.J.E.), the Welch Foundation (I-1660 to J.H.), and the Cancer Prevention and Research Institute of Texas (RP100674 to J.H.). The content of this work is solely the responsibility of the authors and does not necessarily represent the official views of the granting agencies. D.P. designed and performed experiments, analyzed data, made figures, and cowrote the manuscript; Y.J. performed experiments and analyzed data; S.B. performed experiments; C.M.P. provided electrophysiological equipment and expertise; M.-S.K. made Mef2a<SUP>flox/flox</SUP> mice;. J.H. and A.J.E. designed experiments and cowrote the manuscript. The authors thank Ami Pettersen, Junie Leblanc, Sohail Kamrudin, and Sean Goetsch for technical assistance and Jose Cabrera for artwork.	Ables JL, 2010, J NEUROSCI, V30, P10484, DOI 10.1523/JNEUROSCI.4721-09.2010; Aboulkassim T, 2011, MOL PHARMACOL, V80, P498, DOI 10.1124/mol.111.071332; Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Aimone JB, 2011, EUR J NEUROSCI, V33, P1160, DOI 10.1111/j.1460-9568.2011.07615.x; ALTMAN J, 1965, NATURE, V207, P953, DOI 10.1038/207953a0; Arguello AA, 2009, NEUROSCIENCE, V159, P1003, DOI 10.1016/j.neuroscience.2009.01.020; Arisi GM, 2007, BRAIN RES, V1165, P126, DOI 10.1016/j.brainres.2007.06.037; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Chohan MO, 2011, NEUROBIOL AGING, V32, P1420, DOI 10.1016/j.neurobiolaging.2009.08.008; Clark PJ, 2009, HIPPOCAMPUS, V19, P937, DOI 10.1002/hipo.20543; DeCarolis NA, 2010, NEUROPHARMACOLOGY, V58, P884, DOI 10.1016/j.neuropharm.2009.12.013; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Ding S, 2004, NAT BIOTECHNOL, V22, P833, DOI 10.1038/nbt987; Dioum EM, 2011, P NATL ACAD SCI USA, V108, P20713, DOI 10.1073/pnas.1118526109; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Duan X, 2008, CURR OPIN NEUROBIOL, V18, P108, DOI 10.1016/j.conb.2008.04.001; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Encinas JM, 2012, BEHAV BRAIN RES, V227, P433, DOI 10.1016/j.bbr.2011.10.010; Encinas JM, 2008, METHOD CELL BIOL, V85, P243, DOI 10.1016/S0091-679X(08)85011-X; Ermini FV, 2008, AM J PATHOL, V172, P1520, DOI 10.2353/ajpath.2008.060520; Fabel K, 2008, NEUROMOL MED, V10, P59, DOI 10.1007/s12017-008-8031-4; Farioli-Vecchioli S, 2008, PLOS BIOL, V6, P2188, DOI 10.1371/journal.pbio.0060246; Ge SY, 2007, TRENDS NEUROSCI, V30, P1, DOI 10.1016/j.tins.2006.11.001; Gilley JA, 2011, HIPPOCAMPUS, V21, P33, DOI 10.1002/hipo.20719; Guo WX, 2011, NAT MED, V17, P559, DOI 10.1038/nm.2336; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Halt AR, 2012, EMBO J, V31, P1203, DOI 10.1038/emboj.2011.482; Hawasli AH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005808; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Inoue T, 2007, J NEUROSCI, V27, P5461, DOI 10.1523/JNEUROSCI.4046-06.2007; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; John JPP, 2009, HIPPOCAMPUS, V19, P731, DOI 10.1002/hipo.20553; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempermann G, 1998, CURR BIOL, V8, P939, DOI 10.1016/S0960-9822(07)00377-6; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Kohl Z, 2007, BRAIN RES, V1155, P24, DOI 10.1016/j.brainres.2007.04.039; Krampert M, 2010, MOL CELL BIOL, V30, P3685, DOI 10.1128/MCB.00434-09; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Kuhn HG, 2007, CURR PHARM BIOTECHNO, V8, P127; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Lagace DC, 2010, P NATL ACAD SCI USA, V107, P4436, DOI 10.1073/pnas.0910072107; Lam BYH, 2007, NEUROSCI LETT, V427, P153, DOI 10.1016/j.neulet.2007.09.030; Lazarov O, 2010, TRENDS NEUROSCI, V33, P569, DOI 10.1016/j.tins.2010.09.003; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Lin X, 1996, MOL BRAIN RES, V42, P307, DOI 10.1016/S0169-328X(96)00135-0; Lipinski C, 2004, NATURE, V432, P855, DOI 10.1038/nature03193; LYONS GE, 1995, J NEUROSCI, V15, P5727, DOI 10.1523/jneurosci.15-08-05727.1995; Mandyam CD, 2007, NEUROSCIENCE, V146, P108, DOI 10.1016/j.neuroscience.2006.12.064; Mandyam CD, 2004, J NEUROSCI RES, V76, P783, DOI 10.1002/jnr.20090; Mandyam CD, 2012, TRENDS NEUROSCI, V35, P250, DOI 10.1016/j.tins.2011.12.005; MILLER MW, 1988, BRAIN RES, V457, P44, DOI 10.1016/0006-8993(88)90055-8; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Murphy GG, 2004, CURR BIOL, V14, P1907, DOI 10.1016/j.cub.2004.10.021; Noonan MA, 2010, J NEUROSCI, V30, P304, DOI 10.1523/JNEUROSCI.4256-09.2010; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Perera TD, 2007, J NEUROSCI, V27, P4894, DOI 10.1523/JNEUROSCI.0237-07.2007; Petrik D, 2012, NEUROPHARMACOLOGY, V62, P21, DOI 10.1016/j.neuropharm.2011.09.003; Pieper AA, 2010, CELL, V142, P39, DOI 10.1016/j.cell.2010.06.018; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Rose SPR, 2002, NAT REV NEUROSCI, V3, P975, DOI 10.1038/nrn984; Ross AP, 2009, NEUROBIOL LEARN MEM, V92, P410, DOI 10.1016/j.nlm.2009.05.007; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Samuels BA, 2011, EUR J NEUROSCI, V33, P1152, DOI 10.1111/j.1460-9568.2011.07614.x; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Schneider JW, 2008, NAT CHEM BIOL, V4, P408, DOI 10.1038/nchembio.95; Seki T, 2007, J COMP NEUROL, V502, P275, DOI 10.1002/cne.21301; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.3.CO;2-H; Tronel S, 2010, P NATL ACAD SCI USA, V107, P7963, DOI 10.1073/pnas.0914613107; Udo H, 2008, J NEUROSCI, V28, P14522, DOI 10.1523/JNEUROSCI.3673-08.2008; Van der Borght K, 2009, HIPPOCAMPUS, V19, P928, DOI 10.1002/hipo.20545; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Vetere G, 2011, P NATL ACAD SCI USA, V108, P8456, DOI 10.1073/pnas.1016275108; Wang JW, 2008, J NEUROSCI, V28, P1374, DOI 10.1523/JNEUROSCI.3632-07.2008; Wang XK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-360; Wojtowicz JM, 2008, EUR J NEUROSCI, V27, P1494, DOI 10.1111/j.1460-9568.2008.06128.x; Wurdak H, 2010, P NATL ACAD SCI USA, V107, P16542, DOI 10.1073/pnas.1010300107; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037; Zhang L, 2011, DIFFERENTIATION, V81, P233, DOI 10.1016/j.diff.2011.02.005	93	55	58	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2012	26	8					3148	3162		10.1096/fj.11-201426	http://dx.doi.org/10.1096/fj.11-201426			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22542682	Green Published			2022-12-25	WOS:000307162800007
J	Dey, S; Savant, S; Teske, BF; Hatzoglou, M; Calkhoven, CF; Wek, RC				Dey, Souvik; Savant, Sudha; Teske, Brian F.; Hatzoglou, Maria; Calkhoven, Cornelis F.; Wek, Ronald C.			Transcriptional Repression of ATF4 Gene by CCAAT/Enhancer-binding Protein beta (C/EBP beta) Differentially Regulates Integrated Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; ASPARAGINE SYNTHETASE GENE; VANISHING WHITE-MATTER; AMINO-ACID DEPRIVATION; CANCER-CELL LINES; TRANSLATION INITIATION; MAMMALIAN-CELLS; MESSENGER-RNA; INCREASES TRANSLATION; MOLECULAR-MECHANISMS	Different environmental stresses induce the phosphorylation of eIF2 (eIF2 similar to P), repressing global protein synthesis coincident with preferential translation of ATF4. ATF4 is a transcriptional activator of genes involved in metabolism and nutrient uptake, antioxidation, and regulation of apoptosis. Because ATF4 is a common downstream target that integrates signaling from different eIF2 kinases and their respective stress signals, the eIF2 similar to P/ATF4 pathway is collectively referred to as the integrated stress response. Although eIF2 similar to P elicits translational control in response to many different stresses, there are selected stresses, such as exposure to UV irradiation, that do not increase ATF4 expression despite robust eIF2 similar to P. The rationale for this discordant induction of ATF4 expression and eIF2 similar to P in response to UV irradiation is that transcription of ATF4 is repressed, and therefore ATF4 mRNA is not available for preferential translation. In this study, we show that C/EBP beta is a transcriptional repressor of ATF4 during UV stress. C/EBP beta binds to critical elements in the ATF4 promoter, resulting in its transcriptional repression. Expression of C/EBP beta increases in response to UV stress, and the liver-enriched inhibitory protein (LIP) isoform of C/EBP beta, but not the liver-enriched activating protein (LAP) version, represses ATF4 transcription. Loss of the liver-enriched inhibitory protein isoform results in increased ATF4 mRNA levels in response to UV irradiation and subsequent recovery of ATF4 translation, leading to enhanced expression of its target genes. Together these results illustrate how eIF2 similar to P and translational control combined with transcription factors regulated by alternative signaling pathways can direct programs of gene expression that are specifically tailored to each environmental stress.	[Dey, Souvik; Savant, Sudha; Teske, Brian F.; Wek, Ronald C.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Hatzoglou, Maria] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Calkhoven, Cornelis F.] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany	Indiana University System; Indiana University-Purdue University Indianapolis; Case Western Reserve University; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Wek, RC (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	rwek@iupui.edu		Calkhoven, Cornelis/0000-0001-6318-7210	National Institutes of Health [GM049164, DK053307, T32DK064466]; American Heart Association Predoctoral Fellowship [11PRE7240012]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK064466, R01DK053307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049164, R29GM049164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM049164 (to R. C. W.), DK053307 (to M. H.), and T32DK064466 (a predoctoral fellowship to B. F. T.). This work was also supported by American Heart Association Predoctoral Fellowship 11PRE7240012 (to B. F. T).	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Afonyushkin T, 2010, ARTERIOSCL THROM VAS, V30, P1007, DOI 10.1161/ATVBAHA.110.204354; Armstrong JL, 2010, J BIOL CHEM, V285, P6091, DOI 10.1074/jbc.M109.014092; Bergalet J, 2011, MOL CANCER RES, V9, P485, DOI 10.1158/1541-7786.MCR-10-0351; Bruhat A, 2002, J BIOL CHEM, V277, P48107, DOI 10.1074/jbc.M206149200; Bugiani M, 2010, J NEUROPATH EXP NEUR, V69, P987, DOI 10.1097/NEN.0b013e3181f2eafa; Calkhoven CF, 2000, GENE DEV, V14, P1920; Chen C, 2005, BIOCHEM J, V391, P649, DOI 10.1042/BJ20050882; Chen C, 2004, J BIOL CHEM, V279, P27948, DOI 10.1074/jbc.M313920200; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Chiribau CB, 2010, MOL CELL BIOL, V30, P3722, DOI 10.1128/MCB.01507-09; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Deng J, 2002, CURR BIOL, V12, P1279, DOI 10.1016/S0960-9822(02)01037-0; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Gale M, 1998, MOL CELL BIOL, V18, P5208, DOI 10.1128/MCB.18.9.5208; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Han AP, 2001, EMBO J, V20, P6909, DOI 10.1093/emboj/20.23.6909; Hanlon M, 2001, J BIOL CHEM, V276, P38449, DOI 10.1074/jbc.M102165200; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hatzoglou M, 2004, ANNU REV NUTR, V24, P377, DOI 10.1146/annurev.nutr.23.011702.073120; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2002, EUKARYOT CELL, V1, P22, DOI 10.1128/EC.01.1.22-32.2002; Igarashi T, 2007, ONCOGENE, V26, P4749, DOI 10.1038/sj.onc.1210289; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jiang HY, 2005, BIOCHEM J, V385, P371, DOI 10.1042/BJ20041164; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; Kumar R, 2003, J CEREBR BLOOD F MET, V23, P462, DOI 10.1097/01.WCB.0000056064.25434.CA; Levenson VV, 2000, CANCER RES, V60, P5027; Li B, 2008, J CELL BIOCHEM, V103, P1657, DOI 10.1002/jcb.21554; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Miyamoto N, 2011, INVEST OPHTH VIS SCI, V52, P1226, DOI 10.1167/iovs.10-5775; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Pavitt GD, 2009, BIOCHEM SOC T, V37, P1298, DOI 10.1042/BST0371298; Piwien-Pilipuk G, 2002, J BIOL CHEM, V277, P44557, DOI 10.1074/jbc.M206886200; Powley IR, 2009, GENE DEV, V23, P1207, DOI 10.1101/gad.516509; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Sachdeva MM, 2009, P NATL ACAD SCI USA, V106, P19090, DOI 10.1073/pnas.0904849106; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Schmitt-Ney M, 2000, J BIOL CHEM, V275, P40839, DOI 10.1074/jbc.M007440200; Siu F, 2001, J BIOL CHEM, V276, P48100, DOI 10.1074/jbc.M109533200; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tanabe M, 2003, CANCER RES, V63, P8592; Timchenko LT, 2002, MOL CELL BIOL, V22, P7242, DOI 10.1128/MCB.22.20.7242-7257.2002; Timchenko LT, 2006, J BIOL CHEM, V281, P32806, DOI 10.1074/jbc.M605701200; Timchenko NA, 2005, J BIOL CHEM, V280, P20549, DOI 10.1074/jbc.M409563200; Tsukada J, 2011, CYTOKINE, V54, P6, DOI 10.1016/j.cyto.2010.12.019; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Wethmar K, 2010, GENE DEV, V24, P15, DOI 10.1101/gad.557910; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	67	28	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21936	21949		10.1074/jbc.M112.351783	http://dx.doi.org/10.1074/jbc.M112.351783			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22556424	Green Published, hybrid			2022-12-25	WOS:000306418600033
J	Savalli, N; Pantazis, A; Yusifov, T; Sigg, D; Olcese, R				Savalli, Nicoletta; Pantazis, Antonios; Yusifov, Taleh; Sigg, Daniel; Olcese, Riccardo			The Contribution of RCK Domains to Human BK Channel Allosteric Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CONFORMATIONAL-CHANGES; CA2+-ACTIVATED K+ CHANNELS; VOLTAGE SENSOR ACTIVATION; GATED ION CHANNELS; POTASSIUM CHANNELS; CA2+ BINDING; GATING RING; KINETIC-PROPERTIES; BETA-SUBUNITS; DM-NITROPHEN	Large conductance voltage- and Ca2+-activated K+ (BK) channels are potent regulators of cellular processes including neuronal firing, synaptic transmission, cochlear hair cell tuning, insulin release, and smooth muscle tone. Their unique activation pathway relies on structurally distinct regulatory domains including one transmembrane voltage-sensing domain (VSD) and two intracellular high affinity Ca2+-sensing sites per subunit (located in the RCK1 and RCK2 domains). Four pairs of RCK1 and RCK2 domains form a Ca2+-sensing apparatus known as the "gating ring." The allosteric interplay between voltage- and Ca2+-sensing apparati is a fundamental mechanism of BK channel function. Using voltage- clamp fluorometry and UV photolysis of intracellular caged Ca2+, we optically resolved VSD activation prompted by Ca2+ binding to the gating ring. The sudden increase of intracellular Ca2+ concentration ([Ca2+](i)) induced a hyperpolarizing shift in the voltage dependence of both channel opening and VSD activation, reported by a fluorophore labeling position 202, located in the upper side of the S4 transmembrane segment. The neutralization of the Ca2+ sensor located in the RCK2 domain abolished the effect of [Ca2+](i) increase on the VSD rearrangements. On the other hand, the mutation of RCK1 residues involved in Ca2+ sensing did not prevent the effect of Ca2+ release on the VSD, revealing a functionally distinct interaction between RCK1 and RCK2 and the VSD. A statistical-mechanical model quantifies the complex thermodynamics interplay between Ca2+ association in two distinct sites, voltage sensor activation, and BK channel opening.	[Savalli, Nicoletta; Pantazis, Antonios; Yusifov, Taleh; Sigg, Daniel; Olcese, Riccardo] Univ Calif Los Angeles, Div Mol Med, Dept Anesthesiol, David Geffen Sch Med, Los Angeles, CA 90075 USA; [Olcese, Riccardo] Univ Calif Los Angeles, Brain Res Inst, David Geffen Sch Med, Los Angeles, CA 90075 USA; [Olcese, Riccardo] Univ Calif Los Angeles, Cardiovasc Res Labs, David Geffen Sch Med, Los Angeles, CA 90075 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Olcese, R (corresponding author), Univ Calif Los Angeles, Div Mol Med, Dept Anesthesiol, David Geffen Sch Med, BH 570 CHS, Los Angeles, CA 90075 USA.	rolcese@ucla.edu	Pantazis, Antonios/AAB-3846-2019	Pantazis, Antonios/0000-0002-6467-1327; Sigg, Daniel/0000-0003-4944-2988	National Institutes of Health [R01GM082289]; Laubisch Foundation; American Heart Association [11POST7140046]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Laubisch Foundation; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM082289 (to R. O.). This work was also supported by funds from the Laubisch Foundation (to R. O.) and American Heart Association Post-doctoral Fellowship (Western States Affiliate) 11POST7140046 (to A. P.).	Altomare C, 2001, J GEN PHYSIOL, V117, P519, DOI 10.1085/jgp.117.6.519; Armstrong Clay M, 2003, Sci STKE, V2003, pre10, DOI 10.1126/stke.2003.188.re10; Bao L, 2004, J GEN PHYSIOL, V123, P475, DOI 10.1085/jgp.200409052; Bao L, 2002, J GEN PHYSIOL, V120, P173, DOI 10.1085/jgp.20028627; Bian S, 2001, P NATL ACAD SCI USA, V98, P4776, DOI 10.1073/pnas.081072398; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Cui J, 2009, CELL MOL LIFE SCI, V66, P852, DOI 10.1007/s00018-008-8609-x; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; Diaz L, 1998, J BIOL CHEM, V273, P32430, DOI 10.1074/jbc.273.49.32430; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Ellis-Davies GCR, 2003, METHOD ENZYMOL, V360, P226; Ellis-Davies GCR, 2007, NAT METHODS, V4, P619, DOI 10.1038/NMETH1072; Escobar AL, 1997, PFLUG ARCH EUR J PHY, V434, P615, DOI 10.1007/s004240050444; Faas GC, 2005, BIOPHYS J, V88, P4421, DOI 10.1529/biophysj.104.057745; Fettiplace R, 1999, ANNU REV PHYSIOL, V61, P809, DOI 10.1146/annurev.physiol.61.1.809; Gandhi C. S., 2008, METHODS MOL BIOL POT; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Haug T, 2004, J GEN PHYSIOL, V124, P173, DOI 10.1085/jgp.200308949; Horrigan FT, 2008, J GEN PHYSIOL, V131, P13, DOI 10.1085/jgp.200709877; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Hou SW, 2009, PHYSIOLOGY, V24, P26, DOI 10.1152/physiol.00032.2008; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Javaherian AD, 2011, J BIOL CHEM, V286, P20701, DOI 10.1074/jbc.M111.235234; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Latorre R, 2010, J PHYSIOL-LONDON, V588, P3141, DOI 10.1113/jphysiol.2010.191999; Lee US, 2010, TRENDS NEUROSCI, V33, P415, DOI 10.1016/j.tins.2010.06.004; Liu GX, 2010, J GEN PHYSIOL, V135, P449, DOI 10.1085/jgp.201010417; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu R, 2006, J PHYSIOL-LONDON, V570, P65, DOI 10.1113/jphysiol.2005.098913; Ma ZM, 2006, J GEN PHYSIOL, V127, P309, DOI 10.1085/jgp.200509421; Magleby RL, 2003, J GEN PHYSIOL, V121, P81, DOI 10.1085/jgp.20028721; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; MOCZYDLOWSKI E, 1983, J GEN PHYSIOL, V82, P511, DOI 10.1085/jgp.82.4.511; Niu XW, 2002, P NATL ACAD SCI USA, V99, P11441, DOI 10.1073/pnas.172254699; Pantazis A, 2010, J GEN PHYSIOL, V136, P645, DOI 10.1085/jgp.201010503; Pantazis A, 2010, P NATL ACAD SCI USA, V107, P4459, DOI 10.1073/pnas.0911959107; Piper DR, 2008, CELL PHYSIOL BIOCHEM, V21, P37, DOI 10.1159/000113745; Roosild TP, 2004, TRENDS BIOCHEM SCI, V29, P39, DOI 10.1016/j.tibs.2003.11.008; Rothberg BS, 2000, J GEN PHYSIOL, V116, P75, DOI 10.1085/jgp.116.1.75; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Savalli N, 2007, J GEN PHYSIOL, V130, P117, DOI 10.1085/jgp.200709803; Savalli N, 2006, P NATL ACAD SCI USA, V103, P12619, DOI 10.1073/pnas.0601176103; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; SHEN KZ, 1994, PFLUG ARCH EUR J PHY, V426, P440, DOI 10.1007/BF00388308; Sheng JZ, 2005, BIOPHYS J, V89, P3079, DOI 10.1529/biophysj.105.063610; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Stefani E, 1998, METHOD ENZYMOL, V293, P300; Stefani E, 1997, P NATL ACAD SCI USA, V94, P5427, DOI 10.1073/pnas.94.10.5427; Sun XP, 2004, J PHYSIOL-LONDON, V557, P207, DOI 10.1113/jphysiol.2003.060509; Sweet TB, 2008, J GEN PHYSIOL, V132, P491, DOI 10.1085/jgp.200810094; Sy T, 2010, NEUROSCIENCE, V165, P715, DOI 10.1016/j.neuroscience.2009.11.003; Taraska JW, 2007, NAT STRUCT MOL BIOL, V14, P854, DOI 10.1038/nsmb1281; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Wallner M, 1995, RECEPTOR CHANNEL, V3, P185; Wu RS, 2010, KIDNEY INT, V78, P963, DOI 10.1038/ki.2010.325; Wu YK, 2010, NATURE, V466, P393, DOI 10.1038/nature09252; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Yang HH, 2008, NAT STRUCT MOL BIOL, V15, P1152, DOI 10.1038/nsmb.1507; Yang JQ, 2010, NEURON, V66, P871, DOI 10.1016/j.neuron.2010.05.009; Yuan P, 2012, NATURE, V481, P94, DOI 10.1038/nature10670; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Yusifov T, 2008, P NATL ACAD SCI USA, V105, P376, DOI 10.1073/pnas.0705261105; Yusifov T, 2010, J GEN PHYSIOL, V136, P189, DOI 10.1085/jgp.200910374; Zandany N, 2008, P NATL ACAD SCI USA, V105, P11697, DOI 10.1073/pnas.0804104105; Zeng XH, 2005, J GEN PHYSIOL, V125, P273, DOI 10.1085/jgp.200409239; Zhang GH, 2010, P NATL ACAD SCI USA, V107, P18700, DOI 10.1073/pnas.1010124107	68	30	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21741	21750		10.1074/jbc.M112.346171	http://dx.doi.org/10.1074/jbc.M112.346171			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22556415	Green Published, hybrid			2022-12-25	WOS:000306418600015
J	Zhang, Y; Xie, RL; Gordon, J; LeBlanc, K; Stein, JL; Lian, JB; van Wijnen, AJ; Stein, GS				Zhang, Ying; Xie, Rong-lin; Gordon, Jonathan; LeBlanc, Kimberly; Stein, Janet L.; Lian, Jane B.; van Wijnen, Andre J.; Stein, Gary S.			Control of Mesenchymal Lineage Progression by MicroRNAs Targeting Skeletal Gene Regulators Trps1 and Runx2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLAST DIFFERENTIATION; EXPRESSION; IDENTIFICATION; PROLIFERATION; MUTATIONS; NETWORK; CHONDROGENESIS; TRANSCRIPTION; CHONDROCYTES; APOPTOSIS	Multiple microRNAs (miRNAs) that target the osteogenic Runt-related transcription factor 2 (RUNX2) define an interrelated network of miRNAs that control osteoblastogenesis. We addressed whether these miRNAs have functional targets beyond RUNX2 that coregulate skeletal development. Here, we find that seven RUNX2-targeting miRNAs (miR-23a, miR-30c, miR-34c, miR-133a, miR-135a, miR-205, and miR-217) also regulate the chondrogenic GATA transcription factor tricho-rhino-phalangeal syndrome I (TRPS1). Although the efficacy of each miRNA to target RUNX2 or TRPS1 differs in osteoblasts and chondrocytes, each effectively blocks maturation of pre-committed osteoblasts and chondrocytes. Furthermore, these miRNAs can redirect mesenchymal stem cells into adipogenic cell fate with concomitant up-regulation of key lineage-specific transcription factors. Thus, a program of multiple miRNAs controls mesenchymal lineage progression by selectively blocking differentiation of osteoblasts and chondrocytes to control skeletal development.	[Stein, Gary S.] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; [Stein, Gary S.] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Stein, GS (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol, 55 Lake Ave N, Worcester, MA 01655 USA.	gary.stein@umassmed.edu	van Wijnen, Andre J./AAG-3578-2019; Gordon, Jonathan/B-3904-2016	van Wijnen, Andre J./0000-0002-4458-0946; Gordon, Jonathan/0000-0003-2644-696X	National Institutes of Health [R01 AR039588, R01 AR049069, R37 DE012528]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039588, R01AR049069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE012528] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR039588 (to G. S. S. and J. B. L.), R01 AR049069 (to A. v. W.), and R37 DE012528 (to J. B. L.).	Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Augello A, 2010, HUM GENE THER, V21, P1226, DOI 10.1089/hum.2010.173; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Furumatsu T, 2005, J BIOL CHEM, V280, P35203, DOI 10.1074/jbc.M502409200; Gaur T, 2010, DEV BIOL, V340, P10, DOI 10.1016/j.ydbio.2010.01.008; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Hassan MQ, 2010, P NATL ACAD SCI USA, V107, P19879, DOI 10.1073/pnas.1007698107; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; Itoh S, 2008, GENES CELLS, V13, P355, DOI 10.1111/j.1365-2443.2008.01170.x; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jones SW, 2009, OSTEOARTHR CARTILAGE, V17, P464, DOI 10.1016/j.joca.2008.09.012; Kanno S, 2011, EXP MOL PATHOL, V90, P143, DOI 10.1016/j.yexmp.2010.11.010; Kapinas K, 2010, J BIOL CHEM, V285, P25221, DOI 10.1074/jbc.M110.116137; Kelly DJ, 2010, BIRTH DEFECTS RES C, V90, P75, DOI 10.1002/bdrc.20173; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Komori T, 2011, J CELL BIOCHEM, V112, P750, DOI 10.1002/jcb.22994; Lengner CJ, 2004, J CELL PHYSIOL, V200, P327, DOI 10.1002/jcp.20118; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Miraoui H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3146re9; Momeni P, 2000, NAT GENET, V24, P71, DOI 10.1038/71717; Nakamura Y, 2009, INT J CANCER, V125, P1859, DOI 10.1002/ijc.24538; Napierala D, 2005, MOL GENET METAB, V86, P257, DOI 10.1016/j.ymgme.2005.07.012; Napierala D, 2008, HUM MOL GENET, V17, P2244, DOI 10.1093/hmg/ddn125; Oskowitz AZ, 2008, P NATL ACAD SCI USA, V105, P18372, DOI 10.1073/pnas.0809807105; Piccione M, 2009, AM J MED GENET A, V149A, P1837, DOI 10.1002/ajmg.a.32952; Piscopo DM, 2009, J BIOL CHEM, V284, P31690, DOI 10.1074/jbc.M109.052316; Qiao B, 2005, J BIOL CHEM, V280, P17562, DOI 10.1074/jbc.M500646200; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Rozenblum E, 2002, HUM GENET, V110, P111, DOI 10.1007/s00439-001-0646-6; Shi S, 2009, J BIOL CHEM, V284, P6697, DOI 10.1074/jbc.M807859200; Stricker S, 2002, DEV BIOL, V245, P95, DOI 10.1006/dbio.2002.0640; Suda S, 2006, BIOCHEM BIOPH RES CO, V344, P246, DOI 10.1016/j.bbrc.2006.03.138; Suemoto H, 2007, DEV BIOL, V312, P572, DOI 10.1016/j.ydbio.2007.10.001; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang T, 2010, BIOCHEM BIOPH RES CO, V402, P186, DOI 10.1016/j.bbrc.2010.08.031; Wuelling M, 2010, PEDIATR NEPHROL, V25, P625, DOI 10.1007/s00467-009-1368-6; Wuelling M, 2009, DEV BIOL, V328, P40, DOI 10.1016/j.ydbio.2009.01.012; Xu JA, 2011, NUCLEIC ACIDS RES, V39, P825, DOI 10.1093/nar/gkq832; Yekta S, 2008, NAT REV GENET, V9, P789, DOI 10.1038/nrg2400; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P9863, DOI 10.1073/pnas.1018493108	45	90	97	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21926	21935		10.1074/jbc.M112.340398	http://dx.doi.org/10.1074/jbc.M112.340398			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22544738	Green Published, hybrid			2022-12-25	WOS:000306418600032
J	Khan, MJ; Alam, MR; Waldeck-Weiermair, M; Karsten, F; Groschner, L; Riederer, M; Hallstrom, S; Rockenfeller, P; Konya, V; Heinemann, A; Madeo, F; Graier, WF; Malli, R				Khan, Muhammad Jadoon; Alam, Muhammad Rizwan; Waldeck-Weiermair, Markus; Karsten, Felix; Groschner, Lukas; Riederer, Monika; Hallstroem, Seth; Rockenfeller, Patrick; Konya, Viktoria; Heinemann, Akos; Madeo, Frank; Graier, Wolfgang F.; Malli, Roland			Inhibition of Autophagy Rescues Palmitic Acid-induced Necroptosis of Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; FATTY-ACIDS; PROGRAMMED NECROSIS; DEATH MECHANISMS; APOPTOSIS; CALCIUM; PROTEIN; BETA; DEGRADATION; MOTILITY	Accumulation of palmitic acid (PA) in cells from nonadipose tissues is known to induce lipotoxicity resulting in cellular dysfunction and death. The exact molecular pathways of PA-induced cell death are still mysterious. Here, we show that PA triggers autophagy, which did not counteract but in contrast promoted endothelial cell death. The PA-induced cell death was predominantly necrotic as indicated by annexin V and propidium iodide (PI) staining, absence of caspase activity, low levels of DNA hypoploidy, and an early ATP depletion. In addition PA induced a strong elevation of mRNA levels of ubiquitin carboxyl-terminalhydrolase(CYLD), aknownmediatorofnecroptosis. Moreover, siRNA-mediated knockdown of CYLD significantly antagonized PA-induced necrosis of endothelial cells. In contrast, inhibition and knockdown of receptor interacting protein kinase 1 (RIPK1) had no effect on PA-induced necrosis, indicating the induction of a CYLD-dependent but RIPK1-independent cell death pathway. PA was recognized as a strong and early inducer of autophagy. The inhibition of autophagy by both pharmacological inhibitors and genetic knockdown of the autophagy-specific genes, vacuolar protein sorting 34 (VPS34), and autophagy-related protein 7 (ATG7), could rescue the PA-induced death of endothelial cells. Moreover, the initiation of autophagy and cell death by PA was reduced in endothelial cells loaded with the Ca2+ chelator 1,2-bis(o-aminophenoxy) ethane-N,N,N',N'-tetraacetic acid-(acetoxymethyl) ester (BAPTA-AM), indicating that Ca2+ triggers the fatal signaling of PA. In summary, we introduce an unexpected mechanism of lipotoxicity in endothelial cells and provide several novel strategies to counteract the lipotoxic signaling of PA.	[Khan, Muhammad Jadoon; Alam, Muhammad Rizwan; Waldeck-Weiermair, Markus; Karsten, Felix; Groschner, Lukas; Riederer, Monika; Graier, Wolfgang F.; Malli, Roland] Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, A-8010 Graz, Austria; [Hallstroem, Seth] Med Univ Graz, Ctr Physiol Med, Inst Physiol Chem, A-8010 Graz, Austria; [Konya, Viktoria; Heinemann, Akos] Med Univ Graz, Inst Expt & Clin Pharmacol, Ctr Mol Med, A-8010 Graz, Austria; [Rockenfeller, Patrick; Madeo, Frank] Graz Univ, Ctr Mol Biosci, A-8010 Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz; University of Graz	Malli, R (corresponding author), Harrachgasse 21-3, Graz, Austria.	roland.malli@medunigraz.at	Groschner, Lukas/J-9398-2012; Khan, Muhammad Jadoon/AAG-5484-2019; Waldeck-Weiermair, Markus/AAV-5193-2020; Groschner, Lukas/AHD-6319-2022; Graier, Wolfgang F./B-7052-2008; Alam, Muhammad Rizwan/AAE-2266-2019	Groschner, Lukas/0000-0002-4325-0232; Waldeck-Weiermair, Markus/0000-0002-5792-6766; Groschner, Lukas/0000-0002-4325-0232; Graier, Wolfgang F./0000-0003-1871-3298; Alam, Muhammad Rizwan/0000-0002-1578-5723; Malli, Roland/0000-0001-6327-8729; Rockenfeller, Patrick/0000-0002-1643-3885; Konya, Viktoria/0000-0002-7999-9093; Madeo, Frank/0000-0002-5070-1329; Heinemann, Akos/0000-0002-8554-2372	Austrian Science Fund (FWF) [F3010-B05 (SFB LIPOTOX), P21857-B18, P22553-B18, P23490]; FWF at Medical University of Graz; Austrian Science Fund (FWF) [P 21857, P 23490, P 22553, P 22521] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); FWF at Medical University of Graz; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by Austrian Science Fund (FWF) Grants F3010-B05 (SFB LIPOTOX), P21857-B18, P22553-B18, and P23490.; Supported by the FWF within the Molecular Medicine and Neuroscience Ph.D. programs at the Medical University of Graz.	Almaguel FG, 2010, BRAIN RES, V1318, P133, DOI 10.1016/j.brainres.2009.12.038; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Borradaile NA, 2005, CURR HYPERTENS REP, V7, P412, DOI 10.1007/s11906-005-0035-y; Brookheart RT, 2009, CELL METAB, V10, P9, DOI 10.1016/j.cmet.2009.03.011; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Choi SE, 2009, ENDOCRINOLOGY, V150, P126, DOI 10.1210/en.2008-0483; Csordas A, 2011, CARDIOVASC RES, V92, P141, DOI 10.1093/cvr/cvr165; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Esenabhalu VE, 2003, ANTIOXID REDOX SIGN, V5, P147, DOI 10.1089/152308603764816505; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; Fu M, 2011, CELL DEATH DIFFER, V18, P1057, DOI 10.1038/cdd.2010.181; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gao P, 2010, J BIOL CHEM, V285, P25570, DOI 10.1074/jbc.M110.118125; Grotemeier A, 2010, CELL SIGNAL, V22, P914, DOI 10.1016/j.cellsig.2010.01.015; Gwiazda KS, 2009, AM J PHYSIOL-ENDOC M, V296, pE690, DOI 10.1152/ajpendo.90525.2008; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Ilangovan R, 2003, J BIOL CHEM, V278, P30993, DOI 10.1074/jbc.M303763200; Johnson VL, 2000, J CELL SCI, V113, P2941; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kristensen AR, 2008, MOL CELL PROTEOMICS, V7, P2419, DOI 10.1074/mcp.M800184-MCP200; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Las G, 2011, J BIOL CHEM, V286, P42534, DOI 10.1074/jbc.M111.242412; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Mayer CM, 2010, ENDOCRINOLOGY, V151, P576, DOI 10.1210/en.2009-1122; Mei S, 2011, J PHARMACOL EXP THER, V339, P487, DOI 10.1124/jpet.111.184341; Meyers Melissa R, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P365, DOI 10.1097/MED.0b013e3282be90a8; Naghdi S, 2010, J CELL SCI, V123, P2553, DOI 10.1242/jcs.070151; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Pfaffenbach KT, 2010, AM J PHYSIOL-ENDOC M, V298, pE1027, DOI 10.1152/ajpendo.00642.2009; Ricchi M, 2009, J GASTROEN HEPATOL, V24, P830, DOI 10.1111/j.1440-1746.2008.05733.x; Rockenfeller P, 2010, CELL CYCLE, V9, P2836, DOI 10.4161/cc.9.14.12346; Roh MS, 2004, APOPTOSIS, V9, P583, DOI 10.1023/B:APPT.0000038037.68908.6e; Samara C, 2008, CELL DEATH DIFFER, V15, P105, DOI 10.1038/sj.cdd.4402231; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shcherbo D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-24; Stegmeier F, 2007, P NATL ACAD SCI USA, V104, P8869, DOI 10.1073/pnas.0703268104; Tait SWG, 2008, ONCOGENE, V27, P6452, DOI 10.1038/onc.2008.311; Tsujimoto Y, 1997, CELL DEATH DIFFER, V4, P429, DOI 10.1038/sj.cdd.4400262; Unger RH, 2001, DIABETES, V50, pS118, DOI 10.2337/diabetes.50.2007.S118; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vanlangenakker N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.111; Yuan JY, 2010, GENE DEV, V24, P2592, DOI 10.1101/gad.1984410; Zhivotovsky B, 2011, CELL CALCIUM, V50, P211, DOI 10.1016/j.ceca.2011.03.003	46	98	100	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21110	21120		10.1074/jbc.M111.319129	http://dx.doi.org/10.1074/jbc.M111.319129			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22556413	hybrid, Green Published			2022-12-25	WOS:000306416800032
J	Laviad, EL; Kelly, S; Merrill, AH; Futerman, AH				Laviad, Elad L.; Kelly, Samuel; Merrill, Alfred H., Jr.; Futerman, Anthony H.			Modulation of Ceramide Synthase Activity via Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED APOPTOSIS; SPHINGOLIPID METABOLISM; (DIHYDRO)CERAMIDE SYNTHASE; SUBSTRATE-SPECIFICITY; QUANTITATIVE-ANALYSIS; FAMILY-MEMBERS; CELLS; COA; ACCUMULATION; MECHANISM	Ceramide, the backbone of all sphingolipids, is synthesized by a family of ceramide synthases (CerS) that each use acyl-CoAs of defined chain length for N-acylation of the sphingoid long chain base. CerS mRNA expression and enzymatic activity do not always correlate with the sphingolipid acyl chain composition of a particular tissue, suggesting post-translational mechanism(s) of regulation of CerS activity. We now demonstrate that CerS activity can be modulated by dimer formation. Under suitable conditions, high M-r CerS complexes can be detected by Western blotting, and various CerS co-immunoprecipitate. CerS5 activity is inhibited in a dominant-negative fashion by co-expression with catalytically inactive CerS5, and CerS2 activity is enhanced by co-expression with a catalytically active form of CerS5 or CerS6. In a constitutive heterodimer comprising CerS5 and CerS2, the activity of CerS2 depends on the catalytic activity of CerS5. Finally, CerS dimers are formed upon rapid stimulation of ceramide synthesis by curcumin. Together, these data demonstrate that ceramide synthesis can be regulated by the formation of CerS dimers and suggest a novel way to generate the acyl chain composition of ceramide (and downstream sphingolipids), which may depend on the interaction of CerS with each other.	[Laviad, Elad L.; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Kelly, Samuel; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Kelly, Samuel; Merrill, Alfred H., Jr.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	Weizmann Institute of Science; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Futerman, AH (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tony.futerman@weizmann.ac.il		Futerman, Anthony/0000-0003-0013-0115; Merrill, Alfred/0000-0002-6673-968X	National Institutes of Health [GM076217]; Israel Science Foundation [1404/07]; Minerva Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); Minerva Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM076217. This work was also supported by the Israel Science Foundation (1404/07) and the Minerva Foundation.	Basnakian AG, 2005, AM J PHYSIOL-RENAL, V288, pF308, DOI 10.1152/ajprenal.00204.2004; Ben-David O, 2011, J BIOL CHEM, V286, P30022, DOI 10.1074/jbc.M111.261206; Blazquez C, 2000, FASEB J, V14, P2315, DOI 10.1096/fj.00-0122com; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Denic V, 2007, CELL, V130, P663, DOI 10.1016/j.cell.2007.06.031; FOLCH J, 1957, J BIOL CHEM, V226, P497; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hilchie AL, 2010, NUTR CANCER, V62, P379, DOI 10.1080/01635580903441238; HIRSCHBERG K, 1993, BIOCHEM J, V290, P751, DOI 10.1042/bj2900751; Jenkins GM, 2002, J BIOL CHEM, V277, P42572, DOI 10.1074/jbc.M207346200; Kageyama-Yahara N, 2006, BIOCHEM J, V398, P585, DOI 10.1042/BJ20060697; Lahiri S, 2007, CELL MOL LIFE SCI, V64, P2270, DOI 10.1007/s00018-007-7076-0; Lahiri S, 2005, J BIOL CHEM, V280, P33735, DOI 10.1074/jbc.M506485200; Lahiri S, 2007, FEBS LETT, V581, P5289, DOI 10.1016/j.febslet.2007.10.018; Lahiri S, 2009, J BIOL CHEM, V284, P16090, DOI 10.1074/jbc.M807438200; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Liao WC, 1999, J BIOL CHEM, V274, P17908, DOI 10.1074/jbc.274.25.17908; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Mesika A, 2007, J BIOL CHEM, V282, P27366, DOI 10.1074/jbc.M703487200; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Mondal MS, 2001, FEBS LETT, V489, P14, DOI 10.1016/S0014-5793(00)02428-5; Moussavi M, 2006, CARCINOGENESIS, V27, P1636, DOI 10.1093/carcin/bgi371; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Mullen TD, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230870; Mullen TD, 2011, J LIPID RES, V52, P68, DOI 10.1194/jlr.M009142; Panjarian S, 2008, PROSTAG OTH LIPID M, V86, P41, DOI 10.1016/j.prostaglandins.2008.02.004; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Sridevi P, 2009, BBA-MOL CELL RES, V1793, P1218, DOI 10.1016/j.bbamcr.2009.04.006; Sullards M C, 2001, Sci STKE, V2001, ppl1; Tidhar R, 2012, J BIOL CHEM, V287, P3197, DOI 10.1074/jbc.M111.280271; Vallee B, 2005, EMBO J, V24, P730, DOI 10.1038/sj.emboj.7600562; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Yu J, 2007, J BIOL CHEM, V282, P25940, DOI 10.1074/jbc.M701812200; Zhao LH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002063	43	72	72	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21025	21033		10.1074/jbc.M112.363580	http://dx.doi.org/10.1074/jbc.M112.363580			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22539345	Green Published, hybrid			2022-12-25	WOS:000306416800024
J	Tran, DT; Lim, JM; Liu, M; Stalnaker, SH; Wells, L; Ten Hagen, KG; Live, D				Tran, Duy T.; Lim, Jae-Min; Liu, Mian; Stalnaker, Stephanie H.; Wells, Lance; Ten Hagen, Kelly G.; Live, David			Glycosylation of alpha-Dystroglycan O-MANNOSYLATION INFLUENCES THE SUBSEQUENT ADDITION OF GalNAc BY UDP-GalNAc POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NEIGHBORING RESIDUE GLYCOSYLATION; ELECTRON-TRANSFER DISSOCIATION; RABBIT SKELETAL-MUSCLE; LAMININ-BINDING; DROSOPHILA-MELANOGASTER; CONSECUTIVE THREONINES; MUSCULAR-DYSTROPHY; GLYCAN STRUCTURES	O-Linked glycosylation is a functionally and structurally diverse type of protein modification present in many tissues and across many species. alpha-Dystroglycan (alpha-DG), a protein linked to the extracellular matrix, whose glycosylation status is associated with human muscular dystrophies, displays two predominant types of O-glycosylation, O-linked mannose (O-Man) and O-linked N-acetylgalactosamine (O-GalNAc), in its highly conserved mucin-like domain. The O-Man is installed by an enzyme complex present in the endoplasmic reticulum. O-GalNAc modifications are initiated subsequently in the Golgi apparatus by the UDP-GalNAc polypeptide N-acetylgalactosaminyltransferase (ppGalNAc-T) enzymes. How the presence and position of O-Man influences the action of the ppGalNAc-Ts on alpha-DG and the distribution of the two forms of glycosylation in this domain is not known. Here, we investigated the interplay between O-Man and the addition of O-GalNAc by examining the activity of the ppGalNAc-Ts on peptides and O-Man-containing glycopeptides mimicking those found in native alpha-DG. These synthetic glycopeptides emulate intermediate structures, not otherwise readily available from natural sources. Through enzymatic and mass spectrometric methods, we demonstrate that the presence and specific location of O-Man can impact either the regional exclusion or the site of O-GalNAc addition on alpha-DG, elucidating the factors contributing to the glycosylation patterns observed in vivo. These results provide evidence that one form of glycosylation can influence another form of glycosylation in alpha-DG and suggest that in the absence of proper O-mannosylation, as is associated with certain forms of muscular dystrophy, aberrant O-GalNAc modifications may occur and could play a role in disease presentation.	[Tran, Duy T.; Ten Hagen, Kelly G.] NIDCR, Dev Glycobiol Unit, NIH, Bethesda, MD 20892 USA; [Lim, Jae-Min; Liu, Mian; Stalnaker, Stephanie H.; Wells, Lance; Live, David] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University System of Georgia; University of Georgia	Ten Hagen, KG (corresponding author), Bldg 30,Rm 426,30 Convent Dr,MSC4370, Bethesda, MD 20892 USA.	Kelly.Tenhagen@nih.gov; dlive@ccrc.uga.edu	Wells, Lance/H-3118-2013	Wells, Lance/0000-0003-4956-5363	National Institutes of Health [R21AR056055, R01GM066148]; Resource for Integrated Glycotechnology Grant [P41GM103390]; Integrated Technology Resource for Biomedical Glycomics Grant [P41GM103490]; NIDCR at the National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR056055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390, P41GM103490, R01GM066148] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Resource for Integrated Glycotechnology Grant; Integrated Technology Resource for Biomedical Glycomics Grant; NIDCR at the National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21AR056055 and R01GM066148 and Resource for Integrated Glycotechnology Grant P41GM103390 (to D. L.), Integrated Technology Resource for Biomedical Glycomics Grant P41GM103490 (to L. W.), and by the Intramural Research Program of NIDCR at the National Institutes of Health (to K. T. H.).	Aguilan JT, 2009, GLYCOBIOLOGY, V19, P971, DOI 10.1093/glycob/cwp074; ALBONE EF, 1994, J BIOL CHEM, V269, P16845; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Borgert A., 2012, ACS CHEM BI IN PRESS; BRANCACCIO A, 1995, FEBS LETT, V368, P139, DOI 10.1016/0014-5793(95)00628-M; Breloy I, 2008, J BIOL CHEM, V283, P18832, DOI 10.1074/jbc.M802834200; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Chai WG, 1999, EUR J BIOCHEM, V263, P879, DOI 10.1046/j.1432-1327.1999.00572.x; Coltart DM, 2002, J AM CHEM SOC, V124, P9833, DOI 10.1021/ja020208f; Gerken TA, 2004, BIOCHEMISTRY-US, V43, P9888, DOI 10.1021/bi049178e; Gerken TA, 2002, J BIOL CHEM, V277, P49850, DOI 10.1074/jbc.M205851200; Gerken TA, 2011, J BIOL CHEM, V286, P14493, DOI 10.1074/jbc.M111.218701; Gill DJ, 2010, J CELL BIOL, V189, P843, DOI 10.1083/jcb.201003055; Godfrey C, 2011, CURR OPIN GENET DEV, V21, P278, DOI 10.1016/j.gde.2011.02.001; Hagen FK, 1997, J BIOL CHEM, V272, P13843, DOI 10.1074/jbc.272.21.13843; HAGEN FK, 1993, J BIOL CHEM, V268, P18960; Hara Y, 2011, P NATL ACAD SCI USA, V108, P17426, DOI 10.1073/pnas.1114836108; Harrison R, 2012, GLYCOBIOLOGY, V22, P662, DOI 10.1093/glycob/cws002; Kato K, 2001, BIOCHEM BIOPH RES CO, V287, P110, DOI 10.1006/bbrc.2001.5562; Kojima K, 2011, KIDNEY INT, V79, P311, DOI 10.1038/ki.2010.403; Kunz S, 2004, VIROLOGY, V325, P207, DOI 10.1016/j.virol.2004.04.044; Liu MA, 2008, BIOPOLYMERS, V90, P358, DOI 10.1002/bip.20847; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Mo KF, 2011, J AM CHEM SOC, V133, P14418, DOI 10.1021/ja205473q; Moore CJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-3; Moore C, 2009, GLYCOCONJUGATE J, V26, P349, DOI 10.1007/s10719-008-9182-0; Nakamura N, 2010, SEMIN CELL DEV BIOL, V21, P622, DOI 10.1016/j.semcdb.2010.03.010; Nilsson J, 2010, GLYCOBIOLOGY, V20, P1160, DOI 10.1093/glycob/cwq082; Oldstone MBA, 2011, VIROLOGY, V411, P170, DOI 10.1016/j.virol.2010.11.023; OTTENHOFFKALFF AE, 1992, CANCER RES, V52, P4773; Patnaik SK, 2005, J BIOL CHEM, V280, P20851, DOI 10.1074/jbc.M500069200; Perrine CL, 2009, J BIOL CHEM, V284, P20387, DOI 10.1074/jbc.M109.017236; Raman J, 2008, J BIOL CHEM, V283, P22942, DOI 10.1074/jbc.M803387200; Raman J, 2012, GLYCOBIOLOGY, V22, P768, DOI 10.1093/glycob/cwr183; Sasaki T, 1998, BBA-GEN SUBJECTS, V1425, P599, DOI 10.1016/S0304-4165(98)00114-7; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; Shimojo H, 2011, PROSTATE, V71, P1151, DOI 10.1002/pros.21330; Singh J, 2004, CANCER RES, V64, P6152, DOI 10.1158/0008-5472.CAN-04-1638; Stalnaker SH, 2011, J BIOL CHEM, V286, P21180, DOI 10.1074/jbc.M110.203281; Stalnaker SH, 2010, J BIOL CHEM, V285, P24882, DOI 10.1074/jbc.M110.126474; Tabak LA, 2010, SEMIN CELL DEV BIOL, V21, P616, DOI 10.1016/j.semcdb.2010.02.001; Takeuchi H, 2002, EUR J BIOCHEM, V269, P6173, DOI 10.1046/j.1432-1033.2002.03334.x; Ten Hagen BG, 1998, J BIOL CHEM, V273, P27749; Ten Hagen KG, 2002, J BIOL CHEM, V277, P22616, DOI 10.1074/jbc.M201807200; Ten Hagen KG, 1999, J BIOL CHEM, V274, P27867; Ten Hagen KG, 2003, J BIOL CHEM, V278, P35039, DOI 10.1074/jbc.M303836200; Ten Hagen KG, 2001, J BIOL CHEM, V276, P17395, DOI 10.1074/jbc.M009638200; Tian E, 2007, GLYCOBIOLOGY, V17, P820, DOI 10.1093/glycob/cwm056; Tian E, 2009, GLYCOCONJUGATE J, V26, P325, DOI 10.1007/s10719-008-9162-4; Wang ZH, 2010, MOL CELL PROTEOMICS, V9, P153, DOI 10.1074/mcp.M900268-MCP200; WHITE T, 1995, J BIOL CHEM, V270, P24156, DOI 10.1074/jbc.270.41.24156; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512; Zara J, 1996, BIOCHEM BIOPH RES CO, V228, P38, DOI 10.1006/bbrc.1996.1613; Zhang LP, 2010, J BIOL CHEM, V285, P19491, DOI 10.1074/jbc.M109.098145; Zhao P, 2011, J PROTEOME RES, V10, P4088, DOI 10.1021/pr2002726	57	15	16	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20967	20974		10.1074/jbc.M112.370387	http://dx.doi.org/10.1074/jbc.M112.370387			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22549772	hybrid, Green Published			2022-12-25	WOS:000306416800018
J	Villota, C; Campos, A; Vidaurre, S; Oliveira-Cruz, L; Boccardo, E; Burzio, VA; Varas, M; Villegas, J; Villa, LL; Valenzuela, PDT; Socias, M; Roberts, S; Burzio, LO				Villota, Claudio; Campos, America; Vidaurre, Soledad; Oliveira-Cruz, Luciana; Boccardo, Enrique; Burzio, Veronica A.; Varas, Manuel; Villegas, Jaime; Villa, Luisa L.; Valenzuela, Pablo D. T.; Socias, Miguel; Roberts, Sally; Burzio, Luis O.			Expression of Mitochondrial Non-coding RNAs (ncRNAs) Is Modulated by High Risk Human Papillomavirus (HPV) Oncogenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; TUMOR-SUPPRESSOR; E2 PROTEIN; TRANSGENIC MICE; TYPE-16 E7; CANCER; GENES; TELOMERASE; SUFFICIENT; MICRORNA	The study of RNA and DNA oncogenic viruses has proved invaluable in the discovery of key cellular pathways that are rendered dysfunctional during cancer progression. An example is high risk human papillomavirus (HPV), the etiological agent of cervical cancer. The role of HPV oncogenes in cellular immortalization and transformation has been extensively investigated. We reported the differential expression of a family of human mitochondrial non-coding RNAs (ncRNAs) between normal and cancer cells. Normal cells express a sense mitochondrial ncRNA (SncmtRNA) that seems to be required for cell proliferation and two antisense transcripts (ASncmtRNAs). In contrast, the ASncmtRNAs are down-regulated in cancer cells. To shed some light on the mechanisms that trigger down-regulation of the ASncmtRNAs, we studied human keratinocytes (HFK) immortalized with HPV. Here we show that immortalization of HFK with HPV-16 or 18 causes down-regulation of the ASncmtRNAs and induces the expression of a new sense transcript named SncmtRNA-2. Transduction of HFK with both E6 and E7 is sufficient to induce expression of SncmtRNA-2. Moreover, E2 oncogene is involved in down-regulation of the ASncmtRNAs. Knockdown of E2 in immortalized cells reestablishes in a reversible manner the expression of the ASncmtRNAs, suggesting that endogenous cellular factors(s) could play functions analogous to E2 during non-HPV-induced oncogenesis.	[Villota, Claudio; Campos, America; Vidaurre, Soledad; Oliveira-Cruz, Luciana; Burzio, Veronica A.; Varas, Manuel; Villegas, Jaime; Valenzuela, Pablo D. T.; Burzio, Luis O.] Andes Biotechnol SA, Santiago 8370146, Chile; [Villota, Claudio; Campos, America; Vidaurre, Soledad; Oliveira-Cruz, Luciana; Burzio, Veronica A.; Varas, Manuel; Villegas, Jaime; Valenzuela, Pablo D. T.; Burzio, Luis O.] Fdn Ciencia Vida, Santiago 8370146, Chile; [Villota, Claudio; Campos, America; Vidaurre, Soledad; Burzio, Veronica A.; Varas, Manuel; Villegas, Jaime; Burzio, Luis O.] Univ Andres Bello, Fac Ciencias Biol, Santiago 8370146, Chile; [Boccardo, Enrique; Villa, Luisa L.] Ludwig Inst Canc Res, BR-1323903 Sao Paulo, Brazil; [Boccardo, Enrique] Univ Sao Paulo, Dept Microbiol, Inst Ciencias Biomed, BR-05508900 Sao Paulo, Brazil; [Socias, Miguel] Clin Alemana, Santiago 7650567, Chile; [Roberts, Sally] Univ Birmingham, Canc Res UK Inst Canc Studies, Birmingham B15 2TT, W Midlands, England	Universidad Andres Bello; Ludwig Institute for Cancer Research; Universidade de Sao Paulo; Clinica Alemana; Cancer Research UK; University of Birmingham	Villota, C (corresponding author), Andes Biotechnol SA, Zanartu 1482, Santiago 8370146, Chile.	claudio.villota@gmail.com; lburzio@gmail.com	Villegas, Jaime/AAW-5938-2020; Roberts, Sally/N-6143-2014; Oliveira-Cruz, Luciana/N-7756-2014; VILLA, LUISA/AAH-4761-2019; Boccardo, Enrique/A-3960-2012	Roberts, Sally/0000-0003-4653-9442; VILLA, LUISA/0000-0003-4074-2335; Boccardo, Enrique/0000-0003-1900-0273; Varas-Godoy, Manuel/0000-0001-5857-4793; Villegas, Jaime/0000-0002-9556-4655	Fondecyt [11090060, 1085210, 1110835]; Fondef [D04I1338]; CCTE-PFB16 Program Grant; Conicyt, Chile; Universidad Andres Bello, Chile [DI-34-09/R, DI-31-09/R, DI-28-09/R4, DI-06-09/R]	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondef; CCTE-PFB16 Program Grant; Conicyt, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Universidad Andres Bello, Chile	This work was supported by Fondecyt Grants 11090060, 1085210, and 1110835; Fondef Grant D04I1338; CCTE-PFB16 Program Grant; Conicyt, Chile, and Universidad Andres Bello, Chile, Grants DI-34-09/R, DI-31-09/R, DI-28-09/R4, and DI-06-09/R.	Alvarez-Salas LM, 2003, ANTIVIR THER, V8, P265; BARBOSA MS, 1989, ONCOGENE, V4, P1529; Bellanger S, 2011, AM J CANCER RES, V1, P373; BERNARD BA, 1989, J VIROL, V63, P4317, DOI 10.1128/JVI.63.10.4317-4324.1989; Bischof O, 2005, MOL CELL BIOL, V25, P1013, DOI 10.1128/MCB.25.3.1013-1024.2005; Blachon S, 2005, J BIOL CHEM, V280, P36088, DOI 10.1074/jbc.M505138200; Boccardo E, 2010, CARCINOGENESIS, V31, P521, DOI 10.1093/carcin/bgp333; Burzio VA, 2009, P NATL ACAD SCI USA, V106, P9430, DOI 10.1073/pnas.0903086106; Cazalla D, 2010, SCIENCE, V328, P1563, DOI 10.1126/science.1187197; Chatterjee A, 2011, CANCER PREV RES, V4, P638, DOI 10.1158/1940-6207.CAPR-10-0326; Chen LL, 2010, CURR OPIN CELL BIOL, V22, P357, DOI 10.1016/j.ceb.2010.03.003; D'Agostino DM, 2005, ADV CANCER RES, V94, P87, DOI 10.1016/S0065-230X(05)94003-7; DOORBAR J, 1991, NATURE, V352, P824, DOI 10.1038/352824a0; Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Felty Q, 2005, ONCOGENE, V24, P4883, DOI 10.1038/sj.onc.1208667; GAINES G, 1984, MOL CELL BIOL, V4, P1605, DOI 10.1128/MCB.4.8.1605; Gewin L, 2001, J VIROL, V75, P7198, DOI 10.1128/JVI.75.15.7198-7201.2001; Guccione E, 2004, ONCOGENE, V23, P4662, DOI 10.1038/sj.onc.1207631; HALBERT CL, 1991, J VIROL, V65, P473, DOI 10.1128/JVI.65.1.473-478.1991; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HAWLEYNELSON P, 1989, EMBO J, V8, P3905, DOI 10.1002/j.1460-2075.1989.tb08570.x; Hellwig S, 2008, P NATL ACAD SCI USA, V105, P12897, DOI 10.1073/pnas.0805118105; Helt AM, 2001, J VIROL, V75, P6737, DOI 10.1128/JVI.75.15.6737-6747.2001; Hufbauer M, 2010, VIROLOGY, V403, P128, DOI 10.1016/j.virol.2010.04.013; Kapushoc ST, 1999, RNA, V5, P656, DOI 10.1017/S1355838299982250; Knight GL, 2011, VIROLOGY, V412, P196, DOI 10.1016/j.virol.2011.01.007; Kroemer G, 2006, ONCOGENE, V25, P4630, DOI 10.1038/sj.onc.1209589; Kruse B, 1995, Methods Mol Biol, V37, P179; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Landerer E, 2011, CELL ONCOL, V34, P297, DOI 10.1007/s13402-011-0018-8; Lee AY, 2009, J BIOL CHEM, V284, P2778, DOI 10.1074/jbc.M805835200; Lee D, 2002, J BIOL CHEM, V277, P27748, DOI 10.1074/jbc.M203706200; Lee SK, 2011, DISCOV MED, V11, P245; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Leykauf K, 2008, TRANSGENIC RES, V17, P1, DOI 10.1007/s11248-007-9130-y; Lin KY, 1996, CANCER RES, V56, P21; Liu QH, 2010, ANNU REV BIOCHEM, V79, P295, DOI 10.1146/annurev.biochem.052208.151733; Liu XF, 2008, VIROLOGY, V375, P611, DOI 10.1016/j.virol.2008.02.025; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; MCBRIDE AA, 1991, J BIOL CHEM, V266, P18411; McBride AA, 2006, CELL CYCLE, V5, P1499, DOI 10.4161/cc.5.14.3094; McLaughlin-Drubin ME, 2008, BBA-MOL BASIS DIS, V1782, P127, DOI 10.1016/j.bbadis.2007.12.005; McLaughlin-Drubin ME, 2009, VIRUS RES, V143, P195, DOI 10.1016/j.virusres.2009.06.008; Payne SR, 2005, CARCINOGENESIS, V26, P2031, DOI 10.1093/carcin/bgi223; Pfefferle R, 2008, J INVEST DERMATOL, V128, P2310, DOI 10.1038/jid.2008.73; Raj K, 2004, J VIROL, V78, P7199, DOI 10.1128/JVI.78.13.7199-7207.2004; Ramirez-Salazar E, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-247; Rogers K, 2007, J BIOL CHEM, V282, P29073, DOI 10.1074/jbc.M704551200; ROMANCZUK H, 1990, J VIROL, V64, P2849, DOI 10.1128/JVI.64.6.2849-2859.1990; ROMANCZUK H, 1991, J VIROL, V65, P2739, DOI 10.1128/JVI.65.5.2739-2744.1991; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Simpson L, 2004, RNA, V10, P159, DOI 10.1261/rna.5170704; Sligh JE, 2000, P NATL ACAD SCI USA, V97, P14461, DOI 10.1073/pnas.250491597; Smith JA, 2010, P NATL ACAD SCI USA, V107, P3752, DOI 10.1073/pnas.0914818107; Steger G, 1997, J VIROL, V71, P50, DOI 10.1128/JVI.71.1.50-58.1997; Swindle CS, 1999, J VIROL, V73, P1001, DOI 10.1128/JVI.73.2.1001-1009.1999; Villegas J, 2002, NUCLEIC ACIDS RES, V30, P1895, DOI 10.1093/nar/30.9.1895; Villegas J, 2007, NUCLEIC ACIDS RES, V35, P7336, DOI 10.1093/nar/gkm863; Wahid AM, 2008, J BIOL CHEM, V283, P17485, DOI 10.1074/jbc.M802300200; Wang QQ, 2004, MICROBIOL MOL BIOL R, V68, P432, DOI 10.1128/MMBR.68.3.432-452.2004; Webster K, 2000, J BIOL CHEM, V275, P87, DOI 10.1074/jbc.275.1.87; Xue YZ, 2010, CANCER RES, V70, P5316, DOI 10.1158/0008-5472.CAN-09-3789; YOUNG PG, 1975, BIOCHEM BIOPH RES CO, V65, P1201, DOI 10.1016/S0006-291X(75)80357-3; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	67	29	31	2	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21303	21315		10.1074/jbc.M111.326694	http://dx.doi.org/10.1074/jbc.M111.326694			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22539350	hybrid, Green Published			2022-12-25	WOS:000306416800049
J	Marongiu, MF; Poddie, D; Porcu, S; Manchinu, MF; Castelli, MP; Sogos, V; Bini, V; Frau, R; Caredda, E; Collu, M; Ristaldi, MS				Marongiu, Maria Franca; Poddie, Daniela; Porcu, Susanna; Manchinu, Maria Francesca; Castelli, Maria Paola; Sogos, Valeria; Bini, Valentina; Frau, Roberto; Caredda, Elisabetta; Collu, Maria; Ristaldi, Maria Serafina			Reversible Disruption of Pre-Pulse Inhibition in Hypomorphic-Inducible and Reversible CB1(-/-) Mice	PLOS ONE			English	Article							CANNABINOID RECEPTOR TRAFFICKING; PREPULSE INHIBITION; GATING DEFICITS; STARTLE REFLEX; CB1 RECEPTORS; MOUSE MODELS; CNR1 GENE; SCHIZOPHRENIA; SUSCEPTIBILITY; BRAIN	Although several genes are implicated in the pathogenesis of schizophrenia, in animal models for such a severe mental illness only some aspects of the pathology can be represented (endophenotypes). Genetically modified mice are currently being used to obtain or characterize such endophenotypes. Since its cloning and characterization CB1 receptor has increasingly become of significant physiological, pharmacological and clinical interest. Recently, its involvement in schizophrenia has been reported. Among the different approaches employed, gene targeting permits to study the multiple roles of the endocannabinoid system using knockout ((-/-)) mice represent a powerful model but with some limitations due to compensation. To overcome such a limitation, we have generated an inducible and reversible tet-off dependent tissue-specific CB1(-/-) mice where the CB1R is re-expressed exclusively in the forebrain at a hypomorphic level due to a mutation (IRh-CB1(-/-)) only in absence of doxycycline (Dox). In such mice, under Dox(+) or vehicle, as well as in wild-type (WT) and CB1(-/-), two endophenotypes motor activity (increased in animal models of schizophrenia) and pre-pulse inhibition (PPI) of startle reflex (disrupted in schizophrenia) were analyzed. Both CB1(-/-) and IRh-CB1(-/-) showed increased motor activity when compared to WT animals. The PPI response, unaltered in WT and CB1(-/-) animals, was on the contrary highly and significantly disrupted only in Dox(+) IRh-CB1(-/-) mice. Such a response was easily reverted after either withdrawal from Dox or haloperidol treatment. This is the first Inducible and Reversible CB1(-/-) mice model to be described in the literature. It is noteworthy that the PPI disruption is not present either in classical full CB1(-/-) mice or following acute administration of rimonabant. Such a hypomorphic model may provide a new tool for additional in vivo and in vitro studies of the physiological and pathological roles of cannabinoid system in schizophrenia and in other psychiatric disorders.	[Marongiu, Maria Franca; Poddie, Daniela; Porcu, Susanna; Manchinu, Maria Francesca; Ristaldi, Maria Serafina] Natl Res Council IRGB CNR, Inst Genet & Biomed Res, Monserrato, Italy; [Castelli, Maria Paola; Sogos, Valeria; Bini, Valentina; Frau, Roberto; Caredda, Elisabetta; Collu, Maria] Univ Cagliari, Dept Biomed Sci, Div Neurosci & Clin Pharmacol, Monserrato, Italy; [Castelli, Maria Paola; Collu, Maria] Univ Cagliari, Ctr Excellence Neurobiol Drug Dependence, Monserrato, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Cagliari; University of Cagliari	Marongiu, MF (corresponding author), Natl Res Council IRGB CNR, Inst Genet & Biomed Res, Monserrato, Italy.	mcollu@unica.it; ristaldi@inn.cnr.it	Ristaldi, Maria S/N-8549-2013; Collu, Maria/F-7113-2012; MARONGIU, MARIAFRANCA/AAC-3152-2021; Castelli, Maria Paola/F-9295-2012; PORCU, SUSANNA/AAY-3325-2020; Sogos, Valeria/B-5471-2012; Porcu, Susanna/AAC-3031-2019; Ristaldi, Maria Serafina/AAW-6270-2020	Collu, Maria/0000-0001-5406-2934; MARONGIU, MARIAFRANCA/0000-0003-3363-8046; Castelli, Maria Paola/0000-0003-3249-4706; PORCU, SUSANNA/0000-0001-8053-7075; Sogos, Valeria/0000-0002-4021-1043; Frau, Roberto/0000-0002-5922-2404; Ristaldi, Maria Serafina/0000-0003-4122-9293	Italian Ministry of University and Scientific Research	Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by a grant from the Italian Ministry of University and Scientific Research (FISR - Fondo Integrativo Speciale Ricerca Anno 1999 - D.M.16/10/2000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Amann LC, 2010, BRAIN RES BULL, V83, P147, DOI 10.1016/j.brainresbull.2010.04.008; Andersson H, 2003, MOL PHARMACOL, V64, P570, DOI 10.1124/mol.64.3.570; Azad SC, 2008, LEARN MEMORY, V15, P143, DOI 10.1101/lm.741908; Ballmaier M, 2007, NEUROPSYCHOPHARMACOL, V32, P2098, DOI 10.1038/sj.npp.1301344; Bodor AL, 2005, J NEUROSCI, V25, P6845, DOI 10.1523/JNEUROSCI.0442-05.2005; Bohn LM, 2007, MOL PHARMACOL, V71, P957, DOI 10.1124/mol.107.034223; Bortolato M, 2005, PSYCHOPHARMACOLOGY, V177, P264, DOI 10.1007/s00213-004-1941-4; Bortolato M, 2007, PSYCHOPHARMACOLOGY, V194, P361, DOI 10.1007/s00213-007-0845-5; Bossong MG, 2010, PROG NEUROBIOL, V92, P370, DOI 10.1016/j.pneurobio.2010.06.010; Braff DL, 2010, CURR TOP BEHAV NEURO, V4, P349, DOI 10.1007/7854_2010_61; Brailoiu GC, 2011, J BIOL CHEM, V286, P29166, DOI 10.1074/jbc.M110.217463; Bucan M, 2002, NAT REV GENET, V3, P114, DOI 10.1038/nrg728; Castelli MP, 2007, NEUROSCIENCE, V147, P197, DOI 10.1016/j.neuroscience.2007.02.062; Chaouloff F, 2011, PHYSIOLOGY, V26, P76, DOI 10.1152/physiol.00050.2010; de Fonseca FR, 2005, ALCOHOL ALCOHOLISM, V40, P2, DOI 10.1093/alcalc/agh110; Denzer AJ, 1995, EMBO J, V14, P6311, DOI 10.1002/j.1460-2075.1995.tb00321.x; Egertova M, 2000, J COMP NEUROL, V422, P159, DOI 10.1002/(SICI)1096-9861(20000626)422:2<159::AID-CNE1>3.0.CO;2-1; El Manira A, 2010, PHYSIOLOGY, V25, P230, DOI 10.1152/physiol.00007.2010; Giakournaki SG, 2007, BIOL PSYCHIAT, V62, P1418, DOI 10.1016/j.biopsych.2006.12.002; Giuffrida A, 2004, NEUROPSYCHOPHARMACOL, V29, P2108, DOI 10.1038/sj.npp.1300558; Grimsey NL, 2008, CLIN EXP PHARMACOL P, V35, P1377, DOI 10.1111/j.1440-1681.2008.04991.x; Haring M, 2007, NEUROSCIENCE, V146, P1212, DOI 10.1016/j.neuroscience.2007.02.021; Haller J, 2009, PSYCHOPHARMACOLOGY, V204, P607, DOI 10.1007/s00213-009-1494-7; Hamdani N, 2008, EUR NEUROPSYCHOPHARM, V18, P34, DOI 10.1016/j.euroneuro.2007.05.005; Haring M, 2012, NEUROSCIENCE; Jones CA, 2011, BRIT J PHARM; Karlsgodt KH, 2011, BIOL PSYCHIAT, V69, P28, DOI 10.1016/j.biopsych.2010.09.012; Kirby BP, 2010, BRAIN RES BULL, V83, P162, DOI 10.1016/j.brainresbull.2009.09.010; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; Leroy S, 2001, AM J MED GENET, V105, P749, DOI 10.1002/ajmg.10038; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; Long LE, 2010, INT J NEUROPSYCHOPH, V13, P861, DOI 10.1017/S1461145709990605; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Malone DT, 2010, BRIT J PHARMACOL, V160, P511, DOI 10.1111/j.1476-5381.2010.00721.x; Malone DT, 2004, PHARMACOL BIOCHEM BE, V77, P839, DOI 10.1016/j.pbb.2004.02.010; Mansuy IM, 2000, CURR OPIN NEUROBIOL, V10, P593, DOI 10.1016/S0959-4388(00)00127-6; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Martin RS, 2003, PSYCHOPHARMACOLOGY, V165, P128, DOI 10.1007/s00213-002-1240-x; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; Monory K, 2007, PLOS BIOL, V5, P2354, DOI 10.1371/journal.pbio.0050269; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Moreira FA, 2005, EUR J PHARMACOL, V512, P199, DOI 10.1016/j.ejphar.2005.02.040; Nagai H, 2006, PHARMACOL BIOCHEM BE, V84, P330, DOI 10.1016/j.pbb.2006.05.018; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nonchev SG, 2000, PRACT APPROACH SER, P61; Ortega-Alvaro A, 2011, NEUROPSYCHOPHARMACOL, V36, P1489, DOI 10.1038/npp.2011.34; Papaleo F, 2012, NEUROPHARMACOLOGY, V62, P1204, DOI 10.1016/j.neuropharm.2011.04.025; Papaleo F, 2011, BIOL PSYCHIAT, V69, P2, DOI 10.1016/j.biopsych.2010.10.028; Parolaro D, 2010, EXP NEUROL, V224, P3, DOI 10.1016/j.expneurol.2010.03.018; Perry W, 2009, ARCH GEN PSYCHIAT, V66, P1072, DOI 10.1001/archgenpsychiatry.2009.58; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pertwee RG, 2008, ADDICT BIOL, V13, P147, DOI 10.1111/j.1369-1600.2008.00108.x; Pettit DAD, 1998, J NEUROSCI RES, V51, P391; Powell SB, 2009, BEHAV BRAIN RES, V204, P282, DOI 10.1016/j.bbr.2009.04.021; Rozenfeld R, 2008, FASEB J, V22, P2311, DOI 10.1096/fj.07-102731; Rozenfeld R, 2011, TRAFFIC, V12, P12, DOI 10.1111/j.1600-0854.2010.01130.x; Saunders TL, 2008, TRANSGENIC MOUSE MET, P125; Schneider M, 2002, BEHAV PHARMACOL, V13, P29, DOI 10.1097/00008877-200202000-00003; Schonig Kai, 2003, Methods Mol Biol, V209, P69; Seifert J, 2007, NEUROSCI LETT, V426, P29, DOI 10.1016/j.neulet.2007.08.008; Sigel E, 2011, P NATL ACAD SCI USA, V108, P18150, DOI 10.1073/pnas.1113444108; Spano MS, 2010, EUR NEUROPSYCHOPHARM, V20, P25, DOI 10.1016/j.euroneuro.2009.09.004; Steiner H, 1999, PNAS US, V96, P5787; Swerdlow NR, 2008, PSYCHOPHARMACOLOGY, V199, P331, DOI 10.1007/s00213-008-1072-4; Ujike H, 2002, MOL PSYCHIATR, V7, P515, DOI 10.1038/sj.mp.4001029; Valverde O, 2005, HANDB EXP PHARMACOL, V168, P117; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	69	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35013	10.1371/journal.pone.0035013	http://dx.doi.org/10.1371/journal.pone.0035013			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558109	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336000021
J	Milton, JN; Sebastiani, P; Solovieff, N; Hartley, SW; Bhatnagar, P; Arking, DE; Dworkis, DA; Casella, JF; Barron-Casella, E; Bean, CJ; Hooper, WC; DeBaun, MR; Garrett, ME; Soldano, K; Telen, MJ; Ashley-Koch, A; Gladwin, MT; Baldwin, CT; Steinberg, MH; Klings, ES				Milton, Jacqueline N.; Sebastiani, Paola; Solovieff, Nadia; Hartley, Stephen W.; Bhatnagar, Pallav; Arking, Dan E.; Dworkis, Daniel A.; Casella, James F.; Barron-Casella, Emily; Bean, Christopher J.; Hooper, W. Craig; DeBaun, Michael R.; Garrett, Melanie E.; Soldano, Karen; Telen, Marilyn J.; Ashley-Koch, Allison; Gladwin, Mark T.; Baldwin, Clinton T.; Steinberg, Martin H.; Klings, Elizabeth S.			A Genome-Wide Association Study of Total Bilirubin and Cholelithiasis Risk in Sickle Cell Anemia	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; GILBERTS-SYNDROME; UGT1A1-ASTERISK-28 ALLELE; PROMOTER POLYMORPHISMS; ALPHA-THALASSEMIA; HYDROXYUREA THERAPY; UGT1A1 POLYMORPHISM; PLASMA BILIRUBIN; HYPERBILIRUBINEMIA; HEMOLYSIS	Serum bilirubin levels have been associated with polymorphisms in the UGT1A1 promoter in normal populations and in patients with hemolytic anemias, including sickle cell anemia. When hemolysis occurs circulating heme increases, leading to elevated bilirubin levels and an increased incidence of cholelithiasis. We performed the first genome-wide association study (GWAS) of bilirubin levels and cholelithiasis risk in a discovery cohort of 1,117 sickle cell anemia patients. We found 15 single nucleotide polymorphisms (SNPs) associated with total bilirubin levels at the genome-wide significance level (p value <5x10(-8)). SNPs in UGT1A1, UGT1A3, UGT1A6, UGT1A8 and UGT1A10, different isoforms within the UGT1A locus, were identified (most significant rs887829, p = 9.08x10(-25)). All of these associations were validated in 4 independent sets of sickle cell anemia patients. We tested the association of the 15 SNPs with cholelithiasis in the discovery cohort and found a significant association (most significant p value 1.15x10(-4)). These results confirm that the UGT1A region is the major regulator of bilirubin metabolism in African Americans with sickle cell anemia, similar to what is observed in other ethnicities.	[Milton, Jacqueline N.; Sebastiani, Paola; Solovieff, Nadia; Hartley, Stephen W.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA; [Dworkis, Daniel A.; Baldwin, Clinton T.; Steinberg, Martin H.; Klings, Elizabeth S.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Klings, Elizabeth S.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Bhatnagar, Pallav; Arking, Dan E.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Casella, James F.; Barron-Casella, Emily] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Pediat Hematol, Baltimore, MD 21205 USA; [Bean, Christopher J.; Hooper, W. Craig] Ctr Dis Control & Prevent, Clin & Mol Hemostasis Lab Branch, Div Blood Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA; [DeBaun, Michael R.] Vanderbilt Univ Sch Med, Nashville, TN USA; [Garrett, Melanie E.; Soldano, Karen; Telen, Marilyn J.; Ashley-Koch, Allison] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Gladwin, Mark T.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; [Gladwin, Mark T.] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA USA	Boston University; Boston University; Boston University; Johns Hopkins University; Johns Hopkins University; Centers for Disease Control & Prevention - USA; Vanderbilt University; Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Milton, JN (corresponding author), Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA.	klingon@bu.edu	Bhatnagar, Pallav/A-1280-2013	Ashley-Koch, Allison/0000-0001-5409-9155; Steinberg, Martin/0000-0001-8800-8020; Bean, Christopher/0000-0001-7433-9769; Baldwin, Clinton/0000-0002-3275-9463; Klings, Elizabeth/0000-0003-4879-720X; sebastiani, paola/0000-0001-6419-1545; Telen, Marilyn/0000-0003-3809-1780; Dworkis, Daniel/0000-0003-0706-5117	National Institutes of Health/ National Heart, Lung and Blood Institute [1RC2HL101212]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101212, T32HL007501] Funding Source: NIH RePORTER	National Institutes of Health/ National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by National Institutes of Health/ National Heart, Lung and Blood Institute grant # 1RC2HL101212. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam S, 2008, AM J MED, V121, P916, DOI 10.1016/j.amjmed.2008.04.040; Au WY, 2005, ANN HEMATOL, V84, P671, DOI 10.1007/s00277-005-1091-8; Au WY, 2003, HAEMATOLOGICA, V88, P220; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Benjamin EJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S11; Bosma PJ, 2003, CLIN CHEM, V49, P1180, DOI 10.1373/49.7.1180; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Buch S, 2010, GASTROENTEROLOGY, V139, P1942, DOI 10.1053/j.gastro.2010.09.003; Carpenter SL, 2008, AM J HEMATOL, V83, P800, DOI 10.1002/ajh.21264; Cecchin E, 2009, J CLIN ONCOL, V27, P2457, DOI 10.1200/JCO.2008.19.0314; Chaar V, 2005, HAEMATOLOGICA, V90, P188; Chaar V, 2006, AM J HEMATOL, V81, P377, DOI 10.1002/ajh.20574; Chen GM, 2011, EUR ACCOUNT REV, V20, P669, DOI 10.1080/09638180.2011.599929; Clementi M, 2007, DIGEST LIVER DIS, V39, P351, DOI 10.1016/j.dld.2006.12.019; Galanello R, 2001, BRIT J HAEMATOL, V115, P926, DOI 10.1046/j.1365-2141.2001.03200.x; GASTON M, 1982, AM J PEDIAT HEMATOL, V4, P197; Haider MZ, 1998, ACTA HAEMATOL-BASEL, V100, P147, DOI 10.1159/000040890; Haverfield EV, 2005, BLOOD, V105, P968, DOI 10.1182/blood-2004-02-0521; Heeney MM, 2003, J LAB CLIN MED, V141, P279, DOI 10.1067/mlc.2003.28; Horsfall LJ, 2011, ANN HUM GENET, V75, P236, DOI 10.1111/j.1469-1809.2010.00638.x; Hunt SC, 2001, ATHEROSCLEROSIS, V154, P747, DOI 10.1016/S0021-9150(00)00420-2; Italia KY, 2010, CLIN BIOCHEM, V43, P1329, DOI 10.1016/j.clinbiochem.2010.08.006; Johnson AD, 2009, HUM MOL GENET, V18, P2700, DOI 10.1093/hmg/ddp202; Kama NA, 2001, SURG ENDOSC-ULTRAS, V15, P942, DOI 10.1007/s00464-001-0005-7; Kang TW, 2010, HUM MOL GENET, V19, P3672, DOI 10.1093/hmg/ddq281; Kato GJ, 2006, BLOOD, V107, P2279, DOI 10.1182/blood-2005-06-2373; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; Kohle C, 2003, BIOCHEM PHARMACOL, V65, P1521, DOI 10.1016/S0006-2952(03)00074-1; Krawczyk M, 2011, SEMIN LIVER DIS, V31, P157, DOI 10.1055/s-0031-1276645; Kronenberg F, 2002, EUR J HUM GENET, V10, P539, DOI 10.1038/sj.ejhg.5200842; Lammert F, 2005, NAT CLIN PRACT GASTR, V2, P423, DOI 10.1038/ncpgasthep0257; Lammert Frank, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P163, DOI 10.2174/1568008054064841; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lin JP, 2006, CIRCULATION, V114, P1476, DOI 10.1161/CIRCULATIONAHA.106.633206; Lingenhel A, 2008, EXP GERONTOL, V43, P1102, DOI 10.1016/j.exger.2008.08.047; Liu Jian, 2009, Zhonghua Yi Xue Za Zhi, V89, P3122; Machado RF, 2011, BLOOD, V118, P855, DOI 10.1182/blood-2010-09-306167; Martins R, 2008, J HUM GENET, V53, P524, DOI 10.1007/s10038-008-0281-3; McDonagh AF, 2010, SEMIN FETAL NEONAT M, V15, P141, DOI 10.1016/j.siny.2009.10.005; Ockenga J, 2003, GASTROENTEROLOGY, V124, P1802, DOI 10.1016/S0016-5085(03)00294-4; Passon RG, 2001, J PEDIAT HEMATOL ONC, V23, P448, DOI 10.1097/00043426-200110000-00011; Perera MA, 2008, PHARMACOTHERAPY, V28, P755, DOI 10.1592/phco.28.6.755; Persico M, 2001, HEPATOLOGY, V33, P627, DOI 10.1053/jhep.2001.22499; Portincasa P, 2006, LANCET, V368, P230, DOI 10.1016/S0140-6736(06)69044-2; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rantner B, 2008, CLIN CHEM, V54, P851, DOI 10.1373/clinchem.2007.102046; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Sanna S, 2009, HUM MOL GENET, V18, P2711, DOI 10.1093/hmg/ddp203; Schwertner HA, 2008, ATHEROSCLEROSIS, V198, P1, DOI 10.1016/j.atherosclerosis.2008.01.001; Sebastiani P, 2010, AM J HEMATOL, V85, P29, DOI 10.1002/ajh.21572; Steinberg MH, 2003, JAMA-J AM MED ASSOC, V289, P1645, DOI 10.1001/jama.289.13.1645; Strassburg CP, 1998, J BIOL CHEM, V273, P8719, DOI 10.1074/jbc.273.15.8719; Taylor JG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002095; Teng HC, 2007, CLIN GENET, V72, P321, DOI 10.1111/j.1399-0004.2007.00873.x; Van Erpecum KJ, 2011, CLIN RES HEPATOL GAS, V35, P281, DOI 10.1016/j.clinre.2011.01.009; Vasavda N, 2007, BRIT J HAEMATOL, V138, P263, DOI 10.1111/j.1365-2141.2007.06643.x; Vogel A, 2001, GASTROENTEROLOGY, V121, P1136, DOI 10.1053/gast.2001.28655; WEST MS, 1992, J CLIN EPIDEMIOL, V45, P893	58	37	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e34741	10.1371/journal.pone.0034741	http://dx.doi.org/10.1371/journal.pone.0034741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558097	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000305336000016
J	Durward, M; Radhakrishnan, G; Harms, J; Bareiss, C; Magnani, D; Splitter, GA				Durward, Marina; Radhakrishnan, Girish; Harms, Jerome; Bareiss, Claire; Magnani, Diogo; Splitter, Gary A.			Active Evasion of CTL Mediated Killing and Low Quality Responding CD8+T Cells Contribute to Persistence of Brucellosis	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; DOMAIN-CONTAINING PROTEIN; MEMORY T-CELLS; ABORTUS INFECTION; IMMUNE-RESPONSES; VACCINE DESIGN; PROTECTIVE IMMUNITY; REVERSE VACCINOLOGY; CYTOKINE PRODUCTION; MACROPHAGE CONTROL	Brucellosis is a common zoonotic disease that remains endemic in many parts of the world. Dissecting the host immune response during this disease provides insight as to why brucellosis is often difficult to resolve. We used a Brucella epitope specific in vivo killing assay to investigate the ability of CD8+ T cells to kill targets treated with purified pathogenic protein. Importantly, we found the pathogenic protein TcpB to be a novel effector of adaptive immune evasion by inhibiting CD8+ T cell killing of Brucella epitope specific target cells in mice. Further, BALB/c mice show active Brucella melitensis infection beyond one year, many with previously unreported focal infection of the urogenital area. A fraction of CD8+ T cells show a CD8+ Tmem phenotype of LFA-1hi, CD127hi, KLRG-1lo during the course of chronic brucellosis, while the CD8+ T cell pool as a whole had a very weak polyfunctional cytokine response with diminished co-expression of IFN-gamma with TNF alpha and/or IL-2, a hallmark of exhaustion. When investigating the expression of these 3 cytokines individually, we observed significant IFN-gamma expression at 90 and 180 days post-infection. TNF alpha expression did not significantly exceed or fall below background levels at any time. IL-2 expression did not significantly exceeded background, but, interestingly, did fall significantly below that of uninfected mice at 180 days post-infection. Brucella melitensis evades and blunts adaptive immunity during acute infection and our findings provide potential mechanisms for the deficit observed in responding CD8+ T cells during chronic brucellosis.	[Durward, Marina] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pathol & Lab Med, Madison, WI 53715 USA; [Radhakrishnan, Girish; Harms, Jerome; Bareiss, Claire; Magnani, Diogo; Splitter, Gary A.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Durward, M (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Pathol & Lab Med, Madison, WI 53715 USA.	splitter@svm.vetmed.wisc.edu		Radhakrishnan, Girish/0000-0001-9088-0029; Magnani, Diogo/0000-0002-1773-2406; Diioia, Marina/0000-0002-9906-1633	National Institutes of Health [1-R01-AI-073558, 1-R21-AI-088038]; Great Lakes Regional Center of Excellence [1-U54-AI-057153]; Binational Agricultural and Research Foundation (BARD) [US-4378-11]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088038, U54AI057153, R01AI073558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Great Lakes Regional Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Binational Agricultural and Research Foundation (BARD); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant 1-R01-AI-073558, 1-R21-AI-088038, the Great Lakes Regional Center of Excellence grant 1-U54-AI-057153, and Binational Agricultural and Research Foundation (BARD) US-4378-11 (to G. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dahouk S, 2008, PROTEOMICS, V8, P3862, DOI 10.1002/pmic.200800026; Araki K, 2010, IMMUNOL REV, V235, P234, DOI 10.1111/j.0105-2896.2010.00898.x; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Arens R, 2010, IMMUNOL REV, V235, P190, DOI 10.1111/j.0105-2896.2010.00899.x; Baldwin CL, 2002, VET MICROBIOL, V90, P367, DOI 10.1016/S0378-1135(02)00222-5; Baldwin CL, 2006, CRIT REV IMMUNOL, V26, P407, DOI 10.1615/CritRevImmunol.v26.i5.30; Baldwin Cynthia L., 1993, Trends in Microbiology, V1, P99, DOI 10.1016/0966-842X(93)90115-8; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631; Brandao APMS, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/589494; Capasso L, 2002, J INFECTION, V45, P122, DOI 10.1053/jinf.2002.0996; Celli J, 2004, CURR OPIN MICROBIOL, V7, P93, DOI 10.1016/j.mib.2003.11.001; Chen F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006830; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Colmenero JD, 1996, MEDICINE, V75, P195, DOI 10.1097/00005792-199607000-00003; Colmenero JD, 2002, EUR J CLIN MICROBIOL, V21, P897, DOI 10.1007/s10096-002-0848-4; Commander Nicola J, 2010, Genet Vaccines Ther, V8, P5, DOI 10.1186/1479-0556-8-5; Cox MA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/159152; Cui WG, 2010, IMMUNOL REV, V236, P151, DOI 10.1111/j.1600-065X.2010.00926.x; D'Anastasio R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006439; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Dornand J, 2002, VET MICROBIOL, V90, P383, DOI 10.1016/S0378-1135(02)00223-7; Durward Marina, 2010, J Vis Exp, DOI 10.3791/2250; Durward MA, 2010, INFECT IMMUN, V78, P168, DOI 10.1128/IAI.00994-09; Fooksman DR, 2009, J IMMUNOL, V182, P5179, DOI 10.4049/jimmunol.0801797; Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Fuller MJ, 2005, J IMMUNOL, V174, P5926, DOI 10.4049/jimmunol.174.10.5926; Fuller MJ, 2004, J IMMUNOL, V172, P4204, DOI 10.4049/jimmunol.172.7.4204; Fuller MJ, 2003, J IMMUNOL, V170, P477, DOI 10.4049/jimmunol.170.1.477; High KP, 2007, BIOGERONTOLOGY, V8, P583, DOI 10.1007/s10522-007-9106-6; Ingulli Elizabeth, 2007, Methods Mol Biol, V380, P365; JIANG XS, 1993, INFECT IMMUN, V61, P124, DOI 10.1128/IAI.61.1.124-134.1993; JIANG XS, 1993, CELL IMMUNOL, V151, P309, DOI 10.1006/cimm.1993.1241; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Ko J, 2002, INFECT IMMUN, V70, P7004, DOI 10.1128/IAI.70.12.7004-7012.2002; Ko JY, 2003, CLIN MICROBIOL REV, V16, P65, DOI 10.1128/CMR.16.1.65-78.2003; Lamkanfi M, 2010, CELL HOST MICROBE, V8, P44, DOI 10.1016/j.chom.2010.06.007; Lapaque N, 2006, CELL MICROBIOL, V8, P197, DOI 10.1111/j.1462-5822.2005.00609.x; Leclerq S, 2002, J MED MICROBIOL, V51, P20, DOI 10.1099/0022-1317-51-1-20; Lee SJ, 2010, J IMMUNOL, V185, P2442, DOI 10.4049/jimmunol.1000743; Lefrancois L, 2010, IMMUNOL REV, V235, P206, DOI 10.1111/j.0105-2896.2010.00895.x; Lin JP, 2010, VACCINE, V28, P5669, DOI 10.1016/j.vaccine.2010.06.053; Lopez-Goni I, 2004, BRUCELLA MOL CELLULA; Magnani DM, 2009, INFECT IMMUN, V77, P5181, DOI 10.1128/IAI.00231-09; Makedonas G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000798; Mantur B G, 2007, Indian J Med Microbiol, V25, P188; Markman B, 2010, ONCOTARGET, V1, P530, DOI 10.18632/oncotarget.188; Martirosyan A, 2011, IMMUNOL REV, V240, P211, DOI 10.1111/j.1600-065X.2010.00982.x; MONTARAZ JA, 1986, INFECT IMMUN, V53, P245, DOI 10.1128/IAI.53.2.245-251.1986; Mora M, 2006, CURR OPIN MICROBIOL, V9, P532, DOI 10.1016/j.mib.2006.07.003; Mueller SN, 2009, P NATL ACAD SCI USA, V106, P8623, DOI 10.1073/pnas.0809818106; Murphy EA, 2001, IMMUNOLOGY, V103, P511, DOI 10.1046/j.1365-2567.2001.01258.x; Obar JJ, 2010, INT IMMUNOL, V22, P619, DOI 10.1093/intimm/dxq053; Obar JJ, 2010, J IMMUNOL, V185, P263, DOI 10.4049/jimmunol.1000492; OLIVEIRA SC, 1995, EUR J IMMUNOL, V25, P2551, DOI 10.1002/eji.1830250922; Pappas G, 2006, CELL MOL LIFE SCI, V63, P2229, DOI 10.1007/s00018-006-6311-4; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; Radhakrishnan GK, 2010, BIOCHEM BIOPH RES CO, V397, P59, DOI 10.1016/j.bbrc.2010.05.056; Radhakrishnan GK, 2009, J BIOL CHEM, V284, P9892, DOI 10.1074/jbc.M805458200; Rafiei A, 2006, J INFECTION, V53, P315, DOI 10.1016/j.jinf.2005.11.024; Rajashekara G, 2005, CELL MICROBIOL, V7, P1459, DOI 10.1111/j.1462-5822.2005.00570.x; Rappuoli R, 2000, CURR OPIN MICROBIOL, V3, P445, DOI 10.1016/S1369-5274(00)00119-3; Rueda CM, 2010, TUBERCULOSIS, V90, P346, DOI 10.1016/j.tube.2010.09.003; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Schurig GG, 2002, VET MICROBIOL, V90, P479, DOI 10.1016/S0378-1135(02)00255-9; Sette A, 2003, CURR OPIN IMMUNOL, V15, P461, DOI 10.1016/S0952-7915(03)00083-9; Sette A, 2007, CURR OPIN IMMUNOL, V19, P106, DOI 10.1016/j.coi.2006.11.002; Singh A, 2007, J LEUKOCYTE BIOL, V82, P1201, DOI 10.1189/jlb.0407240; Singh A, 2010, MOL CELL BIOL, V30, P5145, DOI 10.1128/MCB.01045-09; Singh V, 2010, J INFECT DIS, V202, P480, DOI 10.1086/653827; Skendros P, 2011, MICROBES INFECT, V13, P134, DOI 10.1016/j.micinf.2010.10.015; Slifka MK, 2000, IMMUNITY, V12, P451, DOI 10.1016/S1074-7613(00)80197-1; STEVENS MG, 1992, INFECT IMMUN, V60, P4407, DOI 10.1128/IAI.60.10.4407-4409.1992; Suresh M, 2001, J IMMUNOL, V167, P5565, DOI 10.4049/jimmunol.167.10.5565; Titball RW, 2008, DRUG DISCOV TODAY, V13, P596, DOI 10.1016/j.drudis.2008.04.010; Vrioni G, 2008, CLIN INFECT DIS, V46, pE131, DOI 10.1086/588482; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Yi JS, 2010, IMMUNOLOGY, V129, P474, DOI 10.1111/j.1365-2567.2010.03255.x; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zanetti M, 2010, ADV EXP MED BIOL, V684, P108; Zhou SH, 2004, J VIROL, V78, P3578, DOI 10.1128/JVI.78.7.3578-3600.2004	86	39	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e34925	10.1371/journal.pone.0034925	http://dx.doi.org/10.1371/journal.pone.0034925			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558103	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345200015
J	Lore, NI; Cigana, C; De Fino, I; Riva, C; Juhas, M; Schwager, S; Eberl, L; Bragonzi, A				Lore, Nicola Ivan; Cigana, Cristina; De Fino, Ida; Riva, Camilla; Juhas, Mario; Schwager, Stephan; Eberl, Leo; Bragonzi, Alessandra			Cystic Fibrosis-Niche Adaptation of Pseudomonas aeruginosa Reduces Virulence in Multiple Infection Hosts	PLOS ONE			English	Article							BURKHOLDERIA-CENOCEPACIA STRAINS; INNATE IMMUNITY; LASR MUTANTS; RESISTANT; PHENOTYPES; TOLERANCE; MICE	The opportunistic pathogen Pseudomonas aeruginosa is able to thrive in diverse ecological niches and to cause serious human infection. P. aeruginosa environmental strains are producing various virulence factors that are required for establishing acute infections in several host organisms; however, the P. aeruginosa phenotypic variants favour long-term persistence in the cystic fibrosis (CF) airways. Whether P. aeruginosa strains, which have adapted to the CF-niche, have lost their competitive fitness in the other environment remains to be investigated. In this paper, three P. aeruginosa clonal lineages, including early strains isolated at the onset of infection, and late strains, isolated after several years of chronic lung infection from patients with CF, were analysed in multi-host model systems of acute infection. P. aeruginosa early isolates caused lethality in the three non-mammalian hosts, namely Caenorhabditis elegans, Galleria mellonella, and Drosophila melanogaster, while late adapted clonal isolates were attenuated in acute virulence. When two different mouse genetic background strains, namely C57Bl/6NCrl and Balb/cAnNCrl, were used as acute infection models, early P. aeruginosa CF isolates were lethal, while late isolates exhibited reduced or abolished acute virulence. Severe histopathological lesions, including high leukocytes recruitment and bacterial load, were detected in the lungs of mice infected with P. aeruginosa CF early isolates, while late isolates were progressively cleared. In addition, systemic bacterial spread and invasion of epithelial cells, which were detected for P. aeruginosa CF early strains, were not observed with late strains. Our findings indicate that niche-specific selection in P. aeruginosa reduced its ability to cause acute infections across a broad range of hosts while maintaining the capacity for chronic infection in the CF host.	[Lore, Nicola Ivan; Cigana, Cristina; De Fino, Ida; Riva, Camilla; Bragonzi, Alessandra] Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, Infect & Cyst Fibrosis Unit, I-20132 Milan, Italy; [Juhas, Mario; Schwager, Stephan; Eberl, Leo] Univ Zurich, Inst Plant Biol, Dept Microbiol, CH-8008 Zurich, Switzerland	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Zurich	Lore, NI (corresponding author), Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, Infect & Cyst Fibrosis Unit, I-20132 Milan, Italy.	bragonzi.alessandra@hsr.it	Cigana, Cristina/D-2883-2016; Lorè, Nicola Ivan/K-9285-2016; Eberl, Leo/A-8380-2012; Riva, Camilla/AAN-3789-2020; Eberl, Leo/AAE-8165-2019; De Fino, Ida/AAN-5189-2020; Bragonzi, Alessandra/AAC-6751-2022	Cigana, Cristina/0000-0003-0436-9721; Lorè, Nicola Ivan/0000-0001-9159-1632; Eberl, Leo/0000-0002-7241-0864; De Fino, Ida/0000-0002-5747-7155; Bragonzi, Alessandra/0000-0002-5808-7669	European Commission [223670]; Italian Cystic Fibrosis Research Foundation (FFC) [20/2011]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK027651] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); Italian Cystic Fibrosis Research Foundation (FFC)(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was supported by the European Commission (http://cordis.europa.eu/fp7/dc/index.cfm) (Grant NABATIVI, EU-FP7-HEALTH-2007-B, contract number 223670) and Italian Cystic Fibrosis Research Foundation (FFC#20/2011) (http://www.fibrosicisticaricerca.it/) with the contribution of the Delegazione FFC di Bergamo Villa d'Alme, Amici della Ricerca di Milano, Latteria Montello 70 degrees compleanno nonno Armando. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apidianakis Y, 2009, NAT PROTOC, V4, P1285, DOI 10.1038/nprot.2009.124; Bernd Rehm HA, 2008, PSEUDOMONAS MODEL OR; Bianconi I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001270; Bragonzi A, 2005, J INFECT DIS, V192, P410, DOI 10.1086/431516; Bragonzi A, 2006, MICROBIOL-SGM, V152, P3261, DOI 10.1099/mic.0.29175-0; Bragonzi A, 2010, INT J MED MICROBIOL, V300, P584, DOI 10.1016/j.ijmm.2010.08.012; Bragonzi A, 2009, AM J RESP CRIT CARE, V180, P138, DOI 10.1164/rccm.200812-1943OC; Cigana C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/852513; Cigana C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008439; D'Argenio DA, 2007, MOL MICROBIOL, V64, P512, DOI 10.1111/j.1365-2958.2007.05678.x; EGAN M, 1992, NATURE, V358, P581, DOI 10.1038/358581a0; Engelmann I, 2010, ADV EXP MED BIOL, V708, P105; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Furukawa S, 2006, J BACTERIOL, V188, P1211, DOI 10.1128/JB.188.4.1211-1217.2006; Garvis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000540; Hoffman LR, 2009, J CYST FIBROS, V8, P66, DOI 10.1016/j.jcf.2008.09.006; Jain M, 2004, J CLIN MICROBIOL, V42, P5229, DOI 10.1128/JCM.42.11.5229-5237.2004; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Mahajan-Miklos S, 2000, MOL MICROBIOL, V37, P981, DOI 10.1046/j.1365-2958.2000.02056.x; MAHENTHIRALINGAM E, 1994, INFECT IMMUN, V62, P596, DOI 10.1128/IAI.62.2.596-605.1994; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Monk AB, 2008, INFECT IMMUN, V76, P5127, DOI 10.1128/IAI.00606-08; Morissette C, 1996, INFECT IMMUN, V64, P4984, DOI 10.1128/IAI.64.12.4984-4992.1996; MORISSETTE C, 1995, INFECT IMMUN, V63, P1718, DOI 10.1128/IAI.63.5.1718-1724.1995; Mowat E, 2011, AM J RESP CRIT CARE, V183, P1674, DOI 10.1164/rccm.201009-1430OC; Nguyen D, 2006, P NATL ACAD SCI USA, V103, P8305, DOI 10.1073/pnas.0602526103; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Pirone L, 2008, ENVIRON MICROBIOL, V10, P2773, DOI 10.1111/j.1462-2920.2008.01697.x; Raberg L, 2009, PHILOS T R SOC B, V364, P37, DOI 10.1098/rstb.2008.0184; Read AF, 2008, PLOS BIOL, V6, P2638, DOI 10.1371/journal.pbio.1000004; Sapru K, 1999, CLIN EXP IMMUNOL, V115, P103; Sarkar K, 2009, P NATL ACAD SCI USA, V106, P18769, DOI 10.1073/pnas.0910561106; Schwab U, 2002, INFECT IMMUN, V70, P4547, DOI 10.1128/IAI.70.8.4547-4555.2002; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Tam M, 1999, AM J RESP CELL MOL, V20, P710, DOI 10.1165/ajrcmb.20.4.3223; Uehlinger S, 2009, INFECT IMMUN, V77, P4102, DOI 10.1128/IAI.00398-09; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313	40	81	82	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35648	10.1371/journal.pone.0035648	http://dx.doi.org/10.1371/journal.pone.0035648			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558188	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000305345200060
J	Major, JM; Kiruthu, C; Weinstein, SJ; Horst, RL; Snyder, K; Virtamo, J; Albanes, D				Major, Jacqueline M.; Kiruthu, Christine; Weinstein, Stephanie J.; Horst, Ronald L.; Snyder, Kirk; Virtamo, Jarmo; Albanes, Demetrius			Pre-Diagnostic Circulating Vitamin D and Risk of Melanoma in Men	PLOS ONE			English	Article							MALIGNANT-MELANOMA; CANCER	Purpose: Various studies have examined the association between serum vitamin D levels and different cancers; however, this is the first prospective study of this association with melanoma risk. The aim of this study is to investigate the association between serum vitamin D [25(OH)D] levels and melanoma in a cohort of older, middle-aged Finnish male smokers. Methods: We conducted a nested case-control study within the Alpha-Tocopherol Beta-Carotene Cancer Prevention (ATBC) Study. From the ATBC cohort, 368 subjects were chosen for our study; 92 participants that developed melanoma and 276 matched control subjects. At study baseline, lifestyle questionnaires and blood samples were collected. Serum 25(OH)D was modeled as three sets of categorical variables: clinically-defined categories, season-specific quartiles and season-adjusted residual quartiles. Conditional logistic regression was used to obtain odds ratios (ORs) and 95% confidence intervals (95% CIs) to estimate the association between circulating vitamin D and melanoma risk. Results: Overall no association of serum 25(OH)D and melanoma risk was observed. A decreased risk of developing melanoma was observed in the middle categories compared to the lowest category, albeit not significant. Conclusion: Results indicate no association between serum 25(OH)D levels and melanoma. Additional studies, including possibly consortium efforts, are needed to investigate the association between serum 25(OH)D levels and risk of melanoma in larger, more diverse study populations.	[Major, Jacqueline M.; Kiruthu, Christine; Weinstein, Stephanie J.; Albanes, Demetrius] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Horst, Ronald L.] Heartland Assays Inc, Ames, IA USA; [Snyder, Kirk] Informat Management Serv Inc, Silver Spring, MD USA; [Virtamo, Jarmo] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Information Management Services, Inc.; Finland National Institute for Health & Welfare	Major, JM (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	jacqueline.major@nih.gov	Albanes, Demetrius/B-9749-2015; Weinstein, Stephanie J/P-1627-2017	Weinstein, Stephanie J/0000-0002-3834-1535	National Cancer Institute, NIH; US Public Health Service from the National Cancer Institute, NIH, DHHS [N01-CN-45165, N01-RC-45035, N01-RC-37004, HHSN261201000006C]; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN045165] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIACP010195] Funding Source: NIH RePORTER	National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Public Health Service from the National Cancer Institute, NIH, DHHS; DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study is supported by the Intramural Research Program of the National Cancer Institute, NIH, and by US Public Health Service contracts N01-CN-45165, N01-RC-45035, N01-RC-37004, and HHSN261201000006C from the National Cancer Institute, NIH, DHHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ronald L. Horst is an employee of Heartland Assays, Inc., and Kirk Snyder is an analytic programmer employed by Information Management Services, Inc. These authors played a role in performing the experiments and analysis of the data.	American Cancer Society, 2022, CANC FACTS FIGURES 2; [Anonymous], 1994, Ann Epidemiol, V4, P1, DOI 10.1016/1047-2797(94)90036-1; COLSTON K, 1981, ENDOCRINOLOGY, V108, P1083, DOI 10.1210/endo-108-3-1083; Elwood JM, 1997, INT J CANCER, V73, P198, DOI 10.1002/(SICI)1097-0215(19971009)73:2<198::AID-IJC6>3.0.CO;2-R; Evans SRT, 1996, J SURG RES, V61, P127, DOI 10.1006/jsre.1996.0092; Gallicchio L, 2010, AM J EPIDEMIOL, V172, P10, DOI 10.1093/aje/kwq116; Gandini S, 2005, EUR J CANCER, V41, P45, DOI 10.1016/j.ejca.2004.10.016; Gandini S, 2011, INT J CANCER, V128, P1414, DOI 10.1002/ijc.25439; Giovannucci E, 2009, ANN EPIDEMIOL, V19, P84, DOI 10.1016/j.annepidem.2007.12.002; Gruber SB, 2006, CANC EPIDEMIOLOGY PR, V2005, P1196, DOI DOI 10.1093/ACPROF:OSO/9780195149616.003.0063; Hofmann JN, 2010, CANCER EPIDEM BIOMAR, V19, P927, DOI 10.1158/1055-9965.EPI-09-1121; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hutchinson PE, 2010, J CLIN ONCOL US, P494; Hutchinson PE, 2010, J CLIN ONCOL, V28, pE492, DOI 10.1200/JCO.2010.29.6095; Jorde R, 2010, AM J EPIDEMIOL, V171, P903, DOI 10.1093/aje/kwq005; Millen AE, 2004, CANCER EPIDEM BIOMAR, V13, P1042; Newton-Bishop JA, 2009, J CLIN ONCOL, V27, P5439, DOI 10.1200/JCO.2009.22.1135; Nurnberg B, 2009, ANTICANCER RES, V29, P3669; OSTERLIND A, 1988, INT J CANCER, V42, P319, DOI 10.1002/ijc.2910420303; Randerson-Moor JA, 2009, EUR J CANCER, V45, P3271, DOI 10.1016/j.ejca.2009.06.011; Reichrath R, 2004, CANCER CAUSE CONTROL, V15, P97; Stolzenberg-Solomon RZ, 2009, CANCER RES, V69, P1439, DOI 10.1158/0008-5472.CAN-08-2694; Tang JY, 2011, J CLIN ONCOL, V29, P3078, DOI 10.1200/JCO.2011.34.5967; Tang JY, 2010, CANCER CAUSE CONTROL, V21, P387, DOI 10.1007/s10552-009-9470-4; Tuohimaa P, 2004, INT J CANCER, V108, P104, DOI 10.1002/ijc.11375; Tworoger SS, 2007, CANCER EPIDEM BIOMAR, V16, P783, DOI 10.1158/1055-9965.EPI-06-0981; Vinceti M, 2011, NUTR CANCER, V63, P506, DOI 10.1080/01635581.2011.539314; WEINSTOCK MA, 1992, J INVEST DERMATOL, V98, P809, DOI 10.1111/1523-1747.ep12499962	28	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35112	10.1371/journal.pone.0035112	http://dx.doi.org/10.1371/journal.pone.0035112			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558121	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345200026
J	Bodilis, J; Nsigue-Meilo, S; Besaury, L; Quillet, L				Bodilis, Josselin; Nsigue-Meilo, Sandrine; Besaury, Ludovic; Quillet, Laurent			Variable Copy Number, Intra-Genomic Heterogeneities and Lateral Transfers of the 16S rRNA Gene in Pseudomonas	PLOS ONE			English	Article							MULTILOCUS SEQUENCE-ANALYSIS; DISTINCT TYPES; PHYLOGENY; OPERONS; FLUORESCENS; DIVERSITY; BACTERIA; SIZE; IDENTIFICATION; RHIZOSPHERE	Even though the 16S rRNA gene is the most commonly used taxonomic marker in microbial ecology, its poor resolution is still not fully understood at the intra-genus level. In this work, the number of rRNA gene operons, intra-genomic heterogeneities and lateral transfers were investigated at a fine-scale resolution, throughout the Pseudomonas genus. In addition to nineteen sequenced Pseudomonas strains, we determined the 16S rRNA copy number in four other Pseudomonas strains by Southern hybridization and Pulsed-Field Gel Electrophoresis, and studied the intra-genomic heterogeneities by Denaturing Gradient Gel Electrophoresis and sequencing. Although the variable copy number (from four to seven) seems to be correlated with the evolutionary distance, some close strains in the P. fluorescens lineage showed a different number of 16S rRNA genes, whereas all the strains in the P. aeruginosa lineage displayed the same number of genes (four copies). Further study of the intra-genomic heterogeneities revealed that most of the Pseudomonas strains (15 out of 19 strains) had at least two different 16S rRNA alleles. A great difference (5 or 19 nucleotides, essentially grouped near the V1 hypervariable region) was observed only in two sequenced strains. In one of our strains studied (MFY30 strain), we found a difference of 12 nucleotides (grouped in the V3 hypervariable region) between copies of the 16S rRNA gene. Finally, occurrence of partial lateral transfers of the 16S rRNA gene was further investigated in 1803 full-length sequences of Pseudomonas available in the databases. Remarkably, we found that the two most variable regions (the V1 and V3 hypervariable regions) had probably been laterally transferred from another evolutionary distant Pseudomonas strain for at least 48.3 and 41.6% of the 16S rRNA sequences, respectively. In conclusion, we strongly recommend removing these regions of the 16S rRNA gene during the intra-genus diversity studies.	[Bodilis, Josselin; Nsigue-Meilo, Sandrine; Besaury, Ludovic; Quillet, Laurent] Univ Rouen, Lab M2C, UMR CNRS 6143, Mont St Aignan, France	Universite de Rouen Normandie	Bodilis, J (corresponding author), Univ Rouen, Lab M2C, UMR CNRS 6143, Mont St Aignan, France.	josselin.bodilis@univ-rouen.fr		BESAURY, Ludovic/0000-0002-1463-1239	GRR VATA 'Vegetal, Agronomie et transformation des Agroressources' de la Region de Haute Normandie	GRR VATA 'Vegetal, Agronomie et transformation des Agroressources' de la Region de Haute Normandie	This research was supported by the GRR VATA 'Vegetal, Agronomie et transformation des Agroressources' de la Region de Haute Normandie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; ANDERSSON SGE, 1995, J BACTERIOL, V177, P4171, DOI 10.1128/jb.177.14.4171-4175.1995; Anzai Y, 1997, INT J SYST BACTERIOL, V47, P249, DOI 10.1099/00207713-47-2-249; Anzai Y, 2000, INT J SYST EVOL MICR, V50, P1563, DOI 10.1099/00207713-50-4-1563; BENTLEY RW, 1995, FEMS IMMUNOL MED MIC, V12, P1; BERCOVIER H, 1986, BIOCHEM BIOPH RES CO, V136, P1136, DOI 10.1016/0006-291X(86)90452-3; Binnerup SJ, 2001, FEMS MICROBIOL ECOL, V37, P231, DOI 10.1111/j.1574-6941.2001.tb00870.x; Bodilis J, 2004, SYST APPL MICROBIOL, V27, P93, DOI 10.1078/0723-2020-00253; Bodilis J, 2011, MOL BIOL EVOL, V28, P2723, DOI 10.1093/molbev/msr099; Candela M, 2004, LETT APPL MICROBIOL, V38, P229, DOI 10.1111/j.1472-765X.2003.01475.x; Case RJ, 2007, APPL ENVIRON MICROB, V73, P278, DOI 10.1128/AEM.01177-06; CHEN HW, 1990, J BACTERIOL, V172, P4206, DOI 10.1128/jb.172.8.4206-4213.1990; Christen R, 2008, MICROBES ENVIRON, V23, P253, DOI 10.1264/jsme2.ME08525; Daubin V, 2003, SCIENCE, V301, P829, DOI 10.1126/science.1086568; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fogel GB, 1999, MICROB ECOL, V38, P93, DOI 10.1007/s002489900162; Frapolli M, 2007, ENVIRON MICROBIOL, V9, P1939, DOI 10.1111/j.1462-2920.2007.01310.x; Gonzalez-Escalona N, 2005, FEMS MICROBIOL LETT, V246, P213, DOI 10.1016/j.femsle.2005.04.009; GUGI B, 1991, J BACTERIOL, V173, P3814; Hashimoto JQ, 2003, J BACTERIOL, V185, P966, DOI 10.1128/JB.185.3.966-972.2003; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Jeraldo P, 2011, ENVIRON MICROBIOL, V13, P3000, DOI 10.1111/j.1462-2920.2011.02577.x; Johansen T, 1996, FEMS MICROBIOL LETT, V136, P325, DOI 10.1016/0378-1097(96)00031-6; Kampfer P, 2011, ENV MICROBIOL   1031; Kiewitz C, 2000, J BACTERIOL, V182, P3125, DOI 10.1128/JB.182.11.3125-3135.2000; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lee C, 2008, APPL MICROBIOL BIOT, V78, P371, DOI 10.1007/s00253-007-1300-6; Liao DQ, 2000, J MOL EVOL, V51, P305, DOI 10.1007/s002390010093; Lopez-Lopez A, 2007, J MOL EVOL, V65, P687, DOI 10.1007/s00239-007-9047-3; Mattatall NR, 1996, J BACTERIOL, V178, P5323, DOI 10.1128/jb.178.17.5323-5326.1996; Michon AL, 2010, MICROBIOL-SGM, V156, P2080, DOI 10.1099/mic.0.038224-0; Moore ERB, 1996, SYST APPL MICROBIOL, V19, P478, DOI 10.1016/S0723-2020(96)80021-X; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; MYLVAGANAM S, 1992, GENETICS, V130, P399; NEEFS JM, 1993, NUCLEIC ACIDS RES, V21, P3025, DOI 10.1093/nar/21.13.3025; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Niepceron M, 2010, FEMS MICROBIOL ECOL, V71, P137, DOI 10.1111/j.1574-6941.2009.00788.x; Ortet P, 2011, J BACTERIOL, V193, P3146, DOI 10.1128/JB.00411-11; Pascual J, 2010, INT J SYST EVOL MICR, V60, P154, DOI 10.1099/ijs.0.010702-0; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Pei AY, 2010, APPL ENVIRON MICROB, V76, P3886, DOI 10.1128/AEM.02953-09; Rainey FA, 1996, MICROBIOL-UK, V142, P2087, DOI 10.1099/13500872-142-8-2087; Ramos-Gonzalez MI, 1998, J BACTERIOL, V180, P3421; Sarkar SF, 2006, GENETICS, V174, P1041, DOI 10.1534/genetics.106.060996; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Smit S, 2007, NUCLEIC ACIDS RES, V35, P3339, DOI 10.1093/nar/gkm101; Smith LM, 1999, ENVIRON MICROBIOL, V1, P495, DOI 10.1046/j.1462-2920.1999.00067.x; Spiers AJ, 2000, MICROBIOL-SGM, V146, P2345, DOI 10.1099/00221287-146-10-2345; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stevenson BS, 2004, APPL ENVIRON MICROB, V70, P6670, DOI 10.1128/AEM.70.11.6670-6677.2004; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tayeb LA, 2005, RES MICROBIOL, V156, P763, DOI 10.1016/j.resmic.2005.02.009; Tsakris A, 2007, J ANTIMICROB CHEMOTH, V60, P649, DOI 10.1093/jac/dkm246; Turmel M, 1997, NUCLEIC ACIDS RES, V25, P2610, DOI 10.1093/nar/25.13.2610; VANELSAS JD, 1988, FEMS MICROBIOL ECOL, V53, P299, DOI 10.1016/0378-1097(88)90487-9; Wang Y, 1997, J BACTERIOL, V179, P3270, DOI 10.1128/jb.179.10.3270-3276.1997; Yamamoto S, 2000, MICROBIOL-SGM, V146, P2385, DOI 10.1099/00221287-146-10-2385; Yap WH, 1999, J BACTERIOL, V181, P5201, DOI 10.1128/JB.181.17.5201-5209.1999	63	34	39	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35647	10.1371/journal.pone.0035647	http://dx.doi.org/10.1371/journal.pone.0035647			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545126	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343200046
J	Hyenne, V; Tremblay-Boudreault, T; Velmurugan, R; Grant, BD; Loerke, D; Labbe, JC				Hyenne, Vincent; Tremblay-Boudreault, Thierry; Velmurugan, Ramraj; Grant, Barth D.; Loerke, Dinah; Labbe, Jean-Claude			RAB-5 Controls the Cortical Organization and Dynamics of PAR Proteins to Maintain C. elegans Early Embryonic Polarity	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; POLARIZATION; TRAFFICKING; DROSOPHILA; ESTABLISHMENT; MAINTENANCE; MATURATION; ENDOSOMES; ASYMMETRY; ROLES	In all organisms, cell polarity is fundamental for most aspects of cell physiology. In many species and cell types, it is controlled by the evolutionarily conserved PAR-3, PAR-6 and aPKC proteins, which are asymmetrically localized at the cell cortex where they define specific domains. While PAR proteins define the antero-posterior axis of the early C. elegans embryo, the mechanism controlling their asymmetric localization is not fully understood. Here we studied the role of endocytic regulators in embryonic polarization and asymmetric division. We found that depleting the early endosome regulator RAB-5 results in polarity-related phenotypes in the early embryo. Using Total Internal Reflection Fluorescence (TIRF) microscopy, we observed that PAR-6 is localized at the cell cortex in highly dynamic puncta and depleting RAB-5 decreased PAR-6 cortical dynamics during the polarity maintenance phase. Depletion of RAB-5 also increased PAR-6 association with clathrin heavy chain (CHC-1) and this increase depended on the presence of the GTPase dynamin, an upstream regulator of endocytosis. Interestingly, further analysis indicated that loss of RAB-5 leads to a disorganization of the actin cytoskeleton and that this occurs independently of dynamin activity. Our results indicate that RAB-5 promotes C. elegans embryonic polarity in both dynamin-dependent and -independent manners, by controlling PAR-6 localization and cortical dynamics through the regulation of its association with the cell cortex and the organization of the actin cytoskeleton.	[Hyenne, Vincent; Tremblay-Boudreault, Thierry; Velmurugan, Ramraj; Labbe, Jean-Claude] Univ Montreal, IRIC, Montreal, PQ, Canada; [Labbe, Jean-Claude] Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ, Canada; [Grant, Barth D.] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA; [Loerke, Dinah] Univ Denver, Dept Phys & Astron, Denver, CO USA	Universite de Montreal; Universite de Montreal; Rutgers State University New Brunswick; University of Denver	Hyenne, V (corresponding author), Univ Montreal, IRIC, Montreal, PQ, Canada.	worm.machine@gmail.com	Hyenne, Vincent/AAW-8244-2020; Hyenne, Vincent/F-7716-2013	Loerke, Dinah/0000-0002-2068-0408; Grant, Barth/0000-0002-5943-8336; Labbe, Jean-Claude/0000-0003-0520-4566; Hyenne, Vincent/0000-0002-1254-2814	Canadian Center of Excellence in Commercialization and Research (CECR); Canada Foundation for Innovation (CFI); Fonds de Recherche en Sante du Quebec (FRSQ); Research Fellow of the Terry Fox Foundation through an award from the National Cancer Institute of Canada; National Institutes of Health (NIH) [GM067237]; Canadian Cancer Society [019378]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067237] Funding Source: NIH RePORTER	Canadian Center of Excellence in Commercialization and Research (CECR); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Fonds de Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Research Fellow of the Terry Fox Foundation through an award from the National Cancer Institute of Canada; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Cancer Society(Canadian Cancer Society (CCS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Institute of Research in Immunology and Cancer is supported in part by the Canadian Center of Excellence in Commercialization and Research (CECR, http://www.nce-rce.gc.ca/ReportsPublications-RapportsPublications/CECR/Program-Guide-Programme_eng.asp), the Canada Foundation for Innovation (CFI, http://www.innovation.ca/en), and the Fonds de Recherche en Sante du Quebec (FRSQ, http://www.frsq.gouv.qc.ca/fr/index.shtml). V. H. was a Research Fellow of the Terry Fox Foundation through an award from the National Cancer Institute of Canada (http://www.terryfox.org). B. D. G. was supported by National Institutes of Health (NIH) grant GM067237 (http://www.nih.gov). This work was supported by grant #019378 from the Canadian Cancer Society (http://www.cancer.ca/Research.aspx) to J.-C.L., who holds the Canada Research Chair in Cell Division and Differentiation (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000493; Audhya A, 2007, J CELL BIOL, V178, P43, DOI 10.1083/jcb.200701139; Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; Beatty A, 2010, DEVELOPMENT, V137, P3995, DOI 10.1242/dev.056028; Boyd L, 1996, DEVELOPMENT, V122, P3075; BRENNER S, 1974, GENETICS, V77, P71; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; Edgar LG, 1995, METHOD CELL BIOL, V48, P303; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Gould GW, 2009, NAT REV MOL CELL BIO, V10, P287, DOI 10.1038/nrm2652; Hung TJ, 1999, DEVELOPMENT, V126, P127; Hyenne V, 2008, DEV BIOL, V321, P368, DOI 10.1016/j.ydbio.2008.06.037; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kinchen JM, 2008, NAT CELL BIOL, V10, P556, DOI 10.1038/ncb1718; Labbe JC, 2006, GENETICS, V174, P285, DOI 10.1534/genetics.106.060517; Lalli G, 2009, J CELL SCI, V122, P1499, DOI 10.1242/jcs.044339; Langevin J, 2005, DEV CELL, V9, P365, DOI 10.1016/j.devcel.2005.07.013; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Li R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003475; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; McCaffrey LM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001370; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Nakayama Y, 2009, DEV CELL, V16, P889, DOI 10.1016/j.devcel.2009.04.009; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Thyagarajan K, 2011, DEVELOPMENT, V138, P2773, DOI 10.1242/dev.063354; Velarde N, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-142; Wallenfang MR, 2000, NATURE, V408, P89, DOI 10.1038/35040562; Watts JL, 1996, DEVELOPMENT, V122, P3133; Zhang HN, 2008, MOL BIOL CELL, V19, P2553, DOI 10.1091/mbc.E07-09-0862	31	13	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35286	10.1371/journal.pone.0035286	http://dx.doi.org/10.1371/journal.pone.0035286			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545101	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343200022
J	Marrocco, K; Criqui, MC; Zervudacki, J; Schott, G; Eisler, H; Parnet, A; Dunoyer, P; Genschik, P				Marrocco, Katia; Criqui, Marie-Claire; Zervudacki, Jerome; Schott, Gregory; Eisler, Herfried; Parnet, Aude; Dunoyer, Patrice; Genschik, Pascal			APC/C-Mediated Degradation of dsRNA-Binding Protein 4 (DRB4) Involved in RNA Silencing	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; TRANS-ACTING SIRNAS; DICER-LIKE PROTEINS; ARABIDOPSIS; MICRORNA; BIOGENESIS; ENDOREDUPLICATION; PHOSPHORYLATION; REQUIRES; SUBUNIT	Background: Selective protein degradation via the ubiquitin-26S proteasome is a major mechanism underlying DNA replication and cell division in all Eukaryotes. In particular, the APC/C (Anaphase Promoting Complex or Cyclosome) is a master ubiquitin protein ligase (E3) that targets regulatory proteins for degradation allowing sister chromatid separation and exit from mitosis. Interestingly, recent work also indicates that the APC/C remains active in differentiated animal and plant cells. However, its role in post-mitotic cells remains elusive and only a few substrates have been characterized. Methodology/Principal Findings: In order to identify novel APC/C substrates, we performed a yeast two-hybrid screen using as the bait Arabidopsis APC10/DOC1, one core subunit of the APC/C, which is required for substrate recruitment. This screen identified DRB4, a double-stranded RNA binding protein involved in the biogenesis of different classes of small RNA (sRNA). This protein interaction was further confirmed in vitro and in plant cells. Moreover, APC10 interacts with DRB4 through the second dsRNA binding motif (dsRBD2) of DRB4, which is also required for its homodimerization and binding to its Dicer partner DCL4. We further showed that DRB4 protein accumulates when the proteasome is inactivated and, most importantly, we found that DRB4 stability depends on APC/C activity. Hence, depletion of Arabidopsis APC/C activity by RNAi leads to a strong accumulation of endogenous DRB4, far beyond its normal level of accumulation. However, we could not detect any defects in sRNA production in lines where DRB4 was overexpressed. Conclusions/Significance: Our work identified a first plant substrate of the APC/C, which is not a regulator of the cell cycle. Though we cannot exclude that APC/C-dependent degradation of DRB4 has some regulatory roles under specific growth conditions, our work rather points to a housekeeping function of APC/C in maintaining precise cellular-protein concentrations and homeostasis of DRB4.	[Marrocco, Katia; Criqui, Marie-Claire; Zervudacki, Jerome; Schott, Gregory; Eisler, Herfried; Parnet, Aude; Dunoyer, Patrice; Genschik, Pascal] Univ Strasbourg, CNRS, Inst Biol Mol Plantes, Unite Propre Rech 2357, Strasbourg, France; [Schott, Gregory] Swiss Fed Inst Technol, Zurich, Switzerland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Swiss Federal Institutes of Technology Domain; ETH Zurich	Marrocco, K (corresponding author), Univ Strasbourg, CNRS, Inst Biol Mol Plantes, Unite Propre Rech 2357, Strasbourg, France.	pascal.genschik@ibmp-cnrs.unistra.fr		GENSCHIK, Pascal/0000-0002-4107-5071	French National Research Agency [ANR-05-BLAN-0072-01]; CNRS	French National Research Agency(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	K.M. was funded by a grant of the French National Research Agency (ANR-05-BLAN-0072-01). Additional funding was provided by the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adenot X, 2006, CURR BIOL, V16, P927, DOI 10.1016/j.cub.2006.03.035; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Capron A, 2003, TRENDS PLANT SCI, V8, P83, DOI 10.1016/S1360-1385(02)00028-6; Carroll CW, 2005, CURR BIOL, V15, P11, DOI 10.1016/j.cub.2004.12.066; Carroll CW, 2002, NAT CELL BIOL, V4, P880, DOI 10.1038/ncb871; Cebolla A, 1999, EMBO J, V18, P4476, DOI 10.1093/emboj/18.16.4476; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtin SJ, 2008, FEBS LETT, V582, P2753, DOI 10.1016/j.febslet.2008.07.004; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; da Fonseca PCA, 2011, NATURE, V470, P274, DOI 10.1038/nature09625; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Dunoyer P, 2007, NAT GENET, V39, P848, DOI 10.1038/ng2081; Eamens AL, 2009, RNA, V15, P2219, DOI 10.1261/rna.1646909; Eguren M, 2011, SEMIN CELL DEV BIOL, V22, P572, DOI 10.1016/j.semcdb.2011.03.010; Eloy NB, 2011, PLANT J, V68, P351, DOI 10.1111/j.1365-313X.2011.04691.x; Felippes FF, 2009, EMBO REP, V10, P264, DOI 10.1038/embor.2008.247; Fu AKY, 2011, NAT NEUROSCI, V14, P181, DOI 10.1038/nn.2715; Fukudome A, 2011, RNA, V17, P750, DOI 10.1261/rna.2455411; Gieffers C, 1999, P NATL ACAD SCI USA, V96, P11317, DOI 10.1073/pnas.96.20.11317; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Hiraguri A, 2005, PLANT MOL BIOL, V57, P173, DOI 10.1007/s11103-004-6853-5; James P, 1996, GENETICS, V144, P1425; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kasili R, 2010, GENETICS, V185, P257, DOI 10.1534/genetics.109.113274; Kevei Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020618; Kim YK, 2010, CELL, V143, P703, DOI 10.1016/j.cell.2010.11.018; Kolonin MG, 2000, METHOD ENZYMOL, V328, P26, DOI 10.1016/S0076-6879(00)28388-2; Kwee HS, 2003, PLANT J, V36, P853, DOI 10.1046/j.1365-313X.2003.01925.x; Lammens T, 2008, P NATL ACAD SCI USA, V105, P14721, DOI 10.1073/pnas.0806510105; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Li WQ, 2007, FASEB J, V21, P3606, DOI 10.1096/fj.07-8159com; Marrocco K, 2010, CURR OPIN PLANT BIOL, V13, P631, DOI 10.1016/j.pbi.2010.07.004; Marrocco K, 2009, DEVELOPMENT, V136, P1475, DOI 10.1242/dev.035535; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Montgomery TA, 2008, P NATL ACAD SCI USA, V105, P20055, DOI 10.1073/pnas.0810241105; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; Nakazawa Y, 2007, PLANT MOL BIOL, V63, P777, DOI 10.1007/s11103-006-9125-8; Paroo Z, 2009, CELL, V139, P112, DOI 10.1016/j.cell.2009.06.044; Pelissier T, 2011, RNA, V17, P1502, DOI 10.1261/rna.2680711; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Perez-Perez JM, 2008, PLANT J, V53, P78, DOI 10.1111/j.1365-313X.2007.03312.x; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Rybak A, 2009, NAT CELL BIOL, V11, P1411, DOI 10.1038/ncb1987; Stolpe T, 2005, PROTOPLASMA, V226, P137, DOI 10.1007/s00709-005-0122-6; Tang XL, 2010, NUCLEIC ACIDS RES, V38, P6610, DOI 10.1093/nar/gkq547; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; Vanstraelen M, 2009, P NATL ACAD SCI USA, V106, P11806, DOI 10.1073/pnas.0901193106; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Vinardell JM, 2003, PLANT CELL, V15, P2093, DOI 10.1105/tpc.014373; Vodermaier HC, 2001, CURR BIOL, V11, pR834, DOI 10.1016/S0960-9822(01)00498-5; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Zheng BL, 2011, PLANT CELL, V23, P1033, DOI 10.1105/tpc.111.083980	58	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35173	10.1371/journal.pone.0035173	http://dx.doi.org/10.1371/journal.pone.0035173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545099	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343200020
J	Neal, AL; Ahmad, S; Gordon-Weeks, R; Ton, J				Neal, Andrew L.; Ahmad, Shakoor; Gordon-Weeks, Ruth; Ton, Jurriaan			Benzoxazinoids in Root Exudates of Maize Attract Pseudomonas putida to the Rhizosphere	PLOS ONE			English	Article							SOIL TRANSFORMATION; DEFENSE CHEMICALS; INNATE IMMUNITY; CHEMOTAXIS; KT2440; METABOLITES; RESISTANCE; INDUCTION; WHEAT; ACIDS	Benzoxazinoids, such as 2,4-dihydroxy-7-methoxy-2H-1,4-benzoxazin-3(4H)-one (DIMBOA), are secondary metabolites in grasses. In addition to their function in plant defence against pests and diseases above-ground, benzoxazinoids (BXs) have also been implicated in defence below-ground, where they can exert allelochemical or antimicrobial activities. We have studied the impact of BXs on the interaction between maize and Pseudomonas putida KT2440, a competitive coloniser of the maize rhizosphere with plant-beneficial traits. Chromatographic analyses revealed that DIMBOA is the main BX compound in root exudates of maize. In vitro analysis of DIMBOA stability indicated that KT2440 tolerance of DIMBOA is based on metabolism-dependent breakdown of this BX compound. Transcriptome analysis of DIMBOA-exposed P. putida identified increased transcription of genes controlling benzoate catabolism and chemotaxis. Chemotaxis assays confirmed motility of P. putida towards DIMBOA. Moreover, colonisation essays in soil with GREEN FLUORESCENT PROTEIN (GFP)-expressing P. putida showed that DIMBOA-producing roots of wild-type maize attract significantly higher numbers of P. putida cells than roots of the DIMBOA-deficient bx1 mutant. Our results demonstrate a central role for DIMBOA as a below-ground semiochemical for recruitment of plant-beneficial rhizobacteria during the relatively young and vulnerable growth stages of maize.	[Neal, Andrew L.; Ahmad, Shakoor; Gordon-Weeks, Ruth] Rothamsted Res, Ctr Sustainable Soils & Grassland Syst, Harpenden, Herts, England; [Ahmad, Shakoor] Univ Utrecht, Inst Environm Biol, Utrecht, Netherlands; [Ton, Jurriaan] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Utrecht University; University of Sheffield	Neal, AL (corresponding author), Rothamsted Res, Ctr Sustainable Soils & Grassland Syst, Harpenden, Herts, England.	andy.neal@rothamsted.ac.uk; j.ton@sheffield.ac.uk	Ton, Jurriaan/G-3295-2014; Neal, Andrew L/C-7596-2011	Ton, Jurriaan/0000-0002-8512-2802; Neal, Andrew L/0000-0003-4225-1396	Biotechnology and Biological Science Research Council of the U.K. (BBSRC); BBSRC-ICPF fellowship [BB/E023959/1]; European Union [FP7-KBBE-2010-4]; BBSRC [BB/E023959/1, BBS/E/C/00004981, BBS/E/C/00005196] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E023959/1, BBS/E/C/00005196] Funding Source: researchfish	Biotechnology and Biological Science Research Council of the U.K. (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC-ICPF fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Rothamsted Research receives grant in aid from the Biotechnology and Biological Science Research Council of the U.K. (BBSRC). The work was also supported by a BBSRC-ICPF fellowship (BB/E023959/1) and European Union funding ("PURE"; FP7-KBBE-2010-4) to J.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios G. N., 2005, PLANT PATHOL; Ahmad S, 2011, PLANT PHYSIOL, V157, P317, DOI 10.1104/pp.111.180224; ANZAI K, 1960, J ANTIBIOT, V13, P125; BJOSTAD LB, 1992, J CHEM ECOL, V18, P931, DOI 10.1007/BF00980054; Blankenfeldt W, 2004, P NATL ACAD SCI USA, V101, P16431, DOI 10.1073/pnas.0407371101; CHASE WR, 1991, J CHEM ECOL, V17, P1575, DOI 10.1007/BF00984689; Dabney AR, 2007, BIOSTATISTICS, V8, P128, DOI 10.1093/biostatistics/kxj038; de Weert S, 2002, MOL PLANT MICROBE IN, V15, P1173, DOI 10.1094/MPMI.2002.15.11.1173; Dechesne A, 2005, APPL ENVIRON MICROB, V71, P8123, DOI 10.1128/AEM.71.12.8123-8131.2005; Dobbelaere S, 2003, CRIT REV PLANT SCI, V22, P107, DOI 10.1080/713610853; Erb M, 2009, PLANT SIGNAL BEHAV, V4, P636, DOI 10.1111/j.1365-313X.2009.03868.x; Erb M, 2009, PLANT J, V59, P292, DOI 10.1111/j.1365-313X.2009.03868.x; Fischer F, 1999, J BACTERIOL, V181, P5725, DOI 10.1128/JB.181.18.5725-5733.1999; Frey M, 2009, PHYTOCHEMISTRY, V70, P1645, DOI 10.1016/j.phytochem.2009.05.012; Friebe A, 1996, J APPL BOT-ANGEW BOT, V70, P150; Friebe A, 1998, APPL ENVIRON MICROB, V64, P2386; GAGLIARDO RW, 1992, J CHEM ECOL, V18, P1683, DOI 10.1007/BF02751095; GERBER NN, 1964, BIOCHEMISTRY-US, V3, P598, DOI 10.1021/bi00892a022; Glauser G, 2011, PLANT J, V68, P901, DOI 10.1111/j.1365-313X.2011.04740.x; Haichar FE, 2008, ISME J, V2, P1221, DOI 10.1038/ismej.2008.80; Handelsman J, 1996, PLANT CELL, V8, P1855, DOI 10.1105/tpc.8.10.1855; HARWOOD CS, 1984, J BACTERIOL, V160, P622, DOI 10.1128/JB.160.2.622-628.1984; HARWOOD CS, 1994, J BACTERIOL, V176, P6479, DOI 10.1128/JB.176.21.6479-6488.1994; Jones DL, 2009, PLANT SOIL, V321, P5, DOI 10.1007/s11104-009-9925-0; Krogh SS, 2006, J AGR FOOD CHEM, V54, P1064, DOI 10.1021/jf051147i; KUMAR P, 1993, J CHEM ECOL, V19, P2453, DOI 10.1007/BF00980682; LINDERMAN RG, 1988, PHYTOPATHOLOGY, V78, P366; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Lugtenberg BJJ, 1999, ENVIRON MICROBIOL, V1, P9, DOI 10.1046/j.1462-2920.1999.00005.x; Maresh J, 2006, ACS CHEM BIOL, V1, P165, DOI 10.1021/cb600051w; Matilla MA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r179; Matilla MA, 2010, ENV MICROBIOL REP, V2, P381, DOI 10.1111/j.1758-2229.2009.00091.x; Miyakoshi M, 2007, J BACTERIOL, V189, P6849, DOI 10.1128/JB.00684-07; Molina L, 2000, SOIL BIOL BIOCHEM, V32, P315, DOI 10.1016/S0038-0717(99)00156-X; Morant AV, 2008, PHYTOCHEMISTRY, V69, P1795, DOI 10.1016/j.phytochem.2008.03.006; Nakazawa T, 2002, ENVIRON MICROBIOL, V4, P782, DOI 10.1046/j.1462-2920.2002.00310.x; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Niemeyer HM, 2009, J AGR FOOD CHEM, V57, P1677, DOI 10.1021/jf8034034; NIEMEYER HM, 1988, PHYTOCHEMISTRY, V27, P3349, DOI 10.1016/0031-9422(88)80731-3; Niemeyer HM, 1994, ALLELOPATHY, P260; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Parales RE, 2002, CURR OPIN MICROBIOL, V5, P266, DOI 10.1016/S1369-5274(02)00320-X; Ramos-Gonzalez MI, 2005, J BACTERIOL, V187, P4033, DOI 10.1128/JB.187.12.4033-4041.2005; Rangel-Castro JI, 2005, ENVIRON MICROBIOL, V7, P828, DOI 10.1111/j.1462-2920.2005.00756.x; Robert CAM, 2012, ECOL LETT, V15, P55, DOI 10.1111/j.1461-0248.2011.01708.x; Rudrappa T, 2008, PLANT PHYSIOL, V148, P1547, DOI 10.1104/pp.108.127613; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Song YY, 2011, MYCORRHIZA, V21, P721, DOI 10.1007/s00572-011-0380-4; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van Wees SCM, 2008, CURR OPIN PLANT BIOL, V11, P443, DOI 10.1016/j.pbi.2008.05.005; Whipps JM, 2001, J EXP BOT, V52, P487, DOI 10.1093/jexbot/52.suppl_1.487; Wolanin PM, 2003, BIOCHEMISTRY-US, V42, P14075, DOI 10.1021/bi034883t; WOODWARD MD, 1978, PLANT PHYSIOL, V61, P796, DOI 10.1104/pp.61.5.796	54	279	288	16	222	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35498	10.1371/journal.pone.0035498	http://dx.doi.org/10.1371/journal.pone.0035498			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545111	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000305343200031
J	Schaab, M; Kausch, H; Klammt, J; Nowicki, M; Anderegg, U; Gebhardt, R; Rose-John, S; Scheller, J; Thiery, J; Kratzsch, J				Schaab, Michael; Kausch, Henriette; Klammt, Juergen; Nowicki, Marcin; Anderegg, Ulf; Gebhardt, Rolf; Rose-John, Stefan; Scheller, Juergen; Thiery, Joachim; Kratzsch, Juergen			Novel Regulatory Mechanisms for Generation of the Soluble Leptin Receptor: Implications for Leptin Action	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; TYPE-1 DIABETES-MELLITUS; IN-VIVO; OB-R; RESISTANCE; APOPTOSIS; CLEAVAGE; INSULIN; OBESITY	Background: The adipokine leptin realizes signal transduction via four different membrane-anchored leptin receptor (Ob-R) isoforms in humans. However, the amount of functionally active Ob-R is affected by constitutive shedding of the extracellular domain via a so far unknown mechanism. The product of the cleavage process the so-called soluble leptin receptor (sOb-R) is the main binding protein for leptin in human blood and modulates its bioavailability. sOb-R levels are differentially regulated in metabolic disorders like type 1 diabetes mellitus or obesity and can, therefore, enhance or reduce leptin sensitivity. Methodology/Principal Findings: To describe mechanisms of Ob-R cleavage and to investigate the functional significance of differential sOb-R levels we established a model of HEK293 cells transiently transfected with different human Ob-R isoforms. Using siRNA knockdown experiments we identified ADAM10 (A Disintegrin And Metalloproteinase 10) as a major protease for constitutive and activated Ob-R cleavage. Additionally, the induction of lipotoxicity and apoptosis led to enhanced shedding shown by increased levels of the soluble leptin receptor (sOb-R) in cell supernatants. Conversely, high leptin concentrations and ER stress reduced sOb-R levels. Decreased amounts of sOb-R due to ER stress were accompanied by impaired leptin signaling and reduced leptin binding. Conclusions: Lipotoxicity and apoptosis increased Ob-R cleavage via ADAM10-dependent mechanisms. In contrast high leptin levels and ER stress led to reduced sOb-R levels. While increased sOb-R concentrations seem to directly block leptin action, reduced amounts of sOb-R may reflect decreased membrane expression of Ob-R. These findings could explain changes of leptin sensitivity which are associated with variations of serum sOb-R levels in metabolic diseases.	[Schaab, Michael; Kausch, Henriette; Thiery, Joachim; Kratzsch, Juergen] Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany; [Klammt, Juergen] Univ Leipzig, Hosp Children & Adolescents, Leipzig, Germany; [Nowicki, Marcin] Univ Leipzig, Fac Med, Inst Anat, Leipzig, Germany; [Anderegg, Ulf] Univ Leipzig, Fac Med, Dept Dermatol Venerol & Allergol, Leipzig, Germany; [Gebhardt, Rolf] Univ Leipzig, Fac Med, Inst Biochem, Leipzig, Germany; [Rose-John, Stefan; Scheller, Juergen] Univ Kiel, Inst Biochem, D-2300 Kiel, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University; Leipzig University; University of Kiel	Schaab, M (corresponding author), Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany.	Juergen.Kratzsch@medizin.uni-leipzig.de	Rose-John, Stefan/A-7998-2010; Scheller, Jürgen/K-5290-2015	Rose-John, Stefan/0000-0002-7519-3279; Klammt, Jurgen/0000-0003-2293-9193	Foundation of Pathobiochemistry and Molecular Diagnostics of the German Society of Clinical Chemistry and Laboratory Medicine e.V.; German Science Foundation;  [SFB610 TP B7]	Foundation of Pathobiochemistry and Molecular Diagnostics of the German Society of Clinical Chemistry and Laboratory Medicine e.V.; German Science Foundation(German Research Foundation (DFG)); 	This work was supported by the Foundation of Pathobiochemistry and Molecular Diagnostics of the German Society of Clinical Chemistry and Laboratory Medicine e.V.(http://www.dgkl.de), the SFB610 TP B7 and the German Science Foundation (http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka Y, 2010, BBA-MOL CELL BIOL L, V1801, P1115, DOI 10.1016/j.bbalip.2010.06.009; Amit T, 1997, J CLIN ENDOCR METAB, V82, P3813, DOI 10.1210/jc.82.11.3813; Atkinson LL, 2002, J BIOL CHEM, V277, P29424, DOI 10.1074/jbc.M203813200; Bacart J, 2010, FEBS LETT, V584, P2213, DOI 10.1016/j.febslet.2010.03.033; Bates SH, 2005, CELL METAB, V1, P169, DOI 10.1016/j.cmet.2005.02.001; Batra A, 2010, ENDOCRINOLOGY, V151, P56, DOI 10.1210/en.2009-0565; Belmokhtar CA, 2001, ONCOGENE, V20, P3354, DOI 10.1038/sj.onc.1204436; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Budagian V, 2004, J BIOL CHEM, V279, P40368, DOI 10.1074/jbc.M404125200; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Chan JL, 2002, DIABETES, V51, P2105, DOI 10.2337/diabetes.51.7.2105; DUKSIN D, 1977, J BIOL CHEM, V252, P955; Fujikawa T, 2010, P NATL ACAD SCI USA, V107, P17391, DOI 10.1073/pnas.1008025107; Ge HF, 2002, J BIOL CHEM, V277, P45898, DOI 10.1074/jbc.M205825200; Gutwein P, 2005, CLIN CANCER RES, V11, P2492, DOI 10.1158/1078-0432.CCR-04-1688; Hakulinen J, 2006, J BIOL CHEM, V281, P21369, DOI 10.1074/jbc.M602053200; Hileman SM, 2002, ENDOCRINOLOGY, V143, P775, DOI 10.1210/en.143.3.775; Hosoi T, 2008, MOL PHARMACOL, V74, P1610, DOI 10.1124/mol.108.050070; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Huo L, 2009, CELL METAB, V9, P537, DOI 10.1016/j.cmet.2009.05.003; Kratzsch J, 2006, EUR J ENDOCRINOL, V155, P609, DOI 10.1530/eje.1.02261; Kratzsch J, 2004, EUR J ENDOCRINOL, V151, P475, DOI 10.1530/eje.0.1510475; Kratzsch J, 2002, J CLIN ENDOCR METAB, V87, P4587, DOI 10.1210/jc.2002-020001; Lam QLK, 2010, P NATL ACAD SCI USA, V107, P13812, DOI 10.1073/pnas.1004185107; Lammert A, 2001, BIOCHEM BIOPH RES CO, V283, P982, DOI 10.1006/bbrc.2001.4885; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Lizama C, 2010, BIOCH BIOPHYS ACTA; Lou PH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011669; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Lund IK, 2005, J MOL ENDOCRINOL, V34, P339, DOI 10.1677/jme.1.01694; Maamra M, 2001, ENDOCRINOLOGY, V142, P4389, DOI 10.1210/en.142.10.4389; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Reed AS, 2010, DIABETES, V59, P894, DOI 10.2337/db09-1024; Reinehr T, 2005, INT J OBESITY, V29, P1230, DOI 10.1038/sj.ijo.0803027; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Shapiro NI, 2010, J IMMUNOL, V185, P517, DOI 10.4049/jimmunol.0903975; Sun Q, 2010, DIABETES, V59, P611, DOI 10.2337/db09-1343; Suzuki A, 2007, MOL CELL BIOL, V27, P4317, DOI 10.1128/MCB.02222-06; Tanaka M, 2010, ENDOCR J, V57, P61, DOI 10.1507/endocrj.K09E-296; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Tu H, 2008, J CELL PHYSIOL, V214, P301, DOI 10.1002/jcp.21195; Uotani S, 1999, DIABETES, V48, P279, DOI 10.2337/diabetes.48.2.279; van Dielen FMH, 2002, J CLIN ENDOCR METAB, V87, P1708, DOI 10.1210/jc.87.4.1708; Wang MY, 2010, P NATL ACAD SCI USA, V107, P4813, DOI 10.1073/pnas.0909422107; Wang Y, 2010, J IMMUNOL, V184, P4447, DOI 10.4049/jimmunol.0902925; Wauman J, 2011, J CELL SCI, V124, P921, DOI 10.1242/jcs.078055; White DW, 1997, J BIOL CHEM, V272, P4065, DOI 10.1074/jbc.272.7.4065; Yang GQ, 2004, MOL ENDOCRINOL, V18, P1354, DOI 10.1210/me.2004-0027; Yu X, 2008, P NATL ACAD SCI USA, V105, P14070, DOI 10.1073/pnas.0806993105; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X; Zastrow O, 2003, INT J OBESITY, V27, P1472, DOI 10.1038/sj.ijo.0802432; Zhang JJ, 2009, BRIT J PHARMACOL, V158, P475, DOI 10.1111/j.1476-5381.2009.00246.x; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhang Y, 2000, ENDOCRINOLOGY, V141, P4342, DOI 10.1210/en.141.12.4342; Zhou YT, 1998, DIABETES, V47, P1904, DOI 10.2337/diabetes.47.12.1904; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	61	50	53	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e34787	10.1371/journal.pone.0034787	http://dx.doi.org/10.1371/journal.pone.0034787			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545089	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343200012
J	te Marvelde, L; Schaper, SV; Visser, ME				te Marvelde, Luc; Schaper, Sonja V.; Visser, Marcel E.			A Single Long Day Triggers Follicle Growth in Captive Female Great Tits (Parus major) in Winter but Does Not Affect Laying Dates in the Wild in Spring	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; CLIMATE-CHANGE; FLIGHT PERFORMANCE; JAPANESE-QUAIL; PREDATION RISK; TEMPERATURE; PHOTOPERIOD; PHENOLOGY; CYCLES; FOOD	In many forest passerine bird species, rapid climate warming has led to a phenological mismatch between the period of maximum nestlings' food requirements and the period of maximum food availability (seasonal caterpillar biomass peak) due to an insufficient advancement of the birds' laying dates. The initiation of laying is preceded by the development of the gonads, which in birds are regressed outside the breeding season. Increasing day length in late winter and early spring triggers a cascade of hormones which induces gonadal development. Since day length is not altered by climate change, one potential restriction to advancing laying date is the seasonal timing of gonadal development. To assess the importance of gonadal growth for timing of reproduction we experimentally manipulated the timing of gonadal development. We show that the growth of the largest follicle of captive female great tits (Parus major) increased after being exposed to just a single long day in winter (20 hours of light followed by 4 hours darkness). We then photostimulated wild female great tits from two study areas in a field experiment in spring for a single day and determined their laying date. These populations differed in the availability of food allowing us to test if food availability in combination with photostimulation affected egg laying dates. Despite an expected difference in the onset of gonadal growth, laying dates of photostimulated females did not differ from control females in both populations. These results suggest that wild great tits are not restricted in the advancement of their laying date by limited gonadal development.	[te Marvelde, Luc; Schaper, Sonja V.; Visser, Marcel E.] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	te Marvelde, L (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands.	l.temarvelde@nioo.knaw.nl	Visser, Marcel E/A-9151-2009; KNAW, NIOO-KNAW/A-4320-2012	Visser, Marcel E/0000-0002-1456-1939; KNAW, NIOO-KNAW/0000-0002-3835-159X				AVERY MI, 1984, IBIS, V126, P33, DOI 10.1111/j.1474-919X.1984.tb03661.x; Caro SP, 2012, GEN COMP EN IN PRESS; CREIGHTON JA, 1987, J ENDOCRINOL, V113, P419, DOI 10.1677/joe.0.1130419; Crick HQP, 1999, NATURE, V399, P423, DOI 10.1038/20839; DAWSON A, 1986, IBIS, V128, P572, DOI 10.1111/j.1474-919X.1986.tb02709.x; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; FARNER DS, 1980, ANNU REV PHYSIOL, V42, P457, DOI 10.1146/annurev.ph.42.030180.002325; FOLLETT BK, 1975, GEN COMP ENDOCR, V26, P126, DOI 10.1016/0016-6480(75)90223-3; HEDENSTROM A, 1992, J THEOR BIOL, V158, P535, DOI 10.1016/S0022-5193(05)80714-3; Lambrechts MM, 2000, P ROY SOC B-BIOL SCI, V267, P585, DOI 10.1098/rspb.2000.1041; METCALFE NB, 1995, P ROY SOC B-BIOL SCI, V261, P395, DOI 10.1098/rspb.1995.0165; Murton RK, 1977, AVIAN BREEDING CYCLE; NICHOLLS TJ, 1983, J ENDOCRINOL, V97, P121, DOI 10.1677/joe.0.0970121; Perfito N, 2008, HORM BEHAV, V53, P567, DOI 10.1016/j.yhbeh.2008.01.002; R Development Core Team, 2009, R FDN STAT COMP; Saab SS, 2010, J NEUROENDOCRINOL, V22, P196, DOI 10.1111/j.1365-2826.2010.01954.x; Schaper SV, 2012, AM NAT, V179, pE55, DOI 10.1086/663675; Schaper SV, GEN COMP ENDOC UNPUB; Sharp PJ, 2005, ANN NY ACAD SCI, V1040, P189, DOI 10.1196/annals.1327.024; SILVERIN B, 1994, ETHOL ECOL EVOL, V6, P131, DOI 10.1080/08927014.1994.9522990; Silverin B, 2008, HORM BEHAV, V54, P60, DOI 10.1016/j.yhbeh.2008.01.015; Stevenson IR, 2000, NATURE, V406, P366, DOI 10.1038/35019151; te Marvelde L, 2012, OECOLOGIA, V168, P631, DOI 10.1007/s00442-011-2122-x; VANNOORDWIJK AJ, 1995, J ANIM ECOL, V64, P451, DOI 10.2307/5648; Verboven N, 1998, OIKOS, V81, P511, DOI 10.2307/3546771; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Visser ME, 2011, FUNCT ECOL, V25, P868, DOI 10.1111/j.1365-2435.2011.01844.x; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Visser ME, 1999, OIKOS, V85, P445, DOI 10.2307/3546694; WINGFIELD JC, 1993, GEN COMP ENDOCR, V92, P388, DOI 10.1006/gcen.1993.1176; WITTER MS, 1994, ANIM BEHAV, V48, P201, DOI 10.1006/anbe.1994.1227; ZANN RA, 1995, EMU, V95, P208, DOI 10.1071/MU9950208	33	8	8	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35617	10.1371/journal.pone.0035617	http://dx.doi.org/10.1371/journal.pone.0035617			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545123	Green Published, gold			2022-12-25	WOS:000305343200043
J	Shih, CC; Liao, CC; Su, YC; Tsai, CC; Lin, JG				Shih, Chun-Chuan; Liao, Chien-Chang; Su, Yi-Chang; Tsai, Chin-Chuan; Lin, Jaung-Geng			Gender Differences in Traditional Chinese Medicine Use among Adults in Taiwan	PLOS ONE			English	Article							HEALTH INTERVIEW SURVEY; POPULATION-BASED SURVEY; ALTERNATIVE MEDICINE; UNITED-STATES; WESTERN MEDICINE; ACUPUNCTURE USE; NATIONAL-SURVEY; OBESE WOMEN; COMPLEMENTARY; PATTERNS	Objectives: The increasing use of complementary, alternative medicine (CAM) and traditional Chinese medicine (TCM) has attracted attention. We report on the gender difference in TCM use among the general population in Taiwan in a population-based, cross-sectional study. Methods: We collected data on socio-demographic factors, lifestyle and health behavior from the 2001 Taiwan National Health Interview Survey. The medical records of interviewees aged 20-69 years were obtained from National Health Insurance claims data with informed consent. The prevalence of TCM use and the average frequency of TCM use were compared between women and men. Results: Among 14,064 eligible participants, the one-year prevalence of TCM use for women and men was 31.8% and 22.4%, respectively. Compared with men, women had a higher average TCM use frequency (1.55 visits vs. 1.04 visits, p<0.001). This significant difference remained evident after excluding gender-specific diseases (1.43 visits vs. 1.03 visits, p<0.001). The average TCM use frequency was significantly higher in women than in men across all age groups. TCM use correlates differed for women and men. Marital status (odds ratio [OR] = 1.55, 95% confidence interval [CI] = 1.30-1.85), family income and unhealthy lifestyle (OR = 1.50, 95% CI = 1.30-1.74) were factors associated with TCM use in men but not in women. Conclusions: In Taiwan, women used more TCM services than men and the gender differences in the TCM use profile persisted across age groups.	[Shih, Chun-Chuan; Tsai, Chin-Chuan] I Shou Univ, Sch Chinese Med Postbaccalaureate, Kaohsiung Cty, Taiwan; [Shih, Chun-Chuan; Su, Yi-Chang; Lin, Jaung-Geng] China Med Univ, Coll Chinese Med, Grad Inst Chinese Med, Taichung, Taiwan; [Shih, Chun-Chuan] Taipei Chinese Med Assoc, Taipei, Taiwan; [Liao, Chien-Chang] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Liao, Chien-Chang] Taipei Med Univ, Sch Med, Taipei, Taiwan; [Liao, Chien-Chang] Taipei Med Univ Hosp, Ctr Hlth Res, Taipei, Taiwan; [Liao, Chien-Chang] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan	I Shou University; China Medical University Taiwan; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan	Shih, CC (corresponding author), I Shou Univ, Sch Chinese Med Postbaccalaureate, Kaohsiung Cty, Taiwan.	jglin@mail.cmu.edu.tw		Su, Yi-Chang/0000-0002-8765-5389	Committee on Chinese Medicine and Pharmacy, Department of Health, Taiwan [CCMP98-RD-038]; China Medical University Hospital [1MS1]; Taiwan Department of Health Clinical Trial and Research Center for Excellence [DOH100-TD-B-111-004]; Taiwan Department of Health Cancer Research Center of Excellence [DOH100-TD-C-111-005]	Committee on Chinese Medicine and Pharmacy, Department of Health, Taiwan; China Medical University Hospital; Taiwan Department of Health Clinical Trial and Research Center for Excellence; Taiwan Department of Health Cancer Research Center of Excellence	This study was supported in part by a grant from Committee on Chinese Medicine and Pharmacy, Department of Health, Taiwan (grant number CCMP98-RD-038), China Medical University Hospital (grant number 1MS1), Taiwan Department of Health Clinical Trial and Research Center for Excellence (grant number DOH100-TD-B-111-004) and Taiwan Department of Health Cancer Research Center of Excellence (grant number DOH100-TD-C-111-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes P. M., 2008, COMPLEMENTARY ALTERN; Bishop FL, 2010, EVID-BASED COMPL ALT, V7, P11, DOI 10.1093/ecam/nen023; Buettner C, 2006, BREAST CANCER RES TR, V100, P219, DOI 10.1007/s10549-006-9239-3; Burke A, 2006, J ALTERN COMPLEM MED, V12, P639, DOI 10.1089/acm.2006.12.639; Chang LC, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-170; Chang PJ, 2010, INT J NURS STUD, V47, P13, DOI 10.1016/j.ijnurstu.2009.06.002; Chen FP, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-26; Chen JX, 2006, J ALTERN COMPLEM MED, V12, P763, DOI 10.1089/acm.2006.12.763; Chen YC, 2008, HEPATO-GASTROENTEROL, V55, P467; Chi CH, 1996, SOC SCI MED, V43, P1329, DOI 10.1016/0277-9536(95)00429-7; Chuang CH, 2007, PHARMACOEPIDEM DR S, V16, P464, DOI 10.1002/pds.1332; Chuang CH, 2006, DRUG SAFETY, V29, P537, DOI 10.2165/00002018-200629060-00006; Chuang CH, 2009, INT J NURS STUD, V46, P787, DOI 10.1016/j.ijnurstu.2008.12.015; Chung V, 2007, J ALTERN COMPLEM MED, V13, P361, DOI 10.1089/acm.2006.6152; Chung VCH, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-207; Daly M, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-10; Davis MP, 2003, ARCH PEDIAT ADOL MED, V157, P393, DOI 10.1001/archpedi.157.4.393; Dello Buono M, 2001, J PSYCHOSOM RES, V50, P147, DOI 10.1016/S0022-3999(00)00223-3; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Hanssen B, 2005, SCAND J PRIM HEALTH, V23, P57, DOI 10.1080/02813430510018419; Hsu CH, 2005, J WOMENS HEALTH, V14, P434, DOI 10.1089/jwh.2005.14.434; Hsu CH, 2009, J WOMENS HEALTH, V18, P813, DOI 10.1089/jwh.2008.1005; Huang N, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-18; Kim M, 2002, J COMMUN HEALTH, V27, P109, DOI 10.1023/A:1014509200352; Lai D, 2007, FAM PRACT, V24, P56, DOI 10.1093/fampra/cml058; Liao CC, 2005, TAIWAN J PUBLIC HLTH, V24, P209; Liao CC, 2006, TAIWAN J PUBLIC HLTH, V25, P223; Loh CH, 2009, SINGAP MED J, V50, P1162; MacPherson H, 2006, COMPLEMENT THER MED, V14, P20, DOI 10.1016/j.ctim.2005.07.006; Oliver MI, 2005, BRIT J PSYCHIAT, V186, P297, DOI 10.1192/bjp.186.4.297; Pu CY, 2008, EUR J CANCER CARE, V17, P340, DOI 10.1111/j.1365-2354.2007.00865.x; Shih CC, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-191; Shih CC, 2009, CHINESE MED J-PEKING, V122, P1544, DOI 10.3760/cma.j.issn.0366-6999.2009.13.013; Shih SF, 2008, SOC SCI MED, V67, P1183, DOI 10.1016/j.socscimed.2008.06.011; Shih Y-T, 2003, TAIWAN J PUBLIC HEAL, V22, P419; Shmueli A, 2004, ISRAEL MED ASSOC J, V6, P3; Sikand A, 1998, ARCH PEDIAT ADOL MED, V152, P1059; Thomas KJ, 2001, COMPLEMENT THER MED, V9, P2, DOI 10.1054/ctim.2000.0407; Tindle HA, 2005, ALTERN THER HEALTH M, V11, P42; Upchurch DM, 2008, WOMEN HEALTH ISS, V18, P62, DOI 10.1016/j.whi.2007.08.003; Wu APW, 2007, FAM MED, V39, P195; Yang YH, 2009, CLIMACTERIC, V12, P541, DOI 10.3109/13697130903060081; Yeh LLL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000719; Zhang ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017239	44	70	70	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e32540	10.1371/journal.pone.0032540	http://dx.doi.org/10.1371/journal.pone.0032540			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UP	22539941	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341000004
J	Wu, KH; Hsieh, YH; Tai, PC				Wu, Kai-Hui; Hsieh, Ying-Hsin; Tai, Phang C.			Mutational Analysis of Cvab, an ABC Transporter Involved in the Secretion of Active Colicin V	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTER; CYSTEINE PROTEASE; AROMATIC INTERACTIONS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; SERINE PROTEASES; CATALYTIC TRIAD; OXYANION HOLE; SITE; PAPAIN	CvaB is the central membrane transporter of the colicin V secretion system that belongs to an ATP-binding cassette superfamily. Previous data showed that the N-terminal and C-terminal domains of CvaB are essential for the function of CvaB. N-terminal domain of CvaB possesses Ca2+-dependent cysteine proteolytic activity, and two critical residues, Cys32 and His105, have been identified. In this study, we also identify Asp121 as being the third residue of the putative catalytic triad within the active site of the enzyme. The Asp121 mutants lose both their colicin V secretion activity and N-terminal proteolytic activity. The adjacent residue Pro122 also appears to play a critical role in the colicin V secretion. However, the reversal of the two residues D121P - P122D results in loss of activity. Based on molecular modeling and protein sequence alignment, several residues adjacent to the critical residues, Cys32 and His105, were also examined and characterized. Site-directed mutagenesis of Trp101, Asp102, Val108, Leu76, Gly77, and Gln26 indicate that the neighboring residues around the catalytic triad affect colicin V secretion. Several mutated CvaB proteins with defective secretion were also tested, including Asp121 and Pro122, and were found to be structurally stable. These results indicate that the residues surrounding the identified catalytic triad are functionally involved in the secretion of biologically active colicin V.	[Wu, Kai-Hui; Hsieh, Ying-Hsin; Tai, Phang C.] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Wu, KH (corresponding author), Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA.	biopct@gsu.edu			National Institutes of Health [GM34766]; Georgia State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034766] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM34766 and Georgia State University's Research Enhancement Program. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Asp T, 2004, BBA-PROTEINS PROTEOM, V1699, P111, DOI 10.1016/j.bbapap.2004.02.002; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Bromme D, 1996, BIOCHEMISTRY-US, V35, P3970, DOI 10.1021/bi9523015; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CRAIK CS, 1987, SCIENCE, V237, P909, DOI 10.1126/science.3303334; DESSENS JT, 1991, VIROLOGY, V184, P738, DOI 10.1016/0042-6822(91)90444-G; DRENTH J, 1976, BIOCHEMISTRY-US, V15, P3731, DOI 10.1021/bi00662a014; ENDICOTT JA, 1989, ANNU REV BIOCHEM, V58, P137, DOI 10.1146/annurev.bi.58.070189.001033; FATH MJ, 1994, BIOCHEMISTRY-US, V33, P6911, DOI 10.1021/bi00188a021; GILSON L, 1990, EMBO J, V9, P3875, DOI 10.1002/j.1460-2075.1990.tb07606.x; Hata S, 2001, SEIKAGAKU, V73, P1129; HAVARSTEIN LS, 1995, MOL MICROBIOL, V16, P229, DOI 10.1111/j.1365-2958.1995.tb02295.x; Hwang JW, 1997, J BACTERIOL, V179, P6264, DOI 10.1128/jb.179.20.6264-6270.1997; Im YJ, 2004, J BIOL CHEM, V279, P53451, DOI 10.1074/jbc.M410437200; Ishii S, 2006, J BIOL CHEM, V281, P4726, DOI 10.1074/jbc.M512516200; James R, 1992, BACTERIOCINS MICROCI; Kim MS, 2004, INT J ONCOL, V25, P373; LOEWENTHAL R, 1992, J MOL BIOL, V224, P759, DOI 10.1016/0022-2836(92)90560-7; Maniatis T., 1982, MOL CLONING LAB MANU; MENARD R, 1990, BIOCHEMISTRY-US, V29, P6706, DOI 10.1021/bi00480a021; MENARD R, 1991, BIOCHEMISTRY-US, V30, P8924, DOI 10.1021/bi00101a002; MENARD R, 1992, BIOL CHEM H-S, V373, P393, DOI 10.1515/bchm3.1992.373.2.393; Neuvonen H, 1997, BIOCHEM J, V322, P351, DOI 10.1042/bj3220351; RIORDAN JR, 1989, SCIENCE, V245, P1066; SKVIRSKY RC, 1991, METHOD CELL BIOL, V34, P205; Strobl S, 2000, P NATL ACAD SCI USA, V97, P588, DOI 10.1073/pnas.97.2.588; Tanksale AM, 2000, BIOCHEM BIOPH RES CO, V270, P910, DOI 10.1006/bbrc.2000.2494; Tzeng WP, 2002, J VIROL, V76, P3189, DOI 10.1128/JVI.76.7.3189-3201.2002; VERNET T, 1995, J BIOL CHEM, V270, P16645, DOI 10.1074/jbc.270.28.16645; Wu KH, 2004, J BIOL CHEM, V279, P901, DOI 10.1074/jbc.M308296200; Zhong XT, 1998, J BACTERIOL, V180, P1347, DOI 10.1128/JB.180.6.1347-1353.1998; Zhu MF, 2004, P NATL ACAD SCI USA, V101, P302, DOI 10.1073/pnas.2036536100	33	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35382	10.1371/journal.pone.0035382	http://dx.doi.org/10.1371/journal.pone.0035382			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539970	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341000035
J	Zhao, LY; Stancik, AD; Brown, CJ				Zhao, Luyi; Stancik, Amber D.; Brown, Celeste J.			Differential Transcription of Bacteriophage phi X174 Genes at 37 degrees C and 42 degrees C	PLOS ONE			English	Article							EXONUCLEASE-III ANALYSIS; MESSENGER-RNA; ESCHERICHIA-COLI; IN-VIVO; VIRAL ADAPTATION; TERMINATION; STABILITY; EVOLUTION; PROMOTERS; SEQUENCES	To investigate how high temperature affects viral transcription, the absolute amounts of mRNA for six bacteriophage phi X174 genes were compared at 37 degrees C and 42 degrees C using Q-PCR. At 37 degrees C, mRNA levels for all genes were consistent with previous studies, but at 42uC mRNA levels for four genes were significantly different from levels at 37 degrees C. Transcript levels were higher for genes B and D; the promoter before gene B appears to be up-regulated at high temperature. Levels for genes F and G were reduced at high temperature, possibly due to increased efficiency of the transcription termination signal immediately upstream of gene F. These functional changes in phi X174 gene regulation at high temperature have not been described previously. Studies of phage evolution at high temperatures indicate that this difference in transcript levels is subject to adaptation.	[Zhao, Luyi; Stancik, Amber D.; Brown, Celeste J.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA	Idaho; University of Idaho	Zhao, LY (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.	celesteb@uidaho.edu			National Institutes of Health [NCRR P20RR16448]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Institutes of Health (www.nih.gov) grant NCRR P20RR16448. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 1996, BIOCHIMIE, V78, P1035, DOI 10.1016/S0300-9084(97)86727-2; ARQUINT M, 1987, J VIROL, V61, P3694, DOI 10.1128/JVI.61.12.3694-3700.1987; ARQUINT M, 1994, BBA-GENE STRUCT EXPR, V1218, P339, DOI 10.1016/0167-4781(94)90186-4; Bernal RA, 2003, J MOL BIOL, V325, P11, DOI 10.1016/S0022-2836(02)01201-9; Brown CJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-378; Bull JJ, 1997, GENETICS, V147, P1497; Crill WD, 2000, GENETICS, V154, P27; DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; Ermolaeva MD, 2000, J MOL BIOL, V301, P27, DOI 10.1006/jmbi.2000.3836; Fane B., 2006, BACTERIOPHAGES, P129; FLOOR E, 1970, Journal of Molecular Biology, V47, P293, DOI 10.1016/0022-2836(70)90303-7; Geissmann T, 2009, RNA BIOL, V6, P153, DOI 10.4161/rna.6.2.8047; HARLEY CB, 1987, NUCLEIC ACIDS RES, V15, P2343, DOI 10.1093/nar/15.5.2343; HAYASHI M, 1976, P NATL ACAD SCI USA, V73, P3519, DOI 10.1073/pnas.73.10.3519; HAYASHI M, 1988, BACTERIOPHAGES, P1; HAYASHI MN, 1983, J VIROL, V48, P186, DOI 10.1128/JVI.48.1.186-196.1983; HAYASHI MN, 1981, J VIROL, V38, P198, DOI 10.1128/JVI.38.1.198-207.1981; HAYASHI MN, 1981, J VIROL, V37, P506, DOI 10.1128/JVI.37.1.506-510.1981; HAYASHI MN, 1989, MOL GEN GENET, V216, P364, DOI 10.1007/BF00334377; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; NEIDHARDT FC, 1984, ANNU REV GENET, V18, P295, DOI 10.1146/annurev.ge.18.120184.001455; Ott, 1993, INTRO STAT METHODS D; Rokyta DR, 2006, J BACTERIOL, V188, P1134, DOI 10.1128/JB.188.3.1134-1142.2006; ROSENBERG M, 1979, ANNU REV GENET, V13, P319, DOI 10.1146/annurev.ge.13.120179.001535; Sorensen SE, 1998, BIOCHEM CELL BIOL, V76, P625, DOI 10.1139/bcb-76-4-625; STERNBERG N, 1973, J MOL BIOL, V76, P25, DOI 10.1016/0022-2836(73)90079-X; Wade JT, 2006, NAT STRUCT MOL BIOL, V13, P806, DOI 10.1038/nsmb1130; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422; WILSON KS, 1994, J MOL BIOL, V244, P36, DOI 10.1006/jmbi.1994.1702	30	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35909	10.1371/journal.pone.0035909	http://dx.doi.org/10.1371/journal.pone.0035909			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540010	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341000076
J	Firestone, SM; Cogger, N; Ward, MP; Toribio, JALML; Moloney, BJ; Dhand, NK				Firestone, Simon M.; Cogger, Naomi; Ward, Michael P.; Toribio, Jenny-Ann L. M. L.; Moloney, Barbara J.; Dhand, Navneet K.			The Influence of Meteorology on the Spread of Influenza: Survival Analysis of an Equine Influenza (A/H3N8) Outbreak	PLOS ONE			English	Article							NEW-SOUTH-WALES; ABSOLUTE-HUMIDITY; ENVIRONMENTAL-FACTORS; RELATIVE-HUMIDITY; CLINICAL SIGNS; TRANSMISSION; VIRUSES; HORSES; EPIDEMIOLOGY; INACTIVATION	The influences of relative humidity and ambient temperature on the transmission of influenza A viruses have recently been established under controlled laboratory conditions. The interplay of meteorological factors during an actual influenza epidemic is less clear, and research into the contribution of wind to epidemic spread is scarce. By applying geostatistics and survival analysis to data from a large outbreak of equine influenza (A/H3N8), we quantified the association between hazard of infection and air temperature, relative humidity, rainfall, and wind velocity, whilst controlling for premises-level covariates. The pattern of disease spread in space and time was described using extraction mapping and instantaneous hazard curves. Meteorological conditions at each premises location were estimated by kriging daily meteorological data and analysed as time-lagged time-varying predictors using generalised Cox regression. Meteorological covariates time-lagged by three days were strongly associated with hazard of influenza infection, corresponding closely with the incubation period of equine influenza. Hazard of equine influenza infection was higher when relative humidity was <60% and lowest on days when daily maximum air temperature was 20-25 degrees C. Wind speeds >30 km hour(-1) from the direction of nearby infected premises were associated with increased hazard of infection. Through combining detailed influenza outbreak and meteorological data, we provide empirical evidence for the underlying environmental mechanisms that influenced the local spread of an outbreak of influenza A. Our analysis supports, and extends, the findings of studies into influenza A transmission conducted under laboratory conditions. The relationships described are of direct importance for managing disease risk during influenza outbreaks in horses, and more generally, advance our understanding of the transmission of influenza A viruses under field conditions.	[Firestone, Simon M.; Ward, Michael P.; Toribio, Jenny-Ann L. M. L.; Dhand, Navneet K.] Univ Sydney, Fac Vet Sci, Camden, NSW, Australia; [Cogger, Naomi] Massey Univ, EpiCtr, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand; [Moloney, Barbara J.] New S Wales Govt Dept Primary Ind, Principal Dept Trade & Investment, Reg Infrastruct & Serv, Orange, NSW, Australia	University of Sydney; Massey University; NSW Department of Primary Industries	Firestone, SM (corresponding author), Univ Sydney, Fac Vet Sci, Camden, NSW, Australia.	simon.firestone@sydney.edu.au	Toribio, Jenny-Ann LML/B-5032-2011; Moloney, Barbara Jean/G-2003-2011; Dhand, Navneet K/H-5762-2019; Ward, Michael Patrick/GRX-1851-2022; Ward, Michael Patrick/W-1897-2019; Ward, Michael/C-5758-2009	Moloney, Barbara Jean/0000-0002-4416-3579; Dhand, Navneet K/0000-0002-4362-3596; Ward, Michael Patrick/0000-0002-9921-4986; Ward, Michael/0000-0002-9921-4986; Firestone, Simon/0000-0002-3239-1419	Australian Biosecurity Cooperative Research Centre for Emerging Infectious Diseases; Rural Industries Research and Development Corporation	Australian Biosecurity Cooperative Research Centre for Emerging Infectious Diseases(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Rural Industries Research and Development Corporation	This research was jointly funded by the Australian Biosecurity Cooperative Research Centre for Emerging Infectious Diseases and the Rural Industries Research and Development Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Allison P. D., 2010, SURVIVAL ANAL USING, VSecond; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Animal Health Australia, 2011, DIS STRAT EQ INFL VE; Armitage P, 2001, STAT METHODS MED RES, P356; Australian Government Department of Health and Ageing, 2010, AUSTR HLTH MAN PLAN; BEAN B, 1982, J INFECT DIS, V146, P47, DOI 10.1093/infdis/146.1.47; Belser JA, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001705; Callinan I., 2008, EQUINE INFLUENZA AUG; Center for International Earth Science Information Network International Food Policy Research Institute The World Bank Centro Internacional de Agricultura Tropical, 2011, GLOB RUR URB MAPP PR; Chan T.C., 2010, PLOS ONE, V5; Charland KML, 2009, EPIDEMIOL INFECT, V137, P1377, DOI 10.1017/S0950268809002283; Cowled B, 2009, PREV VET MED, V92, P60, DOI 10.1016/j.prevetmed.2009.08.006; Daly JM, 2011, VET J, V189, P7, DOI 10.1016/j.tvjl.2010.06.026; Davies TM, 2011, J STAT SOFTW, V39, P1; Davies TM, 2010, STAT MED, V29, P2423, DOI 10.1002/sim.3995; Davis J, 2009, TRANSBOUND EMERG DIS, V56, P31, DOI 10.1111/j.1865-1682.2008.01060.x; Dhand NK, 2011, AUST VET J, V89, P73, DOI 10.1111/j.1751-0813.2011.00754.x; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; Dohoo I., 2014, VET EPIDEMIOLOGIC RE, V2nd; du Prel JB, 2009, CLIN INFECT DIS, V49, P861, DOI 10.1086/605435; Dups JN, 2011, AUST VET J, V89, P17, DOI 10.1111/j.1751-0813.2011.00729.x; East IJ, 2011, AUST VET J, V89, P88, DOI 10.1111/j.1751-0813.2011.00756.x; Faehrmann P, 2011, AUST VET J, V89, P22, DOI 10.1111/j.1751-0813.2011.00733.x; Fang LQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002268; Firestone SM, 2012, PREV VET MED, V106, P123, DOI 10.1016/j.prevetmed.2012.01.020; Firestone SM, 2011, PREV VET MED, V102, P185, DOI 10.1016/j.prevetmed.2011.07.006; Firestone SM, 2011, PREV VET MED, V100, P53, DOI 10.1016/j.prevetmed.2011.03.002; Foord AJ, 2009, VET MICROBIOL, V137, P1, DOI 10.1016/j.vetmic.2008.12.006; Garner MG, 2011, PREV VET MED, V99, P15, DOI 10.1016/j.prevetmed.2010.02.007; Garner MG, 1995, POTENTIAL WIND BORNE; Geoscience Australia, 2008, GEODATA 9 2 DIG EL M; Geoscience Australia, 2006, GEOD TOPO 250K 3; Gloster J, 2011, REV SCI TECH OIE, V30, P457; Gloster J, 2010, VET J, V183, P278, DOI 10.1016/j.tvjl.2008.11.011; Harrell FE, 2001, REGRESSION MODELING; HEMMES JH, 1960, NATURE, V188, P430, DOI 10.1038/188430a0; Hosmer DW, 2008, APPL SURVIVAL ANAL R, V2nd; Inggs MR, 1996, IEEE T GEOSCI REMOTE, V34, P250, DOI 10.1109/36.481909; Journel A. G., 1978, MINING GEOSTATISTICS; Kedmi M, 2010, PREV VET MED, V96, P152, DOI 10.1016/j.prevetmed.2010.06.008; Lowen AC, 2008, J VIROL, V82, P5650, DOI 10.1128/JVI.00325-08; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Ma E, 2010, EPIDEMIOL INFECT, V138, P1779, DOI 10.1017/S0950268810002256; Matheron G., 1963, ECON GEOL, V58, P1246, DOI [DOI 10.2113/GSECONGEO.58.8.1246, 10.2113/gsecongeo.58.8.1246]; McDevitt J, 2010, APPL ENVIRON MICROB, V76, P3943, DOI 10.1128/AEM.02674-09; MCGEADY ML, 1979, APPL ENVIRON MICROB, V37, P972, DOI 10.1128/AEM.37.5.972-977.1979; MCQUEEN JL, 1966, AM J EPIDEMIOL, V83, P280, DOI 10.1093/oxfordjournals.aje.a120584; Moloney B, 2011, AUST VET J, V89, P56, DOI 10.1111/j.1751-0813.2011.00749.x; MUMFORD JA, 1990, EQUINE VET J, V22, P93, DOI 10.1111/j.2042-3306.1990.tb04217.x; MUMFORD JA, 1994, EPIDEMIOL INFECT, V112, P421, DOI 10.1017/S0950268800057848; Murray EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024042; Myers C., 2006, Clinical Techniques in Equine Practice, V5, P187, DOI 10.1053/j.ctep.2006.03.013; Paillot R, 2006, VACCINE, V24, P4047, DOI 10.1016/j.vaccine.2006.02.030; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; SCHAFFER FL, 1976, ARCH VIROL, V51, P263, DOI 10.1007/BF01317930; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Shoji M, 2011, TOHOKU J EXP MED, V224, P251, DOI 10.1620/tjem.224.251; Steel J, 2011, J VIROL, V85, P1400, DOI 10.1128/JVI.02186-10; Stevenson M., 2010, EPIR FUNCTIONS ANAL; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; THERNEAU TM, 1990, BIOMETRIKA, V77, P147, DOI 10.1093/biomet/77.1.147; Therneau TM, 2000, MODELING SURVIVAL DA; von Klot S, 2009, EPIDEMIOLOGY, V20, P547, DOI 10.1097/EDE.0b013e31819d9501; Ward MP, 2000, PREV VET MED, V45, P257, DOI 10.1016/S0167-5877(00)00133-1; Weber TP, 2008, J INFECTION, V57, P361, DOI 10.1016/j.jinf.2008.08.013; Wong D, 2011, AUST VET J, V89, P15, DOI 10.1111/j.1751-0813.2011.00728.x; WOOD J, 2007, EQUINE RESP MED SURG, P287; World Bank, 2011, WORLD DEV IND ONL DA; Yadav M. P., 1993, International Journal of Animal Sciences, V8, P93; Yuan JS, 2006, AM J INFECT CONTROL, V34, P234, DOI 10.1016/j.ajic.2005.12.006	72	29	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35284	10.1371/journal.pone.0035284	http://dx.doi.org/10.1371/journal.pone.0035284			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536366	gold, Green Published			2022-12-25	WOS:000305339200049
J	Mahla, RS; Reddy, N; Goel, S				Mahla, Ranjeet Singh; Reddy, Niranjan; Goel, Sandeep			Spermatogonial Stem Cells (SSCs) in Buffalo (Bubalus bubalis) Testis	PLOS ONE			English	Article							PRIMITIVE GERM-CELLS; NEONATAL PIG TESTIS; MOUSE TESTES; IN-VITRO; RETROVIRAL TRANSDUCTION; NUCLEAR TRANSFER; PRION PROTEIN; SELF-RENEWAL; TRANSPLANTATION; LINE	Background: Water buffalo is an economically important livestock species and about half of its total world population exists in India. Development of stem cell technology in buffalo can find application in targeted genetic modification of this species. Testis has emerged as a source of pluripotent stem cells in mice and human; however, not much information is available in buffalo. Objectives and Methods: Pou5f1 (Oct 3/4) is a transcription factor expressed by pluripotent stem cells. Therefore, in the present study, expression of POU5F1 transcript and protein was examined in testes of both young and adult buffaloes by semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) and immunohistochemical analysis. Further, using the testis transplantation assay, a functional assay for spermatogonial stem cells (SSCs), stem cell potential of gonocytes/spermatogonia isolated from prepubertal buffalo testis was also determined. Results: Expression of POU5F1transcript and protein was detected in prepubertal and adult buffalo testes. Western blot analysis revealed that the POU5F1 protein in the buffalo testis exists in two isoforms; large (similar to 47 kDa) and small (similar to 21 kDa). Immunohistochemical analysis revealed that POU5F1 expression in prepubertal buffalo testis was present in gonocytes/spermatogonia and absent from somatic cells. In the adult testis, POU5F1 expression was present primarily in post-meiotic germ cells such as round spermatids, weakly in spermatogonia and spermatocytes, and absent from elongated spermatids. POU5F1 protein expression was seen both in cytoplasm and nuclei of the stained germ cells. Stem cell potential of prepubertal buffalo gonocytes/spermatogonia was confirmed by the presence of colonized DBA-stained cells in the basal membrane of seminiferous tubules of xenotransplanted mice testis. Conclusion/Significance: These findings strongly indicate that gonocytes/spermatogonia, isolated for prepubertal buffalo testis can be a potential target for establishing a germ stem cell line that would enable genetic modification of buffaloes.	[Mahla, Ranjeet Singh; Reddy, Niranjan; Goel, Sandeep] CSIR, Ctr Cellular & Mol Biol, Lab Conservat Endangered Species, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Goel, S (corresponding author), CSIR, Ctr Cellular & Mol Biol, Lab Conservat Endangered Species, Hyderabad, Andhra Pradesh, India.	sandeep@ccmb.res.in	Goel, Sandeep/C-5985-2009; Mahla, Ranjeet/J-4691-2016; Mahla, Ranjeet/J-4691-2016	Goel, Sandeep/0000-0001-7485-5392; Mahla, Ranjeet/0000-0002-5525-8442; Mahla, Ranjeet/0000-0002-4351-9385	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR 10908/MED/31/35/2008]	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This work was supported by grants from Department of Biotechnology, Ministry of Science and Technology, Government of India (Grant No. BT/PR 10908/MED/31/35/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borghese A., 2006, BUFFALO PRODUCTION R, P1; Brehm A, 1998, APMIS, V106, P114, DOI 10.1111/j.1699-0463.1998.tb01326.x; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Clouthier DE, 1996, NATURE, V381, P418, DOI 10.1038/381418a0; Denning C, 2001, NAT BIOTECHNOL, V19, P559, DOI 10.1038/89313; Dobrinski I, 1999, BIOL REPROD, V61, P1331, DOI 10.1095/biolreprod61.5.1331; Dobrinski I, 2000, MOL REPROD DEV, V57, P270, DOI 10.1002/1098-2795(200011)57:3&lt;270::AID-MRD9&gt;3.0.CO;2-Z; Donovan PJ, 2003, CURR OPIN GENET DEV, V13, P463, DOI 10.1016/j.gde.2003.08.010; Fujihara M, 2011, J REPROD DEVELOP, V57, P355, DOI 10.1262/jrd.10-185M; Goel S, 2008, REPRODUCTION, V135, P785, DOI 10.1530/REP-07-0476; Goel S, 2011, ANIM REPROD SCI, V126, P251, DOI 10.1016/j.anireprosci.2011.05.012; Goel S, 2010, THERIOGENOLOGY, V74, P1221, DOI 10.1016/j.theriogenology.2010.05.025; Goel S, 2009, REPROD FERT DEVELOP, V21, P696, DOI 10.1071/RD08176; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Hamra FK, 2005, P NATL ACAD SCI USA, V102, P17430, DOI 10.1073/pnas.0508780102; Hamra FK, 2002, P NATL ACAD SCI USA, V99, P14931, DOI 10.1073/pnas.222561399; He ZP, 2010, BIOL REPROD, V82, P363, DOI 10.1095/biolreprod.109.078550; Izadyar F, 2002, REPRODUCTION, V124, P85, DOI 10.1530/rep.0.1240085; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kanatsu-Shinohara M, 2005, BIOL REPROD, V72, P985, DOI 10.1095/biolreprod.104.036400; Kanatsu-Shinohara M, 2004, BIOL REPROD, V71, P1202, DOI 10.1095/biolreprod.104.031294; Kanatsu-Shinohara M, 2006, P NATL ACAD SCI USA, V103, P8018, DOI 10.1073/pnas.0601139103; Kanatsu-Shinohara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023663; Kim Y, 2006, J ANDROL, V27, P248, DOI 10.2164/jandrol.05034; Kubota H, 2004, BIOL REPROD, V71, P722, DOI 10.1095/biolreprod.104.029207; Kuroiwa Y, 2004, NAT GENET, V36, P775, DOI 10.1038/ng1373; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Lee J, 2011, CELL RES, V21, P1164, DOI 10.1038/cr.2011.111; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; McCreath KJ, 2000, NATURE, V405, P1066, DOI 10.1038/35016604; Mitchell RT, 2008, HUM REPROD, V23, P2755, DOI 10.1093/humrep/den295; Moore TJ, 2002, ENDOCRINOLOGY, V143, P3171, DOI 10.1210/en.143.8.3171; Nagano M, 1998, TISSUE CELL, V30, P389, DOI 10.1016/S0040-8166(98)80053-0; Nagano M, 2003, BIOL REPROD, V68, P2207, DOI 10.1095/biolreprod.102.014050; Nagano M, 2001, P NATL ACAD SCI USA, V98, P13090, DOI 10.1073/pnas.231473498; Nagano M, 2000, FEBS LETT, V475, P7, DOI 10.1016/S0014-5793(00)01606-9; Nagano M, 2001, BIOL REPROD, V64, P1409, DOI 10.1095/biolreprod64.5.1409; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Ogawa T, 1999, BIOL REPROD, V60, P515, DOI 10.1095/biolreprod60.2.515; Ohbo K, 2003, DEV BIOL, V258, P209, DOI 10.1016/S0012-1606(03)00111-8; Ovitt CE, 1998, MOL HUM REPROD, V4, P1021, DOI 10.1093/molehr/4.11.1021; Perera B, 2008, REPROD DOMEST ANIM, V43, P200, DOI 10.1111/j.1439-0531.2008.01162.x; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Pesce M, 1998, BIOESSAYS, V20, P722, DOI 10.1002/(SICI)1521-1878(199809)20:9&lt;722::AID-BIES5&gt;3.0.CO;2-I; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Shinohara T, 2003, BIOL REPROD, V68, P1064, DOI 10.1095/biolreprod.102.009977; Singh N, 2012, GENE, V491, P165, DOI 10.1016/j.gene.2011.09.036; Singh SR, 2011, J CELL MOL MED, V15, P468, DOI 10.1111/j.1582-4934.2010.01242.x; Surani MA, 2001, NATURE, V414, P122, DOI 10.1038/35102186; Tadokoro Y, 2002, MECH DEVELOP, V113, P29, DOI 10.1016/S0925-4773(02)00004-7; Yoshida S, 2010, DEV GROWTH DIFFER, V52, P311, DOI 10.1111/j.1440-169X.2010.01174.x	52	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e36020	10.1371/journal.pone.0036020	http://dx.doi.org/10.1371/journal.pone.0036020			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536454	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200126
J	Dang, X; Wuthrich, C; Gordon, J; Sawa, H; Koralnik, IJ				Dang, Xin; Wuethrich, Christian; Gordon, Jennifer; Sawa, Hirofumi; Koralnik, Igor J.			JC Virus Encephalopathy Is Associated with a Novel Agnoprotein-Deletion JCV Variant	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PRODUCTIVE INFECTION; GLIAL-CELLS; T-ANTIGEN; NEURONS; PROTEIN; BRAIN; SIMIAN-VIRUS-40; DISSOCIATION; NATALIZUMAB	JC virus encephalopathy (JCVE) is a newly described gray matter disease of the brain caused by productive infection of cortical pyramidal neurons. We characterized the full length sequence of JCV isolated from the brain of a JCVE patient, analyzed its distribution in various compartments by PCR, and determined viral gene expression in the brain by immunohistochemistry(IHC). We identified a novel JCV variant, JCV(CPN1), with a unique 143 bp deletion in the Agno gene encoding a truncated 10 amino acid peptide, and harboring an archetype-like regulatory region. This variant lacked one of three nuclear protein binding regions in the Agno gene. It was predominant in the brain, where it coexisted with an Agno-intact wild-type strain. Double immunostaining with anti-Agno and anti-VP1 antibodies demonstrated that the truncated JCVCPN1 Agno peptide was present in the majority of cortical cells productively infected with JCV. We then screened 68 DNA samples from 8 brain, 30 CSF and 30 PBMC samples of PML patients, HIV+and HIV-control subjects. Another JCV(CPN) strain with a different pattern of Agno-deletion was found in the CSF of an HIV+/PML patient, where it also coexisted with wildtype, Agno-intact JCV. These findings suggest that the novel tropism for cortical pyramidal neurons of JCV(CPN1,) may be associated with the Agno deletion. Productive and lytic infection of these cells, resulting in fulminant JCV encephalopathy and death may have been facilitated by the co-infection with a wild-type strain of JCV.	[Dang, Xin; Wuethrich, Christian; Koralnik, Igor J.] Beth Israel Deaconess Med Ctr, Dept Neurol, Div Neurovirol, Boston, MA 02215 USA; [Dang, Xin; Wuethrich, Christian; Koralnik, Igor J.] Beth Israel Deaconess Med Ctr, Dept Med, Div Viral Pathogenesis, Boston, MA 02215 USA; [Gordon, Jennifer] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA; [Gordon, Jennifer] Temple Univ, Sch Med, Ctr Neurovirol, Philadelphia, PA 19122 USA; [Sawa, Hirofumi] Hokkaido Univ, Dept Mol Pathobiol, Res Ctr Zoonosis Control, Global COE Program Zoonosis Control, Sapporo, Hokkaido, Japan	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Hokkaido University	Dang, X (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Div Neurovirol, Boston, MA 02215 USA.	ikoralni@bidmc.harvard.edu	Sawa, Hirofumi/F-6954-2012; Sawa, Hirofumi/AAW-8816-2021	Sawa, Hirofumi/0000-0003-2569-2755; 	Public Health Service [R01 NS 047029, R01 NS 074995, R56 NS 041198, K24 NS 060950]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS041198, K24NS060950, R01NS047029, R01NS074995] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by Public Health Service R01 NS 047029, R01 NS 074995, R56 NS 041198, and K24 NS 060950 to Dr. Koralnik. Funders website: www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGOSTINI HT, 1995, J NEUROVIROL, V1, P316, DOI 10.3109/13550289509114028; Akan I, 2006, VIROLOGY, V349, P66, DOI 10.1016/j.virol.2006.01.025; Ashok A, 2003, J VIROL, V77, P1347, DOI 10.1128/JVI.77.2.1347-1356.2003; Carson KR, 2009, BLOOD, V113, P4834, DOI 10.1182/blood-2008-10-186999; Dang X, 2008, J NEUROPATH EXP NEUR, V67, P784, DOI 10.1097/NEN.0b013e318180f0d5; Dang X, 2006, J GEN VIROL, V87, P2533, DOI 10.1099/vir.0.81945-0; Del Valle L, 2002, JNCI-J NATL CANCER I, V94, P267, DOI 10.1093/jnci/94.4.267; Du Pasquier RA, 2003, NEUROLOGY, V61, P775, DOI 10.1212/01.WNL.0000081306.86961.33; Jensen PN, 2001, J NEUROVIROL, V7, P280; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Koralnik IJ, 2005, ANN NEUROL, V57, P576, DOI 10.1002/ana.20431; Major EO, 2010, ANNU REV MED, V61, P35, DOI 10.1146/annurev.med.080708.082655; Okada Y, 2005, EMBO REP, V6, P452, DOI 10.1038/sj.embor.7400406; Okada Y, 2002, ACTA NEUROPATHOL, V104, P130, DOI 10.1007/s00401-002-0526-8; Okada Y, 2001, J NEUROVIROL, V7, P302; Safak M, 2001, J VIROL, V75, P1476, DOI 10.1128/JVI.75.3.1476-1486.2001; Sariyer IK, 2006, J VIROL, V80, P3893, DOI 10.1128/JVI.80.8.3893-3903.2006; Sariyer IK, 2008, VIROLOGY, V375, P464, DOI 10.1016/j.virol.2008.02.020; Suzuki T, 2005, J BIOL CHEM, V280, P24948, DOI 10.1074/jbc.M411499200; Suzuki T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000801; Tan CS, 2010, J VIROL, V84, P9200, DOI 10.1128/JVI.00609-10; Tyler KL, 2003, NEUROLOGY, V61, P734, DOI 10.1212/WNL.61.6.734; Van Assche G, 2005, NEW ENGL J MED, V353, P362, DOI 10.1056/NEJMoa051586; Weber T, 1997, J INFECT DIS, V176, P250, DOI 10.1086/514032; Wuthrich C, 2012, J NEUROPATH EXP NEUR, V71, P54, DOI 10.1097/NEN.0b013e31823ede59; Wuthrich C, 2009, ANN NEUROL, V65, P742, DOI 10.1002/ana.21619	26	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35793	10.1371/journal.pone.0035793	http://dx.doi.org/10.1371/journal.pone.0035793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536439	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336200068
J	Niu, KC; Schmid, B; Choler, P; Du, GZ				Niu, Kechang; Schmid, Bernhard; Choler, Philippe; Du, Guozhen			Relationship between Reproductive Allocation and Relative Abundance among 32 Species of a Tibetan Alpine Meadow: Effects of Fertilization and Grazing	PLOS ONE			English	Article							COMMUNITY STRUCTURE; FUNCTIONAL TRAITS; PLANT-COMMUNITIES; DIVERSITY LOSS; LIFE-HISTORY; TRADE-OFFS; LAND-USE; COMPETITION; COEXISTENCE; ECOLOGY	Background: Understanding the relationship between species traits and species abundance is an important goal in ecology and biodiversity science. Although theoretical studies predict that traits related to performance (e.g. reproductive allocation) are most directly linked to species abundance within a community, empirical investigations have rarely been done. It also remains unclear how environmental factors such as grazing or fertilizer application affect the predicted relationship. Methodology: We conducted a 3-year field experiment in a Tibetan alpine meadow to assess the relationship between plant reproductive allocation (RA) and species relative abundance (SRA) on control, grazed and fertilized plots. Overall, the studied plant community contained 32 common species. Principal Findings: At the treatment level, (i) RA was negatively correlated with SRA on control plots and during the first year on fertilized plots. (ii) No negative RA-SRA correlations were observed on grazed plots and during the second and third year on fertilized plots. (iii) Seed size was positively correlated with SRA on control plots. At the plot level, the correlation between SRA and RA were not affected by treatment, year or species composition. Conclusions/Significance: Our study shows that the performance-related trait RA can negatively affect SRA within communities, which is possibly due to the tradeoffs between clonal growth (for space occupancy) and sexual reproduction. We propose that if different species occupy different positions along these tradeoffs it will contribute to biodiversity maintenance in local communities or even at lager scale.	[Niu, Kechang] Nanjing Univ, Dept Biol, Nanjing 210008, Peoples R China; [Niu, Kechang; Du, Guozhen] Lanzhou Univ, MOE Key Lab Arid & Grassland Ecol, Lanzhou 730000, Peoples R China; [Schmid, Bernhard] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Choler, Philippe] Univ Grenoble, CNRS, UMR 5553, Lab Ecol Alpine, Grenoble, France; [Choler, Philippe] Univ Grenoble, CNRS, UMS 3370, Stn Alpine J Fourier, Grenoble, France	Nanjing University; Lanzhou University; University of Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Niu, KC (corresponding author), Nanjing Univ, Dept Biol, Nanjing 210008, Peoples R China.	kechangniu@nju.edu.cn	Schmid, Bernhard/C-8625-2009; Choler, Philippe/A-7270-2008; Niu, Kechang/F-7648-2014	Schmid, Bernhard/0000-0002-8430-3214; Choler, Philippe/0000-0002-9062-2721; Niu, Kechang/0000-0003-4845-2930	National Science Foundation of China [31000198, 40930533]; Swiss National Science Foundation [130720]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was supported by the National Science Foundation of China (Grant no 31000198 to Kechang Niu and no 40930533 to Guozhen Du). B. Schmid was supported by the Swiss National Science Foundation (Grant no. 130720). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2006, ECOLOGY, V87, pS50, DOI 10.1890/0012-9658(2006)87[50:NEAART]2.0.CO;2; Bazzaz, 1996, PLANTS CHANGING ENV; Bazzaz Fakhri A., 1997, P1, DOI 10.1016/B978-012083490-7/50002-5; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Cadotte MW, 2007, ECOLOGY, V88, P823, DOI 10.1890/06-1117; Carson WP., 2008, TROPICAL FOREST COMM, P210; CHEPLICK GP, 1989, CAN J BOT, V67, P2514, DOI 10.1139/b89-321; CONNELL JH, 1984, ECOL MONOGR, V54, P141, DOI 10.2307/1942659; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Cornwell WK, 2010, J ECOL, V98, P814, DOI 10.1111/j.1365-2745.2010.01662.x; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; Diaz S, 1998, J VEG SCI, V9, P113, DOI 10.2307/3237229; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Fakheran S, 2010, P NATL ACAD SCI USA, V107, P19120, DOI 10.1073/pnas.1010846107; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; GLEESON SK, 1990, ECOLOGY, V71, P1144, DOI 10.2307/1937382; Grime J. P., 1979, Plant strategies and vegetation processes.; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Hubbell Stephen P., 2001, V32, pi; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; Kelly CK, 2008, ECOLOGY, V89, P962, DOI 10.1890/07-0322.1; Kneitel JM, 2004, ECOL LETT, V7, P69, DOI 10.1046/j.1461-0248.2003.00551.x; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Leishman MR, 2001, OIKOS, V94, P151, DOI 10.1034/j.1600-0706.2001.10392.x; Leishman MR, 2001, OIKOS, V93, P294, DOI 10.1034/j.1600-0706.2001.930212.x; LEVIN SA, 1974, P NATL ACAD SCI USA, V71, P2744, DOI 10.1073/pnas.71.7.2744; Levine JM, 2002, AM NAT, V160, P452, DOI 10.1086/342073; LEVINS R, 1971, P NATL ACAD SCI USA, V68, P1246, DOI 10.1073/pnas.68.6.1246; Li W, 2011, NORD J BOT, V29, P81, DOI 10.1111/j.1756-1051.2010.00954.x; Luo YJ, 2006, J VEG SCI, V17, P417, DOI 10.1658/1100-9233(2006)17[417:IOATAF]2.0.CO;2; Maechler M., 2011, LME4 LINEAR MIXED EF; Martin PH, 2010, OIKOS, V119, P807, DOI 10.1111/j.1600-0706.2009.17941.x; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; Murray BR, 2002, AUSTRAL ECOL, V27, P291, DOI 10.1046/j.1442-9993.2002.01181.x; NEWMAN EI, 1973, NATURE, V244, P310, DOI 10.1038/244310a0; Niu Ke-Chang, 2006, Zhiwu Shengtai Xuebao, V30, P817; Niu KC, 2008, BASIC APPL ECOL, V9, P485, DOI 10.1016/j.baae.2007.06.015; Niu KC, 2010, PLANT SOIL, V330, P215, DOI 10.1007/s11104-009-0194-8; Niu KC, 2009, FUNCT ECOL, V23, P274, DOI 10.1111/j.1365-2435.2008.01502.x; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PINHEIRO JC, 2011, NLME LINEAR NONLINEA, V3, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018860; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Prinzing A, 2008, ECOL LETT, V11, P809, DOI 10.1111/j.1461-0248.2008.01189.x; R Development Core Team, 2011, R LANG ENV STAT COMO; Rajaniemi TK, 2003, OIKOS, V101, P449, DOI 10.1034/j.1600-0706.2003.12128.x; Reader RJ, 1998, PLANT ECOL, V134, P43, DOI 10.1023/A:1009700100343; Reekie EG, 2005, REPROD ALLOCATION PL, P191; Shea K, 2004, ECOL LETT, V7, P491, DOI 10.1111/j.1461-0248.2004.00600.x; Shipley B, 2006, SCIENCE, V314, P812, DOI 10.1126/science.1131344; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; Stearns S.C., 1992, pi; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; Suding KN, 2003, ECOLOGY, V84, P1; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tilman D, 2000, NATURE, V405, P208, DOI 10.1038/35012217; TILMAN D, 1988; Turnbull LA, 2004, J ECOL, V92, P97, DOI 10.1111/j.1365-2745.2004.00856.x; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Vojtech E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000499; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Westoby M, 2006, TRENDS ECOL EVOL, V21, P261, DOI 10.1016/j.tree.2006.02.004; [赵彬彬 ZHAO Bin-Bin], 2009, [生态学报, Acta Ecologica Sinica], V29, P1596	71	22	24	5	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35448	10.1371/journal.pone.0035448	http://dx.doi.org/10.1371/journal.pone.0035448			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536385	Green Published, Green Accepted, gold			2022-12-25	WOS:000305336200042
J	Opalinski, L; Bartoszewska, M; Fekken, S; Liu, HY; de Boer, R; van der Klei, I; Veenhuis, M; Kiel, JAKW				Opalinski, Lukasz; Bartoszewska, Magdalena; Fekken, Susan; Liu, Haiyin; de Boer, Rinse; van der Klei, Ida; Veenhuis, Marten; Kiel, Jan A. K. W.			De Novo Peroxisome Biogenesis in Penicillium Chrysogenum Is Not Dependent on the Pex11 Family Members or Pex16	PLOS ONE			English	Article							YEAST HANSENULA-POLYMORPHA; ENDOPLASMIC-RETICULUM; MEMBRANE BIOGENESIS; TARGETING SIGNALS; FILAMENTOUS FUNGI; MAMMALIAN-CELLS; FISSION; PROTEIN; BIOSYNTHESIS; DIVISION	We have analyzed the role of the three members of the Pex11 protein family in peroxisome formation in the filamentous fungus Penicillium chrysogenum. Two of these, Pex11 and Pex11C, are components of the peroxisomal membrane, while Pex11B is present at the endoplasmic reticulum. We show that Pex11 is a major factor involved in peroxisome proliferation. We also demonstrate that P. chrysogenum cells deleted for known peroxisome fission factors (all Pex11 family proteins and Vps1) still contain peroxisomes. Interestingly, we find that, unlike in mammals, Pex16 is not essential for peroxisome biogenesis in P. chrysogenum, as partially functional peroxisomes are present in a pex16 deletion strain. We also show that Pex16 is not involved in de novo biogenesis of peroxisomes, as peroxisomes were still present in quadruple Delta pex11 Delta pex11B Delta pex11C Delta pex16 mutant cells. By contrast, pex3 deletion in P. chrysogenum led to cells devoid of peroxisomes, suggesting that Pex3 may function independently of Pex16. Finally, we demonstrate that the presence of intact peroxisomes is important for the efficiency of beta-lactam antibiotics production by P. chrysogenum. Remarkably, distinct from earlier results with low penicillin producing laboratory strains, upregulation of peroxisome numbers in a high producing P. chrysogenum strain had no significant effect on penicillin production.	[Opalinski, Lukasz; Bartoszewska, Magdalena; Fekken, Susan; Liu, Haiyin; de Boer, Rinse; van der Klei, Ida; Veenhuis, Marten; Kiel, Jan A. K. W.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst GBB, Kluyver Ctr Genom Ind Fermentat, Ag Groningen, Netherlands	University of Groningen	Opalinski, L (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst GBB, Kluyver Ctr Genom Ind Fermentat, Ag Groningen, Netherlands.	J.A.K.W.Kiel@RUG.nl	van der Klei, Ida J/D-1919-2012	Van der Klei, Ida J./0000-0001-7165-9679; Opalinska, Magdalena/0000-0003-1449-4243; Liu, Haiyin/0000-0003-3103-6949; Opalinski, Lukasz/0000-0001-9656-8714	Kluyver Centre for Genomics of Industrial Fermentation, part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research; Netherlands Ministry of Economic Affairs; B-Basic partner organizations through B-Basic; IBOS Programme (Integration of Biosynthesis and Organic Synthesis), part of Advanced Chemical Technologies for Sustainability (ACTS)	Kluyver Centre for Genomics of Industrial Fermentation, part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research; Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); B-Basic partner organizations through B-Basic; IBOS Programme (Integration of Biosynthesis and Organic Synthesis), part of Advanced Chemical Technologies for Sustainability (ACTS)	L.O. and M.B. were financially supported by the research programme of the Kluyver Centre for Genomics of Industrial Fermentation, which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research. J.A.K.W.K. and S.F. were financially supported by the Netherlands Ministry of Economic Affairs and the B-Basic partner organizations (www.b-basic.nl) through B-Basic, a public-private NWO-ACTS programme (ACTS = Advanced Chemical Technologies for Sustainability). R.d.B. was supported by the IBOS Programme (Integration of Biosynthesis and Organic Synthesis), which is part of Advanced Chemical Technologies for Sustainability (ACTS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal G, 2011, P NATL ACAD SCI USA, V108, P9113, DOI 10.1073/pnas.1018749108; Aksam EB, 2009, FEMS YEAST RES, V9, P808, DOI 10.1111/j.1567-1364.2009.00534.x; Antonenkov VD, 2011, BIOCH BIOPHYS ACTA; Bartoszewska M, 2011, BIOTECHNOL LETT, V33, P1921, DOI 10.1007/s10529-011-0664-y; CANTORAL JM, 1987, BIO-TECHNOL, V5, P494, DOI 10.1038/nbt0587-494; Eitzen GA, 1997, J CELL BIOL, V137, P1265, DOI 10.1083/jcb.137.6.1265; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Gidijala L, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-29; Guo T, 2007, J CELL BIOL, V177, P289, DOI 10.1083/jcb.200609072; Hoepfner D, 2001, J CELL BIOL, V155, P979, DOI 10.1083/jcb.200107028; Honsho M, 1998, AM J HUM GENET, V63, P1622, DOI 10.1086/302161; Honsho M, 2002, J BIOL CHEM, V277, P44513, DOI 10.1074/jbc.M206139200; Huber A, 2012, TRAFFIC, V13, P157, DOI 10.1111/j.1600-0854.2011.01290.x; Karnik SK, 2007, J EXP BOT, V58, P1677, DOI 10.1093/jxb/erm018; Karnik SK, 2005, PLANT PHYSIOL, V138, P1967, DOI [10.1104/pp.105.061291, 10.1104/PP.105.061291]; Kiel JAKW, 2005, FUNGAL GENET BIOL, V42, P154, DOI 10.1016/j.fgb.2004.10.010; Kiel JAKW, 2004, FUNGAL GENET BIOL, V41, P708, DOI 10.1016/j.fgb.2004.02.006; Kiel JAKW, 2006, TRAFFIC, V7, P1291, DOI 10.1111/j.1600-0854.2006.00479.x; Kiel JAKW, 2009, FUNCT INTEGR GENOMIC, V9, P167, DOI 10.1007/s10142-009-0110-6; Kim PK, 2006, J CELL BIOL, V173, P521, DOI 10.1083/jcb.200601036; Koch A, 2005, MOL BIOL CELL, V16, P5077, DOI 10.1091/mbc.E05-02-0159; Koch Johannes, 2011, Biomol Concepts, V2, P353; Koch J, 2010, J CELL SCI, V123, P3389, DOI 10.1242/jcs.064907; Kuravi K, 2006, J CELL SCI, V119, P3994, DOI 10.1242/jcs.03166; Lam SK, 2011, P NATL ACAD SCI USA, V108, pE51, DOI 10.1073/pnas.1103526108; Li XL, 2003, J BIOL CHEM, V278, P17012, DOI 10.1074/jbc.M212031200; Lingard MJ, 2008, PLANT CELL, V20, P1567, DOI 10.1105/tpc.107.057679; Lingard MJ, 2006, J CELL SCI, V119, P1961, DOI 10.1242/jcs.02904; Martin JF, 2012, J IND MICROBIOL BIOT, V39, P367, DOI 10.1007/s10295-011-1063-z; Matsuzaki T, 2008, J CELL BIOL, V183, P1275, DOI 10.1083/jcb.200806062; Meijer WH, 2010, APPL ENVIRON MICROB, V76, P5702, DOI 10.1128/AEM.02327-09; Motley AM, 2008, J CELL SCI, V121, P1633, DOI 10.1242/jcs.026344; Motley AM, 2007, J CELL BIOL, V178, P399, DOI 10.1083/jcb.200702167; MULLER WH, 1991, EMBO J, V10, P489, DOI 10.1002/j.1460-2075.1991.tb07971.x; Nagotu S, 2008, BBA-MOL CELL RES, V1783, P760, DOI 10.1016/j.bbamcr.2007.10.018; Nuttall JM, 2011, CURR OPIN CELL BIOL, V23, P421, DOI 10.1016/j.ceb.2011.05.005; Opalinski L, 2011, INT J BIOCHEM CELL B, V43, P847, DOI 10.1016/j.biocel.2011.03.006; Opalinski L, 2011, EMBO J, V30, P5, DOI 10.1038/emboj.2010.299; Opalinski L, 2010, FEBS J, V277, P3203, DOI 10.1111/j.1742-4658.2010.07726.x; Sambrook J., 2002, MOL CLONING LAB MANU; Saraya R, 2011, J CELL BIOL, V193, P885, DOI 10.1083/jcb.201012083; Saraya R, 2010, FEBS J, V277, P3279, DOI 10.1111/j.1742-4658.2010.07740.x; Schliebs W, 2004, CURR BIOL, V14, pR397, DOI 10.1016/j.cub.2004.05.017; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toro AA, 2009, J CELL BIOCHEM, V107, P1083, DOI 10.1002/jcb.22210; van den Berg MA, 2008, NAT BIOTECHNOL, V26, P1161, DOI 10.1038/nbt.1498; van der Klei IJ, 2006, BBA-MOL CELL RES, V1763, P1364, DOI 10.1016/j.bbamcr.2006.09.014; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; WATERHAM HR, 1994, J CELL BIOL, V127, P737, DOI 10.1083/jcb.127.3.737; Zhang XC, 2010, PLANT CELL, V22, P431, DOI 10.1105/tpc.109.071324	50	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35490	10.1371/journal.pone.0035490	http://dx.doi.org/10.1371/journal.pone.0035490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536392	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336200046
J	Tang, S; Mishra, M; Frazier, DP; Moore, ML; Inoue, K; Deora, R; Sui, GC; Dubey, P				Tang, Shuai; Mishra, Meenu; Frazier, Donna P.; Moore, Miranda L.; Inoue, Kazushi; Deora, Rajendar; Sui, Guangchao; Dubey, Purnima			Positive and Negative Regulation of Prostate Stem Cell Antigen Expression by Yin Yang 1 in Prostate Epithelial Cell Lines	PLOS ONE			English	Article							TRANSCRIPTION FACTOR YY1; CANCER DEVELOPMENT; GENETIC-VARIATION; PSCA; CARCINOMA; DELETION; IDENTIFICATION; YIN-YANG-1; TUMORS; PTEN	Prostate cancer is influenced by epigenetic modification of genes involved in cancer development and progression. Increased expression of Prostate Stem Cell Antigen (PSCA) is correlated with development of malignant human prostate cancer, while studies in mouse models suggest that decreased PSCA levels promote prostate cancer metastasis. These studies suggest that PSCA has context-dependent functions, and could be differentially regulated during tumor progression. In the present study, we identified the multi-functional transcription factor Yin Yang 1 (YY1) as a modulator of PSCA expression in prostate epithelial cell lines. Increased YY1 levels are observed in prostatic intraepithelial neoplasia (PIN) and advanced disease. We show that androgen-mediated up-regulation of PSCA in prostate epithelial cell lines is dependent on YY1. We identified two direct YY1 binding sites within the PSCA promoter, and showed that the upstream site inhibited, while the downstream site, proximal to the androgen-responsive element, stimulated PSCA promoter activity. Thus, changes in PSCA expression levels in prostate cancer may at least partly be affected by cellular levels of YY1. Our results also suggest multiple roles for YY1 in prostate cancer which may contribute to disease progression by modulation of genes such as PSCA.	[Tang, Shuai; Dubey, Purnima] Wake Forest Sch Med, Mol Pathol Grad Program, Winston Salem, NC 27106 USA; [Tang, Shuai; Mishra, Meenu; Frazier, Donna P.; Moore, Miranda L.; Inoue, Kazushi; Dubey, Purnima] Wake Forest Sch Med, Dept Pathol Tumor Biol, Winston Salem, NC USA; [Inoue, Kazushi; Sui, Guangchao; Dubey, Purnima] Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC USA; [Inoue, Kazushi; Sui, Guangchao; Dubey, Purnima] Wake Forest Sch Med, Ctr Comprehens Canc, Winston Salem, NC USA; [Deora, Rajendar; Dubey, Purnima] Wake Forest Sch Med, Dept Microbiol & Immunol, Winston Salem, NC USA	Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University	Tang, S (corresponding author), Wake Forest Sch Med, Mol Pathol Grad Program, Winston Salem, NC 27106 USA.	pdubey@wakehealth.edu	Dubey, Purnima/AAY-2462-2021	Sui, Guangchao/0000-0002-8164-5585	Wake Forest School of Medicine Department of Pathology Research; American Cancer Society Research Scholar [RSG-07-196-01-LIB, R01CA106314]; American Cancer Society [RSG-07-207-01-MGO, 1R01AI075081, RSG-09-082-01-MGO]; NATIONAL CANCER INSTITUTE [R01CA106314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075081] Funding Source: NIH RePORTER	Wake Forest School of Medicine Department of Pathology Research; American Cancer Society Research Scholar(American Cancer Society); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Wake Forest School of Medicine Department of Pathology Research Support (PD), American Cancer Society Research Scholar Grant RSG-07-196-01-LIB (PD), R01CA106314 and American Cancer Society Research Scholar Grant RSG-07-207-01-MGO (KI), 1R01AI075081 (RD), and American Cancer Society Research Scholar Grant RSG-09-082-01-MGO (GS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backman SA, 2004, P NATL ACAD SCI USA, V101, P1725, DOI 10.1073/pnas.0308217100; Bahrenberg G, 2001, CANCER LETT, V168, P37, DOI 10.1016/S0304-3835(01)00497-9; Castellano G, 2009, CELL CYCLE, V8, P1367, DOI 10.4161/cc.8.9.8314; Deng Z, 2009, ONCOGENE, V28, P3746, DOI 10.1038/onc.2009.231; Deng ZY, 2007, MOL CELL BIOL, V27, P3780, DOI 10.1128/MCB.01761-06; Deng ZY, 2010, TRANSCR-AUSTIN, V1, P81, DOI 10.4161/trns.1.2.12375; Deora R, 2001, MOL MICROBIOL, V40, P669, DOI 10.1046/j.1365-2958.2001.02415.x; Dobosy JR, 2007, J UROLOGY, V177, P822, DOI 10.1016/j.juro.2006.10.063; Dubey P, 2001, CANCER RES, V61, P3256; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hirai H, 1996, MOL CELL BIOL, V16, P6457; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; HYDEDERUYSCHER RP, 1995, NUCLEIC ACIDS RES, V23, P4457, DOI 10.1093/nar/23.21.4457; Jain A, 2002, MOL ENDOCRINOL, V16, P2323, DOI 10.1210/me.2002-0004; Jiao J, 2007, CANCER RES, V67, P6083, DOI 10.1158/0008-5472.CAN-06-4202; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kibel AS, 1998, CANCER RES, V58, P5652; Lepin EJ, 2010, EUR J NUCL MED MOL I, V37, P1529, DOI 10.1007/s00259-010-1433-1; Lieberthal JG, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2329; Mishra M, 2005, J BACTERIOL, V187, P6290, DOI 10.1128/JB.187.18.6290-6299.2005; Moore ML, 2008, PROSTATE, V68, P139, DOI 10.1002/pros.20686; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Reiter RE, 1998, P NATL ACAD SCI USA, V95, P1735, DOI 10.1073/pnas.95.4.1735; Ross S, 2002, CANCER RES, V62, P2546; Ross S, 2001, AM J PATHOL, V158, P809, DOI 10.1016/S0002-9440(10)64028-X; Saffran DC, 2001, P NATL ACAD SCI USA, V98, P2658, DOI 10.1073/pnas.051624698; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; Seligson D, 2005, INT J ONCOL, V27, P131; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; Sreeramaneni R, 2005, MOL CELL BIOL, V25, P220, DOI 10.1128/MCB.25.1.220-232.2005; Tan DP, 2002, NUCLEIC ACIDS RES, V30, P1213, DOI 10.1093/nar/30.5.1213; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Tran CP, 2002, MOL CANCER RES, V1, P113; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Watabe T, 2002, P NATL ACAD SCI USA, V99, P401, DOI 10.1073/pnas.012574899; Wu XF, 2009, NAT GENET, V41, P991, DOI 10.1038/ng.421; Zhao ZG, 2007, PROSTATE, V67, P1143, DOI 10.1002/pros.20610	39	6	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35570	10.1371/journal.pone.0035570	http://dx.doi.org/10.1371/journal.pone.0035570			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536409	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336200056
J	Ma, HT; Chan, YY; Chen, X; On, KF; Poon, RYC				Ma, Hoi Tang; Chan, Yan Yan; Chen, Xiao; On, Kin Fan; Poon, Randy Y. C.			Depletion of p31(comet) Protein Promotes Sensitivity to Antimitotic Drugs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; MITOTIC CATASTROPHE; CYCLIN-A; CELLS; MAD2; MITOSIS; DETERMINANTS; MECHANISMS; BINDING; CANCER	Antimitotic spindle poisons are among the most important chemotherapeutic agents available. However, precocious mitotic exit by mitotic slippage limits the cytotoxicity of spindle poisons. The MAD2-binding protein p31(comet) is implicated in silencing the spindle assembly checkpoint after all kinetochores are attached to spindles. In this study, we report that the levels of p31(comet) and MAD2 in different cell lines are closely linked with susceptibility to mitotic slippage. Down-regulation of p31(comet) increased the sensitivity of multiple cancer cell lines to spindle poisons, including nocodazole, vincristine, and Taxol. In the absence of p31(comet), lower concentrations of spindle poisons were required to induce mitotic block. The delay in checkpoint silencing was induced by an accumulation of mitotic checkpoint complexes. The increase in the duration of mitotic block after p31(comet) depletion resulted in a dramatic increase in mitotic cell death upon challenge with spindle poisons. Significantly, cells that are normally prone to mitotic slippage and resistant to spindle disruption-mediated mitotic death were also sensitized after p31(comet) depletion. These results highlight the importance of p31(comet) in checkpoint silencing and its potential as a target for antimitotic therapies.	[Poon, Randy Y. C.] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, Ctr Canc Res, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Poon, RYC (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China.	rycpoon@ust.hk	Chen, Xiao/R-2157-2016	Poon, Randy/0000-0001-5571-6231; MA, Hoi Tang/0000-0001-5876-0107	Research Grants Council [662208, AOE-MG/M-08/06, HKU7/CRG/09]	Research Grants Council(Hong Kong Research Grants Council)	This work was supported in part by Research Grants Council Grants 662208, AOE-MG/M-08/06, and HKU7/CRG/09 (to R. Y. C. P.).	Arooz T, 2000, BIOCHEMISTRY-US, V39, P9494, DOI 10.1021/bi0009643; Ausubel FM., 2006, ENZYMATIC MANIPULATI; Chan YW, 2008, CELL CYCLE, V7, P1449, DOI 10.4161/cc.7.10.5880; Chow JPH, 2010, CONTEMP CANCER RES, P79, DOI 10.1007/978-1-4419-1770-6_5; Fung TK, 2005, CELL CYCLE, V4, P1411, DOI 10.4161/cc.4.10.2046; Fung TK, 2002, J BIOL CHEM, V277, P35140, DOI 10.1074/jbc.M205503200; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Habu T, 2002, EMBO J, V21, P6419, DOI 10.1093/emboj/cdf659; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Ma HT, 2011, J BIOL CHEM, V286, P13052, DOI 10.1074/jbc.M110.201897; Ma HT, 2009, MOL CELL BIOL, V29, P6500, DOI 10.1128/MCB.00669-09; Mapelli M, 2006, EMBO J, V25, P1273, DOI 10.1038/sj.emboj.7601033; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; On KF, 2011, MOL CANCER THER, V10, P784, DOI 10.1158/1535-7163.MCT-10-0809; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; POON RYC, 1995, MOL BIOL CELL, V6, P1197, DOI 10.1091/mbc.6.9.1197; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Siu WY, 2004, MOL CANCER THER, V3, P621; Siu WY, 1999, EXP CELL RES, V250, P131, DOI 10.1006/excr.1999.4551; Teichner A, 2011, P NATL ACAD SCI USA, V108, P3187, DOI 10.1073/pnas.1100023108; Varetti G, 2011, MOL CELL, V44, P710, DOI 10.1016/j.molcel.2011.11.014; Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Westhorpe FG, 2011, J CELL SCI, V124, P3905, DOI 10.1242/jcs.093286; Wong J, 2006, J CELL BIOL, V173, P879, DOI 10.1083/jcb.200511132; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Yam CH, 2000, J BIOL CHEM, V275, P3158, DOI 10.1074/jbc.275.5.3158; Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048	29	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21561	21569		10.1074/jbc.M112.364356	http://dx.doi.org/10.1074/jbc.M112.364356			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22544748	Green Published, hybrid			2022-12-25	WOS:000306416800073
J	Macaire, H; Riquet, A; Moncollin, V; Biemont-Trescol, MC; Dodon, MD; Hermine, O; Debaud, AL; Mahieux, R; Mesnard, JM; Pierre, M; Gazzolo, L; Bonnefoy, N; Valentin, H				Macaire, Heloise; Riquet, Aurelien; Moncollin, Vincent; Biemont-Trescol, Marie-Claude; Dodon, Madeleine Duc; Hermine, Olivier; Debaud, Anne-Laure; Mahieux, Renaud; Mesnard, Jean-Michel; Pierre, Marlene; Gazzolo, Louis; Bonnefoy, Nathalie; Valentin, Helene			Tax Protein-induced Expression of Antiapoptotic Bfl-1 Protein Contributes to Survival of Human T-cell Leukemia Virus Type 1 (HTLV-1)-infected T-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTOR AP-1; BCL-X-L; HTLV-I; UP-REGULATION; GENE-EXPRESSION; CONSTITUTIVE ACTIVATION; POTENTIAL MECHANISM; BINDING PROTEIN; DOWN-REGULATION	Human T lymphotropic virus type 1 (HTLV-1) is the etiologic agent of adult T-cell leukemia/lymphoma (ATLL). ATLL is a severe malignancy with no effective treatment. HTLV-1 regulatory proteins Tax and HTLV-1 basic leucine zipper factor (HBZ) play a major role in ATLL development, by interfering with cellular functions such as CD4(+) T-cell survival. In this study, we observed that the expression of Bfl-1, an antiapoptotic protein of the Bcl-2 family, is restricted to HTLV-1-infected T-cell lines and to T-cells expressing both Tax and HBZ proteins. We showed that Tax-induced bfl-1 transcription through the canonical NF-kappa B pathway. Moreover, we demonstrated that Tax cooperated with c-Jun or JunD, but not JunB, transcription factors of the AP-1 family to stimulate bfl-1 gene activation. By contrast, HBZ inhibited c-Jun-induced bfl-1 gene activation, whereas it increased JunD-induced bfl-1 gene activation. We identified one NF-kappa B, targeted by RelA, c-Rel, RelB, p105/p50, and p100/p52, and two AP-1, targeted by both c-Jun and JunD, binding sites in the bfl-1 promoter of T-cells expressing both Tax and HBZ. Analyzing the potential role of antiapoptotic Bcl-2 proteins in HTLV-1-infected T-cell survival, we demonstrated that these cells are differentially sensitive to silencing of Bfl-1, Bcl-x(L), and Bcl-2. Indeed, both Bfl-1 and Bcl-x(L) knock-downs decreased the survival of HTLV-1-infected T-cell lines, although no cell death was observed after Bcl-2 knockdown. Furthermore, we demonstrated that Bfl-1 knockdown sensitizes HTLV-1-infected T-cells to ABT-737 or etoposide treatment. Our results directly implicate Bfl-1 and Bcl-x(L) in HTLV-1-infected T-cell survival and suggest that both Bfl-1 and Bcl-x(L) represent potential therapeutic targets for ATLL treatment.	[Macaire, Heloise; Riquet, Aurelien; Biemont-Trescol, Marie-Claude; Dodon, Madeleine Duc; Debaud, Anne-Laure; Mahieux, Renaud; Pierre, Marlene; Gazzolo, Louis; Bonnefoy, Nathalie; Valentin, Helene] Univ Lyon, Lyon, France; [Macaire, Heloise; Riquet, Aurelien; Biemont-Trescol, Marie-Claude; Debaud, Anne-Laure; Pierre, Marlene; Bonnefoy, Nathalie; Valentin, Helene] INSERM, U851, F-69007 Lyon, France; [Riquet, Aurelien; Moncollin, Vincent; Biemont-Trescol, Marie-Claude; Dodon, Madeleine Duc; Debaud, Anne-Laure; Mahieux, Renaud; Pierre, Marlene; Gazzolo, Louis; Valentin, Helene] Univ Lyon 1, UMS3444, US8, F-69365 Lyon, France; [Moncollin, Vincent; Dodon, Madeleine Duc; Gazzolo, Louis] Ecole Normale Super Lyon, CNRS, UMR5239, Lab Biol Mol Cellule, F-69007 Lyon, France; [Hermine, Olivier] Hop Necker Enfants Malad, CNRS, UMR8603, F-75015 Paris, France; [Mahieux, Renaud] Ecole Normale Super Lyon, INSERM, U758, F-69007 Lyon, France; [Mesnard, Jean-Michel] CNRS, UMR5236, Ctr Etud Agents Pathogenes & Biotechnol Sante, F-34060 Montpellier, France; Hosp Civils Lyon, F-69229 Lyon 02, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CHU Lyon	Valentin, H (corresponding author), Fac Med Lyon Sud, UMR5239, 165 Chemin Grand Revoyet,BP 12, F-69921 Oullins, France.	valentin@ens-lyon.fr	Bonnefoy, Nathalie/J-2536-2012; MONCOLLIN, Vincent/R-1941-2017; Duc-Dodon, Madeleine/I-6580-2016; Valentin, Helene/AAA-4265-2020; Hermine, Olivier/Q-7072-2018	Bonnefoy, Nathalie/0000-0003-4814-6722; MONCOLLIN, Vincent/0000-0002-4163-0231; Mesnard, Jean-Michel/0000-0003-3344-5367; Hermine, Olivier/0000-0003-2574-3874; mahieux, renaud/0000-0002-5129-6804; Mathieu, Anne-Laure/0000-0002-2893-7001	INSERM; UCBL; Region Rhone-Alpes Cluster 10, Cent pour Sang la Vie, Fondation de France, and the Ar'mony; Convention for Industrial Research Training (Imaxio Biotech); Ligue Nationale Contre le Cancer; National Cancer Institute (InCa)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); UCBL; Region Rhone-Alpes Cluster 10, Cent pour Sang la Vie, Fondation de France, and the Ar'mony(Region Auvergne-Rhone-Alpes); Convention for Industrial Research Training (Imaxio Biotech); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); National Cancer Institute (InCa)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)Institut National du Cancer (INCA) France)	This work was supported in part by institutional grants from INSERM and UCBL and from Region Rhone-Alpes Cluster 10, Cent pour Sang la Vie, Fondation de France, and the Ar'mony.; Supported by a fellowship from Convention for Industrial Research Training (Imaxio Biotech).; Supported by a fellowship from the Ligue Nationale Contre le Cancer.; Supported by a grant from National Cancer Institute (InCa).	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Arnold J, 2008, BLOOD, V112, P3788, DOI 10.1182/blood-2008-04-154286; Basbous J, 2003, J BIOL CHEM, V278, P43620, DOI 10.1074/jbc.M307275200; Bellon M, 2010, BLOOD, V115, P2441, DOI 10.1182/blood-2009-08-241117; Brien G, 2007, ONCOGENE, V26, P5828, DOI 10.1038/sj.onc.1210363; Cavrois M, 1996, BLOOD, V88, P4646, DOI 10.1182/blood.V88.12.4646.bloodjournal88124646; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Cheng QW, 2000, ONCOGENE, V19, P4936, DOI 10.1038/sj.onc.1203861; Chlichlia K, 2010, CHEM-BIOL INTERACT, V188, P359, DOI 10.1016/j.cbi.2010.06.005; Chung HK, 2003, BLOOD, V102, P4130, DOI 10.1182/blood-2003-04-1043; Cottalorda A, 2006, EUR J IMMUNOL, V36, P1684, DOI 10.1002/eji.200636181; D'Souza B, 2000, J VIROL, V74, P6652, DOI 10.1128/JVI.74.14.6652-6658.2000; D'Souza BN, 2004, J VIROL, V78, P1800, DOI 10.1128/JVI.78.4.1800-1816.2004; de la Fuente C, 2003, MOL CELL BIOCHEM, V245, P99, DOI 10.1023/A:1022866027585; Edelstein LC, 2003, MOL CELL BIOL, V23, P2749, DOI 10.1128/MCB.23.8.2749-2761.2003; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Etoh K, 1997, CANCER RES, V57, P4862; FRANCHINI G, 1984, P NATL ACAD SCI-BIOL, V81, P6207, DOI 10.1073/pnas.81.19.6207; Fujii MI, 2000, AIDS RES HUM RETROV, V16, P1603, DOI 10.1089/08892220050193029; FUJITA M, 1995, ONCOGENE, V11, P15; FURUKAWA Y, 1995, BLOOD, V85, P1865, DOI 10.1182/blood.V85.7.1865.bloodjournal8571865; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; GRASSMANN R, 1992, J VIROL, V66, P4570, DOI 10.1128/JVI.66.7.4570-4575.1992; GROSSMAN WJ, 1995, P NATL ACAD SCI USA, V92, P1057, DOI 10.1073/pnas.92.4.1057; Grumont RJ, 1999, GENE DEV, V13, P400, DOI 10.1101/gad.13.4.400; Hagiya K, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-19; Hall WW, 2005, ONCOGENE, V24, P5965, DOI 10.1038/sj.onc.1208975; Harhaj EW, 1999, ONCOGENE, V18, P1341, DOI 10.1038/sj.onc.1202405; Hasegawa H, 2006, NAT MED, V12, P466, DOI 10.1038/nm1389; Hivin P, 2005, J CELL SCI, V118, P1355, DOI 10.1242/jcs.01727; Ishikawa C, 2011, CARCINOGENESIS, V32, P110, DOI 10.1093/carcin/bgq222; Ishitsuka K, 2012, CANCER LETT, V317, P218, DOI 10.1016/j.canlet.2011.11.030; Iwai K, 2001, VIROLOGY, V279, P38, DOI 10.1006/viro.2000.0669; Iwanaga Y, 1999, J VIROL, V73, P1271, DOI 10.1128/JVI.73.2.1271-1277.1999; Journo C, 2009, FUTURE MICROBIOL, V4, P425, DOI 10.2217/FMB.09.13; Kirkin V, 2004, BBA-MOL CELL RES, V1644, P229, DOI 10.1016/j.bbamcr.2003.08.009; Kuhlmann AS, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-92; Lam LT, 2005, CLIN CANCER RES, V11, P28; Lamsoul I, 2005, MOL CELL BIOL, V25, P10391, DOI 10.1128/MCB.25.23.10391-10406.2005; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; Lemasson I, 1997, J VIROL, V71, P1975, DOI 10.1128/JVI.71.3.1975-1983.1997; Li M, 2007, J VIROL METHODS, V142, P159, DOI 10.1016/j.jviromet.2007.01.023; Mahieux R, 2001, BLOOD, V98, P3762, DOI 10.1182/blood.V98.13.3762; Matsumoto J, 2005, ONCOGENE, V24, P1001, DOI 10.1038/sj.onc.1208297; Matsuoka M, 2011, ONCOGENE, V30, P1379, DOI 10.1038/onc.2010.537; Matsuoka M, 2010, MOL ASPECTS MED, V31, P359, DOI 10.1016/j.mam.2010.06.002; Meertens L, 2004, J BIOL CHEM, V279, P43307, DOI 10.1074/jbc.M400497200; Meertens L, 2004, ONCOGENE, V23, P5447, DOI 10.1038/sj.onc.1207719; Michael B, 2004, FRONT BIOSCI-LANDMRK, V9, P2556, DOI 10.2741/1417; Morales AA, 2005, INT J CANCER, V113, P730, DOI 10.1002/ijc.20614; Mori N, 2002, BLOOD, V100, P1828, DOI 10.1182/blood-2002-01-0151; Mori N, 2001, VIRUS GENES, V22, P279, DOI 10.1023/A:1011158021749; Mori N, 2000, BLOOD, V95, P3915; Nagakubo D, 2007, INT J CANCER, V120, P1591, DOI 10.1002/ijc.22483; NAGATA K, 1989, J VIROL, V63, P3220, DOI 10.1128/JVI.63.8.3220-3226.1989; Nakayama T, 2008, ONCOGENE, V27, P3221, DOI 10.1038/sj.onc.1210984; NERENBERG M, 1987, SCIENCE, V237, P1324, DOI 10.1126/science.2888190; Nicot C, 2000, BLOOD, V96, P275, DOI 10.1182/blood.V96.1.275.013k43_275_281; Olsson A, 2007, BRIT J CANCER, V97, P769, DOI 10.1038/sj.bjc.6603951; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Peloponese JM, 2006, J BIOL CHEM, V281, P8927, DOI 10.1074/jbc.M510598200; Polster BM, 2004, BBA-MOL CELL RES, V1644, P211, DOI 10.1016/j.bbamcr.2003.11.001; Portis T, 2004, ONCOGENE, V23, P8619, DOI 10.1038/sj.onc.1207905; Postigo A, 2009, MICROBES INFECT, V11, P1071, DOI 10.1016/j.micinf.2009.08.012; POZZATTI R, 1990, MOL CELL BIOL, V10, P413, DOI 10.1128/MCB.10.1.413; Robek MD, 1999, J VIROL, V73, P4856, DOI 10.1128/JVI.73.6.4856-4865.1999; Satou Y, 2006, P NATL ACAD SCI USA, V103, P720, DOI 10.1073/pnas.0507631103; Satou Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001274; Schneider TJ, 1997, J IMMUNOL, V159, P4834; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Silbermann K., 2007, Signal Transduction, V7, P34, DOI 10.1002/sita.200600119; Simonian PL, 1997, BLOOD, V90, P1208, DOI 10.1182/blood.V90.3.1208.1208_1208_1216; SMITH MR, 1990, GENE DEV, V4, P1875, DOI 10.1101/gad.4.11.1875; SUGAMURA K, 1984, INT J CANCER, V34, P221, DOI 10.1002/ijc.2910340213; Sun SC, 1996, MOL CELL BIOL, V16, P1058; Takeda S, 2004, INT J CANCER, V109, P559, DOI 10.1002/ijc.20007; Taylor JM, 2008, APOPTOSIS, V13, P733, DOI 10.1007/s10495-008-0208-7; Thebault S, 2004, FEBS LETT, V562, P165, DOI 10.1016/S0014-5793(04)00225-X; Tsukasaki K, 2009, J CLIN ONCOL, V27, P453, DOI 10.1200/JCO.2008.18.2428; Usui T, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-34; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Villaudy J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002231; Vogler M, 2012, CELL DEATH DIFFER, V19, P67, DOI 10.1038/cdd.2011.158; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Vogler M, 2009, BLOOD, V113, P4403, DOI 10.1182/blood-2008-08-173310; Wang CY, 1999, MOL CELL BIOL, V19, P5923; White E, 2006, CELL DEATH DIFFER, V13, P1371, DOI 10.1038/sj.cdd.4401941; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304; Zane L, 2010, VIROLOGY, V407, P341, DOI 10.1016/j.virol.2010.07.023; Zhao T, 2009, BLOOD, V113, P2755, DOI 10.1182/blood-2008-06-161729; Zhi HJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002025; Zong WX, 1999, GENE DEV, V13, P382, DOI 10.1101/gad.13.4.382	94	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21357	21370		10.1074/jbc.M112.340992	http://dx.doi.org/10.1074/jbc.M112.340992			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22553204	Green Published, hybrid			2022-12-25	WOS:000306416800054
J	Takagi, Y; Setoyama, D; Ito, R; Kamiya, H; Yamagata, Y; Sekiguchi, M				Takagi, Yasumitsu; Setoyama, Daiki; Ito, Riyoko; Kamiya, Hiroyuki; Yamagata, Yuriko; Sekiguchi, Mutsuo			Human MTH3 (NUDT18) Protein Hydrolyzes Oxidized Forms of Guanosine and Deoxyguanosine Diphosphates COMPARISON WITH MTH1 AND MTH2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MUTT HOMOLOG; OXIDATIVE DAMAGE; NUDIX HYDROLASES; DNA-SYNTHESIS; ENCODING 8-OXO-DGTPASE; MUTAGENIC SUBSTRATE; ESCHERICHIA-COLI; NUCLEOTIDES; MECHANISMS; CLONING	Most of the proteins carrying the 23-residue MutT-related sequence are capable of hydrolyzing compounds with a general structure of nucleoside diphosphate linked to another moiety X and are called the Nudix hydrolases. Among the 22 human Nudix proteins (identified by the sequence signature), some remain uncharacterized as enzymes without a defined substrate. Here, we reveal that the NUDT18 protein, whose substrate was unknown, can degrade 8-oxo-7,8-dihydroguanine (8-oxo-Gua)-containing nucleoside diphosphates to the monophosphates. Because this enzyme is closely related to MTH1 (NUDT1) and MTH2 (NUDT15), we propose that it should be named MTH3. Although these three human proteins resemble each other in their sequences, their substrate specificities differ considerably. MTH1 cleaves 8-oxo-dGTP but not 8-oxo-dGDP, whereas MTH2 can degrade both 8-oxo-dGTP and 8-oxo-dGDP, although the intrinsic enzyme activity of MTH2 is considerably lower than that of MTH1. On the other hand, MTH3 is specifically active against 8-oxo-dGDP and hardly cleaves 8-oxodGTP. Other types of oxidized nucleoside diphosphates, 2-hydroxy-dADP and 8-hydroxy-dADP, were also hydrolyzed by MTH3. Another notable feature of the MTH3 enzyme is its action toward the ribonucleotide counterpart. MTH3 can degrade 8-oxo-GDP as efficiently as 8-oxo-dGDP, which is in contrast to the finding that MTH1 and MTH2 show a limited activity against the ribonucleotide counterpart, 8-oxo-GTP. These three enzymes may function together to help maintain the high fidelity of DNA replication and transcription under oxidative stress.	Fukuoka Dent Coll, Fukuoka 8140193, Japan; [Kamiya, Hiroyuki] Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan; [Yamagata, Yuriko] Kumamoto Univ, Grad Sch Pharmaceut Sci, Kumamoto 8620973, Japan	Fukuoka Dental College (FDC); Ehime University; Kumamoto University		mseki@college.fdcnet.ac.jp	Kamiya, Hiroyuki/G-2383-2019	Kamiya, Hiroyuki/0000-0001-6866-5322	Ministry of Education, Culture, Sports, Science and Technology of Japan; MEXT-supported Program for the Strategic Research Foundation at Private Universities	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT-supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, including the MEXT-supported Program for the Strategic Research Foundation at Private Universities (2008-2012).	Arimori T, 2011, NUCLEIC ACIDS RES, V39, P8972, DOI 10.1093/nar/gkr575; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Bjelland S, 2003, MUTAT RES-FUND MOL M, V531, P37, DOI 10.1016/j.mrfmmm.2003.07.002; Cai JP, 2003, BIOCHEM BIOPH RES CO, V305, P1073, DOI 10.1016/S0006-291X(03)00864-7; Evans MD, 2004, BIOESSAYS, V26, P533, DOI 10.1002/bies.20027; Fujikawa K, 1999, J BIOL CHEM, V274, P18201, DOI 10.1074/jbc.274.26.18201; FURUICHI M, 1994, GENOMICS, V24, P485, DOI 10.1006/geno.1994.1657; Gasmi L, 1999, BIOCHEM J, V344, P331, DOI 10.1042/0264-6021:3440331; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Hayakawa H, 1999, BIOCHEMISTRY-US, V38, P3610, DOI 10.1021/bi982361l; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Ishibashi T, 2005, NUCLEIC ACIDS RES, V33, P3779, DOI 10.1093/nar/gki682; Ishibashi T, 2003, EMBO REP, V4, P479, DOI 10.1038/sj.embor.embor838; Ito R, 2005, BIOCHEMISTRY-US, V44, P6670, DOI 10.1021/bi047550k; Ito R, 2011, J BIOCHEM, V149, P731, DOI 10.1093/jb/mvr028; Kamiya H, 2009, DNA REPAIR, V8, P1250, DOI 10.1016/j.dnarep.2009.07.011; KUCHINO Y, 1987, NATURE, V327, P77, DOI 10.1038/327077a0; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017; MO JY, 1992, P NATL ACAD SCI USA, V89, P11021, DOI 10.1073/pnas.89.22.11021; Nakamura T, 2006, ACTA CRYSTALLOGR F, V62, P1283, DOI 10.1107/S1744309106049529; Nakamura T, 2010, J BIOL CHEM, V285, P444, DOI 10.1074/jbc.M109.066373; Nunoshiba T, 2004, NUCLEIC ACIDS RES, V32, P5339, DOI 10.1093/nar/gkh868; Rafty LA, 2002, J BIOL CHEM, V277, P47114, DOI 10.1074/jbc.M208997200; SAKUMI K, 1993, J BIOL CHEM, V268, P23524; Sanada U, 2011, J BIOCHEM, V150, P649, DOI 10.1093/jb/mvr107; Sekiguchi M, 2002, ONCOGENE, V21, P8895, DOI 10.1038/sj.onc.1206023; Sekiguchi M, 1996, GENES CELLS, V1, P139, DOI 10.1046/j.1365-2443.1996.d01-232.x; Svensson LM, 2011, FEBS LETT, V585, P2617, DOI 10.1016/j.febslet.2011.07.017; Taddei F, 1997, SCIENCE, V278, P128, DOI 10.1126/science.278.5335.128; TAJIRI T, 1995, MUTAT RES-DNA REPAIR, V336, P257, DOI 10.1016/0921-8777(94)00062-B; Tsuzuki T, 2001, P NATL ACAD SCI USA, V98, P11456, DOI 10.1073/pnas.191086798; Tsuzuki T, 2007, CANCER SCI, V98, P465, DOI 10.1111/j.1349-7006.2007.00409.x; Yang HJ, 2000, J BIOL CHEM, V275, P8844, DOI 10.1074/jbc.275.12.8844; Zha MW, 2006, J MOL BIOL, V364, P1021, DOI 10.1016/j.jmb.2006.09.078	36	79	89	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21541	21549		10.1074/jbc.M112.363010	http://dx.doi.org/10.1074/jbc.M112.363010			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22556419	Green Published, hybrid			2022-12-25	WOS:000306416800071
J	Fufezan, C; Simionato, D; Morosinotto, T				Fufezan, Christian; Simionato, Diana; Morosinotto, Tomas			Identification of Key Residues for pH Dependent Activation of Violaxanthin De-Epoxidase from Arabidopsis thaliana	PLOS ONE			English	Article							XANTHOPHYLL-CYCLE; ESCHERICHIA-COLI; IN-VIVO; LIGHT; DIADINOXANTHIN; PROTEINS; BINDING; FIELD; DEEPOXIDATION; SIMULATION	Plants are often exposed to saturating light conditions, which can lead to oxidative stress. The carotenoid zeaxanthin, synthesized from violaxanthin by Violaxanthin De-Epoxidase (VDE) plays a major role in the protection from excess illumination. VDE activation is triggered by a pH reduction in the thylakoids lumen occurring under saturating light. In this work the mechanism of the VDE activation was investigated on a molecular level using multi conformer continuum electrostatic calculations, site directed mutagenesis and molecular dynamics. The pK(a) values of residues of the inactive VDE were determined to identify target residues that could be implicated in the activation. Five such target residues were investigated closer by site directed mutagenesis, whereas variants in four residues (D98, D117, H168 and D206) caused a reduction in enzymatic activity indicating a role in the activation of VDE while D86 mutants did not show any alteration. The analysis of the VDE sequence showed that the four putative activation residues are all conserved in plants but not in diatoms, explaining why VDE in these algae is already activated at higher pH. Molecular dynamics showed that the VDE structure was coherent at pH 7 with a low amount of water penetrating the hydrophobic barrel. Simulations carried out with the candidate residues locked into their protonated state showed instead an increased amount of water penetrating the barrel and the rupture of the H121-Y214 hydrogen bond at the end of the barrel, which is essential for VDE activation. These results suggest that VDE activation relies on a robust and redundant network, in which the four residues identified in this study play a major role.	[Fufezan, Christian] Univ Munster, Inst Biol & Biotechnol Plants, Munster, Germany; [Simionato, Diana; Morosinotto, Tomas] Univ Padua, Dept Biol, Padua, Italy	University of Munster; University of Padua	Fufezan, C (corresponding author), Univ Munster, Inst Biol & Biotechnol Plants, Munster, Germany.	christian@fufezan.net; tomas.morosinotto@unipd.it	Morosinotto, Tomas/AAC-3188-2019	Morosinotto, Tomas/0000-0002-0803-7591; Fufezan, Christian/0000-0002-7048-6822; simionato, diana/0000-0002-2774-6641	Universita di Padova [CPDA089403]	Universita di Padova	The work was supported by Universita di Padova (grant CPDA089403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnoux P, 2009, PLANT CELL, V21, P2036, DOI 10.1105/tpc.109.068007; Ballottari M, 2007, J BIOL CHEM, V282, P8947, DOI 10.1074/jbc.M606417200; BRATT CE, 1995, PHOTOSYNTH RES, V45, P169, DOI 10.1007/BF00032588; Bugos RC, 1996, P NATL ACAD SCI USA, V93, P6320, DOI 10.1073/pnas.93.13.6320; Coesel S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002896; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fufezan C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-258; Goss R, 2005, BIOCHEMISTRY-US, V44, P4028, DOI 10.1021/bi047464k; HAGER A, 1969, PLANTA, V89, P224, DOI 10.1007/BF00385028; HAGER A, 1994, PLANTA, V192, P581, DOI 10.1007/BF00203597; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hieber AD, 2000, BBA-PROTEIN STRUCT M, V1482, P84, DOI 10.1016/S0167-4838(00)00141-2; Hieber AD, 2002, PLANTA, V214, P476, DOI 10.1007/s00425-001-0704-2; Jahns P, 2009, BBA-BIOENERGETICS, V1787, P3, DOI 10.1016/j.bbabio.2008.09.013; Jakob T, 2001, J PLANT PHYSIOL, V158, P383, DOI 10.1078/0176-1617-00288; Kawano M, 2000, FEBS LETT, V481, P101, DOI 10.1016/S0014-5793(00)01991-8; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Li XP, 2002, FUNCT PLANT BIOL, V29, P1131, DOI 10.1071/FP02065; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Lohr M, 1999, P NATL ACAD SCI USA, V96, P8784, DOI 10.1073/pnas.96.15.8784; Morosinotto T, 2002, J BIOL CHEM, V277, P36913, DOI 10.1074/jbc.M205339200; PFUNDEL EE, 1993, PLANT PHYSIOL, V101, P65, DOI 10.1104/pp.101.1.65; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Rockholm DC, 1996, PLANT PHYSIOL, V110, P697, DOI 10.1104/pp.110.2.697; Saga G, 2010, J BIOL CHEM, V285, P23763, DOI 10.1074/jbc.M110.115097; Song YF, 2009, J COMPUT CHEM, V30, P2231, DOI 10.1002/jcc.21222; YAMAMOTO HY, 1978, ARCH BIOCHEM BIOPHYS, V190, P514, DOI 10.1016/0003-9861(78)90305-3	30	17	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35669	10.1371/journal.pone.0035669	http://dx.doi.org/10.1371/journal.pone.0035669			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558195	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000046
J	Ippolito, GC; Hoi, KH; Reddy, ST; Carroll, SM; Ge, X; Rogosch, T; Zemlin, M; Shultz, LD; Ellington, AD; VanDenBerg, CL; Georgiou, G				Ippolito, Gregory C.; Hoi, Kam Hon; Reddy, Sai T.; Carroll, Sean M.; Ge, Xin; Rogosch, Tobias; Zemlin, Michael; Shultz, Leonard D.; Ellington, Andrew D.; VanDenBerg, Carla L.; Georgiou, George			Antibody Repertoires in Humanized NOD-scid-IL2R gamma(null) Mice and Human B Cells Reveals Human-Like Diversification and Tolerance Checkpoints in the Mouse	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; IMMUNOGLOBULIN REPERTOIRE; CORD BLOOD; GENE USAGE; SEQUENCE-ANALYSIS; IMMUNE-SYSTEM; PLASMA-CELLS; V-REGIONS; DIVERSITY; SELECTION	Immunodeficient mice reconstituted with human hematopoietic stem cells enable the in vivo study of human hematopoiesis. In particular, NOD-scid-IL2R gamma(null) engrafted mice have been shown to have reasonable levels of T and B cell repopulation and can mount T-cell dependent responses; however, antigen-specific B-cell responses in this model are generally poor. We explored whether developmental defects in the immunoglobulin gene repertoire might be partly responsible for the low level of antibody responses in this model. Roche 454 sequencing was used to obtain over 685,000 reads from cDNA encoding immunoglobulin heavy (IGH) and light (IGK and IGL) genes isolated from immature, naive, or total splenic B cells in engrafted NOD-scid-IL2R gamma(null) mice, and compared with over 940,000 reads from peripheral B cells of two healthy volunteers. We find that while naive B-cell repertoires in humanized mice are chiefly indistinguishable from those in human blood B cells, and display highly correlated patterns of immunoglobulin gene segment use, the complementarity-determining region H3 (CDR-H3) repertoires are nevertheless extremely diverse and are specific for each individual. Despite this diversity, preferential D-H-J(H) pairings repeatedly occur within the CDR-H3 interval that are strikingly similar across all repertoires examined, implying a genetic constraint imposed on repertoire generation. Moreover, CDR-H3 length, charged amino-acid content, and hydropathy are indistinguishable between humans and humanized mice, with no evidence of global autoimmune signatures. Importantly, however, a statistically greater usage of the inherently autoreactive IGHV4-34 and IGKV4-1 genes was observed in the newly formed immature B cells relative to naive B or total splenic B cells in the humanized mice, a finding consistent with the deletion of autoreactive B cells in humans. Overall, our results provide evidence that key features of the primary repertoire are shaped by genetic factors intrinsic to human B cells and are principally unaltered by differences between mouse and human stromal microenvironments.	[Ippolito, Gregory C.; Georgiou, George] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Hoi, Kam Hon; Georgiou, George] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Reddy, Sai T.] ETH, Dept Biosyst Sci & Engn, Zurich, Switzerland; [Carroll, Sean M.; Georgiou, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Ge, Xin] Univ Calif Riverside, Riverside, CA 92521 USA; [Shultz, Leonard D.] Jackson Lab, Bar Harbor, ME 04609 USA; [Rogosch, Tobias; Zemlin, Michael] Univ Marburg, Dept Pediat, Marburg, Germany; [Ellington, Andrew D.; Georgiou, George] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [VanDenBerg, Carla L.] Univ Texas Austin, Dept Pharmacol & Toxicol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Texas System; University of Texas Austin; University of California System; University of California Riverside; Jackson Laboratory; Philipps University Marburg; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Ippolito, GC (corresponding author), Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA.	gg@che.utexas.edu	Ippolito, Gregory C./AAR-2930-2021; Rogosch, Tobias/A-1522-2009; Ge, Xin/I-8181-2013; Zemlin, Michael/AAB-5746-2020; Reddy, Sai/B-4190-2012	Ippolito, Gregory C./0000-0002-7565-7002; Rogosch, Tobias/0000-0002-1674-1423; Ge, Xin/0000-0001-7491-7805; Zemlin, Michael/0000-0001-9528-7419; Reddy, Sai/0000-0002-9177-0857	Cancer Prevention and Research Institute of Texas; Clayton Foundation; Defense Advanced Research Projects Agency; Deutsche Forschungsgemeinschaft; National Institutes of Health	Cancer Prevention and Research Institute of Texas; Clayton Foundation; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by the Cancer Prevention and Research Institute of Texas; the Clayton Foundation; the Defense Advanced Research Projects Agency; Deutsche Forschungsgemeinschaft; and the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker P. D., 2010, PLOS ONE, V5; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Brehm MA, 2010, CLIN IMMUNOL, V135, P84, DOI 10.1016/j.clim.2009.12.008; BREZINSCHEK HP, 1995, J IMMUNOL, V155, P190; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Cancro MP, 2004, J IMMUNOL, V173, P15, DOI 10.4049/jimmunol.173.1.15; Cappione A, 2005, J CLIN INVEST, V115, P3205, DOI 10.1172/JCI24179; Dorner T, 2005, CLIN EXP MED, V4, P159, DOI 10.1007/s10238-004-0051-2; EISENBERG D, 1984, ANNU REV BIOCHEM, V53, P595, DOI 10.1146/annurev.bi.53.070184.003115; Giassi LJ, 2008, EXP BIOL MED, V233, P997, DOI 10.3181/0802-RM-70; Glanville J, 2011, P NATL ACAD SCI USA, V108, P20066, DOI 10.1073/pnas.1107498108; Glanville J, 2009, P NATL ACAD SCI USA, V106, P20216, DOI 10.1073/pnas.0909775106; Ippolito GC, 2006, J EXP MED, V203, P1567, DOI 10.1084/jem.20052217; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ishikawa F, 2007, BLOOD, V110, P3591, DOI 10.1182/blood-2007-02-071613; Ito R, 2008, CURR TOP MICROBIOL, V324, P95; JEONG HD, 1989, J IMMUNOL, V143, P2752; Jiang N, 2011, P NATL ACAD SCI USA, V108, P5348, DOI 10.1073/pnas.1014277108; KABAT EA, 1991, J IMMUNOL, V147, P1709; Kolar GR, 2006, SCAND J IMMUNOL, V64, P314, DOI 10.1111/j.1365-3083.2006.01817.x; Kolar GR, 2004, BLOOD, V104, P2981, DOI 10.1182/blood-2003-11-3961; Foreman AL, 2007, AUTOIMMUN REV, V6, P387, DOI 10.1016/j.autrev.2006.12.005; Lim TS, 2010, NEW BIOTECHNOL, V27, P108, DOI 10.1016/j.nbt.2010.01.001; Manz MG, 2007, IMMUNITY, V26, P537, DOI 10.1016/j.immuni.2007.05.001; Manz Markus G, 2009, Nat Immunol, V10, P1039, DOI 10.1038/ni1009-1039; Maynard Jennifer A, 2002, Methods Mol Biol, V182, P149; Meffre E, 2001, J CLIN INVEST, V108, P879, DOI 10.1172/JCI13051; Meyers G, 2011, P NATL ACAD SCI US; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; Nikbakht N, 2011, J IMMUNOL, V187, P37, DOI 10.4049/jimmunol.1003924; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; PASCUAL V, 1991, J IMMUNOL, V146, P4385; Prak ETL, 2011, ANN NY ACAD SCI, V1217, P96, DOI 10.1111/j.1749-6632.2010.05877.x; Pugh-Bernard AE, 2001, J CLIN INVEST, V108, P1061, DOI 10.1172/JCI12462; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rao SP, 1999, J IMMUNOL, V163, P2732; Reddy ST, 2010, NAT BIOTECHNOL, V28, P965, DOI 10.1038/nbt.1673; Rogosch T, 2010, J IMMUNOL, V184, P4947, DOI 10.4049/jimmunol.0900859; Rossi MID, 2001, J IMMUNOL, V167, P3033, DOI 10.4049/jimmunol.167.6.3033; Sblattero D, 1998, IMMUNOTECHNOLOGY, V3, P271, DOI 10.1016/S1380-2933(97)10004-5; Schroeder HW, 1998, VACCINE, V16, P1383, DOI 10.1016/S0264-410X(98)00096-6; Schroeder HW, 2006, DEV COMP IMMUNOL, V30, P119, DOI 10.1016/j.dci.2005.06.006; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; SILBERSTEIN LE, 1991, BLOOD, V78, P2372; Stadanlick JE, 2008, CURR OPIN IMMUNOL, V20, P158, DOI 10.1016/j.coi.2008.03.015; Stollar BD, 1995, ANN NY ACAD SCI, V764, P265; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Warren RL, 2010, GENOME RES; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020; Willinger T, 2011, TRENDS IMMUNOL, V32, P321, DOI 10.1016/j.it.2011.04.005; Wu YC, 2010, BLOOD, V116, P1070, DOI 10.1182/blood-2010-03-275859; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; YAMADA M, 1991, J EXP MED, V173, P395, DOI 10.1084/jem.173.2.395; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251; Yurasov S, 2007, CURR OPIN RHEUMATOL, V19, P421, DOI 10.1097/BOR.0b013e328277ef3b; Zheng NY, 2004, J CLIN INVEST, V113, P1188, DOI 10.1172/JCI200420255	57	58	62	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35497	10.1371/journal.pone.0035497	http://dx.doi.org/10.1371/journal.pone.0035497			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558161	Green Published, gold			2022-12-25	WOS:000305336000035
J	Vandrangi, P; Sosa, M; Shyy, JYJ; Rodgers, VGJ				Vandrangi, Prashanthi; Sosa, Martha; Shyy, John Y. -J.; Rodgers, Victor G. J.			Flow-Dependent Mass Transfer May Trigger Endothelial Signaling Cascades	PLOS ONE			English	Article							FLUID SHEAR-STRESS; MESSENGER-RNA LEVELS; ARTERIAL WALL SHEAR; INDUCED ATP RELEASE; CELLS IN-VITRO; FACTOR-B CHAIN; GENE-EXPRESSION; GROWTH-FACTOR; CELLULAR MECHANOTRANSDUCTION; BIOMECHANICAL ACTIVATION	It is well known that fluid mechanical forces directly impact endothelial signaling pathways. But while this general observation is clear, less apparent are the underlying mechanisms that initiate these critical signaling processes. This is because fluid mechanical forces can offer a direct mechanical input to possible mechanotransducers as well as alter critical mass transport characteristics (i.e., concentration gradients) of a host of chemical stimuli present in the blood stream. However, it has recently been accepted that mechanotransduction (direct mechanical force input), and not mass transfer, is the fundamental mechanism for many hemodynamic force-modulated endothelial signaling pathways and their downstream gene products. This conclusion has been largely based, indirectly, on accepted criteria that correlate signaling behavior and shear rate and shear stress, relative to changes in viscosity. However, in this work, we investigate the negative control for these criteria. Here we computationally and experimentally subject mass-transfer limited systems, independent of mechanotransduction, to the purported criteria. The results showed that the negative control (mass-transfer limited system) produced the same trends that have been used to identify mechanotransduction-dominant systems. Thus, the widely used viscosity-related shear stress and shear rate criteria are insufficient in determining mechanotransduction-dominant systems. Thus, research should continue to consider the importance of mass transfer in triggering signaling cascades.	[Vandrangi, Prashanthi; Sosa, Martha; Rodgers, Victor G. J.] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA; [Shyy, John Y. -J.] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Vandrangi, P (corresponding author), Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.	vrodgers@engr.ucr.edu	Rodgers, Victor G. J./AAF-3838-2021; Rodgers, Victor G/G-3652-2016	Rodgers, Victor G. J./0000-0002-1857-8025; Rodgers, Victor G/0000-0002-1857-8025				ADAMS DJ, 1989, FASEB J, V3, P2389, DOI 10.1096/fasebj.3.12.2477294; ANDO J, 1994, AM J PHYSIOL, V267, pC679, DOI 10.1152/ajpcell.1994.267.3.C679; ANDO J, 1988, IN VITRO CELL DEV B, V24, P871; BACKX PH, 1989, J GEN PHYSIOL, V93, P963, DOI 10.1085/jgp.93.5.963; CARO CG, 1971, PROC R SOC SER B-BIO, V177, P109, DOI 10.1098/rspb.1971.0019; CARO CG, 1969, NATURE, V223, P1159, DOI 10.1038/2231159a0; CARO CG, 1973, CIRC RES, V32, P187, DOI 10.1161/01.RES.32.2.187; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Chen KD, 1999, J BIOL CHEM, V274, P18393, DOI 10.1074/jbc.274.26.18393; Chen K, 2007, ANTIOXID REDOX SIGN, V9, P1097, DOI 10.1089/ars.2007.1594; Chien S, 1998, HYPERTENSION, V31, P162, DOI 10.1161/01.HYP.31.1.162; Comerford A, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2838026; David T, 2003, ANN BIOMED ENG, V31, P1231, DOI 10.1114/1.1615574; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; DEWEY CF, 1981, J BIOMECH ENG-T ASME, V103, P177, DOI 10.1115/1.3138276; DIAMOND SL, 1989, SCIENCE, V243, P1483, DOI 10.1126/science.2467379; DIAMOND SL, 1990, J CELL PHYSIOL, V143, P364, DOI 10.1002/jcp.1041430222; DULL RO, 1992, J VASC RES, V29, P410, DOI 10.1159/000158959; Ethier CR, 2002, ANN BIOMED ENG, V30, P461, DOI 10.1114/1.1468890; Fadel AA, 2009, ANN BIOMED ENG, V37, P943, DOI 10.1007/s10439-009-9658-5; Fisher AB, 2001, AM J PHYSIOL-LUNG C, V281, pL529, DOI 10.1152/ajplung.2001.281.3.L529; FRANGOS JA, 1985, SCIENCE, V227, P1477, DOI 10.1126/science.3883488; FRY DL, 1968, CIRC RES, V22, P165, DOI 10.1161/01.RES.22.2.165; Garcia-Cardena G, 2001, ANN NY ACAD SCI, V947, P1; Garcia-Cardena G, 2001, P NATL ACAD SCI USA, V98, P4478, DOI 10.1073/pnas.071052598; Gimbrone MA, 1997, J CLIN INVEST, V99, P1809, DOI 10.1172/JCI119346; Guilak F, 2010, COMPUTATIONAL MODELI, P49; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; John K, 2001, ANN BIOMED ENG, V29, P740, DOI 10.1114/1.1397792; KAMIYA A, 1980, AM J PHYSIOL, V239, pH14, DOI 10.1152/ajpheart.1980.239.1.H14; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; Konstantopoulos K, 1998, ADV DRUG DELIVER REV, V33, P141, DOI 10.1016/S0169-409X(98)00024-6; Korenaga R, 1997, AM J PHYSIOL-CELL PH, V273, pC1506; Korenaga R, 2001, AM J PHYSIOL-HEART C, V280, pH2214, DOI 10.1152/ajpheart.2001.280.5.H2214; Kosaki K, 1998, CIRC RES, V82, P794, DOI 10.1161/01.RES.82.7.794; KU DN, 1985, ARTERIOSCLEROSIS, V5, P293, DOI 10.1161/01.ATV.5.3.293; LEVESQUE MJ, 1990, BIOMATERIALS, V11, P702, DOI 10.1016/0142-9612(90)90031-K; LEVESQUE MJ, 1986, ARTERIOSCLEROSIS, V6, P220, DOI 10.1161/01.ATV.6.2.220; LEVESQUE MJ, 1985, J BIOMECH ENG-T ASME, V107, P341, DOI 10.1115/1.3138567; MALEK AM, 1994, CIRC RES, V74, P852, DOI 10.1161/01.RES.74.5.852; MALEK AM, 1993, J CLIN INVEST, V92, P2013, DOI 10.1172/JCI116796; MALEK AM, 1994, J HYPERTENS, V12, P989; MITSUMATA M, 1993, AM J PHYSIOL, V265, pH3, DOI 10.1152/ajpheart.1993.265.1.H3; NAGEL T, 1994, J CLIN INVEST, V94, P885, DOI 10.1172/JCI117410; Nakatsuka H, 2006, AM J PHYSIOL-GASTR L, V291, pG26, DOI 10.1152/ajpgi.00467.2005; NEREM RM, 1993, J CARDIOVASC PHARM, V21, pS6, DOI 10.1097/00005344-199321001-00002; NEREM RM, 1981, J BIOMECH ENG-T ASME, V103, P172, DOI 10.1115/1.3138275; NEREM RM, 1992, J BIOMECH ENG-T ASME, V114, P274, DOI 10.1115/1.2891384; Nerem RM, 1985, FED PROC, V107, P341; NOLLERT MU, 1989, BIOCHIM BIOPHYS ACTA, V1005, P72, DOI 10.1016/0005-2760(89)90033-7; NOLLERT MU, 1991, BIOTECHNOL BIOENG, V38, P588, DOI 10.1002/bit.260380605; NOLLERT MU, 1990, BIOCHEM BIOPH RES CO, V170, P281, DOI 10.1016/0006-291X(90)91271-S; Obi S, 2009, J APPL PHYSIOL, V106, P203, DOI 10.1152/japplphysiol.00197.2008; Olgac U, 2008, AM J PHYSIOL-HEART C, V294, pH909, DOI 10.1152/ajpheart.01082.2007; PATRICK CW, 1995, BLOOD PURIFICAT, V13, P112; Plank MJ, 2006, PROG BIOPHYS MOL BIO, V91, P287, DOI 10.1016/j.pbiomolbio.2005.07.005; Qin KR, 2008, BIOMECH MODEL MECHAN, V7, P345, DOI 10.1007/s10237-007-0088-8; Quarteroni A, 2002, SIAM J NUMER ANAL, V39, P1488, DOI 10.1137/S0036142900369714; RANJAN V, 1995, AM J PHYSIOL-HEART C, V269, pH550, DOI 10.1152/ajpheart.1995.269.2.H550; Rappitsch G, 1997, INT J NUMER METH FL, V25, P847, DOI 10.1002/(SICI)1097-0363(19971015)25:7<847::AID-FLD590>3.0.CO;2-1; RESNICK N, 1993, P NATL ACAD SCI USA, V90, P4591, DOI 10.1073/pnas.90.10.4591; RESNICK N, 1995, FASEB J, V9, P874, DOI 10.1096/fasebj.9.10.7615157; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SAMPATH R, 1995, ANN BIOMED ENG, V23, P247, DOI 10.1007/BF02584426; Schmidt C, 1998, J BIOL CHEM, V273, P5081, DOI 10.1074/jbc.273.9.5081; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Seliktar D, 2001, ANN BIOMED ENG, V29, P923, DOI 10.1114/1.1415522; SHAREFKIN JB, 1991, J VASC SURG, V14, P1; Shi ZD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012196; Shyy JYJ, 1997, CURR OPIN CELL BIOL, V9, P707, DOI 10.1016/S0955-0674(97)80125-1; Tarbell JM, 2003, ANNU REV BIOMED ENG, V5, P79, DOI 10.1146/annurev.bioeng.5.040202.121529; Truskey G., 2009, TRANSPORT PHENOMENA; TSUBOI H, 1995, BIOCHEM BIOPH RES CO, V206, P988, DOI 10.1006/bbrc.1995.1140; Tzima E, 2002, EMBO J, V21, P6791, DOI 10.1093/emboj/cdf688; Uematsu M, 1995, AM J PHYSIOL-CELL PH, V269, pC1371, DOI 10.1152/ajpcell.1995.269.6.C1371; Urbich C, 2000, CIRC RES, V87, P683, DOI 10.1161/01.RES.87.8.683; Wiesner TF, 1996, AM J PHYSIOL-CELL PH, V270, pC1556, DOI 10.1152/ajpcell.1996.270.5.C1556; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592; Yamamoto K, 2000, CIRC RES, V87, P385; Yamamoto K, 2000, AM J PHYSIOL-HEART C, V279, pH285, DOI 10.1152/ajpheart.2000.279.1.H285; Yamamoto K, 2005, AM J PHYSIOL-HEART C, V288, pH1915, DOI 10.1152/ajpheart.00956.2004	83	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35260	10.1371/journal.pone.0035260	http://dx.doi.org/10.1371/journal.pone.0035260			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558132	gold, Green Published			2022-12-25	WOS:000305336000027
J	Ke, YZ; Dramiga, J; Schutz, U; Kril, JJ; Ittner, LM; Schroder, H; Gotz, J				Ke, Yazi; Dramiga, Joe; Schuetz, Ulrich; Kril, Jillian J.; Ittner, Lars M.; Schroeder, Hannsjoerg; Goetz, Juergen			Tau-Mediated Nuclear Depletion and Cytoplasmic Accumulation of SFPQ in Alzheimer's and Pick's Disease	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; RNA-SPLICING FACTOR; TRANSGENIC MICE; BINDING PROTEIN; NEURODEGENERATIVE DISORDERS; GENE-EXPRESSION; ANIMAL-MODELS; PATHOLOGY; TDP-43; BETA	Tau dysfunction characterizes neurodegenerative diseases such as Alzheimer's disease (AD) and frontotemporal lobar degeneration (FTLD). Here, we performed an unbiased SAGE (serial analysis of gene expression) of differentially expressed mRNAs in the amygdala of transgenic pR5 mice that express human tau carrying the P301L mutation previously identified in familial cases of FTLD. SAGE identified 29 deregulated transcripts including Sfpq that encodes a nuclear factor implicated in the splicing and regulation of gene expression. To assess the relevance for human disease we analyzed brains from AD, Pick's disease (PiD, a form of FTLD), and control cases. Strikingly, in AD and PiD, both dementias with a tau pathology, affected brain areas showed a virtually complete nuclear depletion of SFPQ in both neurons and astrocytes, along with cytoplasmic accumulation. Accordingly, neurons harboring either AD tangles or Pick bodies were also depleted of SFPQ. Immunoblot analysis of human entorhinal cortex samples revealed reduced SFPQ levels with advanced Braak stages suggesting that the SFPQ pathology may progress together with the tau pathology in AD. To determine a causal role for tau, we stably expressed both wild-type and P301L human tau in human SH-SY5Y neuroblastoma cells, an established cell culture model of tau pathology. The cells were differentiated by two independent methods, mitomycin C-mediated cell cycle arrest or neuronal differentiation with retinoic acid. Confocal microscopy revealed that SFPQ was confined to nuclei in non-transfected wild-type cells, whereas in wild-type and P301L tau over-expressing cells, irrespective of the differentiation method, it formed aggregates in the cytoplasm, suggesting that pathogenic tau drives SFPQ pathology in post-mitotic cells. Our findings add SFPQ to a growing list of transcription factors with an altered nucleo-cytoplasmic distribution under neurodegenerative conditions.	[Ke, Yazi; Ittner, Lars M.; Goetz, Juergen] Univ Sydney, Brain & Mind Res Inst, Alzheimers & Parkinsons Dis Lab, Camperdown, NSW, Australia; [Dramiga, Joe; Schuetz, Ulrich; Schroeder, Hannsjoerg] Univ Cologne, Dept Anat & Neuroanat 2, D-50931 Cologne, Germany; [Dramiga, Joe; Schuetz, Ulrich; Schroeder, Hannsjoerg] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Kril, Jillian J.] Univ Sydney, Discipline Med, Sydney, NSW 2006, Australia; [Kril, Jillian J.] Univ Sydney, Discipline Pathol, Sydney, NSW 2006, Australia	University of Sydney; University of Cologne; University of Cologne; University of Sydney; University of Sydney	Ke, YZ (corresponding author), Univ Sydney, Brain & Mind Res Inst, Alzheimers & Parkinsons Dis Lab, Camperdown, NSW, Australia.	schroeder.anatomie@uni-koeln.de; juergen.goetz@sydney.edu.au	Götz, Jürgen/C-2448-2014; Ke, Yazi/ABC-3052-2020	Götz, Jürgen/0000-0001-8501-7896; Ke, Yazi/0000-0002-1423-0451; Kril, Jillian/0000-0001-9407-8674; Ittner, Lars/0000-0001-6738-3825	NHMRC (National Health & Medical Research Council); ARC (Australian Research Council); J.O. & J.R. Wicking Trust; Center for Molecular Medicine Cologne [TV79]	NHMRC (National Health & Medical Research Council); ARC (Australian Research Council)(Australian Research Council); J.O. & J.R. Wicking Trust; Center for Molecular Medicine Cologne	The authors acknowledge funding by the NHMRC (National Health & Medical Research Council), the ARC (Australian Research Council), and the J.O. & J.R. Wicking Trust, as well as the Center for Molecular Medicine Cologne (TV79). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Boutin JA, 2009, CELL MOL LIFE SCI, V66, P3009, DOI 10.1007/s00018-009-0056-9; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Chen F, 2004, P NATL ACAD SCI USA, V101, P7687, DOI 10.1073/pnas.0402338101; Choi P, 2003, MOL BRAIN RES, V117, P179, DOI 10.1016/S0169-328X(03)00318-8; Cook C, 2008, EXPERT OPIN BIOL TH, V8, P969, DOI 10.1517/14712598.8.7.969 ; David DC, 2005, PROG NEUROBIOL, V76, P153, DOI 10.1016/j.pneurobio.2005.07.001; David DC, 2005, J BIOL CHEM, V280, P23802, DOI 10.1074/jbc.M500356200; Deters N, 2008, EUR J NEUROSCI, V28, P137, DOI 10.1111/j.1460-9568.2008.06318.x; Deters N, 2009, BIOCHEM BIOPH RES CO, V379, P400, DOI 10.1016/j.bbrc.2008.12.140; DiProspero NA, 2004, J NEUROCYTOL, V33, P517, DOI 10.1007/s11068-004-0514-8; Eckert A, 2008, NEURODEGENER DIS, V5, P157, DOI 10.1159/000113689; Estey MP, 2011, CURR BIOL, V21, pR384, DOI 10.1016/j.cub.2011.03.067; Ferrari A, 2003, J BIOL CHEM, V278, P40162, DOI 10.1074/jbc.M308243200; Gotz J, 2001, BRAIN RES REV, V35, P266, DOI 10.1016/S0165-0173(01)00055-8; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Hall-Pogar T, 2007, RNA, V13, P1103, DOI 10.1261/rna.577707; Harigaya Y, 1996, J NEUROSCI RES, V43, P87, DOI 10.1002/jnr.490430111; HOLT IJ, 1989, LANCET, V1, P524; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Julien C, 2008, J NEUROSCI RES, V86, P2292, DOI 10.1002/jnr.21667; Kaneko S, 2007, GENE DEV, V21, P1779, DOI 10.1101/gad.1565207; Kovacech B, 2009, CELL MOL NEUROBIOL, V29, P799, DOI 10.1007/s10571-009-9358-6; Krupka N, 2010, PLASMID, V63, P155, DOI 10.1016/j.plasmid.2010.01.002; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lowery LA, 2007, DEV DYNAM, V236, P1347, DOI 10.1002/dvdy.21132; Martin JA, 2011, CURR BIOL, V21, P97, DOI 10.1016/j.cub.2010.12.014; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Patel VP, 2011, INT J CLIN EXP PATHO, V4, P215; PATTON JG, 1993, GENE DEV, V7, P393, DOI 10.1101/gad.7.3.393; Pennanen L, 2006, GENES BRAIN BEHAV, V5, P369, DOI 10.1111/j.1601-183X.2005.00165.x; Pennanen L, 2004, NEUROBIOL DIS, V15, P500, DOI 10.1016/j.nbd.2003.11.020; Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106; SARAIVA MJM, 1986, J LAB CLIN MED, V108, P17; Schild A, 2006, INT J DEV NEUROSCI, V24, P437, DOI 10.1016/j.ijdevneu.2006.08.005; Sewer MB, 2002, ENDOCRINOLOGY, V143, P1280, DOI 10.1210/en.143.4.1280; Shav-Tal Y, 2001, MOL BIOL CELL, V12, P2328, DOI 10.1091/mbc.12.8.2328; Song X, 2005, P NATL ACAD SCI USA, V102, P12189, DOI 10.1073/pnas.0505179102; Stork O, 2001, LEARN MEMORY, V8, P209, DOI 10.1101/lm.39401; Straub T, 1998, J BIOL CHEM, V273, P26261, DOI 10.1074/jbc.273.41.26261; Sultan A, 2011, J BIOL CHEM, V286, P4566, DOI 10.1074/jbc.M110.199976; Tannenberg RK, 2006, NEUROCHEM INT, V49, P631, DOI 10.1016/j.neuint.2006.05.004; Tapia-Paez I, 2008, FASEB J, V22, P3001, DOI 10.1096/fj.07-104455; Urban RJ, 2000, MOL ENDOCRINOL, V14, P774, DOI 10.1210/me.14.6.774; Urwin H, 2010, ACTA NEUROPATHOL, V120, P33, DOI 10.1007/s00401-010-0698-6; van Eersel J, 2010, P NATL ACAD SCI USA, V107, P13888, DOI 10.1073/pnas.1009038107; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Yoshida T, 2010, INT J MOL MED, V25, P649, DOI 10.3892/ijmm_00000388; Yu P, 2002, GENOMICS, V79, P869, DOI 10.1006/geno.2002.6770	53	71	73	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35678	10.1371/journal.pone.0035678	http://dx.doi.org/10.1371/journal.pone.0035678			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558197	gold, Green Submitted, Green Published			2022-12-25	WOS:000305345200065
J	Petrucci, E; Pasquini, L; Bernabei, M; Saulle, E; Biffoni, M; Accarpio, F; Sibio, S; Di Giorgio, A; Di Donato, V; Casorelli, A; Benedetti-Panici, P; Testa, U				Petrucci, Eleonora; Pasquini, Luca; Bernabei, Manuela; Saulle, Ernestina; Biffoni, Mauro; Accarpio, Fabio; Sibio, Simone; Di Giorgio, Angelo; Di Donato, Violante; Casorelli, Assunta; Benedetti-Panici, Pierluigi; Testa, Ugo			A Small Molecule SMAC Mimic LBW242 Potentiates TRAIL- and Anticancer Drug-Mediated Cell Death of Ovarian Cancer Cells	PLOS ONE			English	Article							X-LINKED INHIBITOR; NF-KAPPA-B; APOPTOSIS PROTEINS; ACTIVATION; IAPS; SMAC/DIABLO; COMBINATION; RESISTANCE; THERAPIES; BLOCKADE	Background: Ovarian cancer remains a leading cause of death in women and development of new therapies is essential. Second mitochondria derived activator of caspase (SMAC) has been described to sensitize for apoptosis. We have explored the pro-apoptotic activity of LBW242, a mimic of SMAC/DIABLO, on ovarian cancer cell lines (A2780 cells and its chemoresistant derivative A2780/ADR, SKOV3 and HEY cells) and in primary ovarian cancer cells. The effects of LBW242 on ovarian cancer cell lines and primary ovarian cancer cells was determined by cell proliferation, apoptosis and biochemical assays. Principal Findings: LBW242 added alone elicited only a moderate pro-apoptotic effect; however, it strongly synergizes with tumor necrosis factor-related apoptosis inducing ligand (TRAIL) or anticancer drugs in inducing apoptosis of both ovarian cancer cell lines and primary ovarian cancer cells. Mechanistic studies show that LBW242-induced apoptosis in ovarian cancer cells is associated with activation of caspase-8. In line with this mechanism, c-FLIP overexpression inhibits LBW242-mediated apoptosis. Conclusion: LBW242 sensitizes ovarian cancer cells to the antitumor effects of TRAIL and anticancer drugs commonly used in clinic. These observations suggest that the SMAC/DIABLO mimic LBW242 could be of value for the development of experimental strategies for treatment of ovarian cancer.	[Petrucci, Eleonora; Pasquini, Luca; Bernabei, Manuela; Saulle, Ernestina; Biffoni, Mauro; Testa, Ugo] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Accarpio, Fabio; Sibio, Simone; Di Giorgio, Angelo] Univ Roma La Sapienza, Dept Surg Pietro Valdoni, Policlin Umberto I, Rome, Italy; [Di Giorgio, Angelo; Di Donato, Violante; Casorelli, Assunta] Univ Roma La Sapienza, Dept Obstet & Gynaecol, Rome, Italy	Istituto Superiore di Sanita (ISS); Sapienza University Rome; University Hospital Sapienza Rome; Sapienza University Rome	Petrucci, E (corresponding author), Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	u.testa@iss.it	SAULLE, ERNESTINA/J-8834-2016; Biffoni, Mauro/J-8318-2016; Di Donato, Violante/J-1556-2012; Saulle, Ernestina/AAE-4654-2021; Di Donato, Violante/O-1742-2019; pasquini, luca/J-8319-2016; PETRUCCI, ELEONORA/J-8778-2016; Testa, Ugo/J-6472-2016; sibio, simone/A-3639-2019	Biffoni, Mauro/0000-0002-1304-9060; Di Donato, Violante/0000-0002-9254-5790; Di Donato, Violante/0000-0002-9254-5790; pasquini, luca/0000-0002-3484-6288; PETRUCCI, ELEONORA/0000-0001-6459-490X; Testa, Ugo/0000-0001-7900-8942; sibio, simone/0000-0002-5694-951X; saulle, ernestina/0000-0001-6681-6887; Accarpio, Fabio/0000-0001-8317-2323	Italian Health Ministery, Progetto Oncotecnologico	Italian Health Ministery, Progetto Oncotecnologico	This study was supported by the grants from the Italian Health Ministery, Progetto Oncotecnologico to UT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2010, BIOCHEM J, V430, P199, DOI 10.1042/BJ20100814; Chauhan D, 2007, BLOOD, V109, P1220, DOI 10.1182/blood-2006-04-015149; Cheung HH, 2009, CANCER RES, V69, P7729, DOI 10.1158/0008-5472.CAN-09-1794; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Dai Y, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-392; Darding M, 2011, CELL DEATH DIFFER, V18, P1376, DOI 10.1038/cdd.2011.10; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Engel C, 2010, CANCER EPIDEM BIOMAR, V19, P2859, DOI 10.1158/1055-9965.EPI-10-0517; Ferreira CG, 2000, CANCER RES, V60, P7133; Fraser M, 2003, CANCER RES, V63, P7081; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Georgakis GV, 2005, BRIT J HAEMATOL, V130, P501, DOI 10.1111/j.1365-2141.2005.05656.x; Griffith TS, 2003, CANCER CHEMOTH PHARM, V52, P175, DOI 10.1007/s00280-003-0656-2; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Lecis D, 2010, BRIT J CANCER, V102, P1707, DOI 10.1038/sj.bjc.6605687; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Lu JF, 2008, CANCER RES, V68, P9384, DOI 10.1158/0008-5472.CAN-08-2655; Lu JF, 2011, MOL CANCER THER, V10, P902, DOI 10.1158/1535-7163.MCT-10-0864; Mehrotra S, 2010, CANCER CELL, V17, P53, DOI 10.1016/j.ccr.2009.11.021; Petersen SL, 2010, P NATL ACAD SCI USA, V107, P11936, DOI 10.1073/pnas.1005667107; Petronelli A, 2009, CANCER LETT, V282, P214, DOI 10.1016/j.canlet.2009.03.018; Petrucci E, 2007, GYNECOL ONCOL, V105, P481, DOI 10.1016/j.ygyno.2007.01.011; Probst BL, 2010, CELL DEATH DIFFER, V17, P1645, DOI 10.1038/cdd.2010.44; Pukac L, 2005, BRIT J CANCER, V92, P1430, DOI 10.1038/sj.bjc.6602487; Ricci MS, 2007, CANCER CELL, V12, P66, DOI 10.1016/j.ccr.2007.05.006; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Sharma SK, 2006, INT J PEPT RES THER, V12, P21, DOI 10.1007/s10989-005-9003-2; Sun T, 2007, NAT GENET, V39, P605, DOI 10.1038/ng2030; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vucic D, 2008, CURR CANCER DRUG TAR, V8, P110, DOI 10.2174/156800908783769373; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Weber A, 2010, CELL DEATH DIFFER, V17, P942, DOI 10.1038/cdd.2009.190; Weisberg E, 2007, MOL CANCER THER, V6, P1951, DOI 10.1158/1535-7163.MCT-06-0810; Xu Y, 2011, CLIN CANCER RES, V17, P5412, DOI 10.1158/1078-0432.CCR-11-0426; Ziegler DS, 2008, J CLIN INVEST, V118, P3109, DOI 10.1172/JCI34120	42	27	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35073	10.1371/journal.pone.0035073	http://dx.doi.org/10.1371/journal.pone.0035073			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558117	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345200023
J	Bailey, H; Thorne, C; Semenenko, I; Malyuta, R; Tereschenko, R; Adeyanova, I; Kulakovskaya, E; Ostrovskaya, L; Kvasha, L; Cortina-Borja, M; Townsend, CL				Bailey, Heather; Thorne, Claire; Semenenko, Igor; Malyuta, Ruslan; Tereschenko, Rostislav; Adeyanova, Irina; Kulakovskaya, Elena; Ostrovskaya, Lyudmila; Kvasha, Liliana; Cortina-Borja, Mario; Townsend, Claire L.			Cervical Screening within HIV Care: Findings from an HIV-Positive Cohort in Ukraine	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; SQUAMOUS INTRAEPITHELIAL LESIONS; ACTIVE ANTIRETROVIRAL THERAPY; BACTERIAL VAGINOSIS; WOMEN; CANCER; IMMUNODEFICIENCY; RISK; PREVALENCE; PREVENTION	Introduction: HIV-positive women have an increased risk of invasive cervical cancer but cytologic screening is effective in reducing incidence. Little is known about cervical screening coverage or the prevalence of abnormal cytology among HIV-positive women in Ukraine, which has the most severe HIV epidemic in Europe. Methods: Poisson regression models were fitted to data from 1120 women enrolled at three sites of the Ukraine Cohort Study of HIV-infected Childbearing Women to investigate factors associated with receiving cervical screening as part of HIV care. All women had been diagnosed as HIV-positive before or during their most recent pregnancy. Prevalence of cervical abnormalities (high/low grade squamous intraepithelial lesions) among women who had been screened was estimated, and associated factors explored. Results: Overall, 30% (337/1120) of women had received a cervical screening test as part of HIV care at study enrolment (median 10 months postpartum), a third (115/334) of whom had been tested >12 months previously. In adjusted analyses, women diagnosed as HIV-positive during (vs before) their most recent pregnancy were significantly less likely to have a screening test reported, on adjusting for other potential risk factors (adjusted prevalence ratio (APR) 0.62, 95% CI 0.51-0.75 p<0.01 for 1st/2nd trimester diagnosis and APR 0.42, 95% CI 0.28-0.63 p<0.01 for 3rd trimester/intrapartum diagnosis). Among those with a cervical screening result reported at any time (including follow-up), 21% (68/325) had a finding of cervical abnormality. In adjusted analyses, Herpes simplex virus 2 seropositivity and a recent diagnosis of bacterial vaginosis were associated with an increased risk of abnormal cervical cytology (APR 1.83 95% CI 1.07-3.11 and APR 3.49 95% CI 2.11-5.76 respectively). Conclusions: In this high risk population, cervical screening coverage as part of HIV care was low and could be improved by an organised cervical screening programme for HIV-positive women. Bacterial vaginosis testing and treatment may reduce vulnerability to cervical abnormalities.	[Bailey, Heather; Thorne, Claire; Cortina-Borja, Mario; Townsend, Claire L.] UCL, UCL Inst Child Hlth, MRC Ctr Epidemiol Child Hlth, London, England; [Semenenko, Igor; Malyuta, Ruslan] Perinatal Prevent AIDS Initiat, Odessa, Ukraine; [Tereschenko, Rostislav] Odessa Reg Ctr HIV AIDS, Odessa, Ukraine; [Adeyanova, Irina] Kiev City Ctr HIV AIDS, Kiev, Ukraine; [Kulakovskaya, Elena] Donetsk Reg Ctr HIV AIDS, Donetsk, Ukraine; [Ostrovskaya, Lyudmila] Mykolaiv Reg Ctr HIV AIDS, Mykolaiv, Ukraine; [Kvasha, Liliana] Kriviy Rig City Ctr HIV AIDS, Kriviy Rig, Ukraine	University of London; University College London	Bailey, H (corresponding author), UCL, UCL Inst Child Hlth, MRC Ctr Epidemiol Child Hlth, London, England.	claire.thorne@ucl.ac.uk	Thorne, Claire/C-5943-2008; Kulakovskaya, Elena/ABI-5390-2020; Borja, Mario Cortina/A-3847-2009	Thorne, Claire/0000-0003-0389-1956; Borja, Mario Cortina/0000-0003-0627-2624; Bailey, Heather/0000-0003-3266-1041	Medical Research Council (MRC) Doctoral Training Account Ph.D. Studentship; WellChild Trust through a research training Fellowship; Wellcome Trust Research Career Development Fellowship [081082]; European Union FP6 [PENTA/ECS018865]; EU Seventh Framework Programme under EuroCoord grant [260694]; UK Department of Health's NIHR Biomedical Research Centres funding scheme; MRC in its capacity as the MRC Centre of Epidemiology for Child Health [G0400546]; MRC [G0400546] Funding Source: UKRI; Medical Research Council [G0400546] Funding Source: researchfish	Medical Research Council (MRC) Doctoral Training Account Ph.D. Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); WellChild Trust through a research training Fellowship; Wellcome Trust Research Career Development Fellowship(Wellcome Trust); European Union FP6(European Commission); EU Seventh Framework Programme under EuroCoord grant; UK Department of Health's NIHR Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR)); MRC in its capacity as the MRC Centre of Epidemiology for Child Health(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	HB is supported by a Medical Research Council (MRC) Doctoral Training Account Ph.D. Studentship. CLT is funded by the WellChild Trust through a research training Fellowship. CT holds a Wellcome Trust Research Career Development Fellowship (grant number 081082) which supports the postnatal cohort. The ECS has previously received funding from the European Union FP6 (PENTA/ECS018865) and receives funding from the EU Seventh Framework Programme (FP7/2007-2013) under EuroCoord grant agreement no 260694. Some of this work was undertaken at GOSH/UCL Institute of Child Health which received a proportion of funding from the UK Department of Health's NIHR Biomedical Research Centres funding scheme. The Centre for Paediatric Epidemiology and Biostatistics also benefits from funding support from the MRC in its capacity as the MRC Centre of Epidemiology for Child Health (grant number G0400546). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahdieh-Grant L, 2004, JNCI-J NATL CANCER I, V96, P1070, DOI 10.1093/jnci/djh192; Allsworth JE, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.060; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Boer K, 2010, HIV MED, V11, P368, DOI 10.1111/j.1468-1293.2009.00800.x; Boyle DCM, 2003, INT J GYNECOL CANCER, V13, P159, DOI 10.1046/j.1525-1438.2003.13007.x; Castellsague X, 2007, HPV CERVICAL CANC WO; Castle Philip E, 2003, J Natl Cancer Inst Monogr, P29; Centers for Disease Control and Prevention, 2009, MMWR, V58; Clifford G, 2006, VACCINE, V24, P26, DOI 10.1016/j.vaccine.2006.05.026; Clifford GM, 2005, JNCI-J NATL CANCER I, V97, P425, DOI 10.1093/jnci/dji072; Del Mistro A, 2004, CLIN INFECT DIS, V38, P737, DOI 10.1086/381681; Fakoya A, 2008, HIV MED, V9, P681, DOI 10.1111/j.1468-1293.2008.00634.x; Flannelly G, 2010, BEST PRACT RES CL OB, V24, P51, DOI 10.1016/j.bpobgyn.2009.07.001; Franceschi S, 2007, CLIN INFECT DIS, V45, P510, DOI 10.1086/520022; Franceschi S, 2010, AIDS, V24, P2570, DOI 10.1097/QAD.0b013e32833f39b2; Frisch M, 2000, JNCI-J NATL CANCER I, V92, P1500, DOI 10.1093/jnci/92.18.1500; Gakidou E, 2008, PLOS MED, V5, P863, DOI 10.1371/journal.pmed.0050132; Gillet E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-10; GUIJON F, 1992, INT J GYNECOL OBSTET, V37, P185, DOI 10.1016/0020-7292(92)90379-W; Gustafsson L, 1997, CANCER CAUSE CONTROL, V8, P755, DOI 10.1023/A:1018435522475; Heard I, 2009, CURR OPIN HIV AIDS, V4, P68, DOI 10.1097/COH.0b013e328319bcbe; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2010, GLOB REP UNAIDS REP; King CC, 2011, INFECT DIS OBSTET GY, V2011, DOI DOI 10.1155/2011/; Kitchener H, 2007, INT J CANCER, V121, P2484, DOI 10.1002/ijc.22947; Kojic EM, 2007, CURR OPIN ONCOL, V19, P464, DOI 10.1097/CCO.0b013e3282c8c84c; Kruglov YV, 2008, SEX TRANSM INFECT, V84, pI37, DOI 10.1136/sti.2008.031195; Leitich H, 2003, AM J OBSTET GYNECOL, V189, P139, DOI 10.1067/mob.2003.339; Maiman M, 1998, GYNECOL ONCOL, V68, P233, DOI 10.1006/gyno.1998.4938; Maiman M, 1998, J Natl Cancer Inst Monogr, P43; Massad LS, 2004, AIDS, V18, P109, DOI 10.1097/00002030-200401020-00013; Mbizvo EM, 2005, INT J STD AIDS, V16, P789, DOI 10.1258/095646205774988046; Ministry of Health of Ukraine, 2010, UKR NAT REP MON PROG; Ministry of Health of Ukraine, 2002, 503 MIN HLTH UKR; Minkoff H, 1998, AM J OBSTET GYNECOL, V178, P982, DOI 10.1016/S0002-9378(98)70535-6; Minkoff H, 2010, J INFECT DIS, V201, P681, DOI 10.1086/650467; Moscicki AB, 2001, JAMA-J AM MED ASSOC, V285, P2995, DOI 10.1001/jama.285.23.2995; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Newmann SJ, 2005, CANCER CAUSE CONTROL, V16, P63, DOI 10.1007/s10552-004-1290-y; NHS Cancer Screening Programmes, 2010, COLP PROGR MAN GUID, P20; PETERS N, 1995, SEX TRANSM DIS, V22, P296, DOI 10.1097/00007435-199509000-00005; Peto J, 2004, LANCET, V364, P249, DOI 10.1016/S0140-6736(04)16674-9; PETRY KU, 1994, INT J CANCER, V57, P836, DOI 10.1002/ijc.2910570612; Phelan DF, 2009, SEX TRANSM DIS, V36, P149, DOI 10.1097/OLQ.0b013e31818d3df3; PLATZCHRISTENSEN JJ, 1994, ACTA OBSTET GYN SCAN, V73, P586, DOI 10.3109/00016349409006278; Sawaya GF, 2009, NEW ENGL J MED, V361, P2503, DOI 10.1056/NEJMp0911380; Saxton J, 2010, HUM REPROD, V25, P2366, DOI 10.1093/humrep/deq093; Shah S, 2006, HIV MED, V7, P46, DOI 10.1111/j.1468-1293.2005.00331.x; Smith JS, 2002, JNCI-J NATL CANCER I, V94, P1604, DOI 10.1093/jnci/94.21.1604; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Sun XW, 1997, NEW ENGL J MED, V337, P1343, DOI 10.1056/NEJM199711063371903; Thorne C, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-40; Uberti-Foppa C, 2003, AIDS, V17, P2136, DOI 10.1097/00002030-200309260-00021; Verteramo R, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-16; Watts DH, 2005, J INFECT DIS, V191, P1129, DOI 10.1086/427777; WHO/ICO Information Centre on HPV and Cervical Cancer, 2010, HUM PAP REL CANC UKR; World Health Organization, 2006, WHO CAS DEF HIV SURV; Wright TC, 2007, AM J OBSTET GYNECOL, V197, P340, DOI 10.1016/j.ajog.2007.07.050	57	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e34706	10.1371/journal.pone.0034706	http://dx.doi.org/10.1371/journal.pone.0034706			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545087	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343200010
J	Linnenbaum, M; Busker, M; Kraehling, JR; Behrends, S				Linnenbaum, Monika; Busker, Mareike; Kraehling, Jan R.; Behrends, Soenke			Heme Oxygenase Isoforms Differ in Their Subcellular Trafficking during Hypoxia and Are Differentially Modulated by Cytochrome P450 Reductase	PLOS ONE			English	Article							THIOL/DISULFIDE REDOX SWITCH; P450 OXIDOREDUCTASE; REGULATORY MOTIFS; OXIDATIVE STRESS; LIVER; EXPRESSION; FORM; BINDING; ENZYME; OLIGOMERIZATION	Heme oxygenase (HO) degrades heme in concert with NADPH cytochrome P450 reductase (CPR) which donates electrons to the reaction. Earlier studies reveal the importance of the hydrophobic carboxy-terminus of HO-1 for anchorage to the endoplasmic reticulum (ER) which facilitates the interaction with CPR. In addition, HO-1 has been shown to undergo regulated intramembrane proteolysis of the carboxy-terminus during hypoxia and subsequent translocation to the nucleus. Translocated nuclear HO-1 was demonstrated to alter binding of transcription factors and to alter gene expression. Little is known about the homologous membrane anchor of the HO-2 isoform. The current work is the first systematic analysis in a eukaryotic system that demonstrates the crucial role of the membrane anchor of HO-2 for localization at the endoplasmic reticulum, oligomerization and interaction with CPR. We show that although the carboxy-terminal deletion mutant of HO-2 is found in the nucleus, translocation of HO-2 to the nucleus does not occur under conditions of hypoxia. Thus, we demonstrate that proteolytic regulation and nuclear translocation under hypoxic conditions is specific for HO-1. In addition we show for the first time that CPR prevents this translocation and promotes oligomerization of HO-1. Based on these findings, CPR may modulate gene expression via the amount of nuclear HO-1. This is of particular relevance as CPR is a highly polymorphic gene and deficiency syndromes of CPR have been described in humans.	[Linnenbaum, Monika; Busker, Mareike; Kraehling, Jan R.; Behrends, Soenke] Tech Univ Carolo Wilhelmina Braunschweig, Inst Technol, Dept Pharmacol Toxicol & Clin Pharm, Braunschweig, Germany	Braunschweig University of Technology	Linnenbaum, M (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Technol, Dept Pharmacol Toxicol & Clin Pharm, Braunschweig, Germany.	s.behrends@tu-braunschweig.de	Behrends, Sönke/A-2551-2010; Kraehling, Jan/D-5327-2009	Behrends, Sönke/0000-0002-9068-0729; Kraehling, Jan/0000-0002-0979-2900	Deutsche Forschungsgemeinschaft [INST 188/286-1, BE 1865/5-1]; European cooperation in science and technology program [BM1005]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European cooperation in science and technology program	The study was supported by the Deutsche Forschungsgemeinschaft (INST 188/286-1; BE 1865/5-1) and the European cooperation in science and technology program BM1005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2004, BIOCHEM BIOPH RES CO, V320, P514, DOI 10.1016/j.bbrc.2004.05.195; BRAGGINS PE, 1986, BIOCHEM BIOPH RES CO, V141, P528, DOI 10.1016/S0006-291X(86)80205-4; Efendiev R, 2006, FEBS LETT, V580, P5067, DOI 10.1016/j.febslet.2006.08.035; Elangovan M, 2003, METHODS, V29, P58, DOI 10.1016/S1046-2023(02)00283-9; Fluck CE, 2004, NAT GENET, V36, P228, DOI 10.1038/ng1300; Gomes AM, 2009, PHARMACOGENOMICS, V10, P579, DOI [10.2217/pgs.09.7, 10.2217/PGS.09.7]; Haase N, 2010, J NEUROCHEM, V112, P542, DOI 10.1111/j.1471-4159.2009.06484.x; Haase T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011617; Higashimoto Y, 2008, BIOCHEM BIOPH RES CO, V367, P852, DOI 10.1016/j.bbrc.2008.01.016; Huang N, 2008, P NATL ACAD SCI USA, V105, P1733, DOI 10.1073/pnas.0711621105; Huber WJ, 2007, BIOCHEMISTRY-US, V46, P12212, DOI 10.1021/bi701496z; Huber WJ, 2009, BIOCHEMISTRY-US, V48, P190, DOI 10.1021/bi801912z; Hwang HW, 2009, J BIOL CHEM, V284, P22672, DOI 10.1074/jbc.M109.028001; ISHIKAWA K, 1991, EUR J BIOCHEM, V202, P161, DOI 10.1111/j.1432-1033.1991.tb16357.x; ISHIKAWA K, 1995, J BIOL CHEM, V270, P6345, DOI 10.1074/jbc.270.11.6345; Kang DH, 2002, B KOREAN CHEM SOC, V23, P1511; Kemp PJ, 2005, BIOCHEM BIOPH RES CO, V338, P648, DOI 10.1016/j.bbrc.2005.08.110; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; Lin QS, 2008, FREE RADICAL BIO MED, V44, P847, DOI 10.1016/j.freeradbiomed.2007.11.012; MAINES MD, 1974, P NATL ACAD SCI USA, V71, P4293, DOI 10.1073/pnas.71.11.4293; MAINES MD, 1986, J BIOL CHEM, V261, P411; Marohnic CC, 2011, ARCH BIOCHEM BIOPHYS, V513, P42, DOI 10.1016/j.abb.2011.06.008; Miller WL, 2011, MOL CELL ENDOCRINOL, V336, P174, DOI 10.1016/j.mce.2010.10.022; Reed James R, 2011, Drug Metab Lett, V5, P6; SCHACTER BA, 1972, J BIOL CHEM, V247, P3601; Schuller DJ, 1999, NAT STRUCT BIOL, V6, P860; Szczesna-Skorupa E, 2003, J BIOL CHEM, V278, P31269, DOI 10.1074/jbc.M301489200; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; TRAKSHEL GM, 1986, J BIOL CHEM, V261, P1131; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Wang JL, 2003, J BIOL CHEM, V278, P20069, DOI 10.1074/jbc.M300989200; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; WILKS A, 1993, J BIOL CHEM, V268, P22357; Williams SEJ, 2004, SCIENCE, V306, P2093, DOI 10.1126/science.1105010; Yi L, 2007, J BIOL CHEM, V282, P21056, DOI 10.1074/jbc.M700664200; Yi L, 2009, J BIOL CHEM, V284, P20556, DOI 10.1074/jbc.M109.015651; YOSHIDA T, 1991, EUR J BIOCHEM, V199, P729, DOI 10.1111/j.1432-1033.1991.tb16177.x; YOSHIDA T, 1989, BIOCHEM BIOPH RES CO, V163, P1086, DOI 10.1016/0006-291X(89)92332-2; Youvan D. C., 1997, BIOTECHNOLOGY, V3, P1	39	39	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35483	10.1371/journal.pone.0035483	http://dx.doi.org/10.1371/journal.pone.0035483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545110	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343200030
J	Garcia-Gomez, A; Ocio, EM; Crusoe, E; Santamaria, C; Hernandez-Campo, P; Blanco, JF; Sanchez-Guijo, FM; Hernandez-Iglesias, T; Brinon, JG; Fisac-Herrero, RM; Lee, FY; Pandiella, A; San Miguel, JF; Garayoa, M				Garcia-Gomez, Antonio; Ocio, Enrique M.; Crusoe, Edvan; Santamaria, Carlos; Hernandez-Campo, Pilar; Blanco, Juan F.; Sanchez-Guijo, Fermin M.; Hernandez-Iglesias, Teresa; Brinon, Jesus G.; Fisac-Herrero, Rosa M.; Lee, Francis Y.; Pandiella, Atanasio; San Miguel, Jesus F.; Garayoa, Mercedes			Dasatinib as a Bone-Modifying Agent: Anabolic and Anti-Resorptive Effects	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA; MULTIPLE-MYELOMA; OSTEOBLAST DIFFERENTIATION; STROMAL CELLS; INHIBITOR; MARROW; IMATINIB; EXPRESSION; GROWTH	Background: Bone loss, in malignant or non-malignant diseases, is caused by increased osteoclast resorption and/or reduced osteoblast bone formation, and is commonly associated with skeletal complications. Thus, there is a need to identify new agents capable of influencing bone remodeling. We aimed to further pre-clinically evaluate the effects of dasatinib (BMS-354825), a multitargeted tyrosine kinase inhibitor, on osteoblast and osteoclast differentiation and function. Methods: For studies on osteoblasts, primary human bone marrow mensenchymal stem cells (hMSCs) together with the hMSC-TERT and the MG-63 cell lines were employed. Osteoclasts were generated from peripheral blood mononuclear cells (PBMC) of healthy volunteers. Skeletally-immature CD1 mice were used in the in vivo model. Results: Dasatinib inhibited the platelet derived growth factor receptor-beta (PDGFR-beta), c-Src and c-Kit phosphorylation in hMSC-TERT and MG-63 cell lines, which was associated with decreased cell proliferation and activation of canonical Wnt signaling. Treatment of MSCs from healthy donors, but also from multiple myeloma patients with low doses of dasatinib (2-5 nM), promoted its osteogenic differentiation and matrix mineralization. The bone anabolic effect of dasatinib was also observed in vivo by targeting endogenous osteoprogenitors, as assessed by elevated serum levels of bone formation markers, and increased trabecular microarchitecture and number of osteoblast-like cells. By in vitro exposure of hemopoietic progenitors to a similar range of dasatinib concentrations (1-2 nM), novel biological sequelae relative to inhibition of osteoclast formation and resorptive function were identified, including F-actin ring disruption, reduced levels of c-Fos and of nuclear factor of activated T cells 1 (NFATc1) in the nucleus, together with lowered cathepsin K, alpha V beta 3 integrin and CCR1 expression. Conclusions: Low dasatinib concentrations show convergent bone anabolic and reduced bone resorption effects, which suggests its potential use for the treatment of bone diseases such as osteoporosis, osteolytic bone metastasis and myeloma bone disease.	[Garcia-Gomez, Antonio; Ocio, Enrique M.; Crusoe, Edvan; Hernandez-Iglesias, Teresa; Pandiella, Atanasio; San Miguel, Jesus F.; Garayoa, Mercedes] Univ Salamanca, CSIC, IBMCC, Ctr Invest Canc, E-37008 Salamanca, Spain; [Garcia-Gomez, Antonio; Santamaria, Carlos; Hernandez-Campo, Pilar; Sanchez-Guijo, Fermin M.; San Miguel, Jesus F.; Garayoa, Mercedes] Ctr Red Med Regenerat & Terapia Celular Castilla, Salamanca, Spain; [Garcia-Gomez, Antonio; Ocio, Enrique M.; Crusoe, Edvan; Blanco, Juan F.; Sanchez-Guijo, Fermin M.; Pandiella, Atanasio; San Miguel, Jesus F.; Garayoa, Mercedes] Hosp Univ Salamanca IBSAL, Salamanca, Spain; [Brinon, Jesus G.] Univ Salamanca, Fac Med, Dept Biol Celular & Patol, E-37008 Salamanca, Spain; [Fisac-Herrero, Rosa M.] Hosp Gen Segovia, Serv Hematol, Segovia, Spain; [Lee, Francis Y.] Bristol Myers Squibb Pharmaceut Res Inst, Princeton, NJ USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; Bristol-Myers Squibb	Garcia-Gomez, A (corresponding author), Univ Salamanca, CSIC, IBMCC, Ctr Invest Canc, E-37008 Salamanca, Spain.	mgarayoa@usal.es	Garayoa, Mercedes/O-6039-2017; San-Miguel, Jesús F./V-8977-2018; Crusoe, Edvan/AAK-1497-2021; Sanchez-Guijo, Fermin/D-8542-2018; Blanco, Juan F/AAI-5787-2021; Pandiella, Atanasio/O-5180-2014; Brinon, Jesus G./L-7316-2014	Garayoa, Mercedes/0000-0003-2194-2841; San-Miguel, Jesús F./0000-0002-9183-4857; Crusoe, Edvan/0000-0002-8599-4731; Sanchez-Guijo, Fermin/0000-0002-7076-7739; Blanco, Juan F/0000-0001-7803-9149; Pandiella, Atanasio/0000-0002-4704-8971; Garcia, Antonio/0000-0003-0527-7351; Brinon, Jesus G./0000-0002-3503-0539; Ocio, Enrique M./0000-0002-5765-0085	Spanish Ministry of Science and Innovation - ISCIII [PI081825]; Mutua Madrilena Medical Research Foundation [AP27262008]; Centro en Red of Regenerative Medicine and Cellular Therapy from Castilla y Leon, Consejeria de Sanidad JCyL - ISCIII; Cooperative Research Thematic Network in Cancer (RTICC) [RD06/0020/0006, RD03/0020/0041]; Spanish FIS [PS09/01897]; Centro en Red of Regenerative Medicine and Cellular Therapy from Castilla y Leon Project	Spanish Ministry of Science and Innovation - ISCIII; Mutua Madrilena Medical Research Foundation; Centro en Red of Regenerative Medicine and Cellular Therapy from Castilla y Leon, Consejeria de Sanidad JCyL - ISCIII; Cooperative Research Thematic Network in Cancer (RTICC); Spanish FIS; Centro en Red of Regenerative Medicine and Cellular Therapy from Castilla y Leon Project	This work was supported by grants from the Spanish Ministry of Science and Innovation - ISCIII (PI081825); Mutua Madrilena Medical Research Foundation (AP27262008); Centro en Red of Regenerative Medicine and Cellular Therapy from Castilla y Leon, Consejeria de Sanidad JCyL - ISCIII; the Cooperative Research Thematic Network in Cancer (RTICC; RD06/0020/0006 and RD03/0020/0041); and Spanish FIS (PS09/01897). AG-G and CS are supported by the Centro en Red of Regenerative Medicine and Cellular Therapy from Castilla y Leon Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera Dolly G, 2009, Ther Clin Risk Manag, V5, P281; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Basak GW, 2009, CURR PHARM BIOTECHNO, V10, P335, DOI 10.2174/138920109787847493; Boufker HI, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-298; Brownlow N, 2009, LEUKEMIA, V23, P590, DOI 10.1038/leu.2008.237; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; Charbord P, 2010, HUM GENE THER, V21, P1045, DOI 10.1089/hum.2010.115; Chaudhary LR, 2004, BONE, V34, P402, DOI 10.1016/j.bone.2003.11.014; Choi YH, 2011, BIOCHEM BIOPH RES CO, V415, P472, DOI 10.1016/j.bbrc.2011.10.097; Christopher LJ, 2008, DRUG METAB DISPOS, V36, P1357, DOI 10.1124/dmd.107.018267; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coluccia AML, 2008, BLOOD, V112, P1346, DOI 10.1182/blood-2007-10-116590; Corre J, 2007, LEUKEMIA, V21, P1079, DOI 10.1038/sj.leu.2404621; Dewar AL, 2006, BLOOD, V107, P4334, DOI 10.1182/blood-2005-09-3568; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fitter S, 2008, BLOOD, V111, P2538, DOI 10.1182/blood-2007-07-104281; Fowler JA, 2011, BONE, V48, P121, DOI 10.1016/j.bone.2010.06.029; Garayoa M, 2009, LEUKEMIA, V23, P1515, DOI 10.1038/leu.2009.65; Garderet L, 2007, LEUKEMIA LYMPHOMA, V48, P2032, DOI 10.1080/10428190701593644; Giuliani N, 2006, BLOOD, V108, P3992, DOI 10.1182/blood-2006-05-026112; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Han JH, 2001, BLOOD, V97, P3349, DOI 10.1182/blood.V97.11.3349; HOCK JM, 1994, ENDOCRINOLOGY, V134, P1423, DOI 10.1210/en.134.3.1423; Jonsson S, 2010, LEUKEMIA, V24, P1357, DOI 10.1038/leu.2010.84; Kagami H, 2011, INT J BIOCHEM CELL B, V43, P286, DOI 10.1016/j.biocel.2010.12.006; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Khosla S, 2010, STEM CELLS, V28, P2124, DOI 10.1002/stem.546; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Kulterer B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-70; Lee YC, 2010, ONCOGENE, V29, P3196, DOI 10.1038/onc.2010.73; Lentzsch S, 2003, BLOOD, V101, P3568, DOI 10.1182/blood-2002-08-2383; Luo FR, 2006, CLIN CANCER RES, V12, P7180, DOI 10.1158/1078-0432.CCR-06-1112; Maiso P, 2006, CANCER RES, V66, P5781, DOI 10.1158/0008-5472.CAN-05-4186; Martinez-Martinez S, 2006, J BIOL CHEM, V281, P6227, DOI 10.1074/jbc.M513885200; Marzia M, 2000, J CELL BIOL, V151, P311, DOI 10.1083/jcb.151.2.311; Mazo M, 2010, CELL TRANSPLANT, V19, P313, DOI 10.3727/096368909X480323; Mihara K, 2003, BRIT J HAEMATOL, V120, P846, DOI 10.1046/j.1365-2141.2003.04217.x; Nakamura I, 2007, J BONE MINER METAB, V25, P337, DOI 10.1007/s00774-007-0773-9; Nandi SK, 2010, INDIAN J MED RES, V132, P15; O'Sullivan S, 2007, J BONE MINER RES, V22, P1679, DOI 10.1359/JBMR.070719; Olivieri A, 2007, ANN ONCOL, V18, P42, DOI 10.1093/annonc/mdm223; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qiang YW, 2009, BLOOD, V113, P4319, DOI 10.1182/blood-2008-08-174300; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Roodman GD, 2009, LEUKEMIA, V23, P435, DOI 10.1038/leu.2008.336; Roodman GD, 2008, CANCER TREAT REV, V34, P92, DOI 10.1016/j.ctrv.2007.09.002; Rosen Lee S, 2004, Oncology (Williston Park), V18, P26; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Susa Mira, 2004, J Transl Med, V2, P6, DOI 10.1186/1479-5876-2-6; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Terpos E, 2009, ANN ONCOL, V20, P1303, DOI 10.1093/annonc/mdn796; Tibullo D, 2011, HEMATOL ONCOL; Todoerti K, 2010, EXP HEMATOL, V38, P141, DOI 10.1016/j.exphem.2009.11.009; Tokunaga A, 2008, J BONE MINER RES, V23, P1519, DOI 10.1359/JBMR.080409; Vaananen HK, 2008, ARCH BIOCHEM BIOPHYS, V473, P132, DOI 10.1016/j.abb.2008.03.037; Vallet S, 2010, CLIN CANCER RES, V16, P4084, DOI 10.1158/1078-0432.CCR-10-0600; Vandyke K, 2009, LEUKEMIA, V23, P994, DOI 10.1038/leu.2008.356; Vandyke K, 2010, J BONE MINER RES, V25, P1759, DOI 10.1002/jbmr.85; Vandyke K, 2010, BLOOD, V115, P766, DOI 10.1182/blood-2009-08-237404; Veracini L, 2005, BIOCHEM SOC T, V33, P1313, DOI 10.1042/BST0331313; Voorzanger-Rousselot N, 2007, BRIT J CANCER, V97, P964, DOI 10.1038/sj.bjc.6603959; Wallace SR, 2001, CANCER-AM CANCER SOC, V91, P1219, DOI 10.1002/1097-0142(20010401)91:7<1219::AID-CNCR1122>3.0.CO;2-1; Wang LP, 2006, BIOMATERIALS, V27, P3716, DOI 10.1016/j.biomaterials.2006.02.022; Wang XY, 2007, ENDOCRINOLOGY, V148, P1629, DOI 10.1210/en.2006-1000; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; Xiao GZ, 2005, J BIOL CHEM, V280, P30689, DOI 10.1074/jbc.M500750200; Yaccoby S, 2010, BRIT J HAEMATOL, V149, P311, DOI 10.1111/j.1365-2141.2010.08141.x; Yaccoby S, 2010, LEUKEMIA LYMPHOMA, V51, P213, DOI 10.3109/10428190903503438	72	52	55	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e34914	10.1371/journal.pone.0034914	http://dx.doi.org/10.1371/journal.pone.0034914			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539950	Green Published, gold			2022-12-25	WOS:000305341000013
J	Shen, R; Mo, QX; Schultz, N; Seshan, VE; Olshen, AB; Huse, J; Ladanyi, M; Sander, C				Shen, Ronglai; Mo, Qianxing; Schultz, Nikolaus; Seshan, Venkatraman E.; Olshen, Adam B.; Huse, Jason; Ladanyi, Marc; Sander, Chris			Integrative Subtype Discovery in Glioblastoma Using iCluster	PLOS ONE			English	Article							MODEL; SELECTION; NUMBER; CLUSTERS; BREAST	Large-scale cancer genome projects, such as the Cancer Genome Atlas (TCGA) project, are comprehensive molecular characterization efforts to accelerate our understanding of cancer biology and the discovery of new therapeutic targets. The accumulating wealth of multidimensional data provides a new paradigm for important research problems including cancer subtype discovery. The current standard approach relies on separate clustering analyses followed by manual integration. Results can be highly data type dependent, restricting the ability to discover new insights from multidimensional data. In this study, we present an integrative subtype analysis of the TCGA glioblastoma (GBM) data set. Our analysis revealed new insights through integrated subtype characterization. We found three distinct integrated tumor subtypes. Subtype 1 lacks the classical GBM events of chr 7 gain and chr 10 loss. This subclass is enriched for the G-CIMP phenotype and shows hypermethylation of genes involved in brain development and neuronal differentiation. The tumors in this subclass display a Proneural expression profile. Subtype 2 is characterized by a near complete association with EGFR amplification, overrepresentation of promoter methylation of homeobox and G-protein signaling genes, and a Classical expression profile. Subtype 3 is characterized by NF1 and PTEN alterations and exhibits a Mesenchymal-like expression profile. The data analysis workflow we propose provides a unified and computationally scalable framework to harness the full potential of large-scale integrated cancer genomic data for integrative subtype discovery.	[Shen, Ronglai; Seshan, Venkatraman E.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Mo, Qianxing] Baylor Coll Med, Div Biostat, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Schultz, Nikolaus; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10021 USA; [Olshen, Adam B.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Huse, Jason; Ladanyi, Marc] Univ Calif San Francisco, Dept Epidemiol & Biostat, Dept Pathol & Human Oncol, San Francisco, CA 94143 USA; [Huse, Jason; Ladanyi, Marc] Univ Calif San Francisco, Dept Epidemiol & Biostat, Pathogenesis Program, San Francisco, CA 94143 USA	Memorial Sloan Kettering Cancer Center; Baylor College of Medicine; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Shen, R (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA.	shenr@mskcc.org	Ladanyi, Marc/AAG-8585-2019; Schultz, Nikolaus/ABE-6347-2020	Schultz, Nikolaus/0000-0002-0131-4904	Genome Data Analysis Center type B (GDAC-B), National Cancer Institute (NCI)/National Human Genome Research Institute (NHGRI) [U24 CA143840]; Starr Cancer Consortium; NATIONAL CANCER INSTITUTE [U24CA143840] Funding Source: NIH RePORTER	Genome Data Analysis Center type B (GDAC-B), National Cancer Institute (NCI)/National Human Genome Research Institute (NHGRI); Starr Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a Genome Data Analysis Center type B (GDAC-B) grant (U24 CA143840) awarded as part of the National Cancer Institute (NCI)/National Human Genome Research Institute (NHGRI) funded Cancer Genome Atlas (TCGA) project. RS, QM, and VES are supported in part by a Starr Cancer Consortium grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dudoit S, 2002, GENOME BIOL, V3; Fang K.T., 1994, NUMBER THEORETIC MET; Friedman JH, 2004, J R STAT SOC B, V66, P815, DOI 10.1111/j.1467-9868.2004.02059.x; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kapp AV, 2007, BIOSTATISTICS, V8, P9, DOI 10.1093/biostatistics/kxj029; Le Cao KA, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-34; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Pan W, 2007, J MACH LEARN RES, V8, P1145; Parkhomenko E, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1406; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Shen R, 2012, MEMORIAL SLOAN KETTE; Shen RL, 2009, BIOINFORMATICS, V25, P2906, DOI 10.1093/bioinformatics/btp543; Soneson C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-191; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Taylor BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003179; Tibshirani R, 2005, J COMPUT GRAPH STAT, V14, P511, DOI 10.1198/106186005X59243; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van de Wiel MA, 2007, CANCER INFORM, V3, P55; van Wieringen WN, 2011, BIOINFORMATICS, V27, P556, DOI 10.1093/bioinformatics/btq704; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Waaijenborg S, 2008, STAT APPL GENET MOL, V7; Wang SJ, 2008, BIOMETRICS, V64, P440, DOI 10.1111/j.1541-0420.2007.00922.x; Witten DM, 2010, J AM STAT ASSOC, V105, P713, DOI 10.1198/jasa.2010.tm09415; Witten DM, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1470; Witten DM, 2009, BIOSTATISTICS, V10, P515, DOI 10.1093/biostatistics/kxp008; Xie BH, 2008, ELECTRON J STAT, V2, P168, DOI 10.1214/08-EJS194	29	152	154	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35236	10.1371/journal.pone.0035236	http://dx.doi.org/10.1371/journal.pone.0035236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539962	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341000026
J	Huynh, L; Kececioglu, J; Koppe, M; Tagkopoulos, I				Linh Huynh; Kececioglu, John; Koeppe, Matthias; Tagkopoulos, Ilias			Automatic Design of Synthetic Gene Circuits through Mixed Integer Non-linear Programming	PLOS ONE			English	Article							CELLULAR CONTROL PROCESSES; COMPUTATIONAL DESIGN; NETWORKS; CONSTRUCTION; MATHEMATICS; FEEDBACK; LIBRARY	Automatic design of synthetic gene circuits poses a significant challenge to synthetic biology, primarily due to the complexity of biological systems, and the lack of rigorous optimization methods that can cope with the combinatorial explosion as the number of biological parts increases. Current optimization methods for synthetic gene design rely on heuristic algorithms that are usually not deterministic, deliver sub-optimal solutions, and provide no guaranties on convergence or error bounds. Here, we introduce an optimization framework for the problem of part selection in synthetic gene circuits that is based on mixed integer non-linear programming (MINLP), which is a deterministic method that finds the globally optimal solution and guarantees convergence in finite time. Given a synthetic gene circuit, a library of characterized parts, and user-defined constraints, our method can find the optimal selection of parts that satisfy the constraints and best approximates the objective function given by the user. We evaluated the proposed method in the design of three synthetic circuits (a toggle switch, a transcriptional cascade, and a band detector), with both experimentally constructed and synthetic promoter libraries. Scalability and robustness analysis shows that the proposed framework scales well with the library size and the solution space. The work described here is a step towards a unifying, realistic framework for the automated design of biological circuits.	[Linh Huynh; Tagkopoulos, Ilias] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA; [Linh Huynh; Tagkopoulos, Ilias] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Kececioglu, John] Univ Arizona, Dept Comp Sci, Tucson, AZ 85721 USA; [Koeppe, Matthias] Univ Calif Davis, Dept Math, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Arizona; University of California System; University of California Davis	Tagkopoulos, I (corresponding author), Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA.	itagkopoulos@ucdavis.edu		Koppe, Matthias/0000-0003-2492-4139; Tagkopoulos, Ilias/0000-0003-1104-7616; HUYNH, VIET LINH/0000-0002-6736-295X	National Science Foundation [0941360, 1146926]; Vietnam Education Foundation; Direct For Computer & Info Scie & Enginr [1147844, 1146926] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Vietnam Education Foundation; Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	The authors would like to acknowledge support from grant 0941360 and 1146926 from the National Science Foundation. LH is supported by the Vietnam Education Foundation fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal V, 2003, COMPUT CHEM ENG, V27, P647, DOI 10.1016/S0098-1354(02)00261-2; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Basu S, 2002, DNA COMPUTING, P61; Beal J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022490; BELLMAN R, 1953, STABILITY THEORY DIF; Belotti P, 2009, OPTIM METHOD SOFTW, V24, P597, DOI 10.1080/10556780903087124; Berkeley 2006 iGEM Team, CONST PROM FAM; Boyce WE, 2009, ELEMENTARY DIFFERENT; Braun D, 2005, INT CONF ACOUST SPEE, P769; British-Columbia 2009 iGEM Team, PBAD PROM FAM; Dasika MS, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-24; Davis JH, 2011, NUCLEIC ACIDS RES, V39, P1131, DOI 10.1093/nar/gkq810; Densmore D, 2010, IEEE INT SYMP CIRC S, P557, DOI 10.1109/ISCAS.2010.5537540; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Feng XJ, 2004, BIOPHYS J, V87, P2195, DOI 10.1529/biophysj.104.044131; Francois P, 2004, P NATL ACAD SCI USA, V101, P580, DOI 10.1073/pnas.0304532101; Garcia-Ojalvo J, 2004, P NATL ACAD SCI USA, V101, P10955, DOI 10.1073/pnas.0307095101; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; GRIFFITH JS, 1968, J THEOR BIOL, V20, P202, DOI 10.1016/0022-5193(68)90189-6; GRIFFITH JS, 1968, J THEOR BIOL, V20, P209, DOI 10.1016/0022-5193(68)90190-2; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Kuhlman T, 2007, P NATL ACAD SCI USA, V104, P6043, DOI 10.1073/pnas.0606717104; Lu TK, 2009, P NATL ACAD SCI USA, V106, P4629, DOI 10.1073/pnas.0800442106; Moler C, 2003, SIAM REV, V45, P3, DOI 10.1137/S00361445024180; Morgan-Kiss RM, 2002, P NATL ACAD SCI USA, V99, P7373, DOI 10.1073/pnas.122227599; Mukhopadhyay A, 2008, CURR OPIN BIOTECH, V19, P228, DOI 10.1016/j.copbio.2008.05.003; NATH K, 1970, J BIOL CHEM, V245, P2889; Pedersen M, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2008.0516.focus; Rodrigo G, 2007, BIOINFORMATICS, V23, P1857, DOI 10.1093/bioinformatics/btm237; Rodrigo G, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr616; Tuttle LM, 2005, BIOPHYS J, V89, P3873, DOI 10.1529/biophysj.105.064204; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; Wu CH, 2011, BIOINFORMATICS, V27, P2700, DOI 10.1093/bioinformatics/btr465	36	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35529	10.1371/journal.pone.0035529	http://dx.doi.org/10.1371/journal.pone.0035529			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536398	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200074
J	Molina-Quiroz, RC; Munoz-Villagran, CM; de la Torre, E; Tantalean, JC; Vasquez, CC; Perez-Donoso, JM				Molina-Quiroz, Roberto C.; Munoz-Villagran, Claudia M.; de la Torre, Erick; Tantalean, Juan C.; Vasquez, Claudio C.; Perez-Donoso, Jose M.			Enhancing the Antibiotic Antibacterial Effect by Sub Lethal Tellurite Concentrations: Tellurite and Cefotaxime Act Synergistically in Escherichia coli	PLOS ONE			English	Article							POTASSIUM TELLURITE; OXIDATIVE STRESS; CELL-DEATH; RESISTANCE; MECHANISM; SURVIVAL; GROWTH; PENICILLIN; TOXICITY; BACTERIA	The emergence of antibiotic-resistant pathogenic bacteria during the last decades has become a public health concern worldwide. Aiming to explore new alternatives to treat antibiotic-resistant bacteria and given that the tellurium oxyanion tellurite is highly toxic for most microorganisms, we evaluated the ability of sub lethal tellurite concentrations to strengthen the effect of several antibiotics. Tellurite, at nM or mu M concentrations, increased importantly the toxicity of defined antibacterials. This was observed with both Gram negative and Gram positive bacteria, irrespective of the antibiotic or tellurite tolerance of the particular microorganism. The tellurite-mediated antibiotic-potentiating effect occurs in laboratory and clinical, uropathogenic Escherichia coli, especially with antibiotics disturbing the cell wall (ampicillin, cefotaxime) or protein synthesis (tetracycline, chloramphenicol, gentamicin). In particular, the effect of tellurite on the activity of the clinically-relevant, third-generation cephalosporin (cefotaxime), was evaluated. Cell viability assays showed that tellurite and cefotaxime act synergistically against E. coli. In conclusion, using tellurite like an adjuvant could be of great help to cope with several multi-resistant pathogens.	[Molina-Quiroz, Roberto C.; Munoz-Villagran, Claudia M.; Vasquez, Claudio C.; Perez-Donoso, Jose M.] Univ Santiago Chile, Mol Microbiol Lab, Dept Biol, Fac Quim & Biol, Santiago, Chile; [de la Torre, Erick; Tantalean, Juan C.] Univ San Luis Gonzaga, Lab Microbiol & Biotecnol, Fac Ciencias, Ica, Peru; [Perez-Donoso, Jose M.] Univ Chile, Fac Ciencias Quim & Farmaceut, Lab Bioquim, Santiago, Chile	Universidad de Santiago de Chile; Universidad Nacional San Luis Gonzaga; Universidad de Chile	Vasquez, CC (corresponding author), Univ Santiago Chile, Mol Microbiol Lab, Dept Biol, Fac Quim & Biol, Santiago, Chile.	claudio.vasquez@usach.cl; joseperez@ciq.uchile.cl	Molina-Quiroz, Roberto C/H-4696-2019; Pérez-Donoso, José M./G-3668-2013	Molina-Quiroz, Roberto C/0000-0003-3653-7160; Pérez-Donoso, José M./0000-0002-9506-1716; De La Torre Tarazona, Humberto Erick/0000-0003-0325-3735; TANTALEAN, JUAN/0000-0002-9541-7102	FONDECYT (Fondo Nacional de Ciencia y Tecnologia) [1090097, 3100049]; IFS (International Foundation for Science, Sweden) [4733-1]; DICYT (Direccion de Investigacion Cientifica y Tecnologica, Universidad de Santiago de Chile); CONICYT (Comision Nacional de Ciencia y Tecnologia) [24100031]	FONDECYT (Fondo Nacional de Ciencia y Tecnologia)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); IFS (International Foundation for Science, Sweden)(International Foundation for Science); DICYT (Direccion de Investigacion Cientifica y Tecnologica, Universidad de Santiago de Chile); CONICYT (Comision Nacional de Ciencia y Tecnologia)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work received financial support from FONDECYT (Fondo Nacional de Ciencia y Tecnologia) 1090097 (CCV) and 3100049 (JMPD); IFS (International Foundation for Science, Sweden) 4733-1 (JMPD); DICYT (Direccion de Investigacion Cientifica y Tecnologica, Universidad de Santiago de Chile) (CCV, JMPD). A doctoral fellowship and grant 24100031 from CONICYT (Comision Nacional de Ciencia y Tecnologia) to RCMQ is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASAKURA T, 1984, BLOOD, V64, P305; Banin E, 2008, P NATL ACAD SCI USA, V105, P16761, DOI 10.1073/pnas.0808608105; Calderon IL, 2009, MICROBIOL-SGM, V155, P1840, DOI 10.1099/mic.0.026260-0; Castro ME, 2009, BIOCHEM BIOPH RES CO, V380, P148, DOI 10.1016/j.bbrc.2009.01.078; CHAPMAN PA, 1991, J MED MICROBIOL, V35, P107, DOI 10.1099/00222615-35-2-107; Chasteen TG, 2009, FEMS MICROBIOL REV, V33, P820, DOI 10.1111/j.1574-6976.2009.00177.x; Dantas G, 2008, SCIENCE, V320, P100, DOI 10.1126/science.1155157; Fleming A, 1932, J PATHOL BACTERIOL, V35, P831, DOI 10.1002/path.1700350603; Ford C. W., 2001, Current Drug Targets - Infectious Disorders, V1, P181, DOI 10.2174/1568005014606099; Guillamet E, 2008, MUTAT RES-GEN TOX EN, V654, P22, DOI 10.1016/j.mrgentox.2008.04.005; Hemaiswarya S, 2010, J MED MICROBIOL, V59, P1469, DOI 10.1099/jmm.0.022426-0; Horii T, 2002, HELICOBACTER, V7, P39, DOI 10.1046/j.1523-5378.2002.00054.x; Ison CA, 2011, EURO SURVEILL, V16; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; LaPlante KL, 2004, EXPERT OPIN PHARMACO, V5, P2321, DOI 10.1517/14656566.5.11.2321; Lepercq J, 2009, ANTIMICROB AGENTS CH, V53, P2342, DOI 10.1128/AAC.01429-08; Livermore DM, 2006, TRENDS MICROBIOL, V14, P413, DOI 10.1016/j.tim.2006.07.008; Lu TK, 2009, P NATL ACAD SCI USA, V106, P4629, DOI 10.1073/pnas.0800442106; Nicola G, 2010, BIOCHEMISTRY-US, V49, P8094, DOI 10.1021/bi100879m; NIX DE, 1995, DIAGN MICR INFEC DIS, V22, P71, DOI 10.1016/0732-8893(95)00074-K; Perez JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000211; Perez JM, 2008, J BIOL CHEM, V283, P7346, DOI 10.1074/jbc.M708846200; Sandoval JM, 2010, BIOMETALS, V23, P623, DOI 10.1007/s10534-010-9316-2; SCHROEDE.HA, 1971, J NUTR, V101, P1531, DOI 10.1093/jn/101.11.1531; SCHROEDER HA, 1972, ARCH ENVIRON HEALTH, V24, P66, DOI 10.1080/00039896.1972.10666052; SCHROEDER HA, 1967, J NUTR, V92, P334, DOI 10.1093/jn/92.3.334; Turner RJ, 2001, CAN J MICROBIOL, V47, P33, DOI 10.1139/cjm-47-1-33; WAGNER M, 1995, J NEUROCHEM, V64, P2169; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727	32	22	24	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35452	10.1371/journal.pone.0035452	http://dx.doi.org/10.1371/journal.pone.0035452			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536386	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339200066
J	Kubicek, J; Schlesinger, R; Baeken, C; Buldt, G; Schafer, F; Labahn, J				Kubicek, Jan; Schlesinger, Ramona; Baeken, Christian; Bueldt, Georg; Schaefer, Frank; Labahn, Joerg			Controlled In Meso Phase Crystallization - A Method for the Structural Investigation of Membrane Proteins	PLOS ONE			English	Article							SENSORY RHODOPSIN-II; X-RAY-STRUCTURE; CRYSTAL-STRUCTURE; SOLUBLE-PROTEINS; VAPOR DIFFUSION; BACTERIORHODOPSIN; ANGSTROMS; MECHANISM; SYSTEM	We investigated in meso crystallization of membrane proteins to develop a fast screening technology which combines features of the well established classical vapor diffusion experiment with the batch meso phase crystallization, but without premixing of protein and monoolein. It inherits the advantages of both methods, namely (i) the stabilization of membrane proteins in the meso phase, (ii) the control of hydration level and additive concentration by vapor diffusion. The new technology (iii) significantly simplifies in meso crystallization experiments and allows the use of standard liquid handling robots suitable for 96 well formats. CIMP crystallization furthermore allows (iv) direct monitoring of phase transformation and crystallization events. Bacteriorhodopsin (BR) crystals of high quality and diffraction up to 1.3 angstrom resolution have been obtained in this approach. CIMP and the developed consumables and protocols have been successfully applied to obtain crystals of sensory rhodopsin II (SRII) from Halobacterium salinarum for the first time.	[Kubicek, Jan; Schaefer, Frank] QIAGEN GmbH, Hilden, Germany; [Schlesinger, Ramona; Baeken, Christian; Bueldt, Georg; Labahn, Joerg] Forschungszentrum Julich, Inst Struct Biol & Biophys, D-52425 Julich, Germany	QIAGEN GmbH; Helmholtz Association; Research Center Julich	Kubicek, J (corresponding author), QIAGEN GmbH, Hilden, Germany.	j.labahn@fz-juelich.de	Büldt, Georg/H-9509-2014; Buldt, Georg/K-5345-2013; Schlesinger, Ramona/W-2620-2018; Labahn, Jörg/G-9593-2013	Schlesinger, Ramona/0000-0002-7716-4439; Labahn, Jörg/0000-0002-0648-8145	Research Center Julich; QIAGEN GmbH	Research Center Julich(Helmholtz Association); QIAGEN GmbH	The work was supported by Research Center Julich and QIAGEN GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benvenuti M, 2007, NAT PROTOC, V2, P1633, DOI 10.1038/nprot.2007.198; Brumshtein B, 2008, J APPL CRYSTALLOGR, V41, P969, DOI 10.1107/S0021889808024667; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Caffrey M, 2008, CRYST GROWTH DES, V8, P4244, DOI 10.1021/cg800693r; Chayen NE, 1997, J APPL CRYSTALLOGR, V30, P198, DOI 10.1107/S0021889896013532; Chen AH, 1998, CHEM PHYS LIPIDS, V95, P11, DOI 10.1016/S0009-3084(98)00060-7; Cherezov V, 2004, ACTA CRYSTALLOGR D, V60, P1795, DOI 10.1107/S0907444904019109; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Engstrom S, 1998, PROG COLL POL SCI S, V108, P93; Gordeliy VI, 2002, NATURE, V419, P484, DOI 10.1038/nature01109; Grabe M, 2003, BIOPHYS J, V84, P854, DOI 10.1016/S0006-3495(03)74904-2; Hato M, 2009, J PHYS CHEM B, V113, P10196, DOI 10.1021/jp902883q; HEYMANN JAW, 1993, MOL MICROBIOL, V7, P623, DOI 10.1111/j.1365-2958.1993.tb01153.x; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Kors CA, 2009, ACTA CRYSTALLOGR D, V65, P1062, DOI 10.1107/S0907444909029163; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; Liu W, 2010, BIOPHYS J, V98, P1539, DOI 10.1016/j.bpj.2009.12.4296; Luecke H, 2001, SCIENCE, V293, P1499, DOI 10.1126/science.1062977; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; McPherson A, 2006, J STRUCT BIOL, V156, P387, DOI 10.1016/j.jsb.2006.09.006; MICHEL H, 1982, EMBO J, V1, P1267, DOI 10.1002/j.1460-2075.1982.tb00023.x; Mironova OS, 2005, FEBS LETT, V579, P3147, DOI 10.1016/j.febslet.2005.05.010; Misquitta LV, 2004, STRUCTURE, V12, P2113, DOI 10.1016/j.str.2004.09.020; Misquitta Y, 2004, J STRUCT BIOL, V148, P169, DOI 10.1016/j.jsb.2004.06.008; Misquitta Y, 2003, BIOPHYS J, V85, P3084, DOI 10.1016/S0006-3495(03)74727-4; Moiseeva ES, 2009, J SURF INVESTIG, V3, P29, DOI 10.1134/S1027451009010054; Nollert P, 2001, FEBS LETT, V504, P179, DOI 10.1016/S0014-5793(01)02747-8; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; Qiu H, 2000, BIOMATERIALS, V21, P223, DOI 10.1016/S0142-9612(99)00126-X; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Royant A, 2001, P NATL ACAD SCI USA, V98, P10131, DOI 10.1073/pnas.181203898; Wadsten P, 2006, J MOL BIOL, V364, P44, DOI 10.1016/j.jmb.2006.06.043; Wohri AB, 2008, STRUCTURE, V16, P1003, DOI 10.1016/j.str.2008.06.003	33	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35458	10.1371/journal.pone.0035458	http://dx.doi.org/10.1371/journal.pone.0035458			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536388	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336200043
J	Jagan, I; Fatehullah, A; Deevi, RK; Bingham, V; Campbell, FC				Jagan, I.; Fatehullah, A.; Deevi, R. K.; Bingham, V.; Campbell, F. C.			Rescue of glandular dysmorphogenesis in PTEN-deficient colorectal cancer epithelium by PPAR gamma-targeted therapy	ONCOGENE			English	Article						PTEN; cdc42; epithelium; morphogenesis	PLECKSTRIN HOMOLOGY DOMAIN; POLARITY PROTEIN PAR6; SPINDLE ORIENTATION; GLYCOGEN-SYNTHASE; TUMOR-SUPPRESSOR; CELL-POLARITY; RHO-GTPASES; CDC42 GEF; DUAL ROLE; KINASE B	Disruption of glandular architecture associates with poor clinical outcome in high-grade colorectal cancer (CRC). Phosphatase and tensin homolog deleted on chromosome ten (PTEN) regulates morphogenic growth of benign MDCK (Madin Darby Canine Kidney) cells through effects on the Rho-like GTPase cdc42 (cell division cycle 42). This study investigates PTEN-dependent morphogenesis in a CRC model. Stable short hairpin RNA knockdown of PTEN in Caco-2 cells influenced expression or localization of cdc42 guanine nucleotide exchange factors and inhibited cdc42 activation. Parental Caco-2 cells formed regular hollow gland-like structures (glands) with a single central lumen, in three-dimensional (3D) cultures. Conversely, PTEN-deficient Caco-2 ShPTEN cells formed irregular glands with multiple abnormal lumens as well as intra-and/or intercellular vacuoles evocative of the high-grade CRC phenotype. Effects of targeted treatment were investigated. Phosphatidinylinositol 3-kinase (PI3K) modulating treatment did not affect gland morphogenesis but did influence gland number, gland size and/or cell size within glands. As PTEN may be regulated by the nuclear receptor peroxisome proliferator-activated receptor-gamma (PPAR gamma), cultures were treated with the PPAR gamma ligand rosiglitazone. This treatment enhanced PTEN expression, cdc42 activation and rescued dysmorphogenesis by restoring single lumen formation in Caco-2 ShPTEN glands. Rosiglitazone effects on cdc42 activation and Caco-2 ShPTEN gland development were attenuated by cotreatment with GW9662, a PPAR gamma antagonist. Taken together, these studies show PTEN-cdc42 regulation of lumen formation in a 3D model of human CRC glandular morphogenesis. Treatment by the PPAR gamma ligand rosiglitazone, but not PI3K modulators, rescued colorectal glandular dysmorphogenesis of PTEN deficiency. Oncogene (2013) 32, 1305-1315; doi:10.1038/onc.2012.140; published online 30 April 2012	[Jagan, I.; Fatehullah, A.; Deevi, R. K.; Bingham, V.; Campbell, F. C.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast BT9 7BL, Antrim, North Ireland	Queens University Belfast	Campbell, FC (corresponding author), Queens Univ Belfast, Ctr Canc Res & Cell Biol, Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.	f.c.campbell@qub.ac.uk		Campbell, Frederick/0000-0002-0363-9964	Wellcome Trust [WT081232MA]; Department for Education and Learning, Northern Ireland	Wellcome Trust(Wellcome TrustEuropean Commission); Department for Education and Learning, Northern Ireland	We gratefully acknowledge the support of the Wellcome Trust (WT081232MA) and the Department for Education and Learning, Northern Ireland for financial support. We are greatly indebted to Dr T Waldman, Georgetown University, USA, for supply of PTEN<SUP>+/+</SUP> HCT116 and PTEN <SUP>-/-</SUP> HCT116 cells, to Dr Pietro DiCamilli, Howard Hughes Medical Institute, Yale, for his generous provision of anti-human Tuba antibody, to Dr Estelle McLean for technical help, to Dr James Murray for the gift of PI-103 and to S Church for assistance with all imaging.	Al-Khouri AM, 2005, J BIOL CHEM, V280, P35195, DOI 10.1074/jbc.M503045200; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Aoki K, 2005, MOL BIOL CELL, V16, P2207, DOI 10.1091/mbc.e04-10-0904; Backman SA, 2002, CURR OPIN NEUROBIOL, V12, P516, DOI 10.1016/S0959-4388(02)00354-9; Balciunaite E, 2001, BIOCHEM J, V358, P281, DOI 10.1042/0264-6021:3580281; Boehm JS, 2005, MOL CELL BIOL, V25, P6464, DOI 10.1128/MCB.25.15.6464-6474.2005; Carracedo A, 2011, CANCER RES, V71, P629, DOI 10.1158/0008-5472.CAN-10-2488; Cho YB, 2009, HEPATO-GASTROENTEROL, V56, P1335; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; De Sarno P, 2002, NEUROPHARMACOLOGY, V43, P1158, DOI 10.1016/S0028-3908(02)00215-0; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Deevi R, 2011, BRIT J CANCER, V105, P1313, DOI 10.1038/bjc.2011.384; Donev IS, 2011, CLIN CANCER RES, V17, P2260, DOI 10.1158/1078-0432.CCR-10-1993; Durgan J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.174235; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Fuentes EJ, 2003, J BIOL CHEM, V278, P21188, DOI 10.1074/jbc.M211792200; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Grant S, 2008, J CLIN INVEST, V118, P3003, DOI 10.1172/JCI36898; Gunaratne J, 2011, J BIOL CHEM, V286, P18093, DOI 10.1074/jbc.M111.221184; Guruswamy S, 2008, INT J CANCER, V122, P25, DOI 10.1002/ijc.23031; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Johnson K, 2003, NAT CELL BIOL, V5, P12, DOI 10.1038/ncb0103-12; Kong M, 2000, J BIOL CHEM, V275, P36035, DOI 10.1074/jbc.M005621200; Lee C, 2004, CANCER RES, V64, P6906, DOI 10.1158/0008-5472.CAN-04-1767; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Maccario H, 2007, BIOCHEM J, V405, P439, DOI 10.1042/BJ20061837; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Mitsushima M, 2009, MOL CELL BIOL, V29, P2816, DOI 10.1128/MCB.01713-08; Nassif NT, 2004, ONCOGENE, V23, P617, DOI 10.1038/sj.onc.1207059; Noda Y, 2001, GENES CELLS, V6, P107, DOI 10.1046/j.1365-2443.2001.00404.x; Orena SJ, 2000, J BIOL CHEM, V275, P15765, DOI 10.1074/jbc.M910002199; Patel L, 2001, CURR BIOL, V11, P764, DOI 10.1016/S0960-9822(01)00225-1; PELZ C, 1989, J CELL BIOCHEM, V39, P197, DOI 10.1002/jcb.240390211; Pertz O, 2010, J CELL SCI, V123, P1841, DOI 10.1242/jcs.064345; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Pruitt WM, 2003, BBA-MOL CELL RES, V1640, P61, DOI 10.1016/S0167-4889(03)00002-8; Qin Y, 2010, J CELL BIOL, V189, P661, DOI 10.1083/jcb.201002097; Raynaud FI, 2009, MOL CANCER THER, V8, P1725, DOI 10.1158/1535-7163.MCT-08-1200; Rodriguez-Fraticelli AE, 2010, J CELL BIOL, V189, P725, DOI 10.1083/jcb.201002047; Salazar MA, 2003, J BIOL CHEM, V278, P49031, DOI 10.1074/jbc.M308104200; Sawai H, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-56; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Seargent JM, 2004, BRIT J PHARMACOL, V143, P933, DOI 10.1038/sj.bjp.0705973; Shao J, 2007, CARCINOGENESIS, V28, P2476, DOI 10.1093/carcin/bgm186; Sinha S, 2008, CELL SIGNAL, V20, P1927, DOI 10.1016/j.cellsig.2008.05.002; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Summers SA, 1999, J BIOL CHEM, V274, P17934, DOI 10.1074/jbc.274.25.17934; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Tan I, 2008, CELL, V135, P123, DOI 10.1016/j.cell.2008.09.018; ter Haar E, 2001, NAT STRUCT BIOL, V8, P593, DOI 10.1038/89624; Teresi RE, 2008, HUM MOL GENET, V17, P919, DOI 10.1093/hmg/ddm364; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Wang H, 2010, P NATL ACAD SCI USA, V107, P5142, DOI 10.1073/pnas.0912524107; Whitehead IP, 1997, BBA-REV CANCER, V1332, pF1, DOI 10.1016/S0304-419X(96)00040-6; Wong KK, 2010, CURR OPIN GENET DEV, V20, P87, DOI 10.1016/j.gde.2009.11.002	65	16	19	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 7	2013	32	10					1305	1315		10.1038/onc.2012.140	http://dx.doi.org/10.1038/onc.2012.140			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110OP	22543585	Green Accepted			2022-12-25	WOS:000316454500011
J	Prados-Rosales, RC; Roldan-Rodriguez, R; Serena, C; Lopez-Berges, MS; Guarro, J; Martinez-del-Pozo, A; Di Pietro, A				Prados-Rosales, Rafael C.; Roldan-Rodriguez, Raquel; Serena, Carolina; Lopez-Berges, Manuel S.; Guarro, Josep; Martinez-del-Pozo, Alvaro; Di Pietro, Antonio			A PR-1-like Protein of Fusarium oxysporum Functions in Virulence on Mammalian Hosts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHOGENESIS-RELATED PROTEIN; CANDIDA-ALBICANS; SIGNALING PATHWAYS; FUNGAL PATHOGENESIS; GENETIC DIVERSITY; FILAMENTOUS FUNGI; MAP KINASE; RESISTANCE; PLANT; HOOKWORM	The pathogenesis-related PR-1-like protein family comprises secreted proteins from the animal, plant, and fungal kingdoms whose biological function remains poorly understood. Here we have characterized a PR-1-like protein, Fpr1, from Fusarium oxysporum, an ubiquitous fungal pathogen that causes vascular wilt disease on a wide range of plant species and can produce life-threatening infections in immunocompromised humans. Fpr1 is secreted and proteolytically processed by the fungus. The fpr1 gene is required for virulence in a disseminated immunodepressed mouse model, and its function depends on the integrity of the proposed active site of PR-1-like proteins. Fpr1 belongs to a gene family that has expanded in plant pathogenic Sordariomycetes. These results suggest that secreted PR-1-like proteins play important roles in fungal pathogenicity.	[Prados-Rosales, Rafael C.; Roldan-Rodriguez, Raquel; Lopez-Berges, Manuel S.; Di Pietro, Antonio] Univ Cordoba, Fac Ciencias, Dept Genet, E-14071 Cordoba, Spain; [Serena, Carolina; Guarro, Josep] Univ Rovira & Virgili, IISPV, Fac Med & Ciencies Salut, Unitat Microbiol, E-43201 Reus, Spain; [Martinez-del-Pozo, Alvaro] Univ Complutense, Fac Ciencias Quim, Dept Bioquim & Biol Mol 1, E-28040 Madrid, Spain	Universidad de Cordoba; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Complutense University of Madrid	Di Pietro, A (corresponding author), Univ Cordoba, Fac Ciencias, Dept Genet, E-14071 Cordoba, Spain.	ge2dipia@uco.es	Prados-Rosales, Rafael/B-1240-2016; Sánchez López-Berges, Manuel/ABG-1946-2021; Serena, Carolina/J-5687-2014; López-Berges, Manuel Sánchez/A-1305-2017; Serena, Carolina/AAQ-6831-2021; Prados-Rosales, Rafael/D-5840-2019; Di Pietro, Antonio/K-9220-2014; Martinez-del-Pozo, Alvaro/L-8556-2014	Sánchez López-Berges, Manuel/0000-0002-5523-1725; Serena, Carolina/0000-0003-2251-0856; López-Berges, Manuel Sánchez/0000-0002-5523-1725; Serena, Carolina/0000-0003-2251-0856; Prados-Rosales, Rafael/0000-0001-5964-0166; Di Pietro, Antonio/0000-0001-5930-5763; Martinez-del-Pozo, Alvaro/0000-0003-0043-5939; Guarro, Josep/0000-0002-7839-7568	Ramon y Cajal Program; Ministerio de Ciencia e Innovacion (MICINN) Grant [BIO2010-15505]; MICINN ERA-NET/PathoGenoMics project TRANSPAT Grant [BIO2008-04479-E]; MICINN/Plant KBBE Grant [EUI2009-03942]; Junta de Andalucia Grant [BIO-3847]; Marie Curie ITN ARIADNE Grant [FP7-PEOPLE-ITN-237936]; MICINN PhD fellowships	Ramon y Cajal Program(Spanish Government); Ministerio de Ciencia e Innovacion (MICINN) Grant; MICINN ERA-NET/PathoGenoMics project TRANSPAT Grant; MICINN/Plant KBBE Grant; Junta de Andalucia Grant(Junta de Andalucia); Marie Curie ITN ARIADNE Grant; MICINN PhD fellowships	This research was supported by the Ramon y Cajal Program. This work was also supported by Ministerio de Ciencia e Innovacion (MICINN) Grant BIO2010-15505, by MICINN ERA-NET/PathoGenoMics project TRANSPAT Grant BIO2008-04479-E, MICINN/Plant KBBE Grant EUI2009-03942, Junta de Andalucia Grant BIO-3847, Marie Curie ITN ARIADNE Grant FP7-PEOPLE-ITN-237936), and MICINN PhD fellowships (to R. C. P. R. and M. S. L. B.).	ARMSTRONG GM, 1981, FUSARIUM DIS BIOL TA, P391; Azor M, 2009, J ANTIMICROB CHEMOTH, V63, P1152, DOI 10.1093/jac/dkp095; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Birch PRJ, 2008, CURR OPIN PLANT BIOL, V11, P373, DOI 10.1016/j.pbi.2008.04.005; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Braun BR, 2000, GENETICS, V156, P31; Carr S, 2004, MOL CELL PROTEOMICS, V3, P531, DOI 10.1074/mcp.T400006-MCP200; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CORNELISSEN BJC, 1986, EMBO J, V5, P37, DOI 10.1002/j.1460-2075.1986.tb04174.x; Daub J, 2000, PARASITOLOGY, V120, P171, DOI 10.1017/S0031182099005375; Del Valle A, 2003, MOL BIOCHEM PARASIT, V129, P167, DOI 10.1016/S0166-6851(03)00121-X; Delgado-Jarana JS, 2005, FUNGAL GENET BIOL, V42, P61, DOI 10.1016/j.fgb.2004.10.001; Di Pietro A, 1998, MOL PLANT MICROBE IN, V11, P91, DOI 10.1094/MPMI.1998.11.2.91; Di Pietro A, 2001, MOL MICROBIOL, V39, P1140, DOI 10.1111/j.1365-2958.2001.02307.x; Eberle HB, 2002, J CELL SCI, V115, P827; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; Ellis JG, 2007, CURR OPIN MICROBIOL, V10, P326, DOI 10.1016/j.mib.2007.05.015; Fernandez C, 1997, J MOL BIOL, V266, P576, DOI 10.1006/jmbi.1996.0772; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; GUARRO J, 1995, EUR J CLIN MICROBIOL, V14, P741, DOI 10.1007/BF01690988; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hawdon JM, 1996, J BIOL CHEM, V271, P6672, DOI 10.1074/jbc.271.12.6672; Hawdon JM, 1996, CURR OPIN GENET DEV, V6, P618, DOI 10.1016/S0959-437X(96)80092-X; HAZEN GG, 1965, ANN NY ACAD SCI, V130, P761, DOI 10.1111/j.1749-6632.1965.tb12620.x; JOOSTEN MHAJ, 1994, NATURE, V367, P384, DOI 10.1038/367384a0; Kratzschmar J, 1996, EUR J BIOCHEM, V236, P827, DOI 10.1111/j.1432-1033.1996.t01-1-00827.x; Lane S, 2001, J BIOL CHEM, V276, P48988, DOI 10.1074/jbc.M104484200; LU G, 1993, J IMMUNOL, V150, P2823; Milne TJ, 2003, J BIOL CHEM, V278, P31105, DOI 10.1074/jbc.M304843200; MORRISSETTE J, 1995, BIOPHYS J, V68, P2280, DOI 10.1016/S0006-3495(95)80410-8; MOYLE M, 1994, J BIOL CHEM, V269, P10008; MURPHY EV, 1995, GENE, V159, P131, DOI 10.1016/0378-1119(95)00061-A; Naglik J, 2004, CELL MICROBIOL, V6, P915, DOI 10.1111/j.1462-5822.2004.00439.x; Navarro-Velasco GY, 2011, FUNGAL GENET BIOL, V48, P1124, DOI 10.1016/j.fgb.2011.08.004; NIDERMAN T, 1995, PLANT PHYSIOL, V108, P17, DOI 10.1104/pp.108.1.17; Nucci M, 2007, CLIN MICROBIOL REV, V20, P695, DOI 10.1128/CMR.00014-07; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; O'Donnell K, 2004, J CLIN MICROBIOL, V42, P5109, DOI 10.1128/JCM.42.11.5109-5120.2004; Ortoneda M, 2004, INFECT IMMUN, V72, P1760, DOI 10.1128/IAI.72.3.1760-1766.2004; Prados-Rosales RC, 2006, MICROBES INFECT, V8, P2825, DOI 10.1016/j.micinf.2006.08.015; RAEDER U, 1985, LETT APPL MICROBIOL, V1, P17, DOI 10.1111/j.1472-765X.1985.tb01479.x; Rep M, 2005, FEMS MICROBIOL LETT, V253, P19, DOI 10.1016/j.femsle.2005.09.014; Rep M, 2004, MOL MICROBIOL, V53, P1373, DOI 10.1111/j.1365-2958.2004.04177.x; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Rosenzweig T, 2006, CANCER RES, V66, P4139, DOI 10.1158/0008-5472.CAN-05-2851; Ruiz-Roldan MC, 2008, EUKARYOT CELL, V7, P1227, DOI 10.1128/EC.00072-08; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; Serrano RL, 2004, J MOL BIOL, V339, P173, DOI 10.1016/j.jmb.2004.03.015; Sexton AC, 2006, EUKARYOT CELL, V5, P1941, DOI 10.1128/EC.00277-06; Soanes DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002300; Szyperski T, 1998, P NATL ACAD SCI USA, V95, P2262, DOI 10.1073/pnas.95.5.2262; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tunlid A, 2002, CURR OPIN MICROBIOL, V5, P513, DOI 10.1016/S1369-5274(02)00355-7; UKNES S, 1992, PLANT CELL, V4, P645, DOI 10.1105/tpc.4.6.645; van den Burg HA, 2003, J BIOL CHEM, V278, P27340, DOI 10.1074/jbc.M212196200; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213	58	40	42	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21970	21979		10.1074/jbc.M112.364034	http://dx.doi.org/10.1074/jbc.M112.364034			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22553200	Green Published, hybrid			2022-12-25	WOS:000306418600036
J	Fried, D; Bohm, BB; Krause, K; Burkhardt, H				Fried, Dorothee; Boehm, Beate B.; Krause, Kristin; Burkhardt, Harald			ADAM15 Protein Amplifies Focal Adhesion Kinase Phosphorylation under Genotoxic Stress Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METALLOPROTEINASE ADAM15; OSTEOARTHRITIC CARTILAGE; MDC15 METARGIDIN; TYROSINE KINASE; CELL-SURVIVAL; UP-REGULATION; CANCER; SRC; INHIBITOR; APOPTOSIS	ADAM15, a disintegrin and metalloproteinase, is capable of counteracting genotoxic stress-induced apoptosis by the suppression of caspase-3 activation. A cell line expressing the membrane-bound ADAM15 without its cytoplasmic tail, however, lost this anti-apoptotic property, suggesting a crucial role of the intracellular domain as a scaffold for recruitment of survival signal-transducingkinases. Accordingly, an enhanced phosphorylation of FAK at Tyr-397, Tyr-576, and Tyr-861 was detected upon genotoxic stress by camptothecin in ADAM15-transfected T/C28a4 cells, but not in transfectants expressing an ADAM15 mutant without the cytoplasmic tail. Accordingly, a specific binding of the cytoplasmic ADAM15 domain to the C terminus of FAK could be shown by mammalian two-hybrid, pulldown, and far Western studies. In cells expressing full-length ADAM15, a concomitant activation of Src at Tyr-416 was detected upon camptothecin exposure. Cells transfected with a chimeric construct consisting of the extracellular IL-2 receptor alpha-chain and the cytoplasmic ADAM15 domain were IL-2-stimulated to prove that the ADAM15 tail can transduce a percepted extracellular signal to enhance FAK and Src phosphorylation. Our studies further demonstrate Src binding to FAK but not a direct Src interaction with ADAM15, suggesting FAK as a critical intracellular adaptor for ADAM15-dependent enhancement of FAK/Src activation. Moreover, the apoptosis induction elicited by specific inhibitors (PP2, FAK 14 inhibitor) of FAK/Src signaling was significantly reduced by ADAM15 expression. The newly uncovered counter-regulatory response to genotoxic stress in a chondrocytic survival pathway is potentially also relevant to apoptosis resistance in neoplastic growth.	[Fried, Dorothee; Boehm, Beate B.; Krause, Kristin; Burkhardt, Harald] Goethe Univ Hosp Frankfurt Am Main, Div Rheumatol, D-60590 Frankfurt, Germany		Fried, D (corresponding author), Goethe Univ Hosp Frankfurt Am Main, Div Rheumatol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	harald.burkhardt@kgu.de			Deutsche Forschungsgemeinschaft [BU584/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant BU584/4-1.	Aigner T, 2002, ARTHRITIS RHEUM-US, V46, P1986, DOI 10.1002/art.10554; Aigner T, 2007, NAT CLIN PRACT RHEUM, V3, P391, DOI 10.1038/ncprheum0534; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Bohm B, 2010, ARTHRITIS RHEUM-US, V62, P1372, DOI 10.1002/art.27387; Bohm BB, 2009, J CELL MOL MED, V13, P2634, DOI 10.1111/j.1582-4934.2008.00490.x; Bohm BB, 1999, ARTHRITIS RHEUM, V42, P1946, DOI 10.1002/1529-0131(199909)42:9<1946::AID-ANR21>3.0.CO;2-E; Bohm BB, 2005, ARTHRITIS RHEUM-US, V52, P1100, DOI 10.1002/art.20974; Bohm BB, 2001, ARTHRITIS RHEUM-US, V44, P2046, DOI 10.1002/1529-0131(200109)44:9<2046::AID-ART354>3.0.CO;2-3; Bolos V, 2010, ONCOTARGETS THER, V3, P83; Duffy MJ, 2009, CLIN CANCER RES, V15, P1140, DOI 10.1158/1078-0432.CCR-08-1585; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; Golubovskaya VM, 2008, J MED CHEM, V51, P7405, DOI 10.1021/jm800483v; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hart S, 2005, BIOL CHEM, V386, P845, DOI 10.1515/BC.2005.099; Horiuchi K, 2003, MOL CELL BIOL, V23, P5614, DOI 10.1128/MCB.23.16.5614-5624.2003; Huang D, 2007, AM J PHYSIOL-CELL PH, V292, pC1339, DOI 10.1152/ajpcell.00144.2006; Kang Q, 2000, BIOCHEM J, V352, P883, DOI 10.1042/0264-6021:3520883; Kasahara T, 2002, ANTIOXID REDOX SIGN, V4, P491, DOI 10.1089/15230860260196290; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Kleino I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-90; Kleino I, 2009, J CELL BIOCHEM, V108, P877, DOI 10.1002/jcb.22317; Kratzschmar J, 1996, J BIOL CHEM, V271, P4593; Kurenova E, 2004, MOL CELL BIOL, V24, P4361, DOI 10.1128/MCB.24.10.4361-4371.2004; Lucas N, 2009, J CELL BIOCHEM, V106, P967, DOI 10.1002/jcb.22087; Lunn JA, 2007, J BIOL CHEM, V282, P10370, DOI 10.1074/jbc.M607780200; Maretzky T, 2009, BIOCHEM J, V420, P105, DOI 10.1042/BJ20082127; Marzia M, 2011, BIOL CHEM, V392, P877, DOI 10.1515/BC.2011.080; Mechai N, 2005, J NEUROSCI RES, V82, P753, DOI 10.1002/jnr.20693; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Najy AJ, 2008, J BIOL CHEM, V283, P18393, DOI 10.1074/jbc.M801329200; Nath D, 1999, J CELL SCI, V112, P579; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Sonoda Y, 2000, J BIOL CHEM, V275, P16309, DOI 10.1074/jbc.275.21.16309; Stautz D, 2010, EXP CELL RES, V316, P55, DOI 10.1016/j.yexcr.2009.09.017; Tousseyn T, 2009, J BIOL CHEM, V284, P11738, DOI 10.1074/jbc.M805894200; Yang S, 2009, P NATL ACAD SCI USA, V106, P3776, DOI 10.1073/pnas.0808261106; Zheng DH, 2010, MOL CARCINOGEN, V49, P200, DOI 10.1002/mc.20590; Zhong JL, 2008, MOL CANCER RES, V6, P383, DOI 10.1158/1541-7786.MCR-07-2028	40	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21214	21223		10.1074/jbc.M112.347120	http://dx.doi.org/10.1074/jbc.M112.347120			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22544741	Green Published, hybrid			2022-12-25	WOS:000306416800041
J	Sojka, D; Franta, Z; Frantova, H; Bartosova, P; Horn, M; Vachova, J; O'Donoghue, AJ; Eroy-Reveles, AA; Craik, CS; Knudsen, GM; Caffrey, CR; McKerrow, JH; Mares, M; Kopacek, P				Sojka, Daniel; Franta, Zdenek; Frantova, Helena; Bartosova, Pavla; Horn, Martin; Vachova, Jana; O'Donoghue, Anthony J.; Eroy-Reveles, Alegra A.; Craik, Charles S.; Knudsen, Giselle M.; Caffrey, Conor R.; McKerrow, James H.; Mares, Michael; Kopacek, Petr			Characterization of Gut-associated Cathepsin D Hemoglobinase from Tick Ixodes ricinus (IrCD1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHIPICEPHALUS BOOPHILUS MICROPLUS; HARD TICK; ORNITHODOROS-MOUBATA; ASPARTIC PROTEINASE; RECOGNITION DOMAIN; MOLECULAR-CLONING; ACTIVE-SITE; EXPRESSION; INHIBITOR; PROTEASE	To identify the gut-associated tick aspartic hemoglobinase, this work focuses on the functional diversity of multiple Ixodes ricinus cathepsin D forms (IrCDs). Out of three encoding genes representing Ixodes scapularis genome paralogs, IrCD1 is the most distinct enzyme with a shortened propeptide region and a unique pattern of predicted post-translational modifications. IrCD1 gene transcription is induced by tick feeding and is restricted to the gut tissue. The hemoglobinolytic role of IrCD1 was further supported by immunolocalization of IrCD1 in the vesicles of tick gut cells. Properties of recombinantly expressed rIrCD1 are consistent with the endo-lysosomal environment because the zymogen is autoactivated and remains optimally active in acidic conditions. Hemoglobin cleavage pattern of rIrCD1 is identical to that produced by the native enzyme. The preference for hydrophobic residues at the P1 and P1' position was confirmed by screening a novel synthetic tetradecapeptidyl substrate library. Outside the S1-S1' regions, rIrCD1 tolerates most amino acids but displays a preference for tyrosine at P3 and alanine at P2'. Further analysis of the cleavage site location within the peptide substrate indicated that IrCD1 is a true endopeptidase. The role in hemoglobinolysis was verified with RNAi knockdown of IrCD1 that decreased gut extract cathepsin D activity by >90%. IrCD1 was newly characterized as a unique hemoglobinolytic cathepsin D contributing to the complex intestinal proteolytic network of mainly cysteine peptidases in ticks.	[Sojka, Daniel; Franta, Zdenek; Frantova, Helena; Bartosova, Pavla; Kopacek, Petr] Acad Sci Czech Republic, Ctr Biol, Inst Parasitol, CZ-37005 Ceske Budejovice, Czech Republic; [Horn, Martin; Vachova, Jana; Mares, Michael] Acad Sci Czech Republic, Inst Organ Chem & Biochem, CZ-16610 Prague, Czech Republic; [Knudsen, Giselle M.; Caffrey, Conor R.; McKerrow, James H.] Univ Calif San Francisco, Sandler Ctr Drug Discovery, San Francisco, CA 94158 USA; [O'Donoghue, Anthony J.; Eroy-Reveles, Alegra A.; Craik, Charles S.; Knudsen, Giselle M.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94720 USA	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Sojka, D (corresponding author), Acad Sci Czech Republic, Ctr Biol, Inst Parasitol, Branisovska 31, CZ-37005 Ceske Budejovice, Czech Republic.	sojkadan@gmail.com	Mares, Michael/B-2413-2009; Sojka, Daniel/G-8354-2014; Kopacek, Petr/G-8414-2014; Horn, Martin/A-8701-2008; Sojková, Pavla/G-7314-2014	Mares, Michael/0000-0002-0847-5022; Sojka, Daniel/0000-0002-9848-9435; Kopacek, Petr/0000-0003-2412-5724; Horn, Martin/0000-0001-9110-2018; Sojková, Pavla/0000-0003-2370-6981; Frantova, Helena/0000-0002-8462-0914; Franta, Zdenek/0000-0002-7709-0097	Academy of Sciences of the Czech Republic Grant Agency [IAA 600960910]; Ministry of Education, Youth, and Sports of the Czech Republic [LC06009]; Academy of Sciences of the Czech Republic; Institute of Organic Chemistry and Biochemistry; Academy of Sciences of the Czech Republic [Z602205728, 61388963, KJB 600960911]; Sandler Foundation; Burroughs Welcome Fund Schistosome Toolbox Collaborative Research Travel Award; Grant Agency of the Czech Republic [P502/11/P682, P20/10/2183]; Grant Agency ASCR [IAA400550705]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481, K12GM081266] Funding Source: NIH RePORTER	Academy of Sciences of the Czech Republic Grant Agency; Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Institute of Organic Chemistry and Biochemistry; Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Sandler Foundation; Burroughs Welcome Fund Schistosome Toolbox Collaborative Research Travel Award; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Grant Agency ASCR(Grant Agency of the Czech Republic); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Grant IAA 600960910 (to P. K.), The Academy of Sciences of the Czech Republic Grant Agency, and by Research Center LC06009 (The Ministry of Education, Youth, and Sports of the Czech Republic). Research at the Institute of Parasitology BC, The Academy of Sciences of the Czech Republic, and the Institute of Organic Chemistry and Biochemistry, The Academy of Sciences of the Czech Republic, supported by Research Projects Z602205728 and 61388963 and research performed at the Sandler Center was supported in part by the Sandler Foundation and the Burroughs Welcome Fund Schistosome Toolbox Collaborative Research Travel Award.; Supported by Postdoctoral Project Grants KJB 600960911 from the Grant Agency of The Academy of Sciences of the Czech Republic and P502/11/P682 from the Grant Agency of the Czech Republic. To whom correspondence should be addressed: Institute of Parasitology, Biology Centre ASCR, Branisovska 31, CZ-370 05 Ceske Budejovice, Czech Republic. Tel.: 420-38-777-5453; Fax: 420-38-5310388; E-mail: sojkadan@gmail.com.; Supported by Grant IAA400550705 from Grant Agency ASCR and Grant P20/10/2183 from Grant Agency of the Czech Republic.	Akov S., 1976, Acta Tropica, V33, P37; AOYAGI T, 1969, J ANTIBIOT, V22, P283, DOI 10.7164/antibiotics.22.283; AULD DS, 1988, METHOD ENZYMOL, V158, P110, DOI 10.1016/0076-6879(88)58051-5; BARANSKI TJ, 1991, J BIOL CHEM, V266, P23365; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; Boldbaatar D, 2006, INSECT BIOCHEM MOLEC, V36, P25, DOI 10.1016/j.ibmb.2005.10.003; Caffrey CR, 2004, TRENDS PARASITOL, V20, P241, DOI 10.1016/j.pt.2004.03.004; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Cruz CE, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-63; Delcroix M, 2006, J BIOL CHEM, V281, P39316, DOI 10.1074/jbc.M607128200; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Dunn BM, 2002, CHEM REV, V102, P4431, DOI 10.1021/cr010167q; Franta Z, 2011, INT J PARASITOL, V41, P1253, DOI 10.1016/j.ijpara.2011.06.006; Franta Z, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-119; GABAY T, 1993, EXP PARASITOL, V77, P261, DOI 10.1006/expr.1993.1084; Grunclova L, 2006, BIOL CHEM, V387, P1635, DOI 10.1515/BC.2006.204; Hajdusek O, 2009, P NATL ACAD SCI USA, V106, P1033, DOI 10.1073/pnas.0807961106; Hajdusek O, 2010, VACCINE, V28, P2993, DOI 10.1016/j.vaccine.2010.02.008; HARTSUCK JA, 1992, PROTEINS, V13, P1, DOI 10.1002/prot.340130102; Horimoto Y, 2009, NEW BIOTECHNOL, V25, P318, DOI 10.1016/j.nbt.2009.03.010; Horn M, 2009, CHEM BIOL, V16, P1053, DOI 10.1016/j.chembiol.2009.09.009; Hurst M, 2000, DRUGS, V60, P1371, DOI 10.2165/00003495-200060060-00009; JAMES GT, 1978, ANAL BIOCHEM, V86, P574, DOI 10.1016/0003-2697(78)90784-4; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KNIGHT CG, 1976, BIOCHEM J, V155, P117, DOI 10.1042/bj1550117; Kopacek P, 2003, INSECT BIOCHEM MOLEC, V33, P103, DOI 10.1016/S0965-1748(02)00181-9; Kopacek P, 1995, INSECT BIOCHEM MOLEC, V25, P1081, DOI 10.1016/0965-1748(95)00040-2; Lara FA, 2005, J EXP BIOL, V208, P3093, DOI 10.1242/jeb.01749; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Liu P, 2009, BIOCHEMISTRY-US, V48, P4086, DOI 10.1021/bi802059r; Logullo C, 1998, PARASITOLOGY, V116, P525, DOI 10.1017/S0031182098002698; Luzio JP, 2009, BIOCHEM SOC T, V37, P1019, DOI 10.1042/BST0371019; Mans BJ, 2011, J INNATE IMMUN, V3, P41, DOI 10.1159/000321599; Mans BJ, 2002, MOL BIOL EVOL, V19, P1695, DOI 10.1093/oxfordjournals.molbev.a003992; MARES M, 1989, FEBS LETT, V251, P94, DOI 10.1016/0014-5793(89)81435-8; Mendiola J, 1996, EXP PARASITOL, V82, P27, DOI 10.1006/expr.1996.0004; METCALF P, 1993, EMBO J, V12, P1293, DOI 10.1002/j.1460-2075.1993.tb05774.x; Nijhof AM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-112; Nussbaumerova M, 2010, CHEMBIOCHEM, V11, P1538, DOI 10.1002/cbic.201000182; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pimenta DC, 2001, BBA-PROTEIN STRUCT M, V1544, P113, DOI 10.1016/S0167-4838(00)00209-0; Renard G, 2002, INSECT MOL BIOL, V11, P325, DOI 10.1046/j.1365-2583.2002.00342.x; Sojka D, 2007, INT J PARASITOL, V37, P713, DOI 10.1016/j.ijpara.2006.12.020; Sojka D, 2011, ADV EXP MED BIOL, V712, P177, DOI 10.1007/978-1-4419-8414-2_11; Sojka D, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-7; Sorgine MHF, 2000, J BIOL CHEM, V275, P28659, DOI 10.1074/jbc.M005675200; Steet R, 2005, J BIOL CHEM, V280, P33318, DOI 10.1074/jbc.M505994200; TARNOWSKI BI, 1989, EXP APPL ACAROL, V6, P263, DOI 10.1007/BF01193300; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VUNDLA WRM, 1992, INSECT BIOCHEM MOLEC, V22, P405, DOI 10.1016/0965-1748(92)90079-T; Williamson AL, 2003, TRENDS PARASITOL, V19, P417, DOI 10.1016/S1471-4922(03)00189-2; Wu DD, 2009, MOL BIOL EVOL, V26, P2333, DOI 10.1093/molbev/msp139	52	31	31	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21152	21163		10.1074/jbc.M112.347922	http://dx.doi.org/10.1074/jbc.M112.347922			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22539347	hybrid, Green Published			2022-12-25	WOS:000306416800036
J	Staiger, C; Cadot, S; Kooter, R; Dittrich, M; Muller, T; Klau, GW; Wessels, LFA				Staiger, Christine; Cadot, Sidney; Kooter, Raul; Dittrich, Marcus; Mueller, Tobias; Klau, Gunnar W.; Wessels, Lodewyk F. A.			A Critical Evaluation of Network and Pathway-Based Classifiers for Outcome Prediction in Breast Cancer	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; EXPRESSION SIGNATURE; CLASSIFICATION; MODULES	Recently, several classifiers that combine primary tumor data, like gene expression data, and secondary data sources, such as protein-protein interaction networks, have been proposed for predicting outcome in breast cancer. In these approaches, new composite features are typically constructed by aggregating the expression levels of several genes. The secondary data sources are employed to guide this aggregation. Although many studies claim that these approaches improve classification performance over single genes classifiers, the gain in performance is difficult to assess. This stems mainly from the fact that different breast cancer data sets and validation procedures are employed to assess the performance. Here we address these issues by employing a large cohort of six breast cancer data sets as benchmark set and by performing an unbiased evaluation of the classification accuracies of the different approaches. Contrary to previous claims, we find that composite feature classifiers do not outperform simple single genes classifiers. We investigate the effect of (1) the number of selected features; (2) the specific gene set from which features are selected; (3) the size of the training set and (4) the heterogeneity of the data set on the performance of composite feature and single genes classifiers. Strikingly, we find that randomization of secondary data sources, which destroys all biological information in these sources, does not result in a deterioration in performance of composite feature classifiers. Finally, we show that when a proper correction for gene set size is performed, the stability of single genes sets is similar to the stability of composite feature sets. Based on these results there is currently no reason to prefer prognostic classifiers based on composite features over single genes classifiers for predicting outcome in breast cancer.	[Staiger, Christine; Klau, Gunnar W.] Ctr Wiskunde & Informat, Life Sci Grp, Amsterdam, Netherlands; [Kooter, Raul; Wessels, Lodewyk F. A.] Fac Elect Engn Math & Comp Sci, Delft Bioinformat Lab, Delft, Netherlands; [Dittrich, Marcus; Mueller, Tobias] Univ Wurzburg, Dept Bioinformat, Bioctr, Wurzburg, Germany; [Klau, Gunnar W.] Netherlands Inst Syst Biol, Amsterdam, Netherlands; [Wessels, Lodewyk F. A.] Netherlands Canc Inst, Canc Syst Biol Ctr, Amsterdam, Netherlands	Delft University of Technology; University of Wurzburg; Netherlands Cancer Institute	Staiger, C (corresponding author), Ctr Wiskunde & Informat, Life Sci Grp, Amsterdam, Netherlands.	c.staiger@cwi.nl; gunnar.klau@cwi.nl; l.wessels@nki.nl	Müller, Tobias/A-8952-2008; Klau, Gunnar W./A-6934-2011	Klau, Gunnar W./0000-0002-6340-0090				Abraham G, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-277; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chowdhury SA, 2011, J COMPUT BIOL, V18, P263, DOI 10.1089/cmb.2010.0269; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Dao P, 2010, BIOINFORMATICS, V26, pi625, DOI 10.1093/bioinformatics/btq393; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Dittrich MT, 2008, BIOINFORMATICS, V24, pI223, DOI 10.1093/bioinformatics/btn161; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Gatza ML, 2010, P NATL ACAD SCI USA, V107, P6994, DOI 10.1073/pnas.0912708107; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Ma SG, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-271; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Popovici V, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2468; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Reyal F, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2192; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; ULITSKY I, 2010, PLOS ONE, V0005; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Vliet MH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-375; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wessels LFA, 2005, BIOINFORMATICS, V21, P3755, DOI 10.1093/bioinformatics/bti429	30	42	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e34796	10.1371/journal.pone.0034796	http://dx.doi.org/10.1371/journal.pone.0034796			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558100	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336000018
J	Roche, LM; Latimer, AM; Eastburn, DJ; Tate, KW				Roche, Leslie M.; Latimer, Andrew M.; Eastburn, Danny J.; Tate, Kenneth W.			Cattle Grazing and Conservation of a Meadow-Dependent Amphibian Species in the Sierra Nevada	PLOS ONE			English	Article							TOAD BUFO-CALAMITA; RIPARIAN ECOSYSTEMS; YOSEMITE TOADS; LIVESTOCK; CALIFORNIA; DECLINES; HABITAT; DESICCATION; COMMUNITIES; POPULATIONS	World-wide population declines have sharpened concern for amphibian conservation on working landscapes. Across the Sierra Nevada's national forest lands, where almost half of native amphibian species are considered at risk, permitted livestock grazing is a notably controversial agricultural activity. Cattle (Bos taurus) grazing is thought to degrade the quality, and thus reduce occupancy, of meadow breeding habitat for amphibian species of concern such as the endemic Yosemite toad (Anaxyrus [= Bufo] canorus). However, there is currently little quantitative information correlating cattle grazing intensity, meadow breeding habitat quality, and toad use of meadow habitat. We surveyed biotic and abiotic factors influencing cattle utilization and toad occupancy across 24 Sierra Nevada meadows to establish these correlations and inform conservation planning efforts. We utilized both traditional regression models and Bayesian structural equation modeling to investigate potential drivers of meadow habitat use by cattle and Yosemite toads. Cattle use was negatively related to meadow wetness, while toad occupancy was positively related. In mid and late season (mid July-mid September) grazing periods, cattle selected for higher forage quality diets associated with vegetation in relatively drier meadows, whereas toads were more prevalent in wetter meadows. Because cattle and toads largely occupied divergent zones along the moisture gradient, the potential for indirect or direct negative effects is likely minimized via a partitioning of the meadow habitat. During the early season, when habitat use overlap was highest, overall low grazing levels resulted in no detectable impacts on toad occupancy. Bayesian structural equation analyses supported the hypothesis that meadow hydrology influenced toad meadow occupancy, while cattle grazing intensity did not. These findings suggest cattle production and amphibian conservation can be compatible goals within this working landscape.	[Roche, Leslie M.; Latimer, Andrew M.; Eastburn, Danny J.; Tate, Kenneth W.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Roche, LM (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	lmroche@ucdavis.edu		Roche, Leslie/0000-0003-2954-8056; Latimer, Andrew/0000-0001-8098-0448	USDA Forest Service, Pacific Southwest Region	USDA Forest Service, Pacific Southwest Region(United States Department of Agriculture (USDA)United States Forest Service)	Research was funded by USDA Forest Service, Pacific Southwest Region. Other than providing preliminary data, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber JD, 2004, FOREST ECOL MANAG, V196, P1, DOI 10.1016/j.foreco.2004.03.009; Adams MJ, 2009, J HERPETOL, V43, P132, DOI 10.1670/08-016R2.1; Alford RA, 1999, ANNU REV ECOL SYST, V30, P133, DOI 10.1146/annurev.ecolsys.30.1.133; ALLENDIAZ BH, 1991, AM MIDL NAT, V126, P30, DOI 10.2307/2426147; Anderson TM, 2007, AM NAT, V170, P343, DOI 10.1086/520120; [Anonymous], CDFG SPEC AN 883 TAX; [Anonymous], 2013, MEASUREMENTS TERREST; AOAC, 1997, 97318 AOAC ASASSA IN; AOAC, 2006, OFFICIAL METHODS ANA, V18th, P30; Bagozzi R.P., 1988, J ACAD MARKET SCI, V16, P74, DOI [10.1007/BF02723327, DOI 10.1007/BF02723327]; Belsky AJ, 1999, J SOIL WATER CONSERV, V54, P419; BOSCH JM, 1982, J HYDROL, V55, P3, DOI 10.1016/0022-1694(82)90117-2; Bull EL, 2000, J RANGE MANAGE, V53, P291, DOI 10.2307/4003434; Burton EC, 2009, J WILDLIFE MANAGE, V73, P269, DOI 10.2193/2007-562; Carstensen B, EPI PACKAGE STAT ANA; Collins JP, 2003, DIVERS DISTRIB, V9, P89, DOI 10.1046/j.1472-4642.2003.00012.x; Congdon P, 2003, APPL BAYSEIAN MODELI; Denton JS, 1997, CONSERV BIOL, V11, P1329, DOI 10.1046/j.1523-1739.1997.96318.x; Drost CA, 1996, CONSERV BIOL, V10, P414, DOI 10.1046/j.1523-1739.1996.10020414.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; FLEISCHNER TL, 1994, CONSERV BIOL, V8, P629, DOI 10.1046/j.1523-1739.1994.08030629.x; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.2277/0521867061; George M, 2001, ANN RANGE FORAGE PRO; Grace J.B., 2006, STRUCT EQ MOD NAT; Grace JB, 1997, AM NAT, V149, P436, DOI 10.1086/285999; Healey M, 1997, AUST J ECOL, V22, P270, DOI 10.1111/j.1442-9993.1997.tb00672.x; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; Interagency, 1996, BLMRSST960041730 USD; Jansen A, 2003, BIOL CONSERV, V109, P207, DOI 10.1016/S0006-3207(02)00148-9; Jennings M. R., 1994, AMPHIBIAN REPTILE SP; Jennings Mark R., 1996, P921; Jofre G, 2007, AMPHIBIA-REPTILIA, V28, P129, DOI 10.1163/156853807779799126; Johnson ML, 2003, DIS AQUAT ORGAN, V57, P255, DOI 10.3354/dao057255; Karlstrom E. L, 1962, U CALIFORNIA PUBLICA, V62, P1; KAUFFMAN JB, 1984, J RANGE MANAGE, V37, P430, DOI 10.2307/3899631; Knutson MG, 2004, ECOL APPL, V14, P669, DOI 10.1890/02-5305; Lee S.Y., 2007, STRUCTURAL EQUATION, DOI 10.1002/9780470024737; Lind A, 2010, DETERMINING EFFECTS; Lind AJ, 2011, DETERMINING EFFECTS; Loheide SP, 2009, HYDROGEOL J, V17, P229, DOI 10.1007/s10040-008-0380-4; McCullagh P, 1989, GEN LINEAR MODELS EX; McIlroy SK, 2008, IDENTIFYING ECOLOGIC; McMenamin SK, 2008, P NATL ACAD SCI USA, V105, P16988, DOI 10.1073/pnas.0809090105; Meyer G.A., 1992, INDUCTIVELY COUPLED, V2, P473; Millar CI, 2004, ARCT ANTARCT ALP RES, V36, P181, DOI 10.1657/1523-0430(2004)036[0181:ROSCIT]2.0.CO;2; Morton ML, 2010, HERPETOL CONSERV BIO, V5, P388; Norman SP, 2005, FOREST ECOL MANAG, V215, P51, DOI 10.1016/j.foreco.2005.05.003; NRC, 1996, NUTR REQ BEEF CATTL; Null SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009932; Papke LE, 1996, J APPL ECONOM, V11, P619, DOI 10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1; Pinheiro J, 2000, MIXED EFFECTS MODELS; Plummer M, 2010, RJAGS BAYESIAN GRAPH; R Core Team, 2021, R LANG ENV STAT COMP; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Rannap R, 2007, WETLANDS, V27, P390, DOI 10.1672/0277-5212(2007)27[390:COCMDT]2.0.CO;2; Ratliff R, 1985, PSWGTR84 USDA FOR SE; Ready J, 2010, ECOL MODEL, V221, P467, DOI 10.1016/j.ecolmodel.2009.10.025; Riginos C, 2008, ECOLOGY, V89, P2228, DOI 10.1890/07-1250.1; Roche LM, 2012, RANGELAND ECOL MANAG, V65, P56, DOI 10.2111/REM-D-11-00092.1; Roche LM, 2011, THESIS U CALIFORNIA; SAH RN, 1992, ANAL CHEM, V64, P230, DOI 10.1021/ac00026a026; Sarr DA, 2002, ENVIRON MANAGE, V30, P516, DOI 10.1007/s00267-002-2608-8; Schmutzer AC, 2008, FRESHWATER BIOL, V53, P2613, DOI 10.1111/j.1365-2427.2008.02072.x; SHERMAN CK, 1993, J HERPETOL, V27, P186, DOI 10.2307/1564935; SHERMAN CK, 1984, NAT HIST, V93, P72; Smith MA, 2005, ECOGRAPHY, V28, P110; Spiegelhalter D, OPENBUGS USER MANUAL; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; StataCorp, 2007, STAT STAT SOFTW REL; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Sulak A., 2002, General Technical Report - Pacific Southwest Research Station, USDA Forest Service, P43; Thomas A., 2006, R NEWS, V6, P12, DOI DOI 10.1159/000323281; Toledo ZO, 2001, J AM WATER RESOUR AS, V37, P1653, DOI 10.1111/j.1752-1688.2001.tb03667.x; U.S. Department of Interior Fish and Wildlife Service (USFWS), 2002, FED REGISTER, V67, P75834; U.S. Department of Interior Fish and Wildlife Service (USFWS), 2004, FED REGISTER, V69, P25876; USDAForestService, 2005, FOR SERV MAN FSM 267	77	26	26	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35734	10.1371/journal.pone.0035734	http://dx.doi.org/10.1371/journal.pone.0035734			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558211	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345200072
J	Voyles, J; Vredenburg, VT; Tunstall, TS; Parker, JM; Briggs, CJ; Rosenblum, EB				Voyles, Jamie; Vredenburg, Vance T.; Tunstall, Tate S.; Parker, John M.; Briggs, Cheryl J.; Rosenblum, Erica Bree			Pathophysiology in Mountain Yellow-Legged Frogs (Rana muscosa) during a Chytridiomycosis Outbreak	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASE; BATRACHOCHYTRIUM-DENDROBATIDIS; POPULATION DECLINES; FUNGAL PATHOGEN; AMPHIBIANS; EXTINCTION; DYNAMICS	The disease chytridiomycosis is responsible for declines and extirpations of amphibians worldwide. Chytridiomycosis is caused by a fungal pathogen (Batrachochytrium dendrobatidis) that infects amphibian skin. Although we have a basic understanding of the pathophysiology from laboratory experiments, many mechanistic details remain unresolved and it is unknown if disease development is similar in wild amphibian populations. To gain a better understanding of chytridiomycosis pathophysiology in wild amphibian populations, we collected blood biochemistry measurements during an outbreak in mountain yellow-legged frogs (Rana muscosa) in the Sierra Nevada Mountains of California. We found that pathogen load is associated with disruptions in fluid and electrolyte balance, yet is not associated with fluctuations acid-base balance. These findings enhance our knowledge of the pathophysiology of this disease and indicate that disease development is consistent across multiple species and in both laboratory and natural conditions. We recommend integrating an understanding of chytridiomycosis pathophysiology with mitigation practices to improve amphibian conservation.	[Voyles, Jamie; Rosenblum, Erica Bree] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Vredenburg, Vance T.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Tunstall, Tate S.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Tunstall, Tate S.; Briggs, Cheryl J.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Parker, John M.] Univ Calif San Francisco, Anim Care Facil, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; California State University System; San Francisco State University; University of California System; University of California Berkeley; University of California System; University of California Santa Barbara; University of California System; University of California San Francisco	Voyles, J (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	jamie.voyles@gmail.com	Briggs, Cheryl/F-7456-2013	Vredenburg, Vance/0000-0002-9682-1190	National Institutes of Health [R01ES12067]; National Science Foundation [EF-0723563]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012067] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by National Institutes of Health Grant R01ES12067 and National Science Foundation Grant EF-0723563. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bancila RI, 2010, AMPHIBIA-REPTILIA, V31, P558, DOI 10.1163/017353710X518405; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L, 2010, DIS AQUAT ORGAN, V92, P165, DOI 10.3354/dao02238; Boutilier Robert G., 1992, P81; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Briggs CJ, 2005, ECOLOGY, V86, P3149, DOI 10.1890/04-1428; Budaev SV, 2010, ETHOLOGY, V116, P472, DOI 10.1111/j.1439-0310.2010.01758.x; Carver S, 2010, COPEIA, P487, DOI 10.1643/CH-09-128; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; David Rose B, 2001, CLIN PHYSL ACID BASE; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Kinney VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016708; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Marcum RD, 2010, DIS AQUAT ORGAN, V91, P17, DOI 10.3354/dao02235; MUELLER GM, 2004, BIODIVERSITY FUNGI I; Schaechter M., 1993, MECH MICROBIAL DIS; Schloegel LM, 2006, ECOHEALTH, V3, P35, DOI 10.1007/s10393-005-0012-6; Voyles J, 2007, DIS AQUAT ORGAN, V77, P113, DOI 10.3354/dao01838; Voyles J, 2011, MICROBES INFECT, V13, P25, DOI 10.1016/j.micinf.2010.09.015; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Woodhams DC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-8; Wright KM., 2001, AMPHIBIAN MED CAPTIV	28	50	51	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35374	10.1371/journal.pone.0035374	http://dx.doi.org/10.1371/journal.pone.0035374			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558145	gold, Green Published			2022-12-25	WOS:000305345200035
J	Alberdi, A; Garin, I; Aizpurua, O; Aihartza, J				Alberdi, Antton; Garin, Inazio; Aizpurua, Ostaizka; Aihartza, Joxerra			The Foraging Ecology of the Mountain Long-Eared Bat Plecotus macrobullaris Revealed with DNA Mini-Barcodes	PLOS ONE			English	Article							FOOD-HABITS; ECHOLOCATION CALLS; PREY SELECTION; FECAL ANALYSIS; INSECTIVOROUS BATS; LASIURUS-CINEREUS; DIETARY VARIATION; CHIROPTERA; MOTHS; IDENTIFICATION	Molecular analysis of diet overcomes the considerable limitations of traditional techniques for identifying prey remains in bat faeces. We collected faeces from individual Mountain Long-eared Bats Plecotus macrobullaris trapped using mist nets during the summers of 2009 and 2010 in the Pyrenees. We analysed their diet using DNA mini-barcodes to identify prey species. In addition, we inferred some basic features of the bat's foraging ecology that had not yet been addressed. P. macrobullaris fed almost exclusively on moths (97.8%). As prey we detected one dipteran genus (Tipulidae) and 29 moth taxa: 28 were identified at species level (23 Noctuidae, 1 Crambidae, 1 Geometridae, 1 Pyralidae, 1 Sphingidae, 1 Tortricidae), and one at genus level (Rhyacia sp., Noctuidae). Known ecological information about the prey species allowed us to determine that bats had foraged at elevations between 1,500 and 2,500 m amsl (above mean sea level), mostly in subalpine meadows, followed by other open habitats such as orophilous grasslands and alpine meadows. No forest prey species were identified in the diet. As 96.4% of identified prey species were tympanate moths and no evidence of gleaning behaviour was revealed, we suggest P. macrobullaris probably forages by aerial hawking using faint echolocation pulses to avoid detection by hearing moths. As we could identify 87.8% of the analysed sequences (64.1% of the MOTUs, Molecular Operational Taxonomic Units) at species level, we conclude that DNA mini-barcodes are a very useful tool to analyse the diet of moth-specialist bats.	[Alberdi, Antton; Garin, Inazio; Aizpurua, Ostaizka; Aihartza, Joxerra] Univ Basque Country UPV EHU, Fac Sci & Technol, Dept Zool & Anim Cell Biol, Leioa, The Basque Coun, Spain	University of Basque Country	Alberdi, A (corresponding author), Univ Basque Country UPV EHU, Fac Sci & Technol, Dept Zool & Anim Cell Biol, Leioa, The Basque Coun, Spain.	joxerra.aihartza@ehu.es	Aizpurua, Ostaizka/V-9490-2019; Aihartza, Joxerra/GSO-2446-2022; Alberdi, Antton/M-2423-2017; Garin, Inazio/B-8115-2009; Aihartza, Joxerra/Z-3061-2019	Aizpurua, Ostaizka/0000-0001-8053-3672; Alberdi, Antton/0000-0002-2875-6446; Aihartza, Joxerra/0000-0003-0882-8964	Hezkuntza, Unibertsitate eta Ikerketa Saila, Eusko Jaurlaritza - The Basque Government [GIC07/05, IT301-10, BFI-2010-190, BFI-2009-252]; University of The Basque Country, Euskal Herriko Uniberstiatatea UPV/EHU	Hezkuntza, Unibertsitate eta Ikerketa Saila, Eusko Jaurlaritza - The Basque Government; University of The Basque Country, Euskal Herriko Uniberstiatatea UPV/EHU	This work was supported by Hezkuntza, Unibertsitate eta Ikerketa Saila, Eusko Jaurlaritza - The Basque Government (research projects GIC07/05 and IT301-10, and grants BFI-2010-190, and BFI-2009-252) and the University of The Basque Country, Euskal Herriko Uniberstiatatea UPV/EHU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHARYA L, 1992, CAN J ZOOL, V70, P1292, DOI 10.1139/z92-180; Alcalde J. T., 2008, Graellsia, V64, P3; Almenar D, 2008, J ZOOL, V274, P340, DOI 10.1111/j.1469-7998.2007.00390.x; ANDERSON ME, 1991, ANIM BEHAV, V42, P489, DOI 10.1016/S0003-3472(05)80048-X; Animal Behaviour Society, 2006, ANIM BEHAV, V71, P245, DOI DOI 10.1016/J.ANBEHAV.2005.10.001; Ashrafi S, 2010, J ZOOL, V281, P241, DOI 10.1111/j.1469-7998.2010.00697.x; Ashrafi S, 2010, THESIS U BERN SWITZE; Ashrafi S, 2011, EUR J WILDLIFE RES, V57, P843, DOI 10.1007/s10344-011-0496-z; BECK A, 1995, MYOTIS, V32, P109; Beck J, 2010, BASIC APPL ECOL, V11, P714, DOI 10.1016/j.baae.2010.08.009; Benda Petr, 2008, Acta Societatis Zoologicae Bohemicae, V72, P105; Bogdanowicz W, 1999, J ZOOL, V247, P381, DOI 10.1111/j.1469-7998.1999.tb01001.x; Bohmann K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021441; Boye P, 2005, 661 ENGL NAT; Burles DW, 2008, CAN J ZOOL, V86, P1367, DOI 10.1139/Z08-125; Chapman JW, 2008, CURR BIOL, V18, P514, DOI 10.1016/j.cub.2008.02.080; Chiarucci A, 2003, DIVERS DISTRIB, V9, P283, DOI 10.1046/j.1472-4642.2003.00027.x; Clare EL, 2011, MOL ECOL, V20, P1772, DOI 10.1111/j.1365-294X.2011.05040.x; Clare EL, 2009, MOL ECOL, V18, P2532, DOI 10.1111/j.1365-294X.2009.04184.x; Coldea G, 2003, ECOL STU AN, P65; Collin CL, 2010, PLANT ECOL, V206, P1, DOI 10.1007/s11258-009-9620-5; Collin CL, 2003, AM J BOT, V90, P579, DOI 10.3732/ajb.90.4.579; Colwell RK., 2013, STAT ESTIMATION SPEC; Davidson P, 2007, BIRDWATCH CAN, V41, P4; Deagle Bruce E, 2006, Front Zool, V3, P11, DOI 10.1186/1742-9994-3-11; DICKMAN CR, 1988, J MAMMAL, V69, P108, DOI 10.2307/1381753; Dietrich S, 2006, ACTA CHIROPTEROL, V8, P465, DOI 10.3161/1733-5329(2006)8[465:ESOTPB]2.0.CO;2; Dinca Vlad, 2008, Nota Lepidopterologica, V31, P263; Dodd LE, 2007, ACTA CHIROPTEROL, V9, P451, DOI 10.3161/1733-5329(2007)9[451:PCBCTI]2.0.CO;2; Dodok I., 2005, Acta Entomologica Serbica, V8, P1; EASTERLA DA, 1972, J MAMMAL, V53, P887, DOI 10.2307/1379227; Eisentraut M, 1951, ZOOL JB, V79, P114; EPA, 2001, NAT LAND COV DAT LAN; FAURE PA, 1990, J COMP PHYSIOL A, V166, P843; Fukui Dai, 2009, Endangered Species Research, V8, P117, DOI 10.3354/esr00156; FULLARD JH, 1988, EXPERIENTIA, V44, P423, DOI 10.1007/BF01940537; Gajdosik M, 2004, FOLIA ZOOL, V53, P7; Garcia-Gonzalez R, 2008, MANAGEMENT NATURA 20; Garin I, 2003, ACTA CHIROPTEROL, V5, P243, DOI 10.3161/001.005.0207; Goerlitz HR, 2010, CURR BIOL, V20, P1568, DOI 10.1016/j.cub.2010.07.046; Goiti U, 2004, MAMMALIA, V68, P397, DOI 10.1515/mamm.2004.039; Grabherr G, 2000, MT RES DEV, V20, P190, DOI 10.1659/0276-4741(2000)020[0190:GAGORI]2.0.CO;2; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hartbauer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012698; Hebert P. D. N., 2004, BARCODES LIFE; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Henry PY, 2011, BIRD STUDY, V58, P160, DOI 10.1080/00063657.2010.543948; Hodkinson ID, 2005, BIOL REV, V80, P489, DOI 10.1017/S1464793105006767; Huemer Peter, 2005, Vorarlberger Naturschau Forschen und Entdecken, V16, P9; Jones M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019259; Juste J, 2004, MOL PHYLOGENET EVOL, V31, P1114, DOI 10.1016/j.ympev.2003.10.005; Kiefer Andreas, 2001, Myotis, V39, P5; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; Korner C, 1999, ALPINE PLANT LIFE FU; KUNZ TH, 1983, CAN J ZOOL, V61, P1317, DOI 10.1139/z83-177; Lacki MJ, 2001, AM MIDL NAT, V145, P213, DOI 10.1674/0003-0031(2001)145[0213:SUOLPB]2.0.CO;2; Lee YF, 2005, J MAMMAL, V86, P67, DOI 10.1644/1545-1542(2005)086&lt;0067:DVOBFB&gt;2.0.CO;2; Martin KM, 2001, WILDLIFE-HABITAT RELATIONSHIPS IN OREGON AND WASHINGTON, P239; Mattei-Roesli Marzia, 2010, Bollettino della Societa Ticinese di Scienze Naturali, V98, P31; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Miehe G, 2000, ERDKUNDE, V54, P34, DOI DOI 10.3112/erdkunde.2000.01.03; Miller L.A., 1984, Series Entomologica (Dordrecht), V27, P134; Miller LA, 2001, BIOSCIENCE, V51, P570, DOI 10.1641/0006-3568(2001)051[0570:HSIDAA]2.0.CO;2; Moulton MJ, 2010, MOL ECOL RESOUR, V10, P615, DOI 10.1111/j.1755-0998.2009.02823.x; Nappi Armando, 2002, Hystrix, V13, P45; Olsson EGA, 2000, LANDSCAPE ECOL, V15, P155, DOI 10.1023/A:1008173628016; Ortiz AS, 2009, SHILAP-REV. LEPIDOPT, V37, P105; Painter ML, 2009, CAN J ZOOL, V87, P865, DOI 10.1139/Z09-075; Pavey CR, 1998, OIKOS, V81, P143, DOI 10.2307/3546476; Pavlinic Igor, 2004, Natura Croatica, V13, P395; PEPIN D, 1992, ONGULES / UNGULATES 91, P327; Perez De-Gregorio JJ, 2001, ATLAS FOTOGRAFICO LE; Poulton EB, 1929, P ZOOL SOC LOND, V1929, P277; Preatoni DG, 2011, ACTA CHIROPTEROL, V13, P355, DOI 10.3161/150811011X624820; RABINOWITZ AR, 1982, ACTA THERIOL, V27, P283, DOI 10.4098/AT.arch.82-25; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Razgour O, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.49; Robineau R, 2007, GUIDE PAPILLONS NOCT; ROEDER KD, 1957, J EXP ZOOL, V134, P127, DOI 10.1002/jez.1401340107; Roeder KD, 1967, NERVE CELLS INSECT B; Ross A., 1967, Proceedings Western Foundation of Vertebrate Zoology, V1, P204; Rostovskaya M. S., 2000, Russian Entomological Journal, V9, P185; RYDELL J, 1994, P ROY SOC B-BIOL SCI, V257, P175, DOI 10.1098/rspb.1994.0112; Rydell J, 1996, ECOGRAPHY, V19, P62, DOI 10.1111/j.1600-0587.1996.tb00155.x; Salsamendi E, 2008, ACTA CHIROPTEROL, V10, P279, DOI 10.3161/150811008X414854; Scalercio S, 2009, EUR J ENTOMOL, V106, P231, DOI 10.14411/eje.2009.031; Schnepf J, 2010, THESIS U WIEN AUSTRI; Scoble MJ, 1992, LEPIDOPTERA FORM FUN; Shapiro A.M., 1975, P181; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Spitzenberger F, 2006, ZOOL SCR, V35, P187, DOI 10.1111/j.1463-6409.2006.00224.x; Spitzenberger Friederike, 2003, Natura Croatica, V12, P39; Spitzenberger Friederike, 2002, Natura Croatica, V11, P1; Spitzer Karel, 2003, Opera Corcontica, V40, P275; Stephens D.W., 1986, pi; ter Hofstede HM, 2010, J COMP PHYSIOL A, V196, P349, DOI 10.1007/s00359-010-0518-4; Valdez EW, 2009, SOUTHWEST NAT, V54, P195, DOI 10.1894/PS-45.1; Vare H., 2003, VVolume 167, P133; Varga ZS, 2008, BIOL J LINN SOC, V93, P415, DOI 10.1111/j.1095-8312.2007.00934.x; Vaughan N, 1997, MAMMAL REV, V27, P77, DOI 10.1111/j.1365-2907.1997.tb00373.x; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; Waring P, 2003, FIELD GUIDE MOTHS GR; Waters DA, 1996, J EXP BIOL, V199, P847; WATERS DA, 1995, J EXP BIOL, V198, P475; WERNER TK, 1981, CAN J ZOOL, V59, P525, DOI 10.1139/z81-076; Whitaker JO, 1996, J MAMMAL, V77, P716, DOI 10.2307/1382676; Whitaker JO, 2009, ACTA CHIROPTEROL, V11, P393, DOI 10.3161/150811009X485611; Wiebe KL, 1998, IBIS, V140, P14, DOI 10.1111/j.1474-919X.1998.tb04536.x; Wood CR, 2009, B ENTOMOL RES, V99, P525, DOI 10.1017/S0007485308006548; Zeale MRK, 2011, MOL ECOL RESOUR, V11, P236, DOI 10.1111/j.1755-0998.2010.02920.x; Zhang DX, 1996, MOL ECOL, V5, P295, DOI 10.1111/j.1365-294X.1996.tb00317.x	115	40	41	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35692	10.1371/journal.pone.0035692	http://dx.doi.org/10.1371/journal.pone.0035692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545129	gold, Green Published			2022-12-25	WOS:000305343200049
J	Catts, VS; Weickert, CS				Catts, Vibeke Sorensen; Weickert, Cynthia Shannon			Gene Expression Analysis Implicates a Death Receptor Pathway in Schizophrenia Pathology	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; CORTICAL PYRAMIDAL NEURONS; DENDRITIC SPINE DENSITY; ANTERIOR CINGULATE CORTEX; BIPOLAR-DISORDER; SOMAL SIZE; GABAERGIC NEURONS; NADPH-OXIDASE; APOPTOTIC MECHANISMS; SELECTIVE DEFICITS	An increase in apoptotic events may underlie neuropathology in schizophrenia. By data-mining approaches, we identified significant expression changes in death receptor signaling pathways in the dorsolateral prefrontal cortex (DLPFC) of patients with schizophrenia, particularly implicating the Tumor Necrosis Factor Superfamily member 6 (FAS) receptor and the Tumor Necrosis Factor [ ligand] Superfamily member 13 (TNFSF13) in schizophrenia. We sought to confirm and replicate in an independent tissue collection the noted mRNA changes with quantitative real-time RT-PCR. To test for regional and diagnostic specificity, tissue from orbital frontal cortex (OFC) was examined and a bipolar disorder group included. In schizophrenia, we confirmed and replicated significantly increased expression of TNFSF13 mRNA in the DLPFC. Also, a significantly larger proportion of subjects in the schizophrenia group had elevated FAS receptor expression in the DLPFC relative to unaffected controls. These changes were not observed in the bipolar disorder group. In the OFC, there were no significant differences in TNFSF13 or FAS receptor mRNA expression. Decreases in BH3 interacting domain death agonist (BID) mRNA transcript levels were found in the schizophrenia and bipolar disorder groups affecting both the DLPFC and the OFC. We tested if TNFSF13 mRNA expression correlated with neuronal mRNAs in the DLPFC, and found significant negative correlations with interneuron markers, parvalbumin and somatostatin, and a positive correlation with PPP1R9B (spinophilin), but not DLG4 (PSD-95). The expression of TNFSF13 mRNA in DLPFC correlated negatively with tissue pH, but decreasing pH in cultured cells did not cause increased TNFSF13 mRNA nor did exogenous TNFSF13 decrease pH. We concluded that increased TNFSF13 expression may be one of several cell-death cytokine abnormalities that contribute to the observed brain pathology in schizophrenia, and while increased TNFSF13 may be associated with lower brain pH, the change is not necessarily causally related to brain pH.	[Catts, Vibeke Sorensen; Weickert, Cynthia Shannon] Schizophrenia Res Inst, Schizophrenia Res Lab, Sydney, NSW, Australia; [Catts, Vibeke Sorensen; Weickert, Cynthia Shannon] Neurosci Res Australia, Schizophrenia Res Lab, Sydney, NSW, Australia; [Catts, Vibeke Sorensen] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Catts, Vibeke Sorensen; Weickert, Cynthia Shannon] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney; University of New South Wales Sydney	Catts, VS (corresponding author), Schizophrenia Res Inst, Schizophrenia Res Lab, Sydney, NSW, Australia.	v.catts@NeuRA.edu.au	Weickert, Cynthia Shannon/G-3171-2011; Catts, Vibeke S/C-9798-2011	Catts, Vibeke S/0000-0002-9892-0547; Shannon Weickert, Cynthia/0000-0002-4560-0259	Stanley Medical Research Institute (SMRI) [09R-2153]; Schizophrenia Research Institute; NSW Health; Macquarie Group Foundation; Neuroscience Research Australia; University of New South Wales; National Health and Medical Research Council of Australia; National Institute of Alcohol Abuse and Alcoholism (NIH (NIAAA)) [R24AA012725]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R28AA012725, R24AA012725] Funding Source: NIH RePORTER	Stanley Medical Research Institute (SMRI); Schizophrenia Research Institute; NSW Health; Macquarie Group Foundation; Neuroscience Research Australia; University of New South Wales; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institute of Alcohol Abuse and Alcoholism (NIH (NIAAA))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Grant funding was received from the Stanley Medical Research Institute (SMRI Grant No 09R-2153: www.stanleyresearch.org). This work was also supported by the Schizophrenia Research Institute (www.schizophreniaresearch.org.au), utilizing infrastructure funding from NSW Health, the Macquarie Group Foundation, Neuroscience Research Australia and the University of New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Postmortem brain tissue was provided by the SMRI's brain collection courtesy of Drs Michael B Knable, E Fuller Torrey, Maree J Webster, Serge Weis, and Robert H Yolken. Tissues were also received from the New South Wales TRC at the University of Sydney which is supported by the National Health and Medical Research Council of Australia, Schizophrenia Research Institute, National Institute of Alcohol Abuse and Alcoholism (NIH (NIAAA) R24AA012725). We also thank the SMRI for access to array data via the Stanley Online Genomics Database, which uses samples from the SMRI Brain Bank. These samples were processed and run on gene expression arrays by a variety of researchers in collaboration with the SMRI. All of the genomic data have been aggregated in the online database, and a comprehensive set of cross-study analyses have been performed by Dr Michael Elashoff. Thank you to Shan Tsai for capable assistance in the laboratory.	Beasley CL, 1997, SCHIZOPHR RES, V24, P349, DOI 10.1016/S0920-9964(96)00122-3; Beasley CL, 2002, BIOL PSYCHIAT, V52, P708, DOI 10.1016/S0006-3223(02)01360-4; Behrens MM, 2007, SCIENCE, V318, P1645, DOI 10.1126/science.1148045; Behrens MM, 2008, J NEUROSCI, V28, P13957, DOI 10.1523/JNEUROSCI.4457-08.2008; Benes FM, 2003, ARCH GEN PSYCHIAT, V60, P359, DOI 10.1001/archpsyc.60.4.359; Benes FM, 2010, CELL CYCLE, V9, P625, DOI 10.4161/cc.9.4.10820; Benes FM, 2009, P NATL ACAD SCI USA, V106, P11731, DOI 10.1073/pnas.0903066106; Bitanihirwe BKY, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-71; Black JE, 2004, AM J PSYCHIAT, V161, P742, DOI 10.1176/appi.ajp.161.4.742; Broadbelt K, 2002, SCHIZOPHR RES, V58, P75, DOI 10.1016/S0920-9964(02)00201-3; Buttner N, 2007, SCHIZOPHR RES, V93, P33, DOI 10.1016/j.schres.2007.01.030; Catts VS, 2010, SECONDARY SCHIZOPHRE, P141, DOI DOI 10.1017/CBO9780511789977.011; Cerqueira JJ, 2005, J NEUROSCI, V25, P7792, DOI 10.1523/JNEUROSCI.1598-05.2005; Chana G, 2003, BIOL PSYCHIAT, V53, P1086, DOI 10.1016/S0006-3223(03)00114-8; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; Conti B, 2008, NEUROIMMUNE, V6, P21; Corsini NS, 2009, CELL STEM CELL, V5, P178, DOI 10.1016/j.stem.2009.05.004; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; DEFELIPE J, 1992, PROG NEUROBIOL, V39, P563, DOI 10.1016/0301-0082(92)90015-7; Djerbi M, 2001, SCAND J IMMUNOL, V54, P180, DOI 10.1046/j.1365-3083.2001.00941.x; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; FIELD A, 2005, DISCOVERING STAT USI, P32; Franck P, 1996, J BIOTECHNOL, V46, P187, DOI 10.1016/0168-1656(95)00189-1; Fung SJ, 2010, AM J PSYCHIAT, V167, P1479, DOI 10.1176/appi.ajp.2010.09060784; Garey LJ, 1998, J NEUROL NEUROSUR PS, V65, P446, DOI 10.1136/jnnp.65.4.446; Glantz LA, 2006, SCHIZOPHR RES, V81, P47, DOI 10.1016/j.schres.2005.08.014; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Gonzalez-Burgos G, 2010, CURR PSYCHIAT REP, V12, P335, DOI 10.1007/s11920-010-0124-8; Gottfried Y, 2007, SCHIZOPHR RES, V96, P257, DOI 10.1016/j.schres.2007.05.031; Harrison PJ, 1995, NEUROSCI LETT, V200, P151, DOI 10.1016/0304-3940(95)12102-A; Hashimoto T, 2008, MOL PSYCHIATR, V13, P147, DOI 10.1038/sj.mp.4002011; Hashimoto T, 2008, AM J PSYCHIAT, V165, P479, DOI 10.1176/appi.ajp.2007.07081223; HENDERSON LM, 1988, BIOCHEM J, V251, P563, DOI 10.1042/bj2510563; Higgs BW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-70; Hirsch SR, 1997, PHARMACOL BIOCHEM BE, V56, P797, DOI 10.1016/S0091-3057(96)00428-5; Jarskog LF, 2005, PROG NEURO-PSYCHOPH, V29, P846, DOI 10.1016/j.pnpbp.2005.03.010; Jarskog LF, 2004, AM J PSYCHIAT, V161, P109, DOI 10.1176/appi.ajp.161.1.109; Jia PL, 2010, SCHIZOPHR RES, V122, P38, DOI 10.1016/j.schres.2010.07.001; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Kalus P, 2000, NEUROREPORT, V11, P3621, DOI 10.1097/00001756-200011090-00044; Kelly K, 2000, CANCER RES, V60, P1021; Kim S, 2011, MOL PSYCHIATR, V16, P452, DOI 10.1038/mp.2010.23; Kim S, 2010, MOL PSYCHIATR, V15, P326, DOI 10.1038/mp.2008.99; Kim S, 2010, NEUROPSYCHOPHARMACOL, V35, P473, DOI 10.1038/npp.2009.151; KINGSBURY AE, 1995, MOL BRAIN RES, V28, P311, DOI 10.1016/0169-328X(94)00219-5; Kristiansen LV, 2006, MOL PSYCHIATR, V11, P737, DOI 10.1038/sj.mp.4001844; Lavrik I, 2005, J CELL SCI, V118, P265, DOI 10.1242/jcs.01610; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Mackay F, 2003, CYTOKINE GROWTH F R, V14, P311, DOI 10.1016/S1359-6101(03)00023-6; McKernan DP, 2009, PROG NEUROBIOL, V88, P246, DOI 10.1016/j.pneurobio.2009.04.006; Mellios N, 2009, BIOL PSYCHIAT, V65, P1006, DOI 10.1016/j.biopsych.2008.11.019; Mexal S, 2005, MOL BRAIN RES, V139, P317, DOI 10.1016/j.molbrainres.2005.06.006; Mhawech-Fauceglia P, 2006, J LEUKOCYTE BIOL, V80, P697, DOI 10.1189/jlb.1105655; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; Morris HM, 2008, CEREB CORTEX, V18, P1575, DOI 10.1093/cercor/bhm186; Mulkey DK, 2004, AM J PHYSIOL-CELL PH, V286, pC940, DOI 10.1152/ajpcell.00323.2003; PAKKENBERG B, 1993, BIOL PSYCHIAT, V34, P768, DOI 10.1016/0006-3223(93)90065-L; Pennington K, 2008, SCHIZOPHR RES, V106, P164, DOI 10.1016/j.schres.2008.08.022; Pierri JN, 2003, BIOL PSYCHIAT, V54, P111, DOI 10.1016/S0006-3223(03)00294-4; Pierri JN, 2001, ARCH GEN PSYCHIAT, V58, P466, DOI 10.1001/archpsyc.58.5.466; Rajkowska G, 1998, ARCH GEN PSYCHIAT, V55, P215, DOI 10.1001/archpsyc.55.3.215; Reich A, 2008, TRENDS NEUROSCI, V31, P478, DOI 10.1016/j.tins.2008.06.007; Reynolds GP, 2002, J NEURAL TRANSM, V109, P881, DOI 10.1007/s007020200072; Reynolds GP, 2001, J CHEM NEUROANAT, V22, P95, DOI 10.1016/S0891-0618(01)00113-2; Sakai T, 2008, NEUROPATHOLOGY, V28, P143, DOI 10.1111/j.1440-1789.2007.00867.x; Selemon LD, 1998, J COMP NEUROL, V392, P402; SELEMON LD, 1995, ARCH GEN PSYCHIAT, V52, P805; Sweet RA, 2004, BIOL PSYCHIAT, V55, P1128, DOI 10.1016/j.biopsych.2004.03.002; Sweet RA, 2009, NEUROPSYCHOPHARMACOL, V34, P374, DOI 10.1038/npp.2008.67; Thangarajh M, 2007, SCAND J IMMUNOL, V65, P92, DOI 10.1111/j.1365-3083.2006.01867.x; Thompson M, 2009, J PSYCHIATR RES, V43, P970, DOI 10.1016/j.jpsychires.2009.02.005; Thune JJ, 2001, J PSYCHIATR RES, V35, P15, DOI 10.1016/S0022-3956(00)00043-1; Torrey EF, 2005, BIOL PSYCHIAT, V57, P252, DOI 10.1016/j.biopsych.2004.10.019; Weickert CS, 2004, ARCH GEN PSYCHIAT, V61, P544, DOI 10.1001/archpsyc.61.6.544; Weickert CS, 2010, AUST NZ J PSYCHIAT, V44, P59, DOI 10.3109/00048670903393662; Zuliani C, 2006, CELL DEATH DIFFER, V13, P31, DOI 10.1038/sj.cdd.4401720	76	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35511	10.1371/journal.pone.0035511	http://dx.doi.org/10.1371/journal.pone.0035511			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545112	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343200032
J	Justilien, V; Regala, RP; Tseng, IC; Walsh, MP; Batra, J; Radisky, ES; Murray, NR; Fields, AP				Justilien, Verline; Regala, Roderick P.; Tseng, I-Chu; Walsh, Michael P.; Batra, Jyotica; Radisky, Evette S.; Murray, Nicole R.; Fields, Alan P.			Matrix Metalloproteinase-10 Is Required for Lung Cancer Stem Cell Maintenance, Tumor Initiation and Metastatic Potential	PLOS ONE			English	Article							KINASE-C-IOTA; GENE-EXPRESSION; ADENOCARCINOMA; IDENTIFICATION; MARKER; INVOLVEMENT; CARCINOMAS; GROWTH; LINES	Matrix metalloproteinases (Mmps) stimulate tumor invasion and metastasis by degrading the extracellular matrix. Here we reveal an unexpected role for Mmp10 (stromelysin 2) in the maintenance and tumorigenicity of mouse lung cancer stem-like cells (CSC). Mmp10 is highly expressed in oncosphere cultures enriched in CSCs and RNAi-mediated knockdown of Mmp10 leads to a loss of stem cell marker gene expression and inhibition of oncosphere growth, clonal expansion, and transformed growth in vitro. Interestingly, clonal expansion of Mmp10 deficient oncospheres can be restored by addition of exogenous Mmp10 protein to the culture medium, demonstrating a direct role for Mmp10 in the proliferation of these cells. Oncospheres exhibit enhanced tumor-initiating and metastatic activity when injected orthotopically into syngeneic mice, whereas Mmp10-deficient cultures show a severe defect in tumor initiation. Conversely, oncospheres implanted into syngeneic non-transgenic or Mmp10(-/-) mice show no significant difference in tumor initiation, growth or metastasis, demonstrating the importance of Mmp10 produced by cancer cells rather than the tumor microenvironment in lung tumor initiation and maintenance. Analysis of gene expression data from human cancers reveals a strong positive correlation between tumor Mmp10 expression and metastatic behavior in many human tumor types. Thus, Mmp10 is required for maintenance of a highly tumorigenic, cancer-initiating, metastatic stem-like cell population in lung cancer. Our data demonstrate for the first time that Mmp10 is a critical lung cancer stem cell gene and novel therapeutic target for lung cancer stem cells.	[Justilien, Verline; Regala, Roderick P.; Tseng, I-Chu; Walsh, Michael P.; Batra, Jyotica; Radisky, Evette S.; Murray, Nicole R.; Fields, Alan P.] Mayo Clin, Coll Med, Dept Canc Biol, Jacksonville, FL 32224 USA	Mayo Clinic	Justilien, V (corresponding author), Mayo Clin, Coll Med, Dept Canc Biol, Jacksonville, FL 32224 USA.	fields.alan@mayo.edu	Tseng, I-Chu/C-1936-2013; Radisky, Evette S/C-8526-2012	Tseng, I-Chu/0000-0001-8522-6524; Radisky, Evette S/0000-0003-3121-109X	National Institutes of Health/National Cancer Institute [R01 CA081436-13, R21 CA151250-01]; V Foundation for Cancer Research; James and Esther King Biomedical Research Program [1KG-05-33971]; Ruth A. Kirschstein National Cancer Institute Postdoctoral Fellowship [CA115160]; National Institutes of Health Research Supplement to Promote Diversity in Health-related Research Award from the National Cancer Institute; NATIONAL CANCER INSTITUTE [R21CA151250, F32CA115160, R01CA081436] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); V Foundation for Cancer Research; James and Esther King Biomedical Research Program; Ruth A. Kirschstein National Cancer Institute Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Research Supplement to Promote Diversity in Health-related Research Award from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from National Institutes of Health/National Cancer Institute (R01 CA081436-13 and R21 CA151250-01), the V Foundation for Cancer Research, and the James and Esther King Biomedical Research Program (1KG-05-33971) to APF; a Ruth A. Kirschstein National Cancer Institute Postdoctoral Fellowship (CA115160) to RPR; and a National Institutes of Health Research Supplement to Promote Diversity in Health-related Research Award from the National Cancer Institute (VJ). APF is the Monica Flynn Jacoby Professor of Cancer Research, an endowment fund that provides partial support for the investigator's research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Batra J, 2012, J BIOL CHEM UNPUB; Baty F, 2010, AM J RESP CRIT CARE, V181, P181, DOI 10.1164/rccm.200812-1807OC; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bodey B, 2001, IN VIVO, V15, P175; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Bradfute SB, 2005, EXP HEMATOL, V33, P836, DOI 10.1016/j.exphem.2005.04.001; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Delebecq TJ, 2000, CLIN CANCER RES, V6, P1086; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fan X, 2010, STEM CELLS, V28, P5, DOI 10.1002/stem.254; FRANKS LM, 1976, CANCER RES, V36, P1049; Frederick LA, 2008, ONCOGENE, V27, P4841, DOI 10.1038/onc.2008.119; Gill JH, 2004, NEOPLASIA, V6, P777, DOI 10.1593/neo.04283; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang TY, 2009, CANCER RES, V69, P845, DOI 10.1158/0008-5472.CAN-08-2762; Jonsson G, 2010, CLIN CANCER RES, V16, P3356, DOI 10.1158/1078-0432.CCR-09-2509; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Katoh M, 2007, INT J ONCOL, V31, P461; Katoh Y, 2007, INT J MOL MED, V19, P967; Kren L, 2006, Cesk Patol, V42, P16; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; LAYTON MG, 1984, BRIT J CANCER, V49, P415, DOI 10.1038/bjc.1984.67; Lin AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016636; Matsuyama T, 2010, INT J CANCER, V127, P2292, DOI 10.1002/ijc.25256; Regala RP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026439; Regala RP, 2009, CANCER RES, V69, P7603, DOI 10.1158/0008-5472.CAN-09-2066; Regala RP, 2005, CANCER RES, V65, P8905, DOI 10.1158/0008-5472.CAN-05-2372; Regala RP, 2005, J BIOL CHEM, V280, P31109, DOI 10.1074/jbc.M505402200; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rice WR, 2002, AM J PHYSIOL-LUNG C, V283, pL256, DOI 10.1152/ajplung.00302.2001; Solar P, 2011, CANCER LETT, V309, P11, DOI 10.1016/j.canlet.2011.05.008; Sullivan JP, 2010, CANCER RES, V70, P9937, DOI 10.1158/0008-5472.CAN-10-0881; Suzuki K, 1998, BIOL CHEM, V379, P185, DOI 10.1515/bchm.1998.379.2.185; Tan XJ, 2008, INT J CANCER, V123, P1080, DOI 10.1002/ijc.23637; Tirino V, 2009, EUR J CARDIO-THORAC, V36, P446, DOI 10.1016/j.ejcts.2009.03.063; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Weiser-Evans MCM, 2009, CANCER RES, V69, P1733, DOI 10.1158/0008-5472.CAN-08-3766; Yuan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009112	44	70	74	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35040	10.1371/journal.pone.0035040	http://dx.doi.org/10.1371/journal.pone.0035040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545096	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343200018
J	Weghofer, A; Kim, A; Barad, DH; Gleicher, N				Weghofer, Andrea; Kim, Ann; Barad, David H.; Gleicher, Norbert			Follicle Stimulating Hormone and Anti-Mullerian Hormone per Oocyte in Predicting in vitro Fertilization Pregnancy in High Responders: A Cohort Study	PLOS ONE			English	Article							CONTROLLED OVARIAN HYPERSTIMULATION; SMALL ANTRAL FOLLICLES; ASSISTED REPRODUCTION; WOMEN; RESERVE; INFERTILITY; POPULATION; DECLINE; NUMBER; IMPLANTATION	Background: Follicle stimulating hormone (FSH) and Anti-Mullerian hormone (AMH) are utilized to differentiate between good and poor response to controlled ovarian hyperstimulation. Their respective roles in defining functional ovarian reserve remain, however, to be elucidated. To better understand those we investigated AMH and FSH per oocyte retrieved (AMHo and FSHo). Methodology/Principal Findings: Three-hundred and ninety-six women, undergoing first in vitro fertilization cycles, were retrospectively evaluated. Women with oocyte yields >75th percentile for their age group were identified as high responders. In a series of logistic regression analyses, AMHo and FSHo levels were then evaluated as predictive factors for pregnancy potential in high responders. Patients presented with a mean age of 38.0 +/- 5.0 years, mean baseline FSH of 11.8 +/- 8.7 mIU/mL and mean AMH of 1.6 +/- 2.1 ng/mL. Those 88 women, who qualified as high responders, showed mean FSH of 9.7 +/- 6.5 mIU/mL, AMH of 3.1 +/- 3.1 ng/mL and oocyte yields of 15.8 +/- 7.1. Baseline FSH and AMH did not predict pregnancy in high responders. However, a statistically significant association between FSHo and pregnancy was observed in high responders, both after univariate regression (p = 0.02) and when adjusted for age, percentage of usable embryos, and number of embryos transferred (p = 0.03). Rate of useable embryos also significantly affected pregnancy outcome independently of FSHo (p = 0.01). AMHo was also associated with clinical pregnancy chances in high responders (p = 0.03) and remained significant when adjusted for usable embryos and number of embryos transferred (p = 0.04). Conclusions: AMHo and FSHo are predictive of pregnancy potential in high responders, but likely reflect different responsibilities in recruitment and maturation of growing follicle cohorts.	[Weghofer, Andrea] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria; [Weghofer, Andrea; Kim, Ann; Barad, David H.; Gleicher, Norbert] Ctr Human Reprod, New York, NY USA; [Weghofer, Andrea; Kim, Ann; Barad, David H.; Gleicher, Norbert] Fdn Reprod Med, New York, NY USA; [Barad, David H.] Albert Einstein Coll Med, Dept Epidemiol & Social Med, Bronx, NY 10467 USA; [Barad, David H.] Albert Einstein Coll Med, Dept Obstet, Bronx, NY 10467 USA; [Barad, David H.] Albert Einstein Coll Med, Dept Gynecol & Womens Hlth, Bronx, NY 10467 USA; [Gleicher, Norbert] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA	Medical University of Vienna; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yale University	Weghofer, A (corresponding author), Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria.	andrea.weghofer@meduniwien.ac.at	Barad, David/AAF-4332-2021		extramural funds from the Foundation for Reproductive Medicine; Center for Human Reproduction; CHR	extramural funds from the Foundation for Reproductive Medicine; Center for Human Reproduction; CHR	This study was funded by extramural funds from the Foundation for Reproductive Medicine, a not-for-profit research foundation, and by limited intramural support from the Center for Human Reproduction. Both funding organizations had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript with the following caveats: Authors, NG and DHB, are members of the Board of the Foundation for Reproductive Medicine and author, NG, is owner of the Center for Human Reproduction, a for-profit fertility center.; AW, DHB and NG have received research grant support, travel funds and speaker honoraria from various pharmaceutical and medical device companies, none, however, related to here presented topic. NG and DHB are listed as inventors on already awarded and still pending United States patents, claiming beneficial effects on diminished ovarian reserve and embryo ploidy from DHEA supplementation. NG is owner of Center for Human Reproduction (CHR), a for-profit infertility center, where this research was conducted. NG and DHB are listed as co-inventors on a number of pending, and one already awarded, United States patents claiming diagnostic benefits from dehydroepiandrosterone (DHEA)/androgen supplementation in women with diminished ovarian reserve (DOR). CHR recently received notice that a second United States DHEA patent, including the claim that DHEA/androgen supplementation reduces embryo aneuploidy in women with DOR, would be issued in the near future. NG and DHB are also co-inventors on a number of pending U. S. patent applications, claiming diagnostic relevance for the assessment of CGG triple repeats on the FMR1 gene in determining risk towards DOR and related issues. NG, AW and DHB have in the past received research support, travel funds and speakers; honoraria from different pharma and medical device companies, none, however, in any way related to here presented research data. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. At time of this submission only one United States user patent with any relevance to this manuscript has been awarded (November 10, 2009; #7615544). It claims benefits from supplementation with DHEA/Androgens on ovarian reserve and pregnancy rates win women with DOR. Above noted second user patent (#8067400) is expected within weeks from this submission, claiming expanded benefits on pregnancy chances and decreased embryo aneuploidy (and, therefore, miscarriage risk) from DHEA/androgen supplementation. Amongst patent applications pending in regards to the FMR1 gene, one describes ovarian genotypes and sub-genotypes used in this manuscript, and claims that they reflect different ovarian aging patterns. All patent applications filed by researchers at CHR are 50% owned by CHR and 50% by the investigators who did the research that led to the application. A full list of all patent information can be provided on request. This study was funded by CHR with no current external funding. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abdalla H, 2004, HUM REPROD, V19, P893, DOI 10.1093/humrep/deh141; Almog B, 2011, FERTIL STERIL, V95, P2359, DOI 10.1016/j.fertnstert.2011.02.057; ANDERSEN CY, 1993, J CLIN ENDOCR METAB, V77, P1227, DOI 10.1210/jc.77.5.1227; Barad D, 2006, HUM REPROD, V21, P2845, DOI 10.1093/humrep/del254; Barad DH, 2007, OBSTET GYNECOL, V109, P1404, DOI 10.1097/01.AOG.0000264065.37661.a0; Barad DH, 2011, REPROD BIOMED ONLINE, V22, P284, DOI 10.1016/j.rbmo.2010.12.002; Barad DH, 2009, FERTIL STERIL, V91, P1553, DOI 10.1016/j.fertnstert.2008.09.069; Buyuk E, 2011, FERTIL STERIL, V95, P2369, DOI 10.1016/j.fertnstert.2011.03.071; Chen QJ, 2007, ACTA OBSTET GYN SCAN, V86, P849, DOI 10.1080/00016340701415152; Deb S, 2009, HUM REPROD, V24, P2124, DOI 10.1093/humrep/dep204; Elgindy EA, 2008, FERTIL STERIL, V89, P1670, DOI 10.1016/j.fertnstert.2007.05.040; Fortune JE, 2004, ANIM REPROD SCI, V82-3, P109, DOI 10.1016/j.anireprosci.2004.04.031; Freour T, 2007, CLIN CHIM ACTA, V375, P162, DOI 10.1016/j.cca.2006.06.013; Gleicher N, J CLIN ENDO IN PRESS; Gleicher N, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-116; Gleicher N, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-23; Gleicher N, 2010, FERTIL STERIL, V94, P2824, DOI 10.1016/j.fertnstert.2010.04.067; Gleicher N, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-64; Haadsma ML, 2007, HUM REPROD, V22, P1925, DOI 10.1093/humrep/dem081; Holte J, 2011, FERTIL STERIL, V96, P594, DOI 10.1016/j.fertnstert.2011.06.071; La Marca A, 2011, GYNECOL ENDOCRINOL; Lin YH, 2011, FERTIL STERIL, V96, P230, DOI 10.1016/j.fertnstert.2011.04.003; Nakhuda GS, 2011, REPROD BIOMED ONLINE, V22, pS88, DOI [10.1016/j.rbmo.2009.10.009, 10.1016/S1472-6483(11)60014-X]; Nardo LG, 2009, FERTIL STERIL, V92, P1586, DOI 10.1016/j.fertnstert.2008.08.127; Nelson SM, 2011, REPROD BIOMED ONLINE, V23, P204, DOI 10.1016/j.rbmo.2011.05.006; Nelson SM, 2009, HUM REPROD, V24, P867, DOI 10.1093/humrep/den480; Onagawa T, 2004, GYNECOL ENDOCRINOL, V18, P335, DOI 10.1080/0951359042000196303; Pellicer A, 1996, FERTIL STERIL, V65, P1190, DOI 10.1016/S0015-0282(16)58337-X; Riggs R, 2011, FERTIL STERIL, V95, P410, DOI 10.1016/j.fertnstert.2010.07.1042; Swanton A, 2010, EUR J OBSTET GYN R B, V149, P68, DOI 10.1016/j.ejogrb.2009.11.017; Tremellen K, 2010, AUST NZ J OBSTET GYN, V50, P568, DOI 10.1111/j.1479-828X.2010.01232.x; van den Berg MH, 2010, HUM REPROD, V25, P1520, DOI 10.1093/humrep/deq071; Weghofer A, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-98; Weghofer A, 2011, HUM REPROD, V26, P1905, DOI 10.1093/humrep/der134; Yates AP, 2011, HUM REPROD, V26, P2353, DOI 10.1093/humrep/der182	35	10	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e34290	10.1371/journal.pone.0034290	http://dx.doi.org/10.1371/journal.pone.0034290			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545082	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343200005
J	Boubou, A; Migeon, A; Roderick, GK; Auger, P; Cornuet, JM; Magalhaes, S; Navajas, M				Boubou, Angham; Migeon, Alain; Roderick, George K.; Auger, Philippe; Cornuet, Jean-Marie; Magalhaes, Sara; Navajas, Maria			Test of Colonisation Scenarios Reveals Complex Invasion History of the Red Tomato Spider Mite Tetranychus evansi	PLOS ONE			English	Article							GENETIC-VARIATION; BIOLOGICAL INVASIONS; SPECIES INVASIONS; EVOLUTION; PEST; DIVERSITY; INFERENCE; ACARI; ABC; HYBRIDIZATION	The spider mite Tetranychus evansi is an emerging pest of solanaceous crops worldwide. Like many other emerging pests, its small size, confusing taxonomy, complex history of associations with humans, and propensity to start new populations from small inocula, make the study of its invasion biology difficult. Here, we use recent developments in Approximate Bayesian Computation (ABC) and variation in multi-locus genetic markers to reconstruct the complex historical demography of this cryptic invasive pest. By distinguishing among multiple pathways and timing of introductions, we find evidence for the "bridgehead effect", in which one invasion serves as source for subsequent invasions. Tetranychus evansi populations in Europe and Africa resulted from at least three independent introductions from South America and involved mites from two distinct sources in Brazil, corresponding to highly divergent mitochondrial DNA lineages. Mites from southwest Brazil (BR-SW) colonized the African continent, and from there Europe through two pathways in a "bridgehead" type pattern. One pathway resulted in a widespread invasion, not only to Europe, but also to other regions in Africa, southern Europe and eastern Asia. The second pathway involved the mixture with a second introduction from BR-SW leading to an admixed population in southern Spain. Admixture was also detected between invasive populations in Portugal. A third introduction from the Brazilian Atlantic region resulted in only a limited invasion in Europe. This study illustrates that ABC methods can provide insights into, and distinguish among, complex invasion scenarios. These processes are critical not only in understanding the biology of invasions, but also in refining management strategies for invasive species. For example, while reported observations of the mite and outbreaks in the invaded areas were largely consistent with estimates of geographical expansion from the ABC approach, historical observations failed to recognize the complex pathways involved and the corresponding effects on genetic diversity.	[Boubou, Angham; Migeon, Alain; Auger, Philippe; Cornuet, Jean-Marie; Navajas, Maria] INRA, UMR CBGP INRA IRD Cirad Montpellier SupAgro, Montferrier Sur Lez, France; [Roderick, George K.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Magalhaes, Sara] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Portugal	CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); University of California System; University of California Berkeley; Universidade de Lisboa	Boubou, A (corresponding author), INRA, UMR CBGP INRA IRD Cirad Montpellier SupAgro, CS 30016, Montferrier Sur Lez, France.	navajas@supagro.inra.fr	NAVAJAS, Maria/AAM-2294-2020; S., Magalhaes/B-9673-2012	NAVAJAS, Maria/0000-0002-0702-4238; S., Magalhaes/0000-0002-8609-7768; Roderick, George/0000-0001-7557-2415	PESSOA exchange program, Portugal; "Agence National de la Recherche" [ANR-SVE7, 2010 BLANC 1715 02]	PESSOA exchange program, Portugal; "Agence National de la Recherche"(French National Research Agency (ANR))	Financial support for field trips in Portugal was provided by the PESSOA exchange program accorded to Dr. Magalhaes. This work beneficiated from support of the "Agence National de la Recherche" program ANR-SVE7 to Dr. Navajas; grant ID: 2010 BLANC 1715 02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailly X, 2004, BIOL J LINN SOC, V82, P69, DOI 10.1111/j.1095-8312.2004.00316.x; BAKER EDWARD W., 1960, HILGARDIA, V29, P455; Beaumont MA, 2002, GENETICS, V162, P2025; Bertorelle G, 2010, MOL ECOL, V19, P2609, DOI 10.1111/j.1365-294X.2010.04690.x; Bonato O, 1999, EXP APPL ACAROL, V23, P11, DOI 10.1023/A:1006144610009; Boubou A, 2011, BIOL INVASIONS, V13, P81, DOI 10.1007/s10530-010-9791-y; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Crawford KM, 2010, MOL ECOL, V19, P1253, DOI 10.1111/j.1365-294X.2010.04550.x; Crooks J, 2005, ECOSCIENCE, V12; Cros-Arteil S, 2009, MOL ECOLOGY RESOURCE, V9, P1375; Dana AN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-119; de Mendonca RS, 2011, EXP APPL ACAROL, V55, P1, DOI 10.1007/s10493-011-9453-5; DEMORAES GJ, 1987, EXP APPL ACAROL, V3, P95, DOI 10.1007/BF01270471; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Dlugosch KM, 2008, ECOL LETT, V11, P701, DOI 10.1111/j.1461-0248.2008.01181.x; Downie DA, 2002, MOL ECOL, V11, P2013, DOI 10.1046/j.1365-294X.2002.01584.x; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2006, ARLEQUIN VER 3 0 INT; Facon B, 2005, J EVOLUTION BIOL, V18, P524, DOI 10.1111/j.1420-9101.2005.00887.x; Facon B, 2008, CURR BIOL, V18, P363, DOI 10.1016/j.cub.2008.01.063; Falush D, 2003, GENETICS, V164, P1567; Ferragut F, 1997, RES 6 JORN SEEA ED U; Ferreira M.A., 1995, P385; Furtado IP, 2006, EXP APPL ACAROL, V40, P157, DOI 10.1007/s10493-006-9045-y; Geller JB, 2010, ANNU REV MAR SCI, V2, P367, DOI 10.1146/annurev.marine.010908.163745; Golani D, 2007, BIOLOGY LETT, V3, P541, DOI 10.1098/rsbl.2007.0308; Gotoh T, 2009, INT J ACAROL, V35, P485, DOI 10.1080/01647950903431156; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Keller SR, 2010, J EVOLUTION BIOL, V23, P1720, DOI 10.1111/j.1420-9101.2010.02037.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knapp M, 2003, AFR ENTOMOL, V11, P300; Kolbe JJ, 2008, BIOL LETTERS, V4, P434, DOI 10.1098/rsbl.2008.0205; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743; Migeon A., 2005, Phytoma, P38; Migeon A., 2006, SPIDER MITES WEB COM; Migeon A, 2009, EXP APPL ACAROL, V48, P199, DOI 10.1007/s10493-008-9229-8; Miller N, 2005, SCIENCE, V310, P992, DOI 10.1126/science.1115871; Miller NJ, 2009, AGR FOREST ENTOMOL, V11, P47, DOI 10.1111/j.1461-9563.2008.00398.x; MOUTIA L. ANDRE, 1958, BULL ENT RES, V49, P59, DOI 10.1017/S0007485300053438; Muirhead JR, 2008, MOL ECOL, V17, P1020, DOI 10.1111/j.1365-294X.2008.03669.x; Navajas M, 2010, ALIEN TERRESTRIAL AR; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Palevsky E, 2003, PHYTOPARASITICA, V31, P144, DOI 10.1007/BF02980784; Pascual M, 2007, MOL ECOL, V16, P3069, DOI 10.1111/j.1365-294X.2007.03336.x; Pautasso M, 2010, BIOL REV, V85, P729, DOI 10.1111/j.1469-185X.2010.00123.x; Pool JE, 2010, GENOME RES, V20, P291, DOI 10.1101/gr.079509.108; Pritchard JK, 2000, GENETICS, V155, P945; Puillandre N, 2008, BIOL INVASIONS, V10, P319, DOI 10.1007/s10530-007-9132-y; Roderick GK, 2003, NAT REV GENET, V4, P889, DOI 10.1038/nrg1201; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sabelis M.W., 1985, P265; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Silva P., 1954, Boletim do Instituto Biologico da Bahia, V1, P1; Solignac M, 2005, P ROY SOC B-BIOL SCI, V272, P411, DOI 10.1098/rspb.2004.2853; Suarez AV, 2001, P NATL ACAD SCI USA, V98, P1095, DOI 10.1073/pnas.98.3.1095; Thomson RC, 2010, MOL ECOL, V19, P2184, DOI 10.1111/j.1365-294X.2010.04650.x; Tixier MS, 2010, B ENTOMOL RES, V100, P569, DOI 10.1017/S0007485309990617; Tobacco Research Board Z, 1982, ANN REP ACC YEAR END; Tsagkarakou A, 2007, PHYTOPARASITICA, V35, P519, DOI 10.1007/BF03020610; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Verdu P, 2009, CURR BIOL, V19, P312, DOI 10.1016/j.cub.2008.12.049; Waage JK, 2008, PHILOS T R SOC B, V363, P863, DOI 10.1098/rstb.2007.2188; Willi Y, 2006, ANNU REV ECOL EVOL S, V37, P433, DOI 10.1146/annurev.ecolsys.37.091305.110145; Xu J, 2010, B ENTOMOL RES, V100, P359, DOI 10.1017/S0007485310000015; [No title captured]	77	52	54	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35601	10.1371/journal.pone.0035601	http://dx.doi.org/10.1371/journal.pone.0035601			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539983	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341000049
J	Jackson, J; Chugh, D; Nilsson, P; Wood, J; Carlstrom, K; Lindvall, O; Ekdahl, CT				Jackson, Johanna; Chugh, Deepti; Nilsson, Per; Wood, James; Carlstrom, Karl; Lindvall, Olle; Ekdahl, Christine T.			Altered Synaptic Properties During Integration of Adult-Born Hippocampal Neurons Following a Seizure Insult	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; GENERATED GRANULE CELLS; GAMMA-AMINOBUTYRIC-ACID; FUNCTIONAL-INTEGRATION; INHIBITORY SYNAPSES; ADHESION MOLECULE; GABA(A) RECEPTORS; DENTATE GYRUS; NEUROLIGIN 2; N-CADHERIN	Pathological conditions affect several stages of neurogenesis in the adult brain, including proliferation, survival, cell fate, migration, and functional integration. Here we explored how a pathological environment modulates the heterogeneous afferent synaptic input that shapes the functional properties of newly formed neurons. We analyzed the expression of adhesion molecules and other synaptic proteins on adult-born hippocampal neurons formed after electrically-induced partial status epilepticus (pSE). New cells were labeled with a GFP-retroviral vector one week after pSE. One and three weeks thereafter, synaptic proteins were present on dendritic spines and shafts, but without differences between pSE and control group. In contrast, at six weeks, we found fewer dendritic spines and decreased expression of the scaffolding protein PSD-95 on spines, without changes in expression of the adhesion molecules N-cadherin or neuroligin-1, primarily located at excitatory synapses. Moreover, we detected an increased expression of the inhibitory scaffolding protein gephyrin in newborn but not mature neurons after SE. However, this increase was not accompanied by a difference in GABA expression, and there was even a region-specific decrease in the adhesion molecule neuroligin-2 expression, both in newborn and mature neurons. Neuroligin-2 clusters co-localized with presynaptic cholecystokinin terminals, which were also reduced. The expression of neuroligin-4 and glycine receptor was unchanged. Increased postsynaptic clustering of gephyrin, without an accompanying increase in GABAergic input or neuroligin-2 and -4 expression, the latter important for clustering of GABA(A) and glycine receptors, respectively, could imply an increased but altered inhibitory connectivity specific for newborn neurons. The changes were transient and expression of both gephyrin and NL-2 was normalized 3 months post-SE. Our findings indicate that seizure-induced brain pathology alters the sub-cellular expression of synaptic adhesion molecules and scaffolding proteins related to particularly inhibitory but also excitatory synapses, which may yield functional consequences for the integration of adult-born neurons.	[Jackson, Johanna; Chugh, Deepti; Nilsson, Per; Wood, James; Carlstrom, Karl; Lindvall, Olle; Ekdahl, Christine T.] Wallenberg Neurosci Ctr, Lab Neurogenesis & Cell Therapy, Lund, Sweden; [Jackson, Johanna; Chugh, Deepti; Nilsson, Per; Wood, James; Carlstrom, Karl; Lindvall, Olle; Ekdahl, Christine T.] Lund Univ, Lund Stem Cell Ctr, Lund, Sweden; [Ekdahl, Christine T.] Div Clin Neurophysiol, Inflammat & Stem Cell Therapy Grp, Lund, Sweden	Lund University	Jackson, J (corresponding author), Lilly UK, Lilly Res Labs, Windlesham, Surrey, England.	Christine.Ekdahl_Clementson@med.lu.se	Carlström, Karl/AAB-4012-2020; Jackson, Johanna/ACQ-6036-2022	Carlström, Karl/0000-0002-3001-2403; Jackson, Johanna/0000-0002-8459-0591; Wood, James/0000-0003-2956-0709	Swedish Research Council; Swedish Government Initiative for Strategic Research Areas (StemTherapy); ALF Grant	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Government Initiative for Strategic Research Areas (StemTherapy); ALF Grant	This work was supported by the Swedish Research Council, Swedish Government Initiative for Strategic Research Areas (StemTherapy), and ALF Grant for funding for medical training and research ("Avtalet mellan Landstinget och Staten om samarbete om Lakarutbildning och Forskning"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AB, 2008, CEREB CORTEX, V18, P1260, DOI 10.1093/cercor/bhm160; Arabadzisz D, 2005, EXP NEUROL, V194, P76, DOI 10.1016/j.expneurol.2005.01.029; Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; Benson DL, 1998, J NEUROSCI, V18, P6892; Blundell J, 2009, GENES BRAIN BEHAV, V8, P114, DOI 10.1111/j.1601-183X.2008.00455.x; Boulland JL, 2007, J COMP NEUROL, V503, P466, DOI 10.1002/cne.21384; Bozdagi O, 2004, MOL CELL NEUROSCI, V27, P509, DOI 10.1016/j.mcn.2004.08.008; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chiou TT, 2011, J BIOL CHEM, V286, P22456, DOI 10.1074/jbc.M111.236190; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; COTMAN CW, 1973, P NATL ACAD SCI USA, V70, P3473, DOI 10.1073/pnas.70.12.3473; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; El-Hussein AE, 2000, SCIENCE, V290, P1364; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fasen K, 2002, J NEUROPATH EXP NEUR, V61, P903, DOI 10.1093/jnen/61.10.903; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Fritschy JM, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.005.2008; Fu ZY, 2009, MOL CELL NEUROSCI, V42, P45, DOI 10.1016/j.mcn.2009.05.004; Fujita M, 2001, NEUROSCI LETT, V297, P13, DOI 10.1016/S0304-3940(00)01635-9; Gascon E, 2010, ADV EXP MED BIOL, V663, P127, DOI 10.1007/978-1-4419-1170-4_8; Gasser EMS, 2006, NAT PROTOC, V1, P1887, DOI 10.1038/nprot.2006.265; Ge SY, 2008, J PHYSIOL-LONDON, V586, P3759, DOI 10.1113/jphysiol.2008.155655; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; Hoon M, 2011, P NATL ACAD SCI USA, V108, P3053, DOI 10.1073/pnas.1006946108; Hoon M, 2009, J NEUROSCI, V29, P8039, DOI 10.1523/JNEUROSCI.0534-09.2009; Jakubs K, 2006, NEURON, V52, P1047, DOI 10.1016/j.neuron.2006.11.004; Jakubs K, 2008, J NEUROSCI, V28, P12477, DOI 10.1523/JNEUROSCI.3240-08.2008; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Liu YWJ, 2008, EUR J NEUROSCI, V28, P2254, DOI 10.1111/j.1460-9568.2008.06518.x; LOTHMAN EW, 1989, EPILEPSY RES, V3, P107, DOI 10.1016/0920-1211(89)90038-7; Mendez P, 2010, J CELL BIOL, V189, P589, DOI 10.1083/jcb.201003007; Mohapel P, 2004, NEUROBIOL DIS, V15, P196, DOI 10.1016/j.nbd.2003.11.010; Murphy BL, 2011, J NEUROSCI, V31, P105, DOI 10.1523/JNEUROSCI.2728-10.2011; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Parent JM, 2002, PROG BRAIN RES, V135, P121; Parent JM, 1997, J NEUROSCI, V17, P3727; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rannals MD, 2011, J NEUROSCI, V31, P17701, DOI 10.1523/JNEUROSCI.4476-11.2011; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shan WS, 2002, J NEUROSCI RES, V69, P292, DOI 10.1002/jnr.10305; Sheffield JB, 2007, MICROSC MICROANAL, V13, P200, DOI 10.1017/S1431927607076611; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Spigelman I, 1998, NEUROSCIENCE, V86, P109, DOI 10.1016/S0306-4522(98)00028-1; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sun CS, 2007, J COMP NEUROL, V500, P876, DOI 10.1002/cne.21207; Sun QJ, 2009, BEHAV BRAIN RES, V201, P292, DOI 10.1016/j.bbr.2009.02.027; Takeichi M, 2005, TRENDS CELL BIOL, V15, P216, DOI 10.1016/j.tcb.2005.02.002; Thind KK, 2010, J COMP NEUROL, V518, P647, DOI 10.1002/cne.22235; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; Toni N, 2011, EUR J NEUROSCI, V33, P1062, DOI 10.1111/j.1460-9568.2011.07604.x; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; van Spronsen M, 2010, CURR NEUROL NEUROSCI, V10, P207, DOI 10.1007/s11910-010-0104-8; Washbourne P, 2004, J NEUROSCI, V24, P9244, DOI 10.1523/JNEUROSCI.3339-04.2004; WONG, 2008, EXPERT REV NEUROTHER, V8, P907; Wood JC, 2011, EXP NEUROL, V229, P484, DOI 10.1016/j.expneurol.2011.03.019; Wyeth MS, 2010, J NEUROSCI, V30, P8993, DOI 10.1523/JNEUROSCI.1183-10.2010; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	64	18	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35557	10.1371/journal.pone.0035557	http://dx.doi.org/10.1371/journal.pone.0035557			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539981	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341000047
J	Li, GD; Thomas, AM; Williams, JA; Kong, B; Liu, J; Inaba, Y; Xie, W; Guo, GL				Li, Guodong; Thomas, Ann M.; Williams, Jessica A.; Kong, Bo; Liu, Jie; Inaba, Yuka; Xie, Wen; Guo, Grace L.			Farnesoid X Receptor Induces Murine Scavenger Receptor Class B Type I via Intron Binding	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; SR-BI; TRANSGENIC MICE; MOUSE-LIVER; CHOLESTEROL; ACTIVATION; IDENTIFICATION; EXPRESSION; FXR; METABOLISM	Farnesoid X receptor (FXR) is a nuclear receptor and a key regulator of liver cholesterol and triglyceride homeostasis. Scavenger receptor class B type I (SR-BI) is critical for reverse cholesterol transport (RCT) by transporting high-density lipoprotein (HDL) into liver. FXR induces SR-BI, however, the underlying molecular mechanism of this induction is not known. The current study confirmed induction of SR-BI mRNA by activated FXR in mouse livers, a human hepatoma cell line, and primary human hepatocytes. Genome-wide FXR binding analysis in mouse livers identified 4 putative FXR response elements in the form of inverse repeat separated by one nucleotide (IR1) at the first intron and 1 IR1 at the downstream of the mouse Sr-bi gene. ChIP-qPCR analysis revealed FXR binding to only the intronic IR1s, but not the downstream one. Luciferase assays and site-directed mutagenesis further showed that 3 out of 4 IR1s were able to activate gene transcription. A 16-week high-fat diet (HFD) feeding in mice increased hepatic Sr-bi gene expression in a FXR-dependent manner. In addition, FXR bound to the 3 bona fide IR1s in vivo, which was increased following HFD feeding. Serum total and HDL cholesterol levels were increased in FXR knockout mice fed the HFD, compared to wild-type mice. In conclusion, the Sr-bi/SR-BI gene is confirmed as a FXR target gene in both mice and humans, and at least in mice, induction of Sr-bi by FXR is via binding to intronic IR1s. This study suggests that FXR may serve as a promising molecular target for increasing reverse cholesterol transport.	[Li, Guodong; Thomas, Ann M.; Williams, Jessica A.; Kong, Bo; Liu, Jie; Guo, Grace L.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA; [Li, Guodong] Harbin Med Univ, Affiliated Hosp 4, Canc Treatment Ctr, Dept Abdominal Surg, Harbin, Peoples R China; [Inaba, Yuka; Xie, Wen] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA USA; [Inaba, Yuka; Xie, Wen] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA USA	University of Kansas; University of Kansas Medical Center; Harbin Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Li, GD (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.	lguo@kumc.edu	Xie, Wen/M-1768-2016; Kong, Bo/G-7650-2014	Kong, Bo/0000-0002-8200-7817; Inaba, Yuka/0000-0001-9757-9669	National Institutes of Health [DK081343, P20-RR021940]; University of Kansas Medical Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD073070] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Kansas Medical Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institutes of Health funding [Grants DK081343 (GLG) and P20-RR021940 (GLG)]; and University of Kansas Medical Center Endowment fund (GLG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ACTON SL, 1994, J BIOL CHEM, V269, P21003; Ahmed RAM, 2009, ENDOCRINE, V35, P233, DOI 10.1007/s12020-008-9142-2; Al-Jarallah A, 2010, BBA-MOL CELL BIOL L, V1801, P1239, DOI 10.1016/j.bbalip.2010.08.006; Chao F, 2010, ATHEROSCLEROSIS, V213, P443, DOI 10.1016/j.atherosclerosis.2010.09.016; Chong HK, 2010, NUCLEIC ACIDS RES, V38, P6007, DOI 10.1093/nar/gkq397; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Flatt B, 2009, J MED CHEM, V52, P904, DOI 10.1021/jm8014124; Fuchs M, 2001, HEPATOLOGY, V33, P1451, DOI 10.1053/jhep.2001.24373; Gadaleta RM, 2010, BBA-MOL CELL BIOL L, V1801, P683, DOI 10.1016/j.bbalip.2010.04.006; Gao H, 2008, MOL ENDOCRINOL, V22, P10, DOI 10.1210/me.2007-0121; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Han SX, 2010, MOL ENDOCRINOL, V24, P1151, DOI 10.1210/me.2009-0482; Hartman HB, 2009, J LIPID RES, V50, P1090, DOI 10.1194/jlr.M800619-JLR200; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; Kok T, 2003, J BIOL CHEM, V278, P41930, DOI 10.1074/jbc.M306309200; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; Krieger M, 1999, ANNU REV BIOCHEM, V68, P523, DOI 10.1146/annurev.biochem.68.1.523; Lambert G, 2003, J BIOL CHEM, V278, P2563, DOI 10.1074/jbc.M209525200; Landschulz KT, 1996, J CLIN INVEST, V98, P984, DOI 10.1172/JCI118883; Li GD, 2010, MOL ENDOCRINOL, V24, P1404, DOI 10.1210/me.2010-0014; Lopez D, 2006, MOL CELL ENDOCRINOL, V251, P67, DOI 10.1016/j.mce.2006.02.011; Malerod L, 2003, BIOCHEM BIOPH RES CO, V305, P557, DOI 10.1016/S0006-291X(03)00819-2; Malerod L, 2002, BIOCHEM BIOPH RES CO, V299, P916, DOI 10.1016/S0006-291X(02)02760-2; Malerod L, 2005, BIOCHEM BIOPH RES CO, V336, P1096, DOI 10.1016/j.bbrc.2005.08.237; Mardones P, 2003, J BIOL CHEM, V278, P7884, DOI 10.1074/jbc.M211627200; Mencarelli A, 2009, AM J PHYSIOL-HEART C, V296, pH272, DOI 10.1152/ajpheart.01075.2008; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Schoonjans K, 2002, EMBO REP, V3, P1181, DOI 10.1093/embo-reports/kvf238; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Tanaka Y, 2008, J PHARMACOL EXP THER, V325, P655, DOI 10.1124/jpet.107.135822; Teodoro JS, 2011, TRENDS ENDOCRIN MET, V22, P458, DOI 10.1016/j.tem.2011.07.002; Thomas AM, 2010, HEPATOLOGY, V51, P1410, DOI 10.1002/hep.23450; Torra IP, 2003, MOL ENDOCRINOL, V17, P259, DOI 10.1210/me.2002-0120; Ueda Y, 1999, J BIOL CHEM, V274, P7165, DOI 10.1074/jbc.274.11.7165; Van Eck M, 2003, J BIOL CHEM, V278, P23699, DOI 10.1074/jbc.M211233200; Wang N, 1998, J BIOL CHEM, V273, P32920, DOI 10.1074/jbc.273.49.32920; Zhang YQ, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.083899; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103; Zhu Y, 2011, PHARMACOL RES, V63, P259, DOI 10.1016/j.phrs.2010.12.018	42	28	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35895	10.1371/journal.pone.0035895	http://dx.doi.org/10.1371/journal.pone.0035895			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540009	Green Published, gold			2022-12-25	WOS:000305341000075
J	Shakibaei, M; Shayan, P; Busch, F; Aldinger, C; Buhrmann, C; Lueders, C; Mobasheri, A				Shakibaei, Mehdi; Shayan, Parviz; Busch, Franziska; Aldinger, Constance; Buhrmann, Constanze; Lueders, Cora; Mobasheri, Ali			Resveratrol Mediated Modulation of Sirt-1/Runx2 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells: Potential Role of Runx2 Deacetylation	PLOS ONE			English	Article							NF-KAPPA-B; HUMAN ARTICULAR CHONDROCYTES; MC3T3-E1 CELLS; PPAR-GAMMA; TRABECULAR BONE; IN-VITRO; ACTIVATION; EXPRESSION; RECEPTORS; PROLIFERATION	Objective: Osteogenic repair in response to bone injury is characterized by activation and differentiation of mesenchymal stem cells (MSCs) to osteoblasts. This study determined whether activation of Sirt-1 (a NAD(+)-dependent histone deacetylase) by the phytoestrogen resveratrol affects osteogenic differentiation. Methods: Monolayer and high-density cultures of MSCs and pre-osteoblastic cells were treated with an osteogenic induction medium with/without the Sirt-1 inhibitor nicotinamide or/and resveratrol in a concentration dependent manner. Results: MSCs and pre-osteoblastic cells differentiated to osteoblasts when exposed to osteogenic-induction medium. The osteogenic response was blocked by nicotinamide, resulting in adipogenic differentiation and expression of the adipose transcription regulator PPAR-gamma (peroxisome proliferator-activated receptor). However, in nicotinamide-treated cultures, pretreatment with resveratrol significantly enhanced osteogenesis by increasing expression of Runx2 (bone specific transcription factor) and decreasing expression of PPAR-gamma. Activation of Sirt-1 by resveratrol in MSCs increased its binding to PPAR-gamma and repressed PPAR-gamma activity by involving its cofactor NCoR (nuclear receptor co-repressor). The modulatory effects of resveratrol on nicotinamide-induced expression of PPAR-gamma and its cofactor NCoR were found to be mediated, at least in part, by Sirt-1/Runx2 association and deacetylation of Runx2. Finally, knockdown of Sirt-1 by using antisense oligonucleotides downregulated the expression of Sirt-1 protein and abolished the inhibitory effects of resveratrol, namely nicotinamide-induced Sirt-1 suppression and Runx2 acetylation, suggesting that the acetylated content of Runx2 is related to downregulated Sirt-1 expression. Conclusion: These data support a critical role for Runx2 acetylation/deacetylation during osteogenic differentiation in MSCs in vitro. (242 words in abstract)	[Shakibaei, Mehdi; Busch, Franziska; Aldinger, Constance; Buhrmann, Constanze] Univ Munich, Inst Anat, Munich, Germany; [Shayan, Parviz] Invest Inst Mol Biol Syst Transfer, Tehran, Iran; [Lueders, Cora] German Heart Inst Berlin, Lab Tissue Engn, Dept Thorac & Cardiovasc Surg, Berlin, Germany; [Mobasheri, Ali] Univ Nottingham, Fac Med & Hlth Sci, Sch Vet Med & Sci, Div Vet Med, Loughborough, England	University of Munich; German Heart Center Berlin; University of Nottingham	Shakibaei, M (corresponding author), Univ Munich, Inst Anat, Munich, Germany.	mehdi.shakibaei@med.uni-muenchen.de	Prof. Dr. Shakibaei, Mehdi/AAA-7004-2020; Mobasheri, Ali/D-5770-2011	Prof. Dr. Shakibaei, Mehdi/0000-0002-6304-7506; Mobasheri, Ali/0000-0001-6261-1286; Buhrmann, Constanze/0000-0002-0786-0463				Backesjo CM, 2006, J BONE MINER RES, V21, P993, DOI 10.1359/JBMR.060415; Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x; Bhardwaj A, 2007, BLOOD, V109, P2293, DOI 10.1182/blood-2006-02-003988; Blank RD, 1999, J CLIN DENSITOM, V2, P435, DOI 10.1016/S1094-6950(06)60409-5; Bowers JL, 2000, ENDOCRINOLOGY, V141, P3657, DOI 10.1210/en.141.10.3657; Buhrmann C, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3065; BURKHARDT R, 1987, BONE, V8, P157, DOI 10.1016/8756-3282(87)90015-9; Cao ZX, 2004, EUR J PHARMACOL, V489, P39, DOI 10.1016/j.ejphar.2004.02.031; Chalk AM, 2002, BIOINFORMATICS, V18, P1567, DOI 10.1093/bioinformatics/18.12.1567; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Csaki C, 2007, HISTOCHEM CELL BIOL, V128, P507, DOI 10.1007/s00418-007-0337-z; Ducy P, 2000, DEV DYNAM, V219, P461, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1074>3.0.CO;2-C; Fatokun AA, 2006, BONE, V39, P542, DOI 10.1016/j.bone.2006.02.062; Gehm BD, 1997, P NATL ACAD SCI USA, V94, P14138, DOI 10.1073/pnas.94.25.14138; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huang ZQ, 2008, BIOCHEM BIOPH RES CO, V374, P517, DOI 10.1016/j.bbrc.2008.07.058; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Kanno T, 2007, J CELL BIOCHEM, V101, P1266, DOI 10.1002/jcb.21249; Kundu JK, 2006, CARCINOGENESIS, V27, P1465, DOI 10.1093/carcin/bgi349; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Liu BL, 2004, PLANTA MED, V70, P305, DOI 10.1055/s-2004-818940; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Michalik L, 2006, J CLIN INVEST, V116, P598, DOI 10.1172/JCI27958; Mizutani K, 1998, BIOCHEM BIOPH RES CO, V253, P859, DOI 10.1006/bbrc.1998.9870; Nuttall ME, 1998, J BONE MINER RES, V13, P371, DOI 10.1359/jbmr.1998.13.3.371; Nuttall ME, 2004, CURR OPIN PHARMACOL, V4, P290, DOI 10.1016/j.coph.2004.03.002; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; QUARLES LD, 1992, J BONE MINER RES, V7, P683; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Savouret JF, 2002, BIOMED PHARMACOTHER, V56, P84, DOI 10.1016/S0753-3322(01)00158-5; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; Shakibaei M, 1997, CELL BIOL INT, V21, P115, DOI 10.1006/cbir.1996.0118; Shakibaei M, 1998, EXP CELL RES, V240, P95, DOI 10.1006/excr.1998.3933; Shakibaei M, 1999, BIOCHEM J, V342, P615, DOI 10.1042/0264-6021:3420615; Shakibaei M, 2008, BIOCHEM PHARMACOL, V76, P1426, DOI 10.1016/j.bcp.2008.05.029; Shakibaei M, 2007, BIOCHEM PHARMACOL, V73, P1434, DOI 10.1016/j.bcp.2007.01.005; Shakibaei M, 2011, J BIOL CHEM, V286, P11492, DOI 10.1074/jbc.M110.198713; Sherman JM, 1999, MOL BIOL CELL, V10, P3045, DOI 10.1091/mbc.10.9.3045; Shibata H, 1997, MOL ENDOCRINOL, V11, P714, DOI 10.1210/me.11.6.714; Song LH, 2006, TOXICOL IN VITRO, V20, P915, DOI 10.1016/j.tiv.2006.01.016; Tseng PC, 2011, J BONE MINER RES, V26, P2552, DOI 10.1002/jbmr.460; Venkatesan B, 2008, FASEB J, V22, P3469, DOI 10.1096/fj.08-109488; Vihtamaki T, 1999, MATURITAS, V33, P99, DOI 10.1016/S0378-5122(99)00047-X	50	156	172	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35712	10.1371/journal.pone.0035712	http://dx.doi.org/10.1371/journal.pone.0035712			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539994	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341000060
J	Soumare, POL; Freire, CCM; Faye, O; Diallo, M; de Oliveira, JVC; Zanotto, PMA; Sall, AA				Soumare, P. O. Ly; Freire, Caio C. M.; Faye, Ousmane; Diallo, Mawlouth; de Oliveira, Juliana Velasco C.; Zanotto, Paolo M. A.; Sall, Amadou Alpha			Phylogeography of Rift Valley Fever Virus in Africa Reveals Multiple Introductions in Senegal and Mauritania	PLOS ONE			English	Article							RECENT COMMON ANCESTRY; MOLECULAR EPIDEMIOLOGY; SEQUENCE ALIGNMENT; DIVERGENCE TIMES; ABSOLUTE RATES; SOUTH-AFRICA; NSS PROTEIN; OUTBREAK; EMERGENCE; EGYPT	Rift Valley Fever (RVF) virus (Family Bunyaviridae) is an arthropod-borne RNA virus that infects primarily domestic ruminants and occasionally humans. RVF epizootics are characterized by numerous abortions and mortality among young animals. In humans, the illness is usually characterized by a mild self-limited febrile illness, which could progress to more serious complications. RVF virus is widespread and endemic in many regions of Africa. In Western Africa, several outbreaks have been reported since 1987 when the first major one occurred at the frontier of Senegal and Mauritania. Aiming to evaluate the spreading and molecular epidemiology in these countries, RVFV isolates from 1944 to 2008 obtained from 18 localities in Senegal and Mauritania and 15 other countries were investigated. Our results suggest that a more intense viral activity possibly took place during the last century compared to the recent past and that at least 5 introductions of RVFV took place in Senegal and Mauritania from distant African regions. Moreover, Barkedji in Senegal was possibly a hub associated with the three distinct entries of RVFV in West Africa.	[Soumare, P. O. Ly; Faye, Ousmane; Diallo, Mawlouth; Sall, Amadou Alpha] Inst Pasteur, Dakar, Senegal; [Freire, Caio C. M.; de Oliveira, Juliana Velasco C.; Zanotto, Paolo M. A.] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Lab Mol Evolut & Bioinformat, Sao Paulo, Brazil	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Universidade de Sao Paulo	Soumare, POL (corresponding author), Inst Pasteur, Dakar, Senegal.	freire@ime.usp.br	faye, Ousmane/GMW-6500-2022; Freire, Caio/C-8248-2014; de A. Zanotto, Paolo M./B-9286-2019	Freire, Caio/0000-0002-7723-4230; de A. Zanotto, Paolo M./0000-0002-8167-0625	Institute Pasteur of Dakar in Senegal; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil) [00/04205-6]; CAPES; CNPq-PQ	Institute Pasteur of Dakar in Senegal; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq-PQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by Institute Pasteur of Dakar in Senegal and FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil) project #00/04205-6 (VGDN program). CCMF has CAPES scholarship and PMAZ holds a CNPq-PQ scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, RIFT VALL FEV KEN SO; Archer BN, 2011, SAMJ S AFR MED J, V101, P263, DOI 10.7196/SAMJ.4544; Ba Y, 2005, J MED ENTOMOL, V42, P739, DOI 10.1603/0022-2585(2005)042[0739:AOBOTR]2.0.CO;2; Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004; Bird BH, 2008, J VIROL, V82, P11152, DOI 10.1128/JVI.01519-08; Bird BH, 2007, J VIROL, V81, P2805, DOI 10.1128/JVI.02095-06; Bouloy MB, 1998, LANCET, V352, P1596, DOI 10.1016/S0140-6736(05)61043-4; Chevalier V, 2009, TRANSBOUND EMERG DIS, V56, P372, DOI 10.1111/j.1865-1682.2009.01083.x; COLLETT MS, 1985, VIROLOGY, V144, P228, DOI 10.1016/0042-6822(85)90320-4; Daubney R, 1932, LANCET, V1, P611; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Favier C, 2006, TROP MED INT HEALTH, V11, P1878, DOI 10.1111/j.1365-3156.2006.01746.x; Faye O, 2007, EMERG INFECT DIS, V13, P1016, DOI 10.3201/eid1307.061487; Findlay GM, 1931, LANCET, V2, P1350; GAD AM, 1986, J TROP MED HYG, V89, P233; GIORGI C, 1991, VIROLOGY, V180, P738, DOI 10.1016/0042-6822(91)90087-R; Grobbelaar AA, 2011, EMERG INFECT DIS, V17, P2270, DOI 10.3201/eid1712.111035; Johnson K, 1993, EMERGING VIRUSES; LaBeaud AD, 2011, AM J TROP MED HYG, V84, P641, DOI 10.4269/ajtmh.2011.10-0187; LAUGHLIN LW, 1979, T ROY SOC TROP MED H, V73, P630, DOI 10.1016/0035-9203(79)90006-3; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Marrama Laurence, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1487; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin V, 2008, REV SCI TECH OIE, V27, P413, DOI 10.20506/rst.27.2.1802; MEEGAN JM, 1979, T ROY SOC TROP MED H, V73, P618, DOI 10.1016/0035-9203(79)90004-X; Miller BR, 2002, EMERG INFECT DIS, V8, P1492, DOI 10.3201/eid0812.020194; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Moutailler S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001156; MULLER R, 1994, J GEN VIROL, V75, P1345, DOI 10.1099/0022-1317-75-6-1345; Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033; Pfeffer M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-35; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rich KM, 2010, AM J TROP MED HYG, V83, P52, DOI 10.4269/ajtmh.2010.09-0291; Sall AA, 1999, J VIROL, V73, P8196, DOI 10.1128/JVI.73.10.8196-8200.1999; Sall AA, 1998, MEM I OSWALDO CRUZ, V93, P609, DOI 10.1590/S0074-02761998000500009; Sall AA, 1997, J GEN VIROL, V78, P2853, DOI 10.1099/0022-1317-78-11-2853; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Traore-Lamizana M, 2001, J MED ENTOMOL, V38, P480, DOI 10.1603/0022-2585-38.4.480; Weaver SC, 2005, ARCH VIROL, P33; Wertheim JO, 2011, MOL BIOL EVOL, V28, P3355, DOI 10.1093/molbev/msr170; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330; World Health Organization, 2010, RIFT VALL FEV S AFR; World Health Organization, 2008, RIFT VALL FEV SUD; World Health Organization, 2000, SAUD AR YEM 1 CAS RI; Zeller HG, 1997, AM J TROP MED HYG, V56, P265, DOI 10.4269/ajtmh.1997.56.265; Zwickl D.J., 2006, THESIS U TEXAS AUSTI	51	21	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35216	10.1371/journal.pone.0035216	http://dx.doi.org/10.1371/journal.pone.0035216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539961	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341000025
J	Guerineau, M; Kriz, Z; Kozakova, L; Bednarova, K; Janos, P; Palecek, J				Guerineau, Marc; Kriz, Zdenek; Kozakova, Lucie; Bednarova, Katerina; Janos, Pavel; Palecek, Jan			Analysis of the Nse3/MAGE-Binding Domain of the Nse4/EID Family Proteins	PLOS ONE			English	Article							DNA-REPAIR; MOLECULAR-DYNAMICS; SMC PROTEIN; EID FAMILY; CELL-CYCLE; COMPLEX; DIFFERENTIATION; INHIBITOR; SMC5-SMC6; MEMBER	Background: The Nse1, Nse3 and Nse4 proteins form a tight sub-complex of the large SMC5-6 protein complex. hNSE3/MAGEG1, the mammalian ortholog of Nse3, is the founding member of the MAGE (melanoma-associated antigen) protein family and the Nse4 kleisin subunit is related to the EID (E1A-like inhibitor of differentiation) family of proteins. We have recently shown that human MAGE proteins can interact with NSE4/EID proteins through their characteristic conserved hydrophobic pocket. Methodology/Principal Findings: Using mutagenesis and protein-protein interaction analyses, we have identified a new Nse3/MAGE-binding domain (NMBD) of the Nse4/EID proteins. This short domain is located next to the Nse4 N-terminal kleisin motif and is conserved in all NSE4/EID proteins. The central amino acid residues of the human NSE4b/EID3 domain were essential for its binding to hNSE3/MAGEG1 in yeast two-hybrid assays suggesting they form the core of the binding domain. PEPSCAN ELISA measurements of the MAGEC2 binding affinity to EID2 mutant peptides showed that similar core residues contribute to the EID2-MAGEC2 interaction. In addition, the N-terminal extension of the EID2 binding domain took part in the EID2-MAGEC2 interaction. Finally, docking and molecular dynamic simulations enabled us to generate a structure model for EID2-MAGEC2. Combination of our experimental data and the structure modeling showed how the core helical region of the NSE4/EID domain binds into the conserved pocket characteristic of the MAGE protein family. Conclusions/Significance: We have identified a new Nse4/EID conserved domain and characterized its binding to Nse3/MAGE proteins. The conservation and binding of the interacting surfaces suggest tight co-evolution of both Nse4/EID and Nse3/MAGE protein families.	[Guerineau, Marc; Kriz, Zdenek; Kozakova, Lucie; Bednarova, Katerina; Janos, Pavel; Palecek, Jan] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic; [Kriz, Zdenek; Janos, Pavel] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, CS-61137 Brno, Czech Republic	Masaryk University Brno; Masaryk University Brno	Palecek, J (corresponding author), Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic.	jpalecek@sci.muni.cz	Guerineau, Marc/AAR-1167-2021; Janoš, Pavel/A-1117-2015; Zabrady, Katerina/D-9232-2012; Palecek, Jan/D-6864-2012; Bozděchová, Lucie/D-9149-2012	Janoš, Pavel/0000-0002-3098-4333; Zabrady, Katerina/0000-0003-1946-0851; Palecek, Jan/0000-0002-6223-5169; Bozděchová, Lucie/0000-0002-7113-4343; Guerineau, Marc/0000-0002-0546-3106; Janos, Pavel/0000-0002-9068-2652	Grant Agency of the Czech Academy of Sciences [IAA501630902]; Grant Agency of the Czech Republic [204/08/H054]; Ministry of Education, Youth, and Sports of the Czech Republic [LM2010005]	Grant Agency of the Czech Academy of Sciences(Grant Agency of the Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by a grant to JP from the Grant Agency of the Czech Academy of Sciences (IAA501630902, http://www.gaav.cz/index2.html). Institutional support was provided by the Czech Ministry of Education, Youth and Sports (MSM0021622415, http://www.msmt.cz/index.php?lang = 2). MG was supported by the Grant Agency of the Czech Republic (204/08/H054, http://www.gacr.cz/international.htm). The access to the MetaCentrum computing facilities, provided under the programme LM2010005 funded by the Ministry of Education, Youth, and Sports of the Czech Republic, is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker PA, 2002, J NEUROSCI RES, V67, P705, DOI 10.1002/jnr.10160; Bavner A, 2005, NUCLEIC ACIDS RES, V33, P3561, DOI 10.1093/nar/gki667; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bush JR, 2008, DIFFERENTIATION, V76, P994, DOI 10.1111/j.1432-0436.2008.00281.x; Caballero OL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012773; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chomez P, 2001, CANCER RES, V61, P5544; De Piccoli G, 2009, CHROMOSOME RES, V17, P251, DOI 10.1007/s10577-008-9016-8; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Duan XY, 2009, J BIOL CHEM, V284, P8507, DOI 10.1074/jbc.M809139200; Fousteri MI, 2000, EMBO J, V19, P1691, DOI 10.1093/emboj/19.7.1691; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Hudson JJR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017270; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ji AM, 2003, GENE, V318, P35, DOI 10.1016/j.gene.2003.06.001; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Katsura Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020365; Lehmann AR, 2005, DNA REPAIR, V4, P309, DOI 10.1016/j.dnarep.2004.07.009; LEHMANN AR, 1995, MOL CELL BIOL, V15, P7067; Miyake S, 2003, J BIOL CHEM, V278, P17060, DOI 10.1074/jbc.M212212200; Miyake S, 2000, MOL CELL BIOL, V20, P8889, DOI 10.1128/MCB.20.23.8889-8902.2000; Murray JM, 2008, NAT REV MOL CELL BIO, V9, P177, DOI 10.1038/nrm2309; Palecek J, 2006, J BIOL CHEM, V281, P36952, DOI 10.1074/jbc.M608004200; Pebernard S, 2006, MOL CELL BIOL, V26, P1617, DOI 10.1128/MCB.26.5.1617-1630.2006; Pospisilova S, 2000, J IMMUNOL METHODS, V237, P51, DOI 10.1016/S0022-1759(99)00246-X; Ritchie DW, 2008, BIOINFORMATICS, V24, P1865, DOI 10.1093/bioinformatics/btn334; Routzahn Karen M., 2002, Journal of Structural and Functional Genomics, V2, P83, DOI 10.1023/A:1020424023207; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schleiffer A, 2003, MOL CELL, V11, P571, DOI 10.1016/S1097-2765(03)00108-4; Sergeant J, 2005, MOL CELL BIOL, V25, P172, DOI 10.1128/MCB.25.1.172-184.2005; Taylor EM, 2008, MOL CELL BIOL, V28, P1197, DOI 10.1128/MCB.00767-07; Taylor EM, 2001, MOL BIOL CELL, V12, P1583, DOI 10.1091/mbc.12.6.1583	33	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35813	10.1371/journal.pone.0035813	http://dx.doi.org/10.1371/journal.pone.0035813			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536443	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339200115
J	Liu, YD; Su, Y; Sun, SG; Wang, T; Qiao, X; Run, XQ; Liang, ZH				Liu, Yudong; Su, Ying; Sun, Shenggang; Wang, Tao; Qiao, Xian; Run, Xiaoqin; Liang, Zhihou			Tau Phosphorylation and mu-Calpain Activation Mediate the Dexamethasone-Induced Inhibition on the Insulin-Stimulated Akt Phosphorylation	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; GROWTH-FACTOR-I; ALZHEIMERS-DISEASE; DIABETES-MELLITUS; GLUCOSE-METABOLISM; SIGNALING PATHWAY; MEMORY DEFICITS; DOWN-REGULATION; AMYLOID-BETA; A-BETA	Evidence has suggested that insulin resistance (IR) or high levels of glucocorticoids (GCs) may be linked with the pathogenesis andor progression of Alzheimer's disease (AD). Although studies have shown that a high level of GCs results in IR, little is known about the molecular details that link GCs and IR in the context of AD. Abnormal phosphorylation of tau and activation of mu-calpain are two key events in the pathology of AD. Importantly, these two events are also related with GCs and IR. We therefore speculate that tau phosphorylation and mu-calpain activation may mediate the GCs-induced IR. Akt phosphorylation at Ser-473 (pAkt) is commonly used as a marker for assessing IR. We employed two cell lines, wild-type HEK293 cells and HEK293 cells stably expressing the longest human tau isoform (tau-441; HEK293tau441 cells). We examined whether DEX, a synthetic GCs, induces tau phosphorylation and mu-calpain activation. If so, we examined whether the DEX-induced tau phosphorylation and mu-calpain activation mediate the DEX-induced inhibition on the insulin-stimulated Akt phosphorylation. The results showed that DEX increased tau phosphorylation and induced tau-mediated mu-calpain activation. Furthermore, pre-treatment with LiCl prevented the effects of DEX on tau phosphorylation and mu-calpain activation. Finally, both LiCl pre-treatment and calpain inhibition prevented the DEX-induced inhibition on the insulin-stimulated Akt phosphorylation. In conclusion, our study suggests that the tau phosphorylation and mu-calpain activation mediate the DEX-induced inhibition on the insulin-stimulated Akt phosphorylation.	[Su, Ying; Sun, Shenggang; Wang, Tao; Qiao, Xian; Liang, Zhihou] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Neurol, Wuhan 430074, Hubei, Peoples R China; [Liu, Yudong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Orthoped, Wuhan 430074, Hubei, Peoples R China; [Run, Xiaoqin] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gen Surg, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Liang, ZH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Neurol, Wuhan 430074, Hubei, Peoples R China.	zhihouliang@msn.com			National Nature Science Foundation of China [30901386]; Wuhan Science and Technology Bureau, China [200960323132]; Research Fund for the Doctoral Program of Higher Education of China [200804871026]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wuhan Science and Technology Bureau, China; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the National Nature Science Foundation of China (30901386), the Wuhan Science and Technology Bureau, China (200960323132), and the Research Fund for the Doctoral Program of Higher Education of China (200804871026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadoro G, 2006, P NATL ACAD SCI USA, V103, P2892, DOI 10.1073/pnas.0511065103; Baier LJ, 2000, J CLIN INVEST, V106, pR69, DOI 10.1172/JCI10665; Baker LD, 2011, ARCH NEUROL-CHICAGO, V68, P51, DOI 10.1001/archneurol.2010.225; Beltran L, 2011, P NATL ACAD SCI USA, V108, P16217, DOI 10.1073/pnas.1107692108; Bosco D, 2011, J CELL MOL MED, V15, P1807, DOI 10.1111/j.1582-4934.2011.01318.x; Caccamo A, 2007, AM J PATHOL, V170, P1669, DOI 10.2353/ajpath.2007.061178; Cao DF, 2007, J BIOL CHEM, V282, P36275, DOI 10.1074/jbc.M703561200; Clodfelder-Miller BJ, 2006, DIABETES, V55, P3320, DOI 10.2337/db06-0485; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Congdon EE, 2008, J ALZHEIMERS DIS, V14, P453; Cowan CM, 2010, ACTA NEUROPATHOL, V120, P593, DOI 10.1007/s00401-010-0716-8; Craft S, 2007, CURR ALZHEIMER RES, V4, P147, DOI 10.2174/156720507780362137; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; de la Monte SM, 2005, J ALZHEIMERS DIS, V7, P45; Derbel S, 2006, J CYST FIBROS, V5, P47, DOI 10.1016/j.jcf.2005.09.011; Dimakopoulos Aristotelis C., 2005, Current Alzheimer Research, V2, P19, DOI 10.2174/1567205052772795; ELLIOTT EM, 1993, J NEUROCHEM, V61, P57, DOI 10.1111/j.1471-4159.1993.tb03537.x; Freude S, 2005, DIABETES, V54, P3343, DOI 10.2337/diabetes.54.12.3343; Frisardi V, 2010, J ALZHEIMERS DIS, V21, P57, DOI 10.3233/JAD-2010-100015; Gallagher EJ, 2011, MED CLIN N AM, V95, P855, DOI 10.1016/j.mcna.2011.06.001; Gong CX, 2010, DRUG AGING, V27, P351, DOI 10.2165/11536110-000000000-00000; Green KN, 2006, J NEUROSCI, V26, P9047, DOI 10.1523/JNEUROSCI.2797-06.2006; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Harmann A, 1998, NEUROBIOL AGING, V18, P285; Hiltunen M, 2011, J CELL MOL IN PRESS; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Hong M, 1997, J BIOL CHEM, V272, P19547, DOI 10.1074/jbc.272.31.19547; Horikawa Y, 2003, J CLIN ENDOCR METAB, V88, P244, DOI 10.1210/jc.2002-020847; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hsieh YY, 2008, INT J BIOL SCI, V4, P300; Jameson RR, 2006, NEUROPSYCHOPHARMACOL, V31, P1647, DOI 10.1038/sj.npp.1300967; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kang ES, 2006, J HUM GENET, V51, P629, DOI 10.1007/s10038-006-0410-9; Ke YD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007917; Kim B, 2009, APOPTOSIS, V14, P665, DOI 10.1007/s10495-009-0331-0; Leroy K, 2010, J ALZHEIMERS DIS, V19, P705, DOI [10.3233/JAD-2009-1276, 10.3233/JAD-2010-1276]; Lesort M, 1999, J NEUROCHEM, V72, P576, DOI 10.1046/j.1471-4159.1999.0720576.x; Lesort M, 2000, NEUROSCIENCE, V99, P305, DOI 10.1016/S0306-4522(00)00200-1; Liang ZH, 2007, J NEUROCHEM, V103, P2462, DOI 10.1111/j.1471-4159.2007.04942.x; Liu F, 2005, J BIOL CHEM, V280, P1790, DOI 10.1074/jbc.M410775200; Liu Y, 2012, NEUROCHEM RES   0201, P1; Liu Y, 2011, J PATHOL, V225, P54, DOI 10.1002/path.2912; Lu FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004144; Luo DZ, 2011, EUR J PHARMACOL, V664, P14, DOI 10.1016/j.ejphar.2011.04.045; Lupien SJ, 1998, NAT NEUROSCI, V1, P69, DOI 10.1038/271; Maccioni RB, 2010, ARCH MED RES, V41, P226, DOI 10.1016/j.arcmed.2010.03.007; Meier M, 2007, J ENDOCRINOL, V193, P45, DOI 10.1677/joe.1.07087; MukaetovaLadinska EB, 1996, DEMENTIA, V7, P95, DOI 10.1159/000106861; Nixon RA, 2003, AGEING RES REV, V2, P407, DOI 10.1016/S1568-1637(03)00029-1; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; Otani K, 2006, AM J PHYSIOL-ENDOC M, V291, pE544, DOI 10.1152/ajpendo.00510.2005; Park SA, 2011, J CLIN NEUROL, V7, P10, DOI 10.3988/jcn.2011.7.1.10; Paul DS, 2003, BIOCHEM J, V376, P625, DOI 10.1042/BJ20030681; Permutt MA, 2000, J CLIN INVEST, V106, P819, DOI 10.1172/JCI11228; Perrin BJ, 2002, INT J BIOCHEM CELL B, V34, P722, DOI 10.1016/S1357-2725(02)00009-2; Pfau A, 2007, MOL CELL ENDOCRINOL, V264, P35, DOI 10.1016/j.mce.2006.10.002; Planel E, 2007, J NEUROSCI, V27, P13635, DOI 10.1523/JNEUROSCI.3949-07.2007; Randriamboavonjy V, 2008, CIRCULATION, V117, P52, DOI 10.1161/CIRCULATIONAHA.107.719807; Reaven GM, 2011, MED CLIN N AM, V95, P875, DOI 10.1016/j.mcna.2011.06.002; Ren QG, 2007, FEBS LETT, V581, P1521, DOI 10.1016/j.febslet.2007.02.065; Riedere RP, 2011, NEUROTOX RES, V19, P253; Rissman RA, 2009, J ALZHEIMERS DIS, V18, P453, DOI 10.3233/JAD-2009-1153; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101; Smith IJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE762, DOI 10.1152/ajpendo.90226.2008; Smith IJ, 2007, EXP PHYSIOL, V92, P561, DOI 10.1113/expphysiol.2006.035790; Sreenan SK, 2001, DIABETES, V50, P2013, DOI 10.2337/diabetes.50.9.2013; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; SZENDREI GI, 1993, J NEUROSCI RES, V34, P243, DOI 10.1002/jnr.490340212; To AWM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016991; Town T, 2002, J NEUROSCI RES, V69, P362, DOI 10.1002/jnr.10299; Trinchese F, 2008, J CLIN INVEST, V118, P2796, DOI 10.1172/JCI34254; Tsoyi K, 2010, ATHEROSCLEROSIS, V213, P115, DOI 10.1016/j.atherosclerosis.2010.07.061; Turner MD, 2005, DIABETES-METAB RES, V21, P505, DOI 10.1002/dmrr.578; Vega IE, 2008, J NEUROCHEM, V106, P96, DOI 10.1111/j.1471-4159.2008.05339.x; Yaniv SP, 2008, EUR J PHARMACOL, V596, P14, DOI 10.1016/j.ejphar.2008.08.006; Yu G, 2011, J ALZHEIMERS DIS, V24, P525, DOI 10.3233/JAD-2011-101779; Zhang H, 2003, EXP CELL RES, V289, P352, DOI 10.1016/S0014-4827(03)00286-6	78	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35783	10.1371/journal.pone.0035783	http://dx.doi.org/10.1371/journal.pone.0035783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536436	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200110
J	Nickel, GC; Barnholtz-Sloan, J; Gould, MP; McMahon, S; Cohen, A; Adams, MD; Guda, K; Cohen, M; Sloan, AE; LaFramboise, T				Nickel, Gabrielle C.; Barnholtz-Sloan, Jill; Gould, Meetha P.; McMahon, Sarah; Cohen, Andrea; Adams, Mark D.; Guda, Kishore; Cohen, Mark; Sloan, Andrew E.; LaFramboise, Thomas			Characterizing Mutational Heterogeneity in a Glioblastoma Patient with Double Recurrence	PLOS ONE			English	Article							INTEGRATED GENOMIC ANALYSIS; ALLELE-SPECIFIC EXPRESSION; EVOLUTION; PATHWAYS; TGFBR1	Human cancers are driven by the acquisition of somatic mutations. Separating the driving mutations from those that are random consequences of general genomic instability remains a challenge. New sequencing technology makes it possible to detect mutations that are present in only a minority of cells in a heterogeneous tumor population. We sought to leverage the power of ultra-deep sequencing to study various levels of tumor heterogeneity in the serial recurrences of a single glioblastoma multiforme patient. Our goal was to gain insight into the temporal succession of DNA base-level lesions by querying intra-and inter-tumoral cell populations in the same patient over time. We performed targeted "next-generation" sequencing on seven samples from the same patient: two foci within the primary tumor, two foci within an initial recurrence, two foci within a second recurrence, and normal blood. Our study reveals multiple levels of mutational heterogeneity. We found variable frequencies of specific EGFR, PIK3CA, PTEN, and TP53 base substitutions within individual tumor regions and across distinct regions within the same tumor. In addition, specific mutations emerge and disappear along the temporal spectrum from tumor at the time of diagnosis to second recurrence, demonstrating evolution during tumor progression. Our results shed light on the spatial and temporal complexity of brain tumors. As sequencing costs continue to decline and deep sequencing technology eventually moves into the clinic, this approach may provide guidance for treatment choices as we embark on the path to personalized cancer medicine.	[Nickel, Gabrielle C.; Gould, Meetha P.; McMahon, Sarah; Cohen, Andrea; Adams, Mark D.; LaFramboise, Thomas] Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; [Barnholtz-Sloan, Jill; Guda, Kishore] Case Western Reserve Univ, Sch Med, Dept Gen Med Sci Oncol, Cleveland, OH USA; [Barnholtz-Sloan, Jill; Guda, Kishore; Sloan, Andrew E.; LaFramboise, Thomas] Case Comprehens Canc Ctr, Cleveland, OH USA; [Cohen, Mark] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Sloan, Andrew E.] Univ Hosp Case Med Ctr, Dept Neurol Surg, Neurol Inst, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital	LaFramboise, T (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA.	Thomas.LaFramboise@case.edu	Barnholtz-Sloan, Jill/A-4817-2011; Sloan, Andrew/AAE-9842-2020	Barnholtz-Sloan, Jill/0000-0001-6190-9304; 	National Institutes of Health, National Cancer Institute [R01CA131341, P30 CA043703]; National Science Foundation [IIS-0916102]; NATIONAL CANCER INSTITUTE [P30CA043703, R01CA131341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; Div Of Information & Intelligent Systems [0916102] Funding Source: National Science Foundation	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	Supported by grants from the National Institutes of Health, National Cancer Institute (Grant Nos. R01CA131341 and P30 CA043703), and the National Science Foundation (IIS-0916102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Clarke J, 2010, ARCH NEUROL-CHICAGO, V67, P279, DOI 10.1001/archneurol.2010.5; Forbes SA, 2010, CURR PROTOC HUM GENE, P11; Franceschi E, 2009, EXPERT REV ANTICANC, V9, P613, DOI [10.1586/era.09.23, 10.1586/ERA.09.23]; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Guda K, 2009, CANCER RES, V69, P4959, DOI 10.1158/0008-5472.CAN-09-0225; Hou Lewis C, 2006, Neurosurg Focus, V20, pE5; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kaminker JS, 2007, CANCER RES, V67, P465, DOI 10.1158/0008-5472.CAN-06-1736; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Ohgaki H, 2009, CANCER SCI, V100, P2235, DOI 10.1111/j.1349-7006.2009.01308.x; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; Tomsic J, 2010, CARCINOGENESIS, V31, P1800, DOI 10.1093/carcin/bgq165; Tsiatis AC, 2010, J MOL DIAGN, V12, P425, DOI 10.2353/jmoldx.2010.090188; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	28	50	50	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35262	10.1371/journal.pone.0035262	http://dx.doi.org/10.1371/journal.pone.0035262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536362	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339200047
J	Broderick, R; Ramadurai, S; Toth, K; Togashi, DM; Ryder, AG; Langowski, J; Nasheuer, HP				Broderick, Ronan; Ramadurai, Sivaramakrishnan; Toth, Katalin; Togashi, Denisio M.; Ryder, Alan G.; Langowski, Joerg; Nasheuer, Heinz Peter			Cell Cycle-Dependent Mobility of Cdc45 Determined in vivo by Fluorescence Correlation Spectroscopy	PLOS ONE			English	Article							EUKARYOTIC DNA-REPLICATION; PROTEIN-A; POLYMERASE-ALPHA; MCM2-7 HELICASE; S-PHASE; COMPLEX; INITIATION; DYNAMICS; CHROMATIN; GINS	Eukaryotic DNA replication is a dynamic process requiring the co-operation of specific replication proteins. We measured the mobility of eGFP-Cdc45 by Fluorescence Correlation Spectroscopy (FCS) in vivo in asynchronous cells and in cells synchronized at the G1/S transition and during S phase. Our data show that eGFP-Cdc45 mobility is faster in G1/S transition compared to S phase suggesting that Cdc45 is part of larger protein complex formed in S phase. Furthermore, the size of complexes containing Cdc45 was estimated in asynchronous, G1/S and S phase-synchronized cells using gel filtration chromatography; these findings complemented the in vivo FCS data. Analysis of the mobility of eGFP-Cdc45 and the size of complexes containing Cdc45 and eGFP-Cdc45 after UVC-mediated DNA damage revealed no significant changes in diffusion rates and complex sizes using FCS and gel filtration chromatography analyses. This suggests that after UV-damage, Cdc45 is still present in a large multi-protein complex and that its mobility within living cells is consistently similar following UVC-mediated DNA damage.	[Broderick, Ronan; Ramadurai, Sivaramakrishnan; Nasheuer, Heinz Peter] Syst Biol Ireland, Galway, Ireland; [Broderick, Ronan; Ramadurai, Sivaramakrishnan; Nasheuer, Heinz Peter] Natl Univ Ireland Galway, Sch Nat Sci, Ctr Chromosome Biol, Galway, Ireland; [Togashi, Denisio M.; Ryder, Alan G.] Natl Univ Ireland Galway, Sch Chem, Nanoscale Biophoton Lab, Galway, Ireland; [Toth, Katalin; Langowski, Joerg] German Canc Res Ctr, Heidelberg, Germany	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Helmholtz Association; German Cancer Research Center (DKFZ)	Broderick, R (corresponding author), Syst Biol Ireland, Galway, Ireland.	h.nasheuer@nuigalway.ie	Toth, Katalin/ABA-2276-2021; Toth, Katalin/AAC-2064-2020; Ryder, Alan/C-1297-2009; Nasheuer, Heinz P./B-9025-2008; Langowski, Jörg/A-1843-2011; Ryder, Alan/AAW-1056-2020	Toth, Katalin/0000-0002-0081-4720; Ryder, Alan/0000-0002-3133-4340; Langowski, Jörg/0000-0001-8600-0666; Ryder, Alan/0000-0002-3133-4340; Nasheuer, Heinz Peter/0000-0002-9218-9079; broderick, ronan/0000-0001-6840-4755	Science Foundation Ireland through Systems Biology Ireland; Thomas Crawford Hayes Fund; Irish research council for science, engineering & technology (IRCSET)	Science Foundation Ireland through Systems Biology Ireland(Science Foundation Ireland); Thomas Crawford Hayes Fund; Irish research council for science, engineering & technology (IRCSET)(Irish Research Council for Science, Engineering and Technology)	This work was supported by the Science Foundation Ireland through Systems Biology Ireland, the Thomas Crawford Hayes Fund and Irish research council for science, engineering & technology (IRCSET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudendistel N, 2005, CHEMPHYSCHEM, V6, P984, DOI 10.1002/cphc.200400639; Bauerschmidt C, 2007, GENES CELLS, V12, P745, DOI 10.1111/j.1365-2443.2007.01090.x; Behlke-Steinert S, 2009, CELL CYCLE, V8, P2211, DOI 10.4161/cc.8.14.8979; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Braet C, 2007, EXP MOL PATHOL, V82, P156, DOI 10.1016/j.yexmp.2006.12.008; Brazda P, 2011, J CELL SCI, V124, P3631, DOI 10.1242/jcs.086082; Broderick R, 2009, BIOCHEM SOC T, V37, P926, DOI 10.1042/BST0370926; Chen Y, 2002, BIOPHYS J, V82, P133, DOI 10.1016/S0006-3495(02)75380-0; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Dross N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005041; Fritsch CC, 2011, CHROMOSOME RES, V19, P63, DOI 10.1007/s10577-010-9168-1; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; Guigas G, 2008, BIOPHYS J, V95, pL25, DOI 10.1529/biophysj.108.136069; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; Hemmerich P, 2011, CHROMOSOME RES, V19, P131, DOI 10.1007/s10577-010-9161-8; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Kaufmann WK, 2010, CARCINOGENESIS, V31, P751, DOI 10.1093/carcin/bgp230; Liu PJ, 2006, J BIOL CHEM, V281, P30631, DOI 10.1074/jbc.M602982200; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Mahen R, 2011, P NATL ACAD SCI USA, V108, P9310, DOI 10.1073/pnas.1101112108; Masuda T, 2003, GENES CELLS, V8, P145, DOI 10.1046/j.1365-2443.2003.00621.x; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Nasheuer HP, 2002, PROG NUCLEIC ACID RE, V72, P41, DOI 10.1016/S0079-6603(02)72067-9; Pestryakov PE, 2003, J BIOL CHEM, V278, P17515, DOI 10.1074/jbc.M301265200; Petrasek Z, 2010, METHOD ENZYMOL, V472, P317, DOI 10.1016/S0076-6879(10)72005-X; Pollok S, 2007, FEBS J, V274, P3669, DOI 10.1111/j.1742-4658.2007.05900.x; QIAN H, 1991, APPL OPTICS, V30, P1185, DOI 10.1364/AO.30.001185; Renz M, 2008, CHROMOSOME RES, V16, P427, DOI 10.1007/s10577-008-1234-6; Ritzi M, 1998, J BIOL CHEM, V273, P24543, DOI 10.1074/jbc.273.38.24543; Schwille P, 1999, BIOPHYS J, V77, P2251, DOI 10.1016/S0006-3495(99)77065-7; Slaughter BD, 2010, MOL BIOL CELL, V21, P4306, DOI 10.1091/mbc.E10-05-0451; Stephan H, 2009, NUCLEIC ACIDS RES, V37, P6028, DOI 10.1093/nar/gkp605; Takeda DY, 2005, ONCOGENE, V24, P2827, DOI 10.1038/sj.onc.1208616; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; Wang ZF, 2006, BIOPHYS J, V91, P343, DOI 10.1529/biophysj.105.077891; Weidtkamp-Peters Stefanie, 2008, V464, P321; Widengren J, 1998, CELL MOL BIOL, V44, P857; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	41	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35537	10.1371/journal.pone.0035537	http://dx.doi.org/10.1371/journal.pone.0035537			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536402	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336200052
J	Han, RJ; Li, AY; Li, LJ; Kitlinska, JB; Zukowska, Z				Han, Ruijun; Li, Aiyun; Li, Lijun; Kitlinska, Joanna B.; Zukowska, Zofia			Maternal low-protein diet up-regulates the neuropeptide Y system in visceral fat and leads to abdominal obesity and glucose intolerance in a sex- and time-specific manner	FASEB JOURNAL			English	Article						NPY-Y2R; sex differences; metabolic syndrome	ADIPOSE-TISSUE; METABOLIC SYNDROME; FOOD-INTAKE; GROWTH; EXPOSURE; PREGNANCY; INSULIN; WEIGHT; STRESS; CELLS	Neuropeptide Y (NPY) mediates stress-induced obesity in adult male mice by activating its Y2 receptor (Y2R) in visceral adipose tissue (VAT). Here, we studied whether the NPY-Y2R system is also activated by maternal low-protein diet (LPD) and linked to obesity in offspring. Prenatal LPD offspring had lower birth weights compared to normal-protein diet (NPD) offspring. Female prenatal and lactation stress (PLS) offspring from mothers fed an LPD developed abdominal adiposity and glucose intolerance associated with a 5-fold up-regulation of NPY mRNA and a 6-fold up-regulation of Y2R mRNA specifically in VAT, in addition to elevated platelet-rich-plasma (PRP) NPY, compared to control females fed a high-fat diet (HFD). Conversely, PLS male offspring showed lower NPY in PRP, a 10-fold decrease of Y2R mRNA in VAT, lower adiposity, and improved glucose tolerance compared to control males. Interestingly, prenatal LPD offspring cross-fostered to control lactating mothers had completely inverse metabolic and NPY phenotypes. Taken together, these findings suggested that maternal LPD activates the VAT NPY-Y2R system and increases abdominal adiposity and glucose intolerance in a sex-and time-specific fashion, suggesting that the peripheral NPY system is a potential mediator of programming for the offspring's vulnerability to obesity and metabolic syndrome.-Han, R., Li, A., Li, L., Kitlinska, J. B., Zukowska, Z. Maternal low-protein diet up-regulates the neuropeptide Y system in visceral fat and leads to abdominal obesity and glucose intolerance in a sex-and time-specific manner. FASEB J. 26, 3528-3536 (2012). www.fasebj.org	[Han, Ruijun; Zukowska, Zofia] Univ Minnesota, Dept Integrat Biol & Physiol, Stress Physiol Ctr, Minneapolis, MN 55455 USA; [Han, Ruijun; Li, Aiyun; Li, Lijun; Kitlinska, Joanna B.; Zukowska, Zofia] Georgetown Univ, Dept Physiol & Biophys, Washington, DC USA	University of Minnesota System; University of Minnesota Twin Cities; Georgetown University	Han, RJ (corresponding author), Univ Minnesota, Dept Integrat Biol & Physiol, Stress Physiol Ctr, 321 Church St SE, Minneapolis, MN 55455 USA.	rhan@umn.edu	Han, Ruijun/K-6614-2012		U.S. National Institutes of Health [R01HL067357, R37HL055310]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067357, R37HL055310] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health grants R01HL067357 and R37HL055310 to Z.Z. The authors thank Allison Gurney, Amrutesh Puranik, Dalay Hirsch, Jana Strakova, Jixia Liu, Shuangwei Li, and Allan V. Kalueff for their insightful comments and editing. The authors thank Naz Moaddab for the pilot study reporting that prenatal LPD stress increased anxiety in male offspring, with lower NPY levels in the amygdala. The authors declare no conflicts of interest.	Abe K, 2010, EXP BIOL MED, V235, P1179, DOI 10.1258/ebm.2010.009136; ANGUITA RM, 1993, J NUTR, V123, P1421; Bartness TJ, 2002, J CLIN INVEST, V110, P1235, DOI 10.1172/JCI200217047; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Casson IF, 1997, BRIT MED J, V315, P275, DOI 10.1136/bmj.315.7103.275; Costa E, 2009, EXPERT REV NEUROTHER, V9, P87, DOI 10.1586/14737175.9.1.87; Dunn GA, 2009, ENDOCRINOLOGY, V150, P4999, DOI 10.1210/en.2009-0500; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; HAHN P, 1984, J NUTR, V114, P1231, DOI 10.1093/jn/114.7.1231; Hales CN, 2003, DIABETOLOGIA, V46, P1013, DOI 10.1007/s00125-003-1131-7; Han R, 2007, DIABETOLOGIA, V50, P1960, DOI 10.1007/s00125-007-0752-7; HEYMANN E, 1984, KLIN WOCHENSCHR, V62, P2, DOI 10.1007/BF01725186; Jaquet D, 2000, J CLIN ENDOCR METAB, V85, P1401, DOI 10.1210/jc.85.4.1401; Kalra SP, 2004, NEUROPEPTIDES, V38, P201, DOI 10.1016/j.npep.2004.06.003; Koulu M, 2004, ANN MED, V36, P232, DOI 10.1080/07853890410031236; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; LAW CM, 1992, J EPIDEMIOL COMMUN H, V46, P184, DOI 10.1136/jech.46.3.184; Lee EW, 2003, J CLIN INVEST, V111, P1853, DOI 10.1172/JCI200316929; Li LJ, 2011, J CARDIOVASC TRANSL, V4, P351, DOI 10.1007/s12265-011-9271-5; Lindsay RS, 1996, DIABETOLOGIA, V39, P1299, DOI 10.1007/s001250050573; Lucas A, 1996, BRIT J NUTR, V76, P605, DOI 10.1079/BJN19960066; LUNDBERG JM, 1990, FUNDAM CLIN PHARM, V4, P373, DOI 10.1111/j.1472-8206.1990.tb00692.x; Mashiko S, 2007, MOL PHARMACOL, V71, P602, DOI 10.1124/mol.106.029991; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; Nilsson C, 1996, PEPTIDES, V17, P359, DOI 10.1016/0196-9781(96)00013-7; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b; Ozanne SE, 2004, CLIN SCI, V106, P141, DOI 10.1042/CS20030278; Ozanne SE, 1996, AM J PHYSIOL-ENDOC M, V270, pE559, DOI 10.1152/ajpendo.1996.270.4.E559; Painter RC, 2008, BJOG-INT J OBSTET GY, V115, P1243, DOI 10.1111/j.1471-0528.2008.01822.x; Parker RMC, 1999, EUR J NEUROSCI, V11, P1431, DOI 10.1046/j.1460-9568.1999.00553.x; Pembrey ME, 2010, HUM FERTIL, V13, P268, DOI 10.3109/14647273.2010.524721; Plagemann A, 2002, DIABETES CARE, V25, P16, DOI 10.2337/diacare.25.1.16; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; Sainsbury A, 2006, DIABETES, V55, P19; Seckl JR, 2004, EUR J ENDOCRINOL, V151, pU49, DOI 10.1530/eje.0.151u049; Shepherd PR, 1997, BRIT J NUTR, V78, P121, DOI 10.1079/BJN19970124; Shi YC, 2011, OBESITY, V19, P2137, DOI 10.1038/oby.2011.99; Son MY, 2011, J CELL MOL MED, V15, P152, DOI 10.1111/j.1582-4934.2009.00956.x; STANLEY BG, 1992, PEPTIDES, V13, P581, DOI 10.1016/0196-9781(92)90093-I; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; URBAN JH, 1993, ENDOCRINOLOGY, V132, P139, DOI 10.1210/en.132.1.139; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Whitelaw NC, 2008, CURR OPIN GENET DEV, V18, P273, DOI 10.1016/j.gde.2008.07.001; Yang KP, 2008, FASEB J, V22, P2452, DOI 10.1096/fj.07-100735; Zambrano E, 2006, J PHYSIOL-LONDON, V571, P221, DOI 10.1113/jphysiol.2005.100313; Zambrano E, 2005, J PHYSIOL-LONDON, V566, P225, DOI 10.1113/jphysiol.2005.086462; ZukowskaGrojec Z, 1995, ANN NY ACAD SCI, V771, P219, DOI 10.1111/j.1749-6632.1995.tb44683.x	48	29	31	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2012	26	8					3528	3536		10.1096/fj.12-203943	http://dx.doi.org/10.1096/fj.12-203943			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22539639	Green Published			2022-12-25	WOS:000307162800039
J	Punthambaker, S; Blum, JA; Hume, RI				Punthambaker, Sukanya; Blum, Jacob A.; Hume, Richard I.			High Potency Zinc Modulation of Human P2X2 Receptors and Low Potency Zinc Modulation of Rat P2X2 Receptors Share a Common Molecular Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; SWISS-MODEL WORKSPACE; P2X(2) RECEPTORS; ATP; CHANNELS; PHYSIOLOGY; PORE; PH	Human P2X2 receptors (hP2X2) are strongly inhibited by zinc over the range of 2-100 mu M, whereas rat P2X2 receptors (rP2X2) are strongly potentiated over the same range, and then inhibited by zinc over 100 mu M. However, the biological role of zinc modulation is unknown in either species. To identify candidate regions controlling zinc inhibition in hP2X2 a homology model based on the crystal structure of zebrafish P2X4.1 was made. In this model, His-204 and His-209 of one subunit were near His-330 of the adjacent subunit. Cross-linking studies confirmed that these residues are within 8 angstrom of each other. Simultaneous mutation of these three histidines to alanines decreased the zinc potency of hP2X2 nearly 100-fold. In rP2X2, one of these histidines is replaced by a lysine, and in a background in which zinc potentiation was eliminated, mutation of Lys-197 to histidine converted rP2X2 from low potency to high potency inhibition. We explored whether the zinc-binding site lies within the vestibules running down the central axis of the receptor. Elimination of all negatively charged residues from the upper vestibule had no effect on zinc inhibition. In contrast, mutation of several residues in the hP2X2 middle vestibule resulted in dramatic changes in the potency of zinc inhibition. In particular, the zinc potency of P206C could be reversibly shifted from extremely high (similar to 10 nM) to very low (>100 mu M) by binding and unbinding MTSET. These results suggest that the cluster of histidines at the subunit interface controls access of zinc to its binding site.	[Punthambaker, Sukanya; Blum, Jacob A.; Hume, Richard I.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Hume, RI (corresponding author), 830 N Univ Ave, Ann Arbor, MI USA.	rhume@umich.edu	, Richard/AAI-5000-2020; Punthambaker, Sukanya/AAR-9166-2020	Hume, Richard/0000-0001-9807-112X	National Institutes of Health Grant [NS039196]; Okkelberg Fellowship from the University of Michigan; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039196] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Okkelberg Fellowship from the University of Michigan; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS039196 (to R. I. H.) and an Okkelberg Fellowship from the University of Michigan (to S. P.).	AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; Andreini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026325; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Burnstock G, 2004, INT REV CYTOL, V240, P31, DOI 10.1016/S0074-7696(04)40002-3; Clyne JD, 2003, NEUROPHARMACOLOGY, V44, P403, DOI 10.1016/S0028-3908(02)00406-9; Clyne JD, 2002, J PHYSIOL-LONDON, V539, P347, DOI 10.1113/jphysiol.2001.013244; Clyne JD, 2002, J NEUROSCI, V22, P3873, DOI 10.1523/JNEUROSCI.22-10-03873.2002; Cockayne DA, 2005, J PHYSIOL-LONDON, V567, P621, DOI 10.1113/jphysiol.2005.088435; Coddou C, 2011, REV NEUROSCIENCE, V22, P335, DOI 10.1515/RNS.2011.014; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frederickson CJ, 2006, EXP NEUROL, V198, P285, DOI 10.1016/j.expneurol.2005.08.030; Illes P, 2004, EUR J PHARMACOL, V483, P5, DOI 10.1016/j.ejphar.2003.10.030; Kawate T, 2011, J GEN PHYSIOL, V137, P579, DOI 10.1085/jgp.201010593; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Koles L, 2011, ADV PHARMACOL, V61, P441, DOI 10.1016/B978-0-12-385526-8.00014-X; Mathie A, 2006, PHARMACOL THERAPEUT, V111, P567, DOI 10.1016/j.pharmthera.2005.11.004; Nagaya N, 2005, J BIOL CHEM, V280, P25982, DOI 10.1074/jbc.M504545200; Nakazawa K, 1996, EUR J PHARMACOL, V296, P119, DOI 10.1016/0014-2999(95)00774-1; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; Samways DSK, 2011, P NATL ACAD SCI USA, V108, P13800, DOI 10.1073/pnas.1017550108; Sindreu C, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00068; Tittle RK, 2008, J NEUROSCI, V28, P11131, DOI 10.1523/JNEUROSCI.2763-08.2008; Wildman SS, 1998, BRIT J PHARMACOL, V123, P1214, DOI 10.1038/sj.bjp.0701717	26	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22099	22111		10.1074/jbc.M112.369157	http://dx.doi.org/10.1074/jbc.M112.369157			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22556417	hybrid, Green Published			2022-12-25	WOS:000306418600047
J	Bruder, J; Siewert, K; Obermeier, B; Malotka, J; Scheinert, P; Kellermann, J; Ueda, T; Hohlfeld, R; Dornmair, K				Bruder, Jessica; Siewert, Katherina; Obermeier, Birgit; Malotka, Joachim; Scheinert, Peter; Kellermann, Josef; Ueda, Takuya; Hohlfeld, Reinhard; Dornmair, Klaus			Target Specificity of an Autoreactive Pathogenic Human gamma delta-T Cell Receptor in Myositis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SYNTHETASE; ANTIGEN RECOGNITION; POLYMYOSITIS; MHC; MUSCLE; LYMPHOCYTES; REPERTOIRE; BINDING; DERMATOMYOSITIS; AUTOANTIGENS	In polymyositis and inclusion body myositis, muscle fibers are surrounded and invaded by CD8-positive cytotoxic T cells expressing the alpha beta-T cell receptor (alpha beta-TCR) for antigen. In a rare variant of myositis, muscle fibers are similarly attacked by CD8-negative T cells expressing the gamma delta-TCR (gamma delta-T cell-mediated myositis). We investigated the antigen specificity of a human gamma delta-TCR previously identified in an autoimmune tissue lesion of gamma delta-T cell-mediated myositis. We show that this V gamma 1.3V delta 2-TCR, termed M88, recognizes various proteins from different species. Several of these proteins belong to the translational apparatus, including some bacterial and human aminoacyl-tRNA synthetases (AA-RS). Specifically, M88 recognizes histidyl-tRNA synthetase, an antigen known to be also targeted by autoantibodies called anti-Jo-1. The M88 target epitope is strictly conformational, independent of post-translational modification, and exposed on the surface of the respective antigenic protein. Extensive mutagenesis of the translation initiation factor-1 from Escherichia coli (EcIF1), which served as a paradigm antigen with known structure, showed that a short alpha-helical loop around amino acids 39 to 42 of EcIF1 is a major part of the M88 epitope. Mutagenesis of M88 showed that the complementarity determining regions 3 of both gamma delta-TCR chains contribute to antigen recognition. M88 is the only known example of a molecularly characterized gamma delta-TCR expressed by autoaggressive T cells in tissue. The observation that AA-RS are targeted by a gamma delta-T cell and by autoantibodies reveals an unexpected link between T cell and antibody responses in autoimmune myositis.	[Bruder, Jessica; Siewert, Katherina; Obermeier, Birgit; Hohlfeld, Reinhard; Dornmair, Klaus] Univ Munich, Inst Clin Neuroimmunol, D-81377 Munich, Germany; [Bruder, Jessica; Siewert, Katherina; Obermeier, Birgit; Malotka, Joachim; Hohlfeld, Reinhard; Dornmair, Klaus] Max Planck Inst Neurobiol, Dept Neuroimmunol, D-82152 Martinsried, Germany; [Scheinert, Peter] AmpTec GmbH, D-22767 Hamburg, Germany; [Kellermann, Josef] Max Planck Inst Biochem, Dept Prot Analyt, D-82152 Martinsried, Germany; [Ueda, Takuya] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba 2778562, Japan	University of Munich; Max Planck Society; Max Planck Society; University of Tokyo	Dornmair, K (corresponding author), Univ Munich, Inst Clin Neuroimmunol, D-81377 Munich, Germany.	klaus.dornmair@med.uni-muenchen.de	; Ueda, Takuya/K-5217-2014	Siewert, Katherina/0000-0003-0380-1594; Ueda, Takuya/0000-0002-7760-8271	Deutsche Forschungsgemeinschaft [SFB 571-A1]; Hermann and Lilly Schilling Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hermann and Lilly Schilling Foundation	This work was supported by the Deutsche Forschungsgemeinschaft Grant SFB 571-A1 and the Hermann and Lilly Schilling Foundation.	Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; Adams EJ, 2008, NAT IMMUNOL, V9, P777, DOI 10.1038/ni.1620; Allison TJ, 2001, NATURE, V411, P820, DOI 10.1038/35081115; AMOR S, 1994, J IMMUNOL, V153, P4349; ARAHATA K, 1988, ANN NEUROL, V23, P168, DOI 10.1002/ana.410230210; Arden Bernhard, 1995, Immunogenetics, V42, P455; Beetz S, 2008, IMMUNOBIOLOGY, V213, P173, DOI 10.1016/j.imbio.2007.10.006; BENDER A, 1995, J EXP MED, V181, P1863, DOI 10.1084/jem.181.5.1863; BLANK U, 1993, EUR J IMMUNOL, V23, P3057, DOI 10.1002/eji.1830231203; Blink SE, 2009, CURR MOL MED, V9, P15, DOI 10.2174/156652409787314516; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; Chervonsky AV, 2010, NAT IMMUNOL, V11, P28, DOI 10.1038/ni.1801; Chien YH, 2007, IMMUNOL REV, V215, P46, DOI 10.1111/j.1600-065X.2006.00470.x; Crowley MP, 2000, SCIENCE, V287, P314, DOI 10.1126/science.287.5451.314; Dalakas MC, 2010, NAT REV RHEUMATOL, V6, P129, DOI 10.1038/nrrheum.2010.2; Dalakas MC, 2004, CURR OPIN NEUROL, V17, P561, DOI 10.1097/00019052-200410000-00006; Dornmair K, 2004, J NEUROIMMUNOL, V152, P168, DOI 10.1016/j.jneuroim.2004.03.016; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; Goebels N, 1996, J CLIN INVEST, V97, P2905, DOI 10.1172/JCI118749; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; HOHLFELD R, 1991, NEW ENGL J MED, V324, P877, DOI 10.1056/NEJM199103283241303; HOHLFELD R, 1994, IMMUNOL TODAY, V15, P269, DOI 10.1016/0167-5699(94)90006-X; Howard OMZ, 2002, J EXP MED, V196, P781, DOI 10.1084/jem.20020186; Ishizuka J, 2008, IMMUNITY, V28, P171, DOI 10.1016/j.immuni.2007.12.018; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Levine SM, 2003, CURR OPIN RHEUMATOL, V15, P708, DOI 10.1097/00002281-200311000-00005; Li HM, 1998, NATURE, V391, P502, DOI 10.1038/35172; Mao YX, 2004, EMBO J, V23, P2963, DOI 10.1038/sj.emboj.7600327; OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1; Onesti S, 2000, BIOCHEMISTRY-US, V39, P12853, DOI 10.1021/bi001487r; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Plotz PH, 2003, NAT REV IMMUNOL, V3, P73, DOI 10.1038/nri976; PLUSCHKE G, 1992, J EXP MED, V176, P1785, DOI 10.1084/jem.176.6.1785; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sarikonda G, 2008, J IMMUNOL, V181, P7738, DOI 10.4049/jimmunol.181.11.7738; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; Seitz S, 2006, P NATL ACAD SCI USA, V103, P12057, DOI 10.1073/pnas.0604247103; Sette M, 1997, EMBO J, V16, P1436, DOI 10.1093/emboj/16.6.1436; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Shin S, 2005, SCIENCE, V308, P252, DOI 10.1126/science.1106480; Stone JD, 2009, IMMUNOLOGY, V126, P165, DOI 10.1111/j.1365-2567.2008.03015.x; Wang H, 2010, J IMMUNOL, V184, P6209, DOI 10.4049/jimmunol.1000231; Wiendl H, 2002, J IMMUNOL, V169, P515, DOI 10.4049/jimmunol.169.1.515; Wucherpfennig KW, 2007, SEMIN IMMUNOL, V19, P216, DOI 10.1016/j.smim.2007.02.012; WUCHERPFENNIG KW, 1992, P NATL ACAD SCI USA, V89, P4588, DOI 10.1073/pnas.89.10.4588; Xu B, 2011, P NATL ACAD SCI USA, V108, P2414, DOI 10.1073/pnas.1015433108; Zhang L, 2010, J AUTOIMMUN, V34, P478, DOI 10.1016/j.jaut.2009.12.008	50	38	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20986	20995		10.1074/jbc.M112.356709	http://dx.doi.org/10.1074/jbc.M112.356709			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22549773	Green Published, hybrid			2022-12-25	WOS:000306416800020
J	Lee, PS; Zhang, HM; Marshall, AG; Yang, XL; Schimmel, P				Lee, Peter S.; Zhang, Hui-Min; Marshall, Alan G.; Yang, Xiang-Lei; Schimmel, Paul			Uncovering of a Short Internal Peptide Activates a tRNA Synthetase Procytokine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY SOLUTION; ION-CYCLOTRON RESONANCE; AMIDE HYDROGEN-EXCHANGE; SMALL-ANGLE SCATTERING; MASS-SPECTROMETRY; CYTOKINE ACTIVITIES; CRYSTAL-STRUCTURE; INTERLEUKIN-8; ANGIOGENESIS; RESOLUTION	In higher organisms, aminoacyl-tRNA synthetases developed receptor-mediated ex-translational functions that are activated by various natural mechanisms. Hydrogen-deuterium exchange combined with mass spectrometry and small-angle x-ray scattering showed that activation of the cytokine function of the 528-amino acid human tyrosyl-tRNA synthetase was associated with pinpointed uncovering of a miniature internal ELR tripeptide that triggers receptor signaling. The results reveal the structural simplicity of how the ex-translational function is implemented.	[Lee, Peter S.; Yang, Xiang-Lei; Schimmel, Paul] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Yang, Xiang-Lei] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Schimmel, Paul] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Zhang, Hui-Min; Marshall, Alan G.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; State University System of Florida; Florida State University	Schimmel, P (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd,BCC379, La Jolla, CA 92037 USA.	schimmel@scripps.edu	Yang, Xiang-Lei/AAR-7107-2020	Yang, Xiang-Lei/0000-0003-2554-084X	National Institutes of Health [GM 15539, 23562, 088278]; National Institutes of Health through NCI [CA92577]; National Science Foundation [DMR-06-54118]; State of Florida; National Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA092577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM015539, R37GM015539, R01GM088278, R01GM023562] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); State of Florida; National Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM 15539, 23562, and 088278 and National Institutes of Health Grant CA92577 through the NCI). This work was also supported by the National Science Foundation Division of Materials Research through Grant DMR-06-54118, by the State of Florida, and by a fellowship from the National Foundation for Cancer Research.	BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Bonfils G, 2012, MOL CELL, V46, P105, DOI 10.1016/j.molcel.2012.02.009; Fang PF, 2011, P NATL ACAD SCI USA, V108, P8239, DOI 10.1073/pnas.1100224108; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Kapoor M, 2009, CHEM BIOL, V16, P531, DOI 10.1016/j.chembiol.2009.03.006; Kazazic S, 2010, J AM SOC MASS SPECTR, V21, P550, DOI 10.1016/j.jasms.2009.12.016; Kim S, 2011, NAT REV CANCER, V11, P708, DOI 10.1038/nrc3124; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Liu JM, 2002, BIOCHEMISTRY-US, V41, P14232, DOI 10.1021/bi0205395; Martinis Susan A., 1999, EMBO (European Molecular Biology Organization) Journal, V18, P4591, DOI 10.1093/emboj/18.17.4591; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Schaub TM, 2008, ANAL CHEM, V80, P3985, DOI 10.1021/ac800386h; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Vo MN, 2011, J BIOL CHEM, V286, P11563, DOI 10.1074/jbc.C110.213876; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wakasugi K, 2002, J BIOL CHEM, V277, P20124, DOI 10.1074/jbc.C200126200; Wakasugi K, 1999, J BIOL CHEM, V274, P23155, DOI 10.1074/jbc.274.33.23155; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Wriggers W, 2001, J APPL CRYSTALLOGR, V34, P773, DOI 10.1107/S0021889801012869; Xu XL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1686; Yang XL, 2007, CHEM BIOL, V14, P1323, DOI 10.1016/j.chembiol.2007.10.016; Yang XL, 2003, HELV CHIM ACTA, V86, P1246, DOI 10.1002/hlca.200390107; Yang XL, 2002, P NATL ACAD SCI USA, V99, P15369, DOI 10.1073/pnas.242611799; Yesylevskyy SO, 2011, BIOPHYS CHEM, V154, P90, DOI 10.1016/j.bpc.2011.01.005; Zhang HM, 2010, ANAL CHEM, V82, P1450, DOI 10.1021/ac902550n; Zhang HM, 2009, J AM SOC MASS SPECTR, V20, P520, DOI 10.1016/j.jasms.2008.11.010; Zhang HM, 2008, ANAL CHEM, V80, P9034, DOI 10.1021/ac801417d; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522; Zhang ZQ, 1997, PROTEIN SCI, V6, P2203; Zhou QS, 2010, NAT STRUCT MOL BIOL, V17, P57, DOI 10.1038/nsmb.1706	33	8	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20504	20508		10.1074/jbc.C112.369439	http://dx.doi.org/10.1074/jbc.C112.369439			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22549774	hybrid, Green Published			2022-12-25	WOS:000306414500071
J	Wang, N; Frank, GD; Ding, RH; Tan, ZJ; Rachakonda, A; Pandolfi, PP; Senbonmatsu, T; Landon, EJ; Inagami, T				Wang, Ning; Frank, Gerald D.; Ding, Ronghua; Tan, Zhongjia; Rachakonda, Amita; Pandolfi, Pier Paolo; Senbonmatsu, Takaaki; Landon, Erwin J.; Inagami, Tadashi			Promyelocytic Leukemia Zinc Finger Protein Activates GATA4 Transcription and Mediates Cardiac Hypertrophic Signaling from Angiotensin II Receptor 2	PLOS ONE			English	Article							TYPE-2 RECEPTOR; HEART-FAILURE; PLZF; PRESSURE; EXPRESSION; GROWTH; INVOLVEMENT; REPRESSION; INHIBITION; RESPONSES	Background: Pressure overload and prolonged angiotensin II (Ang II) infusion elicit cardiac hypertrophy in Ang II receptor 1 (AT(1)) null mouse, whereas Ang II receptor 2 (AT(2)) gene deletion abolishes the hypertrophic response. The roles and signals of the cardiac AT(2) receptor still remain unsettled. Promyelocytic leukemia zinc finger protein (PLZF) was shown to bind to the AT(2) receptor and transmit the hypertrophic signal. Using PLZF knockout mice we directed our studies on the function of PLZF concerning the cardiac specific transcription factor GATA4, and GATA4 targets. Methodology and Principal Findings: PLZF knockout and age-matched wild-type (WT) mice were treated with Ang II, infused at a rate of 4.2 ng.kg(-1) min(-1) for 3 weeks. Ang II elevated systolic blood pressure to comparable levels in PLZF knockout and WT mice (140 mmHg). WT mice developed prominent cardiac hypertrophy and fibrosis after Ang II infusion. In contrast, there was no obvious cardiac hypertrophy or fibrosis in PLZF knockout mice. An AT(2) receptor blocker given to Ang II-infused wild type mice prevented hypertrophy, verifying the role of AT(2) receptor for cardiac hypertrophy. Chromatin immunoprecipitation and electrophoretic mobility shift assay showed that PLZF bound to the GATA4 gene regulatory region. A Luciferase assay verified that PLZF up-regulated GATA4 gene expression and the absence of PLZF expression in vivo produced a corresponding repression of GATA4 protein. Conclusions: PLZF is an important AT(2) receptor binding protein in mediating Ang II induced cardiac hypertrophy through an AT(2) receptor-dependent signal pathway. The angiotensin II-AT(2)-PLZF-GATA4 signal may further augment Ang II induced pathological effects on cardiomyocytes.	[Wang, Ning; Frank, Gerald D.; Ding, Ronghua; Tan, Zhongjia; Rachakonda, Amita; Landon, Erwin J.; Inagami, Tadashi] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA; Beth Israel Deaconess Canc Ctr, Ctr Life Sci, Boston, MA USA; [Pandolfi, Pier Paolo] Saitama Med Univ, Dept Pathol, Saitama, Japan	Vanderbilt University; Harvard University; Beth Israel Deaconess Medical Center; Saitama Medical University	Wang, N (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA.	tadashi.inagami@vanderbilt.edu		Pandolfi, Pier Paolo/0000-0002-5352-5295	National Institutes of Health (NIH) [HL058205]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL058205, R01HL058205] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grant HL058205. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins NL, 2006, BIOCHEM CELL BIOL, V84, P559, DOI 10.1139/O06-062; Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; Bedecs K, 1997, BIOCHEM J, V325, P449, DOI 10.1042/bj3250449; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; Clair MJ, 1998, J MOL CELL CARDIOL, V30, P2355, DOI 10.1006/jmcc.1998.0796; Collins T, 2001, MOL CELL BIOL, V21, P3609, DOI 10.1128/MCB.21.11.3609-3615.2001; COOK M, 1995, P NATL ACAD SCI USA, V92, P2249, DOI 10.1073/pnas.92.6.2249; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Crowley SD, 2006, P NATL ACAD SCI USA, V103, P17985, DOI 10.1073/pnas.0605545103; Cui TX, 2001, CARDIOVASC RES, V49, P863, DOI 10.1016/S0008-6363(00)00299-6; D'Amore A, 2005, HYPERTENSION, V46, P1347, DOI 10.1161/01.HYP.0000193504.51489.cf; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Durocher D, 1996, MOL CELL BIOL, V16, P4648, DOI 10.1128/mcb.16.9.4648; Durocher D, 1998, DEV GENET, V22, P250, DOI 10.1002/(SICI)1520-6408(1998)22:3<250::AID-DVG7>3.0.CO;2-5; Filipponi D, 2007, MOL CELL BIOL, V27, P6770, DOI 10.1128/MCB.00479-07; FUJII N, 1995, BIOCHEM BIOPH RES CO, V212, P326, DOI 10.1006/bbrc.1995.1973; Goutsouliak V, 1998, GEN PHARMACOL, V30, P367, DOI 10.1016/S0306-3623(97)00270-X; Hamawaki M, 1998, AM J PHYSIOL-HEART C, V274, pH868, DOI 10.1152/ajpheart.1998.274.3.H868; Harada K, 1998, CIRCULATION, V97, P1952, DOI 10.1161/01.CIR.97.19.1952; Harada K, 1998, CIRC RES, V82, P779, DOI 10.1161/01.RES.82.7.779; Hasin T, 2011, BASIC RES CARDIOL, V106, P175, DOI 10.1007/s00395-010-0145-9; Herzig TC, 1997, P NATL ACAD SCI USA, V94, P7543, DOI 10.1073/pnas.94.14.7543; Ichihara S, 2001, CIRCULATION, V104, P346, DOI 10.1161/01.CIR.104.3.346; ICHIKI T, 1995, NATURE, V377, P748, DOI 10.1038/377748a0; Kijima K, 1996, CIRC RES, V79, P887, DOI 10.1161/01.RES.79.4.887; Kolesnichenko M, 2011, CELL CYCLE, V10, P771, DOI 10.4161/cc.10.5.14829; Kudoh S, 1998, J BIOL CHEM, V273, P24037, DOI 10.1074/jbc.273.37.24037; Li JY, 1997, J BIOL CHEM, V272, P22447, DOI 10.1074/jbc.272.36.22447; Li YH, 2009, ENDOCRINOLOGY, V150, P3759, DOI 10.1210/en.2008-1353; Liang QR, 2002, J MOL CELL CARDIOL, V34, P611, DOI 10.1006/jmcc.2002.2011; Matsubara H, 1998, CIRC RES, V83, P1182, DOI 10.1161/01.RES.83.12.1182; McConnell MJ, 2003, MOL CELL BIOL, V23, P9375, DOI 10.1128/MCB.23.24.9375-9388.2003; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC8297; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Morisco C, 2001, J BIOL CHEM, V276, P28586, DOI 10.1074/jbc.M103166200; Ohara Y, 2006, BIOL PHARM BULL, V29, P410, DOI 10.1248/bpb.29.410; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Olson EN, 2003, GENE DEV, V17, P1937, DOI 10.1101/gad.1110103; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Ozato K, 2009, IMMUNITY, V30, P757, DOI 10.1016/j.immuni.2009.06.003; Porrello ER, 2009, FRONT BIOSCI-LANDMRK, V14, P958, DOI 10.2741/3289; Schefe JH, 2006, CIRC RES, V99, P1355, DOI 10.1161/01.RES.0000251700.00994.0d; Senbonmatsu T, 2003, EMBO J, V22, P6471, DOI 10.1093/emboj/cdg637; Senbonmatsu T, 2000, J CLIN INVEST, V106, pR25, DOI 10.1172/JCI10037; Temsah R, 2005, REGUL PEPTIDES, V128, P177, DOI 10.1016/j.regpep.2004.12.026; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Tu VC, 2007, AM J PHYSIOL-CELL PH, V292, pC1248, DOI 10.1152/ajpcell.00624.2005; Worck RH, 1998, HYPERTENSION, V31, P384, DOI 10.1161/01.HYP.31.1.384; Xu DK, 2009, IMMUNITY, V30, P802, DOI 10.1016/j.immuni.2009.04.013; Yan XH, 2003, AM J PHYSIOL-HEART C, V285, pH2179, DOI 10.1152/ajpheart.00361.2003; Yayama K, 2004, J PHARMACOL EXP THER, V308, P736, DOI 10.1124/jpet.103.058420; Yeyati PL, 1999, ONCOGENE, V18, P925, DOI 10.1038/sj.onc.1202375; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137	56	27	29	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35632	10.1371/journal.pone.0035632	http://dx.doi.org/10.1371/journal.pone.0035632			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558183	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000041
J	Ward, E; Kerry, BR; Manzanilla-Lopez, RH; Mutua, G; Devonshire, J; Kimenju, J; Hirsch, PR				Ward, Elaine; Kerry, Brian R.; Manzanilla-Lopez, Rosa H.; Mutua, Gerald; Devonshire, Jean; Kimenju, John; Hirsch, Penny R.			The Pochonia chlamydosporia Serine Protease Gene vcp1 Is Subject to Regulation by Carbon, Nitrogen and pH: Implications for Nematode Biocontrol	PLOS ONE			English	Article							FUNGUS VERTICILLIUM-CHLAMYDOSPORIUM; TIME QUANTITATIVE PCR; METARHIZIUM-ANISOPLIAE; AMBIENT PH; REAL-TIME; CATABOLITE REPRESSION; ASPERGILLUS-NIDULANS; NEMATOPHAGOUS FUNGI; BIOLOGICAL-CONTROL; SEQUENCE-ANALYSIS	The alkaline serine protease VCP1 of the fungus Pochonia chlamydosporia belongs to a family of subtilisin-like enzymes that are involved in infection of nematode and insect hosts. It is involved early in the infection process, removing the outer proteinaceous vitelline membrane of nematode eggs. Little is known about the regulation of this gene, even though an understanding of how nutrients and other factors affect its expression is critical for ensuring its efficacy as a biocontrol agent. This paper provides new information on the regulation of vcp1 expression. Sequence analysis of the upstream regulatory region of this gene in 30 isolates revealed that it was highly conserved and contained sequence motifs characteristic of genes that are subject to carbon, nitrogen and pH-regulation. Expression studies, monitoring enzyme activity and mRNA, confirmed that these factors affect VCP1 production. As expected, glucose reduced VCP1 expression and for a few hours so did ammonium chloride. Surprisingly, however, by 24 h VCP1 levels were increased in the presence of ammonium chloride for most isolates. Ambient pH also regulated VCP1 expression, with most isolates producing more VCP1 under alkaline conditions. There were some differences in the response of one isolate with a distinctive upstream sequence including a variant regulatory-motif profile. Cryo-scanning electron microscopy studies indicated that the presence of nematode eggs stimulates VCP1 production by P. chlamydosporia, but only where the two are in close contact. Overall, the results indicate that readily-metabolisable carbon sources and unfavourable pH in the rhizosphere/egg-mass environment may compromise nematode parasitism by P. chlamydosporia. However, contrary to previous indications using other nematophagous and entomopathogenic fungi, ammonium nitrate (e.g. from fertilizers) may enhance biocontrol potential in some circumstances.	[Ward, Elaine; Kerry, Brian R.; Manzanilla-Lopez, Rosa H.; Devonshire, Jean; Hirsch, Penny R.] Rothamsted Res, Plant Pathol & Microbiol Dept, Harpenden, Herts, England; [Mutua, Gerald; Kimenju, John] Univ Nairobi, Dept Plant Sci & Crop Protect, Nairobi, Kenya	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Nairobi	Ward, E (corresponding author), Rothamsted Res, Plant Pathol & Microbiol Dept, Harpenden, Herts, England.	elaine.ward@rothamsted.ac.uk	Hirsch, Penny R/B-5135-2008	Hirsch, Penny R/0000-0002-5909-1934; Manzanilla-Lopez, Rosa Helena/0000-0002-8727-106X	BBSRC; DFID [BB/F003994/1]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004963, BB/F003994/1] Funding Source: researchfish; BBSRC [BB/F003994/1, BBS/E/C/00004963] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); DFID; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by funding from BBSRC (http://www.bbsrc.ac.uk/) and DFID(http://www.dfid.gov.uk/)(Grant BB/F003994/1). Rothamsted Research receives strategic funding from BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahman J, 2002, APPL ENVIRON MICROB, V68, P3408, DOI 10.1128/AEM.68.7.3408-3415.2002; Ahman J, 1996, MICROBIOL-SGM, V142, P1605, DOI 10.1099/13500872-142-7-1605; Aro N, 2005, FEMS MICROBIOL REV, V29, P719, DOI 10.1016/j.femsre.2004.11.006; Atkins SD, 2009, ANN APPL BIOL, V155, P143, DOI 10.1111/j.1744-7348.2009.00333.x; Bourne J. M., 2004, International Journal of Nematology, V14, P111; Bourne JM, 1999, SOIL BIOL BIOCHEM, V31, P75, DOI 10.1016/S0038-0717(98)00107-2; BREY PT, 1986, J INVERTEBR PATHOL, V48, P34, DOI 10.1016/0022-2011(86)90140-0; Caddick CMX, 1995, MOL GEN GENET, V203, P346; CUBERO B, 1994, EMBO J, V13, P407, DOI 10.1002/j.1460-2075.1994.tb06275.x; Druzhinina IS, 2011, NAT REV MICROBIOL, V9, P749, DOI 10.1038/nrmicro2637; Espeso EA, 1997, J MOL BIOL, V274, P466, DOI 10.1006/jmbi.1997.1428; ESPESO EA, 1994, FEBS LETT, V342, P43, DOI 10.1016/0014-5793(94)80581-4; Esteves I, 2009, MYCOL RES, V113, P867, DOI 10.1016/j.mycres.2009.04.005; Fountaine JA, 2007, PHYTOPATHOLOGY, V97, P297, DOI 10.1094/PHYTO-97-3-0297; Hellwig V, 2003, J NAT PROD, V66, P829, DOI 10.1021/np020556v; Hirsch PR, 2000, MYCOL RES, V104, P435, DOI 10.1017/S0953756299001483; Hirsch PR, 2001, PLANT SOIL, V232, P21, DOI 10.1023/A:1010373717186; Jansson HB, 2000, MYCOLOGIA, V92, P10, DOI 10.2307/3761444; Kanda S, 2008, MICROBIOL RES, V163, P63, DOI 10.1016/j.micres.2006.03.005; Kerry BR, 2000, ANNU REV PHYTOPATHOL, V38, P423, DOI 10.1146/annurev.phyto.38.1.423; KUDLA B, 1990, EMBO J, V9, P1355, DOI 10.1002/j.1460-2075.1990.tb08250.x; KULMBURG P, 1993, MOL MICROBIOL, V7, P847, DOI 10.1111/j.1365-2958.1993.tb01175.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockington RA, 2002, MOL MICROBIOL, V43, P1173, DOI 10.1046/j.1365-2958.2002.02811.x; Manzanilla-Lopez RH, 2011, J NEMATOLOG IN PRESS; Marzluf GA, 1997, MICROBIOL MOL BIOL R, V61, P17, DOI 10.1128/.61.1.17-32.1997; Meletiadis J, 2001, J CLIN MICROBIOL, V39, P478, DOI 10.1128/JCM.39.2.478-484.2001; Morton CO, 2004, NEMATOLOGY, V6, P161, DOI 10.1163/1568541041218004; Morton CO, 2003, MYCOL RES, V107, P38, DOI 10.1017/S0953756202007050; Orozco I, 2002, RES MICROBIOL, V153, P611, DOI 10.1016/S0923-2508(02)01373-6; Palma-Guerrero J, 2010, ENZYME MICROB TECH, V46, P568, DOI 10.1016/j.enzmictec.2010.02.009; PATERSON IC, 1994, MICROBIOL-SGM, V140, P185, DOI 10.1099/13500872-140-1-185; Pava-Ripoll M, 2011, MICROBIOL-SGM, V157, P47, DOI 10.1099/mic.0.042200-0; Penalva MA, 2008, TRENDS MICROBIOL, V16, P291, DOI 10.1016/j.tim.2008.03.006; Prusky D, 2003, MOL PLANT PATHOL, V4, P509, DOI [10.1046/j.1364-3703.2003.00196.x, 10.1046/J.1364-3703.2003.00196.X]; Reeves CD, 2008, APPL ENVIRON MICROB, V74, P5121, DOI 10.1128/AEM.00478-08; Rollins JA, 2001, APPL ENVIRON MICROB, V67, P75, DOI 10.1128/AEM.67.1.75-81.2001; RONNE H, 1995, TRENDS GENET, V11, P12, DOI 10.1016/S0168-9525(00)88980-5; Rosso LC, 2011, APPL MICROBIOL BIOT, V90, P1981, DOI 10.1007/s00253-011-3282-7; Ruijter GJG, 1997, FEMS MICROBIOL LETT, V151, P103, DOI 10.1016/S0378-1097(97)00161-4; Screen S, 1997, CURR GENET, V31, P511, DOI 10.1007/s002940050238; Screen S, 1998, GENE, V221, P17, DOI 10.1016/S0378-1119(98)00430-2; Segers R, 1996, MYCOL RES, V100, P421, DOI 10.1016/S0953-7562(96)80138-9; SEGERS R, 1994, MICROBIOL-SGM, V140, P2715, DOI 10.1099/00221287-140-10-2715; SEGERS R, 1996, THESIS U NOTTINGHAM; Seidl V, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-567; SHARON E, 1993, J NEMATOL, V25, P585; SORENSEN AB, 1993, J VIROL, V67, P7118; St Leger RJ, 1999, MICROBIOL-SGM, V145, P2691, DOI 10.1099/00221287-145-10-2691; St Leger RJ, 1998, APPL ENVIRON MICROB, V64, P709; STLEGER RJ, 1988, ARCH MICROBIOL, V150, P413, DOI 10.1007/BF00408316; STLEGER RJ, 1995, CAN J BOT, V73, pS1119, DOI 10.1139/b95-367; Suarez MB, 2007, CURR GENET, V51, P331, DOI 10.1007/s00294-007-0130-5; Sung GH, 2007, STUD MYCOL, P5, DOI 10.3114/sim.2007.57.01; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang CS, 2005, FUNGAL GENET BIOL, V42, P704, DOI 10.1016/j.fgb.2005.04.006; Wong KH, 2008, EUKARYOT CELL, V7, P917, DOI 10.1128/EC.00076-08; Zare R, 2001, NOVA HEDWIGIA, V73, P51; Zare R, 2004, MONOGRAPH VERTICIL S; Zou CG, 2010, ENVIRON MICROBIOL, V12, P3243, DOI 10.1111/j.1462-2920.2010.02296.x; Zou CG, 2010, ENVIRON MICROBIOL, V12, P1868, DOI 10.1111/j.1462-2920.2010.02191.x	61	47	50	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35657	10.1371/journal.pone.0035657	http://dx.doi.org/10.1371/journal.pone.0035657			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558192	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000044
J	Liu, WH; Wang, X; You, N; Tao, KS; Wang, T; Tang, LJ; Dou, KF				Liu, Wei-hui; Wang, Xing; You, Nan; Tao, Kai-shan; Wang, Tao; Tang, Li-jun; Dou, Ke-feng			Efficient Enrichment of Hepatic Cancer Stem-Like Cells from a Primary Rat HCC Model via a Density Gradient Centrifugation-Centered Method	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; SIDE POPULATION; STEM/PROGENITOR CELLS; BONE-MARROW; IDENTIFICATION; LIVER; EXPRESSION; CD133; SUBPOPULATION; MARKERS	Background: Because few definitive markers are available for hepatic cancer stem cells (HCSCs), based on physical rather than immunochemical properties, we applied a novel method to enrich HCSCs. Methodology: After hepatic tumor cells (HTCs) were first isolated from diethylinitrosamine-induced F344 rat HCC model using percoll discontinuous gradient centrifugation (PDGC) and purified via differential trypsinization and differential attachment (DTDA), they were separated into four fractions using percoll continuous gradient centrifugation (PCGC) and sequentially designated as fractions I-IV (FI-IV). Morphological characteristics, mRNA and protein levels of stem cell markers, proliferative abilities, induced differentiation, in vitro migratory capacities, in vitro chemo-resistant capacities, and in vivo malignant capacities were determined for the cells of each fraction. Findings: As the density of cells increased, 22.18%, 11.62%, 4.73% and 61.47% of primary cultured HTCs were segregated in FI-FIV, respectively. The cells from FIII (density between 1.041 and 1.062 g/ml) displayed a higher nuclear-cytoplasmic ratio and fewer organelles and expressed higher levels of stem cell markers (AFP, EpCAM and CD133) than cells from other fractions (P<0.01). Additionally, in vitro, the cells from FIII showed a greater capacity to self-renew, differentiate into mature HTCs, transit across membranes, close scratches, and carry resistance to chemotherapy than did cells from any other fraction; in vivo, injection of only 1x10(4) cells from FIII could generate tumors not only in subcutaneous tissue but also in the livers of nude mice. Conclusions: Through our novel method, HCSC-like cells were successfully enriched in FIII. This study will greatly contribute to two important areas of biological interest: CSC isolation and HCC therapy.	[Liu, Wei-hui; Wang, Tao; Tang, Li-jun] Gen Hosp Chengdu Army Reg, PLA Ctr Gen Surg, Chengdu, Sichuan Provinc, Peoples R China; [Liu, Wei-hui; Wang, Xing; You, Nan; Tao, Kai-shan; Wang, Tao; Dou, Ke-feng] Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian 710032, Shaanxi Provinc, Peoples R China	Air Force Military Medical University	Liu, WH (corresponding author), Gen Hosp Chengdu Army Reg, PLA Ctr Gen Surg, Chengdu, Sichuan Provinc, Peoples R China.	whjtlj@yahoo.com.cn; doukf2008@yahoo.cn			National Natural Science Foundation of China [81170419, 81172061, 8100309]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81170419, 81172061, 8100309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvi AJ, 2003, BREAST CANCER RES, V5, DOI 10.1186/bcr563; Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Baddoo M, 2003, J CELL BIOCHEM, V89, P1235, DOI 10.1002/jcb.10594; Bongiorno MR, 2008, DERMATOL THER, V21, pS1, DOI 10.1111/j.1529-8019.2008.00193.x; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Chang Yuhan, 2009, Chang Gung Med J, V32, P264; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Christ Bruno, 2011, Hepatology, V53, P1388, DOI 10.1002/hep.24222; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clay MR, 2010, HEAD NECK-J SCI SPEC, V32, P1195, DOI 10.1002/hed.21315; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Croce AC, 2007, PHOTOCH PHOTOBIO SCI, V6, P1202, DOI 10.1039/b707309g; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dekaney CM, 2005, GASTROENTEROLOGY, V129, P1567, DOI 10.1053/j.gastro.2005.08.011; Dou J, 2007, CELL MOL IMMUNOL, V4, P467; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Fiume L, 2005, J HEPATOL, V43, P645, DOI 10.1016/j.jhep.2005.02.045; Fujii T, 2008, HUM PATHOL, V39, P1185, DOI 10.1016/j.humpath.2007.12.010; Ghani FI, 2011, BIOCHEM BIOPH RES CO, V404, P735, DOI 10.1016/j.bbrc.2010.12.054; Gu GY, 2007, CANCER RES, V67, P4807, DOI 10.1158/0008-5472.CAN-06-4608; Hadnagy A, 2006, EXP CELL RES, V312, P3701, DOI 10.1016/j.yexcr.2006.08.030; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; HOHNE MW, 1993, MOL CARCINOGEN, V7, P180, DOI 10.1002/mc.2940070308; Hu G, 2012, INT J ONCOL, V40, P798, DOI 10.3892/ijo.2011.1254; Ikegami T, 2009, HEPATOL RES, V39, P847, DOI 10.1111/j.1872-034X.2009.00586.x; Janikova M, 2010, BIOMED PAP, V154, P321, DOI 10.5507/bp.2010.048; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Lingala S, 2010, EXP MOL PATHOL, V89, P27, DOI 10.1016/j.yexmp.2010.05.005; Liu CG, 2011, ANN SURG, V253, P1165, DOI 10.1097/SLA.0b013e318214c54e; Liu WH, 2011, STEM CELL REV REP, V7, P94, DOI 10.1007/s12015-010-9119-4; Liu WH, 2010, TOXICOL IN VITRO, V24, P538, DOI 10.1016/j.tiv.2009.11.008; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Ma S, 2008, MOL CANCER RES, V6, P1146, DOI 10.1158/1541-7786.MCR-08-0035; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Nagata T, 2011, ANTICANCER RES, V31, P495; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ono M, 2007, P NATL ACAD SCI USA, V104, P18700, DOI 10.1073/pnas.0704472104; Pogribny IP, 2007, MUTAT RES-FUND MOL M, V619, P30, DOI 10.1016/j.mrfmmm.2006.12.006; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Qiang L, 2009, CANCER LETT, V279, P13, DOI 10.1016/j.canlet.2009.01.016; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rosca AM, 2010, BIOTECHNOL APPL BIOC, V55, P199, DOI 10.1042/BA20090356; Salnikov AV, 2009, CANCER LETT, V275, P185, DOI 10.1016/j.canlet.2008.10.015; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Shen G, 2008, IN VITRO CELL DEV-AN, V44, P280, DOI 10.1007/s11626-008-9115-z; Shi MF, 2010, CELL MOL LIFE SCI, V67, P3915, DOI 10.1007/s00018-010-0420-9; Shigdar S, 2011, CANCER SCI, V102, P991, DOI 10.1111/j.1349-7006.2011.01897.x; Shimano K, 2003, AM J PATHOL, V163, P3, DOI 10.1016/S0002-9440(10)63624-3; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Shupe T, 2005, STEM CELL REV, V1, P261, DOI 10.1385/SCR:1:3:261; Singh SK, 2003, CANCER RES, V63, P5821; Song W, 2008, INT J CLIN PRACT, V62, P1212, DOI 10.1111/j.1742-1241.2008.01777.x; Su J, 2011, ARCH MED RES, V42, P15, DOI 10.1016/j.arcmed.2011.01.007; Suetsugi A, 2006, BIOCHEM BIOPH RES CO, V351, P820, DOI 10.1016/j.bbrc.2006.10.128; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Venere M, 2011, GLIA, V59, P1148, DOI 10.1002/glia.21185; Xu XJ, 2010, J MOL MED, V88, P1181, DOI 10.1007/s00109-010-0659-5; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yanai H, 2010, J BIOCHEM, V148, P85, DOI 10.1093/jb/mvq034; Yang W, 2008, CANCER RES, V68, P4287, DOI 10.1158/0008-5472.CAN-07-6691; Yang ZF, 2008, HEPATOLOGY, V47, P919, DOI 10.1002/hep.22082; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yu SC, 2008, CANCER LETT, V265, P124, DOI 10.1016/j.canlet.2008.02.010; Zhou ZH, 2009, CANCER LETT, V281, P92, DOI 10.1016/j.canlet.2009.02.033; Zito G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003544	67	12	16	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35720	10.1371/journal.pone.0035720	http://dx.doi.org/10.1371/journal.pone.0035720			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558209	Green Submitted, gold, Green Published			2022-12-25	WOS:000305345200071
J	Lopez-Moliner, J; Keil, MS				Lopez-Moliner, Joan; Keil, Matthias S.			People Favour Imperfect Catching by Assuming a Stable World	PLOS ONE			English	Article							TIME; INFORMATION; COMBINATION; CONSTRAINTS; INTEGRATION; DISPARITY; MOTION; TARGET; SIZE; CUES	The visual angle that is projected by an object (e. g. a ball) on the retina depends on the object's size and distance. Without further information, however, the visual angle is ambiguous with respect to size and distance, because equal visual angles can be obtained from a big ball at a longer distance and a smaller one at a correspondingly shorter distance. Failure to recover the true 3D structure of the object (e. g. a ball's physical size) causing the ambiguous retinal image can lead to a timing error when catching the ball. Two opposing views are currently prevailing on how people resolve this ambiguity when estimating time to contact. One explanation challenges any inference about what causes the retinal image (i.e. the necessity to recover this 3D structure), and instead favors a direct analysis of optic flow. In contrast, the second view suggests that action timing could be rather based on obtaining an estimate of the 3D structure of the scene. With the latter, systematic errors will be predicted if our inference of the 3D structure fails to reveal the underlying cause of the retinal image. Here we show that hand closure in catching virtual balls is triggered by visual angle, using an assumption of a constant ball size. As a consequence of this assumption, hand closure starts when the ball is at similar distance across trials. From that distance on, the remaining arrival time, therefore, depends on ball's speed. In order to time the catch successfully, closing time was coupled with ball's speed during the motor phase. This strategy led to an increased precision in catching but at the cost of committing systematic errors.	[Lopez-Moliner, Joan; Keil, Matthias S.] Univ Barcelona, Dept Psicol Basica, Catalonia, Spain; [Lopez-Moliner, Joan; Keil, Matthias S.] Inst Brain Cognit & Behav IR3C, Catalonia, Spain	University of Barcelona	Lopez-Moliner, J (corresponding author), Univ Barcelona, Dept Psicol Basica, Catalonia, Spain.	j.lopezmoliner@ub.edu		Lopez-Moliner, Joan/0000-0001-5040-8889	Ministry of Science and Innovation [PSI2010-15867]; Catalan government [SGR2009-00308]; Ramon and Cajal program from the Spanish government	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Catalan government; Ramon and Cajal program from the Spanish government	This research was supported by the Ministry of Science and Innovation: PSI2010-15867, and SGR2009-00308 from the Catalan government. MSK was supported by the Ramon and Cajal program from the Spanish government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battaglia PW, 2005, ACM INT C P SERIES, V95, P145, DOI DOI 10.1145/1080402.1080430; Berniker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012686; Billington J, 2010, P ROYAL SOC B, V278, P1476; Brouwer AM, 2005, EXP BRAIN RES, V165, P28, DOI 10.1007/s00221-005-2277-y; Caljouw SR, 2004, EXP BRAIN RES, V155, P427, DOI 10.1007/s00221-003-1739-3; DeLucia PR, 2003, Q J EXP PSYCHOL-A, V56, P1165, DOI 10.1080/02724980343000053; Dessing JC, 2004, ECOL PSYCHOL, V16, P1, DOI 10.1207/s15326969eco1601_1; Faisal AA, 2009, J NEUROPHYSIOL, V101, P1901, DOI 10.1152/jn.90974.2008; Field DT, 2005, CURR BIOL, V15, P453, DOI 10.1016/j.cub.2004.12.081; Fink PW, 2009, J VISION, V9, DOI 10.1167/9.13.14; Glennerster A, 2006, CURR BIOL, V16, P428, DOI 10.1016/j.cub.2006.01.019; Gray R, 1998, VISION RES, V38, P499, DOI 10.1016/S0042-6989(97)00230-7; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; LACQUANITI F, 1989, J NEUROSCI, V9, P134, DOI 10.1523/JNEUROSCI.09-01-00134.1989; LEE DN, 1981, NATURE, V293, P293, DOI 10.1038/293293a0; LEE DN, 1976, PERCEPTION, V5, P437, DOI 10.1068/p050437; Lopez-Moliner J, 2007, PERCEPT PSYCHOPHYS, V69, P887, DOI 10.3758/BF03193925; Lopez-Moliner J, 2010, EXP BRAIN RES, V206, P409, DOI 10.1007/s00221-010-2421-1; Lopez-Moliner J, 2007, J VISION, V7, DOI 10.1167/7.13.11; MANSFIELD RJ, 1973, VISION RES, V13, P2219, DOI 10.1016/0042-6989(73)90224-1; MCBEATH MK, 1995, SCIENCE, V268, P569, DOI 10.1126/science.7725104; McLeod P, 2006, J EXP PSYCHOL HUMAN, V32, P139, DOI 10.1037/0096-1523.32.1.139; Miyazaki M, 2005, J NEUROPHYSIOL, V94, P395, DOI 10.1152/jn.01168.2004; PARDUCCI A, 1965, PSYCHOL REV, V72, P407, DOI 10.1037/h0022602; PEPER L, 1994, J EXP PSYCHOL HUMAN, V20, P591, DOI 10.1037/0096-1523.20.3.591; REGAN D, 1979, VISION RES, V19, P1331, DOI 10.1016/0042-6989(79)90205-0; REGAN D, 1993, VISION RES, V33, P447, DOI 10.1016/0042-6989(93)90252-R; Rushton SK, 1999, NAT NEUROSCI, V2, P186, DOI 10.1038/5750; Rushton SK, 2004, THEORIES TIME TO CON, P327; SAVELSBERGH GJP, 1991, J EXP PSYCHOL HUMAN, V17, P315, DOI 10.1037/0096-1523.17.2.315; Smith MRH, 2001, J EXP PSYCHOL HUMAN, V27, P395, DOI 10.1037//0096-1523.27.2.395; Sun HJ, 1998, NAT NEUROSCI, V1, P296, DOI 10.1038/1110; Tassinari H, 2006, J NEUROSCI, V26, P10154, DOI 10.1523/JNEUROSCI.2779-06.2006; TRESILIAN JR, 1990, PERCEPTION, V19, P223, DOI 10.1068/p190223; Tresilian JR, 1999, TRENDS COGN SCI, V3, P301, DOI 10.1016/S1364-6613(99)01352-2; Tresilian JR, 2002, EXP BRAIN RES, V142, P193, DOI 10.1007/s00221-001-0920-9; Wann JP, 1996, J EXP PSYCHOL HUMAN, V22, P1031, DOI 10.1037/0096-1523.22.4.1031; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Yuille A, 2006, TRENDS COGN SCI, V10, P301, DOI 10.1016/j.tics.2006.05.002	39	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35705	10.1371/journal.pone.0035705	http://dx.doi.org/10.1371/journal.pone.0035705			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VP	22558205	gold, Green Published, Green Submitted			2022-12-25	WOS:000305345200069
J	Wu, CM; Feng, JJ; Wang, R; Liu, H; Yang, HX; Rodriguez, PL; Qin, HJ; Liu, X; Wang, DW				Wu, Chongming; Feng, Juanjuan; Wang, Ran; Liu, Hong; Yang, Huixia; Rodriguez, Pedro L.; Qin, Huanju; Liu, Xin; Wang, Daowen			HRS1 Acts as a Negative Regulator of Abscisic Acid Signaling to Promote Timely Germination of Arabidopsis Seeds	PLOS ONE			English	Article							MEMBRANE H+-ATPASE; PROTEIN PHOSPHATASE 2C; ROOT-GROWTH; ABA; ELONGATION; INHIBITION; DORMANCY; GENE; THALIANA; ABI1	In this work, we conducted functional analysis of Arabidopsis HRS1 gene in order to provide new insights into the mechanisms governing seed germination. Compared with wild type (WT) control, HRS1 knockout mutant (hrs1-1) exhibited significant germination delays on either normal medium or those supplemented with abscisic acid (ABA) or sodium chloride (NaCl), with the magnitude of the delay being substantially larger on the latter media. The hypersensitivity of hrs1-1 germination to ABA and NaCl required ABI3, ABI4 and ABI5, and was aggravated in the double mutant hrs1-1abi1-2 and triple mutant hrs1-1hab1-1abi1-2, indicating that HRS1 acts as a negative regulator of ABA signaling during seed germination. Consistent with this notion, HRS1 expression was found in the embryo axis, and was regulated both temporally and spatially, during seed germination. Further analysis showed that the delay of hrs1-1 germination under normal conditions was associated with reduction in the elongation of the cells located in the lower hypocotyl (LH) and transition zone (TZ) of embryo axis. Interestingly, the germination rate of hrs1-1 was more severely reduced by the inhibitor of cell elongation, and more significantly decreased by the suppressors of plasmalemma H+-ATPase activity, than that of WT control. The plasmalemma H+-ATPase activity in the germinating seeds of hrs1-1 was substantially lower than that exhibited by WT control, and fusicoccin, an activator of this pump, corrected the transient germination delay of hrs1-1. Together, our data suggest that HRS1 may be needed for suppressing ABA signaling in germinating embryo axis, which promotes the timely germination of Arabidopsis seeds probably by facilitating the proper function of plasmalemma H+-ATPase and the efficient elongation of LH and TZ cells.	[Wu, Chongming; Feng, Juanjuan; Wang, Ran; Liu, Hong; Yang, Huixia; Qin, Huanju; Liu, Xin; Wang, Daowen] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China; [Wu, Chongming; Feng, Juanjuan; Wang, Ran; Liu, Hong; Yang, Huixia] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Rodriguez, Pedro L.] Univ Politecn Valencia, Consejo Super Invest Cient, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Wu, CM (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China.	dwwang@genetics.ac.cn	Wu, Chongming/AAQ-9085-2021; Wu, Chongming/GOJ-9081-2022; Rodriguez, Pedro L./K-4605-2014	Rodriguez, Pedro L./0000-0002-5886-9425; wang, dao wen/0000-0002-6230-8735; Wu, Chongming/0000-0003-2898-370X	National Natural Science Foundation of China [30821061]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (30821061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belin C, 2009, PLANT CELL, V21, P2253, DOI 10.1105/tpc.109.067702; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; BOVE J, 2001, GENOME BIOL, V3, DOI DOI 10.1186/GB-2001-3-1-REVIEWS1002; Brocard IM, 2002, PLANT PHYSIOL, V129, P1533, DOI 10.1104/pp.005793; Brocard-Gifford IM, 2003, PLANT PHYSIOL, V131, P78, DOI 10.1104/pp.011916; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Czechowski T, 2005, THESIS U POTSDAM GER; Drechsel G, 2010, J PLANT PHYSIOL, V167, P1418, DOI 10.1016/j.jplph.2010.05.010; Enriquez-Arredondo C, 2005, PLANT SCI, V169, P11, DOI 10.1016/j.plantsci.2005.01.021; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; Graeber K, 2010, PLANT MOL BIOL, V73, P67, DOI 10.1007/s11103-009-9583-x; Guo JJ, 2009, J EXP BOT, V60, P3819, DOI 10.1093/jxb/erp221; Hager A, 2003, J PLANT RES, V116, P483, DOI 10.1007/s10265-003-0110-x; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Hubbard KE, 2010, GENE DEV, V24, P1695, DOI 10.1101/gad.1953910; JOHANSSON F, 1993, PLANT CELL, V5, P321, DOI 10.2307/3869599; Kinoshita N, 2010, PLANT CELL PHYSIOL, V51, P239, DOI 10.1093/pcp/pcp183; Linkies A, 2012, PLANT CELL REP, V31, P253, DOI 10.1007/s00299-011-1180-1; Linkies A, 2009, PLANT CELL, V21, P3803, DOI 10.1105/tpc.109.070201; Liu H, 2009, J INTEGR PLANT BIOL, V51, P382, DOI 10.1111/j.1744-7909.2009.00819.x; Liu PP, 2007, PLANT J, V52, P133, DOI 10.1111/j.1365-313X.2007.03218.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Molina L, 2001, P NATL ACAD SCI USA, V98, P4782, DOI 10.1073/pnas.081594298; Lopez-Molina L, 2002, PLANT J, V32, P317, DOI 10.1046/j.1365-313X.2002.01430.x; Merlot S, 2001, PLANT J, V25, P295, DOI 10.1046/j.1365-313x.2001.00965.x; Mesenko MM, 2005, RUSS J PLANT PHYSL+, V52, P497, DOI 10.1007/s11183-005-0073-y; Mito T, 2011, PLANT BIOTECHNOL J, V9, P736, DOI 10.1111/j.1467-7652.2010.00578.x; Muller K, 2009, PLANT PHYSIOL, V150, P1855, DOI 10.1104/pp.109.139204; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nambara E, 2002, GENETICS, V161, P1247; Nambara E, 2000, DEV BIOL, V220, P412, DOI 10.1006/dbio.2000.9632; Nishimura N, 2007, PLANT J, V50, P935, DOI 10.1111/j.1365-313X.2007.03107.x; Okamoto M, 2006, PLANT PHYSIOL, V141, P97, DOI 10.1104/pp.106.079475; ONEILL SD, 1984, PLANT PHYSIOL, V75, P586, DOI 10.1104/pp.75.3.586; Penfield S, 2006, PLANT CELL, V18, P1887, DOI 10.1105/tpc.106.041277; Penfield S, 2009, P ROY SOC B-BIOL SCI, V276, P3561, DOI 10.1098/rspb.2009.0592; Piskurewicz U, 2008, PLANT CELL, V20, P2729, DOI 10.1105/tpc.108.061515; Qin C, 2008, P NATL ACAD SCI USA, V105, P18308, DOI 10.1073/pnas.0806168105; Roelfsema MRG, 1998, PHYSIOL PLANTARUM, V103, P466, DOI 10.1034/j.1399-3054.1998.1030404.x; Rubio S, 2009, PLANT PHYSIOL, V150, P1345, DOI 10.1104/pp.109.137174; Saez A, 2004, PLANT J, V37, P354, DOI 10.1046/j.1365-313X.2003.01966.x; Saez A, 2006, PLANT PHYSIOL, V141, P1389, DOI 10.1104/pp.106.081018; Sliwinska E, 2009, J EXP BOT, V60, P3587, DOI 10.1093/jxb/erp203; Sveinsdottira H, 2009, J PLANT PHYSIOL, V166, P128, DOI 10.1016/j.jplph.2008.01.012; Taylor NJ, 2007, J PLANT PHYSIOL, V164, P1612, DOI 10.1016/j.jplph.2006.11.008; TIMSON J, 1965, NATURE, V207, P216, DOI 10.1038/207216a0; van den Wijngaard PWJ, 2005, PLANT J, V41, P43, DOI 10.1111/j.1365-313X.2004.02273.x; Weitbrecht K, 2011, J EXP BOT, V62, P3289, DOI 10.1093/jxb/err030; Xi WY, 2010, PLANT CELL, V22, P1733, DOI 10.1105/tpc.109.073072; Yan F, 1998, PLANT PHYSIOL, V117, P311, DOI 10.1104/pp.117.1.311; Yang H, 2009, FUNCT PLANT BIOL, V36, P1; Zhang X, 2004, PLANT PHYSIOL, V136, P4150, DOI 10.1104/pp.104.046573; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	57	32	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35764	10.1371/journal.pone.0035764	http://dx.doi.org/10.1371/journal.pone.0035764			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545134	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343200054
J	Casteel, CL; Hansen, AK; Walling, LL; Paine, TD				Casteel, Clare L.; Hansen, Allison K.; Walling, Linda L.; Paine, Timothy D.			Manipulation of Plant Defense Responses by the Tomato Psyllid (Bactericerca cockerelli) and Its Associated Endosymbiont Candidatus Liberibacter Psyllaurous	PLOS ONE			English	Article							APHID BREVICORYNE-BRASSICAE; MEDIATED INTERACTIONS; INSECT VECTOR; ARABIDOPSIS; IMMUNITY; PHYTOPLASMA; MECHANISMS; RESISTANCE; SALICYLATE; PATHOGENS	Some plant pathogens form obligate relationships with their insect vector and are vertically transmitted via eggs analogous to insect endosymbionts. Whether insect endosymbionts manipulate plant defenses to benefit their insect host remains unclear. The tomato psyllid, Bactericerca cockerelli (Sulc), vectors the endosymbiont "Candidatus Liberibacter psyllaurous" (Lps) during feeding on tomato (Solanum lycopersicum L.). Lps titer in psyllids varied relative to the psyllid developmental stage with younger psyllids harboring smaller Lps populations compared to older psyllids. In the present study, feeding by different life stages of B. cockerelli infected with Lps, resulted in distinct tomato transcript profiles. Feeding by young psyllid nymphs, with lower Lps levels, induced tomato genes regulated by jasmonic acid (JA) and salicylic acid (SA) (Allene oxide synthase, Proteinase inhibitor 2, Phenylalanine ammonia-lyase 5, Pathogenesis-related protein 1) compared to feeding by older nymphs and adults, where higher Lps titers were found. In addition, inoculation of Lps without insect hosts suppressed accumulation of these defense transcripts. Collectively, these data suggest that the endosymbiont-like pathogen Lps manipulates plant signaling and defensive responses to benefit themselves and the success of their obligate insect vector on their host plant.	[Casteel, Clare L.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Hansen, Allison K.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Walling, Linda L.] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Paine, Timothy D.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Walling, Linda L.; Paine, Timothy D.] Univ Calif Riverside, Ctr Dis Vector Res, Riverside, CA 92521 USA	Cornell University; Boyce Thompson Institute for Plant Research; Yale University; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside	Casteel, CL (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	clc269@cornell.edu		Hansen, Allison/0000-0002-3066-5527	TIGR; NSF [IOS 0804008]	TIGR; NSF(National Science Foundation (NSF))	This research was funded partially by a grant from TIGR to TDP and CLC for cDNA microarrays and processing and an NSF grant (IOS 0804008) to LLW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch RB, 2006, NAT REV MOL CELL BIO, V7, P601, DOI 10.1038/nrm1984; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bhattarai KK, 2007, MOL PLANT MICROBE IN, V20, P276, DOI 10.1094/MPMI-20-3-0276; Bhattarai KK, 2010, PLANT J, V63, P229, DOI 10.1111/j.1365-313X.2010.04232.x; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Broekgaarden C, 2008, PLANT CELL ENVIRON, V31, P1592, DOI 10.1111/j.1365-3040.2008.01871.x; Carter RD, 1950, TOXICITY PARATRIOZA; Chang S, 1993, PLANT MOL BIOL REP, V11, P113, DOI DOI 10.1007/BF02670468; Chao WS, 1999, PLANT PHYSIOL, V120, P979, DOI 10.1104/pp.120.4.979; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Davis M. J., 1981, PROKARYOTES, P2172; Davis MJ, 1998, CURR MICROBIOL, V36, P80, DOI 10.1007/s002849900283; de Ilarduya OM, 2003, MOL PLANT MICROBE IN, V16, P699, DOI 10.1094/MPMI.2003.16.8.699; Delp G, 2009, MOL GENET GENOMICS, V281, P233, DOI 10.1007/s00438-008-0409-3; DOUGLAS AE, 1992, J INSECT PHYSIOL, V38, P565, DOI 10.1016/0022-1910(92)90107-O; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Felton GW, 2008, CURR OPIN PLANT BIOL, V11, P457, DOI 10.1016/j.pbi.2008.07.001; Frosch M, 1983, J APPL ENTOMOL, V95, P310; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gao LL, 2007, MOL PLANT MICROBE IN, V20, P82, DOI 10.1094/MPMI-20-0082; Gatineau F, 2002, PHYTOPATHOLOGY, V92, P384, DOI 10.1094/PHYTO.2002.92.4.384; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Hansen AK, 2008, APPL ENVIRON MICROB, V74, P5862, DOI 10.1128/AEM.01268-08; HARTLEY JL, 1993, PCR METH APPL, V3, pS10; Howe GA, 2004, J PLANT GROWTH REGUL, V23, P223, DOI 10.1007/s00344-004-0030-6; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Kempema LA, 2007, PLANT PHYSIOL, V143, P849, DOI 10.1104/pp.106.090662; KNOWLTON GEORGE F., 1934, JOUR ECON ENT, V27, P547, DOI 10.1093/jee/27.2.547; Koga R, 2003, P ROY SOC B-BIOL SCI, V270, P2543, DOI 10.1098/rspb.2003.2537; Kusnierczyk A, 2008, PLANT CELL ENVIRON, V31, P1097, DOI 10.1111/j.1365-3040.2008.01823.x; Leon-Reyes A, 2010, PLANTA, V232, P1423, DOI 10.1007/s00425-010-1265-z; Liefting LW, 2009, PLANT DIS, V93, P208, DOI 10.1094/PDIS-93-3-0208; LIN H, 2011, PLOS ONE, V6; List GM, 1939, COLORADO AGR EXPT ST; McSteen P, 2008, DEV CELL, V14, P467, DOI 10.1016/j.devcel.2008.03.013; Mur LAJ, 2006, PLANT PHYSIOL, V140, P249, DOI 10.1104/pp.105.072348; Nachappa P, 2012, PHYTOPATHOLOGY, V102, P41, DOI 10.1094/PHYTO-03-11-0084; Nachappa P, 2011, CURR MICROBIOL, V62, P1510, DOI 10.1007/s00284-011-9885-5; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Pieterse CMJ, 2007, TRENDS PLANT SCI, V12, P564, DOI 10.1016/j.tplants.2007.09.004; PLETSCH D. J., 1947, Bull. Mont. agric. Exp. Stn., V446; PURCELL AH, 1982, ANNU REV PHYTOPATHOL, V20, P397, DOI 10.1146/annurev.py.20.090182.002145; Puthoff DP, 2010, J CHEM ECOL, V36, P1271, DOI 10.1007/s10886-010-9868-1; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rensink WA, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-124; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Semetey O, 2007, EUR J PLANT PATHOL, V117, P187, DOI 10.1007/s10658-006-9087-3; Stout MJ, 2006, ANNU REV ENTOMOL, V51, P663, DOI 10.1146/annurev.ento.51.110104.151117; TAKABAYASHI J, 1995, J CHEM ECOL, V21, P273, DOI 10.1007/BF02036717; Tang JY, 2006, J EXP BOT, V57, P527, DOI 10.1093/jxb/erj032; Thaler JS, 2010, ECOLOGY, V91, P1075, DOI 10.1890/08-2347.1; VANDENBERG MA, 1992, ISRAEL J ENTOMOL, V25, P51; Verhage A, 2010, PLANT PHYSIOL, V154, P536, DOI 10.1104/pp.110.161570; Walling LL, 2009, ADV BOT RES, V51, P551, DOI 10.1016/S0065-2296(09)51013-0; WALLIS R. L., 1955, Technical Bulletin. United States Department of Agriculture; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Zarate SI, 2007, PLANT PHYSIOL, V143, P866, DOI 10.1104/pp.106.090035; Zhang PJ, 2009, P NATL ACAD SCI USA, V106, P21202, DOI 10.1073/pnas.0907890106	60	80	86	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35191	10.1371/journal.pone.0035191	http://dx.doi.org/10.1371/journal.pone.0035191			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539959	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341000023
J	Fimognari, C; Lenzi, M; Sestili, P; Turrini, E; Ferruzzi, L; Hrelia, P; Cantelli-Forti, G				Fimognari, Carmela; Lenzi, Monia; Sestili, Piero; Turrini, Eleonora; Ferruzzi, Lorenzo; Hrelia, Patrizia; Cantelli-Forti, Giorgio			Sulforaphane Potentiates RNA Damage Induced by Different Xenobiotics	PLOS ONE			English	Article							IN-VITRO; PHENETHYL ISOTHIOCYANATE; SUPEROXIDE GENERATION; CELLULAR ACCUMULATION; ALKYLATION DAMAGE; OXIDATIVE STRESS; CANCER; THIOREDOXIN; GLUTATHIONE; APOPTOSIS	Background: The isothiocyanate sulforaphane (SFN) possesses interesting anticancer activities. However, recent studies reported that SFN promotes the formation of reactive oxygen species (ROS) as well as DNA breakage. Methodology/Principal Findings: We investigated whether SFN is able to damage RNA, whose loss of integrity was demonstrated in different chronic diseases. Considering the ability of SFN to protect from genotoxicity, we also examined whether SFN is able to protect from RNA damage induced by different chemicals (doxorubicin, spermine, S-nitroso-N-acetylpenicillamine, H2O2). We observed that SFN was devoid of either RNA damaging and RNA protective activity in human leukemic cells. It was able to potentiate the RNA damage by doxorubicin and spermine. In the first case, the effect was attributable to its ability of modulating the bioreductive activation of doxorubicin. For spermine, the effects were mainly due to its modulation of ROS levels produced by spermine metabolism. As to the cytotoxic relevance of the RNA damage, we found that the treatment of cells with a mixture of spermine or doxorubicin plus SFN increased their proapoptotic potential. Thus it is conceivable that the presence of RNA damage might concur to the overall toxic response induced by a chemical agent in targeted cells. Conclusions/Significance: Since RNA is emerging as a potential target for anticancer drugs, its ability to enhance spermine- and doxorubicin-induced RNA damage and cytotoxicity could represent an additional mechanism for the potentiating effects of SFN associated with anticancer drugs.	[Fimognari, Carmela; Lenzi, Monia; Turrini, Eleonora; Ferruzzi, Lorenzo; Hrelia, Patrizia; Cantelli-Forti, Giorgio] Univ Bologna, Dept Pharmacol, Alma Mater Studiorum, Bologna, Italy; [Sestili, Piero] Univ Studi Urbino, Dipartimento Scienze Biomol, Urbino, Italy	University of Bologna; University of Urbino	Fimognari, C (corresponding author), Univ Bologna, Dept Pharmacol, Alma Mater Studiorum, Bologna, Italy.	carmela.fimognari@unibo.it	Turrini, Eleonora/I-3629-2019; Hrelia, Patrizia/AAC-2071-2020; Sestili, Piero/H-6082-2019; Fimognari, Carmela/J-7678-2019	Turrini, Eleonora/0000-0003-4743-1126; Sestili, Piero/0000-0001-9412-1660; Fimognari, Carmela/0000-0002-2461-8214; HRELIA, Patrizia/0000-0002-8415-3711	Ministero dell'Istruzione dell'Universita e della Ricerca [2007SSZMPK]; FIRB Piattaforme/Reti (Basic Research Investment Fund Platforms/Networks) [RBPR05NWWC_002]	Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); FIRB Piattaforme/Reti (Basic Research Investment Fund Platforms/Networks)	This work was supported by Ministero dell'Istruzione dell'Universita e della Ricerca (http://sitouniversitario.cineca.it; grant number: 2007SSZMPK) and FIRB Piattaforme/Reti 2006 (Basic Research Investment Fund Platforms/Networks 2006) (http://sitofirb.cineca.it; grant number: RBPR05NWWC_002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Antosiewicz J, 2008, PLANTA MED, V74, P1570, DOI 10.1055/s-2008-1081307; Arnold U, 2006, BIOTECHNOL LETT, V28, P1615, DOI 10.1007/s10529-006-9145-0; Baltimore D, 2001, NATURE, V409, P814, DOI 10.1038/35057267; Barcelo S, 1996, CARCINOGENESIS, V17, P277, DOI 10.1093/carcin/17.2.277; Bellacosa A, 2003, CURR BIOL, V13, pR482, DOI 10.1016/S0960-9822(03)00408-1; Bregeon D, 2005, MUTAT RES-FUND MOL M, V577, P293, DOI 10.1016/j.mrfmmm.2005.04.002; Chen YR, 2002, J BIOL CHEM, V277, P39334, DOI 10.1074/jbc.M202070200; Cheung KL, 2010, AAPS J, V12, P87, DOI 10.1208/s12248-009-9162-8; Cho SD, 2005, NUTR CANCER, V52, P213, DOI 10.1207/s15327914nc5202_11; Clarke JD, 2008, CANCER LETT, V269, P291, DOI 10.1016/j.canlet.2008.04.018; Conaway CC, 2001, CHEM RES TOXICOL, V14, P1170, DOI 10.1021/tx010029w; Das KC, 2000, BIOCHEM BIOPH RES CO, V277, P443, DOI 10.1006/bbrc.2000.3689; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Drobnica J., 1977, CYANATES THEIR THIO, P1003; Fahey JW, 1997, P NATL ACAD SCI USA, V94, P10367, DOI 10.1073/pnas.94.19.10367; Fimognari C, 2005, ENVIRON MOL MUTAGEN, V46, P260, DOI 10.1002/em.20156; Fimognari C, 2005, MUTAT RES-GEN TOX EN, V582, P1, DOI 10.1016/j.mrgentox.2004.11.019; Fimognari C, 2008, MUTAT RES-FUND MOL M, V648, P15, DOI 10.1016/j.mrfmmm.2008.09.003; Fimognari C, 2007, MUTAT RES-REV MUTAT, V635, P90, DOI 10.1016/j.mrrev.2006.10.004; Fimognari C, 2009, MUTAT RES-FUND MOL M, V670, P59, DOI 10.1016/j.mrfmmm.2009.07.005; Gaona-Gaona L, 2011, TOXICOLOGY, V286, P20, DOI 10.1016/j.tox.2011.04.014; Hacker A, 2008, CANCER CHEMOTH PHARM, V63, P45, DOI 10.1007/s00280-008-0706-x; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; HOUEN G, 1994, ACTA CHEM SCAND, V48, P52, DOI 10.3891/acta.chem.scand.48-0052; Hu Y, 2007, BIOL CHEM, V388, P1069, DOI 10.1515/BC.2007.135; Iordanov MS, 2000, CANCER RES, V60, P1983; Kallifatidis G, 2011, MOL THER, V19, P188, DOI 10.1038/mt.2010.216; Kawakami M, 2005, BIOSCI BIOTECH BIOCH, V69, P2439, DOI 10.1271/bbb.69.2439; Kim H, 2006, CANCER RES, V66, P1740, DOI 10.1158/0008-5472.CAN-05-1568; Kirsch-Volders M, 2003, MUTAT RES-GEN TOX EN, V540, P153, DOI 10.1016/j.mrgentox.2003.07.005; Martinet W, 2004, EUR J CLIN INVEST, V34, P323, DOI 10.1111/j.1365-2362.2004.01343.x; Martinet Wim, 2005, RNA Biol, V2, P4, DOI 10.4161/rna.2.1.1430; Miyoshi N, 2004, CARCINOGENESIS, V25, P567, DOI 10.1093/carcin/bgh051; Mustacich D, 2000, BIOCHEM J, V346, P1, DOI 10.1042/0264-6021:3460001; Nunomura A, 2007, CURR MED CHEM, V14, P2968, DOI 10.2174/092986707782794078; Nunomura A, 1999, J NEUROSCI, V19, P1959; Nunomura A, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/200682323; Nunomura A, 2006, J NEUROPATH EXP NEUR, V65, P631, DOI 10.1097/01.jnen.0000228136.58062.bf; Oliveira CJR, 2008, NITRIC OXIDE-BIOL CH, V18, P241, DOI 10.1016/j.niox.2008.02.001; Rausch V, 2010, CANCER RES, V70, P5004, DOI 10.1158/0008-5472.CAN-10-0066; Ravi D, 2004, CANCER CHEMOTH PHARM, V54, P449, DOI 10.1007/s00280-004-0833-y; RHEE Y, 1995, NUCLEIC ACIDS RES, V23, P3275, DOI 10.1093/nar/23.16.3275; Rodon J, 2010, ONCOLOGIST, V15, P37, DOI 10.1634/theoncologist.2009-0117; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Schulenhurg C, 2007, CANCER BIOL THER, V6, P1233; Sestili P, 2010, MUTAT RES-FUND MOL M, V689, P65, DOI 10.1016/j.mrfmmm.2010.05.003; Sharmin S, 2001, BIOCHEM BIOPH RES CO, V282, P228, DOI 10.1006/bbrc.2001.4569; Singh SV, 2005, J BIOL CHEM, V280, P19911, DOI 10.1074/jbc.M412443200; Sinha-Hikim I, 2010, AM J PHYSIOL-CELL PH, V299, pC638, DOI 10.1152/ajpcell.00434.2009; SMITH JA, 1993, J IMMUNOL METHODS, V162, P261, DOI 10.1016/0022-1759(93)90391-J; Tafech A, 2006, CURR MED CHEM, V13, P863, DOI 10.2174/092986706776361021; Wang LG, 2010, INT J ONCOL, V37, P533, DOI 10.3892/ijo_00000702; Witte I, 2007, TOXICOL SCI, V97, P21, DOI 10.1093/toxsci/kfl192; Yoshida K, 2008, TRENDS MOL MED, V14, P305, DOI 10.1016/j.molmed.2008.05.003; Zhang JS, 2003, CARCINOGENESIS, V24, P497, DOI 10.1093/carcin/24.3.497; Zhang YS, 2001, CARCINOGENESIS, V22, P425, DOI 10.1093/carcin/22.3.425; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Zhang YS, 2002, BIOCHEM J, V364, P301, DOI 10.1042/bj3640301; Zhang YS, 2000, CARCINOGENESIS, V21, P1175, DOI 10.1093/carcin/21.6.1175	60	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35267	10.1371/journal.pone.0035267	http://dx.doi.org/10.1371/journal.pone.0035267			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539965	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341000029
J	Liu, Y; Hei, Y; Shu, QM; Dong, J; Gao, YP; Fu, HJ; Zheng, XF; Yang, G				Liu, Yu; Hei, Yan; Shu, Qingming; Dong, Jie; Gao, Yaping; Fu, Hanjiang; Zheng, Xiaofei; Yang, Guang			VCP/p97, Down-Regulated by microRNA-129-5p, Could Regulate the Progression of Hepatocellular Carcinoma	PLOS ONE			English	Article							VALOSIN-CONTAINING-PROTEIN; NF-KAPPA-B; ELEVATED EXPRESSION; INDUCED APOPTOSIS; CANCER; P97; PROGNOSIS; ATPASE; CELLS; LIVER	Valosin containing protein (VCP)/p97 plays various important roles in cells. Moreover, elevated expression of VCP in hepatocellular carcinoma (HCC) is correlated with increased incidence of recurrence. But the role of VCP in HCC progression in vitro and in vivo is unclear. And there are few reports about the regulation mechanism on the expression of VCP in HCC. In this study, it was identified that the level of VCP was frequently increased in human HCC tissues. In addition, down-regulation of VCP with siRNAs could dramatically suppress the genesis and progression of tumor in vivo. It was found that miR-129-5p directly inhibited the expression of VCP in several HCC cell lines. Meanwhile, the level of VCP in HCC tissues was negatively associated with the level of miR-129-5p. Our further investigation showed that the enhanced expression of miR-129-5p also suppressed tumor growth in vivo. Moreover, it was revealed that miR-129-5p could inhibit the degradation of I kappa B alpha and increase the apoptosis and reduce the migration of HCC cells by suppressing the expression of VCP. Our results revealed that the expression of VCP was directly regulated by miR-129-5p and this regulation played an important role in the progression of HCC.	[Liu, Yu; Dong, Jie; Gao, Yaping; Yang, Guang] Beijing Inst Basic Med Sci, Beijing, Peoples R China; [Hei, Yan; Shu, Qingming] Peoples Armed Police Corps Gen Hosp, Beijing, Peoples R China; [Fu, Hanjiang; Zheng, Xiaofei] Beijing Inst Radiat Med, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Academy of Military Medical Sciences - China	Yang, G (corresponding author), Beijing Inst Basic Med Sci, Beijing, Peoples R China.	yanggg@hotmail.com		Fu, Hanjiang/0000-0002-4352-1178	Chinese National Key Program on Basic Research [2010CB529101, 2010CB912801]	Chinese National Key Program on Basic Research	This work was supported by grants from the Chinese National Key Program on Basic Research (2010CB529101, 2010CB912801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2008, J CELL BIOCHEM, V105, P1461, DOI 10.1002/jcb.21966; Asai T, 2002, JPN J CANCER RES, V93, P296, DOI 10.1111/j.1349-7006.2002.tb02172.x; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; Du B, 1999, Pathol Oncol Res, V5, P214, DOI 10.1053/paor.1999.0217; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Huang YW, 2009, CANCER RES, V69, P9038, DOI 10.1158/0008-5472.CAN-09-1499; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Krajewska M, 1996, AM J PATHOL, V148, P1567; Lee TKW, 2011, HEPATOLOGY, V53, P160, DOI 10.1002/hep.24000; Li S, 2009, HEPATOLOGY, V49, P1194, DOI 10.1002/hep.22757; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Qiu Y, 2007, AM J PATHOL, V170, P152, DOI 10.2353/ajpath.2007.060722; RABOUILLE C, 1995, CELL, V82, P905, DOI 10.1016/0092-8674(95)90270-8; Schulze-Bergkamen H, 2004, SEMIN ONCOL, V31, P90, DOI 10.1053/j.seminoncol.2003.11.006; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Tsujimoto Y, 2004, CLIN CANCER RES, V10, P3007, DOI 10.1158/1078-0432.CCR-03-0191; Wang Y, 2008, J BIOL CHEM, V283, P13205, DOI 10.1074/jbc.M707629200; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Wu JJ, 2010, CELL CYCLE, V9, P1809, DOI 10.4161/cc.9.9.11535; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Yamamoto S, 2004, CLIN CANCER RES, V10, P5558, DOI 10.1158/1078-0432.CCR-0723-03; Yamamoto S, 2004, ANN ONCOL, V15, P1432, DOI 10.1093/annonc/mdh354; Yamamoto S, 2004, CLIN CANCER RES, V10, P651, DOI 10.1158/1078-0432.CCR-1576-03; Yamamoto S, 2003, J CLIN ONCOL, V21, P447, DOI 10.1200/JCO.2003.06.068; Yu MC, 2000, CAN J GASTROENTEROL, V14, P703, DOI 10.1155/2000/371801; Zeng CX, 2010, HEPATOLOGY, V52, P1702, DOI 10.1002/hep.23875	34	75	80	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35800	10.1371/journal.pone.0035800	http://dx.doi.org/10.1371/journal.pone.0035800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536440	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339200113
J	Maravelias, CD; Tserpes, G; Pantazi, M; Peristeraki, P				Maravelias, Christos D.; Tserpes, George; Pantazi, Maria; Peristeraki, Panagiota			Habitat Selection and Temporal Abundance Fluctuations of Demersal Cartilaginous Species in the Aegean Sea (Eastern Mediterranean)	PLOS ONE			English	Article							TRENDS; SHARKS; FISH	Predicting the occurrence of keystone top predators in a multispecies marine environment, such as the Mediterranean Sea, can be of considerable value to the long-term sustainable development of the fishing industry and to the protection of biodiversity. We analysed fisheries independent scientific bottom trawl survey data of two of the most abundant cartilaginous fish species (Scyliorhinus canicula, Raja clavata) in the Aegean Sea covering an 11-year sampling period. The current findings revealed a declining trend in R. clavata and S. canicula abundance from the late '90 s until 2004. Habitats with the higher probability of finding cartilaginous fish present were those located in intermediate waters (depth: 200-400 m). The present results also indicated a preferential species' clustering in specific geographic and bathymetric regions of the Aegean Sea. Depth appeared to be one of the key determining factors for the selection of habitats for all species examined. With cartilaginous fish species being among the more biologically sensitive fish species taken in European marine fisheries, our findings, which are based on a standardized scientific survey, can contribute to the rational exploitation and management of their stocks by providing important information on temporal abundance trends and habitat preferences.	[Maravelias, Christos D.; Pantazi, Maria] Hellen Ctr Marine Res, Anavyssos, Attica, Greece; [Tserpes, George; Peristeraki, Panagiota] Hellen Ctr Marine Res, Iraklion, Crete, Greece	Hellenic Centre for Marine Research; Hellenic Centre for Marine Research	Maravelias, CD (corresponding author), Hellen Ctr Marine Res, Anavyssos, Attica, Greece.	cmaravel@hcmr.gr	Tserpes, George/L-6201-2013; Maravelias, Christos/W-4151-2019	Tserpes, George/0000-0001-9052-4091; Maravelias, Christos/0000-0002-2440-3707				Aldebert Y, 1997, VIE MILIEU, V47, P275; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2000, BIOL MAR MEDITERR; Baino Romano, 2001, Rapport du Congress de la CIESM, V36, P234; Bertrand JA, 2002, SCI MAR, V66, P9, DOI 10.3989/scimar.2002.66s29; Damalas D, 2011, FISH RES, V108, P142, DOI 10.1016/j.fishres.2010.12.012; Damalas D, 2010, ESTUAR COAST SHELF S, V89, P107, DOI 10.1016/j.ecss.2010.06.002; Davis J.C., 1986, STAT DATA ANAL GEOLO; FAO, 1995, FAD FISHERIES TECHNI, V350, P52; Ferretti F., 2005, ICES 2005 ANN SCI C; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Fowler SL, 2005, SHARKS RAYS CHIMAERA; GoldenSoftware, 2002, SURF VERS 8; Hastie TJ., 1990, GEN ADDITIVE MODELS; Maravelias CD, 1997, MAR ECOL PROG SER, V159, P151, DOI 10.3354/meps159151; Relini G., 2000, Biologia Marina Mediterranea, V7, P347; Serena F, 2005, 1 INT S MAN BIOL DOG; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Tserpes G, 2002, SCI MAR, V66, P243, DOI 10.3989/scimar.2002.66s2243; Walker P, 2005, SHARKS RAYS CHIMAERA, P86; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2000, J ROY STAT SOC B, V62, P413, DOI 10.1111/1467-9868.00240; [No title captured]; [No title captured]	25	26	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35474	10.1371/journal.pone.0035474	http://dx.doi.org/10.1371/journal.pone.0035474			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536389	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339200069
J	Vaz, MCM; Rocha-Santos, TAP; Rocha, RJM; Lopes, I; Pereira, R; Duarte, AC; Rubec, PJ; Calado, R				Vaz, Marcela C. M.; Rocha-Santos, Teresa A. P.; Rocha, Rui J. M.; Lopes, Isabel; Pereira, Ruth; Duarte, Armando C.; Rubec, Peter J.; Calado, Ricardo			Excreted Thiocyanate Detects Live Reef Fishes Illegally Collected Using Cyanide-A Non-Invasive and Non-Destructive Testing Approach	PLOS ONE			English	Article							RAINBOW-TROUT; EXTINCTION; CORALS	Cyanide fishing is a method employed to capture marine fish alive on coral reefs. They are shipped to markets for human consumption in Southeast Asia, as well as to supply the marine aquarium trade worldwide. Although several techniques can be used to detect cyanide in reef fish, there is still no testing method that can be used to survey the whole supply chain. Most methods for cyanide detection are time-consuming and require the sacrifice of the sampled fish. Thiocyanate anion (SCN-) is a metabolite produced by the main metabolic pathway for cyanide anion (CN-) detoxification. Our study employed an optical fiber (OF) methodology (analytical time <6 min) to detect SCN- in a non-invasive and non-destructive manner. Our OF methodology is able to detect trace levels (>3.16 mu g L-1) of SCN- in seawater. Given that marine fish exposed to cyanide excrete SCN- in the urine, elevated levels of SCN- present in the seawater holding live reef fish indicate that the surveyed specimens were likely exposed to cyanide. In our study, captive-bred clownfish (Amphiprion clarkii) pulse exposed for 60 s to either 12.5 or 25 mg L-1 of CN- excreted up to 6.96 +/- 0.03 and 9.84 +/- 0.03 mu g L-1 of SCN-, respectively, during the 28 days following exposure. No detectable levels of SCN- were recorded in the water holding control organisms not exposed to CN-, or in synthetic seawater lacking fish. While further research is necessary, our methodology allow a rapid detection of SCN- in the holding water and can be used as a screening tool to indicate if live reef fish were collected with cyanide.	[Vaz, Marcela C. M.; Rocha, Rui J. M.; Lopes, Isabel; Pereira, Ruth; Calado, Ricardo] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Vaz, Marcela C. M.; Rocha-Santos, Teresa A. P.; Rocha, Rui J. M.; Lopes, Isabel; Pereira, Ruth; Duarte, Armando C.; Calado, Ricardo] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [Rocha-Santos, Teresa A. P.; Duarte, Armando C.] Univ Aveiro, Dept Quim, P-3800 Aveiro, Portugal; [Rocha-Santos, Teresa A. P.] Inst Piaget, ISEIT Viseu, Lordosa, Viseu, Portugal; [Rubec, Peter J.] Int Marinelife Alliance, St Petersburg, FL USA	Universidade de Aveiro; Universidade de Aveiro; Universidade de Aveiro	Calado, R (corresponding author), Univ Aveiro, Dept Biol, Campus Univ Santiago, P-3800 Aveiro, Portugal.	rjcalado@hotmail.com	Duarte, Armando/C-1424-2008; Rocha, Rui/AAP-9828-2021; Pereira, Ruth/AAY-3535-2021; Calado, Ricardo Jorge Guerra/C-7035-2008; Lopes, Isabel/C-2858-2009; Rocha, Rui Miranda/F-5201-2011; Rocha-Santos, Teresa/A-2355-2009	Duarte, Armando/0000-0002-4868-4099; Rocha, Rui/0000-0002-4385-6074; Pereira, Ruth/0000-0001-6857-5968; Calado, Ricardo Jorge Guerra/0000-0002-1670-9335; Lopes, Isabel/0000-0002-9325-0329; Rocha, Rui Miranda/0000-0002-4385-6074; Rocha-Santos, Teresa/0000-0003-3660-4116	Portuguese Science Foundation (FCT, Portugal) [SFRH/BD/46675/2008, SFRH/BPD/65410/2009]; Programa Ciencia (FCT, FSE and POPH); CESAM, University of Aveiro	Portuguese Science Foundation (FCT, Portugal)(Portuguese Foundation for Science and Technology); Programa Ciencia (FCT, FSE and POPH); CESAM, University of Aveiro	This work has been developed under the scope of the Portuguese Science Foundation (FCT, Portugal) research grants SFRH/BD/46675/2008 (to RJMR) and SFRH/BPD/65410/2009 (to TAPR-S), as well as Programa Ciencia 2007 (funded by FCT, FSE and POPH) (to IL, RP and RC). The research performed was partly financed by a starting grant of CESAM, University of Aveiro (to RC). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Baghshani H, 2010, COMP CLIN PATHOL, P1; Barber CV., 1997, SULLIED SEAS STRATEG; BROWN DG, 1995, ECOTOX ENVIRON SAFE, V30, P302, DOI 10.1006/eesa.1995.1034; Bruckner A. W., 2008, P INT CYAN DET TEST; Burke L., 2011, REEFS RISK REVISITED; Cervino JM, 2003, MAR POLLUT BULL, V46, P573, DOI 10.1016/S0025-326X(03)00071-7; Cinner JE, 2009, CURR BIOL, V19, P206, DOI 10.1016/j.cub.2008.11.055; Cooper WJ, 2009, MOL PHYLOGENET EVOL, V52, P1, DOI 10.1016/j.ympev.2008.12.010; Derivera CE, 2007, MAR BIOL, V150, P1275, DOI 10.1007/s00227-006-0451-9; DIXON DG, 1981, ARCH ENVIRON CON TOX, V10, P117, DOI 10.1007/BF01057580; DonMcAllister E., 1999, SECRETARIAT PACIFIC, V5, P18; Evans DH, 2006, PHYSL FISHES; Fabinyi M, 2011, MAR POLICY, V35, P371, DOI 10.1016/j.marpol.2010.11.001; Hanawa M., 1998, Aquarium Sciences and Conservation, V2, P21, DOI 10.1007/BF00466403; Isom GE, 2010, COMPREHENSIVE TOXICOLOGY, VOL 4: BIOTRANSFORMATION, 2ND EDITION, P485; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Jones RJ, 1999, MAR ECOL PROG SER, V177, P83, DOI 10.3354/meps177083; Jones RJ, 1997, MAR FRESHWATER RES, V48, P517, DOI 10.1071/MF97048; Lanno RP, 1996, AQUAT TOXICOL, V36, P177, DOI 10.1016/S0166-445X(96)00815-6; Leduc G., 1984, AQUAT TOXICOL, V2, P153; Logue BA, 2010, CRIT REV ANAL CHEM, V40, P122, DOI 10.1080/10408340903535315; Ma JA, 2010, ANAL CHIM ACTA, V673, P117, DOI 10.1016/j.aca.2010.05.042; Mak KKW, 2005, BIOSENS BIOELECTRON, V20, P2581, DOI 10.1016/j.bios.2004.09.015; Mak KKW, 2005, MICROCHIM ACTA, V149, P131, DOI 10.1007/s00604-004-0286-3; Moorhead JA, 2010, REV FISH SCI, V18, P315, DOI 10.1080/10641262.2010.516035; Munday PL, 2004, GLOBAL CHANGE BIOL, V10, P1642, DOI 10.1111/j.1365-2486.2004.00839.x; Olivotto I, 2011, J WORLD AQUACULT SOC, V42, P135, DOI 10.1111/j.1749-7345.2011.00453.x; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pet J., 1998, SPC LIVE REEF FISH I, V4, P17; RAYMOND P, 1986, CAN J FISH AQUAT SCI, V43, P2017, DOI 10.1139/f86-247; Reopanichkul P, 2009, MAR POLLUT BULL, V58, P1356, DOI 10.1016/j.marpolbul.2009.04.024; Riegl B, 2009, ANN NY ACAD SCI, V1162, P136, DOI 10.1111/j.1749-6632.2009.04493.x; Riepen, 1995, ENV EC SOCIAL IMPLIC; Rubec P. J., 2001, AQUARIUM SCI CONSERV, V3, P37, DOI DOI 10.1023/A:1011370106291; Rubec PJ, 2003, MARINE ORNAMENTAL SPECIES: COLLECTION, CULTURE & CONSERVATION, P327; Rubec PJ, 2008, P INT CYAN DET TEST, P43; Sadovy YJ, 2003, WHILE STOCKS LAST LI; Silva LIB, 2011, J ENVIRON MONITOR, V13, P1811, DOI 10.1039/c1em10043b; Varsamos S, 2005, COMP BIOCHEM PHYS A, V141, P401, DOI 10.1016/j.cbpb.2005.01.013; Wabnitz C, 2003, OCEAN AQUARIUM; Zar JH, 1999, BIOSTATISTICAL ANAL	41	15	15	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35355	10.1371/journal.pone.0035355	http://dx.doi.org/10.1371/journal.pone.0035355			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536375	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339200060
J	Bambang, IF; Lee, YK; Richardson, DR; Zhang, D				Bambang, I. F.; Lee, Y. K.; Richardson, D. R.; Zhang, D.			Endoplasmic reticulum protein 29 regulates epithelial cell integrity during the mesenchymal-epithelial transition in breast cancer cells	ONCOGENE			English	Article						ERp29; tight junctions; cell polarity; mesenchymal-epithelial transition; epithelial morphogenesis	E-CADHERIN EXPRESSION; TIGHT JUNCTIONS; METASTATIC PROGRESSION; TUMOR PROGRESSION; UP-REGULATION; LIGHT-CHAIN; MYOSIN-II; POLARITY; COMPLEX; ERP29	The epithelial-mesenchymal transition (EMT) correlates with disruption of cell-cell adhesion, loss of cell polarity and development of epithelial cell malignancy. Identifying novel molecules that inhibit EMT has profound potential for developing mechanism-based therapeutics. We previously demonstrated that the endoplasmic reticulum protein 29 (ERp29) is a novel factor that can drive mesenchymal-epithelial transition (MET) and induce cell growth arrest in MDA-MB-231 cells. Here, we show that ERp29 is an important molecule in establishing epithelial cell integrity during the MET. We demonstrate that ERp29 regulates MET in a cell context-dependent manner. ERp29 overexpression induced a complete MET in mesenchymal MDA-MB-231 cells through downregulating the expression of transcriptional repressors (for example, Slug, Snai1, ZEB2 and Twist) of E-cadherin. In contrast, overexpression of ERp29 induces incomplete MET in basal-like BT549 cells in which the expression of EMT-related markers (for example, vimentin; cytokeratin 19 (CK19) and E-cadherin) and the transcriptional repressors of E-cadherin were not altered. However, ERp29 overexpression in both cell-types resulted in loss of filamentous stress fibers, formation of cortical actin and restoration of an epithelial phenotype. Mechanistic studies revealed that overexpression of ERp29 in both cell-types upregulated the expression of TJ proteins (zonula-occludens-1 (ZO-1) and occludin) and the core apical-basal polarity proteins (Par3 and Scribble) at the membrane to enhance cell-cell contact and cell polarization. Knockdown of ERp29 in the epithelial MCF-7 cells decreased the expression of these proteins, leading to the disruption of cell-cell adhesion. Taken together, ERp29 is a novel molecule that regulates MET and epithelial cell integrity in breast cancer cells. Oncogene (2013) 32, 1240-1251; doi:10.1038/onc.2012.149; published online 30 April 2012	[Bambang, I. F.; Zhang, D.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pathol, Singapore 117595, Singapore; [Bambang, I. F.; Lee, Y. K.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore; [Richardson, D. R.; Zhang, D.] Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia; [Richardson, D. R.; Zhang, D.] Univ Sydney, Bosch Inst, Iron Metab & Chelat Program, Sydney, NSW 2006, Australia	National University of Singapore; National University of Singapore; University of Sydney; University of Sydney	Zhang, D (corresponding author), Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia.	d.richardson@med.usyd.edu.au; daohai.zhang@sydney.edu.au		Richardson, Des/0000-0002-5506-3274; Richardson, Des/0000-0003-0960-6415	National Health and Medical Research Council of Australia; Agency of Science, Technology and Research-Biomedical Research Council in Singapore (A*STAR-BMRC) [07/1/21/19/496]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Agency of Science, Technology and Research-Biomedical Research Council in Singapore (A*STAR-BMRC)(Agency for Science Technology & Research (A*STAR))	DRR thanks the National Health and Medical Research Council of Australia for a Senior Principal Research Fellowship. This research was performed in DZ's laboratory in the National University of Singapore and was sponsored by an Individual Research Grant awarded to DZ from the Agency of Science, Technology and Research-Biomedical Research Council in Singapore (A*STAR-BMRC 07/1/21/19/496).	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Auersperg N, 1999, P NATL ACAD SCI USA, V96, P6249, DOI 10.1073/pnas.96.11.6249; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Bambang IF, 2009, LAB INVEST, V89, P1229, DOI 10.1038/labinvest.2009.87; Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Baryshev M, 2006, BIOCHEM BIOPH RES CO, V340, P617, DOI 10.1016/j.bbrc.2005.12.052; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cereijido M, 1998, ANNU REV PHYSIOL, V60, P161, DOI 10.1146/annurev.physiol.60.1.161; Chaffer CL, 2005, CLIN EXP METASTAS, V22, P115, DOI 10.1007/s10585-005-5141-3; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Coradini D, 2011, ACTA PHARMACOL SIN, V32, P552, DOI 10.1038/aps.2011.20; Das S, 2009, MOL BIOL CELL, V20, P2593, DOI 10.1091/mbc.E08-07-0790; De Craene B, 2005, CELL SIGNAL, V17, P535, DOI 10.1016/j.cellsig.2004.10.011; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Farmaki E, 2011, BBA-MOL CELL RES, V1813, P1165, DOI 10.1016/j.bbamcr.2011.03.003; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Gao DM, 2012, LAB INVEST, V92, P200, DOI 10.1038/labinvest.2011.163; Gardiol D, 2006, INT J CANCER, V119, P1285, DOI 10.1002/ijc.21982; Garrod D, 1996, CURR OPIN CELL BIOL, V8, P670, DOI 10.1016/S0955-0674(96)80108-6; Gibson MC, 2003, CURR OPIN CELL BIOL, V15, P747, DOI 10.1016/j.ceb.2003.10.008; Graff JR, 2000, J BIOL CHEM, V275, P2727, DOI 10.1074/jbc.275.4.2727; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hirohashi S, 1998, AM J PATHOL, V153, P333, DOI 10.1016/S0002-9440(10)65575-7; Hoover KB, 1998, AM J PATHOL, V153, P1767, DOI 10.1016/S0002-9440(10)65691-X; Huang L, 2010, CURR OPIN GENET DEV, V20, P41, DOI 10.1016/j.gde.2009.12.001; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hunter MP, 2010, AM J PHYSIOL-CELL PH, V299, pC21, DOI 10.1152/ajpcell.00543.2009; IMHOF BA, 1983, CELL, V35, P667, DOI 10.1016/0092-8674(83)90099-5; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Katoh K, 2001, AM J PHYSIOL-CELL PH, V280, pC1669, DOI 10.1152/ajpcell.2001.280.6.C1669; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Latorre IJ, 2005, J CELL SCI, V118, P4283, DOI 10.1242/jcs.02560; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Martin TA, 2004, EUR J CANCER, V40, P2717, DOI 10.1016/j.ejca.2004.08.008; Niessen CM, 2007, J INVEST DERMATOL, V127, P2525, DOI 10.1038/sj.jid.5700865; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Qi L, 2012, MED ONCOL, V29, P721, DOI 10.1007/s12032-011-9929-5; Ren XD, 2004, J CELL SCI, V117, P3511, DOI 10.1242/jcs.01205; RODRIGUEZBOULAN E, 1992, ANNU REV CELL BIOL, V8, P395, DOI 10.1146/annurev.cb.08.110192.002143; Ross DT, 2001, DIS MARKERS, V17, P99, DOI 10.1155/2001/850531; Rothenberg SM, 2010, CANCER RES, V70, P2158, DOI 10.1158/0008-5472.CAN-09-3458; Royer C, 2011, CELL DEATH DIFFER, V18, P1470, DOI 10.1038/cdd.2011.60; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Shnyder SD, 2008, J PROTEOME RES, V7, P3364, DOI 10.1021/pr800126n; SIMONS K, 1990, CELL, V62, P207, DOI 10.1016/0092-8674(90)90357-K; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Swisshelm K, 2005, ADV DRUG DELIVER REV, V57, P919, DOI 10.1016/j.addr.2005.01.006; Tanos B, 2008, ONCOGENE, V27, P6939, DOI 10.1038/onc.2008.345; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; Watanabe T, 2007, MOL BIOL CELL, V18, P605, DOI 10.1091/mbc.E06-07-0590; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zen K, 2009, ONCOGENE, V28, P2910, DOI 10.1038/onc.2009.148; Zhang DH, 2010, EXP CELL RES, V316, P3522, DOI 10.1016/j.yexcr.2010.08.014	64	27	30	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 7	2013	32	10					1240	1251		10.1038/onc.2012.149	http://dx.doi.org/10.1038/onc.2012.149			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110OP	22543584				2022-12-25	WOS:000316454500005
J	Kammerer, R; Ruttiger, L; Riesenberg, R; Schauble, C; Krupar, R; Kamp, A; Sunami, K; Eisenried, A; Hennenberg, M; Grunert, F; Bress, A; Battaglia, S; Schrewe, H; Knipper, M; Schneider, MR; Zimmermann, W				Kammerer, Robert; Ruettiger, Lukas; Riesenberg, Rainer; Schaeuble, Constanze; Krupar, Rosemarie; Kamp, Annegret; Sunami, Kishiko; Eisenried, Andreas; Hennenberg, Martin; Grunert, Fritz; Bress, Andreas; Battaglia, Sebastiano; Schrewe, Heinrich; Knipper, Marlies; Schneider, Marlon R.; Zimmermann, Wolfgang			Loss of Mammal-specific Tectorial Membrane Component Carcinoembryonic Antigen Cell Adhesion Molecule 16 (CEACAM16) Leads to Hearing Impairment at Low and High Frequencies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER HAIR-CELLS; TONOTOPIC AXIS; ALPHA-TECTORIN; CEA FAMILY; INNER-EAR; RECEPTOR; MURINE; MOUSE; DOMAIN; MICE	The vertebrate-restricted carcinoembryonic antigen gene family evolves extremely rapidly. Among their widely expressed members, the mammal-specific, secreted CEACAM16 is exceptionally well conserved and specifically expressed in the inner ear. To elucidate a potential auditory function, we inactivated murine Ceacam16 by homologous recombination. In young Ceacam16(-/-) mice the hearing threshold for frequencies below 10 kHz and above 22 kHz was raised. This hearing impairment progressed with age. A similar phenotype is observed in hearing-impaired members of Family 1070 with non-syndromic autosomal dominant hearing loss (DFNA4) who carry a missense mutation in CEACAM16. CEACAM16 was found in interdental and Deiters cells and was deposited in the tectorial membrane of the cochlea between postnatal days 12 and 15, when hearing starts in mice. In cochlear sections of Ceacam16(-/-) mice tectorial membranes were significantly more often stretched out as compared with wild-type mice where they were mostly contracted and detached from the outer hair cells. Homotypic cell sorting observed after ectopic cell surface expression of the carboxyl-terminal immunoglobulin variable-like N2 domain of CEACAM16 indicated that CEACAM16 can interact in trans. Furthermore, Western blot analyses of CEACAM16 under reducing and non-reducing conditions demonstrated oligomerization via unpaired cysteines. Taken together, CEACAM16 can probably form higher order structures with other tectorial membrane proteins such as alpha-tectorin and beta-tectorin and influences the physical properties of the tectorial membrane. Evolution of CEACAM16 might have been an important step for the specialization of the mammalian cochlea, allowing hearing over an extended frequency range.	[Kammerer, Robert] Friedrich Loeffler Inst, Inst Immunol, D-17493 Greifswald, Germany; [Ruettiger, Lukas; Bress, Andreas; Knipper, Marlies] Univ Tubingen, Dept Otorhinolaryngol, Hearing Res Ctr Tubingen, D-72076 Tubingen, Germany; [Riesenberg, Rainer; Schaeuble, Constanze; Krupar, Rosemarie; Kamp, Annegret; Eisenried, Andreas; Zimmermann, Wolfgang] Univ Clin Munich, Tumor Immunol Lab, LIFE Ctr, D-81377 Munich, Germany; [Sunami, Kishiko] Osaka City Univ, Dept Otolaryngol, Sch Med, Osaka 5458585, Japan; [Hennenberg, Martin] Univ Clin Munich, Dept Urol, D-81377 Munich, Germany; [Battaglia, Sebastiano; Schrewe, Heinrich] Aldevron Freiburg, D-79111 Freiburg, Germany; [Grunert, Fritz] Charite, Inst Med Genet CBF, D-12203 Berlin, Germany; [Grunert, Fritz] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Schneider, Marlon R.] Univ Munich, Inst Mol Anim Breeding & Biotechnol, Gene Ctr, D-81377 Munich, Germany	Friedrich Loeffler Institute; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich; Osaka Metropolitan University; University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; University of Munich	Zimmermann, W (corresponding author), Univ Munich, Tumor Immunol Lab, LIFE Ctr, Univ Hosp Munich, Marchioninistr 23, D-81377 Munich, Germany.	wolfgang.zimmermann@med.uni-muenchen.de	Kammerer, Robert/AAQ-1338-2021; Zimmermann, Wolfgang/L-9277-2013; Hennenberg, Martin/M-3474-2016	Kammerer, Robert/0000-0003-3038-8205; Schneider, Marlon/0000-0002-9570-3491	Faculty of Medicine, University of Munich	Faculty of Medicine, University of Munich	This work was supported in part by the FoFoLe program of the Faculty of Medicine, University of Munich, and is part of the doctoral theses of Constanze Schauble, Rosemarie Krupar, and Annegret Kamp at the University of Munich.	Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; Conrad M, 2003, BIOTECHNIQUES, V34, P1136, DOI 10.2144/03346bm03; Deans MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012765; Engel J, 2006, NEUROSCIENCE, V143, P837, DOI 10.1016/j.neuroscience.2006.08.060; Finkenzeller D, 2003, MOL CELL BIOL, V23, P272, DOI 10.1128/MCB.23.1.272-279.2003; Gerstel D, 2011, ONCOGENE, V30, P4275, DOI 10.1038/onc.2011.146; Goodyear RJ, 2002, J NEUROBIOL, V53, P212, DOI 10.1002/neu.10097; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; HASKO JA, 1988, HEARING RES, V35, P21, DOI 10.1016/0378-5955(88)90037-8; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; Kammerer R, 2004, J PATHOL, V204, P258, DOI 10.1002/path.1657; Kammerer R, 2001, J IMMUNOL, V166, P6537, DOI 10.4049/jimmunol.166.11.6537; Kammerer R, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-12; Klaile E, 2009, J CELL BIOL, V187, P553, DOI 10.1083/jcb.200904149; Knipper M, 2000, J NEUROPHYSIOL, V83, P3101, DOI 10.1152/jn.2000.83.5.3101; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Lee HSW, 2008, J IMMUNOL, V180, P6827, DOI 10.4049/jimmunol.180.10.6827; Lee SJ, 2008, GASTROENTEROLOGY, V135, P2084, DOI 10.1053/j.gastro.2008.08.007; Legan PK, 2000, NEURON, V28, P273, DOI 10.1016/S0896-6273(00)00102-1; Leung N, 2008, ONCOGENE, V27, P4943, DOI 10.1038/onc.2008.136; Li CX, 2009, EXP CELL RES, V315, P1225, DOI 10.1016/j.yexcr.2008.12.015; LIM DJ, 1987, HEARING RES, V28, P9; NobenTrauth N, 1996, TRANSGENIC RES, V5, P487, DOI 10.1007/BF01980214; OBRINK B, 1991, BIOESSAYS, V13, P227, DOI 10.1002/bies.950130505; Pan H, 2010, IMMUNITY, V33, P620, DOI 10.1016/j.immuni.2010.10.009; Pils S, 2008, INT J MED MICROBIOL, V298, P553, DOI 10.1016/j.ijmm.2008.04.005; Rau A, 1999, J COMP NEUROL, V405, P271; Russell IJ, 2007, NAT NEUROSCI, V10, P215, DOI 10.1038/nn1828; RYAN A, 1975, NATURE, V253, P44, DOI 10.1038/253044a0; Sarantis H, 2007, CELL MICROBIOL, V9, P2167, DOI 10.1111/j.1462-5822.2007.00947.x; Schimmang T, 2003, DEVELOPMENT, V130, P4741, DOI 10.1242/dev.00676; Simmler MC, 2000, NAT GENET, V24, P139, DOI 10.1038/72793; Slevogt H, 2008, NAT IMMUNOL, V9, P1270, DOI 10.1038/ni.1661; Tan KM, 2002, EMBO J, V21, P2076, DOI 10.1093/emboj/21.9.2076; THALMANN I, 1993, CONNECT TISSUE RES, V29, P191, DOI 10.3109/03008209309016826; Verpy E, 2008, NATURE, V456, P255, DOI 10.1038/nature07380; Verpy E, 2011, J COMP NEUROL, V519, P194, DOI 10.1002/cne.22509; Zebhauser R, 2005, GENOMICS, V86, P566, DOI 10.1016/j.ygeno.2005.07.008; Zheng J, 2011, P NATL ACAD SCI USA, V108, P4218, DOI 10.1073/pnas.1005842108	39	35	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21584	21598		10.1074/jbc.M111.320481	http://dx.doi.org/10.1074/jbc.M111.320481			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22544735	Green Published, hybrid			2022-12-25	WOS:000306418600003
J	Khromov, AS; Momotani, K; Jin, L; Artamonov, MV; Shannon, J; Eto, M; Somlyo, AV				Khromov, Alexander S.; Momotani, Ko; Jin, Li; Artamonov, Mykhaylo V.; Shannon, John; Eto, Masumi; Somlyo, Avril V.			Molecular Mechanism of Telokin-mediated Disinhibition of Myosin Light Chain Phosphatase and cAMP/cGMP-induced Relaxation of Gastrointestinal Smooth Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHOA/RHO KINASE PATHWAY; RHO-ASSOCIATED KINASE; PROTEIN PHOSPHATASE; CA2+ SENSITIZATION; SIGNAL-TRANSDUCTION; HEAVY-MEROMYOSIN; IN-VIVO; PHOSPHORYLATION; SUBUNIT; INHIBITION	Phospho-telokin is a target of elevated cyclic nucleotide concentrations that lead to relaxation of gastrointestinal and some vascular smooth muscles (SM). Here, we demonstrate that in telokin-null SM, both Ca2+-activated contraction and Ca(2+)sensitization of force induced by a GST-MYPT1(654-880) fragment inhibiting myosin light chain phosphatase were antagonized by the addition of recombinant S13D telokin, without changing the inhibitory phosphorylation status of endogenous MYPT1 (the regulatory subunit of myosin light chain phosphatase) at Thr-696/Thr-853 or activity of Rho kinase. Cyclic nucleotide-induced relaxation of force in telokin-null ileum muscle was reduced but not correlated with a change in MYPT1 phosphorylation. The 40% inhibited activity of phosphorylated MYPT1 in telokin-null ileum homogenates was restored to nonphosphorylated MYPT1 levels by addition of S13D telokin. Using the GST-MYPT1 fragment as a ligand and SM homogenates from WT and telokin KO mice as a source of endogenous proteins, we found that only in the presence of endogenous telokin, thiophospho-GST-MYPT1 co-precipitated with phospho-20-kDa myosin regulatory light chain 20 and PP1. Surface plasmon resonance studies showed that S13D telokin bound to full-length phospho-MYPT1. Results of a protein ligation assay also supported interaction of endogenous phosphorylated MYPT1 with telokin in SM cells. We conclude that the mechanism of action of phospho-telokin is not through modulation of the MYPT1 phosphorylation status but rather it contributes to cyclic nucleotide-induced relaxation of SM by interacting with and activating the inhibited full-length phospho-MYPT1/PP1 through facilitating its binding to phosphomyosin and thus accelerating 20-kDa myosin regulatory light chain dephosphorylation.	[Khromov, Alexander S.; Momotani, Ko; Jin, Li; Artamonov, Mykhaylo V.; Somlyo, Avril V.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Shannon, John] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Eto, Masumi] Thomas Jefferson Univ, Dept Mol Physiol & Biophys, Philadelphia, PA 19107 USA	University of Virginia; University of Virginia; Jefferson University	Somlyo, AV (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA.	avs5u@virginia.edu	Artamonov, Mykhaylo/AAD-3488-2021; Eto, Masumi/ABE-4700-2020	Artamonov, Mykhaylo/0000-0002-0848-2054; Eto, Masumi/0000-0002-0651-5836	National Institutes of Health [R01 DK088905]; NIGMS [R01 GM086457]; School of Medicine, University of Virginia; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); School of Medicine, University of Virginia; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK088905 (to A. V. S. and M. E.) and Grant R01 GM086457 from NIGMS (to A. V. S.).; We thank Howard Phipps for excellent help in preparation of the manuscript. SPR analysis was performed in the Biomolecular Research Facility, which is supported by the School of Medicine, University of Virginia. We are grateful to Bartosz Zieba for production of recombinant telokins.	Bolz SS, 2003, CIRCULATION, V107, P3081, DOI 10.1161/01.CIR.0000074202.19612.8C; Choudhury N, 2004, J MUSCLE RES CELL M, V25, P657, DOI 10.1007/s10974-004-7807-x; ETO M, 1995, J BIOCHEM, V118, P1104, DOI 10.1093/oxfordjournals.jbchem.a124993; Feng JH, 1999, J BIOL CHEM, V274, P3744, DOI 10.1074/jbc.274.6.3744; GALLAGHER PJ, 1991, J BIOL CHEM, V266, P23945; Given AM, 2007, AM J PHYSIOL-CELL PH, V292, pC432, DOI 10.1152/ajpcell.00175.2006; Guilluy C, 2005, BRIT J PHARMACOL, V146, P1010, DOI 10.1038/sj.bjp.0706408; Hartshorne DJ, 1998, J MUSCLE RES CELL M, V19, P325, DOI 10.1023/A:1005385302064; Herring BP, 1996, AM J PHYSIOL-CELL PH, V270, pC1656, DOI 10.1152/ajpcell.1996.270.6.C1656; Hilgers RHP, 2007, J HYPERTENS, V25, P1687, DOI 10.1097/HJH.0b013e32816f778d; Hofmann F, 2005, J BIOL CHEM, V280, P1, DOI 10.1074/jbc.R400035200; Ichikawa K, 1996, J BIOL CHEM, V271, P4733; IKEBE M, 1988, J BIOL CHEM, V263, P10698; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; ITO M, 1989, J BIOL CHEM, V264, P13971; Johnson D, 1997, EUR J BIOCHEM, V244, P931, DOI 10.1111/j.1432-1033.1997.00931.x; Kandabashi T, 2000, CIRCULATION, V101, P1319, DOI 10.1161/01.CIR.101.11.1319; Karandikar M, 1999, CELL CALCIUM, V26, P219, DOI 10.1054/ceca.1999.0074; Kawano S, 1999, J BIOL CHEM, V274, P2085, DOI 10.1074/jbc.274.4.2085; Khatri JJ, 2001, J BIOL CHEM, V276, P37250, DOI 10.1074/jbc.M105275200; Khromov A, 2009, J BIOL CHEM, V284, P21569, DOI 10.1074/jbc.M109.019729; Khromov AS, 2006, P NATL ACAD SCI USA, V103, P2440, DOI 10.1073/pnas.0508566103; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Koyama M, 2000, FEBS LETT, V475, P197, DOI 10.1016/S0014-5793(00)01654-9; Lee MR, 1997, J BIOL CHEM, V272, P5063, DOI 10.1074/jbc.272.8.5063; Levine RJC, 1996, BIOPHYS J, V71, P898, DOI 10.1016/S0006-3495(96)79293-7; MacDonald JA, 2001, P NATL ACAD SCI USA, V98, P2419, DOI 10.1073/pnas.041331498; MacDonald JA, 2000, FEBS LETT, V479, P83, DOI 10.1016/S0014-5793(00)01884-6; Madden JA, 2008, AM J PHYSIOL-LUNG C, V294, pL1166, DOI 10.1152/ajplung.00375.2007; Masato T, 1997, J BIOCHEM, V121, P225; Michael SK, 2008, P NATL ACAD SCI USA, V105, P6702, DOI 10.1073/pnas.0802128105; Mori D, 2011, NEUROGASTROENT MOTIL, V23, P1111, DOI 10.1111/j.1365-2982.2011.01799.x; Muranyi A, 2002, BIOCHEM J, V366, P211, DOI 10.1042/BJ20020401; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; Nakamura K, 2007, CIRC RES, V101, P712, DOI 10.1161/CIRCRESAHA.107.153981; Neppl RL, 2009, J BIOL CHEM, V284, P6348, DOI 10.1074/jbc.M807040200; Puetz S., 2010, ACTA PHYSL, V198; Puetz S, 2009, PHYSIOLOGY, V24, P342, DOI 10.1152/physiol.00023.2009; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Seko T, 2003, CIRC RES, V92, P411, DOI 10.1161/01.RES.0000059987.90200.44; Shin HM, 2002, CIRC RES, V90, P546, DOI 10.1161/01.RES.0000012822.23273.EC; SHIRINSKY VP, 1993, J BIOL CHEM, V268, P16578; Silver DL, 1997, J BIOL CHEM, V272, P25353, DOI 10.1074/jbc.272.40.25353; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Somlyo AV, 2004, J MUSCLE RES CELL M, V25, P241, DOI 10.1023/B:JURE.0000038362.84697.c0; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Takizawa N, 2002, BIOCHEM BIOPH RES CO, V297, P773, DOI 10.1016/S0006-291X(02)02302-1; Totsukawa G, 1999, J CELL BIOL, V144, P735, DOI 10.1083/jcb.144.4.735; Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7; Vetterkind S, 2010, MOL BIOL CELL, V21, P1214, DOI 10.1091/mbc.E09-08-0711; Walker LA, 2001, J BIOL CHEM, V276, P24519, DOI 10.1074/jbc.M103560200; Wendt T, 2001, P NATL ACAD SCI USA, V98, P4361, DOI 10.1073/pnas.071051098; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Wooldridge AA, 2004, J BIOL CHEM, V279, P34496, DOI 10.1074/jbc.M405957200; Wu XD, 1999, J BIOL CHEM, V274, P20328, DOI 10.1074/jbc.274.29.20328; Wu XQ, 1996, BIOCHEM BIOPH RES CO, V220, P658, DOI 10.1006/bbrc.1996.0460; Wu XQ, 1998, J BIOL CHEM, V273, P11362, DOI 10.1074/jbc.273.18.11362; Zhang HY, 2007, CIRC RES, V100, P730, DOI 10.1161/01.RES.0000260189.38975.35	60	12	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20975	20985		10.1074/jbc.M112.341479	http://dx.doi.org/10.1074/jbc.M112.341479			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22544752	hybrid, Green Published			2022-12-25	WOS:000306416800019
J	Karlsson, D; Ronquist, F				Karlsson, Dave; Ronquist, Fredrik			Skeletal Morphology of Opius dissitus and Biosteres carbonarius (Hymenoptera: Braconidae), with a Discussion of Terminology	PLOS ONE			English	Article							PHYLOGENETIC IMPLICATIONS; INSECTA; CLASSIFICATION; CHALCIDOIDEA; NOMENCLATURE; GENITALIA; OPIINAE	The Braconidae, a family of parasitic wasps, constitute a major taxonomic challenge with an estimated diversity of 40,000 to 120,000 species worldwide, only 18,000 of which have been described to date. The skeletal morphology of braconids is still not adequately understood and the terminology is partly idiosyncratic, despite the fact that anatomical features form the basis for most taxonomic work on the group. To help address this problem, we describe the external skeletal morphology of Opius dissitus Muesebeck 1963 and Biosteres carbonarius Nees 1834, two diverse representatives of one of the least known and most diverse braconid subfamilies, the Opiinae. We review the terminology used to describe skeletal features in the Ichneumonoidea in general and the Opiinae in particular, and identify a list of recommend terms, which are linked to the online Hymenoptera Anatomy Ontology. The morphology of the studied species is illustrated with SEM-micrographs, photos and line drawings. Based on the examined species, we discuss intraspecific and interspecific morphological variation in the Opiinae and point out character complexes that merit further study.	[Karlsson, Dave; Ronquist, Fredrik] Swedish Museum Nat Hist, Dept Entomol, S-10405 Stockholm, Sweden	Swedish Museum of Natural History	Karlsson, D (corresponding author), Stn Linne, Farjestaden, Sweden.	dave.karlsson@stationlinne.se	Ronquist, Fredrik/Q-2013-2015	Ronquist, Fredrik/0000-0002-3929-251X	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) [217-2004-2101]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas)	This research was funded by grant 217-2004-2101 from the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) (http://www.formas.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achterberg Cv, 1975, ENTOMOL BER, V35, P175; Alam S.M., 1951, ALIGARH MUSLIM U PUB, V3, P1; ALAM S. MASHHOOD, 1953, ALIGARH MUSLIM UNIV PUBL ZOOL SER ON INDIAN INSECT TYPES, V3, P1; BASIBUYUK HH, 1995, ZOOL SCR, V24, P157, DOI 10.1111/j.1463-6409.1995.tb00397.x; Bohart R. M., 1976, SPHECID WASPS WORLD; Buckingham G.R., 1988, P199; Chapman R. F., 1969, INSECT STRUCTURE FUN; Chi M, 2005, MOL PHYLOGENET EVOL, V37, P104; Comstock JH, 1898, AM NATURALIST, V32; Comstock JH, 1899, AM NATURALIST, V33; Dowton M, 2002, J MOL EVOL, V54, P210, DOI 10.1007/s00239-001-0003-3; Duncan CD, 1939, CONTRIBUTION BIOL N, VVIII, P1; EADY RD, 1974, J ENTOMOL SER B, V43, P63; FARISH DJ, 1972, ANIM BEHAV, V20, P662, DOI 10.1016/S0003-3472(72)80139-8; Fischer M, 1971, HYMENOPTERA BRACONID, P1; Fischer M., 1972, TIERREICH, V91, P1; Fitton M.G., 1988, Handbooks for the Identification of British Insects, V7, P1; Gauld I. D., 1988, HYMENOPTERA BRIT MUS; Gauld I. D., 1981, TAXONOMY DISTRIBUTIO; Gauld ID, 1978, TAXONOMY DISTRIBUTIO; Gauld ID, 1995, HYMENOPTERA COSTA RI, P185; Ghahari HDS, 2006, BIBLIO FAMILY BRACON; GIBSON GAP, 1986, CAN ENTOMOL, V118, P205, DOI 10.4039/Ent118205-3; GIBSON GAP, 1985, CAN ENTOMOL, V117, P1395, DOI 10.4039/Ent1171395-11; GIBSON GAP, 1993, MEM ENTOMOL SOC CAN, P165, DOI 10.4039/entm125165165-1; Gibson GAP, 2011, CHALCID WASPS CHALCI; Gimeno C, 1997, INSECT MOL BIOL, V6, P273, DOI 10.1046/j.1365-2583.1997.00181.x; Goulet H., 1993, HYMENOPTERA WORLD ID, V1894E; Graham M. W. R. de V., 1969, Bull. Br. Mus. nat. Hist. Ent., V16, P1; Grimaldi David, 2005, pi; Gullan PA, 2014, INSECTS OUTLINE ENTO; Karlsson Dave, 2005, Entomologisk Tidskrift, V126, P43; Krogmann L, 2006, INVERTEBR SYST, V20, P615, DOI 10.1071/IS06012; Kula Robert R., 2003, Journal of Hymenoptera Research, V12, P278; Kutter H., 1977, Insecta helv fauna, V6, P1; Liljeblad J, 1998, SYST ENTOMOL, V23, P229, DOI 10.1046/j.1365-3113.1998.00053.x; Liljeblad J, 2008, ZOOTAXA, P1; Linnaeus C., 1758, SYSTEMA NATURAE SIVE; Masner L, 1980, MEMOIRS ENTOMOLOGICA, V113; Medvedev GS, 1997, KEYS INSECTS EUROP 4, VIII; Medvedev GS, 1995, KEYS INSECTS EUROP 5, VIII; Melika G, 2005, ACTA ZOOL ACAD SCI H, V51, P313; Michener Charles Duncan, 1944, BULL AMER MUS NAT HIST, V82, P151; Miko I, 2007, ZOOTAXA, P1; Nachtigall W, 1998, J COMP PHYSIOL B, V168, P323, DOI 10.1007/s003600050152; Nichols SW, 1989, NEW YORK ENTOMOLOGIC, Vxvii, P1; Oeser R., 1961, Mitteilungen aus dem Zoologischen Museum in Berlin, V37, P3; Pitz KM, 2007, MOL PHYLOGENET EVOL, V43, P338, DOI 10.1016/j.ympev.2006.11.010; Pratt DJ, 1940, J NEW YORK ENTOMOL S, VXLVIII, P155; Quicke DLJ, 1990, ZOOLOGISCHE VERHANDE, V258, P1; Richards O. W., 1956, HDB IDENTIFICATION B, V6, P1; RONQUIST F, 1989, ENTOMOL SCAND, P1; Ronquist Fredrik, 1995, Entomologica Scandinavica Supplement, V46, P1; Ross HH, 1937, ILLINOIS BIOL MONOGR, V15, P1, DOI DOI 10.5962/BHL.TITLE.50339; Schulmeister S, 2003, ORG DIVERS EVOL, V3, P253, DOI 10.1078/1439-6092-00078; Schulmeister S, 2001, ACTA ZOOL-STOCKHOLM, V82, P331, DOI 10.1046/j.1463-6395.2001.00094.x; Sharkey M.J., 1992, Journal of Hymenoptera Research, V1, P15; Sharkey MJ, 2005, ZOOTAXA, P43, DOI 10.11646/zootaxa.1070.1.3; Sharkey MJ, 1988, ADV PARASITIC HYMENO, P169; Shaw M.R., 1991, Handbooks for the Identification of British Insects, V7, P1; SHCHERBAKOV DE, 1981, ZOOL ZH, V60, P205; SHENEFELT ROY D., 1965, BEITRAGE ENTOMOL, V15, P243; Snodgrass R. E., 1942, SMITHSONIAN MISC COLL, V103, P1; Snodgrass R.E., 1956, ANATOMY HONEY BEE; Snodgrass R.E., 1935, MCGRAW HILL PUBLICAT; Surekha K, 1995, J NEW YORK ENTOMOL S, V103, P78; Tobias VI, 1986, SUBFAMILY OPIINAC, V3, P7; Townes H, 1969, MEMOIRS AM ENTOMOLOG, P1; Townes H.K., 1962, MEMOIRS AM ENTOMOLOG, V2, P1, DOI [10.5479/si.03629236.216.1-3, DOI 10.5479/SI.03629236.216.1-3]; van Achterberg C., 1974, Entomologische Berichten, V34, P213; van Achterberg C., 2004, Zoologische Mededelingen (Leiden), V78, P1; van Achterberg C., 2004, Zoologische Mededelingen (Leiden), V78, P331; van Achterberg C., 1993, Zoologische Verhandelingen (Leiden), V283, P1; van Achterberg C., 1984, Entomologisk Tidskrift, V105, P41; van Achterberg C., 1976, Tijdschrift voor Entomologie, V119, P33; van Achterberg C., 1990, Zoologische Mededelingen (Leiden), V64, P1; van Achterberg C., 1983, Tijdschrift voor Entomologie, V126, P25; Van Achterberg C., 1993, Zoologische Mededelingen (Leiden), V67, P365; VANACHTERBERG C, 1988, ZOOL VERH-LEIDEN, V249, P1; VANACHTERBERG K, 1992, CLADISTICS, V8, P237, DOI 10.1111/j.1096-0031.1992.tb00069.x; Vilhelmsen L, 2000, ZOOL SCR, V29, P319, DOI 10.1046/j.1463-6409.2000.00046.x; Vilhelmsen L, 2000, ZOOL ANZ, V239, P105; Vilhelmsen L, 1999, ZOOL SCR, V28, P75, DOI 10.1046/j.1463-6409.1999.00008.x; Vilhelmsen L, 2010, ZOOLOGICAL J LINNEAN, P1; WATERHOUSE DF, 1993, BIOL CONTROL PACIF S, V2; WHARTON R, 1977, PAN-PAC ENTOMOL, V53, P297; Wharton R. A, 1989, FRUIT FLIES THEIR B, P303; WHARTON RA, 1987, P ENTOMOL SOC WASH, V89, P61; WHARTON RA, 1988, CAN ENTOMOL, V120, P333, DOI 10.4039/Ent120333-4; WHARTON RA, 1992, CLADISTICS, V8, P199, DOI 10.1111/j.1096-0031.1992.tb00068.x; Wharton RA, 1987, B ZOOLOGICAL NOMENCL, V43, P369; WHARTON RA, 1997, SPECIAL PUBLICATION, V1; Wharton RA, 2006, ZOOL SCR, V35, P323, DOI 10.1111/j.1463-6409.2006.00236.x; Yu D.S.K., 2016, TAXAPAD 2016 ICHNEUM; Zaldivar-Riveron A, 2006, MOL PHYLOGENET EVOL, V38, P130, DOI 10.1016/j.ympev.2005.08.006	95	60	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e32573	10.1371/journal.pone.0032573	http://dx.doi.org/10.1371/journal.pone.0032573			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558068	Green Submitted, Green Published, gold			2022-12-25	WOS:000305340200002
J	Gronlund, A; Yi, IG; Kim, BJ				Gronlund, Andreas; Yi, Il Gu; Kim, Beom Jun			Fractal Profit Landscape of the Stock Market	PLOS ONE			English	Article							TECHNICAL ANALYSIS; PERFORMANCE	We investigate the structure of the profit landscape obtained from the most basic, fluctuation based, trading strategy applied for the daily stock price data. The strategy is parameterized by only two variables, p and q Stocks are sold and bought if the log return is bigger than p and less than -q, respectively. Repetition of this simple strategy for a long time gives the profit defined in the underlying two-dimensional parameter space of p and q. It is revealed that the local maxima in the profit landscape are spread in the form of a fractal structure. The fractal structure implies that successful strategies are not localized to any region of the profit landscape and are neither spaced evenly throughout the profit landscape, which makes the optimization notoriously hard and hypersensitive for partial or limited information. The concrete implication of this property is demonstrated by showing that optimization of one stock for future values or other stocks renders worse profit than a strategy that ignores fluctuations, i.e., a long-term buy-and-hold strategy.	[Gronlund, Andreas] Uppsala Univ, Dept Math, S-75238 Uppsala, Sweden; [Yi, Il Gu; Kim, Beom Jun] Sungkyunkwan Univ, Phys Res Div BK21, Suwon, South Korea; [Yi, Il Gu; Kim, Beom Jun] Sungkyunkwan Univ, Dept Phys, Suwon, South Korea	Uppsala University; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU)	Gronlund, A (corresponding author), Uppsala Univ, Dept Math, S-75238 Uppsala, Sweden.	beomjun@skku.edu	Grönlund, Andreas/F-1981-2011; Kim, Beom Jun/C-2380-2008; Chanelian, Serena/ABE-4873-2021	Kim, Beom Jun/0000-0003-0854-8647; Chanelian, Serena/0000-0001-5727-6137; Gronlund, Andreas/0000-0002-1543-7358	National Research Foundation of Korea (NRF); Korea government (MEST) [2011-0015731]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (2011-0015731). http://www.nrf.re.kr/html/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axtell RL, 2001, SCIENCE, V293, P1818, DOI 10.1126/science.1062081; Baek Y, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.026109; Barber BM, 2000, J FINANC, V55, P773, DOI 10.1111/0022-1082.00226; BLACK F, 1973, J POLIT ECON, V81, P637, DOI 10.1086/260062; Cowpertwait PSP, 2009, USE R, P1, DOI 10.1007/978-0-387-88698-5_1; Fusai G, 2008, SPRINGER FINANC, pXV; Gopikrishnan P, 1999, PHYS REV E, V60, P5305, DOI 10.1103/PhysRevE.60.5305; Lo AW, 2000, J FINANC, V55, P1705, DOI 10.1111/0022-1082.00265; Malkiel B. G., 2019, RANDOM WALK WALL STR; MANDELBROT B, 1963, J BUS, V36, P394, DOI 10.1086/294632; Mantegna R. N., 2000, INTRO ECONOPHYSICS; Menkhoff L, 2010, J BANK FINANC, V34, P2573, DOI 10.1016/j.jbankfin.2010.04.014; Park C-H, 2004, 200404 PP AGMAS PROJ, P2004; Schoutens W., 2003, LEVY PROCESSES FINAN; Schulmeister S, 2009, REV FINANC ECON, V18, P190, DOI 10.1016/j.rfe.2008.10.001; Stanley MHR, 1996, NATURE, V379, P804, DOI 10.1038/379804a0; Sullivan R, 1999, J FINANC, V54, P1647, DOI 10.1111/0022-1082.00163; Toth B, 2007, EUR PHYS J B, V55, P115, DOI 10.1140/epjb/e2007-00046-2; WEINBERGER E, 1990, BIOL CYBERN, V63, P325, DOI 10.1007/BF00202749; Yamasaki K, 2005, P NATL ACAD SCI USA, V102, P9424, DOI 10.1073/pnas.0502613102; Yeung CH, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026107	21	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e33960	10.1371/journal.pone.0033960	http://dx.doi.org/10.1371/journal.pone.0033960			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TJ	22558079	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000007
J	Schneps, MH; Brockmole, JR; Sonnert, G; Pomplun, M				Schneps, Matthew H.; Brockmole, James R.; Sonnert, Gerhard; Pomplun, Marc			History of Reading Struggles Linked to Enhanced Learning in Low Spatial Frequency Scenes	PLOS ONE			English	Article							REPORT SCALE ASRS; WORKING-MEMORY; VISUAL-SEARCH; PERIPHERAL-VISION; DEVELOPMENTAL DYSLEXIA; MAGNOCELLULAR DEFECT; ATTENTION; CHILDREN; SENSITIVITY; DEFICITS	People with dyslexia, who face lifelong struggles with reading, exhibit numerous associated low-level sensory deficits including deficits in focal attention. Countering this, studies have shown that struggling readers outperform typical readers in some visual tasks that integrate distributed information across an expanse. Though such abilities would be expected to facilitate scene memory, prior investigations using the contextual cueing paradigm failed to find corresponding advantages in dyslexia. We suggest that these studies were confounded by task-dependent effects exaggerating known focal attention deficits in dyslexia, and that, if natural scenes were used as the context, advantages would emerge. Here, we investigate this hypothesis by comparing college students with histories of severe lifelong reading difficulties (SR) and typical readers (TR) in contexts that vary attention load. We find no differences in contextual-cueing when spatial contexts are letter-like objects, or when contexts are natural scenes. However, the SR group significantly outperforms the TR group when contexts are low-pass filtered natural scenes [F(3, 39) = 3.15, p <.05]. These findings suggest that perception or memory for low spatial frequency components in scenes is enhanced in dyslexia. These findings are important because they suggest strengths for spatial learning in a population otherwise impaired, carrying implications for the education and support of students who face challenges in school.	[Schneps, Matthew H.; Sonnert, Gerhard] Harvard Smithsonian Ctr Astrophys, Sci Educ Dept, Cambridge, MA 02138 USA; [Brockmole, James R.] Univ Notre Dame, Dept Psychol, Notre Dame, IN 46556 USA; [Pomplun, Marc] Univ Massachusetts, Dept Comp Sci, Boston, MA 02125 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Notre Dame; University of Massachusetts System; University of Massachusetts Boston	Schneps, MH (corresponding author), Harvard Smithsonian Ctr Astrophys, Sci Educ Dept, 60 Garden St, Cambridge, MA 02138 USA.	mschneps@cfa.harvard.edu	Pomplun, Marc/P-8858-2019	Brockmole, James/0000-0003-3227-1078; Sonnert, Gerhard/0000-0003-4138-2044	National Science Foundation [HRD-0930962]; George E. Burch Foundation	National Science Foundation(National Science Foundation (NSF)); George E. Burch Foundation	This work was supported by National Science Foundation Grant HRD-0930962 (http://www.nsf.gov/awardsearch/showAward.do?AwardNumber = 0930962), and by the George E. Burch Foundation (http://www.si.edu/ofg/) that provided a fellowship to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; Bar M, 2003, J COGNITIVE NEUROSCI, V15, P600, DOI 10.1162/089892903321662976; Bennett IJ, 2008, ANN NY ACAD SCI, V1145, P184, DOI 10.1196/annals.1416.006; Brady TF, 2007, J EXP PSYCHOL HUMAN, V33, P798, DOI 10.1037/0096-1523.33.4.798; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brockmole JR, 2006, J EXP PSYCHOL LEARN, V32, P699, DOI 10.1037/0278-7393.32.4.699; Brockmole JR, 2006, Q J EXP PSYCHOL, V59, P1177, DOI 10.1080/17470210600665996; Brockmole JR, 2010, ATTEN PERCEPT PSYCHO, V72, P1803, DOI 10.3758/APP.72.7.1803; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; CARRASCO M, 1995, PERCEPT PSYCHOPHYS, V57, P1241, DOI 10.3758/BF03208380; Carrasco M, 2003, NAT NEUROSCI, V6, P699, DOI 10.1038/nn1079; Chun MM, 1999, NAT NEUROSCI, V2, P844, DOI 10.1038/12222; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; Craggs JG, 2006, CORTEX, V42, P1107, DOI 10.1016/S0010-9452(08)70222-3; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; DACEY DM, 1994, CIBA F SYMP, V184, P12; DAUTRICH BR, 1993, PERCEPT MOTOR SKILL, V76, P755, DOI 10.2466/pms.1993.76.3.755; Dehaene S, 2010, SCIENCE, V330, P1359, DOI 10.1126/science.1194140; DENCKLA MB, 1976, BRAIN LANG, V3, P1, DOI 10.1016/0093-934X(76)90001-8; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P219, DOI 10.1113/jphysiol.1984.sp015498; Ellemberg D, 2001, SPATIAL VISION, V15, P99, DOI 10.1163/15685680152692042; Facoetti A, 2000, CORTEX, V36, P109, DOI 10.1016/S0010-9452(08)70840-2; Facoetti A, 2000, EXP BRAIN RES, V132, P531, DOI 10.1007/s002219900330; Facoetti A, 2001, NEUROPSYCHOLOGIA, V39, P352, DOI 10.1016/S0028-3932(00)00138-X; Facoetti A, 2008, CORTEX, V44, P1221, DOI 10.1016/j.cortex.2007.10.007; Facoetti A, 2010, DYSLEXIA, V16, P226, DOI 10.1002/dys.413; Facoetti A, 2010, J COGNITIVE NEUROSCI, V22, P1011, DOI 10.1162/jocn.2009.21232; Faust M, 2003, BRAIN COGNITION, V53, P211, DOI 10.1016/S0278-2626(03)00112-X; Fink R., 2006, WHY JANE JOHN COULDN; FINUCCI JM, 1984, DEV MED CHILD NEUROL, V26, P143; GALABURDA A, 1993, ANN NY ACAD SCI, V682, P70, DOI 10.1111/j.1749-6632.1993.tb22960.x; GALABURDA AM, 1985, ANN NEUROL, V18, P222, DOI 10.1002/ana.410180210; Gattass R, 2005, PHILOS T R SOC B, V360, P709, DOI 10.1098/rstb.2005.1629; GEIGER G, 1987, NEW ENGL J MED, V316, P1238, DOI 10.1056/NEJM198705143162003; GEIGER G, 1994, VISION RES, V34, P1223, DOI 10.1016/0042-6989(94)90303-4; GEIGER G, 1992, COGNITIVE BRAIN RES, V1, P39, DOI 10.1016/0926-6410(92)90004-B; Geiger G., 2000, CHILD DEV DISABILITI, VXXVI, P73; Geiger G, 2008, PERCEPTION, V37, P1745, DOI 10.1068/p6036; Geringswald F, 2011, EUR C VIS PERC 2011; Hegde J, 2008, PROG NEUROBIOL, V84, P405, DOI 10.1016/j.pneurobio.2007.09.001; Howard JH, 2006, NEUROPSYCHOLOGIA, V44, P1131, DOI 10.1016/j.neuropsychologia.2005.10.015; Huang TR, 2010, PSYCHOL REV, V117, P1080, DOI 10.1037/a0020664; HUMPHREYS P, 1990, ANN NEUROL, V28, P727, DOI 10.1002/ana.410280602; Jiang YH, 2004, PERCEPT PSYCHOPHYS, V66, P454, DOI 10.3758/BF03194893; Jimenez-Fernandez G, 2011, ANN DYSLEXIA, V61, P85, DOI 10.1007/s11881-010-0048-3; Jones MW, 2010, COGNITION, V116, P56, DOI 10.1016/j.cognition.2010.03.015; Katzir T, 2008, J LEARN DISABIL-US, V41, P47, DOI 10.1177/0022219407311325; KAUFMANN WE, 1989, NEUROLOGY, V39, P238, DOI 10.1212/WNL.39.2.238; Kessels RPC, 2010, AGING NEUROPSYCHOL C, V17, P556, DOI 10.1080/13825585.2010.481354; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Kessler RC, 2007, INT J METH PSYCH RES, V16, P52, DOI 10.1002/mpr.208; Kevan A, 2008, NEUROREPORT, V19, P467, DOI 10.1097/WNR.0b013e3282f5f7ad; Kondo Y, 2005, NEUROIMAGE, V24, P1154, DOI 10.1016/j.neuroimage.2004.10.033; Lefly DL, 2000, J LEARN DISABIL-US, V33, P286, DOI 10.1177/002221940003300306; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; LIVINGSTONE MS, 1991, P NATL ACAD SCI USA, V88, P7943, DOI 10.1073/pnas.88.18.7943; Lorusso Maria Luisa, 2005, Brain Cogn, V57, P135, DOI 10.1016/j.bandc.2004.08.057; Lorusso ML, 2004, VISION RES, V44, P2413, DOI 10.1016/j.visres.2004.05.001; LOVEGROVE WJ, 1980, SCIENCE, V210, P439, DOI 10.1126/science.7433985; McGrath LM, 2010, J CHILD PSYCHOL PSYC; Nakayama K., 1990, VISION CODING EFFICI, P411; Nuzzo R, 2005, P NATL ACAD SCI USA, V102, P8077, DOI 10.1073/pnas.0503019102; Oliva A, 2005, GIST SCENE NEUROBIOL; PERRY AR, 1989, B PSYCHONOMIC SOC, V27, P445; Peyrin C, 2010, J COGNITIVE NEUROSCI, V22, P2768, DOI 10.1162/jocn.2010.21424; Poelmans G, 2011, MOL PSYCHIATR, V16, P365, DOI 10.1038/mp.2010.105; POTTER MC, 1976, J EXP PSYCHOL-HUM L, V2, P509, DOI 10.1037/0278-7393.2.5.509; Prado C, 2007, VISION RES, V47, P2521, DOI 10.1016/j.visres.2007.06.001; *PSYCH CORP, 1997, WECHSL AD INT SCAL; Psychological Corporation, 2002, WECHSL IND ACH TEST; Ramus F, 2004, TRENDS NEUROSCI, V27, P720, DOI 10.1016/j.tins.2004.10.004; Rosen GD, 2007, CEREB CORTEX, V17, P2562, DOI 10.1093/cercor/bhl162; Ruffino M, 2010, NEUROPSYCHOLOGIA, V48, P3793, DOI 10.1016/j.neuropsychologia.2010.09.002; Schneps MH, 2007, MIND BRAIN EDUC, V1, P128, DOI 10.1111/j.1751-228X.2007.00013.x; Schwartz S, 2005, CEREB CORTEX, V15, P770, DOI 10.1093/cercor/bhh178; Shaywitz SE, 2005, BIOL PSYCHIAT, V57, P1301, DOI 10.1016/j.biopsych.2005.01.043; Silva-Pereyra J, 2010, NEUROREPORT, V21, P34, DOI 10.1097/WNR.0b013e328332c566; Sireteanu R, 2008, ANN NY ACAD SCI, V1145, P199, DOI 10.1196/annals.1416.021; Smith-Spark JH, 2003, EUR J COGN PSYCHOL, V15, P567, DOI 10.1080/09541440340000024; Stoodley CJ, 2006, NEUROSCI LETT, V399, P264, DOI 10.1016/j.neulet.2006.02.004; Swanson HL, 2009, J LEARN DISABIL-US, V42, P260, DOI 10.1177/0022219409331958; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; van Asselen M, 2009, ATTEN PERCEPT PSYCHO, V71, P76, DOI 10.3758/APP.71.1.76; Verhaeghen P, 1996, PSYCHOL AGING, V11, P164, DOI 10.1037/0882-7974.11.1.164; Vickery TJ, 2010, J EXP PSYCHOL HUMAN, V36, P1358, DOI 10.1037/a0020558; Vidyasagar TR, 1999, NEUROREPORT, V10, P1283, DOI 10.1097/00001756-199904260-00024; von Karolyi C, 2003, BRAIN LANG, V85, P427, DOI 10.1016/S0093-934X(03)00052-X; Woodcock R.W., 2001, WOODCOCK JOHNSON 3 T	88	21	22	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35724	10.1371/journal.pone.0035724	http://dx.doi.org/10.1371/journal.pone.0035724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TJ	22558210	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000053
J	Marazita, MC; Ogara, MF; Sonzogni, SV; Marti, M; Dusetti, NJ; Pignataro, OP; Canepa, ET				Marazita, Mariela C.; Ogara, M. Florencia; Sonzogni, Silvina V.; Marti, Marcelo; Dusetti, Nelson J.; Pignataro, Omar P.; Canepa, Eduardo T.			CDK2 and PKA Mediated-Sequential Phosphorylation Is Critical for p19INK4d Function in the DNA Damage Response	PLOS ONE			English	Article							CELL-CYCLE CHECKPOINTS; DEPENDENT KINASE CDK6; STRAND BREAK REPAIR; PROTEIN-KINASE; HOMOLOGOUS RECOMBINATION; INHIBITOR P19(INK4D); IONIZING-RADIATION; ULTRAVIOLET-LIGHT; STRUCTURAL BASIS; ATR	DNA damage triggers a phosphorylation-based signaling cascade known as the DNA damage response. p19INK4d, a member of the INK4 family of CDK4/6 inhibitors, has been reported to participate in the DNA damage response promoting DNA repair and cell survival. Here, we provide mechanistic insight into the activation mechanism of p19INK4d linked to the response to DNA damage. Results showed that p19INK4d becomes phosphorylated following UV radiation, beta-amyloid peptide and cisplatin treatments. ATM-Chk2/ATR-Chk1 signaling pathways were found to be differentially involved in p19INK4d phosphorylation depending on the type of DNA damage. Two sequential phosphorylation events at serine 76 and threonine 141 were identified using p19INK4d single-point mutants in metabolic labeling assays with P-32-orthophosphate. CDK2 and PKA were found to participate in p19INK4d phosphorylation process and that they would mediate serine 76 and threonine 141 modifications respectively. Nuclear translocation of p19INK4d induced by DNA damage was shown to be dependent on serine 76 phosphorylation. Most importantly, both phosphorylation sites were found to be crucial for p19INK4d function in DNA repair and cell survival. In contrast, serine 76 and threonine 141 were dispensable for CDK4/6 inhibition highlighting the independence of p19INK4d functions, in agreement with our previous findings. These results constitute the first description of the activation mechanism of p19INK4d in response to genotoxic stress and demonstrate the functional relevance of this activation following DNA damage.	[Marazita, Mariela C.; Ogara, M. Florencia; Sonzogni, Silvina V.; Marti, Marcelo; Canepa, Eduardo T.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Lab Biol Mol, Buenos Aires, DF, Argentina; [Dusetti, Nelson J.] INSERM, Stress Cellulaire U624, F-13258 Marseille, France; [Pignataro, Omar P.] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, Lab Endocrinol Mol Transducc Senales, RA-1033 Buenos Aires, DF, Argentina	University of Buenos Aires; Institut National de la Sante et de la Recherche Medicale (Inserm); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine	Marazita, MC (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Lab Biol Mol, Buenos Aires, DF, Argentina.	ecanepa@qb.fcen.uba.ar	Dusetti, Nelson/O-7919-2017	Dusetti, Nelson/0000-0002-6161-8483; Canepa, Eduardo T./0000-0002-4322-1650; Sonzogni, Silvina/0000-0002-6237-6594; Marti, Marcelo/0000-0002-7911-9340	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Agencia Nacional de Promocion Cientifica y Tecnologica (ANCYPT); Universidad de Buenos Aires	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANCYPT)(ANPCyT); Universidad de Buenos Aires(University of Buenos Aires)	This work was supported by research grants from Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Agencia Nacional de Promocion Cientifica y Tecnologica (ANCYPT) and Universidad de Buenos Aires. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Akbar S, 2001, CELL MOL LIFE SCI, V58, P1708, DOI 10.1007/PL00000808; Al-Mohanna MA, 2007, NUCLEIC ACIDS RES, V35, P223, DOI 10.1093/nar/gkl1075; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bensimon A, SCI SIGNAL, V3, prs3; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Brotherton DH, 1998, NATURE, V395, P244, DOI 10.1038/26164; Canepa ET, 2007, IUBMB LIFE, V59, P419, DOI 10.1080/15216540701488358; Cerqueira A, 2009, J CELL BIOL, V187, P773, DOI 10.1083/jcb.200903033; Ceruti JM, 2005, ONCOGENE, V24, P4065, DOI 10.1038/sj.onc.1208570; Ceruti JM, 2009, INT J BIOCHEM CELL B, V41, P1344, DOI 10.1016/j.biocel.2008.12.005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Deans AJ, 2006, CANCER RES, V66, P8219, DOI 10.1158/0008-5472.CAN-05-3945; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; Gatei M, 2003, J BIOL CHEM, V278, P14806, DOI 10.1074/jbc.M210862200; Giono LE, 2007, MOL CELL BIOL, V27, P4166, DOI 10.1128/MCB.01967-06; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; HELLMICH MR, 1992, P NATL ACAD SCI USA, V89, P10867, DOI 10.1073/pnas.89.22.10867; Hickman MJ, 2004, MOL CELL, V14, P105, DOI 10.1016/S1097-2765(04)00162-5; Hiromura K, 2002, ONCOGENE, V21, P1750, DOI 10.1038/sj.onc.1205238; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Jiang KC, 2003, J BIOL CHEM, V278, P25207, DOI 10.1074/jbc.M300070200; Jung CG, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-47; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Lew DJ, 1996, CURR OPIN CELL BIOL, V8, P795, DOI 10.1016/S0955-0674(96)80080-9; Liu QH, 2000, GENE DEV, V14, P1448; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; Maddika S, 2008, J CELL SCI, V121, P979, DOI 10.1242/jcs.009530; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; Muller-Tidow C, 2004, MOL CELL BIOL, V24, P8917, DOI 10.1128/MCB.24.20.8917-8928.2004; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Pei XH, 2005, ONCOGENE, V24, P2787, DOI 10.1038/sj.onc.1208611; Renner C, 1998, J MOL BIOL, V283, P221, DOI 10.1006/jmbi.1998.2079; Russo AA, 1998, NATURE, V395, P237, DOI 10.1038/26155; Sarkaria JN, 1998, CANCER RES, V58, P4375; Scassa ME, 2007, DNA REPAIR, V6, P626, DOI 10.1016/j.dnarep.2006.12.003; Schnoke M, 2009, BONE, V45, P590, DOI 10.1016/j.bone.2009.05.006; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shell SM, 2009, J BIOL CHEM, V284, P24213, DOI 10.1074/jbc.M109.000745; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiotani B, 2009, MOL CELL, V33, P547, DOI 10.1016/j.molcel.2009.01.024; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Tavera-Mendoza LE, 2006, CELL CYCLE, V5, P596, DOI 10.4161/cc.5.6.2585; Thullberg M, 2000, FEBS LETT, V470, P161, DOI 10.1016/S0014-5793(00)01307-7; Tortora G, 2002, ANN NY ACAD SCI, V968, P139, DOI 10.1111/j.1749-6632.2002.tb04332.x; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	61	17	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35638	10.1371/journal.pone.0035638	http://dx.doi.org/10.1371/journal.pone.0035638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558186	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345200059
J	Perkins, BA; Rabbani, N; Weston, A; Ficociello, LH; Adaikalakoteswari, A; Niewczas, M; Warram, J; Krolewski, AS; Thornalley, P				Perkins, Bruce A.; Rabbani, Naila; Weston, Andrew; Ficociello, Linda H.; Adaikalakoteswari, Antonysunil; Niewczas, Monika; Warram, James; Krolewski, Andrzej S.; Thornalley, Paul			Serum Levels of Advanced Glycation Endproducts and Other Markers of Protein Damage in Early Diabetic Nephropathy in Type 1 Diabetes	PLOS ONE			English	Article							RENAL-FUNCTION DECLINE; DEGRADATION-PRODUCTS; END-PRODUCTS; MICROALBUMINURIA; COMPLICATIONS; RISK; MELLITUS; ALBUMIN; CARBOXYMETHYLLYSINE; OXIDATION	Objective: To determine the role of markers of plasma protein damage by glycation, oxidation and nitration in microalbuminuria onset or subsequent decline of glomerular filtration rate (termed "early GFR decline") in patients with type 1 diabetes. Methods: From the 1st Joslin Kidney Study, we selected 30 patients with longstanding normoalbuminuria and 55 patients with new onset microalbuminuria. Patients with microalbuminuria had 8-12 years follow-up during which 33 had stable GFR and 22 early GFR decline. Mean baseline GFR(CYSTATIN C) was similar between the three groups. Glycation, oxidation and nitration markers were measured in protein and ultrafiltrate at baseline by liquid chromatography-tandem mass spectrometry using the most reliable methods currently available. Results: Though none were significantly different between patients with microalbuminuria with stable or early GFR decline, levels of 6 protein damage adduct residues of plasma protein and 4 related free adducts of plasma ultrafiltrate were significantly different in patients with microalbuminuria compared to normoalbuminuria controls. Three protein damage adduct residues were decreased and 3 increased in microalbuminuria while 3 free adducts were decreased and one increased in microalbuminuria. The most profound differences were of N-formylkynurenine (NFK) protein adduct residue and N-omega-carboxymethylarginine (CMA) free adduct in which levels were markedly lower in microalbuminuria (P<0.001 for both). Conclusions: Complex processes influence levels of plasma protein damage and related proteolysis product free adducts in type 1 diabetes and microalbuminuria. The effects observed point to the possibility that patients who have efficient mechanisms of disposal of damaged proteins might be at an increased risk of developing microalbuminuria but not early renal function decline. The findings support the concept that the mechanisms responsible for microalbuminuria may differ from the mechanisms involved in the initiation of early renal function decline.	[Perkins, Bruce A.] Univ Toronto, Div Endocrinol, Toronto, ON, Canada; [Rabbani, Naila; Weston, Andrew; Adaikalakoteswari, Antonysunil; Thornalley, Paul] Univ Warwick, Warwick Med Sch, Clin Sci Res Inst, Coventry CV4 7AL, W Midlands, England; [Ficociello, Linda H.; Niewczas, Monika; Warram, James; Krolewski, Andrzej S.] Joslin Diabet Ctr, Sect Genet & Epidemiol, Boston, MA 02215 USA	University of Toronto; University of Warwick; Harvard University; Joslin Diabetes Center, Inc.	Perkins, BA (corresponding author), Univ Toronto, Div Endocrinol, Toronto, ON, Canada.	bruce.perkins@uhn.on.ca	Perkins, Bruce A/L-3726-2017	Thornalley, Paul/0000-0001-7659-443X; Rabbani, Naila/0000-0002-5819-2506; Ficociello, Linda/0000-0003-3523-0028	National Institutes of Health [DK041526, DK067638]; Joslin Diabetes Center; Banting and Best Diabetes Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041526, R01DK067638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joslin Diabetes Center; Banting and Best Diabetes Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institutes of Health grants DK041526, DK067638 (to AK) and the Joslin Diabetes Center. BAP was a Canadian Diabetes Association Scholar and was supported by the Banting and Best Diabetes Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalou S, 2005, J AM SOC NEPHROL, V16, P1471, DOI 10.1681/ASN.2004080635; Ahmed N, 2007, DIABETES OBES METAB, V9, P233, DOI 10.1111/j.1463-1326.2006.00595.x; Ahmed N, 2002, BIOCHEM J, V364, P1; Ahmed N, 2005, DIABETOLOGIA, V48, P1590, DOI 10.1007/s00125-005-1810-7; Ahmed N, 2004, J HEPATOL, V41, P913, DOI 10.1016/j.jhep.2004.08.007; Ames JM, 2007, MOL NUTR FOOD RES, V51, P1085, DOI 10.1002/mnfr.200600304; BEISSWENGER PJ, 1995, DIABETES, V44, P824, DOI 10.2337/diabetes.44.7.824; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; CHA T, 1991, DIABETES RES CLIN PR, V12, P149, DOI 10.1016/0168-8227(91)90071-K; de Boer IH, 2011, ARCH INTERN MED, V171, P412, DOI 10.1001/archinternmed.2011.16; Ficociello LH, 2010, DIABETES CARE, V33, P1337, DOI 10.2337/dc10-0227; GARLICK RL, 1984, J CLIN INVEST, V74, P1742, DOI 10.1172/JCI111592; Genuth S, 2005, DIABETES, V54, P3103, DOI 10.2337/diabetes.54.11.3103; Goh SY, 2008, J CLIN ENDOCR METAB, V93, P1143, DOI 10.1210/jc.2007-1817; Karachalias N, 2010, DIABETOLOGIA, V53, P1506, DOI 10.1007/s00125-010-1722-z; KROLEWSKI AS, 1995, NEW ENGL J MED, V332, P1251, DOI 10.1056/NEJM199505113321902; LIARDON R, 1987, J AGR FOOD CHEM, V35, P427, DOI 10.1021/jf00075a035; MacIsaac RJ, 2006, DIABETOLOGIA, V49, P1686, DOI 10.1007/s00125-006-0275-7; MCCANCE DR, 1993, J CLIN INVEST, V91, P2470, DOI 10.1172/JCI116482; Merchant ML, 2009, J AM SOC NEPHROL, V20, P2065, DOI 10.1681/ASN.2008121233; Miura J, 2003, J DIABETES COMPLICAT, V17, P16, DOI 10.1016/S1056-8727(02)00183-6; MOGENSEN CE, 1984, NEW ENGL J MED, V311, P89, DOI 10.1056/NEJM198407123110204; PARVING HH, 1982, ACTA ENDOCRINOL-COP, V100, P550, DOI 10.1530/acta.0.1000550; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Perkins BA, 2003, NEW ENGL J MED, V348, P2285, DOI 10.1056/NEJMoa021835; Perkins BA, 2007, J AM SOC NEPHROL, V18, P1353, DOI 10.1681/ASN.2006080872; Perkins Bruce A, 2005, Curr Diab Rep, V5, P455, DOI 10.1007/s11892-005-0055-7; Perkins BA, 2010, KIDNEY INT, V77, P57, DOI 10.1038/ki.2009.399; Rabbani N, 2009, DIABETOLOGIA, V52, P208, DOI 10.1007/s00125-008-1224-4; Rabbani N, 2007, KIDNEY INT, V72, P1113, DOI 10.1038/sj.ki.5002513; Rabbani N, 2011, AMINO ACIDS IN PRESS; Rosolowsky ET, 2011, J AM SOC NEPHROL, V22, P545, DOI 10.1681/ASN.2010040354; Russo LM, 2002, AM J KIDNEY DIS, V39, P899, DOI 10.1053/ajkd.2002.32764; Scott LJ, 2001, DIABETES, V50, P2842, DOI 10.2337/diabetes.50.12.2842; Sun JK, 2011, DIABETES CARE, V34, P968, DOI 10.2337/dc10-1675; Thornalley P.J., 2006, REDOX PROTEOMICS PRO, P681; Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763; VIBERTI GC, 1982, LANCET, V1, P1430; Williams ME, 2005, AM J NEPHROL, V25, P77, DOI 10.1159/000084286; Wolkow PP, 2008, J AM SOC NEPHROL, V19, P789, DOI 10.1681/ASN.2007050556	40	38	43	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35655	10.1371/journal.pone.0035655	http://dx.doi.org/10.1371/journal.pone.0035655			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558190	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000305345200062
J	Chen, MF; Gutierrez, GJ; Ronai, ZA				Chen, Meifan; Gutierrez, Gustavo J.; Ronai, Ze'ev A.			The Anaphase-Promoting Complex or Cyclosome Supports Cell Survival in Response to Endoplasmic Reticulum Stress	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; CYCLE ARREST; DNA-DAMAGE; DEGRADATION; KINASE; INHIBITOR; APOPTOSIS; CDH1; ER; PHOSPHORYLATION	The anaphase-promoting complex or cyclosome (APC/C) is a multi-subunit ubiquitin ligase that regulates exit from mitosis and G1 phase of the cell cycle. Although the regulation and function of APC/C-Cdh1 in the unperturbed cell cycle is well studied, little is known of its role in non-genotoxic stress responses. Here, we demonstrate the role of APC/C-Cdh1 (APC/C activated by Cdh1 protein) in cellular protection from endoplasmic reticulum (ER) stress. Activation of APC/C-Cdh1 under ER stress conditions is evidenced by Cdh1-dependent degradation of its substrates. Importantly, the activity of APC/C-Cdh1 maintains the ER stress checkpoint, as depletion of Cdh1 by RNAi impairs cell cycle arrest and accelerates cell death following ER stress. Our findings identify APC/C-Cdh1 as a regulator of cell cycle checkpoint and cell survival in response to proteotoxic insults.	[Chen, Meifan; Gutierrez, Gustavo J.; Ronai, Ze'ev A.] Sanford Burnham Med Res Inst, Signal Transduct Program, La Jolla, CA USA	Sanford Burnham Prebys Medical Discovery Institute	Chen, MF (corresponding author), Sanford Burnham Med Res Inst, Signal Transduct Program, La Jolla, CA USA.	ronai@smbri.org	Gutierrez, Gustavo/B-6771-2013; Gutierrez, Gustavo/AAO-9957-2021	Gutierrez, Gustavo/0000-0003-4133-5002; Gutierrez, Gustavo/0000-0001-8652-972X; Chen, Meifan/0000-0002-4190-4001; RONAI, ZEEV/0000-0002-3859-0400	National Cancer Institute [CA78419]; NATIONAL CANCER INSTITUTE [R01CA078419, R01CA138143, T32CA077109] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant CA78419 (to ZR) from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Brewer JW, 1999, P NATL ACAD SCI USA, V96, P8505, DOI 10.1073/pnas.96.15.8505; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen M, P NATL ACAD SCI US, V108, P9119; Crasta K, 2008, NAT CELL BIOL, V10, P665, DOI 10.1038/ncb1729; Gutierrez GJ, NAT CELL BIOL, V12, P686; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Jeganathan KB, 2005, NATURE, V438, P1036, DOI 10.1038/nature04221; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Listovsky T, 2004, EMBO J, V23, P1619, DOI 10.1038/sj.emboj.7600149; Liu WJ, 2008, CARCINOGENESIS, V29, P263, DOI 10.1093/carcin/bgm251; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Ohoka N, BIOCH BIOPHYS RES CO, V392, P289; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Raven JF, 2008, J BIOL CHEM, V283, P3097, DOI 10.1074/jbc.M709677200; Reimann JDR, 2001, GENE DEV, V15, P3278, DOI 10.1101/gad.945701; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; SHI L, 1994, SCIENCE, V263, P1143, DOI 10.1126/science.8108732; Simpson-Lavy KJ, 2009, CELL CYCLE, V8, P3003; Sudo T, 2001, EMBO J, V20, P6499, DOI 10.1093/emboj/20.22.6499; TEWARI M, 1995, J IMMUNOL, V154, P1699; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zhang F, 2006, J BIOL CHEM, V281, P30036, DOI 10.1074/jbc.M604674200; Zhou Y, 2003, J BIOL CHEM, V278, P12530, DOI 10.1074/jbc.M212853200	40	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35520	10.1371/journal.pone.0035520	http://dx.doi.org/10.1371/journal.pone.0035520			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539978	Green Submitted, gold, Green Published			2022-12-25	WOS:000305341000044
J	Ullrich, T; Ermantraut, E; Schulz, T; Steinmetzer, K				Ullrich, Thomas; Ermantraut, Eugen; Schulz, Torsten; Steinmetzer, Katrin			Competitive Reporter Monitored Amplification (CMA) - Quantification of Molecular Targets by Real Time Monitoring of Competitive Reporter Hybridization	PLOS ONE			English	Article							RT-PCR; SENSITIVE DETECTION; CLINICAL MICROBIOLOGY; REVERSE-TRANSCRIPTION; INTERNAL CONTROL; ARMORED RNA; DEVICE; HIV-1; ARRAY; ASSAY	Background: State of the art molecular diagnostic tests are based on the sensitive detection and quantification of nucleic acids. However, currently established diagnostic tests are characterized by elaborate and expensive technical solutions hindering the development of simple, affordable and compact point-of-care molecular tests. Methodology and Principal Findings: The described competitive reporter monitored amplification allows the simultaneous amplification and quantification of multiple nucleic acid targets by polymerase chain reaction. Target quantification is accomplished by real-time detection of amplified nucleic acids utilizing a capture probe array and specific reporter probes. The reporter probes are fluorescently labeled oligonucleotides that are complementary to the respective capture probes on the array and to the respective sites of the target nucleic acids in solution. Capture probes and amplified target compete for reporter probes. Increasing amplicon concentration leads to decreased fluorescence signal at the respective capture probe position on the array which is measured after each cycle of amplification. In order to observe reporter probe hybridization in real-time without any additional washing steps, we have developed a mechanical fluorescence background displacement technique. Conclusions and Significance: The system presented in this paper enables simultaneous detection and quantification of multiple targets. Moreover, the presented fluorescence background displacement technique provides a generic solution for real time monitoring of binding events of fluorescently labelled ligands to surface immobilized probes. With the model assay for the detection of human immunodeficiency virus type 1 and 2 (HIV 1/2), we have been able to observe the amplification kinetics of five targets simultaneously and accommodate two additional hybridization controls with a simple instrument set-up. The ability to accommodate multiple controls and targets into a single assay and to perform the assay on simple and robust instrumentation is a prerequisite for the development of novel molecular point of care tests.	[Ullrich, Thomas; Ermantraut, Eugen; Schulz, Torsten; Steinmetzer, Katrin] Alere Technol GmbH, Jena, Germany	Alere	Ullrich, T (corresponding author), Alere Technol GmbH, Jena, Germany.	Thomas.Ullrich@clondiag.com		Ermantraut, Eugen/0000-0001-6876-0565	research and development grant of the Free State of Thuringia [2008-FE-0039]	research and development grant of the Free State of Thuringia	This work was supported by a research and development grant of the Free State of Thuringia (2008-FE-0039). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RC, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e60; Anthony R M, 2001, Expert Rev Mol Diagn, V1, P30, DOI 10.1586/14737159.1.1.30; Applied Biosystems, 2006, APPL NOT APPL BIOS, P1; Avettand-Fenol V, 2009, J MED VIROL, V81, P217, DOI 10.1002/jmv.21390; Benjamin RJ, 2001, SEMIN HEMATOL, V38, P11, DOI 10.1053/shem.2001.28829; Bienvenue JM, 2010, FORENSIC SCI INT-GEN, V4, P178, DOI 10.1016/j.fsigen.2009.02.010; Brightwell C, 1998, MOL CELL PROBE, V12, P367, DOI 10.1006/mcpr.1998.0195; Christopherson C, 1998, ANTIVIR THER, V3, P247; Cirino N.M, 2007, REAL TIME PCR MICROB, P183; Claas E. C. J., 2007, Real-time PCR in microbiology: from diagnosis to characterization, P231; Collins RA, 2003, BIOCHEM BIOPH RES CO, V300, P507, DOI 10.1016/S0006-291X(02)02896-6; Curtis KA, 2008, J VIROL METHODS, V151, P264, DOI 10.1016/j.jviromet.2008.04.011; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Ferns RB, 2006, J VIROL METHODS, V135, P102, DOI 10.1016/j.jviromet.2006.02.005; Finan JE, 2007, PHARMACOGENOMICS, V8, P85, DOI 10.2217/14622416.8.1.85; Hadd AG, 2005, EXPERT REV MOL DIAGN, V5, P409, DOI 10.1586/14737159.5.3.409; Han SH, 2008, J INVERTEBR PATHOL, V99, P8, DOI 10.1016/j.jip.2008.04.010; Hofmann WP, 2005, J CLIN VIROL, V32, P289, DOI 10.1016/j.jcv.2004.08.011; Kashanchi F, 1997, J MED VIROL, V52, P179, DOI 10.1002/(SICI)1096-9071(199706)52:2&lt;179::AID-JMV11&gt;3.0.CO;2-G; Lamhoujeb S, 2009, CAN J MICROBIOL, V55, P1375, DOI 10.1139/W09-105; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Ling MM, 2007, EXPERT REV MOL DIAGN, V7, P87, DOI 10.1586/14737159.7.1.87; Liu HP, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj006; Liu RH, 2006, ANAL CHEM, V78, P1980, DOI 10.1021/ac0518553; Liu RH, 2006, ANAL CHEM, V78, P4184, DOI 10.1021/ac060450v; Mackay IM, 2004, CLIN MICROBIOL INFEC, V10, P190, DOI 10.1111/j.1198-743X.2004.00722.x; Miller MB, 2009, CLIN MICROBIOL REV, V22, P611, DOI 10.1128/CMR.00019-09; Mrotzek G, 2010, J VIROL METHODS, V168, P262, DOI 10.1016/j.jviromet.2010.05.010; Muska A., 2007, REAL TIME PCR MICROB, P101; Neuzil P, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl416; Pasloske BL, 1998, J CLIN MICROBIOL, V36, P3590, DOI 10.1128/JCM.36.12.3590-3594.1998; Pau CP, 2010, J VIROL METHODS, V164, P55, DOI 10.1016/j.jviromet.2009.11.027; Rebrikov DV, 2006, APPL BIOCHEM MICROB, V42, P520; Saha BK, 2001, J VIROL METHODS, V93, P33, DOI 10.1016/S0166-0934(00)00288-3; SODERLUND H, 1990, ANN BIOL CLIN-PARIS, V48, P489; Stals A, 2009, J MICROBIOL METH, V77, P72, DOI 10.1016/j.mimet.2009.01.018; Stevenson J, 2008, J VIROL METHODS, V150, P73, DOI 10.1016/j.jviromet.2008.02.007; Stranska R, 2004, J CLIN VIROL, V30, P39, DOI 10.1016/j.jcv.2003.08.006; Tang JF, 2009, DIAGN MICR INFEC DIS, V65, P372, DOI 10.1016/j.diagmicrobio.2009.07.017; Valentine-Thon E, 2002, J CLIN VIROL, V25, pS13; Zhao WA, 2008, ANGEW CHEM INT EDIT, V47, P6330, DOI 10.1002/anie.200705982	41	14	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35438	10.1371/journal.pone.0035438	http://dx.doi.org/10.1371/journal.pone.0035438			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539973	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341000038
J	Yamanaka, D; Tamiya, Y; Motoi, M; Ishibashi, K; Miura, NN; Adachi, Y; Ohno, N				Yamanaka, Daisuke; Tamiya, Yumi; Motoi, Masuro; Ishibashi, Ken-ichi; Miura, Noriko N.; Adachi, Yoshiyuki; Ohno, Naohito			The Effect of Enzymatically Polymerised Polyphenols on CD4 Binding and Cytokine Production in Murine Splenocytes	PLOS ONE			English	Article							FACTOR GM-CSF; NF-KAPPA-B; MONOCLONAL-ANTIBODY GK1.5; EPIGALLOCATECHIN GALLATE; LIGNIFIED MATERIALS; VIRUS-INFECTION; TEA POLYPHENOL; CELL-ACTIVITY; CAFFEIC ACID; GREEN TEA	High-molecular weight polymerised polyphenols have been shown to exhibit anti-influenza virus, anti-HIV, and anti-cancer activities. The purpose of this study was to evaluate the immunomodulating activities of enzymatically polymerised polyphenols, and to clarify the underlying mechanisms of their effects. The cytokine-inducing activity of the enzymatically polymerised polyphenols derived from caffeic acid (CA), ferulic acid (FA), and p-coumaric acid (CoA) was investigated using murine splenocytes. Polymerised polyphenols, but not non-polymerised polyphenols, induced cytokine synthesis in murine splenocytes. Polymerised polyphenols induced several cytokines in murine splenocytes, with interferon-gamma (IFN-gamma) and granulocyte-macrophage colony-stimulating factor (GM-CSF) being the most prominent. The underlying mechanisms of the effects of the polymerised polyphenols were then studied using neutralising antibodies and fluorescent-activated cell sorting (FACS) analysis. Our results show that polymerised polyphenols increased IFN-gamma and GM-CSF production in splenocytes. In addition, the anti-CD4 neutralised monoclonal antibody (mAb) inhibited polymerised polyphenol-induced IFN-gamma and GM-CSF secretion. Moreover, polymerised polyphenols bound directly to a recombinant CD4 protein, and FACS analysis confirmed that interaction occurs between polymerised polyphenols and CD4 molecules expressed on the cell surface. In this study, we clearly demonstrated that enzymatic polymerisation confers immunoactivating potential to phenylpropanoic acids, and CD4 plays a key role in their cytokine-inducing activity.	[Yamanaka, Daisuke; Tamiya, Yumi; Motoi, Masuro; Ishibashi, Ken-ichi; Miura, Noriko N.; Adachi, Yoshiyuki; Ohno, Naohito] Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Immunopharmacol Microbial Prod, Hachioji, Tokyo 19203, Japan	Tokyo University of Pharmacy & Life Sciences	Yamanaka, D (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Immunopharmacol Microbial Prod, 1432-1 Horinouchi, Hachioji, Tokyo 19203, Japan.	ohnonao@toyaku.ac.jp			Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN)	Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN)	This work was supported by the the Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN) (http://brain.naro.affrc.go.jp/). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benzie IFF, 1999, J AGR FOOD CHEM, V47, P633, DOI 10.1021/jf9807768; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; DIALYNAS DP, 1983, IMMUNOL REV, V74, P29, DOI 10.1111/j.1600-065X.1983.tb01083.x; DIALYNAS DP, 1983, J IMMUNOL, V131, P2445; DJEU JY, 1982, J EXP MED, V156, P1222, DOI 10.1084/jem.156.4.1222; Fassina G, 2002, AIDS, V16, P939, DOI 10.1097/00002030-200204120-00020; FREUND M, 1992, INFECTION, V20, pS84, DOI 10.1007/BF01705024; FUKUCHI K, 1989, ANTICANCER RES, V9, P313; Gessner DK, 2011, J ANIM PHYS IN PRESS; GIDLUND M, 1978, NATURE, V273, P759, DOI 10.1038/273759a0; Graziani-Bowering GM, 2002, EXP CELL RES, V279, P141, DOI 10.1006/excr.2002.5581; Harada T, 2004, J INTERF CYTOK RES, V24, P478, DOI 10.1089/1079990041689656; Harada T, 2008, INT IMMUNOPHARMACOL, V8, P556, DOI 10.1016/j.intimp.2007.12.011; Hashimoto Satoshi, 2006, International Journal of Medicinal Mushrooms, V8, P329, DOI 10.1615/IntJMedMushr.v8.i4.40; Hirao K, 2010, LIFE SCI, V86, P654, DOI 10.1016/j.lfs.2010.02.017; Ikeda I, 2003, J AGR FOOD CHEM, V51, P7303, DOI 10.1021/jf034728l; Jung CH, 2007, J ETHNOPHARMACOL, V110, P490, DOI 10.1016/j.jep.2006.10.013; Jung WK, 2008, INT J BIOCHEM CELL B, V40, P2572, DOI 10.1016/j.biocel.2008.05.005; Kawai K, 2003, J ALLERGY CLIN IMMUN, V112, P951, DOI 10.1016/S0091-6749(03)02007-4; KURAKATA Y, 1990, In Vivo (Attiki), V4, P377; LAI PK, 1990, AIDS RES HUM RETROV, V6, P205, DOI 10.1089/aid.1990.6.205; Liu Y, 2008, EVID-BASED COMPL ALT, V5, P205, DOI 10.1093/ecam/nem016; Matsumoto-Akanuma Akiko, 2006, International Journal of Medicinal Mushrooms, V8, P67, DOI 10.1615/IntJMedMushr.v8.i1.90; Matsumoto-Akanuma A, 2011, INT J MED MUSHROOMS, V13, P73, DOI 10.1615/IntJMedMushr.v13.i1.90; Milligan SA, 2009, CLIN CANCER RES, V15, P4885, DOI 10.1158/1078-0432.CCR-09-0109; Moon MK, 2009, BIOL PHARM BULL, V32, P1371, DOI 10.1248/bpb.32.1371; Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141; Nagasaka R, 2007, BIOCHEM BIOPH RES CO, V358, P615, DOI 10.1016/j.bbrc.2007.04.178; NAGATA K, 1990, ANTIVIR RES, V13, P11, DOI 10.1016/0166-3542(90)90041-5; NAKASHIMA H, 1992, CHEM PHARM BULL, V40, P2102; Ohno N, 2001, BIOL PHARM BULL, V24, P820, DOI 10.1248/bpb.24.820; Ohno N., 2001, Pharmaceutical and Pharmacological Letters, V11, P87; Rasheed Z, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-1; SAKAGAMI H, 1991, CHEM PHARM BULL, V39, P950; Singh R, 2010, LIFE SCI, V86, P907, DOI 10.1016/j.lfs.2010.04.013; Tada R, 2007, CARBOHYD RES, V342, P2611, DOI 10.1016/j.carres.2007.08.016; Tada R, 2011, IMMUNOPHARM IMMUNOT, V33, P302, DOI 10.3109/08923973.2010.503707; Tada R, 2009, CARBOHYD RES, V344, P400, DOI 10.1016/j.carres.2008.11.005; Toyoda-Ono Y, 2007, BIOSCI BIOTECH BIOCH, V71, P971, DOI 10.1271/bbb.60635; Tucsek Z, 2011, J LEUKOCYTE BIOL, V89, P105, DOI 10.1189/jlb.0610355; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Wasser Solomon P., 2002, International Journal of Medicinal Mushrooms, V4, P267; WEIGENT DA, 1983, INFECT IMMUN, V41, P992, DOI 10.1128/IAI.41.3.992-997.1983; WEISS M, 1992, INFECTION, V20, pS81, DOI 10.1007/BF01705023; WINEMAN JP, 1992, BLOOD, V80, P1717; Yamaguchi K, 2002, ANTIVIR RES, V53, P19, DOI 10.1016/S0166-3542(01)00189-9; Yamanaka D, 2012, IMMUNOPHARM IN PRESS; YEN GC, 1995, J AGR FOOD CHEM, V43, P27, DOI 10.1021/jf00049a007; Yuminamochi E, 2007, IMMUNOLOGY, V121, P197, DOI 10.1111/j.1365-2567.2006.02558.x	49	18	18	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e36025	10.1371/journal.pone.0036025	http://dx.doi.org/10.1371/journal.pone.0036025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540016	Green Submitted, gold, Green Published			2022-12-25	WOS:000305341000082
J	Banerjee, J; Sharma, R; Agarwal, A; Maitra, D; Diamond, MP; Abu-Soud, HM				Banerjee, Jashoman; Sharma, Rakesh; Agarwal, Ashok; Maitra, Dhiman; Diamond, Michael P.; Abu-Soud, Husam M.			IL-6 and Mouse Oocyte Spindle	PLOS ONE			English	Article							OXIDATIVE STRESS; PERITONEAL-FLUID; CYTOKINE PRODUCTION; L-CARNITINE; TNF-ALPHA; IN-VITRO; ENDOMETRIOSIS; INTERLEUKIN-6; WOMEN; ASSOCIATION	Interleukin 6 (IL-6) is considered a major indicator of the acute-phase inflammatory response. Endometriosis and pelvic inflammation, diseases that manifest elevated levels of IL-6, are commonly associated with higher infertility. However, the mechanistic link between elevated levels of IL-6 and poor oocyte quality is still unclear. In this work, we explored the direct role of this cytokine as a possible mediator for impaired oocyte spindle and chromosomal structure, which is a critical hurdle in the management of infertility. Metaphase-II mouse oocytes were exposed to recombinant mouse IL-6 (50, 100 and 200 ng/mL) for 30 minutes and subjected to indirect immunofluorescent staining to identify alterations in the microtubule and chromosomal alignment compared to untreated controls. The deterioration in microtubule and chromosomal alignment were evaluated utilizing both fluorescence and confocal microscopy, and were quantitated with a previously reported scoring system. Our results showed that IL-6 caused a dose-dependent deterioration in microtubule and chromosomal alignment in the treated oocytes as compared to the untreated group. Indeed, IL-6 at a concentration as low as 50 ng/mL caused deterioration in the spindle structure in 60% of the oocytes, which increased significantly (P<0.0001) as IL-6 concentration was increased. In conclusion, elevated levels of IL-6 associated with endometriosis and pelvic inflammation may reduce the fertilizing capacity of human oocyte through a mechanism that involves impairment of the microtubule and chromosomal structure.	[Banerjee, Jashoman; Maitra, Dhiman; Diamond, Michael P.; Abu-Soud, Husam M.] Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI 48202 USA; [Sharma, Rakesh; Agarwal, Ashok] Cleveland Clin, Ctr Reprod Med, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA; [Abu-Soud, Husam M.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI USA	Wayne State University; Cleveland Clinic Foundation; Wayne State University	Banerjee, J (corresponding author), Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI 48202 USA.	habusoud@med.wayne.edu; jbanerje@med.wayne.edu	Agarwal, Ashok/B-1689-2013	Agarwal, Ashok/0000-0003-0585-1026; Diamond, Michael/0000-0001-6353-4489; , dhiman/0000-0002-8775-2963; Maitra, Dhiman/0000-0003-4604-3551				Agarwal SK, 2011, J MANAGE CARE PHARM, V17, pS14, DOI 10.18553/jmcp.2011.17.s9-b.S14; Banerjee J, 2012, J PINEAL RES; Bromfield JJ, 2011, ENDOCRINOLOGY; Chen CY, 1998, ARCH BIOCHEM BIOPHYS, V356, P127, DOI 10.1006/abbi.1998.0761; Choi WJ, 2007, FERTIL STERIL, V88, P1220, DOI 10.1016/j.fertnstert.2007.02.067; de Gonzalo-Calvo D, 2010, FREE RADICAL BIO MED, V49, P733, DOI 10.1016/j.freeradbiomed.2010.05.019; Demir B, 2009, AM J REPROD IMMUNOL, V62, P261, DOI 10.1111/j.1600-0897.2009.00734.x; Desmarquest P, 1998, RESP MED, V92, P951, DOI 10.1016/S0954-6111(98)90195-0; Eichenlaub-Ritter U, 2004, REPROD BIOMED ONLINE, V8, P45, DOI 10.1016/S1472-6483(10)60497-X; Falcone T, 2011, OBSTET GYNECOL, V118, P691, DOI 10.1097/AOG.0b013e31822adfd1; Gabay C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1917; Gardiner CS, 1998, BIOL REPROD, V59, P431, DOI 10.1095/biolreprod59.2.431; Garrido N, 2000, HUM REPROD UPDATE, V6, P67, DOI 10.1093/humupd/6.1.67; Giwa MO, 2012, NEUROLOGY; Goud AP, 2008, FREE RADICAL BIO MED, V44, P1295, DOI 10.1016/j.freeradbiomed.2007.11.014; Goud AP, 2006, BIOCHEMISTRY-US, V45, P11366, DOI 10.1021/bi060910e; Haddad JJE, 2001, CYTOKINE, V13, P138, DOI 10.1006/cyto.2000.0789; Harada T, 1997, AM J OBSTET GYNECOL, V176, P593, DOI 10.1016/S0002-9378(97)70553-2; Helmy AA, 2012, NEURODEGENER DIS; Kang M, 2011, GENES NUTR, V6, P117, DOI 10.1007/s12263-010-0195-5; Kowaltowski AJ, 1999, FREE RADICAL BIO MED, V26, P463, DOI 10.1016/S0891-5849(98)00216-0; Kyama CM, 2006, FERTIL STERIL, V85, P1667, DOI 10.1016/j.fertnstert.2005.11.060; Lee WJ, 2010, J VASC SURG, V52, P1290, DOI 10.1016/j.jvs.2010.04.085; Liu ZL, 2009, ENDOCRINOLOGY, V150, P3360, DOI 10.1210/en.2008-1532; Mahnke JL, 2000, FERTIL STERIL, V73, P166, DOI 10.1016/S0015-0282(99)00466-5; Mansour G, 2010, FERTIL STERIL, V94, P1894, DOI 10.1016/j.fertnstert.2009.09.043; Mansour G, 2009, FERTIL STERIL, V91, P2079, DOI 10.1016/j.fertnstert.2008.02.097; MILLS JL, 1988, NEW ENGL J MED, V318, P671, DOI 10.1056/NEJM198803173181104; Nallella KP, 2004, UROLOGY, V64, P1010, DOI 10.1016/j.urology.2004.05.045; NASRESFAHANI MM, 1991, DEVELOPMENT, V113, P551; Negi G, 2011, J PINEAL RES, V50, P124, DOI 10.1111/j.1600-079X.2010.00821.x; Papaleo E, 2011, ACTA OBSTET GYN SCAN, V90, P878, DOI 10.1111/j.1600-0412.2011.01161.x; Papathanasiou A, 2008, FERTIL STERIL, V90, P391, DOI 10.1016/j.fertnstert.2007.07.1379; Pellicer A, 1998, FERTIL STERIL, V70, P425, DOI 10.1016/S0015-0282(98)00204-0; Punnonen J, 1996, AM J OBSTET GYNECOL, V174, P1522, DOI 10.1016/S0002-9378(96)70600-2; Richter HE, 1999, AM J OBSTET GYNECOL, V181, P940, DOI 10.1016/S0002-9378(99)70329-7; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; Saito H, 2002, GYNECOL OBSTET INVES, V53, P46, DOI 10.1159/000049424; Tarin JJ, 2004, MOL REPROD DEV, V69, P402, DOI 10.1002/mrd.20180; Tseng JF, 1996, J CLIN ENDOCR METAB, V81, P1118, DOI 10.1210/jc.81.3.1118; VanVoorhis WC, 1996, J INFECT DIS, V174, P647, DOI 10.1093/infdis/174.3.647; Wang Wei-Hua, 2002, Cloning and Stem Cells, V4, P269, DOI 10.1089/15362300260339557; WINTER BK, 1995, BRIT J CANCER, V72, P1173, DOI 10.1038/bjc.1995.482; Yang HW, 1998, HUM REPROD, V13, P998, DOI 10.1093/humrep/13.4.998; Yi K, 2011, MOL VIS, V17, P2665	45	27	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35535	10.1371/journal.pone.0035535	http://dx.doi.org/10.1371/journal.pone.0035535			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536401	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339200076
J	Chien, LC; Deshpande, AD; Jeffe, DB; Schootman, M				Chien, Lung-Chang; Deshpande, Anjali D.; Jeffe, Donna B.; Schootman, Mario			Influence of Primary Care Physician Availability and Socioeconomic Deprivation on Breast Cancer from 1988 to 2008: A Spatio-Temporal Analysis	PLOS ONE			English	Article							SCREENING MAMMOGRAPHY; FAMILY-HISTORY; MORTALITY; HEALTH; DISPARITIES; THERAPY; WOMEN; INEQUALITIES; COHORT; RATES	Background: Breast cancer is the most commonly diagnosed cancer and the second leading cause of cancer death among women in the United States. It is unclear how county-level primary care physician (PCP) availability and socioeconomic deprivation affect the spatial and temporal variation of breast cancer incidence and mortality. Methods: We used the 1988-2008 public-use county-based data from nine Surveillance, Epidemiology, and End Results (SEER) programs to analyze the temporal and spatial disparity of PCP availability and socioeconomic deprivation on early-stage incidence, advanced-stage incidence and breast cancer mortality. The spatio-temporal analysis was implemented by a novel structural additive modeling approach. Results: Greater PCP availability was significantly associated with higher early-stage incidence, advanced-stage incidence and mortality during the entire study period while socioeconomic deprivation was significantly negatively associated with early-stage incidence, advanced-stage incidence, and mortality up to 1992. However, the observed influence of PCP availability and socioeconomic deprivation varied by county. Conclusions: We showed important associations of PCP availability and socioeconomic deprivation with the three breast cancer indicators. However, the effect of these associations varied over time and across counties. The association of PCP availability and socioeconomic deprivation was stronger in selected counties.	[Chien, Lung-Chang; Deshpande, Anjali D.; Jeffe, Donna B.; Schootman, Mario] Washington Univ, Sch Med, Dept Internal Med, Div Hlth Behav Res, St Louis, MO 63110 USA	Washington University (WUSTL)	Chien, LC (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Hlth Behav Res, St Louis, MO 63110 USA.	lchien@dom.wustl.edu	Schootman, Mario/AAF-3941-2019; Jeffe, Donna B./AAI-3732-2020	Schootman, Mario/0000-0003-1162-8824; Jeffe, Donna B./0000-0002-7642-3777	National Cancer Institute [CA109675, CA91842]; NATIONAL CANCER INSTITUTE [R01CA109675, P30CA091842] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by grants from the National Cancer Institute (CA109675, CA91842). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Baade PD, 2011, J EPIDEMIOL COMMUN H, V65, P1037, DOI 10.1136/jech.2010.114777; BallardBarbash R, 1996, JNCI-J NATL CANCER I, V88, P716, DOI 10.1093/jnci/88.11.716; Belitz C, 2009, BAYESX SOFTWARE BAYE; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Brezger A, 2006, COMPUT STAT DATA AN, V50, P967, DOI 10.1016/j.csda.2004.10.011; Brezger A, 2005, J STAT SOFTWARE, V14; Chang CH, 2011, JAMA-J AM MED ASSOC, V305, P2096, DOI 10.1001/jama.2011.665; Cui Y, 2007, J HEALTH CARE POOR U, V18, P102, DOI 10.1353/hpu.2007.0115; DeSantis C, 2008, CANCER CAUSE CONTROL, V19, P537, DOI 10.1007/s10552-008-9113-1; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Fahrmeir L, 2001, J ROY STAT SOC C-APP, V50, P201, DOI 10.1111/1467-9876.00229; Ferrante JM, 2000, J AM BOARD FAM PRACT, V13, P408, DOI DOI 10.3122/15572625-13-6-408; Glass AG, 2007, JNCI-J NATL CANCER I, V99, P1152, DOI 10.1093/jnci/djm059; Gonzalez P, 2011, WOMEN HEALTH ISS, V21, P165, DOI 10.1016/j.whi.2010.09.001; Goodwin JS, 1998, AM J PUBLIC HEALTH, V88, P458, DOI 10.2105/AJPH.88.3.458; Gorey KM, 2011, CAN J RURAL MED, V16, P47; Gramling R, 2009, EPIDEMIOLOGY, V20, P752, DOI 10.1097/EDE.0b013e3181a71279; Jemal A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1672; Kazembe Lawrence N, 2007, Int J Equity Health, V6, P5, DOI 10.1186/1475-9276-6-5; Krieger N, 2002, AM J EPIDEMIOL, V156, P471, DOI 10.1093/aje/kwf068; Laden F, 1997, J NATL CANCER I, V89, P1373, DOI 10.1093/jnci/89.18.1373; Lang S, 2004, J COMPUT GRAPH STAT, V13, P183, DOI 10.1198/1061860043010; Lopez EDS, 2009, WOMEN HEALTH ISS, V19, P434, DOI 10.1016/j.whi.2009.07.008; Macinko J, 2007, INT J HEALTH SERV, V37, P111, DOI 10.2190/3431-G6T7-37M8-P224; Meissner HI, 2011, CANCER-AM CANCER SOC, V117, P3101, DOI 10.1002/cncr.25873; Merkin SS, 2002, AM J PUBLIC HEALTH, V92, P64, DOI 10.2105/AJPH.92.1.64; Messer LC, 2006, J URBAN HEALTH, V83, P1041, DOI 10.1007/s11524-006-9094-x; Price MA, 2010, BREAST CANCER RES TR, V124, P509, DOI 10.1007/s10549-010-0868-1; Roux AVD, 2001, ANN EPIDEMIOL, V11, P395, DOI 10.1016/S1047-2797(01)00221-6; Saenz R, 2009, TRENDS BREAST CANC M; Schootman M, 2010, BREAST CANCER RES TR, V122, P533, DOI 10.1007/s10549-009-0729-y; SHEEHAN TJ, 2004, INT J HEALTH GEOGR, V3, P17; Shi L, 2002, HEALTH SERV RES, V37, P529, DOI 10.1111/1475-6773.t01-1-00036; Shi LY, 2005, SOC SCI MED, V61, P65, DOI 10.1016/j.socscimed.2004.11.056; Shi LY, 2001, AM J PUBLIC HEALTH, V91, P1246, DOI 10.2105/AJPH.91.8.1246; Singh GK, 2003, AM J PUBLIC HEALTH, V93, P1137, DOI 10.2105/AJPH.93.7.1137; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Vieira VM, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-46; Vona-Davis L, 2009, J WOMENS HEALTH, V18, P883, DOI 10.1089/jwh.2008.1127; Yankaskas BC, 2010, AM J PUBLIC HEALTH, V100, P947, DOI 10.2105/AJPH.2008.150318	40	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35737	10.1371/journal.pone.0035737	http://dx.doi.org/10.1371/journal.pone.0035737			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UD	22536433	gold, Green Published, Green Submitted			2022-12-25	WOS:000305339200105
J	Li, JL; Li, HX; Gao, XJ; Zhang, JL; Li, S; Xu, SW; Tang, ZX				Li, Jin-Long; Li, Hui-Xin; Gao, Xue-Jiao; Zhang, Jiu-Li; Li, Shu; Xu, Shi-Wen; Tang, Zhao-Xin			Priority in Selenium Homeostasis Involves Regulation of SepSecS Transcription in the Chicken Brain	PLOS ONE			English	Article							SELENOPROTEIN-P; GENE-EXPRESSION; MOUSE-BRAIN; SELENOCYSTEINE; REGIONS; PROTEIN; BIOSYNTHESIS; DEFICIENCY; MACHINERY; MECHANISM	O-Phosphoseryl-tRNA: selenocysteinyl-tRNA synthase (SepSecS) is critical for the biosynthesis and transformation of selenocysteine (Sec) and plays an important role in the biological function of Se through the regulation of selenoprotein synthesis. Selenium (Se) and Selenoprotein play a pivotal role in brain function. However, how intake of the micronutrient Se affects gene expression and how genetic factors influence Se metabolism in the brain is unknown. To investigate the regulation of SepSecS transcription induced by Se in the chicken brain, we determined the Se content of brain tissue, SepSecS gene expression levels and mRNA stability in the chicken brain and primary cultured chicken embryos neurons receiving Se supplements. These results showed that Se content in the brain remains remarkably stable during Se supplementation. A significant increase in SepSecS mRNA levels was observed in all of the brain tissues of chickens fed diets containing 1-5 mg/kg sodium selenite. Most strikingly, significant changes in SepSecS mRNA levels were not observed in neurons treated with Se. However, Se altered the SepSecS mRNA half-life in cells. These data suggest that Se could regulate SepSecS mRNA stability in the avian brain and that SepSecS plays an important role in Se homeostasis regulation.	[Li, Jin-Long; Gao, Xue-Jiao; Zhang, Jiu-Li; Li, Shu; Xu, Shi-Wen] NE Agr Univ, Coll Vet Med, Harbin, Peoples R China; [Li, Jin-Long; Tang, Zhao-Xin] S China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China; [Li, Hui-Xin] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin, Peoples R China	Northeast Agricultural University - China; South China Agricultural University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Xu, SW (corresponding author), NE Agr Univ, Coll Vet Med, Harbin, Peoples R China.	shiwenxu@neau.edu.cn; tangzx@scau.edu.cn	Li, Jin-Long/S-4288-2016	Li, Jin-Long/0000-0002-5133-9165	Program for New Century Excellent Talents in Heilongjiang Provincial University of China [1252-NCET-009]; National Natural Science Foundation of China [30901088, 30871902]; Science Foundation of the Education Department of Heilongjiang Province [12511031, 11551030]; China Postdoctoral Science Foundation [20110491021]	Program for New Century Excellent Talents in Heilongjiang Provincial University of China(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of the Education Department of Heilongjiang Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported by grants from the Program for New Century Excellent Talents in Heilongjiang Provincial University of China (1252-NCET-009), the National Natural Science Foundation of China (30901088 and 30871902), the Science Foundation of the Education Department of Heilongjiang Province (12511031 and 11551030), and China Postdoctoral Science Foundation (20110491021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeby E, 2009, P NATL ACAD SCI USA, V106, P5088, DOI 10.1073/pnas.0901575106; Blanquicett C, 2010, FREE RADICAL BIO MED, V48, P1618, DOI 10.1016/j.freeradbiomed.2010.03.007; Brauer AU, 2004, REV NEUROSCIENCE, V15, P19; Burk RF, 2005, ANNU REV NUTR, V25, P215, DOI 10.1146/annurev.nutr.24.012003.132120; Chen J, 2003, J NEUROCHEM, V86, P1, DOI 10.1046/j.1471-4159.2003.01854.x; De Rubeis S, 2010, MOL CELL NEUROSCI, V43, P43, DOI 10.1016/j.mcn.2009.09.013; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Ebeid TA, 2009, BRIT POULTRY SCI, V50, P641, DOI 10.1080/00071660903303415; FORCHHAMMER K, 1989, NATURE, V342, P453, DOI 10.1038/342453a0; Gu QP, 2002, BIOMETALS, V15, P411, DOI 10.1023/A:1020241032336; HASUNUMA R, 1982, ANAL BIOCHEM, V126, P242, DOI 10.1016/0003-2697(82)90510-3; Hatfield DL, 2006, PROG NUCLEIC ACID RE, V81, P97, DOI 10.1016/S0079-6603(06)81003-2; Hoppe B, 2008, CELL TISSUE RES, V332, P403, DOI 10.1007/s00441-008-0575-y; Kyriakopoulos A, 2000, J TRACE ELEM MED BIO, V14, P179, DOI 10.1016/S0946-672X(00)80008-5; Li JL, 2012, BIOMETALS, V25, P459, DOI 10.1007/s10534-012-9517-y; Li JL, 2011, BIOMETALS, V24, P291, DOI 10.1007/s10534-010-9395-0; Li JL, 2011, MOL BIOL REP, V38, P4015, DOI 10.1007/s11033-010-0520-5; Li JL, 2010, BIOMETALS, V23, P695, DOI 10.1007/s10534-010-9334-0; MANGOURA D, 1993, P NATL ACAD SCI USA, V90, P2915, DOI 10.1073/pnas.90.7.2915; Moriarty PM, 1998, MOL CELL BIOL, V18, P2932, DOI 10.1128/MCB.18.5.2932; Nakayama A, 2007, J NUTR, V137, P690, DOI 10.1093/jn/137.3.690; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Peng X, 2011, BIOL TRACE ELEM RES, V142, P167, DOI 10.1007/s12011-010-8756-4; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Renko K, 2008, BIOCHEM J, V409, P741, DOI 10.1042/BJ20071172; Richardson Des R, 2005, Biochem J, V386, pe5; Sachdev SW, 2001, BIOCHEM J, V357, P851; Savaskan NE, 2002, FASEB J, V16, P112, DOI 10.1096/fj.02-0067fje; Savaskan NE, 2007, BIOL CHEM, V388, P1007, DOI 10.1515/BC.2007.126; Schomburg L, 2004, CELL MOL LIFE SCI, V61, P1988, DOI 10.1007/s00018-004-4114-z; Schomburg L, 2009, BBA-GEN SUBJECTS, V1790, P1453, DOI 10.1016/j.bbagen.2009.03.015; Schweizer U, 2004, BRAIN RES REV, V45, P164, DOI 10.1016/j.brainresrev.2004.03.004; Schweizer U, 2004, J NUTR, V134, P707, DOI 10.1093/jn/134.4.707; Sheppard K, 2008, NUCLEIC ACIDS RES, V36, P1813, DOI 10.1093/nar/gkn015; St Germain DL, 2009, ENDOCRINOLOGY, V150, P1097, DOI 10.1210/en.2008-1588; Su D, 2009, IUBMB LIFE, V61, P35, DOI 10.1002/iub.136; Sun Y, 2001, J NUTR BIOCHEM, V12, P88, DOI 10.1016/S0955-2863(00)00130-3; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Zhang S, 2010, MECH AGEING DEV, V131, P253, DOI 10.1016/j.mad.2010.02.006; Zhang Y, 2008, J BIOL CHEM, V283, P2427, DOI 10.1074/jbc.M707951200; Zhou JC, 2009, J NUTR, V139, P1061, DOI 10.3945/jn.109.104901	41	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35761	10.1371/journal.pone.0035761	http://dx.doi.org/10.1371/journal.pone.0035761			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536434	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200108
J	Fernandez-Martos, CM; Gonzalez, P; Rodriguez, FJ				Maria Fernandez-Martos, Carmen; Gonzalez, Pau; Javier Rodriguez, Francisco			Acute Leptin Treatment Enhances Functional Recovery after Spinal Cord Injury	PLOS ONE			English	Article							METHIONYL HUMAN LEPTIN; ACTIVE ANTIRETROVIRAL THERAPY; ALZHEIMERS-DISEASE; KAPPA-B; HYPOTHALAMIC NEURONS; TAU PHOSPHORYLATION; METABOLIC SYNDROME; NEUROPATHIC PAIN; GAIT ANALYSIS; OBESE GENE	Background: Spinal cord injury is a major cause of long-term disability and has no current clinically accepted treatment. Leptin, an adipocyte-derived hormone, is best known as a regulator of food intake and energy expenditure. Interestingly, several studies have demonstrated that leptin has significant effects on proliferation and cell survival in different neuropathologies. Here, we sought to evaluate the role of leptin after spinal cord injury. Findings: Based on its proposed neuroprotective role, we have evaluated the effects of a single, acute intraparenchymal injection of leptin in a clinically relevant animal model of spinal cord injury. As determined by quantitative Real Time-PCR, endogenous leptin and the long isoform of the leptin receptor genes show time-dependent variations in their expression in the healthy and injured adult spinal cord. Immunohistochemical analysis of post-injury tissue showed the long isoform of the leptin receptor expression in oligodendrocytes and, to a lesser extent, in astrocytes, microglia/macrophages and neurons. Moreover, leptin administered after spinal cord injury increased the expression of neuroprotective genes, reduced caspase-3 activity and decreased the expression of pro-inflammatory molecules. In addition, histological analysis performed at the completion of the study showed that leptin treatment reduced microglial reactivity and increased caudal myelin preservation, but it did not modulate astroglial reactivity. Consequently, leptin improved the recovery of sensory and locomotor functioning. Conclusions: Our data suggest that leptin has a prominent neuroprotective and anti-inflammatory role in spinal cord damage and highlights leptin as a promising therapeutic agent.	[Maria Fernandez-Martos, Carmen; Gonzalez, Pau; Javier Rodriguez, Francisco] HNP, Mol Neurol Lab, Toledo, Spain		Rodriguez, FJ (corresponding author), HNP, Mol Neurol Lab, Toledo, Spain.	fjrodriguez@sescam.jccm.es	Sanchez, Pau Gonzalez/J-2530-2019; Rodríguez Muñoz, Francisco Javier/GZM-5286-2022; Fernandez-Martos, Carmen/J-7770-2014	Sanchez, Pau Gonzalez/0000-0002-8871-8054; Rodríguez Muñoz, Francisco Javier/0000-0001-5902-7556; Fernandez-Martos, Carmen/0000-0002-6387-4456	Spanish Health Council [PI08/1475]; FEDER	Spanish Health Council; FEDER(European Commission)	This study has been supported by the project PI08/1475 from the "Fondo de Investigaciones Sanitarias" from the Spanish Health Council (cofunded by FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almad A, 2010, J COMP NEUROL, V518, P785, DOI 10.1002/cne.22242; Ankeny DP, 2009, NEUROSCIENCE, V158, P1112, DOI 10.1016/j.neuroscience.2008.07.001; Banks WA, 2008, CURR PHARM DESIGN, V14, P1606, DOI 10.2174/138161208784705496; Basso DM, 2004, J NEUROTRAUM, V21, P395, DOI 10.1089/089771504323004548; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beattie MS, 2002, PROG BRAIN RES, V137, P37; Bjorbaek C, 2001, J BIOL CHEM, V276, P4747, DOI 10.1074/jbc.M007439200; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Brennan AM, 2009, EUR J ENDOCRINOL, V160, P173, DOI 10.1530/EJE-08-0597; Cafferty WBJ, 2004, J NEUROSCI, V24, P4432, DOI 10.1523/JNEUROSCI.2245-02.2004; Carro Eva M, 2009, Recent Pat CNS Drug Discov, V4, P200; Chan JL, 2008, CLIN PHARMACOKINET, V47, P753, DOI 10.2165/00003088-200847110-00006; Chan JL, 2007, J CLIN ENDOCR METAB, V92, P2307, DOI 10.1210/jc.2006-2864; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Davies JE, 2006, J NEUROTRAUM, V23, P397, DOI 10.1089/neu.2006.23.397; Davies JE, 2004, EUR J NEUROSCI, V19, P1226, DOI 10.1111/j.1460-9568.2004.03184.x; Dixon W, 1948, J AM STAT ASSOC, V48, P109; DomBourian MG, 2006, SPINE, V31, P2778, DOI 10.1097/01.brs.0000245865.97424.b4; Dominguez E, 2010, J NEUROSCI, V30, P5754, DOI 10.1523/JNEUROSCI.5007-09.2010; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fujioka K, 1999, JAMA-J AM MED ASSOC, V282, P1517, DOI 10.1001/jama.282.16.1517; Garcia-Alias G, 2006, BRAIN RES, V1108, P195, DOI 10.1016/j.brainres.2006.06.029; Ghanizadeh A, 2011, BRAIN DEV-JPN, V33, P92, DOI 10.1016/j.braindev.2010.08.003; Greco SJ, 2008, BIOCHEM BIOPH RES CO, V376, P536, DOI 10.1016/j.bbrc.2008.09.026; Greco SJ, 2010, J ALZHEIMERS DIS, V19, P1155, DOI 10.3233/JAD-2010-1308; Greco SJ, 2009, NEUROSCI LETT, V455, P191, DOI 10.1016/j.neulet.2009.03.066; Greco SJ, 2009, BIOCHEM BIOPH RES CO, V380, P98, DOI 10.1016/j.bbrc.2009.01.041; Guo ZH, 2008, J BIOL CHEM, V283, P1754, DOI 10.1074/jbc.M703753200; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Harvey J, 2010, CLIN CHEM, V56, P696, DOI 10.1373/clinchem.2010.144006; Hwa JJ, 1996, HORM METAB RES, V28, P659, DOI 10.1055/s-2007-979873; Jiao JW, 2005, EMBO J, V24, P1068, DOI 10.1038/sj.emboj.7600589; Jones TB, 2005, CURR PHARM DESIGN, V11, P1223, DOI 10.2174/1381612053507468; Knafo S, 2008, BRIT J NEUROSURG, V22, P3, DOI 10.1080/02688690701593595; KUNKELBAGDEN E, 1993, EXP NEUROL, V119, P153, DOI 10.1006/exnr.1993.1017; Lankhorst AJ, 2001, J NEUROTRAUM, V18, P203, DOI 10.1089/08977150150502622; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Lee JH, 2006, J CLIN ENDOCR METAB, V91, P2605, DOI 10.1210/jc.2005-1545; Lim G, 2009, J CLIN INVEST, V119, P295, DOI 10.1172/JCI36785; Lindsey AE, 2000, NEUROREHAB NEURAL RE, V14, P287, DOI 10.1177/154596830001400405; Fernandez-Martos CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027000; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; McLennan DN, 2003, PHARM RES-DORDR, V20, P1156, DOI 10.1023/A:1025036611949; Munzberg H, 2005, CELL MOL LIFE SCI, V62, P642, DOI 10.1007/s00018-004-4432-1; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Park SW, 2007, J PHARMACOL EXP THER, V320, P1002, DOI 10.1124/jpet.106.113472; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Polak PE, 2005, J NEUROIMMUNOL, V168, P65, DOI 10.1016/j.jneuroim.2005.07.006; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Russo VC, 2004, ENDOCRINOLOGY, V145, P4103, DOI 10.1210/en.2003-1767; Shanley LJ, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0001.2001; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Spencer NFL, 1997, INT IMMUNOL, V9, P1581, DOI 10.1093/intimm/9.10.1581; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Strauch ED, 2003, J AM COLL SURGEONS, V197, P974, DOI 10.1016/S1072-7515(03)00720-8; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Tezapsidis N, 2009, J ALZHEIMERS DIS, V16, P731, DOI 10.3233/JAD-2009-1021; Tian YH, 2011, PAIN, V152, P1263, DOI 10.1016/j.pain.2011.01.054; Valerio A, 2006, J BIOL CHEM, V281, P12950, DOI 10.1074/jbc.M508691200; Weng Z, 2007, J BIOL CHEM, V282, P34479, DOI 10.1074/jbc.M705426200; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101; Zhang F, 2007, STROKE, V38, P2329, DOI 10.1161/STROKEAHA.107.482786; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zimmermann M, 2001, EUR J PHARMACOL, V429, P23, DOI 10.1016/S0014-2999(01)01303-6	67	48	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35594	10.1371/journal.pone.0035594	http://dx.doi.org/10.1371/journal.pone.0035594			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536415	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200084
J	Pedrosa-Gerasmio, IR; Babaran, RP; Santos, MD				Pedrosa-Gerasmio, Ivane R.; Babaran, Ricardo P.; Santos, Mudjekeewis D.			Discrimination of Juvenile Yellowfin (Thunnus albacares) and Bigeye (T-obesus) Tunas using Mitochondrial DNA Control Region and Liver Morphology	PLOS ONE			English	Article								Yellowfin tuna, Thunnus albacares (Bonnaterre, 1788) and bigeye tuna, Thunnus obesus (Lowe, 1839) are two of the most economically important tuna species in the world. However, identification of their juveniles, especially at sizes less than 40 cm, is very difficult, often leading to misidentification and miscalculation of their catch estimates. Here, we applied the mitochondrial DNA control region D-loop, a recently validated genetic marker used for identifying tuna species (Genus Thunnus), to discriminate juvenile tunas caught by purse seine and ringnet sets around fish aggregating devices (FADs) off the Southern Iloilo Peninsula in Central Philippines. We checked individual identifications using the Neighbor-Joining Method and compared results with morphometric analyses and the liver phenotype. We tested 48 specimens ranging from 13 to 31 cm fork length. Morpho-meristic analyses suggested that 12 specimens (25%) were bigeye tuna and 36 specimens (75%) were yellowfin tuna. In contrast, the genetic and liver analyses both showed that 5 specimens (10%) were bigeye tuna and 43 (90%) yellowfin tuna. This suggests that misidentification can occur even with highly stringent morpho-meristic characters and that the mtDNA control region and liver phenotype are excellent markers to discriminate juveniles of yellowfin and bigeye tunas.	[Pedrosa-Gerasmio, Ivane R.; Babaran, Ricardo P.] Univ Philippines Visayas, Coll Fisheries & Ocean Sci, Iloilo, Philippines; [Pedrosa-Gerasmio, Ivane R.; Santos, Mudjekeewis D.] Natl Fisheries Res & Dev Inst, Quezon City, Philippines	University of the Philippines System; University of the Philippines Visayas	Pedrosa-Gerasmio, IR (corresponding author), Natl Fisheries Res & Dev Inst, Quezon City, Philippines.	ivanepedrosa@yahoo.com.ph	Gerasmio, Ivane/ABC-5385-2021	Santos, Mudjekeewis/0000-0002-4770-1221; /0000-0003-0618-099X; BABARAN, RICARDO/0000-0003-4652-3619	Accelerated Science and Technology Human Resource Development (ASTHRD); Department of Science and Technology-Philippine Council for Aquatic and Marine Research and Development (DOST-PCAMRD); National Fisheries Research and Development Institute (NFRDI), Philippines	Accelerated Science and Technology Human Resource Development (ASTHRD); Department of Science and Technology-Philippine Council for Aquatic and Marine Research and Development (DOST-PCAMRD)(Department of Science & Technology (DOST), Philippines); National Fisheries Research and Development Institute (NFRDI), Philippines	This work was supported by the Accelerated Science and Technology Human Resource Development (ASTHRD) and Grants-in-Aid (GIA) Programs of the Department of Science and Technology-Philippine Council for Aquatic and Marine Research and Development (DOST-PCAMRD) and the National Fisheries Research and Development Institute (NFRDI), Philippines. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babaran R, 2006, WCPFCSC22006 U PHIL; Barut N, 2010, ANN REPORT COMMISS 1; Basit S. A., 2009, EMILIO AGUINALDO COL, V7, P1; Chow S, 2006, J FISH BIOL, V68, P24, DOI 10.1111/j.0022-1112.2006.00945.x; Chow Seinen, 1993, Bulletin of the National Research Institute of Far Seas Fisheries, V30, P207; Dickson J, 1997, MECH EFFECTS AGGREGA, P141; GREWE PM, 1998, SOEST PUBLICATION, V9805; Itano D, 2005, HDB IDENTIFICATION Y, P1; Langley A, 2007, WCPFCSC3SA SWG, P1; LANGLEY A, 2006, 7 SECR PAC COMM; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu ZJ, 2004, AQUACULTURE, V238, P1, DOI 10.1016/j.aquaculture.2004.05.027; Martinez P, 2006, MOL PHYLOGENET EVOL, V39, P404, DOI 10.1016/j.ympev.2005.07.022; McCune B., 1999, MULTIVARIATE ANAL EC; Niwa Y, 2003, AQUACULTURE, V218, P387, DOI 10.1016/S0044-8486(03)00015-2; NOAA, 2009, NAT OC ATM ADM GUID; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Santos Mudjekeewis D., 2010, Philippine Journal of Science, V139, P43; Smith L. I., 2002, TUTORIAL PRINCIPAL C; Takeyama H, 2001, J FISH BIOL, V58, P1646, DOI 10.1111/j.1095-8649.2001.tb02319.x; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vinas J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007606; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716	24	25	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35604	10.1371/journal.pone.0035604	http://dx.doi.org/10.1371/journal.pone.0035604			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536417	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336200062
J	Schroder, HC; Wang, XH; Manfrin, A; Yu, SH; Grebenjuk, VA; Korzhev, M; Wiens, M; Schlossmacher, U; Muller, WEG				Schroeder, Heinz C.; Wang, Xiaohong; Manfrin, Alberto; Yu, Shu-Hong; Grebenjuk, Vlad A.; Korzhev, Michael; Wiens, Matthias; Schlossmacher, Ute; Mueller, Werner E. G.			Acquisition of Structure-guiding and Structure-forming Properties during Maturation from the Pro-silicatein to the Silicatein Form	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEMOSPONGE SUBERITES-DOMUNCULA; SILICEOUS SPICULES; MECHANICAL-PROPERTIES; BIOLOGICAL SILICA; AXIAL FILAMENT; CATHEPSIN-L; SPONGE; PROTEIN; NANOINDENTATION; SKELETOGENESIS	Silicateins are the key enzymes involved in the enzymatic polycondensation of the inorganic scaffold of the skeletal elements of the siliceous sponges, the spicules. The gene encoding pro-silicatein is inserted into the pCold TF vector, comprising the gene for the bacterial trigger factor. This hybrid gene is expressed in Escherichia coli and the synthesized fusion protein is purified. The fusion protein is split into the single proteins with thrombin by cleavage of the linker sequence present between the two proteins. At 23 degrees C, the 87 kDa trigger factor-pro-silicatein fusion protein is cleaved to the 51 kDa trigger factor and the 35 kDa pro-silicatein. The cleavage process proceeds and results in the release of the 23 kDa mature silicatein, a process which very likely proceeds by autocatalysis. Almost in parallel with its formation, the mature enzyme precipitates as pure 23 kDa protein. When the precipitate is dissolved in an urea buffer, the solubilized protein displays its full enzymatic activity which is enhanced multi-fold in the presence of the silicatein interactor silintaphin-1 or of poly(ethylene glycol) (PEG). The biosilica product formed increases its compactness if silicatein is supplemented with silintaphin-1 or PEG. The elastic modulus of the silicatein-mediated biosilica product increases in parallel with the addition of silintaphin-1 and/or PEG from 17 MPa(silicatein) via 61 MPa (silicatein: silintaphin-1) to 101 MPa (silicatein: silintaphin-1 and PEG). These data show that the maturation process from the pro-silicatein state to the mature form is the crucial step during which silicatein acquires its structureguiding and structure-forming properties.	[Schroeder, Heinz C.; Wang, Xiaohong; Manfrin, Alberto; Grebenjuk, Vlad A.; Korzhev, Michael; Wiens, Matthias; Schlossmacher, Ute; Mueller, Werner E. G.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, ERC Adv Grant Res Grp, D-55128 Mainz, Germany; [Wang, Xiaohong] Chinese Acad Geol Sci, Natl Res Ctr Geoanal, Beijing 100037, Peoples R China; [Yu, Shu-Hong] Univ Sci & Technol China, Div Nanomat & Chem, Hefei 230026, Peoples R China	Johannes Gutenberg University of Mainz; Chinese Academy of Geological Sciences; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Muller, WEG (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, ERC Adv Grant Res Grp, Duesbergweg 6, D-55128 Mainz, Germany.	wmueller@uni-mainz.de	Wang, Zhong Lin/E-2176-2011; Müller, W. E. G./AAR-8651-2020; Yu, Shu-Hong/A-1903-2010; wang, jie/GRS-0942-2022; Wang, Xiaohong/AAR-5526-2020	Wang, Zhong Lin/0000-0002-5530-0380; Müller, W. E. G./0000-0002-8223-3689; Yu, Shu-Hong/0000-0003-3732-1011; Wiens, Matthias/0000-0001-9219-0478; Schroder, Heinz C./0000-0003-0992-6427	Deutsche Forschungsgemeinschaft [Schr 277/10-2]; European Commission [215507]; Industry-Academia Partnerships and Pathways [286059, 266033, 268476]; International Human Frontier Science Program; Ministry of Land and Resources of the People's Republic of China [201011005-06]; International Science & Technology Cooperation Program of China [2008DFA00980]; ERC Advanced Investigator [268476 BIOSILICA]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Industry-Academia Partnerships and Pathways; International Human Frontier Science Program(Human Frontier Science Program); Ministry of Land and Resources of the People's Republic of China; International Science & Technology Cooperation Program of China; ERC Advanced Investigator	This work was supported by grants from the Deutsche Forschungsgemeinschaft (Schr 277/10-2), the European Commission ("BIOMINTEC": No. 215507; and Industry-Academia Partnerships and Pathways "CoreShell": No. 286059; "SPECIAL": No. 266033; and "MarBioTec*EU-CN*": No. 268476), the International Human Frontier Science Program, the Public Welfare Project of Ministry of Land and Resources of the People's Republic of China (Grant No. 201011005-06) and the International Science & Technology Cooperation Program of China (Grant No. 2008DFA00980).; Recipient of an ERC Advanced Investigator Grant (No. 268476 BIOSILICA). To whom correspondence should be addressed: Institute for Physiological Chemistry, University Medical Center of the Johannes Gutenberg University Mainz, Duesbergweg 6, D-55128 Mainz, Germany. Tel.: 49-6131-39-25910; Fax: 49-6131-39-25243; E-mail: wmueller@uni-mainz.de.	Abrahamson M, 2003, BIOCHEM SOC SYMP, V70, P179, DOI 10.1042/bss0700179; Akhtar R, 2009, J MATER RES, V24, P638, DOI 10.1557/JMR.2009.0130; Askeland D.R., 2006, SCI ENG MAT, V5th, P198; Boury-Esnault N, 1997, SMITHSONIAN CONTRIBU, V596, P1, DOI DOI 10.5479/SI.00810282.596; BRINKHUIS J, 1984, BIOPHYS CHEM, V19, P75, DOI 10.1016/0301-4622(84)85008-5; Cha JN, 1999, P NATL ACAD SCI USA, V96, P361, DOI 10.1073/pnas.96.2.361; Croce G, 2004, BIOPHYS J, V86, P526, DOI 10.1016/S0006-3495(04)74131-4; Ebenstein DM, 2004, J BIOMED MATER RES A, V69A, P222, DOI 10.1002/jbm.a.20096; Harper S., 2008, CURR PROTOC PROTEIN, P661; JAMES GT, 1978, ANAL BIOCHEM, V86, P574, DOI 10.1016/0003-2697(78)90784-4; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kinrade SD, 2002, J CHEM SOC DALTON, P307, DOI 10.1039/b105379p; Krasko A, 2000, EUR J BIOCHEM, V267, P4878, DOI 10.1046/j.1432-1327.2000.01547.x; Kruger N J, 1994, Methods Mol Biol, V32, P9; Le Pennec G, 2003, J BIOTECHNOL, V100, P93, DOI 10.1016/S0168-1656(02)00259-6; Li XD, 2005, NANO LETT, V5, P1982, DOI 10.1021/nl0513885; Meng FG, 2001, INT J BIOCHEM CELL B, V33, P701, DOI 10.1016/S1357-2725(01)00048-6; Morse DE, 1999, TRENDS BIOTECHNOL, V17, P230, DOI 10.1016/S0167-7799(99)01309-8; Muller WEG, 2008, J EXP BIOL, V211, P300, DOI 10.1242/jeb.008193; Muller WEG, 2008, FEBS J, V275, P362, DOI 10.1111/j.1742-4658.2007.06206.x; Muller WEG, 2007, BIOMATERIALS, V28, P4501, DOI 10.1016/j.biomaterials.2007.06.030; Muller WEG, 2007, EUR J CELL BIOL, V86, P473, DOI 10.1016/j.ejcb.2007.06.002; Muller WEG, 2011, BBA-GEN SUBJECTS, V1810, P713, DOI 10.1016/j.bbagen.2011.04.009; Muller WEG, 2010, CHEMBIOCHEM, V11, P1077, DOI 10.1002/cbic.201000078; Muller WEG, 2005, CELL TISSUE RES, V321, P285, DOI 10.1007/s00441-005-1141-5; Muller WEG, 2003, PROG MOLEC, V33, P195; Murr MM, 2005, P NATL ACAD SCI USA, V102, P11657, DOI 10.1073/pnas.0503968102; Nishiguchi Y., 2011, ISRN ZOOLOG IN PRESS; NISHIMURA Y, 1988, ARCH BIOCHEM BIOPHYS, V261, P64, DOI 10.1016/0003-9861(88)90104-X; Prokopowicz M, 2010, J NON-CRYST SOLIDS, V356, P1711, DOI 10.1016/j.jnoncrysol.2010.06.024; REILLY JJ, 1989, BIOCHEM J, V257, P493, DOI 10.1042/bj2570493; Sarikaya M, 2001, J MATER RES, V16, P1420, DOI 10.1557/JMR.2001.0198; Sarikaya M., 2002, 15 ASCE ENG MECH C J; Schlossmacher U, 2011, FEBS J, V278, P1145, DOI 10.1111/j.1742-4658.2011.08040.x; Schroder HC, 2006, J BIOL CHEM, V281, P12001, DOI 10.1074/jbc.M512677200; Schroder HC, 2012, SILICON-NETH, V4, P33, DOI 10.1007/s12633-010-9057-4; Sharp KA, 2001, J CHEM PHYS, V114, P1791, DOI 10.1063/1.1334678; Shimizu K, 1998, P NATL ACAD SCI USA, V95, P6234, DOI 10.1073/pnas.95.11.6234; Tong X, 2002, J APPL POLYM SCI, V86, P3532, DOI 10.1002/app.11152; Uriz MJ, 2006, CAN J ZOOL, V84, P322, DOI 10.1139/Z06-032; Wang XH, 2012, FEBS J, V279, P1721, DOI 10.1111/j.1742-4658.2012.08533.x; Wang XH, 2011, CHEMBIOCHEM, V12, P2316, DOI 10.1002/cbic.201100345; Wang XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020523; Wiens M, 2010, CALCIFIED TISSUE INT, V87, P513, DOI 10.1007/s00223-010-9408-6; Wiens Matthias, 2009, V47, P111, DOI 10.1007/978-3-540-88552-8_5; Wiens M, 2009, BIOMATERIALS, V30, P1648, DOI 10.1016/j.biomaterials.2008.12.021; Woesz A, 2006, J MATER RES, V21, P2068, DOI 10.1557/JMR.2006.0251; Zhu L, 2010, J BIOL CHEM, V285, P39732, DOI 10.1074/jbc.M110.163105	48	26	26	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22196	22205		10.1074/jbc.M112.351486	http://dx.doi.org/10.1074/jbc.M112.351486			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22544742	Green Published, hybrid			2022-12-25	WOS:000306418600058
J	Coburn, GA; Fisch, DN; Moorji, SM; de Muys, JM; Murga, JD; Paul, D; Provoncha, KP; Rotshteyn, Y; Han, AQ; Qian, DP; Maddon, PJ; Olson, WC				Coburn, Glen A.; Fisch, Danielle N.; Moorji, Sameer M.; de Muys, Jean-Marc; Murga, Jose D.; Paul, Dorothy; Provoncha, Kathleen P.; Rotshteyn, Yakov; Han, Amy Q.; Qian, Dapeng; Maddon, Paul J.; Olson, William C.			Novel Small-Molecule Inhibitors of Hepatitis C Virus Entry Block Viral Spread and Promote Viral Clearance in Cell Culture	PLOS ONE			English	Article							B TYPE-I; DENSITY-LIPOPROTEIN RECEPTOR; GENOTYPE 1 INFECTION; ENVELOPE GLYCOPROTEIN; CD81; INTERFERON; IDENTIFICATION; CORECEPTOR; RIBAVIRIN; STEP	Combinations of direct-acting anti-virals offer the potential to improve the efficacy, tolerability and duration of the current treatment regimen for hepatitis C virus (HCV) infection. Viral entry represents a distinct therapeutic target that has been validated clinically for a number of pathogenic viruses. To discover novel inhibitors of HCV entry, we conducted a high throughput screen of a proprietary small-molecule compound library using HCV pseudoviral particle (HCVpp) technology. We independently discovered and optimized a series of 1,3,5-triazine compounds that are potent, selective and non-cytotoxic inhibitors of HCV entry. Representative compounds fully suppress both cell-free virus and cell-to-cell spread of HCV in vitro. We demonstrate, for the first time, that long term treatment of an HCV cell culture with a potent entry inhibitor promotes sustained viral clearance in vitro. We have confirmed that a single amino acid variant, V719G, in the transmembrane domain of E2 is sufficient to confer resistance to multiple compounds from the triazine series. Resistance studies were extended by evaluating both the fusogenic properties and growth kinetics of drug-induced and natural amino acid variants in the HCVpp and HCV cell culture assays. Our results indicate that amino acid variations at position 719 incur a significant fitness penalty. Introduction of I719 into a genotype 1b envelope sequence did not affect HCV entry; however, the overall level of HCV replication was reduced compared to the parental genotype 1b/2a HCV strain. Consistent with these findings, I719 represents a significant fraction of the naturally occurring genotype 1b sequences. Importantly, I719, the most relevant natural polymorphism, did not significantly alter the susceptibility of HCV to the triazine compounds. The preclinical properties of these triazine compounds support further investigation of entry inhibitors as a potential novel therapy for HCV infection.	[Coburn, Glen A.; Fisch, Danielle N.; Moorji, Sameer M.; de Muys, Jean-Marc; Murga, Jose D.; Paul, Dorothy; Provoncha, Kathleen P.; Rotshteyn, Yakov; Han, Amy Q.; Qian, Dapeng; Maddon, Paul J.; Olson, William C.] Progen Pharmaceut Inc, Res & Dev, Tarrytown, NY USA		Coburn, GA (corresponding author), Progen Pharmaceut Inc, Res & Dev, Tarrytown, NY USA.	gcoburn@progenics.com			National Institutes of Health [R44AI051134]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI051134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant R44AI051134 to GAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Baldick CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001086; Benedicto I, 2008, HEPATOLOGY, V48, P1044, DOI 10.1002/hep.22465; Brimacombe CL, 2011, J VIROL, V85, P596, DOI 10.1128/JVI.01592-10; COBURN G, 2009, Patent No. 2009091388; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P7270, DOI 10.1073/pnas.0402253101; Dahari H, 2007, J THEOR BIOL, V247, P371, DOI 10.1016/j.jtbi.2007.03.006; Deng L, 2008, J VIROL, V82, P10375, DOI 10.1128/JVI.00395-08; Dixit NM, 2004, NATURE, V432, P922, DOI 10.1038/nature03153; Drummer HE, 2002, J VIROL, V76, P11143, DOI 10.1128/JVI.76.21.11143-11147.2002; Dubuisson J, 2008, CELL MICROBIOL, V10, P821, DOI 10.1111/j.1462-5822.2007.01107.x; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Freeman A, 2003, J VIRAL HEPATITIS, V10, P345, DOI 10.1046/j.1365-2893.2003.00454.x; Germi R, 2002, J MED VIROL, V68, P206, DOI 10.1002/jmv.10196; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Grove J, 2007, J VIROL, V81, P3162, DOI 10.1128/JVI.02356-06; Harris HJ, 2008, J VIROL, V82, P5007, DOI 10.1128/JVI.02286-07; Howe AYM, 2004, ANTIMICROB AGENTS CH, V48, P4813, DOI 10.1128/AAC.48.12.4813-4821.2004; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Joyce MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000291; Kuiken C, 2008, NUCLEIC ACIDS RES, V36, pD512, DOI 10.1093/nar/gkm962; Lavillette D, 2005, HEPATOLOGY, V41, P265, DOI 10.1002/hep.20542; Liang YQ, 2009, GASTROENTEROLOGY, V137, P1448, DOI 10.1053/j.gastro.2009.07.050; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Meuleman P, 2008, HEPATOLOGY, V48, P1761, DOI 10.1002/hep.22547; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Olsen DB, 2011, ANTIMICROB AGENTS CH, V55, P937, DOI 10.1128/AAC.00990-10; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Perni RB, 2006, ANTIMICROB AGENTS CH, V50, P899, DOI 10.1128/AAC.50.3.899-909.2006; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Rodriguez-Inigo E, 2005, J MOL DIAGN, V7, P535, DOI 10.1016/S1525-1578(10)60585-5; Rong L, 2010, CRIT REV IMMUNOL, V30, P131, DOI 10.1615/CritRevImmunol.v30.i2.30; Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Syder AJ, 2011, J HEPATOL, V54, P48, DOI 10.1016/j.jhep.2010.06.024; Timpe JM, 2008, HEPATOLOGY, V47, P17, DOI 10.1002/hep.21959; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Voisset C, 2005, J BIOL CHEM, V280, P7793, DOI 10.1074/jbc.M411600200; Walters KA, 2006, PLOS PATHOG, V2, P591, DOI 10.1371/journal.ppat.0020059; Zeisel MB, 2007, HEPATOLOGY, V46, P1722, DOI 10.1002/hep.21994; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019; Zhang YJ, 2008, ANTIMICROB AGENTS CH, V52, P666, DOI 10.1128/AAC.01133-07; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	53	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35351	10.1371/journal.pone.0035351	http://dx.doi.org/10.1371/journal.pone.0035351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545104	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343200025
J	Guerra, FM; Gommerman, JL; Corfe, SA; Paige, CJ; Rottapel, R				Guerra, Fiona M.; Gommerman, Jennifer L.; Corfe, Steven A.; Paige, Christopher J.; Rottapel, Robert			Homeodomain-Interacting Protein Kinase (HIPK)-1 Is Required for Splenic B Cell Homeostasis and Optimal T-Independent Type 2 Humoral Response	PLOS ONE			English	Article							MARGINAL-ZONE; C-MYB; BONE-MARROW; CYTOPLASMIC TRANSLOCATION; INDUCED DESUMOYLATION; ADAPTER PROTEIN; GENE-EXPRESSION; FATE DECISION; HIPK2; P53	The homeodomain-interacting protein kinase (HIPK) family is comprised of four highly related serine/threonine kinases originally identified as co-repressors for various homeodomain-containing transcription factors. The HIPKs have been shown to be involved in growth regulation and apoptosis, with numerous studies highlighting HIPK regulation of the tumor suppressor p53. In this study, we have discovered a B cell homeostatic defect in HIPK1-deficient (HIPK1(-/-)) mice. Lymphopoietic populations within the thymus and bone marrow of HIPK1(-/-) mice appeared normal based upon FACS analysis; however, the spleen exhibited a reduced number of total B cells with a significant loss of transitional-1 and follicular B cell populations. Interestingly, the marginal zone B cell population was expanded in HIPK1(-/-) mice, yielding an increased frequency of these cells. HIPK1(-/-) B cells exhibited impaired cell division in response to B cell receptor cross-linking in vitro based upon thymidine incorporation or CFSE dilution; however, the addition of CD40L rescued HIPK1(-/-) proliferation to wild-type levels. Despite the expanded MZ B cell population in the HIPK1(-/-) mice, the T-independent type 2 humoral response was impaired. These data identify HIPK1 as a novel kinase required for optimal B cell function in mice.	[Guerra, Fiona M.; Gommerman, Jennifer L.; Corfe, Steven A.; Paige, Christopher J.; Rottapel, Robert] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Guerra, Fiona M.; Corfe, Steven A.; Paige, Christopher J.; Rottapel, Robert] Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [Rottapel, Robert] Ontario Inst Canc Res, Toronto, ON, Canada; [Paige, Christopher J.; Rottapel, Robert] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Rottapel, Robert] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Paige, Christopher J.; Rottapel, Robert] Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Guerra, FM (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	rottapel@uhnresearch.ca		Gommerman, Jennifer/0000-0003-4576-6168; Rottapel, Robert/0000-0002-6024-5558	National Cancer Institute of Canada (NCIC): Terry Fox Group [20003]; Canadian Institutes of Health Research (CIHR) [MOP-86681]; Ontario Graduate Scholarships in Science and Technology (OGSST); Ontario Student Opportunity Trust Funds (OSOTF); Molecular Medicine Canadian Institutes of Health Research (CIHR)	National Cancer Institute of Canada (NCIC): Terry Fox Group; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarships in Science and Technology (OGSST); Ontario Student Opportunity Trust Funds (OSOTF); Molecular Medicine Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was funded in part by the National Cancer Institute of Canada (NCIC): Terry Fox Group Grant: Molecular biology of hemopoietic progression and function: Program Project Grant #20003, Canadian Institutes of Health Research (CIHR) Operating Grant-MOP-86681, Ontario Graduate Scholarships in Science and Technology (OGSST), Ontario Student Opportunity Trust Funds (OSOTF), and the Molecular Medicine Canadian Institutes of Health Research (CIHR) Collaborative Graduate Training Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agenes F, 1999, J EXP MED, V189, P319, DOI 10.1084/jem.189.2.319; Agenes F, 1997, EUR J IMMUNOL, V27, P1801, DOI 10.1002/eji.1830270731; Aikawa Y, 2006, EMBO J, V25, P3955, DOI 10.1038/sj.emboj.7601273; Allman D, 2004, IMMUNOL REV, V197, P147, DOI 10.1111/j.0105-2896.2004.0108.x; Arai S, 2007, FEBS LETT, V581, P5649, DOI 10.1016/j.febslet.2007.11.022; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Calzado MA, 2007, CELL CYCLE, V6, P139, DOI 10.4161/cc.6.2.3788; Cariappa A, 2005, IMMUNITY, V23, P397, DOI 10.1016/j.immuni.2005.09.004; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; Cariappa A, 2007, BLOOD, V109, P2339, DOI 10.1182/blood-2006-05-021089; Carvalho TL, 2001, J EXP MED, V194, P1141, DOI 10.1084/jem.194.8.1141; Casola S, 2007, CURR OPIN IMMUNOL, V19, P143, DOI 10.1016/j.coi.2007.02.010; Chen G, 2007, MOL CELL BIOL, V27, P3109, DOI 10.1128/MCB.01014-06; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Ecsedy JA, 2003, MOL CELL BIOL, V23, P950, DOI 10.1128/MCB.23.3.950-960.2003; GOLAY J, 1992, J IMMUNOL, V149, P300; Gresko E, 2005, BIOCHEM BIOPH RES CO, V329, P1293, DOI 10.1016/j.bbrc.2005.02.113; Hao ZY, 2001, J EXP MED, V194, P1151, DOI 10.1084/jem.194.8.1151; Harada J, 2003, J BIOL CHEM, V278, P38998, DOI 10.1074/jbc.M307112200; Hardy RR, 2006, J IMMUNOL, V177, P2749, DOI 10.4049/jimmunol.177.5.2749; Hattangadi SM, 2010, BLOOD; He Qin, 2010, Mol Cell Pharmacol, V2, P61; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Iacovelli S, 2009, CELL PROLIFERAT, V42, P373, DOI 10.1111/j.1365-2184.2009.00601.x; Isono K, 2006, MOL CELL BIOL, V26, P2758, DOI 10.1128/MCB.26.7.2758-2771.2006; Kaminski DA, 2006, J IMMUNOL, V177, P6025, DOI 10.4049/jimmunol.177.9.6025; Kanei-Ishii C, 2004, J BIOL CHEM, V279, P44582, DOI 10.1074/jbc.M407831200; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Kanei-Ishii C, 2008, J BIOL CHEM, V283, P30540, DOI 10.1074/jbc.M804340200; Kim EA, 2006, J BIOL CHEM, V281, P7489, DOI 10.1074/jbc.M507227200; Kim EJ, 2002, J BIOL CHEM, V277, P32020, DOI 10.1074/jbc.M200153200; Kim YH, 1998, J BIOL CHEM, V273, P25875, DOI 10.1074/jbc.273.40.25875; Kondo S, 2003, P NATL ACAD SCI USA, V100, P5431, DOI 10.1073/pnas.0530308100; Kurahashi T, 2005, MOL BIOL CELL, V16, P4705, DOI 10.1091/mbc.E05-05-0470; Lee W, 2009, DEV BIOL, V325, P263, DOI 10.1016/j.ydbio.2008.10.029; Lee W, 2009, DEVELOPMENT, V136, P241, DOI 10.1242/dev.025460; Li QX, 2007, CANCER RES, V67, P66, DOI 10.1158/0008-5472.CAN-06-1671; Li X, 2008, CELL DEATH DIFFER, V15, P739, DOI 10.1038/sj.cdd.4402303; Li XH, 2005, J BIOL CHEM, V280, P15061, DOI 10.1074/jbc.M414262200; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Pierantoni GM, 2007, J CLIN INVEST, V117, P693, DOI 10.1172/JCI29852; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Rui YN, 2004, EMBO J, V23, P4583, DOI 10.1038/sj.emboj.7600475; Samardzic T, 2002, EUR J IMMUNOL, V32, P2481, DOI 10.1002/1521-4141(200209)32:9<2481::AID-IMMU2481>3.0.CO;2-C; Song JJ, 2005, J CELL BIOL, V170, P61, DOI 10.1083/jcb.200502070; Takaki S, 2003, J IMMUNOL, V170, P703, DOI 10.4049/jimmunol.170.2.703; Thomas MD, 2005, IMMUNITY, V23, P275, DOI 10.1016/j.immuni.2005.08.005; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8; Wiggins AK, 2004, J CELL BIOL, V167, P257, DOI 10.1083/jcb.200406131; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X; Zhang QH, 2005, P NATL ACAD SCI USA, V102, P2802, DOI 10.1073/pnas.0409373102; Zhang QC, 2007, J PROTEOME RES, V6, P4711, DOI 10.1021/pr700571d; Zhang XK, 2008, J IMMUNOL, V181, P1644, DOI 10.4049/jimmunol.181.3.1644	59	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35533	10.1371/journal.pone.0035533	http://dx.doi.org/10.1371/journal.pone.0035533			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545114	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343200034
J	Kusy, S; Ghosn, EEB; Herzenberg, LA; Contag, CH				Kusy, Sophie; Ghosn, Eliver E. B.; Herzenberg, Leonore A.; Contag, Christopher H.			Development of B Cells and Erythrocytes Is Specifically Impaired by the Drug Celastrol in Mice	PLOS ONE			English	Article							KAPPA-B; TRANSCRIPTION FACTORS; RHEUMATOID-ARTHRITIS; GOD VINE; HOOK-F; INHIBITOR; DISEASE; THUNDER; AGENTS; MODEL	Background: Celastrol, an active compound extracted from the root of the Chinese medicine "Thunder of God Vine" (Tripterygium wilfordii), exhibits anticancer, antioxidant and anti-inflammatory activities, and interest in the therapeutic potential of celastrol is increasing. However, described side effects following treatment are significant and require investigation prior to initiating clinical trials. Here, we investigated the effects of celastrol on the adult murine hematopoietic system. Methodology/Principal Findings: Animals were treated daily with celastrol over a four-day period and peripheral blood, bone marrow, spleen, and peritoneal cavity were harvested for cell phenotyping. Treated mice showed specific impairment of the development of B cells and erythrocytes in all tested organs. In bone marrow, these alterations were accompanied by decreases in populations of common lymphoid progenitors (CLP), common myeloid progenitors (CMP) and megakaryocyte-erythrocyte progenitors (MEP). Conclusions/Significance: These results indicate that celastrol acts through regulators of adult hematopoiesis and could be used as a modulator of the hematopoietic system. These observations provide valuable information for further assessment prior to clinical trials.	[Kusy, Sophie; Contag, Christopher H.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Ghosn, Eliver E. B.; Herzenberg, Leonore A.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Contag, Christopher H.] Stanford Univ, Dept Radiol, Sch Med, Stanford, CA 94305 USA; [Contag, Christopher H.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Kusy, Sophie; Contag, Christopher H.] Stanford Univ, Sch Med, Mol Imaging Program Stanford MIPS, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Kusy, S (corresponding author), Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA.	skusy@stanford.edu	Ghosn, Eliver/AAO-5788-2020	Ghosn, Eliver/0000-0001-7258-906X; Contag, Christopher/0000-0002-1011-8278	National Institutes of Health [CA49605, AI076434]; NATIONAL CANCER INSTITUTE [P01CA049605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076434, R56AI076434] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by grants from the National Institutes of Health (CA49605 and AI076434). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2007, CLIN CANCER RES, V13, P6769, DOI 10.1158/1078-0432.CCR-07-1536; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Cao YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020634; Cleren C, 2005, J NEUROCHEM, V94, P995, DOI 10.1111/j.1471-4159.2005.03253.x; Davenport A, 2010, INT J MOL MED, V25, P465, DOI 10.3892/ijmm_00000366; Gerondakis S, 1999, ONCOGENE, V18, P6888, DOI 10.1038/sj.onc.1203236; Grossmann M, 1999, P NATL ACAD SCI USA, V96, P11848, DOI 10.1073/pnas.96.21.11848; Hassane DC, 2008, BLOOD, V111, P5654, DOI 10.1182/blood-2007-11-126003; Kannaiyan R, 2011, CANCER LETT, V303, P9, DOI 10.1016/j.canlet.2010.10.025; Kim DY, 2009, EUR J PHARMACOL, V612, P98, DOI 10.1016/j.ejphar.2009.03.078; Kusy S, 2011, CELL STEM CELL, V8, P412, DOI 10.1016/j.stem.2011.02.005; Lee JH, 2006, BIOCHEM PHARMACOL, V72, P1311, DOI 10.1016/j.bcp.2006.08.014; Lipsky PE, 1997, SEMIN ARTHRITIS RHEU, V26, P713, DOI 10.1016/S0049-0172(97)80040-6; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; Paris D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-17; Peng B, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-79; Pinna GF, 2004, BIOCHEM BIOPH RES CO, V322, P778, DOI 10.1016/j.bbrc.2004.07.186; Pyatt DW, 2000, MOL PHARMACOL, V57, P512, DOI 10.1124/mol.57.3.512; TAO XL, 1989, CHINESE MED J-PEKING, V102, P327; Wang SF, 2011, DRUG CHEM TOXICOL, V34, P61, DOI 10.3109/01480545.2010.494664; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Yang Y, 2007, P NATL ACAD SCI USA, V104, P4542, DOI 10.1073/pnas.0700001104; Zhang MY, 1998, BLOOD, V91, P4136, DOI 10.1182/blood.V91.11.4136.411k26_4136_4144	23	16	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35733	10.1371/journal.pone.0035733	http://dx.doi.org/10.1371/journal.pone.0035733			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545133	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343200053
J	Munir, S; Larsen, SK; Iversen, TZ; Donia, M; Klausen, TW; Svane, IM; Straten, PT; Andersen, MH				Munir, Shamaila; Larsen, Stine Kiaer; Iversen, Trine Zeeberg; Donia, Marco; Klausen, Tobias Wirenfeldt; Svane, Inge Marie; Straten, Per Thor; Andersen, Mads Hald			Natural CD4(+) T-Cell Responses against Indoleamine 2,3-Dioxygenase	PLOS ONE			English	Article							DENDRITIC CELLS; TUMOR-IMMUNITY; TH17 CELLS; SUPPRESSION; INHIBITION; IDO; PHENOTYPE; MECHANISM; PATHWAY; TARGET	Background: The enzyme indoleamine 2,3-dioxygenase (IDO) contributes to immune tolerance in a variety of settings. In cancer IDO is expressed within the tumor itself as well as in antigen-presenting cells in tumor-draining lymph nodes, where it endorses the establishment of peripheral immune tolerance to tumor antigens. Recently, we described cytotoxic CD8(+) T-cell reactivity towards IDO-derived peptides. Methods and Findings: In the present study, we show that CD4(+) helper T cells additionally spontaneously recognize IDO. Hence, we scrutinized the vicinity of the previously described HLA-A*0201-restricted IDO-epitope for CD4(+) T-cell epitopes. We demonstrated the presence of naturally occurring IDO-specific CD4(+) T cells in cancer patients and to a lesser extent in healthy donors by cytokine release ELISPOT. IDO-reactive CD4(+) T cells released IFN-gamma, TNF-alpha, as well as IL-17. We confirm HLA class II-restriction by the addition of HLA class II specific blocking antibodies. In addition, we detected a trend between class I-and class II-restricted IDO responses and detected an association between IDO-specific CD4(+) T cells and CD8(+) CMV-responses. Finally, we could detect IL-10 releasing IDO-reactive CD4(+) T cells. Conclusion: IDO is spontaneously recognized by HLA class II-restricted, CD4(+) T cells in cancer patients and in healthy individuals. IDO-specific T cells may participate in immune-regulatory networks where the activation of pro-inflammatory IDO-specific CD4(+) responses may well overcome or delay the immune suppressive actions of the IDO-protein, which are otherwise a consequence of the early expression of IDO in maturing antigen presenting cells. In contrast, IDO-specific regulatory T cells may enhance IDO-mediated immune suppression.	[Munir, Shamaila; Larsen, Stine Kiaer; Iversen, Trine Zeeberg; Donia, Marco; Klausen, Tobias Wirenfeldt; Svane, Inge Marie; Straten, Per Thor; Andersen, Mads Hald] Copenhagen Univ Hosp, CCIT, Dept Hematol & Oncol, Herlev, Denmark; [Donia, Marco] Univ Catania, Dept Biomed Sci, Catania, Italy	University of Copenhagen; University of Catania	Munir, S (corresponding author), Copenhagen Univ Hosp, CCIT, Dept Hematol & Oncol, Herlev, Denmark.	mads.hald.andersen@regionh.dk		Donia, Marco/0000-0003-4966-9752; Andersen, Mads Hald/0000-0002-2914-9605; Munir Ahmad, Shamaila/0000-0001-5176-5212; thor Straten, Per/0000-0002-4731-4969; Svane, Inge Marie/0000-0002-9451-6037	Novo Nordisk Foundation; Danish Cancer Society; Danish Medical Research Council; Lundbeck Foundation; John and Birthe Meyer Foundation; Herlev University Hospital	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Cancer Society(Danish Cancer Society); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); John and Birthe Meyer Foundation; Herlev University Hospital	This work was supported by grants from the Novo Nordisk Foundation, the Danish Cancer Society, Danish Medical Research Council, the Lundbeck Foundation, the John and Birthe Meyer Foundation, and Herlev University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MH, 2001, CANCER RES, V61, P869; Ball HJ, 2007, GENE, V396, P203, DOI 10.1016/j.gene.2007.04.010; Banerjee T, 2008, ONCOGENE, V27, P2851, DOI 10.1038/sj.onc.1210939; Bauer TM, 2005, TRANSPL INT, V18, P95, DOI 10.1111/j.1432-2277.2004.00031.x; Chen W, 2008, J IMMUNOL, V181, P5396, DOI 10.4049/jimmunol.181.8.5396; Chen Z, 2008, IMMUNOL RES, V41, P87, DOI 10.1007/s12026-007-8014-9; Cherayil BJ, 2009, INFLAMM BOWEL DIS, V15, P1391, DOI 10.1002/ibd.20910; Divanovic S, 2012, J INFECT DIS, V205, P152, DOI 10.1093/infdis/jir621; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Furset G, 2008, IMMUNOLOGY, V123, P263, DOI 10.1111/j.1365-2567.2007.02695.x; Hou DY, 2007, CANCER RES, V67, P792, DOI 10.1158/0008-5472.CAN-06-2925; KEILHOLZ U, 1993, CANCER, V72, P607, DOI 10.1002/1097-0142(19930715)72:2<607::AID-CNCR2820720245>3.0.CO;2-R; Keilholz U, 2002, J IMMUNOTHER, V25, P97, DOI 10.1097/00002371-200203000-00001; Khan N, 2002, J IMMUNOL, V169, P1984, DOI 10.4049/jimmunol.169.4.1984; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Kumar S, 2008, J MED CHEM, V51, P4968, DOI 10.1021/jm800512z; Kumar S, 2008, J MED CHEM, V51, P1706, DOI 10.1021/jm7014155; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; McCutcheon M, 1997, J IMMUNOL METHODS, V210, P149, DOI 10.1016/S0022-1759(97)00182-8; Mellor AL, 2008, NAT REV IMMUNOL, V8, P74, DOI 10.1038/nri2233; Metz R, 2010, MOL CANCER THER, V9, P1864, DOI 10.1158/1535-7163.MCT-10-0185; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Muller AJ, 2007, CURR CANCER DRUG TAR, V7, P31, DOI 10.2174/156800907780006896; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Munn DH, 2004, J IMMUNOL, V172, P4100, DOI 10.4049/jimmunol.172.7.4100; O'Quinn DB, 2008, ADV IMMUNOL, V99, P115, DOI 10.1016/S0065-2776(08)00605-6; Platten M, 2005, SCIENCE, V310, P850, DOI 10.1126/science.1117634; Popov A, 2008, J MOL MED, V86, P145, DOI 10.1007/s00109-007-0262-6; Prendergast GC, 2009, CELL CYCLE, V8, P1818, DOI 10.4161/cc.8.12.8887; Rammensee HG, 1995, CURR BIOL, V5, P35, DOI DOI 10.1016/S0960-9822(95)00011-X; Scheler M, 2007, AM J PATHOL, V171, P1936, DOI 10.2353/ajpath.2007.070281; Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911; Sorensen RB, 2011, BLOOD, V117, P2200, DOI 10.1182/blood-2010-06-288498; Sorensen RB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006910; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Zhu LQ, 2006, J IMMUNOL, V177, P8226, DOI 10.4049/jimmunol.177.11.8226; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742	38	39	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e34568	10.1371/journal.pone.0034568	http://dx.doi.org/10.1371/journal.pone.0034568			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539948	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341000011
J	Perfito, N; Jeong, SY; Silverin, B; Calisi, RM; Bentley, GE; Hau, M				Perfito, Nicole; Jeong, Sun Young; Silverin, Bengt; Calisi, Rebecca M.; Bentley, George E.; Hau, Michaela			Anticipating Spring: Wild Populations of Great Tits (Parus major) Differ in Expression of Key Genes for Photoperiodic Time Measurement	PLOS ONE			English	Article							ZONOTRICHIA-LEUCOPHRYS-GAMBELII; WHITE-CROWNED SPARROW; TYPE-2 DEIODINASE GENE; JAPANESE-QUAIL; DEEP BRAIN; MEDIAN-EMINENCE; NERVE-TERMINALS; LH-SECRETION; LONG-DAY; HORMONE	Measuring day length is critical for timing annual changes in physiology and behavior in many species. Recently, rapid changes in several photoperiodically-controlled genes following exposure to a single long day have been described. Components of this 'first day release' model have so far only been tested in highly domesticated species: quail, sheep, goats and rodents. Because artificial selection accompanying domestication acts on genes related to photoperiodicity, we must also study this phenomenon in wild organisms for it to be accepted as universal. In a songbird, the great tit (Parus major), we tested whether a) these genes are involved in photoperiodic time measurement (PTM) in a wild species, and b) whether predictable species and population differences in expression patterns exist. Using quantitative RT-PCR, we compared gene expression after a single long day in male great tits from Sweden (57 degrees 42'N) with that from a German (47 degrees 43'N) population. Hypothalamic gene expression key for PTM changed only in the northern population, and occurred earlier after dawn during the single long day than demonstrated in quail; however, gonadotropins (secretion and synthesis) were stimulated in both populations, albeit with different timing. Our data are the first to show acute changes in gene expression in response to photostimulation in any wild species not selected for study of photoperiodism. The pronounced differences in gene expression in response to a single long day between two populations raise exciting new questions about potential environmental selection on photoperiodic cue sensitivity.	[Perfito, Nicole; Jeong, Sun Young; Calisi, Rebecca M.; Bentley, George E.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Perfito, Nicole; Hau, Michaela] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Silverin, Bengt] Gothenburg Univ, Dept Zool, S-40031 Gothenburg, Sweden; [Bentley, George E.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Max Planck Society; University of Gothenburg; University of California System; University of California Berkeley	Perfito, N (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	nperfito@berkeley.edu			Max Planck Society; National Science Foundation Integrative Organismal Systems (NSF IOS) [0920753]	Max Planck Society(Max Planck Society); National Science Foundation Integrative Organismal Systems (NSF IOS)	This study was funded by the Max Planck Society (MH) and National Science Foundation Integrative Organismal Systems (NSF IOS) 0920753 (GB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker JR, 1939, P ZOOL SOC LOND A-GE, V108, P557; BENOIT J, 1964, ANN NY ACAD SCI, V117, P204, DOI 10.1111/j.1749-6632.1964.tb48175.x; BERN HA, 1966, Z ZELLFORSCH MIK ANA, V69, P198, DOI 10.1007/BF00406275; Bronson Franklin H., 1994, P541; Davies WIL, 2011, BIOL LETT; Farner DS, 1967, NEUROENDOCRINOLOGY, P529; FARNER DS, 1979, HORMONES EVOLUTION, P829; FOLLETT BK, 1975, GEN COMP ENDOCR, V26, P126, DOI 10.1016/0016-6480(75)90223-3; FOLLETT BK, 1974, P NATL ACAD SCI USA, V71, P1666, DOI 10.1073/pnas.71.5.1666; FOLLETT BK, 1969, NATURE, V223, P968, DOI 10.1038/223968b0; FOSTER RG, 1994, NEUROSCI BIOBEHAV R, V18, P541, DOI 10.1016/0149-7634(94)90009-4; Gonzalez R, 2008, DATA ANAL EXPT DESIG; Halford S, 2009, CURR BIOL, V19, P1396, DOI 10.1016/j.cub.2009.06.066; Hanon EA, 2008, CURR BIOL, V18, P1147, DOI 10.1016/j.cub.2008.06.076; Hazlerigg D, 2008, CURR BIOL, V18, pR795, DOI 10.1016/j.cub.2008.07.040; Hazlerigg DG, 2006, TRENDS ENDOCRIN MET, V17, P83, DOI 10.1016/j.tem.2006.02.004; Helms C. W., 1960, BIRDBANDING, V31, P1, DOI [DOI 10.2307/4510793, 10.2307/4510793]; Kang SW, 2010, NEUROSCIENCE, V170, P200, DOI 10.1016/j.neuroscience.2010.06.082; LEWIS RA, 1975, CONDOR, V77, P111, DOI 10.2307/1365780; Meddle SL, 1997, J NEUROSCI, V17, P8909; MENAKER M, 1970, P NATL ACAD SCI USA, V67, P320, DOI 10.1073/pnas.67.1.320; Murton RK, 1977, AVIAN BREEDING CYCLE; Nakane Y, 2010, P NATL ACAD SCI USA, V107, P15264, DOI 10.1073/pnas.1006393107; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; NICHOLLS TJ, 1983, J ENDOCRINOL, V97, P121, DOI 10.1677/joe.0.0970121; NICHOLLS TJ, 1974, J COMP PHYSIOL, V93, P301, DOI 10.1007/BF00606799; Ono H, 2008, P NATL ACAD SCI USA, V105, P18238, DOI 10.1073/pnas.0808952105; Paul MJ, 2008, PHILOS T R SOC B, V363, P341, DOI 10.1098/rstb.2007.2143; Revel FG, 2006, ENDOCRINOLOGY, V147, P4680, DOI 10.1210/en.2006-0606; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; SILVER R, 1988, CELL TISSUE RES, V253, P189; SILVERIN B, 1994, ETHOL ECOL EVOL, V6, P131, DOI 10.1080/08927014.1994.9522990; SILVERIN B, 1993, GEN COMP ENDOCR, V90, P14, DOI 10.1006/gcen.1993.1055; STOKES TM, 1974, J COMP NEUROL, V156, P337, DOI 10.1002/cne.901560305; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WADA M, 1979, GEN COMP ENDOCR, V39, P141, DOI 10.1016/0016-6480(79)90219-3; Wada Y, 1998, FEBS LETT, V424, P53, DOI 10.1016/S0014-5793(98)00138-0; Watanabe T, 2007, AM J PHYSIOL-REG I, V292, pR568, DOI 10.1152/ajpregu.00521.2006; Wingfield J.C., 1991, P181; Wingfield J. C., 1993, J ENDOCRINOL, P111; WINGFIELD JC, 1992, J EXP ZOOL, V261, P214, DOI 10.1002/jez.1402610212; Wingfield John C., 2000, P85; Yamamura T, 2006, CELL TISSUE RES, V324, P175, DOI 10.1007/s00441-005-0126-8; Yamamura T, 2004, ENDOCRINOLOGY, V145, P4264, DOI 10.1210/en.2004-0366; Yasuo S, 2006, ENDOCRINOLOGY, V147, P432, DOI 10.1210/en.2005-0507; YOKOYAMA K, 1978, CELL TISSUE RES, V189, P441; Yoshimura T, 2003, NATURE, V426, P178, DOI 10.1038/nature02117; Yoshimura T, 2009, PHOTOPERIODISM BIOL, P446; Yoshimura T, 2007, AM J PHYSL REG 1, V292, pR1315; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	50	43	43	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e34997	10.1371/journal.pone.0034997	http://dx.doi.org/10.1371/journal.pone.0034997			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539953	Green Published, gold			2022-12-25	WOS:000305341000016
J	Sommeijer, JP; Levelt, CN				Sommeijer, Jean-Pierre; Levelt, Christiaan N.			Synaptotagmin-2 Is a Reliable Marker for Parvalbumin Positive Inhibitory Boutons in the Mouse Visual Cortex	PLOS ONE			English	Article							VESICULAR GABA TRANSPORTER; FAST-SPIKING CELLS; CA2+ SENSORS; NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; GABAERGIC INTERNEURONS; POSTNATAL-DEVELOPMENT; DEPENDENT PLASTICITY; CEREBRAL-CORTEX; CRITICAL-PERIOD	Background: Inhibitory innervation by parvalbumin (PV) expressing interneurons has been implicated in the onset of the sensitive period of visual plasticity. Immunohistochemical analysis of the development and plasticity of these inhibitory inputs is difficult because PV expression is low in young animals and strongly influenced by neuronal activity. Moreover, the synaptic boutons that PV neurons form onto each other cannot be distinguished from the innervated cell bodies by immunostaining for this protein because it is present throughout the cells. These problems call for the availability of a synaptic, activity-independent marker for PV+ inhibitory boutons that is expressed before sensitive period onset. We investigated whether synaptotagmin-2 (Syt2) fulfills these properties in the visual cortex. Syt2 is a synaptic vesicle protein involved in fast Ca2+ dependent neurotransmitter release. Its mRNA expression follows a pattern similar to that of PV throughout the brain and is present in 30-40% of hippocampal PV expressing basket cells. Up to now, no quantitative analyses of Syt2 expression in the visual cortex have been carried out. Methodology/Principal Findings: We used immunohistochemistry to analyze colocalization of Syt2 with multiple interneuron markers including vesicular GABA transporter VGAT, calbindin, calretinin, somatostatin and PV in the primary visual cortex of mice during development and after dark-rearing. Conclusions/Significance: We show that in the adult visual cortex Syt2 is only found in inhibitory, VGAT positive boutons. Practically all Syt2 positive boutons also contain PV and vice versa. During development, Syt2 expression can be detected in synaptic boutons prior to PV and in contrast to PV expression, Syt2 is not down-regulated by dark-rearing. These properties of Syt2 make it an excellent marker for analyzing the development and plasticity of perisomatic inhibitory innervations onto both excitatory and inhibitory neurons in the visual cortex.	[Sommeijer, Jean-Pierre; Levelt, Christiaan N.] Netherlands Inst Neurosci, Dept Mol Visual Neurosci, Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Sommeijer, JP (corresponding author), Netherlands Inst Neurosci, Dept Mol Visual Neurosci, Amsterdam, Netherlands.	c.levelt@nin.knaw.nl			AgentschapNL of the Ministry of Health, Welfare and Sports (VWS); European Commission [223326]; Netherlands Organization for Scientific Research (NWO-ALW)	AgentschapNL of the Ministry of Health, Welfare and Sports (VWS); European Commission(European CommissionEuropean Commission Joint Research Centre); Netherlands Organization for Scientific Research (NWO-ALW)(Netherlands Organization for Scientific Research (NWO))	JPS and CNL were funded by a governmental non-commercial grant from AgentschapNL of the Ministry of Health, Welfare and Sports (VWS) to the NeuroBasic PharmaPhenomics Consortium. CNL was funded by an FP7 grant from the European Commission (number 223326, "EuroV1sion") and an "Open Competition" grant from the Netherlands Organization for Scientific Research (NWO-ALW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCANTARA S, 1993, ANAT EMBRYOL, V188, P63; Allen Institute for Brain Science, 2009, ALL MOUS BRAIN ATL; Bucurenciu I, 2008, NEURON, V57, P536, DOI 10.1016/j.neuron.2007.12.026; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; CELLERINO A, 1992, NEUROSCIENCE, V51, P749, DOI 10.1016/0306-4522(92)90514-3; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; DELRIO JA, 1994, DEV BRAIN RES, V81, P247, DOI 10.1016/0165-3806(94)90311-5; Eggermann E, 2012, NAT REV NEUROSCI, V13, P7, DOI 10.1038/nrn3125; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fox MA, 2007, J COMP NEUROL, V503, P280, DOI 10.1002/cne.21381; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Galarreta M, 2002, P NATL ACAD SCI USA, V99, P12438, DOI 10.1073/pnas.192159599; Garcia-Junco-Clemente P, 2010, J NEUROSCI, V30, P7377, DOI 10.1523/JNEUROSCI.0924-10.2010; GEPPERT M, 1991, J BIOL CHEM, V266, P13548; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Jiang M, 2005, NEUROSCIENCE, V135, P839, DOI 10.1016/j.neuroscience.2005.06.073; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kerr AM, 2008, P NATL ACAD SCI USA, V105, P15581, DOI 10.1073/pnas.0800621105; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; LI C, 1995, J BIOL CHEM, V270, P24898, DOI 10.1074/jbc.270.42.24898; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Minelli A, 2003, NEUROSCIENCE, V117, P337, DOI 10.1016/S0306-4522(02)00864-3; Muller M, 2007, J NEUROSCI, V27, P2261, DOI 10.1523/JNEUROSCI.5582-06.2007; Nagy G, 2006, J NEUROSCI, V26, P632, DOI 10.1523/JNEUROSCI.2589-05.2006; Pang ZPP, 2006, J NEUROSCI, V26, P13493, DOI 10.1523/JNEUROSCI.3519-06.2006; Pang ZP, 2006, EMBO J, V25, P2039, DOI 10.1038/sj.emboj.7601103; Sugita S, 2002, EMBO J, V21, P270, DOI 10.1093/emboj/21.3.270; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Tamas G, 1998, J NEUROSCI, V18, P4255; Tropea D, 2006, NAT NEUROSCI, V9, P660, DOI 10.1038/nn1689; ULLRICH B, 1994, NEURON, V13, P1281, DOI 10.1016/0896-6273(94)90415-4; VANBREDERODE JFM, 1991, NEUROSCIENCE, V44, P157, DOI 10.1016/0306-4522(91)90258-P; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485; Young SM, 2009, NEURON, V63, P482, DOI 10.1016/j.neuron.2009.07.028	42	47	47	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35323	10.1371/journal.pone.0035323	http://dx.doi.org/10.1371/journal.pone.0035323			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539967	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341000032
J	Cole, JW; Stine, OC; Liu, XY; Pratap, A; Cheng, YC; Tallon, LJ; Sadzewicz, LK; Dueker, N; Wozniak, MA; Stern, BJ; Meschia, JF; Mitchell, BD; Kittner, SJ; O'Connell, JR				Cole, John W.; Stine, O. Colin; Liu, Xinyue; Pratap, Abhishek; Cheng, Yuching; Tallon, Luke J.; Sadzewicz, Lisa K.; Dueker, Nicole; Wozniak, Marcella A.; Stern, Barney J.; Meschia, James F.; Mitchell, Braxton D.; Kittner, Steven J.; O'Connell, Jeffrey R.			Rare Variants in Ischemic Stroke: An Exome Pilot Study	PLOS ONE			English	Article							READ ALIGNMENT; ASSOCIATION; YOUNG; FRAMEWORK; DISEASE; GENES	The genetic architecture of ischemic stroke is complex and is likely to include rare or low frequency variants with high penetrance and large effect sizes. Such variants are likely to provide important insights into disease pathogenesis compared to common variants with small effect sizes. Because a significant portion of human functional variation may derive from the protein-coding portion of genes we undertook a pilot study to identify variation across the human exome (i.e., the coding exons across the entire human genome) in 10 ischemic stroke cases. Our efforts focused on evaluating the feasibility and identifying the difficulties in this type of research as it applies to ischemic stroke. The cases included 8 African-Americans and 2 Caucasians selected on the basis of similar stroke subtypes and by implementing a case selection algorithm that emphasized the genetic contribution of stroke risk. Following construction of paired-end sequencing libraries, all predicted human exons in each sample were captured and sequenced. Sequencing generated an average of 25.5 million read pairs (75 bp x 2) and 3.8 Gbp per sample. After passing quality filters, screening the exomes against dbSNP demonstrated an average of 2839 novel SNPs among African-Americans and 1105 among Caucasians. In an aggregate analysis, 48 genes were identified to have at least one rare variant across all stroke cases. One gene, CSN3, identified by screening our prior GWAS results in conjunction with our exome results, was found to contain an interesting coding polymorphism as well as containing excess rare variation as compared with the other genes evaluated. In conclusion, while rare coding variants may predispose to the risk of ischemic stroke, this fact has yet to be definitively proven. Our study demonstrates the complexities of such research and highlights that while exome data can be obtained, the optimal analytical methods have yet to be determined.	[Cole, John W.; Wozniak, Marcella A.; Stern, Barney J.; Kittner, Steven J.] Vet Adm Med Ctr, Baltimore, MD 21218 USA; [Cole, John W.; Stine, O. Colin; Liu, Xinyue; Pratap, Abhishek; Cheng, Yuching; Tallon, Luke J.; Sadzewicz, Lisa K.; Dueker, Nicole; Wozniak, Marcella A.; Stern, Barney J.; Mitchell, Braxton D.; Kittner, Steven J.; O'Connell, Jeffrey R.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Meschia, James F.] Mayo Clin, Jacksonville, FL 32224 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Maryland; University of Maryland Baltimore; Mayo Clinic	Cole, JW (corresponding author), Vet Adm Med Ctr, Baltimore, MD 21218 USA.	jcole@som.umaryland.edu	Mitchell, Braxton/CAF-0876-2022; Meschia, James/GPP-1636-2022	Meschia, James/0000-0002-4475-8142; Pratap, Abhishek/0000-0002-5289-6932; Mitchell, Braxton/0000-0003-4920-4744	Department of Veterans Affairs, Baltimore, Office of Research and Development, Medical Research Service; Department of Veterans Affairs; Department of Veterans Affairs, Baltimore; Geriatrics Research, Education, and Clinical Center of Excellence; American Heart Association; National Institute of Neurological Disorders and Stroke (NINDS) [U01 NS069208-01, R01 NS39987]; NIH Office of Research on Women's Health (ORWH) [R01 NS45012]; National Human Genome Research Institute (NHGRI) [U01 HG004436]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS069208, R01NS039987, R01NS045012] Funding Source: NIH RePORTER	Department of Veterans Affairs, Baltimore, Office of Research and Development, Medical Research Service(US Department of Veterans Affairs); Department of Veterans Affairs(US Department of Veterans Affairs); Department of Veterans Affairs, Baltimore(US Department of Veterans Affairs); Geriatrics Research, Education, and Clinical Center of Excellence; American Heart Association(American Heart Association); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH Office of Research on Women's Health (ORWH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the Department of Veterans Affairs, Baltimore, Office of Research and Development, Medical Research Service; the Department of Veterans Affairs Stroke Research Enhancement Award Program; the Department of Veterans Affairs, Baltimore, Geriatrics Research, Education, and Clinical Center of Excellence; the American Heart Association Grant-in-Aid Program; the National Institute of Neurological Disorders and Stroke (NINDS) (Grants U01 NS069208-01 and R01 NS39987); the NIH Office of Research on Women's Health (ORWH) (Grant R01 NS45012); the National Human Genome Research Institute (NHGRI) (Grant U01 HG004436). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; [Anonymous], 2010, NATL VITAL STAT REPO; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Brass LM, 1998, STROKE, V29, P256; CDC, 2007, 2006 SUMM HLTH STAT; Cheng YC, 2011, G3-GENES GENOM GENET, V1, P505, DOI 10.1534/g3.111.001164; Cornelis MC, 2010, GENET EPIDEMIOL, V34, P364, DOI 10.1002/gepi.20492; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Foroud T, 2003, NEUROLOGY, V60, P796, DOI 10.1212/01.WNL.0000049470.00180.07; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hassan A, 2000, BRAIN, V123, P1784, DOI 10.1093/brain/123.9.1784; Hong X, 2001, FEBS LETT, V499, P133, DOI 10.1016/S0014-5793(01)02535-2; Ikram MA, 2009, NEW ENGL J MED, V360, P1718, DOI 10.1056/NEJMoa0900094; Jacobs BS, 2002, STROKE, V33, P2789, DOI 10.1161/01.STR.0000038988.64376.3A; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; King JY, 2005, PHYSIOL GENOMICS, V23, P103, DOI 10.1152/physiolgenomics.00101.2005; Kittner SJ, 1998, NEUROLOGY, V50, P890, DOI 10.1212/WNL.50.4.890; Kleindorfer D, 2006, STROKE, V37, P2473, DOI 10.1161/01.STR.0000242766.65550.92; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lesage S, 2008, J MED GENET, V45, P43, DOI 10.1136/jmg.2007.051854; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; MacArthur D., 2008, GENETIC FUTURE; MacClellan LR, 2006, GENET EPIDEMIOL, V30, P602, DOI 10.1002/gepi.20171; Matarin M, 2009, STROKE, V40, P3436, DOI 10.1161/STROKEAHA.109.558015; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meschia James F, 2002, BMC Med Genet, V3, P1, DOI 10.1186/1471-2350-3-1; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rampersaud E, 2007, DIABETES, V56, P3053, DOI 10.2337/db07-0457; Rosand J, 2010, NEW ENGL J MED, V362, P1547, DOI 10.1056/NEJMc0910050; Schulz UGR, 2004, STROKE, V35, P819, DOI 10.1161/01.STR.0000121646.23955.0f; Weeks JP, 2009, PLINK IRT SEPARATE C; Xin XY, 2009, THROMB RES, V124, P619, DOI 10.1016/j.thromres.2009.07.007; Yoneda-Kato N, 2008, MOL CELL BIOL, V28, P422, DOI 10.1128/MCB.02335-06	39	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35591	10.1371/journal.pone.0035591	http://dx.doi.org/10.1371/journal.pone.0035591			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536414	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200082
J	Galban, S; Lemasson, B; Williams, TM; Li, F; Heist, KA; Johnson, TD; Leopold, JS; Chenevert, TL; Lawrence, TS; Rehemtulla, A; Mikkelsen, T; Holland, EC; Galban, CJ; Ross, BD				Galban, Stefanie; Lemasson, Benjamin; Williams, Terence M.; Li, Fei; Heist, Kevin A.; Johnson, Timothy D.; Leopold, Judith S.; Chenevert, Thomas L.; Lawrence, Theodore S.; Rehemtulla, Alnawaz; Mikkelsen, Tom; Holland, Eric C.; Galban, Craig J.; Ross, Brian D.			DW-MRI as a Biomarker to Compare Therapeutic Outcomes in Radiotherapy Regimens Incorporating Temozolomide or Gemcitabine in Glioblastoma	PLOS ONE			English	Article							FUNCTIONAL DIFFUSION MAP; HIGH-GRADE GLIOMAS; IMAGING BIOMARKER; MALIGNANT GLIOMA; MOUSE MODELS; ADJUVANT TEMOZOLOMIDE; PROMOTER METHYLATION; RESPONSE ASSESSMENT; PRECLINICAL TRIALS; BRAIN-TUMORS	The effectiveness of the radiosensitizer gemcitabine (GEM) was evaluated in a mouse glioma along with the imaging biomarker diffusion-weighted magnetic resonance imaging (DW-MRI) for early detection of treatment effects. A genetically engineered murine GBM model [Ink4a-Arf(-/-) Pten(loxP/loxP)/Ntv-a RCAS/PDGF(+)/Cre(+)] was treated with gemcitabine (GEM), temozolomide (TMZ) +/- ionizing radiation (IR). Therapeutic efficacy was quantified by contrast-enhanced MRI and DW-MRI for growth rate and tumor cellularity, respectively. Mice treated with GEM, TMZ and radiation showed a significant reduction in growth rates as early as three days post-treatment initiation. Both combination treatments (GEM/IR and TMZ/IR) resulted in improved survival over single therapies. Tumor diffusion values increased prior to detectable changes in tumor volume growth rates following administration of therapies. Concomitant GEM/IR and TMZ/IR was active and well tolerated in this GBM model and similarly prolonged median survival of tumor bearing mice. DW-MRI provided early changes to radiosensitization treatment warranting evaluation of this imaging biomarker in clinical trials.	[Lemasson, Benjamin; Li, Fei; Heist, Kevin A.; Lawrence, Theodore S.; Rehemtulla, Alnawaz; Galban, Craig J.; Ross, Brian D.] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA; [Galban, Stefanie; Williams, Terence M.; Leopold, Judith S.; Chenevert, Thomas L.; Rehemtulla, Alnawaz] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Johnson, Timothy D.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Mikkelsen, Tom] Henry Ford Hlth Syst, Hermelin Brain Tumor Ctr, Dept Neurosurg, Detroit, MI USA; [Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA; [Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10021 USA; [Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10021 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Henry Ford Health System; Henry Ford Hospital; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Ross, BD (corresponding author), Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA.	bdross@umich.edu	Williams, Terence M/I-9614-2014; Lemasson, Benjamin/AAC-4092-2019; Lemasson, Benjamin/L-1608-2014	Lemasson, Benjamin/0000-0003-0446-3531; Lemasson, Benjamin/0000-0003-0446-3531; Chenevert, Thomas/0000-0003-1476-4274	NIH [P01-CA085878, P50-CA093990]; NATIONAL CANCER INSTITUTE [P01CA085878, P50CA093990] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH funding only P01-CA085878 and P50-CA093990. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Buijs M, 2007, J VASC INTERV RADIOL, V18, P957, DOI 10.1016/j.jvir.2007.04.025; Chenevert TL, 2009, NEUROIMAG CLIN N AM, V19, P559, DOI 10.1016/j.nic.2009.08.009; Chenevert TL, 1997, CLIN CANCER RES, V3, P1457; Chenevert TL, 2000, JNCI-J NATL CANCER I, V92, P2029, DOI 10.1093/jnci/92.24.2029; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; Cui Y, 2008, RADIOLOGY, V248, P894, DOI 10.1148/radiol.2483071407; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Dai CK, 2005, NEOPLASIA, V7, P397, DOI 10.1593/neo.04691; Day SE, 2011, MAGN RESON MED, V65, P557, DOI 10.1002/mrm.22698; Dudeck O, 2008, J MAGN RESON IMAGING, V27, P1109, DOI 10.1002/jmri.21358; Dzik-Jurasz A, 2002, LANCET, V360, P307, DOI 10.1016/S0140-6736(02)09520-X; Ellingson BM, 2010, J MAGN RESON IMAGING, V31, P538, DOI 10.1002/jmri.22068; Fabi A, 2008, J NEURO-ONCOL, V87, P79, DOI 10.1007/s11060-007-9489-x; Fisher GH, 1999, ONCOGENE, V18, P5253, DOI 10.1038/sj.onc.1203087; Galban CJ, 2010, CLIN CANCER RES, V16, P1542, DOI 10.1158/1078-0432.CCR-08-1812; Gertler SZ, 2000, ANN ONCOL, V11, P315, DOI 10.1023/A:1008336607135; Gupta T, 2002, LANCET ONCOL, V3, P557, DOI 10.1016/S1470-2045(02)00853-7; Hamstra DA, 2005, P NATL ACAD SCI USA, V102, P16759, DOI 10.1073/pnas.0508347102; Hamstra DA, 2008, J CLIN ONCOL, V26, P3387, DOI 10.1200/JCO.2007.15.2363; Hegi ME, 2004, CLIN CANCER RES, V10, P1871, DOI 10.1158/1078-0432.CCR-03-0384; Hu XY, 2005, MUTAT RES-FUND MOL M, V576, P54, DOI 10.1016/j.mrfmmm.2004.08.023; Jones TS, 2011, TOXICOL PATHOL, V39, P158, DOI 10.1177/0192623310387617; Koutcher JA, 2002, NEOPLASIA, V4, P480, DOI 10.1038/sj.neo.7900269; la Fougere C, 2011, NEURO-ONCOLOGY, V13, P806, DOI 10.1093/neuonc/nor054; LeBihan D, 1995, NMR BIOMED, V8, P375, DOI 10.1002/nbm.1940080711; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; McConville P, 2007, CLIN CANCER RES, V13, P2897, DOI 10.1158/1078-0432.CCR-06-3058; Metro G, 2010, CANCER CHEMOTH PHARM, V65, P391, DOI 10.1007/s00280-009-1155-x; Moffat BA, 2006, NEOPLASIA, V8, P259, DOI 10.1593/neo.05844; Momota H, 2009, BRAIN TUMOR PATHOL, V26, P43, DOI 10.1007/s10014-009-0253-0; Orsulic S, 2002, MAMM GENOME, V13, P543, DOI 10.1007/s00335-002-4003-4; Ostruszka LJ, 2000, CANCER RES, V60, P6080; Pauwels B, 2005, ONCOLOGIST, V10, P34, DOI 10.1634/theoncologist.10-1-34; Pitter KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014545; Preusser M, 2011, CLIN NEUROPATHOL, V30, P217, DOI 10.5414/NP300422; Ross Brian D, 1994, Q Magn Reson Biol Med, V1, P89; Sigmond J, 2009, ANN ONCOL, V20, P182, DOI 10.1093/annonc/mdn543; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2006, ONCOLOGIST, V11, P165, DOI 10.1634/theoncologist.11-2-165; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tchougounova E, 2007, ONCOGENE, V26, P6289, DOI 10.1038/sj.onc.1210455; Van Nifterik KA, 2007, INT J RADIAT ONCOL, V69, P1246, DOI 10.1016/j.ijrobp.2007.07.2366; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Waldman AD, 2009, NAT REV CLIN ONCOL, V6, P445, DOI 10.1038/nrclinonc.2009.92; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541	47	26	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35857	10.1371/journal.pone.0035857	http://dx.doi.org/10.1371/journal.pone.0035857			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536446	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339200119
J	Zhang, YL; Xi, QY; Ding, JH; Cai, WG; Meng, FM; Zhou, JY; Li, HY; Jiang, QY; Shu, G; Wang, SB; Zhu, XT; Gao, P; Wu, ZF				Zhang, Yongliang; Xi, Qianyun; Ding, Jinghua; Cai, Weiguang; Meng, Fanmin; Zhou, Junyun; Li, Hongyi; Jiang, Qingyan; Shu, Gang; Wang, Songbo; Zhu, Xiaotong; Gao, Ping; Wu, Zhenfang			Production of Transgenic Pigs Mediated by Pseudotyped Lentivirus and Sperm	PLOS ONE			English	Article							LINE STEM-CELLS; GENE-TRANSFER; IN-VIVO; FOREIGN DNA; REVERSE-TRANSCRIPTASE; FARM-ANIMALS; VECTORS; MICE; GENERATION; TRANSFORMATION	Sperm-mediated gene transfer can be a very efficient method to produce transgenic pigs, however, the results from different laboratories had not been widely repeated. Genomic integration of transgene by injection of pseudotyped lentivirus to the perivitelline space has been proved to be a reliable route to generate transgenic animals. To test whether transgene in the lentivirus can be delivered by sperm, we studied incubation of pseudotyped lentiviruses and sperm before insemination. After incubation with pig spermatozoa, 6263 lentiviral particles were detected per 100 sperm cells using quantitative real-time RT-PCR. The association of lentivirus with sperm was further confirmed by electron microscopy. The sperm incubated with lentiviral particles were artificially inseminated into pigs. Of the 59 piglets born from inseminated 5 sows, 6 piglets (10.17%) carried the transgene based on the PCR identification. Foreign gene and EGFP was successfully detected in ear tissue biopsies from two PCR-positive pigs, revealed via in situ hybridization and immunohistochemistry. Offspring of one PCR-positive boar with normal sows showed PCR-positive. Two PCR-positive founders and offsprings of PCR-positive boar were further identified by Southern-blot analysis, out of which the two founders and two offsprings were positive in Southern blotting, strongly indicating integration of foreign gene into genome. The results indicate that incubation of sperm with pseudotyped lentiviruses can incorporated with sperm-mediated gene transfer to produce transgenic pigs with improved efficiency.	[Zhang, Yongliang; Xi, Qianyun; Ding, Jinghua; Cai, Weiguang; Meng, Fanmin; Zhou, Junyun; Li, Hongyi; Jiang, Qingyan; Shu, Gang; Wang, Songbo; Zhu, Xiaotong; Gao, Ping; Wu, Zhenfang] S China Agr Univ, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Xi, QY (corresponding author), S China Agr Univ, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China.	xqy0228@scau.edu.cn; wzf@scau.edu.cn		Wu, Zhenfang/0000-0002-5586-6771	National Key Project [2009ZX0890-024B, 2008ZX08006-004, 2008ZX08007-003]; National Natural Science Foundation of China [31072105]; Joint Funds of National Natural Science Foundation of China [u0731004]; Chinese Key Basic Plan [2009CB941600]	National Key Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Joint Funds of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Key Basic Plan	This work was supported by National Key Project 2009ZX0890-024B, 2008ZX08006-004 and 2008ZX08007-003, the National Natural Science Foundation of China (31072105), the Joint Funds of National Natural Science Foundation of China, u0731004, and the Chinese Key Basic Plan (No. 2009CB941600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AREZZO F, 1989, CELL BIOL INT REP, V13, P391, DOI 10.1016/0309-1651(89)90166-5; BAGASRA O, 1994, AIDS, V8, P1669, DOI 10.1097/00002030-199412000-00005; BRINSTER RL, 1989, CELL, V59, P239, DOI 10.1016/0092-8674(89)90282-1; Celebi C, 2002, MOL REPROD DEV, V62, P477, DOI 10.1002/mrd.10143; De Palma M, 2005, BLOOD, V105, P2307, DOI 10.1182/blood-2004-03-0798; FURTH PA, 1991, NUCLEIC ACIDS RES, V19, P6205, DOI 10.1093/nar/19.22.6205; Hamra FK, 2002, P NATL ACAD SCI USA, V99, P14931, DOI 10.1073/pnas.222561399; Haruyama Naoto, 2009, Curr Protoc Cell Biol, VChapter 19, DOI 10.1002/0471143030.cb1910s42; Hofmann A, 2006, MOL THER, V13, P59, DOI 10.1016/j.ymthe.2005.07.685; Hofmann A, 2003, EMBO REP, V4, P1054, DOI 10.1038/sj.embor.7400007; KARPEN GH, 1994, CURR OPIN GENET DEV, V4, P281, DOI 10.1016/S0959-437X(05)80055-3; Kues WA, 2004, TRENDS BIOTECHNOL, V22, P286, DOI 10.1016/j.tibtech.2004.04.003; Kuznetsov AV, 2000, MOL REPROD DEV, V56, P292, DOI 10.1002/(SICI)1098-2795(200006)56:2+&lt;292::AID-MRD18&gt;3.0.CO;2-Z; LANDRY ML, 1995, J INFECT DIS, V172, P1641, DOI 10.1093/infdis/172.6.1641a; Lavitrano M, 2002, P NATL ACAD SCI USA, V99, P14230, DOI 10.1073/pnas.222550299; LAVITRANO M, 1989, CELL, V57, P717, DOI 10.1016/0092-8674(89)90787-3; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Maione B, 1998, MOL REPROD DEV, V50, P406, DOI 10.1002/(SICI)1098-2795(199808)50:4&lt;406::AID-MRD4&gt;3.0.CO;2-M; May C, 2000, NATURE, V406, P82, DOI 10.1038/35017565; Nagano M, 2002, FEBS LETT, V524, P111, DOI 10.1016/S0014-5793(02)03010-7; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; NUOVO GJ, 1994, AM J PATHOL, V144, P1142; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Pittoggi C, 2006, MOL REPROD DEV, V73, P1239, DOI 10.1002/mrd.20550; Ritchie WA, 2007, TRANSGENIC RES, V16, P661, DOI 10.1007/s11248-007-9102-2; Robinson KO, 2000, INSECT MOL BIOL, V9, P625, DOI 10.1046/j.1365-2583.2000.00225.x; ROTTMANN OJ, 1992, J ANIM BREED GENET, V109, P64, DOI 10.1111/j.1439-0388.1992.tb00379.x; Rulicke T, 2000, EXP PHYSIOL, V85, P589, DOI 10.1017/S0958067000020923; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Sciamanna I, 2003, BIOCHEM BIOPH RES CO, V312, P1039, DOI 10.1016/j.bbrc.2003.11.024; Scott BB, 2005, P NATL ACAD SCI USA, V102, P16443, DOI 10.1073/pnas.0508437102; Spadafora C, 1998, BIOESSAYS, V20, P955, DOI 10.1002/(SICI)1521-1878(199811)20:11&lt;955::AID-BIES11&gt;3.0.CO;2-8; Spadafora C, 2008, HUM REPROD, V23, P735, DOI 10.1093/humrep/dem425; van den Brandt J, 2004, GENESIS, V39, P94, DOI 10.1002/gene.20037; Wang HJ, 2001, ANIM BIOTECHNOL, V12, P101, DOI 10.1081/ABIO-100108336; Whitelaw CBA, 2004, FEBS LETT, V571, P233, DOI 10.1016/j.febslet.2004.06.076; Wu ZF, 2008, MOL REPROD DEV, V75, P26, DOI 10.1002/mrd.20778; Yonezawa T, 2002, J REPROD DEVELOP, V48, P281, DOI 10.1262/jrd.48.281; Yonezawa T, 2001, MOL REPROD DEV, V60, P196, DOI 10.1002/mrd.1077; Zhan Y, 2000, DNA CELL BIOL, V19, P639, DOI 10.1089/10445490050199045; Zoraqi G, 1997, DNA CELL BIOL, V16, P291, DOI 10.1089/dna.1997.16.291	41	9	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35335	10.1371/journal.pone.0035335	http://dx.doi.org/10.1371/journal.pone.0035335			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536374	gold, Green Published, Green Submitted			2022-12-25	WOS:000305339200057
J	Jain, S; Zweig, M; Peeters, E; Siewering, K; Hackett, KT; Dillard, JP; van der Does, C				Jain, Samta; Zweig, Maria; Peeters, Eveline; Siewering, Katja; Hackett, Kathleen T.; Dillard, Joseph P.; van der Does, Chris			Characterization of the Single Stranded DNA Binding Protein SsbB Encoded in the Gonoccocal Genetic Island	PLOS ONE			English	Article							AGROBACTERIUM VIRE2 PROTEIN; ESCHERICHIA-COLI SSB; SP STRAIN B13; NEISSERIA-GONORRHOEAE; NATURAL TRANSFORMATION; CLC ELEMENT; EXPRESSION; MYCOBACTERIUM; TUMEFACIENS; DELETION	Background: Most strains of Neisseria gonorrhoeae carry a Gonococcal Genetic Island which encodes a type IV secretion system involved in the secretion of ssDNA. We characterize the GGI-encoded ssDNA binding protein, SsbB. Close homologs of SsbB are located within a conserved genetic cluster found in genetic islands of different proteobacteria. This cluster encodes DNA-processing enzymes such as the ParA and ParB partitioning proteins, the TopB topoisomerase, and four conserved hypothetical proteins. The SsbB homologs found in these clusters form a family separated from other ssDNA binding proteins. Methodology/Principal Findings: In contrast to most other SSBs, SsbB did not complement the Escherichia coli ssb deletion mutant. Purified SsbB forms a stable tetramer. Electrophoretic mobility shift assays and fluorescence titration assays, as well as atomic force microscopy demonstrate that SsbB binds ssDNA specifically with high affinity. SsbB binds single-stranded DNA with minimal binding frames for one or two SsbB tetramers of 15 and 70 nucleotides. The binding mode was independent of increasing Mg2+ or NaCl concentrations. No role of SsbB in ssDNA secretion or DNA uptake could be identified, but SsbB strongly stimulated Topoisomerase I activity. Conclusions/Significance: We propose that these novel SsbBs play an unknown role in the maintenance of genetic islands.	[Jain, Samta; van der Does, Chris] Univ Groningen, Dept Microbiol, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands; [Peeters, Eveline] Vrije Univ Brussel, Microbiol Res Grp, Dept Sci & Bioengn Sci, Brussels, Belgium; [Hackett, Kathleen T.; Dillard, Joseph P.] Univ Wisconsin, Madison, WI USA; [Jain, Samta; Zweig, Maria; Siewering, Katja; van der Does, Chris] Max Planck Inst Terr Microbiol, Dept Ecophysiol, D-35043 Marburg, Germany	University of Groningen; Vrije Universiteit Brussel; University of Wisconsin System; University of Wisconsin Madison; Max Planck Society	Jain, S (corresponding author), Univ Groningen, Dept Microbiol, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands.	does@mpi-marburg.mpg.de			University of Groningen; Max-Planck-Gesellschaft; FWO-Vlaanderen (Research Foundation Flanders); National Institutes of Health [AI047958]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047958] Funding Source: NIH RePORTER	University of Groningen; Max-Planck-Gesellschaft(Max Planck Society); FWO-Vlaanderen (Research Foundation Flanders)(FWO); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by intramural funds of the University of Groningen and the Max-Planck-Gesellschaft to CvdD; by FWO-Vlaanderen (Research Foundation Flanders) to EP; and partially by the National Institutes of Health (AI047958) to JPD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Arish A, 2004, J BIOL CHEM, V279, P25359, DOI 10.1074/jbc.M401804200; Acharya N, 2002, J MOL BIOL, V318, P1251, DOI 10.1016/S0022-2836(02)00053-0; BUJALOWSKI W, 1989, J MOL BIOL, V207, P249, DOI 10.1016/0022-2836(89)90454-3; CHRYSOGELOS S, 1982, P NATL ACAD SCI-BIOL, V79, P5803, DOI 10.1073/pnas.79.19.5803; CITOVSKY V, 1989, P NATL ACAD SCI USA, V86, P1193, DOI 10.1073/pnas.86.4.1193; CITOVSKY V, 1992, SCIENCE, V256, P1802, DOI 10.1126/science.1615325; Despalins A, 2011, BIOINFORMATICS, V27, P2905, DOI 10.1093/bioinformatics/btr473; DEVRIES J, 1994, MICROBIOL-SGM, V140, P889, DOI 10.1099/00221287-140-4-889; Dillard JP, 2001, MOL MICROBIOL, V41, P263, DOI 10.1046/j.1365-2958.2001.02520.x; Dominguez NM, 2011, J BACTERIOL, V193, P377, DOI 10.1128/JB.00948-10; Fernandez-Lopez R, 2006, FEMS MICROBIOL REV, V30, P942, DOI 10.1111/j.1574-6976.2006.00042.x; Gaillard M, 2006, J BACTERIOL, V188, P1999, DOI 10.1128/JB.188.5.1999-2013.2006; Gelvin SB, 2010, CURR OPIN MICROBIOL, V13, P53, DOI 10.1016/j.mib.2009.11.003; GOLUB EI, 1985, J BACTERIOL, V162, P235, DOI 10.1128/JB.162.1.235-241.1985; Grange W, 2008, PLOS BIOL, V6, P343, DOI 10.1371/journal.pbio.0060044; Grove DE, 2005, J BIOL CHEM, V280, P11067, DOI 10.1074/jbc.M414057200; Hamilton HL, 2006, MOL MICROBIOL, V59, P376, DOI 10.1111/j.1365-2958.2005.04964.x; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Hamon L, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm147; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; HOWLAND CJ, 1989, J BACTERIOL, V171, P2466, DOI 10.1128/jb.171.5.2466-2473.1989; Huang YH, 2011, PROTEIN J, V30, P102, DOI 10.1007/s10930-011-9309-1; Jan HC, 2011, PROTEIN J, V30, P20, DOI 10.1007/s10930-010-9297-6; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Kramer N, 2007, MOL MICROBIOL, V65, P454, DOI 10.1111/j.1365-2958.2007.05799.x; Krastanova SV, 2010, TRANSGENIC RES, V19, P949, DOI 10.1007/s11248-010-9373-x; Larbig KD, 2002, J BACTERIOL, V184, P6665, DOI 10.1128/JB.184.23.6665-6680.2002; Lindner C, 2004, J BACTERIOL, V186, P1097, DOI 10.1128/JB.186.4.1097-1105.2004; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; MORSE SA, 1974, P SOC EXP BIOL MED, V145, P1418; MULDERS WHAM, 1995, BRAIN RES, V689, P47, DOI 10.1016/0006-8993(95)00534-W; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Pelczar P, 2004, EMBO REP, V5, P632, DOI 10.1038/sj.embor.7400165; Pestryakov PE, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1388, DOI 10.1134/S0006297908130026; PORTER RD, 1991, J BACTERIOL, V173, P2720, DOI 10.1128/jb.173.8.2720-2723.1991; Post DMB, 2005, J BIOL CHEM, V280, P38383, DOI 10.1074/jbc.M508063200; Purnapatre K, 1999, EUR J BIOCHEM, V264, P591, DOI 10.1046/j.1432-1327.1999.00684.x; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Roy R, 2007, J MOL BIOL, V369, P1244, DOI 10.1016/j.jmb.2007.03.079; Salgado-Pabon W, 2010, J BACTERIOL, V192, P1912, DOI 10.1128/JB.01357-09; Savvides SN, 2004, PROTEIN SCI, V13, P1942, DOI 10.1110/ps.04661904; SCHWARZ G, 1983, J MOL BIOL, V163, P467, DOI 10.1016/0022-2836(83)90069-4; SEN P, 1989, J BACTERIOL, V171, P2573, DOI 10.1128/jb.171.5.2573-2580.1989; Sikder D, 2001, J MOL BIOL, V306, P669, DOI 10.1006/jmbi.2000.4384; SPARLING PF, 1966, J BACTERIOL, V92, P1364, DOI 10.1128/JB.92.5.1364-1371.1966; Stohl EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017101; Sundberg C, 1996, J BACTERIOL, V178, P1207, DOI 10.1128/jb.178.4.1207-1212.1996; Szczepankowska AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026942; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; van der Meer JR, 2001, ARCH MICROBIOL, V175, P79; Wade JJ, 2007, FEMS MICROBIOL LETT, V273, P35, DOI 10.1111/j.1574-6968.2007.00776.x	52	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35285	10.1371/journal.pone.0035285	http://dx.doi.org/10.1371/journal.pone.0035285			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536367	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336200032
J	Bel, S; Elkis, Y; Lerer-Goldstein, T; Nyska, A; Shpungin, S; Nir, U				Bel, Shai; Elkis, Yoav; Lerer-Goldstein, Tali; Nyska, Abraham; Shpungin, Sally; Nir, Uri			Loss of TMF/ARA160 Protein Renders Colonic Mucus Refractory to Bacterial Colonization and Diminishes Intestinal Susceptibility to Acute Colitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; DEXTRAN SULFATE SODIUM; NF-KAPPA-B; MICE; BARRIER; HOMEOSTASIS; ACTIVATION; MICROBIOTA; LAYERS; MUCIN	TMF/ARA160 is a Golgi-associated protein with several cellular functions, among them direction of the NF-kappa B subunit, p65 RelA, to ubiquitination and proteasomal degradation in stressed cells. We sought to investigate the role of TMF/ARA160 under imposed stress conditions in vivo. TMF-/- and wild-type (WT) mice were treated with the ulcerative agent dextran sulfate sodium (DSS), and the severity of the inflicted acute colitis was determined. TMF-/- mice were found to be significantly less susceptible to DSS-induced colitis, with profoundly less bacterial penetration into the colonic epithelia. Surprisingly, unlike in WT mice, no bacterial colonies were visualized in colons of healthy untreated TMF-/- mice, indicating the constitutive resistance of TMF-/- colonic mucus to bacterial retention and penetration. Gene expression analysis of colon tissues from unchallenged TMF-/- mice revealed 5-fold elevated transcription of the muc2 gene, which encodes the major component of the colonic mucus gel, the MUC2 mucin. Accordingly, the morphology of the colonic mucus in TMF-/- mice was found to differ from the mucus structure in WT colons. The NF-kappa B subunit, p65, a well known transcription inducer of muc2, was up-regulated significantly in TMF(-/-)intestinal epithelial cells. However, this did not cause spontaneous inflammation or increased colonic crypt cell proliferation. Collectively, our findings demonstrate that absence of TMF/ARA160 renders the colonic mucus refractory to bacterial colonization and the large intestine less susceptible to the onset of colitis.	[Bel, Shai; Elkis, Yoav; Lerer-Goldstein, Tali; Shpungin, Sally; Nir, Uri] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; [Nyska, Abraham] Tel Aviv Univ, Sackler Sch Med, IL-36576 Tel Aviv, Israel	Bar Ilan University; Tel Aviv University; Sackler Faculty of Medicine	Nir, U (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	uri.nir@biu.ac.il	Bel, Shai/AAH-7870-2021	Bel, Shai/0000-0002-7166-4870	The Israeli Ministry of Health Chief Scientist Research Foundation	The Israeli Ministry of Health Chief Scientist Research Foundation	This work was supported by a grant from The Israeli Ministry of Health Chief Scientist Research Foundation.	Abrham G, 2009, INT J CANCER, V125, P43, DOI 10.1002/ijc.24277; Ahn DH, 2005, CELL PHYSIOL BIOCHEM, V15, P29, DOI 10.1159/000083636; Araki A, 2005, J GASTROENTEROL, V40, P16, DOI 10.1007/s00535-004-1492-9; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; BOUGHTONSMITH NK, 1988, AGENTS ACTIONS, V25, P115, DOI 10.1007/BF01969102; COOPER HS, 1993, LAB INVEST, V69, P238; Cunliffe RN, 2004, J LEUKOCYTE BIOL, V75, P49, DOI 10.1189/jlb.0503249; Eckmann L, 2008, P NATL ACAD SCI USA, V105, P15058, DOI 10.1073/pnas.0808216105; Forbes E, 2004, J IMMUNOL, V172, P5664, DOI 10.4049/jimmunol.172.9.5664; Guma M, 2011, J EXP MED, V208, P1889, DOI 10.1084/jem.20110242; Hasnain SZ, 2011, J EXP MED, V208, P893, DOI 10.1084/jem.20102057; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johansson MEV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012238; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kalabis J, 2006, J BIOL CHEM, V281, P6434, DOI 10.1074/jbc.M512905200; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Kitajima S, 1999, EXP ANIM TOKYO, V48, P137, DOI 10.1538/expanim.48.137; Kraus S, 2009, CURR OPIN PHARMACOL, V9, P405, DOI 10.1016/j.coph.2009.06.006; Lerer-Goldshtein T, 2010, DEV BIOL, V348, P12, DOI 10.1016/j.ydbio.2010.07.033; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; Ohtake K, 2010, NITRIC OXIDE-BIOL CH, V23, P65, DOI 10.1016/j.niox.2010.04.004; Perry E, 2004, ONCOGENE, V23, P8908, DOI 10.1038/sj.onc.1208149; Petersson J, 2011, AM J PHYSIOL-GASTR L, V300, pG327, DOI 10.1152/ajpgi.00422.2010; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rivas-Santiago CE, 2011, CLIN EXP IMMUNOL, V164, P80, DOI 10.1111/j.1365-2249.2010.04313.x; Saleh M, 2011, IMMUNITY, V34, P293, DOI 10.1016/j.immuni.2011.03.008; Shea-Donohue T, 2008, INNATE IMMUN-LONDON, V14, P117, DOI 10.1177/1753425908088724; Steinbrecher KA, 2008, J IMMUNOL, V180, P2588, DOI 10.4049/jimmunol.180.4.2588; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Swidsinski A, 2007, INFLAMM BOWEL DIS, V13, P963, DOI 10.1002/ibd.20163; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Wullaert A, 2011, CELL RES, V21, P146, DOI 10.1038/cr.2010.175; Xu G, 2010, FOOD CHEM TOXICOL, V48, P390, DOI 10.1016/j.fct.2009.10.027; Yamane J, 2007, EXP CELL RES, V313, P3472, DOI 10.1016/j.yexcr.2007.07.010; Yan YT, 2011, J IMMUNOL, V187, P1496, DOI 10.4049/jimmunol.1002910	35	10	10	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25631	25639		10.1074/jbc.M112.364786	http://dx.doi.org/10.1074/jbc.M112.364786			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22553199	hybrid, Green Published			2022-12-25	WOS:000306651700070
J	Kraushaar, DC; Rai, S; Condac, E; Nairn, A; Zhang, SY; Yamaguchi, Y; Moremen, K; Dalton, S; Wang, LC				Kraushaar, Daniel C.; Rai, Sumit; Condac, Eduard; Nairn, Alison; Zhang, Siyuan; Yamaguchi, Yu; Moremen, Kelley; Dalton, Stephen; Wang, Lianchun			Heparan Sulfate Facilitates FGF and BMP Signaling to Drive Mesoderm Differentiation of Mouse Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMITIVE STREAK; SELF-RENEWAL; PROTEOGLYCANS; GROWTH; WNT; WINGLESS; RECEPTOR; BIOSYNTHESIS; GASTRULATION; ACTIVATION	Heparan sulfate (HS) has been implicated in regulating cell fate decisions during differentiation of embryonic stem cells (ESCs) into advanced cell types. However, the necessity and the underlying molecular mechanisms of HS in early cell lineage differentiation are still largely unknown. In this study, we examined the potential of EXT1(-/-) mouse ESCs (mESCs), that are deficient in HS, to differentiate into primary germ layer cells. We observed that EXT1(-/-) mESCs lost their differentiation competence and failed to differentiate into Pax6(+)-neural precursor cells and mesodermal cells. More detailed analyses highlighted the importance of HS for the induction of Brachyury(+) pan-mesoderm as well as normal gene expression associated with the dorso-ventral patterning of mesoderm. Examination of developmental cell signaling revealed that EXT1 ablation diminished FGF and BMP but not Wnt signaling. Furthermore, restoration of FGF and BMP signaling each partially rescued mesoderm differentiation defects. We further show that BMP4 is more prone to degradation in EXT1(-/-) mESCs culture medium compared with that of wild type cells. Therefore, our data reveal that HS stabilizes BMP ligand and thereby maintains the BMP signaling output required for normal mesoderm differentiation. In summary, our study demonstrates that HS is required for ESC pluripotency, in particular lineage specification into mesoderm through facilitation of FGF and BMP signaling.	[Kraushaar, Daniel C.; Rai, Sumit; Condac, Eduard; Nairn, Alison; Zhang, Siyuan; Moremen, Kelley; Dalton, Stephen; Wang, Lianchun] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Kraushaar, Daniel C.; Rai, Sumit; Condac, Eduard; Nairn, Alison; Zhang, Siyuan; Moremen, Kelley; Dalton, Stephen; Wang, Lianchun] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Yamaguchi, Yu] Burnham Inst Med Res, Sanford Childrens Hlth Res Ctr, La Jolla, CA 92037 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Sanford Burnham Prebys Medical Discovery Institute	Wang, LC (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	Lwang@ccrc.uga.edu	Moremen, Kelley/AAD-4661-2019	Nairn, Alison/0000-0002-4453-7593; Dalton, Stephen/0000-0002-3450-1263	National Institutes of Health [R01HL093339, RR005351/GM103390, 5P01GM085354, RR018502]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351, P41RR018502] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390, P01GM085354, P41GM103490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grants R01HL093339 (to L. W.), RR005351/GM103390 (to L. W.), 5P01GM085354 (pilot project, to L. W.) and RR018502 (to K. M.) from the National Institutes of Health.	Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Baeg GH, 2001, DEVELOPMENT, V128, P87; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bilechele Travis L., 2008, V468, P99, DOI 10.1007/978-1-59745-249-6_8; Binari RC, 1997, DEVELOPMENT, V124, P2623; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Boyd NL, 2007, EXP BIOL MED, V232, P833; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Dejima K, 2011, J BIOL CHEM, V286, P17103, DOI 10.1074/jbc.M110.208082; Dell'Era P, 2003, CIRC RES, V93, P414, DOI 10.1161/01.RES.0000089460.12061.E1; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Forsberg M., 2012, J BIOL CHEM IN PRESS; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Haerry TE, 1997, DEVELOPMENT, V124, P3055; Han C, 2004, DEVELOPMENT, V131, P1563, DOI 10.1242/dev.01051; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Holley RJ, 2011, J BIOL CHEM, V286, P6241, DOI 10.1074/jbc.M110.178483; Hu ZH, 2009, J CELL SCI, V122, P1145, DOI 10.1242/jcs.034736; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Johnson CE, 2007, STEM CELLS, V25, P1913, DOI 10.1634/stemcells.2006-0445; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kraushaar DC, 2010, J BIOL CHEM, V285, P5907, DOI 10.1074/jbc.M109.066837; Kuo WJ, 2010, MOL BIOL CELL, V21, P4028, DOI 10.1091/mbc.E10-04-0348; Lanner F, 2010, STEM CELLS, V28, P191, DOI 10.1002/stem.265; Lengerke C, 2008, CELL STEM CELL, V2, P72, DOI 10.1016/j.stem.2007.10.022; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Manton KJ, 2007, STEM CELLS, V25, P2845, DOI 10.1634/stemcells.2007-0065; Matsumoto Y, 2010, J BIOL CHEM, V285, P19227, DOI 10.1074/jbc.M110.105338; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Miura S, 2006, DEVELOPMENT, V133, P3767, DOI 10.1242/dev.02552; Nairn AV, 2007, J PROTEOME RES, V6, P4374, DOI 10.1021/pr070446f; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Padera R, 1999, FASEB J, V13, P1677, DOI 10.1096/fasebj.13.13.1677; Sasaki N, 2008, J BIOL CHEM, V283, P3594, DOI 10.1074/jbc.M705621200; Sasaki N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008262; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; Stavridis MP, 2003, BIOCHEM SOC T, V31, P45, DOI 10.1042/bst0310045; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; Subramanian SV, 1997, J BIOL CHEM, V272, P14713, DOI 10.1074/jbc.272.23.14713; Willems E, 2008, DIFFERENTIATION, V76, P745, DOI 10.1111/j.1432-0436.2007.00257.x; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wine-Lee L, 2004, DEVELOPMENT, V131, P5393, DOI 10.1242/dev.01379; YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zheng ZQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012555	52	61	62	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22691	22700		10.1074/jbc.M112.368241	http://dx.doi.org/10.1074/jbc.M112.368241			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22556407	Green Published, hybrid			2022-12-25	WOS:000306495000026
J	Finn, TE; Nunez, AC; Sunde, M; Easterbrook-Smith, SB				Finn, Thomas E.; Nunez, Andrea C.; Sunde, Margaret; Easterbrook-Smith, Simon B.			Serum Albumin Prevents Protein Aggregation and Amyloid Formation and Retains Chaperone-like Activity in the Presence of Physiological Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; CHAIN FATTY-ACIDS; MOLECULAR CHAPERONE; EXTRACELLULAR CHAPERONE; ALPHA-CRYSTALLIN; PLASMA-PROTEINS; BINDING PROPERTIES; SELF-ASSOCIATION; FIBRIL FORMATION; SHEAR-STRESS	Although serum albumin has an established function as a transport protein, evidence is emerging that serum albumin may also have a role as a molecular chaperone. Using established techniques to characterize chaperone interactions, this study demonstrates that bovine serum albumin: 1) preferentially binds stressed over unstressed client proteins; 2) forms stable, soluble, high molecular weight complexes with stressed client proteins; 3) reduces the aggregation of client proteins when it is present at physiological levels; and 4) inhibits amyloid formation by both WT and L55P transthyretin. Although the antiaggregatory effect of serum albumin is maintained in the presence of physiological levels of Ca2+ and Cu2+, the presence of free fatty acids significantly alters this activity: stabilizing serum albumin at normal levels but diminishing chaperone-like activity at high concentrations. Moreover, here it is shown that depletion of albumin from human plasma leads to a significant increase in aggregation under physiologically relevant heat and shear stresses. This study demonstrates that serum albumin possesses chaperone-like properties and that this activity is maintained under a number of physiologically relevant conditions.	[Sunde, Margaret] Univ Sydney, Discipline Pharmacol, Sydney, NSW 2006, Australia; Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Sunde, M (corresponding author), Univ Sydney, Discipline Pharmacol, Bldg D06, Sydney, NSW 2006, Australia.	margaret.sunde@sydney.edu.au	Sunde, Margaret/ABH-2584-2020; Finn, Thomas Edward/U-6315-2019; Sunde, Margaret/A-5186-2016	Sunde, Margaret/0000-0002-0150-3203; Sunde, Margaret/0000-0002-0150-3203; Finn, Thomas/0000-0002-5158-2819				Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; BENVENGA S, 1986, ANN CLIN LAB SCI, V16, P231; BLASCHUK O, 1983, J BIOL CHEM, V258, P7714; Bohrmann B, 1999, J BIOL CHEM, V274, P15990, DOI 10.1074/jbc.274.23.15990; BOWMAN BH, 1982, ADV HUM GENET, V12, P189; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Buczek O, 2007, BIOPOLYMERS, V88, P8, DOI 10.1002/bip.20615; CARVER JA, 1994, BBA-PROTEIN STRUCT M, V1204, P195, DOI 10.1016/0167-4838(94)90009-4; CHANG BS, 1995, BIOTECHNOL APPL BIOC, V22, P203; CHEN RF, 1967, J BIOL CHEM, V242, P173; Cheung MS, 2005, P NATL ACAD SCI USA, V102, P4753, DOI 10.1073/pnas.0409630102; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Choi JK, 2002, J LIPID RES, V43, P1000, DOI 10.1194/jlr.M200041-JLR200; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; Dardik A, 2005, J VASC SURG, V41, P869, DOI 10.1016/j.jvs.2005.01.020; Davis DP, 2001, J MOL BIOL, V313, P1021, DOI 10.1006/jmbi.2001.5092; Ely BR, 2009, J APPL PHYSIOL, V107, P1519, DOI 10.1152/japplphysiol.00577.2009; French K, 2008, BIOCHEMISTRY-US, V47, P1176, DOI 10.1021/bi701976f; Galeazzi L, 2002, NEUROREPORT, V13, P2149, DOI 10.1097/00001756-200211150-00032; GIANAZZA E, 1982, BIOCHEM J, V203, P637, DOI 10.1042/bj2030637; Gonzalez-Alonso J, 1999, J APPL PHYSIOL, V86, P1032, DOI 10.1152/jappl.1999.86.3.1032; Hatters DM, 2002, J BIOL CHEM, V277, P7824, DOI 10.1074/jbc.M110429200; Hollander JM, 2004, CIRCULATION, V110, P3544, DOI 10.1161/01.CIR.0000148825.99184.50; Huang BX, 2004, J AM SOC MASS SPECTR, V15, P1237, DOI 10.1016/j.jasms.2004.05.004; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; KRAGHHANSEN U, 1990, DAN MED BULL, V37, P57; Kugimiya T, 2011, LAB INVEST, V91, P1219, DOI 10.1038/labinvest.2011.71; KUMAR KL, 1986, WESTERN J MED, V144, P753; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Marini I, 2005, CELL MOL LIFE SCI, V62, P3092, DOI 10.1007/s00018-005-5397-4; MASUOKA J, 1994, J BIOL CHEM, V269, P25557; McGugan E A, 2001, Emerg Med (Fremantle), V13, P116, DOI 10.1046/j.1442-2026.2001.00189.x; MCLACHLAN AD, 1977, J MOL BIOL, V112, P543, DOI 10.1016/S0022-2836(77)80163-0; Meng Z, 2007, J SEP SCI, V30, P1537, DOI 10.1002/jssc.200600344; MINTON KW, 1982, P NATL ACAD SCI-BIOL, V79, P7107, DOI 10.1073/pnas.79.23.7107; Morrissey C, 2001, J BIOCHEM BIOPH METH, V48, P13, DOI 10.1016/S0165-022X(00)00137-8; Munishkina LA, 2004, J MOL RECOGNIT, V17, P456, DOI 10.1002/jmr.699; Nagase S, 1980, Jikken Dobutsu, V29, P33; PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0; Poon S, 2000, BIOCHEMISTRY-US, V39, P15953, DOI 10.1021/bi002189x; Poon S, 2002, J BIOL CHEM, V277, P39532, DOI 10.1074/jbc.M204855200; PUTTMANN M, 1993, CLIN CHEM, V39, P825; Quintas A, 1999, J BIOL CHEM, V274, P32943, DOI 10.1074/jbc.274.46.32943; Quintas A, 2001, J BIOL CHEM, V276, P27207, DOI 10.1074/jbc.M101024200; Rahil-Khazen R, 2000, CLIN CHEM LAB MED, V38, P765, DOI 10.1515/CCLM.2000.109; RAO PV, 1993, BIOCHEM BIOPH RES CO, V190, P786, DOI 10.1006/bbrc.1993.1118; Rasmussen T, 2010, PHARM RES-DORDR, V27, P1337, DOI 10.1007/s11095-010-0116-8; REED RG, 1977, J BIOL CHEM, V252, P7483; Ren GP, 2003, J PROTEIN CHEM, V22, P431, DOI 10.1023/B:JOPC.0000005458.08802.11; RICHIERI GV, 1993, BIOCHEMISTRY-US, V32, P7574, DOI 10.1021/bi00080a032; Rivas G, 1999, BIOCHEMISTRY-US, V38, P9379, DOI 10.1021/bi990355z; ROSS PD, 1988, J BIOL CHEM, V263, P11196; RUSSI E, 1983, KLIN WOCHENSCHR, V61, P541, DOI 10.1007/BF01486843; SAIFER A, 1961, J LIPID RES, V2, P268; Sheluho D, 2001, J BIOL CHEM, V276, P39945, DOI 10.1074/jbc.M107252200; Snoussi K, 2005, BIOPHYS J, V88, P2855, DOI 10.1529/biophysj.104.055871; SOLTYS BJ, 1977, J BIOL CHEM, V252, P4043; SPECTOR AA, 1969, J LIPID RES, V10, P56; Sztefko K, 2001, PANCREATOLOGY, V1, P230, DOI 10.1159/000055816; Torricelli C, 2004, J MOL ENDOCRINOL, V33, P335, DOI 10.1677/jme.1.01530; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; van den Berg B, 2000, EMBO J, V19, P3870, DOI 10.1093/emboj/19.15.3870; van den Berg B, 1999, EMBO J, V18, P6927, DOI 10.1093/emboj/18.24.6927; Wilkinson-White LE, 2007, BIOCHEMISTRY-US, V46, P9123, DOI 10.1021/bi700607z; Wyatt AR, 2010, J BIOL CHEM, V285, P3532, DOI 10.1074/jbc.M109.079566; Wyatt AR, 2009, J BIOL CHEM, V284, P21920, DOI 10.1074/jbc.M109.033688; Yerbury JJ, 2005, BIOCHEMISTRY-US, V44, P10914, DOI 10.1021/bi050764x; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com; Yerbury JJ, 2009, J BIOL CHEM, V284, P4246, DOI 10.1074/jbc.M807242200; Zhou BR, 2004, J BIOL CHEM, V279, P55109, DOI 10.1074/jbc.M409086200; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V	75	105	106	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21530	21540		10.1074/jbc.M112.372961	http://dx.doi.org/10.1074/jbc.M112.372961			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22549788	Green Published, hybrid			2022-12-25	WOS:000306416800070
J	Gao, YW; Cimica, V; Reich, NC				Gao, Yiwei; Cimica, Velasco; Reich, Nancy C.			Suppressor of Cytokine Signaling 3 Inhibits Breast Tumor Kinase Activation of STAT3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONRECEPTOR TYROSINE KINASE; CANCER CELLS; SH2 DOMAIN; SOCS BOX; IN-VIVO; BRK; PROTEIN; DEGRADATION; GROWTH; PHOSPHORYLATION	Breast tumor kinase (Brk) was originally isolated from a human metastatic breast tumor, but also is found expressed in other epithelial tumors and in a subset of normal epithelia. Brk is a tyrosine kinase and its expression in breast carcinoma has been linked to tumor progression. The signal transducer and activator of transcription 3 (STAT3) is one of the substrate targets of Brk, and elevated tyrosine phosphorylation of STAT3 is known to contribute to oncogenesis. Conventional activation of STAT3 occurs in response to cytokine stimulation of Janus tyrosine kinases (JAK). One of the negative regulators discovered in cytokine signaling of the JAK-STAT pathway is the suppressor of cytokine signaling 3 (SOCS3). In this report we describe the finding that SOCS3 can also inhibit the unconventional target, Brk. Investigation of the mechanism by which SOCS3 inhibits Brk reveals the SOCS3 protein binds to Brk primarily via its SH2 domain, and its main inhibitory effect is mediated by the SOCS3 kinase inhibitory region (KIR). SOCS3 has only a modest effect on promoting Brk degradation, and this requires the C-terminal SOCS box domain. SOCS3 is the only known inhibitor of Brk, and knowledge of the mechanisms by which SOCS3 inhibits Brk may lead to methods that block Brk in cancer progression.	[Gao, Yiwei; Cimica, Velasco; Reich, Nancy C.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Reich, NC (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	nreich@notes.cc.sunysb.edu	Cimica, Velasco/H-2656-2014	Cimica, Velasco/0000-0001-7489-3145	National Institutes of Health [R01CA122910]; Carol Baldwin Foundation for Breast Cancer Research; NATIONAL CANCER INSTITUTE [R01CA122910] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carol Baldwin Foundation for Breast Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA122910 and the Carol Baldwin Foundation for Breast Cancer Research (to N. C. R.).	AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Babon JJ, 2012, IMMUNITY, V36, P239, DOI 10.1016/j.immuni.2011.12.015; Babon JJ, 2006, MOL CELL, V22, P205, DOI 10.1016/j.molcel.2006.03.024; Bergamin E, 2006, STRUCTURE, V14, P1285, DOI 10.1016/j.str.2006.06.011; Born M, 2005, J PATHOL, V205, P592, DOI 10.1002/path.1720; Boyle K, 2009, CELL SIGNAL, V21, P394, DOI 10.1016/j.cellsig.2008.11.002; Brauer PM, 2010, BBA-REV CANCER, V1806, P66, DOI 10.1016/j.bbcan.2010.02.003; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Campanero MR, 1997, P NATL ACAD SCI USA, V94, P2221, DOI 10.1073/pnas.94.6.2221; Chen HY, 2004, MOL CELL BIOL, V24, P10558, DOI 10.1128/MCB.24.24.10558-10572.2004; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; De Souza D, 2002, BIOCHEMISTRY-US, V41, P9229, DOI 10.1021/bi0259507; Elliott J, 2008, BIOCHEM SOC T, V36, P464, DOI 10.1042/BST0360464; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Haegebarth A, 2006, MOL CELL BIOL, V26, P4949, DOI 10.1128/MCB.01901-05; Harvey AJ, 2009, AM J PATHOL, V175, P1226, DOI 10.2353/ajpath.2009.080811; He B, 2003, P NATL ACAD SCI USA, V100, P14133, DOI 10.1073/pnas.2232790100; He B, 2003, BIOCHEM BIOPH RES CO, V301, P386, DOI 10.1016/S0006-291X(02)03071-1; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Kamalati T, 1996, J BIOL CHEM, V271, P30956, DOI 10.1074/jbc.271.48.30956; Kang SA, 2010, J BIOL CHEM, V285, P26013, DOI 10.1074/jbc.M109.088971; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liu E, 2003, EMBO J, V22, P5036, DOI 10.1093/emboj/cdg503; Liu L, 2006, ONCOGENE, V25, P4904, DOI 10.1038/sj.onc.1209501; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Ludyga N, 2011, MOL BIOSYST, V7, P1603, DOI 10.1039/c0mb00286k; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; MITCHELL PJ, 1994, ONCOGENE, V9, P2383; Nicholson SE, 2000, P NATL ACAD SCI USA, V97, P6493, DOI 10.1073/pnas.100135197; Orr SJ, 2007, J BIOL CHEM, V282, P3418, DOI 10.1074/jbc.C600216200; Ostrander JH, 2007, CANCER RES, V67, P4199, DOI 10.1158/0008-5472.CAN-06-3409; Piessevaux J, 2008, CYTOKINE GROWTH F R, V19, P371, DOI 10.1016/j.cytogfr.2008.08.006; Qiu HQ, 2004, ONCOGENE, V23, P2216, DOI 10.1038/sj.onc.1207339; Qiu HQ, 2002, J BIOL CHEM, V277, P34634, DOI 10.1074/jbc.M203877200; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Sasaki A, 1999, GENES CELLS, V4, P339, DOI 10.1046/j.1365-2443.1999.00263.x; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200; Shen CH, 2008, CANCER RES, V68, P7779, DOI 10.1158/0008-5472.CAN-08-0997; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Weaver AM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1794; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; Xiang B, 2008, P NATL ACAD SCI USA, V105, P12463, DOI 10.1073/pnas.0805009105; Ying MZ, 2010, J CANCER RES CLIN, V136, P1617, DOI 10.1007/s00432-010-0819-6; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	53	21	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20904	20912		10.1074/jbc.M111.334144	http://dx.doi.org/10.1074/jbc.M111.334144			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22547065	hybrid, Green Published			2022-12-25	WOS:000306416800012
J	Li, GD; Pone, EJ; Tran, DC; Patel, PJ; Dao, LS; Xu, ZM; Casali, P				Li, Guideng; Pone, Egest J.; Tran, Daniel C.; Patel, Pina J.; Dao, Lisa; Xu, Zhenming; Casali, Paolo			Iron Inhibits Activation-induced Cytidine Deaminase Enzymatic Activity and Modulates Immunoglobulin Class Switch DNA Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-CELL DIFFERENTIATION; SINGLE-STRANDED-DNA; CRYSTAL-STRUCTURE; B-CELLS; SOMATIC HYPERMUTATION; CYTOSINE DEAMINASE; AID EXPRESSION; HIV-1; GENE; HEMOCHROMATOSIS	Immunoglobulin (Ig) class switch DNA recombination (CSR) and somatic hypermutation (SHM) are critical for the maturation of the antibody response. Activation-induced cytidine deaminase (AID) initiates CSR and SHM by deaminating deoxycytidines (dCs) in switch (S) and V(D) J region DNA, respectively, to generate deoxyuracils (dUs). Processing of dUs by uracil DNA glycosylase (UNG) yields abasic sites, which are excised by apurinic/apyrimidinic endonucleases, eventually generating double strand DNA breaks, the obligatory intermediates of CSR. Here, we found that the bivalent iron ion (Fe2+, ferrous) suppressed CSR, leading to decreased number of switched B cells, decreased postrecombination I mu-C-H transcripts, and reduced titers of secreted class-switched IgG1, IgG3, and IgA antibodies, without alterations in critical CSR factors, such as AID, 14-3-3 gamma, or PTIP, or in general germline I-H-S-C-H transcription. Fe2+ did not affect B cell proliferation or plasmacytoid differentiation. Rather, it inhibited AID-mediated dC deamination in a dose-dependent fashion. The inhibition of intrinsic AID enzymatic activity by Fe2+ was specific, as shown by lack of inhibition of AID-mediated dC deamination by other bivalent metal ions, such as Zn2+, Mn2+, Mg2+, or Ni2+,and the inability of Fe2+ to inhibit UNG-mediated dU excision. Overall, our findings have outlined a novel role of iron in modulating a B cell differentiation process that is critical to the generation of effective antibody responses to microbial pathogens and tumoral cells. They also suggest a possible role of iron in dampening AID-dependent autoimmunity and neoplastic transformation.	[Xu, Zhenming] Univ Calif Irvine, Inst Immunol, Sch Med, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Med, Sch Med, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Xu, ZM (corresponding author), Univ Calif Irvine, Inst Immunol, Sch Med, Irvine, CA 92697 USA.	zhenming@uci.edu			National Institutes of Health; obligatory CSR intermediates [AI 045011, AI 060573, AI 079705]; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060573, R56AI079705, R01AI079705, R56AI045011, R01AI045011] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); obligatory CSR intermediates; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health double strand DNA breaks, the obligatory CSR intermediates Grants AI 045011, AI 060573, and AI 079705 (to P. C.).	Annamalai N, 2009, INDIAN J BIOTECHNOL, V8, P291; Barton JC, 2003, BLOOD CELL MOL DIS, V31, P102, DOI 10.1016/S1079-9796(03)00116-5; Basu U, 2011, CELL, V144, P353, DOI 10.1016/j.cell.2011.01.001; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; BULLEN JJ, 1968, IMMUNOLOGY, V14, P889; Casali P., 2009, LEWINS GENES, P570; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Christianson DW, 1999, ANNU REV BIOCHEM, V68, P33, DOI 10.1146/annurev.biochem.68.1.33; Daniel JA, 2010, SCIENCE, V329, P917, DOI 10.1126/science.1187942; Delker RK, 2009, NAT IMMUNOL, V10, P1147, DOI 10.1038/ni.1799; Fairfax KA, 2008, SEMIN IMMUNOL, V20, P49, DOI 10.1016/j.smim.2007.12.002; Golenser J, 2006, J PARASITOL, V92, P170, DOI 10.1645/GE-3517.1; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Gordeuk VR, 1996, BLOOD, V87, P3470, DOI 10.1182/blood.V87.8.3470.bloodjournal8783470; Hsu HC, 2011, ARTHRITIS RHEUM-US, V63, P2038, DOI 10.1002/art.30257; Ireton GC, 2002, J MOL BIOL, V315, P687, DOI 10.1006/jmbi.2001.5277; Ireton GC, 2003, STRUCTURE, V11, P961, DOI 10.1016/S0969-2126(03)00153-9; Jiang CC, 2007, J IMMUNOL, V178, P7422, DOI 10.4049/jimmunol.178.11.7422; Kadiu I, 2011, J PROTEOME RES, V10, P3225, DOI 10.1021/pr200262q; Khan FA, 2007, INT J INFECT DIS, V11, P482, DOI 10.1016/j.ijid.2007.04.007; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kobayashi K, 2007, WORLD J MICROB BIOT, V23, P1033, DOI 10.1007/s11274-006-9318-y; KOCHAN I, 1984, INFECT IMMUN, V43, P543, DOI 10.1128/IAI.43.2.543-548.1984; Kohli RM, 2010, J BIOL CHEM, V285, P40956, DOI 10.1074/jbc.M110.177402; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Konijn AM, 1999, BLOOD, V94, P2128, DOI 10.1182/blood.V94.6.2128.418k20_2128_2134; LEITER LM, 1995, J NUTR, V125, P474; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Mai T, 2010, J BIOL CHEM, V285, P37797, DOI 10.1074/jbc.M110.169086; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; Maul RW, 2011, NAT IMMUNOL, V12, P70, DOI 10.1038/ni.1970; Mencacci A, 1997, J INFECT DIS, V175, P1467, DOI 10.1086/516481; MOL CD, 1995, CELL, V80, P869, DOI 10.1016/0092-8674(95)90290-2; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Murphy K. M., 2011, JANEWAYS IMMUNOBIOLO, P387; Odegard VH, 2006, NAT REV IMMUNOL, V6, P573, DOI 10.1038/nri1896; Park SR, 2009, NAT IMMUNOL, V10, P540, DOI 10.1038/ni.1725; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Petrat F, 2001, BIOCHEM J, V356, P61, DOI 10.1042/0264-6021:3560061; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Pone EJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1769; PORTER DJT, 1993, J BIOL CHEM, V268, P24005; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Qiao XG, 2006, NAT IMMUNOL, V7, P302, DOI 10.1038/ni1302; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Rudnicka D, 2009, NAT IMMUNOL, V10, P933, DOI 10.1038/ni0909-933; Sayegh CE, 2003, NAT IMMUNOL, V4, P586, DOI 10.1038/ni923; Schrader CE, 2005, J EXP MED, V202, P561, DOI 10.1084/jem.20050872; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Swingler S, 2008, CELL HOST MICROBE, V4, P63, DOI 10.1016/j.chom.2008.05.015; Theurl I, 2009, BLOOD, V113, P5277, DOI 10.1182/blood-2008-12-195651; Tran TH, 2010, NAT IMMUNOL, V11, P148, DOI 10.1038/ni.1829; Van Vlierberghe H, 2001, J HEPATOL, V35, P707, DOI 10.1016/S0168-8278(01)00203-3; Watanabe-Matsui M, 2011, BLOOD, V117, P5438, DOI 10.1182/blood-2010-07-296483; White CA, 2011, AUTOIMMUNITY, V44, P585, DOI 10.3109/08916934.2011.577128; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753; Xu Z., 2012, NAT REV IMM IN PRESS; Xu ZM, 2007, CRIT REV IMMUNOL, V27, P367, DOI 10.1615/CritRevImmunol.v27.i4.60; Xu ZM, 2010, NAT STRUCT MOL BIOL, V17, P1124, DOI 10.1038/nsmb.1884; Yu KF, 2004, J BIOL CHEM, V279, P6496, DOI 10.1074/jbc.M311616200; Zan H, 2008, MOL IMMUNOL, V46, P45, DOI 10.1016/j.molimm.2008.07.003; Zan H, 2009, AUTOIMMUNITY, V42, P89, DOI 10.1080/08916930802629554	65	14	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21520	21529		10.1074/jbc.M112.366732	http://dx.doi.org/10.1074/jbc.M112.366732			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22556412	Green Published, hybrid			2022-12-25	WOS:000306416800069
J	Lin, ZJ; Zhao, WJ; Diao, WT; Xie, XQ; Wang, Z; Zhang, JX; Shen, YQ; Long, JF				Lin, Zhijie; Zhao, Weijing; Diao, Wentao; Xie, Xingqiao; Wang, Zheng; Zhang, Jinxiu; Shen, Yuequan; Long, Jiafu			Crystal Structure of Elongator Subcomplex Elp4-6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; FAMILIAL DYSAUTONOMIA; TRANSCRIPTIONAL ELONGATION; HISTONE ACETYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; HOLO-ELONGATOR; IN-VIVO; COMPLEX; PROTEIN; CHROMATIN	Elongator is a multiprotein complex composed of two subcomplexes, Elp1-3 and Elp4-6. Elongator is highly conserved between yeast and humans and plays an important role in RNA polymerase II-mediated transcriptional elongation and many other processes, including cytoskeleton organization, exocytosis, and tRNA modification. Here, we determined the crystal structure of the Elp4-6 subcomplex of yeast. The overall structure of Elp4-6 revealed that Elp6 acts as a bridge to assemble Elp4 and Elp5. Detailed structural and sequence analyses revealed that each subunit in the Elp4-6 subcomplex forms a RecA-ATPase-like fold, although it lacks the key sequence signature of ATPases. Site-directed mutagenesis and biochemical analyses indicated that the Elp4-6 subcomplex can assemble into a hexameric ring-shaped structure in vitro and in vivo. Furthermore, GST pulldown assays showed that the ring-shaped assembly of the Elp4-6 subcomplex is important for its specific histone H3 binding. Our results may shed light on the substrate recognition and assembly of the holo-Elongator complex.	[Shen, Yuequan; Long, Jiafu] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Lin, Zhijie; Zhao, Weijing; Diao, Wentao; Xie, Xingqiao; Wang, Zheng; Zhang, Jinxiu; Shen, Yuequan; Long, Jiafu] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Shen, YQ (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, 94 Weijin Rd, Tianjin 300071, Peoples R China.	yuequan74@yahoo.com; jflong@nankai.edu.cn	Shen, Yuequan/C-8950-2013; Long, Jiafu/B-7420-2012; Lin, Zhijie/Y-4836-2019	Shen, Yuequan/0000-0002-3775-0900; Long, Jiafu/0000-0002-6625-0147; 	973 Program [2009CB825504, 2012CB917201]; Natural Science Foundation of China [31100527, 31140029, 31170684]; Fundamental Research Funds for the Central Universities [65011621, 65020241]	973 Program(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the 973 Program (Grants 2009CB825504 and 2012CB917201), the Natural Science Foundation of China (Grants 31100527, 31140029, and 31170684), and the Fundamental Research Funds for the Central Universities (Grants 65011621 and 65020241).	Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Close P, 2006, MOL CELL, V22, P521, DOI 10.1016/j.molcel.2006.04.017; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Crolla JA, 2002, AM J HUM GENET, V71, P1138, DOI 10.1086/344396; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Fichtner L, 2002, MOL MICROBIOL, V45, P817, DOI 10.1046/j.1365-2958.2002.03055.x; Frohloff F, 2003, J BIOL CHEM, V278, P956, DOI 10.1074/jbc.M210060200; Glatt S, 2012, NAT STRUCT MOL BIOL, V19, P314, DOI 10.1038/nsmb.2234; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Kim JH, 2002, P NATL ACAD SCI USA, V99, P1241, DOI 10.1073/pnas.251672198; Kleinjan DA, 2002, MAMM GENOME, V13, P102, DOI 10.1007/s00335-001-3058-y; Krogan NJ, 2001, MOL CELL BIOL, V21, P8203, DOI 10.1128/MCB.21.23.8203-8212.2001; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Leipe DD, 2000, GENOME RES, V10, P5; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li Q, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000684; Li Y, 2001, J BIOL CHEM, V276, P29628, DOI 10.1074/jbc.C100274200; Nelissen H, 2010, P NATL ACAD SCI USA, V107, P1678, DOI 10.1073/pnas.0913559107; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Paraskevopoulou C, 2006, MOL MICROBIOL, V59, P795, DOI 10.1111/j.1365-2958.2005.04989.x; Petrakis TG, 2004, J BIOL CHEM, V279, P32087, DOI 10.1074/jbc.M403361200; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ponting CP, 2002, NUCLEIC ACIDS RES, V30, P3643, DOI 10.1093/nar/gkf498; Rahl PB, 2005, MOL CELL, V17, P841, DOI 10.1016/j.molcel.2005.02.018; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Selth LA, 2010, ANNU REV BIOCHEM, V79, P271, DOI 10.1146/annurev.biochem.78.062807.091425; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Simpson CL, 2009, HUM MOL GENET, V18, P472, DOI 10.1093/hmg/ddn375; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Solinger JA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000820; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; Strug LJ, 2009, EUR J HUM GENET, V17, P1171, DOI 10.1038/ejhg.2008.267; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Walker J, 2011, GENETICS, V187, P1067, DOI 10.1534/genetics.110.123893; Winkler GS, 2002, P NATL ACAD SCI USA, V99, P3517, DOI 10.1073/pnas.022042899; Winkler GS, 2001, J BIOL CHEM, V276, P32743, DOI 10.1074/jbc.M105303200; Wittschieben BO, 2000, EMBO J, V19, P3060, DOI 10.1093/emboj/19.12.3060; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; Zhang XH, 2011, MOL VIS, V17, P548; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	51	30	33	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21501	21508		10.1074/jbc.M112.341560	http://dx.doi.org/10.1074/jbc.M112.341560			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22556426	Green Published, hybrid			2022-12-25	WOS:000306416800067
J	Kerkhofs, J; Roberts, SJ; Luyten, FP; Van Oosterwyck, H; Geris, L				Kerkhofs, Johan; Roberts, Scott J.; Luyten, Frank P.; Van Oosterwyck, Hans; Geris, Liesbet			Relating the Chondrocyte Gene Network to Growth Plate Morphology: From Genes to Phenotype	PLOS ONE			English	Article							HORMONE-RELATED PEPTIDE; INDIAN HEDGEHOG; REGULATORY NETWORKS; PARATHYROID-HORMONE; SIGNALING PATHWAYS; BONE-DEVELOPMENT; DUAL ROLES; PTHRP; DIFFERENTIATION; CHONDROGENESIS	During endochondral ossification, chondrocyte growth and differentiation is controlled by many local signalling pathways. Due to crosstalks and feedback mechanisms, these interwoven pathways display a network like structure. In this study, a large-scale literature based logical model of the growth plate network was developed. The network is able to capture the different states (resting, proliferating and hypertrophic) that chondrocytes go through as they progress within the growth plate. In a first corroboration step, the effect of mutations in various signalling pathways of the growth plate network was investigated.	[Kerkhofs, Johan; Geris, Liesbet] Univ Liege, Biomech Res Unit, Liege, Belgium; [Kerkhofs, Johan; Van Oosterwyck, Hans] Katholieke Univ Leuven, Biomech Sect, Louvain, Belgium; [Kerkhofs, Johan; Roberts, Scott J.; Luyten, Frank P.; Van Oosterwyck, Hans; Geris, Liesbet] Katholieke Univ Leuven, Leuven R&D Div Skeletal Tissue Engn, Louvain, Belgium; [Roberts, Scott J.; Luyten, Frank P.] Katholieke Univ Leuven, Dept Rheumatol, Louvain, Belgium	University of Liege; KU Leuven; KU Leuven; KU Leuven	Kerkhofs, J (corresponding author), Univ Liege, Biomech Res Unit, Liege, Belgium.	liesbet.geris@ulg.ac.be	Van Oosterwyck, Hans/C-2528-2016; Luyten, Frank/GPS-7793-2022; geris, liesbet/D-2343-2016	Van Oosterwyck, Hans/0000-0002-2142-9717; geris, liesbet/0000-0002-8180-1445	University of Liege [FRS.D-10/20]	University of Liege(University of Liege)	This work was supported by the Special Research Fund of the University of Liege (FRS.D-10/20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SL, 2007, J CELL PHYSIOL, V213, P635, DOI 10.1002/jcp.21262; Akiyama H, 2008, MOD RHEUMATOL, V18, P213, DOI 10.1007/s10165-008-0048-x; Alvarez J, 2002, DEVELOPMENT, V129, P1913; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Brouwers JEM, 2006, J BIOMECH, V39, P2774, DOI 10.1016/j.jbiomech.2005.10.004; Burdan F, 2009, FOLIA HISTOCHEM CYTO, V47, P5, DOI 10.2478/v10042-009-0007-1; Chaouiya C, 2003, QUALITATIVE ANAL REG, P830; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Christensen C, 2007, IET SYST BIOL, V1, P61, DOI 10.1049/iet-syb:20060071; Darabos C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025110; Eichberger T, 2006, GENOMICS, V87, P616, DOI 10.1016/j.ygeno.2005.12.003; Enomoto-Iwamoto M, 2002, DEV BIOL, V251, P142, DOI 10.1006/dbio.2002.0802; Fasano A, 2010, J THEOR BIOL, V265, P543, DOI 10.1016/j.jtbi.2010.05.030; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Garzon-Alvarado DA, 2009, BIOMECH MODEL MECHAN, V8, P381, DOI 10.1007/s10237-008-0144-z; Garzon-Alvarado DA, 2009, COMPUT BIOL MED, V39, P554, DOI 10.1016/j.compbiomed.2009.03.012; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hartmann C, 2000, DEVELOPMENT, V127, P3141; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Hattori T, 2010, DEVELOPMENT, V137, P901, DOI 10.1242/dev.045203; Hecht J, 2007, GENE EXPR PATTERNS, V7, P102, DOI 10.1016/j.modgep.2006.05.014; HUBERMAN BA, 1993, P NATL ACAD SCI USA, V90, P7716, DOI 10.1073/pnas.90.16.7716; Hyman JM, 2009, P NATL ACAD SCI USA, V106, P14132, DOI 10.1073/pnas.0907134106; Jonason JH, 2009, J DENT RES, V88, P693, DOI 10.1177/0022034509341629; Klemm K, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.055101; Kobayashi T, 2002, DEVELOPMENT, V129, P2977; Komori T, 2003, J BONE MINER METAB, V21, P193, DOI 10.1007/s00774-002-0408-0; Kozhemyakina E, 2009, MOL CELL BIOL, V29, P5751, DOI 10.1128/MCB.00415-09; Koziel L, 2005, DEVELOPMENT, V132, P5249, DOI 10.1242/dev.02097; Kronenberg HM, 2006, ANN NY ACAD SCI, V1068, P1, DOI 10.1196/annals.1346.002; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; Lenas P, 2009, TISSUE ENG PART B-RE, V15, P395, DOI [10.1089/ten.teb.2009.0461, 10.1089/ten.TEB.2009.0461]; Lenas P, 2009, TISSUE ENG PART B-RE, V15, P381, DOI 10.1089/ten.TEB.2008.0575; Li TF, 2005, FRONT BIOSCI-LANDMRK, V10, P681, DOI 10.2741/1563; Liu ZH, 2002, GENE DEV, V16, P859, DOI 10.1101/gad.965602; Mak KK, 2008, DEVELOPMENT, V135, P1947, DOI 10.1242/dev.018044; Mau E, 2007, DEV BIOL, V305, P28, DOI 10.1016/j.ydbio.2007.01.031; Mendoza L, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-13; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; Naldi A, 2009, BIOSYSTEMS, V97, P134, DOI 10.1016/j.biosystems.2009.04.008; Naski MC, 1996, NAT GENET, V13, P233, DOI 10.1038/ng0696-233; Naski MC, 1998, DEVELOPMENT, V125, P4977; Nilsson O, 2007, J ENDOCRINOL, V193, P75, DOI 10.1677/joe.1.07099; Ogawa T, 2003, J BONE MINER METAB, V21, P145, DOI 10.1007/s007740300023; Oh CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010113; Oliveira SM, 2009, TISSUE ENG PT A, V15, P635, DOI 10.1089/ten.tea.2008.0052; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Ouyang ZQ, 2009, P NATL ACAD SCI USA, V106, P21521, DOI 10.1073/pnas.0904863106; Plahte E, 1998, J MATH BIOL, V36, P321, DOI 10.1007/s002850050103; Pogue R, 2006, CURR TOP DEV BIOL, V76, P1, DOI 10.1016/S0070-2153(06)76001-X; Retting KN, 2009, DEVELOPMENT, V136, P1093, DOI 10.1242/dev.029926; Riemer S, 2002, J CELL BIOCHEM, V86, P688, DOI 10.1002/jcb.10260; Schipani E, 1996, NEW ENGL J MED, V335, P708, DOI 10.1056/NEJM199609053351004; Schlatter R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000595; Schlitt T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S9; Segre G, 1997, J BONE MINER METAB, V15, P109; Seshadhri C, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.108701; Shum L, 2002, ARTHRITIS RES, V4, P94, DOI 10.1186/ar396; Solomon Lauren A., 2008, Birth Defects Research, V84, P123, DOI 10.1002/bdrc.20124; Susperregui ARG, 2008, J CELL PHYSIOL, V216, P144, DOI 10.1002/jcp.21389; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; van Donkelaar CC, 2007, BIOMECH MODEL MECHAN, V6, P55, DOI 10.1007/s10237-006-0035-0; Verdicchio MP, 2011, BIOCOMPUT-PAC SYM, P350; Vortkamp A, 1998, MECH DEVELOP, V71, P65, DOI 10.1016/S0925-4773(97)00203-7; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wang L, 2010, J BONE MINER RES, V25, P1138, DOI 10.1002/jbmr.5; Weir EC, 1996, P NATL ACAD SCI USA, V93, P10240, DOI 10.1073/pnas.93.19.10240; Wessels L F, 2001, Pac Symp Biocomput, P508; Wuelling M, 2010, PEDIATR NEPHROL, V25, P625, DOI 10.1007/s00467-009-1368-6; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	74	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e34729	10.1371/journal.pone.0034729	http://dx.doi.org/10.1371/journal.pone.0034729			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558096	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340200006
J	Min, J; Lukowski, ZL; Levine, MA; Meyers, CA; Beattie, AR; Schultz, GS; Samuelson, DA; Sherwood, MB				Min, Jeff; Lukowski, Zachary L.; Levine, Monica A.; Meyers, Craig A.; Beattie, Ashley R.; Schultz, Gregory S.; Samuelson, Don A.; Sherwood, Mark B.			Prevention of Ocular Scarring Post Glaucoma Filtration Surgery Using the Inflammatory Cell and Platelet Binding Modulator Saratin in a Rabbit Model	PLOS ONE			English	Article							TENONS CAPSULE FIBROBLASTS; MITOMYCIN-C; INTRAOPERATIVE 5-FLUOROURACIL; GROWTH-FACTORS; COLLAGEN; TRABECULECTOMY; INHIBITOR; ACTIVATION	Clinical Relevance: Late complications can occur with use of current antimetabolites to prevent scarring following glaucoma filtration surgery (GFS). Safer, more targeted, anti-fibrosis agents are sought. Objectives: The protein saratin has been shown to exhibit anti-fibrotic and anti-thrombotic properties in response to injury, but had not been used for glaucoma surgery. The goal of this study was to compare the efficacy of saratin with that of the widely accepted mitomycin-C (MMC) in prolonging bleb survival following GFS in the rabbit model. Two saratin delivery routes were compared; a single intraoperative topical application versus a combination of intraoperative topical application with two additional postoperative injections. Methods: Twenty-four New Zealand White rabbits underwent GFS and received either intraoperative topical saratin, intraoperative topical saratin plus two injections on post-operative days 4 and 8, balanced saline solution (BSS), or MMC. The bleb tissues and their elevation durations were compared based on clinical and histological findings. Results: Rabbits receiving topical+injections of saratin had a mean bleb survival of 33.6 +/- 8.5 days, significantly higher than the negative BSS controls, which averaged 17.4 +/- 6.0 days (p = 0.018). No improvement over BSS was seen for rabbits receiving topical saratin only (15.5 +/- 4.8 days, p = 0.749). Rabbits receiving saratin did not develop bleb avascularity and thinning associated with MMC treatment and there were no apparent clinical signs of toxicity. Conclusions: Treatment with a single intraoperative topical application plus two additional postoperative injections significantly prolonged bleb elevation comparable to MMC, but without toxicity; however, topical application alone was ineffective.	[Min, Jeff; Lukowski, Zachary L.; Levine, Monica A.; Meyers, Craig A.; Beattie, Ashley R.; Sherwood, Mark B.] Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA; [Schultz, Gregory S.] Univ Florida, Coll Med, Dept Ob Gyn, Gainesville, FL USA; [Schultz, Gregory S.] Univ Florida, Coll Med, Inst Wound Healing, Gainesville, FL USA; [Samuelson, Don A.] Univ Florida, Coll Vet Med, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Min, J (corresponding author), Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA.	Sherwood@ufl.edu	Samuelson, Don/GXA-0970-2022	Min, Jeff/0000-0003-4633-6792	Biovasc Incorporated [00067832]; Research to Prevent Blindness [00068545]; NATIONAL EYE INSTITUTE [P30EY021721] Funding Source: NIH RePORTER	Biovasc Incorporated; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Biovasc Incorporated supplied the protein Saratin used in the study as well as funding for the research with Award # 00067832 (http://www.biovascularinc.com/saratin.html). Research to Prevent Blindness also provided grant support for the study on project # 00068545 (www.rpbusa.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank BioVasc Incorporated for supplying the protein saratin used in the study as well as funding for the research. We also extend thanks to the Research to Prevent Blindness for their generous grant.	Anand N, 2006, BRIT J OPHTHALMOL, V90, P175, DOI 10.1136/bjo.2005.077800; Barnes CS, 2001, SEMIN THROMB HEMOST, V27, P337, DOI 10.1055/s-2001-16887; Beckers HJM, 2003, GRAEF ARCH CLIN EXP, V241, P106, DOI 10.1007/s00417-002-0621-5; Bindlish R, 2002, OPHTHALMOLOGY, V109, P1336, DOI 10.1016/S0161-6420(02)01069-2; Bonnefoy A, 2006, J THROMB HAEMOST, V4, P2151, DOI 10.1111/j.1538-7836.2006.02111.x; Burr J., 2005, COCHRANE DB SYST REV, V18; Connon CJ, 2003, WOUND REPAIR REGEN, V11, P71, DOI 10.1046/j.1524-475X.2003.11111.x; Cordeiro MF, 1997, INVEST OPHTH VIS SCI, V38, P1639; Davis JA, 2004, AM J SURG, V188, P778, DOI 10.1016/j.amjsurg.2004.08.061; DeBry PW, 2002, ARCH OPHTHALMOL-CHIC, V120, P297; Denk PO, 2003, CURR EYE RES, V27, P35, DOI 10.1076/ceyr.27.2.35.15456; DOYLE JW, 1993, INVEST OPHTH VIS SCI, V34, P3313; Dugrillon A, 2002, INT J ORAL MAX SURG, V31, P615, DOI 10.1054/ijom.2002.0322; Francis BA, 2005, ARCH OPHTHALMOL-CHIC, V123, P166, DOI 10.1001/archopht.123.2.166; Gehring S, 1999, TRANSFUSION, V39, P144, DOI 10.1046/j.1537-2995.1999.39299154727.x; Glidden PF, 2010, Patent, Patent No. [US7691839B2, 7691839]; Gronwald W, 2008, J MOL BIOL, V381, P913, DOI 10.1016/j.jmb.2008.06.034; KHAW PT, 1993, OPHTHALMOLOGY, V100, P367; KHAW PT, 1994, EYE, V8, P188, DOI 10.1038/eye.1994.44; Knorr M, 1997, GRAEF ARCH CLIN EXP, V235, P667, DOI 10.1007/BF00946945; Li ZQ, 2009, INVEST OPHTH VIS SCI, V50, P5217, DOI 10.1167/iovs.08-2662; Meyer-Ter-Vehn T, 2008, INVEST OPHTH VIS SCI, V49, P3955, DOI 10.1167/iovs.07-1610; Muckley ED, 2004, OPTOMETRY VISION SCI, V81, P499, DOI 10.1097/00006324-200407000-00010; SCHULTZ G, 1994, EYE, V8, P184, DOI 10.1038/eye.1994.43; Sherwood MB, 2004, J GLAUCOMA, V13, P407, DOI 10.1097/01.ijg.0000131482.86547.5a; Smith Todd P, 2003, Vasc Endovascular Surg, V37, P259, DOI 10.1177/153857440303700405; Vilahur G, 2004, THROMB HAEMOSTASIS, V92, P191, DOI 10.1160/TH03-11-0687; White TC, 2007, FEBS J, V274, P1481, DOI 10.1111/j.1742-4658.2007.05689.x; Xiao YQ, 2009, INVEST OPHTH VIS SCI, V50, P1698, DOI 10.1167/iovs.08-1675	29	22	23	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35627	10.1371/journal.pone.0035627	http://dx.doi.org/10.1371/journal.pone.0035627			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558182	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340200021
J	Boys, CA; Rowland, SJ; Gabor, M; Gabor, L; Marsh, IB; Hum, S; Callinan, RB				Boys, Craig A.; Rowland, Stuart J.; Gabor, Melinda; Gabor, Les; Marsh, Ian B.; Hum, Steven; Callinan, Richard B.			Emergence of Epizootic Ulcerative Syndrome in Native Fish of the Murray-Darling River System, Australia: Hosts, Distribution and Possible Vectors	PLOS ONE			English	Article							RED SPOT DISEASE; FRESH-WATER FISH; MUGIL-CEPHALUS L; SYNDROME EUS; APHANOMYCES-INVADANS; MYXOBOLUS-CEREBRALIS; CHANNEL CATFISH; SEA MULLET; ESTUARINE; HISTOPATHOLOGY	Epizootic ulcerative syndrome (EUS) is a fish disease of international significance and reportable to the Office International des Epizootics. In June 2010, bony herring Nematalosa erebi, golden perch Macquaria ambigua, Murray cod Maccullochella peelii and spangled perch Leiopotherapon unicolor with severe ulcers were sampled from the Murray-Darling River System (MDRS) between Bourke and Brewarrina, New South Wales Australia. Histopathology and polymerase chain reaction identified the fungus-like oomycete Aphanomyces invadans, the causative agent of EUS. Apart from one previous record in N. erebi, EUS has been recorded in the wild only from coastal drainages in Australia. This study is the first published account of A. invadans in the wild fish populations of the MDRS, and is the first confirmed record of EUS in M. ambigua, M. peelii and L. unicolor. Ulcerated carp Cyprinus carpio collected at the time of the same epizootic were not found to be infected by EUS, supporting previous accounts of resistance against the disease by this species. The lack of previous clinical evidence, the large number of new hosts (n = 3), the geographic extent (200 km) of this epizootic, the severity of ulceration and apparent high pathogenicity suggest a relatively recent invasion by A. invadans. The epizootic and associated environmental factors are documented and discussed within the context of possible vectors for its entry into the MDRS and recommendations regarding continued surveillance, research and biosecurity are made.	[Boys, Craig A.] New S Wales Dept Primary Ind, Port Stephens Fisheries Inst, Nelson Bay, NSW, Australia; [Rowland, Stuart J.] New S Wales Dept Primary Ind, Grafton Fisheries Ctr, Grafton, NSW, Australia; [Gabor, Melinda; Gabor, Les; Marsh, Ian B.; Hum, Steven] NSW Dept Primary Ind, State Vet Diagnost Lab, Elizabeth Macarthur Agr Inst, Narellan, NSW, Australia; [Callinan, Richard B.] Univ Sydney, Fac Vet Sci, Camden, NSW, Australia	NSW Department of Primary Industries; NSW Department of Primary Industries; NSW Department of Primary Industries; University of Sydney	Boys, CA (corresponding author), New S Wales Dept Primary Ind, Port Stephens Fisheries Inst, Nelson Bay, NSW, Australia.	craig.boys@dpi.nsw.gov.au	Boys, Craig/AAW-8829-2021		Native Fish Strategy Program of the Murray-Darling Basin Authority	Native Fish Strategy Program of the Murray-Darling Basin Authority	Fish were collected during routine sampling carried out as part of the Bourke to Brewarrina Demonstration Reach Project, funded under the Native Fish Strategy Program of the Murray-Darling Basin Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFFA, 2000, AQUAVETPLAN AGR FISH; Ahmed G.U., 1999, Asian Fisheries Science, V12, P381; AHMED M, 1995, J FISH DIS, V18, P263, DOI 10.1111/j.1365-2761.1995.tb00301.x; ANZECC, 2000, AUSTR NZ GUID FRESH, V1; Blazer VS, 1999, J AQUAT ANIM HEALTH, V11, P340, DOI 10.1577/1548-8667(1999)011&lt;0340:AAACOU&gt;2.0.CO;2; Blazer VS, 2002, J AQUAT ANIM HEALTH, V14, P1, DOI 10.1577/1548-8667(2002)014&lt;0001:AIIAMA&gt;2.0.CO;2; Bly J.E., 1992, Fish & Shellfish Immunology, V2, P159, DOI 10.1016/S1050-4648(05)80056-7; Bondad-Reantaso, 2005, DIS ASIAN AQUACULTUR, VV, P555; Bowling LC, 1996, MAR FRESHWATER RES, V47, P643, DOI 10.1071/MF9960643; Brown GG, 1978, MICROORGANISMS FUNGI; Buller N, 2007, FURTHER RES LAB TRIA; Buller N, 2004, MOL DIAGNOSTIC TESTS; Callinan R, 1999, OUTBREAKS EPIZOOTIC; CALLINAN R. B., 1988, POSTGRAD COMM VET SC, V106, P459; Callinan RB, 2005, DIS AQUAT ORGAN, V63, P247, DOI 10.3354/dao063247; CALLINAN RB, 1989, J FISH DIS, V12, P467, DOI 10.1111/j.1365-2761.1989.tb00558.x; CALLINAN RB, 1995, DIS AQUAT ORGAN, V21, P233, DOI 10.3354/dao021233; CALLINAN RB, 1995, SILVER PERCH CULTURE, P67; Callinan RB, 1997, FIND MISS PAK 9 19 M; Charalambidou I, 2005, WETLANDS, V25, P252, DOI 10.1672/2; CHINABUT S, 1995, J FISH DIS, V18, P41, DOI 10.1111/j.1365-2761.1995.tb01264.x; Choongo K, 2009, B ENVIRON CONTAM TOX, V83, P474, DOI 10.1007/s00128-009-9799-0; Egusa S., 1971, FISH PATHOL, V6, P41; FRASER GC, 1992, J FISH DIS, V15, P173, DOI 10.1111/j.1365-2761.1992.tb00651.x; Gates KK, 2008, N AM J FISH MANAGE, V28, P1453, DOI 10.1577/M08-025.1; Hall KC, 2006, SCI TOTAL ENVIRON, V370, P235, DOI 10.1016/j.scitotenv.2006.07.019; HATAI K, 1977, Fish Pathology, V12, P129; Hawke JP, 2003, J AQUAT ANIM HEALTH, V15, P120, DOI 10.1577/H02-039; Hopley D, 2008, SCIENCE, V57, P1359; Hrubec TC, 1996, VET IMMUNOL IMMUNOP, V50, P157, DOI 10.1016/0165-2427(95)05491-X; Ingram BA, 2005, RES REPORT SERIES; Johnson LE, 2001, ECOL APPL, V11, P1789, DOI 10.1890/1051-0761(2001)011[1789:ODOAIS]2.0.CO;2; Johnson PTJ, 2011, FRESHWATER BIOL, V56, P638, DOI 10.1111/j.1365-2427.2010.02546.x; Khan M.H., 1998, Bulletin of the European Association of Fish Pathologists, V18, P192; Koel TM, 2010, T AM FISH SOC, V139, P976, DOI 10.1577/T09-051.1; Lilley JH, 1997, VET REC, V140, P653, DOI 10.1136/vr.140.25.653; Lilley JH, 1997, J FISH DIS, V20, P135, DOI 10.1046/j.1365-2761.1997.d01-116.x; Lilley JH., 1998, EPIZOOTIC ULCERATIVE; MCKENZIE RA, 1976, AUST VET J, V52, P230, DOI 10.1111/j.1751-0813.1976.tb00076.x; MEYERS TU, 1970, NATURE, V227, P622, DOI 10.1038/227622b0; OIE, 2003, MAN DIAGN TESTS AQ A; Paperna I., 1991, Annual Review of Fish Diseases, V1, P155, DOI 10.1016/0959-8030(91)90028-I; Pathiratne A, 2001, J APPL ICHTHYOL, V17, P30, DOI 10.1046/j.1439-0426.2001.00235.x; Pradhan P.K., 2008, DIS ASIAN AQUACULTUR, P105; PUCKRIDGE JT, 1989, J FISH DIS, V12, P205, DOI 10.1111/j.1365-2761.1989.tb00305.x; Quiniou SMA, 1998, FISH SHELLFISH IMMUN, V8, P1, DOI 10.1006/fsim.1997.0115; ROBERTS RJ, 1993, J FISH DIS, V16, P169, DOI 10.1111/j.1365-2761.1993.tb01248.x; RODGERS LJ, 1981, J FISH DIS, V4, P297, DOI 10.1111/j.1365-2761.1981.tb01137.x; Rowland S. J., 2004, HATCHERY QUALITY ASS; Rowland SJ, 2007, NSW DEP PRIMARY IND; ROWLAND SJ, 1995, ASIAN FISH SCI, V8, P73; Sammut J, 1996, MAR FRESHWATER RES, V47, P669, DOI 10.1071/MF9960669; Sammut J, 1995, AUSTR GEOGRAPHICAL S, V33, P89, DOI DOI 10.1111/J.1467-8470.1995.TB00687.X; SANAULLAH M., 2001, ASIAN FISH SCI, V14, P301; Saylor RK, 2010, DIS AQUAT ORGAN, V88, P169, DOI 10.3354/dao02158; Sosa ER, 2007, J AQUAT ANIM HEALTH, V19, P14, DOI 10.1577/H06-012.1; Taylor Peter W., 1992, Journal of Aquatic Animal Health, V4, P240, DOI 10.1577/1548-8667(1992)004&lt;0240:FEBAPV&gt;2.3.CO;2; Van West Pieter, 2006, Mycologist, V20, P99, DOI 10.1016/j.mycol.2006.06.004; VIRGONA JL, 1992, J FISH DIS, V15, P363, DOI 10.1111/j.1365-2761.1992.tb01236.x; Vishwanath TS, 1998, AQUACULTURE, V165, P1, DOI 10.1016/S0044-8486(98)00227-0; Wedemeyer G.A., 1996, PHYSL FISH INTENSIVE; Willumsen B, 1998, J FISH DIS, V12, P275	62	31	34	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35568	10.1371/journal.pone.0035568	http://dx.doi.org/10.1371/journal.pone.0035568			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558170	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345200049
J	Montalvo, C; Villar, AV; Merino, D; Garcia, R; Ares, M; Llano, M; Cobo, M; Hurle, MA; Nistal, JF				Montalvo, Cecilia; Villar, Ana V.; Merino, David; Garcia, Raquel; Ares, Miguel; Llano, Miguel; Cobo, Manuel; Hurle, Maria A.; Nistal, J. Francisco			Androgens Contribute to Sex Differences in Myocardial Remodeling under Pressure Overload by a Mechanism Involving TGF-beta	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; RENIN-ANGIOTENSIN SYSTEM; GENDER-DIFFERENCES; CARDIAC-HYPERTROPHY; HEART-FAILURE; EXPRESSION; FIBROSIS; MICE; TGF-BETA-1; GROWTH	Background: In clinical studies, myocardial remodeling in aortic valve stenosis appears to be more favorable in women than in men, even after menopause. In the present study, we assessed whether circulating androgens contribute to a less favorable myocardial remodeling under pressure overload in males. We examined sex-related differences in one-year-old male and female mice. Whereas male mice at this age exhibited circulating androgen levels within the normal range for young adults, the circulating estrogens in females were reduced. The contribution of gonadal androgens to cardiac remodeling was analyzed in a group of same-age castrated mice. Methodology/Principal Findings: Animals were subjected to transverse aortic constriction (TAC). Echocardiography was performed 2 weeks after TAC and myocardial mRNA levels of TGF-beta s, Smads 2 and 3, collagens, fibronectin, beta-myosin heavy chain and a-myosin heavy chain were determined by q-PCR. Protein detection of p-SMAD2/3 was performed by Western Blot. Histological staining of fibrosis was performed with picrosirius red and Masson's trichrome. Compared with females, males developed more severe tissue fibrosis, LV dilation and hemodynamic dysfunction. TAC-males showed higher myocardial expression levels of TGF-beta s and the treatment with a neutralizing antibody to TGF-beta prevented myocardial fibrosis development. Orchiectomy diminished TAC-induced up-regulation of TGF-beta s and TGF-beta target genes, and it also reduced fibrosis and hemodynamic dysfunction. The capability of androgens to induce TGF-beta expression was confirmed in NIH-3T3 fibroblasts and H9C2 cardiomyocytes exposed to dihydrotestosterone. Conclusions/Significance: Our results indicate that circulating androgens are responsible for the detrimental effects in the myocardium of older male mice subjected to pressure overload through a mechanism involving TGF-beta s.	[Montalvo, Cecilia; Villar, Ana V.; Merino, David; Hurle, Maria A.] Univ Cantabria, Fac Med, Dept Fisiol & Farmacol, E-39005 Santander, Spain; [Garcia, Raquel; Nistal, J. Francisco] Hosp Univ Marques Valdecilla, Serv Cirugia Cardiovasc, Santander, Spain; [Ares, Miguel] Hosp Comarcal Laredo, Cantabria, Spain; [Llano, Miguel; Cobo, Manuel] Hosp Univ Marque Valdecilla, Serv Cardiol, Santander, Spain; [Montalvo, Cecilia; Villar, Ana V.; Merino, David; Garcia, Raquel; Ares, Miguel; Llano, Miguel; Cobo, Manuel; Hurle, Maria A.; Nistal, J. Francisco] IFIMAV, Santander, Spain	Universidad de Cantabria; Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV)	Montalvo, C (corresponding author), Univ Cantabria, Fac Med, Dept Fisiol & Farmacol, E-39005 Santander, Spain.	hurlem@unican.es	Villar, Ana/I-5190-2015; Garcia, Raquel/Z-2467-2019	Villar, Ana/0000-0003-4588-9598; Hurle, Maria Amor/0000-0002-7710-1358; Garcia, Raquel/0000-0002-1621-5474	Instituto de Salud Carlos III [PS09/01097]; Fundacion Marques de Valdecilla-Universidad de Cantabria [FMV-UC 09/01]; Instituto de Formacion e Investigacion Marques de Valdecilla [FMV-API 10/20]; Ministerio de Ciencia e Innovacion [SAF2010-16894]; Comunidad Autonoma de Cantabria	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Marques de Valdecilla-Universidad de Cantabria; Instituto de Formacion e Investigacion Marques de Valdecilla; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad Autonoma de Cantabria	This work was supported by Instituto de Salud Carlos III (PS09/01097); Fundacion Marques de Valdecilla-Universidad de Cantabria (FMV-UC 09/01); Instituto de Formacion e Investigacion Marques de Valdecilla (FMV-API 10/20); and Ministerio de Ciencia e Innovacion (SAF2010-16894). Dr. Nistal is in the Scientist Stabilization and Research Activity Intensification Program of the National Health System, funded by the Instituto de Salud Carlos III and Comunidad Autonoma de Cantabria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antus B, 2001, KIDNEY INT, V60, P1955, DOI 10.1046/j.1523-1755.2001.00007.x; AURIGEMMA GP, 1995, CARDIOLOGY, V86, P310, DOI 10.1159/000176895; Baggish AL, 2010, CIRC-HEART FAIL, V3, P472, DOI 10.1161/CIRCHEARTFAILURE.109.931063; CARROLL JD, 1992, CIRCULATION, V86, P1099, DOI 10.1161/01.CIR.86.4.1099; Cavasin MA, 2006, AM J PHYSIOL-HEART C, V290, pH2043, DOI 10.1152/ajpheart.01121.2005; DESIMONE G, 1995, HYPERTENSION, V26, P979, DOI 10.1161/01.HYP.26.6.979; Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033; Donaldson C, 2009, CIRC RES, V104, P265, DOI 10.1161/CIRCRESAHA.108.190397; Fanton L, 2009, EXP TOXICOL PATHOL, V61, P317, DOI 10.1016/j.etp.2008.09.007; Fielitz J, 2001, J AM COLL CARDIOL, V37, P1443, DOI 10.1016/S0735-1097(01)01170-6; Gao XM, 2003, ENDOCRINOLOGY, V144, P4097, DOI 10.1210/en.2002-0214; Gonzalez A, 2010, HYPERTENSION, V55, P1418, DOI 10.1161/HYPERTENSIONAHA.109.149112; Gupta MP, 2007, J MOL CELL CARDIOL, V43, P388, DOI 10.1016/j.yjmcc.2007.07.045; Hein S, 2003, CIRCULATION, V107, P984, DOI 10.1161/01.CIR.0000051865.66123.B7; Henein MY, 1999, HEART, V81, P229, DOI 10.1136/hrt.81.3.229; Heymans S, 2005, CIRCULATION, V112, P1136, DOI 10.1161/CIRCULATIONAHA.104.516963; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Hu P, 2003, AM J PHYSIOL-HEART C, V285, pH1261, DOI 10.1152/ajpheart.00108.2003; Hung CL, 2010, J AM COLL CARDIOL, V56, P1812, DOI 10.1016/j.jacc.2010.06.044; Ikeda Y, 2005, J BIOL CHEM, V280, P29661, DOI 10.1074/jbc.M411694200; Inui S, 2002, FASEB J, V16, P1967, DOI 10.1096/fj.02-0043fje; KASPERK C, 1990, J CLIN ENDOCR METAB, V71, P1322, DOI 10.1210/jcem-71-5-1322; Li YH, 2004, ENDOCRINOLOGY, V145, P951, DOI 10.1210/en.2003-0816; Maclver DH, 2008, HEART, V94, P446, DOI 10.1136/hrt.2006.114082; Malkin CJ, 2003, J ENDOCRINOL, V178, P373, DOI 10.1677/joe.0.1780373; Marwick TH, 2004, CURR OPIN CARDIOL, V19, P442, DOI 10.1097/01.hco.0000131535.32657.87; Montisci R, 2010, J AM SOC ECHOCARDIOG, V23, P516, DOI 10.1016/j.echo.2010.03.005; Moreo A, 2009, CIRC-CARDIOVASC IMAG, V2, P437, DOI 10.1161/CIRCIMAGING.108.838367; Otto CM, 1999, NEW ENGL J MED, V341, P142, DOI 10.1056/NEJM199907153410302; Pandya K, 2006, P NATL ACAD SCI USA, V103, P16864, DOI 10.1073/pnas.0607700103; Parker MW, 2010, CIRC-HEART FAIL, V3, P470, DOI 10.1161/CIRCHEARTFAILURE.110.957720; Piro M, 2010, J AM COLL CARDIOL, V55, P1057, DOI 10.1016/j.jacc.2009.09.065; Qi W, 2008, BIOCHEM J, V416, P453, DOI 10.1042/BJ20080651; Regitz-Zagrosek V, 2007, PROG CARDIOVASC DIS, V49, P241, DOI 10.1016/j.pcad.2006.08.011; Regitz-Zagrosek V, 2010, CIRC J, V74, P1265, DOI 10.1253/circj.CJ-10-0196; Rocha FL, 2007, AM J PHYSIOL-HEART C, V293, pH3575, DOI 10.1152/ajpheart.01251.2006; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Rosenkranz S, 2002, AM J PHYSIOL-HEART C, V283, pH1253, DOI 10.1152/ajpheart.00578.2001; Schultz JEJ, 2002, J CLIN INVEST, V109, P787, DOI 10.1172/JCI200214190; Skavdahl M, 2005, AM J PHYSIOL-HEART C, V288, pH469, DOI 10.1152/ajpheart.00723.2004; Vaneckova I, 2011, KIDNEY BLOOD PRESS R, V34, P46, DOI 10.1159/000322618; Villar AV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008476; Villar AV, 2009, J MOL CELL CARDIOL, V46, P526, DOI 10.1016/j.yjmcc.2008.12.024; VILLARI B, 1995, EUR HEART J, V16, P1410, DOI 10.1093/oxfordjournals.eurheartj.a060749; Vinereanu D, 2005, EUR J HEART FAIL, V7, P820, DOI 10.1016/j.ejheart.2005.02.003; Weidemann F, 2009, CIRCULATION, V120, P577, DOI 10.1161/CIRCULATIONAHA.108.847772; Weinberg EO, 1999, J AM COLL CARDIOL, V34, P264, DOI 10.1016/S0735-1097(99)00165-5; Witt H, 2008, J MOL MED, V86, P1013, DOI 10.1007/s00109-008-0385-4; Wu JC, 2003, J AM SOC ECHOCARDIOG, V16, P1158, DOI 10.1067/S0894-7317(03)00648-5; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613	50	33	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35635	10.1371/journal.pone.0035635	http://dx.doi.org/10.1371/journal.pone.0035635			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558184	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345200057
J	Tang, ZQ; Lu, Y				Tang, Zheng-Quan; Lu, Yong			Development of GPCR Modulation of GABAergic Transmission in Chicken Nucleus Laminaris Neurons	PLOS ONE			English	Article							SUPERIOR OLIVARY NUCLEUS; STEM AUDITORY NUCLEI; METABOTROPIC GLUTAMATE RECEPTORS; AVIAN COCHLEAR NUCLEUS; COINCIDENCE DETECTION; SYNAPTIC-TRANSMISSION; GABA(B) RECEPTORS; PATCH-CLAMP; MAGNOCELLULARIS; SPILLOVER	Neurons in the nucleus laminaris (NL) of birds act as coincidence detectors and encode interaural time difference to localize the sound source in the azimuth plane. GABAergic transmission in a number of CNS nuclei including the NL is subject to a dual modulation by presynaptic GABA(B) receptors (GABA(B)Rs) and metabotropic glutamate receptors (mGluRs). Here, using in vitro whole-cell patch clamp recordings from acute brain slices of the chick, we characterized the following important but unknown properties pertaining to such a dual modulation: (1) emergence of functional GABA synapses in NL neurons; (2) the temporal onset of neuromodulation mediated by GABA(B)Rs and mGluRs; and (3) the physiological conditions under which GABA(B)Rs and mGluRs are activated by endogenous transmitters. We found that (1) GABA(A)R-mediated synaptic responses were observed in about half of the neurons at embryonic day 11 (E11); (2) GABA(B)R-mediated modulation of the GABAergic transmission was detectable at E11, whereas the modulation by mGluRs did not emerge until E15; and (3) endogenous activity of GABA(B)Rs was induced by both low- (5 or 10 Hz) and high-frequency (200 Hz) stimulation of the GABAergic pathway, whereas endogenous activity of mGluRs was induced by high- (200 Hz) but not low-frequency (5 or 10 Hz) stimulation of the glutamatergic pathway. Furthermore, the endogenous activity of mGluRs was mediated by group II but not group III members. Therefore, autoreceptor-mediated modulation of GABAergic transmission emerges at the same time when the GABA synapses become functional. Heteroreceptor-mediated modulation appears at a later time and is receptor type dependent in vitro.	[Tang, Zheng-Quan; Lu, Yong] NE Ohio Med Univ, Coll Med, Dept Anat & Neurobiol, Rootstown, OH USA	Northeast Ohio Medical University (NEOMED)	Tang, ZQ (corresponding author), NE Ohio Med Univ, Coll Med, Dept Anat & Neurobiol, Rootstown, OH USA.	ylu@neomed.edu			National Institute on Deafness and other Communication Disorders (NIDCD) [R01 DC008984]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008984] Funding Source: NIH RePORTER	National Institute on Deafness and other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institute on Deafness and other Communication Disorders (NIDCD) Grant R01 DC008984 (YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Bellone C, 2008, CELL MOL LIFE SCI, V65, P2913, DOI 10.1007/s00018-008-8263-3; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Burger RM, 2005, J COMP NEUROL, V481, P6, DOI 10.1002/cne.20334; Cartmell J, 2000, J NEUROCHEM, V75, P889, DOI 10.1046/j.1471-4159.2000.0750889.x; Chalifoux JR, 2011, CURR OPIN NEUROBIOL, V21, P339, DOI 10.1016/j.conb.2011.02.004; CODE RA, 1989, J COMP NEUROL, V284, P504, DOI 10.1002/cne.902840403; de Jong APH, 2009, CURR OPIN NEUROBIOL, V19, P245, DOI 10.1016/j.conb.2009.06.005; Drew GM, 2008, J NEUROSCI, V28, P808, DOI 10.1523/JNEUROSCI.4876-07.2008; Fujino K, 2003, P NATL ACAD SCI USA, V100, P265, DOI 10.1073/pnas.0135345100; Fukui I, 2006, J NEUROPHYSIOL, V96, P633, DOI 10.1152/jn.00916.2005; Galvan A, 2006, NEUROSCIENCE, V143, P351, DOI 10.1016/j.neuroscience.2006.09.019; Gao H, 2008, NEUROSCIENCE, V153, P131, DOI 10.1016/j.neuroscience.2008.01.059; Gladding CM, 2009, PHARMACOL REV, V61, P395, DOI 10.1124/pr.109.001735; Hendricks SJ, 2006, J COMP NEUROL, V498, P433, DOI 10.1002/cne.21031; Hyson RL, 2005, PHYSIOL BEHAV, V86, P297, DOI 10.1016/j.physbeh.2005.08.003; Korn MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027383; Kullmann DM, 2000, PROG BRAIN RES, V125, P339; LACHICA EA, 1994, J COMP NEUROL, V348, P403, DOI 10.1002/cne.903480307; LANZA M, 1993, EUR J PHARMACOL, V237, P191, DOI 10.1016/0014-2999(93)90268-M; LIPPE WR, 1994, J NEUROSCI, V14, P1486, DOI 10.1523/JNEUROSCI.14-03-01486.1994; Lu Y, 2005, J NEUROPHYSIOL, V93, P1429, DOI 10.1152/jn.00786.2004; Lu Y, 2007, J NEUROPHYSIOL, V97, P1018, DOI 10.1152/jn.00883.2006; Luo B, 2011, HEARING RES, V280, P157, DOI 10.1016/j.heares.2011.05.018; Mitchell SJ, 2000, NATURE, V404, P498, DOI 10.1038/35006649; Nicoletti E, 2011, NEUROPHARMACOLOGY, V60, P1017, DOI 10.1016/j.neuropharm.2010.10.022; Nishino E, 2008, J NEUROSCI, V28, P7153, DOI 10.1523/JNEUROSCI.4398-07.2008; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Okubo Y, 2011, J PHYSIOL-LONDON, V589, P481, DOI 10.1113/jphysiol.2010.199539; Panatier A, 2004, NEUROPHARMACOLOGY, V47, P333, DOI 10.1016/j.neuropharm.2004.05.003; PARKS TN, 1983, J COMP NEUROL, V214, P32, DOI 10.1002/cne.902140104; PARKS TN, 1981, J COMP NEUROL, V203, P425, DOI 10.1002/cne.902030307; Pinheiro PS, 2008, NAT REV NEUROSCI, V9, P423, DOI 10.1038/nrn2379; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Ryugo DK, 2003, BRAIN RES BULL, V60, P435, DOI 10.1016/S0361-9230(03)00049-2; Sanchez JT, 2010, J NEUROPHYSIOL, V104, P1774, DOI 10.1152/jn.00468.2010; Sanes DH, 1998, J NEUROPHYSIOL, V80, P209, DOI 10.1152/jn.1998.80.1.209; SAUNDERS JC, 1973, BRAIN RES, V63, P59, DOI 10.1016/0006-8993(73)90076-0; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; SMITH DJ, 1979, J COMP NEUROL, V186, P213, DOI 10.1002/cne.901860207; SMITH ZDJ, 1981, J COMP NEUROL, V203, P309, DOI 10.1002/cne.902030302; Stephens GJ, 2009, TRENDS PHARMACOL SCI, V30, P421, DOI 10.1016/j.tips.2009.05.008; Tabor KM, 2011, J COMP NEUROL, V519, P358, DOI 10.1002/cne.22523; Tang ZQ, 2011, J NEUROSCI, V31, P6121, DOI 10.1523/JNEUROSCI.4733-10.2011; Tang ZQ, 2009, J NEUROPHYSIOL, V102, P1672, DOI 10.1152/jn.00419.2009; Toms NJ, 1996, BRIT J PHARMACOL, V119, P851, DOI 10.1111/j.1476-5381.1996.tb15750.x; Tsukada S, 2005, NEUROPHARMACOLOGY, V48, P479, DOI 10.1016/j.neuropharm.2004.11.006; Ulrich D, 2007, CURR OPIN NEUROBIOL, V17, P298, DOI 10.1016/j.conb.2007.04.001; WARCHOL ME, 1990, J COMP PHYSIOL A, V166, P721; Yang LC, 1999, J NEUROSCI, V19, P2313; Ye JH, 2006, J NEUROSCI METH, V158, P251, DOI 10.1016/j.jneumeth.2006.06.006; YOUNG SR, 1983, J NEUROSCI, V3, P1373; ZHANG S, 1994, J NEUROPHYSIOL, V72, P705, DOI 10.1152/jn.1994.72.2.705	56	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35831	10.1371/journal.pone.0035831	http://dx.doi.org/10.1371/journal.pone.0035831			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545142	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343200062
J	Corbett, HJ; Connell, MG; Fernig, DG; Losty, PD; Jesudason, EC				Corbett, Harriet Jane; Connell, Marilyn Gwen; Fernig, David Garth; Losty, Paul Damion; Jesudason, Edwin Chitran			ANG-1 TIE-2 and BMPR Signalling Defects Are Not Seen in the Nitrofen Model of Pulmonary Hypertension and Congenital Diaphragmatic Hernia	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; EXPERIMENTAL LUNG HYPOPLASIA; ARTERIAL-HYPERTENSION; CELL-PROLIFERATION; PROTEIN-RECEPTOR; RAT MODEL; ANGIOPOIETIN-1; VASCULATURE; MICE; SUSCEPTIBILITY	Background: Pulmonary hypertension (PH) is a lethal disease that is associated with characteristic histological abnormalities of the lung vasculature and defects of angiopoetin-1 (ANG-1), TIE-2 and bone morphogenetic protein receptor (BMPR)related signalling. We hypothesized that if these signalling defects cause PH generically, they will be readily identifiable perinatally in congenital diaphragmatic hernia (CDH), where the typical pulmonary vascular changes are present before birth and are accompanied by PH after birth. Methods: CDH (predominantly left-sided, LCDH) was created in Sprague-Dawley rat pups by e9.5 maternal nitrofen administration. Left lungs from normal and LCDH pups were compared at fetal and postnatal time points for ANG-1, TIE-2, phosphorylated-TIE-2, phosphorylated-SMAD1/5/8 and phosphorylated-ERK1/2 by immunoprecipitation and Western blotting of lung protein extracts and by immunohistochemistry on lung sections. Results: In normal lung, pulmonary ANG-1 protein levels fall between fetal and postnatal life, while TIE-2 levels increase. Over the corresponding time period, LCDH lung retained normal expression of ANG-1, TIE-2, phosphorylated-TIE-2 and, downstream of BMPR, phosphorylated-SMAD1/5/8 and phosphorylated-p44/42. Conclusion: In PH and CDH defects of ANG-1/TIE-2/BMPR-related signalling are not essential for the lethal vasculopathy.	[Corbett, Harriet Jane; Connell, Marilyn Gwen; Losty, Paul Damion; Jesudason, Edwin Chitran] Univ Liverpool, Div Child Hlth, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [Corbett, Harriet Jane; Losty, Paul Damion; Jesudason, Edwin Chitran] Alder Hey Childrens Natl Hlth Serv NHS Fdn Trust, Dept Paediat Surg, Liverpool, Merseyside, England; [Fernig, David Garth] Univ Liverpool, Dept Chem & Struct Biol, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England	University of Liverpool; Alder Hey Children's NHS Foundation Trust; University of Liverpool	Corbett, HJ (corresponding author), Univ Liverpool, Div Child Hlth, Inst Translat Med, Liverpool L69 3BX, Merseyside, England.	harriet.corbett@alderhey.nhs.uk	Fernig, David G/A-3590-2008	Fernig, David G/0000-0003-4875-4293	Royal College of Surgeons of England; Medical Research Council [G84/6485]; Cancer and Polio Research Fund Laboratories; North West Cancer Research Fund; University of Liverpool; MRC [G0802057, G84/6485] Funding Source: UKRI; Medical Research Council [G0802057] Funding Source: researchfish	Royal College of Surgeons of England; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer and Polio Research Fund Laboratories; North West Cancer Research Fund; University of Liverpool; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	HJC was supported by a Clinical Training Fellowship awarded by the Royal College of Surgeons of England, and Medical Research Council (Medical Research Council grant number G84/6485). ECJ is supported by a Medical Research Council New Investigator Award. DGF is funded by Cancer and Polio Research Fund Laboratories and North West Cancer Research Fund. MGC was the Senior Experimental Officer, Funded by The University of Liverpool. PDL is Professor of Paediatric Surgery, funded by the University of Liverpool. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boucherat O, 2010, AM J PHYSIOL-LUNG C, V298, pL849, DOI 10.1152/ajplung.00333.2009; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; Chen C, 2005, AM J PHYSIOL-LUNG C, V288, pL1033, DOI 10.1152/ajplung.00277.2004; Chinoy MR, 2002, AM J PHYSIOL-LUNG C, V283, pL60, DOI 10.1152/ajplung.00317.2001; Cilley RE, 1997, AM J PHYSIOL-LUNG C, V272, pL362, DOI 10.1152/ajplung.1997.272.2.L362; Coleman C, 1998, AM J PHYSIOL-LUNG C, V274, pL636, DOI 10.1152/ajplung.1998.274.4.L636; Du Lingling, 2003, New England Journal of Medicine, V348, P500, DOI 10.1056/NEJMoa021650; Featherstone NC, 2006, AM J RESP CELL MOL, V35, P571, DOI 10.1165/rcmb.2006-0079OC; Finer NN, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000399.pub2; Frank DB, 2008, AM J PHYSIOL-LUNG C, V294, pL98, DOI 10.1152/ajplung.00034.2007; Gallot D, 2007, ULTRASOUND OBST GYN, V29, P276, DOI 10.1002/uog.3863; GEGGEL RL, 1985, J PEDIATR-US, V107, P457, DOI 10.1016/S0022-3476(85)80534-5; Harrison RE, 2003, J MED GENET, V40, P865, DOI 10.1136/jmg.40.12.865; Ihida-Stansbury K, 2006, AM J PHYSIOL-LUNG C, V291, pL694, DOI 10.1152/ajplung.00119.2006; Jesudason EC, 2000, J PEDIATR SURG, V35, P124, DOI 10.1016/S0022-3468(00)80028-7; Jesudason EC, 2000, PEDIATR SURG INT, V16, P247, DOI 10.1007/s003830050738; Jesudason EC, 2000, J PEDIATR SURG, V35, P914, DOI 10.1053/jpsu.2000.6919; Jesudason EC, 2000, J PEDIATR SURG, V35, P129, DOI 10.1016/S0022-3468(00)80092-5; Kanai M, 2001, J PEDIATR SURG, V36, P839, DOI 10.1053/jpsu.2001.23950; Kling DE, 2001, J PEDIATR SURG, V36, P1490, DOI 10.1053/jpsu.2001.27029; KLUTH D, 1990, J PEDIATR SURG, V25, P850, DOI 10.1016/0022-3468(90)90190-K; Kugathasan L, 2009, J EXP MED, V206, P2221, DOI 10.1084/jem.20090389; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Long L, 2006, CIRC RES, V98, P818, DOI 10.1161/01.RES.0000215809.47923.fd; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Maniscalco WM, 2002, AM J PHYSIOL-LUNG C, V282, pL811, DOI 10.1152/ajplung.00325.2001; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Mugford M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001340.pub2; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Okoye BO, 1998, J PEDIATR SURG, V33, P76, DOI 10.1016/S0022-3468(98)90366-9; Okoye BO, 1998, ARCH DIS CHILD-FETAL, V78, pF204, DOI 10.1136/fn.78.3.F204; Perreault T, 2006, PAEDIATR RESPIR REV, V7, pS175, DOI 10.1016/j.prrv.2006.04.211; Reynolds AM, 2012, EUR RESPIR J, V39, P329, DOI 10.1183/09031936.00187310; Richter A, 2004, AM J RESP CRIT CARE, V170, P1340, DOI 10.1164/rccm.200311-1602OC; Rocha GM, 2008, EUR J PEDIATR SURG, V18, P219, DOI 10.1055/s-2008-1038502; Solari V, 2003, J PEDIATR SURG, V38, P808, DOI 10.1016/jpsu.2003.50172; Stewart DJ, 2005, CIRC RES, V96, P1033, DOI 10.1161/01.RES.0000168922.54339.47; Sun LJ, 2007, BIOCHEM BIOPH RES CO, V357, P779, DOI 10.1016/j.bbrc.2007.04.010; Taira Y, 1998, PEDIATR SURG INT, V14, P30, DOI 10.1007/s003830050429; Takahashi H, 2006, AM J PHYSIOL-LUNG C, V290, pL450, DOI 10.1152/ajplung.00206.2005; TENBRINCK R, 1992, J PEDIATR SURG, V27, P862, DOI 10.1016/0022-3468(92)90385-K; Thompson Sophie M, 2011, BMC Dev Biol, V11, P38, DOI 10.1186/1471-213X-11-38; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; West J, 2005, CHEST, V128, p553S, DOI 10.1378/chest.128.6_suppl.553S; Yang XD, 2005, CIRC RES, V96, P1053, DOI 10.1161/01.RES.0000166926.54293.68; Yu PB, 2005, J BIOL CHEM, V280, P24443, DOI 10.1074/jbc.M502825200; Zhao YD, 2003, CIRC RES, V92, P984, DOI 10.1161/01.RES.0000070587.79937.F0	47	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35364	10.1371/journal.pone.0035364	http://dx.doi.org/10.1371/journal.pone.0035364			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539968	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341000033
J	Terzano, C; Di Stefano, F; Conti, V; Di Nicola, M; Paone, G; Petroianni, A; Ricci, A				Terzano, Claudio; Di Stefano, Fabio; Conti, Vittoria; Di Nicola, Marta; Paone, Gregorino; Petroianni, Angelo; Ricci, Alberto			Mixed Acid-Base Disorders, Hydroelectrolyte Imbalance and Lactate Production in Hypercapnic Respiratory Failure: The Role of Noninvasive Ventilation	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; METABOLIC ALKALOSIS; SEVERE SEPSIS; PRIMARY-CARE; HYPOVENTILATION; ACETAZOLAMIDE; FUROSEMIDE; CLEARANCE; MORTALITY; PRESSURE	Background: Hypercapnic Chronic Obstructive Pulmonary Disease (COPD) exacerbation in patients with comorbidities and multidrug therapy is complicated by mixed acid-base, hydro-electrolyte and lactate disorders. Aim of this study was to determine the relationships of these disorders with the requirement for and duration of noninvasive ventilation (NIV) when treating hypercapnic respiratory failure. Methods: Sixty-seven consecutive patients who were hospitalized for hypercapnic COPD exacerbation had their clinical condition, respiratory function, blood chemistry, arterial blood gases, blood lactate and volemic state assessed. Heart and respiratory rates, pH, PaO2 and PaCO2 and blood lactate were checked at the 1st, 2nd, 6th and 24th hours after starting NIV. Results: Nine patients were transferred to the intensive care unit. NIV was performed in 11/17 (64.7%) mixed respiratory acidosis-metabolic alkalosis, 10/36 (27.8%) respiratory acidosis and 3/5 (60%) mixed respiratory-metabolic acidosis patients (p = 0.026), with durations of 45.1 +/- 9.8, 36.2 +/- 8.9 and 53.3 +/- 4.1 hours, respectively (p = 0.016). The duration of ventilation was associated with higher blood lactate (p<0.001), lower pH (p = 0.016), lower serum sodium (p = 0.014) and lower chloride (p = 0.038). Hyponatremia without hypervolemic hypochloremia occurred in 11 respiratory acidosis patients. Hypovolemic hyponatremia with hypochloremia and hypokalemia occurred in 10 mixed respiratory acidosis-metabolic alkalosis patients, and euvolemic hypochloremia occurred in the other 7 patients with this mixed acid-base disorder. Conclusions: Mixed acid-base and lactate disorders during hypercapnic COPD exacerbations predict the need for and longer duration of NIV. The combination of mixed acid-base disorders and hydro-electrolyte disturbances should be further investigated.	[Terzano, Claudio; Di Stefano, Fabio; Conti, Vittoria; Paone, Gregorino; Petroianni, Angelo; Ricci, Alberto] Sapienza Univ Rome, Fondazione Eleonora Lorillard Spencer Cenci, Rome, Italy; [Di Nicola, Marta] Univ G Annunzio Chieti Pescara, Lab Biostat, Dept Biomed Sci, Chieti, Italy	Sapienza University Rome; G d'Annunzio University of Chieti-Pescara	Terzano, C (corresponding author), Sapienza Univ Rome, Fondazione Eleonora Lorillard Spencer Cenci, Rome, Italy.	vittoria_conti@hotmail.com	Conti, Vittoria/J-9229-2016	Conti, Vittoria/0000-0002-1940-2603; Ricci, Alberto/0000-0002-1718-1587; DI NICOLA, MARTA/0000-0003-1748-1931; TERZANO, CLAUDIO/0000-0002-9851-7731				Adrogue HJ, 2000, NEW ENGL J MED, V342, P1493, DOI 10.1056/NEJM200005183422006; Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; [Anonymous], GLOB STRAT DIAGN MAN; Baudouin S, 2002, THORAX, V57, P192; Baudouin SV, 1997, THORAX, V52, P401, DOI 10.1136/thx.52.5.401; BEAR R, 1977, CAN MED ASSOC J, V117, P900; Bernardin G, 1996, INTENS CARE MED, V22, P17; Brijker F, 2002, CHEST, V121, P377, DOI 10.1378/chest.121.2.377; Brijker F, 2001, RESP PHYSIOL, V124, P151, DOI 10.1016/S0034-5687(00)00196-1; Confalonieri M, 2005, EUR RESPIR J, V25, P348, DOI 10.1183/09031936.05.00085304; COOPER CB, 1994, CHEST, V105, P335, DOI 10.1378/chest.105.2.335; de Leeuw PW, 2003, EUR RESPIR J, V22, p33S, DOI 10.1183/09031936.03.00000603a; DICKINSON GE, 1981, ANESTH ANALG, V60, P608; Dubin A, 2007, CRIT CARE MED, V35, P1264, DOI 10.1097/01.CCM.0000259536.11943.90; Foucher P, 1998, CHEST, V113, P1580, DOI 10.1378/chest.113.6.1580; Garpestad E, 2007, CHEST, V132, P711, DOI 10.1378/chest.06-2643; GUTIERREZ G, 1993, AM REV RESPIR DIS, V148, P1204, DOI 10.1164/ajrccm/148.5.1204; JAVAHERI S, 1981, RESP PHYSIOL, V45, P141, DOI 10.1016/0034-5687(81)90056-6; JAVAHERI S, 1982, CHEST, V81, P296, DOI 10.1378/chest.81.3.296; JAVAHERI S, 1987, AM REV RESPIR DIS, V136, P1011, DOI 10.1164/ajrccm/136.4.1011; Kaplan LJ, 2004, CRIT CARE MED, V32, P1120, DOI 10.1097/01.CCM.0000125517.28517.74; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KRAMER N, 1995, AM J RESP CRIT CARE, V151, P1799, DOI 10.1164/ajrccm.151.6.7767523; KREISBERG RA, 1972, NEW ENGL J MED, V287, P132, DOI 10.1056/NEJM197207202870307; MIZOCK BA, 1992, CRIT CARE MED, V20, P80, DOI 10.1097/00003246-199201000-00020; Nguyen HB, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-6; Nguyen HB, 2004, CRIT CARE MED, V32, P1637, DOI 10.1097/01.CCM.0000132904.35713.A7; Plant PK, 2000, LANCET, V355, P1931, DOI 10.1016/S0140-6736(00)02323-0; POKORSKI M, 1982, J APPL PHYSIOL, V53, P75, DOI 10.1152/jappl.1982.53.1.75; Price SR, 2001, AM J KIDNEY DIS, V37, pS112, DOI 10.1053/ajkd.2001.20764; Roberts CM, 2011, THORAX, V66, P43, DOI 10.1136/thx.2010.153114; Scott S, 2010, CRIT CARE RES PRACT, V2010, DOI 10.1155/2010/917053; Stewart PA, 1981, UNDERSTAND ACID BASE, P1; STINEBAUGH BJ, 1967, ARCH INTERN MED, V119, P182, DOI 10.1001/archinte.119.2.182; TEASDALE G, 1974, LANCET, V2, P81; Terzano C, 2010, LUNG, V188, P321, DOI 10.1007/s00408-009-9222-y; Ucgun I, 2008, RESPIRATION, V76, P270, DOI 10.1159/000131707; Valenza F, 2005, CRIT CARE, V9, P588, DOI 10.1186/cc3818; van de Ven MJT, 2002, CHEST, V121, P383, DOI 10.1378/chest.121.2.383; Wooten EW, 2004, CRIT CARE, V8, P448, DOI 10.1186/cc2910	40	38	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35245	10.1371/journal.pone.0035245	http://dx.doi.org/10.1371/journal.pone.0035245			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539963	Green Submitted, gold, Green Published			2022-12-25	WOS:000305341000027
J	Tian, C; Yu, HP; Yang, B; Han, FC; Zheng, Y; Bartels, CF; Schelling, D; Arnold, JE; Scacheri, PC; Zheng, QY				Tian, Cong; Yu, Heping; Yang, Bin; Han, Fengchan; Zheng, Ye; Bartels, Cynthia F.; Schelling, Deborah; Arnold, James E.; Scacheri, Peter C.; Zheng, Qing Yin			Otitis Media in a New Mouse Model for CHARGE Syndrome with a Deletion in the Chd7 Gene	PLOS ONE			English	Article							MIDDLE-EAR EPITHELIUM; IMMUNE-DEFICIENCY; INBRED STRAINS; DOWN-SYNDROME; MICE; MUTATIONS; EXPRESSION; DEFECTS; PROLIFERATION; ASSOCIATION	Otitis media is a middle ear disease common in children under three years old. Otitis media can occur in normal individuals with no other symptoms or syndromes, but it is often seen in individuals clinically diagnosed with genetic diseases such as CHARGE syndrome, a complex genetic disease caused by mutation in the Chd7 gene and characterized by multiple birth defects. Although otitis media is common in human CHARGE syndrome patients, it has not been reported in mouse models of CHARGE syndrome. In this study, we report a mouse model with a spontaneous deletion mutation in the Chd7 gene and with chronic otitis media of early onset age accompanied by hearing loss. These mice also exhibit morphological alteration in the Eustachian tubes, dysregulation of epithelial proliferation, and decreased density of middle ear cilia. Gene expression profiling revealed up-regulation of Muc5ac, Muc5b and Tgf-beta 1 transcripts, the products of which are involved in mucin production and TGF pathway regulation. This is the first mouse model of CHARGE syndrome reported to show otitis media with effusion and it will be valuable for studying the etiology of otitis media and other symptoms in CHARGE syndrome.	[Tian, Cong; Yu, Heping; Han, Fengchan; Zheng, Ye; Arnold, James E.; Zheng, Qing Yin] Case Western Reserve Univ, Sch Med, Univ Hosp Cleveland, Dept Otolaryngol Head & Neck Surg, Cleveland, OH 44106 USA; [Tian, Cong; Bartels, Cynthia F.; Schelling, Deborah; Scacheri, Peter C.; Zheng, Qing Yin] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH USA; [Zheng, Qing Yin] Case Comprehens Canc Ctr, Cleveland, OH USA; [Tian, Cong; Yu, Heping; Yang, Bin; Han, Fengchan; Zheng, Qing Yin] Binzhou Med Univ, Transformat Otol & Neurosci Ctr, Yantai, Shandong Provin, Peoples R China	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University; Binzhou Medical University	Tian, C (corresponding author), Case Western Reserve Univ, Sch Med, Univ Hosp Cleveland, Dept Otolaryngol Head & Neck Surg, Cleveland, OH 44106 USA.	qing.zheng@case.edu	Tian, Cong/E-6300-2012; Tian, Cong/D-4921-2011; Zheng, Qing/C-1731-2012	Tian, Cong/0000-0002-5645-6600	National Institute of Child Health and Development [R01HD056369]; National Human Genome Research Institute [R01HG004722]; National Institute on Deafness and Other Communication Disorders [R01DC009246, R01DC007392, R21DC005846]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD056369] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC005846, R01DC007392, R01DC009246] Funding Source: NIH RePORTER	National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institute of Child Health and Development (R01HD056369 to PCS), the National Human Genome Research Institute (R01HG004722 to PCS) and the National Institute on Deafness and Other Communication Disorders (R01DC009246, R01DC007392, R21DC005846 and Taishan Scholar to QYZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramaki M, 2007, BIRTH DEFECTS RES A, V79, P50, DOI 10.1002/bdra.20330; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Bergman JEH, 2010, EUR J HUM GENET, V18, P171, DOI 10.1038/ejhg.2009.158; Borkowski G, 2000, LARYNGO RHINO OTOL, V79, P135; Bosman EA, 2005, HUM MOL GENET, V14, P3463, DOI 10.1093/hmg/ddi375; BUFFONE GJ, 1985, CLIN CHEM, V31, P164; Chopra C, 2009, ACTA PAEDIATR, V98, P408, DOI 10.1111/j.1651-2227.2008.01077.x; Depreux FFS, 2008, J CLIN INVEST, V118, P651, DOI 10.1172/JCI32899; Furukawa M, 2007, INFECT IMMUN, V75, P2562, DOI 10.1128/IAI.01656-06; Gennery AR, 2008, CLIN EXP IMMUNOL, V153, P75, DOI 10.1111/j.1365-2249.2008.03681.x; Han F, 2010, PHARMACOGENOMICS J; Han FC, 2009, INT J EXP PATHOL, V90, P480, DOI 10.1111/j.1365-2613.2009.00677.x; Han FC, 2009, INFECT IMMUN, V77, P3100, DOI 10.1128/IAI.00204-09; Hardisty RE, 2003, JARO-J ASSOC RES OTO, V4, P130, DOI 10.1007/s10162-002-3015-9; Hardisty-Hughes RE, 2006, HUM MOL GENET, V15, P3273, DOI 10.1093/hmg/ddl403; Hoorens PR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-140; Hoover-Fong J, 2009, J PEDIATR-US, V154, P140, DOI 10.1016/j.jpeds.2008.07.049; Hurd EA, 2007, MAMM GENOME, V18, P94, DOI 10.1007/s00335-006-0107-6; Hurd EA, 2011, HEARING RES, V282, P184, DOI 10.1016/j.heares.2011.08.005; Kaur R, 2010, PEDIATR INFECT DIS J, V29, P741, DOI 10.1097/INF.0b013e3181d9e639; Kerschner JE, 2010, ARCH OTOLARYNGOL, V136, P819, DOI 10.1001/archoto.2010.123; Kerschner JE, 2010, INT J PEDIATR OTORHI, V74, P864, DOI 10.1016/j.ijporl.2010.04.014; Lalani SR, 2006, AM J HUM GENET, V78, P303, DOI 10.1086/500273; Layman WS, 2009, HUM MOL GENET, V18, P1909, DOI 10.1093/hmg/ddp112; MacArthur CJ, 2006, LARYNGOSCOPE, V116, P1071, DOI 10.1097/01.mlg.0000224527.41288.c4; Mao M, 2009, MAMM GENOME, V20, P462, DOI 10.1007/s00335-009-9210-9; PAGON RA, 1981, J PEDIATR-US, V99, P223, DOI 10.1016/S0022-3476(81)80454-4; Parkinson N, 2006, PLOS GENET, V2, P1556, DOI 10.1371/journal.pgen.0020149; Preciado D, 2010, PEDIATR RES, V68, P231, DOI 10.1203/00006450-201011001-00451; Qin Z, 2009, HEARING RES, V263, P93; Randall V, 2009, J CLIN INVEST, V119, P3301, DOI 10.1172/JCI37561; Richtsmeier JT, 2000, DEV DYNAM, V217, P137, DOI 10.1002/(SICI)1097-0177(200002)217:2<137::AID-DVDY1>3.0.CO;2-N; Roomans GM, 2006, UPSALA J MED SCI, V111, P155, DOI 10.3109/2000-1967-010; Rousseau K, 2007, AM J PHYSIOL-LUNG C, V292, pL1396, DOI 10.1152/ajplung.00444.2006; Schnetz MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001023; Schnetz MP, 2009, GENOME RES, V19, P590, DOI 10.1101/gr.086983.108; Seibert JW, 2006, OTOLARYNG CLIN N AM, V39, P1221, DOI 10.1016/j.otc.2006.08.011; SELBY PB, 1987, STAIN TECHNOL, V62, P143, DOI 10.3109/10520298709107984; Tateossian Hilda, 2009, Pathogenetics, V2, P5, DOI 10.1186/1755-8417-2-5; Theodoropoulos DS, 2003, PEDIATRICS, V111, P711, DOI 10.1542/peds.111.3.711-a; Trune DR, 2009, BRAIN RES, V1277, P90, DOI 10.1016/j.brainres.2009.02.047; Vernacchio L, 2004, INT J PEDIATR OTORHI, V68, P795, DOI 10.1016/j.ijporl.2004.01.012; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Zentner GE, 2010, HUM MOL GENET, V19, P3491, DOI 10.1093/hmg/ddq265; Zentner GE, 2010, AM J MED GENET A, V152A, P674, DOI 10.1002/ajmg.a.33323; Zhao SQ, 2009, CHINESE MED J-PEKING, V122, P2149, DOI 10.3760/cma.j.issn.0366-6999.2009.18.014; Zheng QY, 2007, HEARING RES, V231, P23, DOI 10.1016/j.heares.2007.05.011; Zheng QY, 2006, BRAIN RES, V1091, P9, DOI 10.1016/j.brainres.2006.01.046; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	49	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e34944	10.1371/journal.pone.0034944	http://dx.doi.org/10.1371/journal.pone.0034944			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539951	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341000014
J	Ichikawa, S; Miyake, M; Fujii, R; Konishi, Y				Ichikawa, Shintaro; Miyake, Mika; Fujii, Rei; Konishi, Yutaka			MyD88 Associated ROS Generation Is Crucial for Lactobacillus Induced IL-12 Production in Macrophage	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; TOLL-LIKE RECEPTORS; IMMUNOGLOBULIN-E PRODUCTION; INNATE IMMUNITY; NADPH-OXIDASE; DENDRITIC CELLS; DOWN-REGULATION; CUTTING EDGE; MICE; KINASE	It is well known that some strains of lactic acid bacteria (LAB) can induce IL-12 which plays an important role in modulating immune responses. However, the mechanisms by which LAB induce IL-12 production remain unclear. Here, we examine the role of toll-like receptors (TLR's) and reactive oxygen species (ROS) in IL-12 production by LAB stimulated peritoneal macrophages. Our results indicate that a TLR is not necessary for IL-12 induction by LAB, whilst the universal adaptor protein, MyD88, is essential. Specific strains of LAB induced ROS that correlated with both the frequency of phagocytosis and IL-12 production. Reduction in IL-12 production by NADPH oxidase inhibitors or ROS scavengers demonstrates the crucial role of ROS in IL-12 induction. Interestingly, deficiency of TLR2, 4, 9 or MyD88 did not affect the phagocytosis of LAB strain KW3110, a potent IL-12 inducer, and ROS production was significantly reduced only in MyD88 deficient macrophages. These results suggest the existence of TLR-MyD88 independent LAB recognition and MyD88 related ROS induction mechanisms. We show here the importance of ROS for IL-12 induction and provide new insights into IL-12 induction by LAB.	[Ichikawa, Shintaro; Miyake, Mika; Fujii, Rei; Konishi, Yutaka] Kirin Holdings Co Ltd, Cent Labs Frontier Technol, Yokohama, Kanagawa, Japan	Kirin Holdings Co Ltd	Ichikawa, S (corresponding author), Kirin Holdings Co Ltd, Cent Labs Frontier Technol, Yokohama, Kanagawa, Japan.	Shintaro_Ichikawa@kirin.co.jp						Ahrne S, 1998, J APPL MICROBIOL, V85, P88; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Aramaki Y, 2002, BIOL PHARM BULL, V25, P351, DOI 10.1248/bpb.25.351; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; DeLeo FR, 1999, J IMMUNOL, V163, P6732; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Edelson BT, 2002, J IMMUNOL, V169, P3869, DOI 10.4049/jimmunol.169.7.3869; EZEKOWITZ RAB, 1990, J EXP MED, V172, P1785, DOI 10.1084/jem.172.6.1785; Feng CG, 2003, J IMMUNOL, V171, P4758, DOI 10.4049/jimmunol.171.9.4758; Fujiwara D, 2004, INT ARCH ALLERGY IMM, V135, P205, DOI 10.1159/000081305; Guarner F, 1998, INT J FOOD MICROBIOL, V39, P237, DOI 10.1016/S0168-1605(97)00136-0; Hatao F, 2004, J LEUKOCYTE BIOL, V76, P904, DOI 10.1189/jlb.0504277; Hemmi H, 2003, J IMMUNOL, V170, P3059, DOI 10.4049/jimmunol.170.6.3059; Hou L, 2000, INFECT IMMUN, V68, P4681, DOI 10.1128/IAI.68.8.4681-4687.2000; Hsieh CC, 2006, FASEB J, V20, P259, DOI 10.1096/fj.05-4376com; Huang LY, 1999, INFECT IMMUN, V67, P6257; Ichikawa S, 2007, BIOSCI BIOTECH BIOCH, V71, P3026, DOI 10.1271/bbb.70414; Ichikawa S, 2009, BIOSCI BIOTECH BIOCH, V73, P1561, DOI 10.1271/bbb.90058; Kalliomaki MA, 2004, IMMUNOL ALLERGY CLIN, V24, P739, DOI 10.1016/j.iac.2004.06.006; Kato Y, 2000, INT J SYST EVOL MICR, V50, P1143, DOI 10.1099/00207713-50-3-1143; KIPS JC, 1995, INT ARCH ALLERGY IMM, V107, P115, DOI 10.1159/000236947; Laroux FS, 2005, J IMMUNOL, V175, P5596, DOI 10.4049/jimmunol.175.9.5596; Lekstrom-Himes JA, 2000, NEW ENGL J MED, V343, P1703, DOI 10.1056/NEJM200012073432307; Lu HT, 1999, EMBO J, V18, P1845, DOI 10.1093/emboj/18.7.1845; Matsuzaki T, 1998, J DAIRY SCI, V81, P48, DOI 10.3168/jds.S0022-0302(98)75549-3; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Mazzeo D, 2002, CYTOKINE, V17, P285, DOI 10.1006/cyto.2002.1014; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; MONTALTO, 2002, ANN ITAL MED INT, V17, P157; Morita H, 2006, MICROBIOL IMMUNOL, V50, P701, DOI 10.1111/j.1348-0421.2006.tb03842.x; Murata Y, 2002, INT IMMUNOL, V14, P201, DOI 10.1093/intimm/14.2.201; Okusawa T, 2004, INFECT IMMUN, V72, P1657, DOI 10.1128/IAI.72.3.1657-1665.2004; Perdigon G, 2001, Curr Issues Intest Microbiol, V2, P27; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; ROSS GD, 1992, J LEUKOCYTE BIOL, V51, P109, DOI 10.1002/jlb.51.2.109; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Salminen S, 1998, BRIT J NUTR, V80, pS147, DOI 10.1079/BJN19980108; Scanga CA, 2002, J IMMUNOL, V168, P5997, DOI 10.4049/jimmunol.168.12.5997; Su SB, 2005, J IMMUNOL, V175, P6303, DOI 10.4049/jimmunol.175.10.6303; Sun J, 2005, WORLD J GASTROENTERO, V11, P6330, DOI 10.3748/wjg.v11.i40.6330; Takahashi N, 2006, FEMS IMMUNOL MED MIC, V46, P461, DOI 10.1111/j.1574-695X.2006.00064.x; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; TRINCHIERI G, 1994, BLOOD, V84, P4008, DOI 10.1182/blood.V84.12.4008.bloodjournal84124008; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Utsugi M, 2002, J LEUKOCYTE BIOL, V71, P339; VanderVen BC, 2009, TRAFFIC, V10, P372, DOI [10.1111/j.1600-0854.2008.00877.x, 10.1111/j.1600-0854.2009.00877.x]; Vieira LQ, 2008, J CLIN GASTROENTEROL, V42, pS168, DOI 10.1097/MCG.0b013e31818063d4; Wakabayashi H, 2008, INT ARCH ALLERGY IMM, V145, P141, DOI 10.1159/000108139; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Xiao JZ, 2006, CLIN EXP ALLERGY, V36, P1425, DOI 10.1111/j.1365-2222.2006.02575.x; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540	53	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35880	10.1371/journal.pone.0035880	http://dx.doi.org/10.1371/journal.pone.0035880			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536449	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200122
J	Fita, A; Bowen, HC; Hayden, RM; Nuez, F; Pico, B; Hammond, JP				Fita, Ana; Bowen, Helen C.; Hayden, Rory M.; Nuez, Fernando; Pico, Belen; Hammond, John P.			Diversity in Expression of Phosphorus (P) Responsive Genes in Cucumis melo L.	PLOS ONE			English	Article							TRANSCRIPTOMIC ANALYSIS; PLASMA-MEMBRANE; PHOSPHATE STARVATION; ACID-PHOSPHATASES; METABOLIC-CHANGES; ROOT RESPONSES; WHITE LUPIN; ARABIDOPSIS; IDENTIFICATION; REVEALS	Background: Phosphorus (P) is a major limiting nutrient for plant growth in many soils. Studies in model species have identified genes involved in plant adaptations to low soil P availability. However, little information is available on the genetic bases of these adaptations in vegetable crops. In this respect, sequence data for melon now makes it possible to identify melon orthologues of candidate P responsive genes, and the expression of these genes can be used to explain the diversity in the root system adaptation to low P availability, recently observed in this species. Methodology and Findings: Transcriptional responses to P starvation were studied in nine diverse melon accessions by comparing the expression of eight candidate genes (Cm-PAP10.1, Cm-PAP10.2, Cm-RNS1, Cm-PPCK1, Cm-transferase, Cm-SQD1, Cm-DGD1 and Cm-SPX2) under P replete and P starved conditions. Differences among melon accessions were observed in response to P starvation, including differences in plant morphology, P uptake, P use efficiency (PUE) and gene expression. All studied genes were up regulated under P starvation conditions. Differences in the expression of genes involved in P mobilization and remobilization (Cm-PAP10.1, Cm-PAP10.2 and Cm-RNS1) under P starvation conditions explained part of the differences in P uptake and PUE among melon accessions. The levels of expression of the other studied genes were diverse among melon accessions, but contributed less to the phenotypical response of the accessions. Conclusions: This is the first time that these genes have been described in the context of P starvation responses in melon. There exists significant diversity in gene expression levels and P use efficiency among melon accessions as well as significant correlations between gene expression levels and phenotypical measurements.	[Fita, Ana; Nuez, Fernando; Pico, Belen] Univ Politecn Valencia, Ctr Conservac & Mejora Agrodiversidad Valenciana, E-46071 Valencia, Spain; [Bowen, Helen C.; Hayden, Rory M.; Hammond, John P.] Univ Warwick, Warwick HRI, Warwick, England	Universitat Politecnica de Valencia; University of Warwick	Fita, A (corresponding author), Univ Politecn Valencia, Ctr Conservac & Mejora Agrodiversidad Valenciana, E-46071 Valencia, Spain.	anfifer@btc.upv.es	PICO, BELEN/K-6517-2014; Hammond, John P/A-1876-2012; Fita, ANA/K-4250-2017	PICO, BELEN/0000-0001-7761-990X; Hammond, John P/0000-0002-6241-3551; FITA, ANA/0000-0002-8637-5852	programs of foreign mobility "Jose Castillejo" [JC2009-00147]; Universitat Politecnica de Valencia [PAID-00-10]; United Kingdom (UK) Department for the Environment, Food and Rural Affairs [WQ0119]	programs of foreign mobility "Jose Castillejo"; Universitat Politecnica de Valencia; United Kingdom (UK) Department for the Environment, Food and Rural Affairs	This work was supported by the programs of foreign mobility "Jose Castillejo" [JC2009-00147], Universitat Politecnica de Valencia Professor Mobility Program of the Universitat Politecnica de Valencia [PAID-00-10] and United Kingdom (UK) Department for the Environment, Food and Rural Affairs grant [WQ0119]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MX, 2005, J BIOL CHEM, V280, P27578, DOI 10.1074/jbc.M503273200; Andersson MX, 2003, FEBS LETT, V537, P128, DOI 10.1016/S0014-5793(03)00109-1; BARIOLA PA, 1994, PLANT J, V6, P673, DOI 10.1046/j.1365-313X.1994.6050673.x; Calderon-Vazquez C, 2008, J EXP BOT, V59, P2479, DOI 10.1093/jxb/ern115; Chen ZH, 2007, BIOCHEM J, V405, P191, DOI 10.1042/BJ20070102; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Ding GD, 2011, EUPHYTICA, V181, P305, DOI 10.1007/s10681-011-0428-8; Duan K, 2008, PLANT J, V54, P965, DOI 10.1111/j.1365-313X.2008.03460.x; DUFF SMG, 1994, PHYSIOL PLANTARUM, V90, P791, DOI 10.1111/j.1399-3054.1994.tb02539.x; Essigmann B, 1998, P NATL ACAD SCI USA, V95, P1950, DOI 10.1073/pnas.95.4.1950; Fang ZY, 2009, PLANT SCI, V176, P170, DOI 10.1016/j.plantsci.2008.09.007; Fita A, 2011, EUPHYTICA, P1; Fita A, 2008, J AM SOC HORTIC SCI, V133, P448, DOI 10.21273/JASHS.133.3.448; Fita A, 2006, J AM SOC HORTIC SCI, V131, P372, DOI 10.21273/JASHS.131.3.372; Gonzalez VM, 2010, BMC GENOMICS, V11; Gonzalez-Ibeas D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-306; Graham MA, 2006, FUNCT PLANT BIOL, V33, P789, DOI 10.1071/FP06101; Hamburger D, 2002, PLANT CELL, V14, P889, DOI 10.1105/tpc.000745; Hammond JP, 2008, J EXP BOT, V59, P93, DOI 10.1093/jxb/erm221; Hammond JP, 2011, PLANT PHYSIOL, V156, P1230, DOI 10.1104/pp.111.175612; Hammond JP, 2011, PLANT PHYSIOL, V156, P1033, DOI 10.1104/pp.111.175380; Hammond JP, 2009, J EXP BOT, V60, P1953, DOI 10.1093/jxb/erp083; Hammond JP, 2004, ANN BOT-LONDON, V94, P323, DOI 10.1093/aob/mch156; Hammond JP, 2003, PLANT PHYSIOL, V132, P578, DOI 10.1104/pp.103.020941; Heffer P., 2006, PHOSPHORUS FERTILISA; Hernandez G, 2007, PLANT PHYSIOL, V144, P752, DOI 10.1104/pp.107.096958; Hernandez G, 2009, PLANT PHYSIOL, V151, P1221, DOI 10.1104/pp.109.143842; International Cucurbit Genomics Initiative (ICuGI), 2007, CUC GEN DAT; Li LH, 2010, CHINESE SCI BULL, V55, P251, DOI 10.1007/s11434-010-0012-y; Lynch JP, 2007, AUST J BOT, V55, P493, DOI 10.1071/BT06118; Lynch JP, 2011, PLANT PHYSIOL, V156, P1041, DOI 10.1104/pp.111.175414; Blanca JM, 2011, PLANT GENOME-US, V4, P118, DOI 10.3835/plantgenome2011.01.0003; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Morcuende R, 2007, PLANT CELL ENVIRON, V30, P85, DOI 10.1111/j.1365-3040.2006.01608.x; Muller R, 2007, PLANT PHYSIOL, V143, P156, DOI 10.1104/pp.106.090167; Munger H.M., 1991, CUCURBIT GENETICS CO, V14, P43; Nagata T, 2003, J AGR FOOD CHEM, V51, P2992, DOI 10.1021/jf026179+; Pitrat Michel, 2008, V1, P283; Plaxton WC, 2011, PLANT PHYSIOL, V156, P1006, DOI 10.1104/pp.111.175281; Raven John A., 2008, V7, P271; Tiessen Holm, 2008, V7, P1; Tjellstrom H, 2008, CHEM PHYS LIPIDS, V154, pS30, DOI 10.1016/j.chemphyslip.2008.05.083; Uhde-Stone C, 2003, PLANT PHYSIOL, V131, P1064, DOI 10.1104/pp.102.016881; Uhde-Stone C, 2003, PLANT SOIL, V248, P99, DOI 10.1023/A:1022335519879; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; Wang Y, 2004, PLANT PHYSIOL, V135, P400, DOI 10.1104/pp.103.037945; Wasaki J, 2003, PLANT CELL ENVIRON, V26, P1515, DOI 10.1046/j.1365-3040.2003.01074.x; Wasaki J, 2006, J EXP BOT, V57, P2049, DOI 10.1093/jxb/erj158; White PJ, 2009, J ENVIRON QUAL, V38, P13, DOI 10.2134/jeq2007.0658; Wu P, 2003, PLANT PHYSIOL, V132, P1260, DOI 10.1104/pp.103.021022; Zhang Q, 2011, PLANT BIOLOGY, V13, P7, DOI 10.1111/j.1438-8677.2010.00346.x; Zheng LQ, 2009, PLANT PHYSIOL, V151, P262, DOI 10.1104/pp.109.141051	52	11	11	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35387	10.1371/journal.pone.0035387	http://dx.doi.org/10.1371/journal.pone.0035387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536378	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000305336200037
J	Graff, JW; Dickson, AM; Clay, G; McCaffrey, AP; Wilson, ME				Graff, Joel W.; Dickson, Anne M.; Clay, Gwendolyn; McCaffrey, Anton P.; Wilson, Mary E.			Identifying Functional MicroRNAs in Macrophages with Polarized Phenotypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY RESPONSE; ACTIVATED MACROPHAGE; SIGNALING PROTEINS; EXPRESSION; INDUCTION; CELLS; DIFFERENTIATION; STIMULATION; MONOCYTES; SHRNAS	Macrophages respond to external stimuli with rapid changes in expression of many genes. Different combinations of external stimuli lead to distinct polarized activation patterns, resulting in a spectrum of possible macrophage activation phenotypes. MicroRNAs (miRNAs) are small, noncoding RNAs that can repress the expression of many target genes. We hypothesized that miRNAs play a role in macrophage polarization. miRNA expression profiles were determined in monocyte-derived macrophages (MDMs) incubated in conditions causing activation toward M1, M2a, M2b, or M2c phenotypes. One miRNA guide strand and seven miRNA passenger strands were significantly altered. Changes were confirmed in MDMs from six separate donors. The amplitude of miRNA expression changes in MDMs was smaller than described studies of monocytes responding to inflammatory stimuli. Further investigation revealed this correlated with higher basal miRNA expression in MDMs compared with monocytes. The regulation of M1- and M2b-responsive miRNAs (miR-27a, miR-29b, miR-125a, miR-146a, miR-155, and miR-222) was similar in differentiated THP-1 cells and primary MDMs. Studies in this model revealed cross-talk between IFN gamma- and LPS-associated pathways regulating miRNA expression. Furthermore, expression of M1-associated transcripts was increased in THP-1 cells transfected with mimics of miR-29b, miR-125a-5p, or miR-155. The apparent inflammatory property of miR-29b and miR-125a-5p can be at least partially explained by repression of TNFAIP3, a negative regulator of NF-kappa B signaling. Overall, these data suggest miRNAs can contribute to changes in macrophage gene expression that occur in different exogenous activating conditions.	[Graff, Joel W.; Dickson, Anne M.; Clay, Gwendolyn; McCaffrey, Anton P.; Wilson, Mary E.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Graff, Joel W.; Wilson, Mary E.] Dept Vet Affairs, Iowa City, IA 52240 USA; [Wilson, Mary E.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Wilson, Mary E.] Univ Iowa, Dept Epidemiol, Iowa City, IA 52242 USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; University of Iowa	Wilson, ME (corresponding author), Univ Iowa, Dept Internal Med, SW34 GH,200 Hawkins Dr, Iowa City, IA 52242 USA.	mary-wilson@uiowa.edu		Wilson, Mary/0000-0001-8680-7275; Clay, Gwendolyn/0000-0001-8218-7646	OES-OIS from Department of Veterans Affairs; National Institutes of Health [R21 AI080801, R01 AI045540, R01 AI067874, R01 AI076233]; National Institutes of Health Training [T32 AI007511, T32 AI007343-21]; Veterans Affairs CDA-1 career award; Merit Review; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067874, T32AI007343, R21AI080801, R01AI045540, R01AI076233, T32AI007511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	OES-OIS from Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs CDA-1 career award; Merit Review(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a Merit Review and an OES-OIS program award from the Department of Veterans Affairs (to M. E. W.) and Grants R21 AI080801, R01 AI045540, R01 AI067874, and R01 AI076233 from the National Institutes of Health.; Supported by a Veterans Affairs CDA-1 career award and National Institutes of Health Training Grant T32 AI007511.; Supported National Institutes of Health Training Grant T32 AI007343-21.	Anderson CF, 2002, J LEUKOCYTE BIOL, V72, P101; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; Boudreau RL, 2008, RNA, V14, P1834, DOI 10.1261/rna.1062908; Boudreau RL, 2009, MOL THER, V17, P169, DOI 10.1038/mt.2008.231; Chen AL, 2008, BIOTECHNOL LETT, V30, P2045, DOI 10.1007/s10529-008-9800-8; Chen T, 2009, CARDIOVASC RES, V83, P131, DOI 10.1093/cvr/cvp121; Coley W, 2010, J BIOL CHEM, V285, P31930, DOI 10.1074/jbc.M110.101709; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Forrest ARR, 2010, LEUKEMIA, V24, P460, DOI 10.1038/leu.2009.246; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gantt KR, 2003, J IMMUNOL, V170, P2613, DOI 10.4049/jimmunol.170.5.2613; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; MACKANESS GB, 1964, J EXP MED, V120, P105, DOI 10.1084/jem.120.1.105; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Monk CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013669; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Ruggiero T, 2009, FASEB J, V23, P2898, DOI 10.1096/fj.09-131342; Schulte LN, 2011, EMBO J, V30, P1977, DOI 10.1038/emboj.2011.94; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Sutterwala FS, 1998, J EXP MED, V188, P217, DOI 10.1084/jem.188.1.217; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Tserel L, 2011, J BIOL CHEM, V286, P26487, DOI 10.1074/jbc.M110.213561; TSUCHIYA S, 1982, CANCER RES, V42, P1530	39	267	282	0	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21816	21825		10.1074/jbc.M111.327031	http://dx.doi.org/10.1074/jbc.M111.327031			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22549785	hybrid, Green Published			2022-12-25	WOS:000306418600023
J	Kusche-Gullberg, M; Nybakken, K; Perrimon, N; Lindahl, U				Kusche-Gullberg, Marion; Nybakken, Kent; Perrimon, Norbert; Lindahl, Ulf			Drosophila Heparan Sulfate, a Novel Design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-LINKAGE REGION; MAST-CELLS; CAENORHABDITIS-ELEGANS; STRUCTURAL-ANALYSIS; NONREDUCING END; TOUT-VELU; IN-VIVO; GLYCOSAMINOGLYCANS; PROTEOGLYCANS; BIOSYNTHESIS	Heparan sulfate (HS) proteoglycans play critical roles in a wide variety of biological processes such as growth factor signaling, cell adhesion, wound healing, and tumor metastasis. Functionally important interactions between HS and a variety of proteins depend on specific structural features within the HS chains. The fruit fly (Drosophila melanogaster) is frequently applied as a model organism to study HS function in development. Previous structural studies of Drosophila HS have been restricted to disaccharide composition, without regard to the arrangement of saccharide domains typically found in vertebrate HS. Here, we biochemically characterized Drosophila HS by selective depolymerization with nitrous acid. Analysis of the generated saccharide products revealed a novel HS design, involving a peripheral, extended, presumably single, N-sulfated domain linked to an N-acetylated sequence contiguous with the linkage to core protein. The N-sulfated domain may be envisaged as a heparin structure of unusually low O-sulfate content.	[Kusche-Gullberg, Marion] Univ Bergen, Dept Biomed, NO-5009 Bergen, Norway; [Nybakken, Kent] Boston Biomed Res Inst, Watertown, MA 02472 USA; [Perrimon, Norbert] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Perrimon, Norbert] Howard Hughes Med Inst, Boston, MA 02115 USA; [Lindahl, Ulf] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden	University of Bergen; Boston Biomedical Research Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Uppsala University	Kusche-Gullberg, M (corresponding author), Univ Bergen, Dept Biomed, Jonas Lies Vei 91, NO-5009 Bergen, Norway.	marion.kusche@biomed.uib.no	Kusche-Gullberg, Marion/P-4466-2016	Kusche-Gullberg, Marion/0000-0002-5636-1695; Perrimon, Norbert/0000-0001-7542-472X	University of Bergen; Polysackaridforskning AB, Uppsala, Sweden; National Institutes of Health Postdoctoral Training Grant [5 F32 GM064232-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM064232] Funding Source: NIH RePORTER	University of Bergen; Polysackaridforskning AB, Uppsala, Sweden; National Institutes of Health Postdoctoral Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the University of Bergen (to M. K.-G.) and Polysackaridforskning AB, Uppsala, Sweden (to U. L.).; Supported by National Institutes of Health Postdoctoral Training Grant 5 F32 GM064232-02.	Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; Bornemann DJ, 2004, DEVELOPMENT, V131, P1927, DOI 10.1242/dev.01061; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Casu B, 2001, ADV CARBOHYD CHEM BI, V57, P159, DOI 10.1016/S0065-2318(01)57017-1; Dagalv A, 2011, J BIOL CHEM, V286, P44433, DOI 10.1074/jbc.M111.303891; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Feta A, 2009, BIOCHEM J, V419, P585, DOI 10.1042/BJ20082081; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; GALLAGHER JT, 1985, BIOCHEM J, V230, P665, DOI 10.1042/bj2300665; GUO Y, 1989, ANAL BIOCHEM, V176, P96, DOI 10.1016/0003-2697(89)90278-9; Han C, 2004, DEVELOPMENT, V131, P1563, DOI 10.1242/dev.01051; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Kamimura K, 2011, GLYCOBIOLOGY, V21, P607, DOI 10.1093/glycob/cwq202; Kasevayuth K, 2004, BIOCHEM BIOPH RES CO, V324, P205, DOI 10.1016/j.bbrc.2004.09.036; Kramer KL, 2003, ANNU REV GENET, V37, P461, DOI 10.1146/annurev.genet.37.061103.090226; KUSCHE M, 1990, J BIOL CHEM, V265, P7292; KUSCHE M, 1988, BIOCHEM J, V253, P885, DOI 10.1042/bj2530885; Kusche-Gullberg M, 1998, J BIOL CHEM, V273, P11902, DOI 10.1074/jbc.273.19.11902; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Ledin J, 2006, J BIOL CHEM, V281, P35727, DOI 10.1074/jbc.M604113200; Lin XH, 2002, GLYCOCONJUGATE J, V19, P363, DOI 10.1023/A:1025329323438; LINDAHL U, 1966, BIOCHIM BIOPHYS ACTA, V130, P368, DOI 10.1016/0304-4165(66)90233-9; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Lindahl U, 2009, INT REV CEL MOL BIO, V276, P105, DOI 10.1016/S1937-6448(09)76003-4; LYON M, 1987, BIOCHEM J, V242, P493, DOI 10.1042/bj2420493; LYON M, 1994, J BIOL CHEM, V269, P11208; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; Medeiros GF, 2000, BBA-GEN SUBJECTS, V1475, P287, DOI 10.1016/S0304-4165(00)00079-9; Naimy H, 2011, J BIOL CHEM, V286, P19311, DOI 10.1074/jbc.M110.204693; Nybakken K, 2002, BBA-GEN SUBJECTS, V1573, P280, DOI 10.1016/S0304-4165(02)00395-1; PEJLER G, 1987, J BIOL CHEM, V262, P11413; SHAKLEE PN, 1984, BIOCHEM J, V217, P187, DOI 10.1042/bj2170187; Smeds E, 2003, BIOCHEM J, V372, P371, DOI 10.1042/BJ20021665; Staples GO, 2010, J BIOL CHEM, V285, P18336, DOI 10.1074/jbc.M110.101592; SUGAHARA K, 1995, J BIOL CHEM, V270, P22914, DOI 10.1074/jbc.270.39.22914; Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540214928; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Toyoda H, 2000, J BIOL CHEM, V275, P21856, DOI 10.1074/jbc.M003540200; TURNBULL JE, 1991, BIOCHEM J, V273, P553, DOI 10.1042/bj2730553; Wu ZLL, 2003, J BIOL CHEM, V278, P17121, DOI 10.1074/jbc.M212590200; Xian XJ, 2010, CELL TISSUE RES, V339, P31, DOI 10.1007/s00441-009-0829-3; Yamada S, 2002, J BIOL CHEM, V277, P31877, DOI 10.1074/jbc.M205078200; Yan D, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002493	47	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21950	21956		10.1074/jbc.M112.350389	http://dx.doi.org/10.1074/jbc.M112.350389			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22556423	Green Published, hybrid			2022-12-25	WOS:000306418600034
J	Ahmad, R; Alam, M; Rajabi, H; Kufe, D				Ahmad, Rehan; Alam, Maroof; Rajabi, Hasan; Kufe, Donald			The MUC1-C Oncoprotein Binds to the BH3 Domain of the Pro-apoptotic BAX Protein and Blocks BAX Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOMA-ASSOCIATED ANTIGEN; BETA-CATENIN; SURVIVAL RESPONSE; MITOCHONDRIAL DYSFUNCTION; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; PROAPOPTOTIC BAX; C-SRC; ACTIVATION; DIMERIZATION	The pro-apoptotic BAX protein contains a BH3 domain that is necessary for its dimerization and for activation of the intrinsic apoptotic pathway. The MUC1(mucin 1) heterodimeric protein is overexpressed in diverse human carcinomas and blocks apoptosis in the response to stress. In this study, we demonstrate that the oncogenic MUC1-C subunit associates with BAX in human cancer cells. MUC1-C.BAX complexes are detectable in the cytoplasm and mitochondria and are induced by genotoxic and oxidative stress. The association between MUC1-C and BAX is supported by the demonstration that the MUC1-C cytoplasmic domain is sufficient for the interaction with BAX. The results further show that the MUC1-C cytoplasmic domain CQC motif binds directly to the BAX BH3 domain at Cys-62. Consistent with binding to the BAX BH3 domain, MUC1-C blocked BAX dimerization in response to (i) truncated BID in vitro and (ii) treatment of cancer cells with DNA-damaging agents. In concert with these results, MUC1-C attenuated localization of BAX to mitochondria and the release of cytochrome c. These findings indicate that the MUC1-C oncoprotein binds directly to the BAX BH3 domain and thereby blocks BAX function in activating the mitochondrial death pathway.	[Ahmad, Rehan; Alam, Maroof; Rajabi, Hasan; Kufe, Donald] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Kufe, D (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	donald_kufe@dfci.havard.edu	Rather, R A/J-3509-2019		National Institutes of Health from NCI [CA97098, CA42802, CA100707]; NATIONAL CANCER INSTITUTE [R01CA097098, R01CA166480, P50CA100707, R01CA042802] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA97098, CA42802, and CA100707 from NCI. D. K. holds equity in Genus Oncology and is a consultant to the company.	Ahmad R, 2007, NAT CELL BIOL, V9, P1419, DOI 10.1038/ncb1661; Ahmad R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001426; Ahmad R, 2009, CANCER RES, V69, P7013, DOI 10.1158/0008-5472.CAN-09-0523; D'Alessio M, 2005, FASEB J, V19, P1504, DOI 10.1096/fj.04-3329fje; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Fischer PM, 2007, MED RES REV, V27, P755, DOI 10.1002/med.20093; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gavathiotis E, 2010, MOL CELL, V40, P481, DOI 10.1016/j.molcel.2010.10.019; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Leng YM, 2007, J BIOL CHEM, V282, P19321, DOI 10.1074/jbc.M703222200; Li YQ, 2003, ONCOGENE, V22, P6107, DOI 10.1038/sj.onc.1206732; Li YQ, 1998, MOL CELL BIOL, V18, P7216, DOI 10.1128/MCB.18.12.7216; Li YQ, 2001, J BIOL CHEM, V276, P6061, DOI 10.1074/jbc.C000754200; Nie C, 2008, J BIOL CHEM, V283, P15359, DOI 10.1074/jbc.M800847200; Polster BM, 2001, J BIOL CHEM, V276, P37887; Raina D, 2006, EMBO J, V25, P3774, DOI 10.1038/sj.emboj.7601263; Raina D, 2012, INT J ONCOL, V40, P1644, DOI 10.3892/ijo.2011.1308; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Ren J, 2006, ONCOGENE, V25, P20, DOI 10.1038/sj.onc.1209012; Ren J, 2002, J BIOL CHEM, V277, P17616, DOI 10.1074/jbc.M200436200; Ren J, 2006, MOL CANCER RES, V4, P873, DOI 10.1158/1541-7786.MCR-06-0204; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Wang K, 1998, MOL CELL BIOL, V18, P6083, DOI 10.1128/MCB.18.10.6083; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei XL, 2005, CANCER CELL, V7, P167, DOI 10.1016/j.ccr.2005.01.008; Wen YF, 2003, J BIOL CHEM, V278, P38029, DOI 10.1074/jbc.M304333200; Westphal D, 2011, BBA-MOL CELL RES, V1813, P521, DOI 10.1016/j.bbamcr.2010.12.019; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yin L, 2004, J BIOL CHEM, V279, P45721, DOI 10.1074/jbc.M408027200; Yin L, 2003, J BIOL CHEM, V278, P35458, DOI 10.1074/jbc.M301987200; Yin L, 2007, J BIOL CHEM, V282, P257, DOI 10.1074/jbc.M610156200; Yin L, 2009, INT J ONCOL, V34, P1691, DOI 10.3892/ijo_00000300; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhai DY, 2005, J BIOL CHEM, V280, P15815, DOI 10.1074/jbc.M411902200; Zong WX, 2003, J CELL BIOL, V162, P59, DOI 10.1083/jcb.200302084	41	40	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20866	20875		10.1074/jbc.M112.357293	http://dx.doi.org/10.1074/jbc.M112.357293			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22544745	hybrid, Green Published			2022-12-25	WOS:000306416800008
J	Harrison, FE; Best, JL; Meredith, ME; Gamlin, CR; Borza, DB; May, JM				Harrison, Fiona Edith; Best, Jennifer Lee; Meredith, Martha Elizabeth; Gamlin, Clare Ruth; Borza, Dorin-Bogdan; May, James Michael			Increased Expression of SVCT2 in a New Mouse Model Raises Ascorbic Acid in Tissues and Protects against Paraquat-Induced Oxidative Damage in Lung	PLOS ONE			English	Article							VITAMIN-C TRANSPORTERS; MICE; BRAIN; STRESS; CELLS; DEFICITS	A new transgenic mouse model for global increases in the Sodium Dependent Vitamin C transporter 2 (SVCT2) has been generated. The SVCT2-Tg mouse shows increased SVCT2 mRNA levels in all organs tested and correspondingly increased ascorbic acid (ASC) levels in all organs except liver. The extent of the increase in transporter mRNA expression differed among mice and among organs. The increased ASC levels did not have any adverse effects on behavior in the SVCT2-Tg mice, which did not differ from wild-type mice on tests of locomotor activity, anxiety, sensorimotor or cognitive ability. High levels of SVCT2 and ASC were found in the kidneys of SVCT2-Tg mice and urinary albumin excretion was lower in these mice than in wild-types. No gross pathological changes were noted in kidneys from SVCT2-Tg mice. SVCT2 immunoreactivity was detected in both SVCT2 and wild-type mice, and a stronger signal was seen in tubules than in glomeruli. Six treatments with Paraquat (3x10 and 3x15 mg/kg i.p.) were used to induce oxidative stress in mice. SVCT2-Tg mice showed a clear attenuation of Paraquat-induced oxidative stress in lung, as measured by F2-isoprostanes. Paraquat also decreased SVCT2 mRNA signal in liver, lung and kidney in SVCT2-Tg mice.	[Harrison, Fiona Edith; Best, Jennifer Lee; Meredith, Martha Elizabeth; Gamlin, Clare Ruth; May, James Michael] Vanderbilt Univ, Med Ctr, Div Endocrinol Diabet & Metab, Nashville, TN 37240 USA; [Borza, Dorin-Bogdan] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Harrison, FE (corresponding author), Vanderbilt Univ, Med Ctr, Div Endocrinol Diabet & Metab, Nashville, TN 37240 USA.	Fiona.Harrison@Vanderbilt.edu	Borza, Dorin-Bogdan/AAF-2156-2020; Meredith, Elizabeth/AAM-4574-2021	Borza, Dorin-Bogdan/0000-0003-4568-279X; Harrison, Fiona/0000-0003-1121-0647	National Institutes of Health [NS057674]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a grant from the National Institutes of Health (NS057674 to JMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano A, 2010, ARCH BIOCHEM BIOPHYS, V496, P38, DOI 10.1016/j.abb.2010.01.012; Awadalla EA, 2012, EXP TOXICOL PATHOL, V64, P431, DOI 10.1016/j.etp.2010.10.009; Boyer JC, 2005, BIOCHEM BIOPH RES CO, V334, P150, DOI 10.1016/j.bbrc.2005.06.069; Corpe CP, 2010, J CLIN INVEST, V120, P1069, DOI 10.1172/JCI39191; Craven PA, 1997, J AM SOC NEPHROL, V8, P1405; Dinis-Oliveira RJ, 2008, CRIT REV TOXICOL, V38, P13, DOI 10.1080/10408440701669959; DIXON SJ, 1992, J BONE MINER RES, V7, P675; Fan XJ, 2006, P NATL ACAD SCI USA, V103, P16912, DOI 10.1073/pnas.0605101103; Gess B, 2011, J NEUROSCI, V31, P17180, DOI 10.1523/JNEUROSCI.3457-11.2011; Harrison FE, 2010, FREE RADICAL BIO MED, V49, P821, DOI 10.1016/j.freeradbiomed.2010.06.008; Harrison FE, 2009, BEHAV BRAIN RES, V205, P550, DOI 10.1016/j.bbr.2009.08.017; Harrison FE, 2009, NUTR NEUROSCI, V12, P203, DOI 10.1179/147683009X423364; Harrison FE, 2009, PHARMACOL BIOCHEM BE, V93, P443, DOI 10.1016/j.pbb.2009.06.006; Harrison FE, 2008, J NEUROCHEM, V106, P1198, DOI 10.1111/j.1471-4159.2008.05469.x; Harrison FE, 2009, FREE RADICAL BIO MED, V46, P719, DOI 10.1016/j.freeradbiomed.2008.12.018; Ma LJ, 2003, KIDNEY INT, V64, P350, DOI 10.1046/j.1523-1755.2003.00058.x; Maeda N, 2000, P NATL ACAD SCI USA, V97, P841, DOI 10.1073/pnas.97.2.841; May JM, 2009, AM J PHYSIOL-CELL PH, V297, pC169, DOI 10.1152/ajpcell.00674.2008; May JM, 1998, ARCH BIOCHEM BIOPHYS, V349, P281, DOI 10.1006/abbi.1997.0473; Meredith ME, 2011, BIOCHEM BIOPH RES CO, V414, P737, DOI 10.1016/j.bbrc.2011.09.146; Milne GL, 2007, NAT PROTOC, V2, P221, DOI 10.1038/nprot.2006.375; Moon JM, 2011, HUM EXP TOXICOL, V30, P844, DOI 10.1177/0960327110385633; Mun GH, 2006, J NEUROSCI RES, V83, P919, DOI 10.1002/jnr.20751; Pachla L A, 1979, Methods Enzymol, V62, P15, DOI 10.1016/0076-6879(79)62183-3; Prasad K, 2009, EXP NEUROL, V215, P358, DOI 10.1016/j.expneurol.2008.11.003; Qiao H, 2008, BRAIN RES, V1208, P79, DOI 10.1016/j.brainres.2008.02.102; Savini I, 2008, AMINO ACIDS, V34, P347, DOI 10.1007/s00726-007-0555-7; Savini I, 2007, BIOCHEM BIOPH RES CO, V361, P385, DOI 10.1016/j.bbrc.2007.07.007; Sotiriou S, 2002, NAT MED, V8, P514, DOI 10.1038/nm0502-514; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986	30	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35623	10.1371/journal.pone.0035623	http://dx.doi.org/10.1371/journal.pone.0035623			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558179	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340200020
J	Djafarzadeh, R; Sauter, M; Notohamiprodjo, S; Noessner, E; Goyal, P; Siess, W; Wornle, M; Ribeiro, A; Himmelein, S; Sitter, T; Nelson, PJ				Djafarzadeh, Roghieh; Sauter, Matthias; Notohamiprodjo, Susan; Noessner, Elfriede; Goyal, Pankaj; Siess, Wolfgang; Woernle, Markus; Ribeiro, Andrea; Himmelein, Susanne; Sitter, Thomas; Nelson, Peter J.			Recombinant GPI-Anchored TIMP-1 Stimulates Growth and Migration of Peritoneal Mesothelial Cells	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; TISSUE INHIBITORS; GELATINASE-B; EXPRESSION; SECRETION; DIALYSATE; CYTOKINES; MEMBRANE; BIOLOGY; ALPHA	Background: Mesothelial cells are critical in the pathogenesis of post-surgical intraabdominal adhesions as well as in the deterioration of the peritoneal membrane associated with long-term peritoneal dialysis. Mesothelial denudation is a pathophysiolocigally important finding in these processes. Matrix metalloproteinase (MMP) biology underlies aspects of mesothelial homeostasis as well as wound repair. The endogenous tissue inhibitors of metalloproteinases (TIMPs) moderate MMP activity. Methods and Finding: By modifying human TIMP-1 through the addition of a glycosylphosphatidylinositol (GPI) anchor, a recombinant protein was generated that efficiently focuses TIMP-1 on the cell surface. Treatment of primary mesothelial cells with TIMP-1-GPI facilitates their mobilization and migration leading to a dramatic increase in the rate of wound experimental closure. Mesothelial cells treated with TIMP-1-GPI showed a dose dependent increase in cell proliferation, reduced secretion of MMP-2, MMP-9, TNF-alpha and urokinase-type plasminogen activator (uPA), but increased tissue plasminogen activator (t-PA). Treatment resulted in reduced expression and processing of latent TGF-beta 1. Conclusions: TIMP-1-GPI stimulated rapid and efficient in vitro wound closure. The agent enhanced mesothelial cell proliferation and migration and was bioactive in the nanogram range. The application of TIMP-1-GPI may represent a new approach for limiting or repairing damaged mesothelium.	[Djafarzadeh, Roghieh; Notohamiprodjo, Susan; Nelson, Peter J.] Univ Munich, Med Klin & Poliklin 4, Arbeitsgrp Klin Biochem, Munich, Germany; [Noessner, Elfriede] Helmholtz Zentrum Munchen, Inst Mol Immunol, Munich, Germany; [Goyal, Pankaj; Siess, Wolfgang] Klinikum LMU, Inst Prophylaxe & Epidemiol Kreislaufkrankheiten, Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Djafarzadeh, R (corresponding author), Univ Munich, Med Klin & Poliklin 4, Arbeitsgrp Klin Biochem, Munich, Germany.	peter.nelson@med.uni-muenchen.de	Notohamiprodjo, Susan/AAP-3030-2020; Siess, Wolfgang/A-6430-2009	Notohamiprodjo, Susan/0000-0002-1312-1245; Siess, Wolfgang/0000-0003-0698-6416	Deutsche Forschungsgemeinschaft [NE 468/2-3, SFB-TR36 B6, SFB-TR36 B1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by grants from the Deutsche Forschungsgemeinschaft NE 468/2-3 and SFB-TR36 B6 to Dr. Nelson and B1 to Dr. Noessner. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banas B, 2002, J IMMUNOL, V168, P4301, DOI 10.4049/jimmunol.168.9.4301; BARICOS WH, 1995, KIDNEY INT, V47, P1039, DOI 10.1038/ki.1995.150; Brauner A, 1996, AM J KIDNEY DIS, V27, P402, DOI 10.1016/S0272-6386(96)90364-9; Chen JY, 2003, NEPHROL DIAL TRANSPL, V18, P1741, DOI 10.1093/ndt/gfg275; Cohen CD, 2003, METH MOLEC MED, V86, P285; diZeregal GS, 2001, HUM REPROD UPDATE, V7, P547, DOI 10.1093/humupd/7.6.547; Djafarzadeh R, 2006, ONCOGENE, V25, P1496, DOI 10.1038/sj.onc.1209188; Djafarzadeh R, 2004, BIOL CHEM, V385, P655, DOI 10.1515/BC.2004.081; Djafarzadeh R, 2009, CANCER IMMUNOL IMMUN, V58, P361, DOI 10.1007/s00262-008-0559-5; Dobbie JW, 1997, PERITON DIALYSIS INT, V17, pS27; Edwards JG, 2003, BRIT J CANCER, V88, P1553, DOI 10.1038/sj.bjc.6600920; Eming SA, 2007, PROG HISTOCHEM CYTO, V42, P115, DOI 10.1016/j.proghi.2007.06.001; Fukudome K, 2001, NEPHRON, V87, P35, DOI 10.1159/000045882; Gotloib Lazaro, 2009, Adv Perit Dial, V25, P6; Hardman MJ, 2005, AM J PATHOL, V167, P1561, DOI 10.1016/S0002-9440(10)61241-2; Haslinger B, 2001, NEPHRON, V87, P346, DOI 10.1159/000045941; Haslinger-Loffler B, 2007, THROMB HAEMOSTASIS, V98, P813, DOI 10.1160/TH07-01-0003; JONJIC N, 1992, J EXP MED, V176, P1165, DOI 10.1084/jem.176.4.1165; Kim JJ, 2008, NEPHROL DIAL TRANSPL, V23, P534, DOI 10.1093/ndt/gfm553; KIRBY AC, 1995, BIOCHEM BIOPH RES CO, V214, P200, DOI 10.1006/bbrc.1995.2275; Klier CM, 2001, BIOL CHEM, V382, P1405, DOI 10.1515/BC.2001.173; Lakhiaev AV, 2007, THROMB RES, V120, P715, DOI 10.1016/j.thromres.2006.12.001; Li FK, 1998, KIDNEY INT, V54, P2170, DOI 10.1046/j.1523-1755.1998.00174.x; Loureiro J, 2011, J AM SOC NEPHROL, V22, P1682, DOI 10.1681/ASN.2010111197; Lv ZD, 2011, INT J MOL MED, V27, P187, DOI 10.3892/ijmm.2010.574; MACK M, 1995, P NATL ACAD SCI USA, V92, P7021, DOI 10.1073/pnas.92.15.7021; MARSHALL BC, 1993, J CLIN INVEST, V91, P1792, DOI 10.1172/JCI116390; Medof ME, 1996, FASEB J, V10, P574, DOI 10.1096/fasebj.10.5.8621057; Morrison CJ, 2009, CURR OPIN CELL BIOL, V21, P645, DOI 10.1016/j.ceb.2009.06.006; Nagase H, 2003, BIOCHEM SOC SYMP, V70, P201, DOI 10.1042/bss0700201; Nagase H, 1998, Cell Res, V8, P179; Raggi MC, 2009, BIOL CHEM, V390, P893, DOI 10.1515/BC.2009.098; Roberts AB, 1998, MINER ELECTROL METAB, V24, P111, DOI 10.1159/000057358; SCOTTCOOMBES DM, 1995, EUR J SURG, V161, P395; Singer CF, 1999, EUR J BIOCHEM, V259, P40, DOI 10.1046/j.1432-1327.1999.00001.x; SITTER T, 1995, NEPHROL DIAL TRANSPL, V10, P677; Sitter T, 1996, AM J PHYSIOL-REG I, V271, pR1256, DOI 10.1152/ajpregu.1996.271.5.R1256; van der Wal JBC, 2007, COLORECTAL DIS, V9, P9, DOI 10.1111/j.1463-1318.2007.01345.x; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; WHITAKER D, 1982, J PATHOL, V136, P291, DOI 10.1002/path.1711360404; Williams JD, 2002, J AM SOC NEPHROL, V13, P470, DOI 10.1681/ASN.V132470; Williams JD, 2003, KIDNEY INT, V63, pS158, DOI 10.1046/j.1523-1755.63.s84.46.x; Wornle M, 2009, THROMB HAEMOSTASIS, V101, P1128, DOI 10.1160/TH08-11-0744; WojtowiczPraga SM, 1997, INVEST NEW DRUG, V15, P61, DOI 10.1023/A:1005722729132; Yao V, 2004, ANZ J SURG, V74, P997, DOI 10.1111/j.1445-1433.2004.03220.x; Yu AE, 1997, DRUG AGING, V11, P229, DOI 10.2165/00002512-199711030-00006; Yu Q, 2000, GENE DEV, V14, P163; Yung S, 2009, PERITON DIALYSIS INT, V29, pS21	49	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e33963	10.1371/journal.pone.0033963	http://dx.doi.org/10.1371/journal.pone.0033963			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558080	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000008
J	Chen, QR; Huang, Y				Chen Qingrong; Huang Yan			Processing Coordinate Structures in Chinese: Evidence from Eye Movements	PLOS ONE			English	Article							SENTENCE COMPREHENSION; RELATIVE CLAUSES; TIME-COURSE; WRAP-UP; CONTEXT; PREDICTABILITY; COMPETITION; ATTACHMENT; REANALYSIS; HYPOTHESIS	This article reports the results of an eye-tracking experiment that investigated the processing of coordinate structures in Chinese sentence comprehension. The study tracked the eye movements of native Chinese readers as they read sentences consisting of two independent clauses connected by the word huo zhe. The data strongly confirmed readers' preference for an initial noun phrase (NP)-coordination parsing in Chinese coordination structure. When huo zhe was absent from the beginning of a sentence, we identified a cost associated with abandoning the NP-coordination analysis, which was evident with regard to the second NP when the coordination was unambiguous. Otherwise, this cost was evident with regard to the verb, the syntactically disambiguating region, when the coordination was ambiguous. However, the presence of a sentence-initial huo zhe reduced reading times and regressions in the huo zhe NP and the verb regions. We believe that the word huo zhe at the beginning of a sentence helps the reader predict that the sentence contains a parallel structure. Before the corresponding phrases appear, the readers can use the word huo zhe and the language structure thereafter to predicatively construct the syntactic structure. Such predictive capability can eliminate the reader's preference for NP-coordination analysis. Implications for top-down parsing theory and models of initial syntactic analysis and reanalysis are discussed.	[Chen Qingrong] Nanjing Normal Univ, Dept Psychol, Nanjing, Jiangsu, Peoples R China; [Huang Yan] Nanjing Univ, Dept Appl Foreign Language Studies, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University; Nanjing University	Chen, QR (corresponding author), Nanjing Normal Univ, Dept Psychol, Nanjing, Jiangsu, Peoples R China.	jscqr80@sina.com			Natural Science Foundation, China [31100814]; Humanities and Social Science Research Foundation; Ministry of Education, China [10YJC740044]; Philosophy and Social Science Foundation, Jiangsu Province, China [1105007]; Nanjing Normal University [1109008]	Natural Science Foundation, China(National Natural Science Foundation of China (NSFC)); Humanities and Social Science Research Foundation; Ministry of Education, China(Ministry of Education, China); Philosophy and Social Science Foundation, Jiangsu Province, China; Nanjing Normal University	This work was supported by the Natural Science Foundation, China (31100814), the Humanities and Social Science Research Foundation, the Ministry of Education, China (10YJC740044), the Philosophy and Social Science Foundation, Jiangsu Province, China (1105007), and the Nanjing Normal University Fellowship (1109008) to Qingrong Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABNEY SP, 1989, J PSYCHOLINGUIST RES, V18, P129, DOI 10.1007/BF01069051; ALTMANN GTM, 1992, J MEM LANG, V31, P685, DOI 10.1016/0749-596X(92)90035-V; BADER M, 1994, PERSPECTIVES ON SENTENCE PROCESSING, P225; Calvo MG, 2001, PSYCHOL RES-PSYCH FO, V65, P158, DOI 10.1007/s004260000050; Chen BG, 2008, ACTA PSYCHOL, V129, P61, DOI 10.1016/j.actpsy.2008.04.005; Chen E, 2005, J MEM LANG, V52, P144, DOI 10.1016/j.jml.2004.10.001; [陈庆荣 Chen Qingrong], 2010, [心理学报, Acta Psychologica Sinica], V42, P672; CRAIN S, 1985, NATURAL LANGUAGE PAR, P320, DOI DOI 10.1017/CBO9780511597855.011; CROCKER MW, 1994, PERSPECTIVES ON SENTENCE PROCESSING, P245; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; Engelhardt PE, 2004, 45 ANN PSYCH SOC M M; FODOR JD, 1980, COGNITION, V8, P417, DOI 10.1016/0010-0277(80)90003-7; FRAZIER L, 1982, COGNITIVE PSYCHOL, V14, P178, DOI 10.1016/0010-0285(82)90008-1; FRAZIER L, 1987, ATTENTION PERFORM, P559; FRAZIER L, 1978, COGNITION, V6, P291, DOI 10.1016/0010-0277(78)90002-1; Frazier L, 2000, J PSYCHOLINGUIST RES, V29, P125, DOI 10.1023/A:1005136826534; FRAZIER L, 1987, NAT LANG LINGUIST TH, V5, P519, DOI 10.1007/BF00138988; [高兵 GAO Bing], 2008, [心理学报, Acta Psychologica Sinica], V40, P381; Gibson Edward, LANGUAGE CO IN PRESS; GROBER EH, 1978, COGNITION, V6, P117, DOI 10.1016/0010-0277(78)90018-5; Hirotani M, 2006, J MEM LANG, V54, P425, DOI 10.1016/j.jml.2005.12.001; Hoeks JCJ, 2002, J MEM LANG, V46, P99, DOI 10.1006/jmla.2001.2800; Hsiao F, 2003, COGNITION, V90, P3, DOI 10.1016/S0010-0277(03)00124-0; Huang YT, 2011, J EXP PSYCHOL LEARN, V37, P966, DOI 10.1037/a0023218; Institute of Language Teaching and Research, 1986, FREQ DICT MOD CHIN; JUST MA, 1980, PSYCHOL REV, V87, P329, DOI 10.1037/0033-295X.87.4.329; Just MA, 1987, PSYCHOL READING LANG, P305; Kamide Y, 1999, LANG COGNITIVE PROC, V14, P631, DOI 10.1080/016909699386211; Konieczny L, 1997, LANG COGNITIVE PROC, V12, P307, DOI 10.1080/016909697386871; LARSON RK, 1985, NAT LANG LINGUIST TH, V3, P217, DOI 10.1007/BF00133841; Law SP, 2000, BRAIN LANG, V74, P260, DOI 10.1006/brln.2000.2341; Law SP, 2000, BRAIN LANG, V72, P310, DOI 10.1006/brln.2000.2298; MACDONALD MC, 1994, PSYCHOL REV, V101, P676, DOI 10.1037/0033-295X.101.4.676; MACDONALD MC, 1993, J MEM LANG, V32, P692, DOI 10.1006/jmla.1993.1035; McRae K, 1998, J MEM LANG, V38, P283, DOI 10.1006/jmla.1997.2543; Miao X.-C., 1996, ACTA PSYCHOL SIN, V28, P352; Nakatani K, 2008, LINGUISTICS, V46, P63, DOI 10.1515/LING.2008.003; Pickering MJ, 2001, J EXP PSYCHOL LEARN, V27, P556, DOI 10.1037//0278-7393.27.2.556; Pritchett B.L., 1992, GRAMMATICAL COMPETEN; Qiao XM, LANGUAGE CO IN PRESS; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rayner K, 2000, Q J EXP PSYCHOL-A, V53, P1061, DOI 10.1080/02724980050156290; Rayner K, 2005, PSYCHON B REV, V12, P1089, DOI 10.3758/BF03206448; Rayner K, 1996, PSYCHON B REV, V3, P504, DOI 10.3758/BF03214555; Rayner K, 2004, J EXP PSYCHOL LEARN, V30, P1290, DOI 10.1037/0278-7393.30.6.1290; Rayner K, 2004, J EXP PSYCHOL HUMAN, V30, P720, DOI 10.1037/0096-1523.30.4.720; Rayner K., 1989, PSYCHOL READING; Reichle ED, 2003, BEHAV BRAIN SCI, V26, P445, DOI 10.1017/S0140525X03000104; Schneider D, 2001, J MEM LANG, V45, P308, DOI 10.1006/jmla.2001.2777; Schneider D, 1999, THESIS U DELAWARE; Schwarz B, 1999, NAT LANG LINGUIST TH, V17, P339, DOI 10.1023/A:1006046306942; Staub A, 2006, J EXP PSYCHOL LEARN, V32, P425, DOI 10.1037/0278-7393.32.2.425; Staub A., 2007, OXFORD HDB PSYCHOLIN, P327, DOI DOI 10.1093/OXFORDHB/9780198568971.001.0001; Staub A, 2007, J MEM LANG, V57, P299, DOI 10.1016/j.jml.2006.09.001; Sturt P, 2005, COGNITIVE SCI, V29, P291, DOI 10.1207/s15516709cog0000_8; Sturt P, 1999, J MEM LANG, V40, P136, DOI 10.1006/jmla.1998.2606; Su IR, 2001, APPL PSYCHOLINGUIST, V22, P167, DOI 10.1017/S0142716401002028; Su YC, 2007, BRAIN LANG, V101, P1, DOI 10.1016/j.bandl.2006.12.001; Traxler MJ, 1998, J MEM LANG, V39, P558, DOI 10.1006/jmla.1998.2600; van Gompel RPG, 2005, J MEM LANG, V52, P284, DOI 10.1016/j.jml.2004.11.003; van Gompel RPG, 2001, J MEM LANG, V45, P225, DOI 10.1006/jmla.2001.2773; WRIGHT B, 1984, MEM COGNITION, V12, P31, DOI 10.3758/BF03196995; [武宁宁 Wu Ningning], 2002, [心理学报, Acta Psychologica Sinica], V34, P454; Yang HM, 1999, READING CHINESE SCRIPT, P207; Yang JM, 2009, MEM COGNITION, V37, P1164, DOI 10.3758/MC.37.8.1164; Zhang W. T., 1987, ACTA PSYCHOL SINICA, V1, P79; [张亚旭 Zhang Yaxu], 2002, [心理学报, Acta Psychologica Sinica], V34, P126; Zhou ZJ, 2003, PSYCHOL SCI CHINA, V26, P976; 陈永明, 1997, [心理学报, Acta Psychologica Sinica], V29, P1; 石东方, 2001, [心理学报, Acta Psychologica Sinica], V33, P7; 彭聃龄, 1993, [心理学报, Acta Psychologica Sinica], V25, P132; 陈永明, 1994, [心理学报, Acta Psychologica Sinica], V26, P113	72	5	7	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35517	10.1371/journal.pone.0035517	http://dx.doi.org/10.1371/journal.pone.0035517			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	959VP	22558163	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345200044
J	Pathak, S; Rege, M; Gogtay, NJ; Aigal, U; Sharma, SK; Valecha, N; Bhanot, G; Kshirsagar, NA; Sharma, S				Pathak, Sulabha; Rege, Mayuri; Gogtay, Nithya J.; Aigal, Umesh; Sharma, Surya Kant; Valecha, Neena; Bhanot, Gyan; Kshirsagar, Nilima A.; Sharma, Shobhona			Age-Dependent Sex Bias in Clinical Malarial Disease in Hypoendemic Regions	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; ANOPHELES-GAMBIAE; PARASITE DENSITY; VIVAX MALARIA; EPIDEMIOLOGY; TRANSMISSION; POPULATION; CHILDREN; ORISSA; INDIA	Background and Objectives: Experimental models show a male bias in murine malaria; however, extant literature on biases in human clinical malaria is inconclusive. Studies in hyperendemic areas document an absence of sexual dimorphism in clinical malaria. Data on sex bias in clinical malaria in hypoendemic areas is ambiguous-some reports note a male bias but do not investigate the role of differential mosquito exposure in that bias. Moreover, these studies do not examine whether the bias is age related. This study investigates whether clinical malaria in hypoendemic regions exhibits a sex bias and whether this bias is age-dependent. We also consider the role of vector exposure in this bias. Methods: Retrospective passive clinical malaria datasets (2002-2007) and active surveillance datasets (2000-2009) were captured for the hypoendemic Mumbai region in Western India. To validate findings, passive retrospective data was captured from a primary malaria clinic (2006-2007) in hypoendemic Rourkela (Eastern India). Data was normalized by determining percent slide-positivity rates (SPRs) for males and females, and parasite-positivity distributions were established across age groups. The Mann-Whitney test, Wilcoxon Signed Rank test, and Chi-square analysis were used to determine statistical significances. Results: In both the Mumbai and Rourkela regions, clinical malaria exhibited an adult male bias (p<0.01). A sex bias was not observed in children aged <= 10. Post-puberty, male SPRs were significantly greater than females SPRs (p<0.01). This adult male bias was observed for both vivax and falciparum clinical disease. Analysis of active surveillance data did not reveal an age or sex bias in the frequency of parasite positivity. Conclusion: This study demonstrates an age-dependent sex bias in clinical malaria in hypoendemic regions and enhanced incidence of clinical malaria in males following puberty. Possible roles of sex hormones, vector exposure, co-infections, and other factors in this enhanced susceptibility are discussed.	[Pathak, Sulabha; Rege, Mayuri; Sharma, Shobhona] Tata Inst Fundamental Res, Dept Biol Sci, Mumbai 400005, Maharashtra, India; [Gogtay, Nithya J.; Kshirsagar, Nilima A.] King Edward Mem Hosp, Dept Clin Pharmacol, Seth GS Med Coll, Bombay, Maharashtra, India; [Sharma, Surya Kant] Natl Inst Malaria Res, Field Stn, Odisha, India; [Aigal, Umesh] Kasturba Hosp Infect Dis, Mumbai, Maharashtra, India; [Valecha, Neena] Natl Inst Malaria Res ICMR, New Delhi, India; [Bhanot, Gyan] Rutgers State Univ, Dept Phys, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Tata Institute of Fundamental Research (TIFR); Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Rutgers State University New Brunswick	Pathak, S (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Mumbai 400005, Maharashtra, India.	suepathak@tifr.res.in			Homi Bhabha Research Council, Tata Institute of Fundamental Research, Mumbai, India; Homi Bhabha Fellowship	Homi Bhabha Research Council, Tata Institute of Fundamental Research, Mumbai, India; Homi Bhabha Fellowship	This work was supported by the Homi Bhabha Research Council, Tata Institute of Fundamental Research, Mumbai, India. Dr. Pathak is the recipient of Homi Bhabha Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1977, BIONOMICS MALARIA VE; Balmer P, 2000, PARASITOLOGY, V121, P473, DOI 10.1017/S0031182099006757; Barik TK, 2009, ACTA TROP, V109, P87, DOI 10.1016/j.actatropica.2008.09.017; Basu S, 2005, INDIAN PEDIATR, V42, P593; Benegal V, 2005, ADDICTION, V100, P1051, DOI 10.1111/j.1360-0443.2005.01176.x; Bhaskaran Mythili, 2003, Indian J Physiol Pharmacol, V47, P361; Camargo LMA, 1996, AM J TROP MED HYG, V55, P32, DOI 10.4269/ajtmh.1996.55.32; CARNEVALE P, 1978, B WORLD HEALTH ORGAN, V56, P147; CATTANI JA, 1986, AM J TROP MED HYG, V35, P3, DOI 10.4269/ajtmh.1986.35.3; Cernetich A, 2006, INFECT IMMUN, V74, P3190, DOI 10.1128/IAI.00008-06; Das A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-377; Delic D, 2011, STEROIDS, V76, P1204, DOI 10.1016/j.steroids.2011.05.013; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Golenda CF, 1999, AM J TROP MED HYG, V60, P654, DOI 10.4269/ajtmh.1999.60.654; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Hati AK, 1997, INDIAN J MED RES, V106, P149; Iyer A, 2007, INT J HEALTH SERV, V37, P537, DOI 10.2190/1146-7828-5L5H-7757; Kakkar V, 2007, MATURITAS, V57, P306, DOI 10.1016/j.maturitas.2007.02.026; Kamat V., 2000, Parassitologia (Rome), V42, P135; Khasnis AA, 2005, ARCH MED RES, V36, P689, DOI 10.1016/j.arcmed.2005.03.041; Klein SL, 2004, PARASITE IMMUNOL, V26, P247, DOI 10.1111/j.0141-9838.2004.00710.x; Kleinschmidt I, 2001, TROP MED INT HEALTH, V6, P986, DOI 10.1046/j.1365-3156.2001.00817.x; Krucken J, 2005, PARASITE IMMUNOL, V27, P205, DOI 10.1111/j.1365-3024.2005.00763.x; Kshirsagar NA, 2000, AM J TROP MED HYG, V62, P402, DOI 10.4269/ajtmh.2000.62.402; Kumar A, 2007, AM J TROP MED HYG, V77, P69, DOI 10.4269/ajtmh.2007.77.69; Kurtis JD, 2001, INFECT IMMUN, V69, P123, DOI 10.1128/IAI.69.1.123-128.2001; LANDGRAF B, 1994, T ROY SOC TROP MED H, V88, P73, DOI 10.1016/0035-9203(94)90505-3; Leenstra T, 2003, J INFECT DIS, V188, P297, DOI 10.1086/376508; Lefevre T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009546; Luxemburger C, 1997, T ROY SOC TROP MED H, V91, P256, DOI 10.1016/S0035-9203(97)90066-3; Luxemburger C, 1996, T ROY SOC TROP MED H, V90, P105, DOI 10.1016/S0035-9203(96)90102-9; Mannoor MK, 2002, J IMMUNOL, V169, P301, DOI 10.4049/jimmunol.169.1.301; Marwaha RK, 2011, CLIN ENDOCRINOL OXF, DOI [10.1111/j.1365-2265, DOI 10.1111/J.1365-2265]; METSELAAR D., 1959, Tropical and Geographical Medicine, V11, P157; Mohanty S, 2003, T ROY SOC TROP MED H, V97, P69, DOI 10.1016/S0035-9203(03)90027-7; Molineaux, 1980, GARKI PROJECT, P109; Moon Jung Ju, 2001, Korean Journal of Parasitology, V39, P293, DOI 10.3347/kjp.2001.39.4.293; Muturi EJ, 2008, PARASITOL RES, V102, P175, DOI 10.1007/s00436-007-0779-1; Nacher M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-259; Nirmalan PK, 2004, INVEST OPHTH VIS SCI, V45, P4273, DOI 10.1167/iovs.04-0285; Nyakeriga AM, 2004, J INFECT DIS, V190, P439, DOI 10.1086/422331; OKOJIE CEE, 1994, SOC SCI MED, V39, P1237, DOI 10.1016/0277-9536(94)90356-5; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Pierce SK, 2009, J IMMUNOL, V182, P5171, DOI 10.4049/jimmunol.0804153; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Proos LA, 2009, INDIAN J MED RES, V130, P646; Qiu YT, 2006, MED VET ENTOMOL, V20, P280, DOI 10.1111/j.1365-2915.2006.00627.x; Raghavendra K, 2002, ICMR B, P10; Rajgor DD, 2003, T ROY SOC TROP MED H, V97, P438, DOI 10.1016/S0035-9203(03)90082-4; Schofield L, 2006, CURR MOL MED, V6, P205, DOI 10.2174/156652406776055221; Sharma SK, 2004, AM J TROP MED HYG, V71, P457, DOI 10.4269/ajtmh.2004.71.457; Sharma SK, 2006, T ROY SOC TROP MED H, V100, P917, DOI 10.1016/j.trstmh.2006.01.007; SHARP P T, 1980, Papua New Guinea Medical Journal, V23, P132; Smallegange RC, 2011, TRENDS PARASITOL, V27, P143, DOI 10.1016/j.pt.2010.12.009; Snow RW, 1998, BRIT MED BULL, V54, P293, DOI 10.1093/oxfordjournals.bmb.a011689; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Steketee RW, 1996, AM J TROP MED HYG, V55, P2, DOI 10.4269/ajtmh.1996.55.2; Sur D, 2006, T ROY SOC TROP MED H, V100, P725, DOI 10.1016/j.trstmh.2005.10.019; Troye-Blomberg M, 2008, MICROBES INFECT, V10, P948, DOI 10.1016/j.micinf.2008.07.014; WILSON D. Bagster, 1936, Transactions of the Royal Society of Tropical Medicine and Hygiene, V29, P583, DOI 10.1016/S0035-9203(36)90040-8; WUNDERLICH F, 1991, PARASITE IMMUNOL, V13, P357, DOI 10.1111/j.1365-3024.1991.tb00289.x; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI 10.1016/S0020-7519(96)80001-4	63	39	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35592	10.1371/journal.pone.0035592	http://dx.doi.org/10.1371/journal.pone.0035592			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558172	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345200051
J	Seko, Y; Azuma, N; Kaneda, M; Nakatani, K; Miyagawa, Y; Noshiro, Y; Kurokawa, R; Okano, H; Umezawa, A				Seko, Yuko; Azuma, Noriyuki; Kaneda, Makoto; Nakatani, Kei; Miyagawa, Yoshitaka; Noshiro, Yuuki; Kurokawa, Reiko; Okano, Hideyuki; Umezawa, Akihiro			Derivation of Human Differential Photoreceptor-like Cells from the Iris by Defined Combinations of CRX, RX and NEUROD	PLOS ONE			English	Article							RETINAL STEM-CELLS; PIGMENT EPITHELIAL-CELLS; GANGLION-CELLS; PROGENITOR CELLS; VISUAL FUNCTION; HOMEOBOX GENE; EXPRESSION; MELANOPSIN; EYE; TRANSPLANTATION	Examples of direct differentiation by defined transcription factors have been provided for beta-cells, cardiomyocytes and neurons. In the human visual system, there are four kinds of photoreceptors in the retina. Neural retina and iris-pigmented epithelium (IPE) share a common developmental origin, leading us to test whether human iris cells could differentiate to retinal neurons. We here define the transcription factor combinations that can determine human photoreceptor cell fate. Expression of rhodopsin, blue opsin and green/red opsin in induced photoreceptor cells were dependent on combinations of transcription factors: A combination of CRX and NEUROD induced rhodopsin and blue opsin, but did not induce green opsin; a combination of CRX and RX induced blue opsin and green/red opsin, but did not induce rhodopsin. Phototransduction-related genes as well as opsin genes were up-regulated in those cells. Functional analysis; i.e. patch clamp recordings, clearly revealed that generated photoreceptor cells, induced by CRX, RX and NEUROD, responded to light. The response was an inward current instead of the typical outward current. These data suggest that photosensitive photoreceptor cells can be generated by combinations of transcription factors. The combination of CRX and RX generate immature photoreceptors: and additional NEUROD promotes maturation. These findings contribute substantially to a major advance toward eventual cell-based therapy for retinal degenerative diseases.	[Seko, Yuko; Kurokawa, Reiko; Umezawa, Akihiro] Natl Inst Child Hlth & Dev, Ctr Regenerat Med, Dept Reprod Biol, Okura, Setagaya, Japan; [Seko, Yuko; Miyagawa, Yoshitaka; Noshiro, Yuuki] Natl Rehabil Ctr Persons Disabil, Res Inst, Sensory Funct Sect, Tokorozawa, Saitama, Japan; [Azuma, Noriyuki] Natl Ctr Child Hlth & Dev, Dept Ophthalmol, Tokyo, Japan; [Kaneda, Makoto; Okano, Hideyuki] Keio Univ, Dept Physiol, Sch Med, Shinanomachi, Japan; [Nakatani, Kei] Univ Tsukuba, Inst Biol Sci, Ten Noudai, Japan	National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; Keio University; University of Tsukuba	Seko, Y (corresponding author), Natl Inst Child Hlth & Dev, Ctr Regenerat Med, Dept Reprod Biol, Okura, Setagaya, Japan.	umezawa@1985.jukuin.keio.ac.jp	Okano, Hideyuki/I-7584-2019	Miyagawa, Yoshitaka/0000-0003-2629-7503	MEXT; Grants-in-Aid for Scientific Research [24659770, 22390327] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-aid for the Global COE program from MEXT to Keio University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akagi T, 2005, INVEST OPHTH VIS SCI, V46, P3411, DOI 10.1167/iovs.04-1112; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Coles BLK, 2004, P NATL ACAD SCI USA, V101, P15772, DOI 10.1073/pnas.0401596101; Fischer AJ, 2001, NAT NEUROSCI, V4, P247, DOI 10.1038/85090; Foster RG, 1998, NEURON, V20, P829, DOI 10.1016/S0896-6273(00)80464-X; Froen RC, 2011, ACTA OPHTHALMOL, V89, pe635, DOI 10.1111/j.1755-3768.2011.02198.x; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Hartwick ATE, 2007, J NEUROSCI, V27, P13468, DOI 10.1523/JNEUROSCI.3626-07.2007; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Inoue T, 2010, STEM CELLS, V28, P489, DOI 10.1002/stem.279; Kohyama J, 2001, DIFFERENTIATION, V68, P235, DOI 10.1046/j.1432-0436.2001.680411.x; Lamba DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008763; Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015; Liu H, 2008, J NEUROSCI, V28, P749, DOI 10.1523/JNEUROSCI.4832-07.2008; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; MacNeil A, 2007, STEM CELLS, V25, P2430, DOI 10.1634/stemcells.2007-0035; Manavathi B, 2007, P NATL ACAD SCI USA, V104, P13128, DOI 10.1073/pnas.0705878104; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Miyagawa Y, 2008, MOL CELL BIOL, V28, P2125, DOI 10.1128/MCB.00740-07; Morrow EM, 1999, DEVELOPMENT, V126, P23; Ochocinska MJ, 2009, MECH DEVELOP, V126, P128, DOI 10.1016/j.mod.2008.11.009; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Radke ND, 2004, ARCH OPHTHALMOL-CHIC, V122, P1159, DOI 10.1001/archopht.122.8.1159; Rehemtulla A, 1996, P NATL ACAD SCI USA, V93, P191, DOI 10.1073/pnas.93.1.191; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Sidman RL, 1961, STRUCTURE EYE, P487; Sun GW, 2006, DEV BIOL, V289, P243, DOI 10.1016/j.ydbio.2005.10.035; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Xue T, 2011, NATURE, V479, P67, DOI 10.1038/nature10567; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	38	31	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35611	10.1371/journal.pone.0035611	http://dx.doi.org/10.1371/journal.pone.0035611			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558175	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345200052
J	Choi, H; Wang, L; Lin, XH; Spengler, JD; Perera, FP				Choi, Hyunok; Wang, Lu; Lin, Xihong; Spengler, John D.; Perera, Frederica P.			Fetal Window of Vulnerability to Airborne Polycyclic Aromatic Hydrocarbons on Proportional Intrauterine Growth Restriction	PLOS ONE			English	Article							IN-UTERO EXPOSURE; BODY PROPORTIONALITY; PRENATAL EXPOSURE; DNA-ADDUCTS; BENZO(A)PYRENE; RETARDATION; PREGNANCY; RECEPTOR; MOTHERS; IMPACT	Background: Although the entire duration of fetal development is generally considered a highly susceptible period, it is of public health interest to determine a narrower window of heightened vulnerability to polycyclic aromatic hydrocarbons (PAHs) in humans. We posited that exposure to PAHs during the first trimester impairs fetal growth more severely than a similar level of exposure during the subsequent trimesters. Methods: In a group of healthy, non-smoking pregnant women with no known risks of adverse birth outcomes, personal exposure to eight airborne PAHs was monitored once during the second trimester for the entire cohort (n = 344), and once each trimester within a subset (n = 77). Both air monitoring and self-reported PAH exposure data were used in order to statistically estimate PAH exposure during the entire gestational period for each individual newborn. Results: One natural-log unit increase in prenatal exposure to the eight summed PAHs during the first trimester was associated with the largest decrement in the Fetal Growth Ratio (FGR) (-3%, 95% Confidence Interval (CI), -5 to -0%), birthweight (-105 g, 95% CI, -188 to -22 g), and birth length (-0.78 cm, 95% CI, -1.30 to -0.26 cm), compared to the unit effects of PAHs during the subsequent trimesters, after accounting for confounders. Furthermore, a unit exposure during the first trimester was associated with the largest elevation in Cephalization Index (head to weight ratio) (3 mu m/g, 95% CI, 1 to 5 mu m/g). PAH exposure was not associated with evidence of asymmetric growth restriction in this cohort. Conclusion: PAH exposure appears to exert the greatest adverse effect on fetal growth during the first trimester. The present data support the need for the protection of pregnant women and the embryo/fetus, particularly during the earliest stage of pregnancy.	[Choi, Hyunok; Spengler, John D.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Wang, Lu] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Lin, Xihong] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Perera, Frederica P.] Mailman Sch Publ Hlth, Columbia Ctr Childrens Environm Hlth, New York, NY USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Michigan System; University of Michigan; Harvard University; Harvard T.H. Chan School of Public Health	Choi, H (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	hchoi@albany.edu			National Institute of Environmental Health Sciences (NIEHS) [5 P01 ES009600, R01ES014939, 5 R01 ES008977, 5 R01ES11158, 5 R01 ES012468, 5 R01ES10165]; US Environmental Protection Agency [R827027, 82860901, RD-832141]; US National Research Service Award [T32 ES 07069]; Irving General Clinical Research Center [RR00645]; Gladys & Roland Harriman Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007069, R01ES012468, R01ES008977, R01ES010165, R01ES011158, P01ES009600, R01ES015282] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); US Environmental Protection Agency(United States Environmental Protection Agency); US National Research Service Award; Irving General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Gladys & Roland Harriman Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by The National Institute of Environmental Health Sciences (NIEHS) (grant numbers 5 P01 ES009600, R01ES014939, 5 R01 ES008977, 5 R01ES11158, 5 R01 ES012468, 5 R01ES10165), the US Environmental Protection Agency (grant numbers R827027, 82860901, RD-832141), the US National Research Service Award (T32 ES 07069), Irving General Clinical Research Center (grant number RR00645), and The Gladys & Roland Harriman Foundation. None of the authors has any actual or potential competing financial interests. E. Evans, R. Whyatt, H. Andrews, L. Hoepner, W. Jedrychowski, R. Jacek, E. Mroz, A. Pac, E. Flak, W. Tsai, D. Tang, and J. Yu contributed to the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATSDR (Agency for Toxic Substances and Disease Registry), 1995, TOX PROF POL AR HYDR; Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009; Bocskay KA, 2005, CANCER EPIDEM BIOMAR, V14, P506, DOI 10.1158/1055-9965.EPI-04-0566; Bostrom CE, 2002, ENVIRON HEALTH PERSP, V110, P451, DOI 10.1289/ehp.02110s3451; Brown LA, 2007, NEUROTOXICOLOGY, V28, P965, DOI 10.1016/j.neuro.2007.05.005; Castro DJ, 2008, TOXICOL APPL PHARM, V233, P454, DOI 10.1016/j.taap.2008.09.009; Chaddha Vandana, 2004, Semin Fetal Neonatal Med, V9, P357, DOI 10.1016/j.siny.2004.03.006; Choi H, 2008, ENVIRON HEALTH PERSP, V116, P1509, DOI 10.1289/ehp.10972; Choi H, 2008, ENVIRON HEALTH PERSP, V116, P658, DOI 10.1289/ehp.10958; Choi H, 2006, ENVIRON HEALTH PERSP, V114, P1744, DOI 10.1289/ehp.8982; Dejmek J, 2000, ENVIRON HEALTH PERSP, V108, P1159, DOI 10.2307/3434828; Detmar J, 2008, AM J PHYSIOL-ENDOC M, V295, pE519, DOI 10.1152/ajpendo.90436.2008; FinlaysonPitts BJ, 1997, SCIENCE, V276, P1045, DOI 10.1126/science.276.5315.1045; GUYDA HJ, 1990, MOL PHARMACOL, V37, P137; Hemachandra AH, 2006, AM J HUM BIOL, V18, P791, DOI 10.1002/ajhb.20552; IARC (International Agency of Research on Cancer), 1983, IARC MON EV CARC RIS, V32; Junninen H, 2009, ENVIRON SCI TECHNOL, V43, P7964, DOI 10.1021/es8032082; KRAMER MS, 1990, PEDIATRICS, V86, P707; KRAMER MS, 1989, PEDIATRICS, V84, P717; Leitner Y, 2007, J CHILD NEUROL, V22, P580, DOI 10.1177/0883073807302605; Lipsett J, 2006, PEDIATR PULM, V41, P1138, DOI 10.1002/ppul.20480; LU LJW, 1993, CARCINOGENESIS, V14, P1805, DOI 10.1093/carcin/14.9.1805; Malinowski A, 1998, LODZKI CHILD METHODS, P70; Martin-Gronert MS, 2007, J INTERN MED, V261, P437, DOI 10.1111/j.1365-2796.2007.01800.x; Milani S, 2005, PEDIATR RES, V57, P205, DOI 10.1203/01.PDR.0000148452.98518.D5; Nepomnyaschy L, 2006, AM J PUBLIC HEALTH, V96, P1604, DOI 10.2105/AJPH.2005.079400; Neufeld L, 1999, AM J HUM BIOL, V11, P638, DOI 10.1002/(SICI)1520-6300(199909/10)11:5<638::AID-AJHB7>3.0.CO;2-Q; Perera F, 2005, CANCER EPIDEM BIOMAR, V14, P709, DOI 10.1158/1055-9965.EPI-04-0457; Perera F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004488; Perera FP, 2009, PEDIATRICS, V124, pE195, DOI 10.1542/peds.2008-3506; R Core Team, 2022, R LANG ENV STAT COMP; Ramsay J.O., 1997, FUNCTIONAL DATA ANAL; Rodriguez JW, 2002, IMMUNOPHARM IMMUNOT, V24, P365, DOI 10.1081/IPH-120014723; SANYAL MK, 1993, AM J OBSTET GYNECOL, V168, P1587, DOI 10.1016/S0002-9378(11)90803-5; Sanyal MK, 2007, BIRTH DEFECTS RES B, V80, P367, DOI 10.1002/bdrb.20122; Sizonenko SV, 2006, MOL CELL ENDOCRINOL, V254, P163, DOI 10.1016/j.mce.2006.04.035; Smith GCS, 2004, SEMIN PERINATOL, V28, P41, DOI 10.1053/j.semperi.2003.10.012; Sram RJ, 1999, MUTAT RES-FUND MOL M, V428, P203, DOI 10.1016/S1383-5742(99)00048-4; van Wassenaer Aleid, 2005, Pediatr Endocrinol Rev, V2, P372; VILLAR J, 1990, AM J OBSTET GYNECOL, V163, P151, DOI 10.1016/S0002-9378(11)90690-5; Wang S, 2010, ANN HUM GENET, V74, P46, DOI 10.1111/j.1469-1809.2009.00550.x; WHO, 1998, ENV HLTH CRIT 202 SE; World Health Organization, 2000, AIR QUALITY GUIDELIN, V2nd; Xu Y, 2006, FASEB J, V20, P1251, DOI 10.1096/fj.05-4917fje; Yu Z, 2006, CANCER RES, V66, P755, DOI 10.1158/0008-5472.CAN-05-3390; Zhang LY, 1997, BIOCHEM BIOPH RES CO, V231, P117, DOI 10.1006/bbrc.1997.6053	46	49	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35464	10.1371/journal.pone.0035464	http://dx.doi.org/10.1371/journal.pone.0035464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545107	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343200028
J	Eamens, AL; Kim, KW; Curtin, SJ; Waterhouse, PM				Eamens, Andrew L.; Kim, Ki Wook; Curtin, Shaun J.; Waterhouse, Peter M.			DRB2 Is Required for MicroRNA Biogenesis in Arabidopsis thaliana	PLOS ONE			English	Article							SHAPED-COTYLEDON GENES; DSRNA-BINDING PROTEINS; TRANS-ACTING SIRNAS; DICER-LIKE PROTEINS; ARTIFICIAL MICRORNAS; TRANSCRIPTION FACTOR; MERISTEM FORMATION; PLANT DEVELOPMENT; RNA BIOGENESIS; PRI-MIRNA	Background: The Arabidopsis thaliana (Arabidopsis) DOUBLE-STRANDED RNA BINDING (DRB) protein family consists of five members, DRB1 to DRB5. The biogenesis of two developmentally important small RNA (sRNA) species, the microRNAs (miRNAs) and trans-acting small interfering RNAs (tasiRNAs) by DICER-LIKE (DCL) endonucleases requires the assistance of DRB1 and DRB4 respectively. The importance of miRNA-directed target gene expression in plant development is exemplified by the phenotypic consequence of loss of DRB1 activity (drb1 plants). Principal Findings: Here we report that the developmental phenotype of the drb235 triple mutant plant is the result of deregulated miRNA biogenesis in the shoot apical meristem (SAM) region. The expression of DRB2, DRB3 and DRB5 in wild-type seedlings is restricted to the SAM region. Small RNA sequencing of the corresponding tissue of drb235 plants revealed altered miRNA accumulation. Approximately half of the miRNAs detected remained at levels equivalent to those of wild-type plants. However, the accumulation of the remaining miRNAs was either elevated or reduced in the triple mutant. Examination of different single and multiple drb mutants revealed a clear association between the loss of DRB2 activity and altered accumulation for both the elevated and reduced miRNA classes. Furthermore, we show that the constitutive overexpression of DRB2 outside of its wild-type expression domain can compensate for the loss of DRB1 activity in drb1 plants. Conclusions/Significance: Our results suggest that in the SAM region, DRB2 is both antagonistic and synergistic to the role of DRB1 in miRNA biogenesis, adding an additional layer of gene regulatory complexity in this developmentally important tissue.	[Eamens, Andrew L.; Kim, Ki Wook; Waterhouse, Peter M.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Curtin, Shaun J.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA; [Waterhouse, Peter M.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Waterhouse, Peter M.] CSIRO Plant Ind, Canberra, ACT, Australia	University of Sydney; University of Minnesota System; University of Minnesota Twin Cities; University of Sydney; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Eamens, AL (corresponding author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.	andrew.eamens@sydney.edu.au; peter.waterhouse@sydney.edu.au	Kim, Ki Wook/AAV-6899-2020	Kim, Ki Wook/0000-0001-9579-6408; Waterhouse, Peter/0000-0002-2812-3753; Curtin, Shaun/0000-0002-9528-3335; Eamens, Andrew/0000-0002-6327-3618	Australian Research Council Discovery Grant [DP0989050]	Australian Research Council Discovery Grant(Australian Research Council)	This work was funded by the Australian Research Council Discovery Grant (DP0989050). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adenot X, 2006, CURR BIOL, V16, P927, DOI 10.1016/j.cub.2006.03.035; Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Allen RS, 2007, P NATL ACAD SCI USA, V104, P16371, DOI 10.1073/pnas.0707653104; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Baker CC, 2005, CURR BIOL, V15, P303, DOI 10.1016/j.cub.2005.02.017; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Boisnard-Lorig C, 2001, PLANT CELL, V13, P495, DOI 10.1105/tpc.13.3.495; Boutet S, 2003, CURR BIOL, V13, P843, DOI 10.1016/S0960-9822(03)00293-8; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtin SJ, 2008, FEBS LETT, V582, P2753, DOI 10.1016/j.febslet.2008.07.004; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Dong Z, 2008, P NATL ACAD SCI USA, V105, P9970, DOI 10.1073/pnas.0803356105; Eamens AL, 2011, MOL PLANT, V4, P157, DOI 10.1093/mp/ssq061; Eamens AL, 2009, RNA, V15, P2219, DOI 10.1261/rna.1646909; Fang YD, 2007, CURR BIOL, V17, P818, DOI 10.1016/j.cub.2007.04.005; Fujioka Y, 2007, PLANT CELL PHYSIOL, V48, P1243, DOI 10.1093/pcp/pcm099; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; Hasson A, 2011, PLANT CELL, V23, P54, DOI 10.1105/tpc.110.081448; Hiraguri A, 2005, PLANT MOL BIOL, V57, P173, DOI 10.1007/s11103-004-6853-5; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kurihara Y, 2006, RNA, V12, P206, DOI 10.1261/rna.2146906; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Larue CT, 2009, PLANT J, V58, P450, DOI 10.1111/j.1365-313X.2009.03796.x; Laufs P, 2004, DEVELOPMENT, V131, P4311, DOI 10.1242/dev.01320; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Lu C, 2000, PLANT CELL, V12, P2351, DOI 10.1105/tpc.12.12.2351; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Margis R, 2006, FEBS LETT, V580, P2442, DOI 10.1016/j.febslet.2006.03.072; Nakazawa Y, 2007, PLANT MOL BIOL, V63, P777, DOI 10.1007/s11103-006-9125-8; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Pelissier T, 2011, RNA, V17, P1502, DOI 10.1261/rna.2680711; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Raman S, 2008, PLANT J, V55, P65, DOI 10.1111/j.1365-313X.2008.03483.x; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Schwab R, 2010, METHODS MOL BIOL, V592, P71, DOI 10.1007/978-1-60327-005-2_6; Song L, 2007, P NATL ACAD SCI USA, V104, P5437, DOI 10.1073/pnas.0701061104; Takada S, 2001, DEVELOPMENT, V128, P1127; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vaucheret H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006442; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1	49	53	56	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35933	10.1371/journal.pone.0035933	http://dx.doi.org/10.1371/journal.pone.0035933			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545148	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343200068
J	Liu, C; Qin, XQ; Liu, HJ; Xiang, Y				Liu, Chi; Qin, Xiaoqun; Liu, Huijun; Xiang, Yang			Downregulation of Integrin beta 4 Decreases the Ability of Airway Epithelial Cells to Present Antigens	PLOS ONE			English	Article							EXPRESSION; ASTHMA; LUNG; PATHOGENESIS; IMMUNITY; INNATE; B7-H1	Airway epithelial cells have been demonstrated to be accessory antigen presentation cells (APC) capable of activating T cells and may play an important role in the development of allergic airway inflammation of asthma. In asthmatic airways, loss of expression of the adhesion molecule integrin beta 4 (ITGB4) and an increase in Th2 inflammation bias has been observed in our previous study. Given that ITGB4 is engaged in multiple signaling pathways, we studied whether disruption of ITGB4-mediated cell adhesion may contribute to the adaptive immune response of epithelial cells, including their ability to present antigens, induce the activate and differentiate of T cells. We silenced ITGB4 expression in bronchial epithelial cells with an effective siRNA vector and studied the effects of ITGB4 silencing on the antigen presentation ability of airway epithelial cells. T cell proliferation and cytokine production was investigated after co-culturing with ITGB4-silenced epithelial cells. Surface expression of B7 homologs and the major histocompatibility complex (MHC) class II was also detected after ITGB4 was silenced. Our results demonstrated that silencing of ITGB4 resulted in impaired antigen presentation processes and suppressed T cell proliferation. Meanwhile, decrease in Th1 cytokine production and increase in Th17 cytokine production was induced after co-culturing with ITGB4-silenced epithelial cells. Moreover, HLA-DR was decreased and the B7 homologs expression was different after ITGB4 silencing. Overall, this study suggested that downregulation of ITGB4 expression in airway epithelial cells could impair the antigen presentation ability of these cells, which further regulate airway inflammation reaction in allergic asthma.	[Liu, Chi; Qin, Xiaoqun; Liu, Huijun; Xiang, Yang] Cent S Univ, Xiangya Med Sch, Dept Physiol, Changsha, Hunan, Peoples R China	Central South University	Liu, C (corresponding author), Cent S Univ, Xiangya Med Sch, Dept Physiol, Changsha, Hunan, Peoples R China.	liuchi7669@gmail.com			National Natural Science Foundation of China [81100016, 81170024]; National Basic Research Program of China [10K079]; key project from Hunan Science and Technology plans [2007FJ3009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); key project from Hunan Science and Technology plans	This work was supported by grants 81100016 and 81170024 from National Natural Science Foundation of China, grant 10K079 from National Basic Research Program of China and the key project (grant 2007FJ3009) from Hunan Science and Technology plans. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bugeon L, 2000, AM J RESP CRIT CARE, V162, pS164, DOI 10.1164/ajrccm.162.supplement_3.15tac5; CUNNINGHAM AC, 1994, J CELL SCI, V107, P443; Evans CM, 2009, PHARMACOL THERAPEUT, V121, P332, DOI 10.1016/j.pharmthera.2008.11.001; Flohe S, 2004, INTENS CARE MED, V30, P96, DOI 10.1007/s00134-003-2041-3; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Hackett TL, 2007, CURR OPIN ALLERGY CL, V7, P63, DOI 10.1097/ACI.0b013e328013d61b; Haczku A, 1999, AM J RESP CRIT CARE, V159, P1638, DOI 10.1164/ajrccm.159.5.9711040; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; Heijink IH, 2007, J IMMUNOL, V178, P7678, DOI 10.4049/jimmunol.178.12.7678; Heinecke L, 2008, J ALLERGY CLIN IMMUN, V121, P1155, DOI 10.1016/j.jaci.2008.02.009; Holgate Stephen T, 2008, Allergol Int, V57, P1, DOI 10.2332/allergolint.R-07-154; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Holgate ST, 2007, TRENDS IMMUNOL, V28, P248, DOI 10.1016/j.it.2007.04.007; Holgate Stephen T, 2009, Proc Am Thorac Soc, V6, P655, DOI 10.1513/pats.200907-072DP; Holgate ST, 2009, IMMUNITY, V31, P362, DOI 10.1016/j.immuni.2009.08.013; Holt PG, 2008, NAT REV IMMUNOL, V8, P142, DOI 10.1038/nri2236; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Koff JL, 2008, AM J PHYSIOL-LUNG C, V294, pL1068, DOI 10.1152/ajplung.00025.2008; Kurosawa S, 2003, AM J RESP CELL MOL, V28, P563, DOI 10.1165/rcmb.2002-0199OC; Liu C, 2010, ACTA BIOCH BIOPH SIN, V42, P538, DOI 10.1093/abbs/gmq058; Liu C, 2010, MOL CELL BIOCHEM, V341, P259, DOI 10.1007/s11010-010-0457-y; Liu JZ, 2007, BLOOD, V110, P296, DOI 10.1182/blood-2006-10-051482; Nakajima Hiroshi, 2010, Immune Netw, V10, P1, DOI 10.4110/in.2010.10.1.1; Nembrini C, 2009, J ALLERGY CLIN IMMUN, V123, P986, DOI 10.1016/j.jaci.2009.03.033; Oei E, 2004, AM J PHYSIOL-LUNG C, V287, pL318, DOI 10.1152/ajplung.00174.2003; Park HJ, 2009, INT IMMUNOPHARMACOL, V9, P261, DOI 10.1016/j.intimp.2008.10.021; Prasad DVR, 2004, J IMMUNOL, V173, P2500, DOI 10.4049/jimmunol.173.4.2500; Salik E, 1999, AM J RESP CELL MOL, V21, P365, DOI 10.1165/ajrcmb.21.3.3529; Siddiqui S, 2008, CURR ALLERGY ASTHM R, V8, P540, DOI 10.1007/s11882-008-0098-3; Song CW, 2008, J IMMUNOL, V181, P6117, DOI 10.4049/jimmunol.181.9.6117; Takizawa Hajime, 2005, Current Drug Targets - Inflammation and Allergy, V4, P305, DOI 10.2174/1568010054022123; Wan X, 2009, ONCOGENE, V28, P3401, DOI 10.1038/onc.2009.206; Wang YL, 2008, RESP MED, V102, P949, DOI 10.1016/j.rmed.2008.01.017; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC	34	31	35	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e32060	10.1371/journal.pone.0032060	http://dx.doi.org/10.1371/journal.pone.0032060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545078	Green Submitted, gold, Green Published			2022-12-25	WOS:000305343200001
J	Tang, L; Guo, T; Yang, R; Mei, H; Wang, HF; Lu, X; Yu, JM; Wang, QY; Hu, Y				Tang, Liang; Guo, Tao; Yang, Rui; Mei, Heng; Wang, Huafang; Lu, Xuan; Yu, Jianming; Wang, Qingyun; Hu, Yu			Genetic Background Analysis of Protein C Deficiency Demonstrates a Recurrent Mutation Associated with Venous Thrombosis in Chinese Population	PLOS ONE			English	Article							MISSENSE MUTATIONS; BLOOD-COAGULATION; MESSENGER-RNA; RISK-FACTOR; ANTITHROMBIN; SEQUENCE; DOMAIN; MODEL; THROMBOEMBOLISM; MECHANISM	Background: Protein C (PC) is one of the most important physiological inhibitors of coagulation proteases. Hereditary PC deficiency causes a predisposition to venous thrombosis (VT). The genetic characteristics of PC deficiency in the Chinese population remain unknown. Methods: Thirty-four unrelated probands diagnosed with hereditary PC deficiency were investigated. PC activity and antigen levels were measured. Mutation analysis was performed by sequencing the PROC gene. In silico analyses, including PolyPhen-2, SIFT, multiple sequence alignment, splicing prediction, and protein molecular modeling were performed to predict the consequences of each variant identified. One recurrent mutation and its relative risk for thrombosis in relatives were analyzed in 11 families. The recurrent mutation was subsequently detected in a case (VT patients)-control study, and the adjusted odds ratio (OR) for VT risk was calculated by logistic regression analysis. Results: A total of 18 different mutations, including 12 novel variants, were identified. One common mutation, PROC c.565C>T (rs146922325: C>T), was found in 17 of the 34 probands. The family study showed that first-degree relatives bearing this variant had an 8.8-fold (95% CI = 1.1-71.6) increased risk of venous thrombosis. The case-control (1003 vs. 1031) study identified this mutation in 5.88% patients and in 0.87% controls, respectively. The mutant allele conferred a high predisposition to venous thrombosis (adjusted OR = 7.34, 95% CI = 3.61-14.94). The plasma PC activity and antigen levels in heterozygotes were 51.73 +/- 6.92 U/dl and 75.17 +/- 4.84 U/dl, respectively. Conclusions: This is the first study on the genetic background of PC deficiency in the Chinese population. The PROC c.565C>T mutation is the most frequent cause of PC deficiency as well as a prevalent risk factor for VT in Chinese individuals. The inclusion of this variant in routine thrombophilic detection may improve the diagnosis and prevention of venous thrombosis.	[Tang, Liang; Guo, Tao; Yang, Rui; Mei, Heng; Wang, Huafang; Lu, Xuan; Yu, Jianming; Wang, Qingyun; Hu, Yu] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Inst Hematol, Wuhan, Hubei, Peoples R China; [Tang, Liang; Guo, Tao; Yang, Rui; Mei, Heng; Wang, Huafang; Lu, Xuan; Yu, Jianming; Wang, Qingyun; Hu, Yu] Hubei Clin & Res Ctr Thrombosis & Hemostasis, Wuhan, Hubei, Peoples R China; [Tang, Liang; Guo, Tao; Yang, Rui; Mei, Heng; Wang, Huafang; Lu, Xuan; Yu, Jianming; Wang, Qingyun; Hu, Yu] Minist Educ, Targeted Biotherapy Key Lab, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology	Tang, L (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Inst Hematol, Wuhan, Hubei, Peoples R China.	dr_huyu@126.com			National Basic Scientific Research Program of China (973 Program) [2007 CB935803]; National Natural Sciences Foundation of China [30825018]; State Ministry of Health Key Clinical Construction Project [58]	National Basic Scientific Research Program of China (973 Program)(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); State Ministry of Health Key Clinical Construction Project	This work was supported by the National Basic Scientific Research Program of China (973 Program, No. 2007 CB935803), the National Natural Sciences Foundation of China (No. 30825018), and the State Ministry of Health Key Clinical Construction Project (2010 No. 58). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; ALLAART CF, 1993, LANCET, V341, P134, DOI 10.1016/0140-6736(93)90003-Y; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; BECKMANN RJ, 1985, NUCLEIC ACIDS RES, V13, P5233, DOI 10.1093/nar/13.14.5233; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Bounameaux H, 2011, CIRCULATION, V123, P2189, DOI 10.1161/CIRCULATIONAHA.111.031690; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Corral J, 2007, BLOOD, V109, P4258, DOI 10.1182/blood-2006-08-040774; Dahlback B, 2005, ARTERIOSCL THROM VAS, V25, P1311, DOI 10.1161/01.ATV.0000168421.13467.82; Dahlback B, 2003, J THROMB HAEMOST, V1, P1525, DOI 10.1046/j.1538-7836.2003.00299.x; Dahlback B, 2008, BLOOD, V112, P19, DOI 10.1182/blood-2008-01-077909; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Dogan RI, 2007, NUCLEIC ACIDS RES, V35, pW285, DOI 10.1093/nar/gkm407; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Esmon CT, 2003, CHEST, V124, p26S, DOI 10.1378/chest.124.3_suppl.26S; FISHER CL, 1994, PROTEIN SCI, V3, P588; FOSTER DC, 1985, P NATL ACAD SCI USA, V82, P4673, DOI 10.1073/pnas.82.14.4673; FOSTER DC, 1987, BIOCHEMISTRY-US, V26, P7003, DOI 10.1021/bi00396a022; GANDRILLE S, 1995, BLOOD, V86, P2598; GREENGARD JS, 1994, PROTEINS, V18, P367, DOI 10.1002/prot.340180407; GRUNDY CB, 1992, HUM GENET, V89, P685; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; KISIEL W, 1979, J CLIN INVEST, V64, P761, DOI 10.1172/JCI109521; KOSTER T, 1995, BLOOD, V85, P2756, DOI 10.1182/blood.V85.10.2756.bloodjournal85102756; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; MARLAR RA, 1982, BLOOD, V59, P1067; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; MILETICH J, 1987, NEW ENGL J MED, V317, P991, DOI 10.1056/NEJM198710153171604; Millar DS, 2000, HUM GENET, V106, P646, DOI 10.1007/s004390050038; Miyata T, 1996, THROMB HAEMOSTASIS, V76, P302; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Perera L, 2000, BIOPHYS J, V79, P2925, DOI 10.1016/S0006-3495(00)76530-1; PLUTZKY J, 1986, P NATL ACAD SCI USA, V83, P546, DOI 10.1073/pnas.83.3.546; POORT SR, 1993, BLOOD COAGUL FIBRIN, V4, P273, DOI 10.1097/00001721-199304000-00009; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; REITSMA PH, 1991, BLOOD, V78, P890, DOI 10.1182/blood.V78.4.890.bloodjournal784890; REITSMA PH, 1995, THROMB HAEMOSTASIS, V73, P876; Roberts LN, 2009, BRIT J HAEMATOL, V146, P369, DOI 10.1111/j.1365-2141.2009.07786.x; Sakata T, 2004, J THROMB HAEMOST, V2, P528, DOI 10.1111/j.1538-7836.2004.00603.x; Schmidt AE, 2002, J BIOL CHEM, V277, P28987, DOI 10.1074/jbc.M201892200; Singh G, 2003, TRENDS BIOCHEM SCI, V28, P464, DOI 10.1016/S0968-0004(03)00176-2; Suehisa E, 2001, BLOOD COAGUL FIBRIN, V12, P95, DOI 10.1097/00001721-200103000-00002; TAIT RC, 1995, THROMB HAEMOSTASIS, V73, P87; Taschner PEM, 2011, HUM MUTAT, V32, P507, DOI 10.1002/humu.21427; WACEY AI, 1993, BRIT J HAEMATOL, V84, P290, DOI 10.1111/j.1365-2141.1993.tb03067.x; Wang M, 2006, GENE, V366, P219, DOI 10.1016/j.gene.2005.07.015; Wildeman M, 2008, HUM MUTAT, V29, P6, DOI 10.1002/humu.20654; Yang YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026861; Zhu TA, 2011, HAEMATOL-HEMATOL J, V96, P1033, DOI 10.3324/haematol.2010.037515	49	32	42	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35773	10.1371/journal.pone.0035773	http://dx.doi.org/10.1371/journal.pone.0035773			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545135	Green Submitted, gold, Green Published			2022-12-25	WOS:000305343200055
J	Bleicken, S; Garcia-Saez, AJ; Conte, E; Bordignon, E				Bleicken, Stephanie; Garcia-Saez, Ana J.; Conte, Elena; Bordignon, Enrica			Dynamic Interaction of cBid with Detergents, Liposomes and Mitochondria	PLOS ONE			English	Article							CYTOCHROME-C RELEASE; N-TERMINAL FRAGMENT; MEMBRANE PERMEABILIZATION; APOPTOSIS INDUCTION; CONFORMATIONAL-CHANGES; BH3-ONLY PROTEINS; LIPID-MEMBRANES; BH3 DOMAINS; BAX; BCL-X(L)	The BH3-only protein Bid plays a key role in the induction of mitochondrial apoptosis, but its mechanism of action is still not completely understood. Here we studied the two main activation events of Bid: Caspase-8 cleavage and interaction with the membrane bilayer. We found a striking reversible behaviour of the dissociation-association events between the Bid fragments p15 and p7. Caspase-8 cleavage does not induce per se separation of the two Bid fragments, which remain in a stable complex resembling the full length Bid. Detergents trigger a complete dissociation, which can be fully reversed by detergent removal in a range of protein concentrations from 100 mu M down to 500 nM. Incubation of cBid with cardiolipin-containing liposomes leads to partial dissociation of the complex. Only p15 (tBid) fragments are found at the membrane, while p7 shows no tendency to interact with the bilayer, but complete removal of p7 strongly increases the propensity of tBid to become membrane-associated. Despite the striking structural similarities of inactive Bid and Bax, Bid does not form oligomers and reacts differently in the presence of detergents and membranes, highlighting clear differences in the modes of action of the two proteins. The partial dissociation of cBid triggered by the membrane is suggested to depend on the strong and specific interaction between p15 and p7. The reversible disassembly and re-assembly of the cBid molecules at the membrane was as well proven by EPR using spin labeled cBid in the presence of isolated mitochondria. The observed dynamic dissociation of the two Bid fragments could allow the assistance to the pore-forming Bax to occur repeatedly and may explain the proposed "hit-and-run'' mode of action of Bid at the bilayer.	[Bleicken, Stephanie] Max Planck Inst Biochem, Dept Membrane Biochem, D-82152 Martinsried, Germany; [Bleicken, Stephanie; Garcia-Saez, Ana J.] German Canc Res Ctr, D-6900 Heidelberg, Germany; [Bleicken, Stephanie; Garcia-Saez, Ana J.] Max Planck Inst Intelligent Syst, BIOQUANT, Dept Membrane Biophys, Heidelberg, Germany; [Conte, Elena] Univ Bari, Dipartimento Biochim & Biol Mol, CNR, Ctr Studio Mitocondri & Metab Energet, Bari, Italy; [Bordignon, Enrica] ETH, Phys Chem Lab, Zurich, Switzerland	Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society; Ruprecht Karls University Heidelberg; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomembrane e Bioenergetica (IBBE-CNR); Universita degli Studi di Bari Aldo Moro; Swiss Federal Institutes of Technology Domain; ETH Zurich	Bleicken, S (corresponding author), Max Planck Inst Biochem, Dept Membrane Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.	enrica.bordignon@phys.chem.ethz.ch	Conte, Elena/AAF-4055-2019; Conte, Elena/AAV-3153-2020; Saez, Ana J. Garcia/U-1611-2019	Conte, Elena/0000-0001-8571-5125; Bordignon, Enrica/0000-0003-2450-5161; Bleicken, Stephanie/0000-0002-4789-0974				Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Azarkh M, 2011, J MAGN RESON, V212, P450, DOI 10.1016/j.jmr.2011.07.014; Billen LP, 2008, ONCOGENE, V27, pS93, DOI 10.1038/onc.2009.47; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Bleicken S, 2010, J BIOL CHEM, V285, P6636, DOI 10.1074/jbc.M109.081539; Bleicken S, 2009, J BIOENERG BIOMEMBR, V41, P29, DOI 10.1007/s10863-009-9202-1; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Breitschopf K, 2000, J BIOL CHEM, V275, P21648, DOI 10.1074/jbc.M001083200; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Dewson G, 2009, MOL CELL, V36, P696, DOI 10.1016/j.molcel.2009.11.008; DIMITROV DS, 1988, BIOELECTROCH BIOENER, V19, P323, DOI 10.1016/0302-4598(88)80013-8; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Franco R, 2009, CELL DEATH DIFFER, V16, P1303, DOI 10.1038/cdd.2009.107; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Garcia-Saez AJ, 2009, NAT STRUCT MOL BIOL, V16, P1178, DOI 10.1038/nsmb.1671; Gong XM, 2004, J BIOL CHEM, V279, P28954, DOI 10.1074/jbc.M403490200; Grinberg M, 2002, J BIOL CHEM, V277, P12237, DOI 10.1074/jbc.M104893200; Hinds MG, 2007, CELL DEATH DIFFER, V14, P128, DOI 10.1038/sj.cdd.4401934; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Johnson  D., 1967, METHOD ENZYMOL, V10, P94, DOI DOI 10.1016/0076-6879(67)10018-9; Krstic I, 2011, ANGEW CHEM INT EDIT, V50, P5070, DOI 10.1002/anie.201100886; Kudla G, 2000, J BIOL CHEM, V275, P22713, DOI 10.1074/jbc.M003807200; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; NAKAMURA GR, 1952, ANAL CHEM, V24, P1372, DOI 10.1021/ac60068a036; Oh KJ, 2005, J BIOL CHEM, V280, P753, DOI 10.1074/jbc.M405428200; Oh KJ, CONFORMATIONAL CHANG, P28924; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tait SWG, 2007, J CELL BIOL, V179, P1453, DOI 10.1083/jcb.200707063; Tan KO, 1999, J BIOL CHEM, V274, P23687, DOI 10.1074/jbc.274.34.23687; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zaltsman Y, 2010, NAT CELL BIOL, V12, P553, DOI 10.1038/ncb2057	50	24	24	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35910	10.1371/journal.pone.0035910	http://dx.doi.org/10.1371/journal.pone.0035910			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540011	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341000077
J	Bury, L; Malara, A; Gresele, P; Balduini, A				Bury, Loredana; Malara, Alessandro; Gresele, Paolo; Balduini, Alessandra			Outside-In Signalling Generated by a Constitutively Activated Integrin alpha(IIb)beta(3) Impairs Proplatelet Formation in Human Megakaryocytes	PLOS ONE			English	Article							RECEPTOR; ECTODOMAIN; PLATELETS	Background: The interaction of megakaryocytes with matrix proteins of the osteoblastic and vascular niche is essential for megakaryocyte maturation and proplatelet formation. Fibrinogen is present in the vascular niche and the fibrinogen receptor alpha(IIb)beta(3) is abundantly expressed on megakaryocytes, however the role of the interaction between fibrinogen and alpha(IIb)beta(3) in proplatelet formation in humans is not yet fully understood. We have recently reported a novel congenital macrothrombocytopenia associated with a heterozygous mutation of the beta(3) subunit of alpha(IIb)beta(3). The origin of thrombocytopenia in this condition remains unclear and this may represent an interesting natural model to get further insight into the role of the megakaryocyte fibrinogen receptor in megakaryopoiesis. Methodology/Principal Findings: Patients' peripheral blood CD45+ cells in culture were differentiated into primary megakaryocytes and their maturation, spreading on different extracellular matrix proteins, and proplatelet formation were analyzed. Megakaryocyte maturation was normal but proplatelet formation was severely impaired, with tips decreased in number and larger in size than those of controls. Moreover, megakaryocyte spreading on fibrinogen was abnormal, with 50% of spread cells showing disordered actin distribution and more evident focal adhesion points than stress fibres. Integrin alpha(IIb)beta(3) expression was reduced but the receptor was constitutively activated and a sustained, and substrate-independent, activation of proteins of the outside-in signalling was observed. In addition, platelet maturation from preplatelets was impaired. Conclusions/Significance: Our data show that constitutive activation of alpha(IIb)beta(3)-mediated outside-in signalling in human megakaryocytes negatively influences proplatelet formation, leading to macrothombocytopenia.	[Bury, Loredana; Malara, Alessandro; Gresele, Paolo] Univ Perugia, Dept Internal Med, Div Internal & Cardiovasc Med, I-06100 Perugia, Italy; [Bury, Loredana; Malara, Alessandro; Balduini, Alessandra] Univ Pavia, IRCCS San Matteo Fdn, Dept Biochem, Biotechnol Labs, I-27100 Pavia, Italy	University of Perugia; IRCCS Fondazione San Matteo; University of Pavia	Bury, L (corresponding author), Univ Perugia, Dept Internal Med, Div Internal & Cardiovasc Med, I-06100 Perugia, Italy.	grespa@unipg.it	Bury, Loredana/O-2581-2017; BALDUINI, ALESSANDRA/AAC-3363-2022; Balduini, Alessandra/K-6802-2016; Gresele, Paolo/F-6775-2013; gresele, paolo/AAG-8019-2019; malara, alessandro/K-4027-2016; Bury, Loredana/K-1186-2019	Bury, Loredana/0000-0003-0333-0948; BALDUINI, ALESSANDRA/0000-0003-3145-1245; Balduini, Alessandra/0000-0003-3145-1245; Gresele, Paolo/0000-0001-5365-8445; malara, alessandro/0000-0002-3396-3693; Bury, Loredana/0000-0003-0333-0948	Telethon grant [GGP10155]; Cariplo Foundation [2006.0596/10.8485]	Telethon grant(Fondazione Telethon); Cariplo Foundation(Fondazione Cariplo)	This work was supported by a Telethon grant (GGP10155) to PG and by a Cariplo Foundation grant (2006.0596/10.8485) to AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Balduini A, 2008, J THROMB HAEMOST, V6, P1900, DOI 10.1111/j.1538-7836.2008.03132.x; Balduini A, 2006, J THROMB HAEMOST, V4, P848, DOI 10.1111/j.1538-7836.2006.01802.x; Balduini A, 2009, J THROMB HAEMOST, V7, P478, DOI 10.1111/j.1538-7836.2008.03255.x; Bender M, 2010, BLOOD, V116, P1767, DOI 10.1182/blood-2010-03-274340; Chen Z, 2007, BLOOD, V110, P171, DOI 10.1182/blood-2007-02-071589; Coller BS, 2008, BLOOD, V112, P3011, DOI 10.1182/blood-2008-06-077891; Ghevaert C, 2008, BLOOD, V111, P3407, DOI 10.1182/blood-2007-09-112615; Giannini S, 2008, CYTOM PART B-CLIN CY, V74B, P194, DOI 10.1002/cyto.b.20396; Gresele P, 2009, HAEMATOL-HEMATOL J, V94, P663, DOI 10.3324/haematol.2008.002246; Italiano JE, 1999, J CELL BIOL, V147, P1299, DOI 10.1083/jcb.147.6.1299; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; Kasirer-Friede A, 2004, BLOOD, V103, P3403, DOI 10.1182/blood-2003-10-3664; KIEFFER N, 1991, J CELL BIOL, V113, P451, DOI 10.1083/jcb.113.2.451; Kunishima S, 2011, BLOOD, V117, P5479, DOI 10.1182/blood-2010-12-323691; Larson MK, 2006, BLOOD, V108, P1509, DOI 10.1182/blood-2005-11-011957; Mekrache M, 2009, BRIT J HAEMATOL, V119, P1024; Nurden AT, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-10; Nurden P, 2010, BLOOD, V115, P2649, DOI 10.1182/blood-2009-07-231886; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Pecci A, 2009, THROMB HAEMOSTASIS, V102, P90, DOI 10.1160/TH09-01-0068; Thon JN, 2010, J CELL BIOL, V191, P861, DOI 10.1083/jcb.201006102; WILLIAMS N, 1982, BRIT J HAEMATOL, V52, P173, DOI 10.1111/j.1365-2141.1982.tb03878.x; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018	26	46	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e34449	10.1371/journal.pone.0034449	http://dx.doi.org/10.1371/journal.pone.0034449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539947	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341000010
J	Drozdov, I; Bornschein, J; Wex, T; Valeyev, NV; Tsoka, S; Malfertheiner, P				Drozdov, Ignat; Bornschein, Jan; Wex, Thomas; Valeyev, Najl V.; Tsoka, Sophia; Malfertheiner, Peter			Functional and Topological Properties in Hepatocellular Carcinoma Transcriptome	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; GENE-COEXPRESSION NETWORK; VASCULAR INVASION; PROSTATE-CANCER; CELL-CYCLE; EXPRESSION; OVEREXPRESSION; BREAST; RISK; TOOL	Hepatocellular carcinoma (HCC) is a leading cause of global cancer mortality. However, little is known about the precise molecular mechanisms involved in tumor formation and pathogenesis. The primary goal of this study was to elucidate genome-wide molecular networks involved in development of HCC with multiple etiologies by exploring high quality microarray data. We undertook a comparative network analysis across 264 human microarray profiles monitoring transcript changes in healthy liver, liver cirrhosis, and HCC with viral and alcoholic etiologies. Gene co-expression profiling was used to derive a consensus gene relevance network of HCC progression that consisted of 798 genes and 2,012 links. The HCC interactome was further confirmed to be phenotype-specific and non-random. Additionally, we confirmed that co-expressed genes are more likely to share biological function, but not sub-cellular localization. Analysis of individual HCC genes revealed that they are topologically central in a human protein-protein interaction network. We used quantitative RT-PCR in a cohort of normal liver tissue (n = 8), hepatitis C virus (HCV)-induced chronic liver disease (n = 9), and HCC (n=7) to validate co-expressions of several well-connected genes, namely ASPM, CDKN3, NEK2, RACGAP1, and TOP2A. We show that HCC is a heterogeneous disorder, underpinned by complex cross talk between immune response, cell cycle, and mRNA translation pathways. Our work provides a systems-wide resource for deeper understanding of molecular mechanisms in HCC progression and may be used further to define novel targets for efficient treatment or diagnosis of this disease.	[Drozdov, Ignat] Kings Coll London, British Heart Fdn Ctr Excellence, London WC2R 2LS, England; [Drozdov, Ignat; Tsoka, Sophia] Kings Coll London, Sch Nat & Math Sci, Ctr Bioinformat, Dept Informat, London WC2R 2LS, England; [Bornschein, Jan; Wex, Thomas; Malfertheiner, Peter] Univ Magdeburg, Dept Gastroenterol Hepatol & Infect Dis, D-39106 Magdeburg, Germany; [Valeyev, Najl V.] Univ Exeter, Coll Engn Math & Phys Sci, Ctr Syst Dynam & Control, Exeter, Devon, England	University of London; King's College London; University of London; King's College London; Otto von Guericke University; University of Exeter	Drozdov, I (corresponding author), Kings Coll London, British Heart Fdn Ctr Excellence, London WC2R 2LS, England.	ignat.drozdov@kcl.ac.uk; peter.malfertheiner@med.ovgu.de	Bornschein, Jan/U-9402-2018	Bornschein, Jan/0000-0001-8673-3122; Tsoka, Sophia/0000-0001-8403-1282; Drozdov, Ignat/0000-0001-6727-4688	BHF Centre of Excellence, Cardiovascular Division, Kinga s College London	BHF Centre of Excellence, Cardiovascular Division, Kinga s College London	I.D. holds a pre-doctoral Fellowship from the BHF Centre of Excellence, Cardiovascular Division, Kinga s College London. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hamid NM, 2009, J MEMBRANE BIOL, V230, P155, DOI 10.1007/s00232-009-9196-y; Aggarwal A, 2006, CANCER RES, V66, P232, DOI 10.1158/0008-5472.CAN-05-2232; Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Ancona N, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-387; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bae I, 2005, CELL CYCLE, V4, P1641, DOI 10.4161/cc.4.11.2152; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barrenas F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008090; Berg J, 2006, P NATL ACAD SCI USA, V103, P10967, DOI 10.1073/pnas.0602294103; Birney E, 2004, GENOME RES, V14, P925, DOI 10.1101/gr.1860604; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Braconi C, 2009, CANCER-AM CANCER SOC, V115, P3738, DOI 10.1002/cncr.24417; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Carter SL, 2004, BIOINFORMATICS, V20, P2242, DOI 10.1093/bioinformatics/bth234; Chen RX, 2010, MOL BIOL REP; Cheung ST, 2002, CANCER RES, V62, P4711; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; de Souto MCP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-497; Drozdov Ignat, 2011, BMC Res Notes, V4, P462, DOI 10.1186/1756-0500-4-462; Drozdov I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-557; Durkin ME, 2007, ONCOGENE, V26, P4580, DOI 10.1038/sj.onc.1210244; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; El-Serag HB, 2006, CLIN GASTROENTEROL H, V4, P369, DOI 10.1016/j.cgh.2005.12.007; Elo LL, 2007, BIOINFORMATICS, V23, P2096, DOI 10.1093/bioinformatics/btm309; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fliri AF, 2009, J MED CHEM, V52, P8038, DOI 10.1021/jm901001p; Florez AF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-484; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Forsyth CB, 2010, ALCOHOL CLIN EXP RES, V34, P19, DOI 10.1111/j.1530-0277.2009.01061.x; Friedel CC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-297; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; He B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018516; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Hoshida Y, 2010, SEMIN LIVER DIS, V30, P35, DOI 10.1055/s-0030-1247131; Hu L, 2004, ONCOGENE, V23, P298, DOI 10.1038/sj.onc.1206483; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jones WM, 2010, J CELL SCI, V123, P2179, DOI 10.1242/jcs.067868; Koziol JA, 2009, BIOINFORMATICS, V25, P54, DOI 10.1093/bioinformatics/btn354; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lee SW, 2000, MOL CELL BIOL, V20, P1723, DOI 10.1128/MCB.20.5.1723-1732.2000; Lin SY, 2008, CLIN CANCER RES, V14, P4814, DOI 10.1158/1078-0432.CCR-07-5262; Mas VR, 2006, MOL MED, V12, P97, DOI 10.2119/2006-00032.Mas; Masaki T, 2000, HEPATOLOGY, V32, P711, DOI 10.1053/jhep.2000.17705; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Minguez B, 2011, J HEPATOL, V55, P1325, DOI 10.1016/j.jhep.2011.02.034; MOLLER H, 1994, EUR J CANCER, V30A, P344, DOI 10.1016/0959-8049(94)90254-2; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Ni IBP, 2010, PATHOL RES PRACT, V206, P223, DOI 10.1016/j.prp.2009.11.006; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Schutte K, 2009, DIGEST DIS, V27, P80, DOI 10.1159/000218339; Seitz HK, 2006, BIOL CHEM, V387, P349, DOI 10.1515/BC.2006.047; Shi ZA, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-74; Shuda M, 2000, ANTICANCER RES, V20, P2489; Skawran B, 2008, MODERN PATHOL, V21, P1479, DOI 10.1038/modpathol.2008.147; Small M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.066112; Stone R, 2010, CANCER PREV RES, V3, P776, DOI 10.1158/1940-6207.CAPR-09-0189; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Su WH, 2007, NUCLEIC ACIDS RES, V35, pD727, DOI 10.1093/nar/gkl845; Sun JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S3-S5; Sun Y, 2010, CELL BIOCHEM BIOPHYS, V56, P59, DOI 10.1007/s12013-009-9071-6; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92; Wex T, 2003, CLIN CHEM LAB MED, V41, P1033, DOI 10.1515/CCLM.2003.159; Wong CM, 2005, CANCER RES, V65, P8861, DOI 10.1158/0008-5472.CAN-05-1318; Wong N, 2009, INT J CANCER, V124, P644, DOI 10.1002/ijc.23968; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Xulvi-Brunet R, 2010, BIOINFORMATICS, V26, P205, DOI 10.1093/bioinformatics/btp632; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Zhang YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022426; Zotenko E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000140	82	21	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35510	10.1371/journal.pone.0035510	http://dx.doi.org/10.1371/journal.pone.0035510			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539975	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341000041
J	Fan, BA; Dachrut, S; Coral, H; Yuen, ST; Chu, KM; Law, S; Zhang, LH; Ji, JF; Leung, SY; Chen, X				Fan, Biao; Dachrut, Somkid; Coral, Ho; Yuen, Siu Tsan; Chu, Kent Man; Law, Simon; Zhang, Lianhai; Ji, Jiafu; Leung, Suet Yi; Chen, Xin			Integration of DNA Copy Number Alterations and Transcriptional Expression Analysis in Human Gastric Cancer	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; GENE-EXPRESSION; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; PANCREATIC-CANCER; PROTEIN EXPRESSION; PROSTATE-CANCER; CELL-LINES; AMPLIFICATION; MYC	Background: Genomic instability with frequent DNA copy number alterations is one of the key hallmarks of carcinogenesis. The chromosomal regions with frequent DNA copy number gain and loss in human gastric cancer are still poorly defined. It remains unknown how the DNA copy number variations contributes to the changes of gene expression profiles, especially on the global level. Principal Findings: We analyzed DNA copy number alterations in 64 human gastric cancer samples and 8 gastric cancer cell lines using bacterial artificial chromosome (BAC) arrays based comparative genomic hybridization (aCGH). Statistical analysis was applied to correlate previously published gene expression data obtained from cDNA microarrays with corresponding DNA copy number variation data to identify candidate oncogenes and tumor suppressor genes. We found that gastric cancer samples showed recurrent DNA copy number variations, including gains at 5p, 8q, 20p, 20q, and losses at 4q, 9p, 18q, 21q. The most frequent regions of amplification were 20q12 (7/72), 20q12-20q13.1 (12/72), 20q13.1-20q13.2 (11/72) and 20q13.2-20q13.3 (6/72). The most frequent deleted region was 9p21 (8/72). Correlating gene expression array data with aCGH identified 321 candidate oncogenes, which were overexpressed and showed frequent DNA copy number gains; and 12 candidate tumor suppressor genes which were down-regulated and showed frequent DNA copy number losses in human gastric cancers. Three networks of significantly expressed genes in gastric cancer samples were identified by ingenuity pathway analysis. Conclusions: This study provides insight into DNA copy number variations and their contribution to altered gene expression profiles during human gastric cancer development. It provides novel candidate driver oncogenes or tumor suppressor genes for human gastric cancer, useful pathway maps for the future understanding of the molecular pathogenesis of this malignancy, and the construction of new therapeutic targets.	[Fan, Biao; Dachrut, Somkid; Coral, Ho; Chen, Xin] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Fan, Biao; Zhang, Lianhai; Ji, Jiafu] Peking Univ, Sch Oncol, Key Lab Carcinogenesis & Translat Res, Beijing Canc Hosp & Inst,Dept Surg,Minist Educ, Beijing 100871, Peoples R China; [Dachrut, Somkid] Khon Kaen Univ, Fac Med, Liver Fluke & Cholangiocarcinoma Res Ctr, Khon Kaen, Thailand; [Yuen, Siu Tsan; Leung, Suet Yi] Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Pokfulam, Hong Kong, Peoples R China; [Chu, Kent Man; Law, Simon] Univ Hong Kong, Queen Mary Hosp, Dept Surg, Pokfulam, Hong Kong, Peoples R China	University of California System; University of California San Francisco; Peking University; Khon Kaen University; University of Hong Kong; University of Hong Kong	Fan, BA (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.	jiafuj@gmail.com; suetyi@hku.hk; xin.chen@ucsf.edu	Yuen, Siu/K-6311-2014; Leung, Suet Yi/C-4340-2009; Law, Simon/C-4324-2009; Leung, Suet Yi/T-9620-2019	Law, Simon/0000-0002-6518-5806; JI, JIAFU/0000-0001-6878-5543; Leung, Suet Yi/0000-0001-8614-4619	University of California Cancer Research Coordinate Committee; China Scholarship Council [2010601079]	University of California Cancer Research Coordinate Committee; China Scholarship Council(China Scholarship Council)	This work is supported by the funding provided by University of California Cancer Research Coordinate Committee to XC. BF is supported by China Scholarship Council Contract No.2010601079. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Allen TD, 2011, CANCER RES, V71, P6010, DOI 10.1158/0008-5472.CAN-11-0595; An CH, 2011, APMIS, V119, P317, DOI 10.1111/j.1600-0463.2011.02734.x; Andre F, 2009, CLIN CANCER RES, V15, P441, DOI 10.1158/1078-0432.CCR-08-1791; Atienza JM, 2005, MOL CANCER THER, V4, P361; Benjamini Y, 1995, J ROY STAT SOC, V57, P289; Chen X, 2003, MOL BIOL CELL, V14, P3208, DOI 10.1091/mbc.E02-12-0833; Chu D, 2011, ANN ONCOL; Gorringe KL, 2005, GENE CHROMOSOME CANC, V42, P247, DOI 10.1002/gcc.20136; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; Heidenblad M, 2005, ONCOGENE, V24, P1794, DOI 10.1038/sj.onc.1208383; Hippo Y, 2002, CANCER RES, V62, P233; Hodgson JG, 2003, BREAST CANCER RES TR, V78, P337, DOI 10.1023/A:1023085825042; Jain AN, 2002, GENOME RES, V12, P325, DOI 10.1101/gr.210902; Japanese Gastric Cancer A, 1998, GASTRIC CANC, V1, P10; Ji JF, 2002, ONCOGENE, V21, P6549, DOI 10.1038/sj.onc.1205829; Jin SH, 2008, INT J CANCER, V122, P1040, DOI 10.1002/ijc.23181; Junnila S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-73; Kallioniemi A, 2008, CURR OPIN BIOTECH, V19, P36, DOI 10.1016/j.copbio.2007.11.004; Kaptain S, 2001, DIAGN MOL PATHOL, V10, P139, DOI 10.1097/00019606-200109000-00001; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lee K, 2008, J INVEST DERMATOL, V128, P9, DOI 10.1038/sj.jid.5700949; Lee SA, 2008, HEPATOLOGY, V47, P1200, DOI 10.1002/hep.22169; Mahlamaki EH, 2002, GENE CHROMOSOME CANC, V35, P353, DOI 10.1002/gcc.10122; Miyoshi M, 2007, BIOCHEM J, V404, P373, DOI 10.1042/BJ20061597; Mlkvy P, 2010, DIGEST DIS, V28, P615, DOI 10.1159/000320063; Myllykangas S, 2008, INT J CANCER, V123, P817, DOI 10.1002/ijc.23574; Nakamura R, 2005, CANCER SCI, V96, P42, DOI 10.1111/j.1349-7006.2005.00007.x; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Noguchi T, 2001, AM J CLIN PATHOL, V115, P828; Nupponen NN, 2000, GENE CHROMOSOME CANC, V28, P203; Potla L, 2002, CANCER LETT, V175, P187, DOI 10.1016/S0304-3835(01)00613-9; Sakakura C, 2000, INT J CANCER, V89, P217; Schmidt VA, 2008, MOL CELL BIOL, V28, P1489, DOI 10.1128/MCB.01090-07; Schuell B, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-123; Snijders AM, 2003, ONCOGENE, V22, P4370, DOI 10.1038/sj.onc.1206482; Song WJ, 2010, CANCER SCI, V101, P1754, DOI 10.1111/j.1349-7006.2010.01577.x; Thollet A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-291; Tsukamoto Y, 2008, J PATHOL, V216, P471, DOI 10.1002/path.2424; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Dekken H, 2006, CANCER GENET CYTOGEN, V166, P157, DOI 10.1016/j.cancergencyto.2005.11.002; Wang HZ, 2009, CELL RES, V19, P1150, DOI 10.1038/cr.2009.99; Wang Q, 2009, J CELL BIOCHEM, V106, P16, DOI 10.1002/jcb.21969; Weiss MM, 2003, ONCOGENE, V22, P1872, DOI 10.1038/sj.onc.1206350; White CD, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-125; Yeh TS, 2009, CANCER RES, V69, P5039, DOI 10.1158/0008-5472.CAN-08-4021; YUEN ST, 1994, AM J SURG PATHOL, V18, P1158, DOI 10.1097/00000478-199411000-00010; Zhang XW, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-40	50	49	50	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e29824	10.1371/journal.pone.0029824	http://dx.doi.org/10.1371/journal.pone.0029824			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539939	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341000002
J	Hancock, R				Hancock, Ronald			Structure of Metaphase Chromosomes: A Role for Effects of Macromolecular Crowding	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; MITOTIC CHROMOSOMES; FLEXIBLE POLYELECTROLYTES; INTERPHASE CHROMOSOMES; POLY(ETHYLENE GLYCOL); ELECTRON-MICROSCOPY; OSMOTIC-PRESSURE; PHYSICAL STATE; POOR SOLVENTS; LIVING CELLS	In metaphase chromosomes, chromatin is compacted to a concentration of several hundred mg/ml by mechanisms which remain elusive. Effects mediated by the ionic environment are considered most frequently because mono- and di-valent cations cause polynucleosome chains to form compact similar to 30-nm diameter fibres in vitro, but this conformation is not detected in chromosomes in situ. A further unconsidered factor is predicted to influence the compaction of chromosomes, namely the forces which arise from crowding by macromolecules in the surrounding cytoplasm whose measured concentration is 100-200 mg/ml. To mimic these conditions, chromosomes were released from mitotic CHO cells in solutions containing an inert volume-occupying macromolecule (8 kDa polyethylene glycol, 10.5 kDa dextran, or 70 kDa Ficoll) in 100 mu M K-Hepes buffer, with contaminating cations at only low micromolar concentrations. Optical and electron microscopy showed that these chromosomes conserved their characteristic structure and compaction, and their volume varied inversely with the concentration of a crowding macromolecule. They showed a canonical nucleosomal structure and contained the characteristic proteins topoisomerase II alpha and the condensin subunit SMC2. These observations, together with evidence that the cytoplasm is crowded in vivo, suggest that macromolecular crowding effects should be considered a significant and perhaps major factor in compacting chromosomes. This model may explain why similar to 30-nm fibres characteristic of cation-mediated compaction are not seen in chromosomes in situ. Considering that crowding by cytoplasmic macromolecules maintains the compaction of bacterial chromosomes and has been proposed to form the liquid crystalline chromosomes of dinoflagellates, a crowded environment may be an essential characteristic of all genomes.	Univ Laval, Canc Res Ctr, Hop Hotel Dieu, Quebec City, PQ, Canada	Laval University	Hancock, R (corresponding author), Univ Laval, Canc Res Ctr, Hop Hotel Dieu, Quebec City, PQ, Canada.	ronald.hancock@crhdq.ulaval.ca	Hancock, Ronald/F-8009-2016					ADOLPH KW, 1980, CHROMOSOMA, V76, P23, DOI 10.1007/BF00292223; ArrioDupont M, 1996, BIOPHYS J, V70, P2327, DOI 10.1016/S0006-3495(96)79798-9; ASAKURA S, 1954, J CHEM PHYS, V22, P1255, DOI 10.1063/1.1740347; BELMONT AS, 1989, CHROMOSOMA, V98, P129, DOI 10.1007/BF00291049; BENNETT MD, 1983, J CELL SCI, V63, P173; BLUMENTHAL AB, 1979, J CELL BIOL, V81, P255, DOI 10.1083/jcb.81.1.255; Bohn M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014428; Chang RW, 2006, MACROMOLECULES, V39, P821, DOI 10.1021/ma051095y; CHORAZY M, 1963, J CELL BIOL, V19, P59, DOI 10.1083/jcb.19.1.59; Chow MH, 2010, EUKARYOT CELL, V9, P1577, DOI 10.1128/EC.00026-10; Christensen MO, 2002, J CELL BIOL, V157, P31, DOI 10.1083/jcb.200112023; Cole A., 1967, THEORETICAL BIOPHYSI, V1, P305; Compton JL, 1976, EUR J BIOCHEM, V7, P555; Cooke IR, 2004, MACROMOLECULES, V37, P5778, DOI 10.1021/ma0355406; CUNEO P, 1992, BIOCHEM J, V281, P507, DOI 10.1042/bj2810507; Cunha S, 2001, J STRUCT BIOL, V136, P53, DOI 10.1006/jsbi.2001.4420; Daban JR, 2000, BIOCHEMISTRY-US, V39, P3861, DOI 10.1021/bi992628w; Danilowicz C, 2009, P NATL ACAD SCI USA, V106, P19824, DOI 10.1073/pnas.0911214106; DEAVEN LL, 1973, CHROMOSOMA, V41, P129, DOI 10.1007/BF00319690; del Alamo M, 2005, J VIROL, V79, P14271, DOI 10.1128/JVI.79.22.14271-14281.2005; EARNSHAW WC, 1983, J CELL BIOL, V96, P84, DOI 10.1083/jcb.96.1.84; EDELMANN L, 1989, SCANNING MICROSCOPY, V3, P1219; Eltsov M, 2008, P NATL ACAD SCI USA, V105, P19732, DOI 10.1073/pnas.0810057105; Feng B, 2010, CHEM COMMUN, V46, P8231, DOI 10.1039/c0cc03117h; FINCH JT, 1976, P NATL ACAD SCI USA, V73, P1897, DOI 10.1073/pnas.73.6.1897; Galan A, 2001, J BIOL CHEM, V276, P957, DOI 10.1074/jbc.M006861200; GOODERHAM K, 1983, EXP CELL RES, V144, P1, DOI 10.1016/0014-4827(83)90435-4; Gunther T, 2006, MAGNESIUM RES, V19, P225; Hancock R, 2004, J STRUCT BIOL, V146, P281, DOI 10.1016/j.jsb.2003.12.008; Hancock R, 2011, GENOME ORG FUNCTION, P169; Hancock R, 2007, SEMIN CELL DEV BIOL, V18, P668, DOI 10.1016/j.semcdb.2007.08.006; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; HERZOG W, 1978, EUR J BIOCHEM, V91, P249, DOI 10.1111/j.1432-1033.1978.tb20959.x; HOROWITZ SB, 1979, BIOPHYS J, V25, P45, DOI 10.1016/S0006-3495(79)85277-7; HOWELL WM, 1979, CHROMOSOMA, V73, P61, DOI 10.1007/BF00294845; HUNGERFORD DA, 1958, J BIOPHYS BIOCHEM CY, V4, P391, DOI 10.1083/jcb.4.4.391; Jun S, 2010, BACTERIAL CHROMATIN, P97, DOI 10.1007/978-90-481-3473-1_6; KELLENBERGER E, 1992, FEMS MICROBIOL LETT, V100, P361, DOI 10.1016/0378-1097(92)90233-E; KELLERMAYER M, 1986, P NATL ACAD SCI USA, V83, P1011, DOI 10.1073/pnas.83.4.1011; Kim JS, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.168102; Kireeva N, 2004, J CELL BIOL, V166, P775, DOI 10.1083/jcb.200406049; LAVERY PE, 1992, J BIOL CHEM, V267, P9307; LEWIS CD, 1982, CELL, V29, P171, DOI 10.1016/0092-8674(82)90101-5; LING GN, 1990, SCANNING MICROSCOPY, V4, P737; Livolant F, 2006, PHILOS T R SOC A, V364, P2615, DOI 10.1098/rsta.2006.1843; Loh P, 2008, MACROMOLECULES, V41, P9352, DOI 10.1021/ma8014239; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Maeshima K, 2005, CHROMOSOMA, V114, P365, DOI 10.1007/s00412-005-0023-7; Marenduzzo D, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/09/L09002; Maughan DW, 2001, BIOPHYS J, V80, P435, DOI 10.1016/S0006-3495(01)76026-2; Micka U, 1999, LANGMUIR, V15, P4033, DOI 10.1021/la981191a; Mora-Bermudez F, 2007, NAT CELL BIOL, V9, P822, DOI 10.1038/ncb1606; Negendank M, 2005, J CELL PHYSL, V104, P443; Parsegian VA, 1995, METHOD ENZYMOL, V259, P43; Pastre D, 2007, BIOMACROMOLECULES, V8, P3712, DOI 10.1021/bm700856u; PAUL JS, 1970, EXP CELL RES, V59, P227, DOI 10.1016/0014-4827(70)90595-1; PAULSON JR, 1983, J CELL BIOL, V96, P1132, DOI 10.1083/jcb.96.4.1132; Pielak GJ, 2005, P NATL ACAD SCI USA, V102, P5901, DOI 10.1073/pnas.0501812102; Pliss A, 2010, BIOPHYS J, V99, P3483, DOI 10.1016/j.bpj.2010.06.069; Poirier MG, 2002, J CELL BIOCHEM, V85, P422, DOI 10.1002/jcb.10132; Rattner JB, 1996, J CELL BIOL, V134, P1097, DOI 10.1083/jcb.134.5.1097; SAITOH N, 1995, BIOESSAYS, V17, P759, DOI 10.1002/bies.950170905; SIKORAV JL, 1994, BIOPHYS J, V66, P827, DOI 10.1016/S0006-3495(94)80859-8; Spitzer JJ, 2005, TRENDS BIOCHEM SCI, V30, P536, DOI 10.1016/j.tibs.2005.08.002; St-Jean P, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.061923; Stanley CB, 2003, MACROMOLECULES, V36, P6888, DOI 10.1021/ma034079e; Strukov YG, 2003, J CELL BIOL, V162, P23, DOI 10.1083/jcb.200303098; Vasilevskaya VV, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2191049; Vergani L, 1998, MOL BIOL REP, V25, P237, DOI 10.1023/A:1006937212430; Weiss M, 2004, BIOPHYS J, V87, P3518, DOI 10.1529/biophysj.104.044263; WIDOM J, 1986, J MOL BIOL, V190, P411, DOI 10.1016/0022-2836(86)90012-4; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029225; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; ZIMMERMAN SB, 1988, NUCLEIC ACIDS RES, V16, P6309, DOI 10.1093/nar/16.14.6309; ZIMMERMAN SB, 1993, BIOCHIM BIOPHYS ACTA, V1216, P175, DOI 10.1016/0167-4781(93)90142-Z	75	25	25	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e36045	10.1371/journal.pone.0036045	http://dx.doi.org/10.1371/journal.pone.0036045			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540018	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341000084
J	Pan, LP; Zhang, W; Zhang, L; Wu, XP; Zhu, XL; Yan, BY; Li, JY; Xu, AQ; Liu, Y; Li, H				Pan, Li-Ping; Zhang, Wei; Zhang, Li; Wu, Xiao-Pan; Zhu, Xi-Lin; Yan, Bing-Yu; Li, Jing-Yun; Xu, Ai-Qiang; Liu, Ying; Li, Hui			CD3Z Genetic Polymorphism in Immune Response to Hepatitis B Vaccination in Two Independent Chinese Populations	PLOS ONE			English	Article							T-CELL-RECEPTOR; DECREASED EXPRESSION; ANTIBODY-RESPONSE; VIRUS; CD28; IMMUNOGENETICS; COSTIMULATION; ASSOCIATIONS; MODULATION; ACTIVATION	Vaccination against hepatitis B virus is an effective and routine practice that can prevent infection. However, vaccine-induced immunity to hepatitis B varies among individuals. CD4(+) T helper cells, which play an important role in both cellular and humoral immunity, are involved in the immune response elicited by vaccination. Polymorphisms in the genes involved in stimulating the activation and proliferation of CD4(+) T helper cells may influence the immune response to hepatitis B vaccination. In the first stage of the present study, a total of 111 single nucleotide polymorphisms (SNPs) in 17 genes were analyzed, using the iPLEX MassARRAY system, among 214 high responders and 107 low responders to hepatitis B vaccination. Three SNPs (rs12133337 and rs10918706 in CD3Z, rs10912564 in OX40L) were associated significantly with the immune response to hepatitis B vaccination (P = 0.008, 0.041, and 0.019, respectively). The three SNPs were analyzed further with the TaqMan-MGB or TaqMan-BHQ probe-based real-time polymerase chain reaction in another independent population, which included 1090 high responders and 636 low responders. The minor allele 'C' of rs12133337 continued to show an association with a lower response to hepatitis B vaccination (P = 0.033, odds radio = 1.28, 95% confidence interval = 1.01-1.61). Furthermore, in the stratified analysis for both the first and second populations, the association of the minor allele 'C' of rs12133337 with a lower response to hepatitis B vaccination was more prominent after individuals who were overweight or obese (body mass index >= 25 kg/m(2)) were excluded (1st stage: P = 0.003, 2nd stage: P = 0.002, P-combined = 9.47e-5). These findings suggest that the rs12133337 polymorphism in the CD3Z gene might affect the immune response to hepatitis B vaccination, and that a lower BMI might increase the contribution of the polymorphism to immunity to hepatitis B vaccination.	[Pan, Li-Ping; Wu, Xiao-Pan; Zhu, Xi-Lin; Li, Jing-Yun; Liu, Ying] Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, Natl Lab Med Mol Biol,Inst Basic Med Sci, Beijing 100730, Peoples R China; [Zhang, Wei] Beijing Ctr Dis Control & Prevent, Beijing, Peoples R China; [Zhang, Li; Yan, Bing-Yu; Xu, Ai-Qiang] Shandong Ctr Dis Control & Prevent, Jinan, Peoples R China; [Li, Hui] Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, Dept Epidemiol,Inst Basic Med Sci, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Pan, LP (corresponding author), Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, Natl Lab Med Mol Biol,Inst Basic Med Sci, Beijing 100730, Peoples R China.	aqxuepi@163.com; liuyingpumc@yahoo.com; lihui99360@vip.sohu.com			Major Project of National Science and Technology [2008zx10002-001, 2009ZX10002-028]; National Basic Research Program of China (973 Program) [2007CB512806]; National High Technology Research and Development Program of China (863 Program) [2006AA02A4100]; Science Fund for Creative Research Groups [30721063]	Major Project of National Science and Technology; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Science Fund for Creative Research Groups(Science Fund for Creative Research Groups)	This work was supported by grants from the Major Project of National Science and Technology (No. 2008zx10002-001 and No. 2009ZX10002-028), the National Basic Research Program of China (973 Program) (No. 2007CB512806), the National High Technology Research and Development Program of China (863 Program) (No. 2006AA02A4100), and the Science Fund for Creative Research Groups (No. 30721063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Aviles DH, 2009, PEDIATR NEPHROL, V24, P769, DOI 10.1007/s00467-008-1061-1; Banatvala J, 2000, LANCET, V355, P561, DOI 10.1016/S0140-6736(99)07239-6; Boland GJ, 2003, ADV EXP MED BIOL, V531, P185; Bretscher PA, 1999, P NATL ACAD SCI USA, V96, P185, DOI 10.1073/pnas.96.1.185; Caballero B, 2007, EPIDEMIOL REV, V29, P1, DOI 10.1093/epirev/mxm012; Cantrell DA, 2002, IMMUNOLOGY, V105, P369, DOI 10.1046/j.1365-2567.2002.01391.x; Chen J, 2011, VACCINE, V29, P706, DOI 10.1016/j.vaccine.2010.11.023; CLEVERS H, 1988, ANNU REV IMMUNOL, V6, P629, DOI 10.1146/annurev.iy.06.040188.003213; Croft M, 2009, IMMUNOL REV, V229, P173, DOI 10.1111/j.1600-065X.2009.00766.x; D'Oro U, 2002, J IMMUNOL, V169, P6269, DOI 10.4049/jimmunol.169.11.6269; Davila S, 2010, GENES IMMUN, V11, P232, DOI 10.1038/gene.2010.1; De Jager PL, 2009, P NATL ACAD SCI USA, V106, P5264, DOI 10.1073/pnas.0813310106; Geertsma MF, 1999, J INFECT DIS, V180, P649, DOI 10.1086/314941; Godkin A, 2005, HEPATOLOGY, V41, P1383, DOI 10.1002/hep.20716; Goncalves L, 2004, VIROLOGY, V326, P20, DOI 10.1016/j.virol.2004.04.042; Harris NL, 1999, IMMUNOL CELL BIOL, V77, P304, DOI 10.1046/j.1440-1711.1999.00835.x; Hennig BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001898; Hohler T, 2005, HEPATOLOGY, V42, P72, DOI 10.1002/hep.20740; Hohler T, 2002, LANCET, V360, P991, DOI 10.1016/S0140-6736(02)11083-X; HOLLINGER FB, 1989, AM J MED, V87, pS36; Huang IC, 2006, INT J OBESITY, V30, P1250, DOI 10.1038/sj.ijo.0803250; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; JANEWAY CA, 1989, IMMUNOL REV, V109, P77, DOI 10.1111/j.1600-065X.1989.tb00020.x; JANEWAY CA, 1992, ANNU REV IMMUNOL, V10, P645, DOI 10.1146/annurev.immunol.10.1.645; Kimman TG, 2007, COMMUNITY GENET, V10, P201, DOI 10.1159/000106559; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Lu FM, 2009, CHINESE MED J-PEKING, V122, P2925, DOI 10.3760/cma.j.issn.0366-6999.2009.24.001; Lundholm M, 2010, J IMMUNOL, V184, P5537, DOI 10.4049/jimmunol.0904012; Maddrey WC, 2000, J MED VIROL, V61, P362, DOI 10.1002/1096-9071(200007)61:3&lt;362::AID-JMV14&gt;3.0.CO;2-I; Maki A, 2004, J GASTROEN HEPATOL, V19, P1348, DOI 10.1111/j.1440-1746.2004.03455.x; McDermott AB, 1997, TISSUE ANTIGENS, V50, P8, DOI 10.1111/j.1399-0039.1997.tb02827.x; Milich DR, 2003, AUTOIMMUN REV, V2, P248, DOI 10.1016/S1568-9972(03)00031-4; Newport MJ, 2004, GENES IMMUN, V5, P122, DOI 10.1038/sj.gene.6364051; Pan LP, 2012, J MED VIROL, V84, P26, DOI 10.1002/jmv.22251; Png E, 2011, HUM MOL GENET; Poland GA, 2007, CLIN PHARMACOL THER, V82, P653, DOI 10.1038/sj.clpt.6100415; Poland GA, 1998, AM J PREV MED, V15, P73; Portoles P, 2009, CURR PHARM DESIGN, V15, P3290, DOI 10.2174/138161209789105199; Radstake TRDJ, 2010, NAT GENET, V42, P426, DOI 10.1038/ng.565; Rahman F, 2000, HEPATOLOGY, V31, P521, DOI 10.1002/hep.510310237; Rogers PR, 2000, J IMMUNOL, V164, P2955, DOI 10.4049/jimmunol.164.6.2955; Ryckman KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012273; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; TREADWELL TL, 1993, AM J MED, V95, P584, DOI 10.1016/0002-9343(93)90353-Q; Wang CB, 2004, HEPATOLOGY, V39, P978, DOI 10.1002/hep.20142; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; WEBER DJ, 1985, JAMA-J AM MED ASSOC, V254, P3187, DOI 10.1001/jama.254.22.3187; WEISSMAN JY, 1988, JAMA-J AM MED ASSOC, V260, P1734, DOI 10.1001/jama.260.12.1734; WOOD RC, 1993, JAMA-J AM MED ASSOC, V270, P2935, DOI 10.1001/jama.270.24.2935; Yucesoy B, 2002, VACCINE, V20, P3193, DOI 10.1016/S0264-410X(02)00267-0; Yucesoy B, 2009, VACCINE, V27, P6991, DOI 10.1016/j.vaccine.2009.09.076; Yudushkin IA, 2010, P NATL ACAD SCI USA, V107, P22128, DOI 10.1073/pnas.1016388108; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004; Zuckerman JN, 2000, J INFECTION, V41, P130, DOI 10.1053/jinf.2000.0720; Zuckerman JN, 2006, J MED VIROL, V78, P169, DOI 10.1002/jmv.20524	56	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2012	7	4							e35303	10.1371/journal.pone.0035303	http://dx.doi.org/10.1371/journal.pone.0035303			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XD	22536368	Green Published, gold, Green Submitted			2022-12-25	WOS:000305350600073
J	Fennewald, SM; Kantara, C; Sastry, SK; Resto, VA				Fennewald, Susan M.; Kantara, Carla; Sastry, Sarita K.; Resto, Vicente A.			Laminin Interactions with Head and Neck Cancer Cells under Low Fluid Shear Conditions Lead to Integrin Activation and Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATCH BONDS; EXTRACELLULAR-MATRIX; ADHESION MOLECULES; LYMPH-NODES; FLOW; CA2+; CARCINOMA; BETA-1-INTEGRIN; RECEPTORS; CALCIUM	Lymphatic metastasis of cancer cells involves movement from the primary tumor site to the lymph node, where the cells must be able to productively lodge and grow. It is there that tumor cells encounter cellular and non-cellular constituent elements that make up the lymph node parenchyma. Our work shows that head and neck squamous cell carcinoma (HNSCC) cell lines are able to bind to laminin, fibronectin, vitronectin, and hyaluronic acid, which are extracellular matrix elements within the lymph node parenchyma. HNSCC cell lines bound to laminin under lymphodynamic low shear stress (0.07 dynes/cm(2)), consistent with lymph flow via beta 1 integrins, including alpha 2 beta 1, alpha 3 beta 1, and alpha 6 beta 1. Binding occurred in the presence of shear stress and not in the absence of flow. Additionally, tumor cell binding to laminin under flow did result in calcium signaling. Our data indicate a novel role for beta 1 integrin-mediated binding of HNSCC cells to laminin under conditions of lymphodynamic flow that results in intracellular calcium signaling within the cancer cell.	[Sastry, Sarita K.; Resto, Vicente A.] Univ Texas Med Branch, UTMB Hlth, UTMB Canc Ctr, Galveston, TX 77555 USA; [Fennewald, Susan M.; Resto, Vicente A.] Univ Texas Med Branch, Dept Otolaryngol, Galveston, TX 77555 USA; [Kantara, Carla; Sastry, Sarita K.; Resto, Vicente A.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Resto, VA (corresponding author), Univ Texas Med Branch, UTMB Hlth, UTMB Canc Ctr, 301 Univ Blvd, Galveston, TX 77555 USA.	varesto@utmb.edu	Sastry, Sarita/A-1291-2013; Resto, Vicente/D-9891-2014		National Institutes of Heath from NCI [K08 CA132988]; Howard Hughes Medical Institute career physician scientist award; NATIONAL CANCER INSTITUTE [K08CA132988] Funding Source: NIH RePORTER	National Institutes of Heath from NCI; Howard Hughes Medical Institute career physician scientist award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Heath Grant K08 CA132988 from NCI (to V. A. R.). This work was also supported by a Howard Hughes Medical Institute career physician scientist award (to V. A. R.).	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Astrof NS, 2006, BIOCHEMISTRY-US, V45, P15020, DOI 10.1021/bi061566o; BAZZONI G, 1995, J BIOL CHEM, V270, P25570, DOI 10.1074/jbc.270.43.25570; Chen W, 2010, J BIOL CHEM, V285, P35967, DOI 10.1074/jbc.M110.155770; CYBULSKY AV, 1993, AM J PHYSIOL, V264, pC323, DOI 10.1152/ajpcell.1993.264.2.C323; DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Goncalves I, 2003, J BIOL CHEM, V278, P34812, DOI 10.1074/jbc.M306504200; Gorfu G, 2008, J LEUKOCYTE BIOL, V84, P701, DOI 10.1189/jlb.0108048; Haier J, 1999, CLIN EXP METASTAS, V17, P377, DOI 10.1023/A:1006658414040; Haier J, 2001, APMIS, V109, P241, DOI 10.1034/j.1600-0463.2001.d01-118.x; Kitayama J, 1999, BRIT J CANCER, V80, P1927, DOI 10.1038/sj.bjc.6690622; Kitayama J, 2000, CELL IMMUNOL, V199, P97, DOI 10.1006/cimm.1999.1596; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Mazzucato M, 2009, BLOOD, V114, P2793, DOI 10.1182/blood-2008-12-193490; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Resto VA, 2008, J BIOL CHEM, V283, P15816, DOI 10.1074/jbc.M708899200; Ricard I, 1997, EUR J IMMUNOL, V27, P1530, DOI 10.1002/eji.1830270632; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Sackstein R, 2005, CURR OPIN HEMATOL, V12, P444, DOI 10.1097/01.moh.0000177827.78280.79; SCHER RL, 1993, ARCH OTOLARYNGOL, V119, P432; Schottelndreier H, 2001, CELL SIGNAL, V13, P895, DOI 10.1016/S0898-6568(01)00225-X; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; TOZEREN A, 1994, J CELL SCI, V107, P3153; VOKES EE, 1993, NEW ENGL J MED, V328, P184, DOI 10.1056/NEJM199301213280306; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Wrenn RW, 1996, BIOCHEM BIOPH RES CO, V226, P876, DOI 10.1006/bbrc.1996.1443	33	14	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21058	21066		10.1074/jbc.M112.360313	http://dx.doi.org/10.1074/jbc.M112.360313			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22547070	Green Published, hybrid			2022-12-25	WOS:000306416800027
J	Li, W; Liu, H; Zhou, JS; Cao, JF; Zhou, XB; Choi, AMK; Chen, ZH; Shen, HH				Li, Wen; Liu, Hui; Zhou, Jie-Sen; Cao, Jiao-Fei; Zhou, Xiao-Bo; Choi, Augustine M. K.; Chen, Zhi-Hua; Shen, Hua-Hao			Caveolin-1 Inhibits Expression of Antioxidant Enzymes through Direct Interaction with Nuclear Erythroid 2 p45-related Factor-2 (Nrf2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME OXYGENASE-1/CARBON MONOXIDE; NITRIC-OXIDE SYNTHASE; PC12 CELL TOLERANCE; ADAPTIVE RESPONSE; PREMATURE SENESCENCE; TRANSCRIPTION FACTOR; UP-REGULATION; INDUCTION; LUNG; GLUTATHIONE	The Nrf2 (nuclear erythroid 2 p45-related factor-2) signaling pathway is known to play a pivotal role in a variety of oxidative stress-related human disorders. It has been reported recently that the plasma membrane resident protein caveolin-1 (Cav-1) can regulate expression of certain antioxidant enzymes and involves in the pathogenesis of oxidative lung injury, but the detailed molecular mechanisms remain incompletely understood. Here, we demonstrated that Cav-1 inhibited the expression of antioxidant enzymes through direct interaction with Nrf2 and subsequent suppression of its transcriptional activity in lung epithelial Beas-2B cells. Cav-1 deficiency cells exhibited higher levels of antioxidant enzymes and were more resistant to oxidative stress induced cytotoxicity, whereas overexpression of Cav-1 suppressed the induction of these enzymes and further augmented the oxidative cell death. Cav-1 constitutively interacted with Nrf2 in both cytosol and nucleus. Stimulation of 4-hydroxynonenol increased the Cav-1-Nrf2 interaction in cytosol but disrupted their association in the nucleus. Knock-down of Cav-1 also disassociated the interaction between Nrf2 and its cytoplasmic inhibitor Keap1 (Kelch-like ECH-associated protein 1) and increased the Nrf2 transcription activity. Mutation of the resembling Cav-1 binding motif on Nrf2 effectively attenuated their interaction, which exhibited higher transcription activity and induced higher levels of antioxidant enzymes relative to the wild-type control. Altogether, these studies clearly demonstrate that Cav-1 inhibits cellular antioxidant capacity through direct interaction with Nrf2 and subsequent suppression of its activity, thereby implicating in certain oxidative stress-related human pathologies.	[Li, Wen; Liu, Hui; Zhou, Jie-Sen; Chen, Zhi-Hua; Shen, Hua-Hao] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Resp & Crit Care Med, Hangzhou 310058, Zhejiang, Peoples R China; [Zhou, Xiao-Bo] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab, Boston, MA 02115 USA; [Cao, Jiao-Fei] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurol, Hangzhou 310058, Zhejiang, Peoples R China; [Zhou, Xiao-Bo; Choi, Augustine M. K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Shen, Hua-Hao] State Key Lab Resp Dis, Guangzhou 510120, Guangdong, Peoples R China	Zhejiang University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Zhejiang University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; State Key Laboratory of Respiratory Disease	Chen, ZH (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Resp & Crit Care Med, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.	zhihuachen2010@yahoo.com.cn; hh_shen@yahoo.com.cn			National Natural Science Foundation of China [31170859, 81170037, 30825019]; Natural Science Foundation of Zhejiang Province [R2110323]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported in part by Young Investigator Award 30825019 by the National Natural Science Foundation of China (to H. H. S.), Distinguished Young Investigator Award R2110323 by the Natural Science Foundation of Zhejiang Province (to Z. H. C.), and General Projects of the National Natural Science Foundation of China Grants 31170859 (to Z. H. C.) and 81170037 (to W. L.).	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Chan KM, 1999, P NATL ACAD SCI USA, V96, P12731, DOI 10.1073/pnas.96.22.12731; Chen ZH, 2006, IUBMB LIFE, V58, P372, DOI 10.1080/15216540600686896; Chen ZH, 2006, FEBS LETT, V580, P479, DOI 10.1016/j.febslet.2005.12.045; Chen ZH, 2005, J BIOL CHEM, V280, P41921, DOI 10.1074/jbc.M508556200; Chen ZH, 2006, J BIOL CHEM, V281, P14440, DOI 10.1074/jbc.M600260200; Chen ZH, 2010, P NATL ACAD SCI USA, V107, P18880, DOI 10.1073/pnas.1005574107; Chidlow JH, 2010, CARDIOVASC RES, V86, P219, DOI 10.1093/cvr/cvq075; Chretien A, 2008, FEBS LETT, V582, P1685, DOI 10.1016/j.febslet.2008.04.026; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Feng YY, 1999, BIOCHEM BIOPH RES CO, V256, P192, DOI 10.1006/bbrc.1998.9790; Frank PG, 2004, ARTERIOSCL THROM VAS, V24, P98, DOI 10.1161/01.ATV.0000101182.89118.E5; Franklin CC, 2009, MOL ASPECTS MED, V30, P86, DOI 10.1016/j.mam.2008.08.009; Ghosh S, 1998, J BIOL CHEM, V273, P22267, DOI 10.1074/jbc.273.35.22267; Gobeil F, 2003, J BIOL CHEM, V278, P38875, DOI 10.1074/jbc.M212481200; Halliwell B., 2007, FREE RADICALS BIOL M; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Jin Y, 2008, AM J RESP CELL MOL, V39, P171, DOI 10.1165/rcmb.2007-0323OC; Jin Y, 2009, FASEB J, V23, P341, DOI 10.1096/fj.08-108423; Kim HP, 2009, METHOD ENZYMOL, V453, P197, DOI 10.1016/S0076-6879(08)04010-X; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Morse D, 2009, FREE RADICAL BIO MED, V47, P1, DOI 10.1016/j.freeradbiomed.2009.04.007; Niki E, 2004, BIOCHEM SOC T, V32, P156, DOI 10.1042/BST0320156; Papas, 1999, ANTIOXIDANT STATUS D; Rahman I, 2005, ANTIOXID REDOX SIGN, V7, P42, DOI 10.1089/ars.2005.7.42; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Ryter SW, 2011, AUTOPHAGY, V7, P436, DOI 10.4161/auto.7.4.14501; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sanna E, 2007, EXP CELL RES, V313, P1307, DOI 10.1016/j.yexcr.2007.02.005; Santibanez JF, 2008, CARDIOVASC RES, V77, P791, DOI 10.1093/cvr/cvm097; SCHERER PE, 1995, J BIOL CHEM, V270, P16395, DOI 10.1074/jbc.270.27.16395; Volonte D, 2009, EMBO REP, V10, P1334, DOI 10.1038/embor.2009.215; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; Wang XM, 2009, J IMMUNOL, V182, P3809, DOI 10.4049/jimmunol.0712437; Zhang M, 2011, FREE RADICAL BIO MED, V50, P1252, DOI 10.1016/j.freeradbiomed.2011.02.031; Zhang M, 2009, AM J PHYSIOL-LUNG C, V297, pL945, DOI 10.1152/ajplung.00081.2009; Zhang Y, 2010, J MOL CELL CARDIOL, V49, P576, DOI 10.1016/j.yjmcc.2010.05.011	38	62	65	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20922	20930		10.1074/jbc.M112.352336	http://dx.doi.org/10.1074/jbc.M112.352336			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22547061	Green Published, hybrid			2022-12-25	WOS:000306416800014
J	Seong, HA; Jung, H; Manoharan, R; Ha, H				Seong, Hyun-A; Jung, Haiyoung; Manoharan, Ravi; Ha, Hyunjung			PDK1 Protein Phosphorylation at Thr(354) by Murine Protein Serine-Threonine Kinase 38 Contributes to Negative Regulation of PDK1 Protein Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYSICAL INTERACTION; DEPENDENT MANNER; SMAD PROTEINS; MELK; ACTIVATION; IDENTIFICATION; SPECIFICITY; INVOLVEMENT; AKT/PKB; INSULIN	Murine protein serine-threonine kinase 38 (MPK38) is a member of the AMP-activated protein kinase-related serine/threonine kinase family, which acts as cellular energy sensors. In this study, MPK38-induced PDK1 phosphorylation was examined to elucidate the biochemical mechanisms underlying phosphorylation-dependent regulation of 3-phosphoinositide-dependent protein kinase-1 (PDK1) activity. The results showed that MPK38 interacted with and inhibited PDK1 activity via Thr(354) phosphorylation. MPK38-PDK1 complex formation was mediated by the amino-terminal catalytic kinase domain of MPK38 and the pleckstrin homology domain of PDK1. This activity was dependent on insulin, a PI3K/PDK1 stimulator, as well as various apoptotic stimuli, including TNF-alpha, H2O2, thapsigargin, and ionomycin. MPK38 inhibited PDK1 activity in a kinase-dependent manner and alleviated PDK1-mediated suppression of TGF-beta (or ASK1) signaling, probably via the phosphorylation of PDK1 at Thr(354). In addition, MPK38-mediated inhibition of PDK1 activity was accompanied by the modulation of PDK1 binding to its positive and negative regulators, serine/threonine kinase receptor-associated protein and 14-3-3, respectively. Together, these findings suggest an important role for MPK38-mediated phosphorylation of PDK1 in the negative regulation of PDK1 activity.	[Seong, Hyun-A; Jung, Haiyoung; Manoharan, Ravi; Ha, Hyunjung] Chungbuk Natl Univ, Sch Life Sci, Dept Biochem, Cheongju 361763, South Korea	Chungbuk National University	Ha, H (corresponding author), Chungbuk Natl Univ, Sch Life Sci, Dept Biochem, Cheongju 361763, South Korea.	hyunha@chungbuk.ac.kr	Manoharan, Ravi/AAI-4139-2021	Manoharan, Ravi/0000-0002-3494-2173	National Research Foundation of Korea [R0A-2007-000-20006-0]; Korean Government	National Research Foundation of Korea(National Research Foundation of Korea); Korean Government(Korean Government)	This work was supported by National Research Foundation of Korea Grant R0A-2007-000-20006-0 funded by the Korean Government.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; Bayascas JR, 2005, MOL CELL, V18, P143, DOI 10.1016/j.molcel.2005.03.020; Beullens M, 2005, J BIOL CHEM, V280, P40003, DOI 10.1074/jbc.M507274200; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Datta PK, 1998, J BIOL CHEM, V273, P34671, DOI 10.1074/jbc.273.52.34671; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; Fujita N, 2002, J BIOL CHEM, V277, P10346, DOI 10.1074/jbc.M106736200; Gil M, 1997, GENE, V195, P295, DOI 10.1016/S0378-1119(97)00181-9; Gray D, 2005, CANCER RES, V65, P9751, DOI 10.1158/0008-5472.CAN-04-4531; Heyer BS, 1997, MOL REPROD DEV, V47, P148, DOI 10.1002/(SICI)1098-2795(199706)47:2&lt;148::AID-MRD4&gt;3.0.CO;2-M; ITO T, 1993, CANCER RES, V53, P2940; Jakobsen SN, 2001, J BIOL CHEM, V276, P46912, DOI 10.1074/jbc.C100483200; Jung HY, 2007, J BIOL CHEM, V282, P35293, DOI 10.1074/jbc.M705181200; Jung H, 2008, J BIOL CHEM, V283, P34541, DOI 10.1074/jbc.M807219200; Kikani CK, 2005, J CELL BIOCHEM, V96, P1157, DOI 10.1002/jcb.20651; Kim DW, 2003, MOL ENDOCRINOL, V17, P1382, DOI 10.1210/me.2002-0402; Kondo T, 2004, J BIOL CHEM, V279, P37997, DOI 10.1074/jbc.M401339200; Riojas RA, 2006, J BIOL CHEM, V281, P21588, DOI 10.1074/jbc.M600393200; Saito R, 2005, MOL CELL BIOL, V25, P6682, DOI 10.1128/MCB.25.15.6682-6693.2005; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sato S, 2002, J BIOL CHEM, V277, P39360, DOI 10.1074/jbc.M205141200; Scheid MP, 2005, MOL CELL BIOL, V25, P2347, DOI 10.1128/MCB.25.6.2347-2363.2005; Seong HA, 2005, J BIOL CHEM, V280, P42897, DOI 10.1074/jbc.M507539200; Seong HA, 2007, J BIOL CHEM, V282, P12272, DOI 10.1074/jbc.M609279200; Seong HA, 2011, J BIOL CHEM, V286, P31123, DOI 10.1074/jbc.M111.248674; Seong HA, 2010, J BIOL CHEM, V285, P30959, DOI 10.1074/jbc.M110.138370; Seong HA, 2010, J BIOL CHEM, V285, P2397, DOI 10.1074/jbc.M109.064295; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Toker A, 2000, CELL, V103, P185, DOI 10.1016/S0092-8674(00)00110-0; Vulsteke V, 2004, J BIOL CHEM, V279, P8642, DOI 10.1074/jbc.M311466200; Wang CH, 2009, J BIOL CHEM, V284, P2038, DOI 10.1074/jbc.M806336200; Yang KJ, 2008, J BIOL CHEM, V283, P1480, DOI 10.1074/jbc.M706361200	36	16	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20811	20822		10.1074/jbc.M111.331827	http://dx.doi.org/10.1074/jbc.M111.331827			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22544756	hybrid, Green Published			2022-12-25	WOS:000306416800003
J	Ben-Dov, N; Korenstein, R				Ben-Dov, Nadav; Korenstein, Rafi			Enhancement of Cell Membrane Invaginations, Vesiculation and Uptake of Macromolecules by Protonation of the Cell Surface	PLOS ONE			English	Article							LATERAL INTERCELLULAR SPACES; FLUID-PHASE PINOCYTOSIS; INTERFACIAL-TENSION; MOLECULAR-MECHANISM; HISTIDINE-RESIDUES; ELASTIC PROPERTIES; RAT HEPATOCYTES; LIPID RAFTS; PH; ENDOCYTOSIS	The different pathways of endocytosis share an initial step involving local inward curvature of the cell's lipid bilayer. It has been shown that to generate membrane curvature, proteins or lipids enforce transversal asymmetry of the plasma membrane. Thus it emerges as a general phenomenon that transversal membrane asymmetry is the common required element for the formation of membrane curvature. The present study demonstrates that elevating proton concentration at the cell surface stimulates the formation of membrane invaginations and vesiculation accompanied by efficient uptake of macromolecules (Dextran-FITC, 70 kD), relative to the constitutive one. The insensitivity of proton induced uptake to inhibiting treatments and agents of the known endocytic pathways suggests the entry of macromolecules to proceeds via a yet undefined route. This is in line with the fact that neither ATP depletion, nor the lowering of temperature, abolishes the uptake process. In addition, fusion mechanism such as associated with low pH uptake of toxins and viral proteins can be disregarded by employing the polysaccharide dextran as the uptake molecule. The proton induced uptake increases linearly in the extracellular pH range of 6.5 to 4.5, and possesses a steep increase at the range of 4> pH > 3, reaching a plateau at pH <= 3. The kinetics of the uptake implies that the induced vesicles release their content to the cytosol and undergo rapid recycling to the plasma membrane. We suggest that protonation of the cell's surface induces local charge asymmetries across the cell membrane bilayer, inducing inward curvature of the cell membrane and consequent vesiculation and uptake.	[Ben-Dov, Nadav; Korenstein, Rafi] Tel Aviv Univ, Dept Physiol & Pharmacol, Fac Med, IL-69978 Tel Aviv, Israel	Tel Aviv University	Ben-Dov, N (corresponding author), Tel Aviv Univ, Dept Physiol & Pharmacol, Fac Med, IL-69978 Tel Aviv, Israel.	korens@post.tau.ac.il			Israel Science Foundation [1029/03]	Israel Science Foundation(Israel Science Foundation)	The study was supported by the Israel Science Foundation founded by the Israel Academy of Sciences and Humanities (grant 1029/03 to RK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain JM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.158104; Amyere M, 2002, INT J MED MICROBIOL, V291, P487; Anderle P, 1998, J PHARM SCI, V87, P757, DOI 10.1021/js970372e; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Baumgart T, 2011, ANNU REV PHYS CHEM, V62, P483, DOI 10.1146/annurev.physchem.012809.103450; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; CARO I, 1995, INT J PHARMACEUT, V116, P147, DOI 10.1016/0378-5173(94)00280-I; CHATTON JY, 1994, J MEMBRANE BIOL, V140, P89; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; CLAGUE MJ, 1995, FEBS LETT, V367, P272, DOI 10.1016/0014-5793(95)00576-U; Dai JW, 1997, J GEN PHYSIOL, V110, P1, DOI 10.1085/jgp.110.1.1; de Figueiredo RCBQ, 2000, PARASITOL RES, V86, P413, DOI 10.1007/s004360050686; DeCoursey TE, 2008, J PHYSIOL-LONDON, V586, P5305, DOI 10.1113/jphysiol.2008.161703; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Galatola P, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041930; Gandhavadi M, 2002, BIOPHYS J, V82, P1469, DOI 10.1016/S0006-3495(02)75501-X; Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P23, DOI 10.1016/S0005-2728(03)00108-7; Graham TR, 2010, CURR OPIN CELL BIOL, V22, P430, DOI 10.1016/j.ceb.2010.05.002; Hanzal-Bayer MF, 2007, FEBS LETT, V581, P2098, DOI 10.1016/j.febslet.2007.03.019; HARRIS PJ, 1994, AM J PHYSIOL, V266, pC73, DOI 10.1152/ajpcell.1994.266.1.C73; HAUSER H, 1989, P NATL ACAD SCI USA, V86, P5351, DOI 10.1073/pnas.86.14.5351; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; HOLEN I, 1995, BIOCHEM J, V311, P317, DOI 10.1042/bj3110317; Huotari V, 1996, J CELL PHYSIOL, V167, P121, DOI 10.1002/(SICI)1097-4652(199604)167:1<121::AID-JCP14>3.0.CO;2-E; IACOPETTA BJ, 1983, J BIOL CHEM, V258, P9108; Janmey PA, 2006, TRENDS CELL BIOL, V16, P538, DOI 10.1016/j.tcb.2006.08.009; JONES AT, 1995, BIOCHEM J, V311, P31, DOI 10.1042/bj3110031; JULICHER F, 1993, PHYS REV LETT, V70, P2964, DOI 10.1103/PhysRevLett.70.2964; Kaasik A, 2007, AM J PHYSIOL-CELL PH, V292, pC157, DOI 10.1152/ajpcell.00272.2006; Kampmann T, 2006, STRUCTURE, V14, P1481, DOI 10.1016/j.str.2006.07.011; Khalifat N, 2008, BIOPHYS J, V95, P4924, DOI 10.1529/biophysj.108.136077; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Kozlov MM, 2010, TRENDS BIOCHEM SCI, V35, P699, DOI 10.1016/j.tibs.2010.06.003; KOZLOV MM, 1992, J PHYS II, V2, P175, DOI 10.1051/jp2:1992122; Kuzmin PI, 2005, BIOPHYS J, V88, P1120, DOI 10.1529/biophysj.104.048223; LERCHE D, 1987, BIORHEOLOGY, V24, P23; LESUFFLEUR T, 1990, CANCER RES, V50, P6334; Li L, 2010, NATURE, V468, P705, DOI 10.1038/nature09546; Li Y, 2005, EUROPHYS LETT, V70, P411, DOI 10.1209/epl/i2004-10498-4; Lim HWG, 2002, P NATL ACAD SCI USA, V99, P16766, DOI 10.1073/pnas.202617299; Lindberg M, 2001, BIOCHEMISTRY-US, V40, P3141, DOI 10.1021/bi0008985; Lipowsky R, 2002, J BIOL PHYS, V28, P195, DOI 10.1023/A:1019994628793; Liu J, 2006, P NATL ACAD SCI USA, V103, P10277, DOI 10.1073/pnas.0601045103; Lundmark R, 2010, SEMIN CELL DEV BIOL, V21, P363, DOI 10.1016/j.semcdb.2009.11.014; Martin WC, 2010, GROUND LEVEL IONIZAT; MASOLIVA J, 1980, BRIT J PHARMACOL, V70, P617, DOI 10.1111/j.1476-5381.1980.tb09780.x; Matsuyama S, 2000, CELL DEATH DIFFER, V7, P1155, DOI 10.1038/sj.cdd.4400779; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mosiman VL, 1997, CYTOMETRY, V30, P151; Motizuki M, 2004, J BIOCHEM, V135, P713, DOI 10.1093/jb/mvh087; MUIR EM, 1983, BIOCHEM J, V216, P467, DOI 10.1042/bj2160467; Odell LR, 2009, CHEMMEDCHEM, V4, P1182, DOI 10.1002/cmdc.200900054; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Orlowski S, 1996, BIOCHEM J, V317, P515, DOI 10.1042/bj3170515; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Petelska AD, 2006, BIOPHYS CHEM, V120, P199, DOI 10.1016/j.bpc.2005.10.008; Petelska AD, 2002, BBA-BIOMEMBRANES, V1561, P135, DOI 10.1016/S0005-2736(01)00463-1; Petrache HI, 2006, P NATL ACAD SCI USA, V103, P7982, DOI 10.1073/pnas.0509967103; PRATTEN MK, 1979, BIOCHEM J, V180, P567, DOI 10.1042/bj1800567; Prego C, 2005, J CONTROL RELEASE, V101, P151, DOI 10.1016/j.jconrel.2004.07.030; Qin ZL, 2009, J VIROL, V83, P4670, DOI 10.1128/JVI.02646-08; RINK TJ, 1982, J CELL BIOL, V95, P189, DOI 10.1083/jcb.95.1.189; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Safran S. A., 1994, STAT THERMODYNAMICS; Sandvig K, 2005, GENE THER, V12, P865, DOI 10.1038/sj.gt.3302525; SANDVIG K, 1987, J CELL BIOL, V105, P679, DOI 10.1083/jcb.105.2.679; Sandvig K, 2008, HISTOCHEM CELL BIOL, V129, P267, DOI 10.1007/s00418-007-0376-5; SCHNITZER JE, 1988, YALE J BIOL MED, V61, P427; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; Stan RV, 2005, BBA-MOL CELL RES, V1746, P334, DOI 10.1016/j.bbamcr.2005.08.008; Thaokar RM, 2010, PHYS FLUIDS, V22; Thoennes S, 2008, VIROLOGY, V370, P403, DOI 10.1016/j.virol.2007.08.035; WAGNER RC, 1976, J ULTRA MOL STRUCT R, V57, P132, DOI 10.1016/S0022-5320(76)80103-7; WEIGEL PH, 1981, J BIOL CHEM, V256, P2615; WHITE J, 1980, P NATL ACAD SCI-BIOL, V77, P3273, DOI 10.1073/pnas.77.6.3273; WINTERHALTER M, 1988, J PHYS CHEM-US, V92, P6865, DOI 10.1021/j100335a004; Yuan CB, 2002, BIOPHYS J, V82, P2526, DOI 10.1016/S0006-3495(02)75596-3; Zemel A, 2003, BIOPHYS J, V84, P2242, DOI 10.1016/S0006-3495(03)75030-9; Zhou Y, 2007, BIOPHYS J, V92, P2451, DOI 10.1529/biophysj.106.096362; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010	81	22	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35204	10.1371/journal.pone.0035204	http://dx.doi.org/10.1371/journal.pone.0035204			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558127	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340200010
J	Sequeira, A; Morgan, L; Walsh, DM; Cartagena, PM; Choudary, P; Li, J; Schatzberg, AF; Watson, SJ; Akil, H; Myers, RM; Jones, EG; Bunney, WE; Vawter, MP				Sequeira, Adolfo; Morgan, Ling; Walsh, David M.; Cartagena, Preston M.; Choudary, Prabhakara; Li, Jun; Schatzberg, Alan F.; Watson, Stanley J.; Akil, Huda; Myers, Richard M.; Jones, Edward G.; Bunney, William E.; Vawter, Marquis P.			Gene Expression Changes in the Prefrontal Cortex, Anterior Cingulate Cortex and Nucleus Accumbens of Mood Disorders Subjects That Committed Suicide	PLOS ONE			English	Article							METALLOTHIONEIN MESSENGER-RNA; BIPOLAR AFFECTIVE-DISORDER; ADENYLYL-CYCLASE ACTIVITY; PITUITARY-ADRENAL AXIS; POSTMORTEM HUMAN-BRAIN; SEROTONIN 2A RECEPTOR; MAJOR DEPRESSION; FRONTAL-CORTEX; URINARY 17-HYDROXYCORTICOSTEROIDS; WOLFRAM-SYNDROME	Suicidal behaviors are frequent in mood disorders patients but only a subset of them ever complete suicide. Understanding predisposing factors for suicidal behaviors in high risk populations is of major importance for the prevention and treatment of suicidal behaviors. The objective of this project was to investigate gene expression changes associated with suicide in brains of mood disorder patients by microarrays (Affymetrix HG-U133 Plus2.0) in the dorsolateral prefrontal cortex (DLPFC: 6 Non-suicides, 15 suicides), the anterior cingulate cortex (ACC: 6NS, 9S) and the nucleus accumbens (NAcc: 8NS, 13S). ANCOVA was used to control for age, gender, pH and RNA degradation, with P <= 0.01 and fold change +/- 1.25 as criteria for significance. Pathway analysis revealed serotonergic signaling alterations in the DLPFC and glucocorticoid signaling alterations in the ACC and NAcc. The gene with the lowest p-value in the DLPFC was the 5-HT2A gene, previously associated both with suicide and mood disorders. In the ACC 6 metallothionein genes were down-regulated in suicide (MT1E, MT1F, MT1G, MT1H, MT1X, MT2A) and three were down-regulated in the NAcc (MT1F, MT1G, MT1H). Differential expression of selected genes was confirmed by qPCR, we confirmed the 5-HT2A alterations and the global down-regulation of members of the metallothionein subfamilies MT 1 and 2 in suicide completers. MTs 1 and 2 are neuro-protective following stress and glucocorticoid stimulations, suggesting that in suicide victims neuroprotective response to stress and cortisol may be diminished. Our results thus suggest that suicide-specific expression changes in mood disorders involve both glucocorticoids regulated metallothioneins and serotonergic signaling in different regions of the brain.	[Sequeira, Adolfo; Morgan, Ling; Walsh, David M.; Cartagena, Preston M.; Bunney, William E.; Vawter, Marquis P.] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA; [Choudary, Prabhakara; Jones, Edward G.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Li, Jun] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Schatzberg, Alan F.] Stanford Univ, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; [Watson, Stanley J.; Akil, Huda] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Myers, Richard M.] HudsonAlpha Inst Biotechnol, Huntsville, MI USA	University of California System; University of California Irvine; University of California System; University of California Davis; University of Michigan System; University of Michigan; Stanford University; University of Michigan System; University of Michigan; HudsonAlpha Institute for Biotechnology	Sequeira, A (corresponding author), Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA.	psequeir@uci.edu	Sequeira, Adolfo/K-7278-2015	Sequeira, Adolfo/0000-0003-3040-1190; Li, Jun/0000-0001-6727-0812; Choudary, Prabhakara/0000-0002-7163-6466	Pritzker Neuropsychiatric Disorders Research Fund L.L.C.; William Lion Penzner Foundation (Dept of Psychiatry, UCI); Della Martin Foundation; National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085801] Funding Source: NIH RePORTER	Pritzker Neuropsychiatric Disorders Research Fund L.L.C.; William Lion Penzner Foundation (Dept of Psychiatry, UCI); Della Martin Foundation; National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors are members of the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, Stanford University, the Weill Medical College of Cornell University, HudsonAlpha Institute of Biotechnology, the Universities of California at Davis (UCD), and at Irvine (UCI), to encourage the development of appropriate findings for research and clinical applications. The research was further supported by the William Lion Penzner Foundation (Dept of Psychiatry, UCI), Della Martin Foundation (to WEB, AS) and the National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award (to AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atz M, 2007, J NEUROSCI METH, V163, P295, DOI 10.1016/j.jneumeth.2007.03.022; BARRACLOUGH B, 1974, BRIT J PSYCHIAT, V125, P355, DOI 10.1192/bjp.125.4.355; BARTON AJL, 1993, J NEUROCHEM, V61, P1, DOI 10.1111/j.1471-4159.1993.tb03532.x; Bostwick JM, 2000, AM J PSYCHIAT, V157, P1925, DOI 10.1176/appi.ajp.157.12.1925; BOURNE HR, 1968, LANCET, V2, P805; BRENT DA, 1988, ARCH GEN PSYCHIAT, V45, P581, DOI 10.1001/archpsyc.1988.01800300079011; Bunney WE, 2000, NEUROPSYCHOPHARMACOL, V22, P335, DOI 10.1016/S0893-133X(99)00145-1; BUNNEY WE, 1965, PSYCHOSOM MED, V27, P299, DOI 10.1097/00006842-196507000-00001; BUNNEY WE, 1965, ARCH GEN PSYCHIAT, V13, P232; BUNNEY WE, 1969, ARCH GEN PSYCHIAT, V21, P138; BUNNEY WE, 1965, ARCH GEN PSYCHIAT, V13, P483; Chang XL, 2009, EXP BIOL MED, V234, P666, DOI 10.3181/0811-RM-336; Chung RS, 2008, J BIOL CHEM, V283, P15349, DOI 10.1074/jbc.M708446200; COWBURN RF, 1994, BRAIN RES, V633, P297, DOI 10.1016/0006-8993(94)91552-0; Cowen PJ, 2009, PSYCHOL MED, P1; Coyle P, 2002, CELL MOL LIFE SCI, V59, P627, DOI 10.1007/s00018-002-8454-2; Dowlatshahi D, 1999, J NEUROCHEM, V73, P1121, DOI 10.1046/j.1471-4159.1999.0731121.x; Dwivedi Y, 2003, ARCH GEN PSYCHIAT, V60, P273, DOI 10.1001/archpsyc.60.3.273; Garbett Krassimira, 2008, Neuropsychopharmacol Hung, V10, P9; GASULL T, 1994, AM J PHYSIOL, V266, pE760, DOI 10.1152/ajpendo.1994.266.5.E760; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Ghoshal K, 1998, J BIOL CHEM, V273, P27904, DOI 10.1074/jbc.273.43.27904; Goldsmith S.K., 2002, REDUCING SUICIDE NAT; Goodwin FK, 1990, SUICIDE MANIC DEPRES, P227; Greydanus DE, 2007, PRIMARY CARE, V34, P259, DOI 10.1016/j.pop.2007.04.013; Gross-Isseroff R, 1998, NEUROSCI BIOBEHAV R, V22, P653, DOI 10.1016/S0149-7634(97)00061-4; GROSSISSEROFF R, 1990, BRAIN RES, V507, P208, DOI 10.1016/0006-8993(90)90274-F; GUZE SB, 1970, BRIT J PSYCHIAT, V117, P437, DOI 10.1192/bjp.117.539.437; Hidalgo, 1997, Stress, V1, P231; HIDALGO J, 1994, CHEM-BIOL INTERACT, V93, P197, DOI 10.1016/0009-2797(94)90020-5; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; Hrdina PD, 2001, AM J PSYCHIAT, V158, P147, DOI 10.1176/appi.ajp.158.1.147-a; Inskip HM, 1998, BRIT J PSYCHIAT, V172, P35, DOI 10.1192/bjp.172.1.35; Jacob ST, 1999, GENE EXPRESSION, V7, P301; Jamison KR, 2000, J CLIN PSYCHIAT, V61, P47; Jokinen J, 2009, PSYCHIAT RES, V165, P96, DOI 10.1016/j.psychres.2007.10.007; JONES EG, 1992, J NEUROSCI METH, V44, P133, DOI 10.1016/0165-0270(92)90006-Y; KARIN M, 1984, NATURE, V308, P513, DOI 10.1038/308513a0; Kelly EJ, 1997, P NATL ACAD SCI USA, V94, P10045, DOI 10.1073/pnas.94.19.10045; Kelly TM, 1996, ACTA PSYCHIAT SCAND, V94, P337, DOI 10.1111/j.1600-0447.1996.tb09869.x; Kim S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-413; KLEMPAN TA, 2007, MOL PSYCHIAT; Kramer KK, 1996, TOXICOL APPL PHARM, V141, P1; Kramer KK, 1996, TOXICOL APPL PHARM, V136, P94, DOI 10.1006/taap.1996.0011; LESAGE AD, 1994, AM J PSYCHIAT, V151, P1063; Li JZ, 2004, HUM MOL GENET, V13, P609, DOI 10.1093/hmg/ddh065; Lopez JF, 1997, ANN NY ACAD SCI, V836, P106, DOI 10.1111/j.1749-6632.1997.tb52357.x; LOPEZDURAN NL, 2009, PSYCHONEUROENDOCRINO; Mann JJ, 2003, NAT REV NEUROSCI, V4, P819, DOI 10.1038/nrn1220; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; McMahon FJ, 2006, AM J HUM GENET, V78, P804, DOI 10.1086/503820; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Oquendo MA, 2000, PSYCHIAT CLIN N AM, V23, P11, DOI 10.1016/S0193-953X(05)70140-4; Oquendo MA, 2008, AM J PSYCHIAT, V165, P1383, DOI 10.1176/appi.ajp.2008.08020281; Pandey GN, 2002, AM J PSYCHIAT, V159, P419, DOI 10.1176/appi.ajp.159.3.419; Pedersen MO, 2009, BIOFACTORS, V35, P315, DOI 10.1002/biof.44; Rahman S, 1997, J NEUROCHEM, V68, P297; ROBINS E, 1959, AM J PUBLIC HEALTH N, V49, P888, DOI 10.2105/AJPH.49.7.888; Rosel P, 2000, PSYCHIAT RES-NEUROIM, V99, P173, DOI 10.1016/S0925-4927(00)00076-7; Sequeira A, 2007, MOL PSYCHIATR, V12, P640, DOI 10.1038/sj.mp.4001969; Sequeira A, 2006, ARCH GEN PSYCHIAT, V63, P35, DOI 10.1001/archpsyc.63.1.35; Sequeira A, 2003, AM J MED GENET B, V119B, P108, DOI 10.1002/ajmg.b.20011; Sequeira A, 2006, OMICS, V10, P444, DOI 10.1089/omi.2006.10.444; Serretti A, 2007, CURR MED CHEM, V14, P2053; Shelton RC, 2009, NEUROSCIENCE, V158, P1406, DOI 10.1016/j.neuroscience.2008.11.036; Shelton RC, 2010, MOL PSYCHIAT; Sibille E, 2004, NEUROPSYCHOPHARMACOL, V29, P351, DOI 10.1038/sj.npp.1300335; STANLEY M, 1983, LANCET, V1, P214; Stockmeier CA, 1997, NEUROPSYCHOPHARMACOL, V16, P162, DOI 10.1016/S0893-133X(96)00170-4; Swift M, 2005, MOL PSYCHIATR, V10, P799, DOI 10.1038/sj.mp.4001681; SWIFT RG, 1990, LANCET, V336, P667, DOI 10.1016/0140-6736(90)92157-D; Thalmeier A, 2008, INT J NEUROPSYCHOPH, V11, P217, DOI 10.1017/S1461145707007894; Tochigi M, 2008, NEUROSCI RES, V60, P184, DOI 10.1016/j.neures.2007.10.010; Tomita H, 2004, BIOL PSYCHIAT, V55, P346, DOI 10.1016/j.biopsych.2003.10.013; Turecki G, 1999, AM J PSYCHIAT, V156, P1456; Underwood MD, 2011, INT J NEUROPSYCHOPH, P1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vawter MP, 2006, MOL PSYCHIAT, P615; Vreeburg SA, 2009, ARCH GEN PSYCHIAT, V66, P617, DOI 10.1001/archgenpsychiatry.2009.50; Wann BP, 2009, BRAIN RES BULL, V79, P32, DOI 10.1016/j.brainresbull.2008.12.008; WESTER P, 1985, NEUROCHEM PATHOL, V3, P169, DOI 10.1007/BF02834269; World Health Organization, 2000, WORLD HLTH REP 2000; Yanagi M, 2005, J HUM GENET, V50, P210, DOI 10.1007/s10038-005-0241-0; YOUNG LT, 1993, J NEUROCHEM, V61, P890, DOI 10.1111/j.1471-4159.1993.tb03600.x; ZHENG H, 1995, NEUROCHEM INT, V27, P43, DOI 10.1016/0197-0186(94)00167-S	86	59	62	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35367	10.1371/journal.pone.0035367	http://dx.doi.org/10.1371/journal.pone.0035367			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558144	Green Published, gold			2022-12-25	WOS:000305340200016
J	Xie, W; Meng, QS; Wu, QJ; Wang, SL; Yang, X; Yang, NN; Li, RM; Jiao, XG; Pan, HP; Liu, BM; Su, Q; Xu, BY; Hu, SN; Zhou, XG; Zhang, YJ				Xie, Wen; Meng, Qing-shu; Wu, Qing-jun; Wang, Shao-li; Yang, Xin; Yang, Ni-na; Li, Ru-mei; Jiao, Xiao-guo; Pan, Hui-peng; Liu, Bai-ming; Su, Qi; Xu, Bao-yun; Hu, Song-nian; Zhou, Xu-guo; Zhang, You-jun			Pyrosequencing the Bemisia tabaci Transcriptome Reveals a Highly Diverse Bacterial Community and a Robust System for Insecticide Resistance	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; Q-BIOTYPE; ACYRTHOSIPHON-PISUM; IMMUNE-RESPONSE; TREHALASE ACTIVITY; BROWN PLANTHOPPER; CROSS-RESISTANCE; GENE-EXPRESSION; PEA APHIDS; B-BIOTYPE	Background: Bemisia tabaci (Gennadius) is a phloem-feeding insect poised to become one of the major insect pests in open field and greenhouse production systems throughout the world. The high level of resistance to insecticides is a main factor that hinders continued use of insecticides for suppression of B. tabaci. Despite its prevalence, little is known about B. tabaci at the genome level. To fill this gap, an invasive B. tabaci B biotype was subjected to pyrosequencing-based transcriptome analysis to identify genes and gene networks putatively involved in various physiological and toxicological processes. Methodology and Principal Findings: Using Roche 454 pyrosequencing, 857,205 reads containing approximately 340 megabases were obtained from the B. tabaci transcriptome. De novo assembly generated 178,669 unigenes including 30,980 from insects, 17,881 from bacteria, and 129,808 from the nohit. A total of 50,835 (28.45%) unigenes showed similarity to the non-redundant database in GenBank with a cut-off E-value of 10-5. Among them, 40,611 unigenes were assigned to one or more GO terms and 6,917 unigenes were assigned to 288 known pathways. De novo metatranscriptome analysis revealed highly diverse bacterial symbionts in B. tabaci, and demonstrated the host-symbiont cooperation in amino acid production. In-depth transcriptome analysis indentified putative molecular markers, and genes potentially involved in insecticide resistance and nutrient digestion. The utility of this transcriptome was validated by a thiamethoxam resistance study, in which annotated cytochrome P450 genes were significantly overexpressed in the resistant B. tabaci in comparison to its susceptible counterparts. Conclusions: This transcriptome/metatranscriptome analysis sheds light on the molecular understanding of symbiosis and insecticide resistance in an agriculturally important phloem-feeding insect pest, and lays the foundation for future functional genomics research of the B. tabaci complex. Moreover, current pyrosequencing effort greatly enriched the existing whitefly EST database, and makes RNAseq a viable option for future genomic analysis.	[Xie, Wen; Wu, Qing-jun; Wang, Shao-li; Yang, Xin; Yang, Ni-na; Li, Ru-mei; Jiao, Xiao-guo; Pan, Hui-peng; Liu, Bai-ming; Su, Qi; Xu, Bao-yun; Zhang, You-jun] Chinese Acad Agr Sci, Dept Plant Protect, Inst Vegetables & Flowers, Beijing 100193, Peoples R China; [Meng, Qing-shu; Hu, Song-nian] Chinese Acad Sci, Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China; [Zhou, Xu-guo] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University of Kentucky	Xie, W (corresponding author), Chinese Acad Agr Sci, Dept Plant Protect, Inst Vegetables & Flowers, Beijing 100193, Peoples R China.	husn@big.ac.cn; xuguozhou@uky.edu; zhangyj@mail.caas.net.cn	Yang, Xin/AAG-5375-2020; Zhang, Youjun/AAY-7948-2020; Hu, Songnian/C-6509-2013	Zhang, Youjun/0000-0003-3508-6695; Hu, Songnian/0000-0003-3966-3111; XIE, WEN/0000-0002-3220-1072	National Science Fund for Distinguished Young Scholars [31025020]; 973 Program [2009 CB119200]; National Natural Science Foundation of China [30900153]; Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, People's Republic of China	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, People's Republic of China	This research was supported by the National Science Fund for Distinguished Young Scholars (31025020), the 973 Program (2009 CB119200), the National Natural Science Foundation of China (no. 30900153), and the Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Baldwin WS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-169; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Becker A, 1996, EXPERIENTIA, V52, P433, DOI 10.1007/BF01919312; Behura SK, 2006, MOL ECOL, V15, P3087, DOI 10.1111/j.1365-294X.2006.03014.x; Bensadia F, 2006, J INSECT PHYSIOL, V52, P146, DOI 10.1016/j.jinsphys.2005.09.011; Bextine B, 2009, CDFAS PIERC DIS CONT, P3; BOUSH GM, 1967, J ECON ENTOMOL, V60, P918, DOI 10.1093/jee/60.4.918; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Brumin M, 2011, INSECT SCI, V18, P57, DOI 10.1111/j.1744-7917.2010.01396.x; Burke G, 2010, ISME J, V4, P242, DOI 10.1038/ismej.2009.114; Casida JE, 2011, J AGR FOOD CHEM, V59, P2923, DOI 10.1021/jf102438c; Chang A, 2009, NUCLEIC ACIDS RES, V37, pD588, DOI 10.1093/nar/gkn820; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; Chu D, 2006, FLA ENTOMOL, V89, P168, DOI 10.1653/0015-4040(2006)89[168:TIOTEQ]2.0.CO;2; CLEGG JS, 1961, SCIENCE, V134, P54, DOI 10.1126/science.134.3471.54; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; *DFCI, DFCI GEN IND SOFTW T; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Elbaz M, 2010, B ENTOMOL RES, V100, P581, DOI 10.1017/S0007485309990630; Erdogan C, 2008, CROP PROT, V27, P600, DOI 10.1016/j.cropro.2007.09.002; Feng YT, 2009, J APPL ENTOMOL, V133, P466, DOI 10.1111/j.1439-0418.2009.01383.x; Feng YT, 2010, PEST MANAG SCI, V66, P313, DOI 10.1002/ps.1877; Ferrari J, 2004, ECOL ENTOMOL, V29, P60, DOI 10.1111/j.1365-2311.2004.00574.x; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; FRIEDMAN S, 1978, ANNU REV ENTOMOL, V23, P389, DOI 10.1146/annurev.en.23.010178.002133; Fukatsu T, 2001, APPL ENVIRON MICROB, V67, P1284, DOI 10.1128/AEM.67.3.1284-1291.2001; Ghanim M, 2009, PEST MANAG SCI, V65, P939, DOI 10.1002/ps.1795; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Gorman K, 2007, PEST MANAG SCI, V63, P555, DOI 10.1002/ps.1364; Gottlieb Y, 2010, J VIROL, V84, P9310, DOI 10.1128/JVI.00423-10; Hail D, 2011, ENVIRON ENTOMOL, V40, P23, DOI 10.1603/EN10115; Hansen AK, 2011, P NATL ACAD SCI USA, V108, P2849, DOI 10.1073/pnas.1013465108; Hao OJ, 2002, CHEMOSPHERE, V46, P797, DOI 10.1016/S0045-6535(01)00182-5; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Hlavica P, 2011, J INORG BIOCHEM, V105, P1354, DOI 10.1016/j.jinorgbio.2011.05.003; Honda H, 2006, TOXICOL LETT, V161, P108, DOI 10.1016/j.toxlet.2005.08.004; Horowitz AR, 2004, J ECON ENTOMOL, V97, P2051, DOI 10.1603/0022-0493-97.6.2051; Indiragandhi P, 2007, J APPL MICROBIOL, V103, P2664, DOI 10.1111/j.1365-2672.2007.03506.x; Jaworski DC, 2010, INSECT MOL BIOL, V19, P617, DOI 10.1111/j.1365-2583.2010.01037.x; Jeschke P, 2008, PEST MANAG SCI, V64, P1084, DOI 10.1002/ps.1631; Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Karunker I, 2008, INSECT BIOCHEM MOLEC, V38, P634, DOI 10.1016/j.ibmb.2008.03.008; Karunker I, 2009, INSECT BIOCHEM MOLEC, V39, P697, DOI 10.1016/j.ibmb.2009.08.006; Kontsedalov S, 2008, PEST MANAG SCI, V64, P789, DOI 10.1002/ps.1595; Labbe R, 2011, INSECT MOL BIOL, V20, P243, DOI 10.1111/j.1365-2583.2010.01064.x; Lamelas A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002357; Leshkowitz D, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-79; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Lindh JM, 2005, APPL ENVIRON MICROB, V71, P7217, DOI 10.1128/AEM.71.11.7217-7223.2005; Liu ZW, 2009, J NEUROCHEM, V108, P498, DOI 10.1111/j.1471-4159.2008.05790.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahadav A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-342; Maienfisch P, 2001, PEST MANAG SCI, V57, P906, DOI 10.1002/ps.365; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; Morin S, 2000, VIROLOGY, V276, P404, DOI 10.1006/viro.2000.0549; Morin S, 1999, VIROLOGY, V256, P75, DOI 10.1006/viro.1999.9631; Nauen R, 2005, ARCH INSECT BIOCHEM, V58, P200, DOI 10.1002/arch.20043; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Olafson PU, 2010, ARCH INSECT BIOCHEM, V74, P179, DOI 10.1002/arch.20372; Oliveira MRV, 2001, CROP PROT, V20, P709, DOI 10.1016/S0261-2194(01)00108-9; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Pan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030760; Parkinson John, 2009, V533, P1, DOI 10.1007/978-1-60327-136-3_1; Pauchet Y, 2009, INSECT BIOCHEM MOLEC, V39, P403, DOI 10.1016/j.ibmb.2009.04.001; Peng X, 2011, INSECT MOL BIOL, V20, P745, DOI 10.1111/j.1365-2583.2011.01104.x; Perring TM, 2001, CROP PROT, V20, P725, DOI 10.1016/S0261-2194(01)00109-0; Pidiyar VJ, 2004, AM J TROP MED HYG, V70, P597, DOI 10.4269/ajtmh.2004.70.597; Priya NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030768; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; Qi WH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-172; Ramsey JS, 2010, INSECT MOL BIOL, V19, P155, DOI 10.1111/j.1365-2583.2009.00973.x; Rauch N, 2003, ARCH INSECT BIOCHEM, V54, P165, DOI 10.1002/arch.10114; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Roditakis E, 2009, PEST MANAG SCI, V65, P313, DOI 10.1002/ps.1690; Russell JA, 2005, APPL ENVIRON MICROB, V71, P7987, DOI 10.1128/AEM.71.12.7987-7994.2005; Shatters RG, 2009, J ECON ENTOMOL, V102, P750, DOI 10.1603/029.102.0236; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; Tatun N, 2008, INSECT BIOCHEM MOLEC, V38, P788, DOI 10.1016/j.ibmb.2008.05.003; Tatun N, 2008, J INSECT PHYSIOL, V54, P351, DOI 10.1016/j.jinsphys.2007.10.006; Thao ML, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-25; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Wang XW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-458; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang ZY, 2010, PEST MANAG SCI, V66, P1360, DOI 10.1002/ps.2023; Xu J, 2010, B ENTOMOL RES, V100, P359, DOI 10.1017/S0007485310000015; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Zagrobelny M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-574; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang FJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-303; Zhang LP, 2005, J APPL ENTOMOL, V129, P121, DOI 10.1111/j.1439-0418.2005.00950.x; Zheng RC, 2007, RES MICROBIOL, V158, P258, DOI 10.1016/j.resmic.2006.12.007; Zou Z, 2008, INSECT BIOCHEM MOLEC, V38, P677, DOI 10.1016/j.ibmb.2008.03.009; Zouache K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006388	106	59	78	5	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35181	10.1371/journal.pone.0035181	http://dx.doi.org/10.1371/journal.pone.0035181			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558125	gold, Green Submitted, Green Published			2022-12-25	WOS:000305340200008
J	Farnung, BO; Brun, CM; Arora, R; Lorenzi, LE; Azzalin, CM				Farnung, Benjamin O.; Brun, Catherine M.; Arora, Rajika; Lorenzi, Luca E.; Azzalin, Claus M.			Telomerase Efficiently Elongates Highly Transcribing Telomeres in Human Cancer Cells	PLOS ONE			English	Article							REPEAT-CONTAINING RNA; MAMMALIAN-CELLS; CHROMOSOME ENDS; TERRA; TRANSCRIPTION; YEAST; DNA; INHIBITOR; SILENCE	RNA polymerase II transcribes the physical ends of linear eukaryotic chromosomes into a variety of long non-coding RNA molecules including telomeric repeat-containing RNA (TERRA). Since TERRA discovery, advances have been made in the characterization of TERRA biogenesis and regulation; on the contrary its associated functions remain elusive. Most of the biological roles so far proposed for TERRA are indeed based on in vitro experiments carried out using short TERRA-like RNA oligonucleotides. In particular, it has been suggested that TERRA inhibits telomerase activity. We have exploited two alternative cellular systems to test whether TERRA and/or telomere transcription influence telomerase-mediated telomere elongation in human cancer cells. In cells lacking the two DNA methyltransferases DNMT1 and DNMT3b, TERRA transcription and steady-state levels are greatly increased while telomerase is able to elongate telomeres normally. Similarly, telomerase can efficiently elongate transgenic inducible telomeres whose transcription has been experimentally augmented. Our data challenge the current hypothesis that TERRA functions as a general inhibitor of telomerase and suggest that telomere length homeostasis is maintained independently of TERRA and telomere transcription.	[Farnung, Benjamin O.; Brun, Catherine M.; Arora, Rajika; Lorenzi, Luca E.; Azzalin, Claus M.] ETH, Inst Biochem, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Farnung, BO (corresponding author), ETH, Inst Biochem, Zurich, Switzerland.	claus.azzalin@bc.biol.ethz.ch	azzalin, claus M/K-3898-2015	azzalin, claus M/0000-0002-9396-1980; Arora, Rajika/0000-0001-9396-3671	European Research Council (BFTERRA); Swiss National Science Foundation [3100A0-120090, PP00P3-123356]; Fondazione Cariplo [2008-2507]; Boehringer Ingelheim Fonds	European Research Council (BFTERRA)(European Research Council (ERC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondazione Cariplo(Fondazione Cariplo); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	This work was funded by the European Research Council (BFTERRA), the Swiss National Science Foundation (3100A0-120090 and PP00P3-123356) and Fondazione Cariplo (2008-2507). CMB received a fellowship from Boehringer Ingelheim Fonds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora R, 2012, RNA IN PRESS; Arora R, 2011, PROG MOL SUBCELL BIO, V51, P65, DOI 10.1007/978-3-642-16502-3_4; Azzalin CM, 2008, CELL CYCLE, V7, P1161, DOI 10.4161/cc.7.9.5836; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Azzalin CM, 2007, NATURE, V448, P1001, DOI 10.1038/4481001a; Azzalin CM, 2012, NUCLEUS; Bah A, 2012, NUCLEIC ACIDS RES, V40, P2995, DOI 10.1093/nar/gkr1153; Baird DM, 2003, NAT GENET, V33, P203, DOI 10.1038/ng1084; BARNETT MA, 1993, NUCLEIC ACIDS RES, V21, P27, DOI 10.1093/nar/21.1.27; Chawla R, 2011, EMBO J, V30, P4047, DOI 10.1038/emboj.2011.280; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; Damm K, 2001, EMBO J, V20, P6958, DOI 10.1093/emboj/20.24.6958; Farnung BO, 2010, TRANSCR-AUSTIN, V1, P140, DOI 10.4161/trns.1.3.13191; Flynn RL, 2011, NATURE, V471, P532, DOI 10.1038/nature09772; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Greenwood J, 2012, NUCLEIC ACIDS RES, V40, P2956, DOI 10.1093/nar/gkr1155; Iglesias N, 2011, EMBO REP, V12, P587, DOI 10.1038/embor.2011.73; Kim NW, 1997, NUCLEIC ACIDS RES, V25, P2595, DOI 10.1093/nar/25.13.2595; Luke B, 2009, EMBO J, V28, P2503, DOI 10.1038/emboj.2009.166; Luke B, 2008, MOL CELL, V32, P465, DOI 10.1016/j.molcel.2008.10.019; Nergadze SG, 2009, RNA, V15, P2186, DOI 10.1261/rna.1748309; Ottaviani A, 2008, BIOCHIMIE, V90, P93, DOI 10.1016/j.biochi.2007.07.022; Porro A, 2010, MOL CELL BIOL, V30, P4808, DOI 10.1128/MCB.00460-10; Poulet A, 2012, NUCLEIC ACIDS RES, V40, P2566, DOI 10.1093/nar/gkr1116; Redon S, 2010, NUCLEIC ACIDS RES, V38, P5797, DOI 10.1093/nar/gkq296; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; SANDELL LL, 1994, P NATL ACAD SCI USA, V91, P12061, DOI 10.1073/pnas.91.25.12061; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Vrbsky J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000986; Yehezkel S, 2008, HUM MOL GENET, V17, P2776, DOI 10.1093/hmg/ddn177; Zhao Y, 2009, CELL, V138, P463, DOI 10.1016/j.cell.2009.05.026	32	54	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35714	10.1371/journal.pone.0035714	http://dx.doi.org/10.1371/journal.pone.0035714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558207	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000052
J	Winkler, C; Raab, J; Grallert, H; Ziegler, AG				Winkler, Christiane; Raab, Jennifer; Grallert, Harald; Ziegler, Anette-Gabriele			Lack of Association of Type 2 Diabetes Susceptibility Genotypes and Body Weight on the Development of Islet Autoimmunity and Type 1 Diabetes	PLOS ONE			English	Article							ANTIBODY STANDARDIZATION PROGRAM; HHEX-IDE; AUTOANTIBODIES; ASSAYS; LOCI; PATHOGENESIS; PREVALENCE; PRO12ALA; CHILDREN; PARENTS	Aim: To investigate whether type 2 diabetes susceptibility genes and body weight influence the development of islet autoantibodies and the rate of progression to type 1 diabetes. Methods: Genotyping for single nucleotide polymorphisms (SNP) of the type 2 diabetes susceptibility genes CDKAL1, CDKN2A/2B, FTO, HHEX-IDE, HMGA2, IGF2BP2, KCNJ11, KCNQ1, MTNR1B, PPARG, SLC30A8 and TCF7L2 was obtained in 1350 children from parents with type 1 diabetes participating in the BABYDIAB study. Children were prospectively followed from birth for islet autoantibodies and type 1 diabetes. Data on weight and height were obtained at 9 months, 2, 5, 8, 11, and 14 years of age. Results: None of type 2 diabetes risk alleles at the CDKAL1, CDKN2A/2B, FTO, HHEX-IDE, HMGA2, IGF2BP2, KCNJ11, KCNQ1, MTNR1B, PPARG and SLC30A8 loci were associated with the development of islet autoantibodies or diabetes. The type 2 diabetes susceptible genotype of TCF7L2 was associated with a lower risk of islet autoantibodies (7% vs. 12% by age of 10 years, P = 0.015, P-corrected = 0.18). Overweight children at seroconversion did not progress to diabetes faster than non-overweight children (HR: 1.08; 95% CI: 0.48-2.45, P>0.05). Conclusions: These findings do not support an association of type 2 diabetes risk factors with islet autoimmunity or acceleration of diabetes in children with a family history of type 1 diabetes.	[Winkler, Christiane; Ziegler, Anette-Gabriele] Helmholtz Zentrum Munchen, Diabet Res Inst, Neuherberg, Germany; [Winkler, Christiane; Raab, Jennifer; Ziegler, Anette-Gabriele] Helmholtz Zentrum Munchen, Forschergrp Diabet eV, Neuherberg, Germany; [Grallert, Harald] Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Ziegler, Anette-Gabriele] Univ Technol Munich, Forschergrp Diabet, Klinikum Rechts Isar, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Winkler, C (corresponding author), Helmholtz Zentrum Munchen, Diabet Res Inst, Neuherberg, Germany.	anette-g.ziegler@helmholtz-muenchen.de	Ziegler, Anette-Gabriele/M-4614-2014; Grallert, Harald/B-3424-2013	Ziegler, Anette-Gabriele/0000-0002-6290-5548; Raab, Jennifer/0000-0002-5411-5511	Helmholtz Zentrum Munchen; Competence Network for Diabetes mellitus; Federal Ministry of Education and Research [FKZ 01GI0805-07]; JDRF [17-2012-16]	Helmholtz Zentrum Munchen(Helmholtz Association); Competence Network for Diabetes mellitus; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); JDRF(Juvenile Diabetes Research Foundation)	The work was supported by grants from the Helmholtz Zentrum Munchen, the Competence Network for Diabetes mellitus funded by the Federal Ministry of Education and Research (FKZ 01GI0805-07), and the JDRF (No. 17-2012-16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach P, 2009, DIABETOLOGIA, V52, P1881, DOI 10.1007/s00125-009-1438-0; American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Cecil JE, 2005, DIABETOLOGIA, V48, P1496, DOI 10.1007/s00125-005-1817-0; Dabelea D, 2006, DIABETES CARE, V29, P290, DOI 10.2337/diacare.29.02.06.dc05-1339; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Field SF, 2007, DIABETOLOGIA, V50, P212, DOI 10.1007/s00125-006-0506-y; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Knip M, 2008, PEDIATR DIABETES, V9, P46, DOI 10.1111/j.1399-5448.2007.00344.x; Krischer J, 2007, PEDIATR DIABETES, V8, P286; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Lampasona V, 2011, CLIN CHEM, V57, P1693, DOI 10.1373/clinchem.2011.170662; Libman IM, 2003, DIABETES CARE, V26, P2876, DOI 10.2337/diacare.26.10.2876; Libman IM, 2003, DIABETES CARE, V26, P2871, DOI 10.2337/diacare.26.10.2871; Raj SM, 2009, DIABETOLOGIA, V52, P2109, DOI 10.1007/s00125-009-1391-y; Schenker M, 1999, DIABETOLOGIA, V42, P671, DOI 10.1007/s001250051214; Schlosser M, 2010, DIABETOLOGIA, V53, P2611, DOI 10.1007/s00125-010-1915-5; Torn C, 2008, DIABETOLOGIA, V51, P846, DOI 10.1007/s00125-008-0967-2; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Winkler C, 2009, DIABETOLOGIA, V52, P2072, DOI 10.1007/s00125-009-1461-1; Winkler C, 2010, DIABETES, V59, P2063, DOI 10.2337/db10-0099; Winkler C, 2009, J CLIN ENDOCR METAB, V94, P4113, DOI 10.1210/jc.2009-0970; Zhao JH, 2010, DIABETES, V59, P751, DOI 10.2337/db09-0972; Ziegler AG, 1999, DIABETES, V48, P460, DOI 10.2337/diabetes.48.3.460	24	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35410	10.1371/journal.pone.0035410	http://dx.doi.org/10.1371/journal.pone.0035410			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558147	gold, Green Submitted, Green Published			2022-12-25	WOS:000305345200037
J	Njauw, CNJ; Kim, I; Piris, A; Gabree, M; Taylor, M; Lane, AM; DeAngelis, MM; Gragoudas, E; Duncan, LM; Tsao, H				Njauw, Ching-Ni Jenny; Kim, Ivana; Piris, Adriano; Gabree, Michele; Taylor, Michael; Lane, Anne Marie; DeAngelis, Margaret M.; Gragoudas, Evangelos; Duncan, Lyn M.; Tsao, Hensin			Germline BAP1 Inactivation Is Preferentially Associated with Metastatic Ocular Melanoma and Cutaneous-Ocular Melanoma Families	PLOS ONE			English	Article							CDKN2A CARRIER PROBABILITY; UVEAL MELANOMA; MUTATIONS; MESOTHELIOMA; PREDISPOSE; MENINGIOMA; MODEL	Background: BAP1 has been shown to be a target of both somatic alteration in high-risk ocular melanomas (OM) and germline inactivation in a few individuals from cancer-prone families. These findings suggest that constitutional BAP1 changes may predispose individuals to metastatic OM and that familial permeation of deleterious alleles could delineate a new cancer syndrome. Design: To characterize BAP1's contribution to melanoma risk, we sequenced BAP1 in a set of 100 patients with OM, including 50 metastatic OM cases and 50 matched non-metastatic OM controls, and 200 individuals with cutaneous melanoma (CM) including 7 CM patients from CM-OM families and 193 CM patients from CM-non-OM kindreds. Results: Germline BAP1 mutations were detected in 4/50 patients with metastatic OM and 0/50 cases of non-metastatic OM (8% vs. 0%, p = 0.059). Since 2/4 of the BAP1 carriers reported a family history of CM, we analyzed 200 additional hereditary CM patients and found mutations in 2/7 CM probands from CM-OM families and 1/193 probands from CM-non-OM kindreds (29% vs. 0.52%, p = .003). Germline mutations co-segregated with both CM and OM phenotypes and were associated with the presence of unique nevoid melanomas and highly atypical nevoid melanoma-like melanocytic proliferations (NEMMPs). Interestingly, 7/14 germline variants identified to date reside in C-terminus suggesting that the BRCA1 binding domain is important in cancer predisposition. Conclusion: Germline BAP1 mutations are associated with a more aggressive OM phenotype and a recurrent phenotypic complex of cutaneous/ocular melanoma, atypical melanocytic proliferations and other internal neoplasms (ie. COMMON syndrome), which could be a useful clinical marker for constitutive BAP1 inactivation.	[Njauw, Ching-Ni Jenny; Taylor, Michael; Tsao, Hensin] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Kim, Ivana; Lane, Anne Marie; Gragoudas, Evangelos] Massachusetts Eye & Ear Infirm, Retina Serv, Boston, MA 02114 USA; [Piris, Adriano; Duncan, Lyn M.] Massachusetts Gen Hosp, Dept Pathol, Div Dermatopathol, Boston, MA 02114 USA; [Gabree, Michele; Tsao, Hensin] Massachusetts Gen Hosp, Massachusetts Gen Hosp Canc Ctr, Boston, MA 02114 USA; [DeAngelis, Margaret M.] Univ Utah, Sch Med, John A Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT USA; [Tsao, Hensin] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Utah System of Higher Education; University of Utah; Harvard University; Massachusetts General Hospital	Njauw, CNJ (corresponding author), Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA.	htsao@partners.org	Njauw, Ching-Ni/H-8046-2012; DeAngelis, e/J-7863-2015; Ferris, Laura/I-7689-2012	Kim, Ivana/0000-0003-0310-6129	National Institutes of Health [K24 CA14920, P50 CA93683]; American Skin Association; American Cancer Society; NATIONAL CANCER INSTITUTE [P50CA093683, K24CA149202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Skin Association; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported in part by the National Institutes of Health (K24 CA14920 and P50 CA93683), the American Skin Association, the American Cancer Society, and the generous philanthropic donors to the MGH Millennium Melanoma Fund and the MEEI Melanoma Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman MH, 2011, J MED GENET, V48, P856, DOI 10.1136/jmedgenet-2011-100156; Bott M, 2011, NAT GENET, V43, P668, DOI 10.1038/ng.855; Buecher B, 2010, FAM CANCER, V9, P663, DOI 10.1007/s10689-010-9379-9; CAGIANUT B, 1972, KLIN MONATSBL AUGENH, V161, P407; Eletr ZM, 2011, CELL BIOCHEM BIOPHYS, V60, P3, DOI 10.1007/s12013-011-9184-6; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Niendorf KB, 2006, J MED GENET, V43, P501, DOI 10.1136/jmg.2005.032441; Prescher G, 1996, LANCET, V347, P1222; Singh AD, 2011, OPHTHALMOLOGY, V118, P1881, DOI 10.1016/j.ophtha.2011.01.040; Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912; Torres EM, 2010, CELL, V143, P71, DOI 10.1016/j.cell.2010.08.038; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Wang WY, 2010, CANCER RES, V70, P552, DOI 10.1158/0008-5472.CAN-09-2653; Wiesner T, 2011, NAT GENET, V43, P1018, DOI 10.1038/ng.910; Zhao XS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1421	16	175	175	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35295	10.1371/journal.pone.0035295	http://dx.doi.org/10.1371/journal.pone.0035295			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545102	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343200023
J	van Eekelen, M; Runtuwene, V; Masselink, W; den Hertog, J				van Eekelen, Mark; Runtuwene, Vincent; Masselink, Wouter; den Hertog, Jeroen			Pair-Wise Regulation of Convergence and Extension Cell Movements by Four Phosphatases via RhoA	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; FAS-MEDIATED APOPTOSIS; TISSUE POLARITY GENE; ZEBRAFISH GASTRULATION; XENOPUS-LAEVIS; GROWTH-FACTOR; MICE LACKING; PDZ-DOMAIN; TYROSINE PHOSPHORYLATION; VERTEBRATE GASTRULATION	Various signaling pathways regulate shaping of the main body axis during early vertebrate development. Here, we focused on the role of protein-tyrosine phosphatase signaling in convergence and extension cell movements. We identified Ptpn20 as a structural paralogue of PTP-BL and both phosphatases were required for normal gastrulation cell movements. Interestingly, knockdowns of PTP-BL and Ptpn20 evoked similar developmental defects as knockdown of RPTP alpha and PTP epsilon. Co-knockdown of RPTP alpha and PTP-BL, but not Ptpn20, had synergistic effects and conversely, PTP epsilon and Ptpn20, but not PTP-BL, cooperated, demonstrating the specificity of our approach. RPTP alpha and PTP epsilon knockdowns were rescued by constitutively active RhoA, whereas PTP-BL and Ptpn20 knockdowns were rescued by dominant negative RhoA. Consistently, RPTP alpha and PTP-BL had opposite effects on RhoA activation, both in a PTP-dependent manner. Downstream of the PTPs, we identified NGEF and Arhgap29, regulating RhoA activation and inactivation, respectively, in convergence and extension cell movements. We propose a model in which two phosphatases activate RhoA and two phosphatases inhibit RhoA, resulting in proper cell polarization and normal convergence and extension cell movements.	[van Eekelen, Mark; Runtuwene, Vincent; Masselink, Wouter; den Hertog, Jeroen] Hubrecht Inst, Utrecht, Netherlands; [van Eekelen, Mark; Runtuwene, Vincent; Masselink, Wouter; den Hertog, Jeroen] Univ Med Ctr Utrecht, Utrecht, Netherlands; [den Hertog, Jeroen] Inst Biol, Leiden, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	van Eekelen, M (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	j.denhertog@hubrecht.eu		Masselink, Wouter/0000-0002-4085-3206	Marie Curie Research Training Network [PTPNET/MRTN-CT-2006-035830]; Research Council for Earth and Life Sciences [ALW 815.02.007]; Netherlands Organisation for Scientific Research (NWO)	Marie Curie Research Training Network(European Commission); Research Council for Earth and Life Sciences(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by a Marie Curie Research Training Network (PTPNET/MRTN-CT-2006-035830) and a grant from the Research Council for Earth and Life Sciences (ALW 815.02.007) with financial aid from the Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATALIOTIS P, 1995, DEVELOPMENT, V121, P3099; Boutros M, 1999, MECH DEVELOP, V83, P27, DOI 10.1016/S0925-4773(99)00046-5; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Chae J, 1999, DEVELOPMENT, V126, P5421; Chan J, 2001, DEV BIOL, V234, P470, DOI 10.1006/dbio.2001.0281; Conway G, 1997, P NATL ACAD SCI USA, V94, P3082, DOI 10.1073/pnas.94.7.3082; Dunah AW, 2005, NAT NEUROSCI, V8, P458, DOI 10.1038/nn1416; Edouard T, 2007, CELL MOL LIFE SCI, V64, P1585, DOI 10.1007/s00018-007-6509-0; Egea J, 2005, NEURON, V47, P515, DOI 10.1016/j.neuron.2005.06.029; Elchebly M, 1999, NAT GENET, V21, P330, DOI 10.1038/6859; Feiguin F, 2001, DEV CELL, V1, P93, DOI 10.1016/S1534-5807(01)00010-7; Fodero-Tavoletti MT, 2005, BIOCHEM J, V389, P343, DOI 10.1042/BJ20041932; Ghil JS, 1999, INT J DEV BIOL, V43, P329; Gubb D, 1999, GENE DEV, V13, P2315, DOI 10.1101/gad.13.17.2315; Hammerschmidt M, 1996, DEVELOPMENT, V123, P143; Hatta K, 1996, DEV DYNAM, V205, P183, DOI 10.1002/(SICI)1097-0177(199602)205:2<183::AID-AJA9>3.0.CO;2-E; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Heisenberg CP, 1996, DEVELOPMENT, V123, P191; Jenny A, 2003, EMBO J, V22, P4409, DOI 10.1093/emboj/cdg424; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Jones TL, 1998, P NATL ACAD SCI USA, V95, P576, DOI 10.1073/pnas.95.2.576; Jopling C, 2005, EMBO REP, V6, P426, DOI 10.1038/sj.embor.7400386; Jopling C, 2007, PLOS GENET, V3, P2468, DOI 10.1371/journal.pgen.0030225; Jopling C, 2007, MECH DEVELOP, V124, P129, DOI 10.1016/j.mod.2006.10.003; Jorgensen C, 2009, SCIENCE, V326, P1502, DOI 10.1126/science.1176615; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Keys DN, 2002, DEV BIOL, V246, P329, DOI 10.1006/dbio.2002.0656; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; KLINGENSMITH J, 1989, DEV BIOL, V134, P130, DOI 10.1016/0012-1606(89)90084-5; Knoll B, 2004, J NEUROSCI, V24, P6248, DOI 10.1523/JNEUROSCI.0985-04.2004; Li H, 2008, DEV BIOL, V316, P458, DOI 10.1016/j.ydbio.2008.01.001; Li Y, 2000, INT J CANCER, V87, P473, DOI 10.1002/1097-0215(20000815)87:4<473::AID-IJC3>3.0.CO;2-1; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Miyagi C, 2004, J CELL BIOL, V166, P975, DOI 10.1083/jcb.200403110; Montcouquiol M, 2003, J NEUROSCI, V23, P9469; Murdoch JN, 2003, HUM MOL GENET, V12, P87, DOI 10.1093/hmg/ddg014; Myers DC, 2002, DEV BIOL, V243, P81, DOI 10.1006/dbio.2001.0523; Oates AC, 1999, MECH DEVELOP, V83, P77, DOI 10.1016/S0925-4773(99)00036-2; Palmer A, 2002, MOL CELL, V9, P725, DOI 10.1016/S1097-2765(02)00488-4; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Saras J, 1997, J BIOL CHEM, V272, P24333, DOI 10.1074/jbc.272.39.24333; Saunders AE, 2010, CELL SIGNAL, V22, P339, DOI 10.1016/j.cellsig.2009.10.003; Sepich DS, 2000, GENESIS, V27, P159, DOI 10.1002/1526-968X(200008)27:4<159::AID-GENE50>3.0.CO;2-T; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; SolnicaKrezel L, 1996, DEVELOPMENT, V123, P67; Stenzel N, 2009, J CELL SCI, V122, P3374, DOI 10.1242/jcs.046854; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Symes K, 1996, P NATL ACAD SCI USA, V93, P9641, DOI 10.1073/pnas.93.18.9641; Syverud K, 2007, APPITA J, V60, P286; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Taylor J, 1998, GENETICS, V150, P199; THISSE C, 1993, DEVELOPMENT, V119, P1203; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Ungefroren H, 1998, CANCER RES, V58, P1741; van Eekelen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012573; van Eekelen M, 2010, DEV BIOL, V340, P626, DOI 10.1016/j.ydbio.2010.02.026; VINSON CR, 1989, NATURE, V338, P263, DOI 10.1038/338263a0; von der Hardt S, 2007, CURR BIOL, V17, P475, DOI 10.1016/j.cub.2007.02.013; Wallace MJ, 1999, NAT GENET, V21, P334, DOI 10.1038/6866; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Wansink DG, 2004, PHYSIOL GENOMICS, V19, P50, DOI 10.1152/physiolgenomics.00079.2004; WARGA RM, 1990, DEVELOPMENT, V108, P569; Westerfield M, 1995, ZEBRAFISH BOOK; Ybot-Gonzalez P, 2007, DEVELOPMENT, V134, P3203, DOI 10.1242/dev.008177; Zhang Y, 2007, J BIOL CHEM, V282, P31103, DOI 10.1074/jbc.M704430200	68	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35913	10.1371/journal.pone.0035913	http://dx.doi.org/10.1371/journal.pone.0035913			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545146	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343200066
J	Wong, SSY; Ritner, C; Ramachandran, S; Aurigui, J; Pitt, C; Chandra, P; Ling, VB; Yabut, O; Bernstein, HS				Wong, Sharon S. Y.; Ritner, Carissa; Ramachandran, Sweta; Aurigui, Julian; Pitt, Cameron; Chandra, Piyanka; Ling, Vivian B.; Yabut, Odessa; Bernstein, Harold S.			miR-125b Promotes Early Germ Layer Specification through Lin28/let-7d and Preferential Differentiation of Mesoderm in Human Embryonic Stem Cells	PLOS ONE			English	Article							REPROGRAMMING FACTOR LIN28; SMALL RNAS; MICRORNAS; LIN-28; GENE; CARDIOGENESIS; EXPRESSION; BIOLOGY; MOUSE	Unlike other essential organs, the heart does not undergo tissue repair following injury. Human embryonic stem cells (hESCs) grow indefinitely in culture while maintaining the ability to differentiate into many tissues of the body. As such, they provide a unique opportunity to explore the mechanisms that control human tissue development, as well as treat diseases characterized by tissue loss, including heart failure. MicroRNAs are small, non-coding RNAs that are known to play critical roles in the regulation of gene expression. We profiled the expression of microRNAs during hESC differentiation into myocardial precursors and cardiomyocytes (CMs), and determined clusters of human microRNAs that are specifically regulated during this process. We determined that miR-125b overexpression results in upregulation of the early cardiac transcription factors, GATA4 and Nkx2-5, and accelerated progression of hESC-derived myocardial precursors to an embryonic CM phenotype. We used an in silico approach to identify Lin28 as a target of miR-125b, and validated this interaction using miR-125b knockdown. Anti-miR-125b inhibitor experiments also showed that miR-125b controls the expression of miRNA let-7d, likely through the negative regulatory effects of Lin28 on let-7. We then determined that miR-125b overexpression inhibits the expression of Nanog and Oct4 and promotes the onset of Brachyury expression, suggesting that miR-125b controls the early events of human CM differentiation by inhibiting hESC pluripotency and promoting mesodermal differentiation. These studies identified miR-125b as an important regulator of hESC differentiation in general, and the development of hESC-derived mesoderm and cardiac muscle in particular. Manipulation of miR-125b-mediated pathways may provide a novel approach to directing the differentiation of hESC-derived CMs for cell therapy applications.	[Wong, Sharon S. Y.; Ritner, Carissa; Aurigui, Julian; Yabut, Odessa; Bernstein, Harold S.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Ramachandran, Sweta; Chandra, Piyanka; Ling, Vivian B.; Bernstein, Harold S.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Pitt, Cameron; Bernstein, Harold S.] Univ Calif San Francisco, Grad Program Biomed Sci, San Francisco, CA 94143 USA; [Bernstein, Harold S.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wong, SSY (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	harold.bernstein@ucsf.edu		Ritner, Carissa/0000-0002-4968-6838	Public Health Service (PHS) Grant from National Heart, Lung and Blood Institutes (NHLBI) [HL085377]; Comprehensive Research Grant from the California Institute for Regenerative Medicine [RC1-00104]; National Research Service Award (NRSA) from NHLBI [HL007544]; Initiative for Maximizing Student Diversity (IMSD) fellowship from National Institute for General Medical Science (NIGMS) [GM56847]; American Pediatric Society/Society for Pediatric Research (APS/SPR) research fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL085377] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056847] Funding Source: NIH RePORTER	Public Health Service (PHS) Grant from National Heart, Lung and Blood Institutes (NHLBI); Comprehensive Research Grant from the California Institute for Regenerative Medicine; National Research Service Award (NRSA) from NHLBI; Initiative for Maximizing Student Diversity (IMSD) fellowship from National Institute for General Medical Science (NIGMS); American Pediatric Society/Society for Pediatric Research (APS/SPR) research fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Public Health Service (PHS) Grant (HL085377) from National Heart, Lung and Blood Institutes (NHLBI), and a Comprehensive Research Grant (RC1-00104) from the California Institute for Regenerative Medicine to HSB. SSYW and OY were supported by an National Research Service Award (NRSA) (HL007544) from NHLBI. CP was supported by an Initiative for Maximizing Student Diversity (IMSD) fellowship (GM56847) from National Institute for General Medical Science (NIGMS). PC was supported by an American Pediatric Society/Society for Pediatric Research (APS/SPR) research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Chien KR, 2008, SCIENCE, V322, P1494, DOI 10.1126/science.1163267; Darr H, 2009, STEM CELLS, V27, P352, DOI 10.1634/stemcells.2008-0720; Epting CL, 2008, J CELL PHYSIOL, V217, P250, DOI 10.1002/jcp.21500; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ge YJ, 2011, J CELL BIOL, V192, P69, DOI 10.1083/jcb.201007165; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guan Y, 2011, INT J CANCER, V128, P2274, DOI 10.1002/ijc.25575; Hagen JW, 2008, CELL CYCLE, V7, P2327, DOI 10.4161/cc.6447; Hlaing M, 2004, J BIOL CHEM, V279, P43625, DOI 10.1074/jbc.M408391200; HOLM S, 1979, SCAND J STAT, V6, P65; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; King FW, 2009, STEM CELLS DEV, V18, P1441, DOI 10.1089/scd.2009.0012; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Mallanna SK, 2010, DEV BIOL, V344, P16, DOI 10.1016/j.ydbio.2010.05.014; Mizuno Y, 2008, BIOCHEM BIOPH RES CO, V368, P267, DOI 10.1016/j.bbrc.2008.01.073; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Rajabi Hasan, 2010, Genes Cancer, V1, P62; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Ritner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016004; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Shi L, 2010, BRAIN RES, V1312, P120, DOI 10.1016/j.brainres.2009.11.056; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Wu LG, 2005, MOL CELL BIOL, V25, P9198, DOI 10.1128/MCB.25.21.9198-9208.2005; Yang XJ, 2010, CANCER RES, V70, P9463, DOI 10.1158/0008-5472.CAN-10-2388; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang LA, 2011, CELL STEM CELL, V8, P294, DOI 10.1016/j.stem.2011.01.014; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zhong XM, 2010, J BIOL CHEM, V285, P41961, DOI 10.1074/jbc.M110.169607	41	33	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e36121	10.1371/journal.pone.0036121	http://dx.doi.org/10.1371/journal.pone.0036121			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545159	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343200080
J	Xiao, LH; Zhang, LC; Yang, G; Zhu, HL; He, YK				Xiao, Lihong; Zhang, Liechi; Yang, Ge; Zhu, Honglin; He, Yikun			Transcriptome of Protoplasts Reprogrammed into Stem Cells in Physcomitrella patens	PLOS ONE			English	Article							ARABIDOPSIS SHOOT MERISTEM; CYCLIN-DEPENDENT KINASE; FALSE DISCOVERY RATE; DIFFERENTIAL EXPRESSION; MESOPHYLL PROTOPLASTS; APICAL MERISTEM; LAND PLANTS; GENES; THALIANA; FATE	Background: Differentiated plant cells can retain the capacity to be reprogrammed into pluripotent stem cells during regeneration. This capacity is associated with both cell cycle reactivation and acquisition of specific cellular characters. However, the molecular mechanisms underlying the reprogramming of protoplasts into stem cells remain largely unknown. Protoplasts of the moss Physcomitrella patens easily regenerate into protonema and therefore provide an ideal system to explore how differentiated cells can be reprogrammed to produce stem cells. Principal findings: We obtained genome-wide digital gene expression tag profiles within the first three days of P. patens protoplast reprogramming. At four time-points during protoplast reprogramming, the transcript levels of 4827 genes changed more than four-fold and their expression correlated with the reprogramming phase. Gene ontology (GO) and pathway enrichment analysis of differentially expressed genes (DEGs) identified a set of significantly enriched GO terms and pathways, most of which were associated with photosynthesis, protein synthesis and stress responses. DEGs were grouped into six clusters that showed specific expression patterns using a K-means clustering algorithm. An investigation of function and expression patterns of genes identified a number of key candidate genes and pathways in early stages of protoplast reprogramming, which provided important clues to reveal the molecular mechanisms responsible for protoplast reprogramming. Conclusions: We identified genes that show highly dynamic changes in expression during protoplast reprogramming into stem cells in P. patens. These genes are potential targets for further functional characterization and should be valuable for exploration of the mechanisms of stem cell reprogramming. In particular, our data provides evidence that protoplasts of P. patens are an ideal model system for elucidation of the molecular mechanisms underlying differentiated plant cell reprogramming.	[Xiao, Lihong; Zhang, Liechi; Yang, Ge; He, Yikun] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Zhu, Honglin] Beijing Comp Ctr, Beijing, Peoples R China	Capital Normal University	Xiao, LH (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China.	yhe@cnu.edu.ac.cn		Zhu, Honglin/0000-0003-3249-9494	Ministry of Science and Technology of China [2007CB948201, 2009ZX08009-058B]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants from the Ministry of Science and Technology of China (2007CB948201 and 2009ZX08009-058B to YH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida M, 1999, DEVELOPMENT, V126, P1563; ASHTON NW, 1977, MOL GEN GENET, V154, P87, DOI 10.1007/BF00265581; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Babbitt CC, 2010, GENOME BIOL EVOL, V2, P67, DOI 10.1093/gbe/evq002; Balazadeh S, 2010, PLANT J, V62, P250, DOI 10.1111/j.1365-313X.2010.04151.x; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bray EA, 2004, J EXP BOT, V55, P2331, DOI 10.1093/jxb/erh270; Byrne ME, 2003, CURR OPIN GENET DEV, V13, P551, DOI 10.1016/j.gde.2003.08.008; COCKING EC, 1960, NATURE, V187, P962, DOI 10.1038/187962a0; Costa S, 2007, TRENDS CELL BIOL, V17, P101, DOI 10.1016/j.tcb.2006.12.005; Cove D, 2000, J PLANT GROWTH REGUL, V19, P275, DOI 10.1007/s003440000031; Cuming AC, 2007, NEW PHYTOL, V176, P275, DOI 10.1111/j.1469-8137.2007.02187.x; DEBEAUJON I, 1992, PLANT CELL REP, V12, P37, DOI 10.1007/BF00232420; Decker EL, 2006, PLANT BIOLOGY, V8, P397, DOI 10.1055/s-2006-923952; den Boer BGW, 2000, TRENDS CELL BIOL, V10, P245, DOI 10.1016/S0962-8924(00)01765-7; Deveaux Y, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-291; DeYoung BJ, 2006, PLANT J, V45, P1, DOI 10.1111/j.1365-313X.2005.02592.x; Feher A, 2002, BIOLOGIA, V57, P5; Ferreira FJ, 2005, CURR OPIN PLANT BIOL, V8, P518, DOI 10.1016/j.pbi.2005.07.013; Frank W, 2005, PLANT BIOLOGY, V7, P220, DOI 10.1055/s-2005-865645; Gallois JL, 2004, GENE DEV, V18, P375, DOI 10.1101/gad.291204; Gilbert SF, 2006, DEV BIOL; Grafi G, 2004, TRENDS BIOTECHNOL, V22, P388, DOI 10.1016/j.tibtech.2004.06.001; Grewal SIS, 2004, CURR OPIN CELL BIOL, V16, P230, DOI 10.1016/j.ceb.2004.04.002; GRIMSLEY NH, 1977, MOL GEN GENET, V154, P97, DOI 10.1007/BF00265582; Haecker A, 2004, DEVELOPMENT, V131, P657, DOI 10.1242/dev.00963; Harrison CJ, 2009, CURR BIOL, V19, P461, DOI 10.1016/j.cub.2009.02.050; Hord CLH, 2006, PLANT CELL, V18, P1667, DOI 10.1105/tpc.105.036871; Ishikawa M, 2011, PLANT CELL, V23, P2924, DOI 10.1105/tpc.111.088005; Jang G, 2011, DEVELOPMENT, V138, P2273, DOI 10.1242/dev.060582; Johnston JS, 1999, AM J BOT, V86, P609, DOI 10.2307/2656569; Kamiya N, 2003, PLANT J, V35, P429, DOI 10.1046/j.1365-313X.2003.01816.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Masip M, 2010, MOL HUM REPROD, V16, P856, DOI 10.1093/molehr/gaq059; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; McKay R, 2000, NATURE, V406, P361, DOI 10.1038/35019186; Menand B, 2007, SCIENCE, V316, P1477, DOI 10.1126/science.1142618; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nardmann J, 2006, MOL BIOL EVOL, V23, P2492, DOI 10.1093/molbev/msl125; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Ondrej V, 2009, MOL CELLS, V27, P443, DOI 10.1007/s10059-009-0057-4; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Park SO, 2005, DEVELOPMENT, V132, P841, DOI 10.1242/dev.01654; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Reski R, 1998, BOT ACTA, V111, P1; Richardt S, 2007, PLANT PHYSIOL, V143, P1452, DOI 10.1104/pp.107.095760; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sablowski R, 2007, CURR OPIN PLANT BIOL, V10, P639, DOI 10.1016/j.pbi.2007.07.001; Sarkar AK, 2007, NATURE, V446, P811, DOI 10.1038/nature05703; Schulz P, 2000, J PLANT PHYSIOL, V156, P768, DOI 10.1016/S0176-1617(00)80246-1; Schween G, 2003, P NATL ACAD SCI USA, V105, P2415; Slack JMW, 2008, SCIENCE, V322, P1498, DOI 10.1126/science.1162782; TAKEBE I, 1971, NATURWISSENSCHAFTEN, V58, P318, DOI 10.1007/BF00624737; TAKEBE I, 1969, P NATL ACAD SCI USA, V64, P843, DOI 10.1073/pnas.64.3.843; Tessadori F, 2004, TRENDS PLANT SCI, V9, P147, DOI 10.1016/j.tplants.2004.01.008; Tessadori F, 2007, J CELL SCI, V120, P1200, DOI 10.1242/jcs.000026; Trajkovski I, 2008, J BIOMED INFORM, V41, P588, DOI 10.1016/j.jbi.2007.12.001; ULRICH I, 1991, PROTOPLASMA, V165, P212, DOI 10.1007/BF01322292; Umeda M, 2005, PLANT CELL PHYSIOL, V46, P1437, DOI 10.1093/pcp/pci170; van Driel R, 2004, EXP CELL RES, V296, P86, DOI 10.1016/j.yexcr.2004.03.009; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; Wang XQ, 2009, PLANT PHYSIOL, V149, P1739, DOI 10.1104/pp.108.131714; Wang XQ, 2008, PLANTA, V228, P167, DOI 10.1007/s00425-008-0727-z; Won SK, 2009, PLANT PHYSIOL, V150, P1459, DOI 10.1104/pp.109.140905; Wurschum T, 2006, PLANT CELL, V18, P295, DOI 10.1105/tpc.105.038398; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Xiao SQ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-544; Zeeberg BR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-168; Zhao J, 2001, J BIOL CHEM, V276, P22772, DOI 10.1074/jbc.M101756200; Zuo JR, 2002, PLANT J, V30, P349, DOI 10.1046/j.1365-313X.2002.01289.x	73	27	30	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35961	10.1371/journal.pone.0035961	http://dx.doi.org/10.1371/journal.pone.0035961			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545152	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343200072
J	Savignon, T; Costa, E; Tenorio, F; Manhaes, AC; Barradas, PC				Savignon, Tiago; Costa, Everton; Tenorio, Frank; Manhaes, Alex C.; Barradas, Penha C.			Prenatal Hypoxic-Ischemic Insult Changes the Distribution and Number of NADPH-Diaphorase Cells in the Cerebellum	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; RAT SUPERIOR COLLICULUS; PERINATAL BRAIN-DAMAGE; KINASE-IV ACTIVITY; NEWBORN PIGLETS; NEURONAL NUCLEI; PURKINJE-CELLS; DEVELOPMENTAL NEUROPATHOLOGY; CORTICAL DEVELOPMENT; CEREBRAL-CORTEX	Astrogliosis, oligodendroglial death and motor deficits have been observed in the offspring of female rats that had their uterine arteries clamped at the 18th gestational day. Since nitric oxide has important roles in several inflammatory and developmental events, here we evaluated NADPH-diaphorase (NADPH-d) distribution in the cerebellum of rats submitted to this hypoxia-ischemia (HI) model. At postnatal (P) day 9, Purkinje cells of SHAM and non-manipulated (NM) animals showed NADPH-d+ labeling both in the cell body and dendritic arborization in folia 1 to 8, while HI animals presented a weaker labeling in both cellular structures. NADPH-d+ labeling in the molecular (ML), and in both the external and internal granular layer, was unaffected by HI at this age. At P23, labeling in Purkinje cells was absent in all three groups. Ectopic NADPH-d+ cells in the ML of folia 1 to 4 and folium 10 were present exclusively in HI animals. This labeling pattern was maintained up to P90 in folium 10. In the cerebellar white matter (WM), at P9 and P23, microglial (ED1+) NADPH-d+ cells, were observed in all groups. At P23, only HI animals presented NADPH-d labeling in the cell body and processes of reactive astrocytes (GFAP+). At P9 and P23, the number of NADPH-d+ cells in the WM was higher in HI animals than in SHAM and NM ones. At P45 and at P90 no NADPH-d+ cells were observed in the WM of the three groups. Our results indicate that HI insults lead to long-lasting alterations in nitric oxide synthase expression in the cerebellum. Such alterations in cerebellar differentiation might explain, at least in part, the motor deficits that are commonly observed in this model.	[Savignon, Tiago; Costa, Everton; Tenorio, Frank; Barradas, Penha C.] Univ Estado Rio de Janeiro, Dept Farmacol & Psicobiol, Inst Biol Roberto Alcantara Gomes, BR-20550011 Rio De Janeiro, Brazil; [Manhaes, Alex C.] Univ Estado Rio de Janeiro, Dept Ciencias Fisiol, Inst Biol Roberto Alcantara Gomes, BR-20550011 Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	Savignon, T (corresponding author), Univ Estado Rio de Janeiro, Dept Farmacol & Psicobiol, Inst Biol Roberto Alcantara Gomes, BR-20550011 Rio De Janeiro, Brazil.	penhabarradas@gmail.com	Barradas, Penha C/K-9779-2016; ManhÃes, Alex C/F-5499-2011	ManhÃes, Alex C/0000-0003-4629-8343; Barradas, Penha/0000-0002-5868-4447	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Sub-reitoria de Pos-Graduacao e Pesquisa da Universidade do Estado do Rio de Janeiro (SR2/UERJ)	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sub-reitoria de Pos-Graduacao e Pesquisa da Universidade do Estado do Rio de Janeiro (SR2/UERJ)	Support contributed by: Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Sub-reitoria de Pos-Graduacao e Pesquisa da Universidade do Estado do Rio de Janeiro (SR2/UERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADINOLFI M, 1993, EXP CLIN IMMUNOGENET, V10, P103; AKBARIAN S, 1993, ARCH GEN PSYCHIAT, V50, P169; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; ALTMAN J, 1969, J COMP NEUROL, V136, P269, DOI 10.1002/cne.901360303; ALTMAN J, 1972, J COMP NEUROL, V145, P353, DOI 10.1002/cne.901450305; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Biran V, 2011, NEUROBIOL DIS, V41, P138, DOI 10.1016/j.nbd.2010.09.001; BLOMFIELD S, 1970, NATURE, V227, P1224, DOI 10.1038/2271224a0; Blomgren K, 2006, FREE RADICAL BIO MED, V40, P388, DOI 10.1016/j.freeradbiomed.2005.08.040; Bodensteiner JB, 2005, J CHILD NEUROL, V20, P139, DOI 10.1177/08830738050200021101; Bolanos JP, 1999, BBA-BIOENERGETICS, V1411, P415, DOI 10.1016/S0005-2728(99)00030-4; Brazel CY, 2004, DEV NEUROSCI-BASEL, V26, P266, DOI 10.1159/000082143; Bredt DS, 1999, FREE RADICAL RES, V31, P577, DOI 10.1080/10715769900301161; BREDT DS, 1994, NEURON, V13, P301, DOI 10.1016/0896-6273(94)90348-4; BRUNING G, 1993, J NEUROSCI RES, V36, P580, DOI 10.1002/jnr.490360510; Calabrese V, 2006, ANTIOXID REDOX SIGN, V8, P444, DOI 10.1089/ars.2006.8.444; Catania MV, 2001, J NEUROSCI, V21, P7664, DOI 10.1523/JNEUROSCI.21-19-07664.2001; Contestabile A, 2012, CEREBELLUM, V11, P50, DOI 10.1007/s12311-010-0234-1; Cramer KS, 1996, J NEUROSCI, V16, P7995; DERMON CR, 1994, NEUROREPORT, V5, P1941, DOI 10.1097/00001756-199410000-00025; Folkerth RD, 2004, J NEUROPATH EXP NEUR, V63, P990, DOI 10.1093/jnen/63.9.990; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; GALLY JA, 1990, P NATL ACAD SCI USA, V87, P3547, DOI 10.1073/pnas.87.9.3547; GIUILI G, 1994, DEV BRAIN RES, V81, P269, DOI 10.1016/0165-3806(94)90313-1; Golan H, 2004, J NEUROSCI RES, V78, P430, DOI 10.1002/jnr.20269; Gross WL, 1996, P NATL ACAD SCI USA, V93, P5604, DOI 10.1073/pnas.93.11.5604; Haynes V, 2003, IUBMB LIFE, V55, P599, DOI 10.1080/15216540310001628681; HESS DT, 1993, NATURE, V366, P562, DOI 10.1038/366562a0; Hirai H, 2000, J NEUROSCI, V20, P5217, DOI 10.1523/JNEUROSCI.20-14-05217.2000; HOPE BT, 1991, P NATL ACAD SCI USA, V88, P2811, DOI 10.1073/pnas.88.7.2811; Iadecola C, 1997, J NEUROSCI, V17, P9157; Kashiwagi K, 2003, MOL BRAIN RES, V112, P126, DOI 10.1016/S0169-328X(03)00058-5; Kaur C, 2006, INVEST OPHTH VIS SCI, V47, P1126, DOI 10.1167/iovs.05-0518; Kobayashi M, 2000, JPN J OPHTHALMOL, V44, P235, DOI 10.1016/S0021-5155(99)00220-8; KUONEN DR, 1988, J NEUROCHEM, V50, P1017, DOI 10.1111/j.1471-4159.1988.tb10567.x; LEVITON A, 1993, DEV MED CHILD NEUROL, V35, P553; MA LJ, 1991, NEUROSCI LETT, V132, P23, DOI 10.1016/0304-3940(91)90423-Q; Marin-Padilla M, 1999, J NEUROPATH EXP NEUR, V58, P407, DOI 10.1097/00005072-199905000-00001; MarinPadilla M, 1997, J NEUROPATH EXP NEUR, V56, P219, DOI 10.1097/00005072-199703000-00001; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Mazur M, 2010, J NEUROSURG-PEDIATR, V6, P206, DOI 10.3171/2010.5.PEDS1032; Mishra OP, 2006, NEUROCHEM RES, V31, P1463, DOI 10.1007/s11064-006-9204-x; Mishra OP, 2004, NEUROSCIENCE, V123, P179, DOI 10.1016/j.neuroscience.2003.08.008; Mishra OP, 2002, NEUROSCIENCE, V115, P985, DOI 10.1016/S0306-4522(02)00275-0; Nelson KB, 2003, PEDIATR RES, V53, P600, DOI 10.1203/01.PDR.0000056802.22454.AB; NGUYEN T, 1992, P NATL ACAD SCI USA, V89, P3030, DOI 10.1073/pnas.89.7.3030; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Peng JHF, 2005, DEV BRAIN RES, V156, P87, DOI 10.1016/j.devbrainres.2005.02.002; Pisu MB, 2003, DEV BRAIN RES, V145, P229, DOI 10.1016/j.devbrainres.2003.08.007; Pundik S, 2006, METAB BRAIN DIS, V21, P309, DOI 10.1007/s11011-006-9031-4; Rees S, 1997, DEV BRAIN RES, V103, P103, DOI 10.1016/S0165-3806(97)81787-7; REYNOLDS R, 1988, DEVELOPMENT, V102, P409; Robinson S, 2005, NEUROBIOL DIS, V18, P568, DOI 10.1016/j.nbd.2004.10.024; ROSKAMS AJ, 1994, NEURON, V13, P289; Santacana M, 1998, DEV BRAIN RES, V111, P205, DOI 10.1016/S0165-3806(98)00140-0; Saxon DW, 1996, J COMP NEUROL, V371, P41; SAXON DW, 1994, NEUROREPORT, V5, P809, DOI 10.1097/00001756-199403000-00018; SCHILLING K, 1994, NEUROSCIENCE, V59, P893, DOI 10.1016/0306-4522(94)90293-3; Sotelo C, 2009, NEUROSCIENCE, V162, P589, DOI 10.1016/j.neuroscience.2008.12.035; TANAKA M, 1994, NEUROREPORT, V5, P2049, DOI 10.1097/00001756-199410270-00015; Tenorio F, 1996, INT J DEV NEUROSCI, V14, P1, DOI 10.1016/0736-5748(95)00085-2; TENORIO F, 1995, J NEUROSCI RES, V42, P633, DOI 10.1002/jnr.490420505; Tenorio F, 1998, NEUROREPORT, V9, P145, DOI 10.1097/00001756-199801050-00029; Vexler ZS, 2009, DEV NEUROSCI-BASEL, V31, P378, DOI 10.1159/000232556; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; WILLIAMS CV, 1994, J NEUROSCI, V14, P1746, DOI 10.1523/JNEUROSCI.14-03-01746.1994; Wilson MA, 1997, TRENDS NEUROSCI, V20, P102, DOI 10.1016/S0166-2236(96)01023-5; Yan XX, 1996, CEREB CORTEX, V6, P737, DOI 10.1093/cercor/6.5.737; Yan XX, 1997, NEUROSCI LETT, V230, P125, DOI 10.1016/S0304-3940(97)00497-7; YAN XX, 1993, NEUROREPORT, V4, P1227, DOI 10.1097/00001756-199309000-00004; Zhang RL, 2001, ANN NEUROL, V50, P602, DOI 10.1002/ana.1249; ZHANG RL, 1994, J NEUROL SCI, V125, P3, DOI 10.1016/0022-510X(94)90234-8; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhang ZG, 2002, J CEREBR BLOOD F MET, V22, P379, DOI 10.1097/00004647-200204000-00002; Zubrow AB, 2002, NEUROSCI LETT, V335, P5, DOI 10.1016/S0304-3940(02)01138-2; Zubrow AB, 2002, BRAIN RES, V954, P60, DOI 10.1016/S0006-8993(02)03342-5	76	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35786	10.1371/journal.pone.0035786	http://dx.doi.org/10.1371/journal.pone.0035786			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540005	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341000071
J	Toffanello, ED; Perissinotto, E; Sergi, G; Zambon, S; Musacchio, E; Maggi, S; Coin, A; Sartori, L; Corti, MC; Baggio, G; Crepaldi, G; Manzato, E				Toffanello, Elena D.; Perissinotto, Egle; Sergi, Giuseppe; Zambon, Sabina; Musacchio, Estella; Maggi, Stefania; Coin, Alessandra; Sartori, Leonardo; Corti, Maria-Chiara; Baggio, Giovannella; Crepaldi, Gaetano; Manzato, Enzo			Vitamin D and Physical Performance in Elderly Subjects: The Pro.V.A Study	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; MUSCLE STRENGTH; POSTMENOPAUSAL WOMEN; HYPOVITAMINOSIS-D; 6-MINUTE WALK; ASSOCIATION; DISABILITY; PREVALENCE; FRACTURES; CAPACITY	Background: The role of Vitamin D in musculoskeletal functionality among elderly people is still controversial. We investigated the association between serum 25-hydroxyvitamin D (25OHD) levels and physical performance in older adults. Methods: 2694 community-dwelling elderly women and men from the Progetto Veneto Anziani (Pro.V.A.) were included. Physical performances were assessed by: tandem test, 5 timed chair stands (TCS), gait speed, 6-minute walking (6 mW) distance, handgrip strength, and quadriceps strength. For each test, separate general linear models and loess plots were obtained in both genders, in relation to serum 25OHD concentrations, controlling for several potential confounders. Results: Linear associations with 25OHD levels were observed for TCS, gait speed, 6 mW test and handgrip strength, but not for tandem test and quadriceps strength. After adjusting for potential confounders, linear associations with 25OHD levels were still evident for the 6 mW distance in both genders (p=.0002 in women; <.0001 in men), for TCS in women (p=.004) and for gait speed (p=.0006) and handgrip strength (p=.03) in men. In loess analyses, performance in TCS in women, in gait speed and handgrip strength in men and in 6 mW in both genders, improved with increasing levels of 25OHD, with most of the improvements occurring for 25OHD levels from 20 to 100 nmol/L. Conclusion: lower 25OHD levels are associated with a worse coordination and weaker strength (TCS) in women, a slower walking time and a lower upper limb strength in men, and a weaker aerobic capacity (6 mW) in both genders. For optimal physical performances, 25OHD concentrations of 100 nmol/L appear to be more advantageous in elderly men and women, and Vitamin D supplementation should be encouraged to maintain their 25OHD levels as high as this threshold.	[Toffanello, Elena D.; Sergi, Giuseppe; Coin, Alessandra; Manzato, Enzo] Univ Padua, Dept Med & Surg Sci, Div Geriatr, Padua, Italy; [Perissinotto, Egle] Univ Padua, Dept Environm Med & Publ Hlth, Padua, Italy; [Zambon, Sabina; Maggi, Stefania; Crepaldi, Gaetano; Manzato, Enzo] CNR, Aging Branch, Inst Neurosci, Padua, Italy; [Corti, Maria-Chiara] Azienda Unita Locale Socio Sanit, Padua, Italy; [Baggio, Giovannella] Azienda Osped Padova, Div Internal Med, Padua, Italy	University of Padua; University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Padua; Azienda Ospedaliera - Universita di Padova	Toffanello, ED (corresponding author), Univ Padua, Dept Med & Surg Sci, Div Geriatr, Padua, Italy.	elenadebora.toffanello@sanita.padova.it	SERGI, GIUSEPPE/J-9396-2018; Coin, Alessandra/J-9256-2018	SERGI, GIUSEPPE/0000-0001-9757-856X; Coin, Alessandra/0000-0003-1687-4493; Musacchio, Estella/0000-0001-9811-9103	Fondazione Cassa di Risparmio di Padova e Rovigo; University of Padova; Azienda Unita Locale Socio Sanitaria [15]; Veneto region [18]; National Institute on Aging, National Institutes of Health; Veneto Region Research Project [104/02]	Fondazione Cassa di Risparmio di Padova e Rovigo(Fondazione Cariparo); University of Padova; Azienda Unita Locale Socio Sanitaria; Veneto region(Regione Veneto); National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veneto Region Research Project	This study was funded by Fondazione Cassa di Risparmio di Padova e Rovigo, University of Padova, Azienda Unita Locale Socio Sanitaria 15 and 18 of the Veneto region; by the Intramural Research Program of the National Institute on Aging, National Institutes of Health; and by Veneto Region Research Project 104/02 (GC). The funding institutes had no role in the design, methods, subject recruitment, data collection, analysis, or preparation of the manuscript or in the decision to submit the manuscript for publication.	Annweiler C, 2009, J NUTR HEALTH AGING, V13, P893, DOI 10.1007/s12603-009-0248-x; Annweiler C, 2009, J NUTR HEALTH AGING, V13, P90, DOI 10.1007/s12603-009-0013-1; Annweiler C, 2009, J AM GERIATR SOC, V57, P368, DOI 10.1111/j.1532-5415.2009.02118.x; Bandinelli S, 1999, AGING-CLIN EXP RES, V11, P287, DOI 10.1007/BF03339802; Bettica P, 1999, OSTEOPOROSIS INT, V9, P226, DOI 10.1007/s001980050141; Bischoff HA, 1999, ARCH PHYS MED REHAB, V80, P54, DOI 10.1016/S0003-9993(99)90307-6; Bischoff HA, 2001, HISTOCHEM J, V33, P19, DOI 10.1023/A:1017535728844; Bischoff-Ferrari HA, 2004, AM J CLIN NUTR, V80, P752; Bischoff-Ferrari HA, 2004, JAMA-J AM MED ASSOC, V291, P1999, DOI 10.1001/jama.291.16.1999; Boxer RS, 2008, J AM GERIATR SOC, V56, P454, DOI 10.1111/j.1532-5415.2007.01601.x; Boxer RS, 2010, AM HEART J, V160, P893, DOI 10.1016/j.ahj.2010.08.004; Ceglia L, 2008, MOL ASPECTS MED, V29, P407, DOI 10.1016/j.mam.2008.07.002; Corti MC, 2002, J AM GERIATR SOC, V50, P1535, DOI 10.1046/j.1532-5415.2002.50409.x; Dam TTL, 2009, OSTEOPOROSIS INT, V20, P751, DOI 10.1007/s00198-008-0749-1; Dhesi JK, 2002, J BONE MINER RES, V17, P891, DOI 10.1359/jbmr.2002.17.5.891; Faulkner KA, 2006, OSTEOPOROSIS INT, V17, P1318, DOI 10.1007/s00198-006-0071-8; FOLSTEIN MF, 1983, ARCH GEN PSYCHIAT, V40, P812; Fried LP, 2000, J GERONTOL A-BIOL, V55, pM43; Gerdhem P, 2005, OSTEOPOROSIS INT, V16, P1425, DOI 10.1007/s00198-005-1860-1; Grundberg E, 2004, EUR J ENDOCRINOL, V150, P323, DOI 10.1530/eje.0.1500323; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Houston DK, 2007, J GERONTOL A-BIOL, V62, P440, DOI 10.1093/gerona/62.4.440; Isaia G, 2003, OSTEOPOROSIS INT, V14, P577, DOI 10.1007/s00198-003-1390-7; Kalueff AV, 2007, CURR OPIN CLIN NUTR, V10, P12, DOI 10.1097/MCO.0b013e328010ca18; Lips P, 1999, OSTEOPOROSIS INT, V9, P394, DOI 10.1007/s001980050162; Parmelee PA, 1989, PSYCHOL ASSESSMENT J, V1, P331, DOI DOI 10.1037/1040-3590.1.4.331; Pfeifer M, 2001, EXP CLIN ENDOCR DIAB, V109, P87, DOI 10.1055/s-2001-14831; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; SIMPSON RU, 1985, J BIOL CHEM, V260, P8882; Stewart JW, 2009, MENOPAUSE, V16, P1093, DOI 10.1097/gme.0b013e3181a8f7ed; Swanenburg J, 2007, CLIN REHABIL, V21, P523, DOI 10.1177/0269215507075206; Verreault R, 2002, J AM GERIATR SOC, V50, P912, DOI 10.1046/j.1532-5415.2002.50219.x; Wicherts IS, 2007, J CLIN ENDOCR METAB, V92, P2058, DOI 10.1210/jc.2006-1525; Zamboni M, 2002, J GERONTOL A-BIOL, V57, pM7, DOI 10.1093/gerona/57.1.M7	36	74	77	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e34950	10.1371/journal.pone.0034950	http://dx.doi.org/10.1371/journal.pone.0034950			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539952	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341000015
J	Ladiwala, ARA; Litt, J; Kane, RS; Aucoin, DS; Smith, SO; Ranjan, S; Davis, J; Van Nostrand, WE; Tessier, PM				Ladiwala, Ali Reza A.; Litt, Jeffrey; Kane, Ravi S.; Aucoin, Darryl S.; Smith, Steven O.; Ranjan, Swarnim; Davis, Judianne; Van Nostrand, William E.; Tessier, Peter M.			Conformational Differences between Two Amyloid beta Oligomers of Similar Size and Dissimilar Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; FIBRIL FORMATION; MONOCLONAL-ANTIBODIES; ALZHEIMERS-DISEASE; PROTEIN OLIGOMERS; AGGREGATION; COMMON; NEUROTOXICITY; ASSEMBLIES; CONFORMERS	Several protein conformational disorders (Parkinson and prion diseases) are linked to aberrant folding of proteins into prefibrillar oligomers and amyloid fibrils. Although prefibrillar oligomers are more toxic than their fibrillar counterparts, it is difficult to decouple the origin of their dissimilar toxicity because oligomers and fibrils differ both in terms of structure and size. Here we report the characterization of two oligomers of the 42-residue amyloid beta (A beta 42) peptide associated with Alzheimer disease that possess similar size and dissimilar toxicity. We find that A beta 42 spontaneously forms prefibrillar oligomers at A beta concentrations below 30 mu M in the absence of agitation, whereas higher A beta concentrations lead to rapid formation of fibrils. Interestingly, A beta prefibrillar oligomers do not convert into fibrils under quiescent assembly conditions but instead convert into a second type of oligomer with size and morphology similar to those of A beta prefibrillar oligomers. Strikingly, this alternative A beta oligomer is non-toxic to mammalian cells relative to A beta monomer. We find that two hydrophobic peptide segments within A beta (residues 16-22 and 30-42) are more solvent-exposed in the more toxic A beta oligomer. The less toxic oligomer is devoid of beta-sheet structure, insoluble, and non-immunoreactive with oligomer-and fibril-specific antibodies. Moreover, the less toxic oligomer is incapable of disrupting lipid bilayers, in contrast to its more toxic oligomeric counterpart. Our results suggest that the ability of non-fibrillar A beta oligomers to interact with and disrupt cellular membranes is linked to the degree of solvent exposure of their central and C-terminal hydrophobic peptide segments.	[Ladiwala, Ali Reza A.; Litt, Jeffrey; Kane, Ravi S.; Ranjan, Swarnim; Tessier, Peter M.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Aucoin, Darryl S.; Smith, Steven O.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Davis, Judianne; Van Nostrand, William E.] SUNY Stony Brook, Dept Neurosurg & Med, Stony Brook, NY 11794 USA	Rensselaer Polytechnic Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Tessier, PM (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Biol Engn, 110 8th St, Troy, NY 12180 USA.	tessier@rpi.edu	Tessier, Peter/GPP-3396-2022; Smith, Steven/HDM-9496-2022; Tessier, Peter/I-5730-2013	Tessier, Peter/0000-0002-3220-007X; Aucoin, Darryl/0000-0002-0595-8045; /0000-0001-9135-2607	National Institutes of Health [AG-27317]; Alzheimer's Association [NIRG-08-90967]; American Health Assistance Foundation [ADR-A2011355]; National Science Foundation [CBET NIRT 0608978]; P. K. Lashmet Chair; NATIONAL INSTITUTE ON AGING [RF1AG027317, R01AG027317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); American Health Assistance Foundation; National Science Foundation(National Science Foundation (NSF)); P. K. Lashmet Chair; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG-27317 (to S. O. S.). This work was also supported by Alzheimer's Association Grant NIRG-08-90967 (to P. M. T.), American Health Assistance Foundation Grant ADR-A2011355 (to P. M. T.), National Science Foundation Grant CBET NIRT 0608978 (to R. S. K.), and the P. K. Lashmet Chair (to R. S. K.).	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Andreasen N, 1999, ARCH NEUROL-CHICAGO, V56, P673, DOI 10.1001/archneur.56.6.673; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Cizas P, 2010, ARCH BIOCHEM BIOPHYS, V496, P84, DOI 10.1016/j.abb.2010.02.001; Galasko D, 1998, ARCH NEUROL-CHICAGO, V55, P937, DOI 10.1001/archneur.55.7.937; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2006, METHOD ENZYMOL, V413, P326, DOI 10.1016/S0076-6879(06)13017-7; Kayed R, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-57; Keshet B, 2010, BIOTECHNOL BIOENG, V106, P333, DOI 10.1002/bit.22691; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Ladiwala ARA, 2011, CHEMBIOCHEM, V12, P1749, DOI 10.1002/cbic.201100123; Ladiwala ARA, 2011, J BIOL CHEM, V286, P3209, DOI 10.1074/jbc.M110.173856; Ladiwala ARA, 2010, J BIOL CHEM, V285, P24228, DOI 10.1074/jbc.M110.133108; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x; Lee S, 2007, PROTEIN SCI, V16, P723, DOI 10.1110/ps.062514807; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; MUELLER P, 1962, NATURE, V194, P979, DOI 10.1038/194979a0; Munishkina LA, 2004, J MOL RECOGNIT, V17, P456, DOI 10.1002/jmr.699; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Perchiacca JM, 2012, P NATL ACAD SCI USA, V109, P84, DOI 10.1073/pnas.1111232108; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Strozyk D, 2003, NEUROLOGY, V60, P652, DOI 10.1212/01.WNL.0000046581.81650.D0; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Zameer A, 2008, J MOL BIOL, V384, P917, DOI 10.1016/j.jmb.2008.09.068	37	163	165	1	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24765	24773		10.1074/jbc.M111.329763	http://dx.doi.org/10.1074/jbc.M111.329763			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22547072	Green Published, hybrid			2022-12-25	WOS:000306651100069
J	Wang, JY; Papke, RL; Stokes, C; Horenstein, NA				Wang, Jingyi; Papke, Roger L.; Stokes, Clare; Horenstein, Nicole A.			Potential State-selective Hydrogen Bond Formation Can Modulate Activation and Desensitization of the alpha 7 Nicotinic Acetylcholine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIDBRAIN DOPAMINE AREAS; ALZHEIMERS-DISEASE; BINDING; AGONIST; SITE; SCHIZOPHRENIA; DIVERSITY; MECHANISM; PROTEIN; RAT	A series of arylidene anabaseines were synthesized to probe the functional impact of hydrogen bonding on human alpha 7 nicotinic acetylcholine receptor (nAChR) activation and desensitization. The aryl groups were either hydrogen bond acceptors (furans), donors (pyrroles), or neither (thiophenes). These compounds were tested against a series of point mutants of the ligand-binding domain residue Gln-57, a residue hypothesized to be proximate to the aryl group of the bound agonist and a putative hydrogen bonding partner. Q57K, Q57D, Q57E, and Q57L were chosen to remove the dual hydrogen bonding donor/acceptor ability of Gln-57 and replace it with hydrogen bond donating, hydrogen bond accepting, or nonhydrogen bonding ability. Activation of the receptor was compromised with hydrogen bonding mismatches, for example, pairing a pyrrole with Q57K or Q57L, or a furan anabaseine with Q57D or Q57E. Ligand co-applications with the positive allosteric modulator PNU-120596 produced significantly enhanced currents whose degree of enhancement was greater for 2-furans or -pyrroles than for their 3-substituted isomers, whereas the nonhydrogen bonding thiophenes failed to show this correlation. Interestingly, the PNU-120596 agonist co-application data revealed that for wild-type alpha 7 nAChR, the 3-furan desensitized state was relatively stabilized compared with that of 2-furan, a reversal of the relationship observed with respect to the barrier for entry into the desensitized state. These data highlight the importance of hydrogen bonding on the receptor-ligand state, and suggest that it may be possible to fine-tune features of agonists that mediate state selection in the nAChR.	[Wang, Jingyi; Horenstein, Nicole A.] Univ Florida, Dept Chem, Gainesville, FL 32611 USA; [Papke, Roger L.; Stokes, Clare] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Horenstein, NA (corresponding author), Univ Florida, Dept Chem, Gainesville, FL 32611 USA.	horen@chem.ufl.edu	wang, jing/GRS-7509-2022		National Institutes of Health Grant [R01 GM057481]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057481] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM057481 (to R. L. P.).	[Anonymous], 2008, AMBER 10; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; D'Andrea MR, 2006, CURR PHARM DESIGN, V12, P677, DOI 10.2174/138161206775474224; Dani JA, 2000, EUR J PHARMACOL, V393, P31, DOI 10.1016/S0014-2999(00)00003-0; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Grutter T, 2003, EMBO J, V22, P1990, DOI 10.1093/emboj/cdg197; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; Horenstein NA, 2008, MOL PHARMACOL, V74, P1496, DOI 10.1124/mol.108.048892; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Kem WR, 2000, BEHAV BRAIN RES, V113, P169, DOI 10.1016/S0166-4328(00)00211-4; Le Novere N, 2002, J NEUROBIOL, V53, P447, DOI 10.1002/neu.10153; Leiser SC, 2009, PHARMACOL THERAPEUT, V122, P302, DOI 10.1016/j.pharmthera.2009.03.009; Martin LF, 2007, INT REV NEUROBIOL, V78, P225, DOI 10.1016/S0074-7742(06)78008-4; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Papke RL, 1996, NEUROSCI LETT, V213, P201; Papke RL, 2002, BRIT J PHARMACOL, V137, P49, DOI 10.1038/sj.bjp.0704833; Papke RL, 2011, J PHARMACOL EXP THER, V337, P367, DOI 10.1124/jpet.110.177485; Papke RL, 2009, J PHARMACOL EXP THER, V329, P791, DOI 10.1124/jpet.108.150151; Puskar NL, 2011, J BIOL CHEM, V286, P14618, DOI 10.1074/jbc.M110.206565; Quick MW, 2002, J NEUROBIOL, V53, P457, DOI 10.1002/neu.10109; Roncarati R, 2009, J PHARMACOL EXP THER, V329, P459, DOI 10.1124/jpet.108.150094; SEGUELA P, 1993, J NEUROSCI, V13, P596; Stevens KE, 1998, PSYCHOPHARMACOLOGY, V136, P320, DOI 10.1007/s002130050573; Terry AV, 2008, CURR NEUROPHARMACOL, V6, P286, DOI 10.2174/157015908785777247; Wang JY, 2010, MOL PHARMACOL, V78, P1012, DOI 10.1124/mol.110.066662; Wang JY, 2009, BIOORG MED CHEM LETT, V19, P474, DOI 10.1016/j.bmcl.2008.11.044; Williams DK, 2011, MOL PHARMACOL, V80, P1013, DOI 10.1124/mol.111.074302; Williams DK, 2011, J GEN PHYSIOL, V137, P369, DOI 10.1085/jgp.201010587; Wooltorton JRA, 2003, J NEUROSCI, V23, P3176; Xiu XA, 2009, NATURE, V458, P534, DOI 10.1038/nature07768; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; ZOLTEWICZ JA, 1993, HETEROCYCLES, V35, P171	32	8	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21957	21969		10.1074/jbc.M112.339796	http://dx.doi.org/10.1074/jbc.M112.339796			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22556416	hybrid, Green Published			2022-12-25	WOS:000306418600035
J	Bridges, D; Fisher, K; Zolov, SN; Xiong, TT; Inoki, K; Weisman, LS; Saltiel, AR				Bridges, Dave; Fisher, Kaleigh; Zolov, Sergey N.; Xiong, Tingting; Inoki, Ken; Weisman, Lois S.; Saltiel, Alan R.			Rab5 Proteins Regulate Activation and Localization of Target of Rapamycin Complex 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P70 S6 KINASE; SACCHAROMYCES-CEREVISIAE; AMINO-ACIDS; PHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE; ACTIN CYTOSKELETON; PHOSPHOLIPASE-D; GENE-PRODUCTS; LIPID KINASE; CELL-GROWTH; RAG GTPASES	The mechanistic target of rapamycin (mTOR) complex 1 is regulated by small GTPase activators and localization signals. We examine here the role of the small GTPase Rab5 in the localization and activation of TORC1 in yeast and mammalian cells. Rab5 mutants disrupt mTORC1 activation and localization in mammalian cells, whereas disruption of the Rab5 homolog in yeast, Vps21, leads to decreased TORC1 function. Additionally, regulation of PI(3)P synthesis by Rab5 and Vps21 is essential for TORC1 function in both contexts.	[Bridges, Dave; Fisher, Kaleigh; Zolov, Sergey N.; Xiong, Tingting; Inoki, Ken; Weisman, Lois S.; Saltiel, Alan R.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Saltiel, Alan R.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Xiong, Tingting; Inoki, Ken] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Weisman, Lois S.; Saltiel, Alan R.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Saltiel, AR (corresponding author), Univ Michigan, Inst Life Sci, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	saltiel@lsi.umich.edu	Saltiel, Alan/L-3632-2019; Bridges, Dave/A-8825-2010	Bridges, Dave/0000-0002-5334-972X; Saltiel, Alan/0000-0002-9726-9828	National Institutes of Health [DK-061618, GM-050403, DK-083491]; American Diabetes Association fellowship; Rackham graduate studies grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083491, P30DK020572, R01DK061618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association fellowship(American Diabetes Association); Rackham graduate studies grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-061618 (to A. R. S.), GM-050403 (to L. S. W.), and DK-083491 (to K. I.). This work was also supported an American Diabetes Association fellowship (to D. B.) and a Rackham graduate studies grant (to T. X.).	Banuelos MG, 2010, CURR GENET, V56, P121, DOI 10.1007/s00294-009-0285-3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Chiang SH, 2006, METHOD ENZYMOL, V406, P701, DOI 10.1016/S0076-6879(06)06055-1; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Flinn RJ, 2010, MOL BIOL CELL, V21, P833, DOI 10.1091/mbc.E09-09-0756; Foti M, 2001, MOL BIOL CELL, V12, P2396, DOI 10.1091/mbc.12.8.2396; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Guo SL, 1999, J BIOL CHEM, V274, P12990, DOI 10.1074/jbc.274.19.12990; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Huang J, 2001, P NATL ACAD SCI USA, V98, P13084, DOI 10.1073/pnas.241368698; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Hughes WE, 2000, J BIOL CHEM, V275, P801, DOI 10.1074/jbc.275.2.801; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kim J, 2011, ANNU REV BIOCHEM, V80, P1001, DOI 10.1146/annurev-biochem-062209-094414; Li L, 2010, J BIOL CHEM, V285, P19705, DOI 10.1074/jbc.C110.102483; Lodhi IJ, 2008, MOL BIOL CELL, V19, P2718, DOI 10.1091/mbc.E08-01-0105; Lodhi IJ, 2007, CELL METAB, V5, P59, DOI 10.1016/j.cmet.2006.12.006; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Saito T, 2007, J BIOL CHEM, V282, P32280, DOI 10.1074/jbc.M704150200; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; SINGERKRUGER B, 1994, J CELL BIOL, V125, P283, DOI 10.1083/jcb.125.2.283; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2003, J BIOL CHEM, V278, P37288, DOI 10.1074/jbc.M303257200; WELSH GI, 1994, BIOCHEM J, V303, P15, DOI 10.1042/bj3030015; WENG QP, 1995, MOL CELL BIOL, V15, P2333; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xie MW, 2005, P NATL ACAD SCI USA, V102, P7215, DOI 10.1073/pnas.0500297102; Xu LM, 2011, J BIOL CHEM, V286, P25477, DOI 10.1074/jbc.M111.249631; Yoon MS, 2011, J CELL BIOL, V195, P435, DOI 10.1083/jcb.201107033; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P17518, DOI 10.1073/pnas.0702275104; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056; Zurita-Martinez SA, 2007, GENETICS, V176, P2139, DOI 10.1534/genetics.107.072835	48	47	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20913	20921		10.1074/jbc.M111.334060	http://dx.doi.org/10.1074/jbc.M111.334060			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22547071	Green Published, hybrid			2022-12-25	WOS:000306416800013
J	Huo, YQ; Guo, X; Li, HG; Xu, H; Halim, V; Zhang, WY; Wang, H; Fan, YY; Ong, KT; Woo, SL; Chapkin, RS; Mashek, DG; Chen, YM; Dong, H; Lu, F; Wei, L; Wu, CD				Huo, Yuqing; Guo, Xin; Li, Honggui; Xu, Hang; Halim, Vera; Zhang, Weiyu; Wang, Huan; Fan, Yang-Yi; Ong, Kuok Teong; Woo, Shih-Lung; Chapkin, Robert S.; Mashek, Douglas G.; Chen, Yanming; Dong, Hui; Lu, Fuer; Wei, Lai; Wu, Chaodong			Targeted Overexpression of Inducible 6-Phosphofructo-2-kinase in Adipose Tissue Increases Fat Deposition but Protects against Diet-induced Insulin Resistance and Inflammatory Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; RECEPTOR-GAMMA ACTIVATION; HEPATIC STEATOSIS; LIVER-DISEASE; MICE; SENSITIVITY; OBESITY; HEPATOCYTES; GLUCOSE; 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE	Increasing evidence demonstrates the dissociation of fat deposition, the inflammatory response, and insulin resistance in the development of obesity-related metabolic diseases. As a regulatory enzyme of glycolysis, inducible 6-phosphofructo-2-kinase (iPFK2, encoded by PFKFB3) protects against diet-induced adipose tissue inflammatory response and systemic insulin resistance independently of adiposity. Using aP2-PFKFB3 transgenic (Tg) mice, we explored the ability of targeted adipocyte PFKFB3/iPFK2 overexpression to modulate diet-induced inflammatory responses and insulin resistance arising from fat deposition in both adipose and liver tissues. Compared with wild-type littermates (controls) on a high fat diet (HFD), Tg mice exhibited increased adiposity, decreased adipose inflammatory response, and improved insulin sensitivity. In a parallel pattern, HFD-fed Tg mice showed increased hepatic steatosis, decreased liver inflammatory response, and improved liver insulin sensitivity compared with controls. In both adipose and liver tissues, increased fat deposition was associated with lipid profile alterations characterized by an increase in palmitoleate. Additionally, plasma lipid profiles also displayed an increase in palmitoleate in HFD-Tg mice compared with controls. In cultured 3T3-L1 adipocytes, overexpression of PFKFB3/iPFK2 recapitulated metabolic and inflammatory changes observed in adipose tissue of Tg mice. Upon treatment with conditioned medium from iPFK2-overexpressing adipocytes, mouse primary hepatocytes displayed metabolic and inflammatory responses that were similar to those observed in livers of Tg mice. Together, these data demonstrate a unique role for PFKFB3/iPFK2 in adipocytes with regard to diet-induced inflammatory responses in both adipose and liver tissues.	[Huo, Yuqing] Georgia Hlth Sci Univ, Dept Cellular Biol & Anat, Augusta, GA 30912 USA; [Guo, Xin; Li, Honggui; Xu, Hang; Halim, Vera; Fan, Yang-Yi; Woo, Shih-Lung; Chapkin, Robert S.; Wu, Chaodong] Texas A&M Univ, Dept Nutr & Food Sci, Intercollegiate Fac Nutr, College Stn, TX 77843 USA; [Zhang, Weiyu; Wang, Huan] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Ong, Kuok Teong; Mashek, Douglas G.] Univ Minnesota, Dept Food Sci & Nutr, St Paul, MN USA; [Chen, Yanming] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Endocrinol, Guangzhou 510630, Guangdong, Peoples R China; [Dong, Hui; Lu, Fuer] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Inst Integrated Chinese & Western Med, Wuhan 430030, Hubei, Peoples R China; [Wei, Lai] Peking Univ, Hlth Sci Ctr, Inst Hepatol, Beijing 100044, Peoples R China	University System of Georgia; Augusta University; Texas A&M University System; Texas A&M University College Station; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Sun Yat Sen University; Huazhong University of Science & Technology; Peking University	Huo, YQ (corresponding author), Georgia Hlth Sci Univ, Dept Cellular Biol & Anat, Augusta, GA 30912 USA.	YHUO@georgiahealth.edu; cdwu@tamu.edu	Ong, Kuok Teong/H-8274-2015; Mashek, Douglas/ABD-6844-2021	Ong, Kuok Teong/0000-0001-8605-375X; Chapkin, Robert/0000-0002-6515-3898; Mashek, Douglas/0000-0001-7033-3386	National Institutes of Health [HL78679, HL080569]; American Diabetes Association [1-10-BS-76, 1-10-JF-54]; American Heart Association [12BGIA9050003]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095556, R01HL080569, R21HL108922, R01HL078679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL78679 and HL080569 (to Y. H.). This work was also supported by American Diabetes Association Grants 1-10-BS-76 (to Y. H.) and 1-10-JF-54 and American Heart Association Grant 12BGIA9050003 (to C. W.).	Akazawa Y, 2010, J HEPATOL, V52, P586, DOI 10.1016/j.jhep.2010.01.003; Atsumi T, 2005, DIABETES, V54, P3349, DOI 10.2337/diabetes.54.12.3349; Bu SY, 2009, J BIOL CHEM, V284, P30474, DOI 10.1074/jbc.M109.036665; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; CHAPKIN RS, 1990, LIPIDS, V25, P827, DOI 10.1007/BF02535905; Clement S, 2008, HEPATOLOGY, V48, P799, DOI 10.1002/hep.22404; Combs TP, 2004, ENDOCRINOLOGY, V145, P367, DOI 10.1210/en.2003-1068; Guo X, 2010, J BIOL CHEM, V285, P23711, DOI 10.1074/jbc.M110.123174; Huo YQ, 2010, J BIOL CHEM, V285, P3713, DOI 10.1074/jbc.M109.058446; Iozzo P, 2010, GASTROENTEROLOGY, V139, P846, DOI 10.1053/j.gastro.2010.05.039; Joshi-Barve S, 2007, HEPATOLOGY, V46, P823, DOI 10.1002/hep.21752; Kamagate A, 2008, J CLIN INVEST, V118, P2347, DOI [10.1172/JCI32914, 10.1172/JC132914]; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Lesniewski LA, 2007, NAT MED, V13, P455, DOI 10.1038/nm1550; Liu XQ, 2010, ARTERIOSCL THROM VAS, V30, P31, DOI 10.1161/ATVBAHA.109.195636; Menghini R, 2009, GASTROENTEROLOGY, V136, P663, DOI 10.1053/j.gastro.2008.10.079; Minokoshi Y, 2003, J BIOL CHEM, V278, P33609, DOI 10.1074/jbc.R300019200; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Monsenego J, 2012, J HEPATOL, V56, P632, DOI 10.1016/j.jhep.2011.10.008; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Okar DA, 2004, ADV ENZYME REGUL, V44, P123, DOI 10.1016/j.advenzreg.2003.11.006; Rider MH, 2004, BIOCHEM J, V381, P561, DOI 10.1042/BJ20040752; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Stienstra R, 2008, J BIOL CHEM, V283, P22620, DOI 10.1074/jbc.M710314200; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; Tilg H, 2006, GASTROENTEROLOGY, V131, P934, DOI 10.1053/j.gastro.2006.05.054; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu CD, 2005, CELL METAB, V2, P131, DOI 10.1016/j.cmet.2005.07.003; Wu CD, 2001, J CLIN INVEST, V107, P91, DOI 10.1172/JCI11103; Wu CD, 2006, AM J PHYSIOL-ENDOC M, V291, pE536, DOI 10.1152/ajpendo.00126.2006; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhang JF, 2004, P NATL ACAD SCI USA, V101, P10703, DOI 10.1073/pnas.0403652101	37	41	41	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21492	21500		10.1074/jbc.M112.370379	http://dx.doi.org/10.1074/jbc.M112.370379			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22556414	Green Published, hybrid			2022-12-25	WOS:000306416800066
J	Roston, RL; Gao, JP; Murcha, MW; Whelan, J; Benning, C				Roston, Rebecca L.; Gao, Jinpeng; Murcha, Monika W.; Whelan, James; Benning, Christoph			TGD1,-2, and-3 Proteins Involved in Lipid Trafficking Form ATP-binding Cassette (ABC) Transporter with Multiple Substrate-binding Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER ENVELOPE MEMBRANE; BLUE-NATIVE PAGE; ARABIDOPSIS-THALIANA; INSERTIONAL MUTAGENESIS; CHLOROPLAST ENVELOPES; PHOSPHATIDIC-ACID; PEA-CHLOROPLASTS; OUTER-MEMBRANE; COMPLEX; SYSTEM	Members of the ATP-binding cassette (ABC) transporter family are essential proteins in species as diverse as archaea and humans. Their domain architecture has remained relatively fixed across these species, with rare exceptions. Here, we show one exception to be the TRIGALACTOSYLDIACYLGLYCEROL 1, 2, and 3 (TGD1, -2, and -3) putative lipid transporter located at the chloroplast inner envelope membrane. TGD2 was previously shown to be in a complex of >500 kDa. We demonstrate that this complex also contains TGD1 and -3 and is very stable because it cannot be broken down by gentle denaturants to form a "core" complex similar in size to standard ABC transporters. The complex was purified from Pisum sativum (pea) chloroplast envelopes by native gel electrophoresis and examined by mass spectrometry. Identified proteins besides TGD1, -2, or -3 included a potassium efflux antiporter and a TIM17/ 22/23 family protein, but these were shown to be in separate high molecular mass complexes. Quantification of the complex components explained the size of the complex because 8-12 copies of the substrate-binding protein (TGD2) were found per functional transporter.	[Roston, Rebecca L.; Gao, Jinpeng; Benning, Christoph] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Murcha, Monika W.; Whelan, James] Univ Western Australia, Australian Res Council, Ctr Excellence Plant Energy Biol, Crawley, WA 6009, Australia	Michigan State University; University of Western Australia	Benning, C (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	benning@cns.msu.edu	Benning, Christoph/Y-2528-2019; Murcha, Monika W/H-5495-2014; Roston, Rebecca/AAQ-5309-2020; Murcha, Monika W/C-3834-2011; Whelan, James/F-6402-2011; Gao, Jinpeng/F-8460-2012	Benning, Christoph/0000-0001-8585-3667; Murcha, Monika W/0000-0002-3689-6158; Whelan, James/0000-0001-5754-025X; Roston, Rebecca/0000-0002-3063-5002	National Science Foundation [MCB0741395]; US Department of Energy, Basic Energy Sciences [DE-FG02-98ER20305]; Div Of Molecular and Cellular Bioscience [1157231] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); US Department of Energy, Basic Energy Sciences(United States Department of Energy (DOE)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant MCB0741395 and the US Department of Energy, Basic Energy Sciences, DE-FG02-98ER20305 (to C. B.).	Akita M, 1997, J CELL BIOL, V136, P983, DOI 10.1083/jcb.136.5.983; Albers SV, 2004, J BIOENERG BIOMEMBR, V36, P5, DOI 10.1023/B:JOBB.0000019593.84933.e6; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Awai K, 2006, P NATL ACAD SCI USA, V103, P10817, DOI 10.1073/pnas.0602754103; Benning C, 2009, ANNU REV CELL DEV BI, V25, P71, DOI 10.1146/annurev.cellbio.042308.113414; Biemans-Oldehinkel E, 2003, EMBO J, V22, P5983, DOI 10.1093/emboj/cdg581; Brautigam A, 2008, J BIOTECHNOL, V136, P44, DOI 10.1016/j.jbiotec.2008.02.007; Bruce B.D., 1994, PLANT MOL BIOL MANUA, VJ1, P1; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; CLINE K, 1981, P NATL ACAD SCI-BIOL, V78, P3595, DOI 10.1073/pnas.78.6.3595; CLINE K, 1984, PLANT PHYSIOL, V75, P675, DOI 10.1104/pp.75.3.675; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cooper H.M., 2009, CURR PROTOC NEUROSCI, DOI [10.1002/0471142301.ns0505s48, DOI 10.1002/0471142301.NS0505S48]; DORMANN P, 1995, PLANT CELL, V7, P1801, DOI 10.1105/tpc.7.11.1801; Eubel H, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-11; Franssen SU, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-227; HEINZ E, 1983, PLANT PHYSIOL, V72, P273, DOI 10.1104/pp.72.2.273; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Jackson DT, 1998, J BIOL CHEM, V273, P16583, DOI 10.1074/jbc.273.26.16583; Jarvis P, 2000, P NATL ACAD SCI USA, V97, P8175, DOI 10.1073/pnas.100132197; KEEGSTRA K, 1986, METHOD ENZYMOL, V118, P316; Kikuchi S, 2006, PLANT CELL PHYSIOL, V47, P363, DOI 10.1093/pcp/pcj002; Kikuchi S, 2009, PLANT CELL, V21, P1781, DOI 10.1105/tpc.108.063552; Krimm I, 1999, J BIOL CHEM, V274, P34539, DOI 10.1074/jbc.274.49.34539; KUNST L, 1988, P NATL ACAD SCI USA, V85, P4143, DOI 10.1073/pnas.85.12.4143; Ladig R, 2011, PLANT J, V67, P181, DOI 10.1111/j.1365-313X.2011.04577.x; Lee SJ, 2007, TRENDS MICROBIOL, V15, P389, DOI 10.1016/j.tim.2007.08.002; Lu BB, 2007, J BIOL CHEM, V282, P35945, DOI 10.1074/jbc.M704063200; Lu BB, 2009, J BIOL CHEM, V284, P17420, DOI 10.1074/jbc.M109.016014; Malinverni JC, 2009, P NATL ACAD SCI USA, V106, P8009, DOI 10.1073/pnas.0903229106; McElver J, 2001, GENETICS, V159, P1751; Murcha MW, 2007, PLANT PHYSIOL, V143, P199, DOI 10.1104/pp.106.090688; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Peltier JB, 2006, MOL CELL PROTEOMICS, V5, P114, DOI 10.1074/mcp.M500180-MCP200; Roston R, 2011, PLANT J, V66, P759, DOI 10.1111/j.1365-313X.2011.04536.x; ROUGHAN PG, 1980, BIOCHEM J, V188, P17, DOI 10.1042/bj1880017; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Schuurman-Wolters GK, 2005, J BIOL CHEM, V280, P23785, DOI 10.1074/jbc.M500522200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SIEBERTZ HP, 1979, EUR J BIOCHEM, V101, P429, DOI 10.1111/j.1432-1033.1979.tb19736.x; Uteng M, 2003, BIOCHEMISTRY-US, V42, P11417, DOI 10.1021/bi034572i; van der Heide T, 2002, EMBO REP, V3, P938, DOI 10.1093/embo-reports/kvf201; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Wang Z, 2011, JOVE-J VIS EXP, DOI 10.3791/2518; Xu CC, 2005, PLANT CELL, V17, P3094, DOI 10.1105/tpc.105.035592; Xu CC, 2003, EMBO J, V22, P2370, DOI 10.1093/emboj/cdg234; Zhu WH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/840518; Zou Q, 1998, PROTEINS, V31, P107, DOI 10.1002/(SICI)1097-0134(19980501)31:2<107::AID-PROT1>3.0.CO;2-J	51	65	84	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21406	21415		10.1074/jbc.M112.370213	http://dx.doi.org/10.1074/jbc.M112.370213			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22544736	hybrid, Green Published			2022-12-25	WOS:000306416800058
J	Hossaini, M; Goos, JAC; Kohli, SK; Holstege, JC				Hossaini, Mehdi; Goos, Jacqueline A. C.; Kohli, Somesh K.; Holstege, Jan C.			Distribution of Glycine/GABA Neurons in the Ventromedial Medulla with Descending Spinal Projections and Evidence for an Ascending Glycine/GABA Projection	PLOS ONE			English	Article							NUCLEUS RAPHE MAGNUS; RNA-CONTAINING NEURONS; DORSAL-HORN NEURONS; BRAIN-STEM NEURONS; EXPRESSING C-FOS; PERIAQUEDUCTAL GRAY; CYTOARCHITECTONIC ORGANIZATION; GLUTAMATE-DECARBOXYLASE; GABAERGIC NEURONS; PAIN-CONTROL	The ventromedial medulla (VM), subdivided in a rostral (RVM) and a caudal (CVM) part, has a powerful influence on the spinal cord. In this study, we have identified the distribution of glycine and GABA containing neurons in the VM with projections to the cervical spinal cord, the lumbar dorsal horn, and the lumbar ventral horn. For this purpose, we have combined retrograde tracing using fluorescent microspheres with fluorescent in situ hybridization (FISH) for glycine transporter 2 (GlyT2) and GAD67 mRNAs to identify glycinergic and/or GABAergic (Gly/GABA) neurons. Since the results obtained with FISH for GlyT2, GAD67, or GlyT2+GAD67 mRNAs were not significantly different, we concluded that glycine and GABA coexisted in the various projection neurons. After injections in the cervical cord, we found that 29% +/- 1 (SEM) of the retrogradely labeled neurons in the VM were Gly/GABA (RVM: 43%; CVM: 21%). After lumbar dorsal horn injections 31% +/- 3 of the VM neurons were Gly/GABA (RVM: 45%; CVM: 12%), and after lumbar ventral horn injections 25% +/- 2 were Gly/GABA (RVM: 35%; CVM: 17%). In addition, we have identified a novel ascending Gly/GABA pathway originating from neurons in the area around the central canal (CC) throughout the spinal cord and projecting to the RVM, emphasizing the interaction between the ventromedial medulla and the spinal cord. The present study has now firmly established that GABA and glycine are present in many VM neurons that project to the spinal cord. These neurons strongly influence spinal processing, most notably the inhibition of nociceptive transmission.	[Hossaini, Mehdi; Goos, Jacqueline A. C.; Kohli, Somesh K.; Holstege, Jan C.] Erasmus Univ, Dept Neurosci, Med Ctr, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Hossaini, M (corresponding author), Erasmus Univ, Dept Neurosci, Med Ctr, Rotterdam, Netherlands.	j.holstege@erasmusmc.nl			The Netherlands Organization of Scientific Research (NWO) [017.003.030]	The Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was supported by a Mozaiek grant (Nr. 017.003.030) from The Netherlands Organization of Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida A, 2000, EUR J PAIN, V4, P373, DOI 10.1053/eujp.2000.0193; Antal M, 1996, NEUROSCIENCE, V73, P509, DOI 10.1016/0306-4522(96)00063-2; BEITZ AJ, 1982, NEUROSCIENCE, V7, P2753, DOI 10.1016/0306-4522(82)90098-7; BEITZ AJ, 1982, J NEUROSCI, V2, P829; BLESSING WW, 1990, NEUROSCIENCE, V37, P171, DOI 10.1016/0306-4522(90)90202-F; CHAOUCH A, 1983, J COMP NEUROL, V214, P309, DOI 10.1002/cne.902140308; Chase M.H., 2005, PRINCIPLES PRACTICE, P154; Chery N, 1999, J NEUROSCI, V19, P7342, DOI 10.1523/JNEUROSCI.19-17-07342.1999; Dostrovsky J. O., 2006, WALL MELZACKS TXB PA, P187; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; FIELDS HL, 1991, ANNU REV NEUROSCI, V14, P219, DOI 10.1146/annurev.neuro.14.1.219; Foo H, 2003, J NEUROSCI, V23, P1933; Gao KM, 2000, J NEUROPHYSIOL, V84, P1719, DOI 10.1152/jn.2000.84.4.1719; HEADLEY PM, 1978, BRAIN RES, V145, P185, DOI 10.1016/0006-8993(78)90809-0; Heinricher MM, 2009, BRAIN RES REV, V60, P214, DOI 10.1016/j.brainresrev.2008.12.009; HEINRICHER MM, 1994, NEUROSCIENCE, V63, P279, DOI 10.1016/0306-4522(94)90022-1; HOLSTEGE JC, 1991, BRAIN RES, V566, P308, DOI 10.1016/0006-8993(91)91715-D; Holstege JC, 1996, PROG BRAIN RES, V107, P159; HOLSTEGE JC, 1991, J NEUROSCI, V11, P159; HONDA CN, 1985, BRAIN RES, V340, P285, DOI 10.1016/0006-8993(85)90925-4; HONDA CN, 1985, J NEUROPHYSIOL, V53, P1059, DOI 10.1152/jn.1985.53.4.1059; Hopman AHN, 1998, J HISTOCHEM CYTOCHEM, V46, P771, DOI 10.1177/002215549804600611; Hossaini M, 2011, NEUROSCIENCE, V196, P265, DOI 10.1016/j.neuroscience.2011.08.050; Hossaini M, 2007, BRAIN RES, V1142, P61, DOI 10.1016/j.brainres.2007.01.078; Hossaini M, 2010, PAIN, V151, P356, DOI 10.1016/j.pain.2010.07.023; HYLDEN JLK, 1983, LIFE SCI, V33, P789, DOI 10.1016/0024-3205(83)90785-3; JONES BE, 1991, J COMP NEUROL, V313, P349, DOI 10.1002/cne.903130210; JONES BE, 1985, J COMP NEUROL, V242, P56, DOI 10.1002/cne.902420105; JORDAN LM, 1978, PAIN, V5, P135, DOI 10.1016/0304-3959(78)90035-0; Kato G, 2006, J NEUROSCI, V26, P1787, DOI 10.1523/JNEUROSCI.4856-05.2006; KATZ LC, 1990, NEUROSCIENCE, V34, P511, DOI 10.1016/0306-4522(90)90159-2; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; KWIAT GC, 1992, SOMATOSENS MOT RES, V9, P157, DOI 10.3109/08990229209144768; Lefler Y, 2008, J COMP NEUROL, V506, P960, DOI 10.1002/cne.21586; LUQUE JM, 1995, NEUROSCIENCE, V64, P525, DOI 10.1016/0306-4522(94)00404-S; Mason P, 2001, ANNU REV NEUROSCI, V24, P737, DOI 10.1146/annurev.neuro.24.1.737; MCGOWAN MK, 1993, BRAIN RES, V620, P86, DOI 10.1016/0006-8993(93)90274-Q; MCGOWAN MK, 1993, BRAIN RES, V607, P39, DOI 10.1016/0006-8993(93)91487-D; MOLANDER C, 1989, J COMP NEUROL, V289, P375, DOI 10.1002/cne.902890303; MOLANDER C, 1984, J COMP NEUROL, V230, P133, DOI 10.1002/cne.902300112; Morgan MM, 2008, PAIN, V140, P376, DOI 10.1016/j.pain.2008.09.009; MORI S, 1989, BRAIN RES, V505, P66, DOI 10.1016/0006-8993(89)90116-9; NAHIN RL, 1983, J COMP NEUROL, V220, P321, DOI 10.1002/cne.902200306; NAHIN RL, 1986, NEUROSCI LETT, V65, P271, DOI 10.1016/0304-3940(86)90273-9; Nason MW, 2004, J NEUROPHYSIOL, V92, P510, DOI 10.1152/jn.00089.2004; NESS TJ, 1987, J NEUROPHYSIOL, V57, P1867, DOI 10.1152/jn.1987.57.6.1867; NESS TJ, 1989, BRAIN RES, V486, P301, DOI 10.1016/0006-8993(89)90516-7; Neubert MJ, 2004, PAIN, V110, P158, DOI 10.1016/j.pain.2004.03.017; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; POTREBIC SB, 1994, J NEUROSCI, V14, P1655, DOI 10.1523/JNEUROSCI.14-03-01655.1994; Poyatos I, 1997, MOL BRAIN RES, V49, P63, DOI 10.1016/S0169-328X(97)00124-1; REICHLING DB, 1990, J COMP NEUROL, V302, P370, DOI 10.1002/cne.903020213; SKAGERBERG G, 1985, NEUROSCIENCE, V15, P445, DOI 10.1016/0306-4522(85)90225-8; SORKIN LS, 1993, BRAIN RES, V618, P95, DOI 10.1016/0006-8993(93)90433-N; Stornetta RL, 1999, J COMP NEUROL, V407, P367; TAAL W, 1994, NEUROREPORT, V5, P2225, DOI 10.1097/00001756-199411000-00005; Tanaka I, 2004, NEUROSCI RES, V49, P165, DOI 10.1016/j.neures.2004.02.007; TODD AJ, 1990, J COMP NEUROL, V296, P496, DOI 10.1002/cne.902960312; URBAN MO, 1994, NEUROSCI LETT, V174, P21, DOI 10.1016/0304-3940(94)90109-0; URBAN MO, 1994, BRAIN RES, V652, P9, DOI 10.1016/0006-8993(94)90311-5; Vanegas H, 2004, BRAIN RES REV, V46, P295, DOI 10.1016/j.brainresrev.2004.07.004; Vanegas H, 2004, NEUROSCI LETT, V361, P225, DOI 10.1016/j.neulet.2003.12.002; Vetrivelan R, 2009, J NEUROSCI, V29, P9361, DOI 10.1523/JNEUROSCI.0737-09.2009; Wang CC, 1999, J COMP NEUROL, V415, P341, DOI 10.1002/(SICI)1096-9861(19991220)415:3<341::AID-CNE3>3.0.CO;2-7; Zeilhofer HU, 2012, PHYSIOL REV, V92, P193, DOI 10.1152/physrev.00043.2010; Zeilhofer HU, 2005, J COMP NEUROL, V482, P123, DOI 10.1002/cne.20349; Zhuo M, 1997, J NEUROPHYSIOL, V78, P746, DOI 10.1152/jn.1997.78.2.746	68	41	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35293	10.1371/journal.pone.0035293	http://dx.doi.org/10.1371/journal.pone.0035293			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558137	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340200012
J	Krauland, MG; Hotopp, JCD; Riley, DR; Daugherty, SC; Marsh, JW; Messonnier, NE; Mayer, LW; Tettelin, H; Harrison, LH				Krauland, Mary G.; Hotopp, Julie C. Dunning; Riley, David R.; Daugherty, Sean C.; Marsh, Jane W.; Messonnier, Nancy E.; Mayer, Leonard W.; Tettelin, Herve; Harrison, Lee H.			Whole Genome Sequencing to Investigate the Emergence of Clonal Complex 23 Neisseria meningitidis Serogroup Y Disease in the United States	PLOS ONE			English	Article							HIDDEN MARKOV MODEL; GENETIC-CHARACTERIZATION; MENINGOCOCCAL DISEASE; PILIN GLYCOSYLATION; SIGNAL PEPTIDES; VACCINE; IDENTIFICATION; ALIGNMENT; STRAIN; CORE	In the United States, serogroup Y, ST-23 clonal complex Neisseria meningitidis was responsible for an increase in meningococcal disease incidence during the 1990s. This increase was accompanied by antigenic shift of three outer membrane proteins, with a decrease in the population that predominated in the early 1990s as a different population emerged later in that decade. To understand factors that may have been responsible for the emergence of serogroup Y disease, we used whole genome pyrosequencing to investigate genetic differences between isolates from early and late N. meningitidis populations, obtained from meningococcal disease cases in Maryland in the 1990s. The genomes of isolates from the early and late populations were highly similar, with 1231 of 1776 shared genes exhibiting 100% amino acid identity and an average pi(N) = 0.0033 and average pi(S) = 0.0216. However, differences were found in predicted proteins that affect pilin structure and antigen profile and in predicted proteins involved in iron acquisition and uptake. The observed changes are consistent with acquisition of new alleles through horizontal gene transfer. Changes in antigen profile due to the genetic differences found in this study likely allowed the late population to emerge due to escape from population immunity. These findings may predict which antigenic factors are important in the cyclic epidemiology of meningococcal disease.	[Krauland, Mary G.; Marsh, Jane W.; Harrison, Lee H.] Univ Pittsburgh, Sch Med, Infect Dis Epidemiol Res Unit, Pittsburgh, PA 15260 USA; [Krauland, Mary G.; Marsh, Jane W.; Harrison, Lee H.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; [Hotopp, Julie C. Dunning; Riley, David R.; Daugherty, Sean C.; Tettelin, Herve] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Messonnier, Nancy E.; Mayer, Leonard W.] Ctr Dis Control & Prevent, Meningitis & Vaccine Preventable Dis Branch, Atlanta, GA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Maryland; University of Maryland Baltimore; Centers for Disease Control & Prevention - USA	Krauland, MG (corresponding author), Univ Pittsburgh, Sch Med, Infect Dis Epidemiol Res Unit, Pittsburgh, PA 15260 USA.	mgk8@pitt.edu	Dunning Hotopp, Julie/E-7762-2010	Dunning Hotopp, Julie/0000-0003-3862-986X; Krauland, Mary/0000-0002-1548-6221	Centers for Disease Control and Prevention; Sanofi Pasteur	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Sanofi Pasteur	This study was supported by a cooperative agreement from the Centers for Disease Control and Prevention and a grant from Sanofi Pasteur. Sanofi Pasteur had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTMAN M, 1995, TRENDS MICROBIOL, V3, P186, DOI 10.1016/S0966-842X(00)88918-0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-272; [Anonymous], 2009, VACCINE, DOI DOI 10.1016/j.vaccine.2009.04.063; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bennett JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-652; Budroni S, 2011, P NATL ACAD SCI USA, V108, P4494, DOI 10.1073/pnas.1019751108; Carbonnelle E, 2006, MOL MICROBIOL, V61, P1510, DOI 10.1111/j.1365-2958.2006.05341.x; Castillo-Ramirez S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002129; Cehovin A, 2010, VACCINE, V28, P4817, DOI 10.1016/j.vaccine.2010.04.065; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chou AC, 2008, J MED MICROBIOL, V57, P839, DOI 10.1099/jmm.0.47612-0; Comanducci M, 2002, J EXP MED, V195, P1445, DOI 10.1084/jem.20020407; Crabtree Jonathan, 2007, V408, P93, DOI 10.1007/978-1-59745-547-3_6; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher Arthur L, 2003, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1003s00; Didelot X, 2009, MICROBIOL-SGM, V155, P3176, DOI 10.1099/mic.0.031534-0; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egan A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-524; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; Gupta S, 1996, NAT MED, V2, P437, DOI 10.1038/nm0496-437; Harrison LH, 2006, J INFECT DIS, V193, P1266, DOI 10.1086/501371; Hotopp JCD, 2006, MICROBIOL-SGM, V152, P3733, DOI 10.1099/mic.0.29261-0; Hsu CA, 2008, PROTEOMICS, V8, P2115, DOI 10.1002/pmic.200700574; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jackson Lisa A., 1993, Morbidity and Mortality Weekly Report, V42, P21; Jiang HQ, 2010, VACCINE, V28, P6086, DOI 10.1016/j.vaccine.2010.06.083; Joseph B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018441; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kahler CM, 2001, INFECT IMMUN, V69, P1687, DOI 10.1128/IAI.69.3.1687-1696.2001; KROGH A, 1994, NUCLEIC ACIDS RES, V22, P4768, DOI 10.1093/nar/22.22.4768; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Leimkugel J, 2007, PLOS MED, V4, P535, DOI 10.1371/journal.pmed.0040101; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; McEllistrem MC, 2004, EMERG INFECT DIS, V10, P451; MOORE PS, 1992, CLIN INFECT DIS, V14, P515, DOI 10.1093/clinids/14.2.515; NASSIF X, 1993, MOL MICROBIOL, V8, P719, DOI 10.1111/j.1365-2958.1993.tb01615.x; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Peng JP, 2008, GENOMICS, V91, P78, DOI 10.1016/j.ygeno.2007.10.004; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Power PM, 2003, MOL MICROBIOL, V49, P833, DOI 10.1046/j.1365-2958.2003.03602.x; Power PM, 2000, MICROBIOL-UK, V146, P967, DOI 10.1099/00221287-146-4-967; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Riley DR, 2011, BIOINFORMATICS; Rosenstein NE, 1999, J INFECT DIS, V180, P1894, DOI 10.1086/315158; RUDEL T, 1995, NATURE, V373, P357, DOI 10.1038/373357a0; Salzberg S, 1998, J COMPUT BIOL, V5, P667, DOI 10.1089/cmb.1998.5.667; Schoen C, 2008, P NATL ACAD SCI USA, V105, P3473, DOI 10.1073/pnas.0800151105; Schuchat A, 2001, EMERG INFECT DIS, V7, P92, DOI 10.3201/eid0701.010114; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhu PX, 2001, P NATL ACAD SCI USA, V98, P5234, DOI 10.1073/pnas.061386098	56	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35699	10.1371/journal.pone.0035699	http://dx.doi.org/10.1371/journal.pone.0035699			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558202	Green Published, Green Accepted, gold			2022-12-25	WOS:000305336000048
J	Boomsma, RA; Geenen, DL				Boomsma, Robert A.; Geenen, David L.			Mesenchymal Stem Cells Secrete Multiple Cytokines That Promote Angiogenesis and Have Contrasting Effects on Chemotaxis and Apoptosis	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; H9C2 CELLS; CHEMOKINE RECEPTORS; INHIBIT APOPTOSIS; STROMAL CELLS; BAD; PHOSPHORYLATION; MIGRATION; PATHWAY; SURVIVAL	We have previously shown that mesenchymal stem cells (MSC) improve function upon integration in ischemic myocardium. We examined whether specific cytokines and growth factors produced by MSCs are able to affect angiogenesis, cellular migration and apoptosis. Conditioned media (CM) was prepared by culturing MSC for 48 hours. CM displayed significantly elevated levels of VEGF, Monocyte Chemoattractant Protein-1 (MCP-1), macrophage inflammatory protein-1 alpha (MIP-1 alpha), MIP-1 beta and monokine induced by IFN-gamma (MIG) compared to control media. MSC contained RNA for these factors as detected by RT-PCR. CM was able to induce angiogenesis in canine vascular endothelial cells. MCP-1 and MIP-1 alpha increased cell migration of MSC while VEGF reduced it. H9c2 cells treated with CM under hypoxic conditions for 24 hours displayed a 16% reduction in caspase-3 activity compared to controls. PI 3-kinase c inhibitor had no effect on controls but reversed the effect of CM on caspase-3 activity. MCP-1 alone mimicked the protective effect of CM while the PI 3-K gamma inhibitor did not reverse the effect of MCP-1. CM reduced phospho-BAD (Ser112) and phospho-Akt (Ser473) while increasing phospho-Akt (Thr308). MCP-1 reduced the level of phospho-Akt (Ser473) while having no effect on the other two; the PI 3-K gamma inhibitor did not alter the MCP-1 effect. ERK 1/2 phosphorylation was reduced in CM treated H9c2 cells, and inhibition of ERK 1/2 reduced the phosphorylation of Akt (Ser473), Akt (Thr308) and Bad (Ser112). In conclusion, MSC synthesize and secrete multiple paracrine factors that are able to affect MSC migration, promote angiogenesis and reduce apoptosis. While both MCP-1 and PI3-kinase are involved in the protective effect, they are independent of each other. It is likely that multiple pro-survival factors in addition to MCP-1 are secreted by MSC which act on divergent intracellular signaling pathways.	[Boomsma, Robert A.] Trinity Christian Coll, Dept Biol, Palos Hts, IL USA; [Boomsma, Robert A.; Geenen, David L.] Univ Illinois, Dept Med, Cardiol Sect, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Boomsma, RA (corresponding author), Trinity Christian Coll, Dept Biol, Palos Hts, IL USA.	geenen@uic.edu			Illinois Department of Public Health; National Heart, Lung, and Blood Institute [RO1 HL071046]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071046] Funding Source: NIH RePORTER	Illinois Department of Public Health; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was support by the Illinois Department of Public Health and the National Heart, Lung, and Blood Institute RO1 HL071046. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai H, 1996, J BIOL CHEM, V271, P21814, DOI 10.1074/jbc.271.36.21814; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Boomsma RA, 2007, INT J CARDIOL, V122, P17, DOI 10.1016/j.ijcard.2006.11.022; Borchi E, 2009, J CELL MOL MED, V13, P2724, DOI 10.1111/j.1582-4934.2008.00485.x; Burchfield JS, 2008, FIBROGENESIS TISSUE, V1, DOI 10.1186/1755-1536-1-4; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Dimmeler S, 2005, J CLIN INVEST, V115, P572, DOI 10.1172/JCI200524283; Dramsi S, 2002, J BIOL CHEM, V277, P6399, DOI 10.1074/jbc.M109990200; Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056; Fiedler J, 2005, BIOCHEM BIOPH RES CO, V334, P561, DOI 10.1016/j.bbrc.2005.06.116; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Liu CH, 2005, CYTOKINE, V32, P270, DOI 10.1016/j.cyto.2005.11.003; Liu JH, 2008, AM J PHYSIOL-HEART C, V295, pH1956, DOI 10.1152/ajpheart.00407.2008; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Ma J, 2007, BLOOD, V109, P987, DOI 10.1182/blood-2006-07-036400; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Mishima Y, 2008, J ORTHOP RES, V26, P1407, DOI 10.1002/jor.20668; Morimoto H, 2006, CIRC RES, V99, P891, DOI 10.1161/01.RES.0000246113.82111.2d; Parcellier A, 2008, CELL SIGNAL, V20, P21, DOI 10.1016/j.cellsig.2007.07.010; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Schichor C, 2006, EXP NEUROL, V199, P301, DOI 10.1016/j.expneurol.2005.11.027; Schmal H, 2007, CYTOTHERAPY, V9, P69, DOI 10.1080/14653240601011557; Schuleri KH, 2008, AM J PHYSIOL-HEART C, V294, pH2002, DOI 10.1152/ajpheart.00762.2007; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; Singla DK, 2008, AM J PHYSIOL-HEART C, V295, pH907, DOI 10.1152/ajpheart.00279.2008; Singla DK, 2007, AM J PHYSIOL-HEART C, V293, pH1590, DOI 10.1152/ajpheart.00431.2007; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Sze SK, 2007, MOL CELL PROTEOMICS, V6, P1680, DOI 10.1074/mcp.M600393-MCP200; Tan Y, 2000, J BIOL CHEM, V275, P25865, DOI 10.1074/jbc.M004199200; Tang JM, 2006, EUR J CARDIO-THORAC, V30, P353, DOI 10.1016/j.ejcts.2006.02.070; Tarzami ST, 2005, BIOCHEM BIOPH RES CO, V335, P1008, DOI 10.1016/j.bbrc.2005.07.168; Wang Lei, 2002, Hematology, V7, P113; Wymann MP, 2003, BIOCHEM SOC T, V31, P275, DOI 10.1042/bst0310275; Zhou LM, 2006, CIRC RES, V98, P1177, DOI 10.1161/01.RES.0000220106.64661.71; Zhu Y, 2002, J NEUROSCI, V22, P3898, DOI 10.1523/JNEUROSCI.22-10-03898.2002	35	231	251	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35685	10.1371/journal.pone.0035685	http://dx.doi.org/10.1371/journal.pone.0035685			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558198	Green Published, gold			2022-12-25	WOS:000305345200066
J	Wu, YJ; Li, Q; Zhou, XH; Yu, JR; Mu, YC; Munker, S; Xu, CF; Shen, Z; Mullenbach, R; Liu, Y; Li, L; Gretz, N; Zieker, D; Li, J; Matsuzaki, K; Li, YM; Dooley, S; Weng, HL				Wu, Yijun; Li, Qi; Zhou, Xinhui; Yu, Jiren; Mu, Yunchuan; Munker, Stefan; Xu, Chengfu; Shen, Zhe; Muellenbach, Roman; Liu, Yan; Li, Li; Gretz, Norbert; Zieker, Derek; Li, Jun; Matsuzaki, Kouichi; Li, Youming; Dooley, Steven; Weng, Honglei			Decreased Levels of Active SMAD2 Correlate with Poor Prognosis in Gastric Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN COLORECTAL-CANCER; TGF-BETA; TARGETED DISRUPTION; SIGNAL-TRANSDUCTION; TUMOR SUPPRESSION; CELL; PHOSPHORYLATION; CARCINOMA	Background: TGF-beta plays a dual role in the progression of human cancer. During the early stages of carcinogenesis, TGF-beta functions as a tumor suppressor. During the late stages of tumor development, however, TGF-beta can promote tumor growth and metastasis. A shift in Smad2/3 phosphorylation from the carboxy terminus to linker sites is a key event determining biological function of TGF-beta in colorectal and hepatocellular carcinoma. In the present study, we investigated the potential role of differential Smad2/3 phosphorylation in gastric adenocarcinoma. Methodology: Immunohistochemical staining with anti-P-Smad2/3C and P-Smad2/3L antibodies was performed on 130 paraffin-embedded gastric adenocarcinoma specimens. The relationship between P-Smad2/3C and P-Smad2/3L immunohistochemical score and clinicopathologic characteristics of patients was analyzed. Real time PCR was used to measure mRNA expression of Smad2 and Smad3 in cancer and surrounding non-tumor tissue. Principal Findings: No significant P-Smad2L and/ or P-Smad3L positive staining was detected in the majority of specimens (positive staining in 18/130 samples). Positive P-Smad2/3L staining was not associated with a decrease in carboxyterminal phosphorylation staining. Loss of P-Smad2C remarkably correlated with depth of tumor infiltration and poor differentiation of cancer cells in patients with gastric cancer. No correlation was detectable between P-Smad3C and clinicopathologic characteristics of gastric adenocarcinoma. However, co-staining analysis revealed that P-Smad3C co-localised with alpha-SMA and collagen I in gastric cancer cells, indicating a potential link between P-Smad3C and epithelial-to-mesenchymal transition of cancer. Real time PCR demonstrated reduced mRNA expression of Smad2 in gastric cancer when compared with surrounding non-tumor tissue in 15/16 patients. Conclusions: Loss of P-Smad2C tightly correlated with cancer invasion and poor differentiation in gastric cancer. Contrary to colorectal and hepatocellular carcinoma, canonical carboxy-terminal phosphorylation, but not linker phosphorylation, of Smad2 is critical for gastric cancer.	[Wu, Yijun; Yu, Jiren; Mu, Yunchuan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Gen Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Qi; Munker, Stefan; Muellenbach, Roman; Liu, Yan; Dooley, Steven; Weng, Honglei] Univ Heidelberg, Fac Med Mannheim, Med Clin, D-6800 Mannheim, Germany; [Zhou, Xinhui] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Gynecol, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Chengfu; Shen, Zhe; Li, Youming] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Muellenbach, Roman] Univ Saarland, Saarland Univ Hosp, Dept Med 2, D-6650 Homburg, Germany; [Li, Li; Gretz, Norbert] Univ Heidelberg, Med Res Ctr, Med Fac Mannheim, D-6800 Mannheim, Germany; [Zieker, Derek; Li, Jun] Univ Tubingen, Tubingen, Germany; [Matsuzaki, Kouichi] Kansai Med Univ, Dept Gastroenterol, Osaka, Japan; [Matsuzaki, Kouichi] Kansai Med Univ, Dept Hepatol, Osaka, Japan	Zhejiang University; Ruprecht Karls University Heidelberg; Zhejiang University; Zhejiang University; Saarland University; Universitatsklinikum des Saarlandes; Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Kansai Medical University; Kansai Medical University	Wu, YJ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Gen Surg, Hangzhou 310003, Zhejiang, Peoples R China.	wu1jun@sina.com; honglei.weng@medma.uni-heidelberg.de	Xu, Cheng/GXH-4815-2022; Dooley, Steven/T-6491-2018	Xu, Cheng/0000-0003-1000-733X; Dooley, Steven/0000-0002-4840-6240; Liebe, Roman/0000-0002-3199-5595; Ma, Han/0000-0001-9985-3035	Health Bureau of Zhejiang province of China [2009A065]; Else-Kroner Fresenius; BMBF [0313082L, 01GN0987]; Deutsche Forschungsgemeinschaft [DO373/6-1, DO 373/8-1, LA997/5-1]; Dietmar Hopp Stiftung GmbH	Health Bureau of Zhejiang province of China; Else-Kroner Fresenius; BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Dietmar Hopp Stiftung GmbH	The study was supported by the Health Bureau of Zhejiang province of China, 2009A065 (Y.J.W.); Else-Kroner Fresenius (H.L.W., S.D.); BMBF "Hepatosys'' 0313082L, "Virtual liver'' and "cell therapy'' 01GN0987 (S.D.); Deutsche Forschungsgemeinschaft DO373/6-1, DO 373/8-1 (S.D.) and LA997/5-1 (S.D.); and the Dietmar Hopp Stiftung GmbH (S.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; Datto MB, 1999, MOL CELL BIOL, V19, P2495; Fukuchi M, 2006, J SURG ONCOL, V94, P51, DOI 10.1002/jso.20565; Furukawa F, 2003, HEPATOLOGY, V38, P879, DOI 10.1053/jhep.2003.50384; Han SU, 2004, ONCOGENE, V23, P1333, DOI 10.1038/sj.onc.1207259; Hoot KE, 2010, J CLIN INVEST, V120, P3606, DOI 10.1172/JCI43304; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Ju WJ, 2006, MOL CELL BIOL, V26, P654, DOI 10.1128/MCB.26.2.654-667.2006; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Li X, 2008, J CLIN LAB ANAL, V22, P164, DOI 10.1002/jcla.20236; Lin Y, 2006, J GASTROEN HEPATOL, V21, P432, DOI 10.1111/j.1440-1746.2005.03939.x; Maggio-Price L, 2006, CANCER RES, V66, P828, DOI 10.1158/0008-5472.CAN-05-2448; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Matsuzaki K, 2011, CELL TISSUE RES; Matsuzaki K, 2007, HEPATOLOGY, V46, P48, DOI 10.1002/hep.21672; Matsuzaki K, 2006, J GASTROENTEROL, V41, P295, DOI 10.1007/s00535-006-1795-0; Matsuzaki K, 2011, CARCINOGENESIS, V32, P1578, DOI 10.1093/carcin/bgr172; Matsuzaki K, 2009, CANCER RES, V69, P5321, DOI 10.1158/0008-5472.CAN-08-4203; Meulmeester E, 2011, J PATHOL, V223, P205, DOI 10.1002/path.2785; Moustakas A, 2001, J CELL SCI, V114, P4359; Murata M, 2009, HEPATOLOGY, V49, P1203, DOI 10.1002/hep.22765; Petersen M, 2010, ONCOGENE, V29, P1351, DOI 10.1038/onc.2009.426; Sekimoto G, 2007, CANCER RES, V67, P5090, DOI 10.1158/0008-5472.CAN-06-4629; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shinto O, 2010, BRIT J CANCER, V102, P844, DOI 10.1038/sj.bjc.6605561; Shinto O, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-652; Sodir NM, 2006, CANCER RES, V66, P8430, DOI 10.1158/0008-5472.CAN-06-1437; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; Tang B, 2007, CANCER RES, V67, P8643, DOI 10.1158/0008-5472.CAN-07-0982; UEMURA M, 2005, MOL BIOL CELL; Warneke VS, 2011, J CLIN ONCOL, V29, P2364, DOI 10.1200/JCO.2010.34.4358; Wu WKK, 2010, CANCER LETT, V295, P144, DOI 10.1016/j.canlet.2010.04.025; Xie W, 2003, CANCER J, V9, P302, DOI 10.1097/00130404-200307000-00013; Xie W, 2002, CANCER RES, V62, P497; Yamagata H, 2005, CANCER RES, V65, P157; Yang L, 2008, CANCER RES, V68, P9107, DOI 10.1158/0008-5472.CAN-08-2556; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zhang YJ, 2009, CANCER LETT, V275, P102, DOI 10.1016/j.canlet.2008.10.017; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	44	19	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35684	10.1371/journal.pone.0035684	http://dx.doi.org/10.1371/journal.pone.0035684			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539990	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341000056
J	Yan, YX; Gong, YW; Guo, Y; Lv, Q; Guo, C; Zhuang, Y; Zhang, Y; Li, RX; Zhang, XZ				Yan, Yu-xian; Gong, Yuan-wei; Guo, Yong; Lv, Qi; Guo, Chun; Zhuang, Yan; Zhang, Yuan; Li, Ruixin; Zhang, Xi-zheng			Mechanical Strain Regulates Osteoblast Proliferation through Integrin-Mediated ERK Activation	PLOS ONE			English	Article							GROWTH-FACTOR-I; SIGNAL-TRANSDUCTION PATHWAYS; MESENCHYMAL STEM-CELLS; EXTRACELLULAR-MATRIX; SHEAR-STRESS; BONE-CELLS; INSULIN; EXPRESSION; PROTEIN; KINASE	Mechanical strain plays a critical role in the proliferation, differentiation and maturation of bone cells. As mechanical receptor cells, osteoblasts perceive and respond to stress force, such as those associated with compression, strain and shear stress. However, the underlying molecular mechanisms of this process remain unclear. Using a four-point bending device, mouse MC3T3-E1 cells was exposed to mechanical tensile strain. Cell proliferation was determined to be most efficient when stimulated once a day by mechanical strain at a frequency of 0.5 Hz and intensities of 2500 mu epsilon with once a day, and a periodicity of 1 h/day for 3 days. The applied mechanical strain resulted in the altered expression of 1992 genes, 41 of which are involved in the mitogen-activated protein kinase (MAPK) signaling pathway. Activation of ERK by mechanical strain promoted cell proliferation and inactivation of ERK by PD98059 suppressed proliferation, confirming that ERK plays an important role in the response to mechanical strain. Furthermore, the membrane-associated receptors integrin beta 1 and integrin beta 5 were determined to regulate ERK activity and the proliferation of mechanical strain-treated MC3T3-E1 cells in opposite ways. The knockdown of integrin beta 1 led to the inhibition of ERK activity and cell proliferation, whereas the knockdown of integrin beta 5 led to the enhancement of both processes. This study proposes a novel mechanism by which mechanical strain regulates bone growth and remodeling.	[Yan, Yu-xian; Gong, Yuan-wei; Guo, Yong; Guo, Chun; Li, Ruixin; Zhang, Xi-zheng] Acad Mil Med Sci, Inst Med Equipment, Tianjin, Peoples R China; [Yan, Yu-xian; Lv, Qi; Zhuang, Yan; Zhang, Yuan] Peoples Armed Police Forces, Coll Med, Expt Management Ctr, Tianjin, Peoples R China	Academy of Military Medical Sciences - China	Yan, YX (corresponding author), Acad Mil Med Sci, Inst Med Equipment, Tianjin, Peoples R China.	z56787@sohu.com		Lv, Qi/0000-0001-9076-7042	National Natural Science Foundation of China [10832012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation Key Program of China (No. 10832012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batra NN, 2005, J BIOMECH, V38, P1909, DOI 10.1016/j.jbiomech.2004.08.009; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Bikle DD, 1999, J BONE MINER METAB, V17, P233, DOI 10.1007/s007740050090; Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805; Burr DB, 1996, BONE, V18, P405, DOI 10.1016/8756-3282(96)00028-2; CARVALHO RS, 1995, ARCH ORAL BIOL, V40, P257, DOI 10.1016/0003-9969(95)98814-F; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Dufour C, 2007, EXP CELL RES, V313, P394, DOI 10.1016/j.yexcr.2006.10.021; Duquette TL, 2010, J ORTHOP SPORT PHYS, V40, P834, DOI 10.2519/jospt.2010.0421; Ehrlich PJ, 2002, OSTEOPOROSIS INT, V13, P688, DOI 10.1007/s001980200095; Fan M, 2006, J CELL PHYSIOL, V207, P454, DOI 10.1002/jcp.20581; FROST HM, 1992, BONE MINER, V19, P257, DOI 10.1016/0169-6009(92)90875-E; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; GOHEL AR, 1995, J HISTOCHEM CYTOCHEM, V43, P1085, DOI 10.1177/43.11.7560891; Goodyear LJ, 1996, AM J PHYSIOL-ENDOC M, V271, pE403, DOI 10.1152/ajpendo.1996.271.2.E403; Hatton JP, 2003, J BONE MINER RES, V18, P58, DOI 10.1359/jbmr.2003.18.1.58; HILLAM RA, 1995, J BONE MINER RES, V10, P683; Hu SH, 2004, AM J PHYSIOL-CELL PH, V287, pC1184, DOI 10.1152/ajpcell.00224.2004; HUGHESFULFORD M, 2004, SCI STKE, V249, pRE12; Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359; Isaksson H, 2006, J BIOMECH, V39, P1507, DOI 10.1016/j.jbiomech.2005.01.037; Joshi A, 2009, J NEPAL MED ASSOC, V48, P99, DOI 10.31729/jnma.176; Kapur S, 2003, BONE, V32, P241, DOI 10.1016/S8756-3282(02)00979-1; Kasten A, 2010, J CELL BIOCHEM, V111, P1586, DOI 10.1002/jcb.22890; Katz S, 2006, INT J BIOCHEM CELL B, V38, P2082, DOI 10.1016/j.biocel.2006.05.018; Kusumi A, 2009, J BONE MINER METAB, V27, P653, DOI 10.1007/s00774-009-0085-3; Lal H, 2007, J MOL CELL CARDIOL, V43, P137, DOI 10.1016/j.yjmcc.2007.05.012; Lau KHW, 2006, J BIOL CHEM, V281, P9576, DOI 10.1074/jbc.M509205200; Lee DY, 2010, J BIOL CHEM, V285, P30, DOI 10.1074/jbc.M109.010512; Liedert A, 2006, BIOCHEM BIOPH RES CO, V349, P1, DOI 10.1016/j.bbrc.2006.07.214; Liu J, 2006, BIOCHEM BIOPH RES CO, V348, P1167, DOI 10.1016/j.bbrc.2006.07.175; Luan XH, 2007, J HISTOCHEM CYTOCHEM, V55, P127, DOI 10.1369/jhc.6A7018.2006; Martin TJ, 2006, NAT MED, V12, P612, DOI 10.1038/nm0606-612; Matziolis Doerte, 2011, Open Orthop J, V5, P1, DOI 10.2174/1874325001105010001; Owan I, 1997, AM J PHYSIOL-CELL PH, V273, pC810, DOI 10.1152/ajpcell.1997.273.3.C810; Papachroni KK, 2006, TRENDS MOL MED, V15, P1471; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284; Perrien DS, 2006, J CLIN ENDOCR METAB, V91, P1848, DOI 10.1210/jc.2005-2423; Pommerenke H, 2002, J BONE MINER RES, V17, P603, DOI 10.1359/jbmr.2002.17.4.603; Puklin-Faucher E, 2009, J BIOL CHEM, V284, P36557, DOI 10.1074/jbc.M109.041194; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Rubin J, 2002, J BONE MINER RES, V17, P1452, DOI 10.1359/jbmr.2002.17.8.1452; Rubin J, 2006, GENE, V367, P1, DOI 10.1016/j.gene.2005.10.028; Sakata T, 2004, J BONE MINER RES, V19, P436, DOI 10.1359/JBMR.0301241; Shyy JY, 2002, CIRC RES, V91, P769, DOI 10.1161/01.RES.0000038487.19924.18; Silver FH, 2002, BIOMECH MODEL MECHAN, V1, P219, DOI 10.1007/s10237-002-0017-9; Sowa H, 2002, J BIOL CHEM, V277, P36024, DOI 10.1074/jbc.M206030200; Takahiro K, 2007, J CELL BIOCHEM, V101, P1266; Viola V, 2006, MOL CELL BIOL, V7, P265; Wang C, 2011, J BONE MINER METAB, V29, P466, DOI 10.1007/s00774-010-0244-6; Wang LA, 2010, CELL PHYSIOL BIOCHEM, V26, P1093, DOI 10.1159/000323987; Wiesmann Anne, 2006, Head Face Med, V2, P8, DOI 10.1186/1746-160X-2-8; Wozniak M, 2000, J BONE MINER RES, V15, P1731, DOI 10.1359/jbmr.2000.15.9.1731; Xi YT, 2006, EUR J HEART FAIL, V8, P16, DOI 10.1016/j.ejheart.2005.05.014; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Yoshida K, 2002, P NATL ACAD SCI USA, V99, P4580, DOI 10.1073/pnas.062053399; Zhao G, 2000, ENDOCRINOLOGY, V141, P2674, DOI 10.1210/en.141.7.2674; Ziros PG, 2002, J BIOL CHEM, V277, P23934, DOI 10.1074/jbc.M109881200	60	92	108	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35709	10.1371/journal.pone.0035709	http://dx.doi.org/10.1371/journal.pone.0035709			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539993	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341000059
J	Nogi, Y; Nagashima, M; Terasaki, M; Nohtomi, K; Watanabe, T; Hirano, T				Nogi, Yukinori; Nagashima, Masaharu; Terasaki, Michishige; Nohtomi, Kyoko; Watanabe, Takuya; Hirano, Tsutomu			Glucose-Dependent Insulinotropic Polypeptide Prevents the Progression of Macrophage-Driven Atherosclerosis in Diabetic Apolipoprotein E-Null Mice	PLOS ONE			English	Article							FOAM CELL-FORMATION; GASTRIC-INHIBITORY POLYPEPTIDE; GIP RECEPTOR EXPRESSION; E-DEFICIENT MICE; E-KNOCKOUT MICE; DOWN-REGULATION; LESION; INCRETINS; INFUSION	Aim: We recently reported that glucose-dependent insulinotropic polypeptide (GIP) prevents the development of atherosclerosis in apolipoprotein E-null (Apoe(-/-)) mice. GIP receptors (GIPRs) are found to be severely down-regulated in diabetic animals. We examined whether GIP can exert anti-atherogenic effects in diabetes. Methods: Nondiabetic Apoe(-/-) mice, streptozotocin-induced diabetic Apoe(-/-) mice, and db/db mice were administered GIP (25 nmol/kg/day) or saline (vehicle) through osmotic mini-pumps for 4 weeks. The animals were assessed for aortic atherosclerosis and for oxidized low-density lipoprotein-induced foam cell formation in exudate peritoneal macrophages. Results: Diabetic Apoe(-/-) mice of 21 weeks of age exhibited more advanced atherosclerosis than nondiabetic Apoe(-/-) mice of the same age. GIP infusion in diabetic Apoe(-/-) mice increased plasma total GIP levels by 4-fold without improving plasma insulin, glucose, or lipid profiles. GIP infusion significantly suppressed macrophage-driven atherosclerotic lesions, but this effect was abolished by co-infusions with [Pro 3] GIP, a GIPR antagonist. Foam cell formation was stimulated by 3-fold in diabetic Apoe(-/-) mice compared with their nondiabetic counterparts, but this effect was halved by GIP infusion. GIP infusion also attenuated the foam cell formation in db/db mice. In vitro treatment with GIP (1 nM) reduced foam cell formation by 15% in macrophages from diabetic Apoe(-/-) mice, and this attenuating effect was weaker than that attained by the same treatment of macrophages from nondiabetic counterparts (35%). While GIPR expression was reduced by only about a half in macrophages from diabetic mice, it was reduced much more dramatically in pancreatic islets from the same animals. Incubation with high glucose (500 mg/dl) for 9-10 days markedly reduced GIPR expression in pancreatic islet cells, but not in macrophages. Conclusions: Long-term infusion of GIP conferred significant anti-atherogenic effects in diabetic mice even though the GIPR expression in macrophages was mildly down-regulated in the diabetic state.	[Nogi, Yukinori; Nagashima, Masaharu; Terasaki, Michishige; Nohtomi, Kyoko; Hirano, Tsutomu] Showa Univ, Sch Med, Dept Med, Div Diabet Metab & Endocrinol, Tokyo 142, Japan; [Watanabe, Takuya] Univ Pharm & Life Sci, Lab Cardiovasc Med, Tokyo, Japan	Showa University	Hirano, T (corresponding author), Showa Univ, Sch Med, Dept Med, Div Diabet Metab & Endocrinol, Tokyo 142, Japan.	hirano@med.showa-u.ac.jp	Terasaki, Michishige/I-1659-2016	Terasaki, Michishige/0000-0002-7405-7419	Grants-in-Aid for Scientific Research [22590831] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Arakawa M, 2010, DIABETES, V59, P1030, DOI 10.2337/db09-1694; Ban K, 2009, J AM SOC HYPERTENS, V3, P245, DOI 10.1016/j.jash.2009.04.001; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; ELAHI D, 1994, REGUL PEPTIDES, V51, P63, DOI 10.1016/0167-0115(94)90136-8; Goto H, 2011, BIOCHEM BIOPH RES CO, V405, P79, DOI 10.1016/j.bbrc.2010.12.131; Gupta D, 2010, DIABETES, V59, P1445, DOI 10.2337/db09-1655; Hayek T, 2005, ATHEROSCLEROSIS, V183, P25, DOI 10.1016/j.atherosclerosis.2005.02.018; Kim W, 2008, PHARMACOL REV, V60, P470, DOI 10.1124/pr.108.000604; Lee S, 2010, ENDOCR J, V57, P119, DOI 10.1507/endocrj.K09E-269; Lynn FC, 2002, FASEB J, V16, P91, DOI 10.1096/fj.02-0243fje; Lynn FC, 2001, DIABETES, V50, P1004, DOI 10.2337/diabetes.50.5.1004; Matsubara J, 2012, J AM COLL CARDIOL, V59, P265, DOI 10.1016/j.jacc.2011.07.053; Matsui T, 2011, PHARMACOL RES, V63, P383, DOI 10.1016/j.phrs.2011.02.003; Mauerer R, 2009, EXP MOL MED, V41, P126, DOI 10.3858/emm.2009.41.2.015; Nagashima M, 2011, DIABETOLOGIA, V54, P2649, DOI 10.1007/s00125-011-2241-2; Nagashima M, 2010, ATHEROSCLEROSIS, V212, P70, DOI 10.1016/j.atherosclerosis.2010.04.027; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; Shah Z, 2011, CIRCULATION, V124, P2339, DOI 10.1161/CIRCULATIONAHA.111.041418; Shiraishi Y, 2008, J HYPERTENS, V26, P1955, DOI 10.1097/HJH.0b013e32830b61d8; Takeda Y, 2012, DIABETOLOGIA, V55, P404, DOI 10.1007/s00125-011-2365-4; Terasaki M, 2012, METABOLISM IN PRESS; Xu G, 2007, DIABETES, V56, P1551, DOI 10.2337/db06-1033; Xu G, 2009, CIRC RES, V105, P500, DOI 10.1161/CIRCRESAHA.109.193870; Zhou HY, 2005, BIOCHEM BIOPH RES CO, V335, P937, DOI 10.1016/j.bbrc.2005.07.164; Zhou J, 2007, AM J PHYSIOL-ENDOC M, V293, pE538, DOI 10.1152/ajpendo.00070.2007	25	51	54	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35683	10.1371/journal.pone.0035683	http://dx.doi.org/10.1371/journal.pone.0035683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536426	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339200098
J	Kawamura, S; Colozo, AT; Ge, L; Muller, DJ; Park, PSH				Kawamura, Shiho; Colozo, Alejandro T.; Ge, Lin; Mueller, Daniel J.; Park, Paul S. -H.			Structural, Energetic, and Mechanical Perturbations in Rhodopsin Mutant That Causes Congenital Stationary Night Blindness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMIC FORCE SPECTROSCOPY; PROTEIN-COUPLED RECEPTOR; NATIVE BOVINE RHODOPSIN; SCHIFF-BASE COUNTERION; MOLECULAR-INTERACTIONS; MEMBRANE-PROTEINS; RETINITIS-PIGMENTOSA; G90D RHODOPSIN; ACTIVATION; ADHESION	Several point mutations in rhodopsin cause retinal diseases including congenital stationary night blindness and retinitis pigmentosa. The mechanism by which a single amino acid residue substitution leads to dysfunction is poorly understood at the molecular level. A G90D point mutation in rhodopsin causes constitutive activity and leads to congenital stationary night blindness. It is unclear which perturbations the mutation introduces and how they can cause the receptor to be constitutively active. To reveal insight into these mechanisms, we characterized the perturbations introduced into dark state G90D rhodopsin from a transgenic mouse model expressing exclusively the mutant rhodopsin in rod photoreceptor cells. UV-visible absorbance spectroscopy revealed hydroxylamine accessibility to the chromophore-binding pocket of dark state G90D rhodopsin, which is not detected in dark state wild-type rhodopsin but is detected in light-activated wild-type rhodopsin. Single-molecule force spectroscopy suggested that the structural changes introduced by the mutation are small. Dynamic single-molecule force spectroscopy revealed that, compared with dark state wild-type rhodopsin, the G90D mutation decreased energetic stability and increased mechanical rigidity of most structural regions in the dark state mutant receptor. The observed structural, energetic, and mechanical changes in dark state G90D rhodopsin provide insights into the nature of perturbations caused by a pathological point mutation. Moreover, these changed properties observed for dark state G90D rhodopsin are consistent with properties expected for an active state.	[Kawamura, Shiho; Ge, Lin; Mueller, Daniel J.] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Colozo, Alejandro T.; Park, Paul S. -H.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Case Western Reserve University	Muller, DJ (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Mattenstr 26, CH-4058 Basel, Switzerland.	daniel.mueller@bsse.ethz.ch; paul.park@case.edu	Müller, Daniel J./A-5967-2010	Müller, Daniel J./0000-0003-3075-0665	National Institutes of Health [R00EY018085, R01EY021731, P30EY011373]; European Community [211800]; Deutsche Forschungsgemeinschaft; Ohio Lions Eye Research Foundation; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R00EY018085, P30EY011373, R01EY021731] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ohio Lions Eye Research Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R00EY018085, R01EY021731, and P30EY011373. This work was also supported by the European Community's Seventh Framework Programme FP7/2007-2013 Grant 211800, Deutsche Forschungsgemeinschaft, Research to Prevent Blindness (an unrestricted grant and career development award), and the Ohio Lions Eye Research Foundation.	Azevedo AW, 2011, J NEUROSCI, V31, P3670, DOI 10.1523/JNEUROSCI.4750-10.2011; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Bieri O, 1999, P NATL ACAD SCI USA, V96, P9597, DOI 10.1073/pnas.96.17.9597; BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Dietz H, 2004, P NATL ACAD SCI USA, V101, P16192, DOI 10.1073/pnas.0404549101; Dizhoor AM, 2008, J NEUROSCI, V28, P11662, DOI 10.1523/JNEUROSCI.4006-08.2008; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans E, 1998, FARADAY DISCUSS, V111, P1; Evans EB, 1999, BIOPHYS CHEM, V82, P83, DOI 10.1016/S0301-4622(99)00108-8; Fahmy K, 1996, BIOCHEMISTRY-US, V35, P15065, DOI 10.1021/bi961486s; Fanelli F, 2010, FASEB J, V24, P3196, DOI 10.1096/fj.09-151084; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Gether U, 1997, J BIOL CHEM, V272, P2587, DOI 10.1074/jbc.272.5.2587; Grater F, 2007, J STRUCT BIOL, V157, P557, DOI 10.1016/j.jsb.2006.11.005; Howard J., 2001, MECH MOTOR PROTEINS; Jager S, 1997, BIOCHEMISTRY-US, V36, P1999, DOI 10.1021/bi962320u; Janovjak H, 2008, CHEMPHYSCHEM, V9, P954, DOI 10.1002/cphc.200700662; Jastrzebska B, 2011, J BIOL CHEM, V286, P18930, DOI 10.1074/jbc.M111.234583; Javadpour MM, 1999, BIOPHYS J, V77, P1609, DOI 10.1016/S0006-3495(99)77009-8; Jin SN, 2003, NAT NEUROSCI, V6, P731, DOI 10.1038/nn1070; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; Kawamura S, 2010, BIOCHEMISTRY-US, V49, P10412, DOI 10.1021/bi101345x; Kedrov A, 2007, ANNU REV BIOPH BIOM, V36, P233, DOI 10.1146/annurev.biophys.36.040306.132640; Kim JM, 2004, P NATL ACAD SCI USA, V101, P12508, DOI 10.1073/pnas.0404519101; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Naash MI, 2004, J COMP NEUROL, V478, P149, DOI 10.1002/cne.20283; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Park PSH, 2012, CURR MED CHEM, V19, P1146; Park PSH, 2007, J BIOL CHEM, V282, P11377, DOI 10.1074/jbc.M610341200; Park PSH, 2009, BIOCHEMISTRY-US, V48, P4294, DOI 10.1021/bi900417b; Rader AJ, 2004, P NATL ACAD SCI USA, V101, P7246, DOI 10.1073/pnas.0401429101; RAO VR, 1994, NATURE, V367, P639, DOI 10.1038/367639a0; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Sapra KT, 2008, LANGMUIR, V24, P1330, DOI 10.1021/la702299z; Sapra KT, 2006, J MOL BIOL, V358, P255, DOI 10.1016/j.jmb.2006.02.008; SIEVING PA, 1995, P NATL ACAD SCI USA, V92, P880, DOI 10.1073/pnas.92.3.880; Sieving PA, 2001, J NEUROSCI, V21, P5449, DOI 10.1523/JNEUROSCI.21-15-05449.2001; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Sum CS, 2002, J BIOL CHEM, V277, P36188, DOI 10.1074/jbc.M201731200; Toledo D, 2011, J BIOL CHEM, V286, P39993, DOI 10.1074/jbc.M110.201517; Vogel R, 2002, BIOCHEMISTRY-US, V41, P3536, DOI 10.1021/bi016024f; WALD G, 1953, J GEN PHYSIOL, V37, P189, DOI 10.1085/jgp.37.2.189; Wilson MH, 2000, BIOCHEMISTRY-US, V39, P693, DOI 10.1021/bi9920275; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154; Zvyaga TA, 1996, BIOCHEMISTRY-US, V35, P7536, DOI 10.1021/bi960391n	47	20	22	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21826	21835		10.1074/jbc.M112.340182	http://dx.doi.org/10.1074/jbc.M112.340182			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22549882	hybrid, Green Published			2022-12-25	WOS:000306418600024
J	Yamashita, S; Miyaki, S; Kato, Y; Yokoyama, S; Sato, T; Barrionuevo, F; Akiyama, H; Scherer, G; Takada, S; Asahara, H				Yamashita, Satoshi; Miyaki, Shigeru; Kato, Yoshio; Yokoyama, Shigetoshi; Sato, Tempei; Barrionuevo, Francisco; Akiyama, Haruhiko; Scherer, Gerd; Takada, Shuji; Asahara, Hiroshi			L-Sox5 and Sox6 Proteins Enhance Chondrogenic miR-140 MicroRNA Expression by Strengthening Dimeric Sox9 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROCYTE-SPECIFIC ENHANCER; GENE-EXPRESSION; CARTILAGE FORMATION; RETINOIC ACID; COLLAGEN GENE; AGGRECAN GENE; IN-VIVO; TRANSCRIPTION; DIFFERENTIATION; MOUSE	Sox9 plays a critical role in early chondrocyte initiation and promotion as well as repression of later maturation. Fellow Sox family members L-Sox5 and Sox6 also function as regulators of cartilage development by boosting Sox9 activation of chondrocyte-specific genes such as Col2a1 and Agc1; however, the regulatory mechanism and other target genes are largely unknown. MicroRNAs are a class of short, non-coding RNAs that act as negative regulators of gene expression by promoting target mRNA degradation and/or repressing translation. Analysis of genetically modified mice identified miR-140 as a cartilage-specific microRNA that could be a critical regulator of cartilage development and homeostasis. Recent findings suggest Sox9 promotes miR-140 expression, although the detailed mechanisms are not fully understood. In this study we demonstrate that the proximal upstream region of pri-miR-140 has chondrogenic promoter activity in vivo. We found an L-Sox5/Sox6/Sox9 (Sox trio) response element and detailed binding site in the promoter region. Furthermore, detailed analysis suggests the DNA binding and/or transactivation ability of Sox9 as a homodimer is boosted by L-Sox5 and Sox6. These findings provide new insight into cartilage-specific gene regulation by the Sox trio.	[Yamashita, Satoshi; Yokoyama, Shigetoshi; Sato, Tempei; Takada, Shuji; Asahara, Hiroshi] Natl Res Inst Child Hlth & Dev, Dept Syst Biomed, Setagaya Ku, Tokyo 1578535, Japan; [Miyaki, Shigeru; Asahara, Hiroshi] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Kato, Yoshio] Natl Inst Adv Ind Sci & Technol, Res Inst Cell Engn, Tsukuba, Ibaraki 3058562, Japan; [Sato, Tempei; Asahara, Hiroshi] Tokyo Med & Dent Univ, Dept Syst Biomed, Bunkyo Ku, Tokyo 1138510, Japan; [Barrionuevo, Francisco] Univ Granada, Dept Genet, Ctr Biomed Res, Lab 127, ES-18100 Granada, Spain; [Akiyama, Haruhiko] Kyoto Univ, Grad Sch Med, Dept Orthoped, Kyoto 6068507, Japan; [Scherer, Gerd] Univ Freiburg, Inst Human Genet, D-79106 Freiburg, Germany; [Asahara, Hiroshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo, Japan	National Center for Child Health & Development - Japan; Scripps Research Institute; National Institute of Advanced Industrial Science & Technology (AIST); Tokyo Medical & Dental University (TMDU); University of Granada; Kyoto University; University of Freiburg; Japan Science & Technology Agency (JST)	Asahara, H (corresponding author), 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	asahara@scripps.edu	Kato, Yoshio/M-1093-2018; yokoyama, shigetoshi/S-5912-2016; Miyaki, Shigeru/E-4293-2013; Barrionuevo, Francisco/AAA-7639-2019	Kato, Yoshio/0000-0001-8584-367X; yokoyama, shigetoshi/0000-0003-4175-0548; Miyaki, Shigeru/0000-0002-1602-5777; Barrionuevo, Francisco/0000-0003-2651-1530; Takada, Shuji/0000-0002-9406-4683; Sato, Tempei/0000-0002-8966-3374	National Institutes of Health [AR050631, AR056120]; Health and Labor Sciences research grants; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Science and Technology Agency; Core Research for Evolutional Science and Technology; Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R56AR050631, R21AR056120, R01AR050631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health and Labor Sciences research grants(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR050631 and AR056120. This work was also supported by Health and Labor Sciences research grants, grants-in-aid for Scientific Research (Ministry of Education, Culture, Sports, Science, and Technology of Japan), and Japan Science and Technology Agency, Core Research for Evolutional Science and Technology. This work was also supported by a grant from the Deutsche Forschungsgemeinschaft (to G. S.).	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Arango NA, 1999, CELL, V99, P409, DOI 10.1016/S0092-8674(00)81527-5; Barrionuevo F, 2006, DEV BIOL, V295, P128, DOI 10.1016/j.ydbio.2006.03.014; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bernard P, 2003, HUM MOL GENET, V12, P1755, DOI 10.1093/hmg/ddg182; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bridgewater LC, 2003, NUCLEIC ACIDS RES, V31, P1541, DOI 10.1093/nar/gkg230; Bridgewater LC, 1998, J BIOL CHEM, V273, P14998, DOI 10.1074/jbc.273.24.14998; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Coustry F, 2010, NUCLEIC ACIDS RES, V38, P6018, DOI 10.1093/nar/gkq417; De Santa Barbara P, 1998, MOL CELL BIOL, V18, P6653, DOI 10.1128/MCB.18.11.6653; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Haag J, 2008, PATHOBIOLOGY, V75, P195, DOI 10.1159/000124980; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Kawakami Y, 2005, P NATL ACAD SCI USA, V102, P2414, DOI 10.1073/pnas.0407510102; Kou I, 2004, J BIOL CHEM, V279, P50942, DOI 10.1074/jbc.M406786200; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Miyaki S, 2010, GENE DEV, V24, P1173, DOI 10.1101/gad.1915510; Miyaki S, 2009, ARTHRITIS RHEUM-US, V60, P2723, DOI 10.1002/art.24745; Nakamura Y., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P321; Nakamura Y, 2012, APPL BIOCHEM BIOTECH, V166, P64, DOI 10.1007/s12010-011-9404-y; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Saito T, 2007, EMBO REP, V8, P504, DOI 10.1038/sj.embor.7400934; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Sock E, 2003, HUM MOL GENET, V12, P1439, DOI 10.1093/hmg/ddg158; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; Wilhelm D, 2007, J BIOL CHEM, V282, P10553, DOI 10.1074/jbc.M609578200; Xie WF, 1999, J BONE MINER RES, V14, P757, DOI 10.1359/jbmr.1999.14.5.757; Yamashita S, 2009, EXP CELL RES, V315, P2231, DOI 10.1016/j.yexcr.2009.03.008; Yang J, 2011, FEBS LETT, V585, P2992, DOI 10.1016/j.febslet.2011.08.013; Yokoyama S, 2008, GENE EXPR PATTERNS, V8, P155, DOI 10.1016/j.gep.2007.11.001; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zou WG, 2011, NAT CELL BIOL, V13, P59, DOI 10.1038/ncb2134	41	59	68	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22206	22215		10.1074/jbc.M112.343194	http://dx.doi.org/10.1074/jbc.M112.343194			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22547066	hybrid, Green Published			2022-12-25	WOS:000306418600059
J	Pompeo, F; Freton, C; Wicker-Planquart, C; Grangeasse, C; Jault, JM; Galinier, A				Pompeo, Frederique; Freton, Celine; Wicker-Planquart, Catherine; Grangeasse, Christophe; Jault, Jean-Michel; Galinier, Anne			Phosphorylation of CpgA Protein Enhances Both Its GTPase Activity and Its Affinity for Ribosome and Is Crucial for Bacillus subtilis Growth and Morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CRYOELECTRON MICROSCOPY; CRYSTAL-STRUCTURE; SER/THR KINASE; IN-VITRO; SUBUNIT; PRKC; DORMANCY; BINDING; YJEQ	In Bacillus subtilis, the ribosome-associated GTPase CpgA is crucial for growth and proper morphology and was shown to be phosphorylated in vitro by the Ser/Thr protein kinase PrkC. To further understand the function of the Escherichia coli RsgA ortholog, CpgA, we first demonstrated that its GTPase activity is stimulated by its association with the 30 S ribosomal subunit. Then the role of CpgA phosphorylation was analyzed. A single phosphorylated residue, threonine 166, was identified by mass spectrometry. Phosphoablative replacement of this residue in CpgA induces a decrease of both its affinity for the 30 S ribosomal subunit and its GTPase activity, whereas a phosphomimetic replacement has opposite effects. Furthermore, cells expressing a nonphosphorylatable CpgA protein present the morphological and growth defects similar to those of a cpgA-deleted strain. Altogether, our results suggest that CpgA phosphorylation on Thr-166 could modulate its ribosome-induced GTPase activity. Given the role of PrkC in B. subtilis spore germination, we propose that CpgA phosphorylation is a key regulatory process that is essential for B. subtilis development.	[Pompeo, Frederique] Aix Marseille Univ, CNRS, IMM, Lab Chim Bacterienne,UMR7283,FR 3479, F-13402 Marseille 20, France; [Wicker-Planquart, Catherine; Jault, Jean-Michel] Univ Grenoble 1, Inst Biol Struct JP Ebel, Commissariat Energie Atom, UMR 5075,CNRS, F-38027 Grenoble 1, France; [Grangeasse, Christophe] Univ Lyon 1, CNRS, Inst Biol & Chem Prot, Bases Mol & Struct Syst Infect,UMR 5086, F-69367 Lyon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Pompeo, F (corresponding author), Aix Marseille Univ, CNRS, IMM, Lab Chim Bacterienne,UMR7283,FR 3479, 31 Chemin J Aiguier, F-13402 Marseille 20, France.	fpompeo@ifr88.cnrs-mrs.fr	Pompeo, Frederique/Q-5772-2017; jault, jean-michel/G-2086-2012	jault, jean-michel/0000-0003-1743-2777; Grangeasse, Christophe/0000-0002-5484-4589	CNRS; Agence Nationale de la Recherche [ANR-08-BLAN-0143]; Universities of Aix-Marseille; Grenoble; Lyon	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Universities of Aix-Marseille; Grenoble(Region Auvergne-Rhone-Alpes); Lyon(Region Auvergne-Rhone-Alpes)	This work was supported by the CNRS, Agence Nationale de la Recherche "P-loop proteins" Grant ANR-08-BLAN-0143, and the Universities of Aix-Marseille, Grenoble and Lyon.	Absalon C, 2008, J BACTERIOL, V190, P3786, DOI 10.1128/JB.01994-07; Absalon C, 2009, MICROBIOL-SGM, V155, P932, DOI 10.1099/mic.0.022475-0; Achila D, 2012, J BIOL CHEM, V287, P8417, DOI 10.1074/jbc.M111.331322; Arigoni F, 1998, NAT BIOTECHNOL, V16, P851, DOI 10.1038/nbt0998-851; Campbell TL, 2005, BIOCHEM J, V389, P843, DOI 10.1042/BJ20041873; CHAMBON P, 1968, J BIOL CHEM, V243, P5110; Cladiere L, 2006, MOL GENET GENOMICS, V275, P409, DOI 10.1007/s00438-006-0097-9; Daigle DM, 2004, J BACTERIOL, V186, P1381, DOI 10.1128/JB.186.5.1381-1387.2004; Dworkin J, 2010, NAT REV MICROBIOL, V8, P890, DOI 10.1038/nrmicro2453; Fiuza M, 2008, J BIOL CHEM, V283, P18099, DOI 10.1074/jbc.M802615200; Gaidenko TA, 2002, J BACTERIOL, V184, P6109, DOI 10.1128/JB.184.22.6109-6114.2002; Goto S, 2011, EMBO J, V30, P104, DOI 10.1038/emboj.2010.291; Guo Q, 2011, P NATL ACAD SCI USA, V108, P13100, DOI 10.1073/pnas.1104645108; Himeno H, 2004, NUCLEIC ACIDS RES, V32, P5303, DOI 10.1093/nar/gkh861; Hunt A, 2006, MICROBIOL-SGM, V152, P2895, DOI 10.1099/mic.0.29152-0; Hwang J, 2006, MOL MICROBIOL, V61, P1660, DOI 10.1111/j.1365-2958.2006.05348.x; Inoue K, 2003, MOL MICROBIOL, V48, P1005, DOI 10.1046/j.1365-2958.2003.03475.x; Jomaa A, 2011, RNA, V17, P2026, DOI 10.1261/rna.2922311; KAMMANN M, 1989, NUCLEIC ACIDS RES, V17, P5404, DOI 10.1093/nar/17.13.5404; KUNST F, 1995, J BACTERIOL, V177, P2403, DOI 10.1128/jb.177.9.2403-2407.1995; Levdikov VM, 2004, J MOL BIOL, V340, P767, DOI 10.1016/j.jmb.2004.05.029; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; Macek B, 2007, MOL CELL PROTEOMICS, V6, P697, DOI 10.1074/mcp.M600464-MCP200; Madec E, 2003, J MOL BIOL, V330, P459, DOI 10.1016/S0022-2836(03)00579-5; Madec E, 2002, MOL MICROBIOL, V46, P571, DOI 10.1046/j.1365-2958.2002.03178.x; Matsuo Y, 2006, J BIOL CHEM, V281, P8110, DOI 10.1074/jbc.M512556200; Pietack N, 2010, J MOL MICROB BIOTECH, V18, P129, DOI 10.1159/000308512; Pompeo F, 2011, J MOL MICROB BIOTECH, V20, P156, DOI 10.1159/000329298; Sambrook J., 2002, MOL CLONING LAB MANU; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Schaefer L, 2006, J BACTERIOL, V188, P8252, DOI 10.1128/JB.01213-06; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; Shajani Z, 2011, ANNU REV BIOCHEM, V80, P501, DOI 10.1146/annurev-biochem-062608-160432; Shin DH, 2004, P NATL ACAD SCI USA, V101, P13198, DOI 10.1073/pnas.0405202101; Squeglia F, 2011, J AM CHEM SOC, V133, P20676, DOI 10.1021/ja208080r; Wicker-Planquart C, 2008, J BACTERIOL, V190, P681, DOI 10.1128/JB.01193-07; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3	38	14	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20830	20838		10.1074/jbc.M112.340331	http://dx.doi.org/10.1074/jbc.M112.340331			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22544754	hybrid, Green Published			2022-12-25	WOS:000306416800005
J	Liu, W; Vogt, CA; Luo, JY; He, GM; Frank, KA; Liu, JG				Liu, Wei; Vogt, Christine A.; Luo, Junyan; He, Guangming; Frank, Kenneth A.; Liu, Jianguo			Drivers and Socioeconomic Impacts of Tourism Participation in Protected Areas	PLOS ONE			English	Article							WOLONG NATURE-RESERVE; HOUSEHOLD STRATEGIES; ECOTOURISM; CONSERVATION; MANAGEMENT; FRAMEWORK; BENEFITS; HABITAT; CYCLE; MODEL	Nature-based tourism has the potential to enhance global biodiversity conservation by providing alternative livelihood strategies for local people, which may alleviate poverty in and around protected areas. Despite the popularity of the concept of nature-based tourism as an integrated conservation and development tool, empirical research on its actual socioeconomic benefits, on the distributional pattern of these benefits, and on its direct driving factors is lacking, because relevant long-term data are rarely available. In a multi-year study in Wolong Nature Reserve, China, we followed a representative sample of 220 local households from 1999 to 2007 to investigate the diverse benefits that these households received from recent development of nature-based tourism in the area. Within eight years, the number of households directly participating in tourism activities increased from nine to sixty. In addition, about two-thirds of the other households received indirect financial benefits from tourism. We constructed an empirical household economic model to identify the factors that led to household-level participation in tourism. The results reveal the effects of local households' livelihood assets (i.e., financial, human, natural, physical, and social capitals) on the likelihood to participate directly in tourism. In general, households with greater financial (e.g., income), physical (e.g., access to key tourism sites), human (e.g., education), and social (e.g., kinship with local government officials) capitals and less natural capital (e.g., cropland) were more likely to participate in tourism activities. We found that residents in households participating in tourism tended to perceive more non-financial benefits in addition to more negative environmental impacts of tourism compared with households not participating in tourism. These findings suggest that socioeconomic impact analysis and change monitoring should be included in nature-based tourism management systems for long-term sustainability of protected areas.	[Liu, Wei; Luo, Junyan; He, Guangming; Frank, Kenneth A.; Liu, Jianguo] Michigan State Univ, Dept Fisheries & Wildlife, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48824 USA; [Vogt, Christine A.] Michigan State Univ, Dept Commun Agr Recreat & Resource Studies, E Lansing, MI 48824 USA; [Frank, Kenneth A.] Michigan State Univ, Dept Counseling Educ Psychol & Special Educ, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Liu, W (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48824 USA.	wliu@helppanda.org	Liu, Jianguo/G-5211-2015	Liu, Jianguo/0000-0001-6344-0087	National Science Foundation (NSF) [0709717, OISE-0729709]; National Aeronautics and Space Administration (NASA) [NNX08AL04G]	National Science Foundation (NSF)(National Science Foundation (NSF)); National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA))	Funding for this research was provided by National Science Foundation (NSF Award Numbers 0709717 and OISE-0729709) and National Aeronautics and Space Administration (NASA Award Number NNX08AL04G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An L, 2002, ECOL ECON, V42, P445, DOI 10.1016/S0921-8009(02)00126-X; An L, 2001, ECOL MODEL, V140, P31, DOI 10.1016/S0304-3800(01)00267-8; [Anonymous], 2010, CONSERVATION TOURISM; Balmford A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000144; Berkes F, 2004, CONSERV BIOL, V18, P621, DOI 10.1111/j.1523-1739.2004.00077.x; Bookbinder MP, 1998, CONSERV BIOL, V12, P1399, DOI 10.1046/j.1523-1739.1998.97229.x; Brown K, 2002, GEOGR J, V168, P6, DOI 10.1111/1475-4959.00034; Buckley R, 2011, ANNU REV ENV RESOUR, V36, P397, DOI 10.1146/annurev-environ-041210-132637; BUTLER RW, 1980, CAN GEOGR-GEOGR CAN, V24, P5, DOI 10.1111/j.1541-0064.1980.tb00970.x; Butler RW, 2006, TOURISM AREA LIFE CY; Coria J, 2012, ECOL ECON, V73, P47, DOI 10.1016/j.ecolecon.2011.10.024; Department for International Development (DFID), 1999, SUST LIV GUID SHEETS; Ellis F, 1998, J DEV STUD, V35, P1, DOI 10.1080/00220389808422553; Ellis Frank, 2000, RURAL LIVELIHOODS DI; ESRI, 2009, ARCGIS 9 3; Ghimire KB, SOCIAL CHANGE CONSER; Ghimire KB, 1994, CONSERVATION SOCIAL; Grumbine RE, 2011, BIOL CONSERV, V144, P1347, DOI 10.1016/j.biocon.2011.03.006; Haggblade S., 2007, TRANSFORMING RURAL N; He GM, 2008, ENVIRON MANAGE, V42, P1017, DOI 10.1007/s00267-008-9214-3; Hirano K., 2001, HLTH SERVICES OUTCOM, V2, P259, DOI [10.1023/A:1020371312283, DOI 10.1023/A:1020371312283]; Hughes R., 2001, INTEGRATING CONSERVA; IUCN, 2006, SICH GIANT PAND SANC; IUCN and UNEP-WCMC, 2011, WORLD DAT PROT AR WD; Kinzig AP, 2011, SCIENCE, V334, P603, DOI 10.1126/science.1210297; Kiss A, 2004, TRENDS ECOL EVOL, V19, P232, DOI 10.1016/j.tree.2004.03.010; Kruger O, 2005, BIODIVERS CONSERV, V14, P579, DOI 10.1007/s10531-004-3917-4; Li C., 1992, ANIMAL PLANT RESOURC; Li C, 1992, ANIMAL PLANT RESOURC; Li W., 1989, CHINAS NATURE RESERV; Li WJ, 2001, AMBIO, V30, P62, DOI 10.1639/0044-7447(2001)030[0062:EMICSN]2.0.CO;2; Liu JG, 2003, SCIENCE, V300, P1240, DOI 10.1126/science.1078868; Liu JG, 2003, NATURE, V421, P530, DOI 10.1038/nature01359; Liu JG, 1999, POPUL ENVIRON, V21, P45, DOI 10.1023/A:1022101026466; Liu JG, 1999, CONSERV BIOL, V13, P1360, DOI 10.1046/j.1523-1739.1999.98418.x; Liu JG, 2001, SCIENCE, V292, P98, DOI 10.1126/science.1058104; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; Liu JG, 2008, SCIENCE, V319, P37, DOI 10.1126/science.1150416; Liu JG, 2007, SCIENCE, V317, P1513, DOI 10.1126/science.1144004; Lovejoy TE, 2006, TRENDS ECOL EVOL, V21, P329, DOI 10.1016/j.tree.2006.04.005; MA, 2005, ECOSYSTEMS HUMAN WEL; McShane T.O., 2004, GETTING BIODIVERSITY, P49; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Newsome D., 2012, NATURAL AREA TOURISM, V2nd edn, DOI [10.21832/9781845413835, DOI 10.21832/9781845413835]; Reardon T., 2007, TRANSFORMING RURAL N, P115; ROSENBAUM PR, 1987, J AM STAT ASSOC, V82, P387, DOI 10.2307/2289440; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Ross K.A., 2009, ENCYCL DATABASE SYST, P532, DOI [DOI 10.1007/978-0-387-39940-9_565, 10.1007/978-0-387-39940-9]; Rural Survey Department of National Bureau of Statistics, 2000, POV MON REP RUR CHIN; Rural Survey Department of National Bureau of Statistics, 2007, POV MON REP RUR CHIN; Salafsky N, 2000, WORLD DEV, V28, P1421, DOI 10.1016/S0305-750X(00)00031-0; Schaller G.B., 1985, GIANT PANDAS WOLONG; Schaller GB, 1994, LAST PANDA; Scheyvens R, 1999, TOURISM MANAGE, V20, P245, DOI 10.1016/S0261-5177(98)00069-7; Scoones I., 1998, Working Paper - Institute of Development Studies, University of Sussex; Secretariat of the Convention on Biological Diversity, 2010, GLOB BIOD OUTL 3; Sekercioglu CH, 2002, ENVIRON CONSERV, V29, P282, DOI 10.1017/S0376892902000206; Singh I., 1986, Agricultural household models. Extensions, applications, and policy, P17; Spiteri A, 2006, ENVIRON MANAGE, V37, P1, DOI 10.1007/s00267-004-0311-7; Stem CJ, 2003, SOC NATUR RESOUR, V16, P387, DOI 10.1080/08941920309177; Su BR, 2011, TOURISM MANAGE, V32, P1438, DOI 10.1016/j.tourman.2010.12.005; Timothy D. J., 2002, Tourism and development: concepts and issues, P149; UNED-UK, 1999, GEND TOUR WOM EMPL P; United Nations World Tourism Organization, 2001, TOUR 2020 VIS; UNWTO, 2010, TOUR MILL DEV GOALS; Vina A, 2011, AMBIO, V40, P274, DOI 10.1007/s13280-010-0098-0; Wallace C, 2002, SOCIOLOGY, V36, P275, DOI 10.1177/0038038502036002003; Walpole MJ, 2000, ANN TOURISM RES, V27, P559, DOI 10.1016/S0160-7383(99)00088-2; Weaver DB, 2007, TOURISM MANAGE, V28, P1168, DOI 10.1016/j.tourman.2007.03.004; Wells MP., 2004, GETTING BIODIVERSITY, P232, DOI [10.7312/mcsh12764-013, DOI 10.7312/MCSH12764-013]; Wheelock J, 1996, J ECON ISSUES, V30, P143, DOI 10.1080/00213624.1996.11505770; Wolong Administration Bureau, 2009, WOL NAT NAT RES EC D; Wolong Administration Bureau, 2004, CHRON WOL NAT RES; Wolong Administration Bureau Department of Social and Economic Development, 2006, ANN REP RUR EC WOL N; Wolong Nature Reserve Administration Bureau Department of Biology at Nanchong Normal University Conservation Bureau of Sichuan Department of Forestry, 1987, WOL VEG RES PLANTS; Wunder S, 2000, ECOL ECON, V32, P465, DOI 10.1016/S0921-8009(99)00119-6; Wunder S, 2005, PAYMENTS ENV SERVICE, DOI DOI 10.17528/CIFOR/001760; Xie Y, 2004, CHINAS PROTECTED ARE; Zhong LS, 2008, TOURISM MANAGE, V29, P841, DOI 10.1016/j.tourman.2007.10.002	79	98	102	2	164	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35420	10.1371/journal.pone.0035420	http://dx.doi.org/10.1371/journal.pone.0035420			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VP	22558149	Green Submitted, gold, Green Published			2022-12-25	WOS:000305345200039
J	Masini, MA; Albi, E; Barmo, C; Bonfiglio, T; Bruni, L; Canesi, L; Cataldi, S; Curcio, F; D'Amora, M; Ferri, I; Goto, K; Kawano, F; Lazzarini, R; Loreti, E; Nakai, N; Ohira, T; Ohira, Y; Palmero, S; Prato, P; Ricci, F; Scarabelli, L; Shibaguchi, T; Spelat, R; Strollo, F; Ambesi-Impiombato, FS				Masini, Maria Angela; Albi, Elisabetta; Barmo, Cristina; Bonfiglio, Tommaso; Bruni, Lara; Canesi, Laura; Cataldi, Samuela; Curcio, Francesco; D'Amora, Marta; Ferri, Ivana; Goto, Katsumasa; Kawano, Fuminori; Lazzarini, Remo; Loreti, Elisabetta; Nakai, Naoya; Ohira, Takashi; Ohira, Yoshinobu; Palmero, Silvio; Prato, Paola; Ricci, Franco; Scarabelli, Linda; Shibaguchi, Tsubasa; Spelat, Renza; Strollo, Felice; Ambesi-Impiombato, Francesco Saverio			The Impact of Long-Term Exposure to Space Environment on Adult Mammalian Organisms: A Study on Mouse Thyroid and Testis	PLOS ONE			English	Article							SIMULATED MICROGRAVITY; THYROTROPIN RECEPTOR; HORMONE RECEPTOR; LIPID RAFTS; RAT TESTIS; CELL; SPERMATOGENESIS; GROWTH; MICE; TESTOSTERONE	Hormonal changes in humans during spaceflight have been demonstrated but the underlying mechanisms are still unknown. To clarify this point thyroid and testis/epididymis, both regulated by anterior pituitary gland, have been analyzed on long-term space-exposed male C57BL/10 mice, either wild type or pleiotrophin transgenic, overexpressing osteoblast stimulating factor-1. Glands were submitted to morphological and functional analysis. In thyroids, volumetric ratios between thyrocytes and colloid were measured. cAMP production in 10(-7) M and 10(-8) M thyrotropin-treated samples was studied. Thyrotropin receptor and caveolin-1 were quantitized by immunoblotting and localized by immunofluorescence. In space-exposed animals, both basal and thyrotropin-stimulated cAMP production were always higher. Also, the structure of thyroid follicles appeared more organized, while thyrotropin receptor and caveolin-1 were overexpressed. Unlike the control samples, in the space samples thyrotropin receptor and caveolin-1 were both observed at the intracellular junctions, suggesting their interaction in specific cell membrane microdomains. In testes, immunofluorescent reaction for 3 beta-steroid dehydrogenase was performed and the relative expressions of hormone receptors and interleukin-1 beta were quantified by RT-PCR. Epididymal sperm number was counted. In space-exposed animals, the presence of 3 beta and 17 beta steroid dehydrogenase was reduced. Also, the expression of androgen and follicle stimulating hormone receptors increased while lutenizing hormone receptor levels were not affected. The interleukin 1 beta expression was upregulated. The tubular architecture was altered and the sperm cell number was significantly reduced in spaceflight mouse epididymis (approx. -90% vs. laboratory and ground controls), indicating that the space environment may lead to degenerative changes in seminiferous tubules. Space-induced changes of structure and function of thyroid and testis/epididymis could be responsible for variations of hormone levels in human during space missions. More research, hopefully a reflight of MDS, would be needed to establish whether the space environment acts directly on the peripheral glands or induces changes in the hypotalamus-pituitary-glandular axis.	[Masini, Maria Angela; Barmo, Cristina; Bonfiglio, Tommaso; Bruni, Lara; Canesi, Laura; D'Amora, Marta; Prato, Paola; Scarabelli, Linda] Univ Genoa, DIPTERIS, Genoa, Italy; [Albi, Elisabetta; Cataldi, Samuela; Lazzarini, Remo] Univ Perugia, Dept Clin & Expt Med, I-06100 Perugia, Italy; [Curcio, Francesco; Spelat, Renza; Ambesi-Impiombato, Francesco Saverio] Univ Udine, Dept Clin & Biol Sci, I-33100 Udine, Italy; [Ferri, Ivana; Loreti, Elisabetta] Univ Perugia, Inst Pathol Anat & Histol, I-06100 Perugia, Italy; [Goto, Katsumasa] Toyohashi SOZO Univ, Sch Hlth Sci, Aichi, Japan; [Kawano, Fuminori; Nakai, Naoya; Ohira, Yoshinobu] Osaka Univ, Grad Sch Med, Osaka, Japan; [Ohira, Takashi; Ohira, Yoshinobu; Shibaguchi, Tsubasa] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; [Palmero, Silvio] Univ Genoa, DIBIO, Genoa, Italy; [Ricci, Franco] ENEA CR Casaccia, Rome, Italy; [Strollo, Felice] INRCA IRCCS, Rome, Italy	University of Genoa; University of Perugia; University of Udine; University of Perugia; Osaka University; Osaka University; University of Genoa; Italian National Agency New Technical Energy & Sustainable Economics Development; IRCCS INRCA	Masini, MA (corresponding author), Univ Genoa, DIPTERIS, Genoa, Italy.	ambesi@uniud.it	Goto, Katsumasa/T-6789-2019; d'Amora, Marta/A-1226-2014; Strollo, Felice/AAZ-4861-2020; Curcio, Francesco/K-4669-2014; Spelat, Renza/AAZ-2980-2021; Bonfiglio, Tommaso/AAB-2579-2019; Albi, Elisabetta/K-3369-2016	Goto, Katsumasa/0000-0001-5380-4561; Spelat, Renza/0000-0001-5794-8976; CURCIO, Francesco/0000-0002-9070-4807; Albi, Elisabetta/0000-0002-5745-5343; d'Amora, Marta/0000-0001-6234-8078; Canesi, Laura/0000-0003-2061-3819	ASI (Agenzia Spaziale Italiana)	ASI (Agenzia Spaziale Italiana)(Agenzia Spaziale Italiana (ASI))	The authors acknowledge that this work has been partially funded by ASI (Agenzia Spaziale Italiana). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Albi E, 2011, ASTROBIOLOGY, V11, P57, DOI 10.1089/ast.2010.0519; Albi E, 2010, ASTROBIOLOGY, V10, P811, DOI 10.1089/ast.2010.0461; AMANN RP, 1992, J APPL PHYSIOL, V73, pS174, DOI 10.1152/jappl.1992.73.2.S174; Guazzone VA, 2009, MICROSC RES TECHNIQ, V72, P620, DOI 10.1002/jemt.20704; Bergh A, 2001, BIOL REPROD, V64, P13, DOI 10.1095/biolreprod64.1.13; Calebiro D, 2006, MOL ENDOCRINOL, V20, P3196, DOI 10.1210/me.2005-0493; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Cancedda R, 2002, J GRAVIT PHYSL, V9, P337; Cascianelli G, 2008, MOL BIOL CELL, V19, P5289, DOI 10.1091/mbc.E08-05-0517; COONS AH, 1955, J EXP MED, V102, P49, DOI 10.1084/jem.102.1.49; Del Conte E, 1975, CELL PATHOL, V18, P297; Dufau ML, 1998, ANNU REV PHYSIOL, V60, P461, DOI 10.1146/annurev.physiol.60.1.461; Elmlinger MW, 2001, CLIN CHEM LAB MED, V39, P973, DOI 10.1515/CCLM.2001.158; FEDOROVA N. L., 1967, KOSM BIOL MED, V1, P28; Graves PN, 1996, ENDOCRINOLOGY, V137, P3915, DOI 10.1210/en.137.9.3915; Hartoft-Nielsen ML, 2005, J ANAT, V207, P117, DOI 10.1111/j.1469-7580.2005.00442.x; Helmreich DL, 2005, NEUROENDOCRINOLOGY, V81, P183, DOI 10.1159/000087001; Kamiya H, 2003, J ANDROL, V24, P885; Kholodenko BN, 2008, CELL, V133, P566, DOI 10.1016/j.cell.2008.04.033; Latif R, 2007, ENDOCRINOLOGY, V148, P3164, DOI 10.1210/en.2006-1580; Latif R, 2003, ENDOCRINOLOGY, V144, P4725, DOI 10.1210/en.2003-0932; Lee PA, 1998, J UROLOGY, V160, P1155, DOI 10.1016/S0022-5347(01)62724-1; Li GX, 2001, J VET MED SCI, V63, P373, DOI 10.1292/jvms.63.373; Loukil L Hadjkacem, 2005, Arch Inst Pasteur Tunis, V82, P47; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu NZ, 2006, PHARMACOL REV, V58, P782, DOI 10.1124/pr.58.4.9; Lysiak JJ, 2003, BIOL REPROD, V69, P202, DOI 10.1095/biolreprod.102.013318; Masuda H, 1997, BIOCHEM BIOPH RES CO, V238, P528, DOI 10.1006/bbrc.1997.7188; McLachlan RI, 2002, J ANDROL, V23, P149; MERRILL AH, 1992, J APPL PHYSIOL, V73, pS132, DOI 10.1152/jappl.1992.73.2.S132; MIDGLEY J E M, 1985, Nuclear Medizin, V24, P57; Miguel J, 1978, PHYSIOLOGIST, V21, P80; Motabagani MAH, 2007, CHINESE J PHYSIOL, V50, P199; Neves SR, 2008, CELL, V133, P666, DOI 10.1016/j.cell.2008.04.025; Ozen OA, 2005, TOXICOL IND HEALTH, V21, P249, DOI 10.1191/0748233705th235oa; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philpott D E, 1985, Physiologist, V28, pS211; PHILPOTT DE, 1983, SCAN ELECTRON MICROS, P1345; SAPP WJ, 1992, ADV SPACE RES-SERIES, V12, P179, DOI 10.1016/0273-1177(92)90106-8; SAPP WJ, 1990, FASEB J, V4, P101, DOI 10.1096/fasebj.4.1.2295370; Serova L V, 1989, Physiologist, V32, pS29; Serova Lyubov V., 1993, Physiologist, V36, P31; Sharma CS, 2008, MOL CELL BIOCHEM, V313, P71, DOI 10.1007/s11010-008-9743-3; Simoni M, 1997, ENDOCR REV, V18, P739, DOI 10.1210/er.18.6.739; Tash JS, 2002, J APPL PHYSIOL, V92, P1191, DOI 10.1152/japplphysiol.00931.2001; Uva B M, 2005, J Endocrinol Invest, V28, P84; VASSART G, 1992, ENDOCR REV, V13, P596, DOI 10.1210/er.13.3.596; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Yang XB, 2003, J BONE MINER RES, V18, P47, DOI 10.1359/jbmr.2003.18.1.47; ZIRKIN BR, 1989, ENDOCRINOLOGY, V124, P3043, DOI 10.1210/endo-124-6-3043	50	28	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35418	10.1371/journal.pone.0035418	http://dx.doi.org/10.1371/journal.pone.0035418			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558148	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345200038
J	Abramson, DH; Marr, BP; Brodie, SE; Dunkel, I; Palioura, S; Gobin, YP				Abramson, David H.; Marr, Brian P.; Brodie, Scott E.; Dunkel, Ira; Palioura, Sotiria; Gobin, Y. Pierre			Ophthalmic Artery Chemosurgery for Less Advanced Intraocular Retinoblastoma: Five Year Review	PLOS ONE			English	Review							RADIATION-THERAPY; CHEMOTHERAPY; MANAGEMENT; CHEMOREDUCTION; RADIOTHERAPY; OTOTOXICITY; FAILURE	Background: Ophthalmic artery chemosurgery (OAC) for retinoblastoma was introduced by us 5 years ago for advanced intraocular retinoblastoma. Because the success was higher than with existing alternatives and systemic side effects limited we have now treated less advanced intraocular retinoblastoma (Reese-Ellsworth (RE) I-III and International Classification Retinoblastoma (ICRB) B and C). Methodology/Principal Findings: Retrospective review of 5 year experience in eyes with Reese Ellsworth (Table 1) I (7 eyes), II (6 eyes) or III (6 eyes) and/or International Classification (Table 2) B (19 eyes) and C (11 eyes) treated with OAC (melphalan with or without topotecan) introduced directly into the ophthalmic artery. Patient survival was 100%. Ocular event-free survival was 100% for Reese-Ellsworth Groups I, II and III (and 96% for ICRB B and C) at a median of 16 months follow-up. One ICRB Group C (Reese-Ellsworth Vb) eye could not be treated on the second attempt for technical reasons and was therefore enucleated. No patient required a port and only one patient required transfusion of blood products. The electroretinogram (ERG) was unchanged or improved in 14/19 eyes. Conclusions/Significance: Ophthalmic artery chemosurgery for retinoblastoma that was Reese-Ellsworth I, II and III (or International Classification B or C) was associated with high success (100% of treatable eyes were retained) and limited toxicity with results that equal or exceed conventional therapy with less toxicity.	[Abramson, David H.; Marr, Brian P.; Brodie, Scott E.; Palioura, Sotiria] Mem Sloan Kettering Canc Ctr, Ophthalm Oncol Serv, New York, NY 10021 USA; [Brodie, Scott E.] Mt Sinai Sch Med, Dept Ophthalmol, New York, NY USA; [Dunkel, Ira] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [Palioura, Sotiria] Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA; [Gobin, Y. Pierre] Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Gobin, Y. Pierre] Weill Cornell Med Coll, Dept Neurosurg, New York, NY USA	Memorial Sloan Kettering Cancer Center; Icahn School of Medicine at Mount Sinai; Memorial Sloan Kettering Cancer Center; Harvard University; Massachusetts Eye & Ear Infirmary; Cornell University; Cornell University	Abramson, DH (corresponding author), Mem Sloan Kettering Canc Ctr, Ophthalm Oncol Serv, 1275 York Ave, New York, NY 10021 USA.	abramsod@mskcc.org		Dunkel, Ira/0000-0001-8091-6067; Brodie, Scott/0000-0002-3303-4552	Fund for Ophthalmic Knowledge; Alcon Research Institute	Fund for Ophthalmic Knowledge; Alcon Research Institute(Novartis)	This work was supported by grants from the Fund for Ophthalmic Knowledge and the Alcon Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson DH, 2008, OPHTHALMOLOGY, V115, P1398, DOI 10.1016/j.ophtha.2007.12.014; Abramson DH, 2010, BRIT J OPHTHALMOL, V94, P396, DOI 10.1136/bjo.2009.174268; Abramson DH, 2010, ARCH OPHTHALMOL-CHIC, V128, P370, DOI 10.1001/archophthalmol.2010.7; Abramson DH, 2004, OPHTHALMOLOGY, V111, P984, DOI 10.1016/j.ophtha.2003.08.035; ABRAMSON DH, 1981, ARCH OPHTHALMOL-CHIC, V99, P1761; Bhagat SP, 2010, INT J PEDIATR OTORHI, V74, P1156, DOI 10.1016/j.ijporl.2010.07.004; Brodie SE, 2009, DOC OPHTHALMOL, V119, P13, DOI 10.1007/s10633-008-9164-3; CASSADY JR, 1969, RADIOLOGY, V93, P405, DOI 10.1148/93.2.405; EGBERT PR, 1978, ARCH OPHTHALMOL-CHIC, V96, P1826; Friedman DL, 2000, J CLIN ONCOL, V18, P12, DOI 10.1200/JCO.2000.18.1.12; Gobin YP, 2011, ARCH OPHTHALMOL-CHIC, V129, P732, DOI 10.1001/archophthalmol.2011.5; Gombos DS, 2007, OPHTHALMOLOGY, V114, P1378, DOI 10.1016/j.ophtha.2007.03.074; Gunduz K, 2004, OPHTHALMOLOGY, V111, P1917, DOI 10.1016/j.ophtha.2004.04.016; Hernandez JC, 1996, INT J RADIAT ONCOL, V35, P125, DOI 10.1016/S0360-3016(96)85020-6; Jehanne M, 2009, PEDIATR BLOOD CANCER, V52, P637, DOI 10.1002/pbc.21898; KANEKO A, 1990, Rinsho Ganka, V44, P289; Kim Jeong Hun, 2003, Korean J Ophthalmol, V17, P35; Kim JW, 2007, DRUGS, V67, P2173, DOI 10.2165/00003495-200767150-00005; MCCORMICK B, 1988, INT J RADIAT ONCOL, V15, P567, DOI 10.1016/0360-3016(88)90296-9; Munier FL, 2011, RETINA-J RET VIT DIS, V31, P566, DOI 10.1097/IAE.0b013e318203c101; Oktay K, 2009, NEW ENGL J MED, V185, P2430; Liberman PHP, 2011, CLIN TRANSL ONCOL, V13, P348, DOI 10.1007/s12094-011-0665-2; REESE AB, 1958, ARCH OPHTHALMOL-CHIC, V60, P897; Rizzuti AE, 2008, ARCH OPHTHALMOL-CHIC, V126, P862, DOI 10.1001/archopht.126.6.862; Shields CL, 2011, ARCH OPHTHALMOL-CHIC, V150, pE1; Suzuki S, 2011, OPHTHALMOLOGY, V118, P2081, DOI 10.1016/j.ophtha.2011.03.013; Toral-Martinnon Rene, 2006, Cir Cir, V74, P79; Vajzovic LM, 2011, CLIN OPHTHALMOL, V5, P171, DOI 10.2147/OPTH.S12665	28	46	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e34120	10.1371/journal.pone.0034120	http://dx.doi.org/10.1371/journal.pone.0034120			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545080	gold, Green Published			2022-12-25	WOS:000305343200003
J	Benova, L; Fielding, K; Greig, J; Nyang'wa, BT; Casas, EC; da Fonseca, MS; du Cros, P				Benova, Lenka; Fielding, Katherine; Greig, Jane; Nyang'wa, Bern-Thomas; Casas, Esther Carrillo; da Fonseca, Marcio Silveira; du Cros, Philipp			Association of BMI Category Change with TB Treatment Mortality in HIV-Positive Smear-Negative and Extrapulmonary TB Patients in Myanmar and Zimbabwe	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; RISK-FACTORS; SETTINGS; THERAPY; HAART; RATES; GAIN	Objective: The HIV epidemic has increased the proportion of patients with smear-negative and extrapulmonary tuberculosis (TB) diagnoses, with related higher rates of poor TB treatment outcomes. Unlike in smear-positive pulmonary TB, no interim markers of TB treatment progress are systematically used to identify individuals most at risk of mortality. The objective of this study was to assess the association of body mass index (BMI) change at 1 month (+/- 15 days) from TB treatment start with mortality among HIV-positive individuals with smear-negative and extrapulmonary TB. Methods and Findings: A retrospective cohort study of adult HIV-positive new TB patients in Medecins Sans Frontieres (MSF) treatment programmes in Myanmar and Zimbabwe was conducted using Cox proportional hazards regression to estimate the association between BMI category change and mortality. A cohort of 1090 TB patients (605 smear-negative and 485 extrapulmonary) was followed during TB treatment with mortality rate of 28.9 per 100 person-years. In multivariable analyses, remaining severely underweight or moving to a lower BMI category increased mortality (adjusted hazard ratio 4.05, 95% confidence interval 2.77-5.91, p<0.001) compared with remaining in the same or moving to a higher BMI category. Conclusions: We found a strong association between BMI category change during the first month of TB treatment and mortality. BMI category change could be used to identify individuals most at risk of mortality during TB treatment among smear-negative and extrapulmonary patients.	[Benova, Lenka; Fielding, Katherine] London Sch Hyg & Trop Med, London WC1, England; [Greig, Jane; Nyang'wa, Bern-Thomas; du Cros, Philipp] Med Sans Frontieres, London, England; [Casas, Esther Carrillo; da Fonseca, Marcio Silveira] Med Sans Frontieres, Amsterdam, Netherlands	University of London; London School of Hygiene & Tropical Medicine; Doctors Without Borders; Doctors Without Borders	Benova, L (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	lenka.benova@lshtm.ac.uk	Nyang'wa, Bern-Thomas/AAA-9545-2022	Nyang'wa, Bern-Thomas/0000-0001-9915-5878; Greig, Jane/0000-0003-2732-0023; du Cros, Philipp/0000-0002-3599-029X; Fielding, Katherine/0000-0002-6524-3754	M�decins Sans Fronti�res [OCA_pilot_00_Greig] Funding Source: researchfish; MRC [G0700837] Funding Source: UKRI; Medical Research Council [G0700837] Funding Source: Medline	M�decins Sans Fronti�res; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahoua L, 2011, J INT AIDS SOC, V14, DOI [10.1186/1758-2652-1114-1182., DOI 10.1186/1758-2652-1114-1182]; [Anonymous], 2011, GLOB TUB CONTR 2011; [Anonymous], IMPR DIAGN TREATM SM, DOI DOI 10.1186/s12879-016-1967-3; Bernabe-Ortiz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018474; Dembele M, 2008, EUR RESPIR J, V32, P1668, DOI 10.1183/09031936.00106308; Dimairo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011849; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Glynn JR, 2010, AIDS, V24, P1067, DOI 10.1097/QAD.0b013e328337b100; Hanrahan CF, 2010, AIDS, V24, P1501, DOI 10.1097/QAD.0b013e32833a2a4a; Kang'ombe C, 2000, T ROY SOC TROP MED H, V94, P305, DOI 10.1016/S0035-9203(00)90335-3; Khan A, 2006, AM J RESP CRIT CARE, V174, P344, DOI 10.1164/rccm.200511-1834OC; Krapp F, 2008, INT J TUBERC LUNG D, V12, P1153; Kruyt ML, 1999, B WORLD HEALTH ORGAN, V77, P386; Lawn SD, 2011, INT J TUBERC LUNG D, V15, P571, DOI 10.5588/ijtld.10.0483; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Maher D, 2005, TUBERCULOSIS DEATHS; Ramos JM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-215; Maro I, 2010, INT J TUBERC LUNG D, V14, P1447; Mossdorf E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-98; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Mukherjee Abhijit, 2009, Indian J Tuberc, V56, P144; Mupere E, 2010, ANN EPIDEMIOL, V20, P210, DOI 10.1016/j.annepidem.2009.11.001; Nahid P, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-1; Nakanjako D, 2010, INT J TUBERC LUNG D, V14, P1621; Nicholas S, 2009, 5 IAS C HIV PATH TRE; Semba RD, 2010, FOOD NUTR BULL, V31, pS345, DOI 10.1177/15648265100314S404; Waitt CJ, 2011, INT J TUBERC LUNG D, V15, P871, DOI 10.5588/ijtld.10.0352; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; *WHO, 2009, GLOB TUB CONTR SHORT; World Health Organization, 2011, ZIMB TUB COUNTR PROF; World Health Organization, 2011, MYANM TUB COUNTR PRO	33	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35948	10.1371/journal.pone.0035948	http://dx.doi.org/10.1371/journal.pone.0035948			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545150	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000305343200070
J	Cohen, L; Azriel-Tamir, H; Arotsker, N; Sekler, I; Hershfinkel, M				Cohen, Limor; Azriel-Tamir, Hagit; Arotsker, Natan; Sekler, Israel; Hershfinkel, Michal			Zinc Sensing Receptor Signaling, Mediated by GPR39, Reduces Butyrate-Induced Cell Death in HT29 Colonocytes via Upregulation of Clusterin	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; HISTONE DEACETYLASE INHIBITORS; COLON-CANCER CELLS; SODIUM-BUTYRATE; EXTRACELLULAR ZINC; NA+/H+ EXCHANGER; NEURONAL APOPTOSIS; APICAL NHE; EXPRESSION; PROTEIN	Zinc enhances epithelial proliferation, protects the digestive epithelial layer and has profound antiulcerative and antidiarrheal roles in the colon. Despite the clinical significance of this ion, the mechanisms linking zinc to these cellular processes are poorly understood. We have previously identified an extracellular Zn2+ sensing G-protein coupled receptor (ZnR) that activates Ca2+ signaling in colonocytes, but its molecular identity as well as its effects on colonocytes' survival remained elusive. Here, we show that Zn2+, by activation of the ZnR, protects HT29 colonocytes from butyrate induced cell death. Silencing of the G-protein coupled receptor GPR39 expression abolished ZnR-dependent Ca2+ release and Zn2+-dependent survival of butyrate-treated colonocytes. Importantly, GPR39 also mediated ZnR-dependent upregulation of Na+/H+ exchange activity as this activity was found in native colon tissue but not in tissue obtained from GPR39 knock-out mice. Although ZnR-dependent upregulation of Na+/H+ exchange reduced the cellular acid load induced by butyrate, it did not rescue HT29 cells from butyrate induced cell death. ZnR/GPR39 activation however, increased the expression of the antiapoptotic protein clusterin in butyrate-treated cells. Furthermore, silencing of clusterin abolished the Zn2+-dependent survival of HT29 cells. Altogether, our results demonstrate that extracellular Zn2+, acting through ZnR, regulates intracellular pH and clusterin expression thereby enhancing survival of HT29 colonocytes. Moreover, we identify GPR39 as the molecular moiety of ZnR in HT29 and native colonocytes.	[Cohen, Limor; Azriel-Tamir, Hagit; Arotsker, Natan; Hershfinkel, Michal] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Morphol, Beer Sheva, Israel; [Sekler, Israel] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Cohen, L (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Morphol, Beer Sheva, Israel.	hmichal@bgu.ac.il		Hershfinkel, Michal/0000-0003-1652-1989	Israeli Science Foundation [585/05, 513/09]; German Israeli Foundation [912-90.11/2006]	Israeli Science Foundation(Israel Science Foundation); German Israeli Foundation(German-Israeli Foundation for Scientific Research and Development)	This work was supported by the Israeli Science Foundation grants 585/05 and 513/09 and the German Israeli Foundation grant 912-90.11/2006 (to MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenman E, 2000, J NEUROCHEM, V75, P1878, DOI 10.1046/j.1471-4159.2000.0751878.x; Azriel-Tamir H, 2004, J BIOL CHEM, V279, P51804, DOI 10.1074/jbc.M406581200; Bachmann O, 2004, AM J PHYSIOL-GASTR L, V287, pG125, DOI 10.1152/ajpgi.00332.2003; Besser L, 2009, J NEUROSCI, V29, P2890, DOI 10.1523/JNEUROSCI.5093-08.2009; Bordonaro M, 2008, CELL CYCLE, V7, P1178, DOI 10.4161/cc.7.9.5818; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC857, DOI 10.1152/ajpcell.1988.255.6.C857; Chu JS, 2002, AM J PHYSIOL-CELL PH, V283, pC358, DOI 10.1152/ajpcell.01380.2000; Cima RR, 2006, AM J PHYSIOL-GASTR L, V290, pG250, DOI 10.1152/ajpgi.00501.2004; Clarke JM, 2012, CARCINOGENESIS, V33, P197, DOI 10.1093/carcin/bgr254; Codd R, 2009, INT J BIOCHEM CELL B, V41, P736, DOI 10.1016/j.biocel.2008.05.026; Comalada M, 2006, J CANCER RES CLIN, V132, P487, DOI 10.1007/s00432-006-0092-x; Coradini D, 2000, CELL PROLIFERAT, V33, P139, DOI 10.1046/j.1365-2184.2000.00173.x; Criswell T, 2005, J BIOL CHEM, V280, P14212, DOI 10.1074/jbc.M412569200; Djeu JY, 2009, ADV CANCER RES, V105, P77, DOI 10.1016/S0065-230X(09)05005-2; Dubi N, 2008, CARCINOGENESIS, V29, P1692, DOI 10.1093/carcin/bgn027; Frazzini V, 2007, MOL MED, V13, P356, DOI 10.2119/2007-00047.Frazzini; Guan YF, 2006, AM J PHYSIOL-GASTR L, V291, pG689, DOI 10.1152/ajpgi.00342.2005; Hakkoum D, 2008, J NEUROCHEM, V106, P1791, DOI 10.1111/j.1471-4159.2008.05519.x; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Han BH, 2001, NAT MED, V7, P338, DOI 10.1038/85487; Hershfinkel M, 2001, P NATL ACAD SCI USA, V98, P11749, DOI 10.1073/pnas.201193398; Hershfinkel M, 2006, MOL BIOL METAL HOMEO; Hershfinkel M, 2007, MOL MED, V13, P331, DOI 10.2119/2006-00038.Hershfinkel; Hofmanova J, 2005, EUR J NUTR, V44, P40, DOI 10.1007/s00394-004-0490-2; Hogstrand C, 2009, TRENDS MOL MED, V15, P101, DOI 10.1016/j.molmed.2009.01.004; Holst B, 2007, ENDOCRINOLOGY, V148, P13, DOI 10.1210/en.2006-0933; John S, 2011, ONCOL REP, V25, P769, DOI 10.3892/or.2010.1124; Joseph J, 2004, ONCOGENE, V23, P6304, DOI 10.1038/sj.onc.1207852; Kaisman-Elbaz T, 2009, J CELL PHYSIOL, V220, P222, DOI 10.1002/jcp.21754; KEEPERS YP, 1991, EUR J CANCER, V27, P897, DOI 10.1016/0277-5379(91)90142-Z; Kim YS, 2007, J NUTR, V137, p2576S, DOI 10.1093/jn/137.11.2576S; Krishnan S, 2003, AM J PHYSIOL-CELL PH, V285, pC1246, DOI 10.1152/ajpcell.00598.2002; Lambert DW, 2002, BRIT J CANCER, V86, P1262, DOI 10.1038/sj.bjc.6600264; Liu JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019638; Mazzarelli P, 2009, ADV CANCER RES, V105, P45, DOI 10.1016/S0065-230X(09)05003-9; Medina V, 1997, CANCER RES, V57, P3697; Moechars D, 2006, GASTROENTEROLOGY, V131, P1131, DOI 10.1053/j.gastro.2006.07.009; Opoka W, 2010, J PHYSIOL PHARMACOL, V61, P581; Pajak B, 2007, ADV MED SCI-POLAND, V52, P83; Pajak Beata, 2006, Postepy Hig Med Dosw (Online), V60, P45; Pal S, 2004, PFLUG ARCH EUR J PHY, V448, P296, DOI 10.1007/s00424-004-1256-7; Park KS, 2003, AM J PHYSIOL-GASTR L, V19, P19; Paroder V, 2006, P NATL ACAD SCI USA, V103, P7270, DOI 10.1073/pnas.0602365103; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Roy MJ, 2009, NUTRITION, V25, P1193, DOI 10.1016/j.nut.2009.04.008; Ruemmele FM, 1999, CELL DEATH DIFFER, V6, P729, DOI 10.1038/sj.cdd.4400545; Scharlau D, 2009, MUTAT RES-REV MUTAT, V682, P39, DOI 10.1016/j.mrrev.2009.04.001; Schultheiss Gerhard, 2002, Biological Procedures Online, V3, P70, DOI 10.1251/bpo25; Sensi SL, 2006, BIOGERONTOLOGY, V7, P367, DOI 10.1007/s10522-006-9051-9; Shannan B, 2006, CELL DEATH DIFFER, V13, P12, DOI 10.1038/sj.cdd.4401779; Sharir H, 2005, BIOCHEM BIOPH RES CO, V332, P845, DOI 10.1016/j.bbrc.2005.05.036; Sharir H, 2010, J BIOL CHEM, V285, P26097, DOI 10.1074/jbc.M110.107490; Tang Y, 2011, AUTOPHAGY, V7, P235, DOI 10.4161/auto.7.2.14277; Tang Y, 2011, INT J CANCER, V128, P847, DOI 10.1002/ijc.25638; Taylor KM, 2008, ENDOCRINOLOGY, V149, P4912, DOI 10.1210/en.2008-0351; Thamilselvan V, 2003, J SURG RES, V110, P255, DOI 10.1016/S0022-4804(03)00028-3; Thangaraju M, 2009, CANCER RES, V69, P2826, DOI 10.1158/0008-5472.CAN-08-4466; Valentine RA, 2007, J BIOL CHEM, V282, P14389, DOI 10.1074/jbc.M701752200; Vidyasagar S, 2002, J PHYSIOL-LONDON, V539, P163, DOI 10.1113/jphysiol.2001.013056; Waldecker M, 2008, J NUTR BIOCHEM, V19, P587, DOI 10.1016/j.jnutbio.2007.08.002; Wilson AJ, 2010, CANCER RES, V70, P609, DOI 10.1158/0008-5472.CAN-09-2327; Xiao M, 2012, EXP CELL RES, V318, P43, DOI 10.1016/j.yexcr.2011.10.006; Yasuda SI, 2007, J RECEPT SIG TRANSD, V27, P235, DOI 10.1080/10799890701506147; Yu DCW, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-276; Zhang Y, 2010, CHEM-BIOL INTERACT, V185, P174, DOI 10.1016/j.cbi.2010.03.035; Zhang Y, 2007, MOL MED, V13, P350, DOI 10.2119/2007-00042.Zhang; Zhong B, 2010, MOL CANCER THER, V9, P1831, DOI 10.1158/1535-7163.MCT-09-0880	68	36	37	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35482	10.1371/journal.pone.0035482	http://dx.doi.org/10.1371/journal.pone.0035482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545109	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343200029
J	Zwingenberger, AL; Kent, MS; Liu, RW; Kukis, DL; Wisner, ER; DeNardo, SJ; Taylor, SL; Chen, XC; Lam, KS				Zwingenberger, Allison L.; Kent, Michael S.; Liu, Ruiwu; Kukis, David L.; Wisner, Erik R.; DeNardo, Sally J.; Taylor, Sandra L.; Chen, Xiucui; Lam, Kit S.			In-Vivo Biodistribution and Safety of Tc-99m-LLP2A-HYNIC in Canine Non-Hodgkin Lymphoma	PLOS ONE			English	Article							B-CELL LYMPHOMA; CANCER-THERAPY; RADIOIMMUNOTHERAPY; DOSIMETRY; INTEGRIN; PHARMACOKINETICS; TOSITUMOMAB; EXPRESSION; PEPTIDE	Theranostic agents are critical for improving the diagnosis and treatment of non-Hodgkin Lymphoma (NHL). The peptidomimetic LLP2A is a novel peptide receptor radiotherapy candidate for treating NHL that expresses the activated alpha 4 beta 1 integrin. Tumor-bearing dogs are an excellent model of human NHL with similar clinical characteristics, behavior, and compressed clinical course. Canine in vivo imaging studies will provide valuable biodistribution and affinity information that reflects a diverse clinical population of lymphoma. This may also help to determine potential dose-limiting radiotoxicity to organs in human clinical trials. To validate this construct in a naturally occurring model of NHL, we performed in-vivo molecular targeted imaging and biodistribution in 3 normal dogs and 5 NHL bearing dogs. Tc-99m-LLP2A-HYNIC-PEG and Tc-99m-LLP2A-HYNIC were successfully synthesized and had very good labeling efficiency and radiochemical purity. Tc-99m-LLP2A-HYNIC and Tc-99m-LLP2A-HYNIC-PEG had biodistribution in keeping with their molecular size, with Tc-99m-LLP2A-HYNIC-PEG remaining longer in the circulation, having higher tissue uptake, and having more activity in the liver compared to Tc-99m-LLP2A-HYNIC. Tc-99m-LLP2A-HYNIC was mainly eliminated through the kidneys with some residual activity. Radioactivity was reduced to near-background levels at 6 hours after injection. In NHL dogs, tumor showed moderately increased activity over background, with tumor activity in B-cell lymphoma dogs decreasing after chemotherapy. This compound is promising in the development of targeted drug-delivery radiopharmaceuticals and may contribute to translational work in people affected by non-Hodgkin lymphoma.	[Zwingenberger, Allison L.; Kent, Michael S.; Wisner, Erik R.] Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA; [Liu, Ruiwu; Lam, Kit S.] Univ Calif Davis, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Kukis, David L.] Univ Calif Davis, Ctr Mol & Genome Imaging, Davis, CA 95616 USA; [DeNardo, Sally J.; Lam, Kit S.] Univ Calif Davis, Med Ctr, Dept Internal Med, Div Hematol Oncol, Sacramento, CA 95817 USA; [Taylor, Sandra L.; Chen, Xiucui] Univ Calif Davis, Sch Med, Clin & Translat Sci Ctr, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Zwingenberger, AL (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA.	azwingen@ucdavis.edu		Taylor, Sandra/0000-0001-7811-812X; Kent, Michael/0000-0002-7703-7720	National Co-operative Drug Discovery Group [U19CA113298]; NATIONAL CANCER INSTITUTE [U19CA113298, P30CA093373] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024146] Funding Source: NIH RePORTER	National Co-operative Drug Discovery Group; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding was supplied by National Co-operative Drug Discovery Group grant U19CA113298 (http://dtp.nci.nih.gov/branches/gcob/gcob_web3.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennink RJ, 2008, J NUCL MED, V49, P1380, DOI 10.2967/jnumed.108.051755; Berry CR, 2006, TXB VET NUCL MED; Blanco E, 2009, EXP BIOL MED, V234, P123, DOI 10.3181/0808-MR-250; Brannon-Peppas L, 2004, ADV DRUG DELIVER REV, V56, P1649, DOI 10.1016/j.addr.2004.02.014; Davies AJ, 2007, ONCOGENE, V26, P3614, DOI 10.1038/sj.onc.1210378; DeNardo SJ, 2009, J NUCL MED, V50, P625, DOI 10.2967/jnumed.108.056903; DENARDO SJ, 1991, NUCL MED BIOL, V18, P621, DOI 10.1016/0883-2897(91)90032-G; DeNardo SJ, 2003, CLIN CANCER RES, V9, p3854S; Denardo SJ, 2009, J NUCL MED; Dillman RO, 2006, CLIN EXP MED, V6, P1, DOI 10.1007/s10238-006-0087-6; Drillenburg P, 2000, BLOOD, V95, P1900, DOI 10.1182/blood.V95.6.1900; Erwin WD, 1996, NUCL MED BIOL, V23, P525, DOI 10.1016/0969-8051(96)00036-4; Finn WG, 2001, HUM PATHOL, V32, P66, DOI 10.1053/hupa.2001.20891; Hamidi M, 2006, DRUG DELIV, V13, P399, DOI 10.1080/10717540600814402; Holzmann B, 1998, CURR TOP MICROBIOL, V231, P125; Jaspars LH, 1996, J PATHOL, V178, P36, DOI 10.1002/(SICI)1096-9896(199601)178:1<36::AID-PATH426>3.0.CO;2-S; Padilla L, 2008, J NUCL MED, V49, P446, DOI 10.2967/jnumed.107.046722; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Peng L, 2008, MOL CANCER THER, V7, P432, DOI 10.1158/1535-7163.MCT-07-0575; Peng L, 2006, NAT CHEM BIOL, V2, P381, DOI 10.1038/nchembio798; Reubi JC, 2005, J NUCL MED, V46, p67S; Vail DM, 2000, CANCER INVEST, V18, P781, DOI 10.3109/07357900009012210; Wahl RL, 2003, SEMIN ONCOL, V30, P31, DOI 10.1053/sonc.2003.23799; Williams LE, 2008, MED PHYS, V35, P3062, DOI 10.1118/1.2938520; Zwingenberger AL, 2011, VET IMMUNOLOGY UNPUB	25	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e34404	10.1371/journal.pone.0034404	http://dx.doi.org/10.1371/journal.pone.0034404			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545083	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343200006
J	Cornejo-Juarez, P; Perez-Jimenez, C; Silva-Sanchez, J; Velazquez-Acosta, C; Gonzalez-Lara, F; Reyna-Flores, F; Sanchez-Perez, A; Volkow-Fernandez, P				Cornejo-Juarez, Patricia; Perez-Jimenez, Carolina; Silva-Sanchez, Jesus; Velazquez-Acosta, Consuelo; Gonzalez-Lara, Fernanda; Reyna-Flores, Fernando; Sanchez-Perez, Alejandro; Volkow-Fernandez, Patricia			Molecular Analysis and Risk Factors for Escherichia coli Producing Extended-Spectrum beta-Lactamase Bloodstream Infection in Hematological Malignancies	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE; NOSOCOMIAL INFECTIONS; EPIDEMIOLOGY; ESBL; ENTEROBACTERIACEAE; BACTEREMIA; RESISTANCE; OUTCOMES; IMPACT; DNA	Introduction: Patients with hematologic malignancies have greater risk-factors for primary bloodstream infections (BSI). Methods: From 2004-2009, we analyzed bacteremia caused by extended-spectrum beta-lactamase Escherichia coli (ESBL-EC) (n = 100) and we compared with bacteremia caused by cephalosporin-susceptible E. coli (n = 100) in patients with hematologic malignancies. Objective: To assess the clinical features, risk factors, and outcome of ESBL-EC BSI in patients with hematologic malignancies, and to study the molecular epidemiology of ESBL-EC isolates. Results: The main diagnosis was acute leukemia in 115 patients (57.5%). Death-related E. coli infection was significantly increased with ESBL-EC (34% vs. control group, 19%; p = 0.03). Treatment for BSI was considered appropriate in 64 patients with ESBL-EC (mean survival, 245 +/- 345 days), and in 45 control patients this was 443 +/- 613 (p = 0.03). In patients not receiving appropriate antimicrobial treatment, survival was significantly decreased in cases compared with controls (26 +/- 122 vs. 276 +/- 442; p = 0.001). Fifty six of the ESBL-EC isolates were characterized by molecular analysis: 47 (84%) expressed CTX-M-15, two (3.6%) SHV, and seven (12.5%) did not correspond to either of these two ESBL enzymes. No TLA-1 enzyme was detected. Conclusions: Patients who had been previously hospitalized and who received cephalosporins during the previous month, have an increased risk of ESBL-EC bacteremia. Mortality was significantly increased in patients with ESBL-EC BSI. A polyclonal trend was detected, which reflects non-cross transmission of multiresistant E. coli isolates.	[Cornejo-Juarez, Patricia; Perez-Jimenez, Carolina; Velazquez-Acosta, Consuelo; Gonzalez-Lara, Fernanda; Volkow-Fernandez, Patricia] Secretaria Salud Ssa, Inst Nacl Cancerol INCan, Dept Infect Dis, Mexico City, DF, Mexico; [Silva-Sanchez, Jesus; Reyna-Flores, Fernando; Sanchez-Perez, Alejandro] Ssa, CISEI, INSP, Dept Epidemiol Diag, Cuernavaca, Morelos, Mexico	Instituto Nacional de Cancerologia (INCAN)	Cornejo-Juarez, P (corresponding author), Secretaria Salud Ssa, Inst Nacl Cancerol INCan, Dept Infect Dis, Mexico City, DF, Mexico.	patcornejo@yahoo.com		Perez-Jimenez, Carolina/0000-0002-0212-9436; Silva-Sanchez, Jesus/0000-0002-6580-2990	CONACYT (Consejo Nacional de Ciencia y Tecnologia) [SALUD-2003-C01-009]	CONACYT (Consejo Nacional de Ciencia y Tecnologia)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This project had partial support from CONACYT (Consejo Nacional de Ciencia y Tecnologia) SALUD-2003-C01-009 for molecular characterization of ESBL-EC producers. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpaka PE, 2010, W INDIAN MED J, V59, P591; Blot F, 2000, SUPPORT CARE CANCER, V8, P287, DOI 10.1007/s005200000150; Chen CY, 2010, EPIDEMIOL INFECT, V138, P1044, DOI 10.1017/S0950268809991208; Chong Y, 2010, INT J INFECT DIS, V14, pE171, DOI 10.1016/j.ijid.2010.01.004; *CLIN LAB STAND I, 2006, PERF STAND ANT SUSC; Coque T M, 2008, Euro Surveill, V13; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Garza-Gonzalez E, 2011, J MED MICROBIOL, V60, P84, DOI 10.1099/jmm.0.022970-0; Garza-Ramos U, 2007, SALUD PUBLICA MEXICO, V49, P415, DOI 10.1590/S0036-36342007000600008; Gudiol C, 2010, J ANTIMICROB CHEMOTH, V65, P333, DOI 10.1093/jac/dkp411; Hu BJ, 2010, CURR MED RES OPIN, V26, P1443, DOI 10.1185/03007991003769068; Hyle EP, 2005, ARCH INTERN MED, V165, P1375, DOI 10.1001/archinte.165.12.1375; Kaufmann ME, 1988, METHODS MOL MED, V15, P17; KIESER T, 1984, PLASMID, V12, P19, DOI 10.1016/0147-619X(84)90063-5; Lautenbach E, 2001, CLIN INFECT DIS, V32, P1162, DOI 10.1086/319757; Miranda G, 2004, J CLIN MICROBIOL, V42, P30, DOI 10.1128/JCM.42.1.30-35.2004; Mosqueda-Gomez JL, 2008, INT J INFECT DIS, V12, P653, DOI 10.1016/j.ijid.2008.03.008; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pena C, 2008, J HOSP INFECT, V68, P116, DOI 10.1016/j.jhin.2007.11.012; Pena C, 2006, CLIN MICROBIOL INFEC, V12, P279, DOI 10.1111/j.1469-0691.2005.01358.x; Perez F, 2007, CURR OPIN PHARMACOL, V7, P459, DOI 10.1016/j.coph.2007.08.003; Ramphal R, 2006, CLIN INFECT DIS, V42, pS164, DOI 10.1086/500663; Rodriguez-Bano J, 2008, CLIN MICROBIOL INFEC, V14, P180, DOI 10.1111/j.1469-0691.2007.01884.x; Silva J, 2001, J CLIN MICROBIOL, V39, P3193, DOI 10.1128/JCM.39.9.3193-3196.2001; Silva-Sanchez J, 2011, ARCH MED RES, V42, P156, DOI 10.1016/j.arcmed.2011.02.004; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Trecarichi EM, 2009, J INFECTION, V58, P299, DOI 10.1016/j.jinf.2009.02.002; Valverde A, 2004, J CLIN MICROBIOL, V42, P4769, DOI 10.1128/JCM.42.10.4769-4775.2004; Wang FD, 2005, CHEMOTHERAPY, V51, P147, DOI 10.1159/000085623; Wu UI, 2011, EUR J CLIN MICROBIOL, V30, P33, DOI 10.1007/s10096-010-1048-2; Yu Wen-Liang, 2006, Journal of Microbiology Immunology and Infection, V39, P264	31	41	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35780	10.1371/journal.pone.0035780	http://dx.doi.org/10.1371/journal.pone.0035780			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540004	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341000070
J	Geisinger, MT; Astaiza, R; Butler, T; Popoff, SN; Planey, SL; Arnott, JA				Geisinger, Max T.; Astaiza, Randy; Butler, Tiffany; Popoff, Steven N.; Planey, Sonia Lobo; Arnott, John A.			Ets-1 Is Essential for Connective Tissue Growth Factor (CTGF/CCN2) Induction by TGF-beta 1 in Osteoblasts	PLOS ONE			English	Article							CHONDROCYTE-SPECIFIC GENE; FETAL-RAT CALVARIAE; FACTOR-BETA; TGF-BETA; TRANSCRIPTION FACTORS; CTGF EXPRESSION; TRANSFORMING GROWTH-FACTOR-BETA-1; SKELETAL DEVELOPMENT; BONE-FORMATION; BINDING-SITES	Background: Ets-1 controls osteoblast differentiation and bone development; however, its downstream mechanism of action in osteoblasts remains largely undetermined. CCN2 acts as an anabolic growth factor to regulate osteoblast differentiation and function. CCN2 is induced by TGF-beta 1 and acts as a mediator of TGF-beta 1 induced matrix production in osteoblasts; however, the molecular mechanisms that control CCN2 induction are poorly understood. In this study, we investigated the role of Ets-1 for CCN2 induction by TGF-beta 1 in primary osteoblasts. Results: We demonstrated that Ets-1 is expressed and induced by TGF-beta 1 treatment in osteoblasts, and that Ets-1 overexpression induces CCN2 protein expression and promoter activity at a level similar to TGF-beta 1 treatment alone. Additionally, we found that simultaneous Ets-1 over-expression and TGF-beta 1 treatment synergize to enhance CCN2 induction, and that CCN2 induction by TGF-beta 1 treatment was impaired using Ets-1 siRNA, demonstrating the requirement of Ets-1 for CCN2 induction by TGF-beta 1. Site-directed mutagenesis of eight putative Ets-1 motifs (EBE) in the CCN2 promoter demonstrated that specific EBE sites are required for CCN2 induction, and that mutation of EBE sites in closer proximity to TRE or SBE (two sites previously shown to regulate CCN2 induction by TGF-beta 1) had a greater effect on CCN2 induction, suggesting potential synergetic interaction among these sites for CCN2 induction. In addition, mutation of EBE sites prevented protein complex binding, and this protein complex formation was also inhibited by addition of Ets-1 antibody or Smad 3 antibody, demonstrating that protein binding to EBE motifs as a result of TGF-beta 1 treatment require synergy between Ets-1 and Smad 3. Conclusions: This study demonstrates that Ets-1 is an essential downstream signaling component for CCN2 induction by TGF-beta 1 in osteoblasts, and that specific EBE sites in the CCN2 promoter are required for CCN2 promoter transactivation in osteoblasts.	[Geisinger, Max T.; Astaiza, Randy; Butler, Tiffany; Planey, Sonia Lobo; Arnott, John A.] Commonwealth Med Coll, Dept Basic Sci, Scranton, PA USA; [Popoff, Steven N.] Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19122 USA	Geisinger Commonwealth School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Geisinger, MT (corresponding author), Commonwealth Med Coll, Dept Basic Sci, Scranton, PA USA.	jarnott@tcmedc.org	Lobo, Sonia/H-6889-2018	Lobo, Sonia/0000-0002-7406-6956	National Institute of Arthritis and Musculoskeletal and Skin Disease of the National Institutes of Health [1R03AR057193-01]; Commonwealth Medical College; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR057193] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Disease of the National Institutes of Health; Commonwealth Medical College; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by the National Institute of Arthritis and Musculoskeletal and Skin Disease of the National Institutes of Health, grant number 1R03AR057193-01 (to JA) and by The Commonwealth Medical College (to JA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Arnott JA, 2008, BONE, V42, P871, DOI 10.1016/j.bone.2008.01.006; Arnott JA, 2007, J CELL PHYSIOL, V210, P843, DOI 10.1002/jcp.20917; Ascione L, 1992, G Ital Cardiol, V22, P829; Blom IE, 2002, MATRIX BIOL, V21, P473, DOI 10.1016/S0945-053X(02)00055-0; Bonewald L.F., 2002, PRINCIPLES BONE BIOL, Vsecond, P903; BONEWALD LF, 1994, J CELL BIOCHEM, V55, P350, DOI 10.1002/jcb.240550312; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; CENTRELLA M, 1987, J BONE MINER RES, V2, P29; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Chen YJ, 2002, KIDNEY INT, V62, P1149, DOI 10.1111/j.1523-1755.2002.kid567.x; Czuwara-Ladykowska J, 2002, J BIOL CHEM, V277, P20399, DOI 10.1074/jbc.M200206200; DALTON S, 1992, CELL, V68, P597, DOI 10.1016/0092-8674(92)90194-H; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; HOCK JM, 1990, ENDOCRINOLOGY, V126, P421, DOI 10.1210/endo-126-1-421; Hodge DR, 1996, ONCOGENE, V12, P11; Huang Hai-Chang, 2005, Zhonghua Yi Xue Za Zhi, V85, P328; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Kadota H, 2004, J BONE MINER METAB, V22, P293, DOI 10.1007/s00774-004-0486-2; Katabami K, 2005, CLIN EXP METASTAS, V22, P539, DOI 10.1007/s10585-005-5260-x; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Leask A, 2003, J BIOL CHEM, V278, P13008, DOI 10.1074/jbc.M210366200; Leask A, 2003, BIOCHEM CELL BIOL, V81, P355, DOI 10.1139/O03-069; Leivonen SK, 2005, J INVEST DERMATOL, V124, P1162, DOI 10.1111/j.0022-202X.2005.23750.x; Massague J, 2000, GENE DEV, V14, P627; McCarthy SA, 1997, MOL CELL BIOL, V17, P2401, DOI 10.1128/MCB.17.5.2401; Mori Y, 2004, ARTHRITIS RHEUM-US, V50, P4008, DOI 10.1002/art.20658; Nakanishi T, 2000, ENDOCRINOLOGY, V141, P264, DOI 10.1210/endo.141.1.7267; Nakanishi T, 1997, BIOCHEM BIOPH RES CO, V234, P206, DOI 10.1006/bbrc.1997.6528; Nakata E, 2002, BONE, V31, P441, DOI 10.1016/S8756-3282(02)00846-3; Nakerakanti SS, 2006, J BIOL CHEM, V281, P25259, DOI 10.1074/jbc.M600466200; Nishida T, 2002, J CELL PHYSIOL, V192, P55, DOI 10.1002/jcp.10113; Nishida T, 2000, J CELL PHYSIOL, V184, P197, DOI 10.1002/1097-4652(200008)184:2<197::AID-JCP7>3.0.CO;2-R; PARISI MS, 2005, BONE; Pei HP, 2003, ONCOGENE, V22, P2699, DOI 10.1038/sj.onc.1206374; Qi MC, 2008, INT J ORAL MAX SURG, V37, P453, DOI 10.1016/j.ijom.2007.12.008; Raouf A, 2000, ONCOGENE, V19, P6455, DOI 10.1038/sj.onc.1204037; Razmpour R, 2011, TEMPLE U J ORTHOPAED, V6, P47; Safadi FF, 2003, J CELL PHYSIOL, V196, P51, DOI 10.1002/jcp.10319; Sato M, 1998, ONCOGENE, V17, P1517, DOI 10.1038/sj.onc.1202064; SETH A, 1993, ONCOGENE, V8, P1783; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Takigawa M, 2003, J CELL PHYSIOL, V194, P256, DOI 10.1002/jcp.10206; Tanaka H, 2004, J AM SOC NEPHROL, V15, P3083, DOI 10.1097/01.ASN.0000145459.54236.D3; Utsugi M, 2003, AM J RESP CELL MOL, V28, P754, DOI 10.1165/rcmb.4892; Van Beek JP, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1890; Venanzoni MC, 1996, ONCOGENE, V12, P1199; Watson DK, 1997, ONCOGENE, V14, P213, DOI 10.1038/sj.onc.1200839; WRANA JL, 1988, J CELL BIOL, V106, P915, DOI 10.1083/jcb.106.3.915; Xie SP, 2005, AM J PHYSIOL-LUNG C, V288, pL68, DOI 10.1152/ajplung.00156.2004; Xu J, 2000, J CELL BIOCHEM, V77, P103, DOI 10.1002/(SICI)1097-4644(20000401)77:1<103::AID-JCB11>3.0.CO;2-G; Yamashiro T, 2001, J DENT RES, V80, P461, DOI 10.1177/00220345010800021201; Zhang X, 2010, J CELL PHYSIOL, V224, P691, DOI 10.1002/jcp.22173	56	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35258	10.1371/journal.pone.0035258	http://dx.doi.org/10.1371/journal.pone.0035258			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539964	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341000028
J	Fite, BZ; Liu, Y; Kruse, DE; Caskey, CF; Walton, JH; Lai, CY; Mahakian, LM; Larrat, B; Dumont, E; Ferrara, KW				Fite, Brett Z.; Liu, Yu; Kruse, Dustin E.; Caskey, Charles F.; Walton, Jeffrey H.; Lai, Chun-Yen; Mahakian, Lisa M.; Larrat, Benoit; Dumont, Erik; Ferrara, Katherine W.			Magnetic Resonance Thermometry at 7T for Real-Time Monitoring and Correction of Ultrasound Induced Mild Hyperthermia	PLOS ONE			English	Article							RECOMMENDED REFERENCE MATERIALS; TEMPORAL TEMPERATURE CONTROL; IN-VIVO; THERMAL-CONDUCTIVITY; MR THERMOMETRY; NMR; REALIZATION; OXYGENATION; GUIDANCE; WATER	While Magnetic Resonance Thermometry (MRT) has been extensively utilized for non-invasive temperature measurement, there is limited data on the use of high field (>= 7T) scanners for this purpose. MR-guided Focused Ultrasound (MRgFUS) is a promising non-invasive method for localized hyperthermia and drug delivery. MRT based on the temperature sensitivity of the proton resonance frequency (PRF) has been implemented in both a tissue phantom and in vivo in a mouse Met-1 tumor model, using partial parallel imaging (PPI) to speed acquisition. An MRgFUS system capable of delivering a controlled 3D acoustic dose during real time MRT with proportional, integral, and derivative (PID) feedback control was developed and validated. Real-time MRT was validated in a tofu phantom with fluoroptic temperature measurements, and acoustic heating simulations were in good agreement with MR temperature maps. In an in vivo Met-1 mouse tumor, the real-time PID feedback control is capable of maintaining the desired temperature with high accuracy. We found that real time MR control of hyperthermia is feasible at high field, and k-space based PPI techniques may be implemented for increasing temporal resolution while maintaining temperature accuracy on the order of 1 degrees C.	[Fite, Brett Z.; Liu, Yu; Kruse, Dustin E.; Caskey, Charles F.; Lai, Chun-Yen; Mahakian, Lisa M.; Ferrara, Katherine W.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Fite, Brett Z.] Univ Calif Davis, Biophys Grad Grp, Davis, CA 95616 USA; [Walton, Jeffrey H.] Univ Calif Davis, NMR Facil, Davis, CA 95616 USA; [Walton, Jeffrey H.] Univ Calif Davis, Biomed Engn Grad Grp, Davis, CA 95616 USA; [Larrat, Benoit] ESPCI Paristech, Inst Langevin, CNRS UMR7589, INSERM, Paris, France; [Dumont, Erik] Image Guided Therapy, Pessac, France	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Universite Paris Cite	Ferrara, KW (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	kwferrara@ucdavis.edu	, Jeff/AAI-3575-2020; Larrat, Benoit/AAC-4920-2019; Larrat, Benoit/C-3123-2014	, Jeff/0000-0002-2359-955X; Larrat, Benoit/0000-0003-1577-6293; Larrat, Benoit/0000-0003-1577-6293; Ferrara, Katherine/0000-0002-4976-9107	National Institutes of Health [R01CA103828, HL086350-01A1]; National Institute of Biomedical Imaging and Bioengineering (NIBIB) [5T32EB009434]; NATIONAL CANCER INSTITUTE [P30CA093373, R01CA134659, R01CA103828] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL086350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB003827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institutes of Health grants R01CA103828, HL086350-01A1 [http://www.nih.gov], and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) Training Program Engineering Approach to Molecular Imaging grant 5T32EB009434 [http://www.nibib.nih.gov]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bankson JA, 2005, MAGNET RESON MED, V53, P658, DOI 10.1002/mrm.20378; BILANIUK N, 1993, J ACOUST SOC AM, V93, P1609, DOI 10.1121/1.406819; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chen J, 2006, J MAGN RESON IMAGING, V23, P430, DOI 10.1002/jmri.20516; Cheng HLM, 2002, J MAGN RESON IMAGING, V16, P598, DOI 10.1002/jmri.10199; Chung AH, 1996, MAGNET RESON MED, V36, P745, DOI 10.1002/mrm.1910360513; Dietrich O, 2007, J MAGN RESON IMAGING, V26, P375, DOI 10.1002/jmri.20969; Enholm JK, 2010, IEEE T BIO-MED ENG, V57, P103, DOI 10.1109/TBME.2009.2034636; Ergun AS, 2011, ULTRASONICS, V51, P786, DOI 10.1016/j.ultras.2011.03.006; Galiana G, 2008, SCIENCE, V322, P421, DOI 10.1126/science.1163242; Graham SJ, 1999, MAGNET RESON MED, V42, P1061, DOI 10.1002/(SICI)1522-2594(199912)42:6<1061::AID-MRM10>3.0.CO;2-T; Guo JY, 2006, MAGN RESON IMAGING, V24, P903, DOI 10.1016/j.mri.2006.03.001; HENLE KJ, 1978, CANCER RES, V38, P1843; HERINGTON EFG, 1976, PURE APPL CHEM, V48, P243; ISHIHARA Y, 1995, MAGNET RESON MED, V34, P814, DOI 10.1002/mrm.1910340606; Jones EL, 2004, CLIN CANCER RES, V10, P4287, DOI 10.1158/1078-0432.CCR-04-0133; Kickhefel A, 2010, PHYS MEDICA, V26, P192, DOI 10.1016/j.ejmp.2009.11.006; Kim YT, 2009, ULTRASOUND MED BIOL, V35, P472, DOI 10.1016/j.ultrasmedbio.2008.09.005; Kohler MO, 2009, MED PHYS, V36, P3521, DOI 10.1118/1.3152112; Kong G, 2001, CANCER RES, V61, P3027; Larrat B, 2010, PHYS MED BIOL, V55, P365, DOI 10.1088/0031-9155/55/2/003; LEBIHAN D, 1989, RADIOLOGY, V171, P853, DOI 10.1148/radiology.171.3.2717764; Lohr F, 2000, INT J RADIAT ONCOL, V48, P1513, DOI 10.1016/S0360-3016(00)00788-4; MARKHAM JJ, 1951, REV MOD PHYS, V23, P353, DOI 10.1103/RevModPhys.23.353; Maruvada S, 2007, J ACOUST SOC AM, V121, P1434, DOI 10.1121/1.2431332; Mougenot C, 2004, MAGNET RESON MED, V52, P1005, DOI 10.1002/mrm.20280; Mougenot C, 2009, MAGN RESON MED, V61, P603, DOI 10.1002/mrm.21887; MULLER M, 1985, ACUSTICA, V58, P215; Needham D, 2000, CANCER RES, V60, P1197; ONEIL HT, 1949, J ACOUST SOC AM, V21, P516, DOI 10.1121/1.1906542; PARKER DL, 1984, IEEE T BIO-MED ENG, V31, P161, DOI 10.1109/TBME.1984.325382; PARKER DL, 1983, MED PHYS, V10, P321, DOI 10.1118/1.595307; PENNES HH, 1948, J APPL PHYSIOL, V1, P93, DOI 10.1152/jappl.1948.1.2.93; Peters RD, 1998, MAGNET RESON MED, V40, P454, DOI 10.1002/mrm.1910400316; Quesson B, 2000, J MAGN RESON IMAGING, V12, P525, DOI 10.1002/1522-2586(200010)12:4<525::AID-JMRI3>3.0.CO;2-V; Rieke V, 2008, J MAGN RESON IMAGING, V27, P376, DOI 10.1002/jmri.21265; Song CW, 2005, INT J HYPERTHER, V21, P761, DOI 10.1080/02656730500204487; Sun Y, 2000, NMR BIOMED, V13, P460, DOI 10.1002/nbm.676; Todd N, 2011, MAGN RESON MED, V65, P515, DOI 10.1002/mrm.22636; VANVAALS JJ, 1993, JMRI-J MAGN RESON IM, V3, P671, DOI 10.1002/jmri.1880030419; Weidensteiner C, 2004, J MAGN RESON IMAGING, V19, P438, DOI 10.1002/jmri.20019; Wu JR, 2001, ULTRASOUND MED BIOL, V27, P1297, DOI 10.1016/S0301-5629(01)00424-0; YATVIN MB, 1978, SCIENCE, V202, P1290, DOI 10.1126/science.364652; YOUNG IR, 1994, MAGNET RESON MED, V31, P342, DOI 10.1002/mrm.1910310317; Zabransky M, 2010, J PHYS CHEM REF DATA, V39, DOI 10.1063/1.3182831; Zeng XZ, 2008, J ACOUST SOC AM, V123, P68, DOI 10.1121/1.2812579; ZIEBLAND H, 1981, PURE APPL CHEM, V53, P1863, DOI 10.1351/pac198153101863; Zotev V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024522	48	39	40	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35509	10.1371/journal.pone.0035509	http://dx.doi.org/10.1371/journal.pone.0035509			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536396	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339200072
J	Graham, JC; Zarbl, H				Graham, Jessica C.; Zarbl, Helmut			Use of Cell-SELEX to Generate DNA Aptamers as Molecular Probes of HPV-Associated Cervical Cancer Cells	PLOS ONE			English	Article							IN-VITRO SELECTION; NONTUMORIGENIC REVERTANTS; EXPONENTIAL ENRICHMENT; SYSTEMATIC EVOLUTION; LIGANDS; ANGIOGENESIS; PEGAPTANIB; TOXIN	Background: Disease-specific biomarkers are an important tool for the timely and effective management of pathological conditions, including determination of susceptibility, diagnosis, and monitoring efficacy of preventive or therapeutic strategies. Aptamers, comprising single-stranded or double-stranded DNA or RNA, can serve as biomarkers of disease or biological states. Aptamers can bind to specific epitopes on macromolecules by virtue of their three dimensional structures and, much like antibodies, aptamers can be used to target specific epitopes on the basis of their molecular shape. The Systematic Evolution of Ligands by EXponential enrichment (SELEX) is the approach used to select high affinity aptamers for specific macromolecular targets from among the >10(13) oligomers comprising typical random oligomer libraries. In the present study, we used live cell-based SELEX to identify DNA aptamers which recognize cell surface differences between HPV-transformed cervical carcinoma cancer cells and isogenic, nontumorigenic, revertant cell lines. Methodology/Principal Findings: Whole-cell SELEX methodology was adapted for use with adherent cell lines (which we termed Adherent Cell-SELEX (AC-SELEX)). Using this approach, we identified high affinity aptamers (nanomolar range K-d) to epitopes specific to the cell surface of two nontumorigenic, nontumorigenic revertants derived from the human cervical cancer HeLa cell line, and demonstrated the loss of these epitopes in another human papillomavirus transformed cervical cancer cell line (SiHa). We also performed preliminary investigation of the aptamer epitopes and their binding characteristics. Conclusions/Significance: Using AC-SELEX we have generated several aptamers that have high affinity and specificity to the nontumorigenic, revertant of HPV-transformed cervical cancer cells. These aptamers can be used to identify new biomarkers that are related to carcinogenesis. Panels of aptamers, such as these may be useful in predicting the tumorigenic potential and properties of cancer biopsies and aid in the effective management of pathological conditions (diagnosis, predicted outcome, and treatment options).	[Graham, Jessica C.; Zarbl, Helmut] Univ Med & Dent New Jersey, Sch Med, Dept Environm & Occupat Med, Piscataway, NJ 08854 USA; [Zarbl, Helmut] Canc Inst New Jersey, Div Publ Hlth Sci, Program Carcinogenesis & Chemoprevent, New Brunswick, NJ USA; [Zarbl, Helmut] Univ Med & Dent New Jersey, NIEHS Ctr Environm Exposures & Dis, Environm & Occupat Hlth Sci Inst, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Rutgers State University New Brunswick; Rutgers State University Medical Center	Zarbl, H (corresponding author), Univ Med & Dent New Jersey, Sch Med, Dept Environm & Occupat Med, Piscataway, NJ 08854 USA.	zarbl@eohsi.rutgers.edu		Graham, Jessica/0000-0002-3601-1743	Public Health Services Grant [NIEHS P30ES005022]; New Jersey Commission on Cancer Research [09-1962-CCR-EO]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022] Funding Source: NIH RePORTER	Public Health Services Grant(United States Department of Health & Human ServicesUnited States Public Health Service); New Jersey Commission on Cancer Research; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by Public Health Services Grant #NIEHS P30ES005022 (HZ), a fellowship to JCG from the New Jersey Commission on Cancer Research, Award #: 09-1962-CCR-EO, and institutional support from the Robert Wood Johnson Medical School, UMDNJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanassiou M, 1999, CELL GROWTH DIFFER, V10, P729; Boylan MO, 1996, CELL GROWTH DIFFER, V7, P725; Centers for Disease Control and Prevention: Division of Cancer Prevention and Control, 2010, HUM PAP HPV ASS CANC; Cerchia L, 2005, PLOS BIOL, V3, P697, DOI 10.1371/journal.pbio.0030123; Cerchia L, 2002, FEBS LETT, V528, P12, DOI 10.1016/S0014-5793(02)03275-1; Cerchia L, 2010, TRENDS BIOTECHNOL, V28, P517, DOI 10.1016/j.tibtech.2010.07.005; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Cunningham ET, 2005, OPHTHALMOLOGY, V112, P1747, DOI 10.1016/j.ophtha.2005.06.007; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Hermann T, 2000, SCIENCE, V287, P820, DOI 10.1126/science.287.5454.820; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Kyrgiou M, 2008, OBSTET GYNAECOL REPR, V19, P26; Laurenson S, ANAL BIOCH, V410, P161; Lee JH, 2005, P NATL ACAD SCI USA, V102, P18902, DOI 10.1073/pnas.0509069102; Liu X, 2006, J BIOL CHEM, V281, P578, DOI 10.1074/jbc.M508455200; Morris KN, 1998, P NATL ACAD SCI USA, V95, P2902, DOI 10.1073/pnas.95.6.2902; Musheev MU, 2006, ANAL CHIM ACTA, V564, P91, DOI 10.1016/j.aca.2005.09.069; Ng EWM, 2005, CAN J OPHTHALMOL, V40, P352, DOI 10.1016/S0008-4182(05)80078-X; Nimjee SM, 2006, MOL THER, V14, P408, DOI 10.1016/j.ymthe.2006.04.006; Nutiu R, 2005, ANGEW CHEM INT EDIT, V44, P1061, DOI 10.1002/anie.200461848; Orava EW, 2010, BBA-BIOMEMBRANES, V1798, P2190, DOI 10.1016/j.bbamem.2010.02.004; Osborne SE, 1997, CHEM REV, V97, P349, DOI 10.1021/cr960009c; Phillips JA, 2008, ANAL CHIM ACTA, V621, P101, DOI 10.1016/j.aca.2008.05.031; Shangguan DH, 2007, CLIN CHEM, V53, P1153, DOI 10.1373/clinchem.2006.083246; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Siddiqui MAA, 2005, DRUGS, V65, P1571, DOI 10.2165/00003495-200565110-00010; SUMMERHAYES IC, 1982, P NATL ACAD SCI-BIOL, V79, P5292, DOI 10.1073/pnas.79.17.5292; Tang JJ, 2007, BIOSENS BIOELECTRON, V22, P2456, DOI 10.1016/j.bios.2006.09.015; Tang JJ, 2006, ELECTROPHORESIS, V27, P1303, DOI 10.1002/elps.200500489; Toscano-Garibay JD, 2011, ARCH MED RES, V42, P88, DOI 10.1016/j.arcmed.2011.02.005; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Watanabe M, 2011, CANC LETT; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	37	64	74	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e36103	10.1371/journal.pone.0036103	http://dx.doi.org/10.1371/journal.pone.0036103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536456	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200128
J	Lauinger, IL; Bible, JM; Halligan, EP; Aarons, EJ; MacMahon, E; Tong, CYW				Lauinger, Ina L.; Bible, Jon M.; Halligan, Eugene P.; Aarons, Emma J.; MacMahon, Eithne; Tong, Cheuk Y. W.			Lineages, Sub-Lineages and Variants of Enterovirus 68 in Recent Outbreaks	PLOS ONE			English	Article							HUMAN RHINOVIRUS-87; INFECTIONS; CHILDREN; RECOMBINATION; EMERGENCE; ILLNESS; STRAINS	Enterovirus 68 (EV68) was first isolated in 1962. Very few cases of EV68 infection were described over the ensuing 40 years. However, in the past few years, an increase in severe respiratory tract infections associated with EV68 has been reported. We identified two clusters of EV68 infection in South London, UK, one each in the autumn/winters of 2009 and 2010. Sequence comparison showed significant homology of the UK strains with those from other countries including the Netherlands, Japan and the Philippines, which reported EV68 outbreaks between 2008 and 2010. Phylogenetic analysis of all available VP1 sequences indicated the presence of two modern EV68 lineages. The 2010 UK strains belonged to lineage 2. Lineage 1 could be further divided into two sub-lineages: some Japanese and Dutch strains collected between 2004 and 2010 form a distinct sub-lineages (sub-lineage 1.1), whereas other strains from the UK, Japan, Netherlands and Philippines collected between 2008 and 2010 represent sub-lineage 1.2. The UK 2009 strains together with several Dutch and Japanese strains from 2009/2010 represents one variant (1.2.1), whereas those from the Philippines a second variant (1.2.2). Based on specific deletions and substitutions, we suggest rules for the assignment of lineages and sub-lineages. Molecular epidemiological analysis indicates rapid recent evolution of EV68 and this may explain the recent findings of a global resurgence of EV68. Continuous global monitoring of the clinical and molecular epidemiology of EV68 is recommended.	[Lauinger, Ina L.; Tong, Cheuk Y. W.] Kings Coll London, Sch Med, Dept Infect Dis, London WC2R 2LS, England; [Bible, Jon M.; Halligan, Eugene P.] GSTS Pathol, Infect Sci, London, England; [Aarons, Emma J.; MacMahon, Eithne; Tong, Cheuk Y. W.] Guys & St Thomas NHS Fdn Trust, Dept Infect Dis, London, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Tong, CYW (corresponding author), Kings Coll London, Sch Med, Dept Infect Dis, London WC2R 2LS, England.	William.Tong@kcl.ac.uk	Tong, Cheuk Yan William/C-1312-2012	Tong, Cheuk Yan William/0000-0001-8401-6832	British Medical Association (BMA) H C Roscoe grant	British Medical Association (BMA) H C Roscoe grant	This study was funded by the British Medical Association (BMA) H C Roscoe grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blomqvist S, 2002, J CLIN MICROBIOL, V40, P4218, DOI 10.1128/JCM.40.11.4218-4223.2002; Hasegawa S, 2011, ALLERGY, V66, P1618, DOI 10.1111/j.1398-9995.2011.02725.x; Imamura T, 2011, EMERG INFECT DIS, V17, P1430, DOI 10.3201/eid1708.101328; Ishiko H, 2002, INTERVIROLOGY, V45, P136, DOI 10.1159/000065866; Kaida A, 2011, EMERG INFECT DIS, V17, P1494, DOI 10.3201/eid1708.110028; Khetsuriani Nino, 2006, Morbidity and Mortality Weekly Report, V55, P18; Kiang D, 2008, J CLIN MICROBIOL, V46, P3736, DOI 10.1128/JCM.00674-08; Kiang D, 2007, J CLIN VIROL, V38, P227, DOI 10.1016/j.jcv.2006.12.016; Kreuter JD, 2011, ARCH PATHOL LAB MED, V135, P793, DOI 10.1043/2010-0174-CR.1; Leitch ECM, 2012, J VIROL, V86, P2676, DOI 10.1128/JVI.06065-11; Leitch ECM, 2009, J VIROL, V83, P2109, DOI 10.1128/JVI.02109-08; McIntyre CL, 2010, J VIROL, V84, P10297, DOI 10.1128/JVI.00962-10; Meijer A, 2012, VIROLOGY, V423, P49, DOI 10.1016/j.virol.2011.11.021; Oberste MS, 2004, J GEN VIROL, V85, P2577, DOI 10.1099/vir.0.79925-0; Petitjean-Lecherbonnier J, 2011, PATHOL BIOL, V59, P113, DOI 10.1016/j.patbio.2010.07.010; Rahamat-Langendoen J, 2011, J CLIN VIROL, V52, P103, DOI 10.1016/j.jcv.2011.06.019; Savolainen C, 2002, J GEN VIROL, V83, P333, DOI 10.1099/0022-1317-83-2-333; SCHIEBLE JH, 1967, AM J EPIDEMIOL, V85, P297, DOI 10.1093/oxfordjournals.aje.a120693; Smura T, 2010, J MED VIROL, V82, P1940, DOI 10.1002/jmv.21894; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; Tokarz R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-288	21	47	50	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e36005	10.1371/journal.pone.0036005	http://dx.doi.org/10.1371/journal.pone.0036005			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536453	gold, Green Published, Green Submitted			2022-12-25	WOS:000305339200124
J	Regier, JC; Brown, JW; Mitter, C; Baixeras, J; Cho, S; Cummings, MP; Zwick, A				Regier, Jerome C.; Brown, John W.; Mitter, Charles; Baixeras, Joaquin; Cho, Soowon; Cummings, Michael P.; Zwick, Andreas			A Molecular Phylogeny for the Leaf-Roller Moths (Lepidoptera: Tortricidae) and Its Implications for Classification and Life History Evolution	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; FEMALE FRENULUM; NEW-CALEDONIA; NUCLEAR GENE; MISSING DATA; COCHYLIDAE; PATTERNS; SUPPORT	Background: Tortricidae, one of the largest families of microlepidopterans, comprise about 10,000 described species worldwide, including important pests, biological control agents and experimental models. Understanding of tortricid phylogeny, the basis for a predictive classification, is currently provisional. We present the first detailed molecular estimate of relationships across the tribes and subfamilies of Tortricidae, assess its concordance with previous morphological evidence, and re-examine postulated evolutionary trends in host plant use and biogeography. Methodology/Principal Findings: We sequenced up to five nuclear genes (6,633 bp) in each of 52 tortricids spanning all three subfamilies and 19 of the 22 tribes, plus up to 14 additional genes, for a total of 14,826 bp, in 29 of those taxa plus all 14 outgroup taxa. Maximum likelihood analyses yield trees that, within Tortricidae, differ little among data sets and character treatments and are nearly always strongly supported at all levels of divergence. Support for several nodes was greatly increased by the additional 14 genes sequenced in just 29 of 52 tortricids, with no evidence of phylogenetic artifacts from deliberately incomplete gene sampling. There is strong support for the monophyly of Tortricinae and of Olethreutinae, and for grouping of these to the exclusion of Chlidanotinae. Relationships among tribes are robustly resolved in Tortricinae and mostly so in Olethreutinae. Feeding habit (internal versus external) is strongly conserved on the phylogeny. Within Tortricinae, a clade characterized by eggs being deposited in large clusters, in contrast to singly or in small batches, has markedly elevated incidence of polyphagous species. The five earliest-branching tortricid lineages are all species-poor tribes with mainly southern/tropical distributions, consistent with a hypothesized Gondwanan origin for the family. Conclusions/Significance: We present the first robustly supported phylogeny for Tortricidae, and a revised classification in which all of the sampled tribes are now monophyletic.	[Regier, Jerome C.; Mitter, Charles] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Regier, Jerome C.] Inst Biosci & Biotechnol Res, College Pk, MD USA; [Brown, John W.] ARS, Systemat Entomol Lab, USDA, Beltsville, MD USA; [Baixeras, Joaquin] Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain; [Cho, Soowon] Chungbuk Natl Univ, Dept Plant Med, Cheongju, South Korea; [Cummings, Michael P.] Univ Maryland, Lab Mol Evolut, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Zwick, Andreas] State Museum Nat Hist, Dept Entomol, Stuttgart, Germany	University System of Maryland; University of Maryland College Park; Smithsonian Institution; United States Department of Agriculture (USDA); University of Valencia; Chungbuk National University; University System of Maryland; University of Maryland College Park	Regier, JC (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	cmitter@umd.edu	Zwick, Andreas/A-5735-2015; Almela, Joaquin Baixeras/L-1734-2014; Cho, Soowon/AAF-7890-2019	Zwick, Andreas/0000-0002-7532-1752; Almela, Joaquin Baixeras/0000-0002-6092-0496; 	U.S. National Science Foundation [0531626, 0531769]; Spanish Government (Ministerio de Ciencia e Innovacion) [CGL2008-00605]; Division Of Environmental Biology [1042845] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Spanish Government (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Financial support was provided by the U.S. National Science Foundation's Assembling the Tree of Life program, award numbers 0531626 and 0531769, and grant CGL2008-00605 of the Spanish Government (Ministerio de Ciencia e Innovacion) to Dr. Brown. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarvik Leif, 2004, Norwegian Journal of Entomology, V51, P71; Aarvik L, 2009, ZOOTAXA, P18, DOI 10.11646/zootaxa.2026.1.2; Alipanah H, 2011, ZOOTAXA, P33; Baixeras J, 2010, TARTS ONLINE WORLD C; Bazinet A. L, 2009, DISTRIBUTED GRID COM; Brower AVZ, 1998, INSECT MOL BIOL, V7, P73, DOI 10.1046/j.1365-2583.1998.71052.x; BROWN J.W., 1991, U CALIFORNIA PUBLICA, V111, P1; Brown JW, 2007, PAN-PAC ENTOMOL, V83, P352, DOI 10.3956/2007-22.1; Brown John W., 2005, World Catalogue of Insects, V5, P1; BROWN JW, 1989, ENTOMOL SCAND, V20, P439; BROWN JW, 1990, J NEW YORK ENTOMOL S, V98, P369; Brown JW, 2004, P ENTOMOL SOC WASH, V106, P288; BROWN JW, 1990, ENTOMOL NEWS, V101, P109; Brown JW, 1998, PAN-PAC ENTOMOL, V74, P1; Brown JW, 2003, J LEPID SOC, V56, P113; Brown JW, 2010, FOOD PLANT DATABASE; Brown JW, 2000, U CALIF PUBL ENTOMOL, V120; CHAPMAN PJ, 1971, TORTRICID FAUNA APPL; Cho S, 2011, SYST BIOL, V60, P782, DOI 10.1093/sysbio/syr079; COMMON I. F. B., 1965, AUSTRALIAN J ZOOL, V13, P613, DOI 10.1071/ZO9650613; COMMON I. F. B., 1963, AUSTRALIAN JOUR ZOOL, V11, P81, DOI 10.1071/ZO9630081; Cummings M. P, 2005, EDUCAUSE REV, V40, P116; DANG P T, 1990, Journal of the Lepidopterists' Society, V44, P77; Danilevsky AS, 1968, INSECTA LEPIDOPTERA, V5, P1; Dhileepan K, 2004, ENTOMOL EXP APPL, V113, P63, DOI 10.1111/j.0013-8703.2004.00209.x; Dhileepan K, 2003, B ENTOMOL RES, V93, P393, DOI 10.1079/BER2003255; DIAKONOFF A, 1981, P K NED AKAD C BIOL, V84, P155; DIAKONOFF A., 1950, BULL BRIT MUS [NAT HIST] ENT, V1, P173; Diakonoff A., 1977, Zoologische Verh. Leiden, VNo. 158, P1; DIAKONOFF A, 1957, ACTA PHYSIOL PHARM N, V6, P410; Diakonoff A, 1973, ZOOLOGY MONOGRAPHS R, V1; Diakonoff A, 1977, ENTOMOL BER, V37, P36; Falkovitsh ML, 1962, ENTOMOL OBOZR, V41, P546; Fang QQ, 1997, SYST BIOL, V46, P269, DOI 10.2307/2413623; Farrell BD, 2001, EVOLUTION, V55, P2011, DOI 10.1111/j.0014-3820.2001.tb01318.x; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; HEINRICH C., 1923, Bulletin. United States National Museum; HEPPNER JB, 1978, PAN-PAC ENTOMOL, V54, P48; HORAK M, 1984, ENTOMOL SCAND, V15, P423; Horak M., 1991, TORTRICID PESTS THEI, P23, DOI Elsevier; Horak M, 1998, HDB ZOOLOGY 35, VIV, P199; HORAK M., 2006, MONOGRAPHS AUSTR LEP, V10, DOI DOI 10.1071/9780643094086; Horak Marianne, 1996, Monographs on Australian Lepidoptera, V4, P123; Janzen DH, 2010, DYNAMIC DATABASE INV; Jinbo Utsugi, 2000, Tokyo Metropolitan University Bulletin of Natural History, V4, P33; Kawahara AY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005719; Kawahara AY, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-182; Komai F, 2006, MONOGRAPHS AUSTR LEP, V10, P396; Komai Furumi, 1999, Entomologica Scandinavica Supplement, V55, P1; Kuznetsov V. I., 1994, Entomologicheskoe Obozrenie, V73, P700; KUZNETSOV V I, 1970, ENTOMOL REV (ENGL TRANSL ENTOMOL OBOZR), V49, P260; Kuznetsov V. I, 1977, Trudy zool Inst Leningr, V70, P65; Kuznetzov V.I., 1973, Trudy vses ent Obshch, V56, P18; Kuznetzov V.I., 1984, 36 HOL MEM LECT 1 AP, P51; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Meyrick E., 1895, HDB BRIT LEPIDOPTERA; Monsalve S, 2011, P ENTOMOL SOC WASH, V113, P335, DOI 10.4289/0013-8797.113.3.335; Moulton JK, 2004, MOL PHYLOGENET EVOL, V31, P363, DOI 10.1016/S1055-7903(03)00284-7; MULLER H, 1988, CAN ENTOMOL, V120, P109, DOI 10.4039/Ent120109-2; Mutanen M, 2010, P ROY SOC B-BIOL SCI, V277, P2839, DOI 10.1098/rspb.2010.0392; Nyman T, 2006, EVOLUTION, V60, P1622, DOI 10.1111/j.0014-3820.2006.tb00507.x; Obraztsov N., 1949, Entomologische Zeitschrift Stuttgart, V59, P45; Obraztsov NS, 1964, TIJDSCHR ENTOMOL, V107, P1; Phillips MJ, 2004, MOL BIOL EVOL, V21, P1455, DOI 10.1093/molbev/msh137; Pogue M, 1986, THESIS U MINNESOTA; POINAR GO, 1993, ENTOMOL SCAND, V24, P25; Powell GW, 2000, CAN ENTOMOL, V132, P223, DOI 10.4039/Ent132223-2; Powell J. A., 1983, CHECK LIST LEPIDOPTE, P31; POWELL JA, 1985, AUST J ZOOL, V33, P179, DOI 10.1071/ZO9850179; POWELL JA, 1976, PAN-PAC ENTOMOL, V52, P91; POWELL JA, 1986, PAN-PAC ENTOMOL, V62, P372; Powell JA, 1964, U CALIFORNIA PUBLICA, V32; Powell JA, 2011, TORTRICIDAE TORTRICI; Powell Jerry A., 1999, Handbuch der Zoologie (Berlin), V4, P403; RAZOWSKI J, 1976, Acta Zoologica Cracoviensia, V21, P73; RAZOWSKI J, 1988, Acta Zoologica Cracoviensia, V31, P387; RAZOWSKI J, 1987, Acta Zoologica Cracoviensia, V30, P141; Razowski J, 1970, MICROLEPIDOPTERA PAL, V3; Razowski Jozef, 1993, Acta Zoologica Cracoviensia, V35, P665; Razowski J, 2010, FOLIA BIOL-KRAKOW, V58, P189, DOI 10.3409/fb58_3-4.189-194; Regier JC, 1998, MOL BIOL EVOL, V15, P1172, DOI 10.1093/oxfordjournals.molbev.a026024; Regier JC, 2008, SYST ENTOMOL, V33, P219, DOI 10.1111/j.1365-3113.2007.00416.x; Regier JC, 2008, SYST ENTOMOL, V33, P175, DOI 10.1111/j.1365-3113.2007.00409.x; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Regier JC, 2008, SYST BIOL, V57, P920, DOI 10.1080/10635150802570791; Robinson GS, 2010, HOSTS DATABASE WORLD; Roe AD, 2009, GENETICS MOL BIOL LE, P1, DOI [10.1201/9781420060201-c1, DOI 10.1201/9781420060201-C1]; Safonkin AF, 2007, ZOOL ZH, V86, P1464; Smith L, 2003, BIOL CONTROL, V26, P270, DOI 10.1016/S1049-9644(02)00169-X; Staden R, 1999, STADEN PACKAGE; TUCK KR, 1981, SYST ENTOMOL, V6, P337, DOI 10.1111/j.1365-3113.1981.tb00442.x; van der Geest L. P., 1991, TORTRICID PESTS THEI; von Kennel J, 1908, ZOOLOGICA, V21, P1; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330; Wiens JJ, 1998, SYST BIOL, V47, P625, DOI 10.1080/106351598260635; Wiens JJ, 2011, SYST BIOL, V60, P719, DOI 10.1093/sysbio/syr025; Winkler IS, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P240; Yang A, 2009, P ENTOMOL SOC WASH, V111, P743, DOI 10.4289/0013-8797-111.3.743; ZHANG B-C., 1994, INDEX EC IMPORTANT L; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; Zwick A, 2011, SYST ENTOMOL, V36, P31, DOI 10.1111/j.1365-3113.2010.00543.x; ZWICKL D.J., 2006, THESIS U TEXAS AUSTI	103	67	76	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35574	10.1371/journal.pone.0035574	http://dx.doi.org/10.1371/journal.pone.0035574			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536410	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336200057
J	Zhang, M; Xu, GZ; Liu, W; Ni, YQ; Zhou, WT				Zhang, Meng; Xu, Gezhi; Liu, Wei; Ni, Yingqin; Zhou, Wenting			Role of Fractalkine/CX3CR1 Interaction in Light-Induced Photoreceptor Degeneration through Regulating Retinal Microglial Activation and Migration	PLOS ONE			English	Article							CHEMOKINE RECEPTORS; CX3CR1/CX3CL1 AXIS; CEREBRAL-ISCHEMIA; NERVOUS-SYSTEM; BRAIN-INJURY; RAT-BRAIN; CX3CR1; EXPRESSION; INFLAMMATION; CX(3)CR1	Background: Excessive exposure to light enhances the progression and severity of some human retinal degenerative diseases. While retinal microglia are likely to be important in neuron damage associated with these diseases, the relationship between photoreceptor damage and microglial activation remains poorly understood. Some recent studies have indicated that the chemokine fractalkine is involved in the pathogenesis of many neurodegenerative diseases. The present study was performed to investigate the cross-talk between injured photoreceptors and activated retinal microglia, focusing on the role of fractalkine and its receptor CX3CR1 in light-induced photoreceptor degeneration. Methodology/Principal Findings: Both in vivo and in vitro experiments were involved in the research. In vivo, Sprague-Dawley rats were exposed to blue light for 24 hours. In vitro, the co-culture of primary retinal microglia and a photoreceptor cell line (661W cell) was exposed to blue light for five hours. Some cultures were pretreated by the addition of anti-CX3CR1 neutralizing antibody or recombinant fractalkine. Expression of fractalkine/CX3CR1 and inflammatory cytokines was detected by immunofluorescence, real-time PCR, Western immunoblot analysis, and ELISA assay. TUNEL method was used to detect cell apoptosis. In addition, chemotaxis assay was performed to evaluate the impact of soluble fractalkine on microglial migration. Our results showed that the expression of fractalkine that was significantly upregulated after exposure to light, located mainly at the photoreceptors. The extent of photoreceptor degeneration and microglial migration paralleled the increased level of fractalkine/CX3CR1. Compared with the control, the expression of inflammatory cytokines was significantly downregulated in the anti-CX3CR1 neutralizing antibody-treated group, and the number of photoreceptors was also well preserved. The addition of recombinant full-length fractalkine or soluble fractalkine resulted in fewer TUNEL-positive photoreceptors and an increased number of migratory microglia respectively. Conclusions/Significance: These findings demonstrate that fractalkine/CX3CR1 interaction may play an important role in the photoreceptor-microglia cross-talk in light-induced photoreceptor degeneration.	[Zhang, Meng; Xu, Gezhi; Liu, Wei; Ni, Yingqin; Zhou, Wenting] Fudan Univ, Dept Ophthalmol, Eye & ENT Hosp, Shanghai 200433, Peoples R China; [Xu, Gezhi] Fudan Univ, Inst Brain Sci, Shanghai 200433, Peoples R China; [Xu, Gezhi] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Zhang, M (corresponding author), Fudan Univ, Dept Ophthalmol, Eye & ENT Hosp, Shanghai 200433, Peoples R China.	10111260008@fudan.edu.cn			National Basic Research grants of China [30872825, 81170857]; Program Of Shanghai Subject Chief Scientist [09XD1400900]; Shanghai Rising-Star Program [10QA1401200]; National Natural Science Foundation for Young Scholar of China [30901641]	National Basic Research grants of China; Program Of Shanghai Subject Chief Scientist; Shanghai Rising-Star Program; National Natural Science Foundation for Young Scholar of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work has been supported by National Basic Research grants of China (30872825, 81170857), Program Of Shanghai Subject Chief Scientist (A type, 09XD1400900), Shanghai Rising-Star Program (10QA1401200) and National Natural Science Foundation for Young Scholar of China (30901641). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolakis S, 2010, J THROMB THROMBOLYS, V29, P443, DOI 10.1007/s11239-009-0424-1; Battista D, 2006, EUR J NEUROSCI, V23, P83, DOI 10.1111/j.1460-9568.2005.04539.x; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Ceyhan GO, 2009, LAB INVEST, V89, P347, DOI 10.1038/labinvest.2008.170; Chapman GA, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-15-j0004.2000; Clark AK, 2007, P NATL ACAD SCI USA, V104, P10655, DOI 10.1073/pnas.0610811104; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; CRUICKSHANKS KJ, 1993, ARCH OPHTHALMOL-CHIC, V111, P514, DOI 10.1001/archopht.1993.01090040106042; Dagkalis A, 2009, IMMUNOLOGY, V128, P25, DOI 10.1111/j.1365-2567.2009.03046.x; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Denes A, 2008, J CEREBR BLOOD F MET, V28, P1707, DOI 10.1038/jcbfm.2008.64; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Huang DR, 2000, IMMUNOL REV, V177, P52, DOI 10.1034/j.1600-065X.2000.17709.x; Hughes PM, 2002, GLIA, V37, P314, DOI 10.1002/glia.10037; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Kempermann G, 2003, SCIENCE, V302, P1689, DOI 10.1126/science.1092864; Klosowska K, 2009, CLIN EXP IMMUNOL, V156, P312, DOI 10.1111/j.1365-2249.2009.03903.x; Kremlev SG, 2005, J NEUROIMMUNOL, V162, P71, DOI 10.1016/j.jneuroim.2005.01.010; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Lauro C, 2008, J IMMUNOL, V180, P7590, DOI 10.4049/jimmunol.180.11.7590; Lauro C, 2006, J IMMUNOL, V177, P7599, DOI 10.4049/jimmunol.177.11.7599; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Li L, 2008, KIDNEY INT, V74, P1526, DOI 10.1038/ki.2008.500; Liang KJ, 2009, INVEST OPHTH VIS SCI, V50, P4444, DOI 10.1167/iovs.08-3357; Limatola C, 2005, J NEUROIMMUNOL, V166, P19, DOI 10.1016/j.jneuroim.2005.03.023; Liu C, 2008, J NEUROIMMUNOL, V198, P98, DOI 10.1016/j.jneuroim.2008.04.016; Liu ZQ, 2010, J NEUROSCI, V30, P17091, DOI 10.1523/JNEUROSCI.4403-10.2010; Lu PR, 2009, CORNEA, V28, P562, DOI 10.1097/ICO.0b013e3181930bcd; Marchesi F, 2010, J NEUROIMMUNOL, V224, P39, DOI 10.1016/j.jneuroim.2010.05.007; Meucci O, 2000, P NATL ACAD SCI USA, V97, P8075, DOI 10.1073/pnas.090017497; Milligan ED, 2004, EUR J NEUROSCI, V20, P2294, DOI 10.1111/j.1460-9568.2004.03709.x; Minghetti L, 2005, CURR OPIN NEUROL, V18, P315, DOI 10.1097/01.wco.0000169752.54191.97; Mizuno T, 2003, BRAIN RES, V979, P65, DOI 10.1016/S0006-8993(03)02867-1; Murphy PM, 2000, PHARMACOL REV, V52, P145; Ng TF, 2001, INVEST OPHTH VIS SCI, V42, P3301; Ni YQ, 2008, INVEST OPHTH VIS SCI, V49, P2589, DOI 10.1167/iovs.07-1173; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nishiyori A, 1998, FEBS LETT, V429, P167, DOI 10.1016/S0014-5793(98)00583-3; Ransohoff RM, 2009, IMMUNITY, V31, P711, DOI 10.1016/j.immuni.2009.09.010; Raoul W, 2008, J NEUROIMMUNOL, V198, P56, DOI 10.1016/j.jneuroim.2008.04.014; Re DB, 2006, NAT NEUROSCI, V9, P859; Ross RJ, 2008, EXP EYE RES, V86, P675, DOI 10.1016/j.exer.2008.01.014; Sciume G, 2010, NEURO-ONCOLOGY, V12, P701, DOI 10.1093/neuonc/nop076; Soriano SG, 2002, J NEUROIMMUNOL, V125, P59, DOI 10.1016/S0165-5728(02)00033-4; Streit WJ, 2004, J NEUROSCI RES, V77, P1, DOI 10.1002/jnr.20093; Sunnemark D, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-17; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; Tarozzo G, 2002, EUR J NEUROSCI, V15, P1663, DOI 10.1046/j.1460-9568.2002.02007.x; Tuo JS, 2007, INVEST OPHTH VIS SCI, V48, P3827, DOI 10.1167/iovs.07-0051; Verge GM, 2004, EUR J NEUROSCI, V20, P1150, DOI 10.1111/j.1460-9568.2004.03593.x; Walton NM, 2006, GLIA, V54, P815, DOI 10.1002/glia.20419; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Yang LP, 2007, MOL VIS, V13, P231; Zhang C, 2005, MOL VIS, V11, P887; Zujovic V, 2000, GLIA, V29, P305, DOI 10.1002/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.0.CO;2-V	62	61	65	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35446	10.1371/journal.pone.0035446	http://dx.doi.org/10.1371/journal.pone.0035446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536384	gold, Green Submitted, Green Published			2022-12-25	WOS:000305336200041
J	Kim, DK; Ryu, D; Koh, M; Lee, MW; Lim, D; Kim, MJ; Kim, YH; Cho, WJ; Lee, CH; Park, SB; Koo, SH; Choi, HS				Kim, Don-Kyu; Ryu, Dongryeol; Koh, Minseob; Lee, Min-Woo; Lim, Donghyun; Kim, Min-Jung; Kim, Yong-Hoon; Cho, Won-Jea; Lee, Chul-Ho; Park, Seung Bum; Koo, Seung-Hoi; Choi, Hueng-Sik			Orphan Nuclear Receptor Estrogen-Related Receptor gamma (ERR gamma) Is Key Regulator of Hepatic Gluconeogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GTP; INDEPENDENT TRANSCRIPTIONAL ACTIVATION; PYRUVATE-DEHYDROGENASE KINASE; SMALL-HETERODIMER-PARTNER; GLUCOSE-METABOLISM; GENE-EXPRESSION; CYCLIC-AMP; DEPENDENT REGULATION; COACTIVATOR TORC2; ALPHA	Glucose homeostasis is tightly controlled by hormonal regulation of hepatic glucose production. Dysregulation of this system is often associated with insulin resistance and diabetes, resulting in hyperglycemia in mammals. Here, we show that the orphan nuclear receptor estrogen-related receptor gamma (ERR gamma) is a novel downstream mediator of glucagon action in hepatic gluconeogenesis and demonstrate a beneficial impact of the inverse agonist GSK5182. Hepatic ERR gamma expression was increased by fasting-dependent activation of the cAMP-response element-binding protein-CRTC2 pathway. Overexpression of ERR gamma induced Pck1 and G6PC gene expression and glucose production in primary hepatocytes, whereas abolition of ERR gamma gene expression attenuated forskolin-mediated induction of gluconeogenic gene expression. Deletion and mutation analyses of the Pck1 promoter showed that ERR gamma directly regulates the Pck1 gene transcription via ERR response elements of the Pck1 promoter as confirmed by ChIP assay and in vivo imaging analysis. We also demonstrate that GSK5182, an inverse agonist of ERR gamma, specifically inhibits the transcriptional activity of ERR gamma in a PGC-1 alpha dependent manner. Finally, the ERR gamma inverse agonist ameliorated hyperglycemia through inhibition of hepatic gluconeogenesis in db/db mice. Control of hepatic glucose production by an ERR gamma-specific inverse agonist is a new potential therapeutic approach for the treatment of type 2 diabetes.	[Koh, Minseob; Park, Seung Bum] Seoul Natl Univ, Dept Chem, Coll Nat Sci, Seoul 151747, South Korea; [Cho, Won-Jea] Chonnam Natl Univ, Coll Pharm & Res Inst Drug Dev, Kwangju 500757, South Korea; [Ryu, Dongryeol; Lee, Min-Woo; Kim, Min-Jung; Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, Gyeonggi Do, South Korea; [Ryu, Dongryeol; Lee, Min-Woo; Kim, Min-Jung; Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Suwon 440746, Gyeonggi Do, South Korea; [Lim, Donghyun; Park, Seung Bum] Seoul Natl Univ, Coll Nat Sci, Dept Biophys & Chem Biol, Seoul 151747, South Korea; [Kim, Yong-Hoon; Lee, Chul-Ho] Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Med, Res Inst Med Sci, Dept Biomed Sci, Kwangju 501746, South Korea; [Kim, Don-Kyu; Choi, Hueng-Sik] Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Kwangju 500757, South Korea	Seoul National University (SNU); Chonnam National University; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chonnam National University; Chonnam National University	Park, SB (corresponding author), Seoul Natl Univ, Dept Chem, Coll Nat Sci, Seoul 151747, South Korea.	sbpark@snu.ac.kr; shkoo@skku.edu; hsc@chonnam.ac.kr	Park, Seung Bum/N-1901-2014; Ryu, Dongryeol/AAQ-3642-2020; Koo, Seung-Hoi/E-2763-2015	Park, Seung Bum/0000-0003-1753-1433; Ryu, Dongryeol/0000-0001-5905-6760; Koo, Seung-Hoi/0000-0001-8769-2879; Lim, Donghyun/0000-0002-6070-198X; Koh, Minseob/0000-0003-1935-4776	National Creative Research Initiatives from Korean Ministry of Education, Science and Technology [20110018305]; Korea Healthcare Technology Research and Development Project; National Research Foundation of Korea (NRF) from the Ministry of Education, Science and Technology [20100019512]; Brain Korea 21 Program fellowship award; Seoul Science fellowship award; NRF [2011-0016454, 2011-0019448]; Ministry of Land, Transport and Maritime Affairs (MLTM), Korea; Korea government (Ministry of Education, Science and Technology)	National Creative Research Initiatives from Korean Ministry of Education, Science and Technology; Korea Healthcare Technology Research and Development Project; National Research Foundation of Korea (NRF) from the Ministry of Education, Science and Technology(National Research Foundation of Korea); Brain Korea 21 Program fellowship award; Seoul Science fellowship award; NRF; Ministry of Land, Transport and Maritime Affairs (MLTM), Korea(Ministry of Land, Transport and Maritime Affairs (MLTM), Republic of Korea); Korea government (Ministry of Education, Science and Technology)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported in part by National Creative Research Initiatives Grant 20110018305 from the Korean Ministry of Education, Science and Technology and Korea Healthcare Technology Research and Development Project and Future-based Technology Development Program (BIO Fields) Grant 20100019512 through the National Research Foundation of Korea (NRF) from the Ministry of Education, Science and Technology.	Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; Alaynick WA, 2010, MOL ENDOCRINOL, V24, P299, DOI 10.1210/me.2009-0114; Ariazi EA, 2002, CANCER RES, V62, P6510; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cassuto H, 2005, J BIOL CHEM, V280, P33873, DOI 10.1074/jbc.M504119200; Chao EYH, 2006, BIOORG MED CHEM LETT, V16, P821, DOI 10.1016/j.bmcl.2005.11.030; Chopra AR, 2008, SCIENCE, V322, P1395, DOI 10.1126/science.1164847; Coward P, 2001, P NATL ACAD SCI USA, V98, P8880, DOI 10.1073/pnas.151244398; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Greschik H, 2002, MOL CELL, V9, P303, DOI 10.1016/S1097-2765(02)00444-6; Hakimi P, 2007, J BIOL CHEM, V282, P32844, DOI 10.1074/jbc.M706127200; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Hentschke M, 2002, BIOCHEM BIOPH RES CO, V299, P872, DOI 10.1016/S0006-291X(02)02753-5; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Herzog B, 2006, J BIOL CHEM, V281, P99, DOI 10.1074/jbc.M509276200; Herzog B, 2007, MOL ENDOCRINOL, V21, P2687, DOI 10.1210/me.2007-0213; Hong H, 1999, J BIOL CHEM, V274, P22618, DOI 10.1074/jbc.274.32.22618; Horard B, 2004, J MOL ENDOCRINOL, V33, P493, DOI 10.1677/jme.1.01538; Huppunen J, 2004, BIOCHEM BIOPH RES CO, V314, P964, DOI 10.1016/j.bbrc.2003.12.194; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Jeong BC, 2009, J BIOL CHEM, V284, P14211, DOI 10.1074/jbc.M808345200; Kim DK, 2011, J BIOL CHEM, V286, P38035, DOI 10.1074/jbc.M111.250613; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; Lee YS, 2008, BIOCHEM J, V413, P559, DOI 10.1042/BJ20071637; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; LIU JS, 1991, J BIOL CHEM, V266, P19095; Liu NC, 2007, DIABETES, V56, P2901, DOI 10.2337/db07-0359; Mayers RM, 2005, BIOCHEM SOC T, V33, P367, DOI 10.1042/BST0330367; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Narkar VA, 2011, CELL METAB, V13, P283, DOI 10.1016/j.cmet.2011.01.019; Park YY, 2005, NUCLEIC ACIDS RES, V33, P6756, DOI 10.1093/nar/gki976; Park YY, 2004, MOL ENDOCRINOL, V18, P1082, DOI 10.1210/me.2003-0339; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; QUINN PG, 1990, MOL CELL BIOL, V10, P3357, DOI 10.1128/MCB.10.7.3357; Rangwala SM, 2010, J BIOL CHEM, V285, P22619, DOI 10.1074/jbc.M110.125401; Razzaque MA, 2004, GENE, V340, P275, DOI 10.1016/j.gene.2004.07.010; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Sanyal S, 2004, MOL ENDOCRINOL, V18, P312, DOI 10.1210/me.2003-0165; Sanyal S, 2002, J BIOL CHEM, V277, P1739, DOI 10.1074/jbc.M106140200; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Suzuki T, 2004, CANCER RES, V64, P4670, DOI 10.1158/0008-5472.CAN-04-0250; Wang L, 2006, J BIOL CHEM, V281, P37773, DOI 10.1074/jbc.M608410200; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Wu PF, 2000, ARCH BIOCHEM BIOPHYS, V381, P1, DOI 10.1006/abbi.2000.1946; Xie YB, 2009, J BIOL CHEM, V284, P28762, DOI 10.1074/jbc.M109.034165; Xie YB, 2009, NUCLEIC ACIDS RES, V37, P4100, DOI 10.1093/nar/gkp333; Yang JQ, 2009, J BIOL CHEM, V284, P27031, DOI 10.1074/jbc.R109.040535; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200; Zhang ZP, 2007, MOL CELL ENDOCRINOL, V264, P128, DOI 10.1016/j.mce.2006.11.002	59	94	95	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21628	21639		10.1074/jbc.M111.315168	http://dx.doi.org/10.1074/jbc.M111.315168			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22549789	Green Published, hybrid			2022-12-25	WOS:000306418600006
J	Szabo, A; Sahin-Toth, M				Szabo, Andras; Sahin-Toth, Miklos			Increased Activation of Hereditary Pancreatitis-associated Human Cationic Trypsinogen Mutants in Presence of Chymotrypsin C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZYMOGEN ACTIVATION; MUTATION; PRSS1; GENE; AUTOACTIVATION; SECRETION; EXPRESSION; MECHANISM; VARIANTS; JUICE	Mutations in human cationic trypsinogen (PRSS1) cause autosomal dominant hereditary pancreatitis. Increased intra-pancreatic autoactivation of trypsinogen mutants has been hypothesized to initiate the disease. Autoactivation of cationic trypsinogen is proteolytically regulated by chymotrypsin C (CTRC), which mitigates the development of trypsin activity by promoting degradation of both trypsinogen and trypsin. Paradoxically, CTRC also increases the rate of autoactivation by processing the trypsinogen activation peptide to a shorter form. The aim of this study was to investigate the effect of CTRC on the autoactivation of clinically relevant trypsinogen mutants. We found that in the presence of CTRC, trypsinogen mutants associated with classic hereditary pancreatitis (N29I, N29T, V39A, R122C, and R122H) autoactivated at increased rates and reached markedly higher active trypsin levels compared with wild-type cationic trypsinogen. The A16V mutant, known for its variable disease penetrance, exhibited a smaller increase in autoactivation. The mechanistic basis of increased activation was mutation-specific and involved resistance to degradation (N29I, N29T, V39A, R122C, and R122H) and/or increased N-terminal processing by CTRC (A16V and N29I). These observations indicate that hereditary pancreatitis is caused by CTRC-dependent dysregulation of cationic trypsinogen autoactivation, which results in elevated trypsin levels in the pancreas.	[Szabo, Andras; Sahin-Toth, Miklos] Boston Univ, Dept Mol & Cell Biol, Henry M Goldman Sch Dent Med, Boston, MA 02118 USA	Boston University	Sahin-Toth, M (corresponding author), Boston Univ, Dept Mol & Cell Biol, Henry M Goldman Sch Dent Med, 72 E Concord St,Evans 433, Boston, MA 02118 USA.	miklos@bu.edu		Sahin-Toth, Miklos/0000-0003-4513-9922	National Institutes of Health [R01 DK058088, R01 DK082412, R01 DK082412-S2]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082412, R01DK058088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK058088, R01 DK082412, and R01 DK082412-S2 (to M.S.-T.).	Arduino C, 2005, GUT, V54, P1663, DOI 10.1136/gut.2004.062992; Bence M, 2011, FEBS J, V278, P4338, DOI 10.1111/j.1742-4658.2011.08351.x; Bertin C, 2012, AM J GASTROENTEROL, V107, P311, DOI 10.1038/ajg.2011.424; Chen JM, 2003, MOL BIOL EVOL, V20, P1767, DOI 10.1093/molbev/msg183; Furui T, 2000, PANCREAS, V21, P257, DOI 10.1097/00006676-200010000-00006; GEROLAMI A, 1989, GASTROENTEROLOGY, V96, P881; Grocock CJ, 2010, GUT, V59, P357, DOI 10.1136/gut.2009.186817; HARADA H, 1980, Gastroenterologia Japonica, V15, P355; Howes N, 2004, CLIN GASTROENTEROL H, V2, P252, DOI 10.1016/S1542-3565(04)00013-8; Joergensen MT, 2011, PANCREAS, V40, P540, DOI 10.1097/MPA.0b013e3182152fdf; Joergensen MT, 2010, AM J GASTROENTEROL, V105, P1876, DOI 10.1038/ajg.2010.193; Kereszturi E, 2009, HUM MUTAT, V30, P575, DOI 10.1002/humu.20853; Kiraly O, 2006, PROTEIN EXPRES PURIF, V48, P104, DOI 10.1016/j.pep.2006.01.023; Kiraly O, 2011, METHODS MOL BIOL, V705, P175, DOI 10.1007/978-1-61737-967-3_10; Kukor Z, 2002, J BIOL CHEM, V277, P6111, DOI 10.1074/jbc.M110959200; Lengyel Z, 1998, PROTEIN EXPRES PURIF, V12, P291, DOI 10.1006/prep.1997.0837; Masson E, 2008, HUM GENET, V123, P83, DOI 10.1007/s00439-007-0459-3; Nemoda Z, 2006, J BIOL CHEM, V281, P11879, DOI 10.1074/jbc.M600124200; Ozsvari B, 2008, PANCREAS, V37, P182, DOI 10.1097/MPA.0b013e3181663066; Rebours V, 2009, GUT, V58, P97, DOI 10.1136/gut.2008.149179; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; Sahin-Toth M, 2000, BIOCHEM BIOPH RES CO, V278, P286, DOI 10.1006/bbrc.2000.3797; Sahin-Toth M, 2000, J BIOL CHEM, V275, P22750, DOI 10.1074/jbc.M002943200; Simon P, 2002, J BIOL CHEM, V277, P5404, DOI 10.1074/jbc.M108073200; Szabo A, 2011, J BIOL CHEM, V286, P22535, DOI 10.1074/jbc.M111.235754; Szmola R, 2007, P NATL ACAD SCI USA, V104, P11227, DOI 10.1073/pnas.0703714104; Szmola R, 2010, J MED GENET, V47, P348, DOI 10.1136/jmg.2009.072751; Teich N, 2000, GASTROENTEROLOGY, V119, P461, DOI 10.1053/gast.2000.9312; Teich N, 2005, HUM MUTAT, V25, P343, DOI 10.1002/humu.20148; Teich N, 2006, HUM MUTAT, V27, P721, DOI 10.1002/humu.20343; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 1999, GASTROENTEROLOGY, V117, P7, DOI 10.1016/S0016-5085(99)70543-3; Zhou JY, 2011, J GASTROEN HEPATOL, V26, P1238, DOI 10.1111/j.1440-1746.2011.06791.x	33	59	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20701	20710		10.1074/jbc.M112.360065	http://dx.doi.org/10.1074/jbc.M112.360065			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22539344	Green Published, hybrid			2022-12-25	WOS:000306414500088
J	Marshall-Pescini, S; Passalacqua, C; Petrazzini, MEM; Valsecchi, P; Prato-Previde, E				Marshall-Pescini, Sarah; Passalacqua, Chiara; Petrazzini, Maria Elena Miletto; Valsecchi, Paola; Prato-Previde, Emanuela			Do Dogs (Canis lupus familiaris) Make Counterproductive Choices Because They Are Sensitive to Human Ostensive Cues?	PLOS ONE			English	Article							DIFFERENTIAL SENSITIVITY; HUMAN-COMMUNICATION; HUMAN INFANTS; INFORMATION CONFLICT; WOLVES; TRANSMISSION; MECHANISMS; CULTURE; IMITATE	Dogs appear to be sensitive to human ostensive communicative cues in a variety of situations, however there is still a measure of controversy as to the way in which these cues influence human-dog interactions. There is evidence for instance that dogs can be led into making evaluation errors in a quantity discrimination task, for example losing their preference for a larger food quantity if a human shows a preference for a smaller one, yet there is, so far, no explanation for this phenomenon. Using a modified version of this task, in the current study we investigated whether non-social, social or communicative cues (alone or in combination) cause dogs to go against their preference for the larger food quantity. Results show that dogs' evaluation errors are indeed caused by a social bias, but, somewhat contrary to previous studies, they highlight the potent effect of stimulus enhancement (handling the target) in influencing the dogs' response. A mild influence on the dog's behaviour was found only when different ostensive cues (and no handling of the target) were used in combination, suggesting their cumulative effect. The discussion addresses possible motives for discrepancies with previous studies suggesting that both the intentionality and the directionality of the action may be important in causing dogs' social biases.	[Marshall-Pescini, Sarah; Passalacqua, Chiara; Petrazzini, Maria Elena Miletto; Prato-Previde, Emanuela] Univ Milan, Dept Biomed Sci & Technol, I-20133 Milan, Italy; [Valsecchi, Paola] Univ Parma, Dept Evolutionary & Funct Biol, I-43100 Parma, Italy	University of Milan; University of Parma	Marshall-Pescini, S (corresponding author), Univ Milan, Dept Biomed Sci & Technol, I-20133 Milan, Italy.	sarah.marshall@unimi.it	miletto petrazzini, maria elena/GSO-3842-2022	miletto petrazzini, maria elena/0000-0002-5204-5863; Valsecchi, Paola/0000-0002-0491-9845; Marshall-Pescini, Sarah/0000-0002-5944-4701	Milan University	Milan University	This research was supported by a doctoral and post-doctoral grant from Milan University to Chiara Passalacqua and Sarah Marshall-Pescini. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brugger A, 2007, CHILD DEV, V78, P806, DOI 10.1111/j.1467-8624.2007.01034.x; Cladiere N, PSYCHOL B IN PRESS; Csibra G, 2011, PHILOS T R SOC B, V366, P1149, DOI 10.1098/rstb.2010.0319; Fiset S, 2010, SCIENCE, V329, DOI [10.1126/science.1184045, 10.1126/science.1187748]; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Franz M, 2010, P ROY SOC B-BIOL SCI, V277, P3363, DOI 10.1098/rspb.2010.0705; Galef BG, 2001, ANIM BEHAV, V61, P3, DOI 10.1006/anbe.2000.1557; Giraldeau LA, 2002, PHILOS T R SOC B, V357, P1559, DOI 10.1098/rstb.2002.1065; HEYES CM, 1994, BIOL REV, V69, P207, DOI 10.1111/j.1469-185X.1994.tb01506.x; Hopper LM, 2011, ANIM BEHAV, V81, P1195, DOI 10.1016/j.anbehav.2011.03.002; Hoppitt W, 2008, ADV STUD BEHAV, V38, P105, DOI 10.1016/S0065-3454(08)00003-X; Kaminski J, 2012, DEVELOPMENTAL SCI, V15, P222, DOI 10.1111/j.1467-7687.2011.01120.x; Kaminski J, 2011, ANIM BEHAV, V81, P195, DOI 10.1016/j.anbehav.2010.10.001; Kendal RL, 2004, BEHAV ECOL, V15, P269, DOI 10.1093/beheco/arh008; Kupan K, 2011, ANIM COGN, V14, P259, DOI 10.1007/s10071-010-0359-0; Laland KN, 1998, BEHAV ECOL, V9, P493, DOI 10.1093/beheco/9.5.493; Laland KN, 2004, LEARN BEHAV, V32, P4; Lyons DE, 2007, PNAS, V104, P1158; Lyons DE, 2011, PHILOS T R SOC B, V366, P1158, DOI 10.1098/rstb.2010.0335; Marshall-Pescini S, 2011, ANIM COGN, V14, P137, DOI 10.1007/s10071-010-0340-y; Marshall-Pescini S, 2008, ANIM COGN, V11, P449, DOI 10.1007/s10071-007-0135-y; Mersmann D, 2011, ETHOLOGY, V117, P675, DOI 10.1111/j.1439-0310.2011.01919.x; Nielsen M, 2006, DEV PSYCHOL, V42, P555, DOI 10.1037/0012-1649.42.3.555; Pongracz P, 2004, J COMP PSYCHOL, V118, P375, DOI 10.1037/0735-7036.118.4.375; Prato-Previde E, 2008, ANIM COGN, V11, P167, DOI 10.1007/s10071-007-0102-7; Price EE, 2009, P ROY SOC B-BIOL SCI, V276, P3377, DOI 10.1098/rspb.2009.0640; Range F, 2007, CURR BIOL, V17, P868, DOI 10.1016/j.cub.2007.04.026; Range F, 2009, APPL ANIM BEHAV SCI, V120, P170, DOI 10.1016/j.applanim.2009.05.012; Rieucau G, 2011, PHILOS T R SOC B, V366, P949, DOI 10.1098/rstb.2010.0325; Southgate V, 2009, DEVELOPMENTAL SCI, V12, P1013, DOI 10.1111/j.1467-7687.2009.00861.x; Szetei V, 2003, APPL ANIM BEHAV SCI, V83, P141, DOI 10.1016/S0168-1591(03)00114-X; Tennie C, 2009, ANIM BEHAV, V77, P1491, DOI 10.1016/j.anbehav.2009.03.008; Topal J, 2008, SCIENCE, V321, P1831, DOI 10.1126/science.1161437; Topal J, 2010, SCIENCE, V329, DOI 10.1126/science.1184152; Topal J, 2009, SCIENCE, V325, P1269, DOI 10.1126/science.1176960; van Bergen Y, 2004, P ROY SOC B-BIOL SCI, V271, P957, DOI 10.1098/rspb.2004.2684; WHITEN A, 1992, ADV STUD BEHAV, V21, P239, DOI 10.1016/S0065-3454(08)60146-1; Woodward AL, 1998, COGNITION, V69, P1, DOI 10.1016/S0010-0277(98)00058-4; WOODWARD AL, 1999, INFANT BEHAV DEV, V17, P515	39	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35437	10.1371/journal.pone.0035437	http://dx.doi.org/10.1371/journal.pone.0035437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558150	Green Published, gold			2022-12-25	WOS:000305345200040
J	Patel, MV; Ghosh, M; Fahey, JV; Wira, CR				Patel, Mickey V.; Ghosh, Mimi; Fahey, John V.; Wira, Charles R.			Uterine Epithelial Cells Specifically Induce Interferon-Stimulated Genes in Response to Polyinosinic-Polycytidylic Acid Independently of Estradiol	PLOS ONE			English	Article							FEMALE REPRODUCTIVE-TRACT; HERPES-SIMPLEX-VIRUS; DOUBLE-STRANDED-RNA; INNATE IMMUNITY; CHEMOKINE PRODUCTION; ANTIVIRAL RESPONSES; VIRAL REPLICATION; HIV-1 REPLICATION; TYPE-1 INFECTION; MESSENGER-RNA	Interferon beta (IFN beta) is an antiviral cytokine secreted in response to pathogenic exposure that creates a restrictive intracellular environment through the action of downstream interferon-stimulated genes (ISG). The objective of this study was to examine the expression of IFN beta and ISG in both human uterine epithelial cells (UEC) and the ECC-1 uterine epithelial cell line and determine if expression changes with TLR stimulation and hormone exposure. Stimulation of primary uterine epithelial cells and ECC-1 cells with the TLR3 agonist poly (I: C) induced the mRNA expression of IFN beta, MxA, OAS2 and PKR. Other TLR agonists including imiquimod and CpG had no effect on either IFN beta or ISG expression. In contrast to ECC-1 cell responses which were slower, maximal IFNb upregulation in UEC occurred 3 hours post-stimulation and preceded the ISG response which peaked approximately 12 hours after poly (I: C) exposure. Unexpectedly, estradiol, either alone or prior to treatment with poly (I: C), had no effect on IFN beta or ISG expression. Blockade of the IFN receptor abrogated the upregulation of MxA, OAS2 and PKR. Furthermore, neutralizing antibodies against IFN beta partially inhibited the upregulation of all three ISG. Estradiol, directly and in the presence of poly (I: C) had no effect on IFN beta and ISG expression. These results indicate that uterine epithelial cells are important sentinels of the innate immune system and demonstrate that uterine epithelial cells are capable of mounting a rapid IFN-mediated antiviral response that is independent of estradiol and is therefore potentially sustained throughout the menstrual cycle to aid in the defense of the uterus against potential pathogens.	[Patel, Mickey V.; Ghosh, Mimi; Fahey, John V.; Wira, Charles R.] Dartmouth Med Sch, Dept Physiol & Neurobiol, Lebanon, NH USA	Dartmouth College	Patel, MV (corresponding author), Dartmouth Med Sch, Dept Physiol & Neurobiol, Lebanon, NH USA.	mickey.patel@dartmouth.edu			National Institute of Health [AI51877, AI071761]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071761, P01AI051877, R01AI102838, R56AI071761] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by AI51877 and AI071761 (awarded to Dr. Wira) from National Institute of Health (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson ME, 1999, EUR J BIOCHEM, V264, P806, DOI 10.1046/j.1432-1327.1999.00661.x; Akhtar LN, 2010, J IMMUNOL, V185, P2393, DOI 10.4049/jimmunol.0903563; Andersen JM, 2006, BIOL REPROD, V74, P824, DOI 10.1095/biolreprod.105.048629; Austin BA, 2005, J IMMUNOL, V175, P1100, DOI 10.4049/jimmunol.175.2.1100; Axtell RC, 2011, TRENDS IMMUNOL, V32, P272, DOI 10.1016/j.it.2011.03.008; Bisbal C, 2007, BIOCHIMIE, V89, P789, DOI 10.1016/j.biochi.2007.02.006; Bode JG, 2007, ARCH BIOCHEM BIOPHYS, V462, P254, DOI 10.1016/j.abb.2007.03.033; Brand S, 2005, AM J PHYSIOL-GASTR L, V289, pG960, DOI 10.1152/ajpgi.00126.2005; Brand S, 2005, BIOCHEM BIOPH RES CO, V331, P543, DOI 10.1016/j.bbrc.2005.04.004; Clerzius G, 2009, J VIROL, V83, P10119, DOI 10.1128/JVI.02457-08; Conrady CD, 2011, J VIROL, V85, P1625, DOI 10.1128/JVI.01715-10; Damdinsuren B, 2003, ANN SURG ONCOL, V10, P1184, DOI 10.1245/ASO.2003.03.010; Dogusan Z, 2008, DIABETES, V57, P1236, DOI 10.2337/db07-0844; Escribese MM, 2008, BLOOD, V112, P4574, DOI 10.1182/blood-2008-04-148692; Fahey JV, 2008, MUCOSAL IMMUNOL, V1, P317, DOI 10.1038/mi.2008.20; Fahey JV, 2005, HUM REPROD, V20, P1439, DOI 10.1093/humrep/deh806; Fahey JV, 2002, J INFECT DIS, V185, P1606, DOI 10.1086/340512; Farnell YZ, 2003, J STEROID BIOCHEM, V84, P453, DOI 10.1016/S0960-0760(03)00066-9; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Ghosh M, 2010, IMMUNOLOGY, V129, P207, DOI 10.1111/j.1365-2567.2009.03165.x; Haller O, 2007, BIOCHIMIE, V89, P812, DOI 10.1016/j.biochi.2007.04.015; Hart KM, 2009, J REPROD IMMUNOL, V80, P33, DOI 10.1016/j.jri.2008.12.004; Hovanessian AG, 2007, BIOCHIMIE, V89, P779, DOI 10.1016/j.biochi.2007.02.003; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim CH, 2010, ARCH DERMATOL RES, V302, P301, DOI 10.1007/s00403-009-1012-0; Ku CC, 2011, IMMUNOL CELL BIOL, V89, P173, DOI 10.1038/icb.2010.83; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Lesmeister MJ, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-74; Maitra RK, 1998, J VIROL, V72, P1146, DOI 10.1128/JVI.72.2.1146-1152.1998; Martinand C, 1999, J VIROL, V73, P290, DOI 10.1128/JVI.73.1.290-296.1999; Mo B, 2006, BIOL REPROD, V75, P387, DOI 10.1095/biolreprod.106.051870; Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10; Murphy JA, 2003, J VIROL, V77, P9337, DOI 10.1128/JVI.77.17.9337-9345.2003; Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926; Nazli A, 2009, ANTIVIR RES, V81, P103, DOI 10.1016/j.antiviral.2008.10.005; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Novick D, 2000, J INTERF CYTOK RES, V20, P971, DOI 10.1089/10799900050198417; Nurkkala M, 2007, J REPROD IMMUNOL, V73, P148, DOI 10.1016/j.jri.2006.09.001; Pauli EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000196; Pentecost BT, 1998, J STEROID BIOCHEM, V64, P25, DOI 10.1016/S0960-0760(97)00140-4; Pioli PA, 2004, INFECT IMMUN, V72, P5799, DOI 10.1128/IAI.72.10.5799-5806.2004; PITHA PM, 1994, ANTIVIR RES, V24, P205, DOI 10.1016/0166-3542(94)90068-X; Rintahaka J, 2008, J IMMUNOL, V180, P1749, DOI 10.4049/jimmunol.180.3.1749; Schaefer TM, 2004, IMMUNOLOGY, V112, P428, DOI 10.1111/j.1365-2567.2004.01898.x; Schaefer TM, 2005, J IMMUNOL, V174, P992, DOI 10.4049/jimmunol.174.2.992; Schindler C.W., 2011, J BIOL CHEM; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sen GC, 2007, CURR TOP MICROBIOL, V316, P233; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Trapp S, 2009, J VIROL, V83, P884, DOI 10.1128/JVI.00023-08; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Vlotides G, 2004, BIOCHEM BIOPH RES CO, V320, P1007, DOI 10.1016/j.bbrc.2004.06.051; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Wira CR, 2010, AM J REPROD IMMUNOL, V63, P544, DOI 10.1111/j.1600-0897.2010.00842.x; Yao XD, 2011, J GEN VIROL, V92, P1981, DOI 10.1099/vir.0.030296-0; Zhang SY, 2008, IMMUNOL REV, V226, P29, DOI 10.1111/j.1600-065X.2008.00698.x	58	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35654	10.1371/journal.pone.0035654	http://dx.doi.org/10.1371/journal.pone.0035654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558189	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345200061
J	Adhikari, BN; Savory, EA; Vaillancourt, B; Childs, KL; Hamilton, JP; Day, B; Buell, CR				Adhikari, Bishwo N.; Savory, Elizabeth A.; Vaillancourt, Brieanne; Childs, Kevin L.; Hamilton, John P.; Day, Brad; Buell, C. Robin			Expression Profiling of Cucumis sativus in Response to Infection by Pseudoperonospora cubensis	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; DOWNY MILDEW INFECTION; GENE-EXPRESSION; RNA-SEQ; DISEASE RESISTANCE; PLANT; TRANSCRIPTOME; ACCUMULATION; ARABIDOPSIS; GENOME	The oomycete pathogen, Pseudoperonospora cubensis, is the causal agent of downy mildew on cucurbits, and at present, no effective resistance to this pathogen is available in cultivated cucumber (Cucumis sativus). To better understand the host response to a virulent pathogen, we performed expression profiling throughout a time course of a compatible interaction using whole transcriptome sequencing. As described herein, we were able to detect the expression of 15,286 cucumber genes, of which 14,476 were expressed throughout the infection process from 1 day post-inoculation (dpi) to 8 dpi. A large number of genes, 1,612 to 3,286, were differentially expressed in pair-wise comparisons between time points. We observed the rapid induction of key defense related genes, including catalases, chitinases, lipoxygenases, peroxidases, and protease inhibitors within 1 dpi, suggesting detection of the pathogen by the host. Co-expression network analyses revealed transcriptional networks with distinct patterns of expression including down-regulation at 2 dpi of known defense response genes suggesting coordinated suppression of host responses by the pathogen. Comparative analyses of cucumber gene expression patterns with that of orthologous Arabidopsis thaliana genes following challenge with Hyaloperonospora arabidopsidis revealed correlated expression patterns of single copy orthologs suggesting that these two dicot hosts have similar transcriptional responses to related pathogens. In total, the work described herein presents an in-depth analysis of the interplay between host susceptibility and pathogen virulence in an agriculturally important pathosystem.	[Adhikari, Bishwo N.; Vaillancourt, Brieanne; Childs, Kevin L.; Hamilton, John P.; Buell, C. Robin] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Savory, Elizabeth A.; Day, Brad] Michigan State Univ, Dept Plant Pathol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Adhikari, BN (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.	buell@msu.edu	Hamilton, John P/G-1379-2016; Adhikari, Bishwo/E-8144-2013; Childs, Kevin/C-9513-2014	Hamilton, John P/0000-0002-8682-5526; Adhikari, Bishwo/0000-0003-1594-8470; Buell, C Robin/0000-0002-6727-4677; Vaillancourt, Brieanne/0000-0002-6795-5173; Childs, Kevin/0000-0002-3680-062X; Day, Brad/0000-0002-9880-4319; Adhikari, Bishwo/0000-0003-4840-9609; Savory, Elizabeth/0000-0002-6016-9962	United States Department of Agriculture National Institute for Food and Agriculture [2009-65109-05719, 2011-67011-30758]; National Science Foundation Faculty Early Career Development Award [IOS-0641319]	United States Department of Agriculture National Institute for Food and Agriculture(United States Department of Agriculture (USDA)); National Science Foundation Faculty Early Career Development Award(National Science Foundation (NSF))	Phytopathogen work in the laboratory of CRB was supported by a grant from the United States Department of Agriculture National Institute for Food and Agriculture (2009-65109-05719). Work in the laboratory of BD was supported by a grant from the United States Department of Agriculture National Institute for Food and Agriculture (2011-67011-30758) and in part by a National Science Foundation Faculty Early Career Development Award (IOS-0641319). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2010, J AM SOC HORTIC SCI, V135, P291, DOI 10.21273/JASHS.135.4.291; Arauz LF, 2010, PHYTOPATHOLOGY, V100, P959, DOI 10.1094/PHYTO-100-9-0959; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Baysal T, 2007, ENZYME MICROB TECH, V40, P491, DOI 10.1016/j.enzmictec.2006.11.025; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Bernoux M, 2008, PLANT CELL, V20, P2252, DOI 10.1105/tpc.108.058685; Boddu J, 2007, MOL PLANT MICROBE IN, V20, P1364, DOI 10.1094/MPMI-20-11-1364; Brader G, 2007, MOL PLANT MICROBE IN, V20, P589, DOI 10.1094/MPMI-20-5-0589; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Coates ME, 2010, ANNU REV PHYTOPATHOL, V48, P329, DOI 10.1146/annurev-phyto-080508-094422; Cohen Y, 2003, PHYTOPARASITICA, V31, P458, DOI 10.1007/BF02979739; Colucci S. J., 2006, P CUC 2006; Criswell A, 2008, THESIS NCSU; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gaulin E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001723; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; Gupta S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009030; Hammerschmidt R, 1999, ANNU REV PHYTOPATHOL, V37, P285, DOI 10.1146/annurev.phyto.37.1.285; Hammerschmidt R, 1999, PHYSIOL MOL PLANT P, V55, P77, DOI 10.1006/pmpp.1999.0215; Hilaire E, 2001, MOL PLANT MICROBE IN, V14, P1411, DOI 10.1094/MPMI.2001.14.12.1411; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Huibers RP, 2009, MOL PLANT MICROBE IN, V22, P1104, DOI 10.1094/MPMI-22-9-1104; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Knepper Caleb, 2010, Arabidopsis Book, V8, pe012, DOI 10.1199/tab.0124; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lebeda A, 2002, ACTA HORTIC, P137, DOI 10.17660/ActaHortic.2002.588.20; Lebeda A, 2003, Z PFLANZENK PFLANZEN, V110, P337; Lebeda A., 2004, ACTA FYTOTECH ZOOTEC, V7, P170; Lebeda A, 2011, J PHYTOPATHOL, V159, P589, DOI 10.1111/j.1439-0434.2011.01811.x; Li JW, 2011, PLANT CELL REP, V30, P345, DOI 10.1007/s00299-010-0959-9; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lough TJ, 2006, ANNU REV PLANT BIOL, V57, P203, DOI 10.1146/annurev.arplant.56.032604.144145; Miranda M, 2007, MOL PLANT MICROBE IN, V20, P816, DOI 10.1094/MPMI-20-7-0816; Olczak-Woltman H, 2009, J APPL GENET, V50, P1, DOI 10.1007/BF03195645; Phuntumart V, 2006, PLANT SCI, V171, P555, DOI 10.1016/j.plantsci.2006.05.014; Polesani M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-142; Polesani M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-117; Ren Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005795; Runge F, 2011, EUR J PLANT PATHOL, V129, P135, DOI 10.1007/s10658-010-9714-x; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sarris P, 2009, PLANT PATHOL, V58, P933, DOI 10.1111/j.1365-3059.2009.02093.x; Savory E, 2012, PLOS ONE IN PRESS; Savory EA, 2011, MOL PLANT PATHOL, V12, P217, DOI 10.1111/j.1364-3703.2010.00670.x; Shetty NV, 2002, SCI HORTIC-AMSTERDAM, V94, P231, DOI 10.1016/S0304-4238(02)00013-4; Sticher L, 1997, ANNU REV PHYTOPATHOL, V35, P235, DOI 10.1146/annurev.phyto.35.1.235; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Takemoto Daigo, 2001, Journal of General Plant Pathology, V67, P89, DOI 10.1007/PL00013005; Taler D, 2004, PLANT CELL, V16, P172, DOI 10.1105/tpc.016352; Tanurdzic M, 2004, PLANT CELL, V16, pS61, DOI 10.1105/tpc.016667; THOMAS CE, 1987, PHYTOPATHOLOGY, V77, P1621, DOI 10.1094/Phyto-77-1621; Tian MY, 2011, MOL PLANT MICROBE IN, V24, P543, DOI 10.1094/MPMI-08-10-0185; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Varbanova M, 2011, PLANT PHYSIOL, V157, P1056, DOI 10.1104/pp.111.184358; Volk GM, 2003, J AM SOC HORTIC SCI, V128, P8, DOI 10.21273/JASHS.128.1.0008; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang W, 2011, NATURE, V470, P110, DOI 10.1038/nature09766; Wehner T.C., 2010, CUCURBI GENET COOP R, V28, P105; Woycicki R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022728; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	63	42	47	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e34954	10.1371/journal.pone.0034954	http://dx.doi.org/10.1371/journal.pone.0034954			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545095	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343200017
J	Johnston, CA; Doe, CQ; Prehoda, KE				Johnston, Christopher A.; Doe, Chris Q.; Prehoda, Kenneth E.			Structure of an Enzyme-Derived Phosphoprotein Recognition Domain	PLOS ONE			English	Article							ASYMMETRIC CELL-DIVISION; GUANYLATE KINASE DOMAINS; SPINDLE ORIENTATION; PROTEIN; BINDING; POLARITY; ACTIVATION; MECHANISM; EVOLUTION; HOMOLOG	Membrane Associated Guanylate Kinases (MAGUKs) contain a protein interaction domain (GK(dom)) derived from the enzyme Guanylate Kinase (GK(enz)). Here we show that GK(dom) from the MAGUK Discs large (Dlg) is a phosphoprotein recognition domain, specifically recognizing the phosphorylated form of the mitotic spindle orientation protein Partner of Inscuteable (Pins). We determined the structure of the Dlg-Pins complex to understand the dramatic transition from nucleotide kinase to phosphoprotein recognition domain. The structure reveals that the region of the GK(dom) that once served as the GMP binding domain (GBD) has been co-opted for protein interaction. Pins makes significantly more contact with the GBD than does GMP, but primarily with residues that are conserved between enzyme and domain revealing the versatility of the GBD as a platform for nucleotide and protein interactions. Mutational analysis reveals that the GBD is also used to bind the GK ligand MAP1a, suggesting that this is a common mode of MAGUK complex assembly. The GK(enz) undergoes a dramatic closing reaction upon GMP binding but the protein-bound GK(dom) remains in the 'open' conformation indicating that the dramatic conformational change has been lost in the conversion from nucleotide kinase to phosphoprotein recognition domain.	[Johnston, Christopher A.; Doe, Chris Q.; Prehoda, Kenneth E.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Johnston, Christopher A.; Doe, Chris Q.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; [Johnston, Christopher A.; Doe, Chris Q.] Univ Oregon, Howard Hughes Med Inst, Eugene, OR 97403 USA	University of Oregon; University of Oregon; Howard Hughes Medical Institute; University of Oregon	Johnston, CA (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	prehoda@molbio.uoregon.edu		Prehoda, Ken/0000-0003-4214-6158	National Institutes of Health [GM087457]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health grant GM087457. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwood SX, 2007, J CELL SCI, V120, P3200, DOI 10.1242/jcs.014902; Atwood SX, 2009, CURR BIOL, V19, P723, DOI 10.1016/j.cub.2009.03.056; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Blaszczyk J, 2001, J MOL BIOL, V307, P247, DOI 10.1006/jmbi.2000.4427; Bornberg-Bauer E, 2010, CURR OPIN STRUC BIOL, V20, P390, DOI 10.1016/j.sbi.2010.02.005; Brenman JE, 1998, J NEUROSCI, V18, P8805; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; de Mendoza A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-93; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Hanson JA, 2007, P NATL ACAD SCI USA, V104, P18055, DOI 10.1073/pnas.0708600104; Harms MJ, 2010, CURR OPIN STRUCT BIO; Harris BZ, 2001, J CELL SCI, V114, P3219; Johnston CA, 2011, P NATL ACAD IN PRESS; Johnston CA, 2009, CELL, V138, P1150, DOI 10.1016/j.cell.2009.07.041; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Li YH, 2002, J BIOL CHEM, V277, P4159, DOI 10.1074/jbc.M110792200; Lye MF, 2010, J BIOL CHEM, V285, P13907, DOI 10.1074/jbc.M109.093674; Marcette J, 2009, BIOCHEMISTRY-US, V48, P10014, DOI 10.1021/bi901160f; Masuko N, 1999, J BIOL CHEM, V274, P5782, DOI 10.1074/jbc.274.9.5782; Mathew D, 2002, CURR BIOL, V12, P531, DOI 10.1016/S0960-9822(02)00758-3; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; Naisbitt S, 1997, J NEUROSCI, V17, P5687; Nipper RW, 2007, P NATL ACAD SCI USA, V104, P14306, DOI 10.1073/pnas.0701812104; Olsen O, 2003, J BIOL CHEM, V278, P6873, DOI 10.1074/jbc.M210165200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Prehoda KE, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001388; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Qian Y, 2006, J BIOL CHEM, V281, P35757, DOI 10.1074/jbc.M607057200; Reese ML, 2007, NAT STRUCT MOL BIOL, V14, P155, DOI 10.1038/nsmb1195; Ricketson D, 2010, P NATL ACAD SCI USA, V107, P20964, DOI 10.1073/pnas.1007025107; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Sekulic N, 2002, J BIOL CHEM, V277, P30236, DOI 10.1074/jbc.M204668200; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; Smith NR, 2011, MOL CELL, V43, P540, DOI 10.1016/j.molcel.2011.06.030; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Velthuis AJWT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-129; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Yu FW, 2006, NEURON, V51, P13, DOI 10.1016/j.neuron.2006.06.016; Zhu JW, 2011, EMBO J, V30, P4986, DOI 10.1038/emboj.2011.428	45	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e36014	10.1371/journal.pone.0036014	http://dx.doi.org/10.1371/journal.pone.0036014			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545154	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343200074
J	Kukshal, V; Khanam, T; Chopra, D; Singh, N; Sanyal, S; Ramachandran, R				Kukshal, Vandna; Khanam, Taran; Chopra, Deepti; Singh, Nidhi; Sanyal, Sabyasachi; Ramachandran, Ravishankar			M. tuberculosis Sliding beta-Clamp Does Not Interact Directly with the NAD(+) -Dependent DNA Ligase	PLOS ONE			English	Article							CELL NUCLEAR ANTIGEN; MYCOBACTERIUM-TUBERCULOSIS; POLYMERASE-III; CRYSTAL-STRUCTURE; SUBUNIT; PCNA; IDENTIFICATION; REPLICATION; RV3014C; COMPLEX	The sliding beta-clamp, an important component of the DNA replication and repair machinery, is drawing increasing attention as a therapeutic target. We report the crystal structure of the M. tuberculosis beta-clamp (Mtb beta-clamp) to 3.0 angstrom resolution. The protein crystallized in the space group C222(1) with cell-dimensions a = 72.7, b = 234.9 & c = 125.1 angstrom respectively. Mtb beta-clamp is a dimer, and exhibits head-to-tail association similar to other bacterial clamps. Each monomer folds into three domains with similar structures respectively and associates with its dimeric partner through 6 salt-bridges and about 21 polar interactions. Affinity experiments involving a blunt DNA duplex, primed-DNA and nicked DNA respectively show that Mtb beta-clamp binds specifically to primed DNA about 1.8 times stronger compared to the other two substrates and with an apparent K-d of 300 nM. In bacteria like E. coli, the beta-clamp is known to interact with subunits of the clamp loader, NAD(+) -dependent DNA ligase (LigA) and other partners. We tested the interactions of the Mtb beta-clamp with MtbLigA and the gamma-clamp loader subunit through radioactive gel shift assays, size exclusion chromatography, yeast-two hybrid experiments and also functionally. Intriguingly while Mtb beta-clamp interacts in vitro with the gamma-clamp loader, it does not interact with MtbLigA unlike in bacteria like E. coli where it does. Modeling studies involving earlier peptide complexes reveal that the peptide-binding site is largely conserved despite lower sequence identity between bacterial clamps. Overall the results suggest that other as-yet-unidentified factors may mediate interactions between the clamp, LigA and DNA in mycobacteria.	[Kukshal, Vandna; Khanam, Taran; Chopra, Deepti; Ramachandran, Ravishankar] CSIR, Cent Drug Res Inst, Mol & Struct Biol Div, Lucknow, Uttar Pradesh, India; [Singh, Nidhi; Sanyal, Sabyasachi] CSIR, Cent Drug Res Inst, Drug Target Discovery & Dev Div, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Kukshal, V (corresponding author), CSIR, Cent Drug Res Inst, Mol & Struct Biol Div, Lucknow, Uttar Pradesh, India.	r_ravishankar@cdri.res.in	Sanyal, Sabyasachi/E-8034-2010	Sanyal, Sabyasachi/0000-0002-8603-3828; KHANAM, TARAN/0000-0003-0923-2302; kukshal, vandna/0000-0002-6207-2638	Department of Biotechnology, India [GAP0018]; Council of Scientific and Industrial Research (CSIR), India [NWP0038]; CSIR	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This study was funded by the Department of Biotechnology, India (Grant No. GAP0018) and the Council of Scientific and Industrial Research (CSIR), India (Grant No. NWP0038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Richard Bowater (School of Biological Sciences, University of East Anglia) for the E. coli LigA clone. We also thank Dr. Penny Beuning (Department of Chemistry and Chemical Biology, Northeastern University) and Dr. Linda Bloom (Department of Biochemistry and Molecular Biology, University of Florida) for plasmid constructs that helped standardize the purification of the E. coli beta-clamp. VK, TK and NS are recipients of fellowships from CSIR. This communication bears the CDRI No. 8222	Aniukwu J, 2008, GENE DEV, V22, P512, DOI 10.1101/gad.1631908; Argiriadi MA, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Burnouf DY, 2004, J MOL BIOL, V335, P1187, DOI 10.1016/j.jmb.2003.11.049; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; de Saro FJL, 2003, EMBO J, V22, P6408, DOI 10.1093/emboj/cdg603; de Saro FJL, 2001, P NATL ACAD SCI USA, V98, P8376, DOI 10.1073/pnas.121009498; DeLano W.L., PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Georgescu RE, 2008, P NATL ACAD SCI USA, V105, P11116, DOI 10.1073/pnas.0804754105; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Gomes XV, 2000, EMBO J, V19, P3811, DOI 10.1093/emboj/19.14.3811; Gong CL, 2004, J BIOL CHEM, V279, P20594, DOI 10.1074/jbc.M401841200; Gui WJ, 2011, BIOCHEM BIOPH RES CO, V405, P272, DOI 10.1016/j.bbrc.2011.01.027; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; Jeruzalmi D, 2001, CELL, V106, P417, DOI 10.1016/S0092-8674(01)00462-7; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kurz M, 2004, J BACTERIOL, V186, P3508, DOI 10.1128/JB.186.11.3508-3515.2004; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Levin DS, 2000, CURR BIOL, V10, P919, DOI 10.1016/S0960-9822(00)00619-9; Matsumiya S, 2001, PROTEIN SCI, V10, P17, DOI 10.1110/ps.36401; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pascal JM, 2006, MOL CELL, V24, P279, DOI 10.1016/j.molcel.2006.08.015; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Srivastava SK, 2007, PROTEINS, V69, P97, DOI 10.1002/prot.21457; Srivastava SK, 2005, J BIOL CHEM, V280, P30273, DOI 10.1074/jbc.M503780200; Srivastava SK, 2005, NUCLEIC ACIDS RES, V33, P7090, DOI 10.1093/nar/gki1006; Tom S, 2001, J BIOL CHEM, V276, P24817, DOI 10.1074/jbc.M101673200; Weller GR, 2002, SCIENCE, V297, P1686, DOI 10.1126/science.1074584; Wijffels G, 2004, BIOCHEMISTRY-US, V43, P5661, DOI 10.1021/bi036229j	33	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35702	10.1371/journal.pone.0035702	http://dx.doi.org/10.1371/journal.pone.0035702			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545130	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343200050
J	Joers, V; Seneczko, K; Goecks, NC; Kamp, TJ; Hacker, TA; Brunner, KG; Engle, JW; Barnhart, TE; Nickles, RJ; Holden, JE; Emborg, ME				Joers, Valerie; Seneczko, Kailie; Goecks, Nichole C.; Kamp, Timothy J.; Hacker, Timothy A.; Brunner, Kevin G.; Engle, Jonathan W.; Barnhart, Todd E.; Nickles, R. Jerome; Holden, James E.; Emborg, Marina E.			Nonuniform Cardiac Denervation Observed by C-11-meta-Hydroxyephedrine PET in 6-OHDA-Treated Monkeys	PLOS ONE			English	Article							MULTIPLE SYSTEM ATROPHY; NONMOTOR SYMPTOMS QUESTIONNAIRE; PURE AUTONOMIC FAILURE; PARKINSONS-DISEASE; SYMPATHETIC DENERVATION; CHEMICAL SYMPATHECTOMY; ORTHOSTATIC HYPOTENSION; HEART-TRANSPLANTATION; RHESUS-MONKEYS; 6-HYDROXYDOPAMINE	Parkinson's disease presents nonmotor complications such as autonomic dysfunction that do not respond to traditional anti-parkinsonian therapies. The lack of established preclinical monkey models of Parkinson's disease with cardiac dysfunction hampers development and testing of new treatments to alleviate or prevent this feature. This study aimed to assess the feasibility of developing a model of cardiac dysautonomia in nonhuman primates and preclinical evaluations tools. Five rhesus monkeys received intravenous injections of 6-hydroxydopamine (total dose: 50 mg/kg). The animals were evaluated before and after with a battery of tests, including positron emission tomography with the norepinephrine analog C-11-meta-hydroxyephedrine. Imaging 1 week after neurotoxin treatment revealed nearly complete loss of specific radioligand uptake. Partial progressive recovery of cardiac uptake found between 1 and 10 weeks remained stable between 10 and 14 weeks. In all five animals, examination of the pattern of uptake (using Logan plot analysis to create distribution volume maps) revealed a persistent region-specific significant loss in the inferior wall of the left ventricle at 10 (P<0.001) and 14 weeks (P<0.01) relative to the anterior wall. Blood levels of dopamine, norepinephrine (P<0.05), epinephrine, and 3,4-dihydroxyphenylacetic acid (P<0.01) were notably decreased after 6-hydroxydopamine at all time points. These results demonstrate that systemic injection of 6-hydroxydopamine in nonhuman primates creates a nonuniform but reproducible pattern of cardiac denervation as well as a persistent loss of circulating catecholamines, supporting the use of this method to further develop a monkey model of cardiac dysautonomia.	[Joers, Valerie; Seneczko, Kailie; Goecks, Nichole C.; Brunner, Kevin G.; Holden, James E.; Emborg, Marina E.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Preclin Parkinsons Res Program, Madison, WI 53706 USA; [Joers, Valerie; Emborg, Marina E.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; [Kamp, Timothy J.; Hacker, Timothy A.] Univ Wisconsin, Dept Med, Madison, WI USA; [Engle, Jonathan W.; Barnhart, Todd E.; Nickles, R. Jerome; Holden, James E.; Emborg, Marina E.] Univ Wisconsin, Dept Med Phys, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Joers, V (corresponding author), Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Preclin Parkinsons Res Program, Madison, WI 53706 USA.	emborg@primate.wisc.edu	Joers, Valerie/S-2455-2019; Kamp, Timothy/ABD-1343-2020	Joers, Valerie/0000-0001-6743-6587; Kamp, Timothy/0000-0003-2103-7876; Engle, Jonathan W/0000-0002-3399-7228; Barnhart, Todd/0000-0002-9981-2150	Clinical and Translational Science Award (CTSA) program; National Center for Research Resources (NCRR) [1UL1RR025011]; National Center for Advancing Translational Sciences (NCATS) [9U54TR000021]; WNPRC NIH [P51RR000167]; University of Wisconsin Graduate School, Medical School, and Medical Physics Department; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011, P51RR000167] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	Clinical and Translational Science Award (CTSA) program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); WNPRC NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin Graduate School, Medical School, and Medical Physics Department; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was supported in part by the Clinical and Translational Science Award (CTSA) program, previously through the National Center for Research Resources (NCRR) grant 1UL1RR025011, and now by the National Center for Advancing Translational Sciences (NCATS), grant 9U54TR000021. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health (NIH). The authors also acknowledge the support of WNPRC NIH base grant P51RR000167, and the faculty startup funds from the University of Wisconsin Graduate School, Medical School, and Medical Physics Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amino T, 2005, BRAIN PATHOL, V15, P29, DOI 10.1111/j.1750-3639.2005.tb00097.x; Bai J, 2008, CAN J PHYSIOL PHARM, V86, P700, DOI [10.1139/Y08-075, 10.1139/y08-075]; Bengel FM, 1999, CIRCULATION, V99, P1866, DOI 10.1161/01.CIR.99.14.1866; Berding G, 2003, EUR J NUCL MED MOL I, V30, P127, DOI 10.1007/s00259-002-1019-7; Braak H, 2000, J NEUROL, V247, P3; Braune S, 1998, ACTA NEUROL SCAND, V97, P307, DOI 10.1111/j.1600-0404.1998.tb05958.x; Buendia-Fuentes F, 2011, TRANSPL P, V43, P2247, DOI 10.1016/j.transproceed.2011.05.020; Cersosimo MG, 2008, MOVEMENT DISORD, V23, P1065, DOI 10.1002/mds.22051; Chaudhuri KR, 2006, MOVEMENT DISORD, V21, P916, DOI 10.1002/mds.20844; Deguchi K, 2002, J NEUROL SCI, V199, P31, DOI 10.1016/S0022-510X(02)00079-5; Emborg ME, 2006, NEUROBIOL DIS, V23, P281, DOI 10.1016/j.nbd.2006.03.010; Emborg ME, 2007, ILAR J, V48, P339, DOI 10.1093/ilar.48.4.339; Emborg ME, 2004, J NEUROSCI METH, V139, P121, DOI 10.1016/j.jneumeth.2004.08.004; Emborg ME, 1998, J COMP NEUROL, V401, P253; Emborg ME, 2009, NEUROBIOL DIS; GAUTHIER P, 1972, CIRC RES, V31, P207, DOI 10.1161/01.RES.31.2.207; Goldstein DS, 2008, CLIN AUTON RES, V18, P115, DOI 10.1007/s10286-008-0464-1; Goldstein DS, 2007, CLIN AUTON RES, V17, P118, DOI 10.1007/s10286-007-0396-1; Goldstein DS, 2006, CLIN AUTON RES, V16, P46, DOI 10.1007/s10286-006-0317-8; Goldstein DS, 2000, ANN INTERN MED, V133, P338, DOI 10.7326/0003-4819-133-5-200009050-00009; Goldstein DS, 2003, LANCET NEUROL, V2, P669, DOI 10.1016/S1474-4422(03)00555-6; GOLDSTEIN DS, 1991, J HYPERTENS, V9, P417, DOI 10.1097/00004872-199105000-00005; Goldstein DS, 2003, J PHARMACOL EXP THER, V306, P855, DOI 10.1124/jpet.103.051714; Gross DR, 2009, ANIMAL MODELS IN CARDIOVASCULAR RESEARCH, THIRD EDITION, P55, DOI 10.1007/978-0-387-95962-7_3; Ishizaki F, 1996, No To Shinkei, V48, P443; Jost WH, 2003, J NEUROL, V250, P28, DOI 10.1007/s00415-003-1105-z; Kawamura M, 1999, NEUROCHEM RES, V24, P25, DOI 10.1023/A:1020919828028; KAYE DM, 1993, CIRCULATION, V88, P1110, DOI 10.1161/01.CIR.88.3.1110; King A.E., 2010, MOVEMENT DISORD, V26, P1218; Li ST, 2002, ANN NEUROL, V52, P220, DOI 10.1002/ana.10236; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Martignoni E, 1995, J NEURAL TRANSM-SUPP, P11; Martinez-Martin P, 2007, MOVEMENT DISORD, V22, P1623, DOI 10.1002/mds.21586; Mathias CJ, 1998, CLIN NEUROSCI, V5, P153; NADEAU RA, 1971, CAN J PHYSIOL PHARM, V49, P36, DOI 10.1139/y71-005; Oka H, 2006, J NEUROL SCI, V241, P59, DOI 10.1016/j.jns.2005.10.014; Orimo S, 1999, J NEUROL NEUROSUR PS, V67, P189, DOI 10.1136/jnnp.67.2.189; Orimo S, 2005, ACTA NEUROPATHOL, V109, P583, DOI 10.1007/s00401-005-0995-7; Orimo S, 2002, J NEUROL NEUROSUR PS, V73, P776, DOI 10.1136/jnnp.73.6.776; PODRID PJ, 1990, CIRCULATION, V82, P103; PORTER CC, 1963, J PHARMACOL EXP THER, V140, P308; PORTER CC, 1965, J PHARMACOL EXP THER, V150, P17; Post KK, 2008, PARKINSONISM RELAT D, V14, P524, DOI 10.1016/j.parkreldis.2008.03.008; Pursiainen V, 2002, J NEUROL, V249, P1535, DOI 10.1007/s00415-002-0884-0; Raffel DM, 2006, J NUCL MED, V47, P1769; RAJPUT AH, 1976, J NEUROL NEUROSUR PS, V39, P1092, DOI 10.1136/jnnp.39.11.1092; ROSENSPIRE KC, 1990, J NUCL MED, V31, P1328; Sakata M, 2002, BRAIN RES, V928, P194, DOI 10.1016/S0006-8993(01)03402-3; Slack K, 2010, PARKINSONS DIS-US, V2010, DOI 10.4061/2010/427810; Sleeper MM, 2008, J AM ASSOC LAB ANIM, V47, P22; Suzuki M, 2007, NEUROREPORT, V18, P1867, DOI 10.1097/WNR.0b013e3282f1ab33; Swanson CR, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-91; Takatsu H, 2000, J NUCL MED, V41, P71; Taki J, 2000, EUR J NUCL MED, V27, P566, DOI 10.1007/s002590050544; Tipre DN, 2005, J NUCL MED, V46, P1775; Valappil RA, 2010, MOVEMENT DISORD, V25, P2296, DOI 10.1002/mds.23348	56	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35371	10.1371/journal.pone.0035371	http://dx.doi.org/10.1371/journal.pone.0035371			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539969	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341000034
J	McKinnon, NK; Bali, M; Akabas, MH				McKinnon, Nicole K.; Bali, Moez; Akabas, Myles H.			Length and Amino Acid Sequence of Peptides Substituted for the 5-HT3A Receptor M3M4 Loop May Affect Channel Expression and Desensitization	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; GATED ION-CHANNEL; X-RAY-STRUCTURE; 5-HYDROXYTRYPTAMINE TYPE-3; SEROTONIN-RECEPTOR; CHLORIDE CHANNEL; CYTOPLASMIC LOOP; NG108-15 CELLS; CONDUCTANCE; CA2+	5-HT3A receptors are pentameric neurotransmitter-gated ion channels in the Cys-loop receptor family. Each subunit contains an extracellular domain, four transmembrane segments (M1, M2, M3, M4) and a 115 residue intracellular loop between M3 and M4. In contrast, the M3M4 loop in prokaryotic homologues is <15 residues. To investigate the limits of M3M4 loop length and composition on channel function we replaced the 5-HT3A M3M4 loop with two to seven alanine residues (5-HT3A-A(n) (=) (2-7)). Mutants were expressed in Xenopus laevis oocytes and characterized using two electrode voltage clamp recording. All mutants were functional. The 5-HT EC50's were at most 5-fold greater than wild-type (WT). The desensitization rate differed significantly among the mutants. Desensitization rates for 5-HT3A-A(2), 5-HT3A-A(4), 5-HT3A-A(6), and 5-HT3A-A(7) were similar to WT. In contrast, 5-HT3A-A(3) and 5-HT3A-A(5) had desensitization rates at least an order of magnitude faster than WT. The one Ala loop construct, 5-HT3A-A(1), entered a non-functional state from which it did not recover after the first 5-HT application. These results suggest that the large M3M4 loop of eukaryotic Cys-loop channels is not required for receptor assembly or function. However, loop length and amino acid composition can effect channel expression and desensitization. We infer that the cytoplasmic ends of the M3 and M4 segments may undergo conformational changes during channel gating and desensitization and/or the loop may influence the position and mobility of these segments as they undergo gating-induced conformational changes. Altering structure or conformational mobility of the cytoplasmic ends of M3 and M4 may be the basis by which phosphorylation or protein binding to the cytoplasmic loop alters channel function.	[McKinnon, Nicole K.; Bali, Moez; Akabas, Myles H.] Yeshiva Univ, Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY USA; [Akabas, Myles H.] Yeshiva Univ, Albert Einstein Coll Med, Dept Neurosci, Bronx, NY USA; [Akabas, Myles H.] Yeshiva Univ, Albert Einstein Coll Med, Dept Med, Bronx, NY USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	McKinnon, NK (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY USA.	myles.akabas@einstein.yu.edu		McKinnon, Nicole/0000-0002-7177-1924; Akabas, Myles/0000-0001-8781-7846	National Institutes of Health [NS030808]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported in part by a grant from the National Institutes of Health (http://www.nih.gov/), NS030808 to MHA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akabas MH, 2004, INT REV NEUROBIOL, V62, P1, DOI 10.1016/S0074-7742(04)62001-0; Bar-Lev DD, 2011, J BIOL CHEM, V286, P43830, DOI 10.1074/jbc.M111.282715; Barnes NM, 2009, NEUROPHARMACOLOGY, V56, P273, DOI 10.1016/j.neuropharm.2008.08.003; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Boyd GW, 2002, MOL CELL NEUROSCI, V21, P38, DOI 10.1006/mcne.2002.1160; Connolly CN, 2008, MOL MEMBR BIOL, V25, P293, DOI 10.1080/09687680801898503; Corradi J, 2009, BIOPHYS J, V97, P1335, DOI 10.1016/j.bpj.2009.06.018; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; Deeb TZ, 2007, J BIOL CHEM, V282, P6172, DOI 10.1074/jbc.M607698200; DILGER JP, 1991, BIOCHIM BIOPHYS ACTA, V1063, P253, DOI 10.1016/0005-2736(91)90379-M; Gunthorpe MJ, 2000, J PHYSIOL-LONDON, V522, P187, DOI 10.1111/j.1469-7793.2000.00187.x; Hales TG, 2006, J BIOL CHEM, V281, P8062, DOI 10.1074/jbc.M513222200; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hu XQ, 2008, NEUROPHARMACOLOGY, V54, P1153, DOI 10.1016/j.neuropharm.2008.03.009; Hu XQ, 2006, J BIOL CHEM, V281, P21781, DOI 10.1074/jbc.M600676200; Hu XQ, 2005, J PHYSIOL-LONDON, V568, P381, DOI 10.1113/jphysiol.2005.092866; Ilegems E, 2005, CHEMBIOCHEM, V6, P2180, DOI 10.1002/cbic.200500191; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896; Jones S, 2003, NEUROSCIENCE, V119, P629, DOI 10.1016/S0306-4522(03)00202-1; Jones S, 1998, J PHYSIOL-LONDON, V510, P361, DOI 10.1111/j.1469-7793.1998.361bk.x; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Kracun S, 2008, BRIT J PHARMACOL, V153, P1474, DOI 10.1038/sj.bjp.0707676; Krzywkowski K, 2008, P NATL ACAD SCI USA, V105, P722, DOI 10.1073/pnas.0708454105; Lansdell SJ, 2005, MOL PHARMACOL, V68, P1431, DOI 10.1124/mol.105.017459; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Livesey MR, 2008, J BIOL CHEM, V283, P19301, DOI 10.1074/jbc.M802406200; Lo WY, 2008, J BIOL CHEM, V283, P29740, DOI 10.1074/jbc.M802856200; Lobitz N, 2001, MOL PHARMACOL, V59, P844, DOI 10.1124/mol.59.4.844; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; McKinnon NK, 2011, J GEN PHYSIOL, V138, P453, DOI 10.1085/jgp.201110686; Millar NS, 2008, BRIT J PHARMACOL, V153, pS177, DOI 10.1038/sj.bjp.0707661; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Moroni M, 2011, J NEUROSCI, V31, P14095, DOI 10.1523/JNEUROSCI.1985-11.2011; Noam Y, 2008, J PHYSIOL-LONDON, V586, P3629, DOI 10.1113/jphysiol.2008.153486; O'Toole KK, 2011, J BIOL CHEM, V286, P37990, DOI 10.1074/jbc.M111.258012; Peters JA, 2004, BIOCHEM SOC T, V32, P547, DOI 10.1042/BST0320547; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Reeves DC, 2005, J NEUROSCI, V25, P9358, DOI 10.1523/JNEUROSCI.1045-05.2005; Reeves DC, 2001, J BIOL CHEM, V276, P42035, DOI 10.1074/jbc.M106066200; Solt K, 2007, J NEUROSCI, V27, P13151, DOI 10.1523/JNEUROSCI.3772-07.2007; Sun H, 2008, J PHYSIOL-LONDON, V586, P751, DOI 10.1113/jphysiol.2007.136440; Tasneem A, 2005, GENOME BIOL, V6; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; van Hooft JA, 2003, J NEUROPHYSIOL, V89, P1864, DOI 10.1152/jn.00948.2002; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Xu M, 1996, J GEN PHYSIOL, V107, P195, DOI 10.1085/jgp.107.2.195; YAKEL JL, 1993, P NATL ACAD SCI USA, V90, P5030, DOI 10.1073/pnas.90.11.5030	53	20	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35563	10.1371/journal.pone.0035563	http://dx.doi.org/10.1371/journal.pone.0035563			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539982	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341000048
J	Mirabella, G; Iaconelli, S; Spadacenta, S; Federico, P; Gallese, V				Mirabella, Giovanni; Iaconelli, Sara; Spadacenta, Silvia; Federico, Paolo; Gallese, Vittorio			Processing of Hand-Related Verbs Specifically Affects the Planning and Execution of Arm Reaching Movements	PLOS ONE			English	Article							FIXED-EFFECT FALLACY; MOTOR SYSTEM; ACTION WORDS; LANGUAGE COMPREHENSION; SENTENCE COMPREHENSION; PREMOTOR CORTEX; HUMAN BRAIN; TIME-COURSE; ASYMMETRIES; REPRESENTATIONS	Even though a growing body of research has shown that the processing of action language affects the planning and execution of motor acts, several aspects of this interaction are still hotly debated. The directionality (i.e. does understanding action-related language induce a facilitation or an interference with the corresponding action?), the time course, and the nature of the interaction (i.e. under what conditions does the phenomenon occur?) are largely unclear. To further explore this topic we exploited a go/no-go paradigm in which healthy participants were required to perform arm reaching movements toward a target when verbs expressing either hand or foot actions were shown, and to refrain from moving when abstract verbs were presented. We found that reaction times (RT) and percentages of errors increased when the verb involved the same effector used to give the response. This interference occurred very early, when the interval between verb presentation and the delivery of the go signal was 50 ms, and could be elicited until this delay was about 600 ms. In addition, RTs were faster when subjects used the right arm than when they used the left arm, suggesting that action-verb understanding is left-lateralized. Furthermore, when the color of the printed verb and not its meaning was the cue for movement execution the differences between RTs and error percentages between verb categories disappeared, unequivocally indicating that the phenomenon occurs only when the semantic content of a verb has to be retrieved. These results are compatible with the theory of embodied language, which hypothesizes that comprehending verbal descriptions of actions relies on an internal simulation of the sensory-motor experience of the action, and provide a new and detailed view of the interplay between action language and motor acts.	[Mirabella, Giovanni; Iaconelli, Sara] Ist Neurol Mediterraneo Neuromed, Dept Neurosci, Pozzilli, IS, Italy; [Mirabella, Giovanni; Federico, Paolo] Univ Aquila, Dept Expt Med, I-67100 Laquila, Italy; [Spadacenta, Silvia] Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy; [Gallese, Vittorio] Univ Parma, Dept Neurosci, Physiol Sect, I-43100 Parma, Italy; [Gallese, Vittorio] Brain Ctr Social & Motor Cognit, IIT, Parma, Italy	IRCCS Neuromed; University of L'Aquila; Sapienza University Rome; University of Parma; Istituto Italiano di Tecnologia - IIT	Mirabella, G (corresponding author), Ist Neurol Mediterraneo Neuromed, Dept Neurosci, Pozzilli, IS, Italy.	giovanni.mirabella@uniroma1.it; vittorio.gallese@unipr.it	Mirabella, Giovanni/AAB-2818-2019; Federico, Paolo/K-8865-2016; Gallese, Vittorio/ABD-5097-2021	Mirabella, Giovanni/0000-0002-4405-2609; Federico, Paolo/0000-0001-5218-2545; Gallese, Vittorio/0000-0003-4815-3607	Italian Ministry of Work, Health and Social Policies; Italian Ministry of University and Research [2008_RBFNLH_005]; EU	Italian Ministry of Work, Health and Social Policies(Ministry of Health, Italy); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); EU(European Commission)	This research was supported by the Italian Ministry of Work, Health and Social Policies (Bando Giovani Ricercatori 2007 to GM), by the Italian Ministry of University and Research (PRIN n. 2008_RBFNLH_005 to GM), and by the EU grants TESIS and ROSSI to V. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravena P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011751; Aziz-Zadeh L, 2006, CURR BIOL, V16, P1818, DOI 10.1016/j.cub.2006.07.060; Bak TH, 2001, BRAIN, V124, P103, DOI 10.1093/brain/124.1.103; Barthelemy S, 2002, EXP BRAIN RES, V147, P305, DOI 10.1007/s00221-002-1247-x; Barthelemy S, 2001, NEUROSCI LETT, V315, P41, DOI 10.1016/S0304-3940(01)02313-8; Bertinetto P. M., 2005, CORPUS LESSICO FREQU; Borreggine KL, 2006, COGNITIVE SCI, V30, P1097, DOI 10.1207/s15516709cog0000_91; Boulenger V, 2008, J PHYSIOL-PARIS, V102, P130, DOI 10.1016/j.jphysparis.2008.03.015; Boulenger V, 2008, NEUROPSYCHOLOGIA, V46, P743, DOI 10.1016/j.neuropsychologia.2007.10.007; Boulenger V, 2006, J COGNITIVE NEUROSCI, V18, P1607, DOI 10.1162/jocn.2006.18.10.1607; Boulenger V, 2009, CEREB CORTEX, V19, P1905, DOI 10.1093/cercor/bhn217; Boulinguez P, 2001, CORTEX, V37, P101, DOI 10.1016/S0010-9452(08)70561-6; Bub DN, 2010, COGNITION, V116, P394, DOI 10.1016/j.cognition.2010.06.001; Buccino G, 2005, COGNITIVE BRAIN RES, V24, P355, DOI 10.1016/j.cogbrainres.2005.02.020; Cisek P, 2003, J NEUROPHYSIOL, V89, P922, DOI 10.1152/jn.00607.2002; CLARK HH, 1973, J VERB LEARN VERB BE, V12, P335, DOI 10.1016/S0022-5371(73)80014-3; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Desai RH, 2010, CEREB CORTEX, V20, P468, DOI 10.1093/cercor/bhp115; Donchin O, 2002, J NEUROPHYSIOL, V88, P3498, DOI 10.1152/jn.00335.2001; Fischer MH, 2008, Q J EXP PSYCHOL, V61, P825, DOI 10.1080/17470210701623605; GALABURDA AM, 1978, SCIENCE, V199, P852, DOI 10.1126/science.341314; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Gallese V, 2008, SOC NEUROSCI-UK, V3, P317, DOI 10.1080/17470910701563608; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Hauk O, 2008, J PHYSIOL-PARIS, V102, P50, DOI 10.1016/j.jphysparis.2008.03.013; Hauk O, 2006, NEUROIMAGE, V30, P1383, DOI 10.1016/j.neuroimage.2005.11.048; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hauk O, 2004, HUM BRAIN MAPP, V21, P191, DOI 10.1002/hbm.10157; Kaschak MP, 2008, Q J EXP PSYCHOL, V61, P883, DOI 10.1080/17470210701623852; Kawashima R, 1998, EUR J NEUROSCI, V10, P2254, DOI 10.1046/j.1460-9568.1998.00237.x; Kobayashi M, 2003, NEUROIMAGE, V20, P2259, DOI 10.1016/S1053-8119(03)00220-9; Mahon BZ, 2005, COGN NEUROPSYCHOL, V22, P480, DOI 10.1080/02643290442000446; Naccache L, 2005, P NATL ACAD SCI USA, V102, P7713, DOI 10.1073/pnas.0500542102; Neininger B, 2003, NEUROPSYCHOLOGIA, V41, P53, DOI 10.1016/S0028-3932(02)00126-4; OJEMANN GA, 1991, J NEUROSCI, V11, P2281; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Pulvermuller F, 2005, EUR J NEUROSCI, V21, P793, DOI 10.1111/j.1460-9568.2005.03900.x; Pulvermuller F., 2002, NEUROSCIENCE LANGUAG; Raaijmakers JGW, 2003, CAN J EXP PSYCHOL, V57, P141, DOI 10.1037/h0087421; Sato M, 2008, BRAIN LANG, V105, P83, DOI 10.1016/j.bandl.2007.10.001; Scorolli C, 2007, BRAIN RES, V1130, P119, DOI 10.1016/j.brainres.2006.10.033; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; Willems RM, 2010, PSYCHOL SCI, V21, P67, DOI 10.1177/0956797609354072; Zwaan RA, 2002, PSYCHOL SCI, V13, P168, DOI 10.1111/1467-9280.00430; Zwaan RA, 2006, J EXP PSYCHOL GEN, V135, P1, DOI 10.1037/0096-3445.135.1.1	46	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35403	10.1371/journal.pone.0035403	http://dx.doi.org/10.1371/journal.pone.0035403			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UD	22536380	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339200062
J	Spiro, AS; Wong, A; Boucher, AA; Arnold, JC				Spiro, Adena S.; Wong, Alexander; Boucher, Aurelie A.; Arnold, Jonathon C.			Enhanced Brain Disposition and Effects of Delta(9)-Tetrahydrocannabinol in P-Glycoprotein and Breast Cancer Resistance Protein Knockout Mice	PLOS ONE			English	Article							HETEROZYGOUS NEUREGULIN-1 MICE; MULTIDRUG-RESISTANCE; CANNABIS USE; EXPRESSION; GENE; DRUGS; DELTA-9-TETRAHYDROCANNABINOL; SCHIZOPHRENIA; TRANSPORTERS; IMPACT	The ABC transporters P-glycoprotein (P-gp, Abcb1) and breast cancer resistance protein (Bcrp, Abcg2) regulate the CNS disposition of many drugs. The main psychoactive constituent of cannabis Delta(9)-tetrahydrocannabinol (THC) has affinity for P-gp and Bcrp, however it is unknown whether these transporters modulate the brain accumulation of THC and its functional effects on the CNS. Here we aim to show that mice devoid of Abcb1 and Abcg2 retain higher brain THC levels and are more sensitive to cannabinoid-induced hypothermia than wild-type (WT) mice. Abcb1a/b (-/-), Abcg2 (-/-) and wild-type (WT) mice were injected with THC before brain and blood were collected and THC concentrations determined. Another cohort of mice was examined for THC-induced hypothermia by measuring rectal body temperature. Brain THC concentrations were higher in both Abcb1a/b (-/-) and Abcg2 (-/-) mice than WT mice. ABC transporter knockout mice exhibited delayed elimination of THC from the brain with the effect being more prominent in Abcg2 (-/-) mice. ABC transporter knockout mice were more sensitive to THC-induced hypothermia compared to WT mice. These results show P-gp and Bcrp prolong the brain disposition and hypothermic effects of THC and offer a novel mechanism for both genetic vulnerability to the psychoactive effects of cannabis and drug interactions between CNS therapies and cannabis.	[Spiro, Adena S.; Wong, Alexander; Arnold, Jonathon C.] Univ Sydney, Discipline Pharmacol, Sydney, NSW 2006, Australia; [Boucher, Aurelie A.; Arnold, Jonathon C.] Brain & Mind Res Inst, Sydney, NSW, Australia; [Arnold, Jonathon C.] Schizophrenia Res Inst, Sydney, NSW, Australia	University of Sydney; University of Sydney	Arnold, JC (corresponding author), Univ Sydney, Discipline Pharmacol, Sydney, NSW 2006, Australia.	jonathon.arnold@sydney.edu.au	Arnold, Jonathon C/ACF-5231-2022; Wong, Alexander/GZM-2929-2022	Wong, Alexander/0000-0002-5295-2797; Arnold, Jonathon/0000-0002-0159-9997	University of Sydney Bridging Grant; Brain & Behavior Research Foundation	University of Sydney Bridging Grant; Brain & Behavior Research Foundation(NARSAD)	This work was supported by a University of Sydney Bridging Grant and the Brain & Behavior Research Foundation (formerly National Alliance for Research on Schizophrenia and Depression: Young Investigator Award). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltes S, 2007, NEUROPHARMACOLOGY, V52, P333, DOI 10.1016/j.neuropharm.2006.07.038; Benyamina A, 2009, PROG NEURO-PSYCHOPH, V33, P1270, DOI 10.1016/j.pnpbp.2009.07.016; Bonhomme-Faivre L, 2008, ADDICT BIOL, V13, P295, DOI 10.1111/j.1369-1600.2008.00096.x; BORNHEIM LM, 1995, DRUG METAB DISPOS, V23, P825; Boucher AA, 2007, NEUROSCIENCE, V149, P861, DOI 10.1016/j.neuroscience.2007.08.020; Boucher AA, 2007, PSYCHOPHARMACOLOGY, V192, P325, DOI 10.1007/s00213-007-0721-3; Boucher AA, 2011, INT J NEUROPSYCHOPH, V14, P631, DOI 10.1017/S146114571000091X; BOWERS MB, 1990, SCHIZOPHRENIA BULL, V16, P81, DOI 10.1093/schbul/16.1.81; Breedveld P, 2006, TRENDS PHARMACOL SCI, V27, P17, DOI 10.1016/j.tips.2005.11.009; Caspi A, 2005, BIOL PSYCHIAT, V57, P1117, DOI 10.1016/j.biopsych.2005.01.026; CORDONCARDO C, 1990, J HISTOCHEM CYTOCHEM, V38, P1277, DOI 10.1177/38.9.1974900; de Vries NA, 2007, CLIN CANCER RES, V13, P6440, DOI 10.1158/1078-0432.CCR-07-1335; Doran A, 2005, DRUG METAB DISPOS, V33, P165, DOI 10.1124/dmd.104.001230; FITTON AG, 1982, BRIT J PHARMACOL, V75, P409, DOI 10.1111/j.1476-5381.1982.tb08802.x; Gunasekaran N, 2009, BRIT J PHARMACOL, V158, P1330, DOI 10.1111/j.1476-5381.2009.00399.x; Hall MD, 2009, TRENDS PHARMACOL SCI, V30, P546, DOI 10.1016/j.tips.2009.07.003; Hall W, 2004, DRUG ALCOHOL REV, V23, P433, DOI 10.1080/09595230412331324554; Hemauer SJ, BIOCH PHARM, V80, P1080; Henquet C, 2008, SCHIZOPHRENIA BULL, V34, P1111, DOI 10.1093/schbul/sbn108; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Holland ML, 2007, BRIT J PHARMACOL, V152, P815, DOI 10.1038/sj.bjp.0707467; Holland ML, 2008, EUR J PHARMACOL, V591, P128, DOI 10.1016/j.ejphar.2008.06.079; Holland ML, 2006, BIOCHEM PHARMACOL, V71, P1146, DOI 10.1016/j.bcp.2005.12.033; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; Kamiie J, 2008, PHARM RES-DORDR, V25, P1469, DOI 10.1007/s11095-008-9532-4; Klein C, 2011, PSYCHOPHARMACOLOGY B; Lagas JS, 2009, CLIN CANCER RES, V15, P2344, DOI 10.1158/1078-0432.CCR-08-2253; Langmann T, 2003, CLIN CHEM, V49, P230, DOI 10.1373/49.2.230; Lazarowski A, 2007, EPILEPSIA, V48, P140, DOI 10.1111/j.1528-1167.2007.01302.x; Long LE, 2010, INT J NEUROPSYCHOPH, V13, P861, DOI 10.1017/S1461145709990605; Malone DT, 2009, PHARMACOL BIOCHEM BE, V93, P91, DOI 10.1016/j.pbb.2009.04.010; Morgan CJA, 2008, BRIT J PSYCHIAT, V192, P306, DOI 10.1192/bjp.bp.107.046649; Morgan CJA, 2010, BRIT J PSYCHIAT, V197, P285, DOI 10.1192/bjp.bp.110.077503; MURPHY LL, 1990, NEUROENDOCRINOLOGY, V52, P316, DOI 10.1159/000125604; Nieri P, 2006, BRIT J PHARMACOL, V148, P682, DOI 10.1038/sj.bjp.0706778; O'Brien FE, BR J PHARM; O'Tuathaigh CM, NEUROPSYCHOPHARMACOL, V35, P2262; Potschka H, 2010, EPILEPSIA, V51, P1333, DOI 10.1111/j.1528-1167.2010.02585.x; Quinn HR, 2008, NEUROPSYCHOPHARMACOL, V33, P1113, DOI 10.1038/sj.npp.1301475; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Schinkel AH, 1997, SEMIN CANCER BIOL, V8, P161, DOI 10.1006/scbi.1997.0068; Schinkel AH, 1997, P NATL ACAD SCI USA, V94, P4028, DOI 10.1073/pnas.94.8.4028; Tournier N, 2011, CURR PHARM DES; TURNER WM, 1990, SCHIZOPHRENIA BULL, V16, P87, DOI 10.1093/schbul/16.1.87; Urquhart BL, 2009, EUR J CLIN PHARMACOL, V65, P1063, DOI 10.1007/s00228-009-0714-8; Varvel SA, 2006, PSYCHOPHARMACOLOGY, V186, P226, DOI 10.1007/s00213-006-0356-9; Wang JS, 2004, INT J NEUROPSYCHOPH, V7, P415, DOI 10.1017/S1461145704004390; Wang JS, 2004, NEUROPSYCHOPHARMACOL, V29, P551, DOI 10.1038/sj.npp.1300372; Wang JS, 2008, BASIC CLIN PHARMACOL, V103, P336, DOI 10.1111/j.1742-7843.2008.00298.x; Warren MS, 2009, PHARMACOL RES, V59, P404, DOI 10.1016/j.phrs.2009.02.007; Wenger T, 2002, PROSTAG LEUKOTR ESS, V66, P301, DOI 10.1054/plef.2001.0353; Yanase K, 2006, CANCER LETT, V234, P73, DOI 10.1016/j.canlet.2005.04.039; Yang Johnny J, 2010, Drug Metab Lett, V4, P201; Zhu HJ, 2006, J PHARMACOL EXP THER, V317, P850, DOI 10.1124/jpet.105.098541; Zimmermann C, 2005, DRUG METAB DISPOS, V33, P219, DOI 10.1124/dmd.104.001354	55	39	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35937	10.1371/journal.pone.0035937	http://dx.doi.org/10.1371/journal.pone.0035937			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536451	gold, Green Published, Green Submitted			2022-12-25	WOS:000305339200123
J	Steinmeyer, JD; Yanik, MF				Steinmeyer, Joseph D.; Yanik, Mehmet Fatih			High-Throughput Single-Cell Manipulation in Brain Tissue	PLOS ONE			English	Article							ORGANOTYPIC SLICE CULTURES; NEURONS IN-VIVO; GENE-EXPRESSION; DENDRITIC SPINES; RNA INTERFERENCE; TRANSGENIC MICE; EXCHANGE FACTOR; ELECTROPORATION; KALIRIN-7; TRANSFECTION	The complexity of neurons and neuronal circuits in brain tissue requires the genetic manipulation, labeling, and tracking of single cells. However, current methods for manipulating cells in brain tissue are limited to either bulk techniques, lacking single-cell accuracy, or manual methods that provide single-cell accuracy but at significantly lower throughputs and repeatability. Here, we demonstrate high-throughput, efficient, reliable, and combinatorial delivery of multiple genetic vectors and reagents into targeted cells within the same tissue sample with single-cell accuracy. Our system automatically loads nanoliter-scale volumes of reagents into a micropipette from multiwell plates, targets and transfects single cells in brain tissues using a robust electroporation technique, and finally preps the micropipette by automated cleaning for repeating the transfection cycle. We demonstrate multi-colored labeling of adjacent cells, both in organotypic and acute slices, and transfection of plasmids encoding different protein isoforms into neurons within the same brain tissue for analysis of their effects on linear dendritic spine density. Our platform could also be used to rapidly deliver, both ex vivo and in vivo, a variety of genetic vectors, including optogenetic and cell-type specific agents, as well as fast-acting reagents such as labeling dyes, calcium sensors, and voltage sensors to manipulate and track neuronal circuit activity at single-cell resolution.	[Steinmeyer, Joseph D.; Yanik, Mehmet Fatih] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Yanik, Mehmet Fatih] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Steinmeyer, JD (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.	yanik@mit.edu		Yanik, Mehmet/0000-0002-8963-2893	National Institutes of Health (NIH) [R01 NS066352]; Packard Award in Science and Engineering; National Defense Science and Engineering (NDSEG) Fellowship; National Science Foundation (NSF); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066352] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Award in Science and Engineering; National Defense Science and Engineering (NDSEG) Fellowship; National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by the National Institutes of Health (NIH) Eureka Award (R01NS066352) and a Packard Award in Science and Engineering. J.D.S. was supported by the National Defense Science and Engineering (NDSEG) Fellowship and the National Science Foundation (NSF) Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	del Rio JA, 2010, NAT PROTOC, V5, P217, DOI 10.1038/nprot.2009.202; Bohland JW, 2010, METHODS, V50, P105, DOI 10.1016/j.ymeth.2009.09.001; Boudes M, 2008, J NEUROSCI METH, V170, P204, DOI 10.1016/j.jneumeth.2008.01.018; Brown KT, 1986, ADV MICROPIPETTE TEC; Cho S, 2007, CURR NEUROPHARMACOL, V5, P19, DOI 10.2174/157015907780077105; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; De Simoni A, 2006, NAT PROTOC, V1, P1439, DOI 10.1038/nprot.2006.228; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Duff K, 2002, J MOL NEUROSCI, V19, P317, DOI 10.1385/JMN:19:3:317; Dundr M, 2007, J CELL BIOL, V179, P1095, DOI 10.1083/jcb.200710058; Elias L, 2007, J VISUALIZED EXPT JO; Flusberg BA, 2008, NAT METHODS, V5, P935, DOI 10.1038/nmeth.1256; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Gogolla N, 2006, NAT PROTOC, V1, P1223, DOI 10.1038/nprot.2006.169; Gogolla N, 2006, NAT PROTOC, V1, P1165, DOI 10.1038/nprot.2006.168; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; Haas K, 2002, DIFFERENTIATION, V70, P148, DOI 10.1046/j.1432-0436.2002.700404.x; Hall AA, 2009, NEUROSCIENCE, V164, P470, DOI 10.1016/j.neuroscience.2009.08.051; Helmstaedter M, 2011, NAT NEUROSCI, V14, P1081, DOI 10.1038/nn.2868; Hovis KR, 2010, J NEUROSCI METH, V191, P1, DOI 10.1016/j.jneumeth.2010.05.017; Jessberger S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100122; Johnson RC, 2000, J BIOL CHEM, V275, P19324, DOI 10.1074/jbc.M000676200; Judkewitz B, 2009, NAT PROTOC, V4, P862, DOI 10.1038/nprot.2009.56; Kasri NN, 2008, CHARACTERIZATION OLI; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lovell P, 2006, J NEUROSCI METH, V151, P114, DOI 10.1016/j.jneumeth.2005.06.030; Ma XM, 2008, J NEUROSCI, V28, P711, DOI 10.1523/JNEUROSCI.5283-07.2008; Ma XM, 2003, J NEUROSCI, V23, P10593; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Murphy RC, 2001, MOL THER, V3, P113, DOI 10.1006/mthe.2000.0235; Nelson Sacha B., 2002, Neuron, V36, P19, DOI 10.1016/S0896-6273(02)00944-3; Nitsche JM, 2004, BIOPHYS J, V86, P2058, DOI 10.1016/S0006-3495(04)74267-8; Nolkrantz K, 2001, ANAL CHEM, V73, P4469, DOI 10.1021/ac010403x; Noraberg J, 2004, ATLA-ALTERN LAB ANIM, V32, P329, DOI 10.1177/026119290403200403; O'Brien JA, 2006, NAT PROTOC, V1, P977, DOI 10.1038/nprot.2006.145; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Penzes P, 2000, J BIOL CHEM, V275, P6395, DOI 10.1074/jbc.275.9.6395; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Penzes P, 2008, TRENDS NEUROSCI, V31, P419, DOI 10.1016/j.tins.2008.06.001; Pi HJ, 2010, P NATL ACAD SCI USA, V107, P14437, DOI 10.1073/pnas.1009268107; Prazeres DMF, 2008, BIOTECHNOL BIOENG, V99, P1040, DOI 10.1002/bit.21626; Qing Q, 2010, P NATL ACAD SCI USA, V107, P1882, DOI 10.1073/pnas.0914737107; Rancz EA, 2011, NAT NEUROSCI, V14, P527, DOI 10.1038/nn.2765; Rathenberg J, 2003, J NEUROSCI METH, V126, P91, DOI 10.1016/S0165-0270(03)00069-4; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Schiller MR, 2008, EXP CELL RES, V314, P2674, DOI 10.1016/j.yexcr.2008.05.011; Smith Donna L., 2004, V277, P161; Smith SJ, 2007, CURR OPIN NEUROBIOL, V17, P601, DOI 10.1016/j.conb.2007.11.004; Sommer JE, 2009, J NEUROSCI, V29, P5367, DOI 10.1523/JNEUROSCI.0235-09.2009; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tanaka M, 2009, J NEUROSCI METH, V178, P80, DOI 10.1016/j.jneumeth.2008.11.025; Teschemacher AG, 2005, EXP PHYSIOL, V90, P61, DOI 10.1113/expphysiol.2004.028191; Uesaka N, 2005, J NEUROSCI, V25, P1, DOI 10.1523/JNEUROSCI.3855-04.2005; Uesaka N, 2008, DEV GROWTH DIFFER, V50, P475, DOI [10.1111/j.1440-169x.2008.01024.x, 10.1111/j.1440-169X.2008.01024.x]; Vaira V, 2010, P NATL ACAD SCI USA, V107, P8352, DOI 10.1073/pnas.0907676107; Wei W, 2010, NAT NEUROSCI, V13, P190, DOI 10.1038/nn.2476; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	61	16	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35603	10.1371/journal.pone.0035603	http://dx.doi.org/10.1371/journal.pone.0035603			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536416	Green Published, Green Accepted, gold			2022-12-25	WOS:000305339200085
J	Taylor, S; Kumar, L; Reid, N; Kriticos, DJ				Taylor, Subhashni; Kumar, Lalit; Reid, Nick; Kriticos, Darren J.			Climate Change and the Potential Distribution of an Invasive Shrub, Lantana camara L.	PLOS ONE			English	Article							GEOGRAPHICAL-DISTRIBUTION; PLANT; WEED; VERBENACEAE; MODELS; SHIFTS; RANGE; NICHE	The threat posed by invasive species, in particular weeds, to biodiversity may be exacerbated by climate change. Lantana camara L. (lantana) is a woody shrub that is highly invasive in many countries of the world. It has a profound economic and environmental impact worldwide, including Australia. Knowledge of the likely potential distribution of this invasive species under current and future climate will be useful in planning better strategies to manage the invasion. A process-oriented niche model of L. camara was developed using CLIMEX to estimate its potential distribution under current and future climate scenarios. The model was calibrated using data from several knowledge domains, including phenological observations and geographic distribution records. The potential distribution of lantana under historical climate exceeded the current distribution in some areas of the world, notably Africa and Asia. Under future scenarios, the climatically suitable areas for L. camara globally were projected to contract. However, some areas were identified in North Africa, Europe and Australia that may become climatically suitable under future climates. In South Africa and China, its potential distribution could expand further inland. These results can inform strategic planning by biosecurity agencies, identifying areas to target for eradication or containment. Distribution maps of risk of potential invasion can be useful tools in public awareness campaigns, especially in countries that have been identified as becoming climatically suitable for L. camara under the future climate scenarios.	[Taylor, Subhashni; Kumar, Lalit; Reid, Nick] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia; [Kriticos, Darren J.] CSIRO Ecosyst Sci, Canberra, ACT, Australia; [Kriticos, Darren J.] Charles Sturt Univ, EH Graham Ctr, Wagga Wagga, NSW, Australia	University of New England; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Charles Sturt University	Taylor, S (corresponding author), Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia.	btaylo36@une.edu.au	Taylor, Subhashni/Q-6338-2018; Kumar, Lalit/A-6397-2011; Reid, Nick Charles H./A-6393-2011; Kriticos, Darren J/A-4170-2008	Taylor, Subhashni/0000-0002-1624-0901; Kumar, Lalit/0000-0002-9205-756X; Reid, Nick Charles H./0000-0002-4377-9734; Kriticos, Darren J/0000-0003-2599-8105	National Climate Change Adaptation Research Facility (NCCARF)	National Climate Change Adaptation Research Facility (NCCARF)	The National Climate Change Adaptation Research Facility (NCCARF) kindly provided a grant that allowed the main author to purchase the CLIMEX software as well as attend a training workshop for CLIMEX. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ACHHIREDDY NR, 1984, WEED SCI, V32, P757, DOI 10.1017/S0043174500059944; Andrewartha H.G., 1984, ECOLOGICAL WEB MORE; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; [Anonymous], 1991, WORLDS WORST WEEDS D; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Begon M, 1986, ECOLOGY INDIVIDUALS; Bhuju DR, 2006, NEPAL J SCI TECHNOLO, V7, P35; Binggeli P, 1996, J VEG SCI, V7, P121, DOI 10.2307/3236424; Biswas K., 1934, INDIAN FOR, V60, P861; Chejara VK, 2010, WEED RES, V50, P174, DOI 10.1111/j.1365-3180.2010.00765.x; Chen S., 1994, FLORA CHINA; CILLIERS C J, 1983, Journal of the Entomological Society of Southern Africa, V46, P131; CILLIERS CJ, 1991, AGR ECOSYST ENVIRON, V37, P57, DOI 10.1016/0167-8809(91)90139-O; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Crossman ND, 2011, ECOL INDIC, V11, P183, DOI 10.1016/j.ecolind.2008.10.011; Crossman ND, 2008, DIVERS DISTRIB, V14, P213, DOI 10.1111/j.1472-4642.2007.00436.x; Danin A., 2000, Willdenowia, V30, P305, DOI 10.3372/wi.30.30209; Darin GMS, 2011, J ENVIRON MANAGE, V92, P131, DOI 10.1016/j.jenvman.2010.08.013; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Day M.D., 2003, BIOCONTROL NEWS INFO, V24, P63; DERM, 2010, MAPP LANT US LANDS R; Dobhal P. K., 2011, Journal of Ecology and the Natural Environment, V3, P11; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; FENSHAM RJ, 1994, AUST J ECOL, V19, P297, DOI 10.1111/j.1442-9993.1994.tb00493.x; Follak S, 2010, WEED RES, V50, P544, DOI 10.1111/j.1365-3180.2010.00802.x; Garibaldi A, 2008, PLANT DIS, V92, P1369, DOI 10.1094/PDIS-92-9-1369B; GBIF, 2010, GBIF DAT PORT; Gentle CB, 1997, AUST J ECOL, V22, P298, DOI 10.1111/j.1442-9993.1997.tb00675.x; Gooden B, 2009, BIOL CONSERV, V142, P2631, DOI 10.1016/j.biocon.2009.06.012; Gordon H. B., 2002, 60 CSIRO ATM RES; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; GUJRAL GS, 1983, J SCI IND RES INDIA, V42, P281; Hearne Scientific Software, 2007, CLIMEX SOFTW VERS 3; Henderson S, 2006, PROG PHYS GEOG, V30, P25, DOI 10.1191/0309133306pp468ra; Hennessy K., 2007, GLOBAL CLIMATE CHANG; HUMPHRIES SE, 1992, WEED ASSESSMENT WET; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Intergovernmental Panel on Climate Change, 2022, CLIM CHANG 2022 IMP, P1; IPCC, 2000, SPEC REP EM SCEN SPE; Jafri S.H., 1974, FLORA PAKISTAN; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kohli RK, 2006, BIOL INVASIONS, V8, P1501, DOI 10.1007/s10530-005-5842-1; Kriticos D., 2009, CLIMATE CHANGE INVAS; Kriticos D. J., 2006, 15th Australian Weeds Conference, Papers and Proceedings, Adelaide, South Australia, 24-28 September 2006: Managing weeds in a changing climate, P27; Kriticos D. J., 2001, Weed risk assessment, P61; Kriticos DJ, 2010, ECOGRAPHY, V33, P115, DOI 10.1111/j.1600-0587.2009.06042.x; Kriticos DJ, 2005, WEED RES, V45, P246, DOI 10.1111/j.1365-3180.2005.00458.x; Kriticos DJ, 2003, J APPL ECOL, V40, P111, DOI 10.1046/j.1365-2664.2003.00777.x; Kriticos DJ, 2008, 16 AUSTR WEEDS C, P506; Kriticos DJ, 2011, CLIMOND GLOBAL HIGH; LAMB D, 1991, TROPICAL RAINFOREST, P177; Mabberley DJ, 1997, PLANT BOOK; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Moldenke HN, 1944, BOT GAZ, V106, P158, DOI 10.1086/335282; Munir Ahmad Abid, 1996, Journal of the Adelaide Botanic Gardens, V17, P1; Murali KS, 2001, CURR SCI INDIA, V80, P675; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Poutsma J, 2008, BIOCONTROL, V53, P103, DOI 10.1007/s10526-007-9140-y; Press JR., 2000, ANNOTATED CHECKLIST; Rahmstorf S, 2007, SCIENCE, V316, P709, DOI 10.1126/science.1136843; SANDERS RW, 1987, AM J BOT, V74, P914, DOI 10.2307/2443872; SAPIA, 2006, MON EM SPREAD INV AL; Sharma GP, 2006, APPL ECOL ENV RES, V5, P109; Sharma GR, 2005, WEED BIOL MANAG, V5, P157, DOI 10.1111/j.1445-6664.2005.00178.x; SHELFORD VE, 1963, ECOLOGY N AM; Smith LS, 1982, NATURALISED LANTANA; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stirton C. H., 1977, Proceedings of the Second National Weeds Conference of South Africa., P321; Stock D., 2009, LANTANA BEST PRACTIC; Sutherst RW, 2009, BIOL INVASIONS, V11, P1231, DOI 10.1007/s10530-008-9335-x; Sutherst R W, 2007, CLIMEX VERSION 3 USE; Sutherst R. W., 2007, TERRESTRIAL ECOSYSTE, P211, DOI DOI 10.1007/978-3-540-32730-1_17; Sutherst RW, 2003, J BIOGEOGR, V30, P805, DOI 10.1046/j.1365-2699.2003.00861.x; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Thakur M. L., 1992, Indian Forester, V118, P466; THAMAN R R, 1974, Micronesica, V10, P17; Thomas SE, 2000, P 10 INT S BIOL CONT; van der Ploeg RR, 1999, SOIL SCI SOC AM J, V63, P1055, DOI 10.2136/sssaj1999.6351055x; Vitousek PM, 1996, AM SCI, V84, P468; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Waterhouse D. F., 1987, Biological control: Pacific prospects.; Watt MS, 2009, WEED RES, V49, P381, DOI 10.1111/j.1365-3180.2009.00704.x; Webber BL, 2011, DIVERS DISTRIB, V17, P978, DOI 10.1111/j.1472-4642.2011.00811.x; Wharton TN, 2004, DIVERS DISTRIB, V10, P253, DOI 10.1111/j.1366-9516.2004.00090.x; WINDER JA, 1982, B ENTOMOL RES, V72, P599, DOI 10.1017/S0007485300008634; Winder JA, FACTORS AFFECTING GR; Woodward F.I., 1987, CLIMATE PLANT DISTRI	87	75	79	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35565	10.1371/journal.pone.0035565	http://dx.doi.org/10.1371/journal.pone.0035565			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536408	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000305336200055
J	Imamura, S; Yabu, T; Yamashita, M				Imamura, Shintaro; Yabu, Takeshi; Yamashita, Michiaki			Protective Role of Cell Division Cycle 48 (CDC48) Protein against Neurodegeneration via Ubiquitin-Proteasome System Dysfunction during Zebrafish Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VALOSIN-CONTAINING PROTEIN; RETICULUM-ASSOCIATED DEGRADATION; AAA-ATPASE CDC48/P97; ENDOPLASMIC-RETICULUM; COLD-ACCLIMATION; MYOPATHY; VCP; P97; VCP/P97; DISEASE	Cell division cycle 48 (CDC48), a ubiquitin-dependent molecular chaperone, is thought to mediate a variety of degradative and regulatory processes and maintain cellular homoeostasis. To investigate the protective function of CDC48 against accumulated ubiquitinated proteins during neurodevelopment, we developed an in vivo bioassay technique that detects expression and accumulation of fluorescent proteins with a polyubiquitination signal at the N terminus. When we introduced CDC48 antisense morpholino oligonucleotides into zebrafish embryos, the morphant embryos were lethal and showed defects in neuronal outgrowth and neurodegeneration, and polyubiquitinated fluorescent proteins accumulated in the inner plexiform and ganglion cell layers, as well as the diencephalon and mesencephalon, indicating that the degradation of polyubiquitinated proteins by the ubiquitin-proteasome system was blocked. These abnormal phenotypes in the morphant were rescued by CDC48 or human valosin-containing protein overexpression. Therefore, the protective function of CDC48 is essential for neurodevelopment.	[Imamura, Shintaro; Yabu, Takeshi; Yamashita, Michiaki] Natl Res Inst Fisheries Sci, Yokohama, Kanagawa 2368648, Japan; [Yabu, Takeshi] Nihon Univ, Fujisawa, Kanagawa 2520880, Japan	Japan Fisheries Research & Education Agency (FRA); Nihon University	Yamashita, M (corresponding author), Natl Res Inst Fisheries Sci, 2-12-4 Fukuura, Yokohama, Kanagawa 2368648, Japan.	mic@affrc.go.jp			 [22780195];  [20880045]	; 	This work was supported by Grants-in-aid for Scientific Research 22780195 and 20880045 (to S. I.).	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Askanas V, 2005, MICROSC RES TECHNIQ, V67, P114, DOI 10.1002/jemt.20186; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; Chen H, 2003, P NATL ACAD SCI USA, V100, P14908, DOI 10.1073/pnas.2136625100; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Dalal S, 2004, MOL BIOL CELL, V15, P637, DOI 10.1091/mbc.E03-02-0097; Dreier L, 2005, NEURON, V46, P51, DOI 10.1016/j.neuron.2004.12.058; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Esaki M, 2010, BIOCHEM CELL BIOL, V88, P109, DOI [10.1139/o09-116, 10.1139/O09-116]; Fu XR, 2003, J CELL BIOL, V163, P21, DOI 10.1083/jcb.200307025; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003; Hatakeyama S, 2004, GENES CELLS, V9, P533, DOI 10.1111/j.1356-9597.2004.00742.x; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Higashiyama H, 2002, CELL DEATH DIFFER, V9, P264, DOI 10.1038/sj.cdd.4400955; Hirabayashi M, 2001, CELL DEATH DIFFER, V8, P977, DOI 10.1038/sj.cdd.4400907; Imamura S, 2003, FEBS LETT, V549, P14, DOI 10.1016/S0014-5793(03)00723-3; Imamura S., 2004, MAR BIOTECHNOL, V6, pS1; Imamura S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003364; Janiesch PC, 2007, NAT CELL BIOL, V9, P379, DOI 10.1038/ncb1554; Ju JS, 2008, J BIOL CHEM, V283, P30289, DOI 10.1074/jbc.M805517200; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Kakizuka A, 2008, BIOCHEM SOC T, V36, P105, DOI 10.1042/BST0360105; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152; Kobayashi T, 2002, J BIOL CHEM, V277, P47358, DOI 10.1074/jbc.M207783200; Madeo F, 1998, MOL BIOL CELL, V9, P131, DOI 10.1091/mbc.9.1.131; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; MOIR D, 1982, GENETICS, V100, P547; Muller JMM, 2007, BIOCHEM BIOPH RES CO, V354, P459, DOI 10.1016/j.bbrc.2006.12.206; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Sasagawa Y, 2009, J CELL SCI, V122, P3663, DOI 10.1242/jcs.052415; Tran JR, 2011, J BIOL CHEM, V286, P5744, DOI 10.1074/jbc.M110.179259; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Tursun B, 2005, GENE DEV, V19, P2307, DOI 10.1101/gad.1340605; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014; Wang Q, 2003, J BIOL CHEM, V278, P32784, DOI 10.1074/jbc.M303869200; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426; Weihl CC, 2007, HUM MOL GENET, V16, P919, DOI 10.1093/hmg/ddm037; Weihl CC, 2009, NEUROMUSCULAR DISORD, V19, P308, DOI 10.1016/j.nmd.2009.01.009; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Yamashita M, 1996, FEBS LETT, V382, P261, DOI 10.1016/0014-5793(96)00172-X; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	55	20	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23047	23056		10.1074/jbc.M111.332882	http://dx.doi.org/10.1074/jbc.M111.332882			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22549779	Green Published, hybrid			2022-12-25	WOS:000306495000061
J	Su, Y; Orelli, B; Madireddy, A; Niedernhofer, LJ; Scharer, OD				Su, Yan; Orelli, Barbara; Madireddy, Advaitha; Niedernhofer, Laura J.; Schaerer, Orlando D.			Multiple DNA Binding Domains Mediate the Function of the ERCC1-XPF Protein in Nucleotide Excision Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURE-SPECIFIC ENDONUCLEASES; STRUCTURE-SPECIFIC NUCLEASES; HOLLIDAY JUNCTION RESOLVASE; XERODERMA-PIGMENTOSUM; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; DUAL-INCISION; SLX4; MECHANISMS; ERCC1/XPF	ERCC1-XPF is a heterodimeric, structure-specific endonuclease that cleaves single-stranded/double-stranded DNA junctions and has roles in nucleotide excision repair (NER), interstrand crosslink (ICL) repair, homologous recombination, and possibly other pathways. In NER, ERCC1-XPF is recruited to DNA lesions by interaction with XPA and incises the DNA 5' to the lesion. We studied the role of the four C-terminal DNA binding domains in mediating NER activity and cleavage of model substrates. We found that mutations in the helix-hairpin-helix domain of ERCC1 and the nuclease domain of XPF abolished cleavage activity on model substrates. Interestingly, mutations in multiple DNA binding domains were needed to significantly diminish NER activity in vitro and in vivo, suggesting that interactions with proteins in the NER incision complex can compensate for some defects in DNA binding. Mutations in DNA binding domains of ERCC1-XPF render cells more sensitive to the crosslinking agent mitomycin C than to ultraviolet radiation, suggesting that the ICL repair function of ERCC1-XPF requires tighter substrate binding than NER. Our studies show that multiple domains of ERCC1-XPF contribute to substrate binding, and are consistent with models of NER suggesting that multiple weak protein-DNA and protein-protein interactions drive progression through the pathway. Our findings are discussed in the context of structural studies of individual domains of ERCC1-XPF and of its role in multiple DNA repair pathways.	[Su, Yan; Schaerer, Orlando D.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Orelli, Barbara; Schaerer, Orlando D.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Madireddy, Advaitha] Univ Pittsburgh, Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Niedernhofer, Laura J.] Univ Pittsburgh, Hillman Canc Ctr 2 6, Dept Microbiol, Pittsburgh, PA 15213 USA; [Niedernhofer, Laura J.] Univ Pittsburgh, Hillman Canc Ctr 2 6, Mol Genet & Canc Inst, Pittsburgh, PA 15213 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Scharer, OD (corresponding author), SUNY Stony Brook, Dept Chem, Chem 619, Stony Brook, NY 11794 USA.	orlando@pharm.stonybrook.edu	Schärer, Orlando D./AAF-8613-2021; Classen, Scott/AAY-8176-2020; Scharer, Orlando/B-8908-2008	Scharer, Orlando/0000-0003-2425-2715; Madireddy, Advaitha/0000-0002-4730-5325	National Institute of Health [GM080454, CA092584]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080454] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institute of Health Grants GM080454 and CA092584.	Ahmad A, 2008, MOL CELL BIOL, V28, P5082, DOI 10.1128/MCB.00293-08; Ahmad A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000871; Andersen SL, 2009, MOL CELL, V35, P128, DOI 10.1016/j.molcel.2009.06.019; BARDWELL AJ, 1994, SCIENCE, V265, P2082, DOI 10.1126/science.8091230; Bhagwat N, 2009, MOL CELL BIOL, V29, P6427, DOI 10.1128/MCB.00086-09; Biggerstaff M, 1999, METH MOL B, V113, P357; Coin F, 2004, EMBO J, V23, P4835, DOI 10.1038/sj.emboj.7600480; Crossan GP, 2011, NAT GENET, V43, P147, DOI 10.1038/ng.752; de Laat WL, 1998, GENE DEV, V12, P2598, DOI 10.1101/gad.12.16.2598; de Laat WL, 1998, NUCLEIC ACIDS RES, V26, P4146, DOI 10.1093/nar/26.18.4146; de Laat WL, 1998, J BIOL CHEM, V273, P7835, DOI 10.1074/jbc.273.14.7835; Doherty AJ, 1996, NUCLEIC ACIDS RES, V24, P2488, DOI 10.1093/nar/24.13.2488; Dunand-Sauthier I, 2005, J BIOL CHEM, V280, P7030, DOI 10.1074/jbc.M412228200; Enzlin JH, 2002, EMBO J, V21, P2045, DOI 10.1093/emboj/21.8.2045; Fagbemi AF, 2011, DNA REPAIR, V10, P722, DOI 10.1016/j.dnarep.2011.04.022; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Gaillard PHL, 2001, NUCLEIC ACIDS RES, V29, P872, DOI 10.1093/nar/29.4.872; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Gillet LCJ, 2005, NUCLEIC ACIDS RES, V33, P1961, DOI 10.1093/nar/gki335; Gregg SQ, 2011, DNA REPAIR, V10, P781, DOI 10.1016/j.dnarep.2011.04.026; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Houtsmuller AB, 1999, SCIENCE, V284, P958, DOI 10.1126/science.284.5416.958; HOY CA, 1985, CANCER RES, V45, P1737; Jaspers NGJ, 2007, AM J HUM GENET, V80, P457, DOI 10.1086/512486; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; LI L, 1995, MOL CELL BIOL, V15, P1993; MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; Moser J, 2007, MOL CELL, V27, P311, DOI 10.1016/j.molcel.2007.06.014; Munoz IM, 2009, MOL CELL, V35, P116, DOI 10.1016/j.molcel.2009.06.020; Newman M, 2005, EMBO J, V24, P895, DOI 10.1038/sj.emboj.7600581; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Nishino T, 2005, STRUCTURE, V13, P1183, DOI 10.1016/j.str.2005.04.024; Nishino T, 2005, STRUCTURE, V13, P143, DOI 10.1016/j.str.2004.11.008; Nishino T, 2003, STRUCTURE, V11, P445, DOI 10.1016/S0969-2126(03)00046-7; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; Orans J, 2011, CELL, V145, P212, DOI 10.1016/j.cell.2011.03.005; Orelli B, 2010, J BIOL CHEM, V285, P3705, DOI 10.1074/jbc.M109.067538; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Rouillon C, 2011, RES MICROBIOL, V162, P19, DOI 10.1016/j.resmic.2010.09.003; Salmon P, 2000, BLOOD, V96, P3392; Salmon Patrick, 2006, Curr Protoc Neurosci, VChapter 4, DOI 10.1002/0471142301.ns0421s37; Scharer OD, 2008, ADV EXP MED BIOL, V637, P83; Sgouros J, 1999, TRENDS BIOCHEM SCI, V24, P95, DOI 10.1016/S0968-0004(99)01355-9; Shivji MKK, 1999, METH MOL B, V113, P373; Staresincic L, 2009, EMBO J, V28, P1111, DOI 10.1038/emboj.2009.49; Stauffer ME, 2004, J BIOL CHEM, V279, P30915, DOI 10.1074/jbc.R400015200; Stoepker C, 2011, NAT GENET, V43, P138, DOI 10.1038/ng.751; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Tapias A, 2004, J BIOL CHEM, V279, P19074, DOI 10.1074/jbc.M312611200; Tian M, 2004, MOL CELL BIOL, V24, P1200, DOI 10.1128/MCB.24.3.1200-1205.2004; Tripsianes K, 2005, STRUCTURE, V13, P1849, DOI 10.1016/j.str.2005.08.014; Tripsianes K, 2007, NUCLEIC ACIDS RES, V35, P5789, DOI 10.1093/nar/gkm503; Tsodikov OV, 2007, EMBO J, V26, P4768, DOI 10.1038/sj.emboj.7601894; Tsodikov OV, 2005, P NATL ACAD SCI USA, V102, P11236, DOI 10.1073/pnas.0504341102; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wakasugi M, 1998, P NATL ACAD SCI USA, V95, P6669, DOI 10.1073/pnas.95.12.6669; Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	64	26	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21846	21855		10.1074/jbc.M111.337899	http://dx.doi.org/10.1074/jbc.M111.337899			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22547097	hybrid, Green Published			2022-12-25	WOS:000306418600026
J	Carrasco, P; Sahun, I; McDonald, J; Ramirez, S; Jacas, J; Gratacos, E; Sierra, AY; Serra, D; Herrero, L; Acker-Palmer, A; Hegardt, FG; Dierssen, M; Casals, N				Carrasco, Patricia; Sahun, Ignasi; McDonald, Jerome; Ramirez, Sara; Jacas, Jordi; Gratacos, Esther; Sierra, Adriana Y.; Serra, Dolors; Herrero, Laura; Acker-Palmer, Amparo; Hegardt, Fausto G.; Dierssen, Mara; Casals, Nuria			Ceramide Levels Regulated by Carnitine Palmitoyltransferase 1C Control Dendritic Spine Maturation and Cognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURVIVAL; EXPRESSION; PROTEIN; CPT1C; MICE; PHOSPHATASE-1; MORPHOGENESIS; HOMEOSTASIS; NEURONS; GROWTH	The brain-specific isoform carnitine palmitoyltransferase 1C (CPT1C) has been implicated in the hypothalamic regulation of food intake and energy homeostasis. Nevertheless, its molecular function is not completely understood, and its role in other brain areas is unknown. We demonstrate that CPT1C is expressed in pyramidal neurons of the hippocampus and is located in the endoplasmic reticulum throughout the neuron, even inside dendritic spines. We used molecular, cellular, and behavioral approaches to determine CPT1C function. First, we analyzed the implication of CPT1C in ceramide metabolism. CPT1C overexpression in primary hippocampal cultured neurons increased ceramide levels, whereas in CPT1C-deficient neurons, ceramide levels were diminished. Correspondingly, CPT1C knock-out (KO) mice showed reduced ceramide levels in the hippocampus. At the cellular level, CPT1C deficiency altered dendritic spine morphology by increasing immature filopodia and reducing mature mushroom and stubby spines. Total protrusion density and spine head area in mature spines were unaffected. Treatment of cultured neurons with exogenous ceramide reverted the KO phenotype, as did ectopic overexpression of CPT1C, indicating that CPT1C regulation of spine maturation is mediated by ceramide. To study the repercussions of the KO phenotype on cognition, we performed the hippocampus-dependent Morris water maze test on mice. Results show that CPT1C deficiency strongly impairs spatial learning. All of these results demonstrate that CPT1C regulates the levels of ceramide in the endoplasmic reticulum of hippocampal neurons, and this is a relevant mechanism for the correct maturation of dendritic spines and for proper spatial learning.	[Carrasco, Patricia; Ramirez, Sara; Jacas, Jordi; Gratacos, Esther; Sierra, Adriana Y.; Casals, Nuria] Univ Int Catalunya, Dept Basic Sci, Fac Med & Ciencies Salut, E-08195 Sant Cugat Del Valles, Spain; [Carrasco, Patricia; Ramirez, Sara; Jacas, Jordi; Serra, Dolors; Herrero, Laura; Hegardt, Fausto G.; Casals, Nuria] Ctr Invest Biomed Red CIBER Fisiopatol Obesidad &, Inst Salud Carlos III, E-28029 Madrid, Spain; [Sahun, Ignasi; McDonald, Jerome; Dierssen, Mara] CRG, Genes & Dis Program, E-08003 Barcelona, Spain; [Serra, Dolors; Herrero, Laura; Hegardt, Fausto G.] Univ Barcelona, Sch Pharm, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain; [Acker-Palmer, Amparo] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, D-60438 Frankfurt, Germany; [Acker-Palmer, Amparo] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, D-60438 Frankfurt, Germany; [Dierssen, Mara] CIBER Enfermedades RARAS CIBERER, Inst Salud Carlos III, E-28029 Madrid, Spain	Universitat Internacional de Catalunya (UIC); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Barcelona; Goethe University Frankfurt; Goethe University Frankfurt; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III	Casals, N (corresponding author), Univ Int Catalunya, Dept Basic Sci, Fac Med & Ciencies Salut, Josep Trueta S-N, E-08195 Sant Cugat Del Valles, Spain.	ncasals@csc.uic.es	Ramírez, Sara/AAE-4400-2022; Gratacòs-Batlle, Esther/L-8740-2014; Dierssen, Mara/G-3552-2015; Casals, Nuria/L-3378-2014; Herrero, Laura/D-4011-2014; Serra, Dolors/L-3657-2014; Sahun, Ignasi/H-6892-2015	Gratacòs-Batlle, Esther/0000-0001-8093-3713; Dierssen, Mara/0000-0003-0853-6865; Casals, Nuria/0000-0002-6719-4300; Herrero, Laura/0000-0003-4244-4673; Serra, Dolors/0000-0002-4936-4206; Ramirez Flores, Sara/0000-0002-2072-2495; Sahun, Ignasi/0000-0002-4257-9255	Ministerio de Educacion y Ciencia, Spain [SAF2007-61926, 2009SGR131, SAF2010-16427, CureFXSEU/FISPS09102673, SAF2011-30520-C02-02]; Fundacio La Marato de TV3, Catalunya	Ministerio de Educacion y Ciencia, Spain(Spanish Government); Fundacio La Marato de TV3, Catalunya	This work was supported by Ministerio de Educacion y Ciencia, Spain, Grants SAF2007-61926, 2009SGR131, SAF2010-16427, CureFXSEU/FISPS09102673, and SAF2011-30520-C02-02 and by a grant from Fundacio La Marato de TV3 (2007), Catalunya.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Arque G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002575; Ben-David O, 2010, NEUROMOL MED, V12, P341, DOI 10.1007/s12017-010-8114-x; Breslow DK, 2010, MOL CELL, V40, P267, DOI 10.1016/j.molcel.2010.10.005; Chalfant CE, 1999, J BIOL CHEM, V274, P20313, DOI 10.1074/jbc.274.29.20313; Dai Y, 2007, BIOCHEM BIOPH RES CO, V359, P469, DOI 10.1016/j.bbrc.2007.05.161; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; ESSER V, 1993, J BIOL CHEM, V268, P5817; Gao S, 2011, P NATL ACAD SCI USA, V108, P9691, DOI 10.1073/pnas.1103267108; Gao XF, 2009, DIABETOLOGIA, V52, P912, DOI 10.1007/s00125-009-1284-0; Grimm D, 1998, HUM GENE THER, V9, P2745, DOI 10.1089/hum.1998.9.18-2745; Hering H, 2003, J NEUROSCI, V23, P3262; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Melon I, 2009, NEUROSCIENCE, V159, P657, DOI 10.1016/j.neuroscience.2008.11.056; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Mitoma J, 1998, J NEUROSCI RES, V51, P712, DOI 10.1002/(SICI)1097-4547(19980315)51:6<712::AID-JNR5>3.3.CO;2-Q; Price NT, 2002, GENOMICS, V80, P433, DOI 10.1006/geno.2002.6845; Reamy AA, 2011, J NEUROCHEM, V118, P388, DOI 10.1111/j.1471-4159.2011.07312.x; Segura I, 2007, NAT NEUROSCI, V10, P301, DOI 10.1038/nn1858; Sierra AY, 2008, J BIOL CHEM, V283, P6878, DOI 10.1074/jbc.M707965200; Terry-Lorenzo RT, 2005, MOL BIOL CELL, V16, P2349, DOI 10.1091/mbc.E04-12-1054; Tokutake Y, 2010, BIOCHEM BIOPH RES CO, V402, P158, DOI 10.1016/j.bbrc.2010.10.009; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Wolfgang MJ, 2006, P NATL ACAD SCI USA, V103, P7282, DOI 10.1073/pnas.0602205103; YAMAZAKI N, 1995, FEBS LETT, V363, P41, DOI 10.1016/0014-5793(95)00277-G; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211	26	53	53	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21224	21232		10.1074/jbc.M111.337493	http://dx.doi.org/10.1074/jbc.M111.337493			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22539351	Green Published, hybrid			2022-12-25	WOS:000306416800042
J	Graybill, C; Wee, B; Atwood, SX; Prehoda, KE				Graybill, Chiharu; Wee, Brett; Atwood, Scott X.; Prehoda, Kenneth E.			Partitioning-defective Protein 6 (Par-6) Activates Atypical Protein Kinase C (aPKC) by Pseudosubstrate Displacement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASYMMETRIC CELL-DIVISION; POLARITY; COMPLEX; DOMAIN; PKC; PHOSPHORYLATION; BINDING; SIGNAL; LGL; DIACYLGLYCEROL	Atypical protein kinase C (aPKC) controls cell polarity by modulating substrate cortical localization. Aberrant aPKC activity disrupts polarity, yet the mechanisms that control aPKC remain poorly understood. We used a reconstituted system with purified components and a cultured cell cortical displacement assay to investigate aPKC regulation. We find that aPKC is autoinhibited by two domains within its NH2-terminal regulatory half, a pseudosubstrate motif that occupies the kinase active site, and a C1 domain that assists in this process. The Par complex member Par-6, previously thought to inhibit aPKC, is a potent activator of aPKC in our assays. Par-6 and aPKC interact via PB1 domain heterodimerization, and this interaction activates aPKC by displacing the pseudosubstrate, although full activity requires the Par-6 CRIB-PDZ domains. We propose that, along with its previously described roles in controlling aPKC localization, Par-6 allosterically activates aPKC to allow for high spatial and temporal control of substrate phosphorylation and polarization.	Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Univ Oregon, Dept Chem, Eugene, OR 97403 USA	University of Oregon; University of Oregon	Prehoda, KE (corresponding author), 1229 Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	prehoda@molbio.uoregon.edu		Atwood, Scott/0000-0001-7407-9792	National Institutes of Health [GM068032]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM068032 (to K. E. P.).	Atwood SX, 2007, J CELL SCI, V120, P3200, DOI 10.1242/jcs.014902; Atwood SX, 2009, CURR BIOL, V19, P723, DOI 10.1016/j.cub.2009.03.056; BERRA E, 1993, CELL, V74, P555, DOI 10.1016/0092-8674(93)80056-K; Betschinger J, 2005, CURR BIOL, V15, P276, DOI 10.1016/j.cub.2005.01.012; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Dutil EM, 2000, J BIOL CHEM, V275, P10697, DOI 10.1074/jbc.275.14.10697; Eder AM, 2005, P NATL ACAD SCI USA, V102, P12519, DOI 10.1073/pnas.0505641102; Giorgione JR, 2006, J BIOL CHEM, V281, P1660, DOI 10.1074/jbc.M510251200; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Hirano Y, 2005, J BIOL CHEM, V280, P9653, DOI 10.1074/jbc.M409823200; HOUSE C, 1987, J BIOL CHEM, V262, P772; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; Leonard TA, 2011, CURR OPIN STRUC BIOL, V21, P785, DOI 10.1016/j.sbi.2011.07.006; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lopez-Garcia LA, 2011, CHEM BIOL, V18, P1463, DOI 10.1016/j.chembiol.2011.08.010; Moscat J, 2006, MOL CELL, V23, P631, DOI 10.1016/j.molcel.2006.08.002; Nance J, 2011, DEVELOPMENT, V138, P799, DOI 10.1242/dev.053538; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Peterson FC, 2004, MOL CELL, V13, P665, DOI 10.1016/S1097-2765(04)00086-3; Plant PJ, 2003, NAT CELL BIOL, V5, P301, DOI 10.1038/ncb948; Prehoda KE, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001388; Pu YM, 2006, J BIOL CHEM, V281, P33773, DOI 10.1074/jbc.M606560200; Qian Y, 2006, J BIOL CHEM, V281, P35757, DOI 10.1074/jbc.M607057200; Regala RP, 2005, J BIOL CHEM, V280, P31109, DOI 10.1074/jbc.M505402200; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Smith CA, 2007, EMBO J, V26, P468, DOI 10.1038/sj.emboj.7601495; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Wee B, 2011, J CELL BIOL, V195, P369, DOI 10.1083/jcb.201102130; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049; Yamanaka T, 2003, CURR BIOL, V13, P734, DOI 10.1016/S0960-9822(03)00244-6; Yamanaka T, 2001, GENES CELLS, V6, P721, DOI 10.1046/j.1365-2443.2001.00453.x	36	59	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21003	21011		10.1074/jbc.M112.360495	http://dx.doi.org/10.1074/jbc.M112.360495			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22544755	Green Published, hybrid			2022-12-25	WOS:000306416800022
J	Inoue, K; Furukawa, T; Kumada, T; Yamada, J; Wang, TY; Inoue, R; Fukuda, A				Inoue, Koichi; Furukawa, Tomonori; Kumada, Tatsuro; Yamada, Junko; Wang, Tianying; Inoue, Rieko; Fukuda, Atsuo			Taurine Inhibits K+-Cl- Cotransporter KCC2 to Regulate Embryonic Cl- Homeostasis via With-no-lysine (WNK) Protein Kinase Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION-CHLORIDE COTRANSPORTERS; FUNCTIONAL-CHARACTERIZATION; GABA; EXPRESSION; BRAIN; NEURONS; PHOSPHORYLATION; TRANSPORTER; CELLS; MOUSE	GABA inhibits mature neurons and conversely excites immature neurons due to lower K+-Cl- cotransporter 2 (KCC2) expression. We observed that ectopically expressed KCC2 in embryonic cerebral cortices was not active; however, KCC2 functioned in newborns. In vitro studies revealed that taurine increased KCC2 inactivation in a phosphorylation-dependent manner. When Thr-906 and Thr-1007 residues in KCC2 were substituted with Ala (KCC2T906A/T1007A), KCC2 activity was facilitated, and the inhibitory effect of taurine was not observed. Exogenous taurine activated the with-no-lysine protein kinase 1 (WNK1) and downstream STE20/SPS1-related proline/alanine-rich kinase (SPAK)/oxidative stress response 1 (OSR1), and overexpression of active WNK1 resulted in KCC2 inhibition in the absence of taurine. Phosphorylation of SPAK was consistently higher in embryonic brains compared with that of neonatal brains and down-regulated by a taurine transporter inhibitor in vivo. Furthermore, cerebral radial migration was perturbed by a taurine-insensitive form of KCC2, KCC2T906A/T1007A, which may be regulated by WNK-SPAK/OSR1 signaling. Thus, taurine and WNK-SPAK/OSR1 signaling may contribute to embryonic neuronal Cl- homeostasis, which is required for normal brain development.	[Inoue, Koichi; Furukawa, Tomonori; Kumada, Tatsuro; Wang, Tianying; Inoue, Rieko; Fukuda, Atsuo] Hamamatsu Univ Sch Med, Dept Physiol, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Yamada, Junko] Hirosaki Univ, Grad Sch Med, Dept Neurophysiol, Hirosaki, Aomori 0368562, Japan	Hamamatsu University School of Medicine; Hirosaki University	Inoue, K (corresponding author), Hamamatsu Univ Sch Med, Dept Physiol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	ino-k@umin.ac.jp; axfukuda@hama-med.ac.jp	Fukuda, Atsuo/ABA-6843-2020; Kumada, Tatsuro/AAY-9117-2020; Furukawa, Tomonori/G-7014-2014	Fukuda, Atsuo/0000-0001-7112-4834; 	Ministry of Education, Culture, Sports, Science, and Technology, Japan [2002195, 21026013, 23123505]; Japan Society for the Promotion of Science [19390058, 23500387]; Kanzawa Medical Research Foundation; Salt Science Research Foundation [1125]; Grants-in-Aid for Scientific Research [23123505] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kanzawa Medical Research Foundation(Kanzawa Medical Research Foundation); Salt Science Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research on Priority Areas Elucidation of Neural Network Function in the Brain 2002195 (to A. F.) and Molecular Interaction and Modal Shift of Cellular Sensor 21026013 (to A. F.) and Grant-in-Aid for Scientific Research on Innovative Area Neural Diversity and Neocortical Organization 23123505 (to K. I.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and Grants-in-Aid from the Japan Society for the Promotion of Science 19390058 (to A. F.) and 23500387 (to K. I.), Salt Science Research Foundation Grant 1125 (to K. I.), and a grant from the Kanzawa Medical Research Foundation (to K. I.).	Achilles K, 2007, J NEUROSCI, V27, P8616, DOI 10.1523/JNEUROSCI.5041-06.2007; Aguado F, 2003, DEVELOPMENT, V130, P1267, DOI 10.1242/dev.00351; AKAHORI S, 1986, ACTA MED OKAYAMA, V40, P93; Anselmo AN, 2006, P NATL ACAD SCI USA, V103, P10883, DOI 10.1073/pnas.0604607103; Balakrishnan V, 2003, J NEUROSCI, V23, P4134; Barakat L, 2002, J PHYSIOL-LONDON, V541, P753, DOI 10.1113/jphysiol.2001.015834; Behar TN, 2000, CEREB CORTEX, V10, P899, DOI 10.1093/cercor/10.9.899; Behar TN, 1998, J NEUROSCI, V18, P6378; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Benitez-Diaz P, 2003, DEV NEUROSCI-BASEL, V25, P366, DOI 10.1159/000073514; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Cancedda L, 2007, J NEUROSCI, V27, P5224, DOI 10.1523/JNEUROSCI.5169-06.2007; Caric D, 1997, DEVELOPMENT, V124, P5087; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; de los Heros P, 2006, P NATL ACAD SCI USA, V103, P1976, DOI 10.1073/pnas.0510947103; DeFazio RA, 2000, J NEUROSCI, V20, P8069; del Olmo N, 2000, BRAIN RES, V864, P298, DOI 10.1016/S0006-8993(00)02211-3; Dominy J, 2004, J NEUROCHEM, V89, P1195, DOI 10.1111/j.1471-4159.2004.02410.x; Dowd BFX, 2003, J BIOL CHEM, V278, P27347, DOI 10.1074/jbc.M301899200; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; EBIHARA S, 1995, J PHYSIOL-LONDON, V484, P77, DOI 10.1113/jphysiol.1995.sp020649; Fiumelli H, 2005, NEURON, V48, P773, DOI 10.1016/j.neuron.2005.10.025; Flint AC, 1998, NEURON, V20, P43, DOI 10.1016/S0896-6273(00)80433-X; Fukuda A, 2005, NAT MED, V11, P1153, DOI 10.1038/nm1105-1153; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Garzon-Muvdi T, 2007, AM J PHYSIOL-RENAL, V292, pF1197, DOI 10.1152/ajprenal.00335.2006; GAULL GE, 1989, PEDIATRICS, V83, P433; Georgala PA, 2011, CEREB CORTEX, V21, P81, DOI 10.1093/cercor/bhq061; Hanganu IL, 2009, CEREB CORTEX, V19, P89, DOI 10.1093/cercor/bhn061; Heck N, 2007, CEREB CORTEX, V17, P138, DOI 10.1093/cercor/bhj135; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ikeda K, 2004, J NEUROSCI, V24, P10693, DOI 10.1523/JNEUROSCI.2909-04.2004; Inoue K, 2006, J NEUROCHEM, V96, P598, DOI 10.1111/j.1471-4159.2005.03560.x; Inoue K, 2004, FEBS LETT, V564, P131, DOI 10.1016/S0014-5793(04)00328-X; Inoue K, 2005, BIOCHEM BIOPH RES CO, V327, P300, DOI 10.1016/j.bbrc.2004.12.010; Inoue K, 2010, J BIOL CHEM, V285, P7430, DOI 10.1074/jbc.M109.040485; Janeke G, 2003, J INVEST DERMATOL, V121, P354, DOI 10.1046/j.1523-1747.2003.12366.x; Jarolimek W, 1999, J NEUROSCI, V19, P4695; Kahle KT, 2010, BBA-MOL BASIS DIS, V1802, P1150, DOI 10.1016/j.bbadis.2010.07.009; Kahle KT, 2005, P NATL ACAD SCI USA, V102, P16783, DOI 10.1073/pnas.0508307102; Kelsch W, 2001, J NEUROSCI, V21, P8339, DOI 10.1523/JNEUROSCI.21-21-08339.2001; Khirug S, 2005, EUR J NEUROSCI, V21, P899, DOI 10.1111/j.1460-9568.2005.03886.x; Kilb W, 2008, J NEUROPHYSIOL, V100, P698, DOI 10.1152/jn.00657.2007; Kilb W, 2002, NEUROSCIENCE, V112, P299, DOI 10.1016/S0306-4522(02)00071-4; Kranz H, 2001, INT J PHARM, V212, P11, DOI 10.1016/S0378-5173(00)00568-8; Lambert IH, 2004, NEUROCHEM RES, V29, P27, DOI 10.1023/B:NERE.0000010433.08577.96; Lee HHC, 2007, J BIOL CHEM, V282, P29777, DOI 10.1074/jbc.M705053200; Li H, 2002, EUR J NEUROSCI, V16, P2358, DOI 10.1046/j.1460-9568.2002.02419.x; LIU QR, 1992, P NATL ACAD SCI USA, V89, P12145, DOI 10.1073/pnas.89.24.12145; Lu J, 1999, J NEUROBIOL, V39, P558, DOI 10.1002/(SICI)1097-4695(19990615)39:4<558::AID-NEU9>3.0.CO;2-5; Mienville JM, 1998, J PHYSIOL-LONDON, V512, P809, DOI 10.1111/j.1469-7793.1998.809bd.x; MILLER RA, 1977, J BIOMED MATER RES, V11, P711, DOI 10.1002/jbm.820110507; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; PALACKAL T, 1986, J NEUROSCI RES, V15, P223, DOI 10.1002/jnr.490150212; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Payne JA, 1997, AM J PHYSIOL-CELL PH, V273, pC1516, DOI 10.1152/ajpcell.1997.273.5.C1516; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; RAMAMOORTHY S, 1994, BIOCHEM J, V300, P893, DOI 10.1042/bj3000893; Richardson C, 2008, J CELL SCI, V121, P3293, DOI 10.1242/jcs.029223; Rinehart J, 2011, J BIOL CHEM, V286, P30171, DOI 10.1074/jbc.M111.222893; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; SCHMIEDEN V, 1992, EMBO J, V11, P2025, DOI 10.1002/j.1460-2075.1992.tb05259.x; SHIMADA M, 1984, HISTOCHEMISTRY, V80, P225, DOI 10.1007/BF00495770; Shimizu-Okabe C, 2002, NEUROREPORT, V13, P2433, DOI 10.1097/00001756-200212200-00012; STURMAN JA, 1985, J NEUROSCI RES, V13, P405, DOI 10.1002/jnr.490130307; STURMAN JA, 1993, PHYSIOL REV, V73, P119, DOI 10.1152/physrev.1993.73.1.119; Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656; Veziers J, 2001, J NEUROSURG, V95, P489, DOI 10.3171/jns.2001.95.3.0489; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Wake H, 2007, J NEUROSCI, V27, P1642, DOI 10.1523/JNEUROSCI.3104-06.2007; Wang C, 2002, DEV BRAIN RES, V139, P59, DOI 10.1016/S0165-3806(02)00536-9; Wang DD, 2009, J PHYSIOL-LONDON, V587, P1873, DOI 10.1113/jphysiol.2008.167635; Warskulat U, 2007, ARCH BIOCHEM BIOPHYS, V462, P202, DOI 10.1016/j.abb.2007.03.022; Watanabe M, 2009, J BIOL CHEM, V284, P27980, DOI 10.1074/jbc.M109.043620; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Yamada J, 2004, J PHYSIOL-LONDON, V557, P829, DOI 10.1113/jphysiol.2004.062471; Zagorska A, 2007, J CELL BIOL, V176, P89, DOI 10.1083/jcb.200605093	86	63	63	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20839	20850		10.1074/jbc.M111.319418	http://dx.doi.org/10.1074/jbc.M111.319418			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22544747	Green Published, hybrid			2022-12-25	WOS:000306416800006
J	Campellone, KG; Siripala, AD; Leong, JM; Welch, MD				Campellone, Kenneth G.; Siripala, Anosha D.; Leong, John M.; Welch, Matthew D.			Membrane-deforming Proteins Play Distinct Roles in Actin Pedestal Biogenesis by Enterohemorrhagic Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WASP-WIP COMPLEX; N-WASP; ARP2/3 COMPLEX; EFFECTORS TIR; BAR PROTEINS; ESPF(U); CYTOSKELETON; NCK; POLYMERIZATION; MOTILITY	Many bacterial pathogens reorganize the host actin cytoskeleton during the course of infection, including enterohemorrhagic Escherichia coli (EHEC), which utilizes the effector protein EspF(U) to assemble actin filaments within plasma membrane protrusions called pedestals. EspF(U) activates N-WASP, a host actin nucleation-promoting factor that is normally auto-inhibited and found in a complex with the actin-binding protein WIP. Under native conditions, this N-WASP/WIP complex is activated by the small GTPase Cdc42 in concert with several different SH3 (Src-homology-3) domain-containing proteins. In the current study, we tested whether SH3 domains from the F-BAR (FCH-Bin-Amphiphysin-Rvs) subfamily of membrane-deforming proteins are involved in actin pedestal formation. We found that three F-BAR proteins: CIP4, FBP17, and TOCA1 (transducer of Cdc42-dependent actin assembly), play different roles during actin pedestal biogenesis. Whereas CIP4 and FBP17 inhibited actin pedestal assembly, TOCA1 stimulated this process. TOCA1 was recruited to pedestals by its SH3 domain, which bound directly to proline-rich sequences within EspF(U). Moreover, EspF(U) and TOCA1 activated the N-WASP/WIP complex in an additive fashion in vitro, suggesting that TOCA1 can augment actin assembly within pedestals. These results reveal that EspF(U) acts as a scaffold to recruit multiple actin assembly factors whose functions are normally regulated by Cdc42.	[Campellone, Kenneth G.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Siripala, Anosha D.; Welch, Matthew D.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Leong, John M.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	University of Connecticut; University of California System; University of California Berkeley; Tufts University	Campellone, KG (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	kenneth.campellone@uconn.edu		Siripala, Anosha/0000-0003-4073-9195	National Institutes of Health (NIH) [R01-AI46454, R01-GM59609]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059609] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants R01-AI46454 (to J.M.L.) and R01-GM59609 (to M.D.W.).	Aitio O, 2010, P NATL ACAD SCI USA, V107, P21743, DOI 10.1073/pnas.1010243107; Allen-Vercoe E, 2006, INFECT IMMUN, V74, P6196, DOI 10.1128/IAI.00753-06; Alto NM, 2007, J CELL BIOL, V178, P1265, DOI 10.1083/jcb.200705021; Brady MJ, 2007, CELL MICROBIOL, V9, P2242, DOI 10.1111/j.1462-5822.2007.00954.x; Bu WY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012153; Bu WY, 2009, J BIOL CHEM, V284, P11622, DOI 10.1074/jbc.M805940200; Cameron LA, 1999, P NATL ACAD SCI USA, V96, P4908, DOI 10.1073/pnas.96.9.4908; Campellone KG, 2008, CELL, V134, P148, DOI 10.1016/j.cell.2008.05.032; Campellone KG, 2006, CELL MICROBIOL, V8, P1488, DOI 10.1111/j.1462-5822.2006.00728.x; Campellone KG, 2010, FEBS J, V277, P2390, DOI 10.1111/j.1742-4658.2010.07653.x; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Campellone KG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000191; Campellone KG, 2005, MOL MICROBIOL, V56, P416, DOI 10.1111/j.1365-2958.2005.04558.x; Campellone KG, 2004, DEV CELL, V7, P217, DOI 10.1016/j.devcel.2004.07.004; Cantarelli VV, 2007, CELL MICROBIOL, V9, P1782, DOI 10.1111/j.1462-5822.2007.00913.x; Carlier MF, 2000, J BIOL CHEM, V275, P21946, DOI 10.1074/jbc.M000687200; Cheng HC, 2008, NATURE, V454, P1009, DOI 10.1038/nature07160; Dean P, 2005, CURR OPIN MICROBIOL, V8, P28, DOI 10.1016/j.mib.2004.12.010; Garmendia J, 2005, J CLIN MICROBIOL, V43, P5715, DOI 10.1128/JCM.43.11.5715-5720.2005; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Garmendia J, 2004, CELL MICROBIOL, V6, P1167, DOI 10.1111/j.1462-5822.2004.00459.x; GOLDBERG MB, 1995, P NATL ACAD SCI USA, V92, P6572, DOI 10.1073/pnas.92.14.6572; Haglund CM, 2011, J CELL BIOL, V195, P7, DOI 10.1083/jcb.201103148; Hayward RD, 2006, NAT REV MICROBIOL, V4, P358, DOI 10.1038/nrmicro1391; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Hu JH, 2011, J BIOL CHEM, V286, P2261, DOI 10.1074/jbc.M110.157974; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kakimoto T, 2006, J BIOL CHEM, V281, P29042, DOI 10.1074/jbc.M604025200; Kamioka Y, 2004, J BIOL CHEM, V279, P40091, DOI 10.1074/jbc.M404899200; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Lee K, 2010, SCIENCE, V329, P1341, DOI 10.1126/science.1191710; Leung Y, 2008, CELL HOST MICROBE, V3, P39, DOI 10.1016/j.chom.2007.10.011; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; Rottner K, 2010, TRENDS CELL BIOL, V20, P650, DOI 10.1016/j.tcb.2010.08.014; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Sallee NA, 2008, NATURE, V454, P1005, DOI 10.1038/nature07170; Spears KJ, 2006, FEMS MICROBIOL LETT, V255, P187, DOI 10.1111/j.1574-6968.2006.00119.x; Stevens JM, 2006, NAT REV MICROBIOL, V4, P91, DOI 10.1038/nrmicro1320; Takano K, 2008, EMBO J, V27, P2817, DOI 10.1038/emboj.2008.216; Toguchi M, 2010, BIOL CELL, V102, P215, DOI 10.1042/BC20090033; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Vingadassalom D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001056; Vingadassalom D, 2009, P NATL ACAD SCI USA, V106, P6754, DOI 10.1073/pnas.0809131106; Weiss SM, 2009, CELL HOST MICROBE, V5, P244, DOI 10.1016/j.chom.2009.02.003	47	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20613	20624		10.1074/jbc.M112.363473	http://dx.doi.org/10.1074/jbc.M112.363473			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22544751	Green Published, hybrid			2022-12-25	WOS:000306414500081
J	Papaleo, E; Renzetti, G; Tiberti, M				Papaleo, Elena; Renzetti, Giulia; Tiberti, Matteo			Mechanisms of Intramolecular Communication in a Hyperthermophilic Acylaminoacyl Peptidase: A Molecular Dynamics Investigation	PLOS ONE			English	Article							PROLYL ENDOPEPTIDASE INHIBITOR; TRANSFER-RNA SYNTHETASE; BETA-PROPELLER DOMAIN; ACYLPEPTIDE HYDROLASE; PROTEIN DYNAMICS; ENZYME; FLEXIBILITY; IDENTIFICATION; STABILIZATION; INACTIVATION	Protein dynamics and the underlying networks of intramolecular interactions and communicating residues within the three-dimensional (3D) structure are known to influence protein function and stability, as well as to modulate conformational changes and allostery. Acylaminoacyl peptidase (AAP) subfamily of enzymes belongs to a unique class of serine proteases, the prolyl oligopeptidase (POP) family, which has not been thoroughly investigated yet. POPs have a characteristic multidomain three-dimensional architecture with the active site at the interface of the C-terminal catalytic domain and a beta-propeller domain, whose N-terminal region acts as a bridge to the hydrolase domain. In the present contribution, protein dynamics signatures of a hyperthermophilic acylaminoacyl peptidase (AAP) of the prolyl oligopeptidase (POP) family, as well as of a deletion variant and alanine mutants (I12A, V13A, V16A, L19A, I20A) are reported. In particular, we aimed at identifying crucial residues for long range communications to the catalytic site or promoting the conformational changes to switch from closed to open ApAAP conformations. Our investigation shows that the N-terminal alpha 1-helix mediates structural intramolecular communication to the catalytic site, concurring to the maintenance of a proper functional architecture of the catalytic triad. Main determinants of the effects induced by alpha 1-helix are a subset of hydrophobic residues (V16, L19 and I20). Moreover, a subset of residues characterized by relevant interaction networks or coupled motions have been identified, which are likely to modulate the conformational properties at the interdomain interface.	[Papaleo, Elena; Renzetti, Giulia; Tiberti, Matteo] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy	University of Milano-Bicocca	Papaleo, E (corresponding author), Univ Copenaghen, Copenaghen Bioctr, Dept Biol, Copenaghen, Denmark.	elena.papaleo@unimib.it	Tiberti, Matteo/AGU-8969-2022; Papaleo, Elena/M-6629-2014	Papaleo, Elena/0000-0002-7376-5894; , Elena/0000-0003-2296-898X	CASPUR (Consorzio Interuniversitario per le Applicazioni di Supercalcolo per Universita e Ricerca)	CASPUR (Consorzio Interuniversitario per le Applicazioni di Supercalcolo per Universita e Ricerca)	This research was supported by CASPUR (Consorzio Interuniversitario per le Applicazioni di Supercalcolo per Universita e Ricerca) Standard HPC Grant 2010 and 2011 to Dr. Papaleo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CA, 1999, FEBS LETT, V458, P278, DOI 10.1016/S0014-5793(99)01166-7; Ackerman SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017459; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Armenta-Medina D, 2011, PROTEINS, V79, P1662, DOI 10.1002/prot.22995; Bae E, 2005, J BIOL CHEM, V280, P30943, DOI 10.1074/jbc.M504216200; Bartlam M, 2004, STRUCTURE, V12, P1481, DOI 10.1016/j.str.2004.05.019; Bosshard HR, 2004, J MOL RECOGNIT, V17, P1, DOI 10.1002/jmr.657; Camps J, 2009, BIOINFORMATICS, V25, P1709, DOI 10.1093/bioinformatics/btp304; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; D'Amico S, 2003, J MOL BIOL, V332, P981, DOI 10.1016/j.jmb.2003.07.014; Daniel RM, 2008, EXTREMOPHILES, V12, P51, DOI 10.1007/s00792-007-0089-7; Daniel RM, 2010, BIOCHEM J, V425, P353, DOI 10.1042/BJ20091254; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dodson GG, 2008, EMBO REP, V9, P144, DOI 10.1038/sj.embor.7401160; Echave J, 2010, PROTEINS, V78, P173, DOI 10.1002/prot.22553; ERLANDSSON R, 1991, ONCOGENE, V6, P1293; Estabrook RA, 2005, P NATL ACAD SCI USA, V102, P994, DOI 10.1073/pnas.0409128102; Esteban-Martin S, 2010, J AM CHEM SOC, V132, P4626, DOI 10.1021/ja906995x; Feller G, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/32/323101; Fuhrmans M, 2010, THEOR CHEM ACC, V125, P335, DOI 10.1007/s00214-009-0590-4; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Gao RJ, 2003, J MOL CATAL B-ENZYM, V24-5, P1, DOI 10.1016/S1381-1177(03)00064-X; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P15711, DOI 10.1073/pnas.0704459104; Ghosh A, 2011, J BIOL CHEM, V286, P37721, DOI 10.1074/jbc.M111.246702; Harmat V, 2011, J BIOL CHEM, V286, P1987, DOI 10.1074/jbc.M110.169862; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HUNENBERGER PH, 1995, J MOL BIOL, V252, P492, DOI 10.1006/jmbi.1995.0514; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kamerlin SCL, 2010, PROTEINS, V78, P1339, DOI 10.1002/prot.22654; Kappel C, 2010, BIOPHYS J, V99, P1596, DOI 10.1016/j.bpj.2010.06.032; Kiss AL, 2008, J STRUCT BIOL, V162, P312, DOI 10.1016/j.jsb.2008.01.012; Kormos BL, 2007, J STRUCT BIOL, V157, P500, DOI 10.1016/j.jsb.2006.10.022; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Kwasigroch JM, 2002, BIOINFORMATICS, V18, P1701, DOI 10.1093/bioinformatics/18.12.1701; Law AB, 2009, J AM CHEM SOC, V131, P6322, DOI 10.1021/ja809915a; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lonquety M, 2007, COMPUT SYST BIOINF, P1; Lukman S, 2010, FEBS LETT, V584, P1235, DOI 10.1016/j.febslet.2010.02.035; Lwin TZ, 2007, J MOL BIOL, V373, P1334, DOI 10.1016/j.jmb.2007.07.080; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; Maguid S, 2008, GENE, V422, P7, DOI 10.1016/j.gene.2008.06.002; Marcos E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000738; Markwick PRL, 2009, J AM CHEM SOC, V131, P16968, DOI 10.1021/ja907476w; Mayer KL, 2003, NAT STRUCT BIOL, V10, P962, DOI 10.1038/nsb991; Morain P, 2002, CNS DRUG REV, V8, P31; Morra G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000323; Nashine VC, 2010, CURR OPIN CHEM BIOL, V14, P644, DOI 10.1016/j.cbpa.2010.07.020; Pace CN, 2000, PROTEIN SCI, V9, P1395; Papaleo E, 2011, CURR PROTEIN PEPT SC, V12, P657, DOI 10.2174/1389203711109070657; Papaleo E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024214; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Rhoades E, 2003, P NATL ACAD SCI USA, V100, P3197, DOI 10.1073/pnas.2628068100; Richards PG, 2000, MOL PHARMACOL, V58, P577, DOI 10.1124/mol.58.3.577; Sacquin-Mora S, 2010, BIOPHYS J, V99, P3412, DOI 10.1016/j.bpj.2010.09.026; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Seeber M, 2011, J COMPUT CHEM, V32, P1183, DOI 10.1002/jcc.21688; Shan L, 2005, P NATL ACAD SCI USA, V102, P3599, DOI 10.1073/pnas.0408286102; Silvestre-Ryan J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002023; SOKOLIK CW, 1994, PROTEIN SCI, V3, P126; Suel GM, 2003, NAT STRUCT BIOL, V10, P232, DOI 10.1038/nsb0303-232; Sumida JP, 2008, J BIOL CHEM, V283, P6728, DOI 10.1074/jbc.M707485200; Szeltner Z, 2002, J BIOL CHEM, V277, P44597, DOI 10.1074/jbc.M207386200; Tarrago T, 2009, FEBS LETT, V583, P3344, DOI 10.1016/j.febslet.2009.09.036; Tiberti M, 2011, J STRUCT BIOL, V174, P69, DOI 10.1016/j.jsb.2011.01.006; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; TOIDE K, 1995, J NEUROCHEM, V65, P234; TSOU CL, 1995, BBA-PROTEIN STRUCT M, V1253, P151, DOI 10.1016/0167-4838(95)00172-5; TSUNASAWA S, 1975, J BIOCHEM, V77, P89; Van Elzen R, 2011, CNS NEUROL DISORD-DR, V10, P297, DOI 10.2174/187152711794653814; Villali J, 2010, CURR OPIN CHEM BIOL, V14, P636, DOI 10.1016/j.cbpa.2010.08.007; Vishveshwara S, 2009, CURR PROTEIN PEPT SC, V10, P146, DOI 10.2174/138920309787847590; Yamaguchi M, 1999, BIOCHEM BIOPH RES CO, V263, P139, DOI 10.1006/bbrc.1999.1289; Yang GY, 2009, BBA-PROTEINS PROTEOM, V1794, P94, DOI 10.1016/j.bbapap.2008.09.007; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4; Zhang HF, 2005, ACTA BIOCH BIOPH SIN, V37, P613, DOI 10.1111/j.1745-7270.2005.00085.x; Zhang ZM, 2008, BBA-PROTEINS PROTEOM, V1784, P1176, DOI 10.1016/j.bbapap.2008.05.011	77	34	34	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35686	10.1371/journal.pone.0035686	http://dx.doi.org/10.1371/journal.pone.0035686			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558199	Green Submitted, gold, Green Published			2022-12-25	WOS:000305336000047
J	Adekambi, T; Ibegbu, CC; Kalokhe, AS; Yu, TW; Ray, SM; Rengarajan, J				Adekambi, Toidi; Ibegbu, Chris C.; Kalokhe, Ameeta S.; Yu, Tianwei; Ray, Susan M.; Rengarajan, Jyothi			Distinct Effector Memory CD4(+) T Cell Signatures in Latent Mycobacterium tuberculosis Infection, BCG Vaccination and Clinically Resolved Tuberculosis	PLOS ONE			English	Article							IMMUNE-RESPONSES; PD-1 EXPRESSION; DIFFERENTIATION; ANTIGENS; HIV; INTERLEUKIN-7; POPULATION; MENINGITIS; IMMUNOLOGY; PHENOTYPE	Two billion people worldwide are estimated to be latently infected with Mycobacterium tuberculosis (Mtb) and are at risk for developing active tuberculosis since Mtb can reactivate to cause TB disease in immune-compromised hosts. Individuals with latent Mtb infection (LTBI) and BCG-vaccinated individuals who are uninfected with Mtb, harbor antigen-specific memory CD4(+) T cells. However, the differences between long-lived memory CD4(+) T cells induced by latent Mtb infection (LTBI) versus BCG vaccination are unclear. In this study, we characterized the immune phenotype and functionality of antigen-specific memory CD4(+) T cells in healthy BCG-vaccinated individuals who were either infected (LTBI) or uninfected (BCG) with Mtb. Individuals were classified into LTBI and BCG groups based on IFN-gamma ELISPOT using cell wall antigens and ESAT-6/CFP-10 peptides. We show that LTBI individuals harbored high frequencies of late-stage differentiated (CD45RA(-)CD27(-)) antigen-specific effector memory CD4(+) T cells that expressed PD-1. In contrast, BCG individuals had primarily early-stage (CD45RA(-)CD27(+)) cells with low PD-1 expression. CD27(+) and CD27(-) as well as PD-1(+) and PD-1 2 antigen-specific subsets were polyfunctional, suggesting that loss of CD27 expression and up-regulation of PD-1 did not compromise their capacity to produce IFN-gamma, TNF-alpha and IL-2. PD-1 was preferentially expressed on CD27(-) antigen-specific CD4(+) T cells, indicating that PD-1 is associated with the stage of differentiation. Using statistical models, we determined that CD27 and PD-1 predicted LTBI versus BCG status in healthy individuals and distinguished LTBI individuals from those who had clinically resolved Mtb infection after anti-tuberculosis treatment. This study shows that CD4(+) memory responses induced by latent Mtb infection, BCG vaccination and clinically resolved Mtb infection are immunologically distinct. Our data suggest that differentiation into CD27(-)PD-1(+) subsets in LTBI is driven by Mtb antigenic stimulation in vivo and that CD27 and PD-1 have the potential to improve our ability to evaluate true LTBI status.	[Adekambi, Toidi; Ibegbu, Chris C.; Kalokhe, Ameeta S.; Rengarajan, Jyothi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Kalokhe, Ameeta S.; Ray, Susan M.; Rengarajan, Jyothi] Emory Univ, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA; [Yu, Tianwei] Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA USA	Emory University; Emory University; Emory University; Rollins School Public Health	Adekambi, T (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	jrengar@emory.edu		Ray, Susan/0000-0002-6327-088X; Yu, Tianwei/0000-0003-2502-1628	A Center For AIDS Research (CFAR) Immunology Core grant [P30A01050409]; Emory-CFAR R03 Developmental grant; pilot project grant awarded from the the National Institutes of Health U19 CCHI Grant [AI057266]; Emory Global Health Institute Faculty Distinction Award; National Institute of Allergy and Infectious Diseases [T32AI074492]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI074492, U19AI057266] Funding Source: NIH RePORTER	A Center For AIDS Research (CFAR) Immunology Core grant; Emory-CFAR R03 Developmental grant; pilot project grant awarded from the the National Institutes of Health U19 CCHI Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory Global Health Institute Faculty Distinction Award; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the following funding sources: A Center For AIDS Research (CFAR) Immunology Core grant P30A01050409 (to Emory University), an Emory-CFAR R03 Developmental grant (to JR and SMR), a pilot project grant awarded (to JR) from the the National Institutes of Health U19 CCHI Grant AI057266 (Rafi Ahmed), an Emory Global Health Institute Faculty Distinction Award (to JR) and a T32AI074492 award (to ASK) from National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attiyah R, 2004, CLIN EXP IMMUNOL, V138, P139, DOI 10.1111/j.1365-2249.2004.02609.x; [Anonymous], 2000, Am J Respir Crit Care Med, V161, pS221; [Anonymous], 1996, MMWR Recomm Rep, V45, P1; [Anonymous], 2011, GLOB TUB CONTR; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barry CE, 1996, TRENDS MICROBIOL, V4, P275, DOI 10.1016/0966-842X(96)10031-7; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bennett DE, 2008, AM J RESP CRIT CARE, V177, P348, DOI 10.1164/rccm.200701-057OC; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Bloom Barry R., 1994, P531; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; Chiacchio T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027539; Commandeur S, 2011, EUR J IMMUNOL, V41, P2925, DOI 10.1002/eji.201141602; Commandeur S, 2011, CLIN VACCINE IMMUNOL, V18, P676, DOI 10.1128/CVI.00492-10; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Corbett EL, 1996, BRIT J HOSP MED, V56, P200; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Day CL, 2008, J INFECT DIS, V197, P990, DOI 10.1086/529048; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; Delogu G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018315; Di Mitri D, 2011, J IMMUNOL, V187, P2093, DOI 10.4049/jimmunol.1100978; Duraiswamy J, 2011, J IMMUNOL, V186, P4200, DOI 10.4049/jimmunol.1001783; Fletcher JM, 2005, J IMMUNOL, V175, P8218, DOI 10.4049/jimmunol.175.12.8218; Flynn JL, 2004, TUBERCULOSIS, V84, P93, DOI 10.1016/j.tube.2003.08.010; Fritsch RD, 2005, J IMMUNOL, V175, P6489, DOI 10.4049/jimmunol.175.10.6489; Geldmacher C, 2010, J EXP MED, V207, P2869, DOI 10.1084/jem.20100090; Geng E, 2002, NEW ENGL J MED, V346, P1453, DOI 10.1056/NEJMoa012972; GERDES J, 1984, J IMMUNOL, V133, P1710; Goletti D, 2010, EUR RESPIR J, V36, P135, DOI 10.1183/09031936.00140009; Harari A, 2005, J IMMUNOL, V174, P1037, DOI 10.4049/jimmunol.174.2.1037; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Horsburgh CR, 2011, NEW ENGL J MED, V364, P1441, DOI 10.1056/NEJMcp1005750; Hougardy JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000926; Jurado JO, 2008, J IMMUNOL, V181, P116, DOI 10.4049/jimmunol.181.1.116; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaufmann SHE, 2005, TRENDS IMMUNOL, V26, P660, DOI 10.1016/j.it.2005.09.012; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; Lewinsohn DA, 2007, PLOS PATHOG, V3, P1240, DOI 10.1371/journal.ppat.0030127; Libri V, 2011, IMMUNOLOGY, V132, P326, DOI 10.1111/j.1365-2567.2010.03386.x; Lin PL, 2009, INFECT IMMUN, V77, P4631, DOI 10.1128/IAI.00592-09; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; McShane H, 2005, INT J STD AIDS, V16, P95, DOI 10.1258/0956462053057576; Mueller H, 2008, CYTOKINE, V43, P143, DOI 10.1016/j.cyto.2008.05.002; Petrovas C, 2007, BLOOD, V110, P928, DOI 10.1182/blood-2007-01-069112; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAVIGLIONE MC, 1995, JAMA-J AM MED ASSOC, V273, P220, DOI 10.1001/jama.273.3.220; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sauce D, 2007, AIDS, V21, P2005, DOI 10.1097/QAD.0b013e3282eee548; Schiott A, 2004, IMMUNOLOGY, V113, P363, DOI 10.1111/j.1365-2567.2004.01974.x; Schuck SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005590; Soares AP, 2008, J IMMUNOL, V180, P3569, DOI 10.4049/jimmunol.180.5.3569; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; Sterne JAC, 1998, INT J TUBERC LUNG D, V2, P200; Streitz M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000735; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Torrado E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002196; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Wilkinson KA, 2010, EUR J IMMUNOL, V40, P2139, DOI 10.1002/eji.201040731; Young DB, 2009, TRENDS MICROBIOL, V17, P183, DOI 10.1016/j.tim.2009.02.005; ZWEIG MH, 1993, CLIN CHEM, V39, P561	69	62	65	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e36046	10.1371/journal.pone.0036046	http://dx.doi.org/10.1371/journal.pone.0036046			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545156	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343200076
J	Boumart, Z; Roche, SM; Lalande, F; Virlogeux-Payant, I; Hennequet-Antier, C; Menanteau, P; Gabriel, I; Weill, FX; Velge, P; Chemaly, M				Boumart, Zineb; Roche, Sylvie M.; Lalande, Francoise; Virlogeux-Payant, Isabelle; Hennequet-Antier, Christelle; Menanteau, Pierrette; Gabriel, Irene; Weill, Francois-Xavier; Velge, Philippe; Chemaly, Marianne			Heterogeneity of Persistence of Salmonella enterica Serotype Senftenberg Strains Could Explain the Emergence of this Serotype in Poultry Flocks	PLOS ONE			English	Article							GEL-ELECTROPHORESIS; LISTERIA-MONOCYTOGENES; SEROVAR SENFTENBERG; FIELD STRAINS; LOW-VIRULENCE; CELL-LINE; ENTERITIDIS; INFECTION; OUTBREAK; TYPHIMURIUM	Salmonella enterica serotype Senftenberg (S. Senftenberg) has recently become more frequent in poultry flocks. Moreover some strains have been implicated in severe clinical cases. To explain the causes of this emergence in farm animals, 134 S. Senftenberg isolates from hatcheries, poultry farms and human clinical cases were analyzed. Persistent and non-persistent strains were identified in chicks. The non-persistent strains disappeared from ceca a few weeks post inoculation. This lack of persistence could be related to the disappearance of this serotype from poultry farms in the past. In contrast, persistent S. Senftenberg strains induced an intestinal asymptomatic carrier state in chicks similar to S. Enteritidis, but a weaker systemic infection than S. Enteritidis in chicks and mice. An in vitro analysis showed that the low infectivity of S. Senftenberg is in part related to its low capacity to invade enterocytes and thus to translocate the intestinal barrier. The higher capacity of persistent than non-persistent strains to colonize and persist in the ceca of chickens could explain the increased persistence of S. Senftenberg in poultry flocks. This trait might thus present a human health risk as these bacteria could be present in animals before slaughter and during food processing.	[Boumart, Zineb; Roche, Sylvie M.; Virlogeux-Payant, Isabelle; Menanteau, Pierrette; Velge, Philippe] INRA, Infectiol Anim & Sante Publ UR1282, F-37380 Nouzilly, France; [Boumart, Zineb; Lalande, Francoise; Chemaly, Marianne] ANSES, Lab Ploufragan Plouzane, Unite Hyg & Qual Prod Avicoles & Porcins, Ploufragan, France; [Hennequet-Antier, Christelle; Gabriel, Irene] INRA, Rech Avicoles UR83, F-37380 Nouzilly, France; [Weill, Francois-Xavier] Inst Pasteur, Ctr Natl Reference Salmonella, Unite Bacteries Pathogenes Enter, Paris, France; [Roche, Sylvie M.; Virlogeux-Payant, Isabelle; Menanteau, Pierrette; Velge, Philippe] Univ Tours, Agents Transmissibles & Infectiol IFR136, Tours, France	INRAE; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ploufragan-Plouzane Niort Laboratory; INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universite de Tours	Boumart, Z (corresponding author), INRA, Infectiol Anim & Sante Publ UR1282, F-37380 Nouzilly, France.	Philippe.Velge@tours.inra.fr	velge, philippe/AAK-4165-2021; Virlogeux-Payant, Isabelle/H-5800-2013	Weill, Francois-Xavier/0000-0001-9941-5799; Virlogeux-Payant, Isabelle/0000-0003-4149-0168	Institut National de Recherche Agronomique (INRA); French agency for food, environmental and occupational health safety (Anses); Anses	Institut National de Recherche Agronomique (INRA); French agency for food, environmental and occupational health safety (Anses); Anses	This work was supported by grants from the Institut National de Recherche Agronomique (INRA) and the French agency for food, environmental and occupational health safety (Anses). Zineb Boumart holds a Doctoral fellowship funded by Anses and INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AllenVercoe E, 1997, FEMS MICROBIOL LETT, V153, P33, DOI 10.1111/j.1574-6968.1997.tb10460.x; Amy M, 2004, RES MICROBIOL, V155, P543, DOI 10.1016/j.resmic.2004.03.005; [Anonymous], 2007, EFSA J, V101, P1; [Anonymous], 2010, EFSA J, V8, P1503; Berger CN, 2009, ISME J, V3, P261, DOI 10.1038/ismej.2008.95; Borsoi A, 2011, BRAZ J MICROBIOL, V42, P266, DOI 10.1590/S1517-83822011000100034; Chadfield MS, 2003, VET MICROBIOL, V92, P49, DOI 10.1016/S0378-1135(02)00290-0; EISENSTEIN TK, 1984, J INFECT DIS, V150, P425, DOI 10.1093/infdis/150.3.425; Gal-Mor O, 2010, EMERG INFECT DIS, V16, P1754, DOI 10.3201/eid1611.100100; GOODLAD RA, 1991, GASTROENTEROLOGY, V101, P1235, DOI 10.1016/0016-5085(91)90072-S; Hamada S, 1959, JAPANESE J VET RES, V6, P181; Hu QH, 2008, J CLIN MICROBIOL, V46, P1330, DOI 10.1128/JCM.01255-07; Hume ME, 2003, POULTRY SCI, V82, P1100, DOI 10.1093/ps/82.7.1100; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; KAWAGUCHI T, 1987, CANCER RES, V47, P4460; Kay RS, 2007, INFECT CONT HOSP EP, V28, P805, DOI 10.1086/518458; Kerouanton A, 2007, FOODBORNE PATHOG DIS, V4, P293, DOI 10.1089/fpd.2007.0090; Kidgell C, 2002, INFECT GENET EVOL, V2, P39, DOI 10.1016/S1567-1348(02)00089-8; LEcuyer PB, 1996, CLIN INFECT DIS, V23, P734, DOI 10.1093/clinids/23.4.734; Liebana E, 2001, J CLIN MICROBIOL, V39, P3609, DOI 10.1128/JCM.39.10.3609-3616.2001; Martinez-Urtaza J, 2004, J FOOD PROTECT, V67, P256, DOI 10.4315/0362-028X-67.2.256; Martinez-Urtaza J, 2003, J FOOD PROTECT, V66, P226, DOI 10.4315/0362-028X-66.2.226; PARDON P, 1986, ANN INST PASTEUR MIC, V137B, P47, DOI 10.1016/S0769-2609(86)80093-X; Pedersen TB, 2008, AVIAN PATHOL, V37, P421, DOI 10.1080/03079450802216561; Pezzoli L, 2007, EUROSURVEILLANCE, V12; Pezzoli L, 2008, FOODBORNE PATHOG DIS, V5, P661, DOI 10.1089/fpd.2008.0103; Rabsch W, 2001, MICROBES INFECT, V3, P237, DOI 10.1016/S1286-4579(01)01375-2; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Roche SM, 2005, APPL ENVIRON MICROB, V71, P6039, DOI 10.1128/AEM.71.10.6039-6048.2005; Rushdy AA, 1998, EPIDEMIOL INFECT, V120, P125, DOI 10.1017/S0950268897008546; Sadeyen JR, 2004, MICROBES INFECT, V6, P1278, DOI 10.1016/j.micinf.2004.07.005; Skov MN, 2002, AVIAN DIS, V46, P265, DOI 10.1637/0005-2086(2002)046[0265:TSRTSE]2.0.CO;2; Temoin S, 2008, MICROBIOL-SGM, V154, P939, DOI 10.1099/mic.0.2007/011106-0; Van Immerseel F, 2002, DEV COMP IMMUNOL, V26, P355, DOI 10.1016/S0145-305X(01)00084-2; Velge P, 2005, VET RES, V36, P267, DOI 10.1051/vetres:2005005; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578; Williams J, 2008, BRIT POULTRY SCI, V49, P329, DOI 10.1080/00071660802123351; Withanage GSK, 2005, BRIT POULTRY SCI, V46, P261, DOI 10.1080/00071660500098608	38	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35782	10.1371/journal.pone.0035782	http://dx.doi.org/10.1371/journal.pone.0035782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545136	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343200056
J	Havik, B; Degenhardt, FA; Johansson, S; Fernandes, CPD; Hinney, A; Scherag, A; Lybaek, H; Djurovic, S; Christoforou, A; Ersland, KM; Giddaluru, S; O'Donovan, MC; Owen, MJ; Craddock, N; Muhleisen, T; Mattheisen, M; Schimmelmann, BG; Renner, T; Warnke, A; Herpertz-Dahlmann, B; Sinzig, J; Albayrak, O; Rietschel, M; Nothen, MM; Bramham, CR; Werge, T; Hebebrand, J; Haavik, J; Andreassen, OA; Cichon, S; Steen, VM; Le Hellard, S				Havik, Bjarte; Degenhardt, Franziska A.; Johansson, Stefan; Fernandes, Carla P. D.; Hinney, Anke; Scherag, Andre; Lybaek, Helle; Djurovic, Srdjan; Christoforou, Andrea; Ersland, Kari M.; Giddaluru, Sudheer; O'Donovan, Michael C.; Owen, Michael J.; Craddock, Nick; Muehleisen, ThomasW.; Mattheisen, Manuel; Schimmelmann, Benno G.; Renner, Tobias; Warnke, Andreas; Herpertz-Dahlmann, Beate; Sinzig, Judith; Albayrak, Oezguer; Rietschel, Marcella; Noethen, Markus M.; Bramham, Clive R.; Werge, Thomas; Hebebrand, Johannes; Haavik, Jan; Andreassen, Ole A.; Cichon, Sven; Steen, Vidar M.; Le Hellard, Stephanie			DCLK1 Variants Are Associated across Schizophrenia and Attention Deficit/Hyperactivity Disorder	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VAL66MET POLYMORPHISM; DOUBLECORTIN-LIKE; BIPOLAR DISORDER; BDNF; DEFICIT; KINASE; GENES; ENDOPHENOTYPE; GENETICS	Doublecortin and calmodulin like kinase 1 (DCLK1) is implicated in synaptic plasticity and neurodevelopment. Genetic variants in DCLK1 are associated with cognitive traits, specifically verbal memory and general cognition. We investigated the role of DCLK1 variants in three psychiatric disorders that have neuro-cognitive dysfunctions: schizophrenia (SCZ), bipolar affective disorder (BP) and attention deficit/hyperactivity disorder (ADHD). We mined six genome wide association studies (GWASs) that were available publically or through collaboration; three for BP, two for SCZ and one for ADHD. We also genotyped the DCLK1 region in additional samples of cases with SCZ, BP or ADHD and controls that had not been whole-genome typed. In total, 9895 subjects were analysed, including 5308 normal controls and 4,587 patients (1,125 with SCZ, 2,496 with BP and 966 with ADHD). Several DCLK1 variants were associated with disease phenotypes in the different samples. The main effect was observed for rs7989807 in intron 3, which was strongly associated with SCZ alone and even more so when cases with SCZ and ADHD were combined (P-value = 4x10(-5) and 4x10(-6), respectively). Associations were also observed with additional markers in intron 3 (combination of SCZ, ADHD and BP), intron 19 (SCZ+BP) and the 3'UTR (SCZ+BP). Our results suggest that genetic variants in DCLK1 are associated with SCZ and, to a lesser extent, with ADHD and BP. Interestingly the association is strongest when SCZ and ADHD are considered together, suggesting common genetic susceptibility. Given that DCLK1 variants were previously found to be associated with cognitive traits, these results are consistent with the role of DCLK1 in neurodevelopment and synaptic plasticity.	[Havik, Bjarte; Fernandes, Carla P. D.; Christoforou, Andrea; Ersland, Kari M.; Giddaluru, Sudheer; Cichon, Sven; Steen, Vidar M.; Le Hellard, Stephanie] Univ Bergen, Dept Clin Med, Dr E Martens Res Grp Biol Psychiat, Bergen, Norway; [Havik, Bjarte; Johansson, Stefan; Lybaek, Helle; Christoforou, Andrea; Ersland, Kari M.; Giddaluru, Sudheer; Steen, Vidar M.; Le Hellard, Stephanie] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Degenhardt, Franziska A.; Muehleisen, ThomasW.; Mattheisen, Manuel; Noethen, Markus M.; Cichon, Sven] Univ Bonn, Dept Genom, Life & Brain Ctr, Bonn, Germany; [Degenhardt, Franziska A.; Muehleisen, ThomasW.; Mattheisen, Manuel; Noethen, Markus M.; Cichon, Sven] Univ Bonn, Inst Human Genet, Bonn, Germany; [Johansson, Stefan; Bramham, Clive R.; Haavik, Jan] Univ Bergen, Dept Biomed, Bergen, Norway; [Hinney, Anke; Albayrak, Oezguer; Hebebrand, Johannes] Univ Duisburg Essen, Dept Child & Adolescent Psychiat, Essen, Germany; [Scherag, Andre] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Djurovic, Srdjan; Andreassen, Ole A.] Univ Oslo, Inst Psychiat, Oslo, Norway; [O'Donovan, Michael C.; Owen, Michael J.; Craddock, Nick] Cardiff Univ, Dept Psychol Med & Neurol, MRC Ctr Neuropsychiat Genet & Genom, Neurosci & Mental Hlth Res Inst, Cardiff, S Glam, Wales; [Mattheisen, Manuel] Univ Bonn, IMBIE, Bonn, Germany; [Schimmelmann, Benno G.] Univ Hosp Child & Adolescent Psychiat Bern, Bern, Switzerland; [Renner, Tobias; Warnke, Andreas] Univ Wurzburg, Dept Child & Adolescent Psychiat, Wurzburg, Germany; [Herpertz-Dahlmann, Beate] Rhein Westfal TH Aachen, Univ Clin, Dept Child & Adolescent Psychiat Psychosomat & Ps, Aachen, Germany; [Sinzig, Judith] Univ Cologne, Dept Child & Adolescent Psychiat & Psychotherapy, D-50931 Cologne, Germany; [Sinzig, Judith] LVR Klin Bonn, Dept Child & Adolescent Psychiat & Psychotherapy, Bonn, Germany; [Rietschel, Marcella] Univ Bonn, Dept Psychiat, Bonn, Germany; [Noethen, Markus M.] German Ctr Neurodegenerat Disorders DZNE, Bonn, Germany; [Werge, Thomas] Copenhagen Univ Hosp, Res Inst Biol Psychiat, iPSYCH, Roskilde, Denmark; [Haavik, Jan] Haukeland Hosp, Div Psychiat, N-5021 Bergen, Norway; [Andreassen, Ole A.] Univ Oslo, Inst Clin Med, Div Mental Hlth & Addict, Oslo Univ Hosp, Oslo, Norway; [Cichon, Sven] Forschungszentrum Julich, Inst Neurosci & Med INM 1, D-52425 Julich, Germany	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bonn; University of Bonn; University of Bergen; University of Duisburg Essen; University of Duisburg Essen; University of Oslo; Cardiff University; University of Bonn; University of Bern; University Hospital of Bern; University of Wurzburg; RWTH Aachen University; RWTH Aachen University Hospital; University of Cologne; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); University of Copenhagen; University of Bergen; Haukeland University Hospital; University of Oslo; Helmholtz Association; Research Center Julich	Havik, B (corresponding author), Univ Bergen, Dept Clin Med, Dr E Martens Res Grp Biol Psychiat, Bergen, Norway.	stephanie.hellard@med.uib.no	Werge, Thomas/G-7263-2012; Degenhardt, Franziska/H-4169-2017; Haavik, Jan/ABE-1535-2020; O'Donovan, Michael C/P-7005-2018; Mattheisen, Manuel/B-4949-2012; Renner, Tobias J/I-2120-2013; Haavik, Jan/AAI-3974-2020; Andreassen, Ole A./AAY-7531-2020; Mattheisen, Manuel/S-3725-2019; Scherag, Andre/B-3805-2014; Cichon, Sven/H-8803-2013; Cichon, Sven/B-9618-2014; Johansson, Stefan/C-4394-2011; Hinney, Anke/D-6953-2011; Bramham, Clive/Q-1854-2018	O'Donovan, Michael C/0000-0001-7073-2379; Mattheisen, Manuel/0000-0002-8442-493X; Haavik, Jan/0000-0001-7865-2808; Mattheisen, Manuel/0000-0002-8442-493X; Cichon, Sven/0000-0002-9475-086X; Cichon, Sven/0000-0002-9475-086X; Johansson, Stefan/0000-0002-2298-7008; Hinney, Anke/0000-0001-5659-0706; Ersland, Kari Merete/0000-0003-3674-4151; Scherag, Andre/0000-0002-9406-4704; Djurovic, Srdjan/0000-0002-8140-8061; Nothen, Markus/0000-0002-8770-2464; Sinzig, Judith/0000-0002-3693-3318; Le Hellard, Stephanie/0000-0002-8085-051X; Bramham, Clive/0000-0001-5958-7115; Andreassen, Ole A./0000-0002-4461-3568	Bergen Research Foundation; University of Bergen; FUGE/Research Council of Norway; FUGE program of the Research Council of Norway; Research Council of Norway [151904, 183327, 175345]; Helse Vest RHF (Western Norway Regional Health Authority); Dr. Einar Martens Fund; DFG (Deutsche Forschungsgemeinschaft) [He 1446/9-1]; German Federal Ministry of Education and Research (BMBF), within the context of the National Genome Research Network 2 (NGFN-2); National Genome Research Network plus (NGFNplus); Integrated Genome Research Network (IG) MooDS [01GS08144, 01GS08147]; European Community [245009]; Alfried Krupp von Bohlen und Halbach-Stiftung; Medical Research Council [G0801418B] Funding Source: researchfish	Bergen Research Foundation; University of Bergen; FUGE/Research Council of Norway(Research Council of Norway); FUGE program of the Research Council of Norway; Research Council of Norway(Research Council of Norway); Helse Vest RHF (Western Norway Regional Health Authority); Dr. Einar Martens Fund; DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF), within the context of the National Genome Research Network 2 (NGFN-2)(Federal Ministry of Education & Research (BMBF)); National Genome Research Network plus (NGFNplus); Integrated Genome Research Network (IG) MooDS; European Community(European Commission); Alfried Krupp von Bohlen und Halbach-Stiftung; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by a grant from the Bergen Research Foundation and the University of Bergen to S.L.H. The genotyping of the Norwegian ADHD sample was performed on the Sequenom platform in CIGENE (FUGE/Research Council of Norway-funded national SNP platform) and the SCOPE sample was genotyped using the infrastructure provided by the Norwegian Microarray Consortium FUGE technology platform (www.microarray.no), funded by the FUGE program of the Research Council of Norway. The study was also supported by grants from the Research Council of Norway (incl. FUGE grant nos. 151904 and 183327, and Psykisk Helse grant no. 175345), Helse Vest RHF (Western Norway Regional Health Authority) and Dr. Einar Martens Fund. The GWAS of the German ADHD samples was supported by the grant He 1446/9-1 of the DFG (Deutsche Forschungsgemeinschaft). This study was also supported by the German Federal Ministry of Education and Research (BMBF), within the context of the National Genome Research Network 2 (NGFN-2), the National Genome Research Network plus (NGFNplus), and the Integrated Genome Research Network (IG) MooDS (grant 01GS08144 to S. C. and M.N.N., grant 01GS08147 to M. R.) and the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 245009 to J.H. and O.A. M.M.N. also received support from the Alfried Krupp von Bohlen und Halbach-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; APA, 1994, DIAGN STAT MAN MENT; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Banaschewski T, 2010, EUR CHILD ADOLES PSY, V19, P237, DOI 10.1007/s00787-010-0090-z; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Bradley WEC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009401; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Burgess HA, 2002, J BIOL CHEM, V277, P17696, DOI 10.1074/jbc.M111981200; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen Zhe-Yu, 2008, Novartis Found Symp, V289, P180; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Cichon S, 2011, AM J HUM GENET, V88, P396, DOI [10.1016/j.ajhg.2011.01.017, 10.1016/j.ajhg.2011.03.001]; Cichon S, 2009, AM J PSYCHIAT, V166, P540, DOI 10.1176/appi.ajp.2008.08091354; de la Serna E, 2010, SCHIZOPHR RES, V116, P159, DOI 10.1016/j.schres.2009.09.001; Esslinger C, 2009, SCIENCE, V324, P605, DOI 10.1126/science.1167768; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Green MJ, 2011, MOL PSYCHIATR, V16, P960, DOI 10.1038/mp.2010.88; Gur RE, 2007, SCHIZOPHRENIA BULL, V33, P49, DOI 10.1093/schbul/sbl055; Halmoy A, 2010, J CLIN PSYCHIAT, V71, P48, DOI 10.4088/JCP.08m04722ora; Hansen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000873; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Hasler G, 2006, BIOL PSYCHIAT, V60, P93, DOI 10.1016/j.biopsych.2005.11.006; Havik B, 2011, BIOL PSYCHIAT; Hebebrand J, 2006, MOL PSYCHIATR, V11, P196, DOI 10.1038/sj.mp.4001761; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Hennah W, 2009, MOL PSYCHIATR, V14, P865, DOI 10.1038/mp.2008.22; Hinney A, 2011, AM J MED GENETICSIN; Ingason A, 2011, MOL PSYCHIATR, V16, P17, DOI 10.1038/mp.2009.101; Kalkstein S, 2010, CURR TOP BEHAV NEURO, V4, P373, DOI 10.1007/7854_2010_42; Kuntsi J, 2006, NEUROMOL MED, V8, P461, DOI 10.1385/NMM:8:4:461; Le Hellard S, 2010, MOL PSYCHIATR, V15, P463, DOI 10.1038/mp.2008.110; Le Hellard S, 2009, MOL PSYCHIATR, V14, P308, DOI 10.1038/sj.mp.4002133; Le Hellard S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007534; Lin PT, 2000, J NEUROSCI, V20, P9152; Maydell RJ, 2009, AFR J PSYCHIATRY, V12, P144; McIntyre R, 2009, CNS SPECTRUMS, V14, P8, DOI 10.1017/S1092852900024822; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Neale BM, 2008, AM J MED GENET B, V147B, P1337, DOI 10.1002/ajmg.b.30866; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; O'Donovan MC, 2009, HUM GENET, V126, P3, DOI 10.1007/s00439-009-0703-0; Owen MJ, 2007, SCHIZOPHRENIA BULL, V33, P905, DOI 10.1093/schbul/sbm053; Palo OM, 2007, HUM MOL GENET, V16, P2517, DOI 10.1093/hmg/ddm207; Pedotti P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-124; Prathikanti S, 2005, BRIT MED BULL, V73-74, P107, DOI 10.1093/bmb/ldh055; Rietschel M, 2011, MOL PSYCHIAT; Rybakowski JK, 2008, PHARMACOGENOMICS, V9, P1589, DOI 10.2217/14622416.9.11.1589; Savitz JB, 2005, NEUROMOL MED, V7, P275, DOI 10.1385/NMM:7:4:275; Schenk GJ, 2011, PHYSIOL BEHAV, V102, P323, DOI 10.1016/j.physbeh.2010.11.024; Schenk GJ, 2010, PHYSIOL BEHAV, V101, P541, DOI 10.1016/j.physbeh.2010.08.002; Schimmelmann BG, 2007, J NEURAL TRANSM, V114, P523, DOI 10.1007/s00702-006-0616-1; Sharp SI, 2009, NEUROPHARMACOLOGY, V57, P590, DOI 10.1016/j.neuropharm.2009.08.011; Smith M, 2002, CYTOGENET GENOME RES, V98, P233, DOI 10.1159/000071040; Tanaka T, 2006, CEREB CORTEX, V16, pI69, DOI 10.1093/cercor/bhk005; Vreugdenhil E, 2007, EUR J NEUROSCI, V25, P635, DOI 10.1111/j.1460-9568.2007.05318.x; Wibrand K, 2006, EUR J NEUROSCI, V23, P1501, DOI 10.1111/j.1460-9568.2006.04687.x; Williams HJ, 2011, HUM MOL GENET, V20, P387, DOI 10.1093/hmg/ddq471; Williams NM, 2010, LANCET, V376, P1401, DOI 10.1016/S0140-6736(10)61109-9; Xia K, 2012, BIOINFORMATICS, V28, P451, DOI 10.1093/bioinformatics/btr678; Yatham LN, 2010, BIPOLAR DISORD, V12, P351, DOI 10.1111/j.1399-5618.2010.00830.x	60	20	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35424	10.1371/journal.pone.0035424	http://dx.doi.org/10.1371/journal.pone.0035424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539971	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000305341000036
J	Li, ZQ; Ding, W; Sun, SJ; Li, J; Pan, J; Zhao, C; Wu, WR; Si, WK				Li, Zhi-Qiang; Ding, Wei; Sun, Shi-Jun; Li, Jun; Pan, Jing; Zhao, Chen; Wu, Wei-Ru; Si, Wei-Ke			Cyr61/CCN1 Is Regulated by Wnt/beta-Catenin Signaling and Plays an Important Role in the Progression of Hepatocellular Carcinoma	PLOS ONE			English	Article							SQUAMOUS-CELL-CARCINOMA; TISSUE-GROWTH-FACTOR; CANCER-CELLS; TUMOR PROGRESSION; GENE-EXPRESSION; PATHWAY; TARGET; CTGF; CARCINOGENESIS; IDENTIFICATION	Abnormal activation of the canonical Wnt signaling pathway has been implicated in carcinogenesis. Transcription of Wnt target genes is regulated by nuclear beta-catenin, whose over-expression is observed in Hepatocellular Carcinoma (HCC) tissue. Cyr61, a member of the CCN complex family of multifunctional proteins, is also found over-expressed in many types of tumor and plays dramatically different roles in tumorigenesis. In this study, we investigated the relationship between Cyr61 and beta-catenin in HCC. We found that while Cyr61 protein was not expressed at a detectable level in the liver tissue of healthy individuals, its expression level was elevated in the HCC and HCC adjacent tissues and was markedly increased in cancer-adjacent hepatic cirrhosis tissue. Over-expression of Cyr61 was positively correlated with increased levels of beta-catenin in human HCC samples. Activation of b-catenin signaling elevated the mRNA level of Cyr61 in HepG2 cells, while inhibition of beta-catenin signaling reduced both mRNA and protein levels of Cyr61. We identified two TCF4-binding elements in the promoter region of human Cyr61 gene and demonstrated that beta-catenin/TCF4 complex specifically bound to the Cyr61 promoter in vivo and directly regulated its promoter activity. Furthermore, we found that over-expression of Cyr61 in HepG2 cells promoted the progression of HCC xenografts in SCID mice. These findings indicate that Cyr61 is a direct target of beta-catenin signaling in HCC and may play an important role in the progression of HCC.	[Li, Zhi-Qiang; Ding, Wei; Li, Jun; Pan, Jing; Zhao, Chen; Wu, Wei-Ru; Si, Wei-Ke] Third Mil Med Univ, Dept Clin Hematol, Chongqing, Peoples R China; [Ding, Wei] PLA, KunMing Gen Hosp, Dept Clin Lab, Kunming, Peoples R China; [Sun, Shi-Jun] Third Mil Med Univ, Southwest Hosp, Chongqing, Peoples R China	Army Medical University; Kunming General Hospital; Army Medical University	Li, ZQ (corresponding author), Third Mil Med Univ, Dept Clin Hematol, Chongqing, Peoples R China.	weikesi2004@hotmail.com			National Natural Science Foundation of China [30672393]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (grant 30672393). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austinat M, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-21; Babic AM, 1998, P NATL ACAD SCI USA, V95, P6355, DOI 10.1073/pnas.95.11.6355; Chien WW, 2004, J BIOL CHEM, V279, P53087, DOI 10.1074/jbc.M410254200; D'Antonio KB, 2010, J UROLOGY, V183, P1604, DOI 10.1016/j.juro.2009.12.006; Deng YZ, 2007, J BIOL CHEM, V282, P36571, DOI 10.1074/jbc.M704141200; Dhar A., 2010, Experimental Oncology, V32, P2; Dong H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-5; Du QA, 2006, CANCER RES, V66, P7024, DOI 10.1158/0008-5472.CAN-05-4110; Feng P, 2008, INT J BIOCHEM CELL B, V40, P98, DOI 10.1016/j.biocel.2007.06.020; Haque I, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-8; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hirasaki S, 2001, HEPATOL RES, V19, P294, DOI 10.1016/S1386-6346(00)00101-7; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Ladwa R, 2011, J CLIN PATHOL, V64, P58, DOI 10.1136/jcp.2010.082768; Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3; Lee HS, 2007, LIFE SCI, V80, P690, DOI 10.1016/j.lfs.2006.10.024; Lin MT, 2008, J BIOL CHEM, V283, P15807, DOI 10.1074/jbc.M708933200; Lin MT, 2007, J BIOL CHEM, V282, P34594, DOI 10.1074/jbc.M706600200; Maeta N, 2007, ONCOLOGY-BASEL, V73, P118, DOI 10.1159/000121000; Monga SPS, 2011, INT J BIOCHEM CELL B, V43, P1021, DOI 10.1016/j.biocel.2009.09.001; Nejak-Bowen KN, 2011, SEMIN CANCER BIOL, V21, P44, DOI 10.1016/j.semcancer.2010.12.010; Nguyen N, 2006, CANCER RES, V66, P2658, DOI 10.1158/0008-5472.CAN-05-2082; Renard CA, 2007, CANCER RES, V67, P901, DOI 10.1158/0008-5472.CAN-06-2344; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Song JY, 2008, INT J GYNECOL CANCER, V18, P1051, DOI 10.1111/j.1525-1438.2007.01164.x; Song PP, 2010, BIOSCI TRENDS, V4, P283; Tong XJ, 2004, ONCOGENE, V23, P4847, DOI 10.1038/sj.onc.1207628; Torisu Y, 2008, CANCER SCI, V99, P1139, DOI 10.1111/j.1349-7006.2008.00814.x; Tsai MS, 2002, ONCOGENE, V21, P964, DOI 10.1038/sj/onc/1205131; Wagner RT, 2010, STEM CELLS, V28, P1794, DOI 10.1002/stem.502; Wang BS, 2005, ONCOGENE, V24, P3999, DOI 10.1038/sj.onc.1208550; Wei D, 2008, J 4 MIL MED U, V29; Wei D, 2008, ACTA ACAD MED MILITA, V30, P378; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Xie D, 2004, CANCER RES, V64, P1987, DOI 10.1158/0008-5472.CAN-03-0666; Xie D, 2004, CLIN CANCER RES, V10, P2072, DOI 10.1158/1078-0432.CCR-0659-03; Xie JJ, 2011, INT J MOL MED, V27, P429, DOI 10.3892/ijmm.2011.603; Xu L, 2001, CANCER RES, V61, P3176; Xu LF, 2000, GENE DEV, V14, P585; Yang W, 2008, CANCER RES, V68, P4287, DOI 10.1158/0008-5472.CAN-07-6691; Zeng ZJ, 2004, WORLD J GASTROENTERO, V10, P3414	41	25	33	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35754	10.1371/journal.pone.0035754	http://dx.doi.org/10.1371/journal.pone.0035754			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540002	Green Submitted, gold, Green Published			2022-12-25	WOS:000305341000068
J	Wu, CL; Chou, YH; Chang, YJ; Teng, NY; Hsu, HL; Chen, LY				Wu, Chia-Ling; Chou, Yu-Han; Chang, Yu-Jung; Teng, Nan-Yuan; Hsu, Hsin-Ling; Chen, Linyi			Interplay between Cell Migration and Neurite Outgrowth Determines SH2B1 beta-Enhanced Neurite Regeneration of Differentiated PC12 Cells	PLOS ONE			English	Article							PROTEIN-KINASE-C; NERVE GROWTH-FACTOR; HUMAN NEURODEGENERATIVE DISORDERS; NEURONAL MIGRATION; AXONAL-TRANSPORT; MAP KINASE; PHOSPHATIDYLINOSITOL-3 KINASE; NEUROTROPHIC FACTORS; SENSORY NEURONS; BRAIN-INJURY	The regulation of neurite outgrowth is crucial in developing strategies to promote neurite regeneration after nerve injury and in degenerative diseases. In this study, we demonstrate that overexpression of an adaptor/scaffolding protein SH2B1 beta promotes neurite re-growth of differentiated PC12 cells, an established neuronal model, using wound healing (scraping) assays. Cell migration and the subsequent remodeling are crucial determinants during neurite regeneration. We provide evidence suggesting that overexpressing SH2B1 beta enhances protein kinase C (PKC)-dependent cell migration and phosphatidylinositol 3-kinase (PI3K)-AKT-, mitogen activated protein kinase (MAPK)/extracellular signal-regulated protein kinase (ERK) kinase (MEK)-ERK-dependent neurite re-growth. Our results further reveal a cross-talk between pathways involving PKC and ERK1/2 in regulating neurite re-growth and cell migration. We conclude that temporal regulation of cell migration and neurite outgrowth by SH2B1 beta contributes to the enhanced regeneration of differentiated PC12 cells.	[Wu, Chia-Ling; Chou, Yu-Han; Chang, Yu-Jung; Chen, Linyi] Natl Tsing Hua Univ, Inst Mol Med, Hsinchu, Taiwan; [Chen, Linyi] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan; [Teng, Nan-Yuan] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [Hsu, Hsin-Ling] Natl Hlth Res Inst, Div Mol & Genom Med, Miaoli Cty, Taiwan	National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; National Health Research Institutes - Taiwan	Wu, CL (corresponding author), Natl Tsing Hua Univ, Inst Mol Med, Hsinchu, Taiwan.	lchen@life.nthu.edu.tw	Chen, Linyi/AAV-2632-2020; Hsu, Hsin-Ling/E-3672-2010	Chen, Linyi/0000-0001-7258-8817; Chang, Yu-Jung/0000-0002-4781-0946	National Health Research Institutes of Taiwan [NHRI-EX100-9719NC]; National Science Council of Taiwan [NSC97-2311-B-007-007-MY3]; National Tsing Hua University [100N7726E1, 100N2772E1]	National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Tsing Hua University	This study was supported by grants from the National Health Research Institutes of Taiwan (NHRI-EX100-9719NC), the National Science Council of Taiwan (NSC97-2311-B-007-007-MY3) and the National Tsing Hua University (100N7726E1 and 100N2772E1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2008, CURR OPIN NEUROBIOL, V18, P276, DOI 10.1016/j.conb.2008.06.005; AltunGultekin ZF, 1996, J NEUROSCI RES, V44, P308, DOI 10.1002/(SICI)1097-4547(19960515)44:4<308::AID-JNR2>3.0.CO;2-G; Arevalo JC, 2006, CELL MOL LIFE SCI, V63, P1523, DOI 10.1007/s00018-006-6010-1; Battaini F, 2001, PHARMACOL RES, V44, P353, DOI 10.1006/phrs.2001.0893; Becchetti A, 2010, ADV EXP MED BIOL, V674, P107; Bloch J, 2001, EXP NEUROL, V172, P425, DOI 10.1006/exnr.2001.7778; Bonsall J, 1999, BRAIN RES, V839, P120, DOI 10.1016/S0006-8993(99)01725-4; BURGESS GM, 1984, NATURE, V309, P63, DOI 10.1038/309063a0; CAMPENOT RB, 1994, J NEUROCHEM, V63, P868; Cary LA, 1996, J CELL SCI, V109, P1787; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Cui Q, 2006, MOL NEUROBIOL, V33, P155, DOI 10.1385/MN:33:2:155; Grills BL, 1997, J ORTHOPAED RES, V15, P235, DOI 10.1002/jor.1100150212; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Heacock AM, 1997, NEUROCHEM RES, V22, P1179, DOI 10.1023/A:1021916509858; Herrington J, 2000, J BIOL CHEM, V275, P13126, DOI 10.1074/jbc.275.17.13126; Hoffman PN, 2010, EXP NEUROL, V223, P11, DOI 10.1016/j.expneurol.2009.09.006; Huang YZ, 2010, J BIOL CHEM, V285, P8207, DOI 10.1074/jbc.M109.091041; Ikeda T, 2008, CELL TISSUE RES, V331, P263, DOI 10.1007/s00441-007-0546-8; Jones NP, 2005, J CELL SCI, V118, P2695, DOI 10.1242/jcs.02374; Kimpinski K, 2001, J NEUROSCI RES, V63, P486, DOI 10.1002/jnr.1043; Kojima T, 2010, STEM CELLS, V28, P545, DOI 10.1002/stem.306; Kolkova K, 2000, J NEUROSCI, V20, P2238; Kong M, 2002, J BIOL CHEM, V277, P15962, DOI 10.1074/jbc.M102777200; KRUG E, 1987, J BIOL CHEM, V262, P11852; Kumada T, 2004, P NATL ACAD SCI USA, V101, P8479, DOI 10.1073/pnas.0401000101; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Le Merrer J, 2000, PHARMACOL RES, V41, P503; LEE V, 1977, P NATL ACAD SCI USA, V74, P5021, DOI 10.1073/pnas.74.11.5021; Lin WF, 2009, CELL SIGNAL, V21, P1060, DOI 10.1016/j.cellsig.2009.02.009; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; Lindwall C, 2005, MOL CELL NEUROSCI, V29, P269, DOI 10.1016/j.mcn.2005.03.002; Lu W, 2010, NEW J PHYS, V12, P1, DOI 10.1088/1367-2630/12/8/085002; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Metzger F, 2000, EUR J NEUROSCI, V12, P1993, DOI 10.1046/j.1460-9568.2000.00086.x; Mikule K, 2003, J BIOL CHEM, V278, P21168, DOI 10.1074/jbc.M211828200; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Namikawa K, 2000, J NEUROSCI, V20, P2875; Nelms K, 1999, MAMM GENOME, V10, P1160, DOI 10.1007/s003359901183; Nomura N, 2007, INT J MOL MED, V20, P511; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Park DH, 2009, STEM CELLS DEV, V18, P693, DOI 10.1089/scd.2009.0008; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; Read DE, 2009, CELL MOL LIFE SCI, V66, P2975, DOI 10.1007/s00018-009-0057-8; Reynolds AJ, 2001, NEUROSCIENCE, V105, P761, DOI 10.1016/S0306-4522(01)00235-4; Riedel H, 2000, ONCOGENE, V19, P39, DOI 10.1038/sj.onc.1203253; RODRIGUES PD, 1990, P NATL ACAD SCI USA, V87, P9693, DOI 10.1073/pnas.87.24.9693; Romero MI, 2001, J NEUROSCI, V21, P8408, DOI 10.1523/JNEUROSCI.21-21-08408.2001; Ross ME, 2001, ANNU REV NEUROSCI, V24, P1041, DOI 10.1146/annurev.neuro.24.1.1041; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Rui LY, 1999, J BIOL CHEM, V274, P10590, DOI 10.1074/jbc.274.15.10590; Shioda N, 2009, INT REV NEUROBIOL, V85, P375, DOI 10.1016/S0074-7742(09)85026-5; Snider WD, 2002, NEURON, V35, P13, DOI 10.1016/S0896-6273(02)00762-6; Song W, 2010, CELL METAB, V11, P427, DOI 10.1016/j.cmet.2010.04.002; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; TANAKA C, 1994, ANNU REV NEUROSCI, V17, P551, DOI 10.1146/annurev.ne.17.030194.003003; THEODORE L, 1995, J NEUROSCI, V15, P7158; TODDERUD G, 1990, SCIENCE, V249, P296, DOI 10.1126/science.2374928; Toni N, 1997, SYNAPSE, V27, P199, DOI 10.1002/(SICI)1098-2396(199711)27:3<199::AID-SYN6>3.3.CO;2-I; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F; Waetzig V, 2005, MOL CELL NEUROSCI, V30, P67, DOI 10.1016/j.mcn.2005.06.001; Wang XH, 2004, J BIOL CHEM, V279, P133, DOI 10.1074/jbc.M310040200; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Zhang Y, 2006, J CELL SCI, V119, P1666, DOI 10.1242/jcs.02845; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221	70	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e34999	10.1371/journal.pone.0034999	http://dx.doi.org/10.1371/journal.pone.0034999			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539954	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341000017
J	de Zeeuw, P; Schnack, HG; van Belle, J; Weusten, J; van Dijk, S; Langen, M; Brouwer, RM; van Engeland, H; Durston, S				de Zeeuw, Patrick; Schnack, Hugo G.; van Belle, Janna; Weusten, Juliette; van Dijk, Sarai; Langen, Marieke; Brouwer, Rachel M.; van Engeland, Herman; Durston, Sarah			Differential Brain Development with Low and High IQ in Attention-Deficit/Hyperactivity Disorder	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; NORMAL PEDIATRIC POPULATION; WHITE-MATTER ARCHITECTURE; AUTOMATED 3-D EXTRACTION; CORTICAL GRAY-MATTER; DIFFUSION-TENSOR MRI; HUMAN INTELLIGENCE; CEREBRAL-CORTEX; INTELLECTUAL-PERFORMANCE; GENETIC INFLUENCES	Attention-Deficit/Hyperactivity Disorder (ADHD) and intelligence (IQ) are both heritable phenotypes. Overlapping genetic effects have been suggested to influence both, with neuroimaging work suggesting similar overlap in terms of morphometric properties of the brain. Together, this evidence suggests that the brain changes characteristic of ADHD may vary as a function of IQ. This study investigated this hypothesis in a sample of 108 children with ADHD and 106 typically developing controls, who participated in a cross-sectional anatomical MRI study. A subgroup of 64 children also participated in a diffusion tensor imaging scan. Brain volumes, local cortical thickness and average cerebral white matter microstructure were analyzed in relation to diagnostic group and IQ. Dimensional analyses investigated possible group differences in the relationship between anatomical measures and IQ. Second, the groups were split into above and below median IQ subgroups to investigate possible differences in the trajectories of cortical development. Dimensionally, cerebral gray matter volume and cerebral white matter microstructure were positively associated with IQ for controls, but not for ADHD. In the analyses of the below and above median IQ subgroups, we found no differences from controls in cerebral gray matter volume in ADHD with below-median IQ, but a delay of cortical development in a number of regions, including prefrontal areas. Conversely, in ADHD with above-median IQ, there were significant reductions from controls in cerebral gray matter volume, but no local differences in the trajectories of cortical development. In conclusion, the basic relationship between IQ and neuroanatomy appears to be altered in ADHD. Our results suggest that there may be multiple brain phenotypes associated with ADHD, where ADHD combined with above median IQ is characterized by small, more global reductions in brain volume that are stable over development, whereas ADHD with below median IQ is associated more with a delay of cortical development.	[de Zeeuw, Patrick; van Belle, Janna; Weusten, Juliette; van Dijk, Sarai; Langen, Marieke; van Engeland, Herman; Durston, Sarah] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Child & Adolescent Psychiat, Neuroimaging Lab, Utrecht, Netherlands; [Schnack, Hugo G.; Brouwer, Rachel M.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Struct Neuroimaging Grp, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	de Zeeuw, P (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Child & Adolescent Psychiat, Neuroimaging Lab, Utrecht, Netherlands.	p.dezeeuw@umcutrecht.nl	Hassan, Randa/AAW-3624-2021		Netherlands Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, NWO) [Vidi-91.776.384]; Unilever Foods	Netherlands Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, NWO)(Netherlands Organization for Scientific Research (NWO)); Unilever Foods(Unilever)	This work was supported by a grant from the Netherlands Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, NWO, www.nwo.nl) in the Innovational Research Incentives Scheme (also known as the "Veni, Vidi, Vici"-programme) to SD (grant number: Vidi-91.776.384, further information can be found on http://www.nwo.nl/nwohome.nsf/pages/NWOA_4YJDQ3_Eng). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SD has received a research grant from Unilever Foods that is unrelated to this manuscript. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The other authors have declared that no competing interests exist.	Almeida LG, 2010, J PSYCHIATR RES, V44, P1214, DOI 10.1016/j.jpsychires.2010.04.026; Andersson JLR, 2002, NEUROIMAGE, V16, P177, DOI 10.1006/nimg.2001.1039; [Anonymous], 2006, J NEUROSCI, V26, P4930, DOI [10.1523/JNEUROSCI.5480-05, DOI 10.1523/JNEUROSCI.5480-05, DOI 10.1523/JNEUROSCI.1312-06.2006]; Antshel KM, 2008, J AM ACAD CHILD PSY, V47, P817, DOI 10.1097/CHI.0b013e318172eecf; Antshel KM, 2008, DEV DISABIL RES REV, V14, P293, DOI 10.1002/ddrr.34; Banaschewski T, 2010, EUR CHILD ADOLES PSY, V19, P237, DOI 10.1007/s00787-010-0090-z; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Batty MJ, 2010, J AM ACAD CHILD PSY, V49, P229, DOI 10.1016/j.jaac.2009.11.008; Betjemann RS, 2010, BEHAV GENET, V40, P135, DOI 10.1007/s10519-009-9328-2; Brans RGH, 2010, J NEUROSCI, V30, P5519, DOI 10.1523/JNEUROSCI.5841-09.2010; Bridgett DJ, 2006, PSYCHOL ASSESSMENT, V18, P1, DOI 10.1037/1040-3590.18.1.1; Brouwer RM, 2010, NEUROIMAGE, V49, P467, DOI 10.1016/j.neuroimage.2009.07.041; BUITELAAR JK, 1995, J AM ACAD CHILD PSY, V34, P1025, DOI 10.1097/00004583-199508000-00012; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Charil A, 2010, BRAIN RES REV, V65, P56, DOI 10.1016/j.brainresrev.2010.06.002; Charman T, 2011, PSYCHOL MED, V41, P619, DOI 10.1017/S0033291710000991; Chiang MC, 2009, J NEUROSCI, V29, P2212, DOI 10.1523/JNEUROSCI.4184-08.2009; Choi YY, 2008, J NEUROSCI, V28, P10323, DOI 10.1523/JNEUROSCI.3259-08.2008; Chung MK, 2003, NEUROIMAGE, V18, P198, DOI 10.1016/S1053-8119(02)00017-4; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; de Zeeuw P, 2012, HUM BRAIN MAPP, V33, P1941, DOI 10.1002/hbm.21335; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Deary IJ, 2009, HUM GENET, V126, P215, DOI 10.1007/s00439-009-0655-4; Deary IJ, 2006, NEUROLOGY, V66, P505, DOI 10.1212/01.wnl.0000199954.81900.e2; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; Deutsch CK, 2008, DEV DISABIL RES REV, V14, P285, DOI 10.1002/ddrr.42; Durston S, 2009, NEUROSCI BIOBEHAV R, V33, P674, DOI 10.1016/j.neubiorev.2008.08.009; Durston S, 2009, J AM ACAD CHILD PSY, V48, P206, DOI 10.1097/CHI.0b013e3181930673; Dwyer JB, 2009, PHARMACOL THERAPEUT, V122, P125, DOI 10.1016/j.pharmthera.2009.02.003; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Frangou S, 2004, NEUROIMAGE, V23, P800, DOI 10.1016/j.neuroimage.2004.05.027; Frazier TW, 2004, NEUROPSYCHOLOGY, V18, P543, DOI 10.1037/0894-4105.18.3.543; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gray JR, 2004, NAT REV NEUROSCI, V5, P471, DOI 10.1038/nrn1405; Hart AR, 2008, DEV MED CHILD NEUROL, V50, P655, DOI 10.1111/j.1469-8749.2008.03050.x; Hastie TJ., 1990, GEN ADDITIVE MODELS; Hechtman L, 1999, PEDIATR CLIN N AM, V46, P1039, DOI 10.1016/S0031-3955(05)70171-1; Joshi AA, 2011, NEUROREPORT, V22, P101, DOI 10.1097/WNR.0b013e3283424c84; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Kabani N, 2001, NEUROIMAGE, V13, P375, DOI 10.1006/nimg.2000.0652; Karama S, 2009, INTELLIGENCE, V37, P145, DOI 10.1016/j.intell.2008.09.006; Karama S, 2011, NEUROIMAGE, V55, P1443, DOI 10.1016/j.neuroimage.2011.01.016; Katusic MZ, 2011, J DEV BEHAV PEDIATR, V32, P103, DOI 10.1097/DBP.0b013e318206d700; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Kuntsi J, 2004, AM J MED GENET B, V124B, P41, DOI 10.1002/ajmg.b.20076; Lange N, 2010, DEV NEUROPSYCHOL, V35, P296, DOI 10.1080/87565641003696833; Langen M, 2009, BIOL PSYCHIAT, V66, P327, DOI 10.1016/j.biopsych.2009.03.017; Langer N, 2012, HUM BRAIN MAPP, V33, P1393, DOI 10.1002/hbm.21297; Li J, 2009, AM J MED GENET B, V150B, P375, DOI 10.1002/ajmg.b.30825; Li XB, 2007, BRAIN DEV-JPN, V29, P649, DOI 10.1016/j.braindev.2007.04.008; Lyttelton O, 2007, NEUROIMAGE, V34, P1535, DOI 10.1016/j.neuroimage.2006.10.041; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Makris N, 2007, CEREB CORTEX, V17, P1364, DOI 10.1093/cercor/bhl047; Makris N, 2009, DEV NEUROSCI-BASEL, V31, P36, DOI 10.1159/000207492; Mazzone L, 2011, CNS DRUGS, V25, P503, DOI 10.2165/11590450-000000000-00000; McDaniel MA, 2005, INTELLIGENCE, V33, P337, DOI 10.1016/j.intell.2004.11.005; Nakao T, 2011, AM J PSYCHIAT, V168, P1154, DOI 10.1176/appi.ajp.2011.11020281; Narr KL, 2007, CEREB CORTEX, V17, P2163, DOI 10.1093/cercor/bhl125; Narr KL, 2009, J AM ACAD CHILD PSY, V48, P1014, DOI 10.1097/CHI.0b013e3181b395c0; Neubauer AC, 2009, NEUROSCI BIOBEHAV R, V33, P1004, DOI 10.1016/j.neubiorev.2009.04.001; Nigg JT, 2005, DEV PSYCHOPATHOL, V17, P785, DOI 10.1017/S0954579405050376; O'Donnell S, 2005, NEUROIMAGE, V24, P948, DOI 10.1016/j.neuroimage.2004.10.014; Owens EB, 2003, J CONSULT CLIN PSYCH, V71, P540, DOI 10.1037/0022-006X.71.3.540; Polderman TJC, 2006, ACTA NEUROL BELG, V106, P191; Posthuma D, 2002, NAT NEUROSCI, V5, P83, DOI 10.1038/nn0202-83; Rees S, 2008, INT J DEV NEUROSCI, V26, P3, DOI 10.1016/j.ijdevneu.2007.08.020; Rommelse NNJ, 2008, PSYCHOL MED, V38, P1595, DOI 10.1017/S0033291708002869; Schmithorst VJ, 2005, HUM BRAIN MAPP, V26, P139, DOI 10.1002/hbm.20149; Schnack HG, 2001, NEUROIMAGE, V14, P95, DOI 10.1006/nimg.2001.0800; Schnack HG, 2001, NEUROIMAGE, V13, P230, DOI 10.1006/nimg.2000.0669; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Shaw P, 2006, ARCH GEN PSYCHIAT, V63, P540, DOI 10.1001/archpsyc.63.5.540; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Sowell ER, 2003, LANCET, V362, P1699, DOI 10.1016/S0140-6736(03)14842-8; Sowell ER, 2001, J NEUROSCI, V21, P8819, DOI 10.1523/JNEUROSCI.21-22-08819.2001; Stanfield AC, 2008, EUR PSYCHIAT, V23, P289, DOI 10.1016/j.eurpsy.2007.05.006; Swanson JM, 2007, J AM ACAD CHILD PSY, V46, P1003, DOI 10.1097/CHI.0b013e3180686d63; Talairach J., 1988, COPLANAR STEREOTAXIC; Tamnes CK, 2010, HUM BRAIN MAPP, V31, P1609, DOI 10.1002/hbm.20962; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Valera EM, 2007, BIOL PSYCHIAT, V61, P1361, DOI 10.1016/j.biopsych.2006.06.011; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; van der Oord S, 2008, EUR CHILD ADOLES PSY, V17, P73, DOI 10.1007/s00787-007-0638-8; van Leeuwen M, 2009, INTELLIGENCE, V37, P181, DOI 10.1016/j.intell.2008.10.005; Verhulst F.C., 1996, HANDLEIDING CBCL4 18; Verhulst F.C., 1997, HANDLEIDING TEACHERS; Wallace GL, 2010, BEHAV GENET, V40, P125, DOI 10.1007/s10519-009-9329-1; Wechsler D, 2005, WECHSLER INTELLIGENC; Wilke M, 2003, NEUROIMAGE, V20, P202, DOI 10.1016/S1053-8119(03)00199-X; Wilson VB, 2011, J CHILD PSYCHOL PSYC, V52, P256, DOI 10.1111/j.1469-7610.2010.02347.x; Wolosin SM, 2009, HUM BRAIN MAPP, V30, P175, DOI 10.1002/hbm.20496; Wood AC, 2011, PSYCHOL MED, V41, P861, DOI 10.1017/S003329171000108X; Wood AC, 2010, PSYCHOL MED, V40, P1027, DOI 10.1017/S003329170999119X; Yu CS, 2008, NEUROIMAGE, V40, P1533, DOI 10.1016/j.neuroimage.2008.01.063	99	40	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35770	10.1371/journal.pone.0035770	http://dx.doi.org/10.1371/journal.pone.0035770			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UD	22536435	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339200109
J	Faro-Trindade, I; Willment, JA; Kerrigan, AM; Redelinghuys, P; Hadebe, S; Reid, DM; Srinivasan, N; Wainwright, H; Lang, DM; Steele, C; Brown, GD				Faro-Trindade, Ines; Willment, Janet A.; Kerrigan, Ann M.; Redelinghuys, Pierre; Hadebe, Sabelo; Reid, Delyth M.; Srinivasan, Naren; Wainwright, Helen; Lang, Dirk M.; Steele, Chad; Brown, Gordon D.			Characterisation of Innate Fungal Recognition in the Lung	PLOS ONE			English	Article							ASPERGILLUS-FUMIGATUS CONIDIA; SURFACTANT-PROTEIN-D; BETA-GLUCAN RECEPTOR; TOLL-LIKE RECEPTORS; PULMONARY HOST-DEFENSE; ALVEOLAR MACROPHAGES; STAPHYLOCOCCUS-AUREUS; ANTIFUNGAL IMMUNITY; DECTIN-1; PHAGOCYTOSIS	The innate recognition of fungi by leukocytes is mediated by pattern recognition receptors (PRR), such as Dectin-1, and is thought to occur at the cell surface triggering intracellular signalling cascades which lead to the induction of protective host responses. In the lung, this recognition is aided by surfactant which also serves to maintain the balance between inflammation and pulmonary function, although the underlying mechanisms are unknown. Here we have explored pulmonary innate recognition of a variety of fungal particles, including zymosan, Candida albicans and Aspergillus fumigatus, and demonstrate that opsonisation with surfactant components can limit inflammation by reducing host-cell fungal interactions. However, we found that this opsonisation does not contribute directly to innate fungal recognition and that this process is mediated through non-opsonic PRRs, including Dectin-1. Moreover, we found that pulmonary inflammatory responses to resting Aspergillus conidia were initiated by these PRRs in acidified phagolysosomes, following the uptake of fungal particles by leukocytes. Our data therefore provides crucial new insights into the mechanisms by which surfactant can maintain pulmonary function in the face of microbial challenge, and defines the phagolysosome as a novel intracellular compartment involved in the innate sensing of extracellular pathogens in the lung.	[Faro-Trindade, Ines; Srinivasan, Naren; Brown, Gordon D.] Univ Cape Town, Div Immunol, Inst Infect Dis & Mol Med, Observatory, South Africa; [Willment, Janet A.; Kerrigan, Ann M.; Redelinghuys, Pierre; Hadebe, Sabelo; Reid, Delyth M.; Brown, Gordon D.] Univ Aberdeen, Aberdeen Fungal Grp, Sect Immunol & Infect, Div Appl Med,Inst Med Sci, Aberdeen, Scotland; [Wainwright, Helen] Univ Cape Town, Div Anat Pathol, Observatory, South Africa; [Lang, Dirk M.] Univ Cape Town, Dept Human Biol, Observatory, South Africa; [Steele, Chad] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	University of Cape Town; University of Aberdeen; University of Cape Town; University of Cape Town; University of Alabama System; University of Alabama Birmingham	Brown, GD (corresponding author), Univ Cape Town, Div Immunol, Inst Infect Dis & Mol Med, Observatory, South Africa.	gordon.brown@abdn.ac.uk	Lang, Dirk/I-2554-2015	Lang, Dirk/0000-0003-3901-2079; brown, gordon/0000-0002-0287-5383; Willment, Janet/0000-0002-7040-0857; Hadebe, Sabelo/0000-0002-6049-8395	Wellcome Trust; National Institutes of Health [HL080317, AI068917]; American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068917] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank the Wellcome Trust and National Institutes of Health for funding. This work was also supported by grants from the American Lung Association and National Institutes of Health grants HL080317 and AI068917 (to CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Allen MJ, 1999, INFECT IMMUN, V67, P4563, DOI 10.1128/IAI.67.9.4563-4569.1999; Allen MJ, 2001, INFECT IMMUN, V69, P2037, DOI 10.1128/IAI.69.4.2037-2044.2001; Asmus MJ, 2001, J ALLERGY CLIN IMMUN, V107, P68, DOI 10.1067/mai.2001.111591; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brown GD, 2011, ANNU REV IMMUNOL, V29, P1, DOI 10.1146/annurev-immunol-030409-101229; Chroneos ZC, 2010, CELL PHYSIOL BIOCHEM, V25, P13, DOI 10.1159/000272047; Crouch E, 2001, ANNU REV PHYSIOL, V63, P521, DOI 10.1146/annurev.physiol.63.1.521; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; Dennehy KM, 2008, EUR J IMMUNOL, V38, P500, DOI 10.1002/eji.200737741; Drummond RA, 2011, CURR OPIN MICROBIOL; Evans Scott E, 2010, Proc Am Thorac Soc, V7, P197, DOI 10.1513/pats.200907-075AL; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Fernandez-Mora E, 2005, TRAFFIC, V6, P635, DOI 10.1111/j.1600-0854.2005.00304.x; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Graham LM, 2006, J IMMUNOL METHODS, V314, P164, DOI 10.1016/j.jim.2006.05.013; GRINGHUIS SI, 2009, NAT IMMUNOL; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Haagsman HP, 2008, NEONATOLOGY, V93, P288, DOI 10.1159/000121454; Heinsbroek SEM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000218; Hernanz-Falcon P, 2009, EUR J IMMUNOL, V39, P507, DOI 10.1002/eji.200838687; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Ibrahim-Granet O, 2003, INFECT IMMUN, V71, P891, DOI 10.1128/IAI.71.2.891-903.2003; Ip WKE, 2010, J IMMUNOL, V184, P7071, DOI 10.4049/jimmunol.1000110; Kasperkovitz PV, 2010, J IMMUNOL, V185, P7614, DOI 10.4049/jimmunol.1002760; Kelly MM, 2008, AM J RESP CELL MOL, V38, P227, DOI 10.1165/rcmb.2007-0045OC; Kishore U, 2007, IMMUNOLOGY FUNGAL IN, P151; Lekkala M, 2006, INFECT IMMUN, V74, P4549, DOI 10.1128/IAI.00243-06; Luther K, 2007, CELL MICROBIOL, V9, P368, DOI 10.1111/j.1462-5822.2006.00796.x; Madan T, 1997, INFECT IMMUN, V65, P3171, DOI 10.1128/IAI.65.8.3171-3179.1997; Madan T, 2010, MOL IMMUNOL, V47, P1923, DOI 10.1016/j.molimm.2010.02.027; Maxeiner JH, 2007, NAT PROTOC, V2, P105, DOI 10.1038/nprot.2007.8; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Pastva Amy M, 2007, Proc Am Thorac Soc, V4, P252, DOI 10.1513/pats.200701-018AW; Philippe B, 2003, INFECT IMMUN, V71, P3034, DOI 10.1128/IAI.71.6.3034-3042.2003; Ramirez-Ortiz ZG, 2008, INFECT IMMUN, V76, P2123, DOI 10.1128/IAI.00047-08; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Shepherd VL, 2002, AM J RESP CELL MOL, V26, P257, DOI 10.1165/ajrcmb.26.3.f227; Shimada T, 2010, CELL HOST MICROBE, V7, P38, DOI 10.1016/j.chom.2009.12.008; Singh M, 2009, MOL IMMUNOL, V46, P2363, DOI 10.1016/j.molimm.2009.03.019; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Stokes RW, 1998, J IMMUNOL, V160, P5514; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Taylor PR, 2003, EUR J IMMUNOL, V33, P2090, DOI 10.1002/eji.200324003; Thywissen A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00096; Tsoni SV, 2009, INFECT IMMUN, V77, P3679, DOI 10.1128/IAI.00233-09; Underhill DM, 2003, J ENDOTOXIN RES, V9, P176, DOI 10.1179/096805103125001586; van Rozendaal BAWM, 2000, J INFECT DIS, V182, P917, DOI 10.1086/315799; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106	56	47	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35675	10.1371/journal.pone.0035675	http://dx.doi.org/10.1371/journal.pone.0035675			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536422	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200094
J	Ryland, GL; Bearfoot, JL; Doyle, MA; Boyle, SE; Choong, DYH; Rowley, SM; Tothill, RW; Gorringe, KL; Campbell, IG				Ryland, Georgina L.; Bearfoot, Jennifer L.; Doyle, Maria A.; Boyle, Samantha E.; Choong, David Y. H.; Rowley, Simone M.; Tothill, Richard W.; Gorringe, Kylie L.; Campbell, Ian G.		Australian Ovarian Canc Study Grp	MicroRNA Genes and Their Target 3 '-Untranslated Regions Are Infrequently Somatically Mutated in Ovarian Cancers	PLOS ONE			English	Article							SEQUENCE VARIATIONS; MESSENGER-RNAS; EXPRESSION; PROGRESSION; BIOGENESIS; SIGNATURES; GENOMICS; SURVIVAL; 5'-UTR; MARKER	MicroRNAs are key regulators of gene expression and have been shown to have altered expression in a variety of cancer types, including epithelial ovarian cancer. MiRNA function is most often achieved through binding to the 3'-untranslated region of the target protein coding gene. Mutation screening using massively-parallel sequencing of 712 miRNA genes in 86 ovarian cancer cases identified only 5 mutated miRNA genes, each in a different case. One mutation was located in the mature miRNA, and three mutations were predicted to alter the secondary structure of the miRNA transcript. Screening of the 3'-untranslated region of 18 candidate cancer genes identified one mutation in each of AKT2, EGFR, ERRB2 and CTNNB1. The functional effect of these mutations is unclear, as expression data available for AKT2 and EGFR showed no increase in gene transcript. Mutations in miRNA genes and 3'-untranslated regions are thus uncommon in ovarian cancer.	[Ryland, Georgina L.; Bearfoot, Jennifer L.; Boyle, Samantha E.; Choong, David Y. H.; Rowley, Simone M.; Gorringe, Kylie L.; Campbell, Ian G.] Peter MacCallum Canc Ctr, Victorian Breast Canc Res Consortium Canc Genet L, Melbourne, Vic, Australia; [Ryland, Georgina L.] Monash Univ, Monash Inst Med Res, Ctr Canc Res, Clayton, Vic, Australia; [Bearfoot, Jennifer L.; Gorringe, Kylie L.; Campbell, Ian G.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Doyle, Maria A.] Peter MacCallum Canc Ctr, Bioinformat Core Facil, Melbourne, Vic, Australia; [Tothill, Richard W.] Peter MacCallum Canc Ctr, Mol Genom Core Facil, Melbourne, Vic, Australia	Peter Maccallum Cancer Center; Monash University; University of Melbourne; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center	Campbell, IG (corresponding author), Peter MacCallum Canc Ctr, Victorian Breast Canc Res Consortium Canc Genet L, Melbourne, Vic, Australia.	ian.campbell@petermac.org	Bowtell, David/H-1007-2016; campbell, Ian G/F-6006-2011; Ryland, Georgina L/AAD-9273-2022; Gorringe, Kylie L/H-3264-2019	Bowtell, David/0000-0001-9089-7525; Ryland, Georgina L/0000-0002-4990-0961; Gorringe, Kylie L/0000-0001-5681-2022; Chenevix-Trench, Georgia/0000-0002-1878-2587; Campbell, Ian/0000-0002-7773-4155; Doyle, Maria/0000-0003-4847-8436; Rowley, Simone/0000-0002-5897-7979; Tothill, Richard William/0000-0003-4522-1184	Victorian Breast Cancer Research Consortium, Australia; Australian National Health and Medical Research Council (NHMRC); Australian Postgraduate Award; U.S. Army Medical Research and Materiel Command [DAMD17-01-1-0729]; Cancer Council Tasmania; Cancer Foundation of Western Australia; NHMRC	Victorian Breast Cancer Research Consortium, Australia; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Cancer Council Tasmania(Cancer Council Tasmania); Cancer Foundation of Western Australia(Cancer Council Western Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Victorian Breast Cancer Research Consortium, Australia, and the Australian National Health and Medical Research Council (NHMRC). GLR is supported by an Australian Postgraduate Award. The Australian Ovarian Cancer Study Group was supported by the U.S. Army Medical Research and Materiel Command under DAMD17-01-1-0729, The Cancer Council Tasmania, The Cancer Foundation of Western Australia and the NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers CA, 2010, GENOME RES; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bearfoot JL, 2008, CLIN CANCER RES, V14, P7246, DOI 10.1158/1078-0432.CCR-08-1348; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Birrer MJ, 2007, J CLIN ONCOL, V25, P2281, DOI 10.1200/JCO.2006.09.0795; Bryan EJ, 1996, CANCER RES, V56, P719; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; Diederichs S, 2006, CANCER RES, V66, P6097, DOI 10.1158/0008-5472.CAN-06-0537; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee I, 2009, GENOME RES, V19, P1175, DOI 10.1101/gr.089367.108; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Melo SA, 2011, CELL CYCLE, V10, P922, DOI 10.4161/cc.10.6.15119; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Ramakrishna M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009983; Ramsingh G, 2010, BLOOD, V116, P5316, DOI 10.1182/blood-2010-05-285395; Ratner E, 2010, CANCER RES, V70, P6509, DOI 10.1158/0008-5472.CAN-10-0689; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Said N, 2007, AM J PATHOL, V170, P1054, DOI 10.2353/ajpath.2007.060903; Sheach LA, 2009, BRIT J CANCER, V101, P498, DOI 10.1038/sj.bjc.6605153; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; van Kouwenhove M, 2011, NAT REV CANC; Wu MQ, 2008, CARCINOGENESIS, V29, P1710, DOI 10.1093/carcin/bgn073; Wyman SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005311; Wynendaele J, 2010, CANCER RES, V70, P9641, DOI 10.1158/0008-5472.CAN-10-0527; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yang J, 2008, MUTAT RES-FUND MOL M, V638, P205, DOI 10.1016/j.mrfmmm.2007.08.007; Yiu GK, 2001, AM J PATHOL, V159, P609, DOI 10.1016/S0002-9440(10)61732-4; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	50	21	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35805	10.1371/journal.pone.0035805	http://dx.doi.org/10.1371/journal.pone.0035805			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536442	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200114
J	Sheng, MHC; Wergedal, JE; Mohan, S; Amoui, M; Baylink, DJ; Lau, KHW				Sheng, Matilda H-C; Wergedal, Jon E.; Mohan, Subburaman; Amoui, Mehran; Baylink, David J.; Lau, K-H William			Targeted Overexpression of Osteoactivin in Cells of Osteoclastic Lineage Promotes Osteoclastic Resorption and Bone Loss in Mice	PLOS ONE			English	Article							OSTEOBLAST DIFFERENTIATION; TRANSMEMBRANE PROTEIN; IFN-GAMMA; IN-VIVO; DC-HIL; EXPRESSION; TRANSCRIPTION; REGULATOR; MELANOMA; CLONING	This study sought to test whether targeted overexpression of osteoactivin (OA) in cells of osteoclastic lineage, using the tartrate-resistant acid phosphase (TRAP) exon 1B/C promoter to drive OA expression, would increase bone resorption and bone loss in vivo. OA transgenic osteoclasts showed similar to 2- fold increases in OA mRNA and proteins compared wild- type (WT) osteoclasts. However, the OA expression in transgenic osteoblasts was not different. At 4, 8, and 15.3 week-old, transgenic mice showed significant bone loss determined by pQCT and confirmed by mu-CT. In vitro, transgenic osteoclasts were twice as large, had twice as much TRAP activity, resorbed twice as much bone matrix, and expressed twice as much osteoclastic genes (MMP9, calciton receptor, and ADAM12), as WT osteoclasts. The siRNA-mediated suppression of OA expression in RAW264.7-derived osteoclasts reduced cell size and osteoclastic gene expression. Bone histomorphometry revealed that transgenic mice had more osteoclasts and osteoclast surface. Plasma c-telopeptide (a resorption biomarker) measurements confirmed an increase in bone resorption in transgenic mice in vivo. In contrast, histomorphometric bone formation parameters and plasma levels of bone formation biomarkers (osteocalcin and pro-collagen type I N-terminal peptide) were not different between transgenic mice and WT littermates, indicating the lack of bone formation effects. In conclusion, this study provides compelling in vivo evidence that osteoclast-derived OA is a novel stimulator of osteoclast activity and bone resorption.	[Sheng, Matilda H-C; Baylink, David J.; Lau, K-H William] Loma Linda Univ, Sch Med, Dept Med, Regenerat Med Div, Loma Linda, CA 92354 USA; [Sheng, Matilda H-C; Wergedal, Jon E.; Mohan, Subburaman; Amoui, Mehran; Lau, K-H William] Jerry L Pettis Mem Vet Affair Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA USA	Loma Linda University	Sheng, MHC (corresponding author), Loma Linda Univ, Sch Med, Dept Med, Regenerat Med Div, Loma Linda, CA 92354 USA.	MSheng@llu.edu		Lau, Kin-Hing/0000-0003-1109-5052	National Insititutes of Health [AR55135]; Department of Medicine, School of Medicine of the Loma Linda University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR055135] Funding Source: NIH RePORTER	National Insititutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Medicine, School of Medicine of the Loma Linda University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by a National Insititutes of Health RO3 grant (AR55135), from a special appropriation to the Jerry L. Pettis Memorial Veterans Affairs Medical Center - Musculoskeletal Disease Center, and departmental funds of Department of Medicine, School of Medicine of the Loma Linda University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abdelmagid SM, 2008, EXP CELL RES, V314, P2334, DOI 10.1016/j.yexcr.2008.02.006; Abdelmagid SM, 2007, J CELL PHYSIOL, V210, P26, DOI 10.1002/jcp.20841; Abe H, 2007, BIOCHEM BIOPH RES CO, V356, P610, DOI 10.1016/j.bbrc.2007.03.035; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; AOKI Y, 1986, Hokkaido Journal of Medical Science, V61, P399; Bachner Dietmar, 2002, Brain Res Gene Expr Patterns, V1, P159; Bandari PS, 2003, REGUL PEPTIDES, V111, P169, DOI 10.1016/S0167-0115(02)00288-4; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Chung JS, 2007, BLOOD, V109, P4320, DOI 10.1182/blood-2006-11-053769; Furochi Harumi, 2007, J Med Invest, V54, P248, DOI 10.2152/jmi.54.248; Furochi H, 2007, FEBS LETT, V581, P5743, DOI 10.1016/j.febslet.2007.11.036; Gao YH, 2007, J CLIN INVEST, V117, P122, DOI 10.1172/JCI30074; Haralanova-Ilieva B, 2005, J HEPATOL, V42, P565, DOI 10.1016/j.jhep.2004.12.021; Horne WC, 2005, IMMUNOL REV, V208, P106, DOI 10.1111/j.0105-2896.2005.00335.x; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; KANATANI M, 1995, J BONE MINER RES, V10, P1681, DOI 10.1002/jbmr.5650101110; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Kuan CT, 2006, CLIN CANCER RES, V12, P1970, DOI 10.1158/1078-0432.CCR-05-2797; Ogawa T, 2005, AM J PHYSIOL-CELL PH, V289, pC697, DOI 10.1152/ajpcell.00565.2004; Onaga M, 2003, J HEPATOL, V39, P779, DOI 10.1016/S0168-8278(03)00361-1; Owen TA, 2003, CRIT REV EUKAR GENE, V13, P205; Pahl MV, 2010, CLIN J AM SOC NEPHRO, V5, P56, DOI 10.2215/CJN.03390509; Pan WH, 2005, J BIOL CHEM, V280, P4888, DOI 10.1074/jbc.M409052200; Ripoll VM, 2008, GENE, V413, P32, DOI 10.1016/j.gene.2008.01.014; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Rose AAN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012093; Safadi FF, 2002, J CELL BIOCHEM, V84, P12, DOI 10.1002/jcb.1259; Schwarzbich MA, 2012, CANCER IMMUNOL IMMUN, V61, P193, DOI 10.1007/s00262-011-1096-1; Selim AA, 2003, CRIT REV EUKAR GENE, V13, P265; Sheng MHC, 2008, FEBS LETT, V582, P1451, DOI 10.1016/j.febslet.2008.03.030; Sheng MHC, 2009, J BIOL CHEM, V284, P11531, DOI 10.1074/jbc.M808324200; Sheng MHC, 2004, BONE, V35, P711, DOI 10.1016/j.bone.2004.05.013; Shikano S, 2001, J BIOL CHEM, V276, P8125, DOI 10.1074/jbc.M008539200; Shinohara Masahiro, 2007, Curr Osteoporos Rep, V5, P67; Singh M, 2012, J CELL PHYSIOL, V227, P390, DOI 10.1002/jcp.22791; Tse KF, 2006, CLIN CANCER RES, V12, P1373, DOI 10.1158/1078-0432.CCR-05-2018; Walsh NC, 2003, GENE, V307, P111, DOI 10.1016/S0378-1119(03)00449-9; Williams MD, 2010, MELANOMA RES, V20, P184, DOI 10.1097/CMR.0b013e3283364a08; Zou W, 2010, ANN NY ACAD SCI, V1192, P27, DOI 10.1111/j.1749-6632.2009.05245.x	39	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35280	10.1371/journal.pone.0035280	http://dx.doi.org/10.1371/journal.pone.0035280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536365	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339200048
J	Yu, Y; Zhang, L; Li, XJ; Run, XQ; Liang, ZH; Li, Y; Liu, Y; Lee, MH; Grundke-Iqbal, I; Iqbal, K; Vocadlo, DJ; Liu, F; Gong, CX				Yu, Yang; Zhang, Lan; Li, Xiaojing; Run, Xiaoqin; Liang, Zhihou; Li, Yi; Liu, Ying; Lee, Moon H.; Grundke-Iqbal, Inge; Iqbal, Khalid; Vocadlo, David J.; Liu, Fei; Gong, Cheng-Xin			Differential Effects of an O-GlcNAcase Inhibitor on Tau Phosphorylation	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; SUBCELLULAR-DISTRIBUTION; PROTEIN PHOSPHATASES; INSULIN-RESISTANCE; HYPERPHOSPHORYLATION; EXPRESSION; GLYCOSYLATION; GLCNACYLATION; PP2A; PHOSPHOPROTEIN	Abnormal hyperphosphorylation of microtubule-associated protein tau plays a crucial role in neurodegeneration in Alzheimer's disease (AD). The aggregation of hyperphosphorylated tau into neurofibrillary tangles is also a hallmark brain lesion of AD. Tau phosphorylation is regulated by tau kinases, tau phosphatases, and O-GlcNAcylation, a posttranslational modification of proteins on the serine or threonine residues with beta-N-acetylglucosamine (GlcNAc). O-GlcNAcylation is dynamically regulated by O-GlcNAc transferase, the enzyme catalyzing the transfer of GlcNAc to proteins, and N-acetylglucosaminidase (OGA), the enzyme catalyzing the removal of GlcNAc from proteins. Thiamet-G is a recently synthesized potent OGA inhibitor, and initial studies suggest it can influence O-GlcNAc levels in the brain, allowing OGA inhibition to be a potential route to altering disease progression in AD. In this study, we injected thiamet-G into the lateral ventricle of mice to increase O-GlcNAcylation of proteins and investigated the resulting effects on site-specific tau phosphorylation. We found that acute thiamet-G treatment led to a decrease in tau phosphorylation at Thr181, Thr212, Ser214, Ser262/Ser356, Ser404 and Ser409, and an increase in tau phosphorylation at Ser199, Ser202, Ser396 and Ser422 in the mouse brain. Investigation of the major tau kinases showed that acute delivery of a high dose of thiamet-G into the brain also led to a marked activation of glycogen synthase kinase-3 beta (GSK-3 beta), possibly as a consequence of down-regulation of its upstream regulating kinase, AKT. However, the elevation of tau phosphorylation at the sites above was not observed and GSK-3 beta was not activated in cultured adult hippocampal progenitor cells or in PC12 cells after thiamet-G treatment. These results suggest that acute high-dose thiamet-G injection can not only directly antagonize tau phosphorylation, but also stimulate GSK-3 beta activity, with the downstream consequence being site-specific, bi-directional regulation of tau phosphorylation in the mammalian brain.	[Yu, Yang; Zhang, Lan; Li, Xiaojing; Run, Xiaoqin; Liang, Zhihou; Li, Yi; Liu, Ying; Grundke-Iqbal, Inge; Iqbal, Khalid; Liu, Fei; Gong, Cheng-Xin] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA; [Lee, Moon H.] New York State Inst Basic Res Dev Disabil, Dept Dev Neurobiol, Staten Isl, NY 10314 USA; [Vocadlo, David J.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Institute for Basic Research in Developmental Disabilities; Institute for Basic Research in Developmental Disabilities; Simon Fraser University	Yu, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China.	chengxin.gong@csi.cuny.edu	Vocadlo, David J/E-5508-2014	Vocadlo, David J/0000-0001-6897-5558	New York State Office for People with Developmental Disabilities; National Institutes of Health [R21 AG031969, R01 AG027429, R03 TW008123, R01 AG031969, R01 AG019158]; Alzheimer's Association [IIRG-10-170405]; FOGARTY INTERNATIONAL CENTER [R03TW008123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019158, R21AG031969, R01AG027429] Funding Source: NIH RePORTER	New York State Office for People with Developmental Disabilities; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the New York State Office for People with Developmental Disabilities as well as grants from the National Institutes of Health (R21 AG031969, R01 AG027429, R03 TW008123, R01 AG031969 and R01 AG019158) and the Alzheimer's Association (IIRG-10-170405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso AD, 2004, J BIOL CHEM, V279, P34873, DOI 10.1074/jbc.M405131200; Arias EB, 2004, DIABETES, V53, P921, DOI 10.2337/diabetes.53.4.921; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Camins A, 2006, DRUG NEWS PERSPECT, V19, P453, DOI 10.1358/dnp.2006.19.8.1043961; Chen HH, 2007, NEUROBIOL AGING, V28, P1148, DOI 10.1016/j.neurobiolaging.2006.05.036; Dauphinee SM, 2005, J CELL BIOCHEM, V96, P579, DOI 10.1002/jcb.20508; Deng YQ, 2009, AM J PATHOL, V175, P2089, DOI 10.2353/ajpath.2009.090157; GOEDERT M, 1995, J NEUROCHEM, V65, P2804; Gong CX, 2008, CURR MED CHEM, V15, P2321, DOI 10.2174/092986708785909111; Gong CX, 2010, DRUG AGING, V27, P351, DOI 10.2165/11536110-000000000-00000; GONG CX, 1994, NEUROSCIENCE, V61, P765, DOI 10.1016/0306-4522(94)90400-6; GONG CX, 1993, J NEUROCHEM, V61, P921, DOI 10.1111/j.1471-4159.1993.tb03603.x; Hernandez F, 2009, BRAIN RES BULL, V80, P248, DOI 10.1016/j.brainresbull.2009.05.017; Iqbal K, 1998, NEUROBIOL AGING, V19, pS124; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Ksiezak-Reding H, 2003, BBA-MOL BASIS DIS, V1639, P159, DOI 10.1016/j.bbadis.2003.09.001; Lefebvre T, 2003, BBA-GEN SUBJECTS, V1619, P167, DOI 10.1016/S0304-4165(02)00477-4; Li X, 2006, EUR J NEUROSCI, V23, P2078, DOI 10.1111/j.1460-9568.2006.04735.x; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Liu F, 2007, EUR J NEUROSCI, V26, P3429, DOI 10.1111/j.1460-9568.2007.05955.x; Liu F, 2009, BRAIN, V132, P1820, DOI 10.1093/brain/awp099; Loring JF, 2001, DNA CELL BIOL, V20, P683, DOI 10.1089/10445490152717541; Lovestone S, 1997, NEUROSCIENCE, V78, P309; Luo B, 2008, ARTERIOSCL THROM VAS, V28, P651, DOI 10.1161/ATVBAHA.107.159533; Macauley MS, 2010, CHEM BIOL, V17, P937, DOI 10.1016/j.chembiol.2010.07.006; Macauley MS, 2008, J BIOL CHEM, V283, P34687, DOI 10.1074/jbc.M804525200; Paez Juan, 2003, Cancer Treat Res, V115, P145; Pei JJ, 1997, J NEUROPATH EXP NEUR, V56, P70, DOI 10.1097/00005072-199701000-00007; Pei JJ, 1998, J NEURAL TRANSM, V105, P69, DOI 10.1007/s007020050039; Planel E, 2001, J BIOL CHEM, V276, P34298, DOI 10.1074/jbc.M102780200; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Qian W, 2010, J ALZHEIMERS DIS, V19, P1221, DOI [10.3233/JAD-2009-1317, 10.3233/JAD-2010-1317]; Robertson LA, 2004, J ALZHEIMERS DIS, V6, P489; Run XQ, 2009, J ALZHEIMERS DIS, V16, P619, DOI 10.3233/JAD-2009-1003; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P287, DOI 10.1093/jnen/63.4.287; Tanemura K, 2002, J NEUROSCI, V22, P133, DOI 10.1523/JNEUROSCI.22-01-00133.2002; Tatebayashi Y, 1999, J NEUROSCI, V19, P5245; Vogelsberg-Ragaglia V, 2001, EXP NEUROL, V168, P402, DOI 10.1006/exnr.2001.7630; Whelan SA, 2010, J BIOL CHEM, V285, P5204, DOI 10.1074/jbc.M109.077818; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96	45	67	70	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35277	10.1371/journal.pone.0035277	http://dx.doi.org/10.1371/journal.pone.0035277			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536363	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336200030
J	Cortes-Sempere, M; de Miguel, MP; Pernia, O; Rodriguez, C; Carpeno, JD; Nistal, M; Conde, E; Lopez-Rios, F; Belda-Iniesta, C; Perona, R; Ibanez de Caceres, I				Cortes-Sempere, M.; de Miguel, M. P.; Pernia, O.; Rodriguez, C.; de Castro Carpeno, J.; Nistal, M.; Conde, E.; Lopez-Rios, F.; Belda-Iniesta, C.; Perona, R.; Ibanez de Caceres, I.			IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancer	ONCOGENE			English	Article						NSCLC; cisplatin resistance; IGFIR; IGFBP-3; hypermethylation	GROWTH-FACTOR RECEPTOR; INDUCED DNA HYPERMETHYLATION; OXIDATIVE STRESS; DRUG-RESISTANCE; TUMOR-GROWTH; GENE; CHEMOTHERAPY; EXPRESSION; GEFITINIB; MUTATION	Although many cancers initially respond to cisplatin (CDDP)-based chemotherapy, resistance frequently develops. Insulin-like growth factor-binding protein-3 (IGFBP-3) silencing by promoter methylation is involved in the CDDP-acquired resistance process in non-small cell lung cancer (NSCLC) patients. Our purpose is to design a translational-based profile to predict resistance in NSCLC by studying the role of IGFBP-3 in the phosphatidyl inositol 3-kinase (PI3K) signaling pathway. We have first examined the relationship between IGFBP-3 expression regulated by promoter methylation and activation of the epidermal growth factor receptor (EGFR), insulin-like growth factor-I receptor (IGFIR) and PI3K/AKT pathways in 10 human cancer cell lines and 25 NSCLC patients with known IGFBP-3 methylation status and response to CDDP. Then, to provide a helpful tool that enables clinicians to identify patients with a potential response to CDDP, we have calculated the association between our diagnostic test and the true outcome of analyzed samples in terms of cisplatin IC50; the inhibitory concentration that kills 50% of the cell population. Our results suggest that loss of IGFBP-3 expression by promoter methylation in tumor cells treated with CDDP may activate the PI3K/AKT pathway through the specific derepression of IGFIR signaling, inducing resistance to CDDP. This study also provides a predictive test for clinical practice with an accuracy and precision of 0.84 and 0.9, respectively, (P = 0.0062). We present a biomarker test that could provide clinicians with a robust tool with which to decide on the use of CDDP, improving patient clinical outcomes.	[Cortes-Sempere, M.; Perona, R.] CSIC UAM, CIBER Enfermedades Raras CIBERER, Inst Invest Biomed, Madrid 28029, Spain; [Cortes-Sempere, M.; Pernia, O.; Rodriguez, C.; de Castro Carpeno, J.; Belda-Iniesta, C.; Perona, R.; Ibanez de Caceres, I.] Biomarkers & Expt Therapeut Canc IdiPAZ, Madrid, Spain; [de Miguel, M. P.] La Paz Univ Hosp, IdiPAZ, Lab Cellular Engn, Madrid, Spain; [Pernia, O.; Rodriguez, C.; Ibanez de Caceres, I.] La Paz Univ Hosp, INGEMM, Canc Epigenet Lab, Madrid, Spain; [Nistal, M.] La Paz Univ Hosp, Dept Pathol, Madrid, Spain; [Conde, E.] Madrid Norte Sanchinarro Univ Hosp, Dept Pathol, Madrid, Spain; [Belda-Iniesta, C.] Madrid Norte Sanchinarro Univ Hosp, Dept Med Oncol, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario La Paz	Perona, R (corresponding author), CSIC UAM, CIBER Enfermedades Raras CIBERER, Biomarkers & Expt Therapeut Canc IdiPAZ, Inst Invest Biomed, C Arturo Duperier 4, Madrid 28029, Spain.	rperona@iib.uam.es; inma.ibanezca@salud.madrid.org	Rodriguez-Antolin, Carlos/ABD-9119-2020	Rodriguez-Antolin, Carlos/0000-0001-6682-0771; Belda Iniesta, Cristobal/0000-0003-3254-7492	'Miguel Servet' program [CP08/000689, PI-717]; MINECO [SAF2010-19230]; FIS [PS09/00472, PI08-1485, FIS 11-00949]; Miguel Servet [PI-717, CP 08/000689];  [PI08/1485];  [PI11/00949]	'Miguel Servet' program; MINECO(Spanish Government); FIS(Instituto de Salud Carlos III); Miguel Servet; ; 	We thank J Siegfried for the English correction, F Dominguez for her technical help, the Health Investigation Funding to IIC through the 'Miguel Servet' program (CP08/000689; PI-717) and acknowledge the support of PI08/1485 and PS09/00472 and PI11/00949 projects. We thank MINECO for its support through SAF2010-19230 Grant. This work was supported by FIS PI08-1485, FIS 11-00949, PS09/00472 and Miguel Servet financial support to Ibanez de Caceres, I (CP 08/000689; PI-717).	Aleksic T, 2010, CANCER RES, V70, P6412, DOI 10.1158/0008-5472.CAN-10-0052; Attia SM, 2012, MUTAT RES-GEN TOX EN, V741, P22, DOI 10.1016/j.mrgentox.2011.10.008; Bai T, 2006, INT J ONCOL, V28, P497; Campos ACE, 2007, NEOPLASIA, V9, P1111, DOI 10.1593/neo.07712; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chakravarti A, 2002, CANCER RES, V62, P200; Chang XF, 2010, CANCER RES, V70, P2870, DOI 10.1158/0008-5472.CAN-09-3427; Chang YS, 2002, CLIN CANCER RES, V8, P3796; Chattopadhyay S, 2006, ONCOGENE, V25, P3335, DOI 10.1038/sj.onc.1209364; Chen HB, 2006, CANCER RES, V66, P9009, DOI 10.1158/0008-5472.CAN-06-0101; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Ferroni P, 2011, REJUV RES, V14, P293, DOI 10.1089/rej.2010.1141; Forgacs E, 1998, ONCOGENE, V17, P1557, DOI 10.1038/sj.onc.1202070; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Hamano R, 2011, CLIN CANCER RES, V17, P3029, DOI 10.1158/1078-0432.CCR-10-2532; Ibanez de Caceres I, 2010, ONCOGENE, V29, P1681, DOI 10.1038/onc.2009.454; Ibanez de Caceres I, 2006, CANCER RES, V66, P5021, DOI 10.1158/0008-5472.CAN-05-3365; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; James SR, 2006, ONCOGENE, V25, P6975, DOI 10.1038/sj.onc.1209678; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Judde JG, 2007, INT J CANCER, V120, P1579, DOI 10.1002/ijc.22364; Khan R, 2012, TOXICOL APPL PHARM, V258, P315, DOI 10.1016/j.taap.2011.11.013; Koul S, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-16; Lawless MW, 2009, J CELL MOL MED, V13, P826, DOI 10.1111/j.1582-4934.2008.00571.x; Lawless MW, 2010, EXPERT OPIN THER TAR, V14, P1225, DOI 10.1517/14728222.2010.526933; Malinen M, 2011, NUCLEIC ACIDS RES, V39, P502, DOI 10.1093/nar/gkq820; Morgillo F, 2007, CLIN CANCER RES, V13, P2795, DOI 10.1158/1078-0432.CCR-06-2077; Morgillo F, 2006, CANCER RES, V66, P10100, DOI 10.1158/0008-5472.CAN-06-1684; Niu X, 2012, ONCOGENE, V31, P776, DOI 10.1038/onc.2011.266; NYCE J, 1989, CANCER RES, V49, P5829; Nyce JW, 1997, MUTAT RES-REV MUTAT, V386, P153, DOI 10.1016/S1383-5742(96)00051-8; Oliveras-Ferraros C, 2008, INT J ONCOL, V33, P1165, DOI 10.3892/ijo_00000106; Qiu YY, 2005, CANCER DETECT PREV, V29, P456, DOI 10.1016/j.cdp.2005.05.004; Romanelli RJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704309200; Sanchez-Perez I, 1998, ONCOGENE, V16, P533, DOI 10.1038/sj.onc.1201578; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Sonnweber B, 2006, J CLIN PATHOL, V59, P255, DOI 10.1136/jcp.2005.027615; Takeda K, 2010, J CLIN ONCOL, V28, P753, DOI 10.1200/JCO.2009.23.3445; Tsai CM, 2011, J THORAC ONCOL, V6, P559, DOI 10.1097/JTO.0b013e3182021ff5; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Wiley A, 2006, INT J GYNECOL CANCER, V16, P210, DOI 10.1111/j.1525-1438.2006.00299.x; Yokomizo A, 1998, ONCOGENE, V17, P475, DOI 10.1038/sj.onc.1201956; Zeller C, 2012, ONCOGENE; Zhou XP, 2000, AM J PATHOL, V157, P1123, DOI 10.1016/S0002-9440(10)64627-5	47	52	55	0	22	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 7	2013	32	10					1274	1283		10.1038/onc.2012.146	http://dx.doi.org/10.1038/onc.2012.146			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110OP	22543588				2022-12-25	WOS:000316454500008
J	Kaneko, H; Kobayashi, E; Yamamoto, M; Shimizu, R				Kaneko, Hiroshi; Kobayashi, Eri; Yamamoto, Masayuki; Shimizu, Ritsuko			N- and C-terminal Transactivation Domains of GATA1 Protein Coordinate Hematopoietic Program	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; UROPORPHYRINOGEN-III SYNTHASE; CONGENITAL ERYTHROPOIETIC PORPHYRIA; ERYTHROID-SPECIFIC EXPRESSION; X-LINKED THROMBOCYTOPENIA; DNA-BINDING DOMAIN; DEFINITIVE ERYTHROPOIESIS; CHROMATIN OCCUPANCY; IN-VIVO; MEGAKARYOBLASTIC LEUKEMIA	Transcription factor GATA1 regulates the expression of a cluster of genes important for hematopoietic cell differentiation toward erythroid and megakaryocytic lineages. Three functional domains have been identified in GATA1, a transactivation domain located in the N terminus (N-TAD) and two zinc finger domains located in the middle of the molecule. Although N-TAD is known as a solitary transactivation domain for GATA1, clinical observations in Down syndrome leukemia suggest that there may be additional transactivation domains. In this study, we found in reporter co-transfection assays that transactivation activity of GATA1 was markedly reduced by deletion of the C-terminal 95 amino acids without significant attenuation of the DNA binding activity or self-association potential. We therefore generated transgenic mouse lines that expressed GATA1 lacking the C-terminal region (GATA1-Delta CT). When we crossed these transgenic mouse lines to the Gata1-deficient mouse, we found that the GATA1-Delta CT transgene rescued Gata1-deficient mice from embryonic lethality. The embryos rescued with an almost similar level of GATA1 Delta CT to endogenous GATA1 developed beyond embryonic 13.5 days, showing severe anemia with accumulation of immature erythroid cells, as was the case for the embryos rescued by endogenous levels of GATA1 lacking N-TAD (GATA1-Delta NT). Distinct sets of target genes were affected in the embryos rescued by GATA1-Delta CT and GATA1-Delta NT. We also found attenuated GATA1 function in cell cycle control of immature megakaryocytes in both lines of rescued embryos. These results thus demonstrate that GATA1 has two independent transactivation domains, N-TAD and C-TAD. Both N-TAD and C-TAD retain redundant as well as specific activities for proper hematopoiesis in vivo.	[Kaneko, Hiroshi; Kobayashi, Eri; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kaneko, Hiroshi; Kobayashi, Eri; Shimizu, Ritsuko] Tohoku Univ, Grad Sch Med, Dept Mol Hematol, Aoba Ku, Sendai, Miyagi 9808575, Japan	Tohoku University; Tohoku University	Yamamoto, M (corresponding author), Tohoku Univ, Grad Sch Med, Dept Med Biochem, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	masiyamamoto@med.tohoku.ac.jp; rshimizu@med.tohoku.ac.jp	cheng, yong/I-4270-2012; Yamamoto, Masayuki/A-4873-2010; Shimizu, Ritsuko/A-4877-2010	Yamamoto, Masayuki/0000-0002-9073-9436; Shimizu, Ritsuko/0000-0001-6672-7606	Ministry of Education, Science, Sports and Culture; Naito Foundation; Takeda Foundation; Mitsubishi Foundation; Asahi Glass Foundation; Network Medicine Global-COE program; Grants-in-Aid for Scientific Research [24659456] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Takeda Foundation(Takeda Science Foundation (TSF)); Mitsubishi Foundation; Asahi Glass Foundation; Network Medicine Global-COE program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research on priority areas (to M. Y.), for scientific research (to R. S. and M. Y.), and for exploratory research (to M. Y.) from the Ministry of Education, Science, Sports and Culture, the Naito Foundation (to M. Y.), the Takeda Foundation (to R. S. and M. Y.), the Mitsubishi Foundation (to R. S. and M. Y.), the Asahi Glass Foundation (to R. S.) and the Network Medicine Global-COE program to conquest diseases.	Aizencang G, 2000, GENOMICS, V70, P223, DOI 10.1006/geno.2000.6373; Aizencang GI, 2000, J BIOL CHEM, V275, P2295, DOI 10.1074/jbc.275.4.2295; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; CROSSLEY M, 1995, MOL CELL BIOL, V15, P2448; Ferreira R, 2007, BLOOD, V109, P5481, DOI 10.1182/blood-2006-11-060491; Freson K, 2002, HUM MOL GENET, V11, P147, DOI 10.1093/hmg/11.2.147; Freson K, 2001, BLOOD, V98, P85, DOI 10.1182/blood.V98.1.85; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Hasegawa A, 2012, BLOOD, V119, P2615, DOI 10.1182/blood-2011-09-382473; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Hollanda LM, 2006, NAT GENET, V38, P807, DOI 10.1038/ng1825; HORIKOSHI M, 1988, CELL, V54, P665, DOI 10.1016/S0092-8674(88)80011-4; Hosoya-Ohmura S, 2006, J BIOL CHEM, V281, P32820, DOI 10.1074/jbc.M605735200; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; ITO E, 1993, NATURE, V362, P466, DOI 10.1038/362466a0; Kaneko H, 2010, CURR OPIN HEMATOL, V17, P163, DOI 10.1097/MOH.0b013e32833800b8; Kina T, 2000, BRIT J HAEMATOL, V109, P280, DOI 10.1046/j.1365-2141.2000.02037.x; Kinross KM, 2006, BLOOD, V108, P886, DOI 10.1182/blood-2005-09-008656; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kuhl C, 2005, MOL CELL BIOL, V25, P8592, DOI 10.1128/MCB.25.19.8592-8606.2005; Lavery DN, 2005, BIOCHEM J, V391, P449, DOI 10.1042/BJ20050872; Li Z, 2005, NAT GENET, V37, P613, DOI 10.1038/ng1566; Lurie LJ, 2008, BIOCHEMISTRY-US, V47, P859, DOI 10.1021/bi701692p; Lyons SE, 2002, P NATL ACAD SCI USA, V99, P5454, DOI 10.1073/pnas.082695299; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; MARTIN DIK, 1990, GENE DEV, V4, P1886, DOI 10.1101/gad.4.11.1886; McDevitt MA, 1997, P NATL ACAD SCI USA, V94, P6781, DOI 10.1073/pnas.94.13.6781; Mehaffey MG, 2001, BLOOD, V98, P2681, DOI 10.1182/blood.V98.9.2681; Minegishi N, 2005, GENES CELLS, V10, P693, DOI 10.1111/j.1365-2443.2005.00864.x; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Morrisey EE, 1997, J BIOL CHEM, V272, P8515, DOI 10.1074/jbc.272.13.8515; Nakano M, 2005, GENES CELLS, V10, P47, DOI 10.1111/j.1365-2443.2005.00814.x; Nichols KE, 2000, NAT GENET, V24, P266, DOI 10.1038/73480; Ohneda K, 2002, ACTA HAEMATOL-BASEL, V108, P237, DOI 10.1159/000065660; OMICHINSKI JG, 1993, SCIENCE, V261, P438, DOI 10.1126/science.8332909; Onodera K, 1997, P NATL ACAD SCI USA, V94, P4487, DOI 10.1073/pnas.94.9.4487; Phillips JD, 2007, BLOOD, V109, P2618, DOI 10.1182/blood-2006-06-022848; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Roy A, 2009, BRIT J HAEMATOL, V147, P3, DOI 10.1111/j.1365-2141.2009.07789.x; Shimizu R, 2001, EMBO J, V20, P5250, DOI 10.1093/emboj/20.18.5250; Shimizu R, 2007, J BIOL CHEM, V282, P15862, DOI 10.1074/jbc.M701936200; Shimizu R, 2009, GENES CELLS, V14, P1119, DOI 10.1111/j.1365-2443.2009.01338.x; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; Solis C, 2001, J CLIN INVEST, V107, P753, DOI 10.1172/JCI10642; Suzuki N, 2006, P NATL ACAD SCI USA, V103, P2202, DOI 10.1073/pnas.0508928103; Takahashi S, 2000, BLOOD, V96, P910, DOI 10.1182/blood.V96.3.910.015k29_910_916; Takahashi S, 1997, J BIOL CHEM, V272, P12611, DOI 10.1074/jbc.272.19.12611; Takayama M, 2010, MOL CELL BIOL, V30, P2668, DOI 10.1128/MCB.01304-09; Trainor CD, 1996, MOL CELL BIOL, V16, P2238; Wassarman P. M., 1993, METHODS ENZYMOLOGY G, V225, P747; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650; YANG ZY, 1994, MOL CELL BIOL, V14, P2201, DOI 10.1128/MCB.14.3.2201; Yu CN, 2002, BLOOD, V100, P2040, DOI 10.1182/blood-2002-02-0387; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	58	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21439	21449		10.1074/jbc.M112.370437	http://dx.doi.org/10.1074/jbc.M112.370437			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22556427	Green Published, hybrid			2022-12-25	WOS:000306416800061
J	Bourdais, A; Bidard, F; Zickler, D; Berteaux-Lecellier, V; Silar, P; Espagne, E				Bourdais, Anne; Bidard, Frederique; Zickler, Denise; Berteaux-Lecellier, Veronique; Silar, Philippe; Espagne, Eric			Wood Utilization Is Dependent on Catalase Activities in the Filamentous Fungus Podospora anserina	PLOS ONE			English	Article							BETA-OXIDATION; GENOME SEQUENCE; NADPH; IDENTIFICATION; MITOCHONDRIA; MICROBODIES; PEROXIDASE; MECHANISMS; MUTANTS; SYSTEMS	Catalases are enzymes that play critical roles in protecting cells against the toxic effects of hydrogen peroxide. They are implicated in various physiological and pathological conditions but some of their functions remain unclear. In order to decipher the role(s) of catalases during the life cycle of Podospora anserina, we analyzed the role of the four monofunctional catalases and one bifunctional catalase-peroxidase genes present in its genome. The five genes were deleted and the phenotypes of each single and all multiple mutants were investigated. Intriguingly, although the genes are differently expressed during the life cycle, catalase activity is dispensable during both vegetative growth and sexual reproduction in laboratory conditions. Catalases are also not essential for cellulose or fatty acid assimilation. In contrast, they are strictly required for efficient utilization of more complex biomass like wood shavings by allowing growth in the presence of lignin. The secreted CATB and cytosolic CAT2 are the major catalases implicated in peroxide resistance, while CAT2 is the major player during complex biomass assimilation. Our results suggest that P. anserina produces external H2O2 to assimilate complex biomass and that catalases are necessary to protect the cells during this process. In addition, the phenotypes of strains lacking only one catalase gene suggest that a decrease of catalase activity improves the capacity of the fungus to degrade complex biomass.	[Bourdais, Anne; Bidard, Frederique; Zickler, Denise; Berteaux-Lecellier, Veronique; Silar, Philippe; Espagne, Eric] Univ Paris Sud, Inst Genet & Microbiol, UMR 8621, Orsay, France; [Bourdais, Anne; Bidard, Frederique; Zickler, Denise; Berteaux-Lecellier, Veronique; Silar, Philippe] CNRS, F-91405 Orsay, France; [Bourdais, Anne] CNRS, UMR 6061, Inst Genet & Dev Rennes, Rennes, France; [Bourdais, Anne] UEB Univ Rennes 1, IFR 140, Fac Med, Rennes, France; [Berteaux-Lecellier, Veronique] CRIOBE, USR CNRS EPHE 3278, Lab Excellence CORAIL, Moorea, France; [Silar, Philippe] Univ Paris Diderot, UFR Sci Vivant, Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); UDICE-French Research Universities; Universite Paris Cite	Bourdais, A (corresponding author), Univ Paris Sud, Inst Genet & Microbiol, UMR 8621, Orsay, France.	eric.espagne@igmors.u-psud.fr	Espagne, Eric/AAF-9794-2019; Berteaux-Lecellier, Veronique/O-4767-2018; Espagne, Eric/GMX-2417-2022; BERTEAUX-LECELLIER, Veronique/P-6456-2019	Berteaux-Lecellier, Veronique/0000-0003-2152-6231; BERTEAUX-LECELLIER, Veronique/0000-0003-2152-6231; Espagne, Eric/0000-0002-5813-498X; silar, philippe/0000-0003-0104-987X	Universite Paris Sud 11/Centre National de la Recherche Scientifique (UMR) [8621]; Agence Nationale de la Recherche [ANR-05-Blan-0385-02]	Universite Paris Sud 11/Centre National de la Recherche Scientifique (UMR); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by intramural grants from Universite Paris Sud 11/Centre National de la Recherche Scientifique (UMR 8621) and from "Agence Nationale de la Recherche'' grant no ANR-05-Blan-0385-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Aguirre J, 2005, TRENDS MICROBIOL, V13, P111, DOI 10.1016/j.tim.2005.01.007; Belinky PA, 2003, APPL ENVIRON MICROB, V69, P6500, DOI 10.1128/AEM.69.11.6500-6506.2003; BERTEAUXLECELLIER V, 1995, CELL, V81, P1043, DOI 10.1016/S0092-8674(05)80009-1; Boisnard S, 2009, FUNGAL GENET BIOL, V46, P55, DOI 10.1016/j.fgb.2008.10.006; Bonnet C, 2006, MOL MICROBIOL, V62, P157, DOI 10.1111/j.1365-2958.2006.05353.x; Brun S, 2009, MOL MICROBIOL, V74, P480, DOI 10.1111/j.1365-2958.2009.06878.x; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; Coppin E, 2002, MOL MICROBIOL, V43, P1255, DOI 10.1046/j.1365-2958.2002.02819.x; CORPAS FJ, 2009, EMERGENT FUNCTIONS P, P97; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dashtban M, 2009, INT J BIOL SCI, V5, P578, DOI 10.7150/ijbs.5.578; DEBUCHY R, 1985, EMBO J, V4, P3553, DOI 10.1002/j.1460-2075.1985.tb04116.x; Djordjevic VB, 2004, INT REV CYTOL, V237, P57, DOI 10.1016/S0074-7696(04)37002-6; DOLPHIN D, 1971, P NATL ACAD SCI USA, V68, P614, DOI 10.1073/pnas.68.3.614; Espagne E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r77; Giles SS, 2006, EUKARYOT CELL, V5, P1447, DOI 10.1128/EC.00098-06; Gournas C, 2011, FUNGAL GENET BIOL, V48, P840, DOI 10.1016/j.fgb.2011.03.004; Grant CM, 2001, MOL MICROBIOL, V39, P533, DOI 10.1046/j.1365-2958.2001.02283.x; Grissa I, 2010, FUNGAL BIOL-UK, V114, P766, DOI 10.1016/j.funbio.2010.07.002; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Kawasaki L, 1997, J BACTERIOL, V179, P3284, DOI 10.1128/jb.179.10.3284-3292.1997; Kersten P, 2007, FUNGAL GENET BIOL, V44, P77, DOI 10.1016/j.fgb.2006.07.007; KIONKA C, 1985, J BACTERIOL, V161, P153, DOI 10.1128/JB.161.1.153-157.1985; Kirkman HN, 2007, TRENDS BIOCHEM SCI, V32, P44, DOI 10.1016/j.tibs.2006.11.003; Klotz MG, 1997, MOL BIOL EVOL, V14, P951, DOI 10.1093/oxfordjournals.molbev.a025838; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Krishnan N, 2008, FREE RADICAL BIO MED, V44, P671, DOI 10.1016/j.freeradbiomed.2007.10.054; Kunau WH, 1995, PROG LIPID RES, V34, P267, DOI 10.1016/0163-7827(95)00011-9; Lara-Ortiz T, 2003, MOL MICROBIOL, V50, P1241, DOI 10.1046/j.1365-2958.2003.03800.x; LECELLIER G, 1994, CURR GENET, V25, P122, DOI 10.1007/BF00309536; Maggio-Hall LA, 2004, MOL MICROBIOL, V54, P1173, DOI 10.1111/j.1365-2958.2004.04340.x; Malagnac F, 2004, FUNGAL GENET BIOL, V41, P982, DOI 10.1016/j.fgb.2004.07.008; Malagnac Fabienne, 2008, Commun Integr Biol, V1, P180; Managadze D, 2010, PROTEOMICS, V10, P3222, DOI 10.1002/pmic.201000095; Martinez AT, 2005, INT MICROBIOL, V8, P195; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Michan S, 2003, EUKARYOT CELL, V2, P798, DOI 10.1128/EC.2.4.798-808.2003; Michan S, 2002, FREE RADICAL BIO MED, V33, P521, DOI 10.1016/S0891-5849(02)00909-7; Minard KL, 2001, FREE RADICAL BIO MED, V31, P832, DOI 10.1016/S0891-5849(01)00666-9; Morel M, 2009, CELL MOL LIFE SCI, V66, P3711, DOI 10.1007/s00018-009-0104-5; Passardi F, 2007, GENE, V397, P101, DOI 10.1016/j.gene.2007.04.016; Peraza-Reyes L, 2008, TRAFFIC, V9, P1998, DOI 10.1111/j.1600-0854.2008.00812.x; Reiser K, 2010, CURR GENET, V56, P139, DOI 10.1007/s00294-009-0286-2; Ruprich-Robert G, 2002, GENETICS, V161, P1089; Schliebs W, 2006, EUKARYOT CELL, V5, P1490, DOI 10.1128/EC.00113-06; Scott B, 2008, CURR OPIN MICROBIOL, V11, P488, DOI 10.1016/j.mib.2008.10.008; Shary S, 2008, APPL ENVIRON MICROB, V74, P7252, DOI 10.1128/AEM.01997-08; Silar P, 1999, GENETICS, V151, P87; SILAR P, 1994, J MOL BIOL, V235, P231, DOI 10.1016/S0022-2836(05)80029-4; Silar P, 2005, MYCOL RES, V109, P137, DOI 10.1017/S0953756204002230; ten Have R, 2001, CHEM REV, V101, P3397, DOI 10.1021/cr000115l; Wei DS, 2010, APPL ENVIRON MICROB, V76, P2091, DOI 10.1128/AEM.02929-09; Wesenberg D, 2003, BIOTECHNOL ADV, V22, P161, DOI 10.1016/j.biotechadv.2003.08.011; Zamocky M, 2009, BIOCHEM SOC T, V37, P772, DOI 10.1042/BST0370772; Zintel S, 2011, AGING-US, V3, P768, DOI 10.18632/aging.100360	58	32	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e29820	10.1371/journal.pone.0029820	http://dx.doi.org/10.1371/journal.pone.0029820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558065	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336000001
J	Arango-Gonzalez, B; Schatz, A; Bolz, S; Eslava-Schmalbach, J; Willmann, G; Zhour, A; Zrenner, E; Fischer, MD; Gekeler, F				Arango-Gonzalez, Blanca; Schatz, Andreas; Bolz, Sylvia; Eslava-Schmalbach, Javier; Willmann, Gabriel; Zhour, Ahmad; Zrenner, Eberhart; Fischer, M. Dominik; Gekeler, Florian			Effects of Combined Ketamine/Xylazine Anesthesia on Light Induced Retinal Degeneration in Rats	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; FACTOR-KAPPA-B; IN-VIVO; DAMAGE; KETAMINE; NEUROPROTECTION; RHODOPSIN; XYLAZINE; EXPRESSION; MICE	Objectives: To explore the effect of ketamine-xylazine anesthesia on light-induced retinal degeneration in rats. Methods: Rats were anesthetized with ketamine and xylazine (100 and 5 mg, respectively) for 1 h, followed by a recovery phase of 2 h before exposure to 16,000 lux of environmental illumination for 2 h. Functional assessment by electroretinography (ERG) and morphological assessment by in vivo imaging (optical coherence tomography), histology (hematoxylin/eosin staining, TUNEL assay) and immunohistochemistry (GFAP and rhodopsin staining) were performed at baseline (ERG), 36 h, 7 d and 14 d post-treatment. Non-anesthetized animals treated with light damage served as controls. Results: Ketamine-xylazine pre-treatment preserved retinal function and protected against light-induced retinal degeneration. In vivo retinal imaging demonstrated a significant increase of outer nuclear layer (ONL) thickness in the non-anesthetized group at 36 h (p<0.01) and significant reduction one week (p<0.01) after light damage. In contrast, ketamine-xylazine pre-treated animals showed no significant alteration of total retinal or ONL thickness at either time point (p>0.05), indicating a stabilizing and/or protective effect with regard to phototoxicity. Histology confirmed light-induced photoreceptor cell death and Muller cells gliosis in non-anesthetized rats, especially in the superior hemiretina, while ketamine-xylazine treated rats showed reduced photoreceptor cell death (TUNEL staining: p<0.001 after 7 d), thicker ONL and longer IS/OS. Fourteen days after light damage, a reduction of standard flash induced a-wave amplitudes and a-wave slopes (p = 0.01) and significant alterations in parameters of the scotopic sensitivity function (e. g. Vmax of the Naka Rushton fit p = 0.03) were observed in non-treated vs. ketamine-xylazine treated animals. Conclusions: Our results suggest that pre-treatment with ketamine-xylazine anesthesia protects retinas against light damage, reducing photoreceptor cell death. These data support the notion that anesthesia with ketamine-xylazine provides neuroprotective effects in light-induced cell damage.	[Arango-Gonzalez, Blanca; Schatz, Andreas; Bolz, Sylvia; Willmann, Gabriel; Zhour, Ahmad; Zrenner, Eberhart; Fischer, M. Dominik; Gekeler, Florian] Ctr Ophthalmol, Div Expt Ophthalmol, Tubingen, Germany; [Eslava-Schmalbach, Javier] Univ Nacl Colombia, Clin Res Inst, Bogota, Colombia	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Universidad Nacional de Colombia	Arango-Gonzalez, B (corresponding author), Ctr Ophthalmol, Div Expt Ophthalmol, Tubingen, Germany.	Dominik.Fischer@med.uni-tuebingen.de	Arango-Gonzalez, Blanca/AAR-7427-2021; Eslava-Schmalbach, Javier/O-3954-2019	Arango-Gonzalez, Blanca/0000-0002-9045-182X; Eslava-Schmalbach, Javier/0000-0003-1502-2918	Okuvision GmbH, Reutlingen, Germany; Charlotte and Tistou Kerstan Foundation; fortune Program; University of Tuebingen; Karin and Ewald Hochbaum Foundation	Okuvision GmbH, Reutlingen, Germany; Charlotte and Tistou Kerstan Foundation; fortune Program; University of Tuebingen; Karin and Ewald Hochbaum Foundation	This work was supported by Okuvision GmbH, Reutlingen, Germany (through institution); Charlotte and Tistou Kerstan Foundation (Dr. Arango-Gonzalez), fortune Program, University of Tuebingen and Karin and Ewald Hochbaum Foundation (Dr. Fischer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzolini C, 2001, AM J OPHTHALMOL, V132, P348, DOI 10.1016/S0002-9394(01)01005-4; Barkana Y, 2004, BRAIN RES BULL, V62, P447, DOI 10.1016/S0361-9230(03)00071-6; Capraro AJ, 2001, PEDIATR EMERG CARE, V17, P447, DOI 10.1097/00006565-200112000-00012; Ferro MM, 2007, BRAZ J MED BIOL RES, V40, P89, DOI 10.1590/S0100-879X2006005000053; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; GALLANOSA AG, 1981, CLIN TOXICOL, V18, P663, DOI 10.3109/15563658108990293; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GOSSSAMPSON MA, 1991, LAB ANIM, V25, P360, DOI 10.1258/002367791780810074; GREEN CJ, 1981, LAB ANIM, V15, P163, DOI 10.1258/002367781780959107; Grimm C, 2000, NAT GENET, V25, P63, DOI 10.1038/75614; Grimm C, 2001, INVEST OPHTH VIS SCI, V42, P497; Grimm C, 2000, MOL VIS, V6, P252; Gyulai Ferenc E, 2004, Curr Opin Anaesthesiol, V17, P397, DOI 10.1097/00001503-200410000-00008; Hans P, 2001, Curr Opin Anaesthesiol, V14, P491, DOI 10.1097/00001503-200110000-00005; Hans P, 2000, EUROPEAN J ANAESTHES, P17; Keller C, 2001, INVEST OPHTH VIS SCI, V42, P476; LAVAIL MM, 1987, CURR EYE RES, V6, P825, DOI 10.3109/02713688709034850; Messias A, 2008, DOC OPHTHALMOL, V117, P41; Messias A, 2008, DOC OPHTHALMOL, V116, P177, DOI 10.1007/s10633-007-9081-x; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P536, DOI 10.1113/jphysiol.1966.sp008001; Organisciak DT, 2010, PROG RETIN EYE RES, V29, P113, DOI 10.1016/j.preteyeres.2009.11.004; Ozden S, 2004, J NEUROTRAUM, V21, P73, DOI 10.1089/089771504772695968; Paquet-Durand F, 2004, BRAIN RES, V1011, P33, DOI 10.1016/j.brainres.2004.02.060; Pfenninger E, 1997, ANAESTHESIST, V46, pS47, DOI 10.1007/PL00002465; RAPP LM, 1992, INVEST OPHTH VIS SCI, V33, P3367; Rozza A, 2000, J NEUROSCI METH, V101, P165, DOI 10.1016/S0165-0270(00)00266-1; Sakai T, 2000, CAN J ANAESTH, V47, P1019, DOI 10.1007/BF03024876; Schatz A, 2011, J NEUROSCI METH, V195, P128, DOI 10.1016/j.jneumeth.2010.10.030; Schifilliti D, 2010, CNS DRUGS, V24, P893, DOI 10.2165/11584760-000000000-00000; Shoulson I, 1998, MOVEMENT DISORD, V13, P46; Tang JXX, 2011, CURR OPIN ANESTHESIO, V24, P389, DOI 10.1097/ACO.0b013e32834871c5; Vaughan DK, 2002, PHOTOCHEM PHOTOBIOL, V75, P547, DOI 10.1562/0031-8655(2002)075<0547:EFACRO>2.0.CO;2; Welters ID, 2010, ANESTH ANALG, V110, P934, DOI 10.1213/ANE.0b013e3181c95cfa; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Wu TH, 2002, INVEST OPHTH VIS SCI, V43, P2834; Youssef PN, 2011, EYE, V25, P1, DOI 10.1038/eye.2010.149; Zandieh S, 2003, SPINAL CORD, V41, P16, DOI 10.1038/sj.sc.3101400; Zeng HY, 2008, MOL VIS, V14, P1075	38	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35687	10.1371/journal.pone.0035687	http://dx.doi.org/10.1371/journal.pone.0035687			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558200	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345200067
J	Leach, MC; Klaus, K; Miller, AL; di Perrotolo, MS; Sotocinal, SG; Flecknell, PA				Leach, Matthew C.; Klaus, Kristel; Miller, Amy L.; di Perrotolo, Maud Scotto; Sotocinal, Susana G.; Flecknell, Paul A.			The Assessment of Post-Vasectomy Pain in Mice Using Behaviour and the Mouse Grimace Scale	PLOS ONE			English	Article							ACTION CODING SYSTEM; POSTOPERATIVE PAIN; 2 STRAINS; LAPAROTOMY; CARPROFEN; MOVEMENT; ADULTS; RAT	Background: Current behaviour-based pain assessments for laboratory rodents have significant limitations. Assessment of facial expression changes, as a novel means of pain scoring, may overcome some of these limitations. The Mouse Grimace Scale appears to offer a means of assessing post-operative pain in mice that is as effective as manual behavioural-based scoring, without the limitations of such schemes. Effective assessment of post-operative pain is not only critical for animal welfare, but also the validity of science using animal models. Methodology/Principal Findings: This study compared changes in behaviour assessed using both an automated system ("HomeCageScan") and using manual analysis with changes in facial expressions assessed using the Mouse Grimace Scale (MGS). Mice (n = 6/group) were assessed before and after surgery (scrotal approach vasectomy) and either received saline, meloxicam or bupivacaine. Both the MGS and manual scoring of pain behaviours identified clear differences between the pre and post surgery periods and between those animals receiving analgesia (20 mg/kg meloxicam or 5 mg/kg bupivacaine) or saline post-operatively. Both of these assessments were highly correlated with those showing high MGS scores also exhibiting high frequencies of pain behaviours. Automated behavioural analysis in contrast was only able to detect differences between the pre and post surgery periods. Conclusions: In conclusion, both the Mouse Grimace Scale and manual scoring of pain behaviours are assessing the presence of post-surgical pain, whereas automated behavioural analysis could be detecting surgical stress and/or post-surgical pain. This study suggests that the Mouse Grimace Scale could prove to be a quick and easy means of assessing post-surgical pain, and the efficacy of analgesic treatment in mice that overcomes some of the limitations of behaviour-based assessment schemes.	[Leach, Matthew C.; Klaus, Kristel; Miller, Amy L.; di Perrotolo, Maud Scotto; Flecknell, Paul A.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Leach, Matthew C.; Klaus, Kristel; Miller, Amy L.; di Perrotolo, Maud Scotto; Flecknell, Paul A.] Newcastle Univ, Comparat Biol Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Sotocinal, Susana G.] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Sotocinal, Susana G.] McGill Univ, Alan Edwards Ctr Res Pain, Montreal, PQ, Canada	Newcastle University - UK; Newcastle University - UK; McGill University; McGill University	Leach, MC (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	Matthew.Leach@Newcastle.ac.uk		Flecknell, Paul/0000-0002-1075-1129	NC3Rs; BBSRC; Wellcome Trust; AFSTAL; Laboratory Animals Ltd; AFSTAL (the French Laboratory Animal Science Association); National Centre for the Replacement [G1100563/1] Funding Source: researchfish	NC3Rs(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); AFSTAL; Laboratory Animals Ltd; AFSTAL (the French Laboratory Animal Science Association); National Centre for the Replacement	Dr. Leach was supported by the NC3Rs (www.nc3rs.org.uk), the BBSRC (www.bbsrc.ac.uk) and the Wellcome Trust (www.wellcome.ac.uk). Ms. Scotto received support from AFSTAL (www.afstal.com) and Laboratory Animals Ltd (www.lal.org.uk). Dr. Miller was supported by the NC3Rs (www.nc3rs.org.uk). The animals used in this study were donated by Charles River (www.criver.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. The commercial organizations AFSTAL (the French Laboratory Animal Science Association) and Laboratory Animals Ltd provided financial support for Ms. Scotto in the form of a training scholarship. The commercial organization Charles River UK donated the animals used in the study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Affaitati G, 2002, FUND CLIN PHARMACOL, V16, P23, DOI 10.1046/j.1472-8206.2002.00068.x; BaronCohen S, 1997, VIS COGN, V4, P311, DOI 10.1080/713756761; Darwin C., 1872, EXPRESS EMOT MAN, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Deyo KS, 2004, PAIN, V107, P16, DOI 10.1016/S0304-3959(03)00263-X; Dickinson AL, 2009, LAB ANIM-UK, V43, P357, DOI 10.1258/la.2009.009005; Ekman P, 1978, FACIAL ACTION CODING; Flecknell P, 2011, PAIN, V152, P963, DOI 10.1016/j.pain.2011.01.030; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Leach MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0013347; Leach MC, 2009, RES VET SCI, V87, P336, DOI 10.1016/j.rvsc.2009.02.001; Lints-Martindale AC, 2007, PAIN MED, V8, P678, DOI 10.1111/j.1526-4637.2007.00358.x; Miller AL, 2011, APPL ANIM BEHAV SCI, V131, P138, DOI 10.1016/j.applanim.2011.02.007; National Research Council of the National Academies, 2009, REC ALL PAIN LAB AN; Parr LA, 2010, AM J PHYS ANTHROPOL, V143, P625, DOI 10.1002/ajpa.21401; Roughan JV, 2006, APPL ANIM BEHAV SCI, V96, P327, DOI 10.1016/j.applanim.2005.06.012; Roughan JV, 2004, BEHAV PHARMACOL, V15, P461, DOI 10.1097/00008877-200411000-00002; Roughan JV, 2001, PAIN, V90, P65, DOI 10.1016/S0304-3959(00)00387-0; Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55; Vick SJ, 2007, J NONVERBAL BEHAV, V31, P1, DOI 10.1007/s10919-006-0017-z; Wright-Williams SL, 2007, PAIN, V130, P108, DOI 10.1016/j.pain.2006.11.003	20	130	131	1	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35656	10.1371/journal.pone.0035656	http://dx.doi.org/10.1371/journal.pone.0035656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558191	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345200063
J	Chuang, JH; Huang, AS; Huang, WT; Liu, MT; Chou, JH; Chang, FY; Chiu, WT				Chuang, Jen-Hsiang; Huang, Angela S.; Huang, Wan-Ting; Liu, Ming-Tsan; Chou, Jih-Haw; Chang, Feng-Yee; Chiu, Wen-Ta			Nationwide Surveillance of Influenza during the Pandemic (2009-10) and Post-Pandemic (2010-11) Periods in Taiwan	PLOS ONE			English	Article							VIRUS; EPIDEMIOLOGY; FEATURES; HEALTH	Introduction: Although WHO declared the world moving into the post-pandemic period on August 10, 2010, influenza A(H1N1) 2009 virus continued to circulate globally. Its impact was expected to continue during the 2010-11 influenza season. This study describes the nationwide surveillance findings of the pandemic and post-pandemic influenza periods in Taiwan and assesses the impact of influenza A(H1N1) 2009 during the post-pandemic period. Methods: The Influenza Laboratory Surveillance Network consisted of 12 contract laboratories for collecting and testing samples with acute respiratory tract infections. Surveillance of emergency room visits and outpatient department visits for influenza-like illness (ILI) were conducted using the Real-Time Outbreak and Disease Surveillance system and the National Health Insurance program data, respectively. Hospitalized cases with severe complications and deaths were reported to the National Notifiable Disease Surveillance System. Results: During the 2009-10 influenza season, pandemic A(H1N1) 2009 was the predominant circulating strain and caused 44 deaths. However, the 2010-11 influenza season began with A(H3N2) being the predominant circulating strain, changing to A(H1N1) 2009 in December 2010. Emergency room and outpatient department ILI surveillance displayed similar trends. By March 31, 2011, there were 1,751 cases of influenza with severe complications; 50.1% reported underlying diseases. Of the reported cases, 128 deaths were associated with influenza. Among these, 93 (72.6%) were influenza A(H1N1) 2009 and 30 (23.4%) A(H3N2). Compared to the pandemic period, during the immediate post-pandemic period, increased number of hospitalizations and deaths were observed, and the patients were consistently older. Conclusions: Reemergence of influenza A(H1N1) 2009 during the 2010-11 influenza season had an intense activity with age distribution shift. To further mitigate the impact of future influenza epidemics, Taiwan must continue its multifaceted influenza surveillance systems, remain flexible with antiviral use policies, and revise the vaccine policies to include the population most at risk.	[Chuang, Jen-Hsiang; Huang, Wan-Ting] Ctr Dis Control, Epidem Intelligence Ctr, Taipei, Taiwan; [Chuang, Jen-Hsiang] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Chuang, Jen-Hsiang] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Huang, Angela S.] Ctr Dis Control, Field Epidemiol Training Program, Taipei, Taiwan; [Liu, Ming-Tsan] Ctr Dis Control, Res & Diagnost Ctr, Taipei, Taiwan; [Chou, Jih-Haw] Ctr Dis Control, Deputy Director Gen Off, Taipei, Taiwan; [Chang, Feng-Yee] Ctr Dis Control, Director Gen Off, Taipei, Taiwan; [Chang, Feng-Yee] Natl Def Med Ctr, Dept Internal Med, Taipei, Taiwan; [Chiu, Wen-Ta] Ministers Off, Dept Hlth, Taipei, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Sch Med, Taipei, Taiwan	Centers For Disease Control - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Centers For Disease Control - Taiwan; Centers For Disease Control - Taiwan; Centers For Disease Control - Taiwan; Centers For Disease Control - Taiwan; National Defense Medical Center; Taipei Medical University	Chuang, JH (corresponding author), Ctr Dis Control, Epidem Intelligence Ctr, Taipei, Taiwan.	fychang@cdc.gov.tw	Chuang, Jen-Hsiang/G-4356-2010; Huang, Wan-Ting/E-3497-2010	Chuang, Jen-Hsiang/0000-0002-7114-3418; Huang, Wan-Ting/0000-0002-4344-9567	Centers for Disease Control, Department of Health, Taipei, Taiwan, Republic of China [DOH100-DC-2036]	Centers for Disease Control, Department of Health, Taipei, Taiwan, Republic of China	This work was supported in part by the grants [DOH100-DC-2036] from the Centers for Disease Control, Department of Health, Taipei, Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	[Anonymous], 2011, Wkly Epidemiol Rec, V86, P222; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P61; Athanasiou M, 2011, EUROSURVEILLANCE, V16, P14; Australia Department of Health and Ageing, 2011, FACT SHEET IMM PROV; Benner David G., 2010, OPENING GOD0; Bolotin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030279; Buehler JW, 2003, EMERG INFECT DIS, V9, P1197, DOI 10.3201/eid0910.030231; Bureau of National Health Insurance, 2009, CAT ILLN PAT; Central Weather Bureau, 2011, MONTHL REP CLIM SYST; Chien YS, 2010, J INFECTION, V60, P168, DOI 10.1016/j.jinf.2009.12.012; Ellis J, 2011, EUROSURVEILLANCE, V16, P2; Espino JU, 2001, J AM MED INFORM ASSN, P164; Health Protection Agency, 2011, SURV INFL OTH RESP V; Health Protection Agency, 2011, FREQ ASK QUEST INFL; Ho YC, 2009, J INFECTION, V58, P439, DOI 10.1016/j.jinf.2009.03.007; Hsieh Yu-Chia, 2005, Journal of Microbiology Immunology and Infection, V38, P238; Huang W T, 2010, Euro Surveill, V15, P19575; Huang WT, 2010, VACCINE, V28, P7161, DOI 10.1016/j.vaccine.2010.08.069; Iezzoni LI, 1997, ANN INTERN MED, V127, P666, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00048; Lai SK, 2010, TAIWAN EPIDEMIOLOGY, V26, P251; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; Mytton OT, 2011, EPIDEMIOL INFECT, P1; Shih SR, 2005, J CLIN MICROBIOL, V43, P1651, DOI 10.1128/JCM.43.4.1651-1661.2005; Steel J, 2011, J VIROL, V85, P1400, DOI 10.1128/JVI.02186-10; Su CP, 2010, TAIWAN EPIDEMIOLOGY, V26, P275; Tsui FC, 2003, J AM MED INFORM ASSN, V10, P399, DOI 10.1197/jamia.M1345; Viasus D, 2012, CLIN MICROBIOL INFEC, V18, pE55, DOI 10.1111/j.1469-0691.2011.03753.x; Wang M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016809; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; WHO, 2009, 8 WHO; Yang JR, 2010, ANTIVIR RES, V88, P256, DOI 10.1016/j.antiviral.2010.09.014; Yang JR, 2010, VIRUS RES, V151, P33, DOI 10.1016/j.virusres.2010.03.011	34	54	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e36120	10.1371/journal.pone.0036120	http://dx.doi.org/10.1371/journal.pone.0036120			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545158	Green Published, gold			2022-12-25	WOS:000305343200079
J	Zhu, XL; Chen, C; Ye, D; Guan, DN; Ye, L; Jin, JL; Zhao, H; Chen, YT; Wang, ZY; Wang, X; Xu, Y				Zhu, Xiaolei; Chen, Cong; Ye, Dan; Guan, Dening; Ye, Lan; Jin, Jiali; Zhao, Hui; Chen, Yanting; Wang, Zhongyuan; Wang, Xin; Xu, Yun			Diammonium Glycyrrhizinate Upregulates PGC-1 alpha and Protects against A beta(1-42)-Induced Neurotoxicity	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; ENERGY-METABOLISM; 18-BETA-GLYCYRRHETINIC ACID; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; BETA; PGC-1; CYTOTOXICITY; COACTIVATORS; EXPRESSION	Mitochondrial dysfunction is a hallmark of beta-amyloid (A beta)-induced neurotoxicity in Alzheimer's disease (AD), and is considered an early event in AD pathology. Diammonium glycyrrhizinate (DG), the salt form of Glycyrrhizin, is known for its anti-inflammatory effects, resistance to biologic oxidation and membranous protection. In the present study, the neuroprotective effects of DG on A beta(1-42)-induced toxicity and its potential mechanisms in primary cortical neurons were investigated. Exposure of neurons to 2 mu M A beta(1-42) resulted in significant viability loss and cell apoptosis. Accumulation of reactive oxygen species (ROS), decreased mitochondrial membrane potential, and activation of caspase-9 and caspase-3 were also observed after A beta(1-42) exposure. All these effects induced by A beta(1-42) were markedly reversed by DG treatment. In addition, DG could alleviate lipid peroxidation and partially restore the mitochondrial function in A beta(1-42)-induced AD mice. DG also significantly increased the PGC-1 alpha expression in vivo and in vitro, while knocking down PGC-1 alpha partially blocked the protective effects, which indicated that PGC-1 alpha contributed to the neuroprotective effects of DG. Furthermore, DG significantly decreased the escape latency and search distance and increased the target crossing times of A beta(1-42)-induced AD mice in the Morris water maze test. Therefore, these results demonstrated that DG could attenuate A beta(1-42)-induced neuronal injury by preventing mitochondrial dysfunction and oxidative stress and improved cognitive impairment in A beta(1-42)-induced AD mice, indicating that DG exerted potential beneficial effects on AD.	[Zhu, Xiaolei; Wang, Zhongyuan; Wang, Xin; Xu, Yun] Nanjing Univ Chinese Med, Dept Neurol, Nanjing Drum Tower Hosp Clin Coll Tradit Chinese, Nanjing, Jiangsu, Peoples R China; [Zhu, Xiaolei; Chen, Cong; Ye, Dan; Guan, Dening; Ye, Lan; Jin, Jiali; Zhao, Hui; Chen, Yanting; Wang, Zhongyuan; Wang, Xin; Xu, Yun] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Neurol, Nanjing 210008, Peoples R China; [Xu, Yun] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Xu, Yun] Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine; Nanjing University; Nanjing University	Zhu, XL (corresponding author), Nanjing Univ Chinese Med, Dept Neurol, Nanjing Drum Tower Hosp Clin Coll Tradit Chinese, Nanjing, Jiangsu, Peoples R China.	xuyun20042001@yahoo.com.cn		Schirmer, Claire/0000-0002-7994-1190	National Natural Science Foundation of China [30971010, 30670739, 81171085]; Health Department of Jiangsu Province of China [LJ 201101]; National Natural Science Foundation of Jiangsu Province of China [BK2009037]; Ministry of Science and Technology in China [2009CB521906)]; Science and Technology Achievement transformation Foundation of Jiangsu Province [BA2009124]; Nanjing Municipal Bureau of Health [ZKX08030]; Postgraduate Innovation Project of Jiangsu Province of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health Department of Jiangsu Province of China; National Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Ministry of Science and Technology in China(Ministry of Science and Technology, China); Science and Technology Achievement transformation Foundation of Jiangsu Province; Nanjing Municipal Bureau of Health; Postgraduate Innovation Project of Jiangsu Province of China	This study was supported by the National Natural Science Foundation of China (30971010, 30670739 and 81171085), Outstanding Researcher Program (LJ 201101) of Health Department of Jiangsu Province of China, the National Natural Science Foundation (BK2009037) of Jiangsu Province of China, 973 Fund from the Ministry of Science and Technology in China (2009CB521906), Science and Technology Achievement transformation Foundation of Jiangsu Province (BA2009124) (Y. Xu), Key Project of Nanjing Municipal Bureau of Health (ZKX08030) (D.N. Guan) and the Postgraduate Innovation Project of Jiangsu Province of China (X.L. Zhu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JW, 2001, J NEUROSCI RES, V65, P45, DOI 10.1002/jnr.1126; Arjumand W, 2011, LIFE SCI, V89, P422, DOI 10.1016/j.lfs.2011.06.016; Feng C, 2007, INT IMMUNOPHARMACOL, V7, P1292, DOI 10.1016/j.intimp.2007.05.011; Fiore C, 2008, PHYTOTHER RES, V22, P141, DOI 10.1002/ptr.2295; Gumpricht E, 2005, J BIOL CHEM, V280, P10556, DOI 10.1074/jbc.M411673200; Hauptmann S, 2006, EXP GERONTOL, V41, P668, DOI 10.1016/j.exger.2006.03.012; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; ISHIKAWA A, 1990, BIOCHEM BIOPH RES CO, V167, P876, DOI 10.1016/0006-291X(90)90605-M; Jeong HG, 2002, PHARMACOL RES, V46, P221, DOI 10.1016/S1043-6618(02)00121-4; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2009, MOL ENDOCRINOL, V23, P2, DOI 10.1210/me.2008-0344; Liu C, 2011, ACTA BIOCH BIOPH SIN, V43, P248, DOI 10.1093/abbs/gmr007; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Michaelis M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019705; Miranda S, 2000, PROG NEUROBIOL, V62, P633, DOI 10.1016/S0301-0082(00)00015-0; Pallas M, 2009, CURR NEUROVASC RES, V6, P70, DOI 10.2174/156720209787466019; Qin W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004183; Rasouri S, 2007, M S-MED SCI, V23, P840, DOI 10.1051/medsci/20072310840; Saura CA, 2011, REV NEUROSCIENCE, V22, P153, DOI 10.1515/RNS.2011.018; Scott Bitner R, 2011, BIOCH PHARM; Selkoe DJ, 2000, ANN NY ACAD SCI, V924, P17; Sheng BY, 2012, J NEUROCHEM, V120, P419, DOI 10.1111/j.1471-4159.2011.07581.x; Shoag J, 2010, ARTERIOSCL THROM VAS, V30, P662, DOI 10.1161/ATVBAHA.108.181636; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Sultana R, 2010, J ALZHEIMERS DIS, V19, P341, DOI 10.3233/JAD-2010-1222; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Wareski P, 2009, J BIOL CHEM, V284, P21379, DOI 10.1074/jbc.M109.018911; Winner B, 2011, EUR J NEUROSCI, V33, P1139, DOI 10.1111/j.1460-9568.2011.07613.x; Xu Y, 2004, MOL ENDOCRINOL, V18, P86, DOI 10.1210/me.2003-0262; YAMAMURA Y, 1995, BIOL PHARM BULL, V18, P337, DOI 10.1248/bpb.18.337; Yoshida T, 2006, CYTOKINE, V33, P317, DOI 10.1016/j.cyto.2006.03.001; Zhu HR, 2010, NEUROPHARMACOLOGY, V59, P70, DOI 10.1016/j.neuropharm.2010.03.017	34	41	47	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35823	10.1371/journal.pone.0035823	http://dx.doi.org/10.1371/journal.pone.0035823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540007	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341000073
J	Agostino, M; Yuriev, E; Ramsland, PA				Agostino, Mark; Yuriev, Elizabeth; Ramsland, Paul A.			Antibody Recognition of Cancer-Related Gangliosides and Their Mimics Investigated Using in silico Site Mapping	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; GD2 GANGLIOSIDE; MONOCLONAL-ANTIBODY; PEPTIDES MIMICKING; ANTIGANGLIOSIDE ANTIBODIES; XENOREACTIVE ANTIBODIES; CARBOHYDRATE ANTIGENS; CANONICAL STRUCTURES; MOLECULAR MIMICRY; LIGAND DOCKING	Modified gangliosides may be overexpressed in certain types of cancer, thus, they are considered a valuable target in cancer immunotherapy. Structural knowledge of their interaction with antibodies is currently limited, due to the large size and high flexibility of these ligands. In this study, we apply our previously developed site mapping technique to investigate the recognition of cancer-related gangliosides by anti-ganglioside antibodies. The results reveal a potential ganglioside-binding motif in the four antibodies studied, suggesting the possibility of structural convergence in the anti-ganglioside immune response. The structural basis of the recognition of ganglioside-mimetic peptides is also investigated using site mapping and compared to ganglioside recognition. The peptides are shown to act as structural mimics of gangliosides by interacting with many of the same binding site residues as the cognate carbohydrate epitopes. These studies provide important clues as to the structural basis of immunological mimicry of carbohydrates.	[Agostino, Mark; Yuriev, Elizabeth] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Ramsland, Paul A.] Burnet Inst, Ctr Immunol, Melbourne, Vic, Australia; [Ramsland, Paul A.] Univ Melbourne, Dept Surg Austin Hlth, Heidelberg, Vic, Australia; [Ramsland, Paul A.] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia	Monash University; Burnet Institute; Austin Research Institute; University of Melbourne; Monash University	Yuriev, E (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia.	Elizabeth.Yuriev@monash.edu; pramsland@burnet.edu.au	Yuriev, Elizabeth/A-7132-2016; Agostino, Mark/H-5481-2019	Yuriev, Elizabeth/0000-0002-3909-0379; Agostino, Mark/0000-0002-1799-0392; Ramsland, Paul/0000-0002-2107-2738	Faculty of Pharmacy and Pharmaceutical Sciences, Monash University; Monash University Postgraduate Publication Award; Sir Zelman Cowen Fellowship Fund, Burnet Institute	Faculty of Pharmacy and Pharmaceutical Sciences, Monash University(Monash University); Monash University Postgraduate Publication Award(Monash University); Sir Zelman Cowen Fellowship Fund, Burnet Institute	This research was supported by a small grant from the Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, to EY. MA is a recipient of the Monash University Postgraduate Publication Award. PAR is the Sir Zelman Cowen Senior Research Fellow (Sir Zelman Cowen Fellowship Fund, Burnet Institute). The authors gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program received by the Burnet Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostino M., 2012, ANTICARBOHYDRATE ANT, P203; Agostino M, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00023; Agostino M, 2011, EXPERT OPIN BIOL TH, V11, P211, DOI 10.1517/14712598.2011.542140; Agostino M, 2011, BIOPOLYMERS, V96, P193, DOI 10.1002/bip.21427; Agostino M, 2010, GLYCOBIOLOGY, V20, P724, DOI 10.1093/glycob/cwq022; Agostino M, 2009, MOL IMMUNOL, V47, P233, DOI 10.1016/j.molimm.2009.09.031; Agostino M, 2009, J CHEM INF MODEL, V49, P2749, DOI 10.1021/ci900388a; AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; [Anonymous], 2010, PRIM VERS 2 2; [Anonymous], 2010, GLID VERS 5 6; Astronomo RD, 2010, NAT REV DRUG DISCOV, V9, P308, DOI 10.1038/nrd3012; Blackler RJ, 2011, BIOCHEMISTRY-US, V50, P3357, DOI 10.1021/bi101886v; Brooks CL, 2010, BIOCHEMISTRY-US, V49, P570, DOI 10.1021/bi9011308; Cazet A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2577; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; de Chaves EP, 2010, FEBS LETT, V584, P1748, DOI 10.1016/j.febslet.2009.12.010; Diaz Y, 2009, CANCER IMMUNOL IMMUN, V58, P1117, DOI 10.1007/s00262-008-0634-y; Fernandez Luis E, 2003, Expert Rev Vaccines, V2, P817, DOI 10.1586/14760584.2.6.817; Fernandez LE, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/814397; Foster-Waldl E, 2005, MOL IMMUNOL, V42, P319, DOI 10.1016/j.molimm.2004.07.011; Fredman P, 2003, BIODRUGS, V17, P155, DOI 10.2165/00063030-200317030-00002; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gorelik B, 2008, PROTEINS, V71, P1373, DOI 10.1002/prot.21847; Hakomori S, 2001, ADV EXP MED BIOL, V491, P369; HERRON JN, 1991, PROTEINS, V11, P159, DOI 10.1002/prot.340110302; Horwacik I, 2007, INT J MOL MED, V19, P829; Horwacik I, 2011, INT J MOL MED, V28, P47, DOI 10.3892/ijmm.2011.655; Inoue S, 2010, GLYCOBIOLOGY, V20, P752, DOI 10.1093/glycob/cwq030; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Kaminski MJ, 1999, J BIOL CHEM, V274, P5597, DOI 10.1074/jbc.274.9.5597; Koga M, 1999, J NEUROIMMUNOL, V96, P245, DOI 10.1016/S0165-5728(99)00040-5; Krengel U, 2004, J BIOL CHEM, V279, P5597, DOI 10.1074/jbc.M311693200; Krishnan L, 2008, BIOPHYS J, V94, P1367, DOI 10.1529/biophysj.107.108654; Kusunoki S, 2011, J NEUROCHEM, V116, P828, DOI 10.1111/j.1471-4159.2010.07029.x; Lang PT, 2009, RNA, V15, P1219, DOI 10.1261/rna.1563609; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; Milland J, 2007, IMMUNOL CELL BIOL, V85, P623, DOI 10.1038/sj.icb.7100111; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Navid F, 2010, CURR CANCER DRUG TAR, V10, P200, DOI 10.2174/156800910791054167; Neisser A, 2000, J NEUROIMMUNOL, V102, P85, DOI 10.1016/S0165-5728(99)00159-9; Nguyen HP, 2003, NAT STRUCT BIOL, V10, P1019, DOI 10.1038/nsb1014; Pichla SL, 1997, J STRUCT BIOL, V119, P6, DOI 10.1006/jsbi.1997.3857; Popa I, 2006, FEBS LETT, V580, P1398, DOI 10.1016/j.febslet.2006.01.063; Ramsland PA, 2004, J MOL BIOL, V340, P809, DOI 10.1016/j.jmb.2004.05.037; Rodriguez M, 2003, HYBRIDOMA HYBRIDOM, V22, P307, DOI 10.1089/153685903322538836; Schnaar RL, 2010, FEBS LETT, V584, P1741, DOI 10.1016/j.febslet.2009.10.011; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Schrodinger LLC, 2010, MAESTR VERS 9 2; Snapper CM, 1996, J IMMUNOL, V157, P2229; Talavera A, 2009, MOL IMMUNOL, V46, P3466, DOI 10.1016/j.molimm.2009.07.032; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Thielges MC, 2008, BIOCHEMISTRY-US, V47, P7237, DOI 10.1021/bi800374q; Usuki S, 2010, J NEUROCHEM, V113, P351, DOI 10.1111/j.1471-4159.2010.06627.x; Vazquez AM, 1998, HYBRIDOMA, V17, P527, DOI 10.1089/hyb.1998.17.527; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Willers J, 1999, PEPTIDES, V20, P1021, DOI 10.1016/S0196-9781(99)00095-9; WILSON IA, 1994, CURR OPIN STRUC BIOL, V4, P857, DOI 10.1016/0959-440X(94)90267-4; Wolchok JD, 2001, LANCET ONCOL, V2, P205, DOI 10.1016/S1470-2045(00)00290-4; Wondimu A, 2008, CANCER IMMUNOL IMMUN, V57, P1079, DOI 10.1007/s00262-007-0439-4; Yuriev E, 2008, MOL SIMULAT, V34, P461, DOI 10.1080/08927020701665995; Yuriev E, 2002, SCAND J IMMUNOL, V55, P242, DOI 10.1046/j.0300-9475.2002.01032.x; Yuriev E, 2001, J MOL RECOGNIT, V14, P172, DOI 10.1002/jmr.533; Yuriev E, 2011, J MOL RECOGNIT, V24, P149, DOI 10.1002/jmr.1077	66	14	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35457	10.1371/journal.pone.0035457	http://dx.doi.org/10.1371/journal.pone.0035457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536387	Green Published, gold			2022-12-25	WOS:000305339200067
J	Gunnarsson, G; Latorre-Margalef, N; Hobson, KA; Van Wilgenburg, SL; Elmberg, J; Olsen, B; Fouchier, RAM; Waldenstrom, J				Gunnarsson, Gunnar; Latorre-Margalef, Neus; Hobson, Keith A.; Van Wilgenburg, Steven L.; Elmberg, Johan; Olsen, Bjorn; Fouchier, Ron A. M.; Waldenstrom, Jonas			Disease Dynamics and Bird Migration-Linking Mallards Anas platyrhynchos and Subtype Diversity of the Influenza A Virus in Time and Space	PLOS ONE			English	Article							AVIAN INFLUENZA; STABLE-HYDROGEN; AQUATIC BIRDS; LESSER SCAUP; INFECTION; DUCKS; SURVEILLANCE; POPULATIONS; WATERFOWL; ISOTOPES	The mallard Anas platyrhynchos is a reservoir species for influenza A virus in the northern hemisphere, with particularly high prevalence rates prior to as well as during its prolonged autumn migration. It has been proposed that the virus is brought from the breeding grounds and transmitted to conspecifics during subsequent staging during migration, and so a better understanding of the natal origin of staging ducks is vital to deciphering the dynamics of viral movement pathways. Ottenby is an important stopover site in southeast Sweden almost halfway downstream in the major Northwest European flyway, and is used by millions of waterfowl each year. Here, mallards were captured and sampled for influenza A virus infection, and positive samples were subtyped in order to study possible links to the natal area, which were determined by a novel approach combining banding recovery data and isotopic measurements (delta H-2) of feathers grown on breeding grounds. Geographic assignments showed that the core natal areas of studied mallards were in Estonia, southern and central Finland, and northwestern Russia. This study demonstrates a clear temporal succession of latitudes of natal origin during the course of autumn migration. We also demonstrate a corresponding and concomitant shift in virus subtypes. Acknowledging that these two different patterns were based in part upon different data, a likely interpretation worth further testing is that the early arriving birds with more proximate origins have different influenza A subtypes than the more distantly originating late autumn birds. If true, this knowledge would allow novel insight into the origins and transmission of the influenza A virus among migratory hosts previously unavailable through conventional approaches.	[Gunnarsson, Gunnar; Elmberg, Johan] Kristianstad Univ, Div Nat Sci, Kristianstad, Sweden; [Latorre-Margalef, Neus; Waldenstrom, Jonas] Linnaeus Univ, Sch Nat Sci, Sect Zoonot Ecol & Epidemiol, Kalmar, Sweden; [Hobson, Keith A.; Van Wilgenburg, Steven L.] Environm Canada, Wildlife & Landscape Sci, Saskatoon, SK, Canada; [Olsen, Bjorn] Univ Uppsala Hosp, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden; [Fouchier, Ron A. M.] Erasmus MC, Dept Virol, Rotterdam, Netherlands	Kristianstad University; Linnaeus University; Environment & Climate Change Canada; Uppsala University; Uppsala University Hospital; Erasmus University Rotterdam; Erasmus MC	Gunnarsson, G (corresponding author), Kristianstad Univ, Div Nat Sci, Kristianstad, Sweden.	gunnar.gunnarsson@hkr.se	Hobson, Keith/Q-9306-2019; Elmberg, Johan/H-1868-2014; Gunnarsson, Gunnar/G-8458-2014; Waldenström, Jonas/E-4460-2013; Fouchier, Ron A/A-1911-2014	Gunnarsson, Gunnar/0000-0003-2345-3953; Waldenström, Jonas/0000-0002-1152-4235; Fouchier, Ron A/0000-0001-8095-2869; Olsen, Bjorn/0000-0002-4646-691X; Van Wilgenburg, Steven/0000-0002-6742-4567	Swedish Research Council Formas [2009-1220]; Swedish Environmental Protection Agency [09-210]; National Institute of Allergy and Infectious Diseases/National Institutes of Health, United States [HHSN266200700010C]	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish Environmental Protection Agency; National Institute of Allergy and Infectious Diseases/National Institutes of Health, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded by the Swedish Research Council Formas (grant 2009-1220 to BO), the Swedish Environmental Protection Agency (grant 09-210 to JE), and the National Institute of Allergy and Infectious Diseases/National Institutes of Health, United States (contract HHSN266200700010C to RAMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 1990, BIRD MIGRATION; Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; Bakken V., 2003, NORWEGIAN BIRD RINGI; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Brochet AL, 2009, ECOHEALTH, V6, P449, DOI 10.1007/s10393-010-0275-4; Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Capua I, 2002, ACTA TROP, V83, P7, DOI 10.1016/S0001-706X(02)00057-8; Capua I, 2007, INFLUENZA OTHER RESP, V1, P11, DOI 10.1111/j.1750-2659.2006.00004.x; Chamberlain CP, 1997, OECOLOGIA, V109, P132, DOI 10.1007/s004420050067; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Clark RG, 2006, CAN J ZOOL, V84, P1395, DOI 10.1139/Z06-135; Clark RG, 2009, CAN J ZOOL, V87, P553, DOI 10.1139/Z09-059; Costa TP, 2010, AVIAN DIS, V54, P581, DOI 10.1637/8692-031309-ResNote.1; Cramp S, 1977, BIRDS W PALEARCTIC C; Daoust PY, 2011, J WILDLIFE DIS, V47, P401, DOI 10.7589/0090-3558-47.2.401; Fereidouni SR, 2010, AVIAN DIS, V54, P79, DOI 10.1637/9005-073109-Reg.1; Fereidouni SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006706; Fisher N., 1995, STAT ANAL CIRCULAR D; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Globig A, 2009, EMERG INFECT DIS, V15, P1633, DOI 10.3201/eid1510.090439; Guillemain M, 2005, IBIS, V147, P688, DOI 10.1111/j.1474-919X.2005.00446.x; Hirschfeld Axel, 2005, Berichte zum Vogelschutz, V42, P47; Hobson KA, 2008, TERR ECOL SER, V2, P1; Hobson KA, 1997, OECOLOGIA, V109, P142, DOI 10.1007/s004420050068; Hobson KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007915; Hoye BJ, 2012, P ROY SOC B-BIOL SCI, V279, P529, DOI 10.1098/rspb.2011.0958; Hoye BJ, 2011, OIKOS, V120, P748, DOI 10.1111/j.1600-0706.2010.18961.x; Jahangir A, 2008, AVIAN DIS, V52, P49, DOI 10.1637/8035-062507-Reg; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Kleijn D, 2010, P ROY SOC B-BIOL SCI, V277, P2041, DOI 10.1098/rspb.2010.0026; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Lebarbenchon C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026566; Lebarbenchon C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007289; Marra PP, 2004, BIOSCIENCE, V54, P393, DOI 10.1641/0006-3568(2004)054[0393:WNVAW]2.0.CO;2; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Newton I., 2010, BIRD MIGRATION; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pettersson J, 2001, SVENSK RINGMARKNINGS; Prochazka P, 2011, J AVIAN BIOL, V42, P103, DOI 10.1111/j.1600-048X.2010.05161.x; Prosser DJ, 2009, IBIS, V151, P568, DOI 10.1111/j.1474-919X.2009.00932.x; Reperant LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000854; Scott D.A., 1996, ATLAS ANATIDAE POPUL; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Sorensen T, 1948, K DAN VIDENSK SELSK, V5, P1, DOI DOI 10.1234/12345678; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Stallknecht DE, 2010, AVIAN DIS, V54, P461, DOI 10.1637/8760-033109-Reg.1; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; SUSS J, 1994, ARCH VIROL, V135, P101, DOI 10.1007/BF01309768; van Gils JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000184; Van Noordwijk, 2001, EURING EXCHANGE CODE; Van Wilgenburg SL, 2011, ECOL APPL, V21, P1340, DOI 10.1890/09-2047.1; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Wassenaar LI, 2006, RAPID COMMUN MASS SP, V20, P2505, DOI 10.1002/rcm.2626; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Wunder MB, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P251, DOI 10.1007/978-90-481-3354-3_12; Yohannes E, 2008, OECOLOGIA, V158, P299, DOI 10.1007/s00442-008-1138-3	60	46	46	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35679	10.1371/journal.pone.0035679	http://dx.doi.org/10.1371/journal.pone.0035679			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536424	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200096
J	Wang, W; Xiao, F; Zeng, XH; Yao, J; Ming, YC; Ding, JP				Wang, Wei; Xiao, Feng; Zeng, Xuhui; Yao, Jing; Ming Yuchi; Ding, Jiuping			Optimal Estimation of Ion-Channel Kinetics from Macroscopic Currents	PLOS ONE			English	Article							GENETIC-ALGORITHM	Markov modeling provides an effective approach for modeling ion channel kinetics. There are several search algorithms for global fitting of macroscopic or single-channel currents across different experimental conditions. Here we present a particle swarm optimization(PSO)-based approach which, when used in combination with golden section search (GSS), can fit macroscopic voltage responses with a high degree of accuracy (errors within 1%) and reasonable amount of calculation time (less than 10 hours for 20 free parameters) on a desktop computer. We also describe a method for initial value estimation of the model parameters, which appears to favor identification of global optimum and can further reduce the computational cost. The PSO-GSS algorithm is applicable for kinetic models of arbitrary topology and size and compatible with common stimulation protocols, which provides a convenient approach for establishing kinetic models at the macroscopic level.	[Wang, Wei; Yao, Jing; Ding, Jiuping] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Mol Biophys, Sch Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China; [Xiao, Feng; Ming Yuchi] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Image Proc & Intelligent Control, Sch Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China; [Zeng, Xuhui] Nanchang Univ, Inst Life Sci, Nanchang, Jiangxi, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Nanchang University	Ming, YC (corresponding author), Huazhong Univ Sci & Technol, Minist Educ, Key Lab Mol Biophys, Sch Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China.	m.yuchi@mail.hust.edu.cn; jpding@mail.hust.edu.cn	Yuchi, Ming/AHB-9595-2022	Yuchi, Ming/0000-0003-1506-0631	National Basic Research Program of China [2010CB529804, 2011CB933103]; National Science Foundation of China [30971179, 31170814, 31028006, 31070767, 31171116, 61001141]; Research Fund for the Doctoral Program of Higher Education of China [20090142120091]; Fundamental Research Funds for the Central Universities', HUST [2010ZD028, 2010MS038, 2010QN050, 2011TS086]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities', HUST(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the National Basic Research Program of China (2010CB529804, 2011CB933103), the National Science Foundation of China (30971179, 31170814, 31028006, 31070767, 31171116, 61001141), the Research Fund for the Doctoral Program of Higher Education of China (20090142120091) and the Fundamental Research Funds for the Central Universities', HUST (2010ZD028, 2010MS038, 2010QN050, 2011TS086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COELLO CAC, 2000, INT J SMART ENG SYST, V2, P299; Colquhoun D, 2004, BIOPHYS J, V86, P3510, DOI 10.1529/biophysj.103.038679; Cox DH, 1997, J GEN PHYSIOL, V110, P257, DOI 10.1085/jgp.110.3.257; Gurkiewicz M, 2007, PLOS COMPUT BIOL, V3, P1633, DOI 10.1371/journal.pcbi.0030169; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Horrigan FT, 1999, J GEN PHYSIOL, V114, P277, DOI 10.1085/jgp.114.2.277; Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968; Kewley RH, 2002, IEEE T SYST MAN CY C, V32, P161, DOI 10.1109/TSMCC.2002.801352; KIEFER J, 1953, P AM MATH SOC, V4, P502, DOI 10.2307/2032161; Lo CC, 2000, IEEE T SYST MAN CY B, V30, P461, DOI 10.1109/3477.846234; Lovbjerg M., 2001, P GEN EV COMP C GECC; Milescu LS, 2005, BIOPHYS J, V88, P2494, DOI 10.1529/biophysj.104.053256; Miller J. F., 2000, GENET PROGRAM EVOLVA, V1, P8, DOI DOI 10.1023/A:1010016313373; Qin F, 2000, BIOPHYS J, V79, P1915, DOI 10.1016/S0006-3495(00)76441-1; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Sakmann B, 1995, SINGLE CHANNEL RECOR, P589; Shi YH, 1998, IEEE C EVOL COMPUTAT, P69, DOI 10.1109/ICEC.1998.699146; Sun L, 2009, BIOPHYS J, V97, P1832, DOI 10.1016/j.bpj.2009.06.042; Wang L, 1997, J PARALLEL DISTR COM, V47, P8, DOI 10.1006/jpdc.1997.1392; Xia XM, 2000, J NEUROSCI, V20, P4890; Xunxue Cui, 2004, Fifth World Congress on Intelligent Control and Automation (IEEE Cat. No.04EX788), P2117; Zhao XC, 2010, APPL SOFT COMPUT, V10, P119, DOI 10.1016/j.asoc.2009.06.010; Zhou XX, 1999, IEE P-GENER TRANSM D, V146, P301, DOI 10.1049/ip-gtd:19990047	23	9	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35208	10.1371/journal.pone.0035208	http://dx.doi.org/10.1371/journal.pone.0035208			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536358	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200044
J	Mo, JY; Boyle, JP; Howard, CB; Monie, TP; Davis, BK; Duncan, JA				Mo, Jinyao; Boyle, Joseph P.; Howard, Christopher B.; Monie, Tom P.; Davis, Beckley K.; Duncan, Joseph A.			Pathogen Sensing by Nucleotide-binding Oligomerization Domain-containing Protein 2 (NOD2) Is Mediated by Direct Binding to Muramyl Dipeptide and ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROHNS-DISEASE; CRITICAL RESIDUES; HOST RECOGNITION; CARD15 MUTATIONS; FAMILY; PEPTIDOGLYCAN; INNATE; GENE; RECRUITMENT; ACTIVATION	Nucleotide binding and oligomerization domain-containing protein 2 (NOD2/Card15) is an intracellular protein that is involved in the recognition of bacterial cell wall-derived muramyl dipeptide. Mutations in the gene encoding NOD2 are associated with inherited inflammatory disorders, including Crohn disease and Blau syndrome. NOD2 is a member of the nucleotide-binding domain and leucine-rich repeat-containing protein gene (NLR) family. Nucleotide binding is thought to play a critical role in signaling by NLR family members. However, the molecular mechanisms underlying signal transduction by these proteins remain largely unknown. Mutations in the nucleotide-binding domain of NOD2 have been shown to alter its signal transduction properties in response to muramyl dipeptide in cellular assays. Using purified recombinant protein, we now demonstrate that NOD2 binds and hydrolyzes ATP. Additionally, we have found that the purified recombinant protein is able to bind directly to muramyl dipeptide and can associate with known NOD2-interacting proteins in vitro. Binding of NOD2 to muramyl dipeptide and homo-oligomerization of NOD2 are enhanced by ATP binding, suggesting a model of the molecular mechanism for signal transduction that involves binding of nucleotide followed by binding of muramyl dipeptide and oligomerization of NOD2 into a signaling complex. These findings set the stage for further studies into the molecular mechanisms that underlie detection of muramyl dipeptide and assembly of NOD2-containing signaling complexes.	[Davis, Beckley K.; Duncan, Joseph A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Mo, Jinyao; Duncan, Joseph A.] Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC 27599 USA; [Boyle, Joseph P.; Howard, Christopher B.; Monie, Tom P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Duncan, Joseph A.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Cambridge; University of North Carolina; University of North Carolina Chapel Hill	Davis, BK (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	Beckley.davis@fandm.edu; jaduncan@med.unc.edu	Howard, Christopher/D-3859-2017	Howard, Christopher/0000-0001-9797-8686; Monie, Tom/0000-0003-4097-1680	National Institutes of Health [CA131645, AI088255]; Burroughs Wellcome Fund Career Award for Medical Scientists; Crohn's and Colitis Foundation Career Development Award; Franklin and Marshall College; Wellcome Trust [WT0805090MA]; Biotechnology and Biological Sciences Research Council [RG52820]; NATIONAL CANCER INSTITUTE [R21CA131645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); Crohn's and Colitis Foundation Career Development Award; Franklin and Marshall College; Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants CA131645 (to B. K. D. and J. A. D.) and AI088255 (to J. A. D.). This work was supported by the Burroughs Wellcome Fund Career Award for Medical Scientists (to J. A. D.), the Crohn's and Colitis Foundation Career Development Award and Franklin and Marshall College (to B. K. D.), Wellcome Trust Grant WT0805090MA (to T. P. M.), and Biotechnology and Biological Sciences Research Council Grant RG52820 (to T. P. M.).	Albrecht M, 2003, BIOINFORMATICS, V19, P2171, DOI 10.1093/bioinformatics/btg370; Albrecht M, 2003, FEBS LETT, V554, P520, DOI 10.1016/S0014-5793(03)01222-5; Askari N, 2012, J BIOTECHNOL, V157, P75, DOI 10.1016/j.jbiotec.2011.10.007; Bewry NN, 2007, J BIOL CHEM, V282, P26178, DOI 10.1074/jbc.M611747200; Bonen DK, 2003, GASTROENTEROLOGY, V124, P140, DOI 10.1053/gast.2003.50019; BRANDT DR, 1983, BIOCHEMISTRY-US, V22, P4357, DOI 10.1021/bi00288a002; Chamaillard M, 2003, P NATL ACAD SCI USA, V100, P3455, DOI 10.1073/pnas.0530276100; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chen DQ, 2005, J BIOL CHEM, V280, P22425, DOI 10.1074/jbc.M413380200; Chen DQ, 2004, BIOCHEMISTRY-US, V43, P11796, DOI 10.1021/bi0490789; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2005, J BIOL CHEM, V280, P38648, DOI 10.1074/jbc.M509537200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Harton JA, 1999, SCIENCE, V285, P1402, DOI 10.1126/science.285.5432.1402; Harton JA, 2002, J IMMUNOL, V169, P4088, DOI 10.4049/jimmunol.169.8.4088; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Homer CR, 2010, GASTROENTEROLOGY, V139, P1630, DOI 10.1053/j.gastro.2010.07.006; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2002, CURR OPIN MICROBIOL, V5, P76, DOI 10.1016/S1369-5274(02)00289-8; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Kersse K, 2011, J BIOL CHEM, V286, P35874, DOI 10.1074/jbc.M111.242321; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kufer TA, 2006, INFECT IMMUN, V74, P3115, DOI 10.1128/IAI.00035-06; Laroui H, 2011, J BIOL CHEM, V286, P31003, DOI 10.1074/jbc.M111.257501; LeBlanc PM, 2008, CELL HOST MICROBE, V3, P146, DOI 10.1016/j.chom.2008.02.004; Lu CF, 2005, BIOCHEM BIOPH RES CO, V331, P1114, DOI 10.1016/j.bbrc.2005.04.027; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Marinis JM, 2011, J BIOL CHEM, V286, P1938, DOI 10.1074/jbc.M110.189308; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; NORTHUP JK, 1982, J BIOL CHEM, V257, P1416; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Sansom FM, 2008, MICROBIOL MOL BIOL R, V72, P765, DOI 10.1128/MMBR.00013-08; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Tameling WIL, 2002, PLANT CELL, V14, P2929, DOI 10.1105/tpc.005793; Tameling WIL, 2006, PLANT PHYSIOL, V140, P1233, DOI 10.1104/pp.105.073510; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; TRAUT TW, 1994, EUR J BIOCHEM, V222, P9, DOI 10.1111/j.1432-1033.1994.tb18835.x; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; von Kampen O, 2010, J BIOL CHEM, V285, P19921, DOI 10.1074/jbc.M110.127480; Wagner RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004931; Wang XJ, 2002, ARTHRITIS RHEUM, V46, P3041, DOI 10.1002/art.10618; Ye ZM, 2008, MOL CELL BIOL, V28, P1841, DOI 10.1128/MCB.01468-07; Zhao Y, 2012, INFLAMM BOWEL DIS, V18, P603, DOI 10.1002/ibd.21851; Zurek B, 2012, INNATE IMMUN-LONDON, V18, P100, DOI 10.1177/1753425910394002	54	123	126	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23057	23067		10.1074/jbc.M112.344283	http://dx.doi.org/10.1074/jbc.M112.344283			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22549783	Green Published, hybrid			2022-12-25	WOS:000306495000062
J	Becker, GL; Lu, YH; Hardes, K; Strehlow, B; Levesque, C; Lindberg, I; Sandvig, K; Bakowsky, U; Day, R; Garten, W; Steinmetzer, T				Becker, Gero L.; Lu, Yinghui; Hardes, Kornelia; Strehlow, Boris; Levesque, Christine; Lindberg, Iris; Sandvig, Kirsten; Bakowsky, Udo; Day, Robert; Garten, Wolfgang; Steinmetzer, Torsten			Highly Potent Inhibitors of Proprotein Convertase Furin as Potential Drugs for Treatment of Infectious Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZA-VIRUS HEMAGGLUTININ; SUBTILISIN-LIKE ENDOPROTEASE; SHIGA TOXIN; D-ARGININE; ALPHA-CHYMOTRYPSIN; PROCESSING ENZYME; CRYSTAL-STRUCTURE; INDUCED CLEAVAGE; IN-VIVO; ACTIVATION	Optimization of our previously described peptidomimetic furin inhibitors was performed and yielded several analogs with a significantly improved activity. The most potent compounds containing an N-terminal 4- or 3-(guanidinomethyl) phenylacetyl residue inhibit furin with K-i values of 16 and 8 pM, respectively. These analogs inhibit other proprotein convertases, such as PC1/3, PC4, PACE4, and PC5/6, with similar potency, whereas PC2, PC7, and trypsin-like serine proteases are poorly affected. Incubation of selected compounds with Madin-Darby canine kidney cells over a period of 96 h revealed that they exhibit great stability, making them suitable candidates for further studies in cell culture. Two of the most potent derivatives were used to inhibit the hemagglutinin cleavage and viral propagation of a highly pathogenic avian H7N1 influenza virus strain. The treatment with inhibitor 24 (4-(guanidinomethyl)phenylacetyl-Arg-Val-Arg-4-amidinobenzylamide) resulted in significantly delayed virus propagation compared with an inhibitor-free control. The same analog was also effective in inhibiting Shiga toxin activation in HEp-2 cells. This antiviral effect, as well as the protective effect against a bacterial toxin, suggests that inhibitors of furin or furin-like proprotein convertases could represent promising lead structures for future drug development, in particular for the treatment of infectious diseases.	[Becker, Gero L.; Hardes, Kornelia; Steinmetzer, Torsten] Univ Marburg, Inst Pharmaceut Chem, D-35032 Marburg, Germany; [Lu, Yinghui; Garten, Wolfgang] Univ Marburg, Inst Virol, D-35032 Marburg, Germany; [Strehlow, Boris; Bakowsky, Udo] Univ Marburg, Inst Pharmaceut Technol & Biopharm, D-35032 Marburg, Germany; [Levesque, Christine; Day, Robert] Univ Sherbrooke, Inst Pharmacol Sherbrooke, Sherbrooke, PQ J1H SN4, Canada; [Lindberg, Iris] Univ Maryland, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Sandvig, Kirsten] Norwegian Radium Hosp, Inst Canc Res, Dept Biochem, N-0310 Oslo, Norway; [Sandvig, Kirsten] Norwegian Radium Hosp, Inst Canc Res, Ctr Canc Biomed, N-0310 Oslo, Norway	Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; University of Sherbrooke; University System of Maryland; University of Maryland Baltimore; University of Oslo; University of Oslo	Steinmetzer, T (corresponding author), Univ Marburg, Inst Pharmaceut Chem, Marbacher Weg 6, D-35032 Marburg, Germany.	steinmetzer@staff.uni-marburg.de	Lindberg, Iris/Q-3825-2019	Bakowsky, Udo/0000-0002-3895-0453	National Institutes of Health Grant [DA05084]; Ministere du Developpement Economique, Innovation et Exportation; Canadian Institutes of Health Research; Landesoffensive zur Entwicklung Wissenschaftlich-Okonomischer Exzellenz des Landes Hessen; Roland and Elfriede Schauer-Stiftung; FAZIT-Stiftung; Fonds de Recherche du Quebec-Sante studentship; Deutsche Forschungsgemeinschaft [SFB 593]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA005084, R56DA005084] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministere du Developpement Economique, Innovation et Exportation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Landesoffensive zur Entwicklung Wissenschaftlich-Okonomischer Exzellenz des Landes Hessen; Roland and Elfriede Schauer-Stiftung; FAZIT-Stiftung; Fonds de Recherche du Quebec-Sante studentship; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Institutes of Health Grant DA05084 (to I. L.). This work was supported in part by the Ministere du Developpement Economique, Innovation et Exportation, and Canadian Institutes of Health Research (to R. D.).; Supported by the Landesoffensive zur Entwicklung Wissenschaftlich-Okonomischer Exzellenz des Landes Hessen, the Roland and Elfriede Schauer-Stiftung, and the FAZIT-Stiftung.; Supported by Fonds de Recherche du Quebec-Sante studentship.; Supported by Deutsche Forschungsgemeinschaft SFB 593.	ANGLIKER H, 1995, J MED CHEM, V38, P4014, DOI 10.1021/jm00020a016; Bakowsky H, 2008, BBA-BIOMEMBRANES, V1778, P242, DOI 10.1016/j.bbamem.2007.09.033; Basak A, 2005, J MOL MED, V83, P844, DOI 10.1007/s00109-005-0710-0; Basak A, 2003, BIOCHEM J, V373, P231, DOI 10.1042/BJ20030120; Basak A, 2010, CURR MED CHEM, V17, P2214, DOI 10.2174/092986710791331040; Becker GL, 2011, BIOORG MED CHEM LETT, V21, P4695, DOI 10.1016/j.bmcl.2011.06.091; Becker GL, 2010, J MED CHEM, V53, P1067, DOI 10.1021/jm9012455; BENDER ML, 1966, J AM CHEM SOC, V88, P5890, DOI 10.1021/ja00976a034; BERNATOWICZ MS, 1992, J ORG CHEM, V57, P2497, DOI 10.1021/jo00034a059; Bottcher-Friebertshauser E, 2010, J VIROL, V84, P5605, DOI 10.1128/JVI.00140-10; BRAUN PJ, 1988, BIOCHEMISTRY-US, V27, P6517, DOI 10.1021/bi00417a048; BRAVO DA, 1994, J BIOL CHEM, V269, P25830; Cameron A, 2000, J BIOL CHEM, V275, P36741, DOI 10.1074/jbc.M003848200; Chretien M, 2008, EXPERT OPIN THER TAR, V12, P1289, DOI 10.1517/14728222.12.10.1289 ; DANG QD, 1994, J PROTEIN CHEM, V13, P367, DOI 10.1007/BF01901692; De Vos L, 2008, INT J ONCOL, V32, P1073; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Fugere M, 2005, TRENDS PHARMACOL SCI, V26, P294, DOI 10.1016/j.tips.2005.04.006; FULLER RS, 1989, SCIENCE, V246, P482, DOI 10.1126/science.2683070; Futaki S, 2001, BIOCONJUGATE CHEM, V12, P1005, DOI 10.1021/bc015508l; GARRED O, 1995, J BIOL CHEM, V270, P10817; GARRED O, 1995, EXP CELL RES, V218, P39, DOI 10.1006/excr.1995.1128; GARTEN W, 1989, VIROLOGY, V172, P25, DOI 10.1016/0042-6822(89)90103-7; GARTEN W, 1994, BIOCHIMIE, V76, P217, DOI 10.1016/0300-9084(94)90149-X; Garten Wolfgang, 2008, V27, P156; GU ML, 1995, FEBS LETT, V365, P95, DOI 10.1016/0014-5793(95)00447-H; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; Henrich S, 2005, J MOL BIOL, V345, P211, DOI 10.1016/j.jmb.2004.10.050; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Holyoak T, 2003, BIOCHEMISTRY-US, V42, P6709, DOI 10.1021/bi034434t; JAMESON GW, 1973, BIOCHEM J, V131, P107, DOI 10.1042/bj1310107; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; Jiao GS, 2006, P NATL ACAD SCI USA, V103, P19707, DOI 10.1073/pnas.0606555104; Kacprzak MM, 2004, J BIOL CHEM, V279, P36788, DOI 10.1074/jbc.M400484200; Katayama S, 2011, J CONTROL RELEASE, V149, P29, DOI 10.1016/j.jconrel.2010.02.004; Komiyama T, 2000, BIOCHEMISTRY-US, V39, P15156, DOI 10.1021/bi001907c; Komiyama T, 2009, J BIOL CHEM, V284, P15729, DOI 10.1074/jbc.M901540200; Kuester M, 2011, BIOL CHEM, V392, P973, DOI 10.1515/BC.2011.100; Kurmanova A, 2007, BIOCHEM BIOPH RES CO, V357, P144, DOI 10.1016/j.bbrc.2007.03.110; Lahlil R, 2009, RECENT PAT ANTI-CANC, V4, P83, DOI 10.2174/157489209787002470; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Matsubara T, 2009, J MED CHEM, V52, P4247, DOI 10.1021/jm801570y; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Plaimauer B, 2001, BIOCHEM J, V354, P689, DOI 10.1042/0264-6021:3540689; Remacle AG, 2008, J BIOL CHEM, V283, P20897, DOI 10.1074/jbc.M803762200; Rockwell NC, 2002, CHEM REV, V102, P4525, DOI 10.1021/cr010168i; ROEBROEK AJM, 1986, EMBO J, V5, P2197, DOI 10.1002/j.1460-2075.1986.tb04484.x; Roebroek AJM, 2004, J BIOL CHEM, V279, P53442, DOI 10.1074/jbc.M407152200; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; RYDEL TJ, 1991, J MOL BIOL, V221, P583, DOI 10.1016/0022-2836(91)80074-5; Sandvig K, 2010, FEBS LETT, V584, P2626, DOI 10.1016/j.febslet.2010.04.008; Sarac MS, 2004, INFECT IMMUN, V72, P602, DOI 10.1128/IAI.72.1.602-605.2004; Sarac MS, 2002, INFECT IMMUN, V70, P7136, DOI 10.1128/IAI.70.12.7136-7139.2002; SCHAFER W, 1995, EMBO J, V14, P2424, DOI 10.1002/j.1460-2075.1995.tb07240.x; Schweinitz A, 2004, J BIOL CHEM, V279, P33613, DOI 10.1074/jbc.M314151200; Seidah NG, 2011, ANN NY ACAD SCI, V1220, P149, DOI 10.1111/j.1749-6632.2010.05883.x; Sielaff F, 2011, BIOORG MED CHEM LETT, V21, P836, DOI 10.1016/j.bmcl.2010.11.092; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; STIENEKEGROBER A, 1992, EMBO J, V11, P2407, DOI 10.1002/j.1460-2075.1992.tb05305.x; STONE SR, 1986, BIOCHEMISTRY-US, V25, P4622, DOI 10.1021/bi00364a025; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Tian S, 2011, INT J MOL SCI, V12, P1060, DOI 10.3390/ijms12021060; Tonges L, 2006, RNA, V12, P1431, DOI 10.1261/rna.2252206; VANDEVEN WJM, 1990, MOL BIOL REP, V14, P265, DOI 10.1007/BF00429896; Volchkov VE, 2000, VIROLOGY, V268, P1, DOI 10.1006/viro.1999.0110; Wheatley JL, 2007, P NATL ACAD SCI USA, V104, P6626, DOI 10.1073/pnas.0701983104; Williams J W, 1979, Methods Enzymol, V63, P437	68	78	84	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21992	22003		10.1074/jbc.M111.332643	http://dx.doi.org/10.1074/jbc.M111.332643			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22539349	hybrid, Green Published			2022-12-25	WOS:000306418600038
J	McDaniel, FK; Molden, BM; Mohammad, S; Baldini, G; McPike, L; Narducci, P; Granell, S; Baldini, G				McDaniel, Faith K.; Molden, Brent M.; Mohammad, Sameer; Baldini, Giovanna; McPike, Lakisha; Narducci, Paola; Granell, Susana; Baldini, Giulia			Constitutive Cholesterol-dependent Endocytosis of Melanocortin-4 Receptor (MC4R) Is Essential to Maintain Receptor Responsiveness to alpha-Melanocyte-stimulating Hormone (alpha-MSH)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; INVERSE AGONIST; BETA-ARRESTIN; THROMBIN RECEPTORS; CELL-SURFACE; FOOD-INTAKE; INTERNALIZATION; TRAFFICKING; ADAPTER; OBESITY	Melanocortin-4 receptor (MC4R) is a G-protein-coupled receptor expressed in the hypothalamus where it controls feeding behavior. MC4R cycles constitutively and is internalized at the same rate in the presence or absence of stimulation by the agonist, melanocyte-stimulating hormone (alpha-MSH). This is different from other G-protein-coupled receptors, such as beta(2)-adrenergic receptor (beta(2)AR), which internalizes more rapidly in response to agonist stimulation. Here, it is found that in immortalized neuronal Neuro2A cells expressing exogenous receptors, constitutive endocytosis of MC4R and agonist-dependent internalization of beta(2)AR were equally sensitive to clathrin depletion. Inhibition of MC4R endocytosis by clathrin depletion decreased the number of receptors at the cell surface that were responsive to the agonist, alpha-MSH, by 75%. Mild membrane cholesterol depletion also inhibited constitutive endocytosis of MC4R by similar to 5-fold, while not affecting recycling of MC4R or agonist-dependent internalization of beta(2)AR. Reduced cholesterol did not change the MC4R dose-response curve to alpha-MSH, but it decreased the amount of cAMP generated per receptor number indicating that a population of MC4R at the cell surface becomes nonfunctional. The loss of MC4R function increased over time (25-50%) and was partially reversed by mutations at putative phosphorylation sites (T312A and S329A). This was reproduced in hypothalamic GT1-7 cells expressing endogenous MC4R. The data indicate that constitutive endocytosis of MC4R is clathrin- and cholesterol-dependent. MC4R endocytosis is required to maintain MC4R responsiveness to alpha-MSH by constantly eliminating from the plasma membrane a pool of receptors modified at Thr-312 and Ser-329 that have to be cycled to the endosomal compartment to regain function.	[McDaniel, Faith K.; Molden, Brent M.; Mohammad, Sameer; McPike, Lakisha; Granell, Susana; Baldini, Giulia] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Baldini, Giovanna; Narducci, Paola] Univ Trieste, Dipartimento Univ Clin Biomed, I-34100 Trieste, Italy	University of Arkansas System; University of Arkansas Medical Sciences; University of Trieste	Granell, S (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	SGranell@uams.edu; gbaldini@uams.edu	Mohammad, Sameer/GWV-2875-2022; granell, susana/H-2734-2012		National Institutes of Health [R01-DK080424]; National Center for Research Resources [UL1RR029884]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080424] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK080424 (to G. B.) and by Grant UL1RR029884 from the National Center for Research Resources (to the University of Arkansas for Medical Sciences Translational Research Institute).	Antonescu CN, 2008, TRAFFIC, V9, P1173, DOI 10.1111/j.1600-0854.2008.00755.x; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Baratti-Elbaz C, 1999, MOL ENDOCRINOL, V13, P1751, DOI 10.1210/me.13.10.1751; Bohn LM, 2007, MOL PHARMACOL, V71, P957, DOI 10.1124/mol.107.034223; Breit A, 2006, J BIOL CHEM, V281, P37447, DOI 10.1074/jbc.M605982200; Buch TRH, 2009, J BIOL CHEM, V284, P26411, DOI 10.1074/jbc.M109.039339; Burtey A, 2007, TRAFFIC, V8, P914, DOI 10.1111/j.1600-0854.2007.00578.x; Collin G, 2007, MOL CELL BIOL, V27, P7631, DOI 10.1128/MCB.00543-07; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cossec JC, 2010, BBA-MOL CELL BIOL L, V1801, P846, DOI 10.1016/j.bbalip.2010.05.010; Dalvi PS, 2011, AM J PHYSIOL-REG I, V300, pR1030, DOI 10.1152/ajpregu.00649.2010; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Dugast M, 2005, J BIOL CHEM, V280, P19656, DOI 10.1074/jbc.M501357200; Dumont LM, 2001, MOL CELL ENDOCRINOL, V184, P173, DOI 10.1016/S0303-7207(01)00558-5; Edeling MA, 2006, DEV CELL, V10, P329, DOI 10.1016/j.devcel.2006.01.016; Fan T, 2000, ENDOCRINOLOGY, V141, P3072; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Ferguson Stephen S. G., 2003, V237, P121; Gao ZH, 2003, J PHARMACOL EXP THER, V307, P870, DOI 10.1124/jpet.103.055525; Ge L, 2008, CELL METAB, V7, P508, DOI 10.1016/j.cmet.2008.04.001; Granell S, 2010, MOL ENDOCRINOL, V24, P1805, DOI 10.1210/me.2010-0071; Haskell-Luevano C, 2001, REGUL PEPTIDES, V99, P1, DOI 10.1016/S0167-0115(01)00234-8; HEIN L, 1994, J BIOL CHEM, V269, P27719; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Kanzaki M, 2004, J BIOL CHEM, V279, P30622, DOI 10.1074/jbc.M401443200; Khong K, 2001, NEUROENDOCRINOLOGY, V74, P193, DOI 10.1159/000054686; Kim YM, 2002, J BIOL CHEM, V277, P16340, DOI 10.1074/jbc.M200678200; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Laporte SA, 2000, J BIOL CHEM, V275, P23120, DOI 10.1074/jbc.M002581200; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Laporte SA, 2002, J BIOL CHEM, V277, P9247, DOI 10.1074/jbc.M108490200; Leterrier C, 2006, J NEUROSCI, V26, P3141, DOI 10.1523/JNEUROSCI.5437-05.2006; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; Lubrano-Berthelier C, 2003, ANN NY ACAD SCI, V994, P49, DOI 10.1111/j.1749-6632.2003.tb03161.x; MANDERS EMM, 1992, J CELL SCI, V103, P857; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McDonald NA, 2007, MOL PHARMACOL, V71, P976, DOI 10.1124/mol.106.029348; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Mohammad S, 2007, J BIOL CHEM, V282, P4963, DOI [10.1074/jbc.m608283200, 10.1074/jbc.M608283200]; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Murphy B, 2000, J APPL PHYSIOL, V89, P273, DOI 10.1152/jappl.2000.89.1.273; Nickolls SA, 2005, J PHARMACOL EXP THER, V313, P1281, DOI 10.1124/jpet.105.083337; Nijenhuis WAJ, 2001, MOL ENDOCRINOL, V15, P164, DOI 10.1210/me.15.1.164; Overton JD, 2011, J BIOL CHEM, V286, P18914, DOI 10.1074/jbc.M111.224592; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Roseberry AG, 1999, J BIOL CHEM, V274, P33671, DOI 10.1074/jbc.274.47.33671; Rossi M, 1999, BRAIN RES, V846, P164, DOI 10.1016/S0006-8993(99)02005-3; Scarselli M, 2009, J BIOL CHEM, V284, P3577, DOI 10.1074/jbc.M806819200; Shapiro MJ, 1996, J BIOL CHEM, V271, P32874, DOI 10.1074/jbc.271.51.32874; Shinyama H, 2003, ENDOCRINOLOGY, V144, P1301, DOI 10.1210/en.2002-220931; Srinivasan S, 2004, J CLIN INVEST, V114, P1158, DOI 10.1172/JCI200421927; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Suzuki R, 2010, CELL METAB, V12, P567, DOI 10.1016/j.cmet.2010.11.006; Tao YX, 2010, ENDOCR REV, V31, P506, DOI 10.1210/er.2009-0037; Tao YX, 2003, ENDOCRINOLOGY, V144, P4544, DOI 10.1210/en.2003-0524; TeclemariamMesbah R, 1997, J HISTOCHEM CYTOCHEM, V45, P619, DOI 10.1177/002215549704500414; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Wang GY, 1997, J CELL SCI, V110, P505; Yu LQ, 2006, J BIOL CHEM, V281, P6616, DOI 10.1074/jbc.M511123200	62	20	20	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21873	21890		10.1074/jbc.M112.346890	http://dx.doi.org/10.1074/jbc.M112.346890			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22544740	Green Published, hybrid			2022-12-25	WOS:000306418600029
J	Wang, HL; Shao, ZP; Shi, LZ; Hwang, PYH; Truong, LN; Berns, MW; Chen, DJ; Wu, XH				Wang, Hailong; Shao, Zhengping; Shi, Linda Z.; Hwang, Patty Yi-Hwa; Truong, Lan N.; Berns, Michael W.; Chen, David J.; Wu, Xiaohua			CtIP Protein Dimerization Is Critical for Its Recruitment to Chromosomal DNA Double-stranded Breaks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; MRE11 COMPLEX; HOMOLOGOUS RECOMBINATION; END RESECTION; DAMAGE RESPONSE; COILED-COIL; REPAIR; TRANSLATION; SAE2; RNA	CtIP (CtBP-interacting protein) associates with BRCA1 and the Mre11-Rad50-Nbs1 (MRN) complex and plays an essential role in homologous recombination (HR)-mediated DNA double-stranded break (DSB) repair. It has been described that CtIP forms dimers in mammalian cells, but the biological significance is not clear. In this study, we identified a conserved motif in the the N terminus of CtIP, which is required for dimer formation. We further showed that CtIP mutants impaired in forming dimers are strongly defective in HR, end resection, and activation of the ataxia telangiectasia and Rad3-related pathway, without notable change of CtIP interactions with BRCA1 or Nbs1. In addition to HR, CtIP dimerization is also required for microhomology-mediated end joining. Live cell imaging of enhanced GFP-tagged CtIP demonstrates that the CtIP dimerization mutant fails to be localized to DSBs, whereas placing a heterologous dimerization motif to the dimerization mutant restores CtIP recruitment to DSBs. These studies suggest that CtIP dimer formation is essential for its recruitment to DSBs on chromatin upon DNA damage. Furthermore, DNA damage-induced phosphorylation of CtIP is significantly reduced in the CtIP dimerization mutants. Therefore, in addition to the C-terminal conserved domains critical for CtIP function, the dimerization motif on the N terminus of CtIP is also conserved and essential for its function in DNA damage responses. The severe repair defects of CtIP dimerization mutants are likely due to the failure in localization to chromosomal DSBs upon DNA damage.	[Wang, Hailong; Hwang, Patty Yi-Hwa; Truong, Lan N.; Wu, Xiaohua] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Shao, Zhengping; Chen, David J.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Div Mol Radiat Biol, Dallas, TX 75390 USA; [Shi, Linda Z.; Berns, Michael W.] Univ Calif San Diego, Inst Engn Med, La Jolla, CA 92093 USA	Scripps Research Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego	Wu, XH (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA.	xiaohwu@scripps.edu		Berns, Michael/0000-0002-9640-2885	National Institutes of Health [CA102361, GM080677, CA140972, CA102361-07S1, CA162804]; Beckman Laser Institute; Cancer Prevention Research Institute of Texas [RP110465]; NATIONAL CANCER INSTITUTE [R01CA162804, R01CA102361, R01CA140972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Laser Institute; Cancer Prevention Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA102361, GM080677, CA140972, and CA102361-07S1 (to X. W.) and CA162804 (to D. J. C.). This work was also supported by funds from the Beckman Laser Institute (to M. W. B.) and Cancer Prevention Research Institute of Texas Grant RP110465 (to D. J. C.).	Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Botvinick EL, 2005, MICROSC RES TECHNIQ, V68, P65, DOI 10.1002/jemt.20216; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Chinnadurai G, 2006, BBA-REV CANCER, V1765, P67, DOI 10.1016/j.bbcan.2005.09.002; Dinkelmann M, 2009, NAT STRUCT MOL BIOL, V16, P808, DOI 10.1038/nsmb.1639; Dubin MJ, 2004, J BIOL CHEM, V279, P26932, DOI 10.1074/jbc.M313974200; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; JACKSON RJ, 1990, TRENDS BIOCHEM SCI, V15, P477, DOI 10.1016/0968-0004(90)90302-R; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Kim HS, 2008, GENETICS, V178, P711, DOI 10.1534/genetics.107.081331; Li S, 2000, NATURE, V406, P210, DOI 10.1038/35018134; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Olson E, 2007, MOL CELL BIOL, V27, P6053, DOI 10.1128/MCB.00532-07; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Paull TT, 2010, DNA REPAIR, V9, P1283, DOI 10.1016/j.dnarep.2010.09.015; Paull TT, 2005, CELL CYCLE, V4, P737, DOI 10.4161/cc.4.6.1715; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Rass E, 2009, NAT STRUCT MOL BIOL, V16, P819, DOI 10.1038/nsmb.1641; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Somanathan S, 2001, J CELL BIOCHEM, V81, P56, DOI 10.1002/1097-4644(20010401)81:1<56::AID-JCB1023>3.0.CO;2-#; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Takeda S, 2007, MOL CELL, V28, P351, DOI 10.1016/j.molcel.2007.10.016; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; WILSON IA, 1985, P NATL ACAD SCI USA, V82, P5255, DOI 10.1073/pnas.82.16.5255; Xie AY, 2009, NAT STRUCT MOL BIOL, V16, P814, DOI 10.1038/nsmb.1640; You ZS, 2010, TRENDS CELL BIOL, V20, P402, DOI 10.1016/j.tcb.2010.04.002; You ZS, 2009, MOL CELL, V36, P954, DOI 10.1016/j.molcel.2009.12.002; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zgheib O, 2009, MOL CELL BIOL, V29, P1050, DOI 10.1128/MCB.01011-08	33	56	58	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21471	21480		10.1074/jbc.M112.355354	http://dx.doi.org/10.1074/jbc.M112.355354			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22544744	Green Published, hybrid			2022-12-25	WOS:000306416800064
J	Chen, Y; Xu, XQ; Liu, X; Yu, MQ; Liu, BF; Zhang, GS				Chen, Yin; Xu, Xiangqing; Liu, Xin; Yu, Minquan; Liu, Bi-Feng; Zhang, Guisen			Synthesis and Evaluation of a Series of 2-Substituted-5-Thiopropylpiperazine (Piperidine)-1,3,4-Oxadiazoles Derivatives as Atypical Antipsychotics	PLOS ONE			English	Article							INDUCED WEIGHT-GAIN; DOPAMINE D-3; ARYLPIPERAZINE DERIVATIVES; SEROTONIN RECEPTORS; 5-HT1A RECEPTORS; SCHIZOPHRENIA; DRUGS; LIGANDS; AGENTS; IDENTIFICATION	Background: It is important to develop novel antipsychotics that can effectively treat schizophrenia with minor side-effects. The aim of our work is to develop novel antipsychotics that act on dopamine D-2 and D-3, serotonin 5-HT1A and 5-HT2A receptors with low affinity for the serotonin 5-HT2C and H-1 receptors, which can effectively cure positive symptoms, negative symptoms and cognitive impairment without the weight gain side-effect. Methodology/Principal Findings: A series of 2-substituted-5-thiopropylpiperazine (piperidine) -1,3,4-oxadiazoles derivatives have been synthesized and the target compounds were evaluated for binding affinities to D-2, 5-HT1A and 5-HT2A receptors. Preliminary results indicated that compounds 14, 16 and 22 exhibited high affinities to D-2, 5-HT1A and 5-HT2A receptors among these compounds. Further binding tests showed that compound 22 had high affinity for D-3 receptor, and low affinity for serotonin 5-HT2C and H-1 receptors. In addition, compound 22 inhibited apomorphine-induced climbing behavior and MK-801-induced hyperactivity with no extrapyramidal symptoms liability in mice. Moreover, compound 22 exhibited acceptable pharmacokinetic properties. Conclusions/Significance: Compound 22 showed an atypical antipsychotic activity without liability for extrapyramidal symptoms. We anticipate compound 22 to be useful for developing a novel class of drug for the treatment of schizophrenia.	[Chen, Yin; Liu, Xin; Liu, Bi-Feng; Zhang, Guisen] Huazhong Univ Sci & Technol, Dept Syst Biol, Wuhan 430074, Peoples R China; [Xu, Xiangqing; Yu, Minquan; Zhang, Guisen] Jiangsu Nhwa Pharmaceut Co Ltd, Xuzhou, Jiangsu, Peoples R China	Huazhong University of Science & Technology	Chen, Y (corresponding author), Huazhong Univ Sci & Technol, Dept Syst Biol, Wuhan 430074, Peoples R China.	gszhang@mail.hust.edu.cn			Jiangsu Nhwa Pharmaceutical; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program'' [2012ZX09103-101-010]; Jiangsu Nhwa Pharmaceutical Co., Ltd.	Jiangsu Nhwa Pharmaceutical; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program''; Jiangsu Nhwa Pharmaceutical Co., Ltd.	This study was supported by Jiangsu Nhwa Pharmaceutical, who played a role in study design, data collection and analysis, decision to publish and preparation of the manuscript, and the National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program'' (2012ZX09103-101-010), who had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Jiangsu Nhwa Pharmaceutical Co., Ltd., who played a role in study design, data collection and analysis, decision to publish and preparation of the manuscript. Dr. Xu, Dr. Yu and Dr. Zhang are research staff of Jiangsu Nhwa Pharmaceutical Co., Ltd. Jiangsu Nhwa Pharmaceutical holds the patent of new compounds (patent number: CN201110082555.1) and developed those compounds. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Abdel-Aziz M, 2009, EUR J MED CHEM, V44, P3480, DOI 10.1016/j.ejmech.2009.01.032; Ablordeppey SY, 2008, BIOORGAN MED CHEM, V16, P7291, DOI 10.1016/j.bmc.2008.06.030; BALDESSARINI RJ, 1980, ANNU REV NEUROSCI, V3, P23, DOI 10.1146/annurev.ne.03.030180.000323; Bezard E, 2003, NAT MED, V9, P762, DOI 10.1038/nm875; BOYD AE, 1978, PSYCHONEUROENDOCRINO, V3, P113, DOI 10.1016/0306-4530(78)90001-X; Buckland PR, 2005, AM J PSYCHIAT, V162, P613, DOI 10.1176/appi.ajp.162.3.613; Butini S, 2009, J MED CHEM, V52, P151, DOI 10.1021/jm800689g; Campbell M, 1999, BRIT J CLIN PHARMACO, V47, P13, DOI 10.1046/j.1365-2125.1999.00849.x; Campiani G, 2004, J MED CHEM, V47, P143, DOI 10.1021/jm0309811; COSTALL B, 1978, EUR J PHARMACOL, V50, P39, DOI 10.1016/0014-2999(78)90251-0; DINI S, 1991, AGENTS ACTIONS, V33, P181, DOI 10.1007/BF01993161; Doria JS, 2011, BIOORGAN MED CHEM, V19, P5031; Frecentese F, 2010, EUR J MED CHEM, V45, P752, DOI 10.1016/j.ejmech.2009.11.023; Gaonkar SL, 2006, EUR J MED CHEM, V41, P841, DOI 10.1016/j.ejmech.2006.03.002; Garzya V, 2007, BIOORG MED CHEM LETT, V17, P400, DOI 10.1016/j.bmcl.2006.10.036; GLENNON RA, 1988, J MED CHEM, V31, P1968, DOI 10.1021/jm00118a018; Jones CA, 2008, NEUROPHARMACOLOGY, V55, P1056, DOI 10.1016/j.neuropharm.2008.05.025; Joshi S, 2002, SYNTHETIC COMMUN, V32, P111, DOI 10.1081/SCC-120001516; Khisti RT, 1998, NEUROSCI LETT, V251, P85, DOI 10.1016/S0304-3940(98)00479-0; Kim SF, 2007, P NATL ACAD SCI USA, V104, P3456, DOI 10.1073/pnas.0611417104; Kroeze WK, 2003, NEUROPSYCHOPHARMACOL, V28, P519, DOI 10.1038/sj.npp.1300027; LEWINE RRJ, 1983, SCHIZOPHRENIA BULL, V9, P368, DOI 10.1093/schbul/9.3.368; Li XR, 2010, J CHEM RES, P410, DOI 10.3184/030823410X12790364267642; Liu F, 2008, BIOORGAN MED CHEM, V16, P3632, DOI 10.1016/j.bmc.2008.02.006; LOWE JA, 1991, J MED CHEM, V34, P1860, DOI 10.1021/jm00110a016; MARDER SR, 1991, SCHIZOPHR RES, V4, P81, DOI 10.1016/0920-9964(91)90027-O; Meltzer HY, 2003, PROG NEURO-PSYCHOPH, V27, P1159, DOI 10.1016/j.pnpbp.2003.09.010; Meltzer HY, 2004, CNS SPECTRUMS, V9, P15, DOI 10.1017/S1092852900025098; Meltzer HY, 2004, CURR OPIN PHARMACOL, V4, P53, DOI 10.1016/j.coph.2003.09.010; MELTZER HY, 1989, J PHARMACOL EXP THER, V251, P238; Millan MJ, 2008, J PHARMACOL EXP THER, V324, P600, DOI 10.1124/jpet.107.132563; Millan MJ, 2000, J PHARMACOL EXP THER, V295, P853; Mission NAD, 1969, US3808223, Patent No. 3808223; Morphy R, 2009, CURR PHARM DESIGN, V15, P587, DOI 10.2174/138161209787315594; Neves G, 2010, BIOORGAN MED CHEM, V18, P1925, DOI 10.1016/j.bmc.2010.01.040; Obniska J, 2006, EUR J MED CHEM, V41, P874, DOI 10.1016/j.ejmech.2006.03.001; Ohno Yukihiro, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P148; Politis M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000976; Pramanik SS, 1998, J INDIAN CHEM SOC, V75, P53; Rao MEB, 2011, ASIAN J CHEM, V23, P2648; Reavill C, 1999, BRIT J PHARMACOL, V126, P572, DOI 10.1038/sj.bjp.0702350; Reynolds Gavin P, 2006, J Psychopharmacol, V20, P15, DOI 10.1177/1359786806066040; Roth BL, 2004, PSYCHOPHARMACOLOGY, V174, P17, DOI 10.1007/s00213-003-1683-8; Schultz SH, 2007, AM FAM PHYSICIAN, V75, P1821; Shapiro DA, 2003, NEUROPSYCHOPHARMACOL, V28, P1400, DOI 10.1038/sj.npp.1300203; Tamminga CA, 1997, CAN J PSYCHIAT, V42, P265, DOI 10.1177/070674379704200304; Turilli O., 1963, ANN CHIMICA, V53, P1687; Vohora D, 2007, CURR OPIN INVEST DR, V8, P531; Wong EHF, 2010, PHARMACOL THERAPEUT, V126, P173, DOI 10.1016/j.pharmthera.2010.02.001; Wood MD, 2001, NEUROPHARMACOLOGY, V41, P186, DOI 10.1016/S0028-3908(01)00054-5; Xiberas X, 2001, BRIT J PSYCHIAT, V179, P503, DOI 10.1192/bjp.179.6.503	51	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35186	10.1371/journal.pone.0035186	http://dx.doi.org/10.1371/journal.pone.0035186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558126	gold, Green Published, Green Submitted			2022-12-25	WOS:000305340200009
J	van Eerde, AM; Duran, K; van Riel, E; de Kovel, CGF; Koeleman, BPC; Knoers, NVAM; Renkema, KY; van der Horst, HJR; Bokenkamp, A; van Hagen, JM; van den Berg, LH; Wolffenbuttel, KP; van den Hoek, J; Feitz, WF; de Jong, TPVM; Giltay, JC; Wijmenga, C				van Eerde, Albertien M.; Duran, Karen; van Riel, Els; de Kovel, Carolien G. F.; Koeleman, Bobby P. C.; Knoers, Nine V. A. M.; Renkema, Kirsten Y.; van der Horst, Henricus J. R.; Bokenkamp, Arend; van Hagen, Johanna M.; van den Berg, Leonard H.; Wolffenbuttel, Katja P.; van den Hoek, Joop; Feitz, Wouter F.; de Jong, Tom P. V. M.; Giltay, Jacques C.; Wijmenga, Cisca			Genes in the Ureteric Budding Pathway: Association Study on Vesico-Ureteral Reflux Patients	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; KIDNEY BRANCHING MORPHOGENESIS; UROPLAKIN-III GENE; TRACT MALFORMATIONS; COMPLEX TRAITS; LINKAGE; MUTATIONS; DISEASE; ROBO2; POLYMORPHISM	Vesico-ureteral reflux (VUR) is the retrograde passage of urine from the bladder to the urinary tract and causes 8.5% of end-stage renal disease in children. It is a complex genetic developmental disorder, in which ectopic embryonal ureteric budding is implicated in the pathogenesis. VUR is part of the spectrum of Congenital Anomalies of the Kidney and Urinary Tract (CAKUT). We performed an extensive association study for primary VUR using a two-stage, case-control design, investigating 44 candidate genes in the ureteric budding pathway in 409 Dutch VUR patients. The 44 genes were selected from the literature and a set of 567 single nucleotide polymorphisms (SNPs) capturing their genetic variation was genotyped in 207 cases and 554 controls. The 14 SNPs with p<0.005 were included in a follow-up study in 202 cases and 892 controls. Of the total cohort, similar to 50% showed a clear-cut primary VUR phenotype and similar to 25% had both a duplex collecting system and VUR. We also looked for association in these two extreme phenotype groups. None of the SNPs reached a significant p-value. Common genetic variants in four genes (GREM1, EYA1, ROBO2 and UPK3A) show a trend towards association with the development of primary VUR (GREM1, EYA1, ROBO2) or duplex collecting system (EYA1 and UPK3A). SNPs in three genes (TGFB1, GNB3 and VEGFA) have been shown to be associated with VUR in other populations. Only the result of rs1800469 in TGFB1 hinted at association in our study. This is the first extensive study of common variants in the genes of the ureteric budding pathway and the genetic susceptibility to primary VUR.	[van Eerde, Albertien M.; Duran, Karen; van Riel, Els; de Kovel, Carolien G. F.; Koeleman, Bobby P. C.; Knoers, Nine V. A. M.; Renkema, Kirsten Y.; Giltay, Jacques C.; Wijmenga, Cisca] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [van der Horst, Henricus J. R.] Vrije Univ Amsterdam Med Ctr, Dept Pediat Urol, Amsterdam, Netherlands; [Bokenkamp, Arend] Vrije Univ Amsterdam Med Ctr, Dept Pediat Nephrol, Amsterdam, Netherlands; [van Hagen, Johanna M.] Vrije Univ Amsterdam Med Ctr, Dept Human Genet, Amsterdam, Netherlands; [van den Berg, Leonard H.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands; [Wolffenbuttel, Katja P.; van den Hoek, Joop] Erasmus MC, Sophia Childrens Hosp, Dept Pediat Urol, Rotterdam, Netherlands; [Feitz, Wouter F.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, Pediat Urol Ctr, NL-6525 ED Nijmegen, Netherlands; [de Jong, Tom P. V. M.] Univ Med Ctr Utrecht, Pediat Renal Ctr, Amsterdam, Netherlands; [de Jong, Tom P. V. M.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Wijmenga, Cisca] Univ Groningen, NL-9700 AB Groningen, Netherlands	Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; University of Groningen	van Eerde, AM (corresponding author), Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands.	a.vaneerde@umcutrecht.nl	Feitz, W.F.J./H-8028-2014; Wijmenga, Cisca/D-2173-2009; de Jong, Tom/AAG-5659-2020; Renkema, Kirsten Y./V-2385-2019; Wijmenga, Cisca/AAE-7719-2019; de Kovel, Carolien/AAI-3531-2021	Wijmenga, Cisca/0000-0002-5635-1614; de Kovel, Carolien/0000-0002-7818-1396; van Eerde, Albertien M./0000-0001-5953-5956; Renkema, Kirsten/0000-0003-3922-9382; de Jong, Tom P.V.M./0000-0002-9091-1099	Nuts-Ohra [0801-061]; Dutch Kidney Foundation [C02.2009]	Nuts-Ohra; Dutch Kidney Foundation	The study was supported by a grant from Nuts-Ohra (0801-061, http://www.fondsnutsohra.nl). Collecting of samples was partly supported by a grant from the Dutch Kidney Foundation (C02.2009, http://www.nierstichting.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhak S, 1997, NAT GENET, V15, P157, DOI 10.1038/ng0297-157; [Anonymous], 1996, LANCET, V348, P725; Bertoli-Avella AM, 2008, J AM SOC NEPHROL, V19, P825, DOI 10.1681/ASN.2007060692; Briggs CE, 2010, EUR J HUM GENET, V18, P245, DOI 10.1038/ejhg.2009.142; BURGER RH, 1972, J UROLOGY, V108, P249, DOI 10.1016/S0022-5347(17)60702-X; Chang EH, 2004, HUM MUTAT, V23, P582, DOI 10.1002/humu.20048; CHAPMAN CJ, 1985, AM J MED GENET, V20, P577, DOI 10.1002/ajmg.1320200403; Conte ML, 2008, PEDIATR NEPHROL, V23, P587, DOI 10.1007/s00467-007-0675-z; Cordell HJ, 2010, J AM SOC NEPHROL, V21, P113, DOI 10.1681/ASN.2009060624; Feather SA, 2000, AM J HUM GENET, V66, P1420, DOI 10.1086/302864; Giltay JC, 2004, J UROLOGY, V171, P931, DOI 10.1097/01.ju.0000094802.50650.3d; Grieshammer U, 2004, DEV CELL, V6, P709, DOI 10.1016/S1534-5807(04)00108-X; Hains DS, 2010, J UROLOGY, V183, P2077, DOI 10.1016/j.juro.2009.12.095; Hollowell JG, 2002, J UROLOGY, V168, P2138, DOI 10.1016/S0022-5347(05)64337-6; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Ichikawa I, 2002, KIDNEY INT, V61, P889, DOI 10.1046/j.1523-1755.2002.00188.x; Jenkins D, 2005, J AM SOC NEPHROL, V16, P2141, DOI 10.1681/ASN.2004090776; Jiang SS, 2004, KIDNEY INT, V66, P10, DOI 10.1111/j.1523-1755.2004.00703.x; Kaefer M, 2000, PEDIATRICS, V105, P800, DOI 10.1542/peds.105.4.800; Kelly H, 2007, J MED GENET, V44, P710, DOI 10.1136/jmg.2007.051086; Kelly H, 2005, EUR J HUM GENET, V13, P500, DOI 10.1038/sj.ejhg.5201322; Kuroda S, 2007, J UROLOGY, V178, P1650, DOI 10.1016/j.juro.2007.03.199; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Lu BC, 2009, NAT GENET, V41, P1295, DOI 10.1038/ng.476; Lu WN, 2007, AM J HUM GENET, V80, P616, DOI 10.1086/512735; MACKIE GG, 1975, J UROLOGY, V114, P274, DOI 10.1016/S0022-5347(17)67007-1; McCarthy MI, 2008, DIABETES, V57, P2889, DOI 10.2337/db08-0343; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Michos O, 2007, DEVELOPMENT, V134, P2397, DOI 10.1242/dev.02861; MIDDLETON GW, 1975, J UROLOGY, V114, P36, DOI 10.1016/S0022-5347(17)66937-4; Miklovicova D, 2005, PEDIATR NEPHROL, V20, P1136, DOI 10.1007/s00467-005-1896-7; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Murawski IJ, 2006, CLIN GENET, V69, P105, DOI 10.1111/j.1399-0004.2005.00562.x; Murawski IJ, 2008, PEDIATR NEPHROL, V23, P1021, DOI 10.1007/s00467-007-0704-y; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; NOE HN, 1992, J UROLOGY, V148, P1869, DOI 10.1016/S0022-5347(17)37053-2; NOE HN, 1992, J UROLOGY, V148, P1739, DOI 10.1016/S0022-5347(17)37017-9; Pasch A, 2004, NEPHROL DIAL TRANSPL, V19, P3172, DOI 10.1093/ndt/gfh514; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Sanna-Cherchi S, 2005, J AM SOC NEPHROL, V16, P1781, DOI 10.1681/ASN.2004121034; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Schonfelder EM, 2006, AM J KIDNEY DIS, V47, P1004, DOI 10.1053/j.ajkd.2006.02.177; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Schuchardt A, 1996, DEVELOPMENT, V122, P1919; Sims-Lucas S, 2009, AM J PHYSIOL-RENAL, V297, pF1208, DOI 10.1152/ajprenal.00262.2009; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Smith RJH, 2010, GENEREVIEWS     0323; Solari V, 2005, J UROLOGY, V174, P1609, DOI 10.1097/01.ju.0000179385.64585.dc; van der Zanden LFM, 2011, NAT GENET, V43, P48, DOI 10.1038/ng.721; van Eerde AM, 2007, PEDIATR NEPHROL, V22, P1129, DOI 10.1007/s00467-007-0492-4; van Es MA, 2007, LANCET NEUROL, V6, P869, DOI 10.1016/S1474-4422(07)70222-3; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Williams G, 2008, J AM SOC NEPHROL, V19, P847, DOI 10.1681/ASN.2007020245; WINTER RM, 2006, WINTER BARAITSER DYS; Woolf AS, 2002, PEDIATR DEVEL PATHOL, V5, P108, DOI 10.1007/s10024-001-0141-z; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722; Yim HE, 2007, PEDIATR RES, V62, P183, DOI 10.1203/PDR.0b013e31809871f1; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zagradisnik B, 2004, ANN GENET-PARIS, V47, P209, DOI 10.1016/j.anngen.2004.04.003; Zu SL, 2009, PEDIATR NEPHROL, V24, P1501, DOI 10.1007/s00467-009-1179-9	62	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e31327	10.1371/journal.pone.0031327	http://dx.doi.org/10.1371/journal.pone.0031327			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558067	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336000002
J	Charlton, BD; Filippi, P; Fitch, WT				Charlton, Benjamin D.; Filippi, Piera; Fitch, W. Tecumseh			Do Women Prefer More Complex Music around Ovulation?	PLOS ONE			English	Article							MENSTRUAL-CYCLE; AESTHETIC PREFERENCE; SEXUAL SELECTION; HUMAN MALES; EVOLUTION; VOICE; ATTRACTIVENESS; FREQUENCIES; CONCEPTION; PERCEPTION	The evolutionary origins of music are much debated. One theory holds that the ability to produce complex musical sounds might reflect qualities that are relevant in mate choice contexts and hence, that music is functionally analogous to the sexually-selected acoustic displays of some animals. If so, women may be expected to show heightened preferences for more complex music when they are most fertile. Here, we used computer-generated musical pieces and ovulation predictor kits to test this hypothesis. Our results indicate that women prefer more complex music in general; however, we found no evidence that their preference for more complex music increased around ovulation. Consequently, our findings are not consistent with the hypothesis that a heightened preference/bias in women for more complex music around ovulation could have played a role in the evolution of music. We go on to suggest future studies that could further investigate whether sexual selection played a role in the evolution of this universal aspect of human culture.	[Charlton, Benjamin D.; Fitch, W. Tecumseh] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [Filippi, Piera] Univ Palermo, Dept Philosophy & Mus, Palermo, Italy	University of Vienna; University of Palermo	Charlton, BD (corresponding author), Univ Vienna, Dept Cognit Biol, Vienna, Austria.	benjamin.charlton@univie.ac.at		Charlton, Benjamin/0000-0002-0218-7177	European Research Council Advanced Grant SOMACCA [230604]	European Research Council Advanced Grant SOMACCA	BDC was supported by a European Research Council Advanced Grant SOMACCA (No. 230604) awarded to WTF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apicella CL, 2009, P ROY SOC B-BIOL SCI, V276, P1077, DOI 10.1098/rspb.2008.1542; Beauvois MW, 2007, MUSIC PERCEPT, V24, P247, DOI 10.1525/MP.2007.24.3.247; Chapin H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013812; Darwin G., 1871, P423; Evans S, 2006, BIOL PSYCHOL, V72, P160, DOI 10.1016/j.biopsycho.2005.09.003; Evans S, 2008, PHYSIOL BEHAV, V93, P783, DOI 10.1016/j.physbeh.2007.11.033; Falk D, 2000, ORIGINS OF MUSIC, P197; Feinberg DR, 2006, HORM BEHAV, V49, P215, DOI 10.1016/j.yhbeh.2005.07.004; Feinberg DR, 2005, ANIM BEHAV, V69, P561, DOI 10.1016/j.anbehav.2004.06.012; Fitch WT, 2007, MUSIC PERCEPT, V25, P43, DOI 10.1525/mp.2007.25.1.43; Fitch WT, 2006, COGNITION, V100, P173, DOI 10.1016/j.cognition.2005.11.009; Gaab N, 2003, J COGNITIVE NEUROSCI, V15, P810, DOI 10.1162/089892903322370735; Gangestad SW, 2008, P ROY SOC B-BIOL SCI, V275, P991, DOI 10.1098/rspb.2007.1425; Gangestad SW, 2007, J PERS SOC PSYCHOL, V92, P151, DOI 10.1037/0022-3514.92.1.151; Haselton MG, 2006, HUM NATURE-INT BIOS, V17, P50, DOI 10.1007/s12110-006-1020-0; HEYDUK RG, 1975, PERCEPT PSYCHOPHYS, V17, P84, DOI 10.3758/BF03204003; KONECNI VJ, 1976, J EXP PSYCHOL HUMAN, V2, P347, DOI 10.1037/0096-1523.2.3.347; LONGUETHIGGINS HC, 1984, MUSIC PERCEPT, V1, P424; Lynch CD, 2006, PAEDIATR PERINAT EP, V20, P3, DOI 10.1111/j.1365-3016.2006.00765.x; McDermott J, 2005, MUSIC PERCEPT, V23, P29, DOI 10.1525/mp.2005.23.1.29; McDermott J, 2008, NATURE, V453, P287, DOI 10.1038/453287a; MEADOWCROFT JM, 1987, COMMUN RES, V14, P204, DOI 10.1177/009365087014002004; Merker B, 2000, ORIGINS OF MUSIC, P315; Miller G, 2000, ORIGINS OF MUSIC, P329; Nettl Bruno, 1956, MUSIC PRIMITIVE CULT; North A. C., 1995, PSYCHOMUSICOLOGY, V14, P77, DOI DOI 10.1037/H0094090; Orr M.G., 2001, PSYCHOL MUSIC, V29, P108, DOI DOI 10.1177/0305735601292002; Orr MG, 2005, MUSIC PERCEPT, V22, P583, DOI 10.1525/mp.2005.22.4.583; Pinker S., 1997, MIND WORKS; Ryan MJ, 1998, SCIENCE, V281, P1999, DOI 10.1126/science.281.5385.1999; Sanders G, 1998, NEUROPSYCHOLOGIA, V36, P869, DOI 10.1016/S0028-3932(98)00022-0; Schroeder M, 1991, FRACTALS CHAOS POWER; Sluming VA, 2000, EVOL HUM BEHAV, V21, P1; SMITH JD, 1990, COGNITION, V34, P279, DOI 10.1016/0010-0277(90)90007-7; SMITH JM, 1991, TRENDS ECOL EVOL, V6, P146, DOI 10.1016/0169-5347(91)90055-3; Steck L, 1975, J EXPT PSYCHOL HUMAN, V1, P170; Trehub SE, 2003, NAT NEUROSCI, V6, P669, DOI 10.1038/nn1084; TREHUB SE, 2001, MUSIC SCI, P37; TURINO T, 1983, LAT AM MUSIC REV, V4, P81, DOI 10.2307/780281; VITZ PC, 1966, J EXP PSYCHOL, V71, P74, DOI 10.1037/h0022619; WILCOX AJ, 1995, NEW ENGL J MED, V333, P1517, DOI 10.1056/NEJM199512073332301; Ziv N, 2009, CREATIVITY RES J, V21, P125, DOI 10.1080/10400410802633764; [No title captured]	43	14	14	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35626	10.1371/journal.pone.0035626	http://dx.doi.org/10.1371/journal.pone.0035626			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VP	22558181	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000305345200056
J	Kuo, YR; Chen, CC; Goto, S; Huang, YT; Wang, CT; Tsai, CC; Chen, CL				Kuo, Yur-Ren; Chen, Chien-Chang; Goto, Shigeru; Huang, Yu-Ting; Wang, Chun-Ting; Tsai, Chia-Chun; Chen, Chao-Long			Immunomodulatory Effects of Bone Marrow-Derived Mesenchymal Stem Cells in a Swine Hemi-Facial Allotransplantation Model	PLOS ONE			English	Article							COMPOSITE TISSUE ALLOGRAFT; T-CELLS; SURVIVAL; MODULATION; INHIBIT; PLAY	Background: In this study, we investigated whether the infusion of bone marrow-derived mesenchymal stem cells (MSCs), combined with transient immunosuppressant treatment, could suppress allograft rejection and modulate T-cell regulation in a swine orthotopic hemi-facial composite tissue allotransplantation (CTA) model. Methodology/Principal Findings: Outbred miniature swine underwent hemi-facial allotransplantation (day 0). Group-I (n = 5) consisted of untreated control animals. Group-II (n = 3) animals received MSCs alone (given on days -1, +1, +3, +7, +14, and +21). Group-III (n = 3) animals received CsA (days 0 to +28). Group-IV (n = 5) animals received CsA (days 0 to +28) and MSCs (days -1, +1, +3, +7, +14, and +21). The transplanted face tissue was observed daily for signs of rejection. Biopsies of donor tissues and recipient blood sample were obtained at specified predetermined times (per 2 weeks post-transplant) or at the time of clinically evident rejection. Our results indicated that the MSC-CsA group had significantly prolonged allograft survival compared to the other groups (P<0.001). Histological examination of the MSC-CsA group displayed the lowest degree of rejection in alloskin and lymphoid gland tissues. TNF-alpha expression in circulating blood revealed significant suppression in the MSC and MSC-CsA treatment groups, as compared to that in controls. IHC staining showed CD45 and IL-6 expression were significantly decreased in MSC-CsA treatment groups compared to controls. The number of CD4+/CD25+ regulatory T-cells and IL-10 expressions in the circulating blood significantly increased in the MSC-CsA group compared to the other groups. IHC staining of alloskin tissue biopsies revealed a significant increase in the numbers of foxp3(+)T-cells and TGF-beta 1 positive cells in the MSC-CsA group compared to the other groups. Conclusions: These results demonstrate that MSCs significantly prolong hemifacial CTA survival. Our data indicate the MSCs did not only suppress inflammation and acute rejection of CTA, but also modulate T-cell regulation and related cytokines expression.	[Kuo, Yur-Ren; Chen, Chien-Chang; Huang, Yu-Ting; Wang, Chun-Ting; Tsai, Chia-Chun] Kaohsiung Chang Gung Mem Hosp, Ctr Composite Tissue Allotransplantat, Kaohsiung, Taiwan; [Kuo, Yur-Ren; Chen, Chien-Chang; Goto, Shigeru; Huang, Yu-Ting; Wang, Chun-Ting; Tsai, Chia-Chun; Chen, Chao-Long] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Kuo, Yur-Ren; Chen, Chien-Chang; Huang, Yu-Ting; Wang, Chun-Ting; Tsai, Chia-Chun] Kaohsiung Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Kaohsiung, Taiwan; [Goto, Shigeru; Chen, Chao-Long] Kaohsiung Chang Gung Mem Hosp, Liver Transplantat Program, Kaohsiung, Taiwan; [Goto, Shigeru; Chen, Chao-Long] Kaohsiung Chang Gung Mem Hosp, Dept Surg, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Kuo, YR (corresponding author), Kaohsiung Chang Gung Mem Hosp, Ctr Composite Tissue Allotransplantat, Kaohsiung, Taiwan.	t1207816@ms22.hinet.net			Chang Gung Research Project, Taiwan [CMRPG-850081, CMRPG-860452]; Kaohsiung Chang Gung Memorial Hospital	Chang Gung Research Project, Taiwan; Kaohsiung Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported in part by Contract No. grant CMRPG-850081 and CMRPG-860452 from the Chang Gung Research Project, Taiwan (Internal funding from Kaohsiung Chang Gung Memorial Hospital). No external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Amarnath S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018885; Cendales LC, 2008, AM J TRANSPLANT, V8, P1396, DOI 10.1111/j.1600-6143.2008.02243.x; English K, 2009, CLIN EXP IMMUNOL, V156, P149, DOI 10.1111/j.1365-2249.2009.03874.x; Kakinuma S, 2009, J GASTROENTEROL, V44, P167, DOI 10.1007/s00535-008-2297-z; Kim YH, 2011, MOL MED, V17, P697, DOI 10.2119/molmed.2010.00098; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Kuo YR, 2011, PLAST RECONSTR SURG, V128, p661E, DOI 10.1097/PRS.0b013e318230c60b; Kuo YR, 2011, PLAST RECONSTR SURG, V127, P569, DOI 10.1097/PRS.0b013e318200a92c; Kuo YR, 2009, TRANSPLANTATION, V87, P1769, DOI 10.1097/TP.0b013e3181a664f1; Kuo Yur-Ren, 2006, Chang Gung Med J, V29, P268; Kuo YR, 2009, J SURG RES, V153, P317, DOI 10.1016/j.jss.2008.05.034; Kuo YR, 2009, J SURG RES, V153, P268, DOI 10.1016/j.jss.2008.03.050; LEE WPA, 1991, PLAST RECONSTR SURG, V87, P401, DOI 10.1097/00006534-199103000-00001; Mathes DW, 2003, TRANSPLANTATION, V75, P25, DOI 10.1097/00007890-200301150-00005; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Parekkadan B, 2008, STEM CELLS, V26, P1913, DOI 10.1634/stemcells.2007-0790; Patel SA, 2008, ARCH IMMUNOL THER EX, V56, P1, DOI 10.1007/s00005-008-0001-x; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Sbano P, 2008, ARCH DERMATOL RES, V300, P115, DOI 10.1007/s00403-007-0827-9	20	48	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35459	10.1371/journal.pone.0035459	http://dx.doi.org/10.1371/journal.pone.0035459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558153	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345200042
J	Feng, T; Cong, YZ; Alexander, K; Elson, CO				Feng, Ting; Cong, Yingzi; Alexander, Katie; Elson, Charles O.			Regulation of Toll-like Receptor 5 Gene Expression and Function on Mucosal Dendritic Cells	PLOS ONE			English	Article							BACTERIAL FLAGELLIN; T-CELLS; INNATE IMMUNITY; HUMAN INTESTINE; RETINOIC-ACID; SALMONELLA; MICROBIOTA; ADJUVANT; DISEASE; TLR5	Toll-like receptor (TLR) 5 has been shown to maintain intestinal homeostasis and regulate host defense against enterobacterial infection. However, how TLR5 expression is regulated and its function in the intestine have not been fully elucidated. Here we demonstrate that mucosal dendritic cells (DCs), but not splenic DCs, express high levels of TLR5 protein. Alternatively spliced Tlr5 transcripts were identified but it did not explain the selective expression of TLR5 on mucosal DCs. Treatment with various bacterial ligands downregulated BMDC TLR5 expression, while retinoic acid and host stromal cell-derived signals promoted TLR5 expression in a TGF-beta-independent mechanism. Signaling through TLR5 restrained regulatory T (Treg) cell generation, and accordingly, TLR5(-/-) mice displayed increased frequencies of Foxp3(+) Treg cells in the intestinal lamina propria. Our data indicate that bacterial and host factors differentially regulate DC TLR5 expression. TLR5 signaling regulates immune responses towards the microbiota via modulation of the Treg/effector T cell balance.	[Feng, Ting; Cong, Yingzi; Alexander, Katie; Elson, Charles O.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Feng, Ting; Cong, Yingzi; Alexander, Katie; Elson, Charles O.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Cong, Yingzi] Univ Texas Med Branch, Dept Microbiol Immunol, Galveston, TX USA; [Cong, Yingzi] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Feng, T (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.	coelson@uab.edu		Cong, Yingzi/0000-0003-4167-7395	National Institutes of Health (NIH) [DK071176, DK079918, RR20136]; Digestive Diseases Research Development Center [DK064400]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR020136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079918, R24DK064400, P01DK071176] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Diseases Research Development Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grants DK071176 and DK079918, Digestive Diseases Research Development Center grant DK064400, and NIH RR20136. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Anz D, 2010, J IMMUNOL, V184, P939, DOI 10.4049/jimmunol.0901245; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bates JT, 2009, J IMMUNOL, V182, P7539, DOI 10.4049/jimmunol.0804225; Blumberg RS, 2009, DIGEST DIS, V27, P455, DOI 10.1159/000235851; Bosshart H, 2007, ANN NY ACAD SCI, V1096, P1, DOI 10.1196/annals.1397.064; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Cario E, 2005, GUT, V54, P1182, DOI 10.1136/gut.2004.062794; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Elson CO, 2007, GASTROENTEROLOGY, V132, P2359, DOI 10.1053/j.gastro.2007.03.104; Feng T, 2010, J IMMUNOL IN PRESS; Feng T, 2010, J EXP MED, V207, P1321, DOI 10.1084/jem.20092253; Fitzgerald KA, 2006, CELL, V125, P834, DOI 10.1016/j.cell.2006.05.014; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gewirtz AT, 2006, CURR OPIN GASTROEN, V22, P8, DOI 10.1097/01.mog.0000194791.59337.28; Goodman WA, 2009, J IMMUNOL, V183, P3170, DOI 10.4049/jimmunol.0803721; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Jordan T, 2002, TRENDS PLANT SCI, V7, P392, DOI 10.1016/S1360-1385(02)02311-7; Kelsall BL, 2005, IMMUNOL REV, V206, P132, DOI 10.1111/j.0105-2896.2005.00292.x; Konrad A, 2006, GASTROENTEROLOGY, V130, P2050, DOI 10.1053/j.gastro.2006.02.055; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; McSorley SJ, 2002, J IMMUNOL, V169, P3914, DOI 10.4049/jimmunol.169.7.3914; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Qin HW, 2009, J IMMUNOL, V183, P97, DOI 10.4049/jimmunol.0801986; Rakoff-Nahoum S, 2008, MUCOSAL IMMUNOL, V1, pS10, DOI 10.1038/mi.2008.49; Sanders CJ, 2006, J IMMUNOL, V177, P2810, DOI 10.4049/jimmunol.177.5.2810; Santaolalla R, 2012, CURR OPIN GASTROEN, V28, P124, DOI 10.1097/MOG.0b013e3283506559; Sebastiani G, 2000, GENOMICS, V64, P230, DOI 10.1006/geno.2000.6115; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Strober W, 2009, IMMUNITY, V31, P377, DOI 10.1016/j.immuni.2009.09.001; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Targan SR, 2005, GASTROENTEROLOGY, V128, P2020, DOI 10.1053/j.gastro.2005.03.046; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Van Maele L, 2010, J IMMUNOL, V185, P1177, DOI 10.4049/jimmunol.1000115; Vijay-Kumar M, 2008, J IMMUNOL, V180, P8280, DOI 10.4049/jimmunol.180.12.8280; Zeng H, 2003, J IMMUNOL, V171, P3668, DOI 10.4049/jimmunol.171.7.3668; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	47	27	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35918	10.1371/journal.pone.0035918	http://dx.doi.org/10.1371/journal.pone.0035918			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545147	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343200067
J	Gomez, A; Luckey, D; Yeoman, CJ; Marietta, EV; Miller, MEB; Murray, JA; White, BA; Taneja, V				Gomez, Andres; Luckey, David; Yeoman, Carl J.; Marietta, Eric V.; Miller, Margret E. Berg; Murray, Joseph A.; White, Bryan A.; Taneja, Veena			Loss of Sex and Age Driven Differences in the Gut Microbiome Characterize Arthritis-Susceptible*0401 Mice but Not Arthritis-Resistant*0402 Mice	PLOS ONE			English	Article							GENETIC SUSCEPTIBILITY; FECAL MICROFLORA; RIBOSOMAL-RNA; SP-NOV.; ARTHRITIS; IMMUNITY; BIFIDOBACTERIUM; MECHANISMS; EXPRESSION; DIVERSITY	Background: HLA-DRB1* 0401 is associated with susceptibility, while HLA-DRB1* 0402 is associated with resistance to developing rheumatoid arthritis (RA) and collagen-induced arthritis in humans and transgenic mice respectively. The influence of gut-joint axis has been suggested in RA, though not yet proven. Methodology/Principal Findings: We have used HLA transgenic mice carrying arthritis susceptible and -resistant HLA-DR genes to explore if genetic factors and their interaction with gut flora gut can be used to predict susceptibility to develop arthritis. Pyrosequencing of the 16S rRNA gene from the fecal microbiomes of DRB1*0401 and DRB1*0402 transgenic mice revealed that the guts of *0401 mice is dominated by a Clostridium-like bacterium, whereas the guts of *0402 mice are enriched for members of the Porphyromonadaceae family and Bifidobacteria. DRB1*0402 mice harbor a dynamic sex and age-influenced gut microbiome while DRB1*0401 mice did not show age and sex differences in gut microbiome even though they had altered gut permeability. Cytokine transcripts, measured by rtPCR, in jejuna showed differential TH17 regulatory network gene transcripts in *0401 and *0402 mice. Conclusions/Significance: We have demonstrated for the first time that HLA genes in association with the gut microbiome may determine the immune environment and that the gut microbiome might be a potential biomarker as well as contributor for susceptibility to arthritis. Identification of pathogenic commensal bacteria would provide new understanding of disease pathogenesis, thereby leading to novel approaches for therapy.	[Gomez, Andres; Yeoman, Carl J.; Miller, Margret E. Berg; White, Bryan A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Luckey, David; Murray, Joseph A.; Taneja, Veena] Mayo Clin, Dept Immunol, Rochester, MN USA; [Marietta, Eric V.; Murray, Joseph A.] Mayo Clin, Dept Gasteroenterol, Rochester, MN USA; [Taneja, Veena] Mayo Clin, Dept Rheumatol, Rochester, MN USA; [White, Bryan A.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Illinois System; University of Illinois Urbana-Champaign	Gomez, A (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.	bwhitw44@illinois.edu; taneja.veena@mayo.edu	Yeoman, Carl/ABA-1906-2021	Yeoman, Carl/0000-0002-8775-7879; Berg, Margret/0000-0002-0411-1619; Taneja, Veena/0000-0003-2401-694X; murray, joseph/0000-0003-1941-9090	seed funds from the Mayo Clinic/Illinois Alliance for Technology based Healthcare; Department of Defense	seed funds from the Mayo Clinic/Illinois Alliance for Technology based Healthcare; Department of Defense(United States Department of Defense)	The study was supported by seed funds from the Mayo Clinic/Illinois Alliance for Technology based Healthcare and a grant from Department of Defense to VT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alauzet C, 2007, INT J SYST EVOL MICR, V57, P2216, DOI 10.1099/ijs.0.65173-0; Amirzargar A, 1998, EUR J IMMUNOGENET, V25, P297, DOI 10.1046/j.1365-2370.1998.00101.x; Baba N, 2008, J LEUKOCYTE BIOL, V84, P468, DOI 10.1189/jlb.0108017; BENNO Y, 1992, MICROBIOL IMMUNOL, V36, P683, DOI 10.1111/j.1348-0421.1992.tb02071.x; Caselli M, 2010, GUT MICROBES, V1, P367, DOI 10.4161/gmic.1.6.14390; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Chervonsky AV, 2010, NAT IMMUNOL, V11, P28, DOI 10.1038/ni.1801; Chow J, ADV IMMUNOL, V107, P243; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; De Palma G, 2010, CURR ISSUES MOL BIOL, V12, P1; FINEGOLD SM, 1983, NORMAL INDIGENOUS IN, P3; Fuentes S, 2008, FEMS MICROBIOL ECOL, V63, P65, DOI 10.1111/j.1574-6941.2007.00411.x; Geluk A, 1998, P NATL ACAD SCI USA, V95, P10797, DOI 10.1073/pnas.95.18.10797; Greetham HL, 2004, ANAEROBE, V10, P301, DOI 10.1016/j.anaerobe.2004.06.004; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Ito T, 2011, EXP CELL RES, V317, P613, DOI 10.1016/j.yexcr.2010.12.018; Kelsall BL, 2005, IMMUNOL REV, V206, P132, DOI 10.1111/j.0105-2896.2005.00292.x; Kempsell KE, 2000, INFECT IMMUN, V68, P6012, DOI 10.1128/IAI.68.10.6012-6026.2000; Klareskog L, 2006, NAT CLIN PRACT RHEUM, V2, P425, DOI 10.1038/ncprheum0249; KOUSKOFF V, 1993, J IMMUNOL METHODS, V166, P287, DOI 10.1016/0022-1759(93)90370-M; Kovacs A, 2011, MICROB ECOL, V61, P423, DOI 10.1007/s00248-010-9787-2; Kverka M, 2011, CLIN EXP IMMUNOL, V163, P250, DOI 10.1111/j.1365-2249.2010.04286.x; LANGENDIJK PS, 1995, APPL ENVIRON MICROB, V61, P3069, DOI 10.1128/AEM.61.8.3069-3075.1995; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Lugering A, 2005, AM J PATHOL, V166, P1647, DOI 10.1016/S0002-9440(10)62475-3; Mangin I, 2004, FEMS MICROBIOL ECOL, V50, P25, DOI 10.1016/j.femsec.2004.05.005; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Matsumoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023652; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; McDonald KG, 2011, IMMUN AGEING, V8, DOI 10.1186/1742-4933-8-1; Moen K, 2006, CLIN EXP RHEUMATOL, V24, P656; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006; Nenadic O, 2007, J STAT SOFTW, V20; Ng SC, 2009, INFLAMM BOWEL DIS, V15, P300, DOI 10.1002/ibd.20602; Picco P, 2000, CLIN EXP RHEUMATOL, V18, P773; Round JL, 2010, J AUTOIMMUN, V34, pJ220, DOI 10.1016/j.jaut.2009.11.007; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Sait LC, 2007, INT IMMUNOL, V19, P257, DOI 10.1093/intimm/dxl142; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; So JS, 2008, MOL IMMUNOL, V45, P2690, DOI 10.1016/j.molimm.2007.12.010; Taneja V, 2003, J IMMUNOL, V171, P4431, DOI 10.4049/jimmunol.171.8.4431; Taneja V, 2008, J IMMUNOL, V181, P2869, DOI 10.4049/jimmunol.181.4.2869; Taneja V, 2007, ARTHRITIS RHEUM-US, V56, P69, DOI 10.1002/art.22213; Vaahtovuo J, 2003, FEMS MICROBIOL ECOL, V44, P131, DOI 10.1016/S0168-6496(02)00460-9; Vaahtovuo J, 2008, J RHEUMATOL, V35, P1500; Ventura M, 2009, FRONT BIOSCI-LANDMRK, V14, P3214, DOI 10.2741/3445; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Zaph C, 2010, J CLIN INVEST, V120, P4182, DOI 10.1172/JCI45263; [No title captured]	53	152	161	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e36095	10.1371/journal.pone.0036095	http://dx.doi.org/10.1371/journal.pone.0036095			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22553482	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343200077
J	Luhmann, UFO; Lange, CA; Robbie, S; Munro, PMG; Cowing, JA; Armer, HEJ; Luong, V; Carvalho, LS; MacLaren, RE; Fitzke, FW; Bainbridge, JWB; Ali, RR				Luhmann, Ulrich F. O.; Lange, Clemens A.; Robbie, Scott; Munro, Peter M. G.; Cowing, Jill A.; Armer, Hannah E. J.; Vy Luong; Carvalho, Livia S.; MacLaren, Robert E.; Fitzke, Frederick W.; Bainbridge, James W. B.; Ali, Robin R.			Differential Modulation of Retinal Degeneration by Ccl2 and Cx3cr1 Chemokine Signalling	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; MACULAR DEGENERATION; MICROGLIAL CELLS; TRANSENDOTHELIAL MIGRATION; LESION FORMATION; DENDRITIC CELLS; ANIMAL-MODEL; MICE; MACROPHAGES; BLOOD	Microglia and macrophages are recruited to sites of retinal degeneration where local cytokines and chemokines determine protective or neurotoxic microglia responses. Defining the role of Ccl2-Ccr2 and Cx3cl1-Cx3cr1 signalling for retinal pathology is of particular interest because of its potential role in age-related macular degeneration (AMD). Ccl2, Ccr2, and Cx3cr1 signalling defects impair macrophage trafficking, but have, in several conflicting studies, been reported to show different degrees of age-related retinal degeneration. Ccl2/Cx3cr1 double knockout (CCDKO) mice show an early onset retinal degeneration and have been suggested as a model for AMD. In order to understand phenotypic discrepancies in different chemokine knockout lines and to study how defects in Ccl2 and/or Cx3cr1 signalling contribute to the described early onset retinal degeneration, we defined primary and secondary pathological events in CCDKO mice. To control for genetic background variability, we compared the original phenotype with that of single Ccl2, Cx3cr1 and Ccl2/Cx3cr1 double knockout mice obtained from backcrosses of CCDKO with C57Bl/6 mice. We found that the primary pathological event in CCDKO mice develops in the inferior outer nuclear layer independently of light around postnatal day P14. RPE and vascular lesions develop secondarily with increasing penetrance with age and are clinically similar to retinal telangiectasia not to choroidal neovascularisation. Furthermore, we provide evidence that a third autosomal recessive gene causes the degeneration in CCDKO mice and in all affected re-derived lines and subsequently demonstrated co-segregation of the naturally occurring RD8 mutation in the Crb1 gene. By comparing CCDKO mice with re-derived CCl2(-/-)/Crb1(Rd8/RD8), Cx3cr1(-/-)/Crb1(Rd8/RD8) and CCl2(-/-)/Cx3cr1(-/-)/Crb1(Rd8/RD8) mice, we observed a differential modulation of the retinal phenotype by genetic background and both chemokine signalling pathways. These findings indicate that CCDKO mice are not a model of AMD, but a model for an inherited retinal degeneration that is differentially modulated by Ccl2-Ccr2 and Cx3cl1-Cx3cr1 chemokine signalling.	[Luhmann, Ulrich F. O.; Lange, Clemens A.; Robbie, Scott; Cowing, Jill A.; Carvalho, Livia S.; MacLaren, Robert E.; Bainbridge, James W. B.; Ali, Robin R.] UCL Inst Ophthalmol, Dept Genet, London, England; [Munro, Peter M. G.; Armer, Hannah E. J.] UCL Inst Ophthalmol, Imaging Unit, London, England; [Vy Luong; Fitzke, Frederick W.] UCL Inst Ophthalmol, Dept Visual Sci, London, England; [Robbie, Scott; MacLaren, Robert E.; Bainbridge, James W. B.; Ali, Robin R.] UCL Inst Ophthalmol, Moorfields Eye Hosp, Natl Hlth Sci Fdn Trust, Natl Inst Hlth & Res Biomed Res,Ctr Ophthalmol, London, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Luhmann, UFO (corresponding author), UCL Inst Ophthalmol, Dept Genet, London, England.	u.luhmann@ucl.ac.uk	Luhmann, Ulrich/D-8905-2012; Carvalho, Livia/B-4984-2013	Carvalho, Livia/0000-0002-3909-5778; Ali, Robin/0000-0003-3126-6517; Bainbridge, James/0000-0003-1318-8201; MacLaren, Robert/0000-0002-3096-4682	Wellcome Trust [074617/Z/04/Z]; National Institute for Health Research [NIHR-RP-011-003, NF-SI-0508-10130] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by the Wellcome Trust fellowship 074617/Z/04/Z (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Blomster LV, 2011, MOL CELL NEUROSCI, V48, P236, DOI 10.1016/j.mcn.2011.08.004; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chan CC, 2008, OPHTHALMIC RES, V40, P124, DOI 10.1159/000119862; Chen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022818; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Cook DN, 2001, MOL CELL BIOL, V21, P3159, DOI 10.1128/MCB.21.9.3159-3165.2001; Dzenko KA, 2005, MICROVASC RES, V70, P53, DOI 10.1016/j.mvr.2005.04.005; Eter N, 2008, INVEST OPHTH VIS SCI, V49, P3649, DOI 10.1167/iovs.07-1322; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Guillemin GJ, 2004, J LEUKOCYTE BIOL, V75, P388, DOI 10.1189/jlb.0303114; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Henderson RH, 2011, BRIT J OPHTHALMOL, V95, P811, DOI 10.1136/bjo.2010.186882; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Hughes EH, 2003, INVEST OPHTH VIS SCI, V44, P2229, DOI 10.1167/iovs.02-0824; Jaissle GB, 2010, GRAEF ARCH CLIN EXP, V248, P1063, DOI 10.1007/s00417-009-1253-9; Joly S, 2009, AM J PATHOL, V174, P2310, DOI 10.2353/ajpath.2009.090023; Jonas JB, 2010, ARCH OPHTHALMOL-CHIC, V128, P1281, DOI 10.1001/archophthalmol.2010.227; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lange CAK, 2011, AM J OPHTHALMOL, V152, P406, DOI 10.1016/j.ajo.2011.02.014; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Lee JE, 2008, INVEST OPHTH VIS SCI, V49, P4169, DOI 10.1167/iovs.08-2076; Liang KJ, 2009, INVEST OPHTH VIS SCI, V50, P4444, DOI 10.1167/iovs.08-3357; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Marchesi F, 2010, J NEUROIMMUNOL, V224, P39, DOI 10.1016/j.jneuroim.2010.05.007; McKay GJ, 2011, HUM MUTAT, V32, P1407, DOI 10.1002/humu.21577; McMenamin PG, 1999, BRIT J OPHTHALMOL, V83, P598, DOI 10.1136/bjo.83.5.598; Mehalow AK, 2003, HUM MOL GENET, V12, P2179, DOI 10.1093/hmg/ddg232; Nakazawa T, 2007, P NATL ACAD SCI USA, V104, P2425, DOI 10.1073/pnas.0608167104; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Ng TF, 2001, INVEST OPHTH VIS SCI, V42, P3301; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; RANDOLPH GJ, 1995, J IMMUNOL, V155, P3610; Raoul W, 2008, OPHTHAL RES, V40, P115, DOI 10.1159/000119860; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Robertson MJ, 2002, INVEST OPHTH VIS SCI, V43, P2250; Ross RJ, 2008, EXP EYE RES, V86, P675, DOI 10.1016/j.exer.2008.01.014; Rutar M, 2011, INVEST OPHTH VIS SCI, V52, P2379, DOI 10.1167/iovs.10-6010; Seidler S, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-30; Shu XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027433; Silverman MD, 2003, INVEST OPHTH VIS SCI, V44, P1608, DOI 10.1167/iovs.02-0233; Tou JS, 2004, FASEB J, V18, P1297, DOI 10.1096/fj.04-1862fje; Tsutsumi C, 2003, J LEUKOCYTE BIOL, V74, P25, DOI 10.1189/jlb.0902436; Tuo JS, 2007, INVEST OPHTH VIS SCI, V48, P3827, DOI 10.1167/iovs.07-0051; Tuo JS, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.01.009; Tuo JS, 2009, AM J PATHOL, V175, P799, DOI 10.2353/ajpath.2009.090089; van de Pavert SA, 2004, J CELL SCI, V117, P4169, DOI 10.1242/jcs.01301; van de Pavert SA, 2007, GLIA, V55, P1486, DOI 10.1002/glia.20561; West JB, 2010, RESP PHYSIOL NEUROBI, V170, P202, DOI 10.1016/j.resp.2009.12.010; Xu HP, 2008, AGING CELL, V7, P58, DOI 10.1111/j.1474-9726.2007.00351.x; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Zerbib J, 2011, EXP EYE RES, V93, P382, DOI 10.1016/j.exer.2011.05.005; Zhou YD, 2011, EXP EYE RES, V93, P636, DOI 10.1016/j.exer.2011.07.017	63	53	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35551	10.1371/journal.pone.0035551	http://dx.doi.org/10.1371/journal.pone.0035551			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545116	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343200036
J	Schumacher, T; Krohn, M; Hofrichter, J; Lange, C; Stenzel, J; Steffen, J; Dunkelmann, T; Paarmann, K; Frohlich, C; Uecker, A; Plath, AS; Sommer, A; Bruning, T; Heinze, HJ; Pahnke, J				Schumacher, Toni; Krohn, Markus; Hofrichter, Jacqueline; Lange, Cathleen; Stenzel, Jan; Steffen, Johannes; Dunkelmann, Tina; Paarmann, Kristin; Froehlich, Christina; Uecker, Annekathrin; Plath, Anne-Sophie; Sommer, Alexandra; Bruening, Thomas; Heinze, Hans-Jochen; Pahnke, Jens			ABC Transporters B1, C1 and G2 Differentially Regulate Neuroregeneration in Mice	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; AMYLOID-PRECURSOR-PROTEIN; NEURAL STEM-CELLS; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; IN-VIVO; INCREASED SENSITIVITY; ADULT NEUROGENESIS; PROLIFERATION; EXPRESSION	Background: ATP-binding cassette (ABC) transporters are essential regulators of organismic homeostasis, and are particularly important in protecting the body from potentially harmful exogenous substances. Recently, an increasing number of in vitro observations have indicated a functional role of ABC transporters in the differentiation and maintenance of stem cells. Therefore, we sought to determine brain-related phenotypic changes in animals lacking the expression of distinct ABC transporters (ABCB1, ABCG2 or ABCC1). Methodology and Principal Findings: Analyzing adult neurogenesis in ABC transporter-deficient animals in vivo and neuronal stem/progenitor cells in vitro resulted in complex findings. In vivo, the differentiation of neuronal progenitors was hindered in ABC transporter-deficient mice (ABCB1(0/0)) as evidenced by lowered numbers of doublecortin(+) (-36%) and calretinin(+) (-37%) cells. In vitro, we confirmed that this finding is not connected to the functional loss of single neural stem/progenitor cells (NSPCs). Furthermore, assessment of activity, exploratory behavior, and anxiety levels revealed behavioral alterations in ABCB1(0/0) and ABCC1(0/0) mice, whereas ABCG2(0/0) mice were mostly unaffected. Conclusion and Significance: Our data show that single ABC transporter-deficiency does not necessarily impair neuronal progenitor homeostasis on the single NSPC level, as suggested by previous studies. However, loss of distinct ABC transporters impacts global brain homeostasis with far ranging consequences, leading to impaired neurogenic functions in vivo and even to distinct behavioral phenotypes. In addition to the known role of ABC transporters in proteopathies such as Parkinson's disease and Alzheimer's disease, our data highlight the importance of understanding the general function of ABC transporters for the brain's homeostasis and the regeneration potential.	[Schumacher, Toni; Krohn, Markus; Hofrichter, Jacqueline; Lange, Cathleen; Stenzel, Jan; Steffen, Johannes; Dunkelmann, Tina; Paarmann, Kristin; Froehlich, Christina; Uecker, Annekathrin; Plath, Anne-Sophie; Sommer, Alexandra; Bruening, Thomas; Heinze, Hans-Jochen; Pahnke, Jens] Univ Rostock, Dept Neurol, NRL, Magdeburg, Germany; [Schumacher, Toni; Krohn, Markus; Hofrichter, Jacqueline; Lange, Cathleen; Stenzel, Jan; Steffen, Johannes; Dunkelmann, Tina; Paarmann, Kristin; Froehlich, Christina; Uecker, Annekathrin; Plath, Anne-Sophie; Sommer, Alexandra; Bruening, Thomas; Heinze, Hans-Jochen; Pahnke, Jens] Univ Magdeburg, Dept Neurol, NRL, D-39106 Magdeburg, Germany; [Krohn, Markus; Plath, Anne-Sophie; Sommer, Alexandra; Bruening, Thomas; Heinze, Hans-Jochen; Pahnke, Jens] German Ctr Neurodegenerat Dis DZNE, Magdeburg, Germany; [Heinze, Hans-Jochen; Pahnke, Jens] LIN, Magdeburg, Germany	University of Rostock; Otto von Guericke University; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Leibniz Institut fur Neurobiologie (LIN)	Schumacher, T (corresponding author), Univ Rostock, Dept Neurol, NRL, Magdeburg, Germany.	jens.pahnke@gmail.com	Steffen, Johannes/AAK-3044-2021; Steffen, Johannes/K-4020-2012; Krohn, Markus/AAV-3151-2020; Pahnke, Jens/G-1757-2010; Krohn, Markus/AAD-5511-2019	Steffen, Johannes/0000-0002-0647-4157; Steffen, Johannes/0000-0002-0647-4157; Krohn, Markus/0000-0002-5345-9048; Pahnke, Jens/0000-0001-7355-4213; Krohn, Markus/0000-0002-5345-9048; Bruning, Thomas/0000-0002-7060-6564; Schumacher, Toni/0000-0001-7077-1300	University of Rostock (Landesgraduiertenforderung Mecklenburg-Vorpommern)	University of Rostock (Landesgraduiertenforderung Mecklenburg-Vorpommern)	T.S., J.H., C. L., and J.S. were supported by a study grant of the University of Rostock (Landesgraduiertenforderung Mecklenburg-Vorpommern). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alison MR, 2003, J PATHOL, V200, P547, DOI 10.1002/path.1411; Arendash GW, 2001, BRAIN RES, V891, P42, DOI 10.1016/S0006-8993(00)03186-3; Bates SE, 2001, J BIOENERG BIOMEMBR, V33, P503, DOI 10.1023/A:1012879205914; BECKER KF, 1992, HORM METAB RES, V24, P210, DOI 10.1055/s-2007-1003295; Borovski T, 2011, CANCER RES, V71, P634, DOI 10.1158/0008-5472.CAN-10-3220; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Charrier C, 2006, NEUROSCIENCE, V138, P5, DOI 10.1016/j.neuroscience.2005.10.046; CHAUDHARY PM, 1991, CELL, V66, P85, DOI 10.1016/0092-8674(91)90141-K; Conrad CD, 1997, BRAIN RES, V759, P76, DOI 10.1016/S0006-8993(97)00236-9; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; CRUZ APM, 1994, PHARMACOL BIOCHEM BE, V49, P171, DOI 10.1016/0091-3057(94)90472-3; Dean M, 2005, ANNU REV GENOM HUM G, V6, P123, DOI 10.1146/annurev.genom.6.080604.162122; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Errijgers V, 2007, GENES BRAIN BEHAV, V6, P552, DOI 10.1111/j.1601-183X.2006.00282.x; Ferrari Daniela, 2010, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02d06s15; Ferreira MJ, 2010, J BACTERIOL, V192, P5312, DOI 10.1128/JB.00832-10; Gisin J, 2010, J BACTERIOL, V192, P5943, DOI 10.1128/JB.00742-10; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Islam MO, 2005, FEBS LETT, V579, P3473, DOI 10.1016/j.febslet.2005.05.019; Islam MO, 2005, NEUROSCI RES, V52, P75, DOI 10.1016/j.neures.2005.01.013; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kandasamy M, J NEUROPATHOL EXP NE, V69, P717; KARTNER N, 1983, CANCER RES, V43, P4413; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Komitova M, 2005, STROKE, V36, P1278, DOI 10.1161/01.STR.0000166197.94147.59; Korte SM, 2001, NEUROSCI BIOBEHAV R, V25, P117, DOI 10.1016/S0149-7634(01)00002-1; Kozak L, 2002, J BIOL CHEM, V277, P33580, DOI 10.1074/jbc.M205415200; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Krohn M, 2011, J CLIN INVEST, V121, P3924, DOI 10.1172/JCI57867; Krupa DJ, 2001, J NEUROSCI, V21, P5752, DOI 10.1523/JNEUROSCI.21-15-05752.2001; Lechner A, 2002, BIOCHEM BIOPH RES CO, V293, P670, DOI 10.1016/S0006-291X(02)00275-9; Lee YJ, 2005, J PHARMACOL EXP THER, V312, P44, DOI 10.1124/jpet.104.073320; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Lin TT, 2006, CELL RES, V16, P857, DOI 10.1038/sj.cr.7310107; Linton KJ, 2007, PHYSIOLOGY, V22, P122, DOI 10.1152/physiol.00046.2006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Maldonado E, 2000, PROG NEURO-PSYCHOPH, V24, P463, DOI 10.1016/S0278-5846(99)00112-8; Manuel M, 2007, DEVELOPMENT, V134, P545, DOI 10.1242/dev.02764; Mineur YS, 2002, BRAIN RES BULL, V57, P41, DOI 10.1016/S0361-9230(01)00635-9; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Pahnke J, 2009, FORTSCHR NEUROL PSYC, V77, pS21, DOI 10.1055/s-0028-1109601; Pahnke J, 2008, CURR ALZHEIMER RES, V5, P396, DOI 10.2174/156720508785132262; Pahnke J, 2009, NEUROSCI BIOBEHAV R, V33, P1099, DOI 10.1016/j.neubiorev.2009.05.006; Panwala CM, 1998, J IMMUNOL, V161, P5733; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; Sarkadi B, 2004, FEBS LETT, V567, P116, DOI 10.1016/j.febslet.2004.03.123; Saurin W, 1999, J MOL EVOL, V48, P22, DOI 10.1007/PL00006442; Scheffler K, 2011, CURR ALZHEIMER RES, V8, P781, DOI 10.2174/156720511797633179; Schinkel AH, 1997, P NATL ACAD SCI USA, V94, P4028, DOI 10.1073/pnas.94.8.4028; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; Schmidt A, 2012, J ALZHEIMER IN PRESS; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Shruster A, 2011, J NEUROCHEM, V116, P522, DOI 10.1111/j.1471-4159.2010.07131.x; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Soontornmalai A, 2006, NEUROSCIENCE, V138, P159, DOI 10.1016/j.neuroscience.2005.11.011; Steiner B, 2006, GLIA, V54, P805, DOI 10.1002/glia.20407; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Wijnholds J, 1997, NAT MED, V3, P1275, DOI 10.1038/nm1197-1275; WOLF NS, 1993, EXP HEMATOL, V21, P614; Yamamoto A, 2009, J NEUROSCI RES, V87, P2615, DOI 10.1002/jnr.22094; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008	70	38	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35613	10.1371/journal.pone.0035613	http://dx.doi.org/10.1371/journal.pone.0035613			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545122	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343200042
J	Stemberger, C; Dreher, S; Tschulik, C; Piossek, C; Bet, J; Yamamoto, TN; Schiemann, M; Neuenhahn, M; Martin, K; Schlapschy, M; Skerra, A; Schmidt, T; Edinger, M; Riddell, SR; Germeroth, L; Busch, DH				Stemberger, Christian; Dreher, Stefan; Tschulik, Claudia; Piossek, Christine; Bet, Jeannette; Yamamoto, Tori N.; Schiemann, Matthias; Neuenhahn, Michael; Martin, Klaus; Schlapschy, Martin; Skerra, Arne; Schmidt, Thomas; Edinger, Matthias; Riddell, Stanley R.; Germeroth, Lothar; Busch, Dirk H.			Novel Serial Positive Enrichment Technology Enables Clinical Multiparameter Cell Sorting	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; ONE-STEP PURIFICATION; REGULATORY T-CELLS; F-AB FRAGMENT; ADOPTIVE TRANSFER; CRYSTAL-STRUCTURE; ANTIBODY; LYMPHOCYTES; TRANSPLANTATION; IMMUNOTHERAPY	A general obstacle for clinical cell preparations is limited purity, which causes variability in the quality and potency of cell products and might be responsible for negative side effects due to unwanted contaminants. Highly pure populations can be obtained best using positive selection techniques. However, in many cases target cell populations need to be segregated from other cells by combinations of multiple markers, which is still difficult to achieve - especially for clinical cell products. Therefore, we have generated low-affinity antibody-derived Fab-fragments, which stain like parental antibodies when multimerized via Strep-tag and Strep-Tactin, but can subsequently be removed entirely from the target cell population. Such reagents can be generated for virtually any antigen and can be used for sequential positive enrichment steps via paramagnetic beads. First protocols for multiparameter enrichment of two clinically relevant cell populations, CD4(high)/CD25(high)/CD45RA(high) 'regulatory T cells' and CD8(high)/CD62L(high)/CD45RA(neg) 'central memory T cells', have been established to determine quality and efficacy parameters of this novel technology, which should have broad applicability for clinical cell sorting as well as basic research.	[Stemberger, Christian; Dreher, Stefan; Bet, Jeannette; Schiemann, Matthias; Neuenhahn, Michael; Busch, Dirk H.] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Stemberger, Christian; Dreher, Stefan; Bet, Jeannette; Riddell, Stanley R.; Busch, Dirk H.] Tech Univ Munich, Inst Adv Study, Focus Grp Clin Cell Proc & Purificat, Munich, Germany; [Schlapschy, Martin; Skerra, Arne] Tech Univ Munich, Munich Ctr Integrated Prot Sci CIPS M, Freising Weihenstephan, Germany; [Schlapschy, Martin; Skerra, Arne] Tech Univ Munich, Lehrstuhl Biol Chem, Freising Weihenstephan, Germany; [Tschulik, Claudia; Piossek, Christine; Schmidt, Thomas; Germeroth, Lothar] Stage Cell Therapeut, Gottingen, Germany; [Schiemann, Matthias; Busch, Dirk H.] Helmholtz Ctr Munich Neuherberg, Clin Cooperat Grp Antigen Specif Immunotherapy, Munich, Germany; [Martin, Klaus] German Heart Ctr Munich, Inst Anaesthesiol, Munich, Germany; [Edinger, Matthias] Univ Hosp Regensburg, Dept Hematol & Oncol, Regensburg, Germany; [Yamamoto, Tori N.; Riddell, Stanley R.] Fred Hutchinson Canc Res Ctr, Program Immunol, Seattle, WA 98104 USA; [Neuenhahn, Michael; Busch, Dirk H.] DZIF Natl Ctr Infect Res, Munich, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; German Heart Centre Munich; University of Regensburg; Fred Hutchinson Cancer Center; German Center for Infection Research	Stemberger, C (corresponding author), Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany.	dirk.busch@mikrobio.med.tum.de	Skerra, Arne/A-2269-2013	Edinger, Matthias/0000-0003-2889-2533; Skerra, Arne/0000-0002-5717-498X	National Institutes of Health (NIH) [CA18029]; German Federal Ministry of Education and Research in the framework of the Leading-Edge Cluster m4 Munich;  [SFB 576 (TP-A8)];  [SFB 456 (TP-B13)];  [TR-SFB 36 (TP-B10/13)]; NATIONAL CANCER INSTITUTE [R01CA136551, P01CA018029] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Federal Ministry of Education and Research in the framework of the Leading-Edge Cluster m4 Munich; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the SFB 576 (TP-A8), SFB 456 (TP-B13), TR-SFB 36 (TP-B10/13), National Institutes of Health (NIH) CA18029 and by the German Federal Ministry of Education and Research in the framework of the Leading-Edge Cluster m4 Munich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Attarwala H, 2010, J Young Pharm, V2, P332, DOI 10.4103/0975-1483.66810; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Bes C, 2003, J BIOL CHEM, V278, P14265, DOI 10.1074/jbc.M210694200; Chatenoud L, 2003, NAT REV IMMUNOL, V3, P123, DOI 10.1038/nri1000; Cobbold M, 2005, J EXP MED, V202, P379, DOI 10.1084/jem.20040613; Cohen JL, 2002, J EXP MED, V196, P401, DOI 10.1084/jem.20020090; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Fiedler M, 1999, PROTEIN EXPRES PURIF, V17, P421, DOI 10.1006/prep.1999.1142; Heslop HE, 1996, NAT MED, V2, P551, DOI 10.1038/nm0596-551; Hoffmann P, 2006, BLOOD, V108, P4260, DOI 10.1182/blood-2006-06-027409; Kjer-Nielsen L, 2004, P NATL ACAD SCI USA, V101, P7675, DOI 10.1073/pnas.0402295101; Knabel M, 2002, NAT MED, V8, P631, DOI 10.1038/nm0602-631; Kohm AP, 2006, J IMMUNOL, V176, P3301, DOI 10.4049/jimmunol.176.6.3301; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; NADALI G, 1995, INT J CLIN LAB RES, V25, P121, DOI 10.1007/BF02592552; ORLANDI R, 1989, P NATL ACAD SCI USA, V86, P3833, DOI 10.1073/pnas.86.10.3833; Randolph DA, 2006, ANNU REV MED, V57, P381, DOI 10.1146/annurev.med.57.121304.131337; RIDDELL SR, 1992, SCIENCE, V257, P238; Riley JL, 2009, IMMUNITY, V30, P656, DOI 10.1016/j.immuni.2009.04.006; ROONEY CM, 1995, LANCET, V345, P9, DOI 10.1016/S0140-6736(95)91150-2; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Schiweck W, 1997, J MOL BIOL, V268, P934, DOI 10.1006/jmbi.1997.1006; Schlapschy M, 2004, PROTEIN ENG DES SEL, V17, P847, DOI 10.1093/protein/gzh098; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Schmitt A, 2011, TRANSFUSION, V51, P591, DOI 10.1111/j.1537-2995.2010.02940.x; SKERRA A, 1994, GENE, V141, P79, DOI 10.1016/0378-1119(94)90131-7; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Taylor PA, 2002, BLOOD, V99, P3493, DOI 10.1182/blood.V99.10.3493; Turtle CJ, 2011, CURR OPIN IMMUNOL, V23, P299, DOI 10.1016/j.coi.2010.12.012; Yang SC, 2011, CANCER IMMUNOL IMMUN, V60, P739, DOI 10.1007/s00262-011-0977-7	31	49	66	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35798	10.1371/journal.pone.0035798	http://dx.doi.org/10.1371/journal.pone.0035798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545138	Green Published, gold			2022-12-25	WOS:000305343200058
J	Crepin, A; Barbey, C; Beury-Cirou, A; Helias, V; Taupin, L; Reverchon, S; Nasser, W; Faure, D; Dufour, A; Orange, N; Feuilloley, M; Heurlier, K; Burini, JF; Latour, X				Crepin, Alexandre; Barbey, Corinne; Beury-Cirou, Amelie; Helias, Valerie; Taupin, Laure; Reverchon, Sylvie; Nasser, William; Faure, Denis; Dufour, Alain; Orange, Nicole; Feuilloley, Marc; Heurlier, Karin; Burini, Jean-Francois; Latour, Xavier			Quorum Sensing Signaling Molecules Produced by Reference and Emerging Soft-Rot Bacteria (Dickeya and Pectobacterium spp.)	PLOS ONE			English	Article							ACYL-HOMOSERINE LACTONE; CAROTOVORA SUBSP ATROSEPTICA; N-ACYLHOMOSERINE LACTONES; III SECRETION SYSTEM; ERWINIA-CAROTOVORA; PSEUDOMONAS-AERUGINOSA; ENTERIC PHYTOPATHOGEN; SP-NOV.; VIRULENCE; POTATO	Background: Several small diffusible molecules are involved in bacterial quorum sensing and virulence. The production of autoinducers-1 and -2, quinolone, indole and gamma-amino butyrate signaling molecules was investigated in a set of soft-rot bacteria belonging to six Dickeya or Pectobacterium species including recent or emerging potato isolates. Methodology/Principal Findings: Using bacterial biosensors, immunoassay, and chromatographic analysis, we showed that soft-rot bacteria have the common ability to produce transiently during their exponential phase of growth the N-3-oxohexanoyl- or the N-3-oxo-octanoyl-L-homoserine lactones and a molecule of the autoinducer-2 family. Dickeya spp. produced in addition the indole-3-acetic acid in tryptophan-rich conditions. All these signaling molecules have been identified for the first time in the novel Dickeya solani species. In contrast, quinolone and gamma-amino butyrate signals were not identified and the corresponding synthases are not present in the available genomes of soft-rot bacteria. To determine if the variations of signal production according to growth phase could result from expression modifications of the corresponding synthase gene, the respective mRNA levels were estimated by reverse transcriptase-PCR. While the N-acyl-homoserine lactone production is systematically correlated to the synthase expression, that of the autoinducer-2 follows the expression of an enzyme upstream in the activated methyl cycle and providing its precursor, rather than the expression of its own synthase. Conclusions/Significance: Despite sharing the S-adenosylmethionine precursor, no strong link was detected between the production kinetics or metabolic pathways of autoinducers-1 and -2. In contrast, the signaling pathway of autoinducer-2 seems to be switched off by the indole-3-acetic acid pathway under tryptophan control. It therefore appears that the two genera of soft-rot bacteria have similarities but also differences in the mechanisms of communication via the diffusible molecules. Our results designate autoinducer-1 lactones as the main targets for a global biocontrol of soft-rot bacteria communications, including those of emerging isolates.	[Crepin, Alexandre; Barbey, Corinne; Orange, Nicole; Feuilloley, Marc; Burini, Jean-Francois; Latour, Xavier] Univ Rouen, Normandie Univ, LMSM, EA 4312,IUT Evreux, Evreux, France; [Crepin, Alexandre; Beury-Cirou, Amelie] SIPRE Comite No Stn Rech & Creat Varietale, Bretteville Grand Caux, France; [Beury-Cirou, Amelie; Faure, Denis] CNRS, ISV, UPR 2355, Gif Sur Yvette, France; [Helias, Valerie] FN3PT, Paris, France; [Helias, Valerie] INRA, IGEPP, UMR 1349, F-35042 Rennes, France; [Taupin, Laure; Dufour, Alain] Univ Bretagne S, EA 3884, LBCM, Lorient, France; [Reverchon, Sylvie; Nasser, William] Univ Lyon 1, CNRS, Bayer CropSci,INSA, Microbiol Adaptat & Pathogenie MAP UMR 5240, F-69622 Villeurbanne, France; [Heurlier, Karin] Univ Nottingham, Dept Food Sci, Loughborough, England	Universite de Rouen Normandie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE; Bayer AG; Bayer CropScience; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Nottingham	Crepin, A (corresponding author), Univ Rouen, Normandie Univ, LMSM, EA 4312,IUT Evreux, Evreux, France.	xavier.latour@univ-rouen.fr	Sylvie, Reverchon/P-7932-2016; NASSER, William/C-9611-2019	Sylvie, Reverchon/0000-0002-0478-3474; NASSER, William/0000-0001-9848-3597; FEUILLOLEY, Marc G.J./0000-0001-6467-4336; Crepin, Alexandre/0000-0003-0957-4708; Dufour, Alain/0000-0003-0112-6046	European Union; Conventions Industrielles de Formation par la Recherche (CIFRE); Conseil Regional de Haute-Normandie & Ministere delegue a l'Enseignement Superieur et a la Recherche through the Grand Reseau de recherche Regional Vegetal, Agronomie, Sols et Innovations; National Association of Technical Research through the Compte d'Affectation Speciale pour le Developpement Agricole et Rural;  [CAS-DAR AAP 7124]	European Union(European Commission); Conventions Industrielles de Formation par la Recherche (CIFRE); Conseil Regional de Haute-Normandie & Ministere delegue a l'Enseignement Superieur et a la Recherche through the Grand Reseau de recherche Regional Vegetal, Agronomie, Sols et Innovations(Region Normandie); National Association of Technical Research through the Compte d'Affectation Speciale pour le Developpement Agricole et Rural; 	This work was supported by: European Union grants: Fonds Europeens de DEveloppement Regional (FEDER); National grants: the National Association of Technical Research through the Compte d'Affectation Speciale pour le Developpement Agricole et Rural, (CAS-DAR AAP 7124 and the Conventions Industrielles de Formation par la Recherche (CIFRE) carried by the Association Nationale de la Recherche et de la Technologie (ANRT); Regional grants: Conseil Regional de Haute-Normandie & Ministere delegue a l'Enseignement Superieur et a la Recherche through the Grand Reseau de recherche Regional Vegetal, Agronomie, Sols et Innovations (GRR VASI, ex-GRR VATA). All for financial supports of researches. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAINTON NJ, 1992, BIOCHEM J, V288, P997, DOI 10.1042/bj2880997; Barnard AML, 2007, ANAL BIOANAL CHEM, V387, P415, DOI 10.1007/s00216-006-0701-1; BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; Bell KS, 2004, P NATL ACAD SCI USA, V101, P11105, DOI 10.1073/pnas.0402424101; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Brader G, 2005, J BIOL CHEM, V280, P10403, DOI 10.1074/jbc.M408603200; Broek AV, 1999, J BACTERIOL, V181, P1338, DOI 10.1128/JB.181.4.1338-1342.1999; Burr T, 2006, MOL MICROBIOL, V59, P113, DOI 10.1111/j.1365-2958.2005.04939.x; Cha C, 1998, MOL PLANT MICROBE IN, V11, P1119, DOI 10.1094/MPMI.1998.11.11.1119; Charkowski AO, 2009, CURR OPIN BIOTECH, V20, P178, DOI 10.1016/j.copbio.2009.01.005; Charkowski AO, 2006, PLANT-ASSOCIATED BACTERIA, P423; Chatterjee A, 2005, J BACTERIOL, V187, P8026, DOI 10.1128/JB.187.23.8026-8038.2005; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Chevrot R, 2006, P NATL ACAD SCI USA, V103, P7460, DOI 10.1073/pnas.0600313103; Cirou A, 2011, RES MICROBIOL, V162, P945, DOI 10.1016/j.resmic.2011.01.010; Cirou A, 2009, PLANT PATH 21ST, V1, P121, DOI 10.1007/978-1-4020-8804-9_10; Coulthurst SJ, 2006, MOL PLANT PATHOL, V7, P31, DOI 10.1111/J.1364-3703.2005.00314.X; Crepin A, 2012, PLANT SOIL, V358, P25, DOI 10.1007/s11104-011-1030-5; Cui Y, 2006, J BACTERIOL, V188, P4715, DOI 10.1128/JB.00351-06; Czajkowski R, 2011, PLANT PATHOL, V60, P999, DOI 10.1111/j.1365-3059.2011.02470.x; Czajkowski R, 2009, EUR J PLANT PATHOL, V125, P263, DOI 10.1007/s10658-009-9480-9; Deziel E, 2004, P NATL ACAD SCI USA, V101, P1339, DOI 10.1073/pnas.0307694100; Diallo S, 2011, FEMS MICROBIOL ECOL, V75, P351, DOI 10.1111/j.1574-6941.2010.01023.x; Diallo S, 2009, EUR J PLANT PATHOL, V125, P349, DOI 10.1007/s10658-009-9477-4; Faure D, 2007, EUR J PLANT PATHOL, V119, P353, DOI 10.1007/s10658-007-9149-1; Fernandez-Pinar R, 2011, RES MICROBIOL, V162, P773, DOI 10.1016/j.resmic.2011.06.013; Fessehaie A, 2002, CAN J MICROBIOL, V48, P387, DOI 10.1139/W02-026; Fuqua C, 1999, CELL-CELL SIGNALING IN BACTERIA, P211; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Gardan L, 2003, INT J SYST EVOL MICR, V53, P381, DOI 10.1099/ijs.0.02423-0; Glasner JD, 2008, MOL PLANT MICROBE IN, V21, P1549, DOI 10.1094/MPMI-21-12-1549; Glasner JD, 2011, J BACTERIOL, V193, P2076, DOI 10.1128/JB.01513-10; GLICKMANN E, 1995, APPL ENVIRON MICROB, V61, P793, DOI 10.1128/AEM.61.2.793-796.1995; Ham JH, 2004, MOL PLANT MICROBE IN, V17, P184, DOI 10.1094/MPMI.2004.17.2.184; HANCOCK REW, 1979, J BACTERIOL, V140, P902, DOI 10.1128/JB.140.3.902-910.1979; Hardie KR, 2008, NAT REV MICROBIOL, V6, P635, DOI 10.1038/nrmicro1916; Hasegawa H, 2005, APPL ENVIRON MICROB, V71, P4655, DOI 10.1128/AEM.71.8.4655-4663.2005; Heeb S, 2011, FEMS MICROBIOL REV, V35, P247, DOI 10.1111/j.1574-6976.2010.00247.x; Helias V, 2012, PLANT PATHOL, V61, P339, DOI 10.1111/j.1365-3059.2011.02508.x; Hussain MBBM, 2008, J BACTERIOL, V190, P1045, DOI 10.1128/JB.01472-07; Jaeger CH, 1999, APPL ENVIRON MICROB, V65, P2685; Jafra S, 2006, J PHYTOPATHOL, V154, P729, DOI 10.1111/j.1439-0434.2006.01185.x; Kamilova F, 2006, MOL PLANT MICROBE IN, V19, P250, DOI 10.1094/MPMI-19-0250; Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383; Kim HS, 2009, APPL ENVIRON MICROB, V75, P4539, DOI 10.1128/AEM.01336-08; Kim K, 2010, IMMUNOLOGY, V129, P578, DOI 10.1111/j.1365-2567.2009.03160.x; KOTOUJANSKY A, 1982, J BACTERIOL, V150, P122, DOI 10.1128/JB.150.1.122-131.1982; Laasik E, 2006, FEMS MICROBIOL LETT, V258, P227, DOI 10.1111/j.1574-6968.2006.00222.x; Latour X, 2008, CAH AGRIC, V17, P355, DOI 10.1684/agr.2008.0210; Latour X, 2007, APPL ENVIRON MICROB, V73, P4078, DOI 10.1128/AEM.02681-06; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Liu H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000093; Ma B, 2007, PHYTOPATHOLOGY, V97, P1150, DOI 10.1094/PHYTO-97-9-1150; Miller ST, 2004, MOL CELL, V15, P677, DOI 10.1016/j.molcel.2004.07.020; Morin D, 2003, J CHROMATOGR A, V1002, P79, DOI 10.1016/S0021-9673(03)00730-1; Nasser W, 1998, MOL MICROBIOL, V29, P1391, DOI 10.1046/j.1365-2958.1998.01022.x; Ortori CA, 2011, ANAL BIOANAL CHEM, V399, P839, DOI 10.1007/s00216-010-4341-0; Parveen N, 2011, MOL MICROBIOL, V79, P7, DOI 10.1111/j.1365-2958.2010.07455.x; Patten CL, 1996, CAN J MICROBIOL, V42, P207, DOI 10.1139/m96-032; Perombelon MCM, 2002, PLANT PATHOL, V51, P1, DOI 10.1046/j.0032-0862.2001.Short title.doc.x; PIRHONEN M, 1993, EMBO J, V12, P2467, DOI 10.1002/j.1460-2075.1993.tb05901.x; Pitman AR, 2010, EUR J PLANT PATHOL, V126, P423, DOI 10.1007/s10658-009-9551-y; Reading NC, 2006, FEMS MICROBIOL LETT, V254, P1, DOI 10.1111/j.1574-6968.2005.00001.x; Ryan RP, 2008, MICROBIOL-SGM, V154, P1845, DOI 10.1099/mic.0.2008/017871-0; Sambroock J., 1989, MOL CLONING LAB MANU; Samson R, 2005, INT J SYST EVOL MICR, V55, P1415, DOI 10.1099/ijs.0.02791-0; Shaw PD, 1997, P NATL ACAD SCI USA, V94, P6036, DOI 10.1073/pnas.94.12.6036; Shelp BJ, 2006, PLANT PHYSIOL, V142, P1350, DOI 10.1104/pp.106.088955; Shen DK, 2008, MICROBIOL-SGM, V154, P2195, DOI 10.1099/mic.0.2007/013680-0; Sjobolm S, 2006, MOL MICROBIOL, V60, P1474, DOI 10.1111/j.1365-2958.2006.05210.x; Slawiak M, 2009, EUR J PLANT PATHOL, V125, P245, DOI 10.1007/s10658-009-9479-2; Smadja B, 2004, MOL PLANT MICROBE IN, V17, P1269, DOI 10.1094/MPMI.2004.17.11.1269; Smadja B, 2004, CAN J MICROBIOL, V50, P19, DOI 10.1139/W03-099; Spaepen S, 2007, FEMS MICROBIOL REV, V31, P425, DOI 10.1111/j.1574-6976.2007.00072.x; Surette MG, 1998, P NATL ACAD SCI USA, V95, P7046, DOI 10.1073/pnas.95.12.7046; Takle GW, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-50; Toth IK, 2011, PLANT PATHOL, V60, P385, DOI 10.1111/j.1365-3059.2011.02427.x; Toth IK, 2006, ANNU REV PHYTOPATHOL, V44, P305, DOI 10.1146/annurev.phyto.44.070505.143444; Tsror L, 2009, EUR J PLANT PATHOL, V123, P311, DOI 10.1007/s10658-008-9368-0; Ueno H, 2000, J MOL CATAL B-ENZYM, V10, P67, DOI 10.1016/S1381-1177(00)00114-4; Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146; Wang C, 2006, MOL MICROBIOL, V62, P45, DOI 10.1111/j.1365-2958.2006.05351.x; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Welch M, 2005, BIOORG MED CHEM LETT, V15, P4235, DOI 10.1016/j.bmcl.2005.06.066; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P185, DOI 10.1111/j.1574-6968.1998.tb13044.x; Yang SH, 2007, APPL ENVIRON MICROB, V73, P1079, DOI 10.1128/AEM.01770-06; Yuan ZC, 2008, CELL MICROBIOL, V10, P2339, DOI 10.1111/j.1462-5822.2008.01215.x; ZINK RT, 1984, J BACTERIOL, V157, P809, DOI 10.1128/JB.157.3.809-814.1984	89	38	40	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35176	10.1371/journal.pone.0035176	http://dx.doi.org/10.1371/journal.pone.0035176			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539957	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341000021
J	Mukhopadhyay, A; Maulik, U; Bandyopadhyay, S				Mukhopadhyay, Anirban; Maulik, Ujjwal; Bandyopadhyay, Sanghamitra			A Novel Biclustering Approach to Association Rule Mining for Predicting HIV-1-Human Protein Interactions	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITORS; HIV-1 GP120; ALGORITHMS; ACTIVATION; MECHANISM; TYPE-1	Identification of potential viral-host protein interactions is a vital and useful approach towards development of new drugs targeting those interactions. In recent days, computational tools are being utilized for predicting viral-host interactions. Recently a database containing records of experimentally validated interactions between a set of HIV-1 proteins and a set of human proteins has been published. The problem of predicting new interactions based on this database is usually posed as a classification problem. However, posing the problem as a classification one suffers from the lack of biologically validated negative interactions. Therefore it will be beneficial to use the existing database for predicting new viral-host interactions without the need of negative samples. Motivated by this, in this article, the HIV-1-human protein interaction database has been analyzed using association rule mining. The main objective is to identify a set of association rules both among the HIV-1 proteins and among the human proteins, and use these rules for predicting new interactions. In this regard, a novel association rule mining technique based on biclustering has been proposed for discovering frequent closed itemsets followed by the association rules from the adjacency matrix of the HIV-1-human interaction network. Novel HIV-1-human interactions have been predicted based on the discovered association rules and tested for biological significance. For validation of the predicted new interactions, gene ontology-based and pathway-based studies have been performed. These studies show that the human proteins which are predicted to interact with a particular viral protein share many common biological activities. Moreover, literature survey has been used for validation purpose to identify some predicted interactions that are already validated experimentally but not present in the database. Comparison with other prediction methods is also discussed.	[Mukhopadhyay, Anirban] Univ Kalyani, Dept Comp Sci & Engn, Kalyani 741235, W Bengal, India; [Maulik, Ujjwal] Jadavpur Univ, Dept Comp Sci & Engn, Kolkata, W Bengal, India; [Bandyopadhyay, Sanghamitra] Indian Stat Inst, Machine Intelligence Unit, Kolkata, W Bengal, India	Kalyani University; Jadavpur University; Indian Statistical Institute; Indian Statistical Institute Kolkata	Mukhopadhyay, A (corresponding author), Univ Kalyani, Dept Comp Sci & Engn, Kalyani 741235, W Bengal, India.	anirban@klyuniv.ac.in	Maulik, Ujjwal/AAO-8754-2020; Bandyopadhyay, Sanghamitra/AAP-4578-2020; Bandyopadhyay, Sanghamitra/A-6597-2010; Mukhopadhyay, Anirban/H-3220-2012; Mukhopadhyay, Anirban/ABB-5739-2021; Bandyopadhyay, Sanghamitra/AAO-7010-2020	Bandyopadhyay, Sanghamitra/0000-0001-6370-2083; Mukhopadhyay, Anirban/0000-0001-8128-3521; Maulik, Ujjwal/0000-0003-1167-0774	Humboldt Foundation; Humboldt fellowship for experienced researchers	Humboldt Foundation(Alexander von Humboldt Foundation); Humboldt fellowship for experienced researchers	UM acknowledges the partial support received from Humboldt Foundation during his visit to German Cancer Research Center (DKFZ), Heidelberg, Germany with the Humboldt fellowship for experienced researchers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R., 1993, SIGMOD Record, V22, P207, DOI 10.1145/170036.170072; Agrawal R., 1994, VLDB, P487, DOI DOI 10.1007/BF02948845; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Bandyopadhyay S., 2005, ADV METHODS KNOWLEDG; Ben-Hur A, 2005, BIOINFORMATICS, V21, pI38, DOI 10.1093/bioinformatics/bti1016; Cheung R, 2008, J IMMUNOL, V180, P6675, DOI 10.4049/jimmunol.180.10.6675; DeFranco A., 2007, IMMUNITY IMMUNE RESP; Doolittle JM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-82; Dyer MD, 2011, INFECT GENET EVOL, V11, P917, DOI 10.1016/j.meegid.2011.02.022; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Gibellini D, 2010, BIOCHEM BIOPH RES CO, V401, P429, DOI 10.1016/j.bbrc.2010.09.071; Goethals B, 2002, THESIS U LIMBURG BEL; Gupta P, 2011, J MOL BIOL, V410, P681, DOI 10.1016/j.jmb.2011.03.022; Hipp J., 2000, SIGKDD EXPLOR NEWSL, P1, DOI DOI 10.1145/360402.360421; Huang J, 1997, P NATL ACAD SCI USA, V94, P13396, DOI 10.1073/pnas.94.25.13396; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jiang J, 2010, CARDIOVASC RES, V87, P366, DOI 10.1093/cvr/cvq013; Lin N, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-154; MacPherson JI, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000863; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Maulik U., 2011, MULTIOBJECTIVE GENET; Maulik U, 2011, MOL BIOSYST, V7, P1842, DOI 10.1039/c1mb05026e; Maulik U, 2009, IEEE T INF TECHNOL B, V13, P969, DOI 10.1109/TITB.2009.2017527; Maulik U, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-27; Mukhopadhyay A., 2010, 2010 International Conference on Systems in Medicine and Biology (ICSMB), P344, DOI 10.1109/ICSMB.2010.5735401; Mukhopadhyay A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013803; Mukhopadhyay A, 2010, CURR BIOINFORM, V5, P204, DOI 10.2174/157489310792006701; Panchenko A., 2008, PROTEIN PROTEIN INTE, V9; Pasquier N, 1999, LECT NOTES COMPUT SC, V1540, P398; Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060; Ptak RG, 2008, AIDS RES HUM RETROV, V24, P1497, DOI 10.1089/aid.2008.0113; Qi Y, 2007, BMC BIOINFORMATICS, V8; Qi Y, 2010, BIOINFORMATICS, V26; Saha RN, 2007, FREE RADICAL BIO MED, V42, P1866, DOI 10.1016/j.freeradbiomed.2007.03.022; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tastan O, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P516; Vashistha H, 2009, RENAL FAILURE, V31, P303, DOI 10.1080/08860220902780101; Wang XQ, 2009, MOL IMMUNOL, V46, P3462, DOI 10.1016/j.molimm.2009.08.001; Yamanishi Y, 2004, BIOINFORMATICS, V20, P363, DOI 10.1093/bioinformatics/bth910; Zaki MJ, 2005, IEEE T KNOWL DATA EN, V17, P462, DOI 10.1109/TKDE.2005.60; Zhang LV, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-38; Zhou C, 2011, J BIOL CHEM, V286, P44869, DOI 10.1074/jbc.M111.267393	42	37	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e32289	10.1371/journal.pone.0032289	http://dx.doi.org/10.1371/journal.pone.0032289			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539940	Green Published, gold			2022-12-25	WOS:000305341000003
J	Wang, H; Ren, YS; Bai, LJ; Zhang, WS; Tian, J				Wang, Hu; Ren, Yanshuang; Bai, Lijun; Zhang, Wensheng; Tian, Jie			Morphometry Based on Effective and Accurate Correspondences of Localized Patterns (MEACOLP)	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; ATROPHY; BRAIN; CLASSIFICATION; VENTRICLES; DIAGNOSIS	Local features in volumetric images have been used to identify correspondences of localized anatomical structures for brain morphometry. However, the correspondences are often sparse thus ineffective in reflecting the underlying structures, making it unreliable to evaluate specific morphological differences. This paper presents a morphometry method (MEACOLP) based on correspondences with improved effectiveness and accuracy. A novel two-level scale-invariant feature transform is used to enhance the detection repeatability of local features and to recall the correspondences that might be missed in previous studies. Template patterns whose correspondences could be commonly identified in each group are constructed to serve as the basis for morphometric analysis. A matching algorithm is developed to reduce the identification errors by comparing neighboring local features and rejecting unreliable matches. The two-sample t-test is finally adopted to analyze specific properties of the template patterns. Experiments are performed on the public OASIS database to clinically analyze brain images of Alzheimer's disease (AD) and normal controls (NC). MEACOLP automatically identifies known morphological differences between AD and NC brains, and characterizes the differences well as the scaling and translation of underlying structures. Most of the significant differences are identified in only a single hemisphere, indicating that AD-related structures are characterized by strong anatomical asymmetry. In addition, classification trials to differentiate AD subjects from NC confirm that the morphological differences are reliably related to the groups of interest.	[Wang, Hu; Bai, Lijun; Zhang, Wensheng; Tian, Jie] Chinese Acad Sci, Inst Automat, State Key Lab Management & Control Complex Syst, Beijing, Peoples R China; [Ren, Yanshuang] Chinese Acad Tradit Med, Guanganmen Hosp, Dept Radiol, Beijing, Peoples R China; [Tian, Jie] Xidian Univ, Sch Elect Engn, Life Sci Res Ctr, Xian, Peoples R China	Chinese Academy of Sciences; Institute of Automation, CAS; China Academy of Chinese Medical Sciences; Guang'anmen Hospital, CACMS; Xidian University	Wang, H (corresponding author), Chinese Acad Sci, Inst Automat, State Key Lab Management & Control Complex Syst, Beijing, Peoples R China.	yanshr2006@163.com	Bai, Lijun/C-5119-2015; yongbei, Zhu/L-7015-2016; Tian, Jie/H-1190-2011	Bai, Lijun/0000-0001-8790-5424; Tian, Jie/0000-0003-0498-0432	Chinese Academy of Sciences [KGCX2-YW-129]; Project for the National Key Basic Research and Development Program (973) [2011CB707700]; National Natural Science Foundation of China [81071217, 81071141]; Major Research Plan of the National Natural Science Foundation of China [90924026]; Basic research on the 12th Five-Year Plan Project [0101050302]	Chinese Academy of Sciences(Chinese Academy of Sciences); Project for the National Key Basic Research and Development Program (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Research Plan of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic research on the 12th Five-Year Plan Project	This paper is supported by the Knowledge Innovation Program of the Chinese Academy of Sciences under grant No. KGCX2-YW-129, the Project for the National Key Basic Research and Development Program (973) under Grant No. 2011CB707700, the National Natural Science Foundation of China under Grant Nos. 81071217, 81071141, the Major Research Plan of the National Natural Science Foundation of China under Grant No. 90924026, and the Basic research on the 12th Five-Year Plan Project under Grant No. 0101050302. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Chetelat G, 2008, BRAIN, V131, P60, DOI 10.1093/brain/awm288; Chetelat G, 2003, NEUROIMAGE, V18, P525, DOI 10.1016/S1053-8119(02)00026-5; Cheung W, 2009, IEEE T IMAGE PROCESS, V18, P2012, DOI 10.1109/TIP.2009.2024578; Cooke MA, 2008, SCHIZOPHR RES, V103, P40, DOI 10.1016/j.schres.2008.04.022; Cuingnet R, 2011, NEUROIMAGE, V56, P766, DOI 10.1016/j.neuroimage.2010.06.013; Davatzikos C, 2008, NEUROIMAGE, V41, P1220, DOI 10.1016/j.neuroimage.2008.03.050; Desikan RS, 2009, BRAIN, V132, P2048, DOI 10.1093/brain/awp123; Fan Y, 2007, IEEE T MED IMAGING, V26, P93, DOI 10.1109/TMI.2006.886812; Ferrarini L, 2006, NEUROIMAGE, V32, P1060, DOI 10.1016/j.neuroimage.2006.05.048; Gaser C, 2001, NEUROIMAGE, V13, P1140, DOI 10.1006/nimg.2001.0771; Jubault T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008247; Lao ZQ, 2004, NEUROIMAGE, V21, P46, DOI 10.1016/j.neuroimage.2003.09.027; Lowe D., 1999, P INT C COMP VIS, V2, P1150, DOI DOI 10.1109/ICCV.1999.790410; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Mechelli A, 2005, CURR MED IMAGING, V1, P105, DOI 10.2174/1573405054038726; Mikolajczyk K, 2005, INT J COMPUT VISION, V65, P43, DOI 10.1007/s11263-005-3848-x; Mikolajczyk K, 2005, IEEE T PATTERN ANAL, V27, P1615, DOI 10.1109/TPAMI.2005.188; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Pengas G, 2010, NEUROBIOL AGING, V31, P25, DOI 10.1016/j.neurobiolaging.2008.03.014; Pereira JMS, 2010, NEUROIMAGE, V49, P2205, DOI 10.1016/j.neuroimage.2009.10.068; Postelnicu G, 2009, IEEE T MED IMAGING, V28, P508, DOI 10.1109/TMI.2008.2004426; Rankin KP, 2006, BRAIN, V129, P2945, DOI 10.1093/brain/awl254; Scovanner P., 2007, P 15 ACM INT C MULT, P357, DOI DOI 10.1145/1291233.1291311; Se S, 2002, INT J ROBOT RES, V21, P735, DOI 10.1177/027836402761412467; SLANSKY I, 1995, NEURORADIOLOGY, V37, P270; Sluimer JD, 2009, EUR RADIOL, V19, P2826, DOI 10.1007/s00330-009-1512-5; Thompson PM, 2004, NEUROIMAGE, V22, P1754, DOI 10.1016/j.neuroimage.2004.03.040; Toews M, 2007, IEEE T MED IMAGING, V26, P497, DOI 10.1109/TMI.2007.892510; Toews M, 2010, NEUROIMAGE, V49, P2318, DOI 10.1016/j.neuroimage.2009.10.032; Whitwell JL, 2007, BRAIN, V130, P1777, DOI 10.1093/brain/awm112	34	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35745	10.1371/journal.pone.0035745	http://dx.doi.org/10.1371/journal.pone.0035745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540000	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341000066
J	Barosi, G; Rosti, V; Bonetti, E; Campanelli, R; Carolei, A; Catarsi, P; Isgro, AM; Lupo, L; Massa, M; Poletto, V; Viarengo, G; Villani, L; Magrini, U				Barosi, Giovanni; Rosti, Vittorio; Bonetti, Elisa; Campanelli, Rita; Carolei, Adriana; Catarsi, Paolo; Isgro, Antonina M.; Lupo, Letizia; Massa, Margherita; Poletto, Valentina; Viarengo, Gianluca; Villani, Laura; Magrini, Umberto			Evidence that Prefibrotic Myelofibrosis Is Aligned along a Clinical and Biological Continuum Featuring Primary Myelofibrosis	PLOS ONE			English	Article							INTERNATIONAL WORKING GROUP; BONE-MARROW BIOPSY; ESSENTIAL THROMBOCYTHEMIA; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDERS; IDIOPATHIC MYELOFIBROSIS; DIAGNOSTIC-CRITERIA; PROGNOSTIC-FACTORS; POLYCYTHEMIA-VERA; VEIN-THROMBOSIS	Purpose: In the WHO diagnostic classification, prefibrotic myelofibrosis (pre-MF) is included in the category of primary myelofibrosis (PMF). However, strong evidence for this position is lacking. Patients and Methods: We investigated whether pre-MF may be aligned along a clinical and biological continuum in 683 consecutive patients who received a WHO diagnosis of PMF. Results: As compared with PMF-fibrotic type, pre-MF (132 cases) showed female dominance, younger age, higher hemoglobin, higher platelet count, lower white blood cell count, smaller spleen index and higher incidence of splanchnic vein thrombosis. Female to male ratio and hemoglobin steadily decreased, while age increased from pre-MF to PMF- fibrotic type with early and to advanced bone marrow (BM) fibrosis. Likely, circulating CD34+ cells, LDH levels, and frequency of chromosomal abnormalities increased, while CXCR4 expression on CD34+ cells and serum cholesterol decreased along the continuum of BM fibrosis. Median survival of the entire cohort of PMF cases was 21 years. Ninety-eight, eighty-one and fifty-six percent of patients with pre-MF, PMF- fibrotic type with early and with advanced BM fibrosis, respectively, were alive at 10 years from diagnosis. Conclusion: Pre-MF is a presentation mode of PMF with a very indolent phenotype. The major consequences of this contention is a new clinical vision of PMF, and the need to improve prognosis prediction of the disease.	[Barosi, Giovanni; Rosti, Vittorio; Bonetti, Elisa; Campanelli, Rita; Carolei, Adriana; Catarsi, Paolo; Isgro, Antonina M.; Lupo, Letizia; Poletto, Valentina; Villani, Laura; Magrini, Umberto] IRCCS Policlin S Matteo Fdn, Lab Clin Epidemiol, Pavia, Italy; [Barosi, Giovanni; Rosti, Vittorio; Bonetti, Elisa; Campanelli, Rita; Carolei, Adriana; Catarsi, Paolo; Isgro, Antonina M.; Lupo, Letizia; Poletto, Valentina; Villani, Laura; Magrini, Umberto] IRCCS Policlin S Matteo Fdn, Ctr Study Myelofibrosis, Pavia, Italy; [Massa, Margherita] IRCCS Policlin S Matteo Fdn, Biotechnol Res Area, Pavia, Italy; [Viarengo, Gianluca] IRCCS Policlin S Matteo Fdn, Unit Clin Immunol Immunohematol & Transfus Serv, Pavia, Italy	IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo	Barosi, G (corresponding author), IRCCS Policlin S Matteo Fdn, Lab Clin Epidemiol, Pavia, Italy.	barosig@smatteo.pv.it	Carolei, Adriana/AAQ-7656-2021; Massa, Margherita/K-4682-2016; Rosti, Vittorio/K-1743-2018; Bonetti, Elisa/D-4478-2016; Barosi, Giovanni/AAI-1714-2019; Villani, Laura/K-1794-2018; Campanelli, Rita/K-4686-2016; Catarsi, Paolo/J-4463-2016	Carolei, Adriana/0000-0002-5254-8532; Massa, Margherita/0000-0001-8037-0439; Rosti, Vittorio/0000-0003-4195-2289; Bonetti, Elisa/0000-0002-8406-5252; Villani, Laura/0000-0003-4199-5633; Campanelli, Rita/0000-0003-4923-2761; Catarsi, Paolo/0000-0002-1862-8168	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano)	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano)(Fondazione AIRC per la ricerca sul cancro)	This work has been supported by a grant from Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano) "Special Program Molecular Clinical Oncology 5 x 1000" to AGIMM (AIRC-Gruppo Italiano Malattie Mieloproliferative). A detailed description of the AGIMM project is available at http://www.progettoagimm.it. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra A, 2009, ACTA HAEMATOL-BASEL, V121, P218, DOI 10.1159/000221962; Balduini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021015; Barbui T, 2011, J CLIN ONCOL, V29, P3179, DOI 10.1200/JCO.2010.34.5298; Barosi G, 1999, BRIT J HAEMATOL, V104, P730, DOI 10.1046/j.1365-2141.1999.01262.x; BAROSI G, 1988, BRIT J HAEMATOL, V70, P397, DOI 10.1111/j.1365-2141.1988.tb02507.x; BAROSI G, 1991, CANCER, V68, P2310, DOI 10.1002/1097-0142(19911115)68:10<2310::AID-CNCR2820681034>3.0.CO;2-2; BAROSI G, 1981, BRIT J HAEMATOL, V48, P263; Barosi G, 2001, BLOOD, V98, P3249, DOI 10.1182/blood.V98.12.3249; Barosi G, 2007, BLOOD, V110, P4030, DOI 10.1182/blood-2007-07-099184; Brousseau M, 2010, HISTOPATHOLOGY, V56, P758, DOI 10.1111/j.1365-2559.2010.03545.x; Buhr T, 2011, HAEMATOLOGICA   1104; Cervantes F, 1997, BRIT J HAEMATOL, V97, P635, DOI 10.1046/j.1365-2141.1997.782714.x; Cervantes F, 2009, BLOOD, V113, P2895, DOI 10.1182/blood-2008-07-170449; DAMESHEK W, 1951, BLOOD, V6, P372, DOI 10.1182/blood.V6.4.372.372; De Stefano V, 2007, J THROMB HAEMOST, V5, P708, DOI 10.1111/j.1538-7836.2007.02424.x; Dupriez B, 1996, BLOOD, V88, P1013; Finazzi G, 2011, LEUKEMIA; Gilbert H S, 1984, Prog Clin Biol Res, V154, P3; Guglielmelli P, 2011, BLOOD           0914; Hussein K, 2009, EXP HEMATOL, V37, P1186, DOI 10.1016/j.exphem.2009.07.005; Koopmans SM, 2011, AM J CLIN PATHOL, V136, P618, DOI 10.1309/AJCP2UG9SGGWAHUA; Kreft A, 2003, ANN HEMATOL, V82, P605, DOI 10.1007/s00277-003-0719-9; Kvasnicka HM, 1997, CANCER, V80, P708, DOI 10.1002/(SICI)1097-0142(19970815)80:4<708::AID-CNCR9>3.0.CO;2-I; Landolfi R, 2011, INTERN EMERG ME 0610; LASZLO J, 1975, SEMIN HEMATOL, V12, P409; Orr DW, 2010, ALIMENT PHARM THER, V31, P1330, DOI 10.1111/j.1365-2036.2010.04299.x; PAGLIUCA A, 1990, Q J MED, V76, P981; Pardanani A, 2011, LEUKEMIA; Passamonti F, 2010, BLOOD, V115, P1703, DOI 10.1182/blood-2009-09-245837; Primignani M, 2006, HEPATOLOGY, V44, P1528, DOI 10.1002/hep.21435; Reilly JT, 1997, BRIT J HAEMATOL, V98, P96, DOI 10.1046/j.1365-2141.1997.1722990.x; Risum M, 2011, APMIS, V119, P498, DOI 10.1111/j.1600-0463.2011.02754.x; Rosti V, 2007, BLOOD CELL MOL DIS, V38, P280, DOI 10.1016/j.bcmd.2007.01.003; Rosti V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015277; RUPOLI S, 1994, ANN HEMATOL, V68, P205, DOI 10.1007/BF01834368; Stein BL, 2010, HAEMATOL-HEMATOL J, V95, P1090, DOI 10.3324/haematol.2009.014407; Tefferi A, 2007, BLOOD, V110, P1092, DOI 10.1182/blood-2007-04-083501; Tefferi A, 2010, AM J HEMATOL, V85, P14, DOI 10.1002/ajh.21574; Thiele J, 1999, LEUKEMIA, V13, P1741, DOI 10.1038/sj.leu.2401553; Thiele J, 1999, LEUKEMIA LYMPHOMA, V33, P207, DOI 10.3109/10428199909058421; Thiele J, 1996, LEUKEMIA LYMPHOMA, V22, P303, DOI 10.3109/10428199609051762; THIELE J, 2001, WHO CLASSIFICATION T, P35; Thiele J, 2005, HAEMATOLOGICA, V90, P1128; Thiele J, 2011, BLOOD, V117, P5710, DOI 10.1182/blood-2010-07-293761; VISANI G, 1990, BRIT J HAEMATOL, V75, P4, DOI 10.1111/j.1365-2141.1990.tb02609.x; Wilkins BS, 2008, BLOOD, V111, P60, DOI 10.1182/blood-2007-05-091850	46	71	72	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35631	10.1371/journal.pone.0035631	http://dx.doi.org/10.1371/journal.pone.0035631			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536419	Green Submitted, gold, Green Published			2022-12-25	WOS:000305339200088
J	Martinez-Garcia, M; Brazel, DM; Swan, BK; Arnosti, C; Chain, PSG; Reitenga, KG; Xie, G; Poulton, NJ; Gomez, ML; Masland, DED; Thompson, B; Bellows, WK; Ziervogel, K; Lo, CC; Ahmed, S; Gleasner, CD; Detter, CJ; Stepanauskas, R				Martinez-Garcia, Manuel; Brazel, David M.; Swan, Brandon K.; Arnosti, Carol; Chain, Patrick S. G.; Reitenga, Krista G.; Xie, Gary; Poulton, Nicole J.; Gomez, Monica Lluesma; Masland, Dashiell E. D.; Thompson, Brian; Bellows, Wendy K.; Ziervogel, Kai; Lo, Chien-Chi; Ahmed, Sanaa; Gleasner, Cheryl D.; Detter, Chris J.; Stepanauskas, Ramunas			Capturing Single Cell Genomes of Active Polysaccharide Degraders: An Unexpected Contribution of Verrucomicrobia	PLOS ONE			English	Article							RIBOSOMAL-RNA; HYDROLYSIS RATES; MARINE-BACTERIA; GEN. NOV.; SEQUENCE; IDENTIFICATION; AMPLIFICATION; DEGRADATION; ASSEMBLAGES; METABOLISM	Microbial hydrolysis of polysaccharides is critical to ecosystem functioning and is of great interest in diverse biotechnological applications, such as biofuel production and bioremediation. Here we demonstrate the use of a new, efficient approach to recover genomes of active polysaccharide degraders from natural, complex microbial assemblages, using a combination of fluorescently labeled substrates, fluorescence-activated cell sorting, and single cell genomics. We employed this approach to analyze freshwater and coastal bacterioplankton for degraders of laminarin and xylan, two of the most abundant storage and structural polysaccharides in nature. Our results suggest that a few phylotypes of Verrucomicrobia make a considerable contribution to polysaccharide degradation, although they constituted only a minor fraction of the total microbial community. Genomic sequencing of five cells, representing the most predominant, polysaccharide-active Verrucomicrobia phylotype, revealed significant enrichment in genes encoding a wide spectrum of glycoside hydrolases, sulfatases, peptidases, carbohydrate lyases and esterases, confirming that these organisms were well equipped for the hydrolysis of diverse polysaccharides. Remarkably, this enrichment was on average higher than in the sequenced representatives of Bacteroidetes, which are frequently regarded as highly efficient biopolymer degraders. These findings shed light on the ecological roles of uncultured Verrucomicrobia and suggest specific taxa as promising bioprospecting targets. The employed method offers a powerful tool to rapidly identify and recover discrete genomes of active players in polysaccharide degradation, without the need for cultivation.	[Martinez-Garcia, Manuel; Brazel, David M.; Swan, Brandon K.; Poulton, Nicole J.; Gomez, Monica Lluesma; Masland, Dashiell E. D.; Thompson, Brian; Bellows, Wendy K.; Stepanauskas, Ramunas] Bigelow Lab Ocean Sci, W Boothbay Harbor, ME USA; [Brazel, David M.] Colby Coll, Waterville, ME 04901 USA; [Arnosti, Carol; Ziervogel, Kai] Univ N Carolina, Dept Marine Sci, Chapel Hill, NC USA; [Chain, Patrick S. G.; Reitenga, Krista G.; Xie, Gary; Lo, Chien-Chi; Ahmed, Sanaa; Gleasner, Cheryl D.; Detter, Chris J.] Los Alamos Natl Lab, Genome Sci Grp, Los Alamos, NM USA; [Chain, Patrick S. G.; Reitenga, Krista G.; Xie, Gary; Lo, Chien-Chi; Ahmed, Sanaa; Gleasner, Cheryl D.; Detter, Chris J.] Joint Genome Inst, Microbial & Metagenome Program, Walnut Creek, CA USA	Bigelow Laboratory for Ocean Sciences; Colby College; University of North Carolina; University of North Carolina Chapel Hill; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Stepanauskas, R (corresponding author), Univ Alicante, Dept Physiol Genet & Microbiol, E-03080 Alicante, Spain.	rstepanauskas@bigelow.org	chain, patrick/B-9777-2013; Martínez-García, Manuel/AAT-1935-2021; Chain, Patrick/O-4140-2019; Swan, Brandon K/O-9824-2018	Martínez-García, Manuel/0000-0001-5056-1525; Chain, Patrick/0000-0003-3949-3634; Swan, Brandon K/0000-0003-0465-1444; Brazel, David/0000-0001-5361-2498; Stepanauskas, Ramunas/0000-0003-4458-3108; xie, gary/0000-0002-9176-924X; Poulton, Nicole/0000-0003-3020-4509; Lo, Chien-Chi/0000-0003-3470-1078	NSF [DEB-841933, OCE-821374, OCE-0848703]; Maine Technology Institute; U.S. Department of Energy Joint Genome Institute through the Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; U.S. Defense Threat Reduction Agency [B104153I, B084531I]; Division Of Ocean Sciences [0848703] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Maine Technology Institute; U.S. Department of Energy Joint Genome Institute through the Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by the NSF grants DEB-841933 and OCE-821374 to RS, OCE-0848703 to CA and by a Maine Technology Institute research infrastructure grant to the Bigelow Laboratory. The Los Alamos National Laboratory researchers were supported in part by the U.S. Department of Energy Joint Genome Institute through the Office of Science of the U.S. Department of Energy under Contract Number DE-AC02-05CH11231 and grants from the U.S. Defense Threat Reduction Agency under contract numbers B104153I and B084531I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderkamp AC, 2007, FEMS MICROBIOL ECOL, V59, P108, DOI 10.1111/j.1574-6941.2006.00219.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnds J, 2010, SYST APPL MICROBIOL, V33, P139, DOI 10.1016/j.syapm.2009.12.005; ARNOSTI C, 1995, GEOCHIM COSMOCHIM AC, V59, P4247, DOI 10.1016/0016-7037(95)00247-W; Arnosti C, 1996, ORG GEOCHEM, V25, P105, DOI 10.1016/S0146-6380(96)00112-X; Arnosti C, 2003, J CHROMATOGR B, V793, P181, DOI 10.1016/S1570-0232(03)00375-1; Arnosti C, 2011, ANNU REV MAR SCI, V3, P401, DOI 10.1146/annurev-marine-120709-142731; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Biddanda B, 1997, LIMNOL OCEANOGR, V42, P506, DOI 10.4319/lo.1997.42.3.0506; Blanch HW, 2008, ACS CHEM BIOL, V3, P17, DOI 10.1021/cb700267s; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bruckner CG, 2008, APPL ENVIRON MICROB, V74, P7740, DOI 10.1128/AEM.01399-08; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Buckley DH, 2001, FEMS MICROBIOL ECOL, V35, P105, DOI 10.1111/j.1574-6941.2001.tb00793.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Casamayor EO, 2000, APPL ENVIRON MICROB, V66, P499, DOI 10.1128/AEM.66.2.499-508.2000; Chin KJ, 1999, APPL ENVIRON MICROB, V65, P5042; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Fleming EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017769; Freitas S, 2012, ISME J; Fuhrman J.A., 2008, MICROBIAL ECOLOGY OC; Gasol JM, 2007, AQUAT MICROB ECOL, V46, P71, DOI 10.3354/ame046071; Glockner FO, 2003, P NATL ACAD SCI USA, V100, P8298, DOI 10.1073/pnas.1431443100; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Heywood JL, 2011, ISME J, V5, P674, DOI 10.1038/ismej.2010.155; Hoefel D, 2003, J MICROBIOL METH, V52, P379, DOI 10.1016/S0167-7012(02)00207-5; KENNEDY JF, 1988, CARBOHYDRATE CHEM, P220; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lane D.J., 1991, NUCL ACID TECHNIQUES, DOI [10.1099/ijs.0.060731-0, DOI 10.1099/ijs.0.060731-0]; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Martinez-Garcia M, 2012, ISME J, V6, P703, DOI 10.1038/ismej.2011.126; Martinez-Garcia M, 2012, ISME J, V6, P113, DOI 10.1038/ismej.2011.84; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Petroni G, 2000, P NATL ACAD SCI USA, V97, P1813, DOI 10.1073/pnas.030438197; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Scheuermayer M, 2006, INT J SYST EVOL MICR, V56, P2119, DOI 10.1099/ijs.0.64360-0; Sieracki M., 2005, ALGAL CULTURING TECH, P101, DOI DOI 10.1016/B978-012088426-1/50008-1; Sieracki ME, 1999, APPL ENVIRON MICROB, V65, P2409; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Swan BK, 2011, SCIENCE, V333, P1296, DOI 10.1126/science.1203690; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; Ullrich S, 1996, APPL ENVIRON MICROB, V62, P4587, DOI 10.1128/AEM.62.12.4587-4593.1996; Weiner RM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000087; WEISS MS, 1991, SCIENCE, V254, P1627, DOI 10.1126/science.1721242; Woyke T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026161; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Yoon HS, 2011, SCIENCE, V332, P714, DOI 10.1126/science.1203163; Zeng XH, 2011, RENEW SUST ENERG REV, V15, P3252, DOI 10.1016/j.rser.2011.04.014; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214; Zwart G, 2002, AQUAT MICROB ECOL, V28, P141, DOI 10.3354/ame028141	67	162	164	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35314	10.1371/journal.pone.0035314	http://dx.doi.org/10.1371/journal.pone.0035314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536372	gold, Green Published, Green Submitted			2022-12-25	WOS:000305339200055
J	Thelen, M; Damme, M; Schweizer, M; Hagel, C; Wong, AMS; Cooper, JD; Braulke, T; Galliciotti, G				Thelen, Melanie; Damme, Markus; Schweizer, Michaela; Hagel, Christian; Wong, Andrew M. S.; Cooper, Jonathan D.; Braulke, Thomas; Galliciotti, Giovanna			Disruption of the Autophagy-Lysosome Pathway Is Involved in Neuropathology of the nclf Mouse Model of Neuronal Ceroid Lipofuscinosis	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; STORAGE DISEASE; TRANSMEMBRANE PROTEIN; CELL-DEATH; DEGRADATION; ACTIVATION; MUTATIONS; CLN6; ER; NEURODEGENERATION	Variant late-infantile neuronal ceroid lipofuscinosis, a fatal lysosomal storage disorder accompanied by regional atrophy and pronounced neuron loss in the brain, is caused by mutations in the CLN6 gene. CLN6 is a non-glycosylated endoplasmic reticulum (ER)-resident membrane protein of unknown function. To investigate mechanisms contributing to neurodegeneration in CLN6 disease we examined the nclf mouse, a naturally occurring model of the human CLN6 disease. Prominent autofluorescent and electron-dense lysosomal storage material was found in cerebellar Purkinje cells, thalamus, hippocampus, olfactory bulb and in cortical layer II to V. Another prominent early feature of nclf pathogenesis was the localized astrocytosis that was evident in many brain regions and the more widespread microgliosis. Expression analysis of mutant Cln6 found in nclf mice demonstrated synthesis of a truncated protein with a reduced half-life. Whereas the rapid degradation of the mutant Cln6 protein can be inhibited by proteasomal inhibitors, there was no evidence for ER stress or activation of the unfolded protein response in various brain areas during postnatal development. Age-dependent increases in LC3-II, ubiquitinated proteins, and neuronal p62-positive aggregates were observed, indicating a disruption of the autophagy-lysosome degradation pathway of proteins in brains of nclf mice, most likely due to defective fusion between autophagosomes and lysosomes. These data suggest that proteasomal degradation of mutant Cln6 is sufficient to prevent the accumulation of misfolded Cln6 protein, whereas lysosomal dysfunction impairs constitutive autophagy promoting neurodegeneration.	[Thelen, Melanie; Braulke, Thomas; Galliciotti, Giovanna] Univ Med Ctr Hamburg Eppendorf, Dept Biochem, Childrens Hosp, Hamburg, Germany; [Damme, Markus] Univ Bielefeld, Dept Biochem 1, D-33615 Bielefeld, Germany; [Schweizer, Michaela] Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol, Hamburg, Germany; [Hagel, Christian] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany; [Wong, Andrew M. S.; Cooper, Jonathan D.] Kings Coll London, Dept Neurosci, MRC Ctr Neurodegenerat Res, Inst Psychiat, London WC2R 2LS, England; [Wong, Andrew M. S.; Cooper, Jonathan D.] Kings Coll London, Ctr Cellular Basis Behav, MRC Ctr Neurodegenerat Res, Inst Psychiat, London WC2R 2LS, England	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bielefeld; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of London; King's College London; University of London; King's College London	Galliciotti, G (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Biochem, Childrens Hosp, Hamburg, Germany.	g.galliciotti@uke.uni-hamburg.de	Cooper, Jonathan/C-8117-2009; Braulke, Thomas/AAV-9121-2020; Cooper, Jonathan/V-9962-2019	Cooper, Jonathan/0000-0003-1339-4750; Braulke, Thomas/0000-0002-2336-8532; Cooper, Jonathan/0000-0003-1339-4750; Thelen, Melanie/0000-0003-0707-5921; Galliciotti, Giovanna/0000-0002-2697-2364	Swiss National Science Foundation [PA00A3-117483]; Deutsche Forschungsgemeinschaft [FG885]; Wellcome Trust [GR079491MA]; Batten Disease Support and Research Association; Batten Disease Family Association; Natalie Fund; parent organisation Nachstenliebe e.V. [cgh 0328]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wellcome Trust(Wellcome TrustEuropean Commission); Batten Disease Support and Research Association; Batten Disease Family Association; Natalie Fund; parent organisation Nachstenliebe e.V.	This work was financed by the Swiss National Science Foundation (http://www.snf.ch) PA00A3-117483; the Deutsche Forschungsgemeinschaft (http://www.dfg.de) FG885; the Wellcome Trust (http://www.wellcome.ac.uk/) GR079491MA; the Batten Disease Support and Research Association (http://www.bdsra.org/); the Batten Disease Family Association (http://www.bdfa-uk.org.uk/); the Natalie Fund (http://nataliefund.org/); and parent organisation Nachstenliebe e.V. (cgh 0328). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsov T, 2011, AM J HUM GENET, V88, P566, DOI 10.1016/j.ajhg.2011.04.004; Bible E, 2004, NEUROBIOL DIS, V16, P346, DOI 10.1016/j.nbd.2004.02.010; Bronson RT, 1998, AM J MED GENET, V77, P289, DOI 10.1002/(SICI)1096-8628(19980526)77:4<289::AID-AJMG8>3.0.CO;2-I; Cao Y, 2006, J BIOL CHEM, V281, P20483, DOI 10.1074/jbc.M602180200; Cooper JD, 2006, BBA-MOL BASIS DIS, V1762, P873, DOI 10.1016/j.bbadis.2006.08.002; Cooper JD, 2010, BIOCHEM SOC T, V38, P1448, DOI 10.1042/BST0381448; Damme M, 2011, J NEUROPATH EXP NEUR, V70, P83, DOI 10.1097/NEN.0b013e31820428fa; Farfel-Becker T, 2009, HUM MOL GENET, V18, P1482, DOI 10.1093/hmg/ddp061; Gao HL, 2002, AM J HUM GENET, V70, P324, DOI 10.1086/338190; Goebel HH, 2004, BRAIN PATHOL, V14, P61, DOI 10.1111/j.1750-3639.2004.tb00499.x; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Heine C, 2004, J BIOL CHEM, V279, P22347, DOI 10.1074/jbc.M400643200; Heine C, 2007, MOL MEMBR BIOL, V24, P74, DOI 10.1080/09687860600967317; Jabs S, 2008, J NEUROCHEM, V106, P1415, DOI 10.1111/j.1471-4159.2008.05497.x; Jalanko A, 2009, BBA-MOL CELL RES, V1793, P697, DOI 10.1016/j.bbamcr.2008.11.004; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; Kay GW, 2006, BRAIN PATHOL, V16, P110, DOI 10.1111/j.1750-3639.2006.00002.x; Kielar C, 2007, NEUROBIOL DIS, V25, P150, DOI 10.1016/j.nbd.2006.09.001; Kiselyov K, 2007, AUTOPHAGY, V3, P259, DOI 10.4161/auto.3906; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kurze AK, 2010, HUM MUTAT, V31, pE1163, DOI 10.1002/humu.21184; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Mitchison HM, 2004, BRAIN PATHOL, V14, P86, DOI 10.1111/j.1750-3639.2004.tb00502.x; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mole SE, 2005, NEUROGENETICS, V6, P107, DOI 10.1007/s10048-005-0218-3; Mole SE, 2004, EXP CELL RES, V298, P399, DOI 10.1016/j.yexcr.2004.04.042; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Noskova L, 2011, AM J HUM GENET, V89, P241, DOI 10.1016/j.ajhg.2011.07.003; Oswald MJ, 2008, NEUROBIOL DIS, V32, P50, DOI 10.1016/j.nbd.2008.06.004; Oswald MJ, 2005, NEUROBIOL DIS, V20, P49, DOI 10.1016/j.nbd.2005.01.025; PALMER DN, 1986, J BIOL CHEM, V261, P1773; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pontikis CC, 2005, NEUROBIOL DIS, V20, P823, DOI 10.1016/j.nbd.2005.05.018; Pontikis CC, 2004, BRAIN RES, V1023, P231, DOI 10.1016/j.brainres.2004.07.030; Pressey SNR, 2010, J NEUROPATH EXP NEUR, V69, P1228, DOI 10.1097/NEN.0b013e3181ffe742; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Thelen M, 2012, J NEUROSCI RES, V90, P568, DOI 10.1002/jnr.22773; WAHEED A, 1988, EMBO J, V7, P2351, DOI 10.1002/j.1460-2075.1988.tb03079.x; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Wei H, 2008, HUM MOL GENET, V17, P469, DOI 10.1093/hmg/ddm324; Wheeler RB, 2002, AM J HUM GENET, V70, P537, DOI 10.1086/338708; Yla-Anttila P, 2009, METHOD ENZYMOL, V452, P143, DOI 10.1016/S0076-6879(08)03610-0; Zhang ZJ, 2006, HUM MOL GENET, V15, P337, DOI 10.1093/hmg/ddi451	50	63	63	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35493	10.1371/journal.pone.0035493	http://dx.doi.org/10.1371/journal.pone.0035493			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536393	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200071
J	Fukunishi, Y; Browman, HI; Durif, CMF; Bjelland, RM; Skiftesvik, AB				Fukunishi, Yuichi; Browman, Howard I.; Durif, Caroline M. F.; Bjelland, Reidun M.; Skiftesvik, Anne Berit			Effect of Sub-Lethal Exposure to Ultraviolet Radiation on the Escape Performance of Atlantic Cod Larvae (Gadus morhua)	PLOS ONE			English	Article							CARP CYPRINUS-CARPIO; B RADIATION; DNA-DAMAGE; NORTHERN ANCHOVY; CALANUS-FINMARCHICUS; ENGRAULIS-MORDAX; 280-400 NM; SOLAR; EGGS; REPAIR	The amount of ultraviolet (UV) radiation reaching the earth's surface has increased due to depletion of the ozone layer. Several studies have reported that UV radiation reduces survival of fish larvae. However, indirect and sub-lethal impacts of UV radiation on fish behavior have been given little consideration. We observed the escape performance of larval cod (24 dph, SL: 7.6 +/- 0.2 mm; 29 dph, SL: 8.2 +/- 0.3 mm) that had been exposed to sub-lethal levels of UV radiation vs. unexposed controls. Two predators were used (in separate experiments): two-spotted goby (Gobiusculus flavescens; a suction predator) and lion's mane jellyfish (Cyanea capillata; a "passive'' ambush predator). Ten cod larvae were observed in the presence of a predator for 20 minutes using a digital video camera. Trials were replicated 4 times for goby and 5 times for jellyfish. Escape rate (total number of escapes/total number of attacks x 100), escape distance and the number of larvae remaining at the end of the experiment were measured. In the experiment with gobies, in the UV-treated larvae, both escape rate and escape distance (36%, 38 +/- 7.5 mm respectively) were significantly lower than those of control larvae (75%, 69 +/- 4.7 mm respectively). There was a significant difference in survival as well (UV: 35%, Control: 63%). No apparent escape response was observed, and survival rate was not significantly different, between treatments (UV: 66%, Control: 74%) in the experiment with jellyfish. We conclude that the effect and impact of exposure to sub-lethal levels of UV radiation on the escape performance of cod larvae depends on the type of predator. Our results also suggest that prediction of UV impacts on fish larvae based only on direct effects are underestimations.	[Fukunishi, Yuichi; Browman, Howard I.; Durif, Caroline M. F.; Bjelland, Reidun M.; Skiftesvik, Anne Berit] Inst Marine Res, Austevoll Res Stn, Storebo, Norway	Institute of Marine Research - Norway	Fukunishi, Y (corresponding author), Inst Marine Res, Austevoll Res Stn, Storebo, Norway.	yuichi.fukunishi@imr.no	Browman, Howard/B-4441-2009; Skiftesvik, Anne Berit/M-1266-2013; Browman, Howard/CAA-2802-2022; Durif, Caroline/A-6406-2011	Browman, Howard/0000-0002-6282-7316; Skiftesvik, Anne Berit/0000-0002-7754-5661; Browman, Howard/0000-0002-6282-7316; 	Japan Society for the Promotion of Science; Norwegian Institute of Marine Research [11529]; Research Council of Norway [178731/S40, 201981/F11]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Norwegian Institute of Marine Research; Research Council of Norway(Research Council of Norway)	YF was supported by the FY 2010 Researcher Exchange Program between the Japan Society for the Promotion of Science and the Research Council of Norway; Project number: 201981/F11. This research was supported by the Norwegian Institute of Marine Research (Fine-scale interactions in the plankton -Project 11529 - to HIB) and the Research Council of Norway project "Cascading effects of climate change and UV envirotoxins on the nutritional quality of the food base in marine ecosystems (Project # 178731/S40 to HIB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas E, 2001, OCEANOLOGIA, V43, P139; Alemanni ME, 2003, PHOTOCH PHOTOBIO SCI, V2, P867, DOI 10.1039/b301564e; ANDERSON JT, 1995, CAN J FISH AQUAT SCI, V52, P1978, DOI 10.1139/f95-789; Armstrong TN, 2002, AQUAT TOXICOL, V58, P1, DOI 10.1016/S0166-445X(01)00212-0; BAMSTEDT U, 1994, ICES J MAR SCI, V51, P369, DOI 10.1006/jmsc.1994.1039; Barz K, 2007, MAR BIOL, V151, P1021, DOI 10.1007/s00227-006-0545-4; Beland F, 1999, CAN J FISH AQUAT SCI, V56, P1058, DOI 10.1139/cjfas-56-6-1058; Blazer VS, 1997, J AQUAT ANIM HEALTH, V9, P132, DOI 10.1577/1548-8667(1997)009&lt;0132:EOUBRO&gt;2.3.CO;2; Browman HI, 2002, ECOL STU AN, V153, P261; Browman HI, 2003, PHOTOCHEM PHOTOBIOL, V77, P397, DOI 10.1562/0031-8655(2003)077<0397:UNDDIT>2.0.CO;2; Browman HI, 2000, MAR ECOL PROG SER, V199, P293, DOI 10.3354/meps199293; Dong Q, 2007, J PHOTOCH PHOTOBIO B, V88, P137, DOI 10.1016/j.jphotobiol.2007.07.002; Fields DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026333; Gronkjaer P, 1997, MAR ECOL PROG SER, V154, P91, DOI 10.3354/meps154091; Hader DP, 2011, PHOTOCH PHOTOBIO SCI, V10, P242, DOI 10.1039/c0pp90036b; Helmholz H, 2010, HYDROBIOLOGIA, V645, P223, DOI 10.1007/s10750-010-0216-9; Holtby LB, 2008, CAN J FISH AQUAT SCI, V65, P701, DOI 10.1139/F08-013; Houde ED, 1987, AM FISH SOC S, V2, P17; HUNTER JR, 1979, PHOTOCHEM PHOTOBIOL, V29, P325, DOI 10.1111/j.1751-1097.1979.tb07055.x; HUNTER JR, 1981, PHOTOCHEM PHOTOBIOL, V34, P477, DOI 10.1111/j.1751-1097.1981.tb09028.x; Jokinen IE, 2008, PHOTOCHEM PHOTOBIOL, V84, P1265, DOI 10.1111/j.1751-1097.2008.00358.x; Kelly DJ, 2002, CAN J FISH AQUAT SCI, V59, P474, DOI 10.1139/F02-023; KERR JB, 1993, SCIENCE, V262, P1032, DOI 10.1126/science.262.5136.1032; Koster FW, 2000, ICES J MAR SCI, V57, P310, DOI 10.1006/jmsc.1999.0528; Kouwenberg JHM, 1999, MAR BIOL, V134, P269, DOI 10.1007/s002270050545; Krzyscin JW, 2011, ACTA GEOPHYS, V59, P155, DOI 10.2478/s11600-010-0036-3; Kuhn PS, 2000, LIMNOL OCEANOGR, V45, P1797, DOI 10.4319/lo.2000.45.8.1797; Lassen S, 2010, HYDROBIOLOGIA, V645, P213, DOI 10.1007/s10750-010-0215-x; LEGGETT WC, 1994, NETH J SEA RES, V32, P119, DOI 10.1016/0077-7579(94)90036-1; Lesser MP, 2001, J EXP BIOL, V204, P157; Lough RG, 1996, DEEP-SEA RES PT II, V43, P1875, DOI 10.1016/S0967-0645(96)00053-7; Madronich S, 1998, J PHOTOCH PHOTOBIO B, V46, P5, DOI 10.1016/S1011-1344(98)00182-1; Malloy KD, 1997, P NATL ACAD SCI USA, V94, P1258, DOI 10.1073/pnas.94.4.1258; Manney GL, 2011, NATURE, V478, P469, DOI 10.1038/nature10556; Markkula E, 2009, PHOTOCHEM PHOTOBIOL, V85, P347, DOI 10.1111/j.1751-1097.2008.00446.x; Markkula SE, 2006, FISH SHELLFISH IMMUN, V21, P70, DOI 10.1016/j.fsi.2005.10.007; Markkula SE, 2005, PHOTOCHEM PHOTOBIOL, V81, P595, DOI 10.1562/2004-07-13-RA-231.1; McFadzen I, 2000, MAR ENVIRON RES, V50, P273, DOI 10.1016/S0141-1136(00)00085-4; McKenzie RL, 2007, PHOTOCH PHOTOBIO SCI, V6, P218, DOI 10.1039/b700017k; McKenzie RL, 2011, PHOTOCH PHOTOBIO SCI, V10, P182, DOI 10.1039/c0pp90034f; Miller P.J., 1986, P1019; Paz J., 1992, Journal of Northwest Atlantic Fishery Science, V14, P129; Ravishankara A. R., 2009, Science (Washington), V326, P123, DOI 10.1126/science.1176985; Romansic JM, 2009, HYDROBIOLOGIA, V624, P219, DOI 10.1007/s10750-009-9703-2; Steeger HU, 1999, J SEA RES, V42, P27, DOI 10.1016/S1385-1101(99)00009-X; Svensson PA, 2000, J FISH BIOL, V56, P1477, DOI 10.1111/j.1095-8649.2000.tb02158.x; Tedetti M, 2006, PHOTOCHEM PHOTOBIOL, V82, P389, DOI 10.1562/2005-11-09-IR-733; Tedetti M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029823; Tucker Andrew J., 2011, Freshwater Reviews, V4, P115, DOI 10.1608/FRJ-4.2.474; van der Meeren T, 2007, AQUACULTURE, V265, P206, DOI [10.1016/j.aquaculture.2007.01.042, 10.1016/j.aquaculture.2007.06.038]; Vehniainen ER, 2007, BOREAL ENVIRON RES, V12, P673; Vetter RD, 1999, PHOTOCHEM PHOTOBIOL, V69, P27, DOI 10.1562/0031-8655(1999)069<0027:DCODDA>2.3.CO;2; WALDSTEI.EA, 1974, P NATL ACAD SCI USA, V71, P2651, DOI 10.1073/pnas.71.7.2651; WHEELER A, 1969, P613	54	20	20	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35554	10.1371/journal.pone.0035554	http://dx.doi.org/10.1371/journal.pone.0035554			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536406	Green Published, gold			2022-12-25	WOS:000305336200054
J	Osada, M; Inoue, O; Ding, G; Shirai, T; Ichise, H; Hirayama, K; Takano, K; Yatomi, Y; Hirashima, M; Fujii, H; Suzuki-Inoue, K; Ozaki, Y				Osada, Makoto; Inoue, Osamu; Ding, Guo; Shirai, Toshiaki; Ichise, Hirotake; Hirayama, Kazuyoshi; Takano, Katsuhiro; Yatomi, Yutaka; Hirashima, Masanori; Fujii, Hideki; Suzuki-Inoue, Katsue; Ozaki, Yukio			Platelet Activation Receptor CLEC-2 Regulates Blood/Lymphatic Vessel Separation by Inhibiting Proliferation, Migration, and Tube Formation of Lymphatic Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTIN; BONE MORPHOGENETIC PROTEIN-9; PHOSPHOLIPASE C-GAMMA-2; INTEGRIN ACTIVATION; GLYCOPROTEIN-VI; MICE LACKING; PODOPLANIN; BLOOD; SYK; ANGIOGENESIS	The platelet activation receptor CLEC-2 plays crucial roles in thrombosis/hemostasis, tumor metastasis, and lymphangiogenesis, although its role in thrombosis/hemostasis remains controversial. An endogenous ligand for CLEC-2, podoplanin, is expressed in lymphatic endothelial cells (LECs). We and others have reported that CLEC-2-deficiency is lethal at mouse embryonic/neonatal stages associated with blood-filled lymphatics, indicating that CLEC-2 is essential for blood/lymphatic vessel separation. However, its mechanism, and whether CLEC-2 in platelets is necessary for this separation, remains unknown. We found that specific deletion of CLEC-2 from platelets leads to the misconnection of blood/lymphatic vessels. CLEC-2(+/+) platelets platelets, but not by CLEC-2(-/-) platelets, inhibited LEC migration, proliferation, and tube formation but had no effect on human umbilical vein endothelial cells. Additionally, supernatants from activated platelets significantly inhibited these three functions in LECs, suggesting that released granule contents regulate blood/lymphatic vessel separation. Bone morphologic protein-9 (BMP-9), which we found to be present in platelets and released upon activation, appears to play a key role in regulating LEC functions. Only BMP-9 inhibited tube formation, although other releasates including transforming growth factor-beta and platelet factor 4 inhibited proliferation and/or migration. We propose that platelets regulate blood/lymphatic vessel separation by inhibiting the proliferation, migration, and tube formation of LECs, mainly because of the release of BMP-9 upon activation by CLEC-2/podoplanin interaction.	[Osada, Makoto; Inoue, Osamu; Shirai, Toshiaki; Takano, Katsuhiro; Suzuki-Inoue, Katsue; Ozaki, Yukio] Univ Yamanashi, Fac Med, Dept Clin & Lab Med, Chuo Ku, Yamanashi 4093898, Japan; [Ding, Guo; Hirashima, Masanori] Kobe Univ, Grad Sch Med, Div Vasc Biol, Dept Physiol & Cell Biol,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Ichise, Hirotake] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Lab Dev Genet, Tokyo 1088639, Japan; [Hirayama, Kazuyoshi; Fujii, Hideki] Univ Yamanashi, Fac Med, Dept Surg 1, Chuo Ku, Yamanashi 4093898, Japan; [Yatomi, Yutaka] Univ Tokyo, Grad Sch Med, Dept Lab Med, Tokyo 1138655, Japan	University of Yamanashi; Kobe University; University of Tokyo; University of Yamanashi; University of Tokyo	Suzuki-Inoue, K (corresponding author), Univ Yamanashi, Fac Med, Dept Clin & Lab Med, Chuo Ku, 1110 Shimokato, Yamanashi 4093898, Japan.	katsuei@yamanashi.ac.jp	Ichise, Hirotake/V-3536-2019; Hirashima, Masanori/ABC-9204-2021	Ichise, Hirotake/0000-0002-3424-6637; Hirashima, Masanori/0000-0002-0190-4381; Yatomi, Yutaka/0000-0003-1719-4297	Ministry of Education, Culture, Sports, Science, and Technology; Council for Science and Technology Policy (CSTP); Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [23591984] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology and the Japan Society for the Promotion of Science (JSPS) through the Funding Program for Next Generation World-leading Researchers (NEXT Program) initiated by the Council for Science and Technology Policy (CSTP).	Abtahian F, 2003, SCIENCE, V299, P247, DOI 10.1126/science.1079477; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Banfi C, 2009, J THROMB HAEMOST, V7, P206, DOI 10.1111/j.1538-7836.2008.03204.x; Bertozzi CC, 2010, BLOOD, V116, P661, DOI 10.1182/blood-2010-02-270876; Bialkowska K, 2010, J BIOL CHEM, V285, P18640, DOI 10.1074/jbc.M109.085746; Carramolino L, 2010, CIRC RES, V106, P1197, DOI 10.1161/CIRCRESAHA.110.218073; Chaipan C, 2006, J VIROL, V80, P8951, DOI 10.1128/JVI.00136-06; Chang CH, 2010, J THROMB HAEMOST, V8, P2563, DOI 10.1111/j.1538-7836.2010.04045.x; Christou CM, 2008, BIOCHEM J, V411, P133, DOI 10.1042/BJ20071216; Chung CH, 2004, BLOOD, V103, P2105, DOI 10.1182/blood-2003-07-2483; Colonna M, 2000, EUR J IMMUNOL, V30, P697; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Finney BA, 2012, BLOOD, V119, P1747, DOI 10.1182/blood-2011-09-380709; Ho-Tin-Noe B, 2011, J THROMB HAEMOST, V9, P56, DOI 10.1111/j.1538-7836.2011.04317.x; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Ichise H, 2009, DEVELOPMENT, V136, P191, DOI 10.1242/dev.025353; Ichise T, 2010, DEVELOPMENT, V137, P1003, DOI 10.1242/dev.043489; Inoue O, 2009, FEBS LETT, V583, P81, DOI 10.1016/j.febslet.2008.11.026; Jandrot-Perrus M, 2000, BLOOD, V96, P1798, DOI 10.1182/blood.V96.5.1798.h8001798_1798_1807; Kandler B, 2004, J PERIODONTOL, V75, P1255, DOI 10.1902/jop.2004.75.9.1255; Kato Y, 2008, CANCER SCI, V99, P54, DOI 10.1111/j.1349-7006.2007.00634.x; Kerrigan AM, 2009, J IMMUNOL, V182, P4150, DOI 10.4049/jimmunol.0802808; Levin J, 1999, BLOOD, V94, P3037, DOI 10.1182/blood.V94.9.3037.421k42_3037_3047; Martin-Villar E, 2006, J CELL SCI, V119, P4541, DOI 10.1242/jcs.03218; Miller AF, 2000, J BIOL CHEM, V275, P17937, DOI 10.1074/jbc.275.24.17937; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Mourao-Sa D, 2011, EUR J IMMUNOL, V41, P3040, DOI 10.1002/eji.201141641; Navarro A, 2011, AM J PHYSIOL-LUNG C, V300, pL32, DOI 10.1152/ajplung.00171.2010; Navdaev A, 2001, J BIOL CHEM, V276, P20882, DOI 10.1074/jbc.M101585200; Oka M, 2008, BLOOD, V111, P4571, DOI 10.1182/blood-2007-10-120337; Osada M., 2010, BLOOD, V116, P160; Pipili-Synetos E, 1998, BRIT J PHARMACOL, V125, P1252, DOI 10.1038/sj.bjp.0702191; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Senis YA, 2007, MOL CELL PROTEOMICS, V6, P548, DOI 10.1074/mcp.D600007-MCP200; Shao XJ, 2005, LYMPHOLOGY, V38, P146; Shao XJ, 2005, LYMPHOLOGY, V38, P1; SHIVDASANI RA, 1995, P NATL ACAD SCI USA, V92, P8690, DOI 10.1073/pnas.92.19.8690; SONG JJ, 1995, ENDOCRINOLOGY, V136, P4293, DOI 10.1210/en.136.10.4293; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Suzuki-Inoue K, 2003, BLOOD, V102, P1367, DOI 10.1182/blood-2003-01-0029; Suzuki-Inoue K, 2002, J BIOL CHEM, V277, P21561, DOI 10.1074/jbc.M201012200; Suzuki-Inoue K, 2001, J BIOL CHEM, V276, P1643, DOI 10.1074/jbc.M006191200; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; Suzuki-Inoue K, 2010, J BIOL CHEM, V285, P24494, DOI 10.1074/jbc.M110.130575; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362; Tsuruo T, 2008, P JPN ACAD A-MATH, V84, P189, DOI 10.2183/pjab/84.189; Uhrin P, 2010, BLOOD, V115, P3997, DOI 10.1182/blood-2009-04-216069; WOZNEY JM, 1992, MOL REPROD DEV, V32, P160, DOI 10.1002/mrd.1080320212; Yamashita H, 1996, BONE, V19, P569, DOI 10.1016/S8756-3282(96)00259-1	51	98	102	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22241	22252		10.1074/jbc.M111.329987	http://dx.doi.org/10.1074/jbc.M111.329987			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22556408	Green Published, hybrid			2022-12-25	WOS:000306418600062
J	Choi, SG; Jia, J; Pfeffer, RL; Sealfon, SC				Choi, Soon-Gang; Jia, Jingjing; Pfeffer, Robert L.; Sealfon, Stuart C.			G Proteins and Autocrine Signaling Differentially Regulate Gonadotropin Subunit Expression in Pituitary Gonadotrope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLLICLE-STIMULATING-HORMONE; BONE MORPHOGENETIC PROTEIN-2; LUTEINIZING-HORMONE; HUMAN ENDOMETRIAL; CANCER-CELLS; BETA-SUBUNIT; RECEPTOR; ACTIVIN; GNRH; TRANSCRIPTION	Gonadotropin-releasing hormone (GnRH) acts at gonadotropes to direct the synthesis of the gonadotropins, follicle-stimulating hormone (FSH), and luteinizing hormone (LH). The frequency of GnRH pulses determines the pattern of gonadotropin synthesis. Several hypotheses for how the gonadotrope decodes GnRH frequency to regulate gonadotropin subunit genes differentially have been proposed. However, key regulators and underlying mechanisms remain uncertain. We investigated the role of individual G proteins by perturbations using siRNA or bacterial toxins. In L beta T2 gonadotrope cells, FSH beta gene induction depended predominantly on G alpha(q/11), whereas LH beta expression depended on G alpha(s). Specifically reducing G alpha(s) signaling also disinhibited FSH beta expression, suggesting the presence of a G alpha(s)-dependent signal that suppressed FSH biosynthesis. The presence of secreted factors influencing FSH beta expression levels was tested by studying the effects of conditioned media from G alpha(s) knockdown and cholera toxin-treated cells on FSH beta expression. These studies and related Transwell culture experiments implicate G alpha(s)-dependent secreted factors in regulating both FSH beta and LH beta gene expression. siRNA studies identify inhibin alpha as a G alpha(s)-dependent GnRH-induced autocrine regulatory factor that contributes to feedback suppression of FSH beta expression. These results uncover differential regulation of the gonadotropin genes by G alpha(q/11) and by G alpha(s) and implicate autocrine and gonadotrope-gonadotrope paracrine regulatory loops in the differential induction of gonadotropin genes.	Mt Sinai Sch Med, Ctr Translat Syst Biol, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Sealfon, SC (corresponding author), Neurol Box 1137,1 Gustave L Levy Pl, New York, NY 10029 USA.	stuart.sealfon@mssm.edu	choi, soon gang/AAE-3187-2019; Choi, Soon Gang/G-8337-2013	choi, soon gang/0000-0003-0314-3958; Choi, Soon Gang/0000-0003-0314-3958; SEALFON, Stuart/0000-0001-5791-1217	National Institutes of Health [R01DK046943]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK046943	Achermann JC, 2001, MOL CELL ENDOCRINOL, V179, P89, DOI 10.1016/S0303-7207(01)00474-9; AMATRUDA TT, 1991, P NATL ACAD SCI USA, V88, P5587, DOI 10.1073/pnas.88.13.5587; Armstrong SP, 2009, J BIOL CHEM, V284, P35746, DOI 10.1074/jbc.M109.063917; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernard DJ, 2004, MOL ENDOCRINOL, V18, P606, DOI 10.1210/me.2003-0264; Bilezikjian LM, 2004, MOL CELL ENDOCRINOL, V225, P29, DOI 10.1016/j.mce.2004.02.010; Bowles R, 2011, JOVE-J VIS EXP, DOI 10.3791/2766; Brothers SP, 2003, J CLIN ENDOCR METAB, V88, P6107, DOI 10.1210/jc.2003-031047; Burger LL, 2002, ENDOCRINOLOGY, V143, P3243, DOI 10.1210/en.2002-220216; Cheung LWT, 2008, FEBS J, V275, P5479, DOI 10.1111/j.1742-4658.2008.06677.x; Ciccone NA, 2008, MOL ENDOCRINOL, V22, P1908, DOI 10.1210/me.2007-0455; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Fink MY, 2010, MOL ENDOCRINOL, V24, P1863, DOI 10.1210/me.2009-0530; Grundker C, 2001, ENDOCRINOLOGY, V142, P2369, DOI 10.1210/en.142.6.2369; Grundker C, 2001, EUR J ENDOCRINOL, V145, P651, DOI 10.1530/eje.0.1450651; Hall JE, 1998, J ENDOCRINOL INVEST, V21, P602, DOI 10.1007/BF03350785; Ho CC, 2010, ENDOCRINOLOGY, V151, P3445, DOI 10.1210/en.2010-0071; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; HSIEH KP, 1992, MOL ENDOCRINOL, V6, P1673, DOI 10.1210/me.6.10.1673; Huang HJ, 2001, ENDOCRINOLOGY, V142, P2275, DOI 10.1210/en.142.6.2275; KANYICSKA B, 1991, ENDOCRINOLOGY, V129, P2607, DOI 10.1210/endo-129-5-2607; Kimura A, 1999, CANCER RES, V59, P5133; Krakauer DC, 2002, J THEOR BIOL, V218, P457, DOI 10.1006/jtbi.2002.3092; Krsmanovic LZ, 2003, P NATL ACAD SCI USA, V100, P2969, DOI 10.1073/pnas.0535708100; Lambert NA, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.125re5; Lee KB, 2007, J MOL ENDOCRINOL, V38, P315, DOI 10.1677/jme.1.02196; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Liu FJ, 2002, J BIOL CHEM, V277, P32099, DOI 10.1074/jbc.M203639200; MAPARA MY, 1995, BLOOD, V85, P1836, DOI 10.1182/blood.V85.7.1836.bloodjournal8571836; MARSHALL JC, 1991, RECENT PROG HORM RES, V47, P155; Marshall JC, 2001, MOL CELL ENDOCRINOL, V183, P29, DOI 10.1016/S0303-7207(01)00611-6; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Pernasetti F, 2001, ENDOCRINOLOGY, V142, P2284, DOI 10.1210/en.142.6.2284; Popovics P, 2011, J ENDOCRINOL, V210, P71, DOI 10.1530/JOE-10-0485; Ronnett GV, 2002, ANNU REV PHYSIOL, V64, P189, DOI 10.1146/annurev.physiol.64.082701.102219; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Sealfon SC, 1997, ENDOCR REV, V18, P180, DOI 10.1210/er.18.2.180; SHAH BH, 1994, MOL PHARMACOL, V46, P1; Shimoni Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000828; Siehler S, 2009, BRIT J PHARMACOL, V158, P41, DOI 10.1111/j.1476-5381.2009.00121.x; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Smyth VA, 2008, J BIOL CHEM, V283, P10881, DOI 10.1074/jbc.M710454200; Stanislaus D, 1997, MOL ENDOCRINOL, V11, P738, DOI 10.1210/me.11.6.738; Tang SK, 2010, INT J SYST EVOL MICR, V60, P2113, DOI 10.1099/ijs.0.018440-0; Tsutsumi R, 2010, J BIOL CHEM, V285, P20262, DOI 10.1074/jbc.M110.132662; Washington Talitha M, 2004, Theor Biol Med Model, V1, P9, DOI 10.1186/1742-4682-1-9; Wu JC, 2004, ENDOCRINOLOGY, V145, P5832, DOI 10.1210/en.2004-0257; Wurmbach E, 2001, J BIOL CHEM, V276, P47195, DOI 10.1074/jbc.M108716200; Zhu J, 2012, J BIOL CHEM, V287, P8060, DOI 10.1074/jbc.M111.293381	50	28	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21550	21560		10.1074/jbc.M112.348607	http://dx.doi.org/10.1074/jbc.M112.348607			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22549790	hybrid, Green Published			2022-12-25	WOS:000306416800072
J	Xiao, GZ; Cheng, HQ; Cao, HL; Chen, K; Tu, YZ; Yu, SB; Jiao, HL; Yang, SY; Im, HJ; Chen, D; Chen, J; Wu, CY				Xiao, Guozhi; Cheng, Hongqiang; Cao, Huiling; Chen, Ka; Tu, Yizeng; Yu, Shibing; Jiao, Hongli; Yang, Shengyong; Im, Hee-Jeong; Chen, Di; Chen, Ju; Wu, Chuanyue			Critical Role of Filamin-binding LIM Protein 1 (FBLP-1)/Migfilin in Regulation of Bone Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOCLAST-OSTEOBLAST COMMUNICATION; ACTIVATING TRANSCRIPTION FACTOR-4; OSTEOCALCIN GENE-EXPRESSION; CELL-MATRIX ADHESION; RANKL EXPRESSION; PARATHYROID-HORMONE; STEM-CELLS; MIGFILIN; DIFFERENTIATION; INTEGRIN	Bone remodeling is a complex process that must be precisely controlled to maintain a healthy life. We show here that filamin-binding LIM protein 1 (FBLP-1, also known as migfilin), a kind-lin- and filamin-binding focal adhesion protein, is essential for proper control of bone remodeling. Genetic inactivation of FBLIM1 (the gene encoding FBLP-1) in mice resulted in a severe osteopenic phenotype. Primary FBLP-1 null bone marrow stromal cells (BMSCs) exhibited significantly reduced extracellular matrix adhesion and migration compared with wild type BMSCs. Loss of FBLP-1 significantly impaired the growth and survival of BMSCs in vitro and decreased the number of osteoblast (OB) progenitors in bone marrow and OB differentiation in vivo. Furthermore, the loss of FBLP-1 caused a dramatic increase of osteoclast (OCL) differentiation in vivo. The level of receptor activator of nuclear factor kappa B ligand (RANKL), a key regulator of OCL differentiation, was markedly increased in FBLP-1 null BMSCs. The capacity of FBLP-1 null bone marrow monocytes (BMMs) to differentiate into multinucleated OCLs in response to exogenously supplied RANKL, however, was not different from that of WT BMMs. Finally, we show that a loss of FBLP-1 promotes activating phosphorylation of ERK1/2. Inhibition of ERK1/2 activation substantially suppressed the increase of RANKL induced by the loss of FBLP-1. Our results identify FBLP-1 as a key regulator of bone homeostasis and suggest that FBLP-1 functions in this process through modulating both the intrinsic properties of OB/BMSCs (i.e., BMSC-extracellular matrix adhesion and migration, cell growth, survival, and differentiation) and the communication between OB/BMSCs and BMMs (i.e., RANKL expression) that controls osteoclastogenesis.	[Xiao, Guozhi; Jiao, Hongli; Im, Hee-Jeong; Chen, Di] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA; [Xiao, Guozhi; Cao, Huiling; Yu, Shibing; Jiao, Hongli; Yang, Shengyong] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15240 USA; [Cheng, Hongqiang; Chen, Ju] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Chen, Ka; Tu, Yizeng; Wu, Chuanyue] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA	Rush University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Xiao, GZ (corresponding author), Rush Univ, Med Ctr, Dept Biochem, Cohn Res Bldg,Rm 518,1735 W Harrison St, Chicago, IL 60612 USA.	xiaogz118@gmail.com; juchen@ucsd.edu; carywu@pitt.edu	Chen, Ju/E-5579-2011; Chen, Di/AAJ-3665-2021	Jiao, Hongli/0000-0001-8005-8496; Cheng, Hongqiang/0000-0001-9662-1570	National Institutes of Health [AR059647, GM65188]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055915, R01AR059647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065188] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants AR059647 (to G. X.) and GM65188 (to C. W.).	Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; ASH P, 1980, NATURE, V283, P669, DOI 10.1038/283669a0; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brunner M, 2011, J CELL BIOL, V194, P307, DOI 10.1083/jcb.201007108; Camacho C. L., 2011, THESIS U MANCHESTER; Cao HL, 2010, J CLIN INVEST, V120, P2755, DOI 10.1172/JCI42106; Cao X, 2011, NAT MED, V17, P1344, DOI 10.1038/nm.2499; Cheng HQ, 2010, CIRC RES, V107, P348, DOI 10.1161/CIRCRESAHA.110.218735; Das M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026355; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Gkretsi V, 2005, J CELL SCI, V118, P697, DOI 10.1242/jcs.01638; Hart AW, 2006, HUM MOL GENET, V15, P2457, DOI 10.1093/hmg/ddl168; Henriksen K, 2009, BONE, V44, P1026, DOI 10.1016/j.bone.2009.03.671; Ithychanda SS, 2011, BIOCHEMISTRY-US, V50, P4229, DOI 10.1021/bi2003229; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; Lai-Cheong JE, 2008, J INVEST DERMATOL, V128, P2156, DOI 10.1038/jid.2008.58; Lai-Cheong JE, 2010, INT J BIOCHEM CELL B, V42, P595, DOI 10.1016/j.biocel.2009.10.015; Larjava H, 2008, EMBO REP, V9, P1203, DOI 10.1038/embor.2008.202; Lee JH, 2009, J BIOL CHEM, V284, P13725, DOI 10.1074/jbc.M806941200; Liang XQ, 2005, MOL CELL BIOL, V25, P3056, DOI 10.1128/MCB.25.8.3056-3062.2005; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; Matsushita T, 2009, MOL CELL BIOL, V29, P5843, DOI 10.1128/MCB.01549-08; Meves A, 2009, TRENDS CELL BIOL, V19, P504, DOI 10.1016/j.tcb.2009.07.006; Moik DV, 2011, J CELL SCI, V124, P414, DOI 10.1242/jcs.075960; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moursi AM, 1996, J CELL SCI, V109, P1369; Nakahama K, 2010, CELL MOL LIFE SCI, V67, P4001, DOI 10.1007/s00018-010-0479-3; Nishida S, 2005, BIOCHEM BIOPH RES CO, V328, P91, DOI 10.1016/j.bbrc.2004.12.145; O'Brien CA, 2010, BONE, V46, P911, DOI 10.1016/j.bone.2009.08.050; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Plow EF, 2009, CURR OPIN HEMATOL, V16, P323, DOI 10.1097/MOH.0b013e32832ea389; Qu H, 2011, J CELL SCI, V124, P879, DOI 10.1242/jcs.076976; Roodman GD, 2005, J CLIN INVEST, V115, P200, DOI 10.1172/JCI200524281; Shekaran A, 2011, J BIOMED MATER RES A, V96A, P261, DOI 10.1002/jbm.a.32979; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Sims NA, 2008, SEMIN CELL DEV BIOL, V19, P444, DOI 10.1016/j.semcdb.2008.07.016; Singha UK, 2008, J CELL BIOCHEM, V103, P434, DOI 10.1002/jcb.21411; TERMINE JD, 1990, EXP GERONTOL, V25, P217, DOI 10.1016/0531-5565(90)90055-7; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Walker CG, 2010, BONE, V47, P1020, DOI 10.1016/j.bone.2010.08.025; Wu CY, 2005, J CELL SCI, V118, P659, DOI 10.1242/jcs.01639; Xiao GZ, 1997, MOL ENDOCRINOL, V11, P1103, DOI 10.1210/me.11.8.1103; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yavropoulou M. P., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P204; Yu SB, 2008, ENDOCRINOLOGY, V149, P1960, DOI 10.1210/en.2007-1573; Yu SB, 2008, J BIOL CHEM, V283, P5542, DOI 10.1074/jbc.M705653200; Yu SB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007583; Zhang YJ, 2006, J BIOL CHEM, V281, P12397, DOI 10.1074/jbc.M512107200; Zhang YJ, 2002, J BIOL CHEM, V277, P318, DOI 10.1074/jbc.M108257200; Zhao JP, 2009, J BIOL CHEM, V284, P34308, DOI 10.1074/jbc.M109.045021; Zhou X, 2007, P NATL ACAD SCI USA, V104, P3919, DOI 10.1073/pnas.0608360104	57	41	46	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21450	21460		10.1074/jbc.M111.331249	http://dx.doi.org/10.1074/jbc.M111.331249			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22556421	Green Published, hybrid			2022-12-25	WOS:000306416800062
J	Petrlova, J; Kalai, T; Maezawa, I; Altman, R; Harishchandra, G; Hong, HS; Bricarello, DA; Parikh, AN; Lorigan, GA; Jin, LW; Hideg, K; Voss, JC				Petrlova, Jitka; Kalai, Tamas; Maezawa, Izumi; Altman, Robin; Harishchandra, Ghimire; Hong, Hyun-Seok; Bricarello, Daniel A.; Parikh, Atul N.; Lorigan, Gary A.; Jin, Lee-Way; Hideg, Kalman; Voss, John C.			The Influence of Spin-Labeled Fluorene Compounds on the Assembly and Toxicity of the A beta Peptide	PLOS ONE			English	Article							INTRACELLULAR AMYLOID-BETA; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; CIRCULAR-DICHROISM; IN-VIVO; CYTOTOXICITY; BRAIN; DYSFUNCTION; INHIBITION; NITROXIDES	Background: The deposition and oligomerization of amyloid beta (A beta) peptide plays a key role in the pathogenesis of Alzheimer's disease (AD). A beta peptide arises from cleavage of the membrane-associated domain of the amyloid precursor protein (APP) by beta and gamma secretases. Several lines of evidence point to the soluble A beta oligomer (A beta O) as the primary neurotoxic species in the etiology of AD. Recently, we have demonstrated that a class of fluorene molecules specifically disrupts the A beta O species. Methodology/Principal Findings: To achieve a better understanding of the mechanism of action of this disruptive ability, we extend the application of electron paramagnetic resonance (EPR) spectroscopy of site-directed spin labels in the A beta peptide to investigate the binding and influence of fluorene compounds on A beta O structure and dynamics. In addition, we have synthesized a spin-labeled fluorene (SLF) containing a pyrroline nitroxide group that provides both increased cell protection against A beta O toxicity and a route to directly observe the binding of the fluorene to the A beta O assembly. We also evaluate the ability of fluorenes to target multiple pathological processes involved in the neurodegenerative cascade, such as their ability to block A beta O toxicity, scavenge free radicals and diminish the formation of intracellular A beta O species. Conclusions: Fluorene modified with pyrroline nitroxide may be especially useful in counteracting A beta peptide toxicity, because they posses both antioxidant properties and the ability to disrupt A beta O species.	[Petrlova, Jitka; Altman, Robin; Voss, John C.] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Kalai, Tamas; Hideg, Kalman] Univ Pecs, Inst Organ & Med Chem, Pecs, Hungary; [Maezawa, Izumi; Hong, Hyun-Seok; Jin, Lee-Way] Miami Univ, Dept Pathol, MIND, Oxford, OH 45056 USA; [Harishchandra, Ghimire; Lorigan, Gary A.] Miami Univ, Dept Chem & Biochem, Oxford, OH 45056 USA; [Bricarello, Daniel A.; Parikh, Atul N.] Univ Calif Davis, Dept Appl Sci, Davis, CA 95616 USA	University of California System; University of California Davis; University of Pecs; University System of Ohio; Miami University; University System of Ohio; Miami University; University of California System; University of California Davis	Petrlova, J (corresponding author), Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA.	jcvoss@ucdavis.edu	PARIKH, ATUL/T-8268-2019; PARIKH, ATUL N/D-2243-2014	PARIKH, ATUL N/0000-0002-5927-4968; Voss, John/0000-0001-9279-209X	U.S. National Institutes of Health [R01 AG029246]; Hungarian National Research Fund OTKA [T81123]; NATIONAL INSTITUTE ON AGING [R01AG029246] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hungarian National Research Fund OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by grants from the U.S. National Institutes of Health (R01 AG029246) and the Hungarian National Research Fund OTKA T81123. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; BERLINER LJ, 1982, ANAL BIOCHEM, V119, P450, DOI 10.1016/0003-2697(82)90612-1; Cai LS, 2007, CURR MED CHEM, V14, P19, DOI 10.2174/092986707779313471; Farooqui AA, 1997, NEUROCHEM INT, V30, P517; Glebska J, 2001, BIOMETALS, V14, P159, DOI 10.1023/A:1016689607579; Hideg K, 2007, CARDIOVASC TOXICOL, V7, P160, DOI 10.1007/s12012-007-0019-z; Hong HS, 2007, BRAIN RES, V1130, P223, DOI 10.1016/j.brainres.2006.10.093; Hong HS, 2010, NEUROBIOL AGING, V31, P1690, DOI 10.1016/j.neurobiolaging.2008.09.019; Hong HS, 2009, J NEUROCHEM, V108, P1097, DOI 10.1111/j.1471-4159.2008.05866.x; Jin LW, 2004, AM J PATHOL, V164, P975, DOI 10.1016/S0002-9440(10)63185-9; Kalai T, 2011, EUR J MED CHEM, V46, P1348, DOI 10.1016/j.ejmech.2011.01.059; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lam MA, 2008, CHEM RES TOXICOL, V21, P2111, DOI 10.1021/tx800183t; Lee CW, 2003, NUCL MED BIOL, V30, P573, DOI 10.1016/S0969-8051(03)00050-7; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li J, 2011, BIOPHYS J, V100, P1076, DOI 10.1016/j.bpj.2010.12.3741; Liao MQ, 2007, FEBS LETT, V581, P1161, DOI 10.1016/j.febslet.2007.02.026; Likhtenstein G.I, 1993, BIOPHYSICAL LABELING, P46; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Maezawa I, 2004, J NEUROCHEM, V91, P1312, DOI 10.1111/j.1471-4159.2004.02818.x; Maezawa I, 2008, J NEUROCHEM, V104, P457, DOI 10.1111/j.1471-4159.2007.04972.x; Maezawa I, 2006, J NEUROCHEM, V98, P57, DOI 10.1111/j.1471-4159.2006.03862.x; Mandal R, 2007, J PHARMACOL EXP THER, V323, P119, DOI 10.1124/jpet.107.127167; Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013; Petrlova J, 2011, PROTEINS, V79, P402, DOI 10.1002/prot.22891; SOPHER BL, 1994, MOL BRAIN RES, V26, P207, DOI 10.1016/0169-328X(94)90092-2; Twomey P, 1997, FREE RADICAL BIO MED, V22, P909, DOI 10.1016/S0891-5849(96)00477-7; Wu J., 2009, J BIOL CHEM	32	16	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35443	10.1371/journal.pone.0035443	http://dx.doi.org/10.1371/journal.pone.0035443			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558151	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000305340200017
J	Sammarco, PW; Brazeau, DA; Sinclair, J				Sammarco, Paul W.; Brazeau, Daniel A.; Sinclair, James			Genetic Connectivity in Scleractinian Corals across the Northern Gulf of Mexico: Oil/Gas Platforms, and Relationship to the Flower Garden Banks	PLOS ONE			English	Article							LENGTH POLYMORPHISM AFLP; TUBASTRAEA-COCCINEA; MISSISSIPPI RIVER; POPULATION ALLOCATION; SPECIES BOUNDARIES; NORTHWESTERN GULF; DISPERSAL; CNIDARIA; FLORIDA; BIOGEOGRAPHY	The 3,000 oil/gas structures currently deployed in the northern Gulf of Mexico (GOM) provide hard substratum for marine organisms in a region where such has been rare since the Holocene. The major exception to this are the Flower Garden Banks (FGB). Corals are known to have colonized oil/gas platforms around the FGB, facilitating biogeographic expansion. We ask the question, what are the patterns of genetic affinity in these coral populations. We sampled coral tissue from populations of two species occurring on oil and gas platforms: Madracis decactis (hermatype) and Tubastraea coccinea (invasive ahermatype). We sampled 28 platforms along four transects from 20 km offshore to the continental shelf edge off 1) Matagorda Island, TX; 2) Lake Sabine, TX; 3) Terrebonne Bay, LA; and 4) Mobile, AL. The entire population of M. decactis was sampled between depths of 5 m and 37 m. T. coccinea populations were sub-sampled. Genetic variation was assessed using the PCR-based Amplified Fragment Length Polymorphisms (AFLPs). Data were analyzed via AFLPOP and STRUCTURE. Genetic connectivity among M. decactis platform populations was highest near the FGB and decreased to the east. Connectivity increased again in the eastern sector, indicating isolation between the populations from different sides of the Mississippi River (Transects 3 and 4). A point-drop in genetic affinity (relatedness) at the shelf edge south of Terrebonne Bay, LA indicated a population differing from all others in the northern GOM. Genetic affinities among T. coccinea were highest in the west and decreased to the east. Very low genetic affinities off Mobile, AL indicated a dramatic difference between those populations and those west of the Mississippi River, apparently a formidable barrier to larval dispersal.	[Sammarco, Paul W.] Louisiana Univ Marine Consortium LUMCON, Chauvin, LA 70344 USA; [Sammarco, Paul W.] Louisiana State Univ, Dept Oceanog & Coastal Sci, A&M Coll, Baton Rouge, LA 70803 USA; [Brazeau, Daniel A.] SUNY Buffalo, Pharmaceut Genet Lab, Dept Pharmaceut Sci, Buffalo, NY 14260 USA; [Sinclair, James] Bur Ocean Energy Management Regulat & Enforcement, Environm Sect, Gulf Mexico OCS Reg & Atlantic Activ, US Dept Interior, New Orleans, LA USA	Louisiana State University System; Louisiana State University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; United States Department of the Interior	Sammarco, PW (corresponding author), Louisiana Univ Marine Consortium LUMCON, Chauvin, LA 70344 USA.	psammarco@lumcon.edu						Adamkewicz SL, 1996, AM MALACOL BULL, V13, P97; Adams CL, 1996, THESIS TEXAS A M U C; Amar KO, 2008, MAR BIOTECHNOL, V10, P350, DOI 10.1007/s10126-007-9069-2; Aronson RB, 2007, ECOL STUDIES; ATCHISON AD, 2006, P 10 INT COR REEF S; Atchison AD, 2005, THESIS LOUISIANA STA; Atchison AD, 2008, J EXP MAR BIOL ECOL, V365, P1, DOI 10.1016/j.jembe.2008.07.002; AYRE DJ, 1986, MAR BIOL, V90, P187, DOI 10.1007/BF00569126; Bassim KM, 2003, MAR BIOL, V142, P241, DOI 10.1007/S00227-002-0953-z; Bassim KM, 2002, MAR BIOL, V140, P479, DOI 10.1007/s00227-001-0722-4; Baums IB, 2005, MOL ECOL, V14, P1377, DOI 10.1111/j.1365-294X.2005.02489.x; Bensch S, 2005, MOL ECOL, V14, P2899, DOI 10.1111/j.1365-294X.2005.02655.x; Bergstrom DM, 2009, J APPL ECOL, V46, P73, DOI 10.1111/j.1365-2664.2008.01601.x; Bernatchez L, 2000, CAN J FISH AQUAT SCI, V57, P1, DOI 10.1139/cjfas-57-1-1; Blears MJ, 1998, J IND MICROBIOL BIOT, V21, P99, DOI 10.1038/sj.jim.2900537; Boland G.S., 2002, P GULF MEX FISH FISH; Boland GS, 2000, COMMUNICATION; Brandley MC, 2010, MOL PHYLOGENET EVOL, V57, P552, DOI 10.1016/j.ympev.2010.07.015; Brazeau DA, 2005, MAR BIOL, V147, P1141, DOI 10.1007/s00227-005-0022-5; Brazeau DA, AQUAT BIOL; Brazeau DA, 2008, P 11 INT COR REEF S; BRIGHT T J, 1991, Northeast Gulf Science, V12, P55; BRIGHT TJ, 1984, B MAR SCI, V34, P461; CAIRNS SD, 2000, STUDIES NATURAL HIST, V75, P1; Casey M, 2009, CBS NEWS        0113; Dagg M, 2008, CONT SHELF RES, V28, P1127, DOI 10.1016/j.csr.2008.02.013; Dagg MJ, 2003, J MARINE SYST, V43, P133, DOI 10.1016/j.jmarsys.2003.09.002; de Paula AF, 2004, B MAR SCI, V74, P175; Deslarzes K, 2000, COMMUNICATION; Deslarzes Kenneth J. P., 2007, V192, P126; DOKKEN QR, 2002, LONG TERM MONITORING; DOKKEN QR, 1999, LONG TERM MONITORING; Driessen PK, 1989, PETROLEUM STRUCTURES, P3; Duchesne P, 2002, MOL ECOL NOTES, V2, P380, DOI 10.1046/j.1471-8286.2002.00251.x; Edmondson CH, 1941, OCC PAP BISHOP MUS, V18, P283; Fenner D, 2004, CORAL REEFS, V23, P505, DOI 10.1007/s00338-004-0422-x; Fenner D, 2001, B MAR SCI, V69, P1175; Fenner D, 1999, B MAR SCI, V64, P143; Fitzhugh K, 1999, INVERTEBR BIOL, V118, P357, DOI 10.2307/3227007; Fukami H, 2004, EVOLUTION, V58, P324, DOI 10.1111/j.0014-3820.2004.tb01648.x; Futuyma D. J., 1988, EVOLUTIONARY BIOL; Gallaway BJ, 1981, 10BS8227 USFWS OFF B; GITTINGS SR, 1992, B MAR SCI, V51, P420; Glynn PW, 2008, MAR BIOL, V153, P529, DOI 10.1007/s00227-007-0827-5; Hagman Derek K., 1998, Gulf of Mexico Science, V16, P170; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; He TH, 2004, MOL ECOL, V13, P1099, DOI 10.1111/j.1365-294X.2004.02120.x; Hellberg ME, 2007, CORAL REEFS, V26, P463, DOI 10.1007/s00338-007-0205-2; Hellberg ME, 2002, B MAR SCI, V70, P273; Hewitt CL, 2005, BIOL INVASIONS, V7, P251, DOI 10.1007/s10530-004-0739-y; Hickerson E. L., 2006, EOS T AM GEOPHYS U S, V87; HODGSON G, 1990, CORAL REEFS, V9, P41, DOI 10.1007/BF00686720; Humann P., 2002, REEF CORAL IDENTIFIC; LaJeunesse TC, 2005, CORAL REEFS, V24, P157, DOI 10.1007/s00338-004-0436-4; Lang JC, 1972, COMMUNICATION; Lohrenz SE, 2008, CONT SHELF RES, V28, P1466, DOI 10.1016/j.csr.2007.06.019; Lopez JV, 1999, BIOL BULL-US, V196, P80, DOI 10.2307/1543170; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Lugo-Fernandez A, 2010, CONT SHELF RES, V30, P1226, DOI 10.1016/j.csr.2010.03.014; Lugo-Fernandez A, 2001, CONT SHELF RES, V21, P47, DOI 10.1016/S0278-4343(00)00072-8; Lugo-Fernandez Alexis, 2006, Gulf of Mexico Science, V24, P61; MAC ARTHUR ROBERT H., 1967; Maltagliati F, 2002, B MAR SCI, V71, P473; McGuire MP, 1998, CORAL REEFS, V17, P369, DOI 10.1007/s003380050141; Mettler L.E., 1988, POPULATION GENETICS; Mueller UG, 1999, TRENDS ECOL EVOL, V14, P389, DOI 10.1016/S0169-5347(99)01659-6; National Oceanic and Atmospheric Administration, 2008, FLOW GARD BANKS 2008; Oey L-Y, 2005, GEOPHYS MONGRAPH SER; Olascoaga MJ, 2010, NONLINEAR PROC GEOPH, V17, P685, DOI 10.5194/npg-17-685-2010; Pagad S, 2007, TUBASTRAEA COCCINEA; Pritchard JK, 2000, GENETICS, V155, P945; Pyron RA, 2010, J BIOGEOGR, V37, P2005, DOI 10.1111/j.1365-2699.2010.02336.x; Rabalais NN, 1996, ESTUARIES, V19, P386, DOI 10.2307/1352458; Reggio V. C., 1989, PETROLEUM STRUCTURES, P47; REZAK R, 1983, REEFS BANKS NW GULF; Rezak R., 1985, REEFS BANKS NW GULF; Sammarco, 2011, UNPUB; Sammarco, 2011, IN PRESS; Sammarco P.W., 2007, P AUSTR MAR SCI ASS; Sammarco P.W., GULF DRILLI IN PRESS; Sammarco P.W., 2007, P MIN MAN SERV INF T; Sammarco PW, 2010, AQUAT INVASIONS, V5, P131, DOI 10.3391/ai.2010.5.2.02; Sammarco Paul W., 1994, Coastal and Estuarine Studies, V45, P35; SAMMARCO PW, 1989, LIMNOL OCEANOGR, V34, P896, DOI 10.4319/lo.1989.34.5.0896; Sammarco PW, 2004, MAR ECOL PROG SER, V280, P129, DOI 10.3354/meps280129; Sammarco PW, 2007, ASS MAR LABS CAR AML; Sammarco PW, 1973, COMMUNICATION; Sammarco PW, 2008, GULF DRILLING PLATFO; Sammarco PW, 2002, GULF DRILLING PLATFO; Sammarco PW, 2005, GULF DRILLING PLATFO; Sammarco PW, 2003, GULF DRILLING PLATFO; Schmahl G. P., 2005, 3 INT S DEEP SEA COR; SCHMAHL GP, 2003, P US DEP INT MIN MAN; Schmahl GP, 2006, EOS T AM GEOPHYS U S, V87; Shearer T, 2008, 2008 OC SCI M WAT GL; Shinn EA, 1974, P INT C ART REEFS MA, P91; Simberloff D, 2000, B MAR SCI, V66, P567; Sunnucks P, 2000, TRENDS ECOL EVOL, V15, P199, DOI 10.1016/S0169-5347(00)01825-5; Tunnell JW, 2009, GULF MEXICO ORIGINS; VanToai TT, 1997, CROP SCI, V37, P1370, DOI 10.2135/cropsci1997.0011183X003700040056x; Vermeij MJA, 2006, MAR ECOL PROG SER, V310, P119, DOI 10.3354/meps310119; Vermeij MJA, 2005, CORAL REEFS, V24, P442, DOI 10.1007/s00338-005-0489-z; Vermeij MJA, 2003, MAR ECOL PROG SER, V247, P75, DOI 10.3354/meps247075; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960	106	40	44	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e30144	10.1371/journal.pone.0030144	http://dx.doi.org/10.1371/journal.pone.0030144			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558066	Green Submitted, Green Published, gold			2022-12-25	WOS:000305340200001
J	Baxter, I; Hermans, C; Lahner, B; Yakubova, E; Tikhonova, M; Verbruggen, N; Chao, DY; Salt, DE				Baxter, Ivan; Hermans, Christian; Lahner, Brett; Yakubova, Elena; Tikhonova, Marina; Verbruggen, Nathalie; Chao, Dai-yin; Salt, David E.			Biodiversity of Mineral Nutrient and Trace Element Accumulation in Arabidopsis thaliana	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; METAL HYPERACCUMULATION; FUNCTIONAL GENOMICS; NATURAL VARIATION; LEAF IONOME; TOLERANCE; IDENTIFICATION; MAGNESIUM; QTL; POPULATION	In order to grow on soils that vary widely in chemical composition, plants have evolved mechanisms for regulating the elemental composition of their tissues to balance the mineral nutrient and trace element bioavailability in the soil with the requirements of the plant for growth and development. The biodiversity that exists within a species can be utilized to investigate how regulatory mechanisms of individual elements interact and to identify genes important for these processes. We analyzed the elemental composition (ionome) of a set of 96 wild accessions of the genetic model plant Arabidopsis thaliana grown in hydroponic culture and soil using inductively coupled plasma mass spectrometry (ICP-MS). The concentrations of 17-19 elements were analyzed in roots and leaves from plants grown hydroponically, and leaves and seeds from plants grown in artificial soil. Significant genetic effects were detected for almost every element analyzed. We observed very few correlations between the elemental composition of the leaves and either the roots or seeds. There were many pairs of elements that were significantly correlated with each other within a tissue, but almost none of these pairs were consistently correlated across tissues and growth conditions, a phenomenon observed in several previous studies. These results suggest that the ionome of a plant tissue is variable, yet tightly controlled by genes and genexenvironment interactions. The dataset provides a valuable resource for mapping studies to identify genes regulating elemental accumulation. All of the ionomic data is available at www.ionomicshub.org.	[Baxter, Ivan] ARS, Plant Genet Res Unit, Donald Danforth Plant Sci Ctr, USDA, St Louis, MO 63132 USA; [Baxter, Ivan; Lahner, Brett; Yakubova, Elena; Tikhonova, Marina; Chao, Dai-yin; Salt, David E.] Purdue Univ, Ctr Plant Stress Physiol, W Lafayette, IN 47907 USA; [Hermans, Christian; Verbruggen, Nathalie] Univ Libre Bruxelles, Lab Plant Physiol & Mol Genet, Brussels, Belgium; [Chao, Dai-yin; Salt, David E.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland	Donald Danforth Plant Science Center; United States Department of Agriculture (USDA); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Universite Libre de Bruxelles; University of Aberdeen	Baxter, I (corresponding author), ARS, Plant Genet Res Unit, Donald Danforth Plant Sci Ctr, USDA, St Louis, MO 63132 USA.	ivan.baxter@ars.usda.gov	Baxter, Ivan R/A-1052-2009; Chao, Daiyin/A-5213-2013; Chao, Dai-Yin/GYV-5944-2022	Baxter, Ivan R/0000-0001-6680-1722; Verbruggen, Nathalie/0000-0003-2296-5404; ?, ??/0000-0003-2832-4800	National Institutes of Health, National Institute of General Medicine [R01 GM78536-01A1]; Indiana 21st Century Research and Technology Fund [912010479]; Belgian Science Policy Office (BelSPo) [IAPVI/33]; United States Department of Agriculture-Agricultural Research Service; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078536] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Indiana 21st Century Research and Technology Fund; Belgian Science Policy Office (BelSPo)(Belgian Federal Science Policy Office); United States Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was funded by a grant from the National Institutes of Health, the National Institute of General Medicine (R01 GM78536-01A1) awarded to Dr. Salt, Dr. Guerinot and Dr. Baxter, the Indiana 21st Century Research and Technology Fund (912010479) to Dr. Salt, the Belgian Science Policy Office (BelSPo project IAPVI/33) to Dr. Verbruggen and United States Department of Agriculture-Agricultural Research Service Intramural funds to Dr. Baxter. Dr. Hermans is currently a research associate of the Fonds National de la Recherche Scientifique (FNRS-FRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; BAKER AJM, 1987, NEW PHYTOL, V106, P93; Baxter I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000004; Baxter I, 2007, PLANT PHYSIOL, V143, P600, DOI 10.1104/pp.106.092528; Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Baxter I, 2010, BRIEF FUNCT GENOMICS, V9, P149, DOI 10.1093/bfgp/elp055; Baxter I, 2009, CURR OPIN PLANT BIOL, V12, P381, DOI 10.1016/j.pbi.2009.05.002; Baxter I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000492; Baxter IR, 2008, P NATL ACAD SCI USA, V105, P12081, DOI 10.1073/pnas.0804175105; Becker A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015993; Bradshaw HD, 2005, NEW PHYTOL, V167, P81, DOI 10.1111/j.1469-8137.2005.01408.x; Brady KU, 2005, ANNU REV ECOL EVOL S, V36, P243, DOI 10.1146/annurev.ecolsys.35.021103.105730; Broadley MR, 2010, NEW PHYTOL, V186, P270, DOI 10.1111/j.1469-8137.2009.03145.x; Broadley MR, 2008, PLANT PHYSIOL, V146, P1707, DOI 10.1104/pp.107.114645; Buescher E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011081; Chao DY, 2011, PLANT CELL, V23, P1061, DOI 10.1105/tpc.110.079095; Courbot M, 2007, PLANT PHYSIOL, V144, P1052, DOI 10.1104/pp.106.095133; DeRose-Wilson L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022832; Ding GD, 2010, ANN BOT-LONDON, V105, P1221, DOI 10.1093/aob/mcq050; Durrett TP, 2007, PLANT PHYSIOL, V144, P197, DOI 10.1104/pp.107.097162; Galpaz N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015198; Ghandilyan A, 2009, NEW PHYTOL, V184, P180, DOI 10.1111/j.1469-8137.2009.02953.x; Ghandilyan A, 2009, J EXP BOT, V60, P1409, DOI 10.1093/jxb/erp084; Hanikenne M, 2008, NATURE, V453, P391, DOI 10.1038/nature06877; Hermans C, 2011, NEW PHYTOL, V192, P428, DOI 10.1111/j.1469-8137.2011.03814.x; Hoffmann MH, 2002, J BIOGEOGR, V29, P125, DOI 10.1046/j.1365-2699.2002.00647.x; Karley AJ, 2009, CURR OPIN PLANT BIOL, V12, P291, DOI 10.1016/j.pbi.2009.04.013; Klein MA, 2009, GENOME, V52, P677, DOI [10.1139/G09-039, 10.1139/g09-039]; Kobayashi Y, 2008, PLANT PHYSIOL, V148, P969, DOI 10.1104/pp.108.119933; Lahner B, 2003, NAT BIOTECHNOL, V21, P1215, DOI 10.1038/nbt865; Lexer C, 2003, MOL ECOL, V12, P1225, DOI 10.1046/j.1365-294X.2003.01803.x; Liu J, 2009, PLANT SOIL, V320, P255, DOI 10.1007/s11104-009-9891-6; Loudet O, 2007, NAT GENET, V39, P896, DOI 10.1038/ng2050; Lowry DB, 2009, NEW PHYTOL, V183, P776, DOI 10.1111/j.1469-8137.2009.02901.x; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Morrissey J, 2009, PLANT CELL; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Prinzenberg AE, 2010, PLANT PHYSIOL, V154, P1361, DOI 10.1104/pp.110.161398; Rus A, 2006, PLOS GENET, V2, P1964, DOI 10.1371/journal.pgen.0020210; Salt DE, 2008, ANNU REV PLANT BIOL, V59, P709, DOI 10.1146/annurev.arplant.59.032607.092942; Sankaran RP, 2009, THEOR APPL GENET, V119, P241, DOI 10.1007/s00122-009-1033-2; Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515; Verbruggen N, 2009, NEW PHYTOL, V181, P759, DOI 10.1111/j.1469-8137.2008.02748.x; Vreugdenhil D, 2004, PLANT CELL ENVIRON, V27, P828, DOI 10.1111/j.1365-3040.2004.01189.x; Watanabe T, 2007, NEW PHYTOL, V174, P516, DOI 10.1111/j.1469-8137.2007.02078.x; Waters BM, 2008, NEW PHYTOL, V179, P1033, DOI 10.1111/j.1469-8137.2008.02544.x; Waters BM, 2008, NEW PHYTOL, V177, P389, DOI 10.1111/j.1469-8137.2007.02288.x; White PJ, 2009, NEW PHYTOL, V182, P49, DOI 10.1111/j.1469-8137.2008.02738.x	48	71	78	3	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35121	10.1371/journal.pone.0035121	http://dx.doi.org/10.1371/journal.pone.0035121			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558123	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000025
J	Faisca, PFN; Travasso, RDM; Parisi, A; Rey, A				Faisca, Patricia F. N.; Travasso, Rui D. M.; Parisi, Andrea; Rey, Antonio			Why Do Protein Folding Rates Correlate with Metrics of Native Topology?	PLOS ONE			English	Article							SINGLE-DOMAIN PROTEINS; TOPOMER SEARCH MODEL; TRANSITION-STATE; CONTACT ORDER; NONNATIVE INTERACTIONS; LATTICE MODEL; KINETICS; MECHANISM; PRINCIPLES; NUCLEUS	For almost 15 years, the experimental correlation between protein folding rates and the contact order parameter has been under scrutiny. Here, we use a simple simulation model combined with a native-centric interaction potential to investigate the physical roots of this empirical observation. We simulate a large set of circular permutants, thus eliminating dependencies of the folding rate on other protein properties (e.g. stability). We show that the rate-contact order correlation is a consequence of the fact that, in high contact order structures, the contact order of the transition state ensemble closely mirrors the contact order of the native state. This happens because, in these structures, the native topology is represented in the transition state through the formation of a network of tertiary interactions that are distinctively long-ranged.	[Faisca, Patricia F. N.; Travasso, Rui D. M.; Parisi, Andrea] Univ Lisbon, Ctr Fis Mat Condensada, P-1699 Lisbon, Portugal; [Faisca, Patricia F. N.; Parisi, Andrea] Univ Lisbon, Dept Fis, P-1699 Lisbon, Portugal; [Travasso, Rui D. M.] Univ Coimbra, Dept Fis, P-3000 Coimbra, Portugal; [Travasso, Rui D. M.] Univ Coimbra, Ctr Fis Computac, Coimbra, Portugal; [Travasso, Rui D. M.] Univ Coimbra, Ctr Ophthalmol & Vis Sci, Inst Biomed Res Light & Image IBILI, Fac Med, Coimbra, Portugal; [Rey, Antonio] Univ Complutense, Fac Ciencias Quim, Dept Quim Fis 1, E-28040 Madrid, Spain	Universidade de Lisboa; Universidade de Lisboa; Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Complutense University of Madrid	Faisca, PFN (corresponding author), Univ Lisbon, Ctr Fis Mat Condensada, P-1699 Lisbon, Portugal.	patricia.fn.faisca@gmail.com	Parisi, Andrea/H-9783-2013; Travasso, Rui/B-8342-2018; Rey, Antonio/G-7099-2012; Faisca, Patricia/E-9758-2010	Parisi, Andrea/0000-0003-2972-9770; Travasso, Rui/0000-0001-6078-0721; Rey, Antonio/0000-0002-8901-4198; Faisca, Patricia/0000-0002-2493-2748	Fundacao para a Ciencia e a Tecnologia [PTDC/FIS/113638/2009]; Conselho de Reitores das Universidades Portuguesas (Accao Integrada Luso-Espanhola) [E-16/09]; Ministerio de Ciencia e Innovacion [FIS2009-13364-C02-02]; Accion Integrada Hispano-Portuguesa [HP-2008-0065]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Conselho de Reitores das Universidades Portuguesas (Accao Integrada Luso-Espanhola); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Accion Integrada Hispano-Portuguesa	This work was supported by Fundacao para a Ciencia e a Tecnologia (PTDC/FIS/113638/2009); Conselho de Reitores das Universidades Portuguesas (Accao Integrada Luso-Espanhola E-16/09); Ministerio de Ciencia e Innovacion (FIS2009-13364-C02-02); and Accion Integrada Hispano-Portuguesa (HP-2008-0065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABKEVICH VI, 1994, J CHEM PHYS, V101, P6052, DOI 10.1063/1.467320; ABKEVICH VI, 1994, BIOCHEMISTRY-US, V33, P10026, DOI 10.1021/bi00199a029; Barrick D, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/015001; Best RB, 2010, P NATL ACAD SCI USA, V107, P1088, DOI 10.1073/pnas.0910390107; Bruscolini P, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.038103; Bueno M, 2006, J MOL BIOL, V359, P813, DOI 10.1016/j.jmb.2006.03.067; CAMACHO CJ, 1993, P NATL ACAD SCI USA, V90, P6369, DOI 10.1073/pnas.90.13.6369; Chan HS, 2011, ANNU REV PHYS CHEM, V62, P301, DOI 10.1146/annurev-physchem-032210-103405; Cho SS, 2006, P NATL ACAD SCI USA, V103, P586, DOI 10.1073/pnas.0509768103; Chodera JD, 2007, J CHEM THEORY COMPUT, V3, P26, DOI 10.1021/ct0502864; Clementi C, 2001, J MOL BIOL, V311, P879, DOI 10.1006/jmbi.2001.4871; Daggett V, 2003, NAT REV MOL CELL BIO, V4, P497, DOI 10.1038/nrm1126; Debe DA, 1999, P NATL ACAD SCI USA, V96, P2596, DOI 10.1073/pnas.96.6.2596; DILL KA, 1995, PROTEIN SCI, V4, P561; Du R, 1998, J CHEM PHYS, V108, P334, DOI 10.1063/1.475393; Faisca PFN, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2973624; Faisca PFN, 2010, PROTEIN SCI, V19, P2196, DOI 10.1002/pro.498; Faisca PFN, 2002, J CHEM PHYS, V116, P7231, DOI 10.1063/1.1466833; Fersht AR, 2000, P NATL ACAD SCI USA, V97, P1525, DOI 10.1073/pnas.97.4.1525; Gutin AM, 1996, PHYS REV LETT, V77, P5433, DOI 10.1103/PhysRevLett.77.5433; Hubner IA, 2005, J MOL BIOL, V349, P424, DOI 10.1016/j.jmb.2005.03.050; Ivankov DN, 2003, PROTEIN SCI, V12, P2057, DOI 10.1110/ps.0302503; Kaya H, 2003, PROTEINS, V52, P524, DOI 10.1002/prot.10478; Klimov DK, 1998, J MOL BIOL, V282, P471, DOI 10.1006/jmbi.1998.1997; Klimov DK, 1998, FOLD DES, V3, P127, DOI 10.1016/S1359-0278(98)00018-2; LAU KF, 1989, MACROMOLECULES, V22, P3986, DOI 10.1021/ma00200a030; Li L, 2000, NAT STRUCT BIOL, V7, P336; Lindorff-Larsen K, 2005, TRENDS BIOCHEM SCI, V30, P13, DOI 10.1016/j.tibs.2004.11.008; Lindorff-Larsen K, 2004, NAT STRUCT MOL BIOL, V11, P443, DOI 10.1038/nsmb765; Makarov DE, 2003, PROTEIN SCI, V12, P17, DOI 10.1110/ps.0220003; Makarov DE, 2002, P NATL ACAD SCI USA, V99, P3535, DOI 10.1073/pnas.052713599; Mirny LA, 1996, FOLD DES, V1, P103, DOI 10.1016/S1359-0278(96)00019-3; Munoz V, 1999, P NATL ACAD SCI USA, V96, P11311, DOI 10.1073/pnas.96.20.11311; Paci E, 2003, P NATL ACAD SCI USA, V100, P394, DOI 10.1073/pnas.232704999; Plaxco KW, 2000, BIOCHEMISTRY-US, V39, P11177, DOI 10.1021/bi000200n; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; SHAKHNOVICH EI, 1994, PHYS REV LETT, V72, P3907, DOI 10.1103/PhysRevLett.72.3907; Sosnick TR, 2008, PROTEIN SCI, V17, P1308, DOI 10.1110/ps.036319.108; Travasso RDM, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3485286; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; Wallin S, 2005, PROTEIN SCI, V14, P1643, DOI 10.1110/ps.041317705; Weikl TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P67, DOI 10.1016/j.abb.2007.06.018	42	18	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35599	10.1371/journal.pone.0035599	http://dx.doi.org/10.1371/journal.pone.0035599			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558173	gold, Green Published, Green Accepted			2022-12-25	WOS:000305336000038
J	Yan, CG; Wang, XM; Cao, J; Wu, M; Gao, HW				Yan, Chunguang; Wang, Ximo; Cao, Jay; Wu, Min; Gao, Hongwei			CCAAT/Enhancer-Binding Protein gamma Is a Critical Regulator of IL-1 beta-Induced IL-6 Production in Alveolar Epithelial Cells	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; ACUTE LUNG INJURY; NF-KAPPA-B; C/EBP FAMILY; II CELLS; PROINFLAMMATORY CYTOKINES; AERUGINOSA INFECTION; INTERLEUKIN-6; EXPRESSION; MICE	CCAAT/enhancer binding protein gamma (C/EBP gamma) is a member of the C/EBP family of transcription factors, which lacks known activation domains. C/EBP gamma was originally described as an inhibitor of C/EBP transactivation potential. However, previous study demonstrates that C/EBP gamma augments the C/EBP beta stimulatory activity in lipopolysaccharide induction of IL-6 promoter in a B lymphoblast cell line. These data indicate a complexing functional role for C/EBP gamma in regulating gene expression. Furthermore, the expression and function of C/EBP gamma during inflammation are still largely unknown. In this study, we demonstrate that C/EBP gamma activation was induced by IL-1 beta treatment in lung epithelial cells. Importantly, we demonstrate for the first time that C/EBP gamma plays a critical role in regulating IL-1 beta-induced IL-6 expression in both mouse primary alveolar type II epithelial cells and a lung epithelial cell line, MLE12. We further provide the evidence that C/EBP gamma inhibits IL-6 expression by inhibiting C/EBP gamma but not NF-kappa B stimulatory activity in MLE12 cells. These findings suggest that C/EBP gamma is a key transcription factor that regulates the IL-6 expression in alveolar epithelial cells, and may play an important regulatory role in lung inflammatory responses.	[Yan, Chunguang; Gao, Hongwei] Harvard Univ, Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med,Sch Med, Boston, MA 02115 USA; [Yan, Chunguang; Wu, Min] Univ N Dakota, Dept Biochem & Mol Biol, Grand Forks, ND 58201 USA; [Wang, Ximo] Nankai Univ, Affiliated Hosp, Tianjin Union Med Ctr, Dept Surg, Tianjin 300071, Peoples R China; [Cao, Jay] ARS, Grand Forks Human Nutr Res Ctr, USDA, Grand Forks, ND USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of North Dakota Grand Forks; Nankai University; United States Department of Agriculture (USDA)	Yan, CG (corresponding author), Harvard Univ, Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med,Sch Med, Boston, MA 02115 USA.	min.wu@med.und.edu; hgao@zeus.bwh.harvard.edu	Yan, Chunguang/ABE-5021-2021		NIH [5R01HL092905-04, 3R01HL092905-02S1]; USDA Agricultural Research Service (ARS) [5450-51000-046-00D]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092905] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA Agricultural Research Service (ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by NIH grants 5R01HL092905-04 and 3R01HL092905-02S1 (HG) and the USDA Agricultural Research Service (ARS) program "Mineral Intakes for Optimal Bone Development and Health," Current Research Information System (CRIS) no. 5450-51000-046-00D (JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2008, BRIT J CANCER, V99, P781, DOI 10.1038/sj.bjc.6604544; AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Anastasov N, 2009, HAEMATOLOGICA; Beck-Schimmer B, 1998, INFLAMM RES, V47, P308, DOI 10.1007/s000110050334; Bless NM, 2000, J IMMUNOL, V164, P2650, DOI 10.4049/jimmunol.164.5.2650; BRETZ JD, 1994, P NATL ACAD SCI USA, V91, P7306, DOI 10.1073/pnas.91.15.7306; Chung Kian F., 2005, Current Drug Targets - Inflammation and Allergy, V4, P619, DOI 10.2174/156801005774912806; COOPER C, 1995, NUCLEIC ACIDS RES, V23, P4371, DOI 10.1093/nar/23.21.4371; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Fujinami Y, NEUROCHEM INT, V56, P487; Gao HW, 2006, J IMMUNOL, V177, P612, DOI 10.4049/jimmunol.177.1.612; Gao HW, 2002, J BIOL CHEM, V277, P38827, DOI 10.1074/jbc.M206224200; GRAHAM RC, 1965, J HISTOCHEM CYTOCHEM, V13, P150, DOI 10.1177/13.2.150; Hu HM, 2000, J BIOL CHEM, V275, P16373, DOI 10.1074/jbc.M910269199; Kaisho T, 1999, J EXP MED, V190, P1573, DOI 10.1084/jem.190.11.1573; Kannan S, 2006, CELL DEATH DIFFER, V13, P311, DOI 10.1038/sj.cdd.4401736; Kannan S, 2008, J IMMUNOL, V180, P2396, DOI 10.4049/jimmunol.180.4.2396; Kannan S, 2006, EUR J IMMUNOL, V36, P1739, DOI 10.1002/eji.200635973; Kannan S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004891; KINOSHITA S, 1992, P NATL ACAD SCI USA, V89, P1473, DOI 10.1073/pnas.89.4.1473; Kramer F, 2008, MOL IMMUNOL, V45, P2678, DOI 10.1016/j.molimm.2007.12.017; Maitra U, 2011, J IMMUNOL, V186, P4467, DOI 10.4049/jimmunol.1003300; Mason RJ, 2006, RESPIROLOGY, V11, pS12, DOI 10.1111/j.1440-1843.2006.00800.x; MILLER BE, 1987, EXP LUNG RES, V12, P135, DOI 10.3109/01902148709062837; Rice WR, 2002, AM J PHYSIOL-LUNG C, V283, pL256, DOI 10.1152/ajplung.00302.2001; Sato K, 2002, J INFECT DIS, V185, P1139, DOI 10.1086/340040; STEIN B, 1993, MOL CELL BIOL, V13, P3964, DOI 10.1128/MCB.13.7.3964; Teiken JM, 2008, ANAT REC, V291, P114, DOI 10.1002/ar.20625; Thorley AJ, 2005, AM J RESP CELL MOL, V32, P262, DOI 10.1165/rcmb.2004-0196OC; Thorley AJ, 2007, J IMMUNOL, V178, P463, DOI 10.4049/jimmunol.178.1.463; Vanderbilt JN, 2003, AM J RESP CELL MOL, V29, P661, DOI 10.1165/rcmb.2002-0227OC; Whitsett JA, 2010, ANNU REV MED, V61, P105, DOI 10.1146/annurev.med.60.041807.123500; Wu M, 2003, GENE THER, V10, P1429, DOI 10.1038/sj.gt.3302009; Wu M, 2005, NANOMED-NANOTECHNOL, V1, P67, DOI 10.1016/j.nano.2004.11.011; Yan CG, 2010, J BIOL CHEM, V285, P37227, DOI 10.1074/jbc.M110.132084; Zafarana G, 2000, EMBO J, V19, P5856, DOI 10.1093/emboj/19.21.5856	38	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35492	10.1371/journal.pone.0035492	http://dx.doi.org/10.1371/journal.pone.0035492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558159	Green Submitted, gold, Green Published			2022-12-25	WOS:000305336000033
J	Yang, XY; Wang, W; Qin, JJ; Wang, MH; Sharma, H; Buolamwini, JK; Wang, H; Zhang, RW				Yang, Xinyi; Wang, Wei; Qin, Jiang-Jiang; Wang, Ming-Hai; Sharma, Horrick; Buolamwini, John K.; Wang, Hui; Zhang, Ruiwen			JKA97, a Novel Benzylidene Analog of Harmine, Exerts Anti-Cancer Effects by Inducing G1 Arrest, Apoptosis, and p53-Independent Up-Regulation of p21	PLOS ONE			English	Article							NATURAL-PRODUCTS; DEPENDENT KINASES; EVOLVING ROLE; IN-VITRO; INHIBITOR	JKA97, a benzylidene analog of harmine, has been found to be a promising drug candidate for human cancer therapy, although the underlying molecular mechanisms have not been fully demonstrated. In this study, we evaluated the effects of JKA97 on human breast cancer cells in vitro and in vivo. JKA97 inhibited the growth and proliferation of MCF7 (p53 wildtype), MCF7 (p53 knockdown), and MDA-MB-468 (p53 mutant) cells in a dose-dependent manner. Treatment with JKA97 arrested breast cancer cells in G1 phase and induced apoptosis. JKA97 also significantly suppressed the growth of MCF7 and MDA-MB-468 xenograft tumors. It regulated the expression levels of G1 phase regulators, such as p21, p27, cyclinE, and cylinD1. JKA97 activated p21 transcription, independent of p53, but had little effect on p21 protein stability/degradation. In summary, our results suggest that JKA97 inhibits human breast cancer cell growth through activating p21, independent of p53, which provides a basis for developing this compound as a novel drug for human breast cancer therapy.	[Yang, Xinyi; Wang, Wei; Qin, Jiang-Jiang; Zhang, Ruiwen] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX 79106 USA; [Wang, Wei; Wang, Ming-Hai; Zhang, Ruiwen] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Canc Biol Ctr, Amarillo, TX USA; [Wang, Ming-Hai] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Biomed Sci, Amarillo, TX USA; [Sharma, Horrick; Buolamwini, John K.] Univ Tennessee, Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, Memphis, TN USA; [Wang, Hui] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; University of Tennessee System; University of Tennessee Health Science Center; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Yang, XY (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX 79106 USA.	ruiwen.zhang@ttuhsc.edu	Qin, Jiangjiang/AAM-9553-2020	Qin, Jiangjiang/0000-0002-8559-616X	NIH [R01 CA112029, R01 CA121211, R01 CA91980, R15 CA100102]; Susan G. Komen for the Cure [BCTR070731]; NATIONAL CANCER INSTITUTE [R01CA121211, R15CA100102, R01CA112029, R01CA091980] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	R.Z. was supported by NIH grants R01 CA112029 and R01 CA121211 and a grant from Susan G. Komen for the Cure (BCTR070731). M.H.W. was supported by NIH grant R01 CA91980. J.K.B. was supported by NIH grant R15 CA100102. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ESKELINEN M, 1994, ANTICANCER RES, V14, P699; Gartel AL, 2002, MOL CANCER THER, V1, P639; HARPER JW, 1993, CELL, V75, P805; Ishida J, 1999, BIOORG MED CHEM LETT, V9, P3319, DOI 10.1016/S0960-894X(99)00598-3; Janssen A, 2011, ONCOGENE, V30, P2799, DOI 10.1038/onc.2011.30; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kang KH, 1999, EXP CELL RES, V253, P403, DOI 10.1006/excr.1999.4644; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Luo WJ, 2008, J BIOL CHEM, V283, P8624, DOI 10.1074/jbc.M707860200; Ma Y, 2010, PHYTOTHER RES, V24, P146, DOI 10.1002/ptr.2860; Mishra BB, 2011, EUR J MED CHEM, V46, P4769, DOI 10.1016/j.ejmech.2011.07.057; Nathanson KL, 2011, ANNU REV MED, V62, P295, DOI 10.1146/annurev-med-010910-110221; Oakman C, 2010, NAT REV CLIN ONCOL, V7, P725, DOI 10.1038/nrclinonc.2010.170; Song YC, 2004, BIOCHEM BIOPH RES CO, V317, P128, DOI 10.1016/j.bbrc.2004.03.019; Wang W, 2008, BRIT J CANCER, V98, P792, DOI 10.1038/sj.bjc.6604227; Wang W, 2007, CANCER CHEMOTH PHARM, V59, P589, DOI 10.1007/s00280-006-0300-z; Wang W, 2010, BREAST CANCER RES TR, V123, P321, DOI 10.1007/s10549-009-0638-0; Wang W, 2009, LUNG CANCER, V65, P306, DOI 10.1016/j.lungcan.2008.11.016; Wang W, 2009, CLIN CANCER RES, V15, P3511, DOI 10.1158/1078-0432.CCR-08-2689; Wang W, 2009, CANCER LETT, V278, P241, DOI 10.1016/j.canlet.2009.01.005; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Zhang Z, 2004, J BIOL CHEM, V279, P16000, DOI 10.1074/jbc.M312264200	25	43	44	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e34303	10.1371/journal.pone.0034303	http://dx.doi.org/10.1371/journal.pone.0034303			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558087	Green Submitted, gold, Green Published			2022-12-25	WOS:000305336000012
J	Longcore, T; Rich, C; Mineau, P; MacDonald, B; Bert, DG; Sullivan, LM; Mutrie, E; Gauthreaux, SA; Avery, ML; Crawford, RL; Manville, AM; Travis, ER; Drake, D				Longcore, Travis; Rich, Catherine; Mineau, Pierre; MacDonald, Beau; Bert, Daniel G.; Sullivan, Lauren M.; Mutrie, Erin; Gauthreaux, Sidney A., Jr.; Avery, Michael L.; Crawford, Robert L.; Manville, Albert M., II; Travis, Emilie R.; Drake, David			An Estimate of Avian Mortality at Communication Towers in the United States and Canada	PLOS ONE			English	Article							FLORIDA TELEVISION TOWER; BIRD MORTALITY; NOCTURNAL MIGRANTS; GUY WIRES; MIGRATION; REMOVAL; WEATHER; LIGHTS; HEIGHT; RADAR	Avian mortality at communication towers in the continental United States and Canada is an issue of pressing conservation concern. Previous estimates of this mortality have been based on limited data and have not included Canada. We compiled a database of communication towers in the continental United States and Canada and estimated avian mortality by tower with a regression relating avian mortality to tower height. This equation was derived from 38 tower studies for which mortality data were available and corrected for sampling effort, search efficiency, and scavenging where appropriate. Although most studies document mortality at guyed towers with steady-burning lights, we accounted for lower mortality at towers without guy wires or steady-burning lights by adjusting estimates based on published studies. The resulting estimate of mortality at towers is 6.8 million birds per year in the United States and Canada. Bootstrapped subsampling indicated that the regression was robust to the choice of studies included and a comparison of multiple regression models showed that incorporating sampling, scavenging, and search efficiency adjustments improved model fit. Estimating total avian mortality is only a first step in developing an assessment of the biological significance of mortality at communication towers for individual species or groups of species. Nevertheless, our estimate can be used to evaluate this source of mortality, develop subsequent per-species mortality estimates, and motivate policy action.	[Longcore, Travis; Rich, Catherine] Urban Wildlands Grp, Los Angeles, CA USA; [Longcore, Travis] Univ So Calif, Spatial Sci Inst, Los Angeles, CA USA; [Mineau, Pierre; Bert, Daniel G.; Mutrie, Erin] Environm Canada, Sci & Technol Branch, Natl Wildlife Res Ctr, Ottawa, ON K1A 0H3, Canada; [Sullivan, Lauren M.] Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90024 USA; [Gauthreaux, Sidney A., Jr.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Avery, Michael L.] Wildlife Serv, Natl Wildlife Res Ctr, Florida Field Stn, USDA, Gainesville, FL USA; [Manville, Albert M., II] US Fish & Wildlife Serv, Div Migratory Bird Management, Arlington, VA USA; [Travis, Emilie R.; Drake, David] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI USA	University of Southern California; Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada; University of California System; University of California Los Angeles; Clemson University; United States Department of Agriculture (USDA); United States Department of the Interior; US Fish & Wildlife Service; University of Wisconsin System; University of Wisconsin Madison	Longcore, T (corresponding author), Urban Wildlands Grp, Los Angeles, CA USA.	longcore@urbanwildlands.org	Longcore, Travis/A-4978-2008; Bert, Daniel/A-5666-2013; Gauthreaux, Sidney/Q-3930-2019	Longcore, Travis/0000-0002-1039-2613; Bert, Daniel/0000-0001-7922-6907; 	American Bird Conservancy; Defenders of Wildlife	American Bird Conservancy; Defenders of Wildlife	Collaborators from The Urban Wildlands Group were supported in the early stages of this research by the American Bird Conservancy (www.abcbirds.org) and Defenders of Wildlife (www.defenders.org). The Canadian Wildlife Service (www.ec.gc.ca) purchased the NAV CANADA dataset. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronoff A, 1949, LINNAEAN NEWS LETT, V3, P1; AVERY M, 1972, Prairie Naturalist, V4, P87; AVERY M, 1977, WILSON BULL, V89, P291; AVERY M L, 1975, Proceedings of the North Dakota Academy of Science, V27, P40; AVERY M L, 1978, American Birds, V32, P1114; Avery M. L., 1979, BIRD CONTROL SEMINAR, V8, P3; Avery M.L., 1980, FWSOBS8054; Baird J., 1970, CHICKADEE, V40, P17; Baird J., 1971, CHICKADEE, V41, P20; BEAUCHAMP JJ, 1973, ECOLOGY, V54, P1403, DOI 10.2307/1934208; BELLROSE FRANK C., 1959, ILLINOIS NAT HIST SURV BULL, V27, P235; Bierly M.L., 1973, MIGRANT, V44, P5; Bocetti CI, 2011, WILSON J ORNITHOL, V123, P176, DOI 10.1676/09-168.1; Boso B., 1965, Transactions of the Kansas Academy of Science, V68, P131, DOI 10.2307/3626355; BREWER RICHARD, 1958, AUK, V75, P400; Brown J. A. Harvie, 1880, Zool, P161; Caldwell L. D., 1966, Jack Pine Warbler, V44, P117; Carter J.H. III., 1976, Chat, V40, P1; COCHRAN W. W., 1958, WILSON BULL, V70, P378; Commission for Environmental Cooperation, 1997, EC REG N AM COMM PER; CRAWFORD R L, 1971, Oriole, V36, P33; CRAWFORD RL, 1981, J MAMMAL, V62, P651, DOI 10.2307/1380421; CRAWFORD RL, 1981, WILSON BULL, V93, P189; Crawford RL, 2001, J FIELD ORNITHOL, V72, P380, DOI 10.1648/0273-8570-72.3.380; Crawford RL, 2004, MISCELLANEOUS PUBLIC, V14, P1; Dickerman Robert W., 1998, Western Birds, V29, P122; DUAN N, 1983, J AM STAT ASSOC, V78, P605, DOI 10.2307/2288126; Ganier A.F., 1962, MIGRANT, V33, P58; Gastman EA, 1886, AM NAT, V20, P981; Gauthreaux SA, 2003, AUK, V120, P266, DOI 10.1642/0004-8038(2003)120[0266:ROABC]2.0.CO;2; Gauthreaux Sidney A. Jr., 2006, P67; Gehring J, 2011, J WILDLIFE MANAGE, V75, P848, DOI 10.1002/jwmg.99; Gehring J, 2009, ECOL APPL, V19, P505, DOI 10.1890/07-1708.1; Ginter DL, 2004, SOUTHWEST NAT, V49, P414, DOI 10.1894/0038-4909(2004)049<0414:AMDFMA>2.0.CO;2; Goodpasture K.A., 1975, Migrant, V46, P49; Goodpasture K.A., 1986, Migrant, V57, P70; Goodpasture K.A., 1976, Migrant, V47, P8; Goodpasture K.A., 1984, Migrant, V55, P53; Goodpasture K.A., 1987, Migrant, V58, P85; Goodpasture K.A., 1978, Migrant, V49, P53; Goodpasture K.A., 1974, MIGRANT, V45, P29; Goodpasture K.A., 1974, MIGRANT, V45, P57; Herron Joey, 1997, Redstart, V64, P114; Johnson GD, 2001, SETAC 22 N AM ANN M; Johnston D.W., 1955, ORIOLE, V20, P17; Karlsson J., 1977, Anser, V16, P203; Kemper Charles, 1996, Passenger Pigeon, V58, P219; Kerlinger P, 2010, WILSON J ORNITHOL, V122, P744, DOI 10.1676/06-075.1; Kostecke RM, 2001, J FIELD ORNITHOL, V72, P439, DOI 10.1648/0273-8570-72.3.439; Laskey A. E., 1963, Migrant, V34, P15; Laskey A. R., 1967, Migrant, V38, P43; LASKEY A R, 1969, Migrant, V40, P25; Laskey A. R., 1971, Migrant, V42, P15; Laskey A. R., 1964, Migrant, V35, P95; Laskey A. R., 1968, Migrant, V39, P25; Laskey A. R., 1963, Migrant, V34, P65; LASKEY A R, 1969, Migrant, V40, P79; Laskey A. R., 1956, MIGRANT, V27, P66; LASKEY AMELIA R., 1960, MIGRANT, V31, P61; LASKEY AMELIA R., 1957, MIGRANT, V28, P54; Laskey M. R., 1962, Migrant, V33, P7; Longcore T, 2005, SCI BASIS ESTABLISH; Longcore T, 2008, AUK, V125, P485, DOI 10.1525/auk.2008.06253; Manville, 2001, CELL TOWERS WIRELESS, P75; Manville AM, 2001, P WORKSH HELD CHARL, P85; Manville II A.M., 2005, USDAFOREST SERVICE G, P1051; Mayfield H., 1967, AUDUBON MAGAZINE, V69, P61; Mineau P, 2002, ENVIRON TOXICOL CHEM, V21, P1497, DOI 10.1897/1551-5028(2002)021&lt;1497:ETPOBM&gt;2.0.CO;2; MINEAU P, 1988, FIELD METHODS STUDY, P13; Morris SR, 2003, NORTHEAST NAT, V10, P67, DOI 10.2307/3858673; Morrison M., 2002, NRELSR50030876; Mosman D., 1975, IOWA BIRD LIFE, V45, P88; Munro J. A., 1924, Canadian Field Naturalist, V38, P141; Munro JA, 1924, CAN FIELD NAT, V38, P171; NICHOLSON CP, 2005, ASSESSMENT PREDICTIO; Nielsen LA, 2006, CLEAR CHANNEL NO COL; Orbach DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013912; Overing R., 1936, WILSON B, V48, P222; Piatt JF, 1996, AM FISH S S, V18, P712; Ponce C, 2010, ANIM CONSERV, V13, P603, DOI 10.1111/j.1469-1795.2010.00387.x; ROBBINS CS, 1989, P NATL ACAD SCI USA, V86, P7658, DOI 10.1073/pnas.86.19.7658; Sawyer P.J., 1961, NEW HAMPSHIRE AUDUBO, V14, P46; SEETS JW, 1977, WILSON BULL, V89, P422; Shire G. G., 2000, COMMUNICATION TOWERS; Smallwood KS, 2007, J WILDLIFE MANAGE, V71, P2781, DOI 10.2193/2007-006; Smallwood KS, 2010, J WILDLIFE MANAGE, V74, P1089, DOI 10.2193/2009-266; Spofford W. R., 1949, Wilson Bulletin Baltimore, V61, P86; Squires W. A., 1918, Condor Hollywood, V20, DOI 10.2307/1362354; Stoddard H. L., 1967, Bulletin Tall Timbers Research Station, VNo. 8, P1; Stoddard HL, 1962, B TALL TIMBERS RES S, V1, P1; STRNAD F V, 1975, Loon, V47, P16; TAYLOR W K, 1974, Florida Field Naturalist, V2, P40; TAYLOR WK, 1973, WILSON BULL, V85, P42; Thompson C., 2009, TUNDRA TROPICS CONNE, P262; TORDOFF HARRISON B., 1956, UNIV KANSAS PUBL MUS NAT HIST, V10, P1; Travis E., 2009, THESIS U WISCONSIN M, P1; US Fish and Wildlife Service, 2008, BIRDS CONS CONC 2008; Van Gelder R. G., 1956, Transactions of the Kansas Academy of Science, V59, P220; Velie E. D., 1963, Flicker, V35, P79; Williams TC, 2001, AUK, V118, P389, DOI 10.1642/0004-8038(2001)118[0389:BMTAMP]2.0.CO;2; Young EA, 2001, BIRD MORTALITY KTKA; Young EA, 2000, AVIAN SURVEYS WIND T; [No title captured]	103	71	75	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e34025	10.1371/journal.pone.0034025	http://dx.doi.org/10.1371/journal.pone.0034025			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558082	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345200007
J	Mingels, AM; Joosen, IA; Versteylen, MO; Laufer, EM; Winkens, MH; Wildberger, JE; Van Dieijen-Visser, MP; Hofstra, L				Mingels, Alma M.; Joosen, Ivo A.; Versteylen, Mathijs O.; Laufer, Eduard M.; Winkens, Mark H.; Wildberger, Joachim E.; Van Dieijen-Visser, Marja P.; Hofstra, Leonard			High-Sensitivity Cardiac Troponin T: Risk Stratification Tool in Patients with Symptoms of Chest Discomfort	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; INCIDENT HEART-FAILURE; C-REACTIVE PROTEIN; MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; COMPUTED-TOMOGRAPHY; AMERICAN-COLLEGE; EARLY-DIAGNOSIS; ASSAY; ASSOCIATION	Background: Recent studies have demonstrated the association between increased concentrations of high-sensitivity cardiac troponin T (hs-cTnT) and the incidence of myocardial infarction, heart failure, and mortality. However, most prognostic studies to date focus on the value of hs-cTnT in the elderly or general population. The value of hs-cTnT in symptomatic patients visiting the outpatient department remains unclear. The aim of this study was to investigate the prognostic value of hs-cTnT as a biomarker in patients with symptoms of chest discomfort suspected for coronary artery disease and to assess its additional value in combination with other risk stratification tools in predicting cardiac events. Methods: We studied 1,088 patients (follow-up 2.2 +/- 0.8 years) with chest discomfort who underwent coronary calcium scoring and coronary CT-angiography. Traditional cardiovascular risk factors and concentrations of hs-cTnT, N-terminal pro-brain-type natriuretic peptide (NT-proBNP) and high-sensitivity C-reactive protein (hsCRP) were assessed. Study endpoint was the occurrence of late coronary revascularization (>90 days), acute coronary syndrome, and cardiac mortality. Results: Hs-cTnT was a significant predictor for the composite endpoint (highest quartile [Q4]>6.7 ng/L, HR 3.55; 95%CI 1.88-6.70; P<0.001). Survival analysis showed that hs-cTnT had significant predictive value on top of current risk stratification tools (Chi-square change P<0.01). In patients with hs-cTnT in Q4 versus, Q4, a 2- to 3-fold increase in cardiovascular risk was noticed, either when corrected for high or low Framingham risk score, coronary calcium scoring, or CT-angiography assessment (HR 3.11; 2.73; 2.47; respectively; all P<0.01). This was not the case for hsCRP and NT-proBNP. Conclusions: Hs-cTnT is a useful prognostic biomarker in patients with chest discomfort suspected for coronary artery disease. In addition, hs-cTnT was an independent predictor for cardiac events when corrected for cardiovascular risk profiling, calcium score and CT-angiography results.	[Mingels, Alma M.; Van Dieijen-Visser, Marja P.] Maastricht Univ, Med Ctr, Dept Clin Chem, Maastricht, Netherlands; [Joosen, Ivo A.; Versteylen, Mathijs O.; Laufer, Eduard M.; Winkens, Mark H.] Maastricht Univ, Med Ctr, Dept Cardiol, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Wildberger, Joachim E.] Maastricht Univ, Med Ctr, Dept Radiol, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Hofstra, Leonard] Cardiol Ctr Netherlands, Utrecht, Netherlands	Maastricht University; Maastricht University; Maastricht University	Mingels, AM (corresponding author), Maastricht Univ, Med Ctr, Dept Clin Chem, Maastricht, Netherlands.	l.hofstra@cardiologiecentra.nl		Wildberger, Joachim/0000-0002-4810-6854				AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Alehagen U, 2010, CLIN CHEM, V56, P1718, DOI 10.1373/clinchem.2009.141341; Austen W G, 1975, Circulation, V51, P5; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; deFilippi CR, 2010, JAMA-J AM MED ASSOC, V304, P2494, DOI 10.1001/jama.2010.1708; Fox KF, 2001, EUR HEART J, V22, P228, DOI 10.1053/euhj.2000.2289; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Hadamitzky M, 2009, JACC-CARDIOVASC IMAG, V2, P404, DOI 10.1016/j.jcmg.2008.11.015; Hendel RC, 2006, J AM COLL CARDIOL, V48, P1475, DOI 10.1016/j.jacc.2006.07.003; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kavsak PA, 2009, CLIN CHEM, V55, P1809, DOI 10.1373/clinchem.2009.127241; Keller T, 2009, NEW ENGL J MED, V361, P868, DOI 10.1056/NEJMoa0903515; Korosoglou G, 2011, HEART, V97, P823, DOI 10.1136/hrt.2010.193201; Laufer EM, 2010, ARTERIOSCL THROM VAS, V30, P1269, DOI 10.1161/ATVBAHA.109.200394; Lindahl B, 2010, AM HEART J, V160, P224, DOI 10.1016/j.ahj.2010.05.023; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Otsuka T, 2010, AM HEART J, V159, P972, DOI 10.1016/j.ahj.2010.02.036; Raff Gilbert L, 2009, J Cardiovasc Comput Tomogr, V3, P122, DOI 10.1016/j.jcct.2009.01.001; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Ridker PM, 2007, J AM COLL CARDIOL, V49, P2129, DOI 10.1016/j.jacc.2007.02.052; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Vasile VC, 2010, CLIN CHEM, V56, P1086, DOI 10.1373/clinchem.2009.140616; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994	27	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35059	10.1371/journal.pone.0035059	http://dx.doi.org/10.1371/journal.pone.0035059			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558116	gold, Green Published, Green Submitted			2022-12-25	WOS:000305345200022
J	Quilez, J; Martinez, V; Woolliams, JA; Sanchez, A; Pong-Wong, R; Kennedy, LJ; Quinnell, RJ; Ollier, WER; Roura, X; Ferrer, L; Altet, L; Francino, O				Quilez, Javier; Martinez, Veronica; Woolliams, John A.; Sanchez, Armand; Pong-Wong, Ricardo; Kennedy, Lorna J.; Quinnell, Rupert J.; Ollier, William E. R.; Roura, Xavier; Ferrer, Lluis; Altet, Laura; Francino, Olga			Genetic Control of Canine Leishmaniasis: Genome-Wide Association Study and Genomic Selection Analysis	PLOS ONE			English	Article							SLC11A1 FORMERLY NRAMP1; VISCERAL LEISHMANIASIS; KALA-AZAR; CLASS-II; SUSCEPTIBILITY; INFECTION; IDENTIFICATION; CHAGASI; DISEASE; LOCUS	Background: The current disease model for leishmaniasis suggests that only a proportion of infected individuals develop clinical disease, while others are asymptomatically infected due to immune control of infection. The factors that determine whether individuals progress to clinical disease following Leishmania infection are unclear, although previous studies suggest a role for host genetics. Our hypothesis was that canine leishmaniasis is a complex disease with multiple loci responsible for the progression of the disease from Leishmania infection. Methodology/Principal Findings: Genome-wide association and genomic selection approaches were applied to a population-based case-control dataset of 219 dogs from a single breed (Boxer) genotyped for similar to 170,000 SNPs. Firstly, we aimed to identify individual disease loci; secondly, we quantified the genetic component of the observed phenotypic variance; and thirdly, we tested whether genome-wide SNP data could accurately predict the disease. Conclusions/Significance: We estimated that a substantial proportion of the genome is affecting the trait and that its heritability could be as high as 60%. Using the genome-wide association approach, the strongest associations were on chromosomes 1, 4 and 20, although none of these were statistically significant at a genome-wide level and after correcting for genetic stratification and lifestyle. Amongst these associations, chromosome 4:61.2-76.9 Mb maps to a locus that has previously been associated with host susceptibility to human and murine leishmaniasis, and genomic selection estimated markers in this region to have the greatest effect on the phenotype. We therefore propose these regions as candidates for replication studies. An important finding of this study was the significant predictive value from using the genomic information. We found that the phenotype could be predicted with an accuracy of similar to 0.29 in new samples and that the affection status was correctly predicted in 60% of dogs, significantly higher than expected by chance, and with satisfactory sensitivity-specificity values (AUC = 0.63).	[Quilez, Javier; Martinez, Veronica; Sanchez, Armand] Univ Autonoma Barcelona, Dept Genet Anim, Ctr Recerca Agrigen CRAG, E-08193 Barcelona, Spain; [Sanchez, Armand; Altet, Laura; Francino, Olga] Univ Autonoma Barcelona, Dept Ciencia Anim & Aliments, Fac Vet, Serv Vet Genet Mol, E-08193 Barcelona, Spain; [Woolliams, John A.; Pong-Wong, Ricardo] Univ Edinburgh, Roslin Inst, Easter Bush, Scotland; [Woolliams, John A.; Pong-Wong, Ricardo] Univ Edinburgh, R D SVS, Easter Bush, Scotland; [Kennedy, Lorna J.; Ollier, William E. R.] Univ Manchester, CIGMR, Manchester, Lancs, England; [Quinnell, Rupert J.] Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England; [Roura, Xavier; Ferrer, Lluis] Univ Autonoma Barcelona, Hosp Clin Vet, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); Autonomous University of Barcelona; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Manchester; University of Leeds; Autonomous University of Barcelona	Quilez, J (corresponding author), Univ Autonoma Barcelona, Dept Genet Anim, Ctr Recerca Agrigen CRAG, E-08193 Barcelona, Spain.	javier.quilez@cragenomica.es	ferrer, lluis/ABE-5179-2020; Francino, Olga/K-5683-2017; Quilez, Javier/J-7107-2015; Kennedy, Lorna/AAK-8767-2020; Sanchez, Armand/L-7905-2015; Roura, Xavier/I-2848-2015	ferrer, lluis/0000-0003-1537-0074; Francino, Olga/0000-0002-9022-3835; Quilez, Javier/0000-0002-0108-2672; Kennedy, Lorna/0000-0002-3087-4548; Sanchez, Armand/0000-0001-9160-1124; Pong-Wong, Ricardo/0000-0001-9808-2742	European Commission (LUPA) [GA-201370]; "Centre for Research in Agrigenomics" from the Spanish Ministry of Science and Innovation [CSD2007-00036]; BBSRC [BBS/E/D/05191132] Funding Source: UKRI; MRC [G0900753, G0100594, G0600237, G0901461] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/05191132] Funding Source: researchfish; Medical Research Council [G0100594, G0901461, G0900753, G0600237] Funding Source: researchfish	European Commission (LUPA)(European CommissionEuropean Commission Joint Research Centre); "Centre for Research in Agrigenomics" from the Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the European Commission (LUPA, GA-201370) as well as by the Consolider-Ingenio 2010 Programme CSD2007-00036 "Centre for Research in Agrigenomics" from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRANCHES P, 1991, J PARASITOL, V77, P557, DOI 10.2307/3283159; Altet L, 2002, INFECT IMMUN, V70, P2763, DOI 10.1128/IAI.70.6.2763-2771.2002; [Anonymous], 2005, 3 WORLD C LEISHM PAL; Badalova J, 2002, GENES IMMUN, V3, P187, DOI 10.1038/sj.gene.6363838; Baneth G, 2008, VET J, V175, P14, DOI 10.1016/j.tvjl.2006.11.011; Barber RM, 2011, J HERED, V102, pS40, DOI 10.1093/jhered/esr048; Beebe AM, 1997, GENES IMMUN, V6, P557; Blackwell JM, 2009, PARASITE IMMUNOL, V31, P254, DOI 10.1111/j.1365-3024.2009.01102.x; Blackwell JM, 1996, PARASITOLOGY, V112, pS67, DOI 10.1017/S0031182000076678; Bucheton B, 2003, AM J HUM GENET, V73, P1052, DOI 10.1086/379084; Bucheton B, 2002, MICROBES INFECT, V4, P1449, DOI 10.1016/S1286-4579(02)00027-8; CABELLO PH, 1995, AM J TROP MED HYG, V52, P364, DOI 10.4269/ajtmh.1995.52.364; Cortes E, 2005, INF VET          SEP, P28; Cutler G, 2007, GENOME RES, V17, P1743, DOI 10.1101/gr.6754607; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; Dodman NH, 2010, MOL PSYCHIATR, V15, P8, DOI 10.1038/mp.2009.111; Downs LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021452; FAGHIRI Z, 1995, HUM HERED, V45, P258, DOI 10.1159/000154309; Francino O, 2006, GENES IMMUN, V137, P221; Goldstein O, 2010, MOL VIS, V16, P1549; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Havelkova H, 2006, GENES IMMUN, V7, P220, DOI 10.1038/sj.gene.6364290; Ibrahim ME, 1999, AM J TROP MED HYG, V61, P941, DOI 10.4269/ajtmh.1999.61.941; Jakobsson M, 2008, GENES IMMUN, V451, P1003; Jamieson SE, 2006, GENES IMMUN, V8, P90; Jeronimo SMB, 2007, GENES IMMUN, V8, P539, DOI 10.1038/sj.gene.6364422; Jeronimo SMB, 2007, J INFECT DIS, V196, P1261, DOI 10.1086/521682; Jeronimo SMB, 2004, SCAND J INFECT DIS, V36, P443, DOI 10.1080/00365540410020451; Karplus TM, 2002, INFECT IMMUN, V70, P6919, DOI 10.1128/IAI.70.12.6919-6925.2002; Kidd JM, 2008, GENES IMMUN, V453, P64; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lipoldova M, 2006, NAT REV GENET, V7, P294, DOI 10.1038/nrg1832; Madsen MB, 2011, J HERED, V102, pS62, DOI 10.1093/jhered/esr041; Martinez V, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-57; Mausberg TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020042; Meddeb-Garnaoui A, 2001, HUM IMMUNOL, V62, P509, DOI 10.1016/S0198-8859(01)00237-3; Meurs KM, 2010, HUM GENET, V128, P315, DOI 10.1007/s00439-010-0855-y; Meuwissen THE, 2001, GENETICS, V157, P1819; Miller E, 2007, PLOS GENET, V3; Miranda S, 2008, RES VET SCI, V85, P35, DOI 10.1016/j.rvsc.2007.09.003; Mogensen MS, 2011, J HERED, V102, pS81, DOI 10.1093/jhered/esr021; Mohamed HS, 2004, EUR J HUM GENET, V12, P66, DOI 10.1038/sj.ejhg.5201089; Neff MW, 2006, CELL, V124, P229, DOI 10.1016/j.cell.2006.01.008; Olsson M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001332; Ostrander EA, 2005, GENOME RES, V15, P1706, DOI 10.1101/gr.3736605; Peacock C, 2002, GENES IMMUN, V3, P350, DOI 10.1038/sj.gene.6363852; Peacock CS, 2001, GENET EPIDEMIOL, V20, P383, DOI 10.1002/gepi.8; PONG-WONG R., 2010, BMC P S1, V4, pS4, DOI DOI 10.1186/1753-6561-4-S1-S4; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinnell RJ, 2003, IMMUNOGENETICS, V55, P23, DOI 10.1007/s00251-003-0545-1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roque JB, 2011, J HERED, V102, pS74, DOI 10.1093/jhered/esr054; Sakthianandeswaren A, 2009, TRENDS PARASITOL, V25, P383, DOI 10.1016/j.pt.2009.05.004; Salih MA, 2007, GENES IMMUN, V8, P75, DOI 10.1038/sj.gene.6364353; Sanchez-Robert E, 2008, VET IMMUNOL IMMUNOP, V125, P168, DOI 10.1016/j.vetimm.2008.04.010; Sanchez-Robert E, 2005, J HERED, V96, P755, DOI 10.1093/jhered/esi111; Sanchez-Robert E, 2008, VET RES, V39, DOI 10.1051/vetres:2008013; Solano-Gallego L, 2001, J CLIN MICROBIOL, V39, P560, DOI 10.1128/JCM.39.2.560-563.2001; Solano-Gallego L, 2000, VET PARASITOL, V90, P37, DOI 10.1016/S0304-4017(00)00223-5; Tsai KL, 2011, MAMM GENOME; Vaysse A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002316; Vladimirov V, 2003, INFECT IMMUN, V71, P2041, DOI 10.1128/IAI.71.4.2041-2046.2003; Wilbe M, 2010, NAT GENET, V42, P250, DOI 10.1038/ng.525; Wood SH, 2009, IMMUNOGENETICS, V61, P765, DOI 10.1007/s00251-009-0402-y; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; ZIJLSTRA EE, 1994, AM J TROP MED HYG, V51, P826, DOI 10.4269/ajtmh.1994.51.826	68	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35349	10.1371/journal.pone.0035349	http://dx.doi.org/10.1371/journal.pone.0035349			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558142	Green Published, gold			2022-12-25	WOS:000305345200033
J	Jeong, E; Jo, H; Kim, TG; Ban, C				Jeong, Euiyoung; Jo, Hunho; Kim, Tae Gyun; Ban, Changill			Characterization of Multi-Functional Properties and Conformational Analysis of MutS2 from Thermotoga maritima MSB8	PLOS ONE			English	Article							DNA MISMATCH REPAIR; THERMUS-THERMOPHILUS MUTS2; X-RAY-SCATTERING; CRYSTAL-STRUCTURE; NUCLEASE ACTIVITY; CATALYTIC DOMAIN; PROTEIN; ENDONUCLEASE; RECOMBINATION; RESOLUTION	The MutS2 homologues have received attention because of their unusual activities that differ from those of MutS. In this work, we report on the functional characteristics and conformational diversities of Thermotoga maritima MutS2 (TmMutS2). Various biochemical features of the protein were demonstrated via diverse techniques such as scanning probe microscopy (SPM), ATPase assays, analytical ultracentrifugation, DNA binding assays, size chromatography, and limited proteolytic analysis. Dimeric TmMutS2 showed the temperature-dependent ATPase activity. The non-specific nicking endonuclease activities of TmMutS2 were inactivated in the presence of nonhydrolytic ATP (ADPnP) and enhanced by the addition of TmMutL. In addition, TmMutS2 suppressed the TmRecA-mediated DNA strand exchange reaction in a TmMutL-dependent manner. We also demonstrated that small-angle X-ray scattering (SAXS) analysis of dimeric TmMutS2 exhibited nucleotide- and DNA-dependent conformational transitions. Particularly, TmMutS2-ADPnP showed the most compressed form rather than apo-TmMutS2 and the TmMutS2-ADP complex, in accordance with the results of biochemical assays. In the case of the DNA-binding complexes, the stretched conformation appeared in the TmMutS2-four-way junction (FWJ)-DNA complex. Convergences of biochemical-and SAXS analysis provided abundant information for TmMutS2 and clarified ambiguous experimental results.	[Jeong, Euiyoung; Jo, Hunho; Kim, Tae Gyun; Ban, Changill] Pohang Univ Sci & Technol, Dept Chem, Pohang, Gyungbuk, South Korea	Pohang University of Science & Technology (POSTECH)	Jeong, E (corresponding author), Pohang Univ Sci & Technol, Dept Chem, Pohang, Gyungbuk, South Korea.	ciban@postech.ac.kr	Ban, Changill/F-5426-2013		National Research Foundation of Korea [NRF-20110013431]; KOSEF through the Center for Electro-Photo Behaviors in Advanced Molecular Systems [20110007166]	National Research Foundation of Korea(National Research Foundation of Korea); KOSEF through the Center for Electro-Photo Behaviors in Advanced Molecular Systems	This work was supported by the National Research Foundation of Korea [NRF-20110013431] and by KOSEF through the Center for Electro-Photo Behaviors in Advanced Molecular Systems [20110007166]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Diercks T, 2008, J MOL BIOL, V383, P1156, DOI 10.1016/j.jmb.2008.09.005; Eisen JA, 1998, NUCLEIC ACIDS RES, V26, P4291, DOI 10.1093/nar/26.18.4291; Feigin L.A., 1987, STRUCTURE ANAL SMALL; Friedhoff P, 2001, J BIOL CHEM, V276, P23581, DOI 10.1074/jbc.M101694200; Fukui K, 2004, J BIOCHEM, V135, P375, DOI 10.1093/jb/mvh045; Fukui K, 2007, NUCLEIC ACIDS RES, V35, P850, DOI 10.1093/nar/gkl735; Fukui Kenji, 2011, Mol Biol Int, V2011, P691735, DOI 10.4061/2011/691735; Fukui K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019053; Fukui K, 2008, J BIOL CHEM, V283, P33417, DOI 10.1074/jbc.M806755200; Fukui K, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm575; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Guan C, 2005, NUCLEIC ACIDS RES, V33, P6225, DOI 10.1093/nar/gki921; Gui WJ, 2011, J STRUCT BIOL, V174, P282, DOI 10.1016/j.jsb.2011.01.008; Hadden JM, 2001, NAT STRUCT BIOL, V8, P62; Hagedoorn M, 1999, UUCS199903; Hall MC, 1999, J BIOL CHEM, V274, P1306, DOI 10.1074/jbc.274.3.1306; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; Hopfner KP, 2000, STRUCTURE, V8, pR237, DOI 10.1016/S0969-2126(00)00545-1; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jang DS, 2006, FEBS LETT, V580, P4166, DOI 10.1016/j.febslet.2006.06.069; Joshi A, 2000, NUCLEIC ACIDS RES, V28, P853, DOI 10.1093/nar/28.4.853; Jun SH, 2006, FEBS J, V273, P1609, DOI 10.1111/j.1742-4658.2006.05190.x; Kang J, 2005, J BACTERIOL, V187, P3528, DOI 10.1128/JB.187.10.3528-3537.2005; Kim TG, 2009, BMB REP, V42, P53, DOI 10.5483/BMBRep.2009.42.1.053; Kim TG, 2009, J BIOCHEM, V145, P199, DOI 10.1093/jb/mvn157; Kolodner RD, 2007, P NATL ACAD SCI USA, V104, P12953, DOI 10.1073/pnas.0705698104; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krukenberg KA, 2008, STRUCTURE, V16, P755, DOI 10.1016/j.str.2008.01.021; Lagunavicius A, 2003, J MOL BIOL, V326, P1051, DOI 10.1016/S0022-2836(03)00020-2; Lattuada M, 2003, J COLLOID INTERF SCI, V268, P96, DOI 10.1016/j.jcis.2003.07.028; Lin Z, 2007, NUCLEIC ACIDS RES, V35, P7591, DOI 10.1093/nar/gkm921; Malik HS, 2000, TRENDS BIOCHEM SCI, V25, P414, DOI 10.1016/S0968-0004(00)01623-6; Molloy S, 2005, NAT REV MICROBIOL, V3, P191, DOI 10.1038/nrmicro1123; Moreira D, 1999, TRENDS BIOCHEM SCI, V24, P298, DOI 10.1016/S0968-0004(99)01419-X; Nagar B, 2005, STRUCTURE, V13, P169, DOI 10.1016/j.str.2005.01.001; Nakagawa T, 1999, P NATL ACAD SCI USA, V96, P14186, DOI 10.1073/pnas.96.25.14186; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Neylon C, 2008, EUR BIOPHYS J BIOPHY, V37, P531, DOI 10.1007/s00249-008-0259-2; Nollmann M, 2004, MOL CELL, V16, P127, DOI 10.1016/j.molcel.2004.09.027; Pinto AV, 2005, MOL CELL, V17, P113, DOI 10.1016/j.molcel.2004.11.035; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Scott DJ, 2002, J MOL BIOL, V315, P1179, DOI 10.1006/jmbi.2001.5306; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Sun HB, 2000, ANAL CHEM, V72, P3138, DOI 10.1021/ac991263i; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svetlanov A, 2008, GENETICS, V178, P1937, DOI 10.1534/genetics.107.084798; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vijayvargia R, 2002, CURR MICROBIOL, V44, P224, DOI 10.1007/s00284-001-0025-5; Wang G, 2005, MOL MICROBIOL, V58, P166, DOI 10.1111/j.1365-2958.2005.04833.x; Wang HX, 2002, J BIOL CHEM, V277, P26136, DOI 10.1074/jbc.M200357200; Watanabe N, 2003, J BIOL CHEM, V278, P26102, DOI 10.1074/jbc.M303518200; Whitby MC, 2005, BIOCHEM SOC T, V33, P1451, DOI 10.1042/BST0331451; WORTH L, 1994, P NATL ACAD SCI USA, V91, P3238, DOI 10.1073/pnas.91.8.3238	59	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e34529	10.1371/journal.pone.0034529	http://dx.doi.org/10.1371/journal.pone.0034529			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545085	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343200008
J	Popugaeva, E; Witkowski, PT; Schlegel, M; Ulrich, RG; Auste, B; Rang, A; Kruger, DH; Klempa, B				Popugaeva, Elena; Witkowski, Peter T.; Schlegel, Mathias; Ulrich, Rainer G.; Auste, Brita; Rang, Andreas; Krueger, Detlev H.; Klempa, Boris			Dobrava-Belgrade Hantavirus from Germany Shows Receptor Usage and Innate Immunity Induction Consistent with the Pathogenicity of the Virus in Humans	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; RENAL SYNDROME; MAXIMUM-LIKELIHOOD; APODEMUS-AGRARIUS; CELLULAR ENTRY; EXPRESSION; INFECTION; CELLS; MOUSE; REASSORTMENT	Background: Dobrava-Belgrade virus (DOBV) is a European hantavirus causing hemorrhagic fever with renal syndrome (HFRS) in humans with fatality rates of up to 12%. DOBV-associated clinical cases typically occur also in the northern part of Germany where the virus is carried by the striped field mouse (Apodemus agrarius). However, the causative agent responsible for human illness has not been previously isolated. Methodology/Principal Findings: Here we report on characterization of a novel cell culture isolate from Germany obtained from a lung tissue of "spillover" infected yellow necked mouse (A. flavicollis) trapped near the city of Greifswald. Phylogenetic analyses demonstrated close clustering of the new strain, designated Greifswald/Aa (GRW/Aa) with the nucleotide sequence obtained from a northern German HFRS patient. The virus was effectively blocked by specific antibodies directed against beta 3 integrins and Decay Accelerating Factor (DAF) indicating that the virus uses same receptors as the highly pathogenic Hantaan virus (HTNV). In addition, activation of selected innate immunity markers as interferon beta and lambda and antiviral protein MxA after viral infection of A549 cells was investigated and showed that the virus modulates the first-line antiviral response in a similar way as HTNV. Conclusions/Significance: In summary, our study reveals novel data on DOBV receptor usage and innate immunity induction in relationship to virus pathogenicity and underlines the potency of German DOBV strains to act as human pathogen.	[Popugaeva, Elena; Witkowski, Peter T.; Auste, Brita; Rang, Andreas; Krueger, Detlev H.; Klempa, Boris] Charite, Inst Virol, Berlin, Germany; [Schlegel, Mathias; Ulrich, Rainer G.] Inst Novel & Emerging Infect Dis, Friedrich Loeffler Inst, Greifswald, Germany; [Klempa, Boris] Slovak Acad Sci, Inst Virol, Bratislava, Slovakia	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Friedrich Loeffler Institute; Slovak Academy of Sciences	Popugaeva, E (corresponding author), Charite, Inst Virol, Helmut Ruska Haus, Berlin, Germany.	boris.klempa@charite.de	Popugaeva, Elena/M-7886-2016; Schlegel, Mathias/AAO-6644-2021; Klempa, Boris/J-8876-2012; Klempa, Boris/N-3096-2019	Klempa, Boris/0000-0002-6931-1224; Klempa, Boris/0000-0002-6931-1224; Witkowski, Peter T./0000-0002-6167-8945	Deutsche Forschungsgemeinschaft (Research Training Group 1121) [KR1293/9-1]; European Commission (European Virus Archive) [228292]; Slovak Research and Development Agency [DO7RP-0008-09]; Slovak scientific grant agency VEGA [2/0189/09]	Deutsche Forschungsgemeinschaft (Research Training Group 1121)(German Research Foundation (DFG)); European Commission (European Virus Archive)(European Commission); Slovak Research and Development Agency(Slovak Research and Development Agency); Slovak scientific grant agency VEGA(Vedecka grantova agentura MSVVaS SR a SAV (VEGA))	The current work was funded by Deutsche Forschungsgemeinschaft (Research Training Group 1121 and grant no. KR1293/9-1), European Commission (European Virus Archive, FP7 CAPACITIES project - GA no 228292), Slovak Research and Development Agency (DO7RP-0008-09), and Slovak scientific grant agency VEGA (grant no. 2/0189/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens IG, 2006, EXP CELL RES, V312, P925, DOI 10.1016/j.yexcr.2005.11.036; Avsic-Zupanc T, 1999, CLIN INFECT DIS, V28, P860, DOI 10.1086/515185; Black WC, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-102; Choi Y, 2008, VIROLOGY, V381, P178, DOI 10.1016/j.virol.2008.08.035; Dzagurova TK, 2012, CLIN INFECT DIS, V54, pE1, DOI 10.1093/cid/cir746; Elgh F, 1997, J CLIN MICROBIOL, V35, P1122, DOI 10.1128/JCM.35.5.1122-1130.1997; Emonet SF, 2007, NAT PROTOC, V2, P340, DOI 10.1038/nprot.2006.453; Flohr F, 1999, FEBS LETT, V463, P24, DOI 10.1016/S0014-5793(99)01598-7; Frese M, 1996, J VIROL, V70, P915, DOI 10.1128/JVI.70.2.915-923.1996; Gavrilovskaya IN, 1999, J VIROL, V73, P3951, DOI 10.1128/JVI.73.5.3951-3959.1999; Gavrilovskaya IN, 2002, ARCH VIROL, V147, P1913, DOI 10.1007/s00705-002-0852-0; Gavrilovskaya IN, 1998, P NATL ACAD SCI USA, V95, P7074, DOI 10.1073/pnas.95.12.7074; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076; Handke W, 2009, J IMMUNOL, V182, P2849, DOI 10.4049/jimmunol.0802893; Heider H, 2001, J VIROL METHODS, V96, P17, DOI 10.1016/S0166-0934(01)00314-7; Henderson WW, 1995, VIROLOGY, V214, P602, DOI 10.1006/viro.1995.0071; Holzinger D, 2007, J VIROL, V81, P7776, DOI 10.1128/JVI.00546-06; Kanerva M, 1996, VIROLOGY, V224, P55, DOI 10.1006/viro.1996.0506; Khaiboullina SF, 2005, J MED VIROL, V75, P267, DOI 10.1002/jmv.20266; Kirsanovs S, 2010, VIRUS GENES, V41, P319, DOI 10.1007/s11262-010-0523-2; Klempa B, 2006, EMERG INFECT DIS, V12, P838, DOI 10.3201/eid1205.051487; Klempa B, 2003, J VIROL, V77, P804, DOI 10.1128/JVI.77.1.804-809.2003; Klempa B, 2005, J CLIN MICROBIOL, V43, P2756, DOI 10.1128/JCM.43.6.2756-2763.2005; Klempa B, 2004, J CLIN MICROBIOL, V42, P1322, DOI 10.1128/JCM.42.3.1322-1325.2004; Klempa B, 2008, EMERG INFECT DIS, V14, P617, DOI 10.3201/eid1404.071310; Kramski M, 2007, CLIN CHEM, V53, P1899, DOI 10.1373/clinchem.2007.093245; Kraus AA, 2005, INTERVIROLOGY, V48, P255, DOI 10.1159/000084603; Kraus AA, 2004, J VIROL, V78, P6143, DOI 10.1128/JVI.78.12.6143-6150.2004; Krautkramer E, 2008, J VIROL, V82, P4257, DOI 10.1128/JVI.02210-07; Kruger DH, 2011, HUM VACCINES, V7, P685, DOI 10.4161/hv.7.6.15197; Kruger DH, 2011, MOL DETECTION HUMAN, P631; Mackow ER, 2009, THROMB HAEMOSTASIS, V102, P1030, DOI 10.1160/TH09-09-0640; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Matthys V, 2011, J VIROL, V85, P4752, DOI 10.1128/JVI.01945-10; Nam JH, 2003, VIRUS GENES, V26, P31, DOI 10.1023/A:1022373904357; Nemirov K, 1999, J GEN VIROL, V80, P371, DOI 10.1099/0022-1317-80-2-371; Papa A, 2001, EUR J EPIDEMIOL, V17, P189, DOI 10.1023/A:1017987104363; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prescott J, 2005, J VIROL, V79, P15007, DOI 10.1128/JVI.79.24.15007-15015.2005; Prescott J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011159; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Raymond T, 2005, P NATL ACAD SCI USA, V102, P1163, DOI 10.1073/pnas.0406743102; Razzauti M, 2009, J GEN VIROL, V90, P1923, DOI 10.1099/vir.0.011304-0; Rodriguez LL, 1998, VIROLOGY, V242, P99, DOI 10.1006/viro.1997.8990; Schlegel M, 2009, EMERG INFECT DIS, V15, P2017, DOI 10.3201/eid1512.090923; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schonrich G, 2008, IMMUNOL REV, V225, P163, DOI 10.1111/j.1600-065X.2008.00694.x; Stewart PL, 2007, TRENDS MICROBIOL, V15, P500, DOI 10.1016/j.tim.2007.10.001; Stoltz M, 2010, J VIROL, V84, P9140, DOI 10.1128/JVI.00717-10; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terajima M, 2011, VIRUSES-BASEL, V3, P1059, DOI 10.3390/v3071059	53	27	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35587	10.1371/journal.pone.0035587	http://dx.doi.org/10.1371/journal.pone.0035587			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545121	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343200041
J	Watanabe, N; Wada, M; Irukayama-Tomobe, Y; Ogata, Y; Tsujino, N; Suzuki, M; Furutani, N; Sakurai, T; Yamamoto, M				Watanabe, Noriya; Wada, Mari; Irukayama-Tomobe, Yoko; Ogata, Yousuke; Tsujino, Natsuko; Suzuki, Mika; Furutani, Naoki; Sakurai, Takeshi; Yamamoto, Miyuki			A Single Nucleotide Polymorphism of the Neuropeptide B/W Receptor-1 Gene Influences the Evaluation of Facial Expressions	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; ANXIETY-RELATED TRAITS; HUMAN AMYGDALA; SEROTONIN TRANSPORTER; PREFRONTAL CORTEX; EMOTIONAL INTENSITY; REGULATORY REGION; RAT-BRAIN; ACTIVATION; GPR7	Neuropeptide B/W receptor-1 (NPBWR1) is expressed in discrete brain regions in rodents and humans, with particularly strong expression in the limbic system, including the central nucleus of the amygdala. Recently, Nagata-Kuroiwa et al. reported that Npbwr1(-/-) mice showed changes in social behavior, suggesting that NPBWR1 plays important roles in the emotional responses of social interactions. The human NPBWR1 gene has a single nucleotide polymorphism at nucleotide 404 (404A>T; SNP rs33977775). This polymorphism results in an amino acid change, Y135F. The results of an in vitro experiment demonstrated that this change alters receptor function. We investigated the effect of this variation on emotional responses to stimuli of showing human faces with four categories of emotional expressions (anger, fear, happiness, and neutral). Subjects' emotional levels on seeing these faces were rated on scales of hedonic valence, emotional arousal, and dominance (V-A-D). A significant genotype difference was observed in valence evaluation; the 404AT group perceived facial expressions more pleasantly than did the 404AA group, regardless of the category of facial expression. Statistical analysis of each combination of [V-A-D and facial expression] also showed that the 404AT group tended to feel less submissive to an angry face than did the 404AA group. Thus, a single nucleotide polymorphism of NPBWR1 seems to affect human behavior in a social context.	[Watanabe, Noriya; Wada, Mari; Irukayama-Tomobe, Yoko; Ogata, Yousuke; Yamamoto, Miyuki] Univ Tsukuba, Tsukuba, Ibaraki, Japan; [Watanabe, Noriya; Ogata, Yousuke] Japan Soc Promot Sci, Tokyo, Japan; [Watanabe, Noriya] Tamagawa Univ, Grad Sch Engn, Machida, Tokyo, Japan; [Irukayama-Tomobe, Yoko] Univ Tsukuba, Ctr Behav Mol Genet, Program 1, Tokyo, Japan; [Tsujino, Natsuko; Suzuki, Mika; Furutani, Naoki; Sakurai, Takeshi] Kanazawa Univ, Fac Med, Dept Mol Neurosci & Integrat Physiol, Kanazawa, Ishikawa, Japan; [Sakurai, Takeshi] Japan Sci & Technol Agcy, Exploratory Res Adv Technol Yanagisawa Orphan Rec, Tokyo, Japan	University of Tsukuba; Japan Society for the Promotion of Science; University of Tsukuba; Kanazawa University; Japan Science & Technology Agency (JST)	Watanabe, N (corresponding author), Univ Tsukuba, Tsukuba, Ibaraki, Japan.	tsakurai@med.kanazawa-u.ac.jp; yamamoto444@gmail.com		Watanabe, Noriya/0000-0002-7847-6338; Ogata, Yousuke/0000-0003-4613-7435	University of Tsukuba; Ministry of Education, Culture, Sports, Science and Technology of Japan; John D. and Catherine T. MacArthur Foundation Research Network on Early Experience and Brain Development; Grants-in-Aid for Scientific Research [23300082, 24700322] Funding Source: KAKEN	University of Tsukuba; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); John D. and Catherine T. MacArthur Foundation Research Network on Early Experience and Brain Development; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the 21st Center of Excellence program of the University of Tsukuba, and a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan. NW and YO were supported by Grant-in-Aid for Japan Society for the Promotion of Science Fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Development of the MacBrain Face Stimulus Set was overseen by Nim Tottenham and supported by the John D. and Catherine T. MacArthur Foundation Research Network on Early Experience and Brain Development (tott0006@tc.umn.edu).	ADOLPHS R, 1995, J NEUROSCI, V15, P5879; Adolphs R, 2010, ANN NY ACAD SCI, V1191, P42, DOI 10.1111/j.1749-6632.2010.05445.x; Anders S, 2008, SOC COGN AFFECT NEUR, V3, P233, DOI 10.1093/scan/nsn017; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Bradley M. M., 1999, C1 U FLOR CTR RES PS, V30, P25; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Brezillon S, 2003, J BIOL CHEM, V278, P776, DOI 10.1074/jbc.M206396200; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Costa P.T., 2008, SAGE HDB PERSONALITY, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9, 10.4135/9781849200479.N9]; Cunningham WA, 2004, J COGNITIVE NEUROSCI, V16, P1717, DOI 10.1162/0898929042947919; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Eysenck H, MANUAL MAUDSLEY PERS; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Garavan H, 2001, NEUROREPORT, V12, P2779, DOI 10.1097/00001756-200108280-00036; Goldman-Rakic PSBC, 1999, PRIMATE MESOCORTICAL, P403; Hamann S, 2002, NEUROREPORT, V13, P15, DOI 10.1097/00001756-200201210-00008; Hamann SB, 2002, PSYCHOL SCI, V13, P135, DOI 10.1111/1467-9280.00425; Heinz A, 2005, NAT NEUROSCI, V8, P20, DOI 10.1038/nn1366; Hondo Mari, 2008, V46, P239, DOI 10.1007/400_2007_056; Iidaka T, 2005, J NEUROSCI, V25, P6460, DOI 10.1523/JNEUROSCI.5261-04.2005; Kalin NH, 2004, J NEUROSCI, V24, P5506, DOI 10.1523/JNEUROSCI.0292-04.2004; Katsuragi S, 1999, BIOL PSYCHIAT, V45, P368, DOI 10.1016/S0006-3223(98)00090-0; Kennedy DP, 2009, NAT NEUROSCI, V12, P1226, DOI 10.1038/nn.2381; Kim H, 2003, NEUROREPORT, V14, P2317, DOI 10.1097/00001756-200312190-00006; Kitamura Y, 2006, BRAIN RES, V1093, P123, DOI 10.1016/j.brainres.2006.03.041; Krugel LK, 2009, P NATL ACAD SCI USA, V106, P17951, DOI 10.1073/pnas.0905191106; Lang PJ, 2006, PROG BRAIN RES, V156, P3, DOI 10.1016/S0079-6123(06)56001-7; Lee DK, 1999, MOL BRAIN RES, V71, P96, DOI 10.1016/S0169-328X(99)00171-0; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; LEWIS DA, 1992, J NEURAL TRANSM-GEN, P179; Liberzon I, 2003, NEUROPSYCHOPHARMACOL, V28, P726, DOI 10.1038/sj.npp.1300113; Mehrabian A, 1996, INT J AGING HUM DEV, V42, P251, DOI 10.2190/1QCY-VETT-JJAY-3EY1; Melke J, 2003, ARCH GEN PSYCHIAT, V60, P1017, DOI 10.1001/archpsyc.60.10.1017; Mellado M, 1998, J IMMUNOL, V161, P805; MORA F, 1980, BRAIN RES BULL, V5, P111, DOI 10.1016/0361-9230(80)90181-1; Nagata-Kuroiwa R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016972; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; ODOWD BF, 1995, GENOMICS, V28, P84, DOI 10.1006/geno.1995.1109; Phan KL, 2004, NEUROIMAGE, V21, P768, DOI 10.1016/j.neuroimage.2003.09.072; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Posner J, 2005, DEV PSYCHOPATHOL, V17, P715, DOI 10.1017/S0954579405050340; ROLLS ET, 1980, BRAIN RES, V194, P339, DOI 10.1016/0006-8993(80)91216-0; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; RUSSELL JA, 1977, J RES PERS, V11, P273, DOI 10.1016/0092-6566(77)90037-X; Sabatinelli D, 2005, NEUROIMAGE, V24, P1265, DOI 10.1016/j.neuroimage.2004.12.015; Salimpoor VN, 2011, NAT NEUROSCI, V14, P257, DOI 10.1038/nn.2726; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Sharot T, 2009, CURR BIOL, V19, P2077, DOI 10.1016/j.cub.2009.10.025; Tanaka H, 2003, P NATL ACAD SCI USA, V100, P6251, DOI 10.1073/pnas.0837789100; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Williams LM, 2004, HUM BRAIN MAPP, V21, P64, DOI 10.1002/hbm.10154; Williams MA, 2004, EXP BRAIN RES, V154, P403, DOI 10.1007/s00221-003-1740-x; Williams MA, 2005, NEUROIMAGE, V24, P417, DOI 10.1016/j.neuroimage.2004.08.017; WILLIAMS SM, 1993, CEREB CORTEX, V3, P199, DOI 10.1093/cercor/3.3.199; Wright CI, 2001, NEUROREPORT, V12, P379, DOI 10.1097/00001756-200102120-00039; Yang TT, 2002, NEUROREPORT, V13, P1737, DOI 10.1097/00001756-200210070-00009	60	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35390	10.1371/journal.pone.0035390	http://dx.doi.org/10.1371/journal.pone.0035390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545105	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343200026
J	DeSantis, LRG; Tracy, RAB; Koontz, CS; Roseberry, JC; Velasco, MC				DeSantis, Larisa R. G.; Tracy, Rachel A. Beavins; Koontz, Cassandra S.; Roseberry, John C.; Velasco, Matthew C.			Mammalian Niche Conservation through Deep Time	PLOS ONE			English	Article							GEOGRAPHIC RANGE SIZES; PLEISTOCENE MAMMALS; CLIMATE-CHANGE; HABITAT FRAGMENTATION; FOSSIL HORSES; SPECIES-LEVEL; EXTINCTIONS; HERITABILITY; EVOLUTION; ENVIRONMENTS	Climate change alters species distributions, causing plants and animals to move north or to higher elevations with current warming. Bioclimatic models predict species distributions based on extant realized niches and assume niche conservation. Here, we evaluate if proxies for niches (i.e., range areas) are conserved at the family level through deep time, from the Eocene to the Pleistocene. We analyze the occurrence of all mammalian families in the continental USA, calculating range area, percent range area occupied, range area rank, and range polygon centroids during each epoch. Percent range area occupied significantly increases from the Oligocene to the Miocene and again from the Pliocene to the Pleistocene; however, mammalian families maintain statistical concordance between rank orders across time. Families with greater taxonomic diversity occupy a greater percent of available range area during each epoch and net changes in taxonomic diversity are significantly positively related to changes in percent range area occupied from the Eocene to the Pleistocene. Furthermore, gains and losses in generic and species diversity are remarkably consistent with similar to 2.3 species gained per generic increase. Centroids demonstrate southeastern shifts from the Eocene through the Pleistocene that may correspond to major environmental events and/or climate changes during the Cenozoic. These results demonstrate range conservation at the family level and support the idea that niche conservation at higher taxonomic levels operates over deep time and may be controlled by life history traits. Furthermore, families containing megafauna and/or terminal Pleistocene extinction victims do not incur significantly greater declines in range area rank than families containing only smaller taxa and/or only survivors, from the Pliocene to Pleistocene. Collectively, these data evince the resilience of families to climate and/or environmental change in deep time, the absence of terminal Pleistocene "extinction prone'' families, and provide valuable insights to understanding mammalian responses to current climate change.	[DeSantis, Larisa R. G.; Tracy, Rachel A. Beavins; Roseberry, John C.] Vanderbilt Univ, Dept Earth & Environm Sci, Nashville, TN 37235 USA; [Koontz, Cassandra S.; Velasco, Matthew C.] Vanderbilt Univ, Dept Anthropol, Nashville, TN USA	Vanderbilt University; Vanderbilt University	DeSantis, LRG (corresponding author), Vanderbilt Univ, Dept Earth & Environm Sci, Nashville, TN 37235 USA.	larisa.desantis@vanderbilt.edu		Velasco, Matthew/0000-0001-8784-7076; DeSantis, Larisa/0000-0003-1159-9154	Vanderbilt University	Vanderbilt University	Funding was provided by Vanderbilt University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alroy J, 2001, SCIENCE, V292, P1893, DOI 10.1126/science.1059342; [Anonymous], 1999, WALKERS MAMMALS WORL; Barnosky AD, 2004, SCIENCE, V306, P70, DOI 10.1126/science.1101476; BEYER HL, 2009, GEOSPATIAL MODELLING; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; DeSantis LG, 2011, BIOTROPICA, V43, P746, DOI 10.1111/j.1744-7429.2011.00761.x; DeSantis LRG, 2007, COUR FOR SEKENBG, V258, P147; DeSantis LRG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005750; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Faith JT, 2009, P NATL ACAD SCI USA, V106, P20641, DOI 10.1073/pnas.0908153106; Hadly EA, 2009, P NATL ACAD SCI USA, V106, P19707, DOI 10.1073/pnas.0901648106; Haug GH, 2005, NATURE, V433, P821, DOI 10.1038/nature03332; Hunt G, 2005, AM NAT, V166, P129, DOI 10.1086/430722; Janis CM, 2008, EVOLUTION OF TERTIARY MAMMALS OF NORTH AMERICA, VOL 2, P1, DOI 10.1017/CBO9780511541438; Janis CM, 2000, P NATL ACAD SCI USA, V97, P7899, DOI 10.1073/pnas.97.14.7899; Janis CM, 1998, TERRESTRIAL CARNIVOR; JENKINS S H, 1979, Mammalian Species, P1, DOI 10.2307/3503787; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Lyons SK, 2010, PHILOS T R SOC B, V365, P3681, DOI 10.1098/rstb.2010.0263; Lyons SK, 2004, EVOL ECOL RES, V6, P339; Lyons SK, 2003, J MAMMAL, V84, P385, DOI 10.1644/1545-1542(2003)084<0385:AQAOTR>2.0.CO;2; MacFadden BJ, 2005, SCIENCE, V307, P1728, DOI 10.1126/science.1105458; MACFADDEN BJ, 1994, TRENDS ECOL EVOL, V9, P481, DOI 10.1016/0169-5347(94)90313-1; Martin PS, 1984, QUATERNARY EXTINCTIO; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; MCNAB BK, 1963, AM NAT, V97, P133, DOI 10.1086/282264; Paleobiology Database, 2010, MAMM PAL DAT ONL ARC; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Peres CA, 2001, CONSERV BIOL, V15, P1490, DOI 10.1046/j.1523-1739.2001.01089.x; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Post E, 2004, P NATL ACAD SCI USA, V101, P9286, DOI 10.1073/pnas.0305029101; Reynolds PS, 2002, J MAMMAL, V83, P321, DOI 10.1644/1545-1542(2002)083<0321:HBIAGT>2.0.CO;2; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Sax DF, 2002, AM NAT, V160, P766, DOI 10.1086/343877; Waldron A, 2007, AM NAT, V170, P221, DOI 10.1086/518963; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Webb TJ, 2003, AM NAT, V161, P553, DOI 10.1086/368296; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	42	16	16	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35624	10.1371/journal.pone.0035624	http://dx.doi.org/10.1371/journal.pone.0035624			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539985	Green Submitted, gold, Green Published			2022-12-25	WOS:000305341000051
J	Block, GJ; Petek, LM; Narayanan, D; Amell, AM; Moore, JM; Rabaia, NA; Tyler, A; van der Maarel, SM; Tawil, R; Filippova, GN; Miller, DG				Block, Gregory J.; Petek, Lisa M.; Narayanan, Divya; Amell, Amanda M.; Moore, James M.; Rabaia, Natalia A.; Tyler, Ashlee; van der Maarel, Silvere M.; Tawil, Rabi; Filippova, Galina N.; Miller, Daniel G.			Asymmetric Bidirectional Transcription from the FSHD-Causing D4Z4 Array Modulates DUX4 Production	PLOS ONE			English	Article							CANDIDATE GENE; BINDING-SITES; PROMOTERS; LOCUS; HYPOMETHYLATION; SEQUENCE; REPEATS; ENCODES; CTCF; YY1	Facioscapulohumeral Disease (FSHD) is a dominantly inherited progressive myopathy associated with aberrant production of the transcription factor, Double Homeobox Protein 4 (DUX4). The expression of DUX4 depends on an open chromatin conformation of the D4Z4 macrosatellite array and a specific haplotype on chromosome 4. Even when these requirements are met, DUX4 transcripts and protein are only detectable in a subset of cells indicating that additional constraints govern DUX4 production. Since the direction of transcription, along with the production of non-coding antisense transcripts is an important regulatory feature of other macrosatellite repeats, we developed constructs that contain the non-coding region of a single D4Z4 unit flanked by genes that report transcriptional activity in the sense and antisense directions. We found that D4Z4 contains two promoters that initiate sense and antisense transcription within the array, and that antisense transcription predominates. Transcriptional start sites for the antisense transcripts, as well as D4Z4 regions that regulate the balance of sense and antisense transcripts were identified. We show that the choice of transcriptional direction is reversible but not mutually exclusive, since sense and antisense reporter activity was often present in the same cell and simultaneously upregulated during myotube formation. Similarly, levels of endogenous sense and antisense D4Z4 transcripts were upregulated in FSHD myotubes. These studies offer insight into the autonomous distribution of muscle weakness that is characteristic of FSHD.	[Block, Gregory J.; Petek, Lisa M.; Narayanan, Divya; Amell, Amanda M.; Miller, Daniel G.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Moore, James M.; Rabaia, Natalia A.; Tyler, Ashlee; Filippova, Galina N.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98104 USA; [Tawil, Rabi] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [van der Maarel, Silvere M.] Leiden Univ, Med Ctr, Leiden, Netherlands	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Rochester; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Miller, DG (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.	dgmiller@uw.edu	van der Maarel, Silvere/X-3631-2018	van der Maarel, Silvere/0000-0001-8103-711X; Miller, Daniel/0000-0002-5700-3048	NIH NINDS [P01NS069539-02/03]; Pacific Northwest Friends of FSH Research; Shaw Family Foundation; Muscular Dystrophy Association; Fields Center for FSHD and Neuromuscular Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS069539] Funding Source: NIH RePORTER	NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Pacific Northwest Friends of FSH Research; Shaw Family Foundation; Muscular Dystrophy Association(Muscular Dystrophy Association); Fields Center for FSHD and Neuromuscular Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH NINDS P01NS069539-02/03 (DGM(02), GNF(03)), the Pacific Northwest Friends of FSH Research (GJB, DGM), the Shaw Family Foundation (GNF), the Muscular Dystrophy Association (GNF), and the Fields Center for FSHD and Neuromuscular Research (RT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austen M, 1997, J BIOL CHEM, V272, P1709, DOI 10.1074/jbc.272.3.1709; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Bosnakovski D, 2008, EXP NEUROL, V214, P87, DOI 10.1016/j.expneurol.2008.07.022; Chadwick BP, 2008, GENOME RES, V18, P1259, DOI 10.1101/gr.075713.107; Cho DH, 2005, MOL CELL, V20, P483, DOI 10.1016/j.molcel.2005.09.002; de Greef JC, 2007, NEUROLOGY, V69, P1018, DOI 10.1212/01.wnl.0000271391.44352.fe; de Greef JC, 2008, MUTAT RES-FUND MOL M, V647, P94, DOI 10.1016/j.mrfmmm.2008.07.011; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Dmitriev P, J BIOL CHEM; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; Frisullo G, 2011, J CLIN IMMUNOL, V31, P155, DOI 10.1007/s10875-010-9474-6; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Kan HE, 2010, NMR BIOMED, V23, P563, DOI 10.1002/nbm.1494; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Lemmers RJLF, 2007, AM J HUM GENET, V81, P884, DOI 10.1086/521986; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Moseley SC, 2004, NUCLEIC ACIDS RES, V40, P1596; Ottaviani A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000394; Petek LM, 2010, MOL THER, V18, P1624, DOI 10.1038/mt.2010.102; Petrov A, 2008, GENOME RES, V18, P39, DOI 10.1101/gr.6620908; Reuter M, 2011, NATURE, V480, P264, DOI 10.1038/nature10672; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Snider L, 2009, HUM MOL GENET, V18, P2414, DOI 10.1093/hmg/ddp180; Tawil R, 2008, NEUROTHERAPEUTICS, V5, P601, DOI 10.1016/j.nurt.2008.07.005; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; Wallace LM, 2011, ANN NEUROL, V69, P540, DOI 10.1002/ana.22275; Wan Y, 2010, CELL CYCLE, V9, P3391, DOI 10.4161/cc.9.17.13122; Wuebbles RD, 2010, INT J CLIN EXP PATHO, V3, P386; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yang MQ, 2007, LECT N BIOINFORMAT, V4463, P361; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zeng WH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000559	39	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35532	10.1371/journal.pone.0035532	http://dx.doi.org/10.1371/journal.pone.0035532			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536400	gold, Green Submitted, Green Published			2022-12-25	WOS:000305339200075
J	Trinquart, L; Abbe, A; Ravaud, P				Trinquart, Ludovic; Abbe, Adeline; Ravaud, Philippe			Impact of Reporting Bias in Network Meta-Analysis of Antidepressant Placebo-Controlled Trials	PLOS ONE			English	Article							INDUSTRY SPONSORSHIP; PUBLICATION BIASES; HEALTH-CARE; INTERVENTIONS; DATABASE; REGISTRY	Background: Indirect comparisons of competing treatments by network meta-analysis (NMA) are increasingly in use. Reporting bias has received little attention in this context. We aimed to assess the impact of such bias in NMAs. Methods: We used data from 74 FDA-registered placebo-controlled trials of 12 antidepressants and their 51 matching publications. For each dataset, NMA was used to estimate the effect sizes for 66 possible pair-wise comparisons of these drugs, the probabilities of being the best drug and ranking the drugs. To assess the impact of reporting bias, we compared the NMA results for the 51 published trials and those for the 74 FDA-registered trials. To assess how reporting bias affecting only one drug may affect the ranking of all drugs, we performed 12 different NMAs for hypothetical analysis. For each of these NMAs, we used published data for one drug and FDA data for the 11 other drugs. Findings: Pair-wise effect sizes for drugs derived from the NMA of published data and those from the NMA of FDA data differed in absolute value by at least 100% in 30 of 66 pair-wise comparisons (45%). Depending on the dataset used, the top 3 agents differed, in composition and order. When reporting bias hypothetically affected only one drug, the affected drug ranked first in 5 of the 12 NMAs but second (n = 2), fourth (n = 1) or eighth (n = 2) in the NMA of the complete FDA network. Conclusions: In this particular network, reporting bias biased NMA-based estimates of treatments efficacy and modified ranking. The reporting bias effect in NMAs may differ from that in classical meta-analyses in that reporting bias affecting only one drug may affect the ranking of all drugs.	[Trinquart, Ludovic; Abbe, Adeline; Ravaud, Philippe] French Cochrane Ctr, Paris, France; [Trinquart, Ludovic; Abbe, Adeline; Ravaud, Philippe] Univ Paris Descartes Sorbonne Paris Cite, Paris, France; [Trinquart, Ludovic; Abbe, Adeline; Ravaud, Philippe] INSERM, U738, Paris, France; [Trinquart, Ludovic; Abbe, Adeline; Ravaud, Philippe] Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, F-75181 Paris, France; [Ravaud, Philippe] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Columbia University	Ravaud, P (corresponding author), French Cochrane Ctr, Paris, France.	philippe.ravaud@htd.aphp.fr	Trinquart, Ludovic/H-4961-2019; ravaud, philippe/C-1694-2009	Trinquart, Ludovic/0000-0002-3028-4900; Ravaud, Philippe/0000-0001-8264-9206; ABBE, Adeline/0000-0001-6170-9572	French Ministry of Health Programme Hospitalier de Recherche Clinique National [PHRC 2011 MIN01-66]; European Union [285453]	French Ministry of Health Programme Hospitalier de Recherche Clinique National; European Union(European Commission)	Grant support was from the French Ministry of Health Programme Hospitalier de Recherche Clinique National (PHRC 2011 MIN01-66) and European Union Seventh Framework Programme (FP7 - HEALTH.2011.4.1-2) under grant agreement no 285453 (www.open-project.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bero L, 2007, PLOS MED, V4, P1001, DOI 10.1371/journal.pmed.0040184; Chalmers I, 2006, LANCET, V367, P449, DOI 10.1016/S0140-6736(06)68153-1; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; DeAngelis CD, 2010, JAMA-J AM MED ASSOC, V303, P1196, DOI 10.1001/jama.2010.337; Dickersin K, 2010, SCIENCE, V329, P516, DOI 10.1126/science.1189330; Donegan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011054; Estellat C, 2012, ARCH INTERN MED, V172, P237, DOI 10.1001/archinternmed.2011.1209; Eyding D, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4737; Gartlehner G, 2008, ANN INTERN MED, V149, P734, DOI 10.7326/0003-4819-149-10-200811180-00008; Glenny AM, 2005, HEALTH TECHNOL ASSES, V9, P1; Godlee F, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5641; Hart B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7202; Higgins JPT, 1996, STAT MED, V15, P2733, DOI 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0; Hochman M, 2010, JAMA-J AM MED ASSOC, V303, P951, DOI 10.1001/jama.2010.240; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Institute of Medicine, 2009, IN NAT PRIOR COMP EF, P227, DOI [10.17226/12648, DOI 10.17226/12648]; Ioannidis JPA, 2007, CAN MED ASSOC J, V176, P1091, DOI 10.1503/cmaj.060410; Ioannidis JPA, 2011, ARCH GEN PSYCHIAT, V68, P773, DOI 10.1001/archgenpsychiatry.2011.28; Kent DM, 2008, NEW ENGL J MED, V359, P1287, DOI 10.1056/NEJMe0806806; Lathyris DN, 2010, EUR J CLIN INVEST, V40, P172, DOI 10.1111/j.1365-2362.2009.02240.x; Lee K, 2008, PLOS MED, V5, P1348, DOI 10.1371/journal.pmed.0050191; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Miller JD, 2010, JAMA-J AM MED ASSOC, V303, P773, DOI 10.1001/jama.2010.207; Montori V, 2008, USERS GUIDE MED LIT, P543; Moreno SG, 2011, J CLIN EPIDEMIOL, V64, P1230, DOI 10.1016/j.jclinepi.2011.01.009; Moreno SG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2981; O'Connor AB, 2009, JAMA-J AM MED ASSOC, V302, P191, DOI 10.1001/jama.2009.973; O'Regan C, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-86; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Salanti G, 2008, ANN INTERN MED, V148, P544, DOI 10.7326/0003-4819-148-7-200804010-00011; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Salanti G, 2009, J CLIN EPIDEMIOL, V62, P857, DOI 10.1016/j.jclinepi.2008.10.001; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Song FJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1147; Stafford RS, 2009, NEW ENGL J MED, V361, P1230, DOI 10.1056/NEJMp0906490; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Turner E, 2005, PLOS MED, V2, P1343, DOI 10.1371/journal.pmed.0020422; Turner EH, 2004, PLOS MED, V1, P180, DOI 10.1371/journal.pmed.0010060; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; Vlopp KG, 2009, NEW ENGL J MED, V361, P331, DOI 10.1056/NEJMp0903496; Welton NJ, 2009, AM J EPIDEMIOL, V169, P1158, DOI 10.1093/aje/kwp014; Zarin DA, 2008, SCIENCE, V319, P1340, DOI 10.1126/science.1153632	47	39	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35219	10.1371/journal.pone.0035219	http://dx.doi.org/10.1371/journal.pone.0035219			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536359	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339200045
J	Thomas, PS; Sridurongrit, S; Ruiz-Lozano, P; Kaartinen, V				Thomas, Penny S.; Sridurongrit, Somyoth; Ruiz-Lozano, Pilar; Kaartinen, Vesa			Deficient Signaling via Alk2 (Acvr1) Leads to Bicuspid Aortic Valve Development	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NEURAL CREST CELLS; OUTFLOW TRACT; SEMILUNAR VALVES; EMBRYONIC HEARTS; CHICK-EMBRYOS; MICE; DISEASE; EXPRESSION; DEFECTS	Bicuspid aortic valve (BAV) is the most common congenital cardiac anomaly in humans. Despite recent advances, the molecular basis of BAV development is poorly understood. Previously it has been shown that mutations in the Notch1 gene lead to BAV and valve calcification both in human and mice, and mice deficient in Gata5 or its downstream target Nos3 have been shown to display BAVs. Here we show that tissue-specific deletion of the gene encoding Activin Receptor Type I (Alk2 or Acvr1) in the cushion mesenchyme results in formation of aortic valve defects including BAV. These defects are largely due to a failure of normal development of the embryonic aortic valve leaflet precursor cushions in the outflow tract resulting in either a fused right- and non-coronary leaflet, or the presence of only a very small, rudimentary non-coronary leaflet. The surviving adult mutant mice display aortic stenosis with high frequency and occasional aortic valve insufficiency. The thickened aortic valve leaflets in such animals do not show changes in Bmp signaling activity, while Map kinase pathways are activated. Although dysfunction correlated with some pro-osteogenic differences in gene expression, neither calcification nor inflammation were detected in aortic valves of Alk2 mutants with stenosis. We conclude that signaling via Alk2 is required for appropriate aortic valve development in utero, and that defects in this process lead to indirect secondary complications later in life.	[Thomas, Penny S.; Sridurongrit, Somyoth; Kaartinen, Vesa] Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Ruiz-Lozano, Pilar] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA	University of Michigan System; University of Michigan; Stanford University	Thomas, PS (corresponding author), Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.	vesa@umich.edu	Kaartinen, Vesa/AAU-5396-2021	Kaartinen, Vesa/0000-0002-9432-510X	National Institutes of Health [HL074862]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was financially supported by the National Institutes of Health RO1 grant number HL074862 (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELINI A, 1989, J THORAC CARDIOV SUR, V98, P362; Bajolle F, 2008, DEV BIOL, V313, P25, DOI 10.1016/j.ydbio.2007.09.023; Biben C, 2000, CIRC RES, V87, P888, DOI 10.1161/01.RES.87.10.888; Braverman AC, 2005, CURR PROB CARDIOLOGY, V30, P470, DOI 10.1016/j.cpcardiol.2005.06.002; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; COLVEE E, 1983, ANAT EMBRYOL, V168, P59, DOI 10.1007/BF00305399; Desgrosellier JS, 2005, DEV BIOL, V280, P201, DOI 10.1016/j.ydbio.2004.12.037; Dudas M, 2004, MECH DEVELOP, V121, P173, DOI 10.1016/j.mod.2003.12.003; Dupuis LE, 2011, DEV BIOL, V357, P152, DOI 10.1016/j.ydbio.2011.06.041; Egorova AD, 2011, CIRC RES, V108, P1093, DOI 10.1161/CIRCRESAHA.110.231860; Fernandes SM, 2004, J AM COLL CARDIOL, V44, P1648, DOI 10.1016/j.jacc.2004.05.063; Fernandes SM, 2007, J AM COLL CARDIOL, V49, P2211, DOI 10.1016/j.jacc.2007.01.090; Fernandez B, 2009, J AM COLL CARDIOL, V54, P2312, DOI 10.1016/j.jacc.2009.07.044; Gan LM, 2000, CARDIOVASC RES, V48, P168, DOI 10.1016/S0008-6363(00)00174-7; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Gu XX, 2009, AM J PHYSIOL-HEART C, V296, pH1748, DOI 10.1152/ajpheart.00099.2009; Harlow E., 1988, ANTIBODIES LAB MANUA; Hinton RB, 2011, ANNU REV PHYSIOL, V73, P29, DOI 10.1146/annurev-physiol-012110-142145; Hogan B, 1994, MANIPULATING MOUSE E; HURLE JM, 1980, ANAT EMBRYOL, V160, P83, DOI 10.1007/BF00315651; HURLE JM, 1990, ANAT EMBRYOL, V181, P149; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Joziasse IC, 2011, EUR J HUM GENET, V19, P389, DOI 10.1038/ejhg.2010.224; Kaartinen V, 2004, DEVELOPMENT, V131, P3481, DOI 10.1242/dev.01214; KRUG EL, 1985, DEV BIOL, V112, P414, DOI 10.1016/0012-1606(85)90414-2; Laforest B, 2011, J CLIN INVEST, V121, P2876, DOI 10.1172/JCI44555; Lee TC, 2000, CIRCULATION, V101, P2345, DOI 10.1161/01.CIR.101.20.2345; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; MANNER J, 1993, ANAT EMBRYOL, V188, P269; MARKWALD RR, 1981, SCAN ELECTRON MICROS, P261; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Merryman WD, 2010, J BIOMECH, V43, P87, DOI 10.1016/j.jbiomech.2009.09.013; MITSIADIS TA, 1995, J CELL BIOL, V130, P407, DOI 10.1083/jcb.130.2.407; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Nadaud S, 1996, CIRC RES, V79, P857, DOI 10.1161/01.RES.79.4.857; Nagy E, 2011, CIRCULATION, V123, P1316, DOI 10.1161/CIRCULATIONAHA.110.966846; Nus M, 2011, ARTERIOSCL THROM VAS, V31, P1580, DOI 10.1161/ATVBAHA.111.227561; Peacock JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026769; Person AD, 2005, INT REV CYTOL, V243, P287, DOI 10.1016/S0074-7696(05)43005-3; Rivera-Feliciano J, 2006, DEV BIOL, V295, P580, DOI 10.1016/j.ydbio.2006.03.043; Sacks MS, 2007, PHILOS T R SOC B, V362, P1369, DOI 10.1098/rstb.2007.2122; Schaefer BM, 2007, AM J CARDIOL, V99, P686, DOI 10.1016/j.amjcard.2006.09.118; Sievers HH, 2007, J THORAC CARDIOV SUR, V133, P1226, DOI 10.1016/j.jtcvs.2007.01.039; Siu SC, 2010, J AM COLL CARDIOL, V55, P2789, DOI 10.1016/j.jacc.2009.12.068; Smith KA, 2009, CIRCULATION, V119, P3062, DOI 10.1161/CIRCULATIONAHA.108.843714; Song LY, 2007, DEV BIOL, V301, P276, DOI 10.1016/j.ydbio.2006.08.004; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stennard FA, 2005, DEVELOPMENT, V132, P2451, DOI 10.1242/dev.01799; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; Sugi Y, 2004, DEV BIOL, V269, P505, DOI 10.1016/j.ydbio.2004.01.045; Tamamura Y, 2005, J BIOL CHEM, V280, P19185, DOI 10.1074/jbc.M414275200; Tomanek Robert J., 2005, Angiogenesis, V8, P273, DOI 10.1007/s10456-005-9014-9; VOLLEBERGH FEMG, 1977, BRIT HEART J, V39, P1006; Wang JK, 2005, DEV BIOL, V286, P299, DOI 10.1016/j.ydbio.2005.07.035; Ya J, 1998, CIRC RES, V82, P464, DOI 10.1161/01.RES.82.4.464; Ya J, 1997, J MOL MED, V75, P551, DOI 10.1007/s001090050140; Yener Nuran, 2002, Ann Thorac Cardiovasc Surg, V8, P264	57	53	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35539	10.1371/journal.pone.0035539	http://dx.doi.org/10.1371/journal.pone.0035539			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536403	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336200053
J	Purtell, K; Paroder-Belenitsky, M; Reyna-Neyra, A; Nicola, JP; Koba, W; Fine, E; Carrasco, N; Abbott, GW				Purtell, Kerry; Paroder-Belenitsky, Monika; Reyna-Neyra, Andrea; Nicola, Juan P.; Koba, Wade; Fine, Eugene; Carrasco, Nancy; Abbott, Geoffrey W.			The KCNQ1-KCNE2 K+ channel is required for adequate thyroid I- uptake	FASEB JOURNAL			English	Article						hypothyroidism; Kv7.1; MiRP1; positron emission tomography; sodium/iodide symporter	POTASSIUM CHANNELS; SYMPORTER NIS; ACID; KCNQ1; CLONING	The KCNQ1 alpha subunit and the KCNE2 beta subunit form a potassium channel in thyroid epithelial cells. Genetic disruption of KCNQ1-KCNE2 causes hypothyroidism in mice, resulting in cardiac hypertrophy, dwarfism, alopecia, and prenatal mortality. Here, we investigated the mechanistic requirement for KCNQ1-KCNE2 in thyroid hormone biosynthesis, utilizing whole-animal dynamic positron emission tomography. The KCNQ1-specific antagonist (-)-[3R,4S]-chromanol 293B (C293B) significantly impaired thyroid cell I- uptake, which is mediated by the Na+/I- symporter (NIS), in vivo (dSUV/dt: vehicle, 0.028 +/- 0.004 min(-1); 10 mg/kg C293B, 0.009 +/- 0.006 min(-1)) and in vitro (EC50: 99 +/- 10 mu M C293B). Na+-dependent nicotinate uptake by SMCT, however, was unaffected. Kcne2 deletion did not alter the balance of free vs. thyroglobulin-bound I- in the thyroid (distinguished using ClO4-, a competitive inhibitor of NIS), indicating that KCNQ1-KCNE2 is not required for Duox/TPO-mediated I- organification. However, Kcne2 deletion doubled the rate of free I- efflux from the thyroid following ClO4- injection, a NIS-independent process. Thus, KCNQ1-KCNE2 is necessary for adequate thyroid cell I- uptake, the most likely explanation being that it is prerequisite for adequate NIS activity.-Purtell, K., Paroder-Belenitsky, M., Reyna-Neyra, A., Nicola, J. P., Koba, W., Fine, E., Carrasco, N., Abbott, G. W. The KCNQ1-KCNE2 K+ channel is required for adequate thyroid I- uptake. FASEB J. 26, 3252-3259 (2012). www.fasebj.org	[Purtell, Kerry; Abbott, Geoffrey W.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY USA; [Paroder-Belenitsky, Monika; Reyna-Neyra, Andrea; Carrasco, Nancy] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Koba, Wade; Fine, Eugene] Albert Einstein Coll Med, M Donald Blaufox MicroPET Lab Mol Imaging, Dept Radiol, Bronx, NY 10467 USA; [Carrasco, Nancy] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA; [Nicola, Juan P.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06519 USA	Cornell University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yale University	Abbott, GW (corresponding author), Univ Calif Irvine, Sch Med, Dept Pharmacol, Zot Code 4625, Irvine, CA 92697 USA.	abbottg@uci.edu	Reyna-Neyra, Andrea/F-5621-2013; Carrasco, Nancy/AAH-1053-2019	Carrasco, Nancy/0000-0003-4137-6162; Abbott, Geoffrey/0000-0003-4552-496X	U.S. National Institutes of Health grants [HL079275, DK41544, T32GM073546, 5T32GM002788]; American Heart Association grant [0855756D]; Irma T. Hirschl Career Scientist Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM073546, T32GM007288] Funding Source: NIH RePORTER	U.S. National Institutes of Health grants; American Heart Association grant(American Heart Association); Irma T. Hirschl Career Scientist Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health grants HL079275 (G.W.A.), DK41544 (N.C.), T32GM073546 (K.P.), and 5T32GM002788 (M.P.B.); American Heart Association grant 0855756D (G.W.A.); and an Irma T. Hirschl Career Scientist Award (G.W.A.).	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Beaulieu S, 2003, J NUCL MED, V44, P1044; Dadachova E, 2004, SEMIN NUCL MED, V34, P23, DOI 10.1053/j.semnuclmed.2003.09.004; Dai G, 1996, NATURE, V379, P458, DOI 10.1038/379458a0; Dedek K, 2001, PFLUG ARCH EUR J PHY, V442, P896, DOI 10.1007/s004240100609; Dohan O, 2007, P NATL ACAD SCI USA, V104, P20250, DOI 10.1073/pnas.0707207104; ENGLER H, 1982, ENDOCRINOLOGY, V110, P190, DOI 10.1210/endo-110-1-190; Frohlich H, 2011, PFLUG ARCH EUR J PHY, V461, P45, DOI 10.1007/s00424-010-0890-5; Geibel JP, 2005, WORLD J GASTROENTERO, V11, P5259, DOI 10.3748/wjg.v11.i34.5259; Grahammer F, 2001, GASTROENTEROLOGY, V120, P1363, DOI 10.1053/gast.2001.24053; KISSANE JM, 1958, J BIOL CHEM, V233, P184; Lee MP, 2000, J CLIN INVEST, V106, P1447, DOI 10.1172/JCI10897; McDonald DO, 2009, J MOL MED, V87, P971, DOI 10.1007/s00109-009-0511-y; Paroder-Belenitsky M, 2011, P NATL ACAD SCI USA, V108, P17933, DOI 10.1073/pnas.1108278108; Ris-Stalpers C, 2006, ANTIOXID REDOX SIGN, V8, P1563, DOI 10.1089/ars.2006.8.1563; Roepke TK, 2006, J BIOL CHEM, V281, P23740, DOI 10.1074/jbc.M604155200; Roepke TK, 2011, FASEB J, V25, P4264, DOI 10.1096/fj.11-187609; Roepke TK, 2009, NAT MED, V15, P1186, DOI 10.1038/nm.2029; TAKEUCHI K, 1970, J CLIN ENDOCR METAB, V31, P144, DOI 10.1210/jcem-31-2-144; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17	21	40	41	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2012	26	8					3252	3259		10.1096/fj.12-206110	http://dx.doi.org/10.1096/fj.12-206110			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22549510	Green Published, Green Submitted			2022-12-25	WOS:000307162800016
J	Dai, Q; Lei, TJ; Zhao, CH; Zhong, JQ; Tang, YZ; Chen, B; Yang, J; Li, CH; Wang, SY; Song, X; Li, L; Li, QT				Dai, Qian; Lei, Tingjun; Zhao, Changhong; Zhong, Jianqiao; Tang, Yi-zhi; Chen, Bin; Yang, Jie; Li, Chenghua; Wang, Siyu; Song, Xu; Li, Li; Li, Qintong			Cyclin K-containing Kinase Complexes Maintain Self-renewal in Murine Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; P-TEFB; TRANSCRIPTIONAL ACTIVITY; TERMINAL DOMAIN; IN-VIVO; PHOSPHORYLATION; DIFFERENTIATION; CDK9; PLURIPOTENCY; PRECURSORS	Protein phosphorylation plays an important role in the regulation of self-renewal and differentiation of embryonic stem cells. However, the responsible intracellular kinases are not well characterized. Here, we discovered that cyclin K protein was highly expressed in pluripotent embryonic stem cells but low in their differentiated derivatives or tissue-specific stem cells. Upon cell differentiation, the level of cyclin K protein was decreased. Furthermore, knockdown of cyclin K led to cell differentiation, which could be rescued by an expression construct resistant to RNA interference. Surprisingly, cyclin K did not interact with CDK9 protein in cells as thought previously. Instead, it associated with CrkRS (also known as CDK12) and CDC2L5 (also known as CDK13). Similar to cyclin K, both CDK12 and CDK13 proteins were highly expressed in murine embryonic stem cells and were decreased upon cell differentiation. Importantly, knockdown of either kinase resulted in differentiation. Thus, our studies have uncovered two novel protein kinase complexes that maintain self-renewal in embryonic stem cells.	[Dai, Qian; Lei, Tingjun; Zhao, Changhong; Chen, Bin; Yang, Jie; Li, Chenghua; Li, Qintong] Sichuan Univ, Coll Life Sci, Ctr Growth Metab & Aging, Chengdu 610064, Sichuan, Peoples R China; [Zhong, Jianqiao; Wang, Siyu; Li, Li] Sichuan Univ, Dept Dermatol, W China Ctr Med Sci, Chengdu 610064, Sichuan, Peoples R China; [Tang, Yi-zhi] Aviat Ind Corp China, Hosp 363, Chengdu 610041, Sichuan, Peoples R China	Sichuan University; Sichuan University; Aviation Industry Corporation of China (AVIC)	Li, QT (corresponding author), Sichuan Univ, Coll Life Sci, Ctr Growth Metab & Aging, Chengdu 610064, Sichuan, Peoples R China.	liqintong@scu.edu.cn	Li, Chenghua/L-9825-2019; Li, Li/AEM-3636-2022; LI, LI/GVS-5344-2022; li, li/HII-4157-2022	Li, Chenghua/0000-0003-2978-8762; Dai, Qian/0000-0002-9887-0156; Li, Qintong/0000-0002-8447-9770	National Basic Research Program of China/973 Program [2011CB504200, 2012CB910700]; National Natural Science Foundation of China [30970625, 31171260]; Program for New Century Excellent Talents in University of Ministry of Education of China [NCET-10-0565]	National Basic Research Program of China/973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET))	This work was supported by grants from National Basic Research Program of China/973 Program (2011CB504200 and 2012CB910700), National Natural Science Foundation of China (30970625 and 31171260), and Program for New Century Excellent Talents in University of Ministry of Education of China (NCET-10-0565 to Q. L.).	Abmayr Susan M, 2006, Curr Protoc Pharmacol, VChapter 12, DOI [10.1002/0471142727.mb1201s75, 10.1002/0471141755.ph1203s35]; Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Berro R, 2008, J VIROL, V82, P7155, DOI 10.1128/JVI.02543-07; Biernaskie J, 2009, CELL STEM CELL, V5, P610, DOI 10.1016/j.stem.2009.10.019; Biernaskie JA, 2006, NAT PROTOC, V1, P2803, DOI 10.1038/nprot.2006.422; Blazek D, 2011, GENE DEV, V25, P2158, DOI 10.1101/gad.16962311; Brill LM, 2009, CELL STEM CELL, V5, P204, DOI 10.1016/j.stem.2009.06.002; Edwards MC, 1998, MOL CELL BIOL, V18, P4291, DOI 10.1128/MCB.18.7.4291; Evans M, 2011, NAT REV MOL CELL BIO, V12, P680, DOI 10.1038/nrm3190; Even Y, 2006, J CELL BIOCHEM, V99, P890, DOI 10.1002/jcb.20986; Fu TJ, 1999, J BIOL CHEM, V274, P34527, DOI 10.1074/jbc.274.49.34527; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jeong CH, 2010, STEM CELLS, V28, P2141, DOI 10.1002/stem.540; Ko TK, 2001, J CELL SCI, V114, P2591; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Lin X, 2002, J BIOL CHEM, V277, P16873, DOI 10.1074/jbc.M200117200; Marques F, 2000, BIOCHEM BIOPH RES CO, V279, P832, DOI 10.1006/bbrc.2000.4042; Moretto-Zita M, 2010, P NATL ACAD SCI USA, V107, P13312, DOI 10.1073/pnas.1005847107; Napolitano G, 2000, GENE, V254, P139, DOI 10.1016/S0378-1119(00)00278-X; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Saxe JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004467; Shore SM, 2005, GENE, V350, P51, DOI 10.1016/j.gene.2005.01.015; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yu JY, 2008, GENE DEV, V22, P1987, DOI 10.1101/gad.1689808	29	39	40	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25344	25352		10.1074/jbc.M111.321760	http://dx.doi.org/10.1074/jbc.M111.321760			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22547058	Green Published, hybrid			2022-12-25	WOS:000306651700042
J	Wu, JX; Liu, C; Chen, JJ; Yu, XC				Wu, Jiaxue; Liu, Chao; Chen, Junjie; Yu, Xiaochun			RAP80 Protein Is Important for Genomic Stability and Is Required for Stabilizing BRCA1-A Complex at DNA Damage Sites in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND-BREAK REPAIR; CANCER SUSCEPTIBILITY; POLYUBIQUITIN CHAINS; UBIQUITIN STRUCTURES; TARGETS BRCA1; ACTIVATION; DOMAIN; MUTATIONS; INTERACTS; BRCC36	RAP80 (receptor-associated protein 80) is a ubiquitin-binding protein that can specifically recognize and bind to Lys-63-linked polyubiquitin chains, thus targeting the BRCA1-A complex to DNA damage sites. To study the role of RAP80 in vivo, we generated RAP80-deficient mice. The deficient mice are prone to B-cell lymphomagenesis. B-cell lymphomas in RAP80-deficient mice are nearly diploid but harbor clonal chromosome translocations. Moreover, the deficient mice are hypersensitive to ionizing radiation. Repair of ionizing radiation-induced DNA double-strand breaks is impaired in RAP80-deficient mouse embryonic fibroblasts. Mechanistically, loss of RAP80 suppresses recruitment of the BRCA1-A complex to DNA damage sites and abrogates the DNA damage repair process at DNA damage sites. Taken together, these results reveal that RAP80 plays a crucial role in the DNA damage response and in maintaining genomic integrity.	[Wu, Jiaxue; Liu, Chao; Yu, Xiaochun] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	University of Michigan System; University of Michigan; University of Texas System; UTMD Anderson Cancer Center	Yu, XC (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA.	xiayu@umich.edu			National Institutes of Health [CA132755, CA130899]; American Cancer Society [RSG-08-125-01-CCG]; United States Department of Defense; NATIONAL CANCER INSTITUTE [R01CA130899, R01CA132755] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); United States Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA132755 and CA130899 (to X. Y.). This work was also supported by American Cancer Society Grant RSG-08-125-01-CCG (to X. Y.).; Recipient of the Era of Hope Scholar Award from the United States Department of Defense. To whom correspondence should be addressed. Tel.: 734-615-4945; Fax: 734-647-7950; E-mail: xiayu@umich.edu.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Akbari MR, 2009, BREAST CANCER RES TR, V113, P377, DOI 10.1007/s10549-008-9938-z; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Chen A, 2002, J BIOL CHEM, V277, P22085, DOI 10.1074/jbc.M201252200; Coleman KA, 2011, J BIOL CHEM, V286, P13669, DOI 10.1074/jbc.M110.213728; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; Feng L, 2010, J BIOL CHEM, V285, P30982, DOI 10.1074/jbc.M110.135392; Feng L, 2009, GENE DEV, V23, P719, DOI 10.1101/gad.1770609; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jankovic M, 2007, NAT IMMUNOL, V8, P801, DOI 10.1038/ni1498; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Kotani A, 2005, P NATL ACAD SCI USA, V102, P4506, DOI 10.1073/pnas.0500830102; Kotani A, 2007, P NATL ACAD SCI USA, V104, P1616, DOI 10.1073/pnas.0610732104; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Liu ZX, 2007, NAT STRUCT MOL BIOL, V14, P716, DOI 10.1038/nsmb1279; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mallery DL, 2002, EMBO J, V21, P6755, DOI 10.1093/emboj/cdf691; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Nishikawa H, 2004, J BIOL CHEM, V279, P3916, DOI 10.1074/jbc.M308540200; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Patterson-Fortin J, 2010, J BIOL CHEM, V285, P30971, DOI 10.1074/jbc.M110.135319; Sakasai R, 2008, J BIOL CHEM, V283, P13549, DOI 10.1074/jbc.M710197200; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; Shao G, 2009, GENE DEV, V23, P740, DOI 10.1101/gad.1739609; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Su TT, 2006, ANNU REV GENET, V40, P187, DOI 10.1146/annurev.genet.40.110405.090428; Thompson LH, 2002, MUTAT RES-FUND MOL M, V509, P49, DOI 10.1016/S0027-5107(02)00224-5; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Wu JX, 2009, MOL CELL BIOL, V29, P849, DOI 10.1128/MCB.01302-08; Wu-Baer F, 2003, J BIOL CHEM, V278, P34743, DOI 10.1074/jbc.C300249200; Xia Y, 2003, J BIOL CHEM, V278, P5255, DOI 10.1074/jbc.M204591200; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029	53	30	33	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22919	22926		10.1074/jbc.M112.351007	http://dx.doi.org/10.1074/jbc.M112.351007			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22539352	Green Published, hybrid			2022-12-25	WOS:000306495000049
J	Mininno, M; Brugiere, S; Pautre, V; Gilgen, A; Ma, S; Ferro, M; Tardif, M; Alban, C; Ravanel, S				Mininno, Morgane; Brugiere, Sabine; Pautre, Virginie; Gilgen, Annabelle; Ma, Sheng; Ferro, Myriam; Tardif, Marianne; Alban, Claude; Ravanel, Stephane			Characterization of Chloroplastic Fructose 1,6-Bisphosphate Aldolases as Lysine-methylated Proteins in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE SUBUNIT; POSTTRANSLATIONAL MODIFICATIONS; TERMINAL REGION; ARABIDOPSIS; PURIFICATION; RUBISCO; PHOTOSYNTHESIS; BIOSYNTHESIS; MECHANISM; PROTEOME	In pea (Pisum sativum), the protein-lysine methyltransferase (PsLSMT) catalyzes the trimethylation of Lys-14 in the large subunit (LS) of ribulose 1,5-bisphosphate carboxylase/oxygenase (Rubisco), the enzyme catalyzing the CO2 fixation step during photosynthesis. Homologs of PsLSMT, herein referred to as LSMT-like enzymes, are found in all plant genomes, but methylation of LS Rubisco is not universal in the plant kingdom, suggesting a species-specific protein substrate specificity of the methyltransferase. In this study, we report the biochemical characterization of the LSMT-like enzyme from Arabidopsis thaliana (AtLSMT-L), with a focus on its substrate specificity. We show that, in Arabidopsis, LS Rubisco is not naturally methylated and that the physiological substrates of AtLSMT-L are chloroplastic fructose 1,6-bisphosphate aldolase isoforms. These enzymes, which are involved in the assimilation of CO2 through the Calvin cycle and in chloroplastic glycolysis, are trimethylated at a conserved lysyl residue located close to the C terminus. Both AtLSMT-L and PsLSMT are able to methylate aldolases with similar kinetic parameters and product specificity. Thus, the divergent substrate specificity of LSMT-like enzymes from pea and Arabidopsis concerns only Rubisco. AtLSMT-L is able to interact with unmethylated Rubisco, but the complex is catalytically unproductive. Trimethylation does not modify the kinetic properties and tetrameric organization of aldolases in vitro. The identification of aldolases as methyl proteins in Arabidopsis and other species like pea suggests a role of protein lysine methylation in carbon metabolism in chloroplasts.	[Mininno, Morgane; Pautre, Virginie; Gilgen, Annabelle; Ma, Sheng; Alban, Claude; Ravanel, Stephane] INRA, USC1359, F-38054 Grenoble, France; [Mininno, Morgane; Pautre, Virginie; Gilgen, Annabelle; Ma, Sheng; Alban, Claude; Ravanel, Stephane] CNRS, UMR5168, F-38054 Grenoble, France; [Mininno, Morgane; Pautre, Virginie; Gilgen, Annabelle; Ma, Sheng; Alban, Claude; Ravanel, Stephane] Commissariat Energie Atom, Lab Physiol Cellulaire & Vegetale, F-38054 Grenoble, France; [Mininno, Morgane; Pautre, Virginie; Gilgen, Annabelle; Ma, Sheng; Alban, Claude; Ravanel, Stephane] Univ Grenoble 1, UMR5168, F-38041 Grenoble, France; [Brugiere, Sabine; Ferro, Myriam; Tardif, Marianne] Commissariat Energie Atom, Lab Biol Grande Echelle, F-38054 Grenoble, France; [Brugiere, Sabine; Ferro, Myriam; Tardif, Marianne] INSERM, U1038, F-38054 Grenoble, France; [Brugiere, Sabine; Ferro, Myriam; Tardif, Marianne] Univ Grenoble 1, U1038, F-38041 Grenoble, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Ravanel, S (corresponding author), INRA, USC1359, F-38054 Grenoble, France.	stephane.ravanel@cea.fr	Alban, Claude/ABG-2296-2021; Tardif, Marianne/AAA-5357-2019; FERRO, Myriam/O-6588-2014	Tardif, Marianne/0000-0003-4438-8281; FERRO, Myriam/0000-0002-4222-6847; Ravanel, Stephane/0000-0001-9475-4222; Sabine, BRUGIERE/0000-0002-0757-0968; Alban, Claude/0000-0003-3587-6339	Department of Plant Biology INRA; Cluster 9 of the Region Rhone-Alpes; French National Research Agency [SVSE6]	Department of Plant Biology INRA; Cluster 9 of the Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); French National Research Agency(French National Research Agency (ANR))	This work was supported by the Department of Plant Biology INRA, the Cluster 9 of the Region Rhone-Alpes, and the French National Research Agency Chloro-Pro Project Blanc SVSE6, 2010.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Aquea F, 2011, PLANT CELL REP, V30, P1087, DOI 10.1007/s00299-011-1015-0; Baginsky S, 2009, MOL PLANT, V2, P1141, DOI 10.1093/mp/ssp058; BERTHIAUME L, 1991, J BIOL CHEM, V266, P17099; Blom N, 1997, NAT STRUCT BIOL, V4, P36, DOI 10.1038/nsb0197-36; Curien G, 2003, EUR J BIOCHEM, V270, P4615, DOI 10.1046/j.1432-1033.2003.03851.x; Dirk LMA, 2006, ENZYMES, V24, P179, DOI 10.1016/S1874-6047(06)80009-0; Dupierris V, 2009, BIOINFORMATICS, V25, P1980, DOI 10.1093/bioinformatics/btp301; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Erales J, 2008, FEBS J, V275, P1248, DOI 10.1111/j.1742-4658.2008.06284.x; Ferro M, 2010, MOL CELL PROTEOMICS, V9, P1063, DOI 10.1074/mcp.M900325-MCP200; Finkemeier I, 2011, PLANT PHYSIOL, V155, P1779, DOI 10.1104/pp.110.171595; Graciet E, 2004, J EXP BOT, V55, P1245, DOI 10.1093/jxb/erh107; Haake V, 1999, PLANT J, V17, P479, DOI 10.1046/j.1365-313X.1999.00391.x; Haake V, 1998, PLANT J, V14, P147, DOI 10.1046/j.1365-313X.1998.00089.x; Horecker B. L., 1975, METHOD ENZYMOL, V42, P234; HOUTZ RL, 1992, PLANT PHYSIOL, V98, P1170, DOI 10.1104/pp.98.3.1170; Houtz RL, 2008, J EXP BOT, V59, P1635, DOI 10.1093/jxb/erm360; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Huang Y, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-175; Jaquinod M, 2007, MOL CELL PROTEOMICS, V6, P394, DOI 10.1074/mcp.M600250-MCP200; Magnani R, 2007, J BIOL CHEM, V282, P27857, DOI 10.1074/jbc.M702069200; Ng DWK, 2007, BBA-GENE STRUCT EXPR, V1769, P316, DOI 10.1016/j.bbaexp.2007.04.003; Peltier JB, 2006, MOL CELL PROTEOMICS, V5, P114, DOI 10.1074/mcp.M500180-MCP200; Raines CA, 2011, PLANT PHYSIOL, V155, P36, DOI 10.1104/pp.110.168559; Raunser S, 2009, P NATL ACAD SCI USA, V106, P3160, DOI 10.1073/pnas.0810563106; Ravanel S, 2001, P NATL ACAD SCI USA, V98, P15360, DOI 10.1073/pnas.261585098; Salvi Daniel, 2008, V432, P19, DOI 10.1007/978-1-59745-028-7_2; Stitt M, 2010, PLANT J, V61, P1067, DOI 10.1111/j.1365-313X.2010.04142.x; Suh-Lailam BB, 2010, ANAL BIOCHEM, V398, P218, DOI 10.1016/j.ab.2009.09.005; Trievel RC, 2003, NAT STRUCT BIOL, V10, P545, DOI 10.1038/nsb946; Trievel RC, 2002, CELL, V111, P91, DOI 10.1016/S0092-8674(02)01000-0; Uematsu K., 2012, J EXP BOT IN PRESS; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Zheng Q, 1998, PROTEIN EXPRES PURIF, V14, P104, DOI 10.1006/prep.1998.0936; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	36	42	50	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21034	21044		10.1074/jbc.M112.359976	http://dx.doi.org/10.1074/jbc.M112.359976			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22547063	Green Published, hybrid			2022-12-25	WOS:000306416800025
J	Zhang, P; Cai, Y; Soofi, A; Dressler, GR				Zhang, Peng; Cai, Yi; Soofi, Abdul; Dressler, Gregory R.			Activation of Wnt11 by Transforming Growth Factor-beta Drives Mesenchymal Gene Expression through Non-canonical Wnt Protein Signaling in Renal Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOFIBROBLAST TRANSITION; NUCLEAR TRANSLOCATION; INTERSTITIAL FIBROSIS; STEM-CELLS; KINASE-II; CATENIN; MECHANISMS; DISEASE; DIFFERENTIATION; PATHWAYS	Transforming growth factor beta 1 (TGF-beta) promotes renal interstitial fibrosis in vivo and the expression of mesenchymal genes in vitro; however, most of its direct targets in epithelial cells are still elusive. In a screen for genes directly activated by TGF-beta, we found that components of the Wnt signaling pathway, especially Wnt11, were targets of activation by TGF-beta and Smad3 in primary renal epithelial cells. In gain and loss of function experiments, Wnt11 mediated the actions of TGF-beta through enhanced activation of mesenchymal marker genes, such as Zeb1, Snail1, Pai1, and alpha SMA, without affecting Smad3 phosphorylation. Inhibition of Wnt11 by receptor knockdown or treatment with Wnt inhibitors limited the effects of TGF-beta on gene expression. We found no evidence that Wnt11 activated the canonical Wnt signaling pathway in renal epithelial cells; rather, the function of Wnt11 was mediated by the c-Jun N-terminal kinase (JNK) pathway. Consistent with the in vitro results, all the TGF-beta, Wnt11, and JNK targets were activated in a unilateral ureteral obstruction (UUO) model of renal fibrosis in vivo. Our findings demonstrated cooperativity among the TGF-beta, Wnt11, and JNK signaling pathways and suggest new targets for anti-fibrotic therapy in renal tissue.	[Zhang, Peng; Cai, Yi; Soofi, Abdul; Dressler, Gregory R.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Dressler, GR (corresponding author), Univ Michigan, Dept Pathol, BSRB 2049,109 Zina Pitcher Dr, Ann Arbor, MI 48109 USA.	dressler@umich.edu			National Institutes of Health [DK062914, DK073722]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073722, R01DK062914] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK062914 and DK073722 (to G. R. D.).	Abdul-Ghani M, 2011, MOL CELL BIOL, V31, P163, DOI 10.1128/MCB.01539-09; Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Anton R, 2007, FEBS LETT, V581, P5247, DOI 10.1016/j.febslet.2007.10.012; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BORDER WA, 1990, NATURE, V346, P371, DOI 10.1038/346371a0; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Cha SW, 2009, CURR BIOL, V19, P1573, DOI 10.1016/j.cub.2009.07.062; Djiane A, 2000, DEVELOPMENT, V127, P3091; Dwyer MA, 2010, CANCER RES, V70, P9298, DOI 10.1158/0008-5472.CAN-10-0226; Eisenberg CA, 1997, DEVELOPMENT, V124, P525; ERNEST S, 1995, AM J PHYSIOL-CELL PH, V269, pC323, DOI 10.1152/ajpcell.1995.269.2.C323; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Flaherty MP, 2008, CIRCULATION, V117, P2241, DOI 10.1161/CIRCULATIONAHA.107.741066; Garriock RJ, 2007, DEV BIOL, V304, P127, DOI 10.1016/j.ydbio.2006.12.020; He WC, 2010, J BIOL CHEM, V285, P24665, DOI 10.1074/jbc.M109.091256; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Holzberg D, 2003, J BIOL CHEM, V278, P40213, DOI 10.1074/jbc.M304058200; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Hwang I, 2009, ARCH PHARM RES, V32, P1653, DOI 10.1007/s12272-009-2200-3; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Kopp JB, 1996, LAB INVEST, V74, P991; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Labbe E, 2000, P NATL ACAD SCI USA, V97, P8358, DOI 10.1073/pnas.150152697; Ledbetter S, 2000, KIDNEY INT, V58, P2367, DOI 10.1046/j.1523-1755.2000.00420.x; Lin JM, 2006, MOL CELL BIOL, V26, P4577, DOI 10.1128/MCB.02127-05; Lin JM, 2005, NAT MED, V11, P387, DOI 10.1038/nm1217; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Masszi A, 2004, AM J PATHOL, V165, P1955, DOI 10.1016/S0002-9440(10)63247-6; Maye P, 2004, J BIOL CHEM, V279, P24659, DOI 10.1074/jbc.M311724200; Meng XM, 2010, J AM SOC NEPHROL, V21, P1477, DOI 10.1681/ASN.2009121244; Ouko L, 2004, J BIOL CHEM, V279, P26707, DOI 10.1074/jbc.M402877200; Phanish MK, 2006, BIOCHEM J, V393, P601, DOI 10.1042/BJ20051106; Sano Y, 1999, J BIOL CHEM, V274, P8949, DOI 10.1074/jbc.274.13.8949; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Schiro MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025021; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Surendran K, 2005, J AM SOC NEPHROL, V16, P2373, DOI 10.1681/ASN.2004110949; Taura K, 2010, HEPATOLOGY, V51, P1027, DOI 10.1002/hep.23368; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wang D, 2011, KIDNEY INT, V80, P1159, DOI 10.1038/ki.2011.255; Wang Y, 2008, AM J PHYSIOL-REG I, V295, pR1115, DOI 10.1152/ajpregu.90383.2008; Westfall TA, 2003, J CELL BIOL, V162, P889, DOI 10.1083/jcb.200303107; Wicks SJ, 2000, MOL CELL BIOL, V20, P8103, DOI 10.1128/MCB.20.21.8103-8111.2000; Yamanaka H, 2007, GENES CELLS, V12, P961, DOI 10.1111/j.1365-2443.2007.01106.x; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zhang M, 2010, J BIOL CHEM, V285, P8703, DOI 10.1074/jbc.M109.093526; Zhou BY, 2012, J BIOL CHEM, V287, P7026, DOI 10.1074/jbc.M111.276311; Zhou WL, 2007, NAT GENET, V39, P1225, DOI 10.1038/ng2112	55	55	58	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21290	21302		10.1074/jbc.M112.357202	http://dx.doi.org/10.1074/jbc.M112.357202			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22556418	hybrid, Green Published			2022-12-25	WOS:000306416800048
J	Ben-Yehoshua, LJ; Beider, K; Shimoni, A; Ostrovsky, O; Samookh, M; Peled, A; Nagler, A				Ben-Yehoshua, Liat Josefsberg; Beider, Katia; Shimoni, Avichai; Ostrovsky, Olga; Samookh, Michal; Peled, Amnon; Nagler, Arnon			Characterization of Cyclin E Expression in Multiple Myeloma and Its Functional Role in Seliciclib-Induced Apoptotic Cell Death	PLOS ONE			English	Article							DEPENDENT KINASE INHIBITOR; MEDIATED DRUG-RESISTANCE; UBIQUITIN-PROTEASOME PATHWAY; R-ROSCOVITINE; DOWN-REGULATION; IN-VIVO; MOLECULAR CLASSIFICATION; CANCER-THERAPY; BREAST-CANCER; CAM-DR	Multiple Myeloma (MM) is a lymphatic neoplasm characterized by clonal proliferation of malignant plasma cell that eventually develops resistance to chemotherapy. Drug resistance, differentiation block and increased survival of the MM tumor cells result from high genomic instability. Chromosomal translocations, the most common genomic alterations in MM, lead to dysregulation of cyclin D, a regulatory protein that governs the activation of key cell cycle regulator - cyclin dependent kinase (CDK). Genomic instability was reported to be affected by over expression of another CDK regulator - cyclin E (CCNE). This occurs early in tumorigenesis in various lymphatic malignancies including CLL, NHL and HL. We therefore sought to investigate the role of cyclin E in MM. CCNE1 expression was found to be heterogeneous in various MM cell lines (hMMCLs). Incubation of hMMCLs with seliciclib, a selective CDK-inhibitor, results in apoptosis which is accompanied by down regulation of MCL1 and p27. Ectopic over expression of CCNE1 resulted in reduced sensitivity of the MM tumor cells in comparison to the paternal cell line, whereas CCNE1 silencing with siRNA increased the cell sensitivity to seliciclib. Adhesion to FN of hMMCLs was prevented by seliciclib, eliminating adhesion-mediated drug resistance of MM cells. Combination of seliciclib with flavopiridol effectively reduced CCNE1 and CCND1 protein levels, increased subG1 apoptotic fraction and promoted MM cell death in BMSCs co-culture conditions, therefore over-coming stroma-mediated protection. We suggest that seliciclib may be considered as essential component of modern anti MM drug combination therapy.	[Ben-Yehoshua, Liat Josefsberg; Beider, Katia; Shimoni, Avichai; Ostrovsky, Olga; Samookh, Michal; Peled, Amnon; Nagler, Arnon] Guy Weinshtock Multiple Myeloma Fdn, Chaim Sheba Med Ctr, Dept Hematol & Bone Marrow Transplantat, Tel Hashomer, Israel	Chaim Sheba Medical Center	Ben-Yehoshua, LJ (corresponding author), Guy Weinshtock Multiple Myeloma Fdn, Chaim Sheba Med Ctr, Dept Hematol & Bone Marrow Transplantat, Tel Hashomer, Israel.	arnon.nagler@sheba.health.gov.il			Guy Weinshtock Multiple Myeloma Foundation; Ministry of Immigration, Israel	Guy Weinshtock Multiple Myeloma Foundation; Ministry of Immigration, Israel	This work was supported by The Guy Weinshtock Multiple Myeloma Foundation Jacqueline Seroussi Grant Award (AN) and by a returning scientist grant from the Ministry of Immigration, Israel (LJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akli S, 2003, CANCER BIOL THER, V2, pS38; Appleyard MVCL, 2009, INT J CANCER, V124, P465, DOI 10.1002/ijc.23938; Barille-Nion Sophie, 2003, Hematology Am Soc Hematol Educ Program, P248; Baughn LB, 2006, CANCER RES, V66, P7661, DOI 10.1158/0008-5472.CAN-06-1098; Benson C, 2007, BRIT J CANCER, V96, P29, DOI 10.1038/sj.bjc.6603509; Bergsagel PL, 2005, BLOOD, V106, P296, DOI 10.1182/blood-2005-01-0034; Bergsagel PL, 2003, CLIN CANCER RES, V9, P533; Caldon CE, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-2; Chen-Kiang S, 2003, IMMUNOL REV, V194, P39, DOI 10.1034/j.1600-065X.2003.00065.x; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Conroy A, 2009, CANCER CHEMOTH PHARM, V64, P723, DOI 10.1007/s00280-008-0921-5; Dai Y, 2006, CELL CYCLE, V5, P437, DOI 10.4161/cc.5.4.2441; Damiano JS, 1999, BLOOD, V93, P1658, DOI 10.1182/blood.V93.5.1658; Derenne S, 2002, BLOOD, V100, P194, DOI 10.1182/blood.V100.1.194; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Filipits M, 2003, CLIN CANCER RES, V9, P820; Fonseca R, 2009, LEUKEMIA, V23, P2210, DOI 10.1038/leu.2009.174; Gojo I, 2002, CLIN CANCER RES, V8, P3527; GrayBablin J, 1996, P NATL ACAD SCI USA, V93, P15215, DOI 10.1073/pnas.93.26.15215; Hahntow IN, 2004, LEUKEMIA, V18, P747, DOI 10.1038/sj.leu.2403295; Hardan I, 2004, EXP HEMATOL, V32, P254, DOI 10.1016/j.exphem.2003.12.001; Hazlehurst LA, 2003, CANCER RES, V63, P7900; Hazlehurst LA, 2001, CANCER METAST REV, V20, P43, DOI 10.1023/A:1013156407224; Hideshima T, 2001, CANCER RES, V61, P3071; Hiromura K, 1999, J CLIN INVEST, V103, P597, DOI 10.1172/JCI5461; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Kumar S, 2010, CANCER TREAT REV, V36, pS3, DOI 10.1016/S0305-7372(10)70006-2; Le Gouill S, 2004, CELL CYCLE, V3, P1259; Lokhorst HM, 1999, BRIT J HAEMATOL, V106, P18; MacCallum DE, 2005, CANCER RES, V65, P5399, DOI 10.1158/0008-5472.CAN-05-0233; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mazumder S, 2004, CURR CANCER DRUG TAR, V4, P65, DOI 10.2174/1568009043481669; Mazumder S, 2000, ONCOGENE, V19, P2828, DOI 10.1038/sj.onc.1203623; Minella AC, 2008, GENE DEV, V22, P1677, DOI 10.1101/gad.1650208; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Moroy T, 2004, INT J BIOCHEM CELL B, V36, P1424, DOI 10.1016/S1357-2725(03)00432-1; Noborio-Hatano K, 2009, ONCOGENE, V28, P231, DOI 10.1038/onc.2008.385; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Parker BW, 1998, BLOOD, V91, P458, DOI 10.1182/blood.V91.2.458.458_458_465; Podar K, 2009, LEUKEMIA, V23, P10, DOI 10.1038/leu.2008.259; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; Pratt G, 2002, J CLIN PATHOL-MOL PA, V55, P273, DOI 10.1136/mp.55.5.273; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Raje N, 2005, BLOOD, V106, P1042, DOI 10.1182/blood-2005-01-0320; Raynaud FI, 2005, CLIN CANCER RES, V11, P4875, DOI 10.1158/1078-0432.CCR-04-2264; Semenov I, 2002, LEUKEMIA RES, V26, P271, DOI 10.1016/S0145-2126(01)00103-5; Senderowicz AM, 1999, INVEST NEW DRUG, V17, P313, DOI 10.1023/A:1006353008903; Shain KH, 2009, CANCER RES, V69, P1009, DOI 10.1158/0008-5472.CAN-08-2419; Shaughnessy JD, 2003, IMMUNOL REV, V194, P140, DOI 10.1034/j.1600-065X.2003.00054.x; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Tong WG, 2010, J CLIN ONCOL, V28, P3015, DOI 10.1200/JCO.2009.26.1347; Trakhtenbrot L, GENES CHROMOSOMES CA, V49, P17; UCHIYAMA H, 1992, BLOOD, V80, P2306; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Whittaker SR, 2004, CANCER RES, V64, P262, DOI 10.1158/0008-5472.CAN-03-0110; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458; Zhang B, 2002, BLOOD, V99, P1885, DOI 10.1182/blood.V99.6.1885; Zhou Y, 2009, LEUKEMIA, V23, P1941, DOI 10.1038/leu.2009.160	61	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e33856	10.1371/journal.pone.0033856	http://dx.doi.org/10.1371/journal.pone.0033856			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558078	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345200005
J	Clarke, CL; Graham, JD				Clarke, Christine L.; Graham, J. Dinny			Non-Overlapping Progesterone Receptor Cistromes Contribute to Cell-Specific Transcriptional Outcomes	PLOS ONE			English	Article							ESTROGEN PLUS PROGESTIN; BREAST-CANCER CELLS; ANDROGEN-RECEPTOR; ER-ALPHA; GLUCOCORTICOID-RECEPTOR; POSTMENOPAUSAL WOMEN; RESPONSE ELEMENTS; NUCLEAR RECEPTORS; HUMAN ENDOMETRIUM; GENE ACTIVATION	The transcriptional effects of the ovarian hormone progesterone are pleiotropic, and binding to DNA of the nuclear progesterone receptor (PR), a ligand-activated transcription factor, results in diverse outcomes in a range of target tissues. To determine whether distinct patterns of genomic interaction of PR contribute to the cell specificity of the PR transcriptome, we have compared the genomic binding sites for PR in breast cancer cells and immortalized normal breast cells. PR binding was correlated with transcriptional outcome in both cell lines, with 60% of progestin-regulated genes associated with one or more PR binding regions. There was a remarkably low overlap between the PR cistromes of the two cell lines, and a similarly low overlap in transcriptional targets. A conserved PR binding element was identified in PR binding regions from both cell lines, but there were distinct patterns of enrichment of known cofactor binding motifs, with FOXA1 sites over-represented in breast cancer cell binding regions and NF1 and AP-1 motifs uniquely enriched in the immortalized normal line. Downstream analyses suggested that differential cofactor availability may generate these distinct PR cistromes, indicating that cofactor levels may modulate PR specificity. Taken together these data suggest that cell-specificity of PR binding is determined by the coordinated effects of key binding cofactors.	[Clarke, Christine L.; Graham, J. Dinny] Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Westmead Inst Canc Res,Sydney Med Sch Westmead, Westmead, NSW 2145, Australia	University of Sydney; Westmead Institute for Medical Research	Clarke, CL (corresponding author), Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Westmead Inst Canc Res,Sydney Med Sch Westmead, Westmead, NSW 2145, Australia.	dinny.graham@sydney.edu.au		Clarke, Christine/0000-0001-7568-111X	National Health and Medical Research Council of Australia [570865]; National Breast Cancer Foundation of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation of Australia	The work was supported by National Health and Medical Research Council of Australia project grant 570865 and the National Breast Cancer Foundation of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ace Christopher I, 2004, Reprod Biol Endocrinol, V2, P54, DOI 10.1186/1477-7827-2-54; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-179; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Beguelin W, 2010, MOL CELL BIOL, V30, P5456, DOI 10.1128/MCB.00012-10; Belikov S, 2009, MOL CELL BIOL, V29, P5413, DOI 10.1128/MCB.00368-09; Beral V, 2011, JNCI-J NATL CANCER I, V103, P296, DOI 10.1093/jnci/djq527; Bernardo GM, 2010, DEVELOPMENT, V137, P2045, DOI 10.1242/dev.043299; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Borthwick JM, 2003, MOL HUM REPROD, V9, P19, DOI 10.1093/molehr/gag004; Bravieri R, 1997, NUCLEIC ACIDS RES, V25, P2888, DOI 10.1093/nar/25.14.2888; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chlebowski RT, 2010, JAMA-J AM MED ASSOC, V304, P1684, DOI 10.1001/jama.2010.1500; Cicatiello L, 2004, MOL CELL BIOL, V24, P7260, DOI 10.1128/MCB.24.16.7260-7274.2004; Cirillo LA, 2007, J MOL BIOL, V366, P720, DOI 10.1016/j.jmb.2006.11.087; CLARKE CL, 1990, ENDOCR REV, V11, P266, DOI 10.1210/edrv-11-2-266; CLARKE CL, 1987, ENDOCRINOLOGY, V121, P1123, DOI 10.1210/endo-121-3-1123; Faivre EJ, 2008, MOL ENDOCRINOL, V22, P823, DOI 10.1210/me.2007-0437; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Graham JD, 2009, ENDOCRINOLOGY, V150, P3318, DOI 10.1210/en.2008-1630; Graham JD, 1997, ENDOCR REV, V18, P502, DOI 10.1210/er.18.4.502; Graham JD, 2005, MOL ENDOCRINOL, V19, P2713, DOI 10.1210/me.2005-0126; GRAHAM JD, 1995, CANCER RES, V55, P5063; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hubler TR, 2004, CELL STRESS CHAPERON, V9, P243, DOI 10.1379/CSC-32R.1; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Joseph R, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.109; Kao LC, 2002, ENDOCRINOLOGY, V143, P2119, DOI 10.1210/en.143.6.2119; Krum SA, 2008, MOL ENDOCRINOL, V22, P2393, DOI 10.1210/me.2008-0100; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LIEBERMAN BA, 1993, MOL ENDOCRINOL, V7, P515, DOI 10.1210/me.7.4.515; Liu Z, 2001, P NATL ACAD SCI USA, V98, P12426, DOI 10.1073/pnas.231474798; LONGACRE TA, 1986, AM J SURG PATHOL, V10, P382, DOI 10.1097/00000478-198606000-00003; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; MacQuarrie KL, 2011, TRENDS GENET, V27, P141, DOI 10.1016/j.tig.2011.01.001; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murtagh J, 2003, J MAMMARY GLAND BIOL, V8, P241, DOI 10.1023/A:1025909109843; Nelson CC, 1999, MOL ENDOCRINOL, V13, P2090, DOI 10.1210/me.13.12.2090; ONATE SA, 1995, SCIENCE, V270, P1354; Vicent GP, 2010, J BIOL CHEM, V285, P2622, DOI 10.1074/jbc.M109.060848; Vicent GP, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000567; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; Rayasam GV, 2005, MOL CELL BIOL, V25, P2406, DOI 10.1128/MCB.25.6.2406-2418.2005; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Richer JK, 2002, J BIOL CHEM, V277, P5209, DOI 10.1074/jbc.M110090200; Roschke AV, 2003, CANCER RES, V63, P8634; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Scarpin Katherine M, 2009, Nucl Recept Signal, V7, pe009, DOI 10.1621/nrs.07009; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; STREULI CH, 1995, J BIOL CHEM, V270, P21639, DOI 10.1074/jbc.270.37.21639; Tang QZ, 2011, CANCER RES, V71, P6940, DOI 10.1158/0008-5472.CAN-11-2091; Tseng L, 2003, DNA CELL BIOL, V22, P633, DOI 10.1089/104454903770238102; Vicent GP, 2006, ANN NY ACAD SCI, V1089, P59, DOI 10.1196/annals.1386.025; Vicent GP, 2010, MOL ENDOCRINOL, V24, P2088, DOI 10.1210/me.2010-0027; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Yin P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029021	65	64	68	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35859	10.1371/journal.pone.0035859	http://dx.doi.org/10.1371/journal.pone.0035859			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545144	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343200064
J	Kirsch, W; Herbort, O; Butz, MV; Kunde, W				Kirsch, Wladimir; Herbort, Oliver; Butz, Martin V.; Kunde, Wilfried			Influence of Motor Planning on Distance Perception within the Peripersonal Space	PLOS ONE			English	Article							TOOL-USE; LINE BISECTION; REPRESENTATION; PLASTICITY; MOVEMENTS; EXTENT; SIZE	We examined whether movement costs as defined by movement magnitude have an impact on distance perception in near space. In Experiment 1, participants were given a numerical cue regarding the amplitude of a hand movement to be carried out. Before the movement execution, the length of a visual distance had to be judged. These visual distances were judged to be larger, the larger the amplitude of the concurrently prepared hand movement was. In Experiment 2, in which numerical cues were merely memorized without concurrent movement planning, this general increase of distance with cue size was not observed. The results of these experiments indicate that visual perception of near space is specifically affected by the costs of planned hand movements.	[Kirsch, Wladimir; Kunde, Wilfried] Univ Wurzburg, Dept Psychol, Wurzburg, Germany; [Herbort, Oliver; Butz, Martin V.] Univ Tubingen, Dept Comp Sci, Tubingen, Germany	University of Wurzburg; Eberhard Karls University of Tubingen	Kirsch, W (corresponding author), Univ Wurzburg, Dept Psychol, Wurzburg, Germany.	kirsch@psychologie.uni-wuerzburg.de		Kunde, Wilfried/0000-0001-6256-8011	German Research Council (DFG) [KI 1620/1-1]; DFG; University of Wuerzburg within the funding program Open Access Publishing	German Research Council (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); University of Wuerzburg within the funding program Open Access Publishing	This research was supported by grant KI 1620/1-1 awarded to WLK by the German Research Council (DFG). The publication was funded by the DFG and the University of Wuerzburg within the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berti A, 2000, J COGNITIVE NEUROSCI, V12, P415, DOI 10.1162/089892900562237; Bhalla M, 1999, J EXP PSYCHOL HUMAN, V25, P1076, DOI 10.1037/0096-1523.25.4.1076; Caparos S, 2010, J EXP PSYCHOL HUMAN, V36, P1080, DOI 10.1037/a0020367; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Desmurget M, 2005, J EXP PSYCHOL HUMAN, V31, P1510, DOI 10.1037/0096-1523.31.6.1510; Fajen BR, 2007, ECOL PSYCHOL, V19, P383, DOI 10.1080/10407410701557877; Farne A, 2000, NEUROREPORT, V11, P1645, DOI 10.1097/00001756-200006050-00010; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Gamberini L, 2008, NEUROPSYCHOLOGIA, V46, P1298, DOI 10.1016/j.neuropsychologia.2007.12.016; Gevers W, 2005, PSYCHOL SCI, V47, P10; Ghahramani Z, 1996, J NEUROSCI, V16, P7085; GORDON J, 1994, EXP BRAIN RES, V99, P97, DOI 10.1007/BF00241415; Hamburger K, 2010, ATTEN PERCEPT PSYCHO, V72, P1045, DOI 10.3758/APP.72.4.1045; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Holmes NP, 2004, NEUROSCI LETT, V372, P62, DOI 10.1016/j.neulet.2004.09.024; Iriki A, 1996, NEUROREPORT, V7, P2325; Ito Y, 2004, MEM COGNITION, V32, P662, DOI 10.3758/BF03195857; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Ladavas E, 2002, TRENDS COGN SCI, V6, P17, DOI 10.1016/S1364-6613(00)01814-3; Ladavas E, 2008, COGN NEUROPSYCHOL, V25, P1099, DOI 10.1080/02643290802359113; Linkenauger SA, 2009, J EXP PSYCHOL HUMAN, V35, P1649, DOI 10.1037/a0016875; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Longo MR, 2007, EXP BRAIN RES, V177, P285, DOI 10.1007/s00221-007-0855-x; Longo MR, 2006, NEUROPSYCHOLOGIA, V44, P977, DOI 10.1016/j.neuropsychologia.2005.09.003; Lourenco SF, 2009, COGNITION, V112, P451, DOI 10.1016/j.cognition.2009.05.011; Maravita A, 2002, COGNITION, V83, pB25, DOI 10.1016/S0010-0277(02)00003-3; Maravita A, 2001, NEUROPSYCHOLOGIA, V39, P580, DOI 10.1016/S0028-3932(00)00150-0; Proffitt DR, 2006, PERSPECT PSYCHOL SCI, V1, P110, DOI 10.1111/j.1745-6916.2006.00008.x; Proffitt DR, 2003, PSYCHOL SCI, V14, P106, DOI 10.1111/1467-9280.t01-1-01427; Proffitt DR, 2008, EMBODIMENT EGO SPACE, P179; Rosenbaum DA, 2008, PSYCHON B REV, V15, P1100, DOI 10.3758/PBR.15.6.1100; Schwarz W, 2004, PERCEPT PSYCHOPHYS, V66, P651, DOI 10.3758/BF03194909; Sheerer E., 1984, COGNITION MOTOR PROC, P77, DOI [10.1007/978-3-642-69382-3_6, DOI 10.1007/978-3-642-69382-3_6]; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; Van der Heijden AHC, 1999, COGNITIVE CONTRIBUTI, V129, P19; Vindras P, 1998, J EXP PSYCHOL HUMAN, V24, P569, DOI 10.1037/0096-1523.24.2.569; Witt JK, 2008, PSYCHON B REV, V15, P581, DOI 10.3758/PBR.15.3.581; Witt JK, 2011, J EXP PSYCHOL HUMAN, V37, P1148, DOI 10.1037/a0021933; Witt JK, 2010, J EXP PSYCHOL HUMAN, V36, P1153, DOI 10.1037/a0019947; Witt JK, 2009, PERCEPTION, V38, P1328, DOI 10.1068/p6325; Witt JK, 2008, J EXP PSYCHOL HUMAN, V34, P1479, DOI 10.1037/a0010781; Witt JK, 2005, PSYCHOL SCI, V16, P937, DOI 10.1111/j.1467-9280.2005.01640.x; Witt JK, 2005, J EXP PSYCHOL HUMAN, V31, P880, DOI 10.1037/0096-1523.31.5.880	43	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e34880	10.1371/journal.pone.0034880	http://dx.doi.org/10.1371/journal.pone.0034880			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VE	22545092	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343200015
J	Deo, S; Topp, SM; Garcia, A; Soldner, M; Sokat, KY; Chipukuma, J; Wamulume, CS; Reid, SE; Swann, J				Deo, Sarang; Topp, Stephanie M.; Garcia, Ariel; Soldner, Mallory; Sokat, Kezban Yagci; Chipukuma, Julien; Wamulume, Chibesa S.; Reid, Stewart E.; Swann, Julie			Modeling the Impact of Integrating HIV and Outpatient Health Services on Patient Waiting Times in an Urban Health Clinic in Zambia	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; GLOBAL HEALTH; SCALE-UP; CARE; AFRICA; PROGRAMS; LESSONS; MALAWI	Background: Rapid scale up of HIV treatment programs in sub-Saharan Africa has refueled the long-standing health policy debate regarding the merits and drawbacks of vertical and integrated system. Recent pilots of integrating outpatient and HIV services have shown an improvement in some patient outcomes but deterioration in waiting times, which can lead to worse health outcomes in the long run. Methods: A pilot intervention involving integration of outpatient and HIV services in an urban primary care facility in Lusaka, Zambia was studied. Data on waiting time of patients during two seven-day periods before and six months after the integration were collected using a time and motion study. Statistical tests were conducted to investigate whether the two observation periods differed in operational details such as staffing, patient arrival rates, mix of patients etc. A discrete event simulation model was constructed to facilitate a fair comparison of waiting times before and after integration. The simulation model was also used to develop alternative configurations of integration and to estimate the resulting waiting times. Results: Comparison of raw data showed that waiting times increased by 32% and 36% after integration for OPD and ART patients respectively (p<0.01). Using simulation modeling, we found that a large portion of this increase could be explained by changes in operational conditions before and after integration such as reduced staff availability (p<0.01) and longer breaks between consecutive patients (p<0.05). Controlling for these differences, integration of services, per se, would have resulted in a significant decrease in waiting times for OPD and a moderate decrease for HIV services. Conclusions: Integrating health services has the potential of reducing waiting times due to more efficient use of resources. However, one needs to ensure that other operational factors such as staff availability are not adversely affected due to integration.	[Deo, Sarang] Indian Sch Business Hyderbad, Hyderabad, Andhra Pradesh, India; [Topp, Stephanie M.; Chipukuma, Julien; Reid, Stewart E.] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Topp, Stephanie M.] Univ Melbourne, Nossal Inst Global Hlth, Melbourne, Vic, Australia; [Garcia, Ariel; Soldner, Mallory; Swann, Julie] Georgia Inst Technol Dept, Stewart Sch Ind & Syst Engn, Atlanta, GA USA; [Sokat, Kezban Yagci] Northwestern Univ, Evanston, IL USA; [Wamulume, Chibesa S.] Lusaka Hlth Dist, Lusaka, Zambia; [Topp, Stephanie M.; Reid, Stewart E.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	Indian School of Business (ISB); University of Melbourne; Northwestern University; University of Alabama System; University of Alabama Birmingham	Deo, S (corresponding author), Indian Sch Business Hyderbad, Hyderabad, Andhra Pradesh, India.	sarang_deo@isb.edu	Topp, Stephanie M/H-3923-2019; Deo, Sarang/B-5895-2015	Topp, Stephanie M/0000-0002-3448-7983; Deo, Sarang/0000-0002-3233-6014; Swann, Julie/0000-0003-2151-4396; Reid, Stewart/0000-0001-7779-4820	U.S. Department of Health and Human Services; Centers for Disease Control and Prevention [U62/.CCU12354]	U.S. Department of Health and Human Services; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The work reported herein was supported in part by the President's Emergency Plan for AIDS Relief through a multi-country grant to the Elizabeth Glaser Pediatric AIDS Foundation from the U.S. Department of Health and Human Services and Centers for Disease Control and Prevention's Global AIDS Program (cooperative agreement U62/.CCU12354). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atun RA, 2008, HLTH SYSTEMS POLICY; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Bleich SN, 2009, B WORLD HEALTH ORGAN, V87, P271, DOI 10.2471/BLT.07.050401; Brugha R, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-19; Colebunders R, 2007, AIDS CARE, V19, P149, DOI 10.1080/09540120600762078; Doherty T, 2010, TROP MED INT HEALTH, V15, P296, DOI 10.1111/j.1365-3156.2009.02454.x; England R, 2007, BRIT MED J; England R, 2007, BRIT MED J, V335, P565, DOI 10.1136/bmj.39335.520463.94; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Frenk J, 2006, BRIDGING DIVIDE COMP; Garrett L, 2007, FOREIGN AFF, V86, P14; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Harris JB, 2008, INT J TUBERC LUNG D, V12, P773; Lawn JE, 2008, LANCET, V372, P917, DOI 10.1016/S0140-6736(08)61402-6; Levine R, 2009, JAIDS-J ACQ IMM DEF, V52, pS3, DOI 10.1097/QAI.0b013e3181bbc807; Pfeiffer J, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-3; Price JE, 2009, AIDS CARE, V21, P608, DOI 10.1080/09540120802310957; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Shumbusho F, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000163; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Topp SM, 2011, B WORLD HEALTH ORGAN, V89, P328, DOI 10.2471/BLT.10.084442; Topp SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011522; Wagner G, 2007, AIDS PATIENT CARE ST, V21, P871, DOI 10.1089/apc.2007.0008; World Health Organization, 2010, UN ACC SCAL PRIOR HI	24	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35479	10.1371/journal.pone.0035479	http://dx.doi.org/10.1371/journal.pone.0035479			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UP	22545108	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000305341000039
J	Gosemann, JH; Kuebler, JF; Pozzobon, M; Neunaber, C; Hensel, JHK; Ghionzoli, M; de Coppi, P; Ure, BM; Holze, G				Gosemann, Jan-Hendrik; Kuebler, Joachim F.; Pozzobon, Michela; Neunaber, Claudia; Hensel, Julia H. K.; Ghionzoli, Marco; de Coppi, Paolo; Ure, Benno M.; Holze, Gesine			Activation of Regulatory T Cells during Inflammatory Response Is Not an Exclusive Property of Stem Cells	PLOS ONE			English	Article							BACTERIAL CLEARANCE; THERAPY; SEPSIS; DIFFERENTIATION; LYMPHOCYTE; SURVIVAL; BIOLOGY; FUTURE	Background: Sepsis and systemic-inflammatory-response-syndrome (SIRS) remain major causes for fatalities on intensive care units despite up-to-date therapy. It is well accepted that stem cells have immunomodulatory properties during inflammation and sepsis, including the activation of regulatory T cells and the attenuation of distant organ damage. Evidence from recent work suggests that these properties may not be exclusively attributed to stem cells. This study was designed to evaluate the immunomodulatory potency of cellular treatment during acute inflammation in a model of sublethal endotoxemia and to investigate the hypothesis that immunomodulations by cellular treatment during inflammatory response is not stem cell specific. Methodology/Principal Findings: Endotoxemia was induced via intra-peritoneal injection of lipopolysaccharide (LPS) in wild type mice (C3H/HeN). Mice were treated with either vital or homogenized amniotic fluid stem cells (AFS) and sacrificed for specimen collection 24 h after LPS injection. Endpoints were plasma cytokine levels (BD (TM) Cytometric Bead Arrays), T cell subpopulations (flow-cytometry) and pulmonary neutrophil influx (immunohistochemistry). To define stem cell specific effects, treatment with either vital or homogenized human-embryonic-kidney-cells (HEK) was investigated in a second subset of experiments. Mice treated with homogenized AFS cells showed significantly increased percentages of regulatory T cells and Interleukin-2 as well as decreased amounts of pulmonary neutrophils compared to saline-treated controls. These results could be reproduced in mice treated with vital HEK cells. No further differences were observed between plasma cytokine levels of endotoxemic mice. Conclusions/Significance: The results revealed that both AFS and HEK cells modulate cellular immune response and distant organ damage during sublethal endotoxemia. The observed effects support the hypothesis, that immunomodulations are not exclusive attributes of stem cells.	[Gosemann, Jan-Hendrik; Kuebler, Joachim F.; Hensel, Julia H. K.; Ure, Benno M.; Holze, Gesine] Hannover Med Sch, Ctr Pediat Surg Hannover, D-3000 Hannover, Germany; [Gosemann, Jan-Hendrik; Kuebler, Joachim F.; Hensel, Julia H. K.; Ure, Benno M.; Holze, Gesine] Bult Childrens Hosp, D-3000 Hannover, Germany; [Pozzobon, Michela] Univ Padua, Stem Cell Proc Lab, Clin Pediat Oncohematol, Padua, Italy; [Neunaber, Claudia] Hannover Med Sch, Trauma Dept, D-3000 Hannover, Germany; [Ghionzoli, Marco; de Coppi, Paolo] Great Ormond St Hosp Sick Children, Surg Unit, UCL Inst Child Hlth, London, England	Hannover Medical School; University of Padua; Hannover Medical School; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Gosemann, JH (corresponding author), Hannover Med Sch, Ctr Pediat Surg Hannover, D-3000 Hannover, Germany.	gosemann.jan@mh-hannover.de	Neunaber, Claudia/AAJ-1490-2021; Pozzobon, Michela/X-7504-2019; Pozzobon, Michela/G-7974-2018	Neunaber, Claudia/0000-0002-8537-2238; Pozzobon, Michela/0000-0001-9213-402X; Pozzobon, Michela/0000-0001-9213-402X; De Coppi, Paolo/0000-0002-1659-0207; Ghionzoli, Marco/0000-0002-3128-737X	"TUI Stiftung", Hannover; Great Ormond Street Hospital Charity; Great Ormond Street Hospital Childrens Charity [V1230] Funding Source: researchfish	"TUI Stiftung", Hannover; Great Ormond Street Hospital Charity; Great Ormond Street Hospital Childrens Charity	This study was financially supported by the "TUI Stiftung", Hannover. PDC is supported by the Great Ormond Street Hospital Charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Becker C, 2006, MED MICROBIOL IMMUN, V195, P113, DOI 10.1007/s00430-006-0017-y; Beyersdorf N, 2005, J EXP MED, V202, P445, DOI 10.1084/jem.20051060; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Bollini S, 2011, STEM CELLS DEV, V20, P1985, DOI 10.1089/scd.2010.0424; Chou HS, 2011, HEPATOLOGY, V53, P1007, DOI 10.1002/hep.24162; Cribbs SK, 2011, AM J MED SCI, V341, P325, DOI 10.1097/MAJ.0b013e3181f30dee; D'Alessio FR, 2009, J CLIN INVEST, V119, P2898, DOI 10.1172/JCI36498; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Gonzalez-Rey E, 2009, GUT, V58, P929, DOI 10.1136/gut.2008.168534; Gosemann JH, 2010, INJURY, V41, P1060, DOI 10.1016/j.injury.2010.05.021; Grisafi D, 2008, STEM CELLS DEV, V17, P953, DOI 10.1089/scd.2007.0188; Heuer JG, 2005, J IMMUNOL, V174, P7141, DOI 10.4049/jimmunol.174.11.7141; Hilfiker A, 2011, LANGENBECK ARCH SURG, V396, P489, DOI 10.1007/s00423-011-0762-2; Jeong JO, 2011, CIRC RES, V108, P1340, DOI 10.1161/CIRCRESAHA.110.239848; Jones S, 2007, J IMMUNOL, V179, P2824, DOI 10.4049/jimmunol.179.5.2824; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kronsteiner B, 2011, CELL IMMUNOL, V267, P30, DOI 10.1016/j.cellimm.2010.11.001; Li L, 2011, J CELL PHYSIOL, V226, P1860, DOI 10.1002/jcp.22511; Lodi D, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-9; Maccario R, 2005, HAEMATOLOGICA, V90, P516; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mei SHJ, 2010, AM J RESP CRIT CARE, V182, P1047, DOI 10.1164/rccm.201001-0010OC; Monneret G, 2010, EXPERT REV ANTI-INFE, V8, P1109, DOI [10.1586/eri.10.107, 10.1586/ERI.10.107]; Moorefield EC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026535; Nelson BH, 2004, J IMMUNOL, V172, P3983, DOI 10.4049/jimmunol.172.7.3983; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Perin L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009357; Pietropaoli A, 2009, J CLIN INVEST, V119, P2891, DOI 10.1172/JCI40880; Pozzobon M, 2010, PEDIATR SURG INT, V26, P3, DOI 10.1007/s00383-009-2478-8; Rota C, 2011, STEM CELLS DEV; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Shaw SWS, 2011, CURR OPIN OBSTET GYN, V23, P109, DOI 10.1097/GCO.0b013e32834457b1; Shi M, 2011, CLIN EXP IMMUNOL, V164, P1, DOI 10.1111/j.1365-2249.2011.04327.x; Toda A, 2006, J LEUKOCYTE BIOL, V80, P458, DOI 10.1189/jlb.0206095; Tsai K.S., 2011, GASTROENTEROLOGY; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Uccelli A, 2011, CURR STEM CELL RES T, V6, P69, DOI 10.2174/157488811794480744; Venet F, 2009, J IMMUNOL, V183, P3472, DOI 10.4049/jimmunol.0804119; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Yang HR, 2009, HEPATOLOGY, V50, P1981, DOI 10.1002/hep.23202; Zani A, 2009, J PEDIATR SURG, V44, P659, DOI 10.1016/j.jpedsurg.2008.12.012	43	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35512	10.1371/journal.pone.0035512	http://dx.doi.org/10.1371/journal.pone.0035512			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539976	Green Published, gold			2022-12-25	WOS:000305341000042
J	Hoch, AI; Binder, BY; Genetos, DC; Leach, JK				Hoch, Allison I.; Binder, Bernard Y.; Genetos, Damian C.; Leach, J. Kent			Differentiation-Dependent Secretion of Proangiogenic Factors by Mesenchymal Stem Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BONE REGENERATION; HUMAN MARROW; IN-VITRO; OSTEOGENIC DIFFERENTIATION; PROGENITOR CELLS; STROMAL CELLS; ANGIOGENESIS; EXPRESSION; DEXAMETHASONE	Mesenchymal stem cells (MSCs) are a promising cell population for cell-based bone repair due to their proliferative potential, ability to differentiate into bone-forming osteoblasts, and their secretion of potent trophic factors that stimulate angiogenesis and neovascularization. To promote bone healing, autogenous or allogeneic MSCs are transplanted into bone defects after differentiation to varying degrees down the osteogenic lineage. However, the contribution of the stage of osteogenic differentiation upon angiogenic factor secretion is unclear. We hypothesized that the proangiogenic potential of MSCs was dependent upon their stage of osteogenic differentiation. After 7 days of culture, we observed the greatest osteogenic differentiation of MSCs when cells were cultured with dexamethasone (OM+). Conversely, VEGF protein secretion and upregulation of angiogenic genes were greatest in MSCs cultured in growth media (GM). Using conditioned media from MSCs in each culture condition, GM-conditioned media maximized proliferation and enhanced chemotactic migration and tubule formation of endothelial colony forming cells (ECFCs). The addition of a neutralizing VEGF(165/121) antibody to conditioned media attenuated ECFC proliferation and chemotactic migration. ECFCs seeded on microcarrier beads and co-cultured with MSCs previously cultured in GM in a fibrin gel exhibited superior sprouting compared to MSCs previously cultured in OM+. These results confirm that MSCs induced farther down the osteogenic lineage possess reduced proangiogenic potential, thereby providing important findings for consideration when using MSCs for bone repair.	[Hoch, Allison I.; Binder, Bernard Y.; Leach, J. Kent] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Genetos, Damian C.] Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Leach, JK (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	jkleach@ucdavis.edu	Genetos, Damian C/A-6480-2012; Genetos, Damian/AAF-5953-2021	Genetos, Damian/0000-0002-8599-2867; Hoch, Allison/0000-0002-2418-8736	National Institutes of Health (NIH) [R03-DE021704, R21-AG036963, EB003827]; AO Foundation [C10-39L]; Center of Excellence in Translational Human Stem Cell Research (NIH) [P50-HL085036]; California Institute for Regenerative Medicine University of California Davis [CIRM T1-00006, CIRM TG2-01163];  [R03-AR057547]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL085036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR057547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB003827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE021704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG036963] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AO Foundation; Center of Excellence in Translational Human Stem Cell Research (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine University of California Davis; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (NIH) Grants R03-DE021704 and R21-AG036963 and the AO Foundation (C10-39L) to JKL. DCG was supported by R03-AR057547. The authors acknowledge the University of California Davis Center of Excellence in Translational Human Stem Cell Research for providing GFP-transduced ECFCs. These studies were supported by a pilot grant from the Center of Excellence in Translational Human Stem Cell Research (NIH grant P50-HL085036), the NIH T32 Molecular Imaging Training Grant (NIH grant EB003827), and the California Institute for Regenerative Medicine University of California Davis Stem Cell Training Program (CIRM T1-00006, CIRM TG2-01163). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2010, BIOCHEM BIOPH RES CO, V400, P284, DOI 10.1016/j.bbrc.2010.08.073; Aozuka Y, 2004, CANCER LETT, V216, P35, DOI 10.1016/j.canlet.2004.06.050; BERESFORD JN, 1992, J CELL SCI, V102, P341; Bischoff DS, 2008, J CELL BIOCHEM, V103, P812, DOI 10.1002/jcb.21450; Buschmann J, 2011, TISSUE ENG PT A, V17, P291, DOI 10.1089/ten.TEA.2010.0278; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; CHENG SL, 1994, ENDOCRINOLOGY, V134, P277, DOI 10.1210/en.134.1.277; Coelho MJ, 2000, BIOMATERIALS, V21, P1095, DOI 10.1016/S0142-9612(99)00192-1; Decaris ML, 2009, ANGIOGENESIS, V12, P303, DOI 10.1007/s10456-009-9152-6; Deckers MML, 2000, ENDOCRINOLOGY, V141, P1667, DOI 10.1210/en.141.5.1667; DELANY AM, 1994, J CELL BIOCHEM, V56, P295, DOI 10.1002/jcb.240560304; Dragoo JL, 2003, J BONE JOINT SURG BR, V85B, P740, DOI 10.1302/0301-620X.85B5.13587; Elbjeirami WM, 2006, TISSUE ENG, V12, P381, DOI 10.1089/ten.2006.12.381; Fierro FA, 2011, STEM CELLS BIOL REG; Furumatsu T, 2003, J BIOCHEM, V133, P633, DOI 10.1093/jb/mvg081; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Ghajar CM, 2008, BIOPHYS J, V94, P1930, DOI 10.1529/biophysj.107.120774; Grellier M, 2009, J CELL BIOCHEM, V106, P390, DOI 10.1002/jcb.22018; Gruber R, 2005, TISSUE ENG, V11, P896, DOI 10.1089/ten.2005.11.896; Grunert M, 2007, J MOL HISTOL, V38, P393, DOI 10.1007/s10735-007-9119-0; Hariawala MD, 1996, J SURG RES, V63, P77, DOI 10.1006/jsre.1996.0226; HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3; Haynesworth SE, 1996, J CELL PHYSIOL, V166, P585, DOI 10.1002/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.0.CO;2-6; He JW, 2010, TISSUE ENG PT A, V16, P127, DOI [10.1089/ten.tea.2009.0255, 10.1089/ten.TEA.2009.0255]; He JW, 2010, J CELL BIOCHEM, V110, P87, DOI 10.1002/jcb.22514; Hocking AM, 2010, EXP CELL RES, V316, P2213, DOI 10.1016/j.yexcr.2010.05.009; Huang YC, 2005, J BONE MINER RES, V20, P848, DOI 10.1359/JBMR.041226; Hung SC, 2007, STEM CELLS, V25, P2363, DOI 10.1634/stemcells.2006-0686; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Leach JK, 2006, BIOMATERIALS, V27, P3249, DOI 10.1016/j.biomaterials.2006.01.033; Majumdar MK, 2000, J HEMATOTH STEM CELL, V9, P841, DOI 10.1089/152581600750062264; Mayer H, 2005, J CELL BIOCHEM, V95, P827, DOI 10.1002/jcb.20462; Nakatsu MN, 2007, J VIS EXP; Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Saadeh PB, 2000, ENDOCRINOLOGY, V141, P2075, DOI 10.1210/en.141.6.2075; Schmid J, 1997, CLIN ORAL IMPLAN RES, V8, P244, DOI 10.1034/j.1600-0501.1997.080311.x; Schubert T, 2011, BIOMATERIALS, V32, P8880, DOI 10.1016/j.biomaterials.2011.08.009; Staton C.A., 2006, ANGIOGENESIS ASSAYS; Vater C, 2011, ACTA BIOMATER, V7, P463, DOI 10.1016/j.actbio.2010.07.037; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471	45	97	100	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35579	10.1371/journal.pone.0035579	http://dx.doi.org/10.1371/journal.pone.0035579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536411	Green Submitted, gold, Green Published			2022-12-25	WOS:000305339200081
J	Rodrigues-Ferreira, S; Abdelkarim, M; Dillenburg-Pilla, P; Luissint, AC; di-Tommaso, A; Deshayes, F; Pontes, CLS; Molina, A; Cagnard, N; Letourneur, F; Morel, M; Reis, RI; Casarini, DE; Terris, B; Couraud, PO; Costa-Neto, CM; Di Benedetto, M; Nahmias, C				Rodrigues-Ferreira, Sylvie; Abdelkarim, Mohamed; Dillenburg-Pilla, Patricia; Luissint, Anny-Claude; di-Tommaso, Anne; Deshayes, Frederique; Pontes, Carmen Lucia S.; Molina, Angie; Cagnard, Nicolas; Letourneur, Franck; Morel, Marina; Reis, Rosana I.; Casarini, Dulce E.; Terris, Benoit; Couraud, Pierre-Olivier; Costa-Neto, Claudio M.; Di Benedetto, Melanie; Nahmias, Clara			Angiotensin II Facilitates Breast Cancer Cell Migration and Metastasis	PLOS ONE			English	Article							HUMAN GASTRIC-CANCER; TYPE-1 RECEPTOR; TUMOR ANGIOGENESIS; GROWTH; MICROENVIRONMENT; SYSTEM; RISK; DISSEMINATION; METAANALYSIS; PROGRESSION	Breast cancer metastasis is a leading cause of death by malignancy in women worldwide. Efforts are being made to further characterize the rate-limiting steps of cancer metastasis, i.e. extravasation of circulating tumor cells and colonization of secondary organs. In this study, we investigated whether angiotensin II, a major vasoactive peptide both produced locally and released in the bloodstream, may trigger activating signals that contribute to cancer cell extravasation and metastasis. We used an experimental in vivo model of cancer metastasis in which bioluminescent breast tumor cells (D3H2LN) were injected intra-cardiacally into nude mice in order to recapitulate the late and essential steps of metastatic dissemination. Real-time intravital imaging studies revealed that angiotensin II accelerates the formation of metastatic foci at secondary sites. Pre-treatment of cancer cells with the peptide increases the number of mice with metastases, as well as the number and size of metastases per mouse. In vitro, angiotensin II contributes to each sequential step of cancer metastasis by promoting cancer cell adhesion to endothelial cells, trans-endothelial migration and tumor cell migration across extracellular matrix. At the molecular level, a total of 102 genes differentially expressed following angiotensin II pretreatment were identified by comparative DNA microarray. Angiotensin II regulates two groups of connected genes related to its precursor angiotensinogen. Among those, up-regulated MMP2/MMP9 and ICAM1 stand at the crossroad of a network of genes involved in cell adhesion, migration and invasion. Our data suggest that targeting angiotensin II production or action may represent a valuable therapeutic option to prevent metastatic progression of invasive breast tumors.	[Rodrigues-Ferreira, Sylvie; Dillenburg-Pilla, Patricia; Luissint, Anny-Claude; di-Tommaso, Anne; Deshayes, Frederique; Molina, Angie; Cagnard, Nicolas; Letourneur, Franck; Morel, Marina; Terris, Benoit; Couraud, Pierre-Olivier; Nahmias, Clara] INSERM, Inst Cochin, Paris, France; [Rodrigues-Ferreira, Sylvie; Dillenburg-Pilla, Patricia; Luissint, Anny-Claude; di-Tommaso, Anne; Deshayes, Frederique; Molina, Angie; Cagnard, Nicolas; Letourneur, Franck; Morel, Marina; Terris, Benoit; Couraud, Pierre-Olivier; Nahmias, Clara] Univ Paris 05, Paris, France; [Abdelkarim, Mohamed; Di Benedetto, Melanie] Univ Paris 13, Bobigny, France; [Abdelkarim, Mohamed; Di Benedetto, Melanie] CNRS, UMRS 940, IGM, Paris, France; [Dillenburg-Pilla, Patricia; Reis, Rosana I.; Costa-Neto, Claudio M.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biochem & Immunol, Ribeirao Preto, Brazil; [Pontes, Carmen Lucia S.] Univ Fed Sao Carlos, Dept Physiol Sci, BR-13560 Sao Carlos, SP, Brazil; [Casarini, Dulce E.] Univ Fed Sao Paulo, Dept Med, Div Nephrol, Sao Paulo, Brazil	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; Centre National de la Recherche Scientifique (CNRS); Universidade de Sao Paulo; Universidade Federal de Sao Carlos; Universidade Federal de Sao Paulo (UNIFESP)	Nahmias, C (corresponding author), INSERM, Inst Cochin, Paris, France.	clara.nahmias@inserm.fr	Luissint, Anny/GNM-8096-2022; Terris, Benoit/P-1497-2017; abdelkarim, mohamed/AAK-5563-2020; Di Benedetto, Melanie MD/C-1512-2018; Casarini, Dulce E/D-4091-2012; dos Reis, Rosana Maria/E-3346-2012; Cagnard, Nicolas/K-2754-2014; Costa-Neto, Claudio/K-7291-2015	abdelkarim, mohamed/0000-0002-0984-6083; Di Benedetto, Melanie MD/0000-0003-1119-3752; dos Reis, Rosana Maria/0000-0001-9631-4167; Cagnard, Nicolas/0000-0002-9051-1896; Reis, Rosana/0000-0002-0465-8331; Nahmias, Clara/0000-0001-6863-370X; Costa-Neto, Claudio/0000-0002-7256-6412; Casarini, Dulce/0000-0003-1912-4292; Morel, Marina/0000-0001-6610-3772	University Paris Descartes; Inserm; Centre National de la Recherche Scientifique; Ligue Contre le Cancer-Comite Ile de France; Association pour la Recherche contre le Cancer (ARC); Fondation RAJA; association Prolific	University Paris Descartes; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Ligue Contre le Cancer-Comite Ile de France(Ligue nationale contre le cancer); Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Fondation RAJA; association Prolific	This work was supported by the University Paris Descartes, the Inserm, the Centre National de la Recherche Scientifique, the Ligue Contre le Cancer-Comite Ile de France, the Association pour la Recherche contre le Cancer (ARC), the Fondation RAJA, and the association Prolific. S.R-F was supported by a fellowship from ARC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkarim M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023334; Alvarez A, 2004, BLOOD, V104, P402, DOI 10.1182/blood-2003-08-2974; Bidard FC, 2008, CANCER METAST REV, V27, P5, DOI 10.1007/s10555-007-9103-x; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Bockhorn M, 2007, LANCET ONCOL, V8, P444, DOI 10.1016/S1470-2045(07)70140-7; Carl-McGrath S, 2007, CANCER BIOL THER, V6, P1218; Chae YK, 2011, CANCER INVEST, V29, P585, DOI 10.3109/07357907.2011.616252; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chen Q, 2011, CANCER CELL, V20, P538, DOI 10.1016/j.ccr.2011.08.025; Deshayes F, 2005, TRENDS ENDOCRIN MET, V16, P293, DOI 10.1016/j.tem.2005.07.009; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; Egami K, 2003, J CLIN INVEST, V112, P67, DOI 10.1172/JCI200316645; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fujita M, 2002, BIOCHEM BIOPH RES CO, V294, P441, DOI 10.1016/S0006-291X(02)00496-5; George AJ, 2010, NAT REV CANCER, V10, P745, DOI 10.1038/nrc2945; Huang W, 2008, DIGEST DIS SCI, V53, P163, DOI 10.1007/s10620-007-9838-9; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Imai N, 2007, LAB INVEST, V87, P189, DOI 10.1038/labinvest.3700504; Jenkins DE, 2005, BREAST CANCER RES, V7, pR444, DOI 10.1186/bcr1026; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kinoshita J, 2009, INT J ONCOL, V34, P1573, DOI 10.3892/ijo_00000287; Miyajima A, 2002, CANCER RES, V62, P4176; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Naumov GN, 2002, CANCER RES, V62, P2162; Nectoux J, 2011, J MOL MED, V89, P193, DOI 10.1007/s00109-010-0699-x; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Rhodes DR, 2009, P NATL ACAD SCI USA, V106, P10284, DOI 10.1073/pnas.0900351106; Rodrigues-Ferreira S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007239; Schroder C, 2011, J CANCER RES CLIN, V137, P1193, DOI 10.1007/s00432-011-0984-2; Shibue T, 2011, SEMIN CANCER BIOL, V21, P99, DOI 10.1016/j.semcancer.2010.12.003; Sipahi I, 2010, LANCET ONCOL, V11, P627, DOI 10.1016/S1470-2045(10)70106-6; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Tahmasebi M, 2006, BRIT J CANCER, V95, P67, DOI 10.1038/sj.bjc.6603213; Teo KK, 2011, J HYPERTENS, V29, P623, DOI 10.1097/HJH.0b013e328344a7de; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Witz IP, 2008, ADV CANCER RES, V100, P203, DOI 10.1016/S0065-230X(08)00007-9; Yoon C, 2011, CAN MED ASSOC J, V183, pE1073, DOI 10.1503/cmaj.101497	38	76	81	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35667	10.1371/journal.pone.0035667	http://dx.doi.org/10.1371/journal.pone.0035667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536420	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339200092
J	Tseng, CT; Sbrana, E; Iwata-Yoshikawa, N; Newman, PC; Garron, T; Atmar, RL; Peters, CJ; Couch, RB				Tseng, Chien-Te; Sbrana, Elena; Iwata-Yoshikawa, Naoko; Newman, Patrick C.; Garron, Tania; Atmar, Robert L.; Peters, Clarence J.; Couch, Robert B.			Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus	PLOS ONE			English	Article							ACUTE-RESPIRATORY-SYNDROME; IMMUNE-RESPONSES; NEUTRALIZING ANTIBODY; S-GLYCOPROTEIN; PROTECT MICE; COV; INFECTION; PARTICLES; EFFICACY; IMMUNOGENICITY	Background: Severe acute respiratory syndrome (SARS) emerged in China in 2002 and spread to other countries before brought under control. Because of a concern for reemergence or a deliberate release of the SARS coronavirus, vaccine development was initiated. Evaluations of an inactivated whole virus vaccine in ferrets and nonhuman primates and a virus-like-particle vaccine in mice induced protection against infection but challenged animals exhibited an immunopathologictype lung disease. Design: Four candidate vaccines for humans with or without alum adjuvant were evaluated in a mouse model of SARS, a VLP vaccine, the vaccine given to ferrets and NHP, another whole virus vaccine and an rDNA-produced S protein. Balb/c or C57BL/6 mice were vaccinated IM on day 0 and 28 and sacrificed for serum antibody measurements or challenged with live virus on day 56. On day 58, challenged mice were sacrificed and lungs obtained for virus and histopathology. Results: All vaccines induced serum neutralizing antibody with increasing dosages and/or alum significantly increasing responses. Significant reductions of SARS-CoV two days after challenge was seen for all vaccines and prior live SARS-CoV. All mice exhibited histopathologic changes in lungs two days after challenge including all animals vaccinated (Balb/C and C57BL/6) or given live virus, influenza vaccine, or PBS suggesting infection occurred in all. Histopathology seen in animals given one of the SARS-CoV vaccines was uniformly a Th2-type immunopathology with prominent eosinophil infiltration, confirmed with special eosinophil stains. The pathologic changes seen in all control groups lacked the eosinophil prominence. Conclusions: These SARS-CoV vaccines all induced antibody and protection against infection with SARS-CoV. However, challenge of mice given any of the vaccines led to occurrence of Th2-type immunopathology suggesting hypersensitivity to SARS-CoV components was induced. Caution in proceeding to application of a SARS-CoV vaccine in humans is indicated.	[Atmar, Robert L.; Couch, Robert B.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Tseng, Chien-Te; Iwata-Yoshikawa, Naoko; Peters, Clarence J.] Univ Texas Med Branch, Ctr Biodef & Emerging Dis, Galveston, TX USA; [Tseng, Chien-Te; Sbrana, Elena; Iwata-Yoshikawa, Naoko; Newman, Patrick C.; Garron, Tania; Peters, Clarence J.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [Atmar, Robert L.; Couch, Robert B.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Baylor College of Medicine	Couch, RB (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	rcouch@bcm.edu	Atmar, Robert/AFQ-5392-2022	Atmar, Robert/0000-0001-9989-6772	Public Health Service from the National Institute of Allergy and Infectious Diseases [NO1 AI 30039]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI030039] Funding Source: NIH RePORTER	Public Health Service from the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research performed by the authors and summarized in this report was supported by Public Health Service Contract NO1 AI 30039 from the National Institute of Allergy and Infectious Diseases. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, UPD INT US CAS DEF S; Bolles M, 2011, J VIROL, V85, P12201, DOI 10.1128/JVI.06048-11; Castilow EM, 2007, IMMUNOL RES, V39, P225, DOI 10.1007/s12026-007-0071-6; Collins PL, 2008, J VIROL, V82, P2040, DOI 10.1128/JVI.01625-07; Deming D, 2006, PLOS MED, V3, P2359, DOI 10.1371/journal.pmed.0030525; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Du LY, 2010, VIRAL IMMUNOL, V23, P211, DOI 10.1089/vim.2009.0090; Enjuanes L, 2008, VIRUS RES, V133, P45, DOI 10.1016/j.virusres.2007.01.021; Fowler RA, 2003, JAMA-J AM MED ASSOC, V290, P367, DOI 10.1001/jama.290.3.367; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Gorham JD, 1996, P NATL ACAD SCI USA, V93, P12467, DOI 10.1073/pnas.93.22.12467; Haagmans BL, 2005, 10 INT NID S COL SPR; HSIEH CS, 1995, J EXP MED, V181, P713, DOI 10.1084/jem.181.2.713; Jordan MB, 2004, SCIENCE, V304, P1808, DOI 10.1126/science.1089926; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Kusters IC, 2009, VACCINES FOR BIODEFENSE AND EMERGING AND NEGLECTED DISEASES, P147, DOI 10.1016/B978-0-12-369408-9.00011-1; Lamirande EW, 2008, J VIROL, V82, P7721, DOI 10.1128/JVI.00304-08; Launois P, 1997, IMMUNITY, V6, P541, DOI 10.1016/S1074-7613(00)80342-8; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Lin JT, 2007, ANTIVIR THER, V12, P1107; Liu YV, 2011, VACCINE, V29, P6606, DOI 10.1016/j.vaccine.2011.06.111; Lokugamage KG, 2008, VACCINE, V26, P797, DOI 10.1016/j.vaccine.2007.11.092; Lu BJ, 2010, IMMUNOLOGY, V130, P254, DOI 10.1111/j.1365-2567.2010.03231.x; Martin JE, 2008, VACCINE, V26, P6338, DOI 10.1016/j.vaccine.2008.09.026; Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498; Perlman S, 2005, NAT REV IMMUNOL, V5, P917, DOI 10.1038/nri1732; Polack FP, 2002, J EXP MED, V196, P859, DOI 10.1084/jem.20020781; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Power UF, 2001, J VIROL, V75, P12421, DOI 10.1128/JVI.75.24.12421-12430.2001; Protheroe C, 2009, CLIN GASTROENTEROL H, V7, P749, DOI 10.1016/j.cgh.2009.03.022; Roberts A, 2010, VIRAL IMMUNOL, V23, P509, DOI 10.1089/vim.2010.0028; See RH, 2008, J GEN VIROL, V89, P2136, DOI 10.1099/vir.0.2008/001891-0; See RH, 2006, J GEN VIROL, V87, P641, DOI 10.1099/vir.0.81579-0; Spruth M, 2006, VACCINE, V24, P652, DOI 10.1016/j.vaccine.2005.08.055; Subbarao K, 2004, J VIROL, V78, P3572, DOI 10.1128/JVI.78.7.3572-3577.2004; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666; Tseng CTK, 2007, J VIROL, V81, P1162, DOI 10.1128/JVI.01702-06; Waris ME, 1996, J VIROL, V70, P2852, DOI 10.1128/JVI.70.5.2852-2860.1996; WEISS RC, 1981, COMP IMMUNOL MICROB, V4, P175, DOI 10.1016/0147-9571(81)90003-5; Wentworth DE, 2004, EMERG INFECT DIS, V10, P1293, DOI 10.3201/eid1007.031119; World Health Organization, 2003, CAS DEF SURV SEV AC; Yasui F, 2008, J IMMUNOL, V181, P6337, DOI 10.4049/jimmunol.181.9.6337; Yoshikawa N, 2009, J VIROL, V83, P5451, DOI 10.1128/JVI.02272-08; Zhou ZM, 2006, VACCINE, V24, P3624, DOI 10.1016/j.vaccine.2006.01.059	47	331	350	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35421	10.1371/journal.pone.0035421	http://dx.doi.org/10.1371/journal.pone.0035421			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536382	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339200063
J	Mietus-Snyder, ML; Shigenaga, MK; Suh, JH; Shenvi, SV; Lal, A; McHugh, T; Olson, D; Lilienstein, J; Krauss, RM; Gildengoren, G; McCann, JC; Ames, BN				Mietus-Snyder, Michele L.; Shigenaga, Mark K.; Suh, Jung H.; Shenvi, Swapna V.; Lal, Ashutosh; McHugh, Tara; Olson, Don; Lilienstein, Joshua; Krauss, Ronald M.; Gildengoren, Ginny; McCann, Joyce C.; Ames, Bruce N.			A nutrient-dense, high-fiber, fruit-based supplement bar increases HDL cholesterol, particularly large HDL, lowers homocysteine, and raises glutathione in a 2-wk trial	FASEB JOURNAL			English	Article						antioxidant status; cardiovascular disease risk; dyslipidemia; lipid particles; obesity	CARDIOVASCULAR RISK-FACTORS; POLYUNSATURATED FATTY-ACIDS; CORONARY-HEART-DISEASE; RANDOMIZED CONTROLLED-TRIALS; METABOLIC SYNDROME; LIPOPROTEIN CHOLESTEROL; INSULIN-RESISTANCE; FOLIC-ACID; OXIDATIVE STRESS; GLYCEMIC INDEX	Dietary intake modulates disease risk, but little is known how components within food mixtures affect pathophysiology. A low-calorie, high-fiber, fruit-based nutrient-dense bar of defined composition (e. g., vitamins and minerals, fruit polyphenolics, beta-glucan, docosahexaenoic acid) appropriate for deconstruction and mechanistic studies is described and evaluated in a pilot trial. The bar was developed in collaboration with the U. S. Department of Agriculture. Changes in cardiovascular disease and diabetes risk biomarkers were measured after 2 wk twice-daily consumption of the bar, and compared against baseline controls in 25 healthy adults. Plasma HDL-cholesterol (HDL-c) increased 6.2% (P = 0.001), due primarily to a 28% increase in large HDL (HDL-L; P<0.0001). Total plasma homocysteine (Hcy) decreased 19% (P = 0.017), and glutathione (GSH) increased 20% (P = 0.011). The changes in HDL and Hcy are in the direction associated with decreased risk of cardiovascular disease and cognitive decline; increased GSH reflects improved antioxidant defense. Changes in biomarkers linked to insulin resistance and inflammation were not observed. A defined food-based supplement can, within 2 wk, positively impact metabolic biomarkers linked to disease risk. These results lay the groundwork for mechanistic/deconstruction experiments to identify critical bar components and putative synergistic combinations responsible for observed effects.-Mietus-Snyder, M. L., Shigenaga, M. K., Suh, J. H., Shenvi, S. V., Lal, A., McHugh, T., Olson, D., Lilienstein, J., Krauss, R. M., Gildengoren, G., McCann, J. C., Ames, B. N. A nutrient-dense, high-fiber, fruit-based supplement bar increases HDL cholesterol, particularly large HDL, lowers homo-cysteine, and raises glutathione in a 2-wk trial. FASEB J. 26, 3515-3527 (2012). www.fasebj.org	[Mietus-Snyder, Michele L.; Shigenaga, Mark K.; Suh, Jung H.; Shenvi, Swapna V.; Lal, Ashutosh; Krauss, Ronald M.; Gildengoren, Ginny; McCann, Joyce C.; Ames, Bruce N.] Childrens Hosp Oakland Res Inst, Nutr & Metab Ctr, Oakland, CA 94609 USA; [McHugh, Tara; Olson, Don] ARS, Proc Foods Res Unit, USDA, Western Reg Res Ctr, Albany, CA USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; United States Department of Agriculture (USDA)	Shigenaga, MK (corresponding author), Childrens Hosp Oakland Res Inst, Nutr & Metab Ctr, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	mshigenaga@chori.org; bames@chori.org		Lilienstein, Joshua/0000-0003-3189-9170; Mietus-Snyder, Michele/0000-0003-2791-9896	U.S. National Institutes of Health [UL1RR024131]; Bruce and Giovanna Ames Foundation; Department of Atherosclerosis Research at Children's Hospital Oakland Research Institute; S. D. Bechtel, Jr. Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bruce and Giovanna Ames Foundation; Department of Atherosclerosis Research at Children's Hospital Oakland Research Institute; S. D. Bechtel, Jr. Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Many thanks to Alicia Zhou, Casey Geaney, Katie Woojinski, and Devan Block for technical assistance, the extraordinary staff at the Pediatric Clinical Research Center (PCRC) at Children's Hospital Oakland, especially Annie Higa and Vivian Ng. M. K. S. thanks Wally Yokoyama for helpful discussions on soluble fibers. The authors also thank Pharmachem Laboratories (Kearny, NJ, USA) for donating a nutrient blend for the study and Teresa Klask for invaluable administrative assistance. This publication was made possible by U.S. National Institutes of Health Clinical and Translational Science Award grant UL1RR024131. Additional support was from the Bruce and Giovanna Ames Foundation (J.C.M., M. M. S., M. K. S., J.H.S., S. V. S., A. L.), the Department of Atherosclerosis Research at Children's Hospital Oakland Research Institute (R. M. K.), and the S. D. Bechtel, Jr. Foundation (J.H.S.).	Aasheim ET, 2008, AM J CLIN NUTR, V87, P362, DOI 10.1093/ajcn/87.2.362; Adamsson V, 2011, J INTERN MED, V269, P150, DOI 10.1111/j.1365-2796.2010.02290.x; Adeva MM, 2012, AMINO ACIDS, V43, P171, DOI 10.1007/s00726-011-1088-7; Agodi A, 2011, EUR J CLIN NUTR, V65, P1302, DOI 10.1038/ejcn.2011.125; Al-Mohaissen MA, 2010, MINI-REV MED CHEM, V10, P204, DOI 10.2174/138955710791185046; Alley DE, 2006, BRAIN BEHAV IMMUN, V20, P498, DOI 10.1016/j.bbi.2005.10.003; Ames BN, 2006, P NATL ACAD SCI USA, V103, P17589, DOI 10.1073/pnas.0608757103; Ames BN, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/725071; [Anonymous], 2008, AM J BIOCH BIOTECHNO; Ashfaq S, 2006, J AM COLL CARDIOL, V47, P1005, DOI 10.1016/j.jacc.2005.09.063; Asztalos BF, 2004, ARTERIOSCL THROM VAS, V24, P2181, DOI 10.1161/01.ATV.0000146325.93749.a8; Atkuri KR, 2007, CURR OPIN PHARMACOL, V7, P355, DOI 10.1016/j.coph.2007.04.005; Azadbakht L, 2005, DIABETES CARE, V28, P2823, DOI 10.2337/diacare.28.12.2823; Balk EM, 2006, ATHEROSCLEROSIS, V189, P19, DOI 10.1016/j.atherosclerosis.2006.02.012; Basu A, 2010, J NUTR, V140, P1582, DOI 10.3945/jn.110.124701; Basu TK, 1997, J NUTR, V127, P117, DOI 10.1093/jn/127.1.117; Beck EJ, 2009, MOL NUTR FOOD RES, V53, P1343, DOI 10.1002/mnfr.200800343; Bernstein AM, 2012, J NUTR, V142, P99, DOI 10.3945/jn.111.148973; Billington CJ, 2000, ARCH INTERN MED, V160, P898, DOI 10.1001/archinte.160.7.898; Blasbalg TL, 2011, AM J CLIN NUTR, V93, P950, DOI 10.3945/ajcn.110.006643; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Botella-Carretero JI, 2007, CLIN NUTR, V26, P573, DOI 10.1016/j.clnu.2007.05.009; Bremer AA, 2012, PEDIATRICS, V129, P557, DOI 10.1542/peds.2011-2912; Brotanek JM, 2007, PEDIATRICS, V120, P568, DOI 10.1542/peds.2007-0572; Bueno MB, 2008, NUTRITION, V24, P1110, DOI 10.1016/j.nut.2008.05.020; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Carr DF, 2009, PHARMACOGENOMICS J, V9, P291, DOI 10.1038/tpj.2009.29; Casagrande SS, 2007, AM J PREV MED, V32, P257, DOI 10.1016/j.amepre.2006.12.002; Caulfield MP, 2008, CLIN CHEM, V54, P1307, DOI 10.1373/clinchem.2007.100586; Chan AC, 1999, P SOC EXP BIOL MED, V222, P274, DOI 10.1046/j.1525-1373.1999.d01-144.x; Chapman MJ, 2010, PHARMACOL THERAPEUT, V126, P314, DOI 10.1016/j.pharmthera.2010.01.008; Clarke R, 2011, J INHERIT METAB DIS, V34, P83, DOI 10.1007/s10545-010-9235-y; Cooney MT, 2009, ATHEROSCLEROSIS, V206, P611, DOI 10.1016/j.atherosclerosis.2009.02.041; Crider KS, 2011, AM J CLIN NUTR, V93, P1365, DOI 10.3945/ajcn.110.004671; Culberson A., 2009, INT ARCH MED, V2, P3; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; de Jager CA, 2012, INT J GERIATR PSYCH, V27, P592, DOI 10.1002/gps.2758; Deminice R, 2011, J NUTR, V141, P1799, DOI 10.3945/jn.111.144857; Dierkes Jutta, 2005, Semin Vasc Med, V5, P124; Durstine J L, 1994, Exerc Sport Sci Rev, V22, P477; Elias MF, 2005, AM J EPIDEMIOL, V162, P644, DOI 10.1093/aje/kwi259; Erlund I, 2008, AM J CLIN NUTR, V87, P323, DOI 10.1093/ajcn/87.2.323; Ervin R Bethene, 2009, Natl Health Stat Report, P1; Esmaillzadeh A, 2007, J NUTR, V137, P992, DOI 10.1093/jn/137.4.992; Esmaillzadeh A, 2007, AM J CLIN NUTR, V85, P910, DOI 10.1093/ajcn/85.3.910; EVANS MA, 1992, J AM DIET ASSOC, V92, P1239, DOI 10.1037/10111-000; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Foster-Schubert KE, 2008, J CLIN ENDOCR METAB, V93, P1971, DOI 10.1210/jc.2007-2289; Frassetto LA, 2009, EUR J CLIN NUTR, V63, P947, DOI 10.1038/ejcn.2009.4; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Frost G, 1999, LANCET, V353, P1045, DOI 10.1016/S0140-6736(98)07164-5; Garcia-Sanchez C, 2011, CLIN CHIM ACTA, V412, P292, DOI 10.1016/j.cca.2010.10.021; Gardner CD, 2010, AM J CLIN NUTR, V92, P304, DOI 10.3945/ajcn.2010.29468; Geppert J, 2006, BRIT J NUTR, V95, P779, DOI 10.1079/BJN20051720; Gordon SM, 2011, TRENDS ENDOCRIN MET, V22, P9, DOI 10.1016/j.tem.2010.10.001; Grey Vijaylaxmi, 2003, J Cyst Fibros, V2, P195, DOI 10.1016/S1569-1993(03)00097-3; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Grion CMC, 2010, EUR J CLIN INVEST, V40, P330, DOI 10.1111/j.1365-2362.2010.02269.x; Gutschi LM, 2006, ANN PHARMACOTHER, V40, P1672, DOI 10.1345/aph.1H020; Haan MN, 2007, AM J CLIN NUTR, V85, P511, DOI 10.1093/ajcn/85.2.511; Hartweg J, 2007, DIABETOLOGIA, V50, P1593, DOI 10.1007/s00125-007-0695-z; Hossain MA, 2008, J CARDIOVASC PHARM, V51, P258, DOI 10.1097/FJC.0b013e3181624b22; Houston MC, 2009, PROG CARDIOVASC DIS, V52, P61, DOI 10.1016/j.pcad.2009.02.002; Howarth NC, 2001, NUTR REV, V59, P129, DOI 10.1111/j.1753-4887.2001.tb07001.x; Hu JJ, 1996, CANCER EPIDEM BIOMAR, V5, P263; Innis SM, 2007, AM J CLIN NUTR, V85, P702, DOI 10.1093/ajcn/85.3.702; Jacobs DR, 2009, AM J CLIN NUTR, V89, pS1543, DOI 10.3945/ajcn.2009.26736B; Jafri H, 2010, J AM COLL CARDIOL, V55, P2846, DOI 10.1016/j.jacc.2009.12.069; Jia L, 2010, AM J CLIN NUTR, V92, P218, DOI 10.3945/ajcn.2009.28202; Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865; Jones DP, 2002, FREE RADICAL BIO MED, V33, P1290, DOI 10.1016/S0891-5849(02)01040-7; Jonsson T, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-35; Jun M, 2010, LANCET, V375, P1875, DOI 10.1016/S0140-6736(10)60656-3; Kabir M, 2007, AM J CLIN NUTR, V86, P1670; Kalaria RN, 2010, NUTR REV, V68, pS74, DOI 10.1111/j.1753-4887.2010.00352.x; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kimmons Joel E, 2006, MedGenMed, V8, P59; Krauss RM, 2004, DIABETES CARE, V27, P1496, DOI 10.2337/diacare.27.6.1496; Krebs-Smith SM, 2010, J NUTR, V140, P1832, DOI 10.3945/jn.110.124826; Krebs-Smith SM, 2010, AM J PREV MED, V38, P472, DOI 10.1016/j.amepre.2010.01.016; Kritchevsky D, 2003, J NUTR, V133, p3827S, DOI 10.1093/jn/133.11.3827S; Kruit JK, 2006, WORLD J GASTROENTERO, V12, P6429, DOI 10.3748/wjg.v12.i40.6429; Laitinen DL, 2010, CURR MED RES OPIN, V26, P933, DOI 10.1185/03007991003656968; Lee IT, 2008, DIABETIC MED, V25, P1473, DOI 10.1111/j.1464-5491.2008.02588.x; Lenton KJ, 2003, AM J CLIN NUTR, V77, P189, DOI 10.1093/ajcn/77.1.189; Li Y, 2010, INT J OBESITY, V34, P1070, DOI 10.1038/ijo.2010.14; Liese AD, 2005, DIABETES CARE, V28, P2832, DOI 10.2337/diacare.28.12.2832; Liu HL, 2004, ANN NY ACAD SCI, V1019, P346, DOI 10.1196/annals.1297.059; Livingstone C, 2007, BRIT J DIABETES VASC, V7, P258, DOI [10.1177/14746514070070060201, DOI 10.1177/14746514070070060201]; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Ludwig DS, 2007, NEW ENGL J MED, V357, P2325, DOI 10.1056/NEJMp0706538; Luhovyy BL, 2007, J AM COLL NUTR, V26, p704S, DOI 10.1080/07315724.2007.10719651; Manco M, 2010, ENDOCR REV, V31, P817, DOI 10.1210/er.2009-0030; Mangravite LM, 2011, J NUTR, V141, P2180, DOI 10.3945/jn.111.139477; Mannery YO, 2010, J PHARMACOL EXP THER, V333, P939, DOI 10.1124/jpet.110.166421; Martins D, 2008, J NATL MED ASSOC, V100, P565, DOI 10.1016/S0027-9684(15)31304-3; Mayer O, 2003, EUR J CLIN PHARMACOL, V59, P367, DOI 10.1007/s00228-003-0616-0; McCann JC, 2011, FASEB J, V25, P1793, DOI 10.1096/fj.11-180885; McCann JC, 2009, AM J CLIN NUTR, V90, P889, DOI 10.3945/ajcn.2009.27930; McGrowder D, 2011, CHOLESTEROL, DOI 10.1155/2011/496925; MEISTER A, 1991, PHARMACOL THERAPEUT, V51, P155, DOI 10.1016/0163-7258(91)90076-X; Mellor DD, 2010, DIABETIC MED, V27, P1318, DOI 10.1111/j.1464-5491.2010.03108.x; Mena MP, 2009, AM J CLIN NUTR, V89, P248, DOI 10.3945/ajcn.2008.26094; Meyers CD, 2004, CURR OPIN CARDIOL, V19, P366, DOI 10.1097/01.hco.0000126582.27767.87; Morcos NC, 1999, MED SCI RES, V27, P121; Morris CR, 2008, BLOOD, V111, P402, DOI 10.1182/blood-2007-04-081703; Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w; Mursu J, 2004, FREE RADICAL BIO MED, V37, P1351, DOI 10.1016/j.freeradbiomed.2004.06.002; Na HK, 2008, FOOD CHEM TOXICOL, V46, P1271, DOI 10.1016/j.fct.2007.10.006; Nadtochiy SM, 2011, NUTRITION, V27, P733, DOI 10.1016/j.nut.2010.12.006; Namekata K, 2004, J BIOL CHEM, V279, P52961, DOI 10.1074/jbc.M406820200; Natarajan P, 2010, J AM COLL CARDIOL, V55, P1283, DOI 10.1016/j.jacc.2010.01.008; National Institutes of Health, 2011, NIH PUBL; Neuman RB, 2007, CLIN CHEM, V53, P1652, DOI 10.1373/clinchem.2006.083923; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nichols GA, 2011, AM J CARDIOL, V108, P1124, DOI 10.1016/j.amjcard.2011.05.047; Nordmann AJ, 2011, AM J MED, V124, P841, DOI 10.1016/j.amjmed.2011.04.024; Olson ML, 2012, J CLIN ENDOCR METAB, V97, P279, DOI 10.1210/jc.2011-1507; Olthof MR, 2005, PLOS MED, V2, P446, DOI 10.1371/journal.pmed.0020135; Oulhaj A, 2010, INT J GERIATR PSYCH, V25, P82, DOI 10.1002/gps.2303; Ozata M, 2002, CLIN BIOCHEM, V35, P627, DOI 10.1016/S0009-9120(02)00363-6; Pachikian BD, 2010, J NUTR, V140, P509, DOI 10.3945/jn.109.117374; Parra D, 2008, APPETITE, V51, P676, DOI 10.1016/j.appet.2008.06.003; Perez-Lopez FR, 2009, MATURITAS, V64, P67, DOI 10.1016/j.maturitas.2009.07.013; Peto J, 2001, NATURE, V411, P390, DOI 10.1038/35077256; Pfeiffer CM, 2008, CLIN CHEM, V54, P801, DOI 10.1373/clinchem.2007.100214; Popkin BM, 2007, SCI AM, V297, P88, DOI 10.1038/scientificamerican0907-88; Procaccini C, 2011, EXPERT REV CLIN IMMU, V7, P287, DOI [10.1586/ECI.11.18, 10.1586/eci.11.18]; Qin Y, 2009, AM J CLIN NUTR, V90, P485, DOI 10.3945/ajcn.2009.27814; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Reitz C, 2010, ARCH NEUROL-CHICAGO, V67, P1491, DOI 10.1001/archneurol.2010.297; Reyna-Villasmil Nadia, 2007, Am J Ther, V14, P203, DOI 10.1097/01.pap.0000249917.96509.e7; Rodriguez MA, 2002, ARCH PEDIAT ADOL MED, V156, P269, DOI 10.1001/archpedi.156.3.269; Rodriguez P, 1996, GUT, V39, P416, DOI 10.1136/gut.39.3.416; Rodriguez-Rodriguez E, 2009, PUBLIC HEALTH NUTR, V12, P44, DOI 10.1017/S1368980008001912; Rosenson RS, 2011, CLIN CHEM, V57, P392, DOI 10.1373/clinchem.2010.155333; Ruel G, 2006, BRIT J NUTR, V96, P357, DOI 10.1079/BJN20061814; Sacks FM, 2002, AM J MED, V113, P13, DOI 10.1016/S0002-9343(01)00987-1; Salek RM, 2007, PHYSIOL GENOMICS, V29, P99, DOI 10.1152/physiolgenomics.00194.2006; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Selhub J, 2008, FOOD NUTR BULL, V29, pS116, DOI 10.1177/15648265080292S116; Selhub J, 2007, P NATL ACAD SCI USA, V104, P19995, DOI 10.1073/pnas.0709487104; Simopoulos AP, 2011, MOL NEUROBIOL, V44, P203, DOI 10.1007/s12035-010-8162-0; Siri-Tarino PW, 2011, CURR ATHEROSCLER REP, V13, P453, DOI 10.1007/s11883-011-0207-y; Skovby F, 2010, MOL GENET METAB, V99, P1, DOI 10.1016/j.ymgme.2009.09.009; Smith AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012244; Smulders YM, 2011, J INHERIT METAB DIS, V34, P93, DOI 10.1007/s10545-010-9151-1; Sola R, 2011, ATHEROSCLEROSIS, V218, P174, DOI 10.1016/j.atherosclerosis.2011.04.026; Sonestedt E, 2012, BRIT J NUTR, V107, P1062, DOI 10.1017/S0007114511003783; SPAETH G, 1990, SURGERY, V108, P240; Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101; Suh JH, 2009, J CHROMATOGR B, V877, P3418, DOI 10.1016/j.jchromb.2009.06.041; Suliman ME, 1999, J AM SOC NEPHROL, V10, P1287; Tang WHW, 2009, J AM COLL CARDIOL, V53, P2061, DOI 10.1016/j.jacc.2009.02.036; Tian L, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-118; Tokede OA, 2011, EUR J CLIN NUTR, V65, P879, DOI 10.1038/ejcn.2011.64; Tu Min-Chien, 2010, Acta Neurol Taiwan, V19, P168; U.S. Department of Agriculture; Agricultural Research Service, 2011, USDA NAT NUTR DAT ST; US Department of Agriculture, 2007, USDA DAT FLAV CONT S; Van Dam F, 2009, ARCH GERONTOL GERIAT, V48, P425, DOI 10.1016/j.archger.2008.03.009; van der Ven AJAM, 1998, EUR J CLIN INVEST, V28, P187, DOI 10.1046/j.1365-2362.1998.00267.x; Veeranna V, 2011, J AM COLL CARDIOL, V58, P1025, DOI 10.1016/j.jacc.2011.05.028; Vitaglione P, 2009, APPETITE, V53, P338, DOI 10.1016/j.appet.2009.07.013; Vrolix R, 2010, AM J CLIN NUTR, V92, P366, DOI 10.3945/ajcn.2009.28339; Wang XB, 2007, LANCET, V369, P1876, DOI 10.1016/S0140-6736(07)60854-X; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Watanabe H, 2006, ARTERIOSCL THROM VAS, V26, P897, DOI 10.1161/01.ATV.0000209577.04246.c0; Weisel Tamara, 2006, Biotechnology Journal, V1, P388, DOI 10.1002/biot.200600004; Wierzbicki AS, 2009, CURR OPIN CARDIOL, V24, P372, DOI 10.1097/HCO.0b013e32832c0b3d; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Wyld B, 2010, PUBLIC HEALTH NUTR, V13, P2105, DOI 10.1017/S136898001000073X; Zhang ZY, 2010, LIPIDS, V45, P765, DOI 10.1007/s11745-010-3463-7; Zhong W, 2010, AM J PHYSIOL-GASTR L, V298, pG625, DOI 10.1152/ajpgi.00350.2009	175	18	18	0	31	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2012	26	8					3515	3527		10.1096/fj.11-201558	http://dx.doi.org/10.1096/fj.11-201558			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22549511	Green Published			2022-12-25	WOS:000307162800038
J	Rucktooa, P; Haseler, CA; van Elk, R; Smit, AB; Gallagher, T; Sixma, TK				Rucktooa, Prakash; Haseler, Claire A.; van Elk, Rene; Smit, August B.; Gallagher, Timothy; Sixma, Titia K.			Structural Characterization of Binding Mode of Smoking Cessation Drugs to Nicotinic Acetylcholine Receptors through Study of Ligand Complexes with Acetylcholine-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; 10-SUBSTITUTED CYTISINE DERIVATIVES; CYS-LOOP RECEPTOR; X-RAY-STRUCTURE; CRYSTAL-STRUCTURE; HOMOLOG ACHBP; AGONISTS; DETERMINANTS; SELECTIVITY; RESOLUTION	Smoking cessation is an important aim in public health worldwide as tobacco smoking causes many preventable deaths. Addiction to tobacco smoking results from the binding of nicotine to nicotinic acetylcholine receptors (nAChRs) in the brain, in particular the alpha 4 beta 2 receptor. One way to aid smoking cessation is by the use of nicotine replacement therapies or partial nAChR agonists like cytisine or varenicline. Here we present the co-crystal structures of cytisine and varenicline in complex with Aplysia californica acetylcholine-binding protein and use these as models to investigate binding of these ligands binding to nAChRs. This analysis of the binding properties of these two partial agonists provides insight into differences with nicotine binding to nAChRs. A mutational analysis reveals that the residues conveying subtype selectivity in nAChRs reside on the binding site complementary face and include features extending beyond the first shell of contacting residues.	[Rucktooa, Prakash; Sixma, Titia K.] Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands; [Rucktooa, Prakash; Sixma, Titia K.] Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; [Haseler, Claire A.; Gallagher, Timothy] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England; [van Elk, Rene; Smit, August B.] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Mol & Cellular Neurobiol, NL-1081 HV Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; University of Bristol; Vrije Universiteit Amsterdam	Sixma, TK (corresponding author), Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands.	t.sixma@nki.nl		Sixma, Titia K/0000-0001-6180-0632; Rucktooa, Prakash/0000-0003-2050-7389	European Union [HEALTH-F2-2007-202088]; TiPharma Grant [D2-103]; European Molecular Biology Organization	European Union(European Commission); TiPharma Grant; European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	This work was supported by the European Union Seventh Framework Programme under Grant agreement HEALTH-F2-2007-202088 ("Neuro-Cypres" project) and from TiPharma Grant D2-103 (to A. B. S.).; Supported by a long term fellowship from the European Molecular Biology Organization.	Abin-Carriquiry JA, 2010, BIOORG MED CHEM LETT, V20, P3683, DOI 10.1016/j.bmcl.2010.04.092; Benowitz NL, 2010, NEW ENGL J MED, V362, P2295, DOI 10.1056/NEJMra0809890; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Bricogne G., 2011, BUSTER; Carbonnelle E, 2003, EUR J PHARMACOL, V471, P85, DOI 10.1016/S0014-2999(03)01817-X; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Celie PHN, 2005, J BIOL CHEM, V280, P26457, DOI 10.1074/jbc.M414476200; Chellappan SK, 2006, J MED CHEM, V49, P2673, DOI 10.1021/jm051196m; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Coe JW, 2005, J MED CHEM, V48, P3474, DOI 10.1021/jm050069n; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Daly JW, 2005, CELL MOL NEUROBIOL, V25, P513, DOI 10.1007/s10571-005-3968-4; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Dwoskin LP, 2009, BIOCHEM PHARMACOL, V78, P732, DOI 10.1016/j.bcp.2009.06.002; Eaton JB, 2003, MOL PHARMACOL, V64, P1283, DOI 10.1124/mol.64.6.1283; Edink E, 2011, J AM CHEM SOC, V133, P5363, DOI 10.1021/ja110571r; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Grutter T, 2003, EMBO J, V22, P1990, DOI 10.1093/emboj/cdg197; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Huang XQ, 2006, J MED CHEM, V49, P7661, DOI 10.1021/jm0606701; Imming P, 2001, EUR J MED CHEM, V36, P375, DOI 10.1016/S0223-5234(01)01222-3; Joosten RP, 2011, BIOINFORMATICS, V27, P3392, DOI 10.1093/bioinformatics/btr590; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Kozikowski AP, 2007, CHEMMEDCHEM, V2, P1157, DOI 10.1002/cmdc.200700073; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lancaster T, 2008, EXPERT OPIN PHARMACO, V9, P15, DOI 10.1517/14656566.9.1.15; Lummis SCR, 2011, J PHARMACOL EXP THER, V339, P125, DOI 10.1124/jpet.111.185306; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Rucktooa P, 2009, BIOCHEM PHARMACOL, V78, P777, DOI 10.1016/j.bcp.2009.06.098; Shi JX, 2006, J BIOL CHEM, V281, P12170, DOI 10.1074/jbc.M600154200; SINE SM, 1995, NEURON, V15, P205, DOI 10.1016/0896-6273(95)90077-2; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Slater YE, 2003, NEUROPHARMACOLOGY, V44, P503, DOI 10.1016/S0028-3908(03)00025-X; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Tasso B, 2009, J MED CHEM, V52, P4345, DOI 10.1021/jm900225j; Ulens C, 2006, P NATL ACAD SCI USA, V103, P3615, DOI 10.1073/pnas.0507889103; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Xiu XA, 2009, NATURE, V458, P534, DOI 10.1038/nature07768	53	38	43	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23283	23293		10.1074/jbc.M112.360347	http://dx.doi.org/10.1074/jbc.M112.360347			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22553201	Green Published, hybrid			2022-12-25	WOS:000306511300003
J	Lepur, A; Salomonsson, E; Nilsson, UJ; Leffler, H				Lepur, Adriana; Salomonsson, Emma; Nilsson, Ulf J.; Leffler, Hakon			Ligand Induced Galectin-3 Protein Self-association	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RECOGNITION DOMAIN; BINDING; LECTIN; VISUALIZATION; COMPLEXES; SURFACE	Many functions of galectin-3 entail binding of its carbohydrate recognition site to glycans of a glycoprotein, resulting in cross-linking thought to be mediated by its N-terminal noncarbohydrate-binding domain. Here we studied interaction of galectin-3 with the model glycoprotein asialofetuin (ASF), using a fluorescence anisotropy assay to measure the concentration of free galectin carbohydrate recognition sites in solution. Surprisingly, in the presence of ASF, this remained low even at high galectin-3 concentrations, showing that many more galectin-3 molecules were engaged than expected due to the about nine known glycan-based binding sites per ASF molecule. This suggests that after ASF-induced nucleation, galectin-3 associates with itself by the carbohydrate recognition site binding to another galectin-3 molecule, possibly forming oligomers. We named this type-C self-association to distinguish it from the previously proposed models (type-N) where galectin-3 molecules bind to each other through the N-terminal domain, and all carbohydrate recognition sites are available for binding glycans. Both types of self-association can result in precipitates, as measured here by turbidimetry and dynamic light scattering. Type-C self-association and precipitation occurred even with a galectin-3 mutant (R186S) that bound poorly to ASF but required much higher concentration (similar to 50 mu M) as compared with wild type (similar to 1 mu M). ASF also induced weaker type-C self-association of galectin-3 lacking its N-terminal domains, but as expected, no precipitation. Neither a monovalent nor a divalent N-acetyl-D-lactosamine-containing glycan induced type-C self-association, even if the latter gave precipitates with high concentrations of galectin-3 (>similar to 50 mu M) in agreement with published results and perhaps due to type-N self-association.	[Lepur, Adriana] Lund Univ, Dept Lab Med, Microbiol Immunol Glycobiol MIG Sect, S-22362 Lund, Sweden; [Nilsson, Ulf J.] Lund Univ, Ctr Anal & Synth, SE-22100 Lund, Sweden	Lund University; Lund University	Lepur, A (corresponding author), Lund Univ, Dept Lab Med, Microbiol Immunol Glycobiol MIG Sect, Solvegatan 23, S-22362 Lund, Sweden.	adrianalepur@gmail.com; hakon.leffler@med.lu.se	Nilsson, Ulf J./L-3219-2014; Leffler, Hakon/A-2416-2019	Nilsson, Ulf J./0000-0001-5815-9522; Leffler, Hakon/0000-0003-4482-8945	FP6 project "EuroPharm" [043682]; Swedish Research Council [621-2009-5656, 621-2003-4265]; Swedish Strategic Research Foundation; European Community Seventh Framework Programme [HEALTH-F2-2011-256986 (PANACREAS)]	FP6 project "EuroPharm"; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Strategic Research Foundation(Swedish Foundation for Strategic Research); European Community Seventh Framework Programme(European Commission)	This work was funded by the FP6 project "EuroPharm" Grant 043682 (to A. L.), the Swedish Research Council Grants 621-2009-5656 (to H. L.) and 621-2003-4265 (to U. N.), the program "Chemistry for Life Sciences" sponsored by the Swedish Strategic Research Foundation, and European Community Seventh Framework Programme (FP7-2007-2013) under Grant HEALTH-F2-2011-256986 (PANACREAS).	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Ahmad N, 2004, GLYCOBIOLOGY, V14, P817, DOI 10.1093/glycob/cwh095; Barboni EAM, 1999, GLYCOCONJUGATE J, V16, P365, DOI 10.1023/A:1007004330048; Birdsall B, 2001, BIOCHEMISTRY-US, V40, P4859, DOI 10.1021/bi002907f; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; Dam TK, 2010, GLYCOBIOLOGY, V20, P270, DOI 10.1093/glycob/cwp186; Dam TK, 2005, BIOCHEMISTRY-US, V44, P12564, DOI 10.1021/bi051144z; Delacour D, 2009, TRAFFIC, V10, P1405, DOI 10.1111/j.1600-0854.2009.00960.x; Di Lella S, 2011, BIOCHEMISTRY-US, V50, P7842, DOI 10.1021/bi201121m; HSU DK, 1992, J BIOL CHEM, V267, P14167; Kohatsu L, 2006, J IMMUNOL, V177, P4718, DOI 10.4049/jimmunol.177.7.4718; Kuklinski S, 1998, J NEUROCHEM, V70, P814; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Lepur A, 2012, BBA-GEN SUBJECTS, V1820, P804, DOI 10.1016/j.bbagen.2012.02.018; MASSA SM, 1993, BIOCHEMISTRY-US, V32, P260, DOI 10.1021/bi00052a033; Morris S, 2004, GLYCOBIOLOGY, V14, P293, DOI 10.1093/glycob/cwh029; Newlaczyl AU, 2011, CANCER LETT, V313, P123, DOI 10.1016/j.canlet.2011.09.003; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; OOSAWA F, 1970, J THEOR BIOL, V27, P69, DOI 10.1016/0022-5193(70)90129-3; Paz I, 2010, CELL MICROBIOL, V12, P530, DOI 10.1111/j.1462-5822.2009.01415.x; Salomonsson E, 2010, BIOCHEMISTRY-US, V49, P9518, DOI 10.1021/bi1009584; Salomonsson E, 2010, J BIOL CHEM, V285, P35079, DOI 10.1074/jbc.M109.098160; Shalom-Feuerstein R, 2008, CANCER RES, V68, P6608, DOI 10.1158/0008-5472.CAN-08-1117; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; Yang RY, 1998, BIOCHEMISTRY-US, V37, P4086, DOI 10.1021/bi971409c	25	99	107	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21751	21756		10.1074/jbc.C112.358002	http://dx.doi.org/10.1074/jbc.C112.358002			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22549776	hybrid, Green Published			2022-12-25	WOS:000306418600016
J	Shiratsuchi, A; Mori, T; Sakurai, K; Nagaosa, K; Sekimizu, K; Lee, BL; Nakanishi, Y				Shiratsuchi, Akiko; Mori, Toshinobu; Sakurai, Kenji; Nagaosa, Kaz; Sekimizu, Kazuhisa; Lee, Bok Luel; Nakanishi, Yoshinobu			Independent Recognition of Staphylococcus aureus by Two Receptors for Phagocytosis in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR IMMUNE-RESPONSE; GRAM-NEGATIVE BACTERIA; APOPTOTIC CELLS; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; HOST-DEFENSE; INTEGRINS; INFECTION; IDENTIFICATION; ENGULFMENT	Integrin beta v, one of two beta subunits of Drosophila integrin, acts as a receptor in the phagocytosis of apoptotic cells. We here examined the involvement of this receptor in defense against infection by Staphylococcus aureus. Flies lacking integrin beta v died earlier than control flies upon a septic but not oral infection with this bacterium. A loss of integrin beta v reduced the phagocytosis of S. aureus and increased bacterial growth in flies. In contrast, the level of mRNA of an antimicrobial peptide produced upon infection was unchanged in integrin beta v-lacking flies. The simultaneous loss of integrin beta v and Draper, another receptor involved in the phagocytosis of S. aureus, brought about a further decrease in the level of phagocytosis and accelerated death of flies compared with the loss of either receptor alone. A strain of S. aureus lacking lipoteichoic acid, a cell wall component serving as a ligand for Draper, was susceptible to integrin beta v-mediated phagocytosis. In contrast, a S. aureus mutant strain that produces small amounts of peptidoglycan was less efficiently phagocytosed by larval hemocytes, and a loss of integrin beta v in hemocytes reduced a difference in the susceptibility to phagocytosis between parental and mutant strains. Furthermore, a series of experiments revealed the binding of integrin beta v to peptidoglycan of S. aureus. Taken together, these results suggested that Draper and integrin beta v cooperate in the phagocytic elimination of S. aureus by recognizing distinct cell wall components, and that this dual recognition system is necessary for the host organism to survive infection.	[Shiratsuchi, Akiko; Nagaosa, Kaz; Nakanishi, Yoshinobu] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa 9201192, Japan; [Shiratsuchi, Akiko; Mori, Toshinobu; Nagaosa, Kaz; Nakanishi, Yoshinobu] Kanazawa Univ, Sch Pharm, Kanazawa, Ishikawa 9201192, Japan; [Shiratsuchi, Akiko; Sakurai, Kenji; Nagaosa, Kaz; Nakanishi, Yoshinobu] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Sekimizu, Kazuhisa] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Lee, Bok Luel] Pusan Natl Univ, Coll Pharm, Pusan 609735, South Korea	Kanazawa University; Kanazawa University; Kanazawa University; University of Tokyo; Pusan National University	Shiratsuchi, A (corresponding author), Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	ashira@staff.kanazawa-u.ac.jp; nakanaka@p.kanazawa-u.ac.jp	Nagaosa, Kaz/G-3857-2014; Shiratsuchi, Akiko/D-8391-2015; Nakanishi, Yoshinobu/D-4602-2014	Nagaosa, Kaz/0000-0002-1695-2562; Shiratsuchi, Akiko/0000-0002-7811-4409; Nakanishi, Yoshinobu/0000-0002-8767-3587	Japan Society for the Promotion of Science [20570127, 23570160, 22370049]; Astellas Foundation for Research on Metabolic Disorders; Danone Foundation; Hayashi Memorial Grant for Female Scientists; Kanazawa University; Grants-in-Aid for Scientific Research [22370049] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Astellas Foundation for Research on Metabolic Disorders; Danone Foundation(Danone Nutricia); Hayashi Memorial Grant for Female Scientists; Kanazawa University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (Grant Numbers 20570127 and 23570160, to A. S.; 22370049, to Y. N.), Hayashi Memorial Grant for Female Scientists (to A. S.), a grant from Astellas Foundation for Research on Metabolic Disorders (to A. S.), a grant from Danone Foundation (to A. S.), and an institutional research grant from Kanazawa University (to A. S.).	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Avet-Rochex A, 2005, CELL MICROBIOL, V7, P799, DOI 10.1111/j.1462-5822.2005.00512.x; Avet-Rochex A, 2007, GENES CELLS, V12, P1193, DOI 10.1111/j.1365-2443.2007.01121.x; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Basset A, 2000, P NATL ACAD SCI USA, V97, P3376, DOI 10.1073/pnas.070357597; Bianco A, 2007, NATURE, V448, P362, DOI 10.1038/nature05965; Braun A, 1998, P NATL ACAD SCI USA, V95, P14337, DOI 10.1073/pnas.95.24.14337; Brennan CA, 2007, CURR BIOL, V17, P67, DOI 10.1016/j.cub.2006.11.026; Brower DL, 2003, CURR OPIN CELL BIOL, V15, P607, DOI 10.1016/S0955-0674(03)00102-9; Brown NH, 2000, DEV BIOL, V223, P1, DOI 10.1006/dbio.2000.9711; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Charroux B, 2009, P NATL ACAD SCI USA, V106, P9797, DOI 10.1073/pnas.0903971106; Chung YSA, 2011, J BIOL CHEM, V286, P26524, DOI 10.1074/jbc.M110.214007; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Das S, 2011, P NATL ACAD SCI USA, V108, P2136, DOI 10.1073/pnas.1014775108; Defaye A, 2009, J INNATE IMMUN, V1, P322, DOI 10.1159/000210264; Devenport D, 2004, DEVELOPMENT, V131, P5405, DOI 10.1242/dev.01427; Elrod-Erickson M, 2000, CURR BIOL, V10, P781, DOI 10.1016/S0960-9822(00)00569-8; Fauvarque MO, 2011, J CELL SCI, V124, P1373, DOI 10.1242/jcs.064592; Foley E, 2003, GENE DEV, V17, P115, DOI 10.1101/gad.1018503; Foukas LC, 1998, J BIOL CHEM, V273, P14813, DOI 10.1074/jbc.273.24.14813; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Ha H. M., 2005, SCIENCE         0609, V310, P847; Haine ER, 2008, SCIENCE, V322, P1257, DOI 10.1126/science.1165265; Hashimoto Y, 2009, J IMMUNOL, V183, P7451, DOI 10.4049/jimmunol.0901032; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Irving P, 2005, CELL MICROBIOL, V7, P335, DOI 10.1111/j.1462-5822.2004.00462.x; Khush RS, 2000, TRENDS GENET, V16, P442, DOI 10.1016/S0168-9525(00)02095-3; Kinchen JM, 2007, J CELL SCI, V120, P2143, DOI 10.1242/jcs.03463; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Kuraishi T, 2009, EMBO J, V28, P3868, DOI 10.1038/emboj.2009.343; Kurucz E, 2007, CURR BIOL, V17, P649, DOI 10.1016/j.cub.2007.02.041; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Mamali I, 2009, DEV COMP IMMUNOL, V33, P858, DOI 10.1016/j.dci.2009.02.004; Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200; Moita LF, 2006, INSECT BIOCHEM MOLEC, V36, P282, DOI 10.1016/j.ibmb.2006.01.004; Moita LF, 2005, IMMUNITY, V23, P65, DOI 10.1016/j.immuni.2005.05.006; Mylonakis E, 2005, INFECT IMMUN, V73, P3833, DOI 10.1128/IAI.73.7.3833-3841.2005; Nagaosa K, 2011, J BIOL CHEM, V286, P25770, DOI 10.1074/jbc.M110.204503; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; Nehme NT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014743; Nishida S, 2006, J BIOL CHEM, V281, P1714, DOI 10.1074/jbc.M509277200; Oku Y, 2009, J BACTERIOL, V191, P141, DOI 10.1128/JB.01221-08; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Park JW, 2007, P NATL ACAD SCI USA, V104, P6602, DOI 10.1073/pnas.0610924104; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Strand Michael R., 2008, Insect Science, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Stuart LM, 2008, NAT REV IMMUNOL, V8, P131, DOI 10.1038/nri2240; Williams MJ, 2006, J CELL SCI, V119, P2015, DOI 10.1242/jcs.02920; Williams MJ, 2005, GENES CELLS, V10, P813, DOI 10.1111/j.1365-2443.2005.00883.x; Xavier MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019504; Yu Y, 2010, J BIOL CHEM, V285, P32937, DOI 10.1074/jbc.M110.144014	60	48	53	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21663	21672		10.1074/jbc.M111.333807	http://dx.doi.org/10.1074/jbc.M111.333807			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22547074	hybrid, Green Published			2022-12-25	WOS:000306418600009
J	Icenogle, LM; Hengel, SM; Coye, LH; Streifel, A; Collins, CM; Goodlett, DR; Moseley, SL				Icenogle, Laura M.; Hengel, Shawna M.; Coye, Lisette H.; Streifel, Amber; Collins, Carleen M.; Goodlett, David R.; Moseley, Steve L.			Molecular and Biological Characterization of Streptococcal SpyA-mediated ADP-ribosylation of Intermediate Filament Protein Vimentin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSITION-STATE STRUCTURE; HUMAN NEUTROPHIL PEPTIDE-1; BOTULINUM C3 EXOENZYME; CLOSTRIDIUM-BOTULINUM; PERTUSSIS TOXIN; RIBOSYLTRANSFERASE ACTIVITY; STAPHYLOCOCCUS-AUREUS; PHOSPHORYLATION SITES; FLUOROMETRIC ASSAY; MASS-SPECTROMETRY	The Gram-positive bacterial pathogen Streptococcus pyogenes produces a C3 family ADP-ribosyltransferase designated SpyA (S. pyogenes ADP-ribosyltransferase). Our laboratory has identified a number of eukaryotic protein targets for SpyA, prominent among which are the cytoskeletal proteins actin and vimentin. Because vimentin is an unusual target for modification by bacterial ADP-ribosyltransferases, we quantitatively compared the activity of SpyA on vimentin and actin. Vimentin was the preferred substrate for SpyA (k(cat), 58.5 +/- 3.4 min(-1)) relative to actin (kcat, 10.1 +/- 0.6 min(-1)), and vimentin was modified at a rate 9.48 +/- 1.95-fold greater than actin. We employed tandem mass spectrometry analysis to identify sites of ADP-ribosylation on vimentin. The primary sites of modification were Arg-44 and -49 in the head domain, with several additional secondary sites identified. Because the primary sites are located in a domain of vimentin known to be important for the regulation of polymerization by phosphorylation, we investigated the effects of SpyA activity on vimentin polymerization, utilizing an in vitro NaCl-induced filamentation assay. SpyA inhibited vimentin filamentation, whereas a catalytic site mutant of SpyA had no effect. Additionally, we demonstrated that expression of SpyA in HeLa cells resulted in collapse of the vimentin cytoskeleton, whereas expression in RAW 264.7 cells impeded vimentin reorganization upon stimulation of this macrophage-like cell line with LPS. We conclude that SpyA modification of vimentin occurs in an important regulatory region of the head domain and has significant functional effects on vimentin assembly.	[Icenogle, Laura M.; Coye, Lisette H.; Streifel, Amber; Collins, Carleen M.; Moseley, Steve L.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Hengel, Shawna M.; Goodlett, David R.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Moseley, SL (corresponding author), 1705 NW Pacific St,J257, Seattle, WA 98195 USA.	Moseley@u.washington.edu			National Institutes of Health (NIH) [A1064515, 1U54 AI57141-02]; NIH Pharmacological Sciences Training [T32 GM07750]; NIGMS; National Research Service [GM07270]; University of Washington; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270, T32GM007750] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Pharmacological Sciences Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Research Service; University of Washington(University of Washington); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants A1064515 and 1U54 AI57141-02, NIH Pharmacological Sciences Training Grant T32 GM07750, and NIH, NIGMS, National Research Service Award T32 GM07270. This work was also supported by the University of Washington Proteomics Resource.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; AKTORIES K, 1988, BIOCHEM BIOPH RES CO, V156, P361, DOI 10.1016/S0006-291X(88)80849-0; Aktories K, 2011, FEBS J, V278, P4526, DOI 10.1111/j.1742-4658.2011.08113.x; ANDO S, 1989, BIOCHEMISTRY-US, V28, P2974, DOI 10.1021/bi00433a035; Armstrong S, 2001, ANAL BIOCHEM, V292, P26, DOI 10.1006/abio.2001.5052; Arnoldo A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000005; AULLO P, 1993, EMBO J, V12, P921, DOI 10.1002/j.1460-2075.1993.tb05733.x; Aziz A, 2010, J BIOL CHEM, V285, P15278, DOI 10.1074/jbc.M109.075598; Ballard JD, 1996, P NATL ACAD SCI USA, V93, P12531, DOI 10.1073/pnas.93.22.12531; Benes P, 2006, DIFFERENTIATION, V74, P265, DOI 10.1111/j.1432-0436.2006.00077.x; Bohmer J, 1996, BIOCHEMISTRY-US, V35, P282, DOI 10.1021/bi951784+; Bryant AE, 2006, J INFECT DIS, V193, P1685, DOI 10.1086/504261; Byun Y, 2001, CELL DEATH DIFFER, V8, P443, DOI 10.1038/sj.cdd.4400840; CHARDIN P, 1989, EMBO J, V8, P1087, DOI 10.1002/j.1460-2075.1989.tb03477.x; Chou YH, 1996, J CELL SCI, V109, P817; COBURN J, 1989, INFECT IMMUN, V57, P996, DOI 10.1128/IAI.57.3.996-998.1989; Coulombe PA, 2004, NAT CELL BIOL, V6, P699, DOI 10.1038/ncb0804-699; Coye LH, 2004, MOL MICROBIOL, V54, P89, DOI 10.1111/j.1365-2958.2004.04262.x; Dania N, 2009, P NATL ACAD SCI USA, V106, P4243, DOI 10.1073/pnas.0900066106; Dolan KM, 2000, BIOCHEMISTRY-US, V39, P8266, DOI 10.1021/bi992856q; Eckes B, 1998, J CELL SCI, V111, P1897; Eckes B, 2000, J CELL SCI, V113, P2455; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; FENDRICK JL, 1989, P NATL ACAD SCI USA, V86, P554, DOI 10.1073/pnas.86.2.554; Garg A, 2006, J IMMUNOL, V177, P6192, DOI 10.4049/jimmunol.177.9.6192; GEISLER N, 1989, EUR J BIOCHEM, V183, P441, DOI 10.1111/j.1432-1033.1989.tb14947.x; GEISLER N, 1988, EMBO J, V7, P15, DOI 10.1002/j.1460-2075.1988.tb02778.x; Genth H, 2003, J BIOL CHEM, V278, P28523, DOI 10.1074/jbc.M301915200; Hamilton SM, 2008, J INFECT DIS, V198, P1692, DOI 10.1086/593016; Hengel SM, 2010, RAPID COMMUN MASS SP, V24, P2312, DOI 10.1002/rcm.4600; Hengel SM, 2009, J AM SOC MASS SPECTR, V20, P477, DOI 10.1016/j.jasms.2008.10.025; Herrmann H, 2004, METHOD CELL BIOL, V78, P3; Hochmann H, 2006, BIOCHEMISTRY-US, V45, P1271, DOI 10.1021/bi051810w; Hoff JS, 2011, INFECT IMMUN, V79, P2404, DOI 10.1128/IAI.01191-10; Huang HY, 1996, EXP CELL RES, V226, P147, DOI 10.1006/excr.1996.0213; HUANG HY, 1993, BIOCHEM BIOPH RES CO, V197, P570, DOI 10.1006/bbrc.1993.2517; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Jager D, 2011, MOL CELL BIOCHEM, V348, P125, DOI 10.1007/s11010-010-0646-8; Klebl BM, 1996, ANAL BIOCHEM, V239, P145, DOI 10.1006/abio.1996.0309; Knight DA, 1999, BIOCHEMISTRY-US, V38, P5858, DOI 10.1021/bi982133r; Lee KY, 2012, J CELL PHYSIOL, V227, P739, DOI 10.1002/jcp.22782; Liu XY, 2005, MOL VIS, V11, P1112; Lupi R, 2000, J BIOL CHEM, V275, P9418, DOI 10.1074/jbc.275.13.9418; Lupi R, 2002, BIOCHEM J, V367, P825, DOI 10.1042/BJ20020660; Margarit SM, 2006, STRUCTURE, V14, P1219, DOI 10.1016/j.str.2006.05.022; Martin Judith M, 2006, Semin Pediatr Infect Dis, V17, P140, DOI 10.1053/j.spid.2006.07.001; Minin AA, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1453, DOI 10.1134/S0006297908130063; Miyaoka T, 1996, J BIOCHEM-TOKYO, V119, P200; Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb898; Murli S, 2001, CELL MICROBIOL, V3, P795, DOI 10.1046/j.1462-5822.2001.00158.x; Nagahama M, 2000, J BACTERIOL, V182, P2096, DOI 10.1128/JB.182.8.2096-2103.2000; Nery FC, 2008, J CELL SCI, V121, P3476, DOI 10.1242/jcs.029454; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; OGAWARA M, 1995, J CELL BIOL, V131, P1055, DOI 10.1083/jcb.131.4.1055; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Pallari Hanna-Mari, 2006, Sci STKE, V2006, ppe53, DOI 10.1126/stke.3662006pe53; Paone G, 2002, P NATL ACAD SCI USA, V99, P8231, DOI 10.1073/pnas.122238899; Paone G, 2006, J BIOL CHEM, V281, P17054, DOI 10.1074/jbc.M603042200; Parikh SL, 2004, BIOCHEMISTRY-US, V43, P1204, DOI 10.1021/bi035907z; PATERSON HF, 1990, J CELL BIOL, V111, P1001, DOI 10.1083/jcb.111.3.1001; Perieteanu AA, 2010, BIOCHEMISTRY-US, V49, P8944, DOI 10.1021/bi1008062; Pryzwansky KB, 1998, MOL BIOL CELL, V9, P2933, DOI 10.1091/mbc.9.10.2933; Scheuring J, 1997, BIOCHEMISTRY-US, V36, P8215, DOI 10.1021/bi970379a; Scheuring J, 1998, BIOCHEMISTRY-US, V37, P2748, DOI 10.1021/bi972594x; Schietke R, 2006, EUR J CELL BIOL, V85, P1, DOI 10.1016/j.ejcb.2005.09.019; Styers ML, 2005, TRAFFIC, V6, P359, DOI 10.1111/j.1600-0854.2005.00286.x; TSUJIMURA K, 1994, J BIOL CHEM, V269, P31097; TSURU A, 1990, J CELL BIOL, V110, P1655, DOI 10.1083/jcb.110.5.1655; Visschedyk DD, 2010, J BIOL CHEM, V285, P13525, DOI 10.1074/jbc.M109.077339; Vogelsgesang M, 2006, BIOCHEMISTRY-US, V45, P1017, DOI 10.1021/bi052253g; WEGNER A, 1988, J BIOL CHEM, V263, P13739; WEIGT C, 1989, FEBS LETT, V246, P181, DOI 10.1016/0014-5793(89)80279-0; WIEGERS W, 1991, EUR J CELL BIOL, V54, P237; Wilde C, 2003, BIOCHEMISTRY-US, V42, P9694, DOI 10.1021/bi034583b; Wilde C, 2002, BIOCHEMISTRY-US, V41, P1539, DOI 10.1021/bi015809i; Wilde C, 2002, TRENDS MICROBIOL, V10, P5, DOI 10.1016/S0966-842X(01)02281-8; Wilde C, 2001, J BIOL CHEM, V276, P9537, DOI 10.1074/jbc.M011035200; Wilde C, 2001, TOXICON, V39, P1647, DOI 10.1016/S0041-0101(01)00152-0; WILSON BA, 1990, BIOCHEMISTRY-US, V29, P8643, DOI 10.1021/bi00489a021; Yi EC, 2003, RAPID COMMUN MASS SP, V17, P2093, DOI 10.1002/rcm.1150; Yuan J, 1999, ARCH BIOCHEM BIOPHYS, V363, P314, DOI 10.1006/abbi.1998.1096; Zhou H, 1996, ARCH BIOCHEM BIOPHYS, V334, P214, DOI 10.1006/abbi.1996.0449	83	21	22	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21481	21491		10.1074/jbc.M112.370791	http://dx.doi.org/10.1074/jbc.M112.370791			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22549780	Green Published, hybrid			2022-12-25	WOS:000306416800065
J	Kumar, A; Paslay, LC; Lyons, D; Morgan, SE; Correia, JJ; Rangachari, V				Kumar, Amit; Paslay, Lea C.; Lyons, Daniel; Morgan, Sarah E.; Correia, John J.; Rangachari, Vijayaraghavan			Specific Soluble Oligomers of Amyloid-beta Peptide Undergo Replication and Form Non-fibrillar Aggregates in Interfacial Environments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; PRION PROTEIN; CYCLIC AMPLIFICATION; PATHWAYS; PROTOFIBRILS; CONFORMATION; MEMORY; TRANSMISSION; ASSOCIATION; STRAINS	Aggregates of amyloid-beta (A beta) peptides have been implicated in the etiology of Alzheimer disease. Among the different forms of A beta aggregates, low molecular weight species ranging between similar to 2- and 50-mers, also called "soluble oligomers," have emerged as the species responsible for early synaptic dysfunction and neuronal loss. Emerging evidence suggests that the neurotoxic oligomers need not be formed along the obligatory nucleation-dependant fibril formation pathway. In our earlier work, we reported the isolation of one such " off-pathway" 12-18-mer species of A beta 42 generated from fatty acids called large fatty acid-derived oligomers (LFAOs) (Kumar, A., Bullard, R. L., Patel, P., Paslay, L. C., Singh, D., Bienkiewicz, E. A., Morgan, S. E., and Rangachari, V. (2011) PLoS One 6, e18759). Here, we report the physiochemical aspects of LFAO-monomer interactions as well as LFAO-LFAO associations in the presence of interfaces. We discovered that LFAOs are a replicating strain of oligomers that recruit A beta 42 monomers and quantitatively convert them into LFAO assemblies at the expense of fibrils, a mechanism similar to prion propagation. We also found that in the presence of hexane-buffer or chloroform-buffer interfaces LFAOs are able to associate with themselves to form larger but non-fibrillar aggregates. These results further support the hypothesis that low molecular weight oligomers can be generated via non-fibril formation pathways. Furthermore, the unique replicating property of off-pathway oligomers may hold profound significance for Alzheimer disease pathology.	[Kumar, Amit; Rangachari, Vijayaraghavan] Univ So Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA; [Paslay, Lea C.; Morgan, Sarah E.] Univ So Mississippi, Sch Polymers & High Performance Mat, Hattiesburg, MS 39406 USA; [Lyons, Daniel; Correia, John J.] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA	University of Southern Mississippi; University of Southern Mississippi; University of Mississippi; University of Mississippi Medical Center	Rangachari, V (corresponding author), Univ So Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA.	vijay.rangachari@usm.edu	Kumar, Amit/E-8052-2018; Rangachari, vijay/K-1420-2015	Kumar, Amit/0000-0001-7669-0712; 	National Institutes of Health; National Center for Research Resources [5P20RR016476-11]; NIGMS through the Mississippi IDeA Network of Biomedical Research Excellence [8 P20 GM103476-11]; American Heart Association [10GRNT4190124]; National Science Foundation [1040372]; United States Department of Education Graduate Assistance in Areas of National Need Fellowship Program Award [P200A090066]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER; Direct For Biological Sciences [0959211] Funding Source: National Science Foundation; Direct For Computer & Info Scie & Enginr [1158608] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS through the Mississippi IDeA Network of Biomedical Research Excellence; American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); United States Department of Education Graduate Assistance in Areas of National Need Fellowship Program Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported, in whole or in part, by National Institutes of Health evident from many recent reports that there are alternative Grants 5P20RR016476-11 from the National Center for Research Resources and 8 P20 GM103476-11 from the NIGMS through the Mississippi IDeA Network of Biomedical Research Excellence. This work was also supported by American Heart Association Grant 10GRNT4190124 (to V. R.), National Science Foundation Major Research Instrumentation Grant 1040372 (to J. C. and V. R.), and United States Department of Education Graduate Assistance in Areas of National Need Fellowship Program Award P200A090066.	Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Cordeiro Y, 2004, J BIOL CHEM, V279, P5346, DOI 10.1074/jbc.M312262200; DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Gellermann GP, 2008, NEUROBIOL DIS, V30, P212, DOI 10.1016/j.nbd.2008.01.010; Ghosh P., 2010, P 1 ACM INT C BIOINF, P451; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Goldsbury C, 2005, J MOL BIOL, V352, P282, DOI 10.1016/j.jmb.2005.07.029; Gorman PM, 2003, J MOL BIOL, V325, P743, DOI 10.1016/S0022-2836(02)01279-2; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Huang THJ, 2000, J BIOL CHEM, V275, P36436, DOI 10.1074/jbc.M005698200; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-57; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Kumar A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018759, 10.1371/journal.pone.0026520, 10.1371/journal.pone.0020701]; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lasagna-Reeves CA, 2011, J BIOL CHEM, V286, P22122, DOI 10.1074/jbc.M111.236257; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Nichols MR, 2005, MICROSC RES TECHNIQ, V67, P164, DOI 10.1002/jemt.20189; Nichols MR, 2005, BIOCHEMISTRY-US, V44, P165, DOI 10.1021/bi048846t; Nichols MR, 2002, BIOCHEMISTRY-US, V41, P6115, DOI 10.1021/bi015985r; Philo JS, 2006, ANAL BIOCHEM, V354, P238, DOI 10.1016/j.ab.2006.04.053; Rangachari V, 2007, BIOCHEMISTRY-US, V46, P12451, DOI 10.1021/bi701213s; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shao WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028784; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008	39	35	35	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21253	21264		10.1074/jbc.M112.355156	http://dx.doi.org/10.1074/jbc.M112.355156			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22544746	Green Published, hybrid			2022-12-25	WOS:000306416800045
J	McClure, JM; Wierman, MB; Maqani, N; Smith, JS				McClure, Julie M.; Wierman, Margaret B.; Maqani, Nazif; Smith, Jeffrey S.			Isonicotinamide Enhances Sir2 Protein-mediated Silencing and Longevity in Yeast by Raising Intracellular NAD(+) Concentration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFE-SPAN EXTENSION; SMALL-MOLECULE ACTIVATORS; SACCHAROMYCES-CEREVISIAE; NICOTINAMIDE RIBOSIDE; CALORIE RESTRICTION; SALVAGE PATHWAY; INSULIN-SECRETION; GENE DISRUPTION; CELL-SURVIVAL; RDNA	Sirtuins are an evolutionarily conserved family of NAD(+)-dependent protein deacetylases that function in the regulation of gene transcription, cellular metabolism, and aging. Their activity requires the maintenance of an adequate intracellular NAD(+) concentration through the combined action of NAD(+) biosynthesis and salvage pathways. Nicotinamide (NAM) is a key NAD(+) precursor that is also a byproduct and feedback inhibitor of the deacetylation reaction. In Saccharomyces cerevisiae, the nicotinamidase Pnc1 converts NAM to nicotinic acid (NA), which is then used as a substrate by the NAD(+) salvage pathway enzyme NA phosphoribosyltransferase (Npt1). Isonicotinamide (INAM) is an isostere of NAM that stimulates yeast Sir2 deacetylase activity in vitro by alleviating the NAM inhibition. In this study, we determined that INAM stimulates Sir2 through an additional mechanism in vivo, which involves elevation of the intracellular NAD(+) concentration. INAM enhanced normal silencing at the rDNA locus but only partially suppressed the silencing defects of an npt1 Delta mutant. Yeast cells grown in media lacking NA had a short replicative life span, which was extended by INAM in a SIR2-dependent manner and correlated with increased NAD(+). The INAM-induced increase in NAD(+) was strongly dependent on Pnc1 and Npt1, suggesting that INAM increases flux through the NAD(+) salvage pathway. Part of this effect was mediated by the NR salvage pathways, which generate NAM as a product and require Pnc1 to produce NAD(+). We also provide evidence suggesting that INAM influences the expression of multiple NAD(+) biosynthesis and salvage pathways to promote homeostasis during stationary phase.	[McClure, Julie M.; Wierman, Margaret B.; Maqani, Nazif; Smith, Jeffrey S.] Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Sch Med, Charlottesville, VA 22908 USA	University of Virginia	Smith, JS (corresponding author), Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Sch Med, Jordan Hall,Box 800733, Charlottesville, VA 22908 USA.	jss5y@virginia.edu			National Institutes of Health [GM075240, AG022685, GM008136]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants GM075240 and AG022685 (to J. S. S.) and Training Grant GM008136 (to J. M. M.).	Sorolla MA, 2011, ARCH BIOCHEM BIOPHYS, V510, P27, DOI 10.1016/j.abb.2011.04.002; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Ausubel F. M., 2000, CURR PROTOC MOL BIOL, V2; Balan V, 2008, J BIOL CHEM, V283, P27810, DOI 10.1074/jbc.M804681200; Bedalov A, 2001, P NATL ACAD SCI USA, V98, P15113, DOI 10.1073/pnas.261574398; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Belenky PA, 2008, J BIOL CHEM, V283, P8075, DOI 10.1074/jbc.C800021200; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Bogan KL, 2009, J BIOL CHEM, V284, P34861, DOI 10.1074/jbc.M109.056689; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Brachmann CB, 1998, YEAST, V14, P115; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; Buck SW, 2002, CELL, V111, P1003, DOI 10.1016/S0092-8674(02)01193-5; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; French JB, 2010, BIOCHEMISTRY-US, V49, P10421, DOI 10.1021/bi1012518; Fritze CE, 1997, EMBO J, V16, P6495, DOI 10.1093/emboj/16.21.6495; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Ghislain M, 2002, YEAST, V19, P215, DOI 10.1002/yea.810; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hara N, 2003, J BIOL CHEM, V278, P10914, DOI 10.1074/jbc.M209203200; Hickman MA, 2007, PLOS GENET, V3, P1325, DOI 10.1371/journal.pgen.0030126; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Jiang JC, 2000, FASEB J, V14, P2135; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kucharczyk R, 1998, FEBS LETT, V424, P127, DOI 10.1016/S0014-5793(98)00153-7; Li Y, 2009, EUR J PHARMACOL, V609, P13, DOI 10.1016/j.ejphar.2009.03.004; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; LORENZ MC, 1995, GENE, V158, P113, DOI 10.1016/0378-1119(95)00144-U; Lu SP, 2009, J BIOL CHEM, V284, P17110, DOI 10.1074/jbc.M109.004010; McClure JM, 2008, GENETICS, V180, P797, DOI 10.1534/genetics.108.091090; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; Obrenovich ME, 2010, REJUV RES, V13, P631, DOI 10.1089/rej.2010.1043; Ogata S, 2000, BIOSCI BIOTECH BIOCH, V64, P327, DOI 10.1271/bbb.64.327; PREISS J, 1958, J BIOL CHEM, V233, P488; Rajavel M, 1998, BIOCHEMISTRY-US, V37, P4181, DOI 10.1021/bi9720134; Ramsey KM, 2008, AGING CELL, V7, P78, DOI 10.1111/j.1474-9726.2007.00355.x; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; RINE J, 1987, GENETICS, V116, P9; Sandmeier JJ, 2002, GENETICS, V160, P877; Sauve AA, 2005, MOL CELL, V17, P595, DOI 10.1016/j.molcel.2004.12.032; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smith DL, 2009, AGING CELL, V8, P633, DOI 10.1111/j.1474-9726.2009.00516.x; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Smith JS, 1998, GENETICS, V149, P1205; SU S, 1969, J BIOL CHEM, V244, P2956; SUSSEL L, 1991, P NATL ACAD SCI USA, V88, P7749, DOI 10.1073/pnas.88.17.7749; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Vrablik TL, 2009, DEVELOPMENT, V136, P3637, DOI 10.1242/dev.028431; Wang GD, 2007, PLANT J, V49, P1020, DOI 10.1111/j.1365-313X.2006.03013.x; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yang HY, 2007, AGING CELL, V6, P35, DOI 10.1111/j.1474-9726.2006.00259.x; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014	64	22	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20957	20966		10.1074/jbc.M112.367524	http://dx.doi.org/10.1074/jbc.M112.367524			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22539348	hybrid, Green Published			2022-12-25	WOS:000306416800017
J	Petkau, G; Wingen, C; Jussen, LCA; Radtke, T; Behr, M				Petkau, Georg; Wingen, Christian; Jussen, Laura C. A.; Radtke, Tina; Behr, Matthias			Obstructor-A Is Required for Epithelial Extracellular Matrix Dynamics, Exoskeleton Function, and Tubulogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEPTATE JUNCTIONS; AIRWAY CLEARANCE; DROSOPHILA; CHITIN; FAMILY; GENE; KNICKKOPF; PROTEINS; INSECTS; MEMBER	The epidermis and internal tubular organs, such as gut and lungs, are exposed to a hostile environment. They form an extracellular matrix to provide epithelial integrity and to prevent contact with pathogens and toxins. In arthropods, the cuticle protects, shapes, and enables the functioning of organs. During development, cuticle matrix is shielded from premature degradation; however, underlying molecular mechanisms are poorly understood. Previously, we identified the conserved obstructor multigene-family, which encodes chitin-binding proteins. Here we show that Obstructor-A is required for extracellular matrix dynamics in cuticle forming organs. Loss of obstructor-A causes severe defects during cuticle molting, wound protection, tube expansion and larval growth control. We found that Obstructor-A interacts and forms a core complex with the polysaccharide chitin, the cuticle modifier Knickkopf and the chitin deacetylase Serpentine. Knickkopf protects chitin from chitinase-dependent degradation and deacetylase enzymes ensure extracellular matrix maturation. We provide evidence that Obstructor-A is required to control the presence of Knickkopf and Serpentine in the extracellular matrix. We propose a model suggesting that Obstructor-A coordinates the core complex for extracellular matrix protection from premature degradation. This mechanism enables exoskeletal molting, tube expansion, and epithelial integrity. The evolutionary conservation suggests a common role of Obstructor-A and homologs in coordinating extracellular matrix protection in epithelial tissues of chitinous invertebrates.	[Petkau, Georg; Wingen, Christian; Jussen, Laura C. A.; Radtke, Tina; Behr, Matthias] Univ Bonn, Lab Mol Dev Biol, Life & Med Sci Inst LIMES, D-53115 Bonn, Germany	University of Bonn	Behr, M (corresponding author), Univ Bonn, Lab Mol Dev Biol, Life & Med Sci Inst LIMES, Carl Troll Str 31, D-53115 Bonn, Germany.	mbehr@uni-bonn.de	Behr, Matthias/K-6505-2019	Behr, Matthias/0000-0001-9869-1257; Petkau, Georg/0000-0002-6687-2667	German Research Foundation (Deutsche Forschungsgemeinschaft) [SFB645]; Boehringer Ingelheim Fonds	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	This work was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, SFB645) (to M. B.) and by the Boehringer Ingelheim Fonds (to C. W.).	Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498; Bauer R, 2002, J CELL SCI, V115, P1859; Behr M, 2003, DEV CELL, V5, P611, DOI 10.1016/S1534-5807(03)00275-2; Behr M, 2005, FEBS LETT, V579, P6827, DOI 10.1016/j.febslet.2005.11.021; Behr M, 2007, NAT CELL BIOL, V9, P847, DOI 10.1038/ncb1611; Behr M, 2010, RESP PHYSIOL NEUROBI, V173, pS33, DOI 10.1016/j.resp.2010.04.011; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Casanova J, 2007, EMBO REP, V8, P335, DOI 10.1038/sj.embor.7400942; CHANG ES, 1993, ANNU REV ENTOMOL, V38, P161, DOI 10.1146/annurev.en.38.010193.001113; Chaudhari SS, 2011, P NATL ACAD SCI USA, V108, P17028, DOI 10.1073/pnas.1112288108; Chavoshi TM, 2010, MECH DEVELOP, V127, P308, DOI 10.1016/j.mod.2010.01.003; Dixit R, 2008, INSECT BIOCHEM MOLEC, V38, P440, DOI 10.1016/j.ibmb.2007.12.002; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; Guan X, 2006, P NATL ACAD SCI USA, V103, P16794, DOI 10.1073/pnas.0607616103; Jasrapuria S, 2010, INSECT BIOCHEM MOLEC, V40, P214, DOI 10.1016/j.ibmb.2010.01.011; Lamb RS, 1998, MOL BIOL CELL, V9, P3505, DOI 10.1091/mbc.9.12.3505; Li TR, 2000, DEVELOPMENT, V127, P2897; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Moussian B, 2006, DEVELOPMENT, V133, P163, DOI 10.1242/dev.02177; Moussian B, 2010, INSECT BIOCHEM MOLEC, V40, P363, DOI 10.1016/j.ibmb.2010.03.003; Nisole A, 2010, J INSECT PHYSIOL, V56, P1427, DOI 10.1016/j.jinsphys.2009.12.006; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Stumpges B, 2011, FEBS LETT, V585, P3316, DOI 10.1016/j.febslet.2011.09.018; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012; Tsarouhas V, 2007, DEV CELL, V13, P214, DOI 10.1016/j.devcel.2007.06.008; Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074; Wingen C, 2009, GENE EXPR PATTERNS, V9, P549, DOI 10.1016/j.gep.2009.06.007; Zhu QS, 2008, P NATL ACAD SCI USA, V105, P6650, DOI 10.1073/pnas.0800739105	30	68	75	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21396	21405		10.1074/jbc.M112.359984	http://dx.doi.org/10.1074/jbc.M112.359984			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22544743	hybrid, Green Published			2022-12-25	WOS:000306416800057
J	Wu, CC; Naveen, V; Chien, CH; Chang, YW; Hsiao, CD				Wu, Ching-Chung; Naveen, Vankadari; Chien, Chin-Hsiang; Chang, Yi-Wei; Hsiao, Chwan-Deng			Crystal Structure of DnaK Protein Complexed with Nucleotide Exchange Factor GrpE in DnaK Chaperone System INSIGHT INTO INTERMOLECULAR COMMUNICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MOLECULAR CHAPERONES; SUBSTRATE-BINDING; HSP70 CHAPERONES; DOMAIN; GENE; GROWTH; CONFORMATION; TEMPERATURES; AGGREGATION	The conserved, ATP-dependent bacterial DnaK chaperones process client substrates with the aid of the co-chaperones DnaJ and GrpE. However, in the absence of structural information, how these proteins communicate with each other cannot be fully delineated. For the study reported here, we solved the crystal structure of a full-length Geobacillus kaustophilus HTA426 GrpE homodimer in complex with a nearly full-length G. kaustophilus HTA426 DnaK that contains the interdomain linker (acting as a pseudo-substrate), and the N-terminal nucleotide-binding and C-terminal substrate-binding domains at 4.1-angstrom resolution. Each complex contains two DnaKs and two GrpEs, which is a stoichiometry that has not been found before. The long N-terminal GrpE alpha-helices stabilize the linker of DnaK in the complex. Furthermore, interactions between the DnaK substrate-binding domain and the N-terminal disordered region of GrpE may accelerate substrate release from DnaK. These findings provide molecular mechanisms for substrate binding, processing, and release during the Hsp70 chaperone cycle.	Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Wu, Ching-Chung; Naveen, Vankadari; Chang, Yi-Wei; Hsiao, Chwan-Deng] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; [Naveen, Vankadari] Natl Def Med Ctr, Grad Inst Life Sci, Taiwan Int Grad Program, Taipei 115, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Defense Medical Center		chiench@ym.edu.tw; hsiao@gate.sinica.edu.tw	Hsiao, Chwan-Deng/D-7327-2013; Chang, Yi-Wei/ABH-1418-2020; Hsiao, Chwan-Deng/AAZ-8869-2021; Vankadari, Naveen/AAE-7381-2020	Chang, Yi-Wei/0000-0003-2391-473X; Hsiao, Chwan-Deng/0000-0002-7012-1532; Vankadari, Naveen/0000-0001-9363-080X	Academia Sinica [NSC98-2311-B-001-010-MY3]; National Science Council Taiwan, Republic of China	Academia Sinica(Academia Sinica - Taiwan); National Science Council Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by Research Grant NSC98-2311-B-001-010-MY3 from Academia Sinica and the National Science Council Taiwan, Republic of China (to C.-D. H.).	ANG D, 1986, J BACTERIOL, V167, P25, DOI 10.1128/jb.167.1.25-29.1986; ANG D, 1989, J BACTERIOL, V171, P2748, DOI 10.1128/jb.171.5.2748-2755.1989; Arnau J, 1996, MICROBIOL-UK, V142, P1685, DOI 10.1099/13500872-142-7-1685; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Bogdanov M, 1996, J BIOL CHEM, V271, P11615, DOI 10.1074/jbc.271.20.11615; Brehmer D, 2004, J BIOL CHEM, V279, P27957, DOI 10.1074/jbc.M403558200; Chang YW, 2008, J BIOL CHEM, V283, P15502, DOI 10.1074/jbc.M708992200; Chesnokova LS, 2003, BIOCHEMISTRY-US, V42, P9028, DOI 10.1021/bi0346493; Chou CC, 2003, J BIOL CHEM, V278, P30311, DOI 10.1074/jbc.M304563200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DEMACARIO EC, 1995, J BACTERIOL, V177, P544; Gestwicki JE, 2004, SCIENCE, V306, P865, DOI 10.1126/science.1101262; Grimshaw JPA, 2005, J MOL BIOL, V353, P888, DOI 10.1016/j.jmb.2005.08.069; Han WJ, 2001, FEBS LETT, V497, P55, DOI 10.1016/S0014-5793(01)02435-8; Harrison C, 2003, CELL STRESS CHAPERON, V8, P218, DOI 10.1379/1466-1268(2003)008<0218:GANEFF>2.0.CO;2; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Jinwal UK, 2009, J NEUROSCI, V29, P12079, DOI 10.1523/JNEUROSCI.3345-09.2009; Kumar DP, 2011, J MOL BIOL, V411, P1099, DOI 10.1016/j.jmb.2011.07.001; Liu Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000931; Mally A, 2001, NAT STRUCT BIOL, V8, P254, DOI 10.1038/85002; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Meimaridou E, 2009, J MOL ENDOCRINOL, V42, P1, DOI 10.1677/JME-08-0116; Moro F, 2007, J MOL BIOL, V374, P1054, DOI 10.1016/j.jmb.2007.10.002; Nakamura A, 2010, J MOL BIOL, V396, P1000, DOI 10.1016/j.jmb.2009.12.028; Novoselova TV, 2005, J NEUROCHEM, V94, P597, DOI 10.1111/j.1471-4159.2005.03119.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Raviol H, 2006, FEBS LETT, V580, P168, DOI 10.1016/j.febslet.2005.11.069; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; Su PH, 2010, PLANT CELL, V22, P1516, DOI 10.1105/tpc.109.071415; Wisniewska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008625; Yamamoto N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.92; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	42	31	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21461	21470		10.1074/jbc.M112.344358	http://dx.doi.org/10.1074/jbc.M112.344358			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22544739	hybrid, Green Published			2022-12-25	WOS:000306416800063
J	Dou, YC; Wang, J; Yang, JL; Zhang, C				Dou, Yongchao; Wang, Jun; Yang, Jialiang; Zhang, Chi			L1pred: A Sequence-Based Prediction Tool for Catalytic Residues in Enzymes with the L1-logreg Classifier	PLOS ONE			English	Article							FUNCTIONALLY IMPORTANT RESIDUES; EVOLUTIONARY CONSERVATION; PROTEIN-SEQUENCE; ENTROPY; IDENTIFICATION; SELECTION; ACCURATE; CONSURF; SITES	To understand enzyme functions, identifying the catalytic residues is a usual first step. Moreover, knowledge about catalytic residues is also useful for protein engineering and drug-design. However, to experimentally identify catalytic residues remains challenging for reasons of time and cost. Therefore, computational methods have been explored to predict catalytic residues. Here, we developed a new algorithm, L1pred, for catalytic residue prediction, by using the L1-logreg classifier to integrate eight sequence-based scoring functions. We tested L1pred and compared it against several existing sequence-based methods on carefully designed datasets Data604 and Data63. With ten-fold cross-validation, L1pred showed the area under precision-recall curve (AUPR) and the area under ROC curve (AUC) of 0.2198 and 0.9494 on the training dataset, Data604, respectively. In addition, on the independent test dataset, Data63, it showed the AUPR and AUC values of 0.2636 and 0.9375, respectively. Compared with other sequence-based methods, L1pred showed the best performance on both datasets. We also analyzed the importance of each attribute in the algorithm, and found that all the scores contributed more or less equally to the L1pred performance.	[Dou, Yongchao; Zhang, Chi] Univ Nebraska, Sch Biol Sci, Ctr Plant Sci & Innovat, Lincoln, NE 68508 USA; [Wang, Jun] Sci Comp Key Lab Shanghai Univ, Shanghai, Peoples R China; [Wang, Jun] Shanghai Normal Univ, Dept Math, Shanghai, Peoples R China; [Yang, Jialiang] Chinese Acad Sci, MPI Inst Computat Biol, Shanghai, Peoples R China	University of Nebraska System; University of Nebraska Lincoln; Shanghai Key Laboratory of Scalable Computing & System; Shanghai Normal University; Chinese Academy of Sciences; Max Planck Society	Dou, YC (corresponding author), Univ Nebraska, Sch Biol Sci, Ctr Plant Sci & Innovat, Lincoln, NE 68508 USA.	czhang5@unl.edu	Zhang, Chi/C-4996-2009	Zhang, Chi/0000-0002-1827-8137; Yang, Jialiang/0000-0003-4689-8672	National Natural Science Foundation of China [10731040]; Shanghai Leading Academic Discipline Project [S30405]; Innovation Program of Shanghai Municipal Education Commission [09zz134]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission)	This work was partially supported by the National Natural Science Foundation of China (No. 10731040), Shanghai Leading Academic Discipline Project (No. S30405) and Innovation Program of Shanghai Municipal Education Commission (No. 09zz134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahmad S, 2003, BIOINFORMATICS, V19, P1849, DOI 10.1093/bioinformatics/btg249; Alterovitz R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-197; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Bartlett GJ, 2002, J MOL BIOL, V324, P105, DOI 10.1016/S0022-2836(02)01036-7; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brylinski M, 2007, PLOS COMPUT BIOL, V3, P909, DOI 10.1371/journal.pcbi.0030094; Caffrey DR, 2004, PROTEIN SCI, V13, P190, DOI 10.1110/ps.03323604; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Chea E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-153; Cilia E, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-115; Dou YC, 2010, AMINO ACIDS, V39, P1353, DOI 10.1007/s00726-010-0587-2; Dou YC, 2010, J THEOR BIOL, V262, P317, DOI 10.1016/j.jtbi.2009.09.030; Dou YC, 2009, PROTEIN J, V28, P29, DOI 10.1007/s10930-008-9161-0; Dukka BKC, 2008, BIOINFORMATICS, V24, P2308, DOI 10.1093/bioinformatics/btn454; Fischer JD, 2008, BIOINFORMATICS, V24, P613, DOI 10.1093/bioinformatics/btm626; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gong S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000179; Greenshtein E, 2004, BERNOULLI, V10, P971, DOI 10.3150/bj/1106314846; Gutteridge A, 2003, J MOL BIOL, V330, P719, DOI 10.1016/S0022-2836(03)00515-1; Innis CA, 2003, J MOL BIOL, V337, P053; Kato T, 2010, BIOINFORMATICS, V26, P2698, DOI 10.1093/bioinformatics/btq519; Koh KM, 2007, J MACH LEARN RES, V8, P1519; La D, 2005, PROTEINS, V58, P309, DOI 10.1002/prot.20321; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Liu XS, 2008, AMINO ACIDS, V34, P643, DOI 10.1007/s00726-007-0017-2; Liu ZP, 2010, BIOINFORMATICS, V26, P1616, DOI 10.1093/bioinformatics/btq253; Lopez G, 2007, NUCLEIC ACIDS RES, V35, pW573, DOI 10.1093/nar/gkm297; Buslje CM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000978; Mayrose I, 2004, MOL BIOL EVOL, V21, P1781, DOI 10.1093/molbev/msh194; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mesa AD, 2003, J MOL BIOL, V326, P1289, DOI 10.1016/S0022-2836(02)01451-1; Mihalek I, 2004, J MOL BIOL, V336, P1265, DOI 10.1016/j.jmb.2003.12.078; Mirny LA, 1999, J MOL BIOL, V291, P177, DOI 10.1006/jmbi.1999.2911; Panchenko AR, 2004, PROTEIN SCI, V13, P884, DOI 10.1110/ps.03465504; Pande S, 2007, 2007 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, P247; Pei JM, 2001, BIOINFORMATICS, V17, P700, DOI 10.1093/bioinformatics/17.8.700; Petrova NV, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-312; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Sankararaman S, 2008, BIOINFORMATICS, V24, P2445, DOI 10.1093/bioinformatics/btn474; Sankararaman S, 2010, BIOINFORMATICS, V26, P617, DOI 10.1093/bioinformatics/btq008; Sterner B, 2007, J COMPUT BIOL, V14, P1058, DOI 10.1089/cmb.2007.0042; SWEET RM, 1983, J MOL BIOL, V171, P479, DOI 10.1016/0022-2836(83)90041-4; Tang YR, 2008, PROTEIN ENG DES SEL, V21, P295, DOI 10.1093/protein/gzn003; TAYLOR WR, 1986, J THEOR BIOL, V119, P205, DOI 10.1016/S0022-5193(86)80075-3; Tong WX, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000266; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; van de Geer SA, 2008, ANN STAT, V36, P614, DOI 10.1214/009053607000000929; Vergara IA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-265; Wang K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-385; WILLIAMSON R, 1995, J THEOR BIOL, V24, P908; Ye K, 2008, BIOINFORMATICS, V24, P908, DOI 10.1093/bioinformatics/btn057; Youn E, 2007, PROTEIN SCI, V16, P216, DOI 10.1110/ps.062523907; Zhang SW, 2008, AMINO ACIDS, V35, P495, DOI 10.1007/s00726-007-0586-0; Zhang T, 2008, BIOINFORMATICS, V24, P2329, DOI 10.1093/bioinformatics/btn433; Zhao P, 2006, J MACH LEARN RES, V7, P2541	57	18	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35666	10.1371/journal.pone.0035666	http://dx.doi.org/10.1371/journal.pone.0035666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558194	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000045
J	Kim, SE; Kim, JH; Min, BH; Bae, YM; Hong, ST; Choi, MH				Kim, Sung Eun; Kim, Jae-Hwan; Min, Byung-Hoon; Bae, Young Mee; Hong, Sung-Tae; Choi, Min-Ho			Crude Extracts of Caenorhabditis elegans Suppress Airway Inflammation in a Murine Model of Allergic Asthma	PLOS ONE			English	Article							TRICHURIS-SUIS THERAPY; IFN-GAMMA; PARASITE INFECTION; HELMINTH INFECTION; CONTROLLED-TRIAL; ASCARIS-SUUM; RESPONSES; DISEASE; ATOPY; MICE	Epidemiological studies suggest an inverse relationship between helminth infections and allergic disease, and several helminth-derived products have been shown to suppress allergic responses in animals. This study was undertaken to evaluate the effect of a crude extract of Caenorhabditis elegans on allergic airway inflammation in a murine model of asthma. Allergic airway inflammation was induced in BALB/c mice by sensitization with ovalbumin. The effect of the C. elegans crude extract on the development of asthma and on established asthma was evaluated by analyzing airway hyperresponsiveness, serum antibody titers, lung histology and cell counts and cytokine levels in the bronchoalveolar lavage fluid. The role of IFN-gamma in the suppression of asthma by the C. elegans crude extract was investigated in IFN-gamma knockout and wild-type mice. When mice were sensitized with ovalbumin together with the crude extract of C. elegans, cellular infiltration into the lung was dramatically reduced in comparison with the ovalbumin-treated group. Treatment of mice with the C. elegans crude extract significantly decreased methacholine-induced airway hyperresponsiveness and the total cell counts and levels of IL-4, IL-5 and IL-13 in the bronchoalveolar lavage fluid but increased the levels of IFN-gamma and IL-12. Sensitization with the C. elegans crude extract significantly diminished the IgE and IgG1 responses but provoked elevated IgG2a levels. However, the suppressive effect of the C. elegans crude extract was abolished in IFN-gamma knockout mice, and the Th2 responses in these mice were as strong as those in wild-type mice sensitized with ovalbumin. The crude extract of C. elegans also suppressed the airway inflammation associated with established asthma. This study provides new insights into immune modulation by the C. elegans crude extract, which suppressed airway inflammation in mice not only during the development of asthma but also after its establishment by skewing allergen-induced Th2 responses to Th1 responses.	[Kim, Sung Eun; Kim, Jae-Hwan; Min, Byung-Hoon; Bae, Young Mee; Hong, Sung-Tae; Choi, Min-Ho] Seoul Natl Univ, Coll Med, Dept Parasitol & Trop Med, Seoul, South Korea; [Kim, Sung Eun; Kim, Jae-Hwan; Min, Byung-Hoon; Bae, Young Mee; Hong, Sung-Tae; Choi, Min-Ho] Seoul Natl Univ, Inst Endem Dis, Med Res Ctr, Seoul, South Korea; [Min, Byung-Hoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, SE (corresponding author), Seoul Natl Univ, Coll Med, Dept Parasitol & Trop Med, Seoul, South Korea.	mhchoi@snu.ac.kr	Hong, Sung-Tae/J-5723-2012; Bae, Young-Mee/J-5502-2012	Hong, Sung-Tae/0000-0002-0300-1944	Korea Research Foundation; Korean Government (MOEHRD) [KRF-2007-313-E00166]	Korea Research Foundation(National Research Foundation of Korea); Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government)	This research was supported by the Korea Research Foundation Grant funded by the Korean Government (MOEHRD) (KRF-2007-313-E00166). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adisakwattana P, 2009, ADV EXP MED BIOL, V666, P95; Araujo CA, 2008, CYTOKINE, V44, P335, DOI 10.1016/j.cyto.2008.09.005; Araujo MIAS, 2004, J INFECT DIS, V190, P1797, DOI 10.1086/425017; Bosnjak B, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-114; Capron M, 2011, ALLERGY, V66, P16, DOI 10.1111/j.1398-9995.2011.02624.x; Choi MH, 2011, CLIN EXP ALLERGY, V41, P697, DOI 10.1111/j.1365-2222.2011.03746.x; Cooper PJ, 2006, LANCET, V367, P1598, DOI 10.1016/S0140-6736(06)68697-2; Dagoye D, 2003, AM J RESP CRIT CARE, V167, P1369, DOI 10.1164/rccm.200210-1204OC; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Erb KJ, 2009, TRENDS IMMUNOL, V30, P75, DOI 10.1016/j.it.2008.11.005; Falcone FH, 2005, TRENDS PARASITOL, V21, P157, DOI 10.1016/j.pt.2005.02.002; Fallon PG, 2007, NAT REV IMMUNOL, V7, P220, DOI 10.1038/nri2039; Feary JR, 2010, CLIN EXP ALLERGY, V40, P299, DOI 10.1111/j.1365-2222.2009.03433.x; Finkelman FD, 2008, J ALLERGY CLIN IMMUN, V121, P334, DOI 10.1016/j.jaci.2007.11.028; Flohr C, 2009, CLIN EXP ALLERGY, V39, P20, DOI 10.1111/j.1365-2222.2008.03134.x; Harnett William, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000720; Hartmann S, 2003, INT J PARASITOL, V33, P1291, DOI 10.1016/S0020-7519(03)00163-2; Inman MD, 2010, CLIN EXP ALLERGY, V40, P524, DOI 10.1111/j.1365-2222.2010.03485.x; Itami DM, 2005, CLIN EXP ALLERGY, V35, P873, DOI 10.1111/j.1365-2222.2005.02268.x; Kitagaki K, 2006, J IMMUNOL, V177, P1628, DOI 10.4049/jimmunol.177.3.1628; Koch M, 2006, AM J RESP CELL MOL, V35, P211, DOI 10.1165/rcmb.2005-0293OC; Kradin RL, 2006, ARCH PATHOL LAB MED, V130, P718; Lack G, 1996, J IMMUNOL, V157, P1432; Leonardi-Bee J, 2006, AM J RESP CRIT CARE, V174, P514, DOI 10.1164/rccm.200603-331OC; Mangan NE, 2006, J IMMUNOL, V176, P138, DOI 10.4049/jimmunol.176.1.138; Markaki M, 2010, BIOTECHNOL J, V5, P1261, DOI 10.1002/biot.201000183; Marsland BJ, 2005, IMMUNOL CELL BIOL, V83, P40, DOI [10.1111/j.1440-1711.2004.01303.x, 10.1111/j.1440-1711.2005.01303.x]; McInnes IB, 2003, J IMMUNOL, V171, P2127, DOI 10.4049/jimmunol.171.4.2127; Medeiros M, 2003, J ALLERGY CLIN IMMUN, V111, P947, DOI 10.1067/mai.2003.1381; Melendez AJ, 2007, NAT MED, V13, P1375, DOI 10.1038/nm1654; Palmer LJ, 2002, AM J RESP CRIT CARE, V165, P1489, DOI 10.1164/rccm.2107020; Peters-Golden M, 2004, AM J RESP CELL MOL, V31, P3, DOI 10.1165/rcmb.f279; Pinelli E, 2008, CLIN EXP ALLERGY, V38, P649, DOI 10.1111/j.1365-2222.2007.02908.x; Schierack P, 2003, INFECT IMMUN, V71, P2422, DOI 10.1128/IAI.71.5.2422-2429.2003; Schnoeller C, 2008, J IMMUNOL, V180, P4265, DOI 10.4049/jimmunol.180.6.4265; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; Summers RW, 2005, GUT, V54, P87, DOI 10.1136/gut.2004.041749; Tang CB, 2001, J IMMUNOL, V166, P1471, DOI 10.4049/jimmunol.166.3.1471; van den Biggelaar AHJ, 2004, J INFECT DIS, V189, P892, DOI 10.1086/381767; Wang CC, 2001, CLIN EXP ALLERGY, V31, P495, DOI 10.1046/j.1365-2222.2001.01044.x; Wohlleben G, 2004, INT IMMUNOL, V16, P585, DOI 10.1093/intimm/dxh062; Yoshida M, 2002, AM J RESP CRIT CARE, V166, P451, DOI 10.1164/rccm.200202-095OC; Yu M, 2011, J CLIN INVEST, V121, P3133, DOI 10.1172/JCI43598	43	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35447	10.1371/journal.pone.0035447	http://dx.doi.org/10.1371/journal.pone.0035447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558152	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345200041
J	Williams, JD; Boyko, CB				Williams, Jason D.; Boyko, Christopher B.			The Global Diversity of Parasitic Isopods Associated with Crustacean Hosts (Isopoda: Bopyroidea and Cryptoniscoidea)	PLOS ONE			English	Review							BOPYRID ISOPOD; PROBOPYRUS-PANDALICOLA; PARALOMIS-GRANULOSA; ORTHIONE-GRIFFENIS; ARGEIA-PUGETTENSIS; PALAEMONETES-PUGIO; LIRIOPSIS-PYGMAEA; BEAGLE CHANNEL; GRASS SHRIMP; DECAPODA	Parasitic isopods of Bopyroidea and Cryptoniscoidea (commonly referred to as epicarideans) are unique in using crustaceans as both intermediate and definitive hosts. In total, 795 epicarideans are known, representing similar to 7.7% of described isopods. The rate of description of parasitic species has not matched that of free-living isopods and this disparity will likely continue due to the more cryptic nature of these parasites. Distribution patterns of epicarideans are influenced by a combination of their definitive (both benthic and pelagic species) and intermediate (pelagic copepod) host distributions, although host specificity is poorly known for most species. Among epicarideans, nearly all species in Bopyroidea are ectoparasitic on decapod hosts. Bopyrids are the most diverse taxon (605 species), with their highest diversity in the North West Pacific (139 species), East Asian Sea (120 species), and Central Indian Ocean (44 species). The diversity patterns of Cryptoniscoidea (99 species, endoparasites of a diverse assemblage of crustacean hosts) are distinct from bopyrids, with the greatest diversity of cryptoniscoids in the North East Atlantic (18 species) followed by the Antarctic, Mediterranean, and Arctic regions (13, 12, and 8 species, respectively). Dajidae (54 species, ectoparasites of shrimp, mysids, and euphausids) exhibits highest diversity in the Antarctic (7 species) with 14 species in the Arctic and North East Atlantic regions combined. Entoniscidae (37 species, endoparasites within anomuran, brachyuran and shrimp hosts) show highest diversity in the North West Pacific (10 species) and North East Atlantic (8 species). Most epicarideans are known from relatively shallow waters, although some bopyrids are known from depths below 4000 m. Lack of parasitic groups in certain geographic areas is likely a sampling artifact and we predict that the Central Indian Ocean and East Asian Sea (in particular, the Indo-Malay-Philippines Archipelago) hold a wealth of undescribed species, reflecting our knowledge of host diversity patterns.	[Williams, Jason D.] Hofstra Univ, Dept Biol, Hempstead, NY 11550 USA; [Boyko, Christopher B.] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Boyko, Christopher B.] Dowling Coll, Dept Biol, Oakdale, NY USA	Hofstra University; American Museum of Natural History (AMNH)	Williams, JD (corresponding author), Hofstra Univ, Dept Biol, Hempstead, NY 11550 USA.	biojdw@hofstra.edu						Adkison DL, REV ENTONISCINAE; An J, 2011, TAXONOMY PARASITIC I; An JM, 2009, INTEGR COMP BIOL, V49, P95, DOI 10.1093/icb/icp022; ANDERSON G, 1990, J CRUSTACEAN BIOL, V10, P284, DOI 10.2307/1548487; Arnott SA, 2001, J MAR BIOL ASSOC UK, V81, P171, DOI 10.1017/S002531540100354X; BLOWER SM, 1988, OECOLOGIA, V75, P512, DOI 10.1007/BF00776413; BOURDON R, 1983, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V5, P845; BOURDON R, 1968, Memoires du Museum National d'Histoire Naturelle Serie A Zoologie, V50, P77; Boxshall G, 2005, MARINE PARASITOLOGY, P123, DOI 10.1079/9780643090255.0123; Boyko CB, 2004, B MAR SCI, V74, P353; Boyko CB, 2003, J CRUSTACEAN BIOL, V23, P795, DOI 10.1651/C-2398; Boyko CB, 2012, CRUSTACEAN ISSUES BI, P271; Boyko CB, ZOOTAXA IN PRESS; Boyko Christopher B., 2009, Crustacean Issues, V18, P197; Brandt A, 2003, INVERTEBR SYST, V17, P893, DOI 10.1071/IS02032; Brandt A, 2007, DEEP-SEA RES PT II, V54, P1760, DOI 10.1016/j.dsr2.2007.07.015; Calado R, 2005, J EXP MAR BIOL ECOL, V321, P13, DOI 10.1016/j.jembe.2004.12.038; Carpenter KE, 2005, ENVIRON BIOL FISH, V72, P467, DOI 10.1007/s10641-004-3154-4; Chaplin-Ebanks SA, 2007, J PARASITOL, V93, P73, DOI 10.1645/GE-3537.1; Chapman JW, 2012, BIOL INVASIONS, V14, P1221, DOI 10.1007/s10530-011-0151-3; Chu KH, 1996, J NAT HIST, V30, P835, DOI 10.1080/00222939600770461; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; COYLE KO, 1981, CAN J FISH AQUAT SCI, V38, P1438, DOI 10.1139/f81-190; Deslandes, 1724, HIST ACAD ROYALE SCI, V1722, P19; Dreyer H, 2001, ZOOL-ANAL COMPLEX SY, V103, P157; DUMBAULD B., 2004, P S EC LARG BIOT TID, P53; Dumbauld BR, 2011, ESTUAR COAST, V34, P336, DOI 10.1007/s12237-010-9316-z; Fabricius J.C., 1798, SUPPLEMENTUM ENTOMOL; Feldman KL, 2000, ESTUARIES, V23, P141, DOI 10.2307/1352824; Griffen BD, 2009, MAR ECOL PROG SER, V391, P73, DOI 10.3354/meps08228; Hoeg J, 1997, P 1 INT WORKSH DEM I; Hosie AM, 2008, ZOOTAXA, P1; Itani G., 2004, P S EC LARG BIOT TID, P33; Jarrin JRM, 2008, J CRUSTACEAN BIOL, V28, P613, DOI 10.1651/08-2976.1; JAY CV, 1989, AM MIDL NAT, V121, P68, DOI 10.2307/2425657; Johnson WS, 2001, ADV MAR BIOL, V39, P105, DOI 10.1016/S0065-2881(01)39009-0; Kensley B, 2001, CRUSTACEAN ISS, V13, P205; Kensley B. F, 1989, GUIDE MARINE ISOPOD; Kuris A. M., 2005, Second International Symposium on Biological Control of Arthropods, Davos, Switzerland, 12-16 September, 2005, P102; Lafferty KD, 1996, ECOLOGY, V77, P1989, DOI 10.2307/2265695; Lester RJG, 2006, FISH DISEASES AND DISORDERS, VOL 1: PROTOZOAN AND METAZOAN INFECTIONS, 2ND EDITION, P466, DOI 10.1079/9780851990156.0466; Lovrich GA, 2004, DIS AQUAT ORGAN, V58, P71, DOI 10.3354/dao058071; MARKHAM J C, 1985, Memoirs of the Hourglass Cruises, V7, P1; Markham JC, 2005, J CRUSTACEAN BIOL, V25, P413, DOI 10.1651/C-2566; MARKHAM JC, 1986, CRUSTACEAN BIOGEOGRA, P143, DOI DOI 10.1201/9781315140674-7; Markham John C., 1992, Proceedings of the San Diego Society of Natural History, V17, P1; Markham John C., 2010, Memoirs of the Queensland Museum, V54, P151; MARTIN J. W., 2001, NATURAL HIST MUSEUM, V39, P1; McDermott JJ, 2010, J EXP MAR BIOL ECOL, V394, P2, DOI 10.1016/j.jembe.2010.06.022; McDermott JJ, 2009, J NAT HIST, V43, P785, DOI 10.1080/00222930802702480; Miyashita Y., 1941, Japanese Journal of Zoology, V9, P251; Nielsen SO, 1965, SARSIA, V18, P38; OBRIEN J, 1985, CRUSTACEAN ISSUES 3, P191; OWENS L, 1995, MAR ECOL PROG SER, V122, P159, DOI 10.3354/meps122159; OWENS L, 1993, AUST J MAR FRESH RES, V44, P381, DOI 10.1071/MF9930381; Owens L., 1985, P105; OWENS L, 1991, J PLANKTON RES, V13, P779, DOI 10.1093/plankt/13.4.779; Paradiso ML, 2004, CRUSTACEANA, V77, P397, DOI 10.1163/1568540041643355; Pascual S, 2002, J WILDLIFE DIS, V38, P473, DOI 10.7589/0090-3558-38.2.473; Penha-Lopes G, 2011, ENVIRON POLLUT, V159, P636, DOI 10.1016/j.envpol.2010.09.029; Peresan L, 2005, J NAT HIST, V39, P311, DOI 10.1080/0022293042000200103; Pernet B, 2008, MAR BIOL, V153, P1127, DOI 10.1007/s00227-007-0884-9; Rajkumar M, 2011, CHIN J OCEANOL LIMN, V29, P136, DOI 10.1007/s00343-011-9923-y; RASMUSSEN E, 1973, Ophelia, V11, P1; REINHARD EG, 1945, J PARASITOL, V31, P198, DOI 10.2307/3272543; REINHARD EG, 1949, BIOL BULL, V96, P17, DOI 10.2307/1537997; Repetto M, 2012, MAR FRESHWATER RES, V63, P60, DOI 10.1071/MF11158; Schotte M, 2011, WORLD MARINE FRESHWA; Shields JD, 1996, INT J PARASITOL, V26, P261, DOI 10.1016/0020-7519(95)00126-3; SHIELDS JD, 1985, J INVERTEBR PATHOL, V45, P122, DOI 10.1016/0022-2011(85)90060-6; Shiino S. M., 1952, NATURAL SCI, V1, P33; Shiino SM., 1965, B MUSEUM NATL HIST N, V37, P462; Shimomura M, 2008, P BIOL SOC WASH, V121, P326, DOI 10.2988/07-09.1; Smit NJ, 2004, ADV PARASIT, V58, P289, DOI 10.1016/S0065-308X(04)58005-3; Smith AE, 2008, J CRUSTACEAN BIOL, V28, P228, DOI 10.1651/0278-0372(2008)028[0228:PSAEOT]2.0.CO;2; SOMERS IF, 1991, AUST J MAR FRESH RES, V42, P349; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Trilles Jean-Paul, 1999, Memoires de l' Institut Oceanographique (Monaco), V19, P279; Vinuesa JH, 2010, MAR BIOL RES, V6, P608, DOI 10.1080/17451000903478327; Wells S., 1995, GLOBAL REPRESENTATIV; Wienberg Rasmussen H., 2008, B MIZUNAMI FOSSIL MU, V34, P31; Williams JD, 2006, ZOOSYSTEMA, V28, P285; Williams JD, 2011, INTEGR ZOOL, V6, P13, DOI 10.1111/j.1749-4877.2010.00226.x; Williams JD, 2010, EXP PARASITOL, V125, P23, DOI 10.1016/j.exppara.2009.09.012; Williams JD, 2009, INTEGR COMP BIOL, V49, P114, DOI 10.1093/icb/icp021; Williams JD, 2004, P CALIFORNIA ACAD SC, V55, P435; Williamson CJ, 2009, J ENVIRON SCI HEAL B, V44, P810, DOI 10.1080/03601230903238426; Wilson GDF, 2008, HYDROBIOLOGIA, V595, P231, DOI 10.1007/s10750-007-9019-z	88	90	94	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35350	10.1371/journal.pone.0035350	http://dx.doi.org/10.1371/journal.pone.0035350			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558143	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345200034
J	Yu, Y; Jiang, DH; Xie, JT; Cheng, JS; Li, GQ; Yi, XH; Fu, YP				Yu, Yang; Jiang, Daohong; Xie, Jiatao; Cheng, Jiasen; Li, Guoqing; Yi, Xianhong; Fu, Yanping			Ss-Sl2, a Novel Cell Wall Protein with PAN Modules, Is Essential for Sclerotial Development and Cellular Integrity of Sclerotinia sclerotiorum	PLOS ONE			English	Article							ENZYME-MEDIATED INTEGRATION; HEPATOCYTE GROWTH-FACTOR; COAGULATION-FACTOR-XI; ELONGATION-FACTOR TU; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; APPLE DOMAINS; WORONIN BODY; KLUYVEROMYCES-MARXIANUS; ASPERGILLUS-NIDULANS; FUNCTIONAL-ANALYSIS	The sclerotium is an important dormant body for many plant fungal pathogens. Here, we reported that a protein, named Ss-Sl2, is involved in sclerotial development of Sclerotinia sclerotiorum. Ss-Sl2 does not show significant homology with any protein of known function. Ss-Sl2 contains two putative PAN modules which were found in other proteins with diverse adhesion functions. Ss-Sl2 is a secreted protein, during the initial stage of sclerotial development, copious amounts of Ss-Sl2 are secreted and accumulated on the cell walls. The ability to maintain the cellular integrity of RNAi-mediated Ss-Sl2 silenced strains was reduced, but the hyphal growth and virulence of Ss-Sl2 silenced strains were not significantly different from the wild strain. Ss-Sl2 silenced strains could form interwoven hyphal masses at the initial stage of sclerotial development, but the interwoven hyphae could not consolidate and melanize. Hyphae in these interwoven bodies were thin-walled, and arranged loosely. Co-immunoprecipitation and yeast two-hybrid experiments showed that glyceraldehyde-3-phosphate dehydrogenase (GAPDH), Woronin body major protein (Hex1) and elongation factor 1-alpha interact with Ss-Sl2. GAPDH-knockdown strains showed a similar phenotype in sclerotial development as Ss-Sl2 silenced strains. Hex1-knockdown strains showed similar impairment in maintenance of hyphal integrity as Ss-Sl2 silenced strains. The results suggested that Ss-Sl2 functions in both sclerotial development and cellular integrity of S. sclerotiorum.	[Yu, Yang; Jiang, Daohong; Li, Guoqing] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei Province, Peoples R China; [Yu, Yang; Jiang, Daohong; Xie, Jiatao; Cheng, Jiasen; Li, Guoqing; Yi, Xianhong; Fu, Yanping] Huazhong Agr Univ, Prov Key Lab Plant Pathol Hubei Prov, Coll Plant Sci & Technol, Wuhan, Hubei Province, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Yu, Y (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei Province, Peoples R China.	yanpingfu@mail.hzau.edu.cn	Abbas, Aqleem/M-9403-2016	Abbas, Aqleem/0000-0001-9174-9700	National Natural Science Foundation of China [31071647]; Special Fund for Agro-scientific Research in the Public Interest [201103016]; earmarked fund for China Agriculture Research System [nycytx-00514]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; earmarked fund for China Agriculture Research System	This research was supported by National Natural Science Foundation of China (31071647), the Special Fund for Agro-scientific Research in the Public Interest (Grant No.201103016) and the earmarked fund for China Agriculture Research System (nycytx-00514). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Barbosa MS, 2006, INFECT IMMUN, V74, P382, DOI 10.1128/IAI.74.1.382-389.2006; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BOLAND GJ, 1994, CAN J PLANT PATHOL, V16, P93, DOI 10.1080/07060669409500766; Bolton MD, 2006, MOL PLANT PATHOL, V7, P1, DOI 10.1111/J.1364-3703.2005.00316.X; Brecht S, 2001, J BIOL CHEM, V276, P4119, DOI 10.1074/jbc.M008294200; Brown Philip J., 2003, Journal of Structural and Functional Genomics, V4, P227, DOI 10.1023/B:JSFG.0000016118.87333.03; Brown PJ, 2000, MOL BIOCHEM PARASIT, V107, P91, DOI 10.1016/S0166-6851(00)00179-1; Butler MJ, 2009, MYCOLOGIA, V101, P296, DOI 10.3852/08-120; Chen CB, 2005, MOL MICROBIOL, V55, P299, DOI 10.1111/j.1365-2958.2004.04390.x; Chen CB, 2004, MOL PLANT MICROBE IN, V17, P404, DOI 10.1094/MPMI.2004.17.4.404; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; CHET I, 1975, ANNU REV PHYTOPATHOL, V13, P169, DOI 10.1146/annurev.py.13.090175.001125; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; Dhavale T, 2007, MYCOTA, P87; Egea L, 2007, INT J BIOCHEM CELL B, V39, P1190, DOI 10.1016/j.biocel.2007.03.008; Erental A., 2008, Fungal Biology Reviews, V22, P6, DOI 10.1016/j.fbr.2007.10.001; Erental A, 2007, MOL PLANT MICROBE IN, V20, P944, DOI 10.1094/MPMI-20-8-0944; FERNANDES PA, 1992, BIOCHIM BIOPHYS ACTA, V1159, P67, DOI 10.1016/0167-4838(92)90076-P; Gaulin E, 2002, J CELL SCI, V115, P4565, DOI 10.1242/jcs.00138; Gozalbo D, 1998, INFECT IMMUN, V66, P2052, DOI 10.1128/IAI.66.5.2052-2059.1998; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; Harel A, 2006, MOL PLANT MICROBE IN, V19, P682, DOI 10.1094/MPMI-19-0682; HOOYKAAS PJJ, 1979, J GEN MICROBIOL, V110, P99, DOI 10.1099/00221287-110-1-99; Jedd G, 2000, NAT CELL BIOL, V2, P226, DOI 10.1038/35008652; Jurick WM, 2007, FUNGAL GENET BIOL, V44, P521, DOI 10.1016/j.fgb.2006.11.005; Jurick WM, 2004, PHYSIOL MOL PLANT P, V64, P155, DOI 10.1016/j.pmpp.2004.07.004; Kang Z.S, 1995, ULTRASTRUCTURE PLANT; KOSASIH BD, 1975, ANN BOT-LONDON, V39, P185, DOI 10.1093/oxfordjournals.aob.a084928; Langfelder K, 1998, MED MICROBIOL IMMUN, V187, P79, DOI 10.1007/s004300050077; Langfelder K, 2003, FUNGAL GENET BIOL, V38, P143, DOI 10.1016/S1087-1845(02)00526-1; Lazarovits G, 2000, PESTIC BIOCHEM PHYS, V67, P54, DOI 10.1006/pest.2000.2474; Li MY, 2009, MYCOLOGIA, V101, P34, DOI 10.3852/08-114; LU SW, 1994, P NATL ACAD SCI USA, V91, P12649, DOI 10.1073/pnas.91.26.12649; MARKHAM P, 1987, FEMS MICROBIOL LETT, V46, P1; Mateos FV, 1997, MOL PLANT MICROBE IN, V10, P1045, DOI 10.1094/MPMI.1997.10.9.1045; MCMULLEN BA, 1991, BIOCHEMISTRY-US, V30, P2056, DOI 10.1021/bi00222a008; Momany M, 2002, MYCOLOGIA, V94, P260, DOI 10.2307/3761802; Moreira RF, 1998, MICROBIOL-SGM, V144, P681, DOI 10.1099/00221287-144-3-681; Nguyen QB, 2008, MOL MICROBIOL, V68, P1348, DOI 10.1111/j.1365-2958.2008.06242.x; Pitarch A, 2002, MOL CELL PROTEOMICS, V1, P967, DOI 10.1074/mcp.M200062-MCP200; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Rollins JA, 2003, MOL PLANT MICROBE IN, V16, P785, DOI 10.1094/MPMI.2003.16.9.785; Roper M, 2010, P NATL ACAD SCI USA, V107, P17474, DOI 10.1073/pnas.1003577107; SHI Z, 1995, PHYTOPATHOLOGY, V85, P329, DOI 10.1094/Phyto-85-329; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Soundararajan S, 2004, PLANT CELL, V16, P1564, DOI 10.1105/tpc.020677; Starratt AN, 2002, CAN J MICROBIOL, V48, P320, DOI 10.1139/w02-017; STEADMAN JR, 1979, PHYTOPATHOLOGY, V69, P904, DOI 10.1094/Phyto-69-904; Tenney K, 2000, FUNGAL GENET BIOL, V31, P205, DOI 10.1006/fgbi.2000.1230; Tordai H, 1999, FEBS LETT, V461, P63, DOI 10.1016/S0014-5793(99)01416-7; TOWNSEND B. B., 1954, TRANS BRIT MYCOL SOC, V37, P213; TRINCI APJ, 1973, PROTOPLASMA, V80, P57, DOI 10.1007/BF01666351; Weld RJ, 2006, J MICROBIOL METH, V65, P202, DOI 10.1016/j.mimet.2005.07.010; WILLETTS HJ, 1992, MYCOL RES, V96, P801, DOI 10.1016/S0953-7562(09)81027-7; YELTON MM, 1984, P NATL ACAD SCI-BIOL, V81, P1470, DOI 10.1073/pnas.81.5.1470; Zhou HJ, 1999, BIOCHEMISTRY-US, V38, P14793, DOI 10.1021/bi9908641; ZHU JK, 1994, PLANT CELL, V6, P393, DOI 10.1105/tpc.6.3.393	59	36	40	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e34962	10.1371/journal.pone.0034962	http://dx.doi.org/10.1371/journal.pone.0034962			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558105	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345200016
J	Berthier, K; Leippert, F; Fumagalli, L; Arlettaz, R				Berthier, Karine; Leippert, Fabio; Fumagalli, Luca; Arlettaz, Raphael			Massive Nest-Box Supplementation Boosts Fecundity, Survival and Even Immigration without Altering Mating and Reproductive Behaviour in a Rapidly Recovered Bird Population	PLOS ONE			English	Article							CONSPECIFIC BROOD PARASITISM; EXTRA-PAIR FERTILIZATIONS; HOOPOE UPUPA-EPOPS; COMPUTER-PROGRAM; PATERNITY; MICROSATELLITE; CONSERVATION; BOTTLENECKS; EXPLORATION; EXTINCTION	Habitat restoration measures may result in artificially high breeding density, for instance when nest-boxes saturate the environment, which can negatively impact species' demography. Potential risks include changes in mating and reproductive behaviour such as increased extra-pair paternity, conspecific brood parasitism, and polygyny. Under particular cicumstances, these mechanisms may disrupt reproduction, with populations dragged into an extinction vortex. With the use of nuclear microsatellite markers, we investigated the occurrence of these potentially negative effects in a recovered population of a rare secondary cavity-nesting farmland bird of Central Europe, the hoopoe (Upupa epops). High intensity farming in the study area has resulted in a total eradication of cavity trees, depriving hoopoes from breeding sites. An intensive nest-box campaign rectified this problem, resulting in a spectacular population recovery within a few years only. There was some concern, however, that the new, high artificially-induced breeding density might alter hoopoe mating and reproductive behaviour. As the species underwent a serious demographic bottleneck in the 1970-1990s, we also used the microsatellite markers to reconstitute the demo-genetic history of the population, looking in particular for signs of genetic erosion. We found i) a low occurrence of extra-pair paternity, polygyny and conspecific brood parasitism, ii) a high level of neutral genetic diversity (mean number of alleles and expected heterozygosity per locus: 13.8 and 83%, respectively) and, iii) evidence for genetic connectivity through recent immigration of individuals from well differentiated populations. The recent increase in breeding density did thus not induce so far any noticeable detrimental changes in mating and reproductive behaviour. The demographic bottleneck undergone by the population in the 1970s-1990s was furthermore not accompanied by any significant drop in neutral genetic diversity. Finally, genetic data converged with a concomitant demographic study to evidence that immigration strongly contributed to local population recovery.	[Berthier, Karine; Leippert, Fabio; Arlettaz, Raphael] Univ Bern, Conservat Biol Div, Inst Ecol & Evolut, Bern, Switzerland; [Arlettaz, Raphael] Swiss Ornithol Inst, Valais Field Stn, Nat Ctr, Salgesch, Switzerland; [Fumagalli, Luca] Univ Lausanne, Dept Ecol & Evolut, Lab Conservat Biol, Lausanne, Switzerland; [Berthier, Karine] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Bern; Swiss Ornithological Institute; University of Lausanne; University of Sydney	Berthier, K (corresponding author), Univ Bern, Conservat Biol Div, Inst Ecol & Evolut, Bern, Switzerland.	raphael.arlettaz@iee.unibe.ch	Arlettaz, Raphaël/O-2182-2016	Arlettaz, Raphaël/0000-0001-6360-5339; Fumagalli, Luca/0000-0002-6648-2570; Berthier, Karine/0000-0002-2260-7968				ANDERSSON M, 1982, AM NAT, V120, P1, DOI 10.1086/283965; Arlettaz R, 2010, BIOSCIENCE, V60, P835, DOI 10.1525/bio.2010.60.10.10; Arlettaz R, 2010, J ORNITHOL, V151, P889, DOI 10.1007/s10336-010-0527-7; Belkhir K, 2001, 5000 CNRS UMR U MONT; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cornuet JM, 1996, GENETICS, V144, P2001; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; de Valpine P, 2008, AM NAT, V172, P547, DOI 10.1086/590956; Dubois NS, 2006, P ROY SOC B-BIOL SCI, V273, P1751, DOI 10.1098/rspb.2006.3509; Dunham J, 1999, CONS ECOL, V3; Eadie J, 1998, BEHAVIORAL ECOLOGY AND CONSERVATION BIOLOGY, P306; EADIE JM, 1992, AM NAT, V140, P621, DOI 10.1086/285431; Estoup A, 2001, GENETICS, V159, P1671; Evans SR, 2008, CONSERV BIOL, V22, P1016, DOI 10.1111/j.1523-1739.2008.00972.x; Fournier J, 2001, IBIS, V143, P2, DOI 10.1111/j.1474-919X.2001.tb04163.x; GOWATY PA, 1991, ANIM BEHAV, V41, P661, DOI 10.1016/S0003-3472(05)80904-2; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; JOHNSON LS, 1991, CONDOR, V93, P784, DOI 10.2307/1368219; JOHNSON LS, 1993, ANIM BEHAV, V46, P1111, DOI 10.1006/anbe.1993.1301; JOHNSON LS, 1993, J ANIM ECOL, V62, P669, DOI 10.2307/5387; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Keller V, 2001, LISTE ROUGE OISEAUX; KETTERSON ED, 1994, ANNU REV ECOL SYST, V25, P601, DOI 10.1146/annurev.es.25.110194.003125; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Lyon BE, 2008, ANNU REV ECOL EVOL S, V39, P343, DOI 10.1146/annurev.ecolsys.39.110707.173354; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Martin-Vivaldi M, 2002, IBIS, V144, P236, DOI 10.1046/j.1474-919X.2002.00044.x; MARUYAMA T, 1985, GENETICS, V111, P675; MOLLER AP, 1989, BEHAV ECOL SOCIOBIOL, V25, P33, DOI 10.1007/BF00299708; NEI M, 1978, GENETICS, V89, P583; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pope LC, 2000, MOL ECOL, V9, P2041, DOI 10.1046/j.1365-294X.2000.01110.x; Power HW, 1998, OX ORN SER, V9, P376; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reichlin TS, 2009, J ORNITHOL, V150, P393, DOI 10.1007/s10336-008-0361-3; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schaub M, 2012, OECOLOGIA, V168, P97, DOI 10.1007/s00442-011-2070-5; SEMEL B, 1988, CONDOR, V90, P920, DOI 10.2307/1368849; Semel B, 2001, ANIM BEHAV, V61, P787, DOI 10.1006/anbe.2000.1657; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Stewart SLM, 2010, BEHAV ECOL SOCIOBIOL, V64, P463, DOI 10.1007/s00265-009-0862-y; Sunnucks P, 2011, EMU, V111, P19, DOI 10.1071/MU10008; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Westneat DF, 1997, BEHAV ECOL SOCIOBIOL, V41, P205, DOI 10.1007/s002650050381	49	26	29	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e36028	10.1371/journal.pone.0036028	http://dx.doi.org/10.1371/journal.pone.0036028			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545155	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343200075
J	Canovas, A; Pena, RN; Gallardo, D; Ramirez, O; Amills, M; Quintanilla, R				Canovas, Angela; Pena, Ramona N.; Gallardo, David; Ramirez, Oscar; Amills, Marcel; Quintanilla, Raquel			Segregation of Regulatory Polymorphisms with Effects on the Gluteus Medius Transcriptome in a Purebred Pig Population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; INTRAMUSCULAR FAT-CONTENT; GENE-EXPRESSION; ARCHITECTURE; SERUM; LDL	Background: The main goal of the present study was to analyse the genetic architecture of mRNA expression in muscle, a tissue with an outmost economic importance for pig breeders. Previous studies have used F-2 crosses to detect porcine expression QTL (eQTL), so they contributed with data that mostly represents the between-breed component of eQTL variation. Herewith, we have analysed eQTL segregation in an outbred Duroc population using two groups of animals with divergent fatness profiles. This approach is particularly suitable to analyse the within-breed component of eQTL variation, with a special emphasis on loci involved in lipid metabolism. Methodology/Principal Findings: GeneChip Porcine Genome arrays (Affymetrix) were used to determine the mRNA expression levels of gluteus medius samples from 105 Duroc barrows. A whole-genome eQTL scan was carried out with a panel of 116 microsatellites. Results allowed us to detect 613 genome-wide significant eQTL unevenly distributed across the pig genome. A clear predominance of trans-over cis-eQTL, was observed. Moreover, 11 trans-regulatory hotspots affecting the expression levels of four to 16 genes were identified. A Gene Ontology study showed that regulatory polymorphisms affected the expression of muscle development and lipid metabolism genes. A number of positional concordances between eQTL and lipid trait QTL were also found, whereas limited evidence of a linear relationship between muscle fat deposition and mRNA levels of eQTL regulated genes was obtained. Conclusions/Significance: Our data provide substantial evidence that there is a remarkable amount of within-breed genetic variation affecting muscle mRNA expression. Most of this variation acts in trans and influences biological processes related with muscle development, lipid deposition and energy balance. The identification of the underlying causal mutations and the ascertainment of their effects on phenotypes would allow gaining a fundamental perspective about how complex traits are built at the molecular level.	[Canovas, Angela; Pena, Ramona N.; Quintanilla, Raquel] IRTA, Lleida, Spain; [Gallardo, David; Ramirez, Oscar] Univ Autonoma Barcelona, Fac Vet, Dept Ciencia Anim & Aliments, E-08193 Barcelona, Spain; [Amills, Marcel] Univ Autonoma Barcelona, Dept Genet Anim, Ctr Recerca Agrigen CRAG, E-08193 Barcelona, Spain	IRTA; Autonomous University of Barcelona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG)	Canovas, A (corresponding author), IRTA, Lleida, Spain.	romi.pena@prodan.udl.cat; Raquel.Quintanilla@irta.cat	Pena, Romi/C-7756-2011; Amills, Marcel/D-4908-2019; Quintanilla, Raquel/I-8997-2012; Ramirez, Oscar/E-7293-2012; Amills, Marcel/C-7156-2008; Cánovas, Angela/AAG-6282-2020	Pena, Romi/0000-0002-3558-7302; Amills, Marcel/0000-0002-8999-0770; Quintanilla, Raquel/0000-0003-3274-3434; Ramirez, Oscar/0000-0001-5164-6790; 	Spanish Ministry of Science [GEN2003-20658-C05-05, AGL2007-66707-C02-01, AGL2010-22208-C02-01]; INIA (Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria)	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); INIA (Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria)(Instituto de Investigacion Agropecuaria (INIA))	This project has been funded by the Spanish Ministry of Science (projects GEN2003-20658-C05-05, AGL2007-66707-C02-01 and AGL2010-22208-C02-01). AC received a predoctoral scholarship from INIA (Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balistreri CR, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/802078; Canovas A, 2009, J ANIM SCI, V87, P3905, DOI 10.2527/jas.2009-2091; Casellas J, 2010, J ANIM SCI, V88, P2246, DOI 10.2527/jas.2009-2205; Cheung VG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000480; Cheung VG, 2009, NAT REV GENET, V10, P595, DOI 10.1038/nrg2630; Christodoulides C, 2006, J CELL SCI, V119, P2613, DOI 10.1242/jcs.02975; de Koning DJ, 1999, GENETICS, V152, P1679; de Koning DJ, 2003, J ANIM SCI, V81, P2155; Duan S, 2008, AM J HUM GENET, V82, P1101, DOI 10.1016/j.ajhg.2008.03.006; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Gallardo D, 2009, ANIM GENET, V40, P410, DOI 10.1111/j.1365-2052.2009.01854.x; Gallardo D, 2012, ANIM GENET IN PRESS; Gallardo D, 2008, PHYSIOL GENOMICS, V35, P199, DOI 10.1152/physiolgenomics.90249.2008; Georges M, 2007, ANNU REV GENOM HUM G, V8, P131, DOI 10.1146/annurev.genom.8.080706.092408; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Gomez-Abellan P, 2008, INT J OBESITY, V32, P121, DOI 10.1038/sj.ijo.0803689; Hu ZL, 2007, NUCLEIC ACIDS RES, V35, pD604, DOI 10.1093/nar/gkl946; Hu ZL, 2007, MAMM GENOME, V18, P1, DOI 10.1007/s00335-006-0105-8; Huang Chin-Chang, 2009, Acta Neurol Taiwan, V18, P287; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Liaubet L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-548; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Morris DL, 2011, CURR OPIN CLIN NUTR, V14, P341, DOI 10.1097/MCO.0b013e328347970b; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Nagamine Y, 2003, GENETICS, V164, P629; Ponsuksili S, 2011, J LIPID RES, V52, P668, DOI 10.1194/jlr.M013342; Ponsuksili S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-367; Quintanilla R, 2011, J ANIM SCI, V89, P2963, DOI 10.2527/jas.2011-3974; Sato S, 2006, ANIM GENET, V37, P113, DOI 10.1111/j.1365-2052.2005.01397.x; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Seaton G, 2006, P 8 WCGALP, V27, P633; Steibel JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016766; Tomaszewski M, 2009, ARTERIOSCL THROM VAS, V29, P1316, DOI 10.1161/ATVBAHA.109.185355; Wimmers K, 2010, BRIEF FUNCT GENOMICS, V9, P251, DOI 10.1093/bfgp/elq003; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xu XJ, 2008, BIOINFORMATICS, V24, P137, DOI 10.1093/bioinformatics/btm541; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zhang W, 2008, AM J HUM GENET, V82, P631, DOI 10.1016/j.ajhg.2007.12.015	40	20	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35583	10.1371/journal.pone.0035583	http://dx.doi.org/10.1371/journal.pone.0035583			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545120	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343200040
J	Deneke, C; Rudorf, S; Valleriani, A				Deneke, Carlus; Rudorf, Sophia; Valleriani, Angelo			Transient Phenomena in Gene Expression after Induction of Transcription	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; MESSENGER-RNA; ESCHERICHIA-COLI; TRANSLATION; REVEALS; CELLS	When transcription of a gene is induced by a stimulus, the number of its mRNA molecules changes with time. Here we discuss how this time evolution depends on the shape of the mRNA lifetime distribution. Analysis of the statistical properties of this change reveals transient effects on polysomes, ribosomal profiles, and rate of protein synthesis. Our studies reveal that transient phenomena in gene expression strongly depend on the specific form of the mRNA lifetime distribution.	[Deneke, Carlus; Rudorf, Sophia; Valleriani, Angelo] Max Planck Inst Colloids & Interfaces, Dept Theory & Biosyst, Potsdam, Germany	Max Planck Society	Deneke, C (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Theory & Biosyst, Potsdam, Germany.	angelo.valleriani@mpikg.mpg.de		Rudorf, Sophia/0000-0001-7653-3733; Deneke, Carlus/0000-0002-2509-4950; Valleriani, Angelo/0000-0001-6591-5824				Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Belasco JG, 2010, NAT REV MOL CELL BIO, V11, P467, DOI 10.1038/nrm2917; BERG OG, 1978, J THEOR BIOL, V71, P587, DOI 10.1016/0022-5193(78)90326-0; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Brandt F, 2009, CELL, V136, P261, DOI 10.1016/j.cell.2008.11.016; Cox D., 1962, RENEWAL THEORY; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; IOST I, 1995, EMBO J, V14, P3252, DOI 10.1002/j.1460-2075.1995.tb07328.x; JACQUES N, 1990, MOL MICROBIOL, V4, P1063, DOI 10.1111/j.1365-2958.1990.tb00679.x; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Lewis PJ, 2000, EMBO J, V19, P710, DOI 10.1093/emboj/19.4.710; Liang ST, 2000, J BACTERIOL, V182, P3037, DOI 10.1128/JB.182.11.3037-3044.2000; Mitarai N, 2008, J MOL BIOL, V382, P236, DOI 10.1016/j.jmb.2008.06.068; Nagar A, 2011, J STAT PHYS, V145, P1385, DOI 10.1007/s10955-011-0347-z; Nevo-Dinur K, 2011, SCIENCE, V331, P1081, DOI 10.1126/science.1195691; Rading MM, 2011, J STAT PHYS, V145, P1, DOI 10.1007/s10955-011-0305-9; Selinger DW, 2003, GENOME RES, V13, P216, DOI 10.1101/gr.912603; Steglich C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r54; TAYLOR H., 1998, INTRO STOCHASTIC MOD; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Valleriani A, 2010, EPL, P89; Valleriani A, 2011, PHYS REV E, V83; ZHANG G, 2009, PLOS ONE, V4, pNIL33; Zhang G, 2010, NUCLEIC ACIDS RES, V38, P4778, DOI 10.1093/nar/gkq196	27	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35044	10.1371/journal.pone.0035044	http://dx.doi.org/10.1371/journal.pone.0035044			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22558114	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341000018
J	Schmidt, N; Brandsch, C; Kuhne, H; Thiele, A; Hirche, F; Stangl, GI				Schmidt, Nadine; Brandsch, Corinna; Kuehne, Hagen; Thiele, Alexandra; Hirche, Frank; Stangl, Gabriele I.			Vitamin D Receptor Deficiency and Low Vitamin D Diet Stimulate Aortic Calcification and Osteogenic Key Factor Expression in Mice	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELL; VASCULAR CALCIFICATION; CARDIOVASCULAR-DISEASE; RISK; ATHEROSCLEROSIS; 25-HYDROXYVITAMIN-D; ASSOCIATION; PREVALENCE; MECHANISMS; CALCITRIOL	Low levels of 25-hydroxy vitamin D (25(OH)D) are associated with cardiovascular diseases. Herein, we tested the hypothesis that vitamin D deficiency could be a causal factor in atherosclerotic vascular changes and vascular calcification. Aortic root sections of vitamin D receptor knockout (VDR-/-) mice that were stained for vascular calcification and immunostained for osteoblastic differentiation factors showed more calcified areas and a higher expression of the osteogenic key factors Msx2, Bmp2, and Runx2 than the wild-type mice (P<0.01). Data from LDL receptor knockout (LDLR-/-) mice that were fed western diet with either low (50 IU/kg), recommended (1,000 IU/kg), or high (10,000 IU/kg) amounts of vitamin D-3 over 16 weeks revealed increasing plasma concentrations of 25(OH)D (P<0.001) with increasing intake of vitamin D, whereas levels of calcium and phosphorus in plasma and femur were not influenced by the dietary treatment. Mice treated with the low vitamin D diet had more calcified lesions and a higher expression of Msx2, Bmp2, and Runx2 in aortic roots than mice fed recommended or high amounts of vitamin D (P<0.001). Taken together, these findings indicate vitamin D deficiency as a risk factor for aortic valve and aortic vessel calcification and a stimulator of osteogenic key factor expression in these vascular areas.	[Schmidt, Nadine; Brandsch, Corinna; Kuehne, Hagen; Thiele, Alexandra; Hirche, Frank; Stangl, Gabriele I.] Univ Halle Wittenberg, Inst Agr & Nutr Sci, Halle, Saale, Germany	Martin Luther University Halle Wittenberg	Stangl, GI (corresponding author), Univ Halle Wittenberg, Inst Agr & Nutr Sci, Halle, Saale, Germany.	gabriele.stangl@landw.uni-halle.de		Schutkowski, Alexandra/0000-0002-9387-7869	Federal Ministry of Education and Research of Germany [0315668A]	Federal Ministry of Education and Research of Germany(Federal Ministry of Education & Research (BMBF))	This work was supported by grant 0315668A from the Federal Ministry of Education and Research of Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Allison MA, 2004, ARTERIOSCL THROM VAS, V24, P331, DOI 10.1161/01.ATV.0000110786.02097.0c; Artaza JN, 2009, CLIN J AM SOC NEPHRO, V4, P1515, DOI 10.2215/CJN.02260409; BASSLER R, 1993, CHEM UNTERSUCHUNG FU, V2; BRAUNWALD, 1997, J MOD, V337, P1360; Breslow JL, 1997, NAT MED, V3, P600, DOI 10.1038/nm0697-600; Cannata-Andia JB, 2006, J AM SOC NEPHROL, V17, pS267, DOI 10.1681/ASN.2006080925; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Fleet JC, 2008, J NUTR, V138, P1114, DOI 10.1093/jn/138.6.1114; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Higashi T, 2008, ANAL BIOANAL CHEM, V391, P229, DOI 10.1007/s00216-007-1780-3; HOLICK MF, 1980, SCIENCE, V210, P203, DOI 10.1126/science.6251551; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; KELLY RP, 1992, CIRC RES, V71, P490, DOI 10.1161/01.RES.71.3.490; Kilkkinen A, 2009, AM J EPIDEMIOL, V170, P1032, DOI 10.1093/aje/kwp227; Lips P, 2006, J INTERN MED, V260, P245, DOI 10.1111/j.1365-2796.2006.01685.x; Mathew S, 2008, J AM SOC NEPHROL, V19, P1509, DOI 10.1681/ASN.2007080902; Mizobuchi M, 2009, J AM SOC NEPHROL, V20, P1453, DOI 10.1681/ASN.2008070692; Mori K, 1999, ARTERIOSCL THROM VAS, V19, P2112, DOI 10.1161/01.ATV.19.9.2112; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; *NRC, 1995, NUTR REQ LAB AN, P80, DOI DOI 10.1038/NATURE08778; Rahman A, 2007, J STEROID BIOCHEM, V103, P416, DOI 10.1016/j.jsbmb.2006.12.081; Vinas BR, 2011, ANN NUTR METAB, V59, P84, DOI 10.1159/000332762; ROSS R, 1973, SCIENCE, V180, P1332, DOI 10.1126/science.180.4093.1332; Shoben AB, 2008, J AM SOC NEPHROL, V19, P1613, DOI 10.1681/ASN.2007111164; Speer MY, 2010, J CELL BIOCHEM, V110, P935, DOI 10.1002/jcb.22607; Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070; Takeda M, 2010, ARTERIOSCL THROM VAS, V30, P2495, DOI 10.1161/ATVBAHA.110.215459; Towler DA, 2006, ANN NY ACAD SCI, V1068, P327, DOI 10.1196/annals.1346.036; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Watson KE, 1997, CIRCULATION, V96, P1755, DOI 10.1161/01.CIR.96.6.1755; Wolf M, 2008, J AM SOC NEPHROL, V19, P1379, DOI 10.1681/ASN.2007091002; Zebboudj AF, 2003, J CELL BIOCHEM, V90, P756, DOI 10.1002/jcb.10669	34	66	69	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35316	10.1371/journal.pone.0035316	http://dx.doi.org/10.1371/journal.pone.0035316			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536373	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339200056
J	Yang, P; Zhu, JY; Gong, ZJ; Xu, DL; Chen, XM; Liu, WW; Lin, XD; Li, YF				Yang, Pu; Zhu, Jia-Ying; Gong, Zhong-Jun; Xu, Dong-Li; Chen, Xiao-Ming; Liu, Wei-Wei; Lin, Xin-Da; Li, Yan-Fei			Transcriptome Analysis of the Chinese White Wax Scale Ericerus pela with Focus on Genes Involved in Wax Biosynthesis	PLOS ONE			English	Article							FATTY-ACYL REDUCTASE; PHEROMONE-GLAND; COENZYME; ACYLTRANSFERASE; IDENTIFICATION; SYNTHASE; CLONING; ESTER; PURIFICATION; ENCODES	Background: The Chinese white wax scale, Ericerus pela Chavannes is economically significant for its role in wax production. This insect has been bred in China for over a thousand years. The wax secreted by the male scale insect during the second-instar larval stage has been widespread used in wax candle production, wax printing, engraving, Chinese medicine, and more recently in the chemical, pharmaceutical, food, and cosmetics industries. However, little is known about the mechanisms responsible for white wax biosynthesis. The characterization of its larval transcriptome may promote better understanding of wax biosynthesis. Methodology/Principal Findings: In this study, characterization of the transcriptome of E. pela during peak wax secretion was performed using Illumina sequencing technology. Illumina sequencing produced 41,839 unigenes. These unigenes were annotated by blastx alignment against the NCBI Non-Redundant (NR), Swiss-Prot, KEGG, and COG databases. A total of 104 unigenes related to white wax biosynthesis were identified, and 15 of them were selected for quantitative real-time PCR analysis. We evaluated the variations in gene expression across different development stages, including egg, first/second instar larvae, male pupae, and male and female adults. Then we identified five genes involved in white wax biosynthesis. These genes were expressed most strongly during the second-instar larval stage of male E. pela. Conclusion/Significance: The transcriptome analysis of E. pela during peak wax secretion provided an overview of gene expression information at the transcriptional level and a resource for gene mining. Five genes related to white wax biosynthesis were identified.	[Yang, Pu; Xu, Dong-Li; Chen, Xiao-Ming; Liu, Wei-Wei; Li, Yan-Fei] Chinese Acad Forestry, Res Inst Resources Insects, Key Lab Cultivating & Utilizat Resources Insects, Kunming, Peoples R China; [Zhu, Jia-Ying] SW Forestry Univ, Coll Forestry, Key Lab Forest Disaster Warning & Control Yunnan, Kunming, Peoples R China; [Gong, Zhong-Jun] Henan Acad Agr Sci, Inst Plant Protect, Key Lab Crop Pest Control Henan Prov, Zhengzhou, Peoples R China; [Lin, Xin-Da] China Jiliang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Forestry; Research Institute of Resources Insects, CAF; Henan Academy of Agricultural Sciences; China Jiliang University	Chen, XM (corresponding author), Chinese Acad Forestry, Res Inst Resources Insects, Key Lab Cultivating & Utilizat Resources Insects, Kunming, Peoples R China.	cafchxm@tom.com	Gong, Zhongjun/AAZ-4442-2020; Yang, Pu/L-1442-2019		National Natural Science Foundation of China [31000983]; Applied Basic Research Foundation of Yunnan Province [2010ZC235]; National Nonprofit Institute Research Grant of RIRI-CAF [riricaf200904M-3, riricaf2011006M]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Applied Basic Research Foundation of Yunnan Province; National Nonprofit Institute Research Grant of RIRI-CAF	Funding provided by National Natural Science Foundation of China (Youth Program) (Grant No. 31000983)(Website:http://www.nsfc.gov.cn/Portal0/default152.htm); Applied Basic Research Foundation of Yunnan Province (Grant No. 2010ZC235); National Nonprofit Institute Research Grant of RIRI-CAF (Grant No. riricaf200904M-3, riricaf2011006M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony B, 2009, INSECT BIOCHEM MOLEC, V39, P90, DOI 10.1016/j.ibmb.2008.10.008; Biester EM, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-4; Chen X. M., 2009, INTRO RESOURCE ENTOM, P29; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; Cheng JB, 2004, J BIOL CHEM, V279, P37798, DOI 10.1074/jbc.M406226200; Costaglioli P, 2005, BBA-MOL CELL BIOL L, V1734, P247, DOI 10.1016/j.bbalip.2005.04.002; Doan TTP, 2009, J PLANT PHYSIOL, V166, P787, DOI 10.1016/j.jplph.2008.10.003; Hellenbrand J, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-64; Holtzapple E, 2007, J BACTERIOL, V189, P3804, DOI 10.1128/JB.01932-06; Kalscheuer R, 2003, J BIOL CHEM, V278, P8075, DOI 10.1074/jbc.M210533200; King A, 2007, PLANTA, V226, P381, DOI 10.1007/s00425-007-0489-z; Kunst L, 2003, PROG LIPID RES, V42, P51, DOI 10.1016/S0163-7827(02)00045-0; Lardizabal KD, 2000, PLANT PHYSIOL, V122, P645, DOI 10.1104/pp.122.3.645; Lassance JM, 2010, NATURE, V466, P486, DOI 10.1038/nature09058; Leonard AE, 2004, PROG LIPID RES, V43, P36, DOI 10.1016/S0163-7827(03)00040-7; Li F, 2008, PLANT PHYSIOL, V148, P97, DOI 10.1104/pp.108.123471; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lienard MA, 2010, P NATL ACAD SCI USA, V107, P10955, DOI 10.1073/pnas.1000823107; Lung Tsuen-ni, 2004, AGR HIST CHINA, P18; Metz JG, 2000, PLANT PHYSIOL, V122, P635, DOI 10.1104/pp.122.3.635; Moto K, 2003, P NATL ACAD SCI USA, V100, P9156, DOI 10.1073/pnas.1531993100; Rowland O, 2006, PLANT PHYSIOL, V142, P866, DOI 10.1104/pp.106.086785; Sakuradani E, 2009, APPL MICROBIOL BIOT, V84, P709, DOI 10.1007/s00253-009-1999-3; Shi J, 2011, PLANT CELL, V23, P2225, DOI 10.1105/tpc.111.087528; Suarez E, 2011, ANAL CHIM ACTA, V706, P157, DOI 10.1016/j.aca.2011.08.033; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang Q. Y., 2010, DPS DATA PROCESSING, P82; Teerawanichpan P, 2010, INSECT BIOCHEM MOLEC, V40, P641, DOI 10.1016/j.ibmb.2010.06.004; Teerawanichpan P, 2010, LIPIDS, V45, P263, DOI 10.1007/s11745-010-3395-2; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vogel H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-29; Yang P, 2011, AFR J MICROBIOL RES, V5, P1246; Yang P, 2011, AFR J MICROBIOL RES, V5, P1108	33	32	45	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35719	10.1371/journal.pone.0035719	http://dx.doi.org/10.1371/journal.pone.0035719			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536429	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200101
J	Hammond, JA; Hauton, C; Bennett, KA; Hall, AJ				Hammond, John A.; Hauton, Chris; Bennett, Kimberley A.; Hall, Ailsa J.			Phocid Seal Leptin: Tertiary Structure and Hydrophobic Receptor Binding Site Preservation during Distinct Leptin Gene Evolution	PLOS ONE			English	Article							BODY-MASS; LUNG; HYPOTHESIS; LACTATION; MOTHERS; MODEL; DIVES	The cytokine hormone leptin is a key signalling molecule in many pathways that control physiological functions. Although leptin demonstrates structural conservation in mammals, there is evidence of positive selection in primates, lagomorphs and chiropterans. We previously reported that the leptin genes of the grey and harbour seals (phocids) have significantly diverged from other mammals. Therefore we further investigated the diversification of leptin in phocids, other marine mammals and terrestrial taxa by sequencing the leptin genes of representative species. Phylogenetic reconstruction revealed that leptin diversification was pronounced within the phocid seals with a high dN/dS ratio of 2.8, indicating positive selection. We found significant evidence of positive selection along the branch leading to the phocids, within the phocid clade, but not over the dataset as a whole. Structural predictions indicate that the individual residues under selection are away from the leptin receptor (LEPR) binding site. Predictions of the surface electrostatic potential indicate that phocid seal leptin is notably different to other mammalian leptins, including the otariids. Cloning the grey seal leptin binding domain of LEPR confirmed that this was structurally conserved. These data, viewed in toto, support a hypothesis that phocid leptin divergence is unlikely to have arisen by random mutation. Based upon these phylogenetic and structural assessments, and considering the comparative physiology and varying life histories among species, we postulate that the unique phocid diving behaviour has produced this selection pressure. The Phocidae includes some of the deepest diving species, yet have the least modified lung structure to cope with pressure and volume changes experienced at depth. Therefore, greater surfactant production is required to facilitate rapid lung re-inflation upon surfacing, while maintaining patent airways. We suggest that this additional surfactant requirement is met by the leptin pulmonary surfactant production pathway which normally appears only to function in the mammalian foetus.	[Hammond, John A.] Inst Anim Hlth, Newbury, Berks, England; [Hauton, Chris] Univ Southampton, Natl Oceanog Ctr Southampton, Southampton, Hants, England; [Bennett, Kimberley A.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Sch Marine Sci & Engn, Plymouth PL4 8AA, Devon, England; [Hall, Ailsa J.] Univ St Andrews, Sea Mammal Res Unit, Scottish Oceans Inst, St Andrews, Fife, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; NERC National Oceanography Centre; University of Southampton; University of Plymouth; University of St Andrews	Hammond, JA (corresponding author), Inst Anim Hlth, Newbury, Berks, England.	ajh7@st-andrews.ac.uk	Hall, Ailsa/E-1596-2011; Bennett, Kimberley/O-9142-2016	Bennett, Kimberley/0000-0003-2168-6112; Hammond, John/0000-0002-2213-3248; Hauton, Chris/0000-0002-2313-4226; Hall, Ailsa/0000-0002-7562-1771	UK Natural Environment Research Council; BBSRC from the Institute for Animal Health [BBS/E/I/00001410]; BBSRC [BBS/E/I/00001410] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001410] Funding Source: researchfish; Natural Environment Research Council [smru10001] Funding Source: researchfish	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC from the Institute for Animal Health(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the UK Natural Environment Research Council and a BBSRC Fellowship awarded to JAH from the Institute for Animal Health, BBSRC grant number BBS/E/I/00001410. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; Alende N, 2011, PROTEINS, V79, P1635, DOI 10.1002/prot.22990; Arnason U, 2002, CYTOGENET GENOME RES, V96, P20, DOI 10.1159/000063023; Arnason U, 2006, MOL PHYLOGENET EVOL, V41, P345, DOI 10.1016/j.ympev.2006.05.022; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BOWEN WD, 1992, PHYSIOL ZOOL, V65, P844, DOI 10.1086/physzool.65.4.30158543; Cao Y, 2000, GENE, V259, P149, DOI 10.1016/S0378-1119(00)00427-3; DENISON DM, 1973, RESP PHYSIOL, V17, P1, DOI 10.1016/0034-5687(73)90105-9; Denver RJ, 2011, NEUROENDOCRINOLOGY, V94, P21, DOI 10.1159/000328435; Fong TM, 1998, MOL PHARMACOL, V53, P234, DOI 10.1124/mol.53.2.234; Fruhbeck G, 1998, CLIN PHYSIOL, V18, P399, DOI 10.1046/j.1365-2281.1998.00129.x; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hamann A, 1996, EXP CLIN ENDOCR DIAB, V104, P293, DOI 10.1055/s-0029-1211457; HAMMILL MO, 1991, CAN J FISH AQUAT SCI, V48, P2471, DOI 10.1139/f91-288; Hammond JA, 2005, AM J PHYSIOL-REG I, V289, pR545, DOI 10.1152/ajpregu.00203.2004; Harvey J, 2003, NEUROPHARMACOLOGY, V44, P845, DOI 10.1016/S0028-3908(03)00076-5; HINDELL MA, 1992, CAN J ZOOL, V70, P370, DOI 10.1139/z92-055; Iserentant H, 2005, J CELL SCI, V118, P2519, DOI 10.1242/jcs.02386; Kirwin SM, 2006, PEDIATR RES, V60, P200, DOI 10.1203/01.pdr.0000227478.29271.52; Kooyman GL, 2006, MAR MAMMAL SCI, V22, P507, DOI 10.1111/j.1748-7692.2006.00069.x; KOOYMAN GL, 1973, AM ZOOL, V13, P457; KOVACS KM, 1991, J ZOOL, V223, P213, DOI 10.1111/j.1469-7998.1991.tb04761.x; Krol E, 2007, J ENDOCRINOL, V192, P271, DOI 10.1677/JOE-06-0074; Li XS, 2007, PHYSIOL BIOCHEM ZOOL, V80, P326, DOI 10.1086/513189; Pabst D.A., 1999, MARINE MAMMALS, P15; Peelman F, 2004, J BIOL CHEM, V279, P41038, DOI 10.1074/jbc.M404962200; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Sato K, 2002, POLAR BIOL, V25, P696, DOI 10.1007/s00300-002-0406-7; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Teodorescu O, 2004, PROTEINS, V54, P41, DOI 10.1002/prot.10474; Torday JS, 2002, AM J PHYSIOL-LUNG C, V282, pL405, DOI 10.1152/ajplung.2002.282.3.L405; Torday JS, 2002, AM J PHYSIOL-LUNG C, V283, pL130, DOI 10.1152/ajplung.00380.2001; Tsuchiya T, 1999, EUR J PHARMACOL, V365, P273, DOI 10.1016/S0014-2999(98)00884-X; Wheatley KE, 2008, OECOLOGIA, V155, P11, DOI 10.1007/s00442-007-0888-7; Yang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001472; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026579; Yuan LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027189; Zhang FM, 1997, NATURE, V387, P206, DOI 10.1038/387206a0	40	8	8	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35395	10.1371/journal.pone.0035395	http://dx.doi.org/10.1371/journal.pone.0035395			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536379	Green Published, gold, Green Accepted			2022-12-25	WOS:000305336200038
J	Johannesen, E; Hoines, AS; Dolgov, AV; Fossheim, M				Johannesen, Edda; Hoines, Age S.; Dolgov, Andrey V.; Fossheim, Maria			Demersal Fish Assemblages and Spatial Diversity Patterns in the Arctic-Atlantic Transition Zone in the Barents Sea	PLOS ONE			English	Article							SPECIES-RICHNESS; BIODIVERSITY; RANGE; SCALE; SIZE; CATCHABILITY; GRADIENTS; COMMUNITY; TRAWL	Direct and indirect effects of global warming are expected to be pronounced and fast in the Arctic, impacting terrestrial, freshwater and marine ecosystems. The Barents Sea is a high latitude shelf Sea and a boundary area between arctic and boreal faunas. These faunas are likely to respond differently to changes in climate. In addition, the Barents Sea is highly impacted by fisheries and other human activities. This strong human presence places great demands on scientific investigation and advisory capacity. In order to identify basic community structures against which future climate related or other human induced changes could be evaluated, we analyzed species composition and diversity of demersal fish in the Barents Sea. We found six main assemblages that were separated along depth and temperature gradients. There are indications that climate driven changes have already taken place, since boreal species were found in large parts of the Barents Sea shelf, including also the northern Arctic area. When modelling diversity as a function of depth and temperature, we found that two of the assemblages in the eastern Barents Sea showed lower diversity than expected from their depth and temperature. This is probably caused by low habitat complexity and the distance to the pool of boreal species in the western Barents Sea. In contrast coastal assemblages in south western Barents Sea and along Novaya Zemlya archipelago in the Eastern Barents Sea can be described as diversity "hotspots"; the South-western area had high density of species, abundance and biomass, and here some species have their northern distribution limit, whereas the Novaya Zemlya area has unique fauna of Arctic, coastal demersal fish. (see Information S1 for abstract in Russian).	[Johannesen, Edda] Inst Marine Res, Ecosyst Proc Res Grp, N-5024 Bergen, Norway; [Hoines, Age S.] Inst Marine Res, Pelag Fish Res Grp, N-5024 Bergen, Norway; [Dolgov, Andrey V.] Polar Res Inst Marine Fisheries & Oceanog, Lab Trophol, Murmansk, Russia; [Fossheim, Maria] Inst Marine Res, Ecosyst Proc Res Grp, Tromso, Norway	Institute of Marine Research - Norway; Institute of Marine Research - Norway; Research lnstitute of Fisheries & Oceanography; Institute of Marine Research - Norway	Johannesen, E (corresponding author), Inst Marine Res, Ecosyst Proc Res Grp, POB 1870, N-5024 Bergen, Norway.	eddaj@imr.no	Fossheim, Maria/B-7134-2014; Dolgov, Andrey/D-3708-2012	Dolgov, Andrey/0000-0002-4806-3284	Russian Federation; government in Russian; government in Norway; Norwegian Research Council (NRC) [200793/S30]	Russian Federation(Russian Federation); government in Russian; government in Norway; Norwegian Research Council (NRC)(Research Council of Norway)	The data collecting took place on a joint survey supported by governmental funding from the Russian Federation and Norway. The scientific work and cooperation was also funded by the governments in Russian and Norway, part of this through a project funded by the Norwegian Research Council (NRC contract number 200793/S30). No further external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriashev A.P., 1995, VOP IKHTIOL, V35, P81; Andriyashev A. P., 1954, FISHES NO SEAS USSR; [Anonymous], 2009, IMR PINRO JOINT REPO; Arctic Climate Impact Assessment (ACIA), ARCT CLIM IMP ASS AC; Berg LS, 1939, P DED SCI ACT NM KNI, P207; BERGSTAD OA, 1987, FISH RES, V5, P119, DOI 10.1016/0165-7836(87)90037-3; Bergstad OA, 2002, ENCY OCEAN SCI, P710; Burgos GE, 1989, THESIS U BERGEN; Byrkjedal I, 2007, POLAR RES, V26, P135, DOI 10.1111/J.1751-8369.2007.00030.x; Carrara R, 2010, ECOGRAPHY, V33, P942, DOI 10.1111/j.1600-0587.2009.05756.x; Chernova NV, 1994, ENV ECOSYSTEMS F JOS, P177; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Clifford H.T., 1975, INTRO NUMERICAL CLAS; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Danovaro R, 2008, ECOGRAPHY, V31, P231, DOI 10.1111/j.0906-7590.2008.5484.x; Dinter WP., 2001, BIOGEOGRAPHY OSPAR M; Dolgov, 2006, J ICHTHYOL+, V46, P139, DOI [10.1134/S0032945206020019, DOI 10.1134/S0032945206020019]; Dolgov A., 2004, INVESTIGATIONS PINRO, P230; Dolgov AV, 2010, 2009E ICES CM; Dolgov AV, 2011, BARENTS SEA ECOSYSTE, P193; Dulvy NK, 2004, FISH FISH, V5, P255, DOI 10.1111/j.1467-2679.2004.00158.x; Ehrich S, 2009, FISH OCEANOGR, V18, P36, DOI 10.1111/j.1365-2419.2008.00495.x; EKMAN S, 1967, ZOOGEOGRAPHY SEA; Ellis JR, 2000, ESTUAR COAST SHELF S, V51, P299, DOI 10.1006/ecss.2000.0677; ENGAS A, 1989, J CONSEIL, V45, P269; Essipov V. K., 1952, FISHES KARA SEA; Evans KL, 2005, BIOL REV, V80, P1, DOI 10.1017/S1464793104006517; FIELD JG, 1982, MAR ECOL PROG SER, V8, P37, DOI 10.3354/meps008037; Fisher JAD, 2010, ECOLOGY, V91, P2499, DOI 10.1890/09-1914.1; Fossheim A, 2006, MAR BIOL RES, V2, P260, DOI 10.1080/17451000600815698; Fraser HM, 2007, ICES J MAR SCI, V64, P1800, DOI 10.1093/icesjms/fsm145; Gabriel Wendy L., 1992, Journal of Northwest Atlantic Fishery Science, V14, P29; GAUCH HG, 1981, J ECOL, V69, P537, DOI 10.2307/2259682; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Gratwicke B, 2005, J FISH BIOL, V66, P650, DOI 10.1111/j.0022-1112.2005.00629.x; Greenstreet SPR, 2008, ICES J MAR SCI, V65, P1515, DOI 10.1093/icesjms/fsn102; Harley SJ, 2001, CAN J FISH AQUAT SCI, V58, P1569, DOI 10.1139/cjfas-58-8-1569; Hillebrand H, 2004, MAR ECOL PROG SER, V273, P251, DOI 10.3354/meps273251; Hjermann DO, 2007, MAR ECOL PROG SER, V339, P283, DOI 10.3354/meps339283; Hopkins CC, 1990, POLAR RES, V10, P12; Jakobsen T., 2011, BARENTS SEA ECOSYSTE; Jennings S, 1999, J ANIM ECOL, V68, P617, DOI 10.1046/j.1365-2656.1999.00312.x; Johannesen E, 2012, ICES J MAR SCI, V69, P880, DOI 10.1093/icesjms/fss046; Karamushko OV, 2008, J ICHTHYOL, V48, P293; Karamushko OV, 2003, J ICHTHYOL+, V43, P464; Kendall VJ, 2006, DEEP-SEA RES PT I, V53, P506, DOI 10.1016/j.dsr.2005.12.005; Knijn RJ, 1993, 194 ICES COOP, P268; Levitus S, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039847; LOENG H, 1991, POLAR RES, V10, P5, DOI 10.1111/j.1751-8369.1991.tb00630.x; Macpherson E, 2002, P ROY SOC B-BIOL SCI, V269, P1715, DOI 10.1098/rspb.2002.2091; MACPHERSON E, 1994, ECOGRAPHY, V17, P242, DOI 10.1111/j.1600-0587.1994.tb00099.x; Magurran AE, 2010, TRENDS ECOL EVOL, V25, P574, DOI 10.1016/j.tree.2010.06.016; Mecklenburg Catherine W., 2011, Marine Biodiversity, V41, P109, DOI 10.1007/s12526-010-0070-z; Narayanaswamy BE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014295; Norcross BL, 2010, DEEP-SEA RES PT II, V57, P57, DOI 10.1016/j.dsr2.2009.08.006; Ojaveer H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012467; Oksanen J., MULTIVARIATE ANAL EC; Pinnegar J, 2010, CHARTING PROGR, P378; Reiss H, 2010, ICES J MAR SCI, V67, P278, DOI 10.1093/icesjms/fsp253; Rice J, 1996, ICES J MAR SCI, V53, P1214, DOI 10.1006/jmsc.1996.0146; Smirnov OV, 2000, P FIN SESS PINRO SCI, P79; Smith JM, 2012, ECOL INDIC, V13, P253, DOI 10.1016/j.ecolind.2011.06.009; Smith KF, 2002, GLOBAL ECOL BIOGEOGR, V11, P313, DOI 10.1046/j.1466-822X.2002.00286.x; Sousa P, 2005, FISH RES, V75, P120, DOI 10.1016/j.fishres.2005.03.012; Stefansdottir L, 2010, FISH OCEANOGR, V19, P42, DOI 10.1111/j.1365-2419.2009.00527.x; Thrush SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011899; Wienerroither R, 2011, IMR PINRO JOINT REPO, V1-2011; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zenkevich L.A., 1963, BIOL SEAS USSR	71	44	48	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34924	10.1371/journal.pone.0034924	http://dx.doi.org/10.1371/journal.pone.0034924			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22545093	Green Published, Green Submitted, gold			2022-12-25	WOS:000305347400025
J	Law, ME; Corsino, PE; Jahn, SC; Davis, BJ; Chen, S; Patel, B; Pham, K; Lu, J; Sheppard, B; Norgaard, P; Hong, J; Higgins, P; Kim, JS; Luesch, H; Law, BK				Law, M. E.; Corsino, P. E.; Jahn, S. C.; Davis, B. J.; Chen, S.; Patel, B.; Pham, K.; Lu, J.; Sheppard, B.; Norgaard, P.; Hong, J.; Higgins, P.; Kim, J-S; Luesch, H.; Law, B. K.			Glucocorticoids and histone deacetylase inhibitors cooperate to block the invasiveness of basal-like breast cancer cells through novel mechanisms	ONCOGENE			English	Article						E-cadherin; breast cancer; invasion; glucocorticoid; HDAC inhibitor; PAI-1	DOMAIN-CONTAINING PROTEIN-1; EPITHELIAL TUMOR-CELLS; E-CADHERIN; TYROSINE PHOSPHORYLATION; BETA-CATENIN; BIOLOGICAL SIGNIFICANCE; ADHERENS JUNCTIONS; LOBULAR CARCINOMA; STATISTICAL-MODEL; DOWN-REGULATION	Aggressive cancers often express E-cadherin in cytoplasmic vesicles rather than on the plasma membrane and this may contribute to the invasive phenotype of these tumors. Therapeutic strategies are not currently available that restore the anti-invasive function of E-cadherin in cancers. MDA-MB-231 cells are a frequently used model of invasive triple-negative breast cancer, and these cells express low levels of E-cadherin that is mislocalized to cytoplasmic vesicles. MDA-MB-231 cell lines stably expressing wild-type E-cadherin or E-cadherin fused to glutathione S-transferase or green fluorescent protein were used as experimental systems to probe the mechanisms responsible for cytoplasmic E-cadherin localization in invasive cancers. Although E-cadherin expression partly reduced cell invasion in vitro, E-cadherin was largely localized to the cytoplasm and did not block the invasiveness of the corresponding orthotopic xenograft tumors. Further studies indicated that the glucocorticoid dexamethasone and the highly potent class I histone deacetylase (HDAC) inhibitor largazole cooperated to induce E-cadherin localization to the plasma membrane in triple-negative breast cancers, and to suppress cellular invasion in vitro. Dexamethasone blocked the production of the cleaved form of the CDCP1 (that is, CUB domain-containing protein 1) protein (cCDCP1) previously implicated in the pro-invasive activities of CDCP1 by upregulating the serine protease inhibitor plasminogen activator inhibitor-1. E-cadherin preferentially associated with cCDCP1 compared with the full-length form. In contrast, largazole did not influence CDCP1 cleavage, but increased the association of E-cadherin with gamma-catenin. This effect on E-cadherin/gamma-catenin complexes was shared with the nonisoform selective HDAC inhibitors trichostatin A (TSA) and vorinostat (suberoylanilide hydroxamic acid, SAHA), although largazole upregulated endogenous E-cadherin levels more strongly than TSA. These results demonstrate that glucocorticoids and HDAC inhibitors, both of which are currently in clinical use, cooperate to suppress the invasiveness of breast cancer cells through novel, complementary mechanisms that converge on E-cadherin. Oncogene (2013) 32, 1316-1329; doi:10.1038/onc.2012.138; published online 30 April 2012	[Law, M. E.; Corsino, P. E.; Jahn, S. C.; Davis, B. J.; Pham, K.; Kim, J-S; Law, B. K.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Law, M. E.; Corsino, P. E.; Jahn, S. C.; Davis, B. J.; Patel, B.; Pham, K.; Lu, J.; Kim, J-S; Luesch, H.; Law, B. K.] Univ Florida, UF & Shands Canc Ctr, Gainesville, FL 32610 USA; [Chen, S.] Univ Florida, Dept Biol, Gainesville, FL 32610 USA; [Patel, B.; Lu, J.] Univ Florida, Dept Biochem, Gainesville, FL 32610 USA; [Sheppard, B.] Univ Florida, Dept Infect Dis & Pathol, Gainesville, FL 32610 USA; [Norgaard, P.] Univ Copenhagen, Herlev Hosp, Dept Pathol, DK-2730 Herlev, Denmark; [Hong, J.] Duke Univ, Dept Chem, Durham, NC 27706 USA; [Higgins, P.] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA; [Kim, J-S] Univ Florida, Dept Surg, Gainesville, FL 32610 USA; [Luesch, H.] Univ Florida, Dept Med Chem, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Copenhagen; Herlev & Gentofte Hospital; Duke University; Albany Medical College; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Law, BK (corresponding author), Univ Florida, Dept Pharmacol & Therapeut, 1600 SW Archer Rd,Acad Res Bldg,Room R5-210,POB 1, Gainesville, FL 32610 USA.	bklaw@pharmacology.ufl.edu	Law, Brian/L-6043-2019; Lu, Jianrong/F-5240-2013	Lu, Jianrong/0000-0002-4969-6040	Komen for the Cure grant [KG080510]; Florida Department of Health [07BB-8, 09BB-10]; NIH [R01CA138544, DK079879, GM057242]; NATIONAL CANCER INSTITUTE [R01CA138544, R01CA093651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090115, R01DK079879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057242] Funding Source: NIH RePORTER	Komen for the Cure grant; Florida Department of Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr Al Reynolds, Vanderbilt University, Nashville, TN for generously providing the E-cadherin/LZRS and pMS vectors and for instruction regarding their use. The Proteomics Division at the Interdisciplinary Center for Biotechnology Research (ICBR) (http://www.biotech.ufl.edu/proteomics/) is acknowledged for the mass spectrometry analysis. This work was supported in part by Komen for the Cure grant KG080510 and Florida Department of Health grants 07BB-8 and 09BB-10 to B Law, and NIH grants R01CA138544 (H Luesch and J Hong), DK079879 (J-S Kim), and GM057242 (PJ Higgins).	Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; Benes CH, 2012, ONCOGENE, V31, P653, DOI 10.1038/onc.2011.262; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Bhatt AS, 2005, ONCOGENE, V24, P5333, DOI 10.1038/sj.onc.1208582; Boulos F, 2011, AM J SURG PATHOL, V35, P154, DOI 10.1097/PAS.0b013e3182028f79; Brown TA, 2004, J BIOL CHEM, V279, P14772, DOI 10.1074/jbc.M309678200; BUSE P, 1995, J BIOL CHEM, V270, P28223; BUSSO N, 1987, CANCER RES, V47, P364; Casar B, 2012, ONCOGENE, V31, P3924, DOI 10.1038/onc.2011.555; Chytil A, 2004, J BIOL CHEM, V279, P47688, DOI 10.1074/jbc.M405938200; Cole KE, 2011, J AM CHEM SOC, V133, P12474, DOI 10.1021/ja205972n; Corsino PE, 2008, NEOPLASIA, V10, P1240, DOI 10.1593/neo.08710; Cowin P, 2005, CURR OPIN CELL BIOL, V17, P499, DOI 10.1016/j.ceb.2005.08.014; Daniel JM, 2007, BBA-MOL CELL RES, V1773, P59, DOI 10.1016/j.bbamcr.2006.08.052; Dawson S J, 2009, Eur J Cancer, V45 Suppl 1, P27, DOI 10.1016/S0959-8049(09)70013-9; Facina G, 2010, DIAGN CYTOPATHOL, V38, P235, DOI 10.1002/dc.21181; Feltes CM, 2002, CANCER RES, V62, P6688; Gomez-Hernandez J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-692; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; He Y, 2010, J BIOL CHEM, V285, P26162, DOI 10.1074/jbc.M109.096453; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Hiscox S, 1999, BIOCHEM BIOPH RES CO, V261, P406, DOI 10.1006/bbrc.1999.1002; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Law BK, 2002, MOL CELL BIOL, V22, P8184, DOI 10.1128/MCB.22.23.8184-8198.2002; Law M, 2006, CANCER RES, V66, P1070, DOI 10.1158/0008-5472.CAN-05-1672; Levy L, 2004, MOL CELL BIOL, V24, P3404, DOI 10.1128/MCB.24.8.3404-3414.2004; Lewis JE, 1997, J CELL BIOL, V136, P919, DOI 10.1083/jcb.136.4.919; Liu H, 2011, P NATL ACAD SCI USA, V108, P1379, DOI 10.1073/pnas.1017228108; Liu YX, 2010, J PHARMACOL EXP THER, V335, P351, DOI 10.1124/jpet.110.172387; Lombaerts M, 2006, BRIT J CANCER, V94, P661, DOI 10.1038/sj.bjc.6602996; MATSUYOSHI N, 1992, J CELL BIOL, V118, P703, DOI 10.1083/jcb.118.3.703; Meyers MO, 2011, ANN SURG ONCOL, V18, P2851, DOI 10.1245/s10434-011-1665-8; Miyagawa R, 2010, CORONARY ARTERY DIS, V21, P144, DOI 10.1097/MCA.0b013e328335790e; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; NORDT TK, 1995, CIRCULATION, V91, P764, DOI 10.1161/01.CIR.91.3.764; Ou JN, 2007, BIOCHEM PHARMACOL, V73, P1297, DOI 10.1016/j.bcp.2006.12.032; Pan D, 2011, CANCER RES, V71, P6360, DOI 10.1158/0008-5472.CAN-11-0362; Papageorgis P, 2010, CANCER RES, V70, P968, DOI 10.1158/0008-5472.CAN-09-1872; Pazaiti A, 2011, WOMENS HEALTH, V7, P181, DOI [10.2217/whe.11.5, 10.2217/WHE.11.5]; Pishvaian MJ, 1999, CANCER RES, V59, P947; Querzoli P, 2010, BRIT J CANCER, V103, P1835, DOI 10.1038/sj.bjc.6605991; Rakha EA, 2010, AM J SURG PATHOL, V34, P1472, DOI 10.1097/PAS.0b013e3181f01916; Rubenstein NM, 2003, J BIOL CHEM, V278, P10353, DOI 10.1074/jbc.M213121200; Sheffield J, 2006, PROTEOMICS, V6, P1588, DOI 10.1002/pmic.200500503; Singh R, 2009, EXP CELL RES, V315, P2899, DOI 10.1016/j.yexcr.2009.07.002; Smith AL, 2012, MOL BIOL CELL, V23, P99, DOI 10.1091/mbc.E11-06-0497; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Taori K, 2008, J AM CHEM SOC, V130, P1806, DOI 10.1021/ja7110064; Uekita T, 2008, AM J PATHOL, V172, P1729, DOI 10.2353/ajpath.2008.070981; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Wolf D, 2002, J BIOL CHEM, V277, P25562, DOI 10.1074/jbc.M201196200; Wong AST, 2003, J CELL BIOL, V161, P1191, DOI 10.1083/jcb.200212033; Wong CH, 2009, CLIN CANCER RES, V15, P2311, DOI 10.1158/1078-0432.CCR-08-2533; Wortmann A, 2011, J BIOL CHEM, V286, P42303, DOI 10.1074/jbc.M111.227462; Ying YC, 2008, ORG LETT, V10, P4021, DOI 10.1021/ol801532s; Ying YC, 2008, J AM CHEM SOC, V130, P8455, DOI 10.1021/ja8013727; ZETTL KS, 1992, P NATL ACAD SCI USA, V89, P9069, DOI 10.1073/pnas.89.19.9069; Zhang XC, 2009, PATHOL RES PRACT, V205, P375, DOI 10.1016/j.prp.2008.08.009; Zhu MM, 2010, J PROTEOMICS, V73, P790, DOI 10.1016/j.jprot.2009.11.002	64	58	58	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 7	2013	32	10					1316	1329		10.1038/onc.2012.138	http://dx.doi.org/10.1038/onc.2012.138			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110OP	22543582	Green Accepted			2022-12-25	WOS:000316454500012
J	Carlson, AL; Florek, CA; Kim, JJ; Neubauer, T; Moore, JC; Cohen, RI; Kohn, J; Grumet, M; Moghe, PV				Carlson, Aaron L.; Florek, Charles A.; Kim, Joseph J.; Neubauer, Thomas; Moore, Jennifer C.; Cohen, Rick I.; Kohn, Joachim; Grumet, Martin; Moghe, Prabhas V.			Microfibrous substrate geometry as a critical trigger for organization, self-renewal, and differentiation of human embryonic stem cells within synthetic 3-dimensional microenvironments	FASEB JOURNAL			English	Article						fibrous scaffolds; poly-D-lysine; tissue engineering	DIRECTED DIFFERENTIATION; MATRIX; CULTURE; SURFACES; TYROSINE; LINES; POLYCARBONATES; DERIVATION; SCAFFOLDS; POLYMERS	Substrates used to culture human embryonic stem cells (hESCs) are typically 2-dimensional (2-D) in nature, with limited ability to recapitulate in vivo-like 3-dimensional (3-D) microenvironments. We examined critical determinants of hESC self-renewal in poly-D-lysine-pretreated synthetic polymer-based substrates with variable microgeometries, including planar 2-D films, macroporous 3-D sponges, and microfibrous 3-D fiber mats. Completely synthetic 2-D substrates and 3-D macroporous scaffolds failed to retain hESCs or support self-renewal or differentiation. However, synthetic microfibrous geometries made from electrospun polymer fibers were found to promote cell adhesion, viability, proliferation, self-renewal, and directed differentiation of hESCs in the absence of any exogenous matrix proteins. Mechanistic studies of hESC adhesion within microfibrous scaffolds indicated that enhanced cell confinement in such geometries increased cell-cell contacts and altered colony organization. Moreover, the microfibrous scaffolds also induced hESCs to deposit and organize extracellular matrix proteins like laminin such that the distribution of laminin was more closely associated with the cells than the Matrigel treatment, where the laminin remained associated with the coated fibers. The production of and binding to laminin was critical for formation of viable hESC colonies on synthetic fibrous scaffolds. Thus, synthetic substrates with specific 3-D microgeometries can support hESC colony formation, self-renewal, and directed differentiation to multiple lineages while obviating the stringent needs for complex, exogenous matrices. Similar scaffolds could serve as tools for developmental biology studies in 3-D and for stem cell differentiation in situ and transplantation using defined humanized conditions.-Carlson, A. L., Florek, C. A., Kim, J. J., Neubauer, T., Moore, J. C., Cohen, R. I., Kohn, J., Grumet, M., Moghe, P. V. Microfibrous substrate geometry as a critical trigger for organization, self-renewal, and differentiation of human embryonic stem cells within synthetic 3-dimensional microenvironments. FASEB J. 26, 3240-3251 (2012). www.fasebj.org	[Carlson, Aaron L.; Florek, Charles A.; Kim, Joseph J.; Neubauer, Thomas; Moghe, Prabhas V.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA; [Florek, Charles A.; Kohn, Joachim] Rutgers State Univ, New Jersey Ctr Biomat, Piscataway, NJ 08854 USA; [Moore, Jennifer C.; Cohen, Rick I.; Grumet, Martin] Rutgers State Univ, Rutgers Univ Stem Cell Res Ctr, Piscataway, NJ 08854 USA; [Moore, Jennifer C.; Cohen, Rick I.; Grumet, Martin] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; [Moore, Jennifer C.; Cohen, Rick I.; Grumet, Martin] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; [Kohn, Joachim] Rutgers State Univ, Dept Chem & Chem Engn, Piscataway, NJ 08854 USA; [Moghe, Prabhas V.] Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Moghe, PV (corresponding author), Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.	moghe@rci.rutgers.edu	grumet, martin/ABC-6462-2020		New Jersey Commission on Science and Technology Stem Cell Core grant; U.S. National Institutes of Health grant [EB000146]; New Jersey Commission on Spinal Cord Research exploratory grant [10-3090-SCR-E-0]; National Science Foundation Integrative Graduate Education and Research Traineeship grant [0801620]	New Jersey Commission on Science and Technology Stem Cell Core grant; U.S. National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Commission on Spinal Cord Research exploratory grant; National Science Foundation Integrative Graduate Education and Research Traineeship grant	The authors gratefully acknowledge support from the New Jersey Commission on Science and Technology Stem Cell Core grant (principal investigators P.V.M. and M.G.), U.S. National Institutes of Health grant EB000146 (RESBIO: Integrated Resource for Polymeric Materials; principal investigators P.V.M. and J.K.), New Jersey Commission on Spinal Cord Research exploratory grant 10-3090-SCR-E-0 (principal investigator P.V.M.), and National Science Foundation Integrative Graduate Education and Research Traineeship grant 0801620 (Stem Cell Science and Engineering; principal investigator P.V.M.).	Bahney CS, 2011, FASEB J, V25, P1486, DOI 10.1096/fj.10-165514; Bajpai R, 2008, MOL REPROD DEV, V75, P818, DOI 10.1002/mrd.20809; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bongso A, 2008, J CELL BIOCHEM, V105, P1352, DOI 10.1002/jcb.21957; Bourke SL, 2003, ADV DRUG DELIVER REV, V55, P447, DOI 10.1016/S0169-409X(03)00038-3; Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291; Brafman DA, 2010, BIOMATERIALS, V31, P9135, DOI 10.1016/j.biomaterials.2010.08.007; Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131; Cao HQ, 2009, ADV DRUG DELIVER REV, V61, P1055, DOI 10.1016/j.addr.2009.07.009; Carlberg B, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045004; Chen YF, 2012, HEPATOLOGY, V55, P1193, DOI 10.1002/hep.24790; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; ERTEL SI, 1994, J BIOMED MATER RES, V28, P919, DOI 10.1002/jbm.820280811; Ferreira LS, 2007, BIOMATERIALS, V28, P2706, DOI 10.1016/j.biomaterials.2007.01.021; Gao SY, 2010, J BIOMED MATER RES A, V92A, P683, DOI 10.1002/jbm.a.32401; Gauthaman K, 2009, J CELL MOL MED, V13, P3475, DOI 10.1111/j.1582-4934.2009.00699.x; Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104; Hu BY, 2010, METHODS MOL BIOL, V636, P123, DOI 10.1007/978-1-60761-691-7_8; Huang HR, 2006, BIOCHEM BIOPH RES CO, V351, P321, DOI 10.1016/j.bbrc.2006.09.171; Lee J, 2008, TISSUE ENG PART B-RE, V14, P61, DOI 10.1089/teb.2007.0150; Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100; Li ZS, 2010, BIOMATERIALS, V31, P404, DOI 10.1016/j.biomaterials.2009.09.070; Lim SH, 2010, BIOMATERIALS, V31, P9031, DOI 10.1016/j.biomaterials.2010.08.021; Lim SH, 2009, ADV DRUG DELIVER REV, V61, P1084, DOI 10.1016/j.addr.2009.07.011; Liu E, 2007, J BIOMED MATER RES B, V82B, P284, DOI 10.1002/jbm.b.30732; Liu H, 2006, BIOMATERIALS, V27, P5978, DOI 10.1016/j.biomaterials.2006.05.053; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Mahairaki V, 2011, TISSUE ENG PT A, V17, P855, DOI 10.1089/ten.TEA.2010.0377; McDevitt TC, 2008, CURR OPIN BIOTECH, V19, P527, DOI 10.1016/j.copbio.2008.08.005; Meechaisue C, 2006, J BIOMAT SCI-POLYM E, V17, P1039, DOI 10.1163/156856206778365988; Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629; Meng Y, 2010, FASEB J, V24, P1056, DOI 10.1096/fj.08-126821; Miyazaki T, 2008, BIOCHEM BIOPH RES CO, V375, P27, DOI 10.1016/j.bbrc.2008.07.111; Nat R, 2007, GLIA, V55, P385, DOI 10.1002/glia.20463; Ouyang A, 2007, STEM CELLS, V25, P447, DOI 10.1634/stemcells.2006-0322; Ranucci CS, 2000, BIOMATERIALS, V21, P783, DOI 10.1016/S0142-9612(99)00238-0; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Sands RW, 2007, CURR OPIN BIOTECH, V18, P448, DOI 10.1016/j.copbio.2007.10.004; Shahbazi E, 2011, TISSUE ENG PT A, V17, P3021, DOI [10.1089/ten.tea.2011.0121, 10.1089/ten.TEA.2011.0121]; Smith LA, 2010, BIOMATERIALS, V31, P5526, DOI 10.1016/j.biomaterials.2010.03.065; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; Tai BCU, 2010, BIOMATERIALS, V31, P5927, DOI 10.1016/j.biomaterials.2010.04.003; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107; Villa-Diaz LG, 2010, NAT BIOTECHNOL, V28, P581, DOI 10.1038/nbt.1631; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Yang F, 2010, BIOMACROMOLECULES, V11, P1909, DOI 10.1021/bm100357t; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103	52	43	43	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2012	26	8					3240	3251		10.1096/fj.11-192732	http://dx.doi.org/10.1096/fj.11-192732			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22542683	Green Published			2022-12-25	WOS:000307162800015
J	Gwozdz, T; Dutko-Gwozdz, J; Schafer, C; Bolotina, VM				Gwozdz, Tomasz; Dutko-Gwozdz, Joanna; Schafer, Claudia; Bolotina, Victoria M.			Overexpression of Orai1 and STIM1 Proteins Alters Regulation of Store-operated Ca2+ Entry by Endogenous Mediators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-INDEPENDENT PHOSPHOLIPASE A(2); CALCIUM INFLUX FACTOR; CHANNEL ACTIVATION; CRAC CHANNELS; MECHANISM; DEPLETION; DOMAINS; PATHWAY; COMPLEX; CELLS	Orai1 and STIM1 have been identified as the main determinants of the store-operated Ca2+ entry (SOCE). Their specific roles in SOCE and their molecular interactions have been studied extensively following heterologous overexpression or molecular knockdown and extrapolated to the endogenous processes in naive cells. Using molecular and imaging techniques, we found that variation of expression levels of Orai1 or STIM1 can significantly alter expression and role of some endogenous regulators of SOCE. Although functional inhibition of Ca2+-independent phospholipase A(2) beta (iPLA(2)beta or PLA2g6A), or depletion of plasma membrane cholesterol caused a dramatic loss of endogenous SOCE in HEK293 cells, these effects were attenuated significantly when either Orai1 or STIM1 were overexpressed. Molecular knockdown of iPLA(2)beta impaired SOCE in both control cells and cells overexpressing STIM1. We also discovered important cross-talk between expression of Orai1 and a specific plasma membrane variant of iPLA(2)beta but not STIM1. These data confirm the role of iPLA(2)beta as an essential mediator of endogenous SOCE and demonstrate that its physiological role can be obscured by Orai1 and STIM1 overexpression.	[Gwozdz, Tomasz; Dutko-Gwozdz, Joanna; Schafer, Claudia; Bolotina, Victoria M.] Boston Univ, Sch Med, Dept Med, Ion Channel & Calcium Signaling Unit, Boston, MA 02118 USA	Boston University	Bolotina, VM (corresponding author), Boston Univ, Sch Med, Dept Med, Ion Channel & Calcium Signaling Unit, 650 Albany St,X-704, Boston, MA 02118 USA.	bolotina@bu.edu		Bolotina, Victoria/0000-0001-5862-181X	National Institutes of Health [RO1HL54150, RO1HL71793]; Cellular Imaging Core in the Department of Medicine of the Boston University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054150, R01HL071793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cellular Imaging Core in the Department of Medicine of the Boston University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1HL54150 and RO1HL71793. This work was also supported by the Cellular Imaging Core in the Department of Medicine of the Boston University School of Medicine.	Boittin FX, 2006, J CELL SCI, V119, P3733, DOI 10.1242/jcs.03184; Boittin FX, 2008, AM J PHYSIOL-HEART C, V295, pH2466, DOI 10.1152/ajpheart.00639.2008; Bolotina VM, 2008, J PHYSIOL-LONDON, V586, P3035, DOI 10.1113/jphysiol.2008.154997; Clapham DE, 2009, CELL, V136, P814, DOI 10.1016/j.cell.2009.02.022; Csutora P, 2008, J BIOL CHEM, V283, P14524, DOI 10.1074/jbc.M709575200; Csutora P, 2006, J BIOL CHEM, V281, P34926, DOI 10.1074/jbc.M606504200; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; DeHaven WI, 2009, J PHYSIOL-LONDON, V587, P2275, DOI 10.1113/jphysiol.2009.170431; Derler I, 2008, EXPERT OPIN DRUG DIS, V3, P787, DOI 10.1517/17460441.3.7.787; Fahmer M, 2009, IMMUNOL REV, V231, P99, DOI 10.1111/j.1600-065X.2009.00815.x; Feske S, 2010, PFLUG ARCH EUR J PHY, V460, P417, DOI 10.1007/s00424-009-0777-5; Feske S, 2009, IMMUNOL REV, V231, P189, DOI 10.1111/j.1600-065X.2009.00818.x; Frischauf I, 2008, CHANNELS, V2, P261, DOI 10.4161/chan.2.4.6705; Gwozdz T, 2008, AM J PHYSIOL-CELL PH, V295, pC1133, DOI 10.1152/ajpcell.00306.2008; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Kato N, 2003, BIOCHEMISTRY-US, V42, P11808, DOI 10.1021/bi034758h; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Martinez J, 2005, BIOCHEM PHARMACOL, V70, P733, DOI 10.1016/j.bcp.2005.04.045; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Ross K, 2007, J CELL PHYSIOL, V211, P569, DOI 10.1002/jcp.20993; Schindl R, 2009, CELL CALCIUM, V46, P227, DOI 10.1016/j.ceca.2009.08.003; Singaravelu K, 2006, J NEUROSCI, V26, P9579, DOI 10.1523/JNEUROSCI.2604-06.2006; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Smani T, 2003, J BIOL CHEM, V278, P11909, DOI 10.1074/jbc.M210878200; Smyth JT, 2008, J CELL SCI, V121, P762, DOI 10.1242/jcs.023903; Vanden Abeele F, 2004, J BIOL CHEM, V279, P30326, DOI 10.1074/jbc.M400106200; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842	37	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22865	22872		10.1074/jbc.M112.356626	http://dx.doi.org/10.1074/jbc.M112.356626			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22549787	Green Published, hybrid			2022-12-25	WOS:000306495000043
J	Benabbas, A; Karunakaran, V; Youn, H; Poulos, TL; Champion, PM				Benabbas, Abdelkrim; Karunakaran, Venugopal; Youn, Hwan; Poulos, Thomas L.; Champion, Paul M.			Effect of DNA Binding on Geminate CO Recombination Kinetics in CO-sensing Transcription Factor CooA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIATOMIC LIGAND-BINDING; CARBON-MONOXIDE; HEME DOMAIN; ULTRAFAST DYNAMICS; FERROUS-HEME; PROTEIN; ACTIVATOR; MECHANISM; SPECTROSCOPY; RELAXATION	Carbon monoxide oxidation activator (CooA) proteins are heme-based CO-sensing transcription factors. Here we study the ultrafast dynamics of geminate CO rebinding in two CooA homologues, Rhodospirillum rubrum (RrCooA) and Carboxydothermus hydrogenoformans (ChCooA). The effects of DNA binding and the truncation of the DNA-binding domain on the CO geminate recombination kinetics were specifically investigated. The CO rebinding kinetics in these CooA complexes take place on ultrafast time scales but remain non-exponential over many decades in time. We show that this non-exponential kinetic response is due to a quenched enthalpic barrier distribution resulting from a distribution of heme geometries that is frozen or slowly evolving on the time scale of CO rebinding. We also show that, upon CO binding, the distal pocket of the heme in the CooA proteins relaxes to form a very efficient hydrophobic trap for CO. DNA binding further tightens the narrow distal pocket and slightly weakens the iron-proximal histidine bond. Comparison of the CO rebinding kinetics of RrCooA, truncated RrCooA, and DNA-bound RrCooA proteins reveals that the uncomplexed and inherently flexible DNA-binding domain adds additional structural heterogeneity to the heme doming coordinate. When CooA forms a complex with DNA, the flexibility of the DNA-binding domain decreases, and the distribution of the conformations available in the heme domain becomes restricted. The kinetic studies also offer insights into how the architecture of the heme environment can tune entropic barriers in order to control the geminate recombination of CO in heme proteins, whereas spin selection rules play a minor or non-existent role.	[Champion, Paul M.] Northeastern Univ, Dept Phys, Dana Res Ctr 111, Boston, MA 02115 USA; [Benabbas, Abdelkrim; Karunakaran, Venugopal; Champion, Paul M.] Northeastern Univ, Ctr Interdisciplinary Res Complex Syst, Boston, MA 02115 USA; [Youn, Hwan] Calif State Univ Fresno, Dept Biol, Fresno, CA 93740 USA; [Poulos, Thomas L.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Poulos, Thomas L.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [Poulos, Thomas L.] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA	Northeastern University; Northeastern University; California State University System; California State University Fresno; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Champion, PM (corresponding author), Northeastern Univ, Dept Phys, Dana Res Ctr 111, Boston, MA 02115 USA.	champ@neu.edu			National Institutes of Health [DK35090, GM42614]; National Science Foundation [MCB-0744738]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK35090 (to P. M. C.) and GM42614 (to T. L. P.). This work was also supported by National Science Foundation Grant MCB-0744738 (to P. M. C.).	Akiyama S, 2004, J MOL BIOL, V341, P651, DOI 10.1016/j.jmb.2004.06.040; Aono S, 1996, BIOCHEM BIOPH RES CO, V228, P752, DOI 10.1006/bbrc.1996.1727; Aono S, 2008, DALTON T, P3137, DOI 10.1039/b802070c; AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021; Bell CE, 2000, NAT STRUCT BIOL, V7, P209; Benabbas A, 2010, J AM CHEM SOC, V132, P2811, DOI 10.1021/ja910005b; Borjigin M, 2007, ACTA CRYSTALLOGR D, V63, P282, DOI 10.1107/S0907444906051638; Clark RW, 2006, P NATL ACAD SCI USA, V103, P891, DOI 10.1073/pnas.0505919103; Coyle CM, 2003, J BIOL CHEM, V278, P35384, DOI 10.1074/jbc.M301000200; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Franzen S, 2002, P NATL ACAD SCI USA, V99, P16754, DOI 10.1073/pnas.252590999; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; FRAUENFELDER H, 1985, SCIENCE, V229, P337, DOI 10.1126/science.4012322; Gruia F, 2007, BIOPHYS J, V93, P4404, DOI 10.1529/biophysj.107.114736; He YP, 1996, J BIOL CHEM, V271, P120, DOI 10.1074/jbc.271.1.120; HENRY ER, 1983, J MOL BIOL, V166, P443, DOI 10.1016/S0022-2836(83)80094-1; Ibrahim M, 2007, J INORG BIOCHEM, V101, P1776, DOI 10.1016/j.jinorgbio.2007.07.010; Ibrahim M, 2006, J BIOL CHEM, V281, P29165, DOI 10.1074/jbc.M605568200; Inagaki S, 2005, J BIOL CHEM, V280, P3269, DOI 10.1074/jbc.M409884200; Ionascu D, 2005, J AM CHEM SOC, V127, P16921, DOI 10.1021/ja054249y; Jasaitis A, 2012, CHEM PHYS, V396, P10, DOI 10.1016/j.chemphys.2011.04.003; Karunakaran V, 2011, J AM CHEM SOC, V133, P18816, DOI 10.1021/ja206152m; Kruglik SG, 2007, P NATL ACAD SCI USA, V104, P7408, DOI 10.1073/pnas.0700445104; Kubo M, 2006, J BIOL CHEM, V281, P11271, DOI 10.1074/jbc.M513261200; Kuchinskas M, 2006, BIOCHEMISTRY-US, V45, P7148, DOI 10.1021/bi052609o; Kumazaki S, 2000, J BIOL CHEM, V275, P38378, DOI 10.1074/jbc.M005533200; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Liebl U, 2002, P NATL ACAD SCI USA, V99, P12771, DOI 10.1073/pnas.192311699; LIM M, 1995, SCIENCE, V269, P962, DOI 10.1126/science.7638619; Park J, 2010, J PHYS CHEM B, V114, P10897, DOI 10.1021/jp1050436; Puranik M, 2004, J BIOL CHEM, V279, P21096, DOI 10.1074/jbc.M400613200; Reynolds MF, 2000, BIOCHEMISTRY-US, V39, P388, DOI 10.1021/bi991378g; Roberts GP, 2004, MICROBIOL MOL BIOL R, V68, P453, DOI 10.1128/MMBR.68.3.453-473.2004; Rubtsov IV, 2001, J AM CHEM SOC, V123, P10056, DOI 10.1021/ja011023w; SCHLICHTING I, 1994, NATURE, V371, P808, DOI 10.1038/371808a0; Sharma H, 2009, P NATL ACAD SCI USA, V106, P16604, DOI 10.1073/pnas.0908380106; SHELVER D, 1995, J BACTERIOL, V177, P2157, DOI 10.1128/jb.177.8.2157-2163.1995; Shelver D, 1999, BIOCHEMISTRY-US, V38, P2669, DOI 10.1021/bi982658j; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; SRAJER V, 1988, J AM CHEM SOC, V110, P6656, DOI 10.1021/ja00228a009; Strickland N, 2007, J PHYS CHEM B, V111, P841, DOI 10.1021/jp064091j; TIAN WD, 1992, PHYS REV LETT, V68, P408, DOI 10.1103/PhysRevLett.68.408; Uchida T, 1998, J BIOL CHEM, V273, P19988, DOI 10.1074/jbc.273.32.19988; Vos MH, 2008, BIOCHEMISTRY-US, V47, P5718, DOI 10.1021/bi800288z; Vos MH, 2008, BBA-BIOENERGETICS, V1777, P15, DOI 10.1016/j.bbabio.2007.10.004; Wang W, 2000, J PHYS CHEM B, V104, P10789, DOI 10.1021/jp0008602; Weichsel A, 2000, NAT STRUCT BIOL, V7, P551, DOI 10.1038/76769; Yamashita T, 2008, J BIOL CHEM, V283, P2344, DOI 10.1074/jbc.M708123200; Ye X, 2007, P NATL ACAD SCI USA, V104, P14682, DOI 10.1073/pnas.0702622104; Youn H, 2004, J BIOL CHEM, V279, P45744, DOI 10.1074/jbc.M404336200; Youn H, 2004, J BACTERIOL, V186, P1320, DOI 10.1128/JB.186.5.1320-1329.2004; Yu AC, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.2126808; Zhang ZY, 2009, J PHYS CHEM B, V113, P10923, DOI 10.1021/jp9031805	54	16	16	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21729	21740		10.1074/jbc.M112.345090	http://dx.doi.org/10.1074/jbc.M112.345090			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22544803	Green Published, hybrid			2022-12-25	WOS:000306418600014
J	Mertz, EL; Facchini, M; Pham, AT; Gualeni, B; De Leonardis, F; Rossi, A; Forlino, A				Mertz, Edward L.; Facchini, Marcella; Pham, Anna T.; Gualeni, Benedetta; De Leonardis, Fabio; Rossi, Antonio; Forlino, Antonella			Matrix Disruptions, Growth, and Degradation of Cartilage with Impaired Sulfation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SULFUR; CHONDROITIN SULFATE; INDIAN HEDGEHOG; BIOCHEMICAL-CHARACTERIZATION; CHONDROCYTE DIFFERENTIATION; SKELETAL DEVELOPMENT; CHOLESTEROL SULFATE; ARTICULAR-CARTILAGE; CULTURE-MEDIUM; DYSPLASIA	Diastrophic dysplasia (DTD) is an incurable recessive chondrodysplasia caused by mutations in the SLC26A2 transporter responsible for sulfate uptake by chondrocytes. The mutations cause undersulfation of glycosaminoglycans in cartilage. Studies of dtd mice with a knock-in Slc26a2 mutation showed an unusual progression of the disorder: net undersulfation is mild and normalizing with age, but the articular cartilage degrades with age and bones develop abnormally. To understand underlying mechanisms, we studied newborn dtd mice. We developed, verified and used high-definition infrared hyperspectral imaging of cartilage sections at physiological conditions, to quantify collagen and its orientation, noncollagenous proteins, and chondroitin chains, and their sulfation with 6-mu m spatial resolution and without labeling. We found that chondroitin sulfation across the proximal femur cartilage varied dramatically in dtd, but not in the wild type. Corresponding undersulfation of dtd was mild in most regions, but strong in narrow articular and growth plate regions crucial for bone development. This undersulfation correlated with the chondroitin synthesis rate measured via radioactive sulfate incorporation, explaining the sulfation normalization with age. Collagen orientation was reduced, and the reduction correlated with chondroitin undersulfation. Such disorientation involved the layer of collagen covering the articular surface and protecting cartilage from degradation. Malformation of this layer may contribute to the degradation progression with age and to collagen and proteoglycan depletion from the articular region, which we observed in mice already at birth. The results provide clues to in vivo sulfation, DTD treatment, and cartilage growth.	[Mertz, Edward L.; Pham, Anna T.] Eunice Kennedy Shriver NICHD, Sect Phys Biochem, NIH, Bethesda, MD 20892 USA; [Facchini, Marcella; Gualeni, Benedetta; De Leonardis, Fabio; Rossi, Antonio; Forlino, Antonella] Univ Pavia, Biochem Sect, Dept Mol Med, I-27100 Pavia, Italy	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Pavia	Mertz, EL (corresponding author), Eunice Kennedy Shriver NICHD, Sect Phys Biochem, NIH, 9000 Rockville Pike,Bldg 9,Rm 1E125, Bethesda, MD 20892 USA.	mertze@mail.nih.gov	Forlino, Antonella/H-5385-2015; Rossi, Antonio/E-9935-2012	Forlino, Antonella/0000-0002-6385-1182; Gualeni, Benedetta/0000-0002-5216-1151; Facchini, Marcella/0000-0002-6500-8842	National Institutes of Health Director's Challenge Fund; NICHD Intramural Research Program; PRIN [20094C2H2M]; Regione Lombardia [REGLOM16]; European Community FP6 EuroGrow Grant [LSHM-CT-2007-037471]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008810] Funding Source: NIH RePORTER	National Institutes of Health Director's Challenge Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Regione Lombardia(Regione Lombardia); European Community FP6 EuroGrow Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the National Institutes of Health Director's Challenge Fund, the NICHD Intramural Research Program, PRIN 20094C2H2M, Regione Lombardia REGLOM16, and European Community FP6 EuroGrow Grant LSHM-CT-2007-037471.	Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Arrington CB, 2009, DEVELOPMENT, V136, P3143, DOI 10.1242/dev.031492; Bayliss MT, 1999, J BIOL CHEM, V274, P15892, DOI 10.1074/jbc.274.22.15892; BELANGER LF, 1954, CAN J BIOCHEM PHYS, V32, P161; Boskey A, 2007, BIOMATERIALS, V28, P2465, DOI 10.1016/j.biomaterials.2006.11.043; BUCKWALTER JA, 1986, J BONE JOINT SURG AM, V68A, P243, DOI 10.2106/00004623-198668020-00010; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Camacho NP, 2001, BIOPOLYMERS, V62, P1, DOI 10.1002/1097-0282(2001)62:1<1::AID-BIP10>3.0.CO;2-O; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Chen XS, 2008, ARTHRITIS RHEUM-US, V58, P3788, DOI 10.1002/art.23985; Cohen MM, 2003, AM J MED GENET A, V123A, P5, DOI 10.1002/ajmg.a.20495; Cortes M, 2009, DEVELOPMENT, V136, P1697, DOI 10.1242/dev.030742; DIAB M, 1994, AM J MED GENET, V49, P402, DOI 10.1002/ajmg.1320490411; Dukor R. K., 2002, APPL VIBRATIONAL SPE, P3335; DZIEWIATKOWSKI DD, 1952, J EXP MED, V95, P489, DOI 10.1084/jem.95.5.489; DZIEWIATKOWSKI DD, 1951, J EXP MED, V93, P451, DOI 10.1084/jem.93.5.451; Forlino A, 2005, HUM MOL GENET, V14, P859, DOI 10.1093/hmg/ddi079; Forlino A., 2006, NOVART FDN SYMP, V273, P206; Forlino A., 2006, NOVART FDN SYMP, V273, P261; Forlino Antonella, 2006, Novartis Found Symp, V273, P193; FRASER RDB, 1958, J CHEM PHYS, V28, P1113, DOI 10.1063/1.1744353; Frederick JP, 2008, P NATL ACAD SCI USA, V105, P11605, DOI 10.1073/pnas.0801182105; Galante LL, 2007, J CELL BIOL, V179, P999, DOI 10.1083/jcb.200707150; GHADIALLY FN, 1983, FINE STRUCTURE SYNOV; Gualeni B, 2007, CALCIFIED TISSUE INT, V80, pS77; Gualeni B, 2010, MATRIX BIOL, V29, P453, DOI 10.1016/j.matbio.2010.05.001; HABUCHI H, 1995, J BIOL CHEM, V270, P4172, DOI 10.1074/jbc.270.8.4172; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; Hermanns P, 2008, AM J HUM GENET, V82, P1368, DOI 10.1016/j.ajhg.2008.05.006; Hiraoka S, 2007, NAT MED, V13, P1363, DOI 10.1038/nm1655; HORTON WA, 1978, J PEDIATR-US, V93, P609, DOI 10.1016/S0022-3476(78)80896-8; HUNZIKER EB, 1989, J PHYSIOL-LONDON, V414, P55, DOI 10.1113/jphysiol.1989.sp017676; Kester MHA, 2003, AM J PHYSIOL-ENDOC M, V285, pE592, DOI 10.1152/ajpendo.00046.2003; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Kobayashi T, 2005, J CLIN INVEST, V115, P1734, DOI 10.1172/JCI24397; Koziel L, 2004, DEV CELL, V6, P801, DOI 10.1016/j.devcel.2004.05.009; Lamb R, 2007, ARTHRITIS RHEUM-US, V56, P1286, DOI 10.1002/art.22444; Makitie O, 1997, J PEDIATR-US, V130, P641, DOI 10.1016/S0022-3476(97)70250-6; Marcelino J, 1999, NAT GENET, V23, P319, DOI 10.1038/15496; MAROUDAS A, 1974, BIOCHIM BIOPHYS ACTA, V338, P265, DOI 10.1016/0304-4165(74)90355-9; Mertz E. L., 2008, United States patent, Patent No. [7,355,697, 7355697]; Mertz EL, 2004, BIOCHEMISTRY-US, V43, P14901, DOI 10.1021/bi048788b; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; MOURAO PAS, 1979, COMP BIOCHEM PHYS B, V62, P115, DOI 10.1016/0305-0491(79)90023-3; Myette JR, 2002, BIOCHEM BIOPH RES CO, V290, P1206, DOI 10.1006/bbrc.2001.6268; OOHIRA A, 1974, J BIOL CHEM, V249, P1637; ORELLANA A, 1994, J BIOL CHEM, V269, P2270; ORKIN RW, 1977, J CELL BIOL, V73, P287, DOI 10.1083/jcb.73.2.287; Pecora F, 2006, BIOCHEM J, V398, P509, DOI 10.1042/BJ20060566; Potter K, 2001, ARTHRITIS RHEUM, V44, P846, DOI 10.1002/1529-0131(200104)44:4<846::AID-ANR141>3.0.CO;2-E; Rajpar MH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000691; Rieppo J, 2009, OSTEOARTHR CARTILAGE, V17, P448, DOI 10.1016/j.joca.2008.09.004; Rosenberg L. C., 1983, LIMB DEV REGENERAT B, P67; Rossi A, 1997, EUR J BIOCHEM, V248, P741, DOI 10.1111/j.1432-1033.1997.t01-1-00741.x; Rossi A, 1998, MATRIX BIOL, V17, P361, DOI 10.1016/S0945-053X(98)90088-9; SCHECK M, 1978, VIRCHOWS ARCH A, V378, P347, DOI 10.1007/BF00465601; Schwartz NB, 1998, CHEM-BIOL INTERACT, V109, P143, DOI 10.1016/S0009-2797(97)00129-4; SERIZAWA S, 1990, CLIN EXP DERMATOL, V15, P13, DOI 10.1111/j.1365-2230.1990.tb02010.x; SHAPIRO F, 1992, CALCIFIED TISSUE INT, V51, P324, DOI 10.1007/BF00334495; Sohaskey ML, 2008, DEVELOPMENT, V135, P2215, DOI 10.1242/dev.019950; STANESCU V, 1994, AM J MED GENET, V51, P22, DOI 10.1002/ajmg.1320510106; STANESCU V, 1984, J BONE JOINT SURG AM, V66A, P817, DOI 10.2106/00004623-198466060-00002; Strott CA, 2003, J LIPID RES, V44, P1268, DOI 10.1194/jlr.R300005-JLR200; Superti-Furga A., 2002, CONNECTIVE TISSUE IT, P939; Thiele H, 2004, P NATL ACAD SCI USA, V101, P10155, DOI 10.1073/pnas.0400334101; TORCHIA DA, 1977, J BIOL CHEM, V252, P3617; Tsang KY, 2007, PLOS BIOL, V5, P568, DOI 10.1371/journal.pbio.0050044; Tsang KY, 2010, J CELL SCI, V123, P2145, DOI 10.1242/jcs.068833; Ul Haque MF, 1998, NAT GENET, V20, P157, DOI 10.1038/2458; WALKER BA, 1972, MEDICINE, V51, P41, DOI 10.1097/00005792-197201000-00003; WIKSTROM B, 1985, COLLAGEN REL RES, V5, P193; Wilsman NJ, 1996, J ORTHOP RES, V14, P927, DOI 10.1002/jor.1100140613; Xu D, 2007, J BIOL CHEM, V282, P8356, DOI 10.1074/jbc.M608062200; Yamauchi S, 1999, J BIOL CHEM, V274, P2456, DOI 10.1074/jbc.274.4.2456; Yin JH, 2010, APPL SPECTROSC, V64, P1199, DOI 10.1366/000370210793335124	75	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22030	22042		10.1074/jbc.M110.116467	http://dx.doi.org/10.1074/jbc.M110.116467			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22556422	Green Published, hybrid			2022-12-25	WOS:000306418600041
J	Nanjundaiah, SM; Venkatesha, SH; Yu, H; Tong, L; Stains, JP; Moudgil, KD				Nanjundaiah, Siddaraju M.; Venkatesha, Shivaprasad H.; Yu, Hua; Tong, Li; Stains, Joseph P.; Moudgil, Kamal D.			Celastrus and Its Bioactive Celastrol Protect against Bone Damage in Autoimmune Arthritis by Modulating Osteoimmune Cross-talk	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN-INDUCED ARTHRITIS; SYNOVIAL T-CELLS; RHEUMATOID-ARTHRITIS; OSTEOCLAST FORMATION; IN-VITRO; TEA POLYPHENOLS; SUPPRESSES; DESTRUCTION; RESORPTION; INFLIXIMAB	Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by bone erosion and cartilage destruction in the joints. Many of the conventional antiarthritic drugs are effective in suppressing inflammation, but they do not offer protection against bone damage. Furthermore, the prolonged use of these drugs is associated with severe adverse reactions. Thus, new therapeutic agents that can control both inflammation and bone damage but with minimal side effects are sought. Celastrus is a Chinese herb that has been used for centuries in folk medicine for the treatment of various inflammatory diseases. However, its utility for protection against inflammation-induced bone damage in arthritis and the mechanisms involved therein have not been examined. We tested celastrus and its bioactive component celastrol for this attribute in the adjuvant-induced arthritis model of RA. The treatment of arthritic rats with celastrus/celastrol suppressed inflammatory arthritis and reduced bone and cartilage damage in the joints as demonstrated by histology and bone histomorphometry. The protective effects against bone damage are mediated primarily via the inhibition of defined mediators of osteoclastic bone remodeling (e. g. receptor activator of nuclear factor-kappa B ligand (RANKL)), the deviation of RANKL/osteoprotegerin ratio in favor of antiosteoclastic activity, and the reduction in osteoclast numbers. Furthermore, both theupstreaminducers(proinflammatory cytokines) and the down-stream effectors (MMP-9) of the osteoclastogenic mediators were altered. Thus, celastrus and celastrol controlled inflammation-induced bone damage by modulating the osteoimmune cross-talk. These natural products deserve further consideration and evaluation as adjuncts to conventional therapy for RA.	[Nanjundaiah, Siddaraju M.; Venkatesha, Shivaprasad H.; Yu, Hua; Moudgil, Kamal D.] Univ Maryland, Dept Microbiol & Immunol, Sch Med, Baltimore, MD 21201 USA; [Moudgil, Kamal D.] Univ Maryland, Dept Med, Sch Med, Div Rheumatol, Baltimore, MD 21201 USA; [Stains, Joseph P.] Univ Maryland, Dept Orthopaed, Sch Med, Baltimore, MD 21201 USA; [Tong, Li] So Med Univ, Sch Tradit Chinese Med, Guangzhou 510510, Guangdong, Peoples R China	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Southern Medical University - China	Moudgil, KD (corresponding author), Univ Maryland, Dept Microbiol & Immunol, Sch Med, 685 W Baltimore St,HSF 1,Suite 380, Baltimore, MD 21201 USA.	kmoud001@umaryland.edu	Venkatesha, Shivaprasad/S-3141-2016; yu, hua/F-8948-2012		National Institutes of Health [R01AT004321]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT004321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052719] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AT004321.	Ahmed S, 2008, P NATL ACAD SCI USA, V105, P14692, DOI 10.1073/pnas.0802675105; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Astry B, 2011, J INTERF CYTOK RES, V31, P927, DOI 10.1089/jir.2011.0094; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Chung DJ, 2006, J CELL SCI, V119, P4187, DOI 10.1242/jcs.03162; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dai SM, 2004, ANN RHEUM DIS, V63, P1379, DOI 10.1136/ard.2003.018481; Fonseca JE, 2009, CLIN RHEUMATOL, V28, P1213, DOI 10.1007/s10067-009-1207-y; FRANCK H, 1994, J RHEUMATOL, V21, P1256; Franco GCN, 2011, EXP CELL RES, V317, P1454, DOI 10.1016/j.yexcr.2011.03.014; Goltzman D, 2002, NAT REV DRUG DISCOV, V1, P784, DOI 10.1038/nrd916; Gorman CL, 2008, BEST PRACT RES CL RH, V22, P221, DOI 10.1016/j.berh.2008.01.003; Grassi F, 2004, J CELL PHYSIOL, V199, P244, DOI 10.1002/jcp.10445; Gravallese EM, 2000, ARTHRITIS RHEUM, V43, P250, DOI 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P; Gravallese EM, 2002, ANN RHEUM DIS, V61, P84, DOI 10.1136/ard.61.suppl_2.ii84; Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035; Hahn B, 2004, JCR-J CLIN RHEUMATOL, V10, pS3, DOI 10.1097/01.rhu.0000130683.61892.b2; HILL PA, 1995, ENDOCRINOLOGY, V136, P124, DOI 10.1210/en.136.1.124; Idris AI, 2010, FASEB J, V24, P4545, DOI 10.1096/fj.10-164095; Idris AI, 2009, MOL CANCER THER, V8, P2339, DOI 10.1158/1535-7163.MCT-09-0133; Jones D, 2011, J CLIN INVEST, V121, P2534, DOI 10.1172/JCI46262; Joosten LAB, 1999, J IMMUNOL, V163, P5049; Kannaiyan R, 2011, APOPTOSIS, V16, P1028, DOI 10.1007/s10495-011-0629-6; Karmakar S, 2010, RHEUM DIS CLIN N AM, V36, P385, DOI 10.1016/j.rdc.2010.03.003; Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050; Kim DH, 2009, EUR J CLIN INVEST, V39, P819, DOI 10.1111/j.1365-2362.2009.02186.x; Kim JL, 2012, J CELL BIOCHEM, V113, P247, DOI 10.1002/jcb.23351; Kim WK, 2011, J CELL BIOCHEM, V112, P3159, DOI 10.1002/jcb.23242; Kim Y, 2011, CELL PHYSIOL BIOCHEM, V28, P175, DOI 10.1159/000331729; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Komeh-Nkrumah SA, 2012, PHYTOTHER RES, V26, P54, DOI 10.1002/ptr.3509; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Kremers HM, 2004, J RHEUMATOL, V31, P2366; Li YW, 2006, CANCER RES, V66, P4816, DOI 10.1158/0008-5472.CAN-05-3752; Lipsky P. E., 2008, HARRISONS PRINCIPLES, V2, P2083; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Liu Z, 2011, MOLECULES, V16, P5283, DOI 10.3390/molecules16065283; Lubberts E, 2000, J CLIN INVEST, V105, P1697, DOI 10.1172/JCI7739; Maruotti N, 2011, CLIN EXP MED, V11, P137, DOI 10.1007/s10238-010-0117-2; Mou HB, 2011, TOXICOL IN VITRO, V25, P1027, DOI 10.1016/j.tiv.2011.03.023; Ohshima S, 2002, ARTHRITIS RHEUM, V46, P1094, DOI 10.1002/art.10143; Oka Y, 2012, J PHARMACOL SCI, V118, P55, DOI 10.1254/jphs.11082FP; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Rajaiah R, 2011, J BIOL CHEM, V286, P2817, DOI 10.1074/jbc.M110.187013; Schett G, 2006, WIEN MED WOCHENSCHR, V156, P34, DOI 10.1007/s10354-005-0244-7; Sellers RS, 1997, J BONE JOINT SURG AM, V79A, P1452, DOI 10.2106/00004623-199710000-00002; Shahrara S, 2005, ARTHRITIS RHEUM, V52, P1907, DOI 10.1002/art.21033; Shen CL, 2010, OSTEOPOROSIS INT, V21, P1841, DOI 10.1007/s00198-009-1122-8; Shen CL, 2011, J NUTR BIOCHEM, V22, P673, DOI 10.1016/j.jnutbio.2010.05.007; Smolen JS, 2005, ARTHRITIS RHEUM, V52, P1020, DOI 10.1002/art.20982; Steiner G, 1999, RHEUMATOLOGY, V38, P202, DOI 10.1093/rheumatology/38.3.202; Strand V, 2004, RHEUMATOLOGY, V43, P10, DOI 10.1093/rheumatology/keh202; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Tong L, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2268; Tozawa K, 2011, INT J ONCOL, V39, P1117, DOI 10.3892/ijo.2011.1161; Venkatesha SH, 2011, J BIOL CHEM, V286, P15138, DOI 10.1074/jbc.M111.226365; Wu SH, 2004, J CHROMATOGR A, V1028, P171, DOI 10.1016/j.chroma.2003.11.072; Xu S., 2011, RHEUMATOL I IN PRESS; Yadav VR, 2010, TOXINS, V2, P2428, DOI 10.3390/toxins2102428; Yang YH, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/642027; Yu H, 2011, ARTHRITIS RHEUM-US, V63, P981, DOI 10.1002/art.30219; Zhang F, 2010, CONNECT TISSUE RES, V51, P359, DOI 10.3109/03008200903456942; Zhao BH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3379	63	73	75	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22216	22226		10.1074/jbc.M112.356816	http://dx.doi.org/10.1074/jbc.M112.356816			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22549786	Green Published, hybrid			2022-12-25	WOS:000306418600060
J	Han, LZ; Pan, Y; Wang, BL				Han, Lizhang; Pan, Yong; Wang, Baolin			Small Ubiquitin-like Modifier (SUMO) Modification Inhibits GLI2 Protein Transcriptional Activity in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SONIC HEDGEHOG; VERTEBRATE LIMB; NEURAL-TUBE; KINASE-A; DEGRADATION; REPRESSION; SIGNALS; GENE	The Gli transcription factors are key downstream mediators of the Hedgehog (Hh) signaling pathway. How the activities of Gli transcription factors are regulated by upstream Hh signaling events and protein modifications are not fully understood. Here we show that GLI2 is conjugated by small ubiquitin-like modifier (SUMO) at lysine residues 630 and 716 in the cell. The level of GLI2 sumoylation is reduced by either mutations in six serine residues that are normally phosphorylated by protein kinase A (PKA) or stimulation by HH. This suggests that PKA phosphorylation enhances GLI2 sumoylation, whereas HH signaling inhibits it. In addition, mutation of these two lysines into arginine residues significantly increases GLI2 transcriptional activity in a cell-based reporter assay. The same mutations in the GLI2 locus also result in an increase in GLI2 activity in the mouse. Interestingly, GLI2 can interact with HDAC5 (histone deacetylase 5), but the GLI2 mutant cannot. Taken together, our results suggest that SUMO modification inhibits GLI2 transcriptional activity by recruiting HDAC5.	[Han, Lizhang; Pan, Yong; Wang, Baolin] Cornell Univ, Weill Med Coll, Dept Med Genet, New York, NY 10065 USA; [Wang, Baolin] Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA; [Han, Lizhang] Shandong Univ, Prov Hosp, Dept Neurosurg, Jinan 250012, Shandong, Peoples R China	Cornell University; Cornell University; Shandong University	Wang, BL (corresponding author), Cornell Univ, Weill Med Coll, Dept Med Genet, 1300 York Ave,W404, New York, NY 10065 USA.	baw2001@med.cornell.edu			NICHD, National Institutes of Health [NO1-HD-7-3263]; National Institutes of Health [R01GM070820, R01CA111673]; NATIONAL CANCER INSTITUTE [R01CA111673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070820] Funding Source: NIH RePORTER	NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Tso-Pang Yao for pcDNA-FLAG-HDAC4 and pcDNA-FLAG-HDAC5. Monoclonal antibodies against ISL1, HB9, PAX6, PAX7, NKX2.2, NKX6.1, and FOXA2 were obtained from the Developmental Studies Hybridoma Bank maintained by the University of Iowa, Department of Biological Sciences, Iowa City, IA, under Contract NO1-HD-7-3263 from the NICHD, National Institutes of Health.; This work was supported, in whole or in part, by National Institutes of Health Grants R01GM070820 and R01CA111673 (to B. W.).	Cox B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011996; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Garcia-Dominguez M, 2009, BBA-GENE REGUL MECH, V1789, P451, DOI 10.1016/j.bbagrm.2009.07.001; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; GOLEMIS EA, 1994, CURRENT PROTOCOLS MO; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; HOGAN B, 1994, MANIPULATING MOUSE E, P373; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Lee J, 1997, DEVELOPMENT, V124, P2537; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Pan Y, 2007, J BIOL CHEM, V282, P10846, DOI 10.1074/jbc.M608599200; Pan Y, 2009, DEV BIOL, V326, P177, DOI 10.1016/j.ydbio.2008.11.009; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tuson M, 2011, DEVELOPMENT, V138, P4921, DOI 10.1242/dev.070805; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang BW, 2006, P NATL ACAD SCI USA, V103, P33, DOI 10.1073/pnas.0509927103; Wang CB, 2007, DEV BIOL, V305, P460, DOI 10.1016/j.ydbio.2007.02.029; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7	23	18	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20483	20489		10.1074/jbc.M112.359299	http://dx.doi.org/10.1074/jbc.M112.359299			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22549777	hybrid, Green Published			2022-12-25	WOS:000306414500069
J	Arnold, T; Mealey, C; Leahey, H; Miller, AW; Hall-Spencer, JM; Milazzo, M; Maers, K				Arnold, Thomas; Mealey, Christopher; Leahey, Hannah; Miller, A. Whitman; Hall-Spencer, Jason M.; Milazzo, Marco; Maers, Kelly			Ocean Acidification and the Loss of Phenolic Substances in Marine Plants	PLOS ONE			English	Article							EELGRASS ZOSTERA-MARINA; CARBON-DIOXIDE; INORGANIC CARBON; WASTING DISEASE; CO2 ENRICHMENT; ELEVATED CO2; PROTEIN COMPETITION; CONDENSED TANNINS; CAFFEIC ACID; GROWTH	Rising atmospheric CO2 often triggers the production of plant phenolics, including many that serve as herbivore deterrents, digestion reducers, antimicrobials, or ultraviolet sunscreens. Such responses are predicted by popular models of plant defense, especially resource availability models which link carbon availability to phenolic biosynthesis. CO2 availability is also increasing in the oceans, where anthropogenic emissions cause ocean acidification, decreasing seawater pH and shifting the carbonate system towards further CO2 enrichment. Such conditions tend to increase seagrass productivity but may also increase rates of grazing on these marine plants. Here we show that high CO2 / low pH conditions of OA decrease, rather than increase, concentrations of phenolic protective substances in seagrasses and eurysaline marine plants. We observed a loss of simple and polymeric phenolics in the seagrass Cymodocea nodosa near a volcanic CO2 vent on the Island of Vulcano, Italy, where pH values decreased from 8.1 to 7.3 and pCO(2) concentrations increased ten-fold. We observed similar responses in two estuarine species, Ruppia maritima and Potamogeton perfoliatus, in in situ Free-Ocean-Carbon-Enrichment experiments conducted in tributaries of the Chesapeake Bay, USA. These responses are strikingly different than those exhibited by terrestrial plants. The loss of phenolic substances may explain the higher-than-usual rates of grazing observed near undersea CO2 vents and suggests that ocean acidification may alter coastal carbon fluxes by affecting rates of decomposition, grazing, and disease. Our observations temper recent predictions that seagrasses would necessarily be "winners" in a high CO2 world.	[Arnold, Thomas; Mealey, Christopher; Leahey, Hannah; Maers, Kelly] Dickinson Coll, Dept Biol Sci, Carlisle, PA 17013 USA; [Arnold, Thomas; Miller, A. Whitman] Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA; [Hall-Spencer, Jason M.] Univ Plymouth, Sch Marine Sci & Engn, Plymouth PL4 8AA, Devon, England; [Milazzo, Marco] Univ Palermo, Dipartimento Sci Terra & Mare, Palermo, Italy	Dickinson College; Smithsonian Institution; Smithsonian Environmental Research Center; University of Plymouth; University of Palermo	Arnold, T (corresponding author), Dickinson Coll, Dept Biol Sci, Carlisle, PA 17013 USA.	arnoldt@dickinson.edu	Milazzo, Marco/AAY-9990-2021; Milazzo, Marco/F-8596-2012; Hall-Spencer, Jason/AFN-7866-2022; Miller, Whitman/C-7811-2017	Milazzo, Marco/0000-0002-2202-0542; Hall-Spencer, Jason/0000-0002-6915-2518; Miller, Whitman/0000-0003-0484-182X	NASA [09-GCCE-0139]; Smithsonian Institution; EU [265103]; Dickinson College	NASA(National Aeronautics & Space Administration (NASA)); Smithsonian Institution(Smithsonian Institution); EU(European Commission); Dickinson College	This work was funded by an award from NASA (09-GCCE-0139), a senior postdoctoral fellowship award from the Smithsonian Institution to T. M. A., the EU 'Mediterranean Sea Acidification under a changing climate' project (MedSeA; grant agreement 265103), and Research and Development grants to T. M. A. from Dickinson College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Hady HH, 2007, EGYPTIAN J AQUATIC R, V33, P103; Alcoverro T, 1999, MAR ECOL PROG SER, V187, P121, DOI 10.3354/meps187121; Arnold T, 2004, NEW PHYTOL, V164, P157, DOI 10.1111/j.1469-8137.2004.01157.x; Arnold TA, 2008, AQUAT BOT, V89, P27, DOI 10.1016/j.aquabot.2008.02.001; Arnold TM, 2002, J CHEM ECOL, V28, P1919, DOI 10.1023/A:1020737609151; ARNOLD TM, 1995, MAR ECOL PROG SER, V123, P177, DOI 10.3354/meps123177; Barbehenn RV, 2011, PHYTOCHEMISTRY, V72, P1551, DOI 10.1016/j.phytochem.2011.01.040; BARBERI F, 1974, EARTH PLANET SC LETT, V21, P269, DOI 10.1016/0012-821X(74)90161-7; BAUBRON JC, 1990, NATURE, V344, P51, DOI 10.1038/344051a0; Bazzaz Fakhri A., 1997, P1, DOI 10.1016/B978-012083490-7/50002-5; BECCALUVA L, 1985, EARTH PLANET SC LETT, V74, P187, DOI 10.1016/0012-821X(85)90021-4; Beer S, 1996, MAR ECOL PROG SER, V141, P199, DOI 10.3354/meps141199; Beer S, 1997, AQUAT BOT, V56, P277, DOI 10.1016/S0304-3770(96)01109-6; Bennett RN, 1994, TANSLEY REV, P617; Bidart-Bouzat MG, 2008, J INTEGR PLANT BIOL, V50, P1339, DOI 10.1111/j.1744-7909.2008.00751.x; Bjork M, 1997, MAR BIOL, V129, P363, DOI 10.1007/s002270050176; Bortolus A, 1998, ESTUARIES, V21, P710, DOI 10.2307/1353275; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; BUCHSBAUM RN, 1990, AQUAT BOT, V37, P291, DOI 10.1016/0304-3770(90)90075-V; Cai WJ, 1998, LIMNOL OCEANOGR, V43, P657, DOI 10.4319/lo.1998.43.4.0657; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Coley PD, 2002, OECOLOGIA, V133, P62, DOI 10.1007/s00442-002-1005-6; Cronin G, 2003, OECOLOGIA, V137, P32, DOI 10.1007/s00442-003-1315-3; Den Hartog C., 1996, SEAGRASS BIOL, P307; Den Hartog C, 2006, SEAGRASSES BIOL ECOL; Dickson A.G., 1994, HDB METHODS ANAL VAR; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dorenbosch M, 2011, FRESHWATER BIOL, V56, P1783, DOI 10.1111/j.1365-2427.2011.02618.x; ELKIN RG, 1991, J SCI FOOD AGR, V57, P543, DOI 10.1002/jsfa.2740570407; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; GIACCONE G, 1969, Giornale Botanico Italiano, V103, P353; Goecker ME, 2005, MAR ECOL PROG SER, V286, P239, DOI 10.3354/meps286239; Hagerman AE, 1986, PLANT FLAVONOIDS BIO, P67; HARRISON PG, 1982, MAR BIOL, V67, P225, DOI 10.1007/BF00401288; HARRISON PG, 1985, MAR BIOL, V90, P117, DOI 10.1007/BF00428222; HARRISON PG, 1980, MAR BIOL, V61, P21, DOI 10.1007/BF00410338; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Hughes AR, 2009, FRONT ECOL ENVIRON, V7, P242, DOI 10.1890/080041; Idestam-Almquist J, 1998, OIKOS, V81, P323, DOI 10.2307/3547052; Invers O, 2001, J EXP MAR BIOL ECOL, V265, P203, DOI 10.1016/S0022-0981(01)00332-X; Jiang ZJ, 2010, J INTEGR PLANT BIOL, V52, P904, DOI 10.1111/j.1744-7909.2010.00991.x; Jones CG, 1999, OIKOS, V86, P27, DOI 10.2307/3546567; Keller J, 1980, AEOLIAN ISLANDS ACTI, P29; Kerrison P, 2011, ESTUAR COAST SHELF S, P1; Lindroth RL, 2010, J CHEM ECOL, V36, P2, DOI 10.1007/s10886-009-9731-4; Martin S, 2008, BIOL LETTERS, V4, P689, DOI 10.1098/rsbl.2008.0412; Mattson WJ, 2005, OIKOS, V111, P337, DOI 10.1111/j.0030-1299.2005.13634.x; MCMILLAN C, 1984, AQUAT BOT, V20, P351, DOI 10.1016/0304-3770(84)90099-8; Meehan TD, 2010, SOIL BIOL BIOCHEM, V42, P1132, DOI 10.1016/j.soilbio.2010.03.019; Michot T.C., 1997, ITE Symposium, V30, P93; MICHOT TC, 1994, WETLANDS, V14, P276, DOI 10.1007/BF03160633; MUEHLSTEIN LK, 1992, CAN J BOT, V70, P2081, DOI 10.1139/b92-258; NICHOLSON RL, 1992, ANNU REV PHYTOPATHOL, V30, P369, DOI 10.1146/annurev.py.30.090192.002101; Palacios SL, 2007, MAR ECOL PROG SER, V344, P1, DOI 10.3354/meps07084; Penuelas J, 1997, PHOTOSYNTHETICA, V33, P313, DOI 10.1023/A:1022120431279; Penuelas J, 1998, TRENDS ECOL EVOL, V13, P20, DOI 10.1016/S0169-5347(97)01235-4; Prado P, 2011, MAR ECOL PROG SER, V429, P45, DOI 10.3354/meps09076; QUACKENBUSH RC, 1986, AQUAT BOT, V24, P83, DOI 10.1016/0304-3770(86)90119-1; RAVN H, 1989, BIOCHEM SYST ECOL, V17, P175, DOI 10.1016/0305-1978(89)90076-8; RAVN H, 1994, OPHELIA, V40, P51, DOI 10.1080/00785326.1994.10429550; Ross C, 2008, AQUAT BOT, V88, P134, DOI 10.1016/j.aquabot.2007.09.003; Royal Society, 2005, OC AC DUE INCR ATM C; Sedwick P, 1996, MAR CHEM, V53, P147, DOI 10.1016/0304-4203(96)00020-5; Stamp N, 2003, Q REV BIOL, V78, P23, DOI 10.1086/367580; Steele L, 2005, MAR ECOL PROG SER, V303, P123, DOI 10.3354/meps303123; Stiling P, 2007, GLOBAL CHANGE BIOL, V13, P1823, DOI 10.1111/j.1365-2486.2007.01392.x; Swain T., 1979, Herbivores: their interaction with secondary plant metabolites, P657; Tomas F, 2011, ECOLOGY, V92, P1807, DOI 10.1890/10-2095.1; Valentine JF, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P463; VALIELA I, 1979, NATURE, V280, P55, DOI 10.1038/280055a0; Valkama E, 2007, GLOBAL CHANGE BIOL, V13, P184, DOI 10.1111/j.1365-2486.2006.01284.x; VERGEER LHT, 1995, AQUAT BOT, V52, P35, DOI 10.1016/0304-3770(95)00480-N; Vergeer LHT, 1997, AQUAT BOT, V58, P65, DOI 10.1016/S0304-3770(96)01115-1; Verges A, 2008, OECOLOGIA, V155, P751, DOI 10.1007/s00442-007-0943-4; Verges A, 2007, MAR ECOL PROG SER, V343, P107, DOI 10.3354/meps06885; Vizzini S, 2010, J ECOL, V98, P1284, DOI 10.1111/j.1365-2745.2010.01730.x; Waldbusser GG, 2011, ESTUAR COAST, V34, P221, DOI 10.1007/s12237-010-9307-0; Yao WS, 1998, DEEP-SEA RES PT I, V45, P1383, DOI 10.1016/S0967-0637(98)00018-1	80	139	140	1	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35107	10.1371/journal.pone.0035107	http://dx.doi.org/10.1371/journal.pone.0035107			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558120	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345200025
J	Duerr, AE; Miller, TA; Lanzone, M; Brandes, D; Cooper, J; O'Malley, K; Maisonneuve, C; Tremblay, J; Katzner, T				Duerr, Adam E.; Miller, Tricia A.; Lanzone, Michael; Brandes, Dave; Cooper, Jeff; O'Malley, Kieran; Maisonneuve, Charles; Tremblay, Junior; Katzner, Todd			Testing an Emerging Paradigm in Migration Ecology Shows Surprising Differences in Efficiency between Flight Modes	PLOS ONE			English	Article							FIELD OBSERVATIONS; SOUTHERN ISRAEL; SOARING FLIGHT; BIRD MORTALITY; WIND; SPEED; STRATEGIES; VULTURES; THERMALS; BEHAVIOR	To maximize fitness, flying animals should maximize flight speed while minimizing energetic expenditure. Soaring speeds of large-bodied birds are determined by flight routes and tradeoffs between minimizing time and energetic costs. Large raptors migrating in eastern North America predominantly glide between thermals that provide lift or soar along slopes or ridgelines using orographic lift (slope soaring). It is usually assumed that slope soaring is faster than thermal gliding because forward progress is constant compared to interrupted progress when birds pause to regain altitude in thermals. We tested this slope-soaring hypothesis using high-frequency GPS-GSM telemetry devices to track golden eagles during northbound migration. In contrast to expectations, flight speed was slower when slope soaring and eagles also were diverted from their migratory path, incurring possible energetic costs and reducing speed of progress towards a migratory endpoint. When gliding between thermals, eagles stayed on track and fast gliding speeds compensated for lack of progress during thermal soaring. When thermals were not available, eagles minimized migration time, not energy, by choosing energetically expensive slope soaring instead of waiting for thermals to develop. Sites suited to slope soaring include ridges preferred for wind-energy generation, thus avian risk of collision with wind turbines is associated with evolutionary trade-offs required to maximize fitness of time-minimizing migratory raptors.	[Duerr, Adam E.; Miller, Tricia A.; Katzner, Todd] W Virginia Univ, Div Forestry & Nat Resources, Morgantown, WV 26506 USA; [Miller, Tricia A.] Penn State Univ, Riparia, University Pk, PA 16802 USA; [Lanzone, Michael] Cellular Tracking Technol LLC, Somerset, PA USA; [Brandes, Dave] Lafayette Coll, Dept Civil & Environm Engn, Acopian Engn Ctr, Easton, PA 18042 USA; [Cooper, Jeff] Virginia Dept Game & Inland Fisheries, Fredericksburg, VA USA; [O'Malley, Kieran] W Virginia Div Nat Resources, Romney, WV USA; [Maisonneuve, Charles] Minist Ressources Nat & Faune, Rimouski, PQ, Canada; [Tremblay, Junior] Minist Ressources Nat & Faune, Quebec City, PQ, Canada; [Katzner, Todd] US Forest Serv, USDA, Timber & Watershed Lab, Parsons, WV USA	West Virginia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Lafayette College; United States Department of Agriculture (USDA); United States Forest Service	Duerr, AE (corresponding author), W Virginia Univ, Div Forestry & Nat Resources, Morgantown, WV 26506 USA.	adam.duerr@mail.wvu.edu	Duerr, Adam/J-5545-2019; Tremblay, Junior A./AAX-7353-2020	Duerr, Adam/0000-0002-6145-8897; Tremblay, Junior A./0000-0003-4930-0939; Katzner, Todd/0000-0003-4503-8435	Pennsylvania State Wildlife [T-12, T47-R-1]; United States Department of Energy [DE-EE0003538]; Virginia Department of Game and Inland Fisheries; Invenergy LLC; West Virginia Division of Natural Resources	Pennsylvania State Wildlife; United States Department of Energy(United States Department of Energy (DOE)); Virginia Department of Game and Inland Fisheries; Invenergy LLC; West Virginia Division of Natural Resources	Funding was received from Pennsylvania State Wildlife Grants T-12 and T47-R-1, United States Department of Energy grant DE-EE0003538, the Virginia Department of Game and Inland Fisheries, Invenergy LLC, and the West Virginia Division of Natural Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript that are not represented through coauthorship of this manuscript.	Alerstam T, 1998, J AVIAN BIOL, V29, P343, DOI 10.2307/3677155; Barrios L, 2004, J APPL ECOL, V41, P72, DOI 10.1111/j.1365-2664.2004.00876.x; Bevan RM, 1995, PHILOS T R SOC B, V350, P119, DOI 10.1098/rstb.1995.0146; Bildstein KL, 2009, IBIS, V151, P382, DOI 10.1111/j.1474-919X.2009.00919.x; Bird DM., 2007, RAPTOR RES MANAGEMEN; Bohrer G, 2012, ECOL LETT, V15, P96, DOI 10.1111/j.1461-0248.2011.01713.x; Broun M., 1943, AUK, V60, P487; Elliot D. L., 1986, WIND ENERGY RESOURCE; Gillies JA, 2011, J AVIAN BIOL, V42, P377, DOI 10.1111/j.1600-048X.2011.05105.x; HEDENSTROM A, 1995, PHILOS T ROY SOC B, V348, P471, DOI 10.1098/rstb.1995.0082; HEDENSTROM A, 1993, PHILOS T ROY SOC B, V342, P353, DOI 10.1098/rstb.1993.0164; Hedenstrom A, 2002, BEHAV ECOL SOCIOBIOL, V52, P308, DOI 10.1007/s00265-002-0504-0; Katzner T, 2012, AUK, V129, P168, DOI 10.1525/auk.2011.11078; Kendeigh S.C., 1977, GRANIVOROUS BIRDS EC, P127, DOI [10.1515/isspar-2015-0001, DOI 10.1515/ISSPAR-2015-0001]; Kerlinger P., 1989, FLIGHT STRATEGIES MI; Kjellen N, 2001, J AVIAN BIOL, V32, P57, DOI 10.1034/j.1600-048X.2001.320108.x; Klaassen RHG, 2008, BEHAV ECOL SOCIOBIOL, V62, P1427, DOI 10.1007/s00265-008-0572-x; Leshem Y, 1996, IBIS, V138, P667, DOI 10.1111/j.1474-919X.1996.tb04768.x; Mellone U, 2011, J AVIAN BIOL, V42, P468, DOI 10.1111/j.1600-048X.2011.05454.x; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19050, DOI 10.1073/pnas.0808918105; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; PENNYCUICK CJ, 1978, OIKOS, V30, P165, DOI 10.2307/3543476; PENNYCUICK CJ, 1972, IBIS, V114, P178, DOI 10.1111/j.1474-919X.1972.tb02603.x; Pennycuick CJ, 1998, J AVIAN BIOL, V29, P33, DOI 10.2307/3677338; Sapir N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013956; Sergio F, 2007, BEHAV ECOL, V18, P811, DOI 10.1093/beheco/arm052; Shamoun-Baranes J, 2003, J AVIAN BIOL, V34, P97, DOI 10.1034/j.1600-048X.2003.03079.x; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Smallwood KS, 2008, J WILDLIFE MANAGE, V72, P215, DOI 10.2193/2007-032; Spaar R, 1996, J AVIAN BIOL, V27, P289, DOI 10.2307/3677260; Spaar R, 1997, CONDOR, V99, P458, DOI 10.2307/1369952; Strandberg R, 2008, ARDEA, V96, P159, DOI 10.5253/078.096.0202; Teter S, 2003, AM HAWKWATCHER, P9; Thorup K, 2003, P ROY SOC B-BIOL SCI, V270, pS8, DOI 10.1098/rsbl.2003.0014	34	65	65	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35548	10.1371/journal.pone.0035548	http://dx.doi.org/10.1371/journal.pone.0035548			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558166	Green Published, gold			2022-12-25	WOS:000305345200047
J	Meng, L; Yang, L; Zhao, XX; Zhang, L; Zhu, HZ; Liu, C; Tan, WH				Meng, Ling; Yang, Liu; Zhao, Xiangxuan; Zhang, Lucy; Zhu, Haizhen; Liu, Chen; Tan, Weihong			Targeted Delivery of Chemotherapy Agents Using a Liver Cancer-Specific Aptamer	PLOS ONE			English	Article							MOLECULAR RECOGNITION; SYSTEMATIC EVOLUTION; DRUG-DELIVERY; DOXORUBICIN; BINDING; CELLS; DNA; ELUCIDATION; CONJUGATE; LIGANDS	Background: Using antibody/aptamer-drug conjugates can be a promising method for decreasing toxicity, while increasing the efficiency of chemotherapy. Methodology/Principal Findings: In this study, the antitumor agent Doxorubicin (Dox) was incorporated into the modified DNA aptamer TLS11a-GC, which specifically targets LH86, a human hepatocellular carcinoma cell line. Cell viability tests demonstrated that the TLS11a-GC-Dox conjugates exhibited both potency and target specificity. Importantly, intercalating Dox into the modified aptamer inhibited nonspecific uptake of membrane-permeable Dox to the non-target cell line. Since the conjugates are selective for cells that express higher amounts of target proteins, both criteria noted above are met, making TLS11a-GC-Dox conjugates potential candidates for targeted delivery to liver cancer cells. Conclusions/Significance: Considering the large number of available aptamers that have specific targets for a wide variety of cancer cells, this novel aptamer-drug intercalation method will have promising implications for chemotherapeutics in general.	[Meng, Ling; Yang, Liu; Zhao, Xiangxuan; Zhang, Lucy; Liu, Chen; Tan, Weihong] Univ Florida, Dept Chem, Shands Canc Ctr, Gainesville, FL 32611 USA; [Meng, Ling; Yang, Liu; Zhao, Xiangxuan; Zhang, Lucy; Liu, Chen; Tan, Weihong] Univ Florida, Dept Physiol & Funct Gen, Ctr Res Bio Nano Interface, Gainesville, FL USA; [Meng, Ling; Yang, Liu; Zhao, Xiangxuan; Zhang, Lucy; Liu, Chen; Tan, Weihong] Univ Florida, Coll Med, Dept Pathol Immunol, Gainesville, FL USA; [Meng, Ling; Yang, Liu; Zhao, Xiangxuan; Zhang, Lucy; Liu, Chen; Tan, Weihong] Univ Florida, Coll Med, Lab Med, Gainesville, FL USA; [Zhu, Haizhen] Hunan Univ, Coll Chem & Chem Engn, State Key Lab Chemo Biosensing & Chemometr, Changsha, Peoples R China	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Hunan University	Meng, L (corresponding author), Univ Florida, Dept Chem, Shands Canc Ctr, Gainesville, FL 32611 USA.	liu@pathology.ufl.edu; tan@chem.ufl.edu	Tan, Weihong/A-5412-2008; Tan, Weihong/AAA-4536-2020	Tan, Weihong/0000-0002-8066-1524; 	National Institutes of Health (NIH) [GM066137, GM079359, CA133086]; NATIONAL CANCER INSTITUTE [R01CA133086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079359, R01GM066137] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) GM066137, GM079359, and CA133086. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagalkot V, 2006, ANGEW CHEM INT EDIT, V45, P8149, DOI 10.1002/anie.200602251; Blank M, 2001, J BIOL CHEM, V276, P16464, DOI 10.1074/jbc.M100347200; Carter PJ, 2008, CANCER J, V14, P154, DOI 10.1097/PPO.0b013e318172d704; CHAIRES JB, 1990, BIOCHEMISTRY-US, V29, P6145, DOI 10.1021/bi00478a006; Chari RVJ, 2008, ACCOUNTS CHEM RES, V41, P98, DOI 10.1021/ar700108g; Chen HW, 2008, CHEMMEDCHEM, V3, P991, DOI 10.1002/cmdc.200800030; Chu TC, 2006, CANCER RES, V66, P5989, DOI 10.1158/0008-5472.CAN-05-4583; Daniels DA, 2003, P NATL ACAD SCI USA, V100, P15416, DOI 10.1073/pnas.2136683100; Farokhzad OC, 2004, CANCER RES, V64, P7668, DOI 10.1158/0008-5472.CAN-04-2550; Farokhzad OC, 2006, P NATL ACAD SCI USA, V103, P6315, DOI 10.1073/pnas.0601755103; Flinders J, 2004, CHEMBIOCHEM, V5, P62, DOI 10.1002/cbic.200300701; Haj HTB, 2003, CHEM-BIOL INTERACT, V145, P349, DOI 10.1016/S0009-2797(03)00061-9; Huang YF, 2009, CHEMBIOCHEM, V10, P862, DOI 10.1002/cbic.200800805; HUSAIN N, 1993, J PHYS CHEM-US, V97, P10857, DOI 10.1021/j100143a054; Kuo MT, 2010, ONCOTARGET, V1, P246, DOI 10.18632/oncotarget.135; Lee Y, 2008, BIOCONJUGATE CHEM, V19, P525, DOI 10.1021/bc700382z; LIPSCOMB LA, 1994, BIOCHEMISTRY-US, V33, P3649, DOI 10.1021/bi00178a023; Mallikaratchy P, 2008, CHEMMEDCHEM, V3, P425, DOI 10.1002/cmdc.200700260; Mallikaratchy P, 2007, MOL CELL PROTEOMICS, V6, P2230, DOI 10.1074/mcp.M700026-MCP200; Mann AP, 2011, ONCOTARGET, V2, P298; Patel DJ, 1997, J MOL BIOL, V272, P645, DOI 10.1006/jmbi.1997.1281; Seigneuric R, 2011, ONCOTARGET, V2, P557, DOI 10.18632/oncotarget.297; Shangguan D, 2008, J PROTEOME RES, V7, P2133, DOI 10.1021/pr700894d; Shangguan DH, 2008, ANAL CHEM, V80, P721, DOI 10.1021/ac701962v; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Tang ZW, 2007, ANAL CHEM, V79, P4900, DOI 10.1021/ac070189y; Tang ZW, 2009, CLIN CHEM, V55, P813, DOI 10.1373/clinchem.2008.113514; Wall DM, 2010, ONCOTARGET, V1, P721; Yan Q, 1997, BIOSPECTROSCOPY, V3, P307, DOI 10.1002/(SICI)1520-6343(1997)3:4<307::AID-BSPY6>3.0.CO;2-0; Zhang LF, 2007, CHEMMEDCHEM, V2, P1268, DOI 10.1002/cmdc.200700121; Zhu HZ, 2007, GASTROENTEROLOGY, V133, P1649, DOI 10.1053/j.gastro.2007.09.017	31	88	91	10	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e33434	10.1371/journal.pone.0033434	http://dx.doi.org/10.1371/journal.pone.0033434			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558072	gold, Green Published, Green Submitted			2022-12-25	WOS:000305345200002
J	Shukla, A; Burton, NM; Jayaraman, PS; Gaston, K				Shukla, Anshuman; Burton, Nicholas M.; Jayaraman, Padma-Sheela; Gaston, Kevin			The Proline Rich Homeodomain Protein PRH/Hhex Forms Stable Oligomers That Are Highly Resistant to Denaturation	PLOS ONE			English	Article							MESSENGER-RNA TRANSPORT; NUCLEAR ARCHITECTURE; HEMATOPOIETIC-CELLS; DNA-BINDING; TRANSCRIPTION; THERMOSTABILITY; LOCALIZATION; MECHANISMS; EXPRESSION; REGULATOR	Background: Many transcription factors control gene expression by binding to specific DNA sequences at or near the genes that they regulate. However, some transcription factors play more global roles in the control of gene expression by altering the architecture of sections of chromatin or even the whole genome. The ability to form oligomeric protein assemblies allows many of these proteins to manipulate extensive segments of DNA or chromatin via the formation of structures such as DNA loops or protein-DNA fibres. Principal Findings: Here we show that the proline rich homeodomain protein PRH/Hhex forms predominantly octameric and/or hexadecameric species in solution as well as larger assemblies. We show that these assemblies are highly stable resisting denaturation by temperature and chemical denaturants. Conclusion: These data indicate that PRH is functionally and structurally related to the Lrp/AsnC family of proteins, a group of proteins that are known to act globally to control gene expression in bacteria and archaea.	[Shukla, Anshuman; Jayaraman, Padma-Sheela] Univ Birmingham, Sch Med, Inst Biomed Res, Birmingham, W Midlands, England; [Burton, Nicholas M.; Gaston, Kevin] Univ Bristol, Sch Biochem, Bristol, Avon, England	University of Birmingham; University of Bristol	Shukla, A (corresponding author), Univ Birmingham, Sch Med, Inst Biomed Res, Birmingham, W Midlands, England.	Kevin.Gaston@Bristol.ac.uk	Burton, Nick/C-7064-2013; Gaston, Kevin/K-9237-2019	Gaston, Kevin/0000-0002-7349-5513; /0000-0002-6500-9095	Wellcome Trust [076527]	Wellcome Trust(Wellcome TrustEuropean Commission)	Funding was provided by the Wellcome Trust grant reference 076527. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	D'Elia AV, 2002, J CLIN ENDOCR METAB, V87, P1376, DOI 10.1210/jc.87.3.1376; de los Rios S, 2007, J MOL BIOL, V366, P1589, DOI 10.1016/j.jmb.2006.12.032; Gerk LP, 2000, J MOL BIOL, V299, P805, DOI 10.1006/jmbi.2000.3706; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Guidry JJ, 2000, PROTEIN SCI, V9, P2109, DOI 10.1110/ps.9.11.2109; Guiral M, 2001, J BIOL CHEM, V276, P2961, DOI 10.1074/jbc.M004948200; Jankovic D, 2008, BLOOD, V111, P5672, DOI 10.1182/blood-2007-09-108175; Kaiser TE, 2008, SCIENCE, V322, P1713, DOI 10.1126/science.1165216; Misteli T, 2005, BIOESSAYS, V27, P477, DOI 10.1002/bies.20226; Nichols NM, 2001, BIOCHEMISTRY-US, V40, P3847, DOI 10.1021/bi002088z; Noy P, 2010, MOL CELL BIOL, V30, P2120, DOI 10.1128/MCB.01511-09; Puppin C, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-192; Shevtsov SP, 2011, NAT CELL BIOL, V13, P167, DOI 10.1038/ncb2157; Soufi A, 2008, BIOCHEM J, V412, P399, DOI 10.1042/BJ20080035; Soufi A, 2006, J MOL BIOL, V358, P943, DOI 10.1016/j.jmb.2006.02.020; Soufi A, 2010, NUCLEIC ACIDS RES, V38, P7513, DOI 10.1093/nar/gkq659; Soufi A, 2009, NUCLEIC ACIDS RES, V37, P3288, DOI 10.1093/nar/gkp197; Swingler TE, 2004, J BIOL CHEM, V279, P34938, DOI 10.1074/jbc.M404488200; Thaw P, 2006, NUCLEIC ACIDS RES, V34, P1439, DOI 10.1093/nar/gkl009; THOMAS JO, 1975, P NATL ACAD SCI USA, V72, P2626, DOI 10.1073/pnas.72.7.2626; Topisirovic I, 2003, MOL CELL BIOL, V23, P8992, DOI 10.1128/MCB.23.24.8992-9002.2003; Topisirovic I, 2003, EMBO J, V22, P689, DOI 10.1093/emboj/cdg069; Van den Burg B, 1998, P NATL ACAD SCI USA, V95, P2056, DOI 10.1073/pnas.95.5.2056; Williams H, 2008, J MOL BIOL, V383, P10, DOI 10.1016/j.jmb.2008.08.004; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084	25	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35984	10.1371/journal.pone.0035984	http://dx.doi.org/10.1371/journal.pone.0035984			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540015	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341000081
J	Kim, A; Feng, P; Ohkuri, T; Sauers, D; Cohn, ZJ; Chai, JH; Nelson, T; Bachmanov, AA; Huang, LQ; Wang, H				Kim, Agnes; Feng, Pu; Ohkuri, Tadahiro; Sauers, Daniel; Cohn, Zachary J.; Chai, Jinghua; Nelson, Theodore; Bachmanov, Alexander A.; Huang, Liquan; Wang, Hong			Defects in the Peripheral Taste Structure and Function in the MRL/lpr Mouse Model of Autoimmune Disease	PLOS ONE			English	Article							RAT CIRCUMVALLATE PAPILLAE; BUD CELLS; SJOGRENS-SYNDROME; RECEPTOR-CELLS; SIGNALING PATHWAYS; GENE-EXPRESSION; MAMMALIAN TASTE; SOFT PALATE; MICE; INFLAMMATION	While our understanding of the molecular and cellular aspects of taste reception and signaling continues to improve, the aberrations in these processes that lead to taste dysfunction remain largely unexplored. Abnormalities in taste can develop in a variety of diseases, including infections and autoimmune disorders. In this study, we used a mouse model of autoimmune disease to investigate the underlying mechanisms of taste disorders. MRL/MpJ-Fas(lpr)/J (MRL/lpr) mice develop a systemic autoimmunity with phenotypic similarities to human systemic lupus erythematosus and Sjogren's syndrome. Our results show that the taste tissues of MRL/lpr mice exhibit characteristics of inflammation, including infiltration of T lymphocytes and elevated levels of some inflammatory cytokines. Histological studies reveal that the taste buds of MRL/lpr mice are smaller than those of wild-type congenic control (MRL/+/+) mice. 5-Bromo-2'-deoxyuridine (BrdU) pulse-chase experiments show that fewer BrdU-labeled cells enter the taste buds of MRL/lpr mice, suggesting an inhibition of taste cell renewal. Real-time RT-PCR analyses show that mRNA levels of several type II taste cell markers are lower in MRL/lpr mice. Immunohistochemical analyses confirm a significant reduction in the number of gustducin-positive taste receptor cells in the taste buds of MRL/lpr mice. Furthermore, MRL/lpr mice exhibit reduced gustatory nerve responses to the bitter compound quinine and the sweet compound saccharin and reduced behavioral responses to bitter, sweet, and umami taste substances compared with controls. In contrast, their responses to salty and sour compounds are comparable to those of control mice in both nerve recording and behavioral experiments. Together, our results suggest that type II taste receptor cells, which are essential for bitter, sweet, and umami taste reception and signaling, are selectively affected in MRL/lpr mice, a model for autoimmune disease with chronic inflammation.	[Kim, Agnes; Feng, Pu; Ohkuri, Tadahiro; Sauers, Daniel; Cohn, Zachary J.; Chai, Jinghua; Nelson, Theodore; Bachmanov, Alexander A.; Huang, Liquan; Wang, Hong] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Monell Chemical Senses Center	Kim, A (corresponding author), Drexel Univ, Coll Med, Philadelphia, PA 19104 USA.	hwang@monell.org	Bachmanov, Alexander A./AAH-8857-2020	Bachmanov, Alexander A./0000-0002-2861-3322; Huang, Liquan/0000-0003-3400-0685; Wang, Hong/0000-0003-4130-8741	National Institutes of Health/National Institute on Deafness and Other Communication Disorders [DC010012, DC007487, DC00882, P30 DC011735, T32DC000014]; National Science Foundation [DBJ-0216310]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010012, R01DC000882, R01DC007487, P30DC011735, T32DC000014] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by grants from the National Institutes of Health/National Institute on Deafness and Other Communication Disorders (DC010012 to H.W., DC007487 to L.H., DC00882 to A.A.B., P30 DC011735, and T32DC000014) and from the National Science Foundation (DBJ-0216310). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerlund K, 1999, CLIN EXP IMMUNOL, V115, P32; ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; [Anonymous], 1995, NEUROL DIS; Ballok DA, 2004, HIPPOCAMPUS, V14, P649, DOI 10.1002/hipo.10205; BEIDLER LM, 1965, J CELL BIOL, V27, P263, DOI 10.1083/jcb.27.2.263; Boughter JD, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-36; Boughter JD, 2002, CHEM SENSES, V27, P133, DOI 10.1093/chemse/27.2.133; Brand JG, 2000, LANCET, V356, P1371, DOI 10.1016/S0140-6736(00)02836-1; Breslin PAS, 2006, ADV OTO-RHINO-LARYNG, V63, P152, DOI 10.1159/000093760; Bromley S. M., 2003, Handbook of olfaction and gustation, P935; CAMPBELL SM, 1983, AM J OTOLARYNG, V4, P187, DOI 10.1016/S0196-0709(83)80042-8; Cavallin MA, 2005, J NEUROSCI RES, V80, P75, DOI 10.1002/jnr.20438; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; Clapp TR, 2004, J COMP NEUROL, V468, P311, DOI 10.1002/cne.10963; Cohn ZJ, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-72; FARBMAN AI, 1980, CELL TISSUE KINET, V13, P349, DOI 10.1111/j.1365-2184.1980.tb00474.x; Feng P, 2010, CHEM SENSES, V35, P501, DOI 10.1093/chemse/bjq040; Feng P, 2009, BRAIN BEHAV IMMUN, V23, P760, DOI 10.1016/j.bbi.2009.02.016; Finger TE, 2005, CHEM SENSES, V30, pI54, DOI 10.1093/chemse/bjh110; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; FOSTER RF, 1987, DEV BIOL, V122, P11, DOI 10.1016/0012-1606(87)90327-7; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; FURUKAWA F, 1984, ARCH DERMATOL RES, V276, P186, DOI 10.1007/BF00414018; Glendinning JI, 2002, CHEM SENSES, V27, P461, DOI 10.1093/chemse/27.5.461; Goldstein BJ, 2004, OTOLARYNG CLIN N AM, V37, P1281, DOI 10.1016/j.otc.2004.06.004; Gomez FE, 2004, EUR J CLIN NUTR, V58, P629, DOI 10.1038/sj.ejcn.1601858; Harrison TA, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-34; Heald A E, 1997, N C Med J, V58, P100; HENKIN RI, 1972, ANN INTERN MED, V76, P375, DOI 10.7326/0003-4819-76-3-375; Hevezi P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006395; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Huang LQ, 2003, J COMP NEUROL, V455, P1, DOI 10.1002/cne.10396; Huang YA, 2008, J PHYSIOL-LONDON, V586, P2903, DOI 10.1113/jphysiol.2008.151233; Hutton JL, 2007, J PAIN SYMPTOM MANAG, V33, P156, DOI 10.1016/j.jpainsymman.2006.07.017; Iguchi N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023165; Inoue M, 2004, CHEM SENSES, V29, P789, DOI 10.1093/chemse/bjh083; JABS DA, 1994, ADV EXP MED BIOL, V350, P623; Jonsson R, 2007, ANN NY ACAD SCI, V1108, P433, DOI 10.1196/annals.1422.046; Kataoka S, 2008, CHEM SENSES, V33, P243, DOI 10.1093/chemse/bjm083; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manita S, 2006, CHEM SENSES, V31, P785, DOI 10.1093/chemse/bjl020; Mann NM, 2002, CLEV CLIN J MED, V69, P329, DOI 10.3949/ccjm.69.4.329; Matsumoto I, 2011, NAT NEUROSCI, V14, P685, DOI 10.1038/nn.2820; Medler KF, 2003, J NEUROSCI, V23, P2608; Miura H, 2005, CHEM SENSES, V30, P367, DOI 10.1093/chemse/bji031; Miura H, 2010, ARCH ITAL BIOL, V148, P107; Murata Y, 2009, PHYSIOL BEHAV, V98, P481, DOI 10.1016/j.physbeh.2009.07.016; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Nelson TM, 2003, CHEM SENSES, V28, P695, DOI 10.1093/chemse/bjg062; Ohkuri T, 2012, RESIDUAL CHEMORESPON; Ohkuri T, 2006, CHEM SENSES, V31, P565, DOI 10.1093/chemse/bjj061; Ohkuri T, 2009, AM J PHYSIOL-REG I, V296, pR960, DOI 10.1152/ajpregu.91018.2008; Ohtubo Y, 2011, BRAIN RES, V1367, P13, DOI 10.1016/j.brainres.2010.10.060; Okubo T, 2009, STEM CELLS, V27, P442, DOI 10.1634/stemcells.2008-0611; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Peng SL, 1998, CLIN EXP IMMUNOL, V111, P107; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Phillips LM, 1996, AM J PHYSIOL-REG I, V271, pR857, DOI 10.1152/ajpregu.1996.271.4.R857; Pribitkin E, 2003, ANN OTO RHINOL LARYN, V112, P971, DOI 10.1177/000348940311201110; Pumplin DW, 2000, J COMP NEUROL, V427, P171, DOI 10.1002/1096-9861(20001113)427:2<171::AID-CNE1>3.0.CO;2-W; Reed DR, 2004, J NEUROSCI, V24, P938, DOI 10.1523/JNEUROSCI.1374-03.2004; Reiter ER, 2006, ADV OTO-RHINO-LARYNG, V63, P265, DOI 10.1159/000093765; Sakic B, 1996, BRAIN RES BULL, V41, P305, DOI 10.1016/S0361-9230(96)00190-6; Sakic B, 1997, BRAIN RES BULL, V44, P155, DOI 10.1016/S0361-9230(97)00107-X; SCHIFFMAN SS, 1983, NEW ENGL J MED, V308, P1275; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Steen PW, 2010, NEUROSCIENCE, V167, P894, DOI 10.1016/j.neuroscience.2010.02.056; Suzuki Y, 2002, CELL TISSUE RES, V307, P423, DOI 10.1007/s00441-001-0504-9; Tesch GH, 1999, J EXP MED, V190, P1813, DOI 10.1084/jem.190.12.1813; Thirumangalathu S, 2009, DEVELOPMENT, V136, P1519, DOI 10.1242/dev.029090; Vandenbeuch A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-1; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wang H, 2007, J NEUROSCI, V27, P10703, DOI 10.1523/JNEUROSCI.3102-07.2007; Wang H, 2009, ANN NY ACAD SCI, V1170, P596, DOI 10.1111/j.1749-6632.2009.04480.x; Wang H, 2009, J COMP NEUROL, V512, P384, DOI 10.1002/cne.21899; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WEIFFENBACH JM, 1995, PHYSIOL BEHAV, V57, P89, DOI 10.1016/0031-9384(94)00211-M; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; WU JG, 1993, J EXP MED, V178, P461, DOI 10.1084/jem.178.2.461; Yang RB, 2000, J COMP NEUROL, V424, P205, DOI 10.1002/1096-9861(20000821)424:2<205::AID-CNE2>3.0.CO;2-F; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zipp F, 2006, TRENDS NEUROSCI, V29, P518, DOI 10.1016/j.tins.2006.07.006	85	23	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35588	10.1371/journal.pone.0035588	http://dx.doi.org/10.1371/journal.pone.0035588			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536412	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336200059
J	Kucyi, A; Moayedi, M; Weissman-Fogel, I; Hodaie, M; Davis, KD				Kucyi, Aaron; Moayedi, Massieh; Weissman-Fogel, Irit; Hodaie, Mojgan; Davis, Karen D.			Hemispheric Asymmetry in White Matter Connectivity of the Temporoparietal Junction with the Insula and Prefrontal Cortex	PLOS ONE			English	Article							TRACTOGRAPHY-BASED PARCELLATION; STATE FUNCTIONAL CONNECTIVITY; MULTIPLE SENSORY MODALITIES; HUMAN BRAIN; STRUCTURAL CONNECTIVITY; IMAGING TRACTOGRAPHY; SPATIAL AWARENESS; CORTICAL NETWORK; DIFFUSION TRACTOGRAPHY; VISUOSPATIAL ATTENTION	The temporoparietal junction (TPJ) is a key node in the brain's ventral attention network (VAN) that is involved in spatial awareness and detection of salient sensory stimuli, including pain. The anatomical basis of this network's right-lateralized organization is poorly understood. Here we used diffusion-weighted MRI and probabilistic tractography to compare the strength of white matter connections emanating from the right versus left TPJ to target regions in both hemispheres. Symmetry of structural connectivity was evaluated for connections between TPJ and target regions that are key cortical nodes in the right VAN (insula and inferior frontal gyrus) as well as target regions that are involved in salience and/or pain (putamen, cingulate cortex, thalamus). We found a rightward asymmetry in connectivity strength between the TPJ and insula in healthy human subjects who were scanned with two different sets of diffusion-weighted MRI acquisition parameters. This rightward asymmetry in TPJ-insula connectivity was stronger in females than in males. There was also a leftward asymmetry in connectivity strength between the TPJ and inferior frontal gyrus, consistent with previously described lateralization of language pathways. The rightward lateralization of the pathway between the TPJ and insula supports previous findings on the roles of these regions in stimulus-driven attention, sensory awareness, interoception and pain. The findings also have implications for our understanding of acute and chronic pains and stroke-induced spatial hemineglect.	[Kucyi, Aaron; Moayedi, Massieh; Weissman-Fogel, Irit; Davis, Karen D.] Univ Hlth Network, Toronto Western Res Inst, Div Brain Imaging & Behav Syst Neurosci, Toronto, ON, Canada; [Kucyi, Aaron; Moayedi, Massieh; Hodaie, Mojgan; Davis, Karen D.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Hodaie, Mojgan; Davis, Karen D.] Toronto Western Hosp, Div Neurosurg, Toronto, ON M5T 2S8, Canada; [Hodaie, Mojgan; Davis, Karen D.] Univ Toronto, Dept Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Kucyi, A (corresponding author), Univ Hlth Network, Toronto Western Res Inst, Div Brain Imaging & Behav Syst Neurosci, Toronto, ON, Canada.	kdavis@uhnres.utoronto.ca	Moayedi, Massieh/D-7430-2013	Moayedi, Massieh/0000-0002-7324-2540	Canadian Institutes of Health Research; Physicians' Services Incorporated	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Physicians' Services Incorporated	This study was funded by grants from the Canadian Institutes of Health Research and Physicians' Services Incorporated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwander A, 2007, CEREB CORTEX, V17, P816, DOI 10.1093/cercor/bhk034; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Blankstein U, 2010, GASTROENTEROLOGY, V138, P1783, DOI 10.1053/j.gastro.2009.12.043; Catani M, 2007, P NATL ACAD SCI USA, V104, P17163, DOI 10.1073/pnas.0702116104; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Chica AB, 2011, J NEUROSCI, V31, P8143, DOI 10.1523/JNEUROSCI.5463-10.2010; Committeri G, 2007, BRAIN, V130, P431, DOI 10.1093/brain/awl265; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Davis KD, 2008, NEUROLOGY, V70, P153, DOI 10.1212/01.wnl.0000295509.30630.10; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; Doricchi F, 2008, CORTEX, V44, P983, DOI 10.1016/j.cortex.2008.03.006; Downar J, 2003, NEUROIMAGE, V20, P1540, DOI 10.1016/S1053-8119(03)00407-5; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Downar J, 2001, NEUROIMAGE, V14, P1256, DOI 10.1006/nimg.2001.0946; Downar J, 2001, NEUROIMAGE, V13, pS310; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Downar J, 2000, SOC NEUROSCIENCE, V26, P1587; Eickhoff SB, 2010, J NEUROSCI, V30, P6409, DOI 10.1523/JNEUROSCI.5664-09.2010; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Friederici AD, 2009, TRENDS COGN SCI, V13, P175, DOI 10.1016/j.tics.2009.01.001; Friedrich FJ, 1998, NEUROPSYCHOLOGY, V12, P193, DOI 10.1037/0894-4105.12.2.193; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Geha PY, 2008, NEURON, V60, P570, DOI 10.1016/j.neuron.2008.08.022; Hagmann P, 2010, J NEUROSCI METH, V194, P34, DOI 10.1016/j.jneumeth.2010.01.014; Halligan PW, 2003, TRENDS COGN SCI, V7, P125, DOI 10.1016/S1364-6613(03)00032-9; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Heiervang E, 2006, NEUROIMAGE, V33, P867, DOI 10.1016/j.neuroimage.2006.07.037; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Iturria-Medina Y, 2011, CEREB CORTEX, V21, P56, DOI 10.1093/cercor/bhq058; Jbabdi S, 2011, TRACTOGRAPHY WE GO H; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johansen-Berg H, 2009, ANNU REV NEUROSCI, V32, P75, DOI 10.1146/annurev.neuro.051508.135735; Kaplan E, 2010, NEUROIMAGE, V52, P436, DOI 10.1016/j.neuroimage.2010.04.247; Langner R, 2011, HUM BRAIN MAPP; Loui P, 2011, NEUROIMAGE, V55, P500, DOI 10.1016/j.neuroimage.2010.12.022; Malinen S, 2010, P NATL ACAD SCI USA, V107, P6493, DOI 10.1073/pnas.1001504107; Mars RB, 2011, CONNECTIVITY BASED S; Mars RB, 2011, J NEUROSCI, V31, P4087, DOI 10.1523/JNEUROSCI.5102-10.2011; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Medford N, 2010, BRAIN STRUCT FUNCT, V214, P535, DOI 10.1007/s00429-010-0265-x; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; Moayedi M, 2011, NEUROIMAGE, V55, P277, DOI 10.1016/j.neuroimage.2010.12.013; Mukherjee P, 2008, AM J NEURORADIOL, V29, P843, DOI 10.3174/ajnr.A1052; Naidich TP, 2004, AM J NEURORADIOL, V25, P222; PANDYA DN, 1969, BRAIN RES, V13, P13, DOI 10.1016/0006-8993(69)90141-3; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; Petrides M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000170; Powell HW, 2006, NEUROIMAGE; Salomons TV, 2007, J COGNITIVE NEUROSCI, V19, P993, DOI 10.1162/jocn.2007.19.6.993; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Schmahmann JD, 2006, FIBER PATHWAYS BRAIN, DOI DOI 10.1093/ACPROF:OSO/9780195104233.003.0014; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Starr CJ, 2011, BRAIN, V134, P1987, DOI 10.1093/brain/awr117; Symonds LL, 2006, J NEUROPHYSIOL, V95, P3823, DOI 10.1152/jn.01162.2005; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Tensaouti F, 2011, J MAGN RESON IMAGING, V34, P165, DOI 10.1002/jmri.22584; Thiebaut de Schotten M, 2005, SCIENCE, V309, P2226, DOI 10.1126/science.1116251; Thiebaut de Schotten M, 2011, NAT NEUROSCI, V14, P1245, DOI 10.1038/nn.2905; Thiebaut de Schotten M, 2011, NEUROIMAGE, V54, P49, DOI 10.1016/j.neuroimage.2010.07.055; Tomassini V, 2007, J NEUROSCI, V27, P10259, DOI 10.1523/JNEUROSCI.2144-07.2007; Ture U, 1999, J NEUROSURG, V90, P720, DOI 10.3171/jns.1999.90.4.0720; Umarova RM, 2010, CEREB CORTEX, V20, P121, DOI 10.1093/cercor/bhp086; Urbanski M, 2008, J NEUROL NEUROSUR PS, V79, P598, DOI 10.1136/jnnp.2007.126276; Urbanski M, 2011, EXP BRAIN RES, V208, P491, DOI 10.1007/s00221-010-2496-8; Vallar G, 1998, TRENDS COGN SCI, V2, P87, DOI 10.1016/S1364-6613(98)01145-0; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; VOGT BA, 1987, J COMP NEUROL, V262, P271, DOI 10.1002/cne.902620208; Wager TD, 2007, P NATL ACAD SCI USA, V104, P11056, DOI 10.1073/pnas.0702413104; Weissman-Fogel I, 2011, PAIN, V152, P384, DOI 10.1016/j.pain.2010.10.046	77	62	62	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35589	10.1371/journal.pone.0035589	http://dx.doi.org/10.1371/journal.pone.0035589			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536413	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336200060
J	Luo, S; Mach, J; Abramson, B; Ramirez, R; Schurr, R; Barone, P; Copenhaver, G; Folkerts, O				Luo, Song; Mach, Jennifer; Abramson, Bradley; Ramirez, Rolando; Schurr, Robert; Barone, Pierluigi; Copenhaver, Gregory; Folkerts, Otto			The Cotton Centromere Contains a Ty3-gypsy-like LTR Retroelement	PLOS ONE			English	Article							REPETITIVE DNA ELEMENT; SEQUENCE-ANALYSIS; TRANSPOSABLE ELEMENTS; TANDEM REPEATS; RETROTRANSPOSONS; ORGANIZATION; EVOLUTION; PROTEIN; REGION; WHEAT	The centromere is a repeat-rich structure essential for chromosome segregation; with the long-term aim of understanding centromere structure and function, we set out to identify cotton centromere sequences. To isolate centromere-associated sequences from cotton, (Gossypium hirsutum) we surveyed tandem and dispersed repetitive DNA in the genus. Centromere-associated elements in other plants include tandem repeats and, in some cases, centromere-specific retroelements. Examination of cotton genomic survey sequences for tandem repeats yielded sequences that did not localize to the centromere. However, among the repetitive sequences we also identified a gypsy-like LTR retrotransposon (Centromere Retroelement Gossypium, CRG) that localizes to the centromere region of all chromosomes in domestic upland cotton, Gossypium hirsutum, the major commercially grown cotton. The location of the functional centromere was confirmed by immunostaining with antiserum to the centromere-specific histone CENH3, which co-localizes with CRG hybridization on metaphase mitotic chromosomes. G. hirsutum is an allotetraploid composed of A and D genomes and CRG is also present in the centromere regions of other AD cotton species. Furthermore, FISH and genomic dot blot hybridization revealed that CRG is found in D-genome diploid cotton species, but not in A-genome diploid species, indicating that this retroelement may have invaded the A-genome centromeres during allopolyploid formation and amplified during evolutionary history. CRG is also found in other diploid Gossypium species, including B and E2 genome species, but not in the C, E1, F, and G genome species tested. Isolation of this centromere-specific retrotransposon from Gossypium provides a probe for further understanding of centromere structure, and a tool for future engineering of centromere mini-chromosomes in this important crop species.	[Luo, Song; Mach, Jennifer; Abramson, Bradley; Ramirez, Rolando; Schurr, Robert] Chromatin Inc, Chicago, IL USA; [Copenhaver, Gregory] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Copenhaver, Gregory] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Barone, Pierluigi; Folkerts, Otto] Chromatin Inc, Champaign, IL USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Luo, S (corresponding author), Chromatin Inc, Chicago, IL USA.	ofolkerts@chromatininc.com	Copenhaver, Gregory/AAH-2031-2022; Barone, Pierluigi/A-9730-2008; Copenhaver, Gregory P/A-7549-2014; Copenhaver, Gregory/AFL-9831-2022	Copenhaver, Gregory/0000-0002-7962-3862; Barone, Pierluigi/0000-0002-2579-0913; Copenhaver, Gregory P/0000-0002-7962-3862; Copenhaver, Gregory/0000-0002-7962-3862; Mach, Jennifer/0000-0002-1141-6306				Ananiev EV, 1998, P NATL ACAD SCI USA, V95, P13073, DOI 10.1073/pnas.95.22.13073; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Birchler JA, 2011, CURR OPIN PLANT BIOL, V14, P217, DOI 10.1016/j.pbi.2011.02.004; Birchler JA, 2009, ANNU REV GENET, V43, P287, DOI 10.1146/annurev-genet-102108-134834; Cheng ZJ, 2003, GENETICS, V164, P665; Cheng ZK, 2002, PLANT CELL, V14, P1691, DOI 10.1105/tpc.003079; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; Csaikl UM, 1998, PLANT MOL BIOL REP, V16, P69, DOI 10.1023/A:1007428009556; Dooner HK, 2007, CURR OPIN GENET DEV, V17, P486, DOI 10.1016/j.gde.2007.08.010; Ewing B, 2000, NAT GENET, V25, P232, DOI 10.1038/76115; Gindullis F, 2001, GENOME RES, V11, P253, DOI 10.1101/gr.162301; Hanson RE, 1998, AM J BOT, V85, P1364, DOI 10.2307/2446394; HARRISON GE, 1995, THEOR APPL GENET, V90, P157, DOI 10.1007/BF00222197; Havecker ER, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-225; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Houben A, 2007, CHROMOSOMA, V116, P275, DOI 10.1007/s00412-007-0102-z; Hu GJ, 2010, GENOME, V53, P599, DOI [10.1139/g10-038, 10.1139/G10-038]; Jiang JM, 1996, P NATL ACAD SCI USA, V93, P14210, DOI 10.1073/pnas.93.24.14210; Jiang JM, 2003, TRENDS PLANT SCI, V8, P570, DOI 10.1016/j.tplants.2003.10.011; Kato A, 2006, BIOTECH HISTOCHEM, V81, P71, DOI 10.1080/10520290600643677; Khan H, 2007, J MOL EVOL, V64, P223, DOI 10.1007/s00239-006-0088-9; Kishii M, 2001, CHROMOSOME RES, V9, P417, DOI 10.1023/A:1016739719421; Kulikova O, 2004, CHROMOSOMA, V113, P276, DOI 10.1007/s00412-004-0315-3; Lim KB, 2007, PLANT J, V49, P173, DOI 10.1111/j.1365-313X.2006.02952.x; Liu B, 2000, GENOME, V43, P874, DOI 10.1139/gen-43-5-874; Liu Z, 2008, CHROMOSOMA, V117, P445, DOI 10.1007/s00412-008-0161-9; Ma JX, 2007, TRENDS GENET, V23, P134, DOI 10.1016/j.tig.2007.01.004; MALUSZYNSKA J, 1991, PLANT J, V1, P159, DOI 10.1111/j.1365-313X.1991.00159.x; Miller JT, 1998, GENETICS, V150, P1615; Miller JT, 1998, THEOR APPL GENET, V96, P832, DOI 10.1007/s001220050809; Mroczek RJ, 2003, GENETICS, V165, P809; Nagaki K, 1998, CHROMOSOME RES, V6, P295, DOI 10.1023/A:1009270824142; Neumann P, 2007, GENETICS, V176, P749, DOI 10.1534/genetics.107.071902; PALMER DK, 1991, P NATL ACAD SCI USA, V88, P3734, DOI 10.1073/pnas.88.9.3734; Parisod C, 2010, NEW PHYTOL, V186, P37, DOI 10.1111/j.1469-8137.2009.03096.x; Petit M, 2010, NEW PHYTOL, V186, P135, DOI 10.1111/j.1469-8137.2009.03140.x; Presting GG, 1998, PLANT J, V16, P721, DOI 10.1046/j.1365-313x.1998.00341.x; Round EK, 1997, GENOME RES, V7, P1045, DOI 10.1101/gr.7.11.1045; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Schatz MC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r34; Shi JH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000327; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; Sun XP, 2003, GENOME RES, V13, P182, DOI 10.1101/gr.681703; Sun XP, 1997, CELL, V91, P1007, DOI 10.1016/S0092-8674(00)80491-2; Talbert PB, 2002, PLANT CELL, V14, P1053, DOI 10.1105/tpc.010425; Tek AL, 2010, CHROMOSOME RES, V18, P337, DOI 10.1007/s10577-010-9119-x; Topp CN, 2004, P NATL ACAD SCI USA, V101, P15986, DOI 10.1073/pnas.0407154101; Vahedian M, 1995, PLANT MOL BIOL, V29, P857, DOI 10.1007/BF00041174; Weber B, 2009, CHROMOSOME RES, V17, P379, DOI 10.1007/s10577-009-9029-y; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; Wolfgruber TK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000743; Yang TJ, 2005, CHROMOSOMA, V114, P103, DOI 10.1007/s00412-005-0342-8; Zhao XP, 1998, GENOME RES, V8, P479, DOI 10.1101/gr.8.5.479; Zhong CX, 2002, PLANT CELL, V14, P2825, DOI 10.1105/tpc.006106	54	26	28	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35261	10.1371/journal.pone.0035261	http://dx.doi.org/10.1371/journal.pone.0035261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536361	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336200029
J	Hata, S; Hirayama, J; Kajiho, H; Nakagawa, K; Hata, Y; Katada, T; Furutani-Seiki, M; Nishina, H				Hata, Shoji; Hirayama, Jun; Kajiho, Hiroaki; Nakagawa, Kentaro; Hata, Yutaka; Katada, Toshiaki; Furutani-Seiki, Makoto; Nishina, Hiroshi			A Novel Acetylation Cycle of Transcription Co-activator Yes-associated Protein That Is Downstream of Hippo Pathway Is Triggered in Response to S(N)2 Alkylating Agents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL SELF-RENEWAL; GROWTH-CONTROL; CONTACT INHIBITION; SIZE-CONTROL; DNA-DAMAGE; YAP; REPAIR; ACTIVATION; P300; PHOSPHORYLATION	Yes-associated protein (YAP) is a transcriptional co-activator that acts downstream of the Hippo signaling pathway and regulates multiple cellular processes. Although cytoplasmic retention of YAP is known to be mediated by Hippo pathway-dependent phosphorylation, post-translational modifications that regulate YAP in the nucleus remain unclear. Here we report the discovery of a novel cycle of acetylation/deacetylation of nuclear YAP induced in response to S(N)2 alkylating agents. We show that after treatment of cells with the S(N)2 alkylating agent methyl methanesulfonate, YAP phosphorylation mediated by the Hippo pathway is markedly reduced, leading to nuclear translocation of YAP and its acetylation. This YAP acetylation occurs on specific and highly conserved C-terminal lysine residues and is mediated by the nuclear acetyltransferases CBP (CREB binding protein) and p300. Conversely, the nuclear deacetylase SIRT1 is responsible for YAP deacetylation. Intriguingly, we found that YAP acetylation is induced specifically by S(N)2 alkylating agents and not by other DNA-damaging stimuli. These results identify a novel YAP acetylation cycle that occurs in the nucleus downstream of the Hippo pathway. Intriguingly, our findings also indicate that YAP acetylation is involved in responses to a specific type of DNA damage.	[Hata, Shoji; Hirayama, Jun; Nishina, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Dev & Regenerat Biol, Bunkyo Ku, Tokyo 1138510, Japan; [Kajiho, Hiroaki; Katada, Toshiaki] Univ Tokyo, Dept Physiol Chem, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Nakagawa, Kentaro; Hata, Yutaka] Tokyo Med & Dent Univ, Dept Med Biochem, Grad Sch Med, Bunkyo Ku, Tokyo 1138510, Japan; [Furutani-Seiki, Makoto] Univ Bath, Dept Biol & Biochem, Ctr Regenerat Med, Bath BA2 7AY, Avon, England	Tokyo Medical & Dental University (TMDU); University of Tokyo; Tokyo Medical & Dental University (TMDU); University of Bath	Nishina, H (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Dev & Regenerat Biol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	nishina.dbio@mri.tmd.ac.jp		Hirayama, Jun/0000-0002-8485-3320; Kajiho, Hiroaki/0000-0001-6376-7629	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan; Medical Research Council [G117/563] Funding Source: researchfish; MRC [G117/563] Funding Source: UKRI	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Japan Society for the Promotion of Science, the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and the Ministry of Health, Labor, and Welfare of Japan.	Bao YJ, 2011, J BIOCHEM, V150, P199, DOI 10.1093/jb/mvr063; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Dango S, 2011, MOL CELL, V44, P373, DOI 10.1016/j.molcel.2011.08.039; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Genevet A, 2011, BIOCHEM J, V436, P213, DOI 10.1042/BJ20110217; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Jang ER, 2011, FEBS LETT, V585, P47, DOI 10.1016/j.febslet.2010.11.034; Lapi E, 2008, MOL CELL, V32, P803, DOI 10.1016/j.molcel.2008.11.019; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Li K, 2008, J BIOL CHEM, V283, P7590, DOI 10.1074/jbc.M709707200; Li K, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012286, 10.1371/journal.pone.0010341]; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Ringvoll J, 2006, EMBO J, V25, P2189, DOI 10.1038/sj.emboj.7601109; Sedgwick B, 2007, DNA REPAIR, V6, P429, DOI 10.1016/j.dnarep.2006.10.005; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; Suzuki H, 2001, GENOME RES, V11, P1758, DOI 10.1101/gr.180101; Takahashi S, 2011, CELL DEATH DIFFER, V18, P645, DOI 10.1038/cdd.2010.137; Thompson PR, 2001, J BIOL CHEM, V276, P33721, DOI 10.1074/jbc.M104736200; Tomlinson V, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.7; Ura S, 2007, MOL CELL BIOL, V27, P5514, DOI 10.1128/MCB.00199-07; Vassilopoulos A, 2010, INT J BIOCHEM CELL B, V42, P193, DOI 10.1016/j.biocel.2009.11.020; Wang CG, 2001, J BIOL CHEM, V276, P18375, DOI 10.1074/jbc.M100800200; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yamamori T, 2010, NUCLEIC ACIDS RES, V38, P832, DOI 10.1093/nar/gkp1039; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	38	61	62	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22089	22098		10.1074/jbc.M111.334714	http://dx.doi.org/10.1074/jbc.M111.334714			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22544757	hybrid, Green Published			2022-12-25	WOS:000306418600046
J	Ishikawa, Y; Vranka, JA; Boudko, SP; Pokidysheva, E; Mizuno, K; Zientek, K; Keene, DR; Rashmir-Raven, AM; Nagata, K; Winand, NJ; Bachinger, HP				Ishikawa, Yoshihiro; Vranka, Janice A.; Boudko, Sergei P.; Pokidysheva, Elena; Mizuno, Kazunori; Zientek, Keith; Keene, Douglas R.; Rashmir-Raven, Ann M.; Nagata, Kazuhiro; Winand, Nena J.; Baechinger, Hans Peter			Mutation in Cyclophilin B That Causes Hyperelastosis Cutis in American Quarter Horse Does Not Affect Peptidylprolyl cis-trans Isomerase Activity but Shows Altered Cyclophilin B-Protein Interactions and Affects Collagen Folding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EHLERS-DANLOS-SYNDROME; REGIONAL DERMAL ASTHENIA; I PROCOLLAGEN INCELLULO; X-RAY-STRUCTURE; TRIPLE-HELIX; ENDOPLASMIC-RETICULUM; PROLYL 3-HYDROXYLATION; FK506-BINDING PROTEIN; TARGETED DISRUPTION; MISSENSE MUTATION	The rate-limiting step of folding of the collagen triple helix is catalyzed by cyclophilin B (CypB). The G6R mutation in cyclophilin B found in the American Quarter Horse leads to autosomal recessive hyperelastosis cutis, also known as hereditary equine regional dermal asthenia. The mutant protein shows small structural changes in the region of the mutation at the side opposite the catalytic domain of CypB. The peptidylprolyl cis-trans isomerase activity of the mutant CypB is normal when analyzed in vitro. However, the biosynthesis of type I collagen in affected horse fibroblasts shows a delay in folding and secretion and a decrease in hydroxylysine and glucosyl-galactosyl hydroxylysine. This leads to changes in the structure of collagen fibrils in tendon, similar to those observed in P3H1 null mice. In contrast to cyclophilin B null mice, where little 3-hydroxylation was found in type I collagen, 3-hydroxylation of type I collagen in affected horses is normal. The mutation disrupts the interaction of cyclophilin B with the P-domain of calreticulin, with lysyl hydroxylase 1, and probably other proteins, such as the formation of the P3H1.CypB.cartilage-associated protein complex, resulting in less effective catalysis of the rate-limiting step in collagen folding in the rough endoplasmic reticulum.	[Winand, Nena J.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Ishikawa, Yoshihiro; Vranka, Janice A.; Boudko, Sergei P.; Pokidysheva, Elena; Mizuno, Kazunori; Zientek, Keith; Keene, Douglas R.; Baechinger, Hans Peter] Shriners Hosp Children, Res Dept, Portland, OR 97239 USA; [Ishikawa, Yoshihiro; Boudko, Sergei P.; Pokidysheva, Elena; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Nagata, Kazuhiro] Kyoto Sangyo Univ, Fac Life Sci, Lab Mol & Cellular Biol, Kyoto 6038555, Japan; [Rashmir-Raven, Ann M.] Michigan State Univ, Coll Vet Med, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA	Cornell University; Oregon Health & Science University; Kyoto Sangyo University; Michigan State University	Winand, NJ (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.	njw2@cornell.edu; hpb@shcc.org	Mizuno, Kazunori/AAY-7613-2021	Mizuno, Kazunori/0000-0003-3354-6264; Boudko, Sergei/0000-0003-3856-4859; Ishikawa, Yoshihiro/0000-0003-2013-0518	Shriners Hospitals for Children; American Quarter Horse Association	Shriners Hospitals for Children; American Quarter Horse Association	This work was supported by grants from Shriners Hospitals for Children (to H. P. B. and D. R. K.) and the American Quarter Horse Association (to A. R. R.).	Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; BACHINGER HP, 1993, AM J MED GENET, V45, P152, DOI 10.1002/ajmg.1320450204; BACHINGER HP, 1987, J BIOL CHEM, V262, P17144; BACHINGER HP, 1980, EUR J BIOCHEM, V106, P619, DOI 10.1111/j.1432-1033.1980.tb04610.x; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Borges AS, 2005, VET DERMATOL, V16, P125, DOI 10.1111/j.1365-3164.2005.00431.x; Bradshaw AD, 2003, J INVEST DERMATOL, V120, P949, DOI 10.1046/j.1523-1747.2003.12241.x; Brounts SH, 2001, VET DERMATOL, V12, P219, DOI 10.1046/j.0959-4493.2001.00256.x; BRUCKNER P, 1981, EUR J BIOCHEM, V118, P607, DOI 10.1111/j.1432-1033.1981.tb05562.x; BRUCKNER P, 1984, EUR J BIOCHEM, V140, P391, DOI 10.1111/j.1432-1033.1984.tb08114.x; Bukrinsky MI, 2002, TRENDS IMMUNOL, V23, P323, DOI 10.1016/S1471-4906(02)02237-8; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Choi JW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000750; Colige A, 1999, AM J HUM GENET, V65, P308, DOI 10.1086/302504; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Faiyaz-Ul-Haque M, 2004, AM J MED GENET A, V128A, P39, DOI 10.1002/ajmg.a.30005; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; HARDY MH, 1988, LAB INVEST, V59, P253; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P1684, DOI 10.1021/bi00459a003; Horibe T, 2002, J BIOCHEM, V132, P401, DOI 10.1093/oxfordjournals.jbchem.a003236; Ishikawa Y, 2008, J BIOL CHEM, V283, P31584, DOI 10.1074/jbc.M802535200; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; Kozlov G, 2010, J BIOL CHEM, V285, P35551, DOI 10.1074/jbc.M110.160101; Kyriakides TR, 1998, J CELL BIOL, V140, P419, DOI 10.1083/jcb.140.2.419; LERNER DJ, 1978, J EQUINE MED SURG, V2, P350; Makareeva E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001029; Mao JR, 2001, J CLIN INVEST, V107, P1063, DOI 10.1172/JCI12881; Mao JR, 2002, NAT GENET, V30, P421, DOI 10.1038/ng850; Marini JC, 2007, CELL CYCLE, V6, P1675, DOI 10.4161/cc.6.14.4474; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; MIKOL V, 1994, P NATL ACAD SCI USA, V91, P5183, DOI 10.1073/pnas.91.11.5183; MIKOL V, 1993, J MOL BIOL, V234, P1119, DOI 10.1006/jmbi.1993.1664; Mochal CA, 2010, JAVMA-J AM VET MED A, V237, P304, DOI 10.2460/javma.237.3.304; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Ottiger M, 1997, J MOL BIOL, V272, P64, DOI 10.1006/jmbi.1997.1220; Rashmir-Raven A. M., 2004, Proceedings of the 50th Annual Convention of the American Association of Equine Practitioners, Denver, Colorado, USA, 4-8 December, 2004, P47; Rycyzyn MA, 2000, MOL ENDOCRINOL, V14, P1175, DOI 10.1210/me.14.8.1175; Seidler DG, 2006, J MOL MED, V84, P583, DOI 10.1007/s00109-006-0046-4; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SMITH T, 1995, J BIOL CHEM, V270, P18323, DOI 10.1074/jbc.270.31.18323; SPITZFADEN C, 1994, J BIOMOL NMR, V4, P463, DOI 10.1007/BF00156614; STEINMANN B, 1991, J BIOL CHEM, V266, P1299; SWANSON SKH, 1992, P NATL ACAD SCI USA, V89, P3741, DOI 10.1073/pnas.89.9.3741; Swiderski C., 2006, P 24 ANN AM COLL VET, P756; Takeda U, 2002, J INVEST DERMATOL, V119, P678, DOI 10.1046/j.1523-1747.2002.01863.x; Tryon RC, 2005, AM J VET RES, V66, P437, DOI 10.2460/ajvr.2005.66.437; Tryon RC, 2007, GENOMICS, V90, P93, DOI 10.1016/j.ygeno.2007.03.009; Tryon RC, 2009, JAVMA-J AM VET MED A, V234, P120, DOI 10.2460/javma.234.1.120; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Vranka JA, 2010, J BIOL CHEM, V285, P17253, DOI 10.1074/jbc.M110.102228; Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; White SD, 2004, VET DERMATOL, V15, P207, DOI 10.1111/j.1365-3164.2004.00402.x; Zeng BF, 1998, BIOCHEM J, V330, P109, DOI 10.1042/bj3300109; Zhang JY, 2003, J BIOL CHEM, V278, P7459, DOI 10.1074/jbc.M207976200; Zhao YD, 1996, BIOCHEMISTRY-US, V35, P7356, DOI 10.1021/bi9602775	60	55	57	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22253	22265		10.1074/jbc.M111.333336	http://dx.doi.org/10.1074/jbc.M111.333336			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22556420	hybrid, Green Published			2022-12-25	WOS:000306418600063
J	Agrawal, P; Chen, YT; Schilling, B; Gibson, BW; Hughes, RE				Agrawal, Pooja; Chen, Yu-Ting; Schilling, Birgit; Gibson, Bradford W.; Hughes, Robert E.			Ubiquitin-specific Peptidase 9, X-linked (USP9X) Modulates Activity of Mammalian Target of Rapamycin (mTOR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAM DEUBIQUITYLATING ENZYME; DEUBIQUITINATING ENZYME; EMBRYO DEVELOPMENT; BINDING PARTNER; CELL-SURVIVAL; BETA-CATENIN; FACETS GENE; IN-VIVO; PROTEIN; COMPLEX	The mammalian target of rapamycin (mTOR) is an atypical serine/threonine kinase that responds to extracellular environment to regulate a number of cellular processes. These include cell growth, proliferation, and differentiation. Although both kinase-dependent and -independent functions of mTOR are known to be critical modulators of muscle cell differentiation and regeneration, the signaling mechanisms regulating mTOR activity during differentiation are still unclear. In this study we identify a novel mTOR interacting protein, the ubiquitin-specific protease USP9X, which acts as a negative regulator of mTOR activity and muscle differentiation. USP9X can co-immunoprecipitate mTOR with both Raptor and Rictor, components of mTOR complexes 1 and 2 (mTORC1 and -2), respectively, suggesting that it is present in both mTOR complexes. Knockdown of USP9X leads to increased mTORC1 activity in response to growth factor stimulation. Interestingly, upon initiation of differentiation of C2C12 mouse skeletal myoblasts, knockdown of USP9X increases mTORC2 activity. This increase in mTORC2 activity is accompanied by accelerated differentiation of myoblasts into myotubes. Taken together, our data describe the identification of the deubiquitinase USP9X as a novel mTORC1 and -2 binding partner that negatively regulates mTOR activity and skeletal muscle differentiation.	[Agrawal, Pooja; Chen, Yu-Ting; Schilling, Birgit; Gibson, Bradford W.; Hughes, Robert E.] Buck Inst Res Aging, Novato, CA 94945 USA	Buck Institute for Research on Aging	Gibson, BW (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	bgibson@buckinstitute.org; rhughes@buckinstitute.org			National Institutes of Health [RL1 GM084432, TL1 AG032116]; Center for Research Resources, National Institutes of Health [S10 RR024615]; Geroscience Mass Spectrometry and Imaging Core Grant [PL1 AG032118]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL1GM084432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [TL1AG032116, PL1AG032118] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Geroscience Mass Spectrometry and Imaging Core Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant RL1 GM084432 (to R. H.). Mass spectrometry was supported by Center for Research Resources, National Institutes of Health shared instrumentation Grant S10 RR024615 (to B. W. G.) and Geroscience Mass Spectrometry and Imaging Core Grant PL1 AG032118; to B. W. G.).; Supported by National Institutes of Health Training Grant TL1 AG032116.	Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Erbay E, 2003, J CELL BIOL, V163, P931, DOI 10.1083/jcb.200307158; Erbay E, 2001, J BIOL CHEM, V276, P36079, DOI 10.1074/jbc.C100406200; FISCHERVIZE JA, 1992, DEVELOPMENT, V116, P985; Ge YJ, 2009, AM J PHYSIOL-CELL PH, V297, pC1434, DOI 10.1152/ajpcell.00248.2009; Glass DJ, 2010, CURR TOP MICROBIOL, V346, P267, DOI 10.1007/82_2010_78; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; HUANG YZ, 1995, SCIENCE, V270, P1828, DOI 10.1126/science.270.5243.1828; Izumi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000468; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jolly LA, 2009, MOL BIOL CELL, V20, P2015, DOI 10.1091/mbc.E08-06-0596; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Kaizuka T, 2010, J BIOL CHEM, V285, P20109, DOI 10.1074/jbc.M110.121699; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kuwajima T, 2004, J BIOL CHEM, V279, P40484, DOI 10.1074/jbc.M404143200; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Marx C, 2010, CANCER RES, V70, P3709, DOI 10.1158/0008-5472.CAN-09-3768; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Murray RZ, 2004, MOL BIOL CELL, V15, P1591, DOI 10.1091/mbc.E03-08-0630; Nathan JA, 2008, TRAFFIC, V9, P1130, DOI 10.1111/j.1600-0854.2008.00747.x; Nguyen PH, 2010, BIOORG MED CHEM LETT, V20, P4128, DOI 10.1016/j.bmcl.2010.05.067; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Pantaleon M, 2001, MECH DEVELOP, V109, P151, DOI 10.1016/S0925-4773(01)00551-2; Park IH, 2005, EXP CELL RES, V309, P211, DOI 10.1016/j.yexcr.2005.05.017; Reddy EM, 2010, EXP CELL RES, V316, P2220, DOI 10.1016/j.yexcr.2010.05.030; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sasaki A, 2005, J RECEPT SIG TRANSD, V25, P181, DOI 10.1080/10799890500210511; Sasaki A, 2002, J BIOL CHEM, V277, P22541, DOI 10.1074/jbc.M109728200; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Shu LL, 2009, MOL CELL BIOL, V29, P4691, DOI 10.1128/MCB.00764-09; Taya S, 1999, GENES CELLS, V4, P757, DOI 10.1046/j.1365-2443.1999.00297.x; Taya S, 1998, J CELL BIOL, V142, P1053, DOI 10.1083/jcb.142.4.1053; Van Hoof D, 2006, MOL CELL PROTEOMICS, V5, P1261, DOI 10.1074/mcp.M500405-MCP200; Wang XH, 2011, ANN MED, V43, P347, DOI 10.3109/07853890.2011.573806; Xie XD, 2011, P NATL ACAD SCI USA, V108, P6474, DOI 10.1073/pnas.1016132108; Zhang J, 2010, ASIAN J ANDROL, V12, P744, DOI 10.1038/aja.2010.44; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	53	38	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21164	21175		10.1074/jbc.M111.328021	http://dx.doi.org/10.1074/jbc.M111.328021			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22544753	hybrid, Green Published			2022-12-25	WOS:000306416800037
J	Ji, QJ; Zhang, L; Sun, F; Deng, X; Liang, HH; Bae, TO; He, C				Ji, Quanjiang; Zhang, Liang; Sun, Fei; Deng, Xin; Liang, Haihua; Bae, Taeok; He, Chuan			Staphylococcus aureus CymR Is a New Thiol-based Oxidation-sensing Regulator of Stress Resistance and Oxidative Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; GLOBAL REGULATOR; SULFENIC ACID; OXYR; MECHANISM; PEROXIDE; OHRR; MGRA; PURIFICATION; REDUCTASE	As a human pathogen, Staphylococcus aureus must cope with oxidative stress generated by the human immune system. Here, we report that CymR utilizes its sole Cys-25 to sense oxidative stress. Oxidation followed by thiolation of this cysteine residue leads to dissociation of CymR from its cognate promoter DNA. In contrast, the DNA binding of the CymRC25S mutant was insensitive to oxidation and thiolation, suggesting that CymR senses oxidative stress through oxidation of its sole cysteine to form a mixed disulfide with low molecular weight thiols. The determined crystal structures of the reduced and oxidized forms of CymR revealed that Cys-25 is oxidized to Cys-25-SOH in the presence of H2O2. Deletion of cymR reduced the resistance of S. aureus to oxidative stresses, and the resistance was restored by expressing a C25S mutant copy of cymR. In a C25S substitution mutant, the expression of two genes, tcyP and mccB, was constitutively repressed and did not respond to hydrogen peroxide stress, whereas the expression of the genes were highly induced under oxidative stress in a wild-type strain, indicating the critical role of Cys-25 in redox signaling in vivo. Thus, CymR is another master regulator that senses oxidative stress and connects stress responses to virulence regulation in S. aureus.	[Ji, Quanjiang; Zhang, Liang; Sun, Fei; Deng, Xin; Liang, Haihua; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Bae, Taeok] Indiana Univ Sch Med NW, Gary, IN 46408 USA	University of Chicago; Indiana University System; Indiana University Northwest	He, C (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.	chuanhe@uchicago.edu	Ji, Quanjiang/G-5569-2012; Liang, Haihua/T-2441-2017; Deng, Xin/G-5591-2012; Ji, Quanjiang/AAP-9111-2020; Ji, Quanjiang/AAZ-9793-2020; Zhang, Liang/F-8064-2013	Ji, Quanjiang/0000-0002-2321-8462; Ji, Quanjiang/0000-0002-2321-8462; Zhang, Liang/0000-0002-7672-1168; Bae, Taeok/0000-0002-0576-2851	National Institutes of Health [AI077564, AI074658]; American Heart Association [0835158N]; Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074658, R01AI077564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI077564 (to T. B.) and AI074658 (to C. H.). This work was also supported by Scientist Development Grant 0835158N from the American Heart Association (to T. B.), and a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award (to C. H.).	Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.fmrre.2004.12.008; Archer GL, 1998, CLIN INFECT DIS, V26, P1179, DOI 10.1086/520289; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Ballal A, 2010, J BACTERIOL, V192, P336, DOI 10.1128/JB.01202-09; Ballal A, 2009, J BACTERIOL, V191, P1656, DOI 10.1128/JB.01555-08; Chander M, 2004, J BIOL CHEM, V279, P41603, DOI 10.1074/jbc.M405512200; Chang W, 2006, J BACTERIOL, V188, P1648, DOI 10.1128/JB.188.4.1648-1659.2006; Chen H, 2008, P NATL ACAD SCI USA, V105, P13586, DOI 10.1073/pnas.0803391105; Chen PR, 2006, NAT CHEM BIOL, V2, P591, DOI 10.1038/nchembio820; Chen PR, 2009, MOL MICROBIOL, V71, P198, DOI 10.1111/j.1365-2958.2008.06518.x; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; delCardayre SB, 1998, J BIOL CHEM, V273, P5744, DOI 10.1074/jbc.273.10.5744; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Fuangthong M, 2002, P NATL ACAD SCI USA, V99, P6690, DOI 10.1073/pnas.102483199; Fujimoto DF, 2009, MOL MICROBIOL, V74, P1445, DOI 10.1111/j.1365-2958.2009.06942.x; Hausladen A, 1996, CELL, V86, P719, DOI 10.1016/S0092-8674(00)80147-6; Helmann JD, 2011, ANTIOXID REDOX SIGN, V15, P123, DOI 10.1089/ars.2010.3562; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; Jonsson TJ, 2007, BIOCHEMISTRY-US, V46, P5709, DOI 10.1021/bi7001218; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Klomsiri C, 2011, ANTIOXID REDOX SIGN, V14, P1065, DOI 10.1089/ars.2010.3376; Laarman A, 2010, J MOL MED, V88, P115, DOI 10.1007/s00109-009-0572-y; Lan LF, 2010, MOL MICROBIOL, V75, P76, DOI 10.1111/j.1365-2958.2009.06955.x; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; Lithgow JK, 2004, J BACTERIOL, V186, P1579, DOI 10.1128/JB.186.6.1579-1590.2004; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Luong TT, 2006, J BACTERIOL, V188, P1899, DOI 10.1128/JB.188.5.1899-1910.2006; Luong TT, 2003, J BACTERIOL, V185, P3703, DOI 10.1128/JB.185.13.3703-3710.2003; Maruyama A, 2003, MICROBIOL-SGM, V149, P389, DOI 10.1099/mic.0.25796-0; Newberry KJ, 2007, MOL CELL, V28, P652, DOI 10.1016/j.molcel.2007.09.016; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; Pother DC, 2009, J BACTERIOL, V191, P7520, DOI 10.1128/JB.00937-09; Poor CB, 2009, J BIOL CHEM, V284, P23517, DOI 10.1074/jbc.M109.015826; Shepard W, 2011, FEBS J, V278, P2689, DOI 10.1111/j.1742-4658.2011.08195.x; Soonsanga S, 2008, J BACTERIOL, V190, P5738, DOI 10.1128/JB.00576-08; Soutourina O, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000894; Soutourina O, 2009, MOL MICROBIOL, V73, P194, DOI 10.1111/j.1365-2958.2009.06760.x	41	31	31	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21102	21109		10.1074/jbc.M112.359737	http://dx.doi.org/10.1074/jbc.M112.359737			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22553203	Green Published, hybrid			2022-12-25	WOS:000306416800031
J	Lee, JH; Jin, YT; He, GF; Zeng, SX; Wang, YYV; Wahl, GM; Lu, H				Lee, Jun-Ho; Jin, Yetao; He, Guifen; Zeng, Shelya X.; Wang, Yunyuan V.; Wahl, Geoffrey M.; Lu, Hua			Hypoxia Activates Tumor Suppressor p53 by Inducing ATR-Chk1 Kinase Cascade-mediated Phosphorylation and Consequent 14-3-3 gamma Inactivation of MDMX Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; LIGASE ACTIVITY; FACTOR 1-ALPHA; DEGRADATION; ATM; INHIBITION; REOXYGENATION; APOPTOSIS; DOMAIN; CHK1	It has been known that p53 can be induced and activated by hypoxia, an abnormal condition that often occurs in rapidly growing solid tumors or when normal tissues undergo ischemia. Although the ATR-Chk1 kinase cascade was associated with hypoxia-induced p53 activation, molecules that directly link this hypoxia-ATR-Chk1 pathway to p53 activation have been elusive. Here, we showed that hypoxia could induce phosphorylation of MDMX at Ser-367 and enhance the binding of this phosphorylated MDMX to 14-3-3 gamma, consequently leading to p53 activation. A Chk1 inhibitor or knockdown of ATR and Chk1 inhibited the phosphorylation of MDMX at Ser-367 and impaired the binding of MDMX to 14-3-3 gamma in addition to p53 activation in response to hypoxia. In primary mouse embryonic fibroblast cells that harbor a mutant MDMX, including the S367A mutation, hypoxia also failed to induce the binding of this mutant MDMX to 14-3-3 gamma and to activate p53 and its direct targets. These results demonstrate that hypoxia can activate p53 through inactivation of MDMX by the ATR-Chk1-MDMX-14-3-3 gamma pathway.	[Zeng, Shelya X.; Lu, Hua] Tulane Univ, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Zeng, Shelya X.; Lu, Hua] Tulane Univ, Sch Med, Ctr Canc, New Orleans, LA 70112 USA; [Lee, Jun-Ho; Jin, Yetao; He, Guifen; Zeng, Shelya X.; Lu, Hua] Indiana Univ Sch Med, Simon Canc Ctr, Indianapolis, IN 46202 USA; [Lee, Jun-Ho; Jin, Yetao; He, Guifen; Zeng, Shelya X.; Lu, Hua] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Wang, Yunyuan V.; Wahl, Geoffrey M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Wang, Yunyuan V.; Wahl, Geoffrey M.] Seoul Natl Univ, Med Res Ctr, Genom Med Inst, Seoul 110799, South Korea	Tulane University; Tulane University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Salk Institute; Seoul National University (SNU)	Lu, H (corresponding author), Tulane Univ, Sch Med, Dept Biochem & Mol Biol, 1430 Ave, New Orleans, LA 70112 USA.	hlu2@tulane.edu			National Institutes of Health, NCI [CA095441, CA079721, CA129828, R01 CA 061449]; NATIONAL CANCER INSTITUTE [R01CA061449, R01CA095441, R01CA129828, R01CA079721] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health, NCI Grants CA095441, CA079721, and CA129828 (to H. L.).; Supported by National Institutes of Health, NCI Grants R01 CA 061449.	An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Blagosklonny MV, 1998, J BIOL CHEM, V273, P11995, DOI 10.1074/jbc.273.20.11995; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chao C, 2000, P NATL ACAD SCI USA, V97, P11936, DOI 10.1073/pnas.220252297; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Hammond EM, 2005, BIOCHEM BIOPH RES CO, V331, P718, DOI 10.1016/j.bbrc.2005.03.154; Hammond EM, 2004, DNA REPAIR, V3, P1117, DOI 10.1016/j.dnarep.2004.03.035; Hammond EM, 2004, CANCER RES, V64, P6556, DOI 10.1158/0008-5472.CAN-04-1520; Hammond EM, 2003, J BIOL CHEM, V278, P12207, DOI 10.1074/jbc.M212360200; Hammond EM, 2002, MOL CELL BIOL, V22, P1834, DOI 10.1128/MCB.22.6.1834-1843.2002; Hammond EM, 2006, CANCER LETT, V238, P161, DOI 10.1016/j.canlet.2005.06.029; Huang L, 2011, P NATL ACAD SCI USA, V108, P12001, DOI 10.1073/pnas.1102309108; Iwakuma T, 2003, MOL CANCER RES, V1, P993; Jin Y, 2008, MOL CELL BIOL, V28, P1218, DOI 10.1128/MCB.01198-07; Jin YT, 2006, EMBO J, V25, P1207, DOI 10.1038/sj.emboj.7601010; Kawai H, 2007, CANCER RES, V67, P6026, DOI 10.1158/0008-5472.CAN-07-1313; LeBron C, 2006, EMBO J, V25, P1196, DOI 10.1038/sj.emboj.7601032; Mancini F, 2009, CURR GENOMICS, V10, P42, DOI 10.2174/138920209787581280; Marine JC, 2004, CELL CYCLE, V3, P900; Migliorini D, 2002, MOL CELL BIOL, V22, P5527, DOI 10.1128/MCB.22.15.5527-5538.2002; Nakagawa K, 1999, MOL CELL BIOL, V19, P2828; Okamoto K, 2005, MOL CELL BIOL, V25, P9608, DOI 10.1128/MCB.25.21.9608-9620.2005; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Pant V, 2011, P NATL ACAD SCI USA, V108, P11995, DOI 10.1073/pnas.1102241108; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Pereg Y, 2006, MOL CELL BIOL, V26, P6819, DOI 10.1128/MCB.00562-06; Poyurovsky MV, 2007, EMBO J, V26, P90, DOI 10.1038/sj.emboj.7601465; Ravi R, 2000, GENE DEV, V14, P34; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Schmaltz C, 1998, MOL CELL BIOL, V18, P2845, DOI 10.1128/MCB.18.5.2845; Semenza GL, 2000, GENE DEV, V14, P1983; Sharp DA, 1999, J BIOL CHEM, V274, P38189, DOI 10.1074/jbc.274.53.38189; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Stad R, 2001, EMBO REP, V2, P1029, DOI 10.1093/embo-reports/kve227; Thompson T, 2004, J BIOL CHEM, V279, P53015, DOI 10.1074/jbc.M410233200; Uldrijan S, 2007, EMBO J, V26, P102, DOI 10.1038/sj.emboj.7601469; VAUPEL P, 1991, CANCER RES, V51, P3316; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Wang YYV, 2009, CANCER CELL, V16, P33, DOI 10.1016/j.ccr.2009.05.008; Wenger RH, 1998, CANCER RES, V58, P5678; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yang XH, 2008, GENE DEV, V22, P1147, DOI 10.1101/gad.1632808; Zeng XY, 1999, MOL CELL BIOL, V19, P3257; Zhao B, 2002, J BIOL CHEM, V277, P46609, DOI 10.1074/jbc.M201233200	49	22	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20898	20903		10.1074/jbc.M111.336875	http://dx.doi.org/10.1074/jbc.M111.336875			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22556425	hybrid, Green Published			2022-12-25	WOS:000306416800011
J	Sexton, TJ; Golczak, M; Palczewski, K; Van Gelder, RN				Sexton, Timothy J.; Golczak, Marcin; Palczewski, Krzysztof; Van Gelder, Russell N.			Melanopsin Is Highly Resistant to Light and Chemical Bleaching in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VISUAL PIGMENTS; VERTEBRATE RETINA; RHODOPSIN; CYCLE; HYDROXYLAMINE; CELLS; PHOTORECEPTION; PHOTOPIGMENT; ADAPTATION; EXPRESSION	Melanopsin is the photopigment of mammalian intrinsically photosensitive retinal ganglion cells, where it contributes to light entrainment of circadian rhythms, and to the pupillary light response. Previous work has shown that the melanopsin photocycle is independent of that used by rhodopsin (Tu, D. C., Owens, L. A., Anderson, L., Golczak, M., Doyle, S. E., McCall, M., Menaker, M., Palczewski, K., and Van Gelder, R. N. (2006) Inner retinal photoreception independent of the visual retinoid cycle. Proc. Natl. Acad. Sci. U.S.A. 103, 10426-10431). Here we determined the ability of apo-melanopsin, formed by ex vivo UV light bleaching, to use selected chromophores. We found that 9-cis-retinal, but not all-trans-retinal or 9-cis-retinol, is able to restore light-dependent ipRGC activity after bleaching. Melanopsin was highly resistant to both visible-spectrum photic bleaching and chemical bleaching with hydroxylamine under conditions that fully bleach rod and cone photoreceptor cells. These results suggest that the melanopsin photocycle can function independently of both rod and cone photocycles, and that apo-melanopsin has a strong preference for binding cis-retinal to generate functional pigment. The data support a model in which retinal is continuously covalently bound to melanopsin and may function through a reversible, bistable mechanism.	[Sexton, Timothy J.; Van Gelder, Russell N.] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; [Van Gelder, Russell N.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Golczak, Marcin; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Case Western Reserve University	Van Gelder, RN (corresponding author), Univ Washington, Sch Med, Dept Ophthalmol, Campus Box 359608,325 9th Ave, Seattle, WA 98104 USA.	russvg@uw.edu	Van Gelder, Russell/ABB-4225-2021	Van Gelder, Russell/0000-0001-5368-3659; Sexton, Timothy/0000-0002-8821-880X	National Institutes of Health [EY009339, P30EY001730, P30EY07031, T32EY007031]; Research to Prevent Blindness; Burroughs-Wellcome Clinical Scientist Award in Translational Research; NATIONAL EYE INSTITUTE [F32EY007031, P30EY001730, R01EY009339, T32EY007031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Burroughs-Wellcome Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported, in whole or in part, by National Institutes of Health Grants EY009339, P30EY001730, P30EY07031, and T32EY007031. This work was also supported by unrestricted support from Research to Prevent Blindness and the Burroughs-Wellcome Clinical Scientist Award in Translational Research (to R. N. V. G.).	ABRAHAMSON EW, 1974, EXP EYE RES, V18, P51, DOI 10.1016/0014-4835(74)90043-8; Bellingham J, 2002, MOL BRAIN RES, V107, P128, DOI 10.1016/S0169-328X(02)00454-0; BOWMAKER JK, 1976, VISION RES, V16, P811, DOI 10.1016/0042-6989(76)90140-1; BRIN KP, 1977, J GEN PHYSIOL, V69, P97, DOI 10.1085/jgp.69.1.97; Chen SK, 2011, NATURE, V476, P92, DOI 10.1038/nature10206; Chow BY, 2011, NEUROMETHODS, V55, P99, DOI 10.1007/978-1-61779-031-7_6; DARTNALL HJ, 1968, VISION RES, V8, P339, DOI 10.1016/0042-6989(68)90104-1; Davies WIL, 2011, CELL MOL LIFE SCI, V68, P4115, DOI 10.1007/s00018-011-0785-4; Do MTH, 2009, NATURE, V457, P281, DOI 10.1038/nature07682; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Fu YB, 2005, P NATL ACAD SCI USA, V102, P10339, DOI 10.1073/pnas.0501866102; Garwin GG, 2000, METHOD ENZYMOL, V316, P313; Guler AD, 2007, COLD SPRING HARB SYM, V72, P509, DOI 10.1101/sqb.2007.72.074; Hardie R. C., 2007, SENSES COMPREHENSIVE, V1, P77; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; HILLMAN P, 1983, PHYSIOL REV, V63, P668, DOI 10.1152/physrev.1983.63.2.668; Holy T. E., 2000, SCIENCE         0609, V289, P569; HUBBARD R, 1958, J GEN PHYSIOL, V41, P501, DOI 10.1085/jgp.41.3.501; Kiser P. D., 2011, BIOCHIM BIOPHYS ACTA, V1821, P137; KOUTALOS Y, 1989, BIOCHEMISTRY-US, V28, P2732, DOI 10.1021/bi00432a055; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Kuksa V, 2003, VISION RES, V43, P2959, DOI 10.1016/S0042-6989(03)00482-6; Leibrock CS, 1997, J PHYSIOL-LONDON, V501, P97, DOI 10.1111/j.1469-7793.1997.00097.x; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Matos-Cruz V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025111; Mawad K, 2008, J BIOL RHYTHM, V23, P387, DOI 10.1177/0748730408323063; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Mure LS, 2007, J BIOL RHYTHM, V22, P411, DOI 10.1177/0748730407306043; Nemargut JP, 2009, VISION RES, V49, P2936, DOI 10.1016/j.visres.2009.09.011; Nickle B, 2007, CELL MOL LIFE SCI, V64, P2917, DOI 10.1007/s00018-007-7253-1; OZAKI K, 1983, BIOPHYS J, V44, P127, DOI 10.1016/S0006-3495(83)84285-4; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Peirson S, 2006, NEURON, V49, P331, DOI 10.1016/j.neuron.2006.01.006; PEPPERBERG DR, 1992, EXP EYE RES, V54, P369, DOI 10.1016/0014-4835(92)90049-X; PEPPERBERG DR, 1995, METHOD ENZYMOL, V250, P348; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Saari JC, 2001, NEURON, V29, P739, DOI 10.1016/S0896-6273(01)00248-3; Saari JC, 2002, INVEST OPHTH VIS SCI, V43, P1730; Stecher H, 2000, METHOD ENZYMOL, V316, P330; Terakita A, 2008, J NEUROCHEM, V105, P883, DOI 10.1111/j.1471-4159.2007.05184.x; Thompson CL, 2004, J BIOL RHYTHM, V19, P504, DOI 10.1177/0748730404270519; Tu DC, 2006, P NATL ACAD SCI USA, V103, P10426, DOI 10.1073/pnas.0600917103; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Tu DC, 2004, SCIENCE, V306, P129, DOI 10.1126/science.1101484; Vought BW, 2000, BIOCHEMISTRY-US, V39, P14128, DOI 10.1021/bi001135k; WALD G, 1950, P NATL ACAD SCI USA, V36, P84, DOI 10.1073/pnas.36.2.84; WALD G, 1955, J GEN PHYSIOL, V38, P623, DOI 10.1085/jgp.38.5.623; Walker MT, 2008, P NATL ACAD SCI USA, V105, P8861, DOI 10.1073/pnas.0711397105; Wang JS, 2011, PROG RETIN EYE RES, V30, P115, DOI 10.1016/j.preteyeres.2010.11.001; Wong KY, 2005, NEURON, V48, P1001, DOI 10.1016/j.neuron.2005.11.016; Wong WT, 2000, J NEUROSCI, V20, P351, DOI 10.1523/JNEUROSCI.20-01-00351.2000	54	38	38	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20888	20897		10.1074/jbc.M111.325969	http://dx.doi.org/10.1074/jbc.M111.325969			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22547062	Green Published, hybrid			2022-12-25	WOS:000306416800010
J	Tarragona, M; Pavlovic, M; Arnal-Estape, A; Urosevic, J; Morales, M; Guiu, M; Planet, E; Gonzalez-Suarez, E; Gomis, RR				Tarragona, Maria; Pavlovic, Milica; Arnal-Estape, Anna; Urosevic, Jelena; Morales, Monica; Guiu, Marc; Planet, Evarist; Gonzalez-Suarez, Eva; Gomis, Roger R.			Identification of NOG as a Specific Breast Cancer Bone Metastasis-supporting Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MORPHOGENETIC PROTEINS; EPITHELIAL-CELLS; STEM-CELLS; EXPRESSION; BETA; PROLIFERATION; DIFFERENTIATION; OSTEOBLASTS; MECHANISMS; SKELETON	Metastasis requires numerous biological functions that jointly provide tumor cells from a primary site to seed and colonize a distant organ. Some of these activities are selected for in the primary site, whereas others are acquired at the metastatic niche. We provide molecular evidence showing that the BMP inhibitor, NOG, provides metastatic breast cancer cells with the ability to colonize the bone. NOG expression is acquired during the late events of metastasis, once cells have departed from the primary site, because it is not enriched in primary tumors with high risk of bone relapse. On the contrary, breast cancer bone metastatic lesions do select for high levels of NOG expression when compared with metastasis to the lung, liver, and brain. Pivotal to the bone colonization functions is the contribution of NOG to metastatic autonomous and nonautonomous cell functions. Using genetic approaches, we show that when NOG is expressed in human breast cancer cells, it facilitates bone colonization by fostering osteoclast differentiation and bone degradation and also contributes to metastatic lesions reinitiation. These findings reveal how aggressive cancer cell autonomous and nonautonomous functions can be mechanistically coupled to greater bone metastatic potential.	[Tarragona, Maria; Pavlovic, Milica; Arnal-Estape, Anna; Urosevic, Jelena; Morales, Monica; Guiu, Marc; Gomis, Roger R.] Inst Res Biomed IRB Barcelona, Oncol Programme, Barcelona 08028, Spain; [Planet, Evarist; Gomis, Roger R.] Inst Res Biomed IRB Barcelona, Biostat & Bioinformat Unit, Barcelona 08028, Spain; [Gonzalez-Suarez, Eva] Bellvitge Inst Biomed Res IDIBELL, Canc Epigenet & Biol Program PEBC, Barcelona 08908, Spain; [Gomis, Roger R.] ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); ICREA	Gomis, RR (corresponding author), Inst Res Biomed IRB Barcelona, Oncol Programme, PBB52 Parc Cient Barcelona,C Baldiri i Reixac 10-, Barcelona 08028, Spain.	roger.gomis@irbbarcelona.org	Arnal-Estapé, Anna/A-4091-2011; Morales-Ballús, Mònica/AAE-3086-2021; Gonzalez-Suarez, Eva/L-6298-2014; Gomis, Roger R/E-9788-2016	Arnal-Estapé, Anna/0000-0003-0490-7040; Morales-Ballús, Mònica/0000-0002-9478-6280; Gonzalez-Suarez, Eva/0000-0003-0858-8171; Gomis, Roger R/0000-0001-6473-2858	BBVA Foundation; Asociacion Espa ola Contra el Cancer (AECC) Foundation; Generalitat de Catalunya [2009 SGR 1429]; Spanish Ministerio de Ciencia e Innovacion (MICINN) [SAF2010-21171]; IRB-Barcelona Ph.D. program; "la Caixa" Ph.D. fellowship; MICINN; Institucio Catalana de Recerca i Estudis Avancats (ICREA); ICREA Funding Source: Custom	BBVA Foundation(BBVA Foundation); Asociacion Espa ola Contra el Cancer (AECC) Foundation; Generalitat de Catalunya(Generalitat de Catalunya); Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); IRB-Barcelona Ph.D. program; "la Caixa" Ph.D. fellowship(La Caixa Foundation); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Institucio Catalana de Recerca i Estudis Avancats (ICREA)(ICREA); ICREA(ICREA)	This work was supported by the BBVA Foundation, Asociacion Espa ola Contra el Cancer (AECC) Foundation, the Generalitat de Catalunya (Grant 2009 SGR 1429), and the Spanish Ministerio de Ciencia e Innovacion (MICINN) (Grant SAF2010-21171) (to R. R. G.).; Supported by an IRB-Barcelona Ph.D. program.; Supported by a "la Caixa" Ph.D. fellowship.; Supported by a Ph.D. fellowship by the MICINN.; Supported by the Institucio Catalana de Recerca i Estudis Avancats (ICREA).	Arnal-Estape A, 2010, CANCER RES, V70, P9927, DOI 10.1158/0008-5472.CAN-10-0869; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Beleut M, 2010, P NATL ACAD SCI USA, V107, P2989, DOI 10.1073/pnas.0915148107; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Dai JL, 2008, CANCER RES, V68, P5785, DOI 10.1158/0008-5472.CAN-07-6541; Gazzerro E, 1998, J CLIN INVEST, V102, P2106, DOI 10.1172/JCI3459; Gonzalez-Suarez E, 2010, NATURE, V468, P103, DOI 10.1038/nature09495; Guise Theresa A, 2005, Clin Breast Cancer, V5 Suppl, pS46, DOI 10.3816/CBC.2005.s.004; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hardwick JCH, 2004, GASTROENTEROLOGY, V126, P111, DOI 10.1053/j.gastro.2003.10.067; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kim NS, 2006, MOL CELL BIOL, V26, P1002, DOI 10.1128/MCB.26.3.1002-1013.2006; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Mastro AM, 2004, J CELL BIOCHEM, V91, P265, DOI 10.1002/jcb.10746; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Mercer RR, 2004, CLIN EXP METASTAS, V21, P427, DOI 10.1007/s10585-004-1867-6; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Morales M, 2011, BREAST, V20, pS50, DOI 10.1016/S0960-9776(11)70294-6; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; Schwaninger R, 2007, AM J PATHOL, V170, P160, DOI 10.2353/ajpath.2007.051276; Secondini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016078; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125; Shaw A, 2010, DIFFERENTIATION, V79, P41, DOI 10.1016/j.diff.2009.08.009; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Sporn MB, 1996, LANCET, V347, P1377, DOI 10.1016/S0140-6736(96)91015-6; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Tang B, 2007, CANCER RES, V67, P8643, DOI 10.1158/0008-5472.CAN-07-0982; TAUBE T, 1994, BONE, V15, P161, DOI 10.1016/8756-3282(94)90703-X; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Virk MS, 2011, BONE, V48, P578, DOI 10.1016/j.bone.2010.11.003; Visvader JE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004879; Vukmirovic-Popovic S, 2002, BONE, V31, P529, DOI 10.1016/S8756-3282(02)00847-5; Wozney JM, 1998, EUR J ORAL SCI, V106, P160, DOI 10.1111/j.1600-0722.1998.tb02170.x; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	42	51	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21346	21355		10.1074/jbc.M112.355834	http://dx.doi.org/10.1074/jbc.M112.355834			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22547073	Green Published, hybrid			2022-12-25	WOS:000306416800053
J	Parsi, S; Soltani, BM; Hosseini, E; Tousi, SE; Mowla, SJ				Parsi, Sepideh; Soltani, Bahram M.; Hosseini, Ebrahim; Tousi, Samaneh E.; Mowla, Seyed J.			Experimental Verification of a Predicted Intronic MicroRNA in Human NGFR Gene with a Potential Pro-Apoptotic Function	PLOS ONE			English	Article							P75 NEUROTROPHIN RECEPTOR; MURINE RETINOBLASTOMA; EXPRESSION PROFILES; HUMAN PROSTATE; HOST GENES; WEB SERVER; P75(NTR); CELLS; CANCER; GROWTH	Neurotrophins (NTs) are a family of secreted growth factor proteins primarily involved in the regulation of survival and appropriate development of neural cells, functioning by binding to their specific (TrkA, TtkB, and TrkC) and/or common NGFR receptor. NGFR is the common receptor of NTs, binding with low-affinity to all members of the family. Among different functions assigned to NGFR, it is also involved in apoptosis induction and tumorigenesis processes. Interestingly, some of the functions of NGFR appear to be ligand-independent, suggesting a probable involvement of non-coding RNA residing within the sequence of the gene. Here, we are reporting the existence of a conserved putative microRNA, named Hsa-mir-6165 [EBI accession#: FR873488]. Transfection of a DNA segment corresponding to the pre-mir-6165 sequence in Hela cell line caused the generation of mature exogenous mir-6165 (a similar to 200,000 fold overexpression). Furthermore, using specific primers, we succeeded to detect the endogenous expression of mir-6165 in several glioma cell lines and glioma primary tumors known to express NGFR. Similar to the pro-apoptotic role of NGFR in some cell types, overexpression of premir-6165 in U87 cell line resulted in an elevated rate of apoptosis. Moreover, coordinated with the increased level of mir-6165 in the transfected U87 cell line, two of its predicted target genes (Pkd1 and DAGLA) were significantly down-regulated. The latter findings suggest that some of the previously attributed functions of NGFR could be explained indirectly by co-transcription of mir-6165 in the cells.	[Parsi, Sepideh; Soltani, Bahram M.; Hosseini, Ebrahim; Tousi, Samaneh E.; Mowla, Seyed J.] Tarbiat Modares Univ, Fac Biol Sci, Dept Mol Genet, Tehran, Iran	Tarbiat Modares University	Parsi, S (corresponding author), Tarbiat Modares Univ, Fac Biol Sci, Dept Mol Genet, Tehran, Iran.	soltanib@modares.ac.ir	Ekhteraei-Tousi, Samaneh/AAE-9228-2020; Soltani, Bahram/ABH-2649-2021	Soltani, Bahram/0000-0003-2468-901X; Mowla, Seyed Javad/0000-0002-3300-6332; Parsi, Sepideh/0000-0001-6396-5190; Ekhteraei-Tousi, Samaneh/0000-0002-8123-8058				Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; ANDREWS PW, 1984, LAB INVEST, V50, P147; Antonov AV, 2009, NUCLEIC ACIDS RES, V37, pW323, DOI 10.1093/nar/gkp313; Aranha MM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-514; Barker PA, 2009, NEURON, V62, P3, DOI 10.1016/j.neuron.2009.04.005; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Battini L, 2006, J AM SOC NEPHROL, V17, P3049, DOI 10.1681/ASN.2006030234; Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Blochl A, 2007, J NEUROCHEM, V102, P289, DOI 10.1111/j.1471-4159.2007.04496.x; Boletta A, 2000, MOL CELL, V6, P1267, DOI 10.1016/S1097-2765(00)00123-4; Cantarella G, 2002, FASEB J, V16, P1307, DOI 10.1096/fj.01-1000fje; Caporali A, 2008, CIRC RES, V103, pE15, DOI 10.1161/CIRCRESAHA.108.177386; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dimaras H, 2006, MOL CARCINOGEN, V45, P333, DOI 10.1002/mc.20179; Dimaras H, 2008, INT J CANCER, V122, P2023, DOI 10.1002/ijc.23356; Gao XG, 2007, MOL CELL NEUROSCI, V36, P501, DOI 10.1016/j.mcn.2007.08.013; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Gkirtzou K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011843; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guate JL, 1999, BJU INT, V84, P495; Helvik SA, 2007, BIOINFORMATICS, V23, P142, DOI 10.1093/bioinformatics/btl570; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Jin HF, 2007, NEOPLASIA, V9, P471, DOI 10.1593/neo.07175; Johnston ALM, 2007, PLOS BIOL, V5, P1723, DOI 10.1371/journal.pbio.0050212; Kanik AB, 1996, J CUTAN PATHOL, V23, P205, DOI 10.1111/j.1600-0560.1996.tb01468.x; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356; Krygier S, 2001, MOL CARCINOGEN, V31, P46, DOI 10.1002/mc.1038; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li L, 2010, MAMM GENOME, V21, P1, DOI 10.1007/s00335-009-9241-2; Lin S, BIOCH BIOPHYS RES CO, V310, P754; Lin SL, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/26818; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lutter D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-224; Malakootian M, 2010, MOL CARCINOGEN, V49, P818, DOI 10.1002/mc.20658; Maniatis T., 1982, MOL CLONING LAB MANU; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Marchetti D, 2004, J CELL BIOCHEM, V91, P206, DOI 10.1002/jcb.10649; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Musiyenko A, 2008, J MOL MED, V86, P313, DOI 10.1007/s00109-007-0296-9; Oulas A, 2009, NUCLEIC ACIDS RES, V37, P3276, DOI 10.1093/nar/gkp120; Oulas A, 2009, IEEE T INF TECHNOL B, V13, P67, DOI 10.1109/TITB.2008.2007086; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Ramos A, 2007, J NEUROSCI, V27, P1498, DOI 10.1523/JNEUROSCI.4806-06.2007; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Ritchie W, 2008, BIOINFORMATICS, V24, P1394, DOI 10.1093/bioinformatics/btn137; Rocha AS, 2006, HUM PATHOL, V37, P562, DOI 10.1016/j.humpath.2005.12.016; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Salis MB, 2004, DIABETOLOGIA, V47, P1055, DOI 10.1007/s00125-004-1424-5; Sewer A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-267; Stephan H, 2008, PEDIATR BLOOD CANCER, V50, P218, DOI 10.1002/pbc.21369; Tyagi S, 2008, BIOCHEM BIOPH RES CO, V372, P831, DOI 10.1016/j.bbrc.2008.05.134; Vilar M, 2009, J CELL SCI, V122, P3351, DOI 10.1242/jcs.055061; Wang SY, 2000, AM J PATHOL, V157, P1247, DOI 10.1016/S0002-9440(10)64640-8; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Weber MJ, 2005, FEBS J, V272, P59, DOI 10.1111/j.1432-1033.2004.04389.x; Yoon BJ, 2007, IEEE SIGNAL PROC MAG, V24, P64; Zhao DY, 2010, ARTIF INTELL MED, V49, P127, DOI 10.1016/j.artmed.2010.03.004; Zhou J, 2009, ANNU REV PHYSIOL, V71, P83, DOI 10.1146/annurev.physiol.70.113006.100621	64	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35561	10.1371/journal.pone.0035561	http://dx.doi.org/10.1371/journal.pone.0035561			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558167	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336000036
J	Yang, JM; Xian, M; Su, SZ; Zhao, G; Nie, QJ; Jiang, XL; Zheng, YN; Liu, W				Yang, Jianming; Xian, Mo; Su, Sizheng; Zhao, Guang; Nie, Qingjuan; Jiang, Xinglin; Zheng, Yanning; Liu, Wei			Enhancing Production of Bio-Isoprene Using Hybrid MVA Pathway and Isoprene Synthase in E-coli	PLOS ONE			English	Article							METHYLERYTHRITOL PHOSPHATE-PATHWAY; MEVALONATE PATHWAY; BIOSYNTHESIS; BACTERIA; INTEGRATION; BIOREACTOR	The depleting petroleum reserve, increasingly severe energy crisis, and global climate change are reigniting enthusiasm for seeking sustainable technologies to replace petroleum as a source of fuel and chemicals. In this paper, the efficiency of the MVA pathway on isoprene production has been improved as follows: firstly, in order to increase MVA production, the source of the "upper pathway'' which contains HMG-CoA synthase, acetyl-CoA acetyltransferase and HMG-CoA reductase to covert acetyl-CoA into MVA has been changed from Saccharomyces cerevisiae to Enterococcus faecalis; secondly, to further enhance the production of MVA and isoprene, a alanine 110 of the mvaS gene has been mutated to a glycine. The final genetic strain YJM25 containing the optimized MVA pathway and isoprene synthase from Populus alba can accumulate isoprene up to 6.3 g/L after 40 h of fed-batch cultivation.	[Yang, Jianming; Xian, Mo; Zhao, Guang; Jiang, Xinglin; Zheng, Yanning; Liu, Wei] Chinese Acad Sci, Ctr Biomat, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao, Peoples R China; [Su, Sizheng] China Risun Coal Chem Grp Ltd, Beijing Risun Chem Technol Inst, Dept Biochem, Beijing, Peoples R China; [Nie, Qingjuan] Qingdao Agr Univ, Foreign Languages Sch, Coll English Off, Qingdao, Peoples R China	Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Qingdao Agricultural University	Yang, JM (corresponding author), Chinese Acad Sci, Ctr Biomat, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao, Peoples R China.	xianmo@qibebt.ac.cn	zheng, yonghong/H-3700-2012; zhao, guang/E-4702-2013	zhao, guang/0000-0003-0002-5972; Jiang, Xinglin/0000-0002-4935-8025				Alianell G.A., 2010, Isoprene compositions and methods of use, Patent No. [US2010/0099932 A1, 20100099932]; Anthony JR, 2009, METAB ENG, V11, P13, DOI 10.1016/j.ymben.2008.07.007; Campos N, 2001, BIOCHEM J, V353, P59, DOI 10.1042/bj3530059; Chen HT, 2008, KOREAN J CHEM ENG, V25, P1082, DOI 10.1007/s11814-008-0177-0; Chen XA, 2006, BIOCHEM ENG J, V28, P215, DOI 10.1016/j.bej.2005.03.005; Clomburg JM, 2010, APPL MICROBIOL BIOT, V86, P419, DOI 10.1007/s00253-010-2446-1; DiGiacomo A.A., 1961, CHEM ENG PROG, V57, P3540; Eisenreich W, 2004, CELL MOL LIFE SCI, V61, P1401, DOI 10.1007/s00018-004-3381-z; Eroglu E, 2010, BIORESOURCE TECHNOL, V101, P2359, DOI 10.1016/j.biortech.2009.11.043; Ghimire GP, 2009, APPL ENVIRON MICROB, V75, P7291, DOI 10.1128/AEM.01402-09; Jiang XYJ, 2012, PLOS ONE, DOI 30210.31371/journal.pone.0030267; Julsing MK, 2007, APPL MICROBIOL BIOT, V75, P1377, DOI 10.1007/s00253-007-0953-5; Kilonzo P, 2009, J BIOTECHNOL, V143, P60, DOI 10.1016/j.jbiotec.2009.06.007; Kim SJ, 2006, APPL MICROBIOL BIOT, V72, P982, DOI 10.1007/s00253-006-0359-9; Kuhlman TE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1193; Lindberg P, 2010, METAB ENG, V12, P70, DOI 10.1016/j.ymben.2009.10.001; Loreto F, 2001, PLANT PHYSIOL, V127, P1781, DOI 10.1104/pp.010497; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Newman JD, 2006, BIOTECHNOL BIOENG, V95, P684, DOI 10.1002/bit.21017; Penuelas J, 2005, PLANT CELL ENVIRON, V28, P278, DOI 10.1111/j.1365-3040.2004.01250.x; Pfleger BF, 2007, METAB ENG, V9, P30, DOI 10.1016/j.ymben.2006.08.002; Pitera DJ, 2007, METAB ENG, V9, P193, DOI 10.1016/j.ymben.2006.11.002; REIS T, 1972, CHEM PROCESS ENG, V53, P68; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Rodriguez-Concepion M, 2004, CURR PHARM DESIGN, V10, P2391, DOI 10.2174/1381612043384006; Rodriguez-Villalon A, 2008, J BIOTECHNOL, V135, P78, DOI 10.1016/j.jbiotec.2008.02.023; ROHMER M, 1993, BIOCHEM J, V295, P517, DOI 10.1042/bj2950517; Sacchettini JC, 1997, SCIENCE, V277, P1788, DOI 10.1126/science.277.5333.1788; Sambrook J, 2001, MOL CLONING LAB MANU; Sanadze G, 1957, REP AKAD NAUK GRUZSS, V19, p[19, 83]; Sanadze G.A., 1956, REP AKAD NAUK GRUZSS, V17, P429; SCHWARZ MK, 1994, THESIS ETH ZURICH SW; Seemann M, 2002, TETRAHEDRON LETT, V43, P1413, DOI 10.1016/S0040-4039(02)00003-5; Steinbuchel A, 2003, CURR OPIN MICROBIOL, V6, P261, DOI 10.1016/S1369-5274(03)00061-4; Steussy CN, 2006, BIOCHEMISTRY-US, V45, P14407, DOI 10.1021/bi061505q; Steussy CN, 2005, BIOCHEMISTRY-US, V44, P14256, DOI 10.1021/bi051487x; Tabata K, 2004, BIOTECHNOL LETT, V26, P1487, DOI 10.1023/B:BILE.0000044449.08268.7d; TERRY GM, 1995, J EXP BOT, V46, P1629, DOI 10.1093/jxb/46.10.1629; Ushio S., 1972, CHEM ENG PROG, V79; Xue JF, 2011, APPL ENVIRON MICROB, V77, P2399, DOI 10.1128/AEM.02341-10; Yoon SH, 2009, J BIOTECHNOL, V140, P218, DOI 10.1016/j.jbiotec.2009.01.008; Zhao YG, 2011, ABSTR APPL ANAL, DOI 10.1155/2011/390543	42	86	100	6	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e33509	10.1371/journal.pone.0033509	http://dx.doi.org/10.1371/journal.pone.0033509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558074	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000005
J	Loeb, KR; Asgari, MM; Hawes, SE; Feng, QH; Stern, JE; Jiang, MJ; Argenyi, ZB; de Villiers, EM; Kiviat, NB				Loeb, Keith R.; Asgari, Maryam M.; Hawes, Stephen E.; Feng, Qinghua; Stern, Joshua E.; Jiang, Mingjun; Argenyi, Zsolt B.; de Villiers, Ethel-Michele; Kiviat, Nancy B.			Analysis of Tp53 Codon 72 Polymorphisms, Tp53 Mutations, and HPV Infection in Cutaneous Squamous Cell Carcinomas	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; NONMELANOMA SKIN-CANCER; P53 GENE-MUTATIONS; IMMUNOCOMPETENT INDIVIDUALS; LUNG-CANCER; E6 PROTEINS; ARG72PRO POLYMORPHISM; INDUCED MUTAGENESIS; INDUCED APOPTOSIS; MUTANT P53	Background: Non-melanoma skin cancers are one of the most common human malignancies accounting for 2-3% of tumors in the US and represent a significant health burden. Epidemiology studies have implicated Tp53 mutations triggered by UV exposure, and human papilloma virus (HPV) infection to be significant causes of non-melanoma skin cancer. However, the relationship between Tp53 and cutaneous HPV infection is not well understood in skin cancers. In this study we assessed the association of HPV infection and Tp53 polymorphisms and mutations in lesional specimens with squamous cell carcinomas. Methods: We studied 55 cases of histologically confirmed cutaneous squamous cell carcinoma and 41 controls for the presence of HPV infection and Tp53 genotype (mutations and polymorphism). Results: We found an increased number of Tp53 mutations in the squamous cell carcinoma samples compared with perilesional or control samples. There was increased frequency of homozygous Tp53-72R polymorphism in cases with squamous cell carcinomas, while the Tp53-72P allele (Tp53-72R/P and Tp53-72P/P) was more frequent in normal control samples. Carcinoma samples positive for HPV showed a decreased frequency of Tp53 mutations compared to those without HPV infection. In addition, carcinoma samples with a Tp53-72P allele showed an increased incidence of Tp53 mutations in comparison carcinomas samples homozygous for Tp53-72R. Conclusions: These studies suggest there are two separate pathways (HPV infection and Tp53 mutation) leading to cutaneous squamous cell carcinomas stratified by the Tp53 codon-72 polymorphism. The presence of a Tp53-72P allele is protective against cutaneous squamous cell carcinoma, and carcinoma specimens with Tp53-72P are more likely to have Tp53 mutations. In contrast Tp53-72R is a significant risk factor for cutaneous squamous cell carcinoma and is frequently associated with HPV infection instead of Tp53 mutations. Heterozygosity for Tp53-72R/P is protective against squamous cell carcinomas, possibly reflecting a requirement for both HPV infection and Tp53 mutations.	[Loeb, Keith R.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Loeb, Keith R.; Feng, Qinghua; Stern, Joshua E.; Argenyi, Zsolt B.; Kiviat, Nancy B.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Asgari, Maryam M.; Hawes, Stephen E.] Univ Washington, Dept Epidemiol, Sch Med, Seattle, WA 98195 USA; [Argenyi, Zsolt B.] Univ Washington, Div Dermatol, Sch Med, Seattle, WA 98195 USA; [Kiviat, Nancy B.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [de Villiers, Ethel-Michele] Deutsch Krebsforschungszentrum, Div Characterizat Tumorviruses, D-6900 Heidelberg, Germany; [Jiang, Mingjun] Natl Acad Med Sci, Inst Dermatol, Nanjing, Jiangsu, Peoples R China	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Helmholtz Association; German Cancer Research Center (DKFZ); Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS	Loeb, KR (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	nbk@u.washington.edu	Asgari, Maryam/O-4947-2016		National Institute of Environmental Health Sciences [K08-ES00382]; National Institute of Health [F32 AR47552]; National Cancer Institute [R01 CA084087]; Ministry of Health, Berlin; NATIONAL CANCER INSTITUTE [R01CA084087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR047552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K08ES000382] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ministry of Health, Berlin; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by grants from the National Institute of Environmental Health Sciences (K08-ES00382, KRL), National Institute of Health (F32 AR47552, MMA) and the National Cancer Institute (R01 CA084087, NBK) as well as the Ministry of Health, Berlin (EMV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Alotaibi L, 2006, J CLIN VIROL, V36, P133, DOI 10.1016/j.jcv.2006.02.007; AMSTAD P, 1994, MOL CARCINOGEN, V10, P181, DOI 10.1002/mc.2940100402; Andersson K, 2008, CANCER EPIDEM BIOMAR, V17, P189, DOI 10.1158/1055-9965.EPI-07-0405; ARENDS MJ, 1993, HUM PATHOL, V24, P432, DOI 10.1016/0046-8177(93)90093-V; ARMSTRONG BK, 1995, DERMATOL CLIN, V13, P583, DOI 10.1016/S0733-8635(18)30064-0; Arron ST, 2011, J INVEST DERMATOL; Asgari MM, 2008, J INVEST DERMATOL, V128, P1409, DOI 10.1038/sj.jid.5701227; Azzam GA, 2011, CELL CYCLE, V10, P1352, DOI 10.4161/cc.10.9.15344; Bastiaens MT, 2001, MOL CARCINOGEN, V30, P56, DOI 10.1002/1098-2744(200101)30:1<56::AID-MC1013>3.0.CO;2-2; Bavinck JNB, 2010, CANCER RES, V70, P9777, DOI 10.1158/0008-5472.CAN-10-0352; Bendesky A, 2007, MUTAT RES-FUND MOL M, V619, P38, DOI 10.1016/j.mrfmmm.2007.01.001; Bin X, 2010, CANCER GENET CYTOGEN, V202, P76, DOI 10.1016/j.cancergencyto.2010.02.014; Brachmann RK, 1996, P NATL ACAD SCI USA, V93, P4091, DOI 10.1073/pnas.93.9.4091; Brant O, 2007, ANTICANCER RES, V27, P3301; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; Caceres DD, 2009, LUNG, V187, P110, DOI 10.1007/s00408-008-9133-3; Cairey-Remonnay S, 2002, J INVEST DERMATOL, V118, P1026, DOI 10.1046/j.1523-1747.2002.01787.x; de Oliveira WRP, 2004, INT J DERMATOL, V43, P489, DOI 10.1111/j.1365-4632.2004.02289.x; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; Dokianakis DN, 2000, INT J MOL MED, V5, P405; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Durinck S, 2011, CANCER DISCOV, V1, P137, DOI 10.1158/2159-8290.CD-11-0028; Fallai C, 2009, INT J RADIAT ONCOL, V75, P1053, DOI 10.1016/j.ijrobp.2008.12.088; Fei JW, 2008, INT J CANCER, V123, P108, DOI 10.1002/ijc.23506; Fei JW, 2005, CELL CYCLE, V4, P689, DOI 10.4161/cc.4.5.1653; Feltkamp MCW, 2008, J CLIN VIROL, V43, P353, DOI 10.1016/j.jcv.2008.09.009; Forslund O, 1999, J GEN VIROL, V80, P2437, DOI 10.1099/0022-1317-80-9-2437; Forslund O, 2007, J GEN VIROL, V88, P2662, DOI 10.1099/vir.0.82911-0; Forslund O, 2007, J INFECT DIS, V196, P876, DOI 10.1086/521031; Frank AK, 2011, MOL CELL BIOL, V31, P1201, DOI 10.1128/MCB.01136-10; Galic V, 2007, GENE CHROMOSOME CANC, V46, P239, DOI 10.1002/gcc.20407; Garcia-Zuazaga Jorge, 2008, Adv Dermatol, V24, P33, DOI 10.1016/j.yadr.2008.09.007; Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562; Hainaut P, 1998, NUCLEIC ACIDS RES, V26, P205, DOI 10.1093/nar/26.1.205; Hainaut P, 2000, ADV CANCER RES, V77, P81; Han JL, 2006, MOL CARCINOGEN, V45, P694, DOI 10.1002/mc.20190; HARRIS CC, 1993, SCIENCE, V262, P1980, DOI 10.1126/science.8266092; Harwood CA, 2000, J MED VIROL, V61, P289, DOI 10.1002/1096-9071(200007)61:3&lt;289::AID-JMV2&gt;3.0.CO;2-Z; HAUSEN HZ, 1991, VIROLOGY, V184, P9, DOI 10.1016/0042-6822(91)90816-T; Hjortsberg L, 2008, P53 MUTATION HDB 2 0; Hoffmann M, 2009, ONCOL REP, V21, P809, DOI 10.3892/or_00000288; Hu YC, 2005, CLIN CANCER RES, V11, P2502, DOI 10.1158/1078-0432.CCR-04-1913; Jackson S, 2000, GENE DEV, V14, P3065, DOI 10.1101/gad.182100; Jha P, 2011, EXP MOL PATHOL, V90, P167, DOI 10.1016/j.yexmp.2010.11.002; Jonason AS, 1996, P NATL ACAD SCI USA, V93, P14025, DOI 10.1073/pnas.93.24.14025; Karagas MR, 2006, J NATL CANCER I, V98, P389, DOI 10.1093/jnci/djj092; Kiviat NB, 1999, SEMIN CANCER BIOL, V9, P397, DOI 10.1006/scbi.1999.0143; Koushik A, 2006, INT J CANCER, V119, P1863, DOI 10.1002/ijc.22057; KUBO Y, 1994, J INVEST DERMATOL, V102, P440, DOI 10.1111/1523-1747.ep12373002; Lee JM, 2006, MUTAT RES-FUND MOL M, V594, P181, DOI 10.1016/j.mrfmmm.2005.09.003; Leverrier S, 2007, APOPTOSIS, V12, P549, DOI 10.1007/s10495-006-0004-1; Li CY, 2008, J INVEST DERMATOL, V128, P1585, DOI 10.1038/sj.jid.5701186; Li FL, 2010, CANCER-AM CANCER SOC, V116, P2350, DOI 10.1002/cncr.25072; Li XQ, 1996, J VIROL, V70, P4509, DOI 10.1128/JVI.70.7.4509-4516.1996; Li Y, 2009, LUNG CANCER, V66, P15, DOI 10.1016/j.lungcan.2008.12.009; LORINCZ AT, 1992, OBSTET GYNECOL, V79, P328, DOI 10.1097/00006250-199203000-00002; Mantovani F, 2007, NAT STRUCT MOL BIOL, V14, P912, DOI 10.1038/nsmb1306; Marin MC, 2000, NAT GENET, V25, P47, DOI 10.1038/75586; McGregor JM, 1997, ONCOGENE, V15, P1737, DOI 10.1038/sj.onc.1201339; McGregor JM, 2002, J INVEST DERMATOL, V119, P84, DOI 10.1046/j.1523-1747.2002.01655.x; MILLER DL, 1994, J AM ACAD DERMATOL, V30, P774, DOI 10.1016/S0190-9622(08)81509-5; Mitra S, 2007, J CLIN PATHOL, V60, P1040, DOI 10.1136/jcp.2005.034835; Mojtahedi Z, 2010, BRAZ J OTORHINOLAR, V76, P316, DOI 10.1590/S1808-86942010000300008; Moshinsky DJ, 1997, P NATL ACAD SCI USA, V94, P2266, DOI 10.1073/pnas.94.6.2266; Nan H, 2008, BRIT J DERMATOL, V159, P314, DOI 10.1111/j.1365-2133.2008.08624.x; O'Connor DP, 2001, J CLIN PATHOL, V54, P539, DOI 10.1136/jcp.54.7.539; Orth G, 1987, PAPOVAVIRIDAE; Pantelis A, 2007, ONCOL REP, V17, P1243; Patel AS, 2008, J INVEST DERMATOL, V128, P2888, DOI 10.1038/jid.2008.162; Piao JM, 2011, LUNG CANC; PRESTON DS, 1992, NEW ENGL J MED, V327, P1649, DOI 10.1056/NEJM199212033272307; Purdie KJ, 2005, J INVEST DERMATOL, V125, P98, DOI 10.1111/j.0022-202X.2005.23635.x; REES J, 1994, J INVEST DERMATOL, V103, P747, DOI 10.1111/1523-1747.ep12412256; Ren ZP, 1996, ONCOGENE, V12, P765; Ren ZP, 1997, AM J PATHOL, V150, P1791; Rollison DE, 2008, INT J CANCER, V123, P2337, DOI 10.1002/ijc.23795; ROWE DE, 1992, J AM ACAD DERMATOL, V26, P976, DOI 10.1016/0190-9622(92)70144-5; Sakamuro D, 1997, ONCOGENE, V15, P887, DOI 10.1038/sj.onc.1201263; Salvioli S, 2005, CELL CYCLE, V4, P1264, DOI 10.4161/cc.4.9.1978; Schwartz JL, 2011, ENVIRON MOL MUTAGEN, V52, P77, DOI 10.1002/em.20635; Siddique M, 2006, ONCOGENE, V25, P3489, DOI 10.1038/sj.onc.1209405; Sjalander A, 1996, HUM HERED, V46, P41, DOI 10.1159/000154324; Stefanaki I, 2007, BRIT J DERMATOL, V156, P357, DOI 10.1111/j.1365-2133.2006.07645.x; Storey A, 1998, NATURE, V393, P229, DOI 10.1038/30400; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Strauss BS, 1997, CARCINOGENESIS, V18, P1445, DOI 10.1093/carcin/18.8.1445; Struijk L, 2008, J GEN VIROL, V89, P2303, DOI 10.1099/vir.0.83317-0; Szybka M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-278; Szymanowska A, 2006, LUNG CANCER, V52, P9, DOI 10.1016/j.lungcan.2005.12.007; Thomas M, 1999, MOL CELL BIOL, V19, P1092; Underbrink MP, 2008, J VIROL, V82, P10408, DOI 10.1128/JVI.00902-08; Vasiljevic N, 2008, J GEN VIROL, V89, P2467, DOI 10.1099/vir.0.2008/001925-0; Walker KK, 1996, P NATL ACAD SCI USA, V93, P15335, DOI 10.1073/pnas.93.26.15335; Waterboer T, 2008, BRIT J DERMATOL, V159, P457, DOI 10.1111/j.1365-2133.2008.08621.x; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Yang WJ, 2008, MOL CARCINOGEN, V47, P100, DOI 10.1002/mc.20368; YUTSUDO M, 1994, J CLIN MICROBIOL, V32, P1076, DOI 10.1128/JCM.32.4.1076-1078.1994; Zawlik I, 2009, BRAIN PATHOL, V19, P188, DOI 10.1111/j.1750-3639.2008.00170.x; Zhu F, 2010, CANCER RES, V70, P5851, DOI 10.1158/0008-5472.CAN-09-4646; ZIEGLER A, 1993, P NATL ACAD SCI USA, V90, P4216, DOI 10.1073/pnas.90.9.4216	102	13	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e34422	10.1371/journal.pone.0034422	http://dx.doi.org/10.1371/journal.pone.0034422			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545084	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343200007
J	Majumder, M; Tutunea-Fatan, E; Xin, XP; Rodriguez-Torres, M; Torres-Garcia, J; Wiebe, R; Timoshenko, AV; Bhattacharjee, RN; Chambers, AF; Lala, PK				Majumder, Mousumi; Tutunea-Fatan, Elena; Xin, Xiping; Rodriguez-Torres, Mauricio; Torres-Garcia, Jose; Wiebe, Ryan; Timoshenko, Alexander V.; Bhattacharjee, Rabindra N.; Chambers, Ann F.; Lala, Peeyush K.			Co-Expression of alpha 9 beta 1 Integrin and VEGF-D Confers Lymphatic Metastatic Ability to a Human Breast Cancer Cell Line MDA-MB-468LN	PLOS ONE			English	Article							GROWTH-FACTOR-C; VASCULAR CHANNEL FORMATION; GENE-EXPRESSION PROFILES; ENDOTHELIAL-CELLS; PROGNOSTIC-SIGNIFICANCE; INDUCED ANGIOGENESIS; PROTEIN OSTEOPONTIN; TUMOR-METASTASIS; MELANOMA-CELLS; LUNG-CANCER	Introduction and Objectives: Lymphatic metastasis is a common occurrence in human breast cancer, mechanisms remaining poorly understood. MDA-MB-468LN (468LN), a variant of the MDA-MB-468GFP (468GFP) human breast cancer cell line, produces extensive lymphatic metastasis in nude mice. 468LN cells differentially express alpha 9 beta 1 integrin, a receptor for lymphangiogenic factors VEGF-C/-D. We explored whether (1) differential production of VEGF-C/-D by 468LN cells provides an autocrine stimulus for cellular motility by interacting with alpha 9 beta 1 and a paracrine stimulus for lymphangiogenesis in vitro as measured with capillary-like tube formation by human lymphatic endothelial cells (HMVEC-dLy); (2) differential expression of alpha 9 also promotes cellular motility/invasiveness by interacting with macrophage derived factors; (3) stable knock-down of VEGF-D or alpha 9 in 468LN cells abrogates lymphangiogenesis and lymphatic metastasis in vivo in nude mice. Results: A comparison of expression of cyclo-oxygenase (COX)-2 (a VEGF-C/-D inducer), VEGF-C/-D and their receptors revealed little COX-2 expression by either cells. However, 468LN cells showed differential VEGF-D and alpha 9 beta 1 expression, VEGF-D secretion, proliferative, migratory/invasive capacities, latter functions being stimulated further with VEGF-D. The requirement of alpha 9 beta 1 for native and VEGF-D-stimulated proliferation, migration and Erk activation was demonstrated by treating with alpha 9 beta 1 blocking antibody or knock-down of alpha 9. An autocrine role of VEGF-D in migration was shown by its impairment by silencing VEGF-D and restoration with VEGF-D. 468LN cells and their soluble products stimulated tube formation, migration/invasiveness of HMVEC-dLy cell in a VEGF-D dependent manner as indicated by the loss of stimulation by silencing VEGF-D in 468LN cells. Furthermore, 468LN cells showed alpha 9-dependent stimulation of migration/invasiveness by macrophage products. Finally, capacity for intra-tumoral lymphangiogenesis and lymphatic metastasis in nude mice was completely abrogated by stable knock-down of either VEGF-D or alpha 9 in 468LN cells. Conclusion: Differential capacity for VEGF-D production and alpha 9 beta 1 integrin expression by 468LN cells jointly contributed to their lymphatic metastatic phenotype.	[Majumder, Mousumi; Tutunea-Fatan, Elena; Xin, Xiping; Rodriguez-Torres, Mauricio; Torres-Garcia, Jose; Wiebe, Ryan; Timoshenko, Alexander V.; Bhattacharjee, Rabindra N.; Lala, Peeyush K.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada; [Timoshenko, Alexander V.] Univ Western Ontario, Dept Biol, London, ON, Canada; [Chambers, Ann F.] Univ Western Ontario, Dept Med Biophys, London, ON, Canada; [Chambers, Ann F.; Lala, Peeyush K.] Univ Western Ontario, Dept Oncol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Majumder, M (corresponding author), Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada.	pklala@uwo.ca	Timoshenko, Alexander/H-9873-2019; Chambers, Ann F/L-6285-2015	Timoshenko, Alexander/0000-0002-4237-513X; Chambers, Ann F/0000-0002-9509-5123	Ontario Institute of Cancer Research; Canadian Breast Cancer Foundation (CBCF), Ontario Chapter; Translational Breast Cancer Research Unit (TBCRU); Cancer Research Technology Transfer (CaRTT) of the London Regional Cancer Program; Fellowship of the CBCF; Canada Research Chairs Program	Ontario Institute of Cancer Research; Canadian Breast Cancer Foundation (CBCF), Ontario Chapter; Translational Breast Cancer Research Unit (TBCRU); Cancer Research Technology Transfer (CaRTT) of the London Regional Cancer Program; Fellowship of the CBCF; Canada Research Chairs Program(Canada Research Chairs)	The Ontario Institute of Cancer Research and the Canadian Breast Cancer Foundation (CBCF), Ontario Chapter, for grant support to PKL. ETF is supported by scholarships from the Translational Breast Cancer Research Unit (TBCRU) and Cancer Research Technology Transfer (CaRTT) of the London Regional Cancer Program and RNB by a Fellowship of the CBCF. AFC is Canada Research Chair in Oncology, supported by the Canada Research Chairs Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan AL, 2006, AM J PATHOL, V169, P233, DOI 10.2353/ajpath.2006.051152; Allen MD, 2011, J PATHOL, V223, P646, DOI 10.1002/path.2833; Basu GD, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1626; Belien JAM, 1999, J CLIN PATHOL, V52, P184, DOI 10.1136/jcp.52.3.184; Bertl E, 2006, MOL CANCER THER, V5, P575, DOI 10.1158/1535-7163.MCT-05-0324; Bhattacharjee RN, 2010, CANCER SCI, V101, P2026, DOI 10.1111/j.1349-7006.2010.01647.x; Decaestecker C, 2007, MED RES REV, V27, P149, DOI 10.1002/med.20078; Gimi B, 2006, NEOPLASIA, V8, P207, DOI 10.1593/neo.05547; Gu Y, 2008, CLIN EXP METASTAS, V25, P717, DOI 10.1007/s10585-008-9180-4; Hedley BD, 2008, INT J CANCER, V123, P526, DOI 10.1002/ijc.23542; Henriksen K, 2003, J BIOL CHEM, V278, P48745, DOI 10.1074/jbc.M309193200; Hong YK, 2004, FASEB J, V18, P1111, DOI 10.1096/fj.03-1179fje; Hu Z, 2005, CLIN CANCER RES, V11, P4646, DOI 10.1158/1078-0432.CCR-04-2013; Huang XZ, 2000, MOL CELL BIOL, V20, P5208, DOI 10.1128/MCB.20.14.5208-5215.2000; Iivanainen E, 2003, FASEB J, V17, P1609, DOI 10.1096/fj.02-0939com; Jadeski LC, 1999, AM J PATHOL, V155, P1381, DOI 10.1016/S0002-9440(10)65240-6; Ji Rui-Cheng, 2006, Lymphatic Research and Biology, V4, P83, DOI 10.1089/lrb.2006.4.83; Khodarev NN, 2003, J CELL SCI, V116, P1013, DOI 10.1242/jcs.00281; Leidenius M, 2007, AM J CLIN PATHOL, V128, P759; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Lin CH, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/351010; Liu TC, 2011, INT J ONCOL, V38, P1349, DOI 10.3892/ijo.2011.946; MACKIE EJ, 1987, P NATL ACAD SCI USA, V84, P4621, DOI 10.1073/pnas.84.13.4621; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Marchio S, 1999, J BIOL CHEM, V274, P27617, DOI 10.1074/jbc.274.39.27617; Martinetti A, 2004, ENDOCR-RELAT CANCER, V11, P771, DOI 10.1677/erc.1.00775; McColl BK, 2007, FASEB J, V21, P1088, DOI 10.1096/fj.06-7060com; Mikhaylova M, 2008, NEOPLASIA, V10, P380, DOI 10.1593/neo.07854; Mohammed RAA, 2007, BRIT J CANCER, V96, P1092, DOI 10.1038/sj.bjc.6603678; Nishimichi N, 2009, J BIOL CHEM, V284, P14769, DOI 10.1074/jbc.M901515200; Oommen S, 2011, J BIOL CHEM, V286, P1083, DOI 10.1074/jbc.M110.175158; Pan MR, 2009, J CELL SCI, V122, P3358, DOI 10.1242/jcs.050005; Pandit TS, 2009, INT J ONCOL, V35, P297, DOI 10.3892/ijo_00000340; Partanen TA, 2000, FASEB J, V14, P2087, DOI 10.1096/fj.99-1049com; Rodenhiser DI, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2121; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Rozic JG, 2001, INT J CANCER, V93, P497, DOI 10.1002/ijc.1376; Rudland PS, 2002, CANCER RES, V62, P3417; Saharinen P, 2004, TRENDS IMMUNOL, V25, P387, DOI 10.1016/j.it.2004.05.003; Shang T, 1999, J LEUKOCYTE BIOL, V66, P809, DOI 10.1002/jlb.66.5.809; Shields JD, 2007, ONCOGENE, V26, P2997, DOI 10.1038/sj.onc.1210114; Sleeman JP, 2009, INT J CANCER, V125, P2747, DOI 10.1002/ijc.24702; Sonvilla G, 2008, CARCINOGENESIS, V29, P15, DOI 10.1093/carcin/bgm202; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Tanno S, 2004, LUNG CANCER, V46, P11, DOI 10.1016/j.lungcan.2004.03.006; Timoshenko AV, 2007, BRIT J CANCER, V97, P1090, DOI 10.1038/sj.bjc.6603993; Timoshenko AV, 2006, BRIT J CANCER, V94, P1154, DOI 10.1038/sj.bjc.6603067; Truong PT, 2008, EUR J CANCER, V44, P1670, DOI 10.1016/j.ejca.2008.05.011; Tuck AB, 2007, J CELL BIOCHEM, V102, P859, DOI 10.1002/jcb.21520; Van der Auwera I, 2004, CLIN CANCER RES, V10, P7965, DOI 10.1158/1078-0432.CCR-04-0063; Vantyghem SA, 2005, CLIN EXP METASTAS, V22, P351, DOI 10.1007/s10585-005-0745-1; Vlahakis NE, 2005, J BIOL CHEM, V280, P4544, DOI 10.1074/jbc.M412816200; Vlahakis NE, 2007, J BIOL CHEM, V282, P15187, DOI 10.1074/jbc.M609323200; Watari K, 2008, BIOCHEM BIOPH RES CO, V377, P826, DOI 10.1016/j.bbrc.2008.10.077; Wissmann C, 2006, CLIN CANCER RES, V12, P6865, DOI 10.1158/1078-0432.CCR-06-1800; Xu J, 2008, CANCER GENET CYTOGEN, V181, P1, DOI 10.1016/j.cancergencyto.2007.05.030; Yang WT, 2002, CANCER, V94, P2855, DOI 10.1002/cncr.10553; Zeng YP, 2004, CLIN CANCER RES, V10, P5137, DOI 10.1158/1078-0432.CCR-03-0434	58	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35094	10.1371/journal.pone.0035094	http://dx.doi.org/10.1371/journal.pone.0035094			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545097	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343200019
J	Laskaris, P; Sekine, T; Wellington, EMH				Laskaris, Paris; Sekine, Takuya; Wellington, Elizabeth M. H.			Diversity Analysis of Streptomycetes and Associated Phosphotranspherase Genes in Soil	PLOS ONE			English	Article							16S RDNA; AMINOGLYCOSIDE ANTIBIOTICS; AMINOTRANSFERASE GENES; RESISTANCE; IDENTIFICATION; BIOSYNTHESIS; BACTERIA; CLADE; PCR; ACTINOBACTERIA	An attempt was made to verify the observation that Streptomyces griseus was prevalent in soil based on isolation work. A genus-specific PCR was developed for Streptomyces based on the housekeeping gene atpD and used to investigate species diversity within selected soils. The presence of S. griseus was investigated to determine coexistence of resistance-only streptomycin phosphotransferase (strA) in the same soil as streptomycin producers. Two additional PCR-based assays were developed; one specific for strA in association with production, the other for more diverse strA and other related phosphotranferases. Both the S. griseus atpD and strA genes were below the PCR detection limit in all soils examined. A number of more diverse phosphotransferase genes were amplified, a minority of which may be associated with streptomycin production. We conclude that neither streptomycin producers nor S. griseus are prevalent in the fresh or chitin and starch-amended soils examined (less than 0.1% of soil actinobacteria). One of the soil sites had received plantomycin (active ingredient: streptomycin) and diversity studies suggested that this altered the streptomycete populations present in the soil.	[Laskaris, Paris; Sekine, Takuya; Wellington, Elizabeth M. H.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Laskaris, P (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	plaskaris@ufl.edu		Wellington, ELizabeth/0000-0002-4329-0699	United Kingdom Biotechnology and Biological Sciences Research Council [BBSRC BB/F003498/1]; European Union [222625, KBBE-2007-3-3-05]; Biotechnology and Biological Sciences Research Council [BB/F003498/1] Funding Source: researchfish; BBSRC [BB/F003498/1] Funding Source: UKRI	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was supported by grants from the United Kingdom Biotechnology and Biological Sciences Research Council (grant reference: BBSRC BB/F003498/1) and the European Union's 7th Framework Programme for Research and Technological Development (grant agreement no. 222625 METAEXPLORE, EU FP7 Theme KBBE-2007-3-3-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AS, 2002, J IND MICROBIOL BIOT, V29, P60, DOI 10.1038/sj.jim.7000260; Anderson AS, 2001, INT J SYST EVOL MICR, V51, P797, DOI 10.1099/00207713-51-3-797; Aoki R, 2008, BIOSCI BIOTECH BIOCH, V72, P1388, DOI 10.1271/bbb.80033; Babalola OO, 2009, ENVIRON MICROBIOL, V11, P566, DOI 10.1111/j.1462-2920.2008.01809.x; Baltz RH, 2006, J IND MICROBIOL BIOT, V33, P507, DOI 10.1007/s10295-005-0077-9; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Borjesson S, 2009, INT J ENVIRON HEAL R, V19, P219, DOI 10.1080/09603120802449593; Calvo-Bado L, COMMUNICATION; Casjens S, 1998, ANNU REV GENET, V32, P339, DOI 10.1146/annurev.genet.32.1.339; Chanal A, 2006, ENVIRON MICROBIOL, V8, P514, DOI 10.1111/j.1462-2920.2005.00921.x; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Davelos AL, 2004, MICROB ECOL, V48, P601, DOI 10.1007/s00248-004-0031-9; DSMZ, 2012, CAT MICR; Egan S, 2001, ANTON LEEUW INT J G, V79, P127, DOI 10.1023/A:1010296220929; Euzeby J. P., 2012, LIST PROKARYOTIC NAM; Garcia C, 2004, SITE DESCRIPTION; Gharaibeh R, 2003, J BASIC MICROB, V43, P301, DOI 10.1002/jobm.200390033; Goodfellow M, 2007, ANTON LEEUW INT J G, V92, P173, DOI 10.1007/s10482-007-9146-6; Gundlapally SR, 2006, MICROB ECOL, V52, P345, DOI 10.1007/s00248-006-9011-6; Guo YP, 2008, INT J SYST EVOL MICR, V58, P149, DOI 10.1099/ijs.0.65224-0; Hain T, 1997, INT J SYST BACTERIOL, V47, P202, DOI 10.1099/00207713-47-1-202; Hanage WP, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-6; Holmes AJ, 2000, FEMS MICROBIOL ECOL, V33, P111, DOI 10.1016/S0168-6496(00)00051-9; Jones D, 1944, SCIENCE, V100, P103, DOI 10.1126/science.100.2588.103; Kataoka M, 1997, FEMS MICROBIOL LETT, V151, P249, DOI 10.1016/S0378-1097(97)00169-9; Kim BJ, 2004, INT J SYST EVOL MICR, V54, P593, DOI 10.1099/ijs.0.02941-0; KORMANEC J, 1992, GENE, V114, P133, DOI 10.1016/0378-1119(92)90719-6; Kumar Y, 2008, INT J SYST EVOL MICR, V58, P1369, DOI 10.1099/ijs.0.65408-0; Lanoot B, 2005, RES MICROBIOL, V156, P755, DOI 10.1016/j.resmic.2005.01.017; Laskaris P, 2010, ENVIRON MICROBIOL, V12, P783, DOI 10.1111/j.1462-2920.2009.02125.x; Liu ZH, 2005, INT J SYST EVOL MICR, V55, P1605, DOI 10.1099/ijs.0.63654-0; Manome A, 2008, PLANT PATHOL, V57, P887, DOI 10.1111/j.1365-3059.2008.01881.x; McManus PS, 2002, ANNU REV PHYTOPATHOL, V40, P443, DOI 10.1146/annurev.phyto.40.120301.093927; Metcalfe AC, 2002, APPL ENVIRON MICROB, V68, P5042, DOI 10.1128/AEM.68.10.5042-5050.2002; Monciardini P, 2002, FEMS MICROBIOL ECOL, V42, P419, DOI 10.1111/j.1574-6941.2002.tb01031.x; Mun HS, 2007, SYST APPL MICROBIOL, V30, P401, DOI 10.1016/j.syapm.2007.01.003; Nagaya A, 2005, BIOSCI BIOTECH BIOCH, V69, P1389, DOI 10.1271/bbb.69.1389; Pontiroli A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017916; Qu XS, 2008, PHYTOPATHOLOGY, V98, P405, DOI 10.1094/PHYTO-98-4-0405; Riesenfeld CS, 2004, ENVIRON MICROBIOL, V6, P981, DOI 10.1111/j.1462-2920.2004.00664.x; Rong XY, 2010, INT J SYST EVOL MICR, V60, P696, DOI 10.1099/ijs.0.012419-0; Schlatter DC, 2010, APPL ENVIRON MICROB, V76, P2009, DOI 10.1128/AEM.02320-09; Smith JJ, 2006, MICROB ECOL, V51, P413, DOI 10.1007/s00248-006-9022-3; Stach JEM, 2003, ENVIRON MICROBIOL, V5, P828, DOI 10.1046/j.1462-2920.2003.00483.x; Staley JT, 2006, PHILOS T R SOC B, V361, P1899, DOI 10.1098/rstb.2006.1914; SUNDIN GW, 1995, CAN J MICROBIOL, V41, P792, DOI 10.1139/m95-109; Tamegai H, 2006, BIOSCI BIOTECH BIOCH, V70, P1711, DOI 10.1271/bbb.60045; Tolba S, 2002, FEMS MICROBIOL ECOL, V42, P269, DOI 10.1111/j.1574-6941.2002.tb01017.x; Tolba S, 2004, DISTRIBUTION STREPTO; Valenzuela-Encinas C, 2009, EXTREMOPHILES, V13, P609, DOI 10.1007/s00792-009-0244-4; Wang Y, 1999, J IND MICROBIOL BIOT, V23, P178, DOI 10.1038/sj.jim.2900723; WILLIAMS ST, 1983, J GEN MICROBIOL, V129, P1743; Wink J.M., 2012, COMPENDIUM ACTINOBAC	53	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35756	10.1371/journal.pone.0035756	http://dx.doi.org/10.1371/journal.pone.0035756			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540003	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341000069
J	Summanen, M; Granqvist, N; Tuominen, RK; Yliperttula, M; Verrips, CT; Boonstra, J; Blanchetot, C; Ekokoski, E				Summanen, Milla; Granqvist, Niko; Tuominen, Raimo K.; Yliperttula, Marjo; Verrips, C. Theo; Boonstra, Johannes; Blanchetot, Christophe; Ekokoski, Elina			Kinetics of PKC epsilon Activating and Inhibiting Llama Single Chain Antibodies and Their Effect on PKC epsilon Translocation in HeLa Cells	PLOS ONE			English	Article							PROTEIN-KINASE-C; AMYLOID PRECURSOR PROTEIN; PHOSPHORYLATION; TARGET; CHIP	Dysregulation of PKC epsilon is involved in several serious diseases such as cancer, type II diabetes and Alzheimer's disease. Therefore, specific activators and inhibitors of PKC epsilon hold promise as future therapeutics, in addition to being useful in research into PKC epsilon regulated pathways. We have previously described llama single chain antibodies (VHHs) that specifically activate (A10, C1 and D1) or inhibit (E6 and G8) human recombinant PKC epsilon. Here we report a thorough kinetic analysis of these VHHs. The inhibiting VHHs act as non-competitive inhibitors of PKC epsilon activity, whereas the activating VHHs have several different modes of action, either increasing V-max and/or decreasing K-m values. We also show that the binding of the VHHs to PKC epsilon is conformation-dependent, rendering the determination of affinities difficult. Apparent affinities are in the micromolar range based on surface plasmon resonance studies. Furthermore, the VHHs have no effect on the activity of rat PKC epsilon nor can they bind the rat form of the protein in immunoprecipitation studies despite the 98% identity between the human and rat PKC epsilon proteins. Finally, we show for the first time that the VHHs can influence PKC epsilon function also in cells, since an activating VHH increases the rate of PKC epsilon translocation in response to PMA in HeLa cells, whereas an inhibiting VHH slows down the translocation. These results give insight into the mechanisms of PKC epsilon activity modulation and highlight the importance of protein conformation on VHH binding.	[Summanen, Milla; Verrips, C. Theo; Boonstra, Johannes; Blanchetot, Christophe] Univ Utrecht, Dept Biol, Utrecht, Netherlands; [Summanen, Milla; Tuominen, Raimo K.; Ekokoski, Elina] Univ Helsinki, Div Pharmacol & Toxicol, Fac Pharm, Helsinki, Finland; [Granqvist, Niko; Yliperttula, Marjo] Univ Helsinki, Fac Pharm, Div Biopharmaceut & Pharmacokinet, Helsinki, Finland	Utrecht University; University of Helsinki; University of Helsinki	Boonstra, J (corresponding author), Univ Utrecht, Dept Biol, Utrecht, Netherlands.	j.boonstra@uu.nl		Summanen, Milla/0000-0003-3843-2741; Blanchetot, christophe/0000-0001-9152-9978	Finnish Pharmaceutical Society; Finnish Diabetes Research Foundation	Finnish Pharmaceutical Society; Finnish Diabetes Research Foundation	This work was supported by grants from the Finnish Pharmaceutical Society and the Finnish Diabetes Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita Y, 2002, J BIOCHEM, V132, P847, DOI 10.1093/oxfordjournals.jbchem.a003296; Basu A, 2007, CELL SIGNAL, V19, P1633, DOI 10.1016/j.cellsig.2007.04.008; Bhattacharya S, 2007, J BIOSCIENCES, V32, P405, DOI 10.1007/s12038-007-0038-8; Brandman R, 2007, J BIOL CHEM, V282, P4113, DOI 10.1074/jbc.M608521200; Cha T, 2005, PROTEOMICS, V5, P416, DOI 10.1002/pmic.200400948; Cisse M, 2011, MOL CELL NEUROSCI, V47, P223, DOI 10.1016/j.mcn.2011.04.008; de Barry J, 2010, EXP GERONTOL, V45, P64, DOI 10.1016/j.exger.2009.10.015; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; Dey D, 2007, BIOCHEM BIOPH RES CO, V357, P474, DOI 10.1016/j.bbrc.2007.03.183; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P12798, DOI 10.1073/pnas.96.22.12798; Durgan J, 2008, BIOCHEM J, V411, P319, DOI [10.1042/BJ20071348, 10.1042/bj20071348]; Gorin MA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-9; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Hongpaisan J, 2011, J NEUROSCI, V31, P630, DOI 10.1523/JNEUROSCI.5209-10.2011; Johnson JA, 1996, J BIOL CHEM, V271, P24962, DOI 10.1074/jbc.271.40.24962; Kang JH, 2007, J CHROMATOGR A, V1161, P9, DOI 10.1016/j.chroma.2007.05.023; Liron T, 2007, NEUROSCIENCE, V146, P152, DOI 10.1016/j.neuroscience.2007.01.024; Liu WS, 1998, CELL SIGNAL, V10, P529, DOI 10.1016/S0898-6568(98)00012-6; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; Muyldermans S, 2001, J Biotechnol, V74, P277; Nelson TJ, 2009, J BIOL CHEM, V284, P34514, DOI 10.1074/jbc.M109.016683; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Nieba L, 1997, ANAL BIOCHEM, V252, P217, DOI 10.1006/abio.1997.2326; Paalanen MMI, 2011, EUR J PHARM SCI, V42, P332, DOI 10.1016/j.ejps.2010.12.012; Sampson SR, 2006, MOL GENET METAB, V89, P32, DOI 10.1016/j.ymgme.2006.04.017; Sandler C, 2005, INFLAMM RES, V54, P304, DOI 10.1007/s00011-005-1358-5; Saurin AT, 2009, CELL CYCLE, V8, P549, DOI 10.4161/cc.8.4.7653; Schasfoort RBM, 2008, HANDBOOK OF SURFACE PLASMON RESONANCE, P1, DOI 10.1039/9781847558220; Schmitz-Peiffer C, 2007, CELL METAB, V6, P320, DOI 10.1016/j.cmet.2007.08.012; Shou M, 2001, CURR DRUG METAB, V2, P17, DOI 10.2174/1389200013338784; Tammela P, 2004, DRUG DEVELOP RES, V63, P76, DOI 10.1002/ddr.10399; Toton E, 2011, PHARMACOL REP, V63, P19, DOI 10.1016/S1734-1140(11)70395-4; Van Bockstaele F, 2009, CURR OPIN INVEST DR, V10, P1212; Verheesen P, 2006, HUM MOL GENET, V15, P105, DOI 10.1093/hmg/ddi432; Verheesen P, 2006, BBA-PROTEINS PROTEOM, V1764, P1307, DOI 10.1016/j.bbapap.2006.05.011; Wilson DS, 2002, CURR OPIN CHEM BIOL, V6, P81, DOI 10.1016/S1367-5931(01)00281-2	38	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35630	10.1371/journal.pone.0035630	http://dx.doi.org/10.1371/journal.pone.0035630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536418	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339200087
J	Mohamed, W; Sethi, S; Tchatalbachev, S; Darji, A; Chakraborty, T				Mohamed, Walid; Sethi, Shneh; Tchatalbachev, Svetlin; Darji, Ayub; Chakraborty, Trinad			Protective Immunity to Listeria Monocytogenes Infection Mediated by Recombinant Listeria innocua Harboring the VGC Locus	PLOS ONE			English	Article							T-CELL RESPONSES; BACTERIAL-INFECTION; ACQUIRED-IMMUNITY; GRANULOMA-FORMATION; GENE-EXPRESSION; MICE; RESISTANCE; INDUCTION; MEMORY; LYMPHOCYTES	In this study we propose a novel bacterial vaccine strategy where non-pathogenic bacteria are complemented with traits desirable for the induction of protective immunity. To illustrate the proof of principle of this novel vaccination strategy, we use the model organism of intracellular immunity Listeria. We introduced a, low copy number BAC-plasmid harbouring the virulence gene cluster (vgc) of L. monocytogenes (Lm) into the non-pathogenic L. innocua (L.inn) strain and examined for its ability to induce protective cellular immunity. The resulting strain (L.inn::vgc) was attenuated for virulence in vivo and showed a strongly reduced host detrimental inflammatory response compared to Lm. Like Lm, L.inn::vgc induced the production of Type I Interferon's and protection was mediated by Listeria-specific CD8(+) T cells. Rational vaccine design whereby avirulent strains are equipped with the capabilities to induce protection but lack detrimental inflammatory effects offer great promise towards future studies using non-pathogenic bacteria as vectors for vaccination.	[Mohamed, Walid; Sethi, Shneh; Tchatalbachev, Svetlin; Darji, Ayub; Chakraborty, Trinad] Univ Giessen, German Ctr Infect Res DZIF, Inst Med Microbiol, Giessen, Germany; [Darji, Ayub] Univ Autonoma Barcelona, Ctr Recerca Sanitat Anim, E-08193 Barcelona, Spain	German Center for Infection Research; Justus Liebig University Giessen; Autonomous University of Barcelona; IRTA	Mohamed, W (corresponding author), Univ Giessen, German Ctr Infect Res DZIF, Inst Med Microbiol, Giessen, Germany.	trinad.chakraborty@mikrobio.med.uni-giessen.de	Sethi, Shneh/F-1796-2013; Tawfik, Walid/F-5109-2013	Tawfik, Walid/0000-0002-1675-4187	Federal Ministry of Education and Research (BMBF)	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The work was funded by the Federal Ministry of Education and Research (BMBF) through the ERA-NET Pathogenomics SPATELIS project. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahjat KS, 2006, INFECT IMMUN, V74, P6387, DOI 10.1128/IAI.01088-06; BARRY RA, 1992, INFECT IMMUN, V60, P1625, DOI 10.1128/IAI.60.4.1625-1632.1992; Bouwer HGA, 2006, P NATL ACAD SCI USA, V103, P5102, DOI 10.1073/pnas.0509381103; Brockstedt DG, 2005, NAT MED, V11, P853, DOI 10.1038/nm1276; Busch DH, 1999, IMMUNOL LETT, V65, P93, DOI 10.1016/S0165-2478(98)00130-8; Casswall TH, 2005, EXPERT REV VACCINES, V4, P725, DOI 10.1586/14760584.4.5.725; Darji A, 2003, VACCINE, V21, pS102, DOI 10.1016/S0264-410X(03)00208-1; Du LY, 2008, DRUG TODAY, V44, P63, DOI 10.1358/dot.2008.44.1.1131830; EHLERS S, 1992, J IMMUNOL, V149, P3016; FARBER JM, 1988, CAN MED ASSOC J, V138, P413; Francis KP, 1997, J IND MICROBIOL BIOT, V19, P286, DOI 10.1038/sj.jim.2900463; Glaser P, 2001, SCIENCE, V294, P849; GOOSSENS PL, 1995, INT IMMUNOL, V7, P797, DOI 10.1093/intimm/7.5.797; GOOSSENS PL, 1992, INT IMMUNOL, V4, P591, DOI 10.1093/intimm/4.5.591; Hain T, 2008, APPL ENVIRON MICROB, V74, P1892, DOI 10.1128/AEM.00415-07; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; KAUFMANN SHE, 1984, INFECT IMMUN, V45, P234, DOI 10.1128/IAI.45.1.234-241.1984; LADEL CH, 1994, J IMMUNOL, V153, P3116; LANE FC, 1972, J EXP MED, V135, P1104, DOI 10.1084/jem.135.5.1104; Lecuit M, 2007, MICROBES INFECT, V9, P1216, DOI 10.1016/j.micinf.2007.05.009; Luthy KE, 2006, J AM ACAD NURSE PRAC, V18, P494, DOI 10.1111/j.1745-7599.2006.00163.x; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI13296; McCaffrey RL, 2004, P NATL ACAD SCI USA, V101, P11386, DOI 10.1073/pnas.0403215101; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; MICHEL E, 1990, MOL MICROBIOL, V4, P2167, DOI 10.1111/j.1365-2958.1990.tb00578.x; MIELKE MEA, 1989, J EXP MED, V170, P589, DOI 10.1084/jem.170.2.589; MIELKE MEA, 1988, IMMUNOL LETT, V19, P211, DOI 10.1016/0165-2478(88)90144-7; MIELKE MEA, 1992, INFECT IMMUN, V60, P1875, DOI 10.1128/IAI.60.5.1875-1882.1992; MIYAHIRA Y, 1995, J IMMUNOL METHODS, V181, P45, DOI 10.1016/0022-1759(94)00327-S; NORTH RJ, 1981, J IMMUNOL, V127, P342; NORTH RJ, 1973, CELL IMMUNOL, V7, P166, DOI 10.1016/0008-8749(73)90193-7; PAMER EG, 1991, NATURE, V353, P852, DOI 10.1038/353852a0; Peters C, 2003, FEMS IMMUNOL MED MIC, V35, P243, DOI 10.1016/S0928-8244(02)00469-8; PORTNOY DA, 1992, INFECT IMMUN, V60, P1263, DOI 10.1128/IAI.60.4.1263-1267.1992; ROBERTS AD, 1993, INFECT IMMUN, V61, P1113, DOI 10.1128/IAI.61.3.1113-1116.1993; SAFLEY SA, 1991, J IMMUNOL, V146, P3604; Shata MT, 2000, MOL MED TODAY, V6, P66, DOI 10.1016/S1357-4310(99)01633-0; SHEN H, 1995, P NATL ACAD SCI USA, V92, P3987, DOI 10.1073/pnas.92.9.3987; Tanabe Y, 1999, INFECT IMMUN, V67, P568, DOI 10.1128/IAI.67.2.568-575.1999; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; WIPKE BT, 1993, EUR J IMMUNOL, V23, P2005, DOI 10.1002/eji.1830230842; Zwaferink H, 2008, J IMMUNOL, V180, P4116, DOI 10.4049/jimmunol.180.6.4116	42	7	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35503	10.1371/journal.pone.0035503	http://dx.doi.org/10.1371/journal.pone.0035503			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536395	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336200048
J	Paul, I; Ahmed, SF; Bhowmik, A; Deb, S; Ghosh, MK				Paul, I.; Ahmed, S. F.; Bhowmik, A.; Deb, S.; Ghosh, M. K.			The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity	ONCOGENE			English	Article						Hsp70; Hsp90; c-Myc; CHIP (STUB1); proteasome	PROTEASOMAL DEGRADATION; CELL PROLIFERATION; PROTEIN STABILITY; PHOSPHORYLATION; MUTATIONS; PATHWAYS; COMPLEX; GLIOMA; TUMOR; SKP2	c-Myc is a proto-oncogenic transcription factor and its rapid turnover mediated by the ubiquitin-proteasome system is critical for maintaining normal cellular homeostasis. Multiple ubiquitin ligases have been assigned for c-Myc regulation till date. However, the available data suggest for the possible existence of additional E3 ligase(s). Here, we report a new E3 ligase for c-Myc, the carboxyl terminus of Hsc70-interacting protein or CHIP, which is a chaperone-associated Ubox-containing E3 ligase. In this report, we show that CHIP interacts and ubiquitinates c-Myc, thus targeting it for proteasome-mediated degradation. Overexpression of CHIP could accelerate the turnover rate of c-Myc protein. Conversely, knockdown of CHIP by RNAi stabilizes endogenous c-Myc. The interaction between CHIP and c-Myc depends on the N-terminally located tetratricopeptide repeats of CHIP, which has been implicated as a chaperone-binding motif. Inhibition of Hsp90 chaperone activity by 17-N-allylamino-17-demethoxygeldanamycin reduces c-Myc protein level. We found that the association between CHIP and c-Myc is dependent on the chaperones; particularly Hsp70. CHIP antagonizes the transcriptional activity of c-Myc and decreases the abundance of the transcripts of its target genes. Overall, CHIP-knockdown increases malignant behavior of C6 glioma cells. To the best of our knowledge, this is the first report of c-Myc being regulated by a bona-fide chaperone-associated E3 ligase in HEK293 as well as glioma cells. Because CHIP has been reported earlier to be negatively regulating Akt1, BCR-ABL and hTERT, and now c-Myc, the present study may strengthen the view that CHIP acts as a tumor suppressor. Oncogene (2013) 32, 1284-1295; doi:10.1038/onc.2012.144; published online 30 April 2012	[Paul, I.; Ahmed, S. F.; Bhowmik, A.; Deb, S.; Ghosh, M. K.] CSIR, IICB, Lab Signal Transduct Canc & Stem Cells, Kolkata 700032, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Ghosh, MK (corresponding author), CSIR, IICB, Lab Signal Transduct Canc & Stem Cells, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	mrinal.res@gmail.com	Paul, Indranil/AAX-7638-2021; Ahmed, Syed Feroj/D-7860-2014	Paul, Indranil/0000-0003-0327-5002; Ahmed, Syed Feroj/0000-0003-1033-2538; Deb, Satamita/0000-0003-0315-7030	Council of Scientific and Industrial Research, CSIR (EMPOWER); DST	Council of Scientific and Industrial Research, CSIR (EMPOWER); DST(Department of Science & Technology (India))	This work was supported by grants provided by Council of Scientific and Industrial Research, CSIR (EMPOWER) and DST to MKG.	Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Belova L, 2006, BIOCHEM J, V400, P235, DOI 10.1042/BJ20060905; BHATIA K, 1993, NAT GENET, V5, P56, DOI 10.1038/ng0993-56; Carystinos GD, 2003, MOL PHARMACOL, V63, P821, DOI 10.1124/mol.63.4.821; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Choi SH, 2010, GENE DEV, V24, P1236, DOI 10.1101/gad.1920310; CLARK HM, 1994, CANCER RES, V54, P3383; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Deribe YL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000576; Dickey CA, 2008, P NATL ACAD SCI USA, V105, P3622, DOI 10.1073/pnas.0709180105; Ding XD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005949; Ghosh MK, 2003, MOL CELL, V12, P255, DOI 10.1016/S1097-2765(03)00225-9; Ghosh MK, 2005, ONCOGENE, V24, P7290, DOI 10.1038/sj.onc.1208894; Grobben B, 2002, CELL TISSUE RES, V310, P257, DOI 10.1007/s00441-002-0651-7; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; HENRIKSSON M, 1992, EXP CELL RES, V203, P383, DOI 10.1016/0014-4827(92)90012-W; Herbst A, 2004, ONCOGENE, V23, P3863, DOI 10.1038/sj.onc.1207492; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Kajiro M, 2009, NAT CELL BIOL, V11, P312, DOI 10.1038/ncb1839; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Kundrat L, 2010, BIOCHEMISTRY-US, V49, P7428, DOI 10.1021/bi100386w; Levens David, 2010, Genes Cancer, V1, P547; Li F, 2009, J BIOL CHEM, V284, P20090, DOI 10.1074/jbc.M109.017046; Li XN, 2008, J CELL BIOL, V181, P959, DOI 10.1083/jcb.200711044; McLean PJ, 2004, BIOCHEM BIOPH RES CO, V321, P665, DOI 10.1016/j.bbrc.2004.07.021; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; NAGANO N, 1993, ACTA NEUROPATHOL, V86, P117, DOI 10.1007/BF00334878; Nie L, 2008, J BIOL CHEM, V283, P684, DOI 10.1074/jbc.M704981200; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; Popov N, 2010, NAT CELL BIOL, V12, P973, DOI 10.1038/ncb2104; PULVERER BJ, 1994, ONCOGENE, V9, P59; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sha JF, 2010, J VIROL, V84, P4050, DOI 10.1128/JVI.02131-09; SHINDO H, 1993, ACTA NEUROPATHOL, V86, P345, DOI 10.1007/BF00369446; Sittler A, 2001, HUM MOL GENET, V10, P1307, DOI 10.1093/hmg/10.12.1307; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Whittle IR, 1998, J NEURO-ONCOL, V36, P231, DOI 10.1023/A:1005831111337; Xia T, 2007, AM J PHYSIOL-HEART C, V293, pH3080, DOI 10.1152/ajpheart.00579.2007; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217	44	98	102	3	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 7	2013	32	10					1284	1295		10.1038/onc.2012.144	http://dx.doi.org/10.1038/onc.2012.144			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110OP	22543587				2022-12-25	WOS:000316454500009
J	Hwang, S; Zimmerman, NP; Agle, KA; Turner, JR; Kumar, SN; Dwinell, MB				Hwang, Soonyean; Zimmerman, Noah P.; Agle, Kimberle A.; Turner, Jerrold R.; Kumar, Suresh N.; Dwinell, Michael B.			E-cadherin Is Critical for Collective Sheet Migration and Is Regulated by the Chemokine CXCL12 Protein During Restitution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL-ADHESION; INTESTINAL EPITHELIAL-CELLS; INFLAMMATORY-BOWEL-DISEASE; GROWTH-FACTOR-BETA; ACTIN CYTOSKELETON; BARRIER FUNCTION; TIGHT JUNCTIONS; CROHNS-DISEASE; IN-VITRO; CATENIN	Chemokines and other immune mediators enhance epithelial barrier repair. The intestinal barrier is established by highly regulated cell-cell contacts between epithelial cells. The goal of these studies was to define the role for the chemokine CXCL12 in regulating E-cadherin during collective sheet migration during epithelial restitution. Mechanisms regulating E-cadherin were investigated using Caco2(BBE) and IEC-6 model epithelia. Genetic knockdown confirmed a critical role for E-cadherin in in vitro restitution and in vivo wound repair. During restitution, both CXCL12 and TGF-beta 1 tightened the monolayer by decreasing the paracellular space between migrating epithelial cells. However, CXCL12 differed from TGF-beta 1 by stimulating the significant increase in E-cadherin membrane localization during restitution. Chemokine-stimulated relocalization of E-cadherin was paralleled by an increase in barrier integrity of polarized epithelium during restitution. CXCL12 activation of its cognate receptor CXCR4 stimulated E-cadherin localization and monolayer tightening through Rho-associated protein kinase activation and F-actin reorganization. These data demonstrate a key role for E-cadherin in intestinal epithelial restitution.	[Hwang, Soonyean; Zimmerman, Noah P.; Agle, Kimberle A.; Dwinell, Michael B.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [Kumar, Suresh N.] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Turner, Jerrold R.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	Medical College of Wisconsin; Medical College of Wisconsin; University of Chicago	Dwinell, MB (corresponding author), Med Coll Wisconsin, Dept Microbiol & Mol Genet, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	mdwinell@mcw.edu	Turner, Jerrold/H-1502-2019		National Institutes of Health [R01 DK062066]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062066, R01DK062066] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK062066 (to M. B. D.).	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Adams CL, 1998, CURR OPIN CELL BIOL, V10, P572, DOI 10.1016/S0955-0674(98)80031-8; Adams CL, 1996, J CELL BIOL, V135, P1899, DOI 10.1083/jcb.135.6.1899; Agle KA, 2010, J BIOL CHEM, V285, P16066, DOI 10.1074/jbc.M109.061416; Angres B, 1996, J CELL BIOL, V134, P549, DOI 10.1083/jcb.134.2.549; Azarschab P, 2002, GENE CHROMOSOME CANC, V35, P121, DOI 10.1002/gcc.10101; Barshack I, 2001, J CLIN PATHOL, V54, P684, DOI 10.1136/jcp.54.9.684; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Bjerknes M, 1999, AM J PATHOL, V154, P1831, DOI 10.1016/S0002-9440(10)65439-9; BLAY J, 1985, J CELL PHYSIOL, V124, P107, DOI 10.1002/jcp.1041240117; Boussadia O, 2002, MECH DEVELOP, V115, P53, DOI 10.1016/S0925-4773(02)00090-4; CHEN WC, 1991, J CELL BIOL, V114, P319, DOI 10.1083/jcb.114.2.319; Chinni SR, 2008, MOL CANCER RES, V6, P446, DOI 10.1158/1541-7786.MCR-07-0117; Chu YS, 2004, J CELL BIOL, V167, P1183, DOI 10.1083/jcb.200403043; CIACCI C, 1993, GASTROENTEROLOGY, V105, P93, DOI 10.1016/0016-5085(93)90014-4; DIGNASS AU, 1993, GASTROENTEROLOGY, V105, P1323, DOI 10.1016/0016-5085(93)90136-Z; Durer U, 2007, CELL PHYSIOL BIOCHEM, V20, P329, DOI 10.1159/000107519; Dwinell MB, 1999, GASTROENTEROLOGY, V117, P359, DOI 10.1053/gast.1999.0029900359; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Gassler N, 2001, AM J PHYSIOL-GASTR L, V281, pG216, DOI 10.1152/ajpgi.2001.281.1.G216; Hannemann S, 2008, J BIOL CHEM, V283, P27891, DOI 10.1074/jbc.M801800200; HAY ED, 1995, AM J KIDNEY DIS, V26, P678, DOI 10.1016/0272-6386(95)90610-X; HERMISTON ML, 1995, SCIENCE, V270, P1203, DOI 10.1126/science.270.5239.1203; Herzog D, 2011, J NEUROSCI, V31, P5120, DOI 10.1523/JNEUROSCI.4807-10.2011; HIRANO S, 1987, J CELL BIOL, V105, P2501, DOI 10.1083/jcb.105.6.2501; HOLLANDER D, 1986, ANN INTERN MED, V105, P883, DOI 10.7326/0003-4819-105-6-883; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Jankowski JAZ, 1998, LAB INVEST, V78, P1155; KARTENBECK J, 1991, J CELL BIOL, V113, P881, DOI 10.1083/jcb.113.4.881; KATZ KD, 1989, GASTROENTEROLOGY, V97, P927, DOI 10.1016/0016-5085(89)91499-6; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Kucharzik T, 2001, AM J PATHOL, V159, P2001, DOI 10.1016/S0002-9440(10)63051-9; Kuroiwa M, 2011, J CELL SCI, V124, P1726, DOI 10.1242/jcs.080291; LACY ER, 1984, LAB INVEST, V51, P573; Lin CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015331; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Moriyama N, 2001, J LAB CLIN MED, V138, P236, DOI 10.1067/mlc.2001.118177; Moyer RA, 2007, LAB INVEST, V87, P807, DOI 10.1038/labinvest.3700595; Nelson CM, 2004, MOL BIOL CELL, V15, P2943, DOI 10.1091/mbc.E03-10-0745; Nguyen TN, 2010, J BIOL CHEM, V285, P35439, DOI 10.1074/jbc.M110.119487; NIGAM AK, 1993, BRIT J CANCER, V68, P507, DOI 10.1038/bjc.1993.377; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; Okabe S, 2002, J HEMATOTH STEM CELL, V11, P923, DOI 10.1089/152581602321080583; Polk DB, 1998, GASTROENTEROLOGY, V114, P493, DOI 10.1016/S0016-5085(98)70532-3; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Savagner P, 2005, J CELL PHYSIOL, V202, P858, DOI 10.1002/jcp.20188; Schneider MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014325; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Smalley-Freed WG, 2010, J CLIN INVEST, V120, P1824, DOI 10.1172/JCI41414; Smith JM, 2005, AM J PHYSIOL-GASTR L, V288, pG316, DOI 10.1152/ajpgi.00208.2004; Starodub OT, 2008, AM J PHYSIOL-CELL PH, V294, pC223, DOI 10.1152/ajpcell.00395.2006; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Tunggal JA, 2005, EMBO J, V24, P1146, DOI 10.1038/sj.emboj.7600605; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Uchida D, 2003, EXP CELL RES, V290, P289, DOI 10.1016/S0014-4827(03)00344-6; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Uttamsingh S, 2008, ONCOGENE, V27, P2626, DOI 10.1038/sj.onc.1210915; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vongsa RA, 2009, J BIOL CHEM, V284, P10034, DOI 10.1074/jbc.M805289200; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Yamada A, 2004, GENES CELLS, V9, P843, DOI 10.1111/j.1365-2443.2004.00768.x; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Zhao M, 2006, MOL PHARMACOL, V69, P66, DOI 10.1124/mol.105.016923; Zimmerman NP, 2011, LAB INVEST, V91, P1040, DOI 10.1038/labinvest.2011.77	68	33	33	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22227	22240		10.1074/jbc.M112.367979	http://dx.doi.org/10.1074/jbc.M112.367979			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22549778	hybrid, Green Published			2022-12-25	WOS:000306418600061
J	Sethumadhavan, S; Vasquez-Vivar, J; Migrino, RQ; Harmann, L; Jacob, HJ; Lazar, J				Sethumadhavan, Savitha; Vasquez-Vivar, Jeannette; Migrino, Raymond Q.; Harmann, Leanne; Jacob, Howard J.; Lazar, Jozef			Mitochondrial DNA Variant for Complex I Reveals a Role in Diabetic Cardiac Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-CHAIN SUPERCOMPLEXES; STRAIN ECHOCARDIOGRAPHY; CARDIOMYOPATHY; DYSFUNCTION; HEART; RAT; OBESITY; NUCLEOTIDES; METABOLISM; ACTIVATION	Myocardial remodeling and dysfunction are serious complications of type 2 diabetes mellitus (T2DM). Factors controlling their development are not well established. To specifically address the role of the mitochondrial genome, we developed novel conplastic rat strains, i.e. strains with the same nuclear genome but a different mitochondrial genome. The new animals were named T2DN(mtFHH) and T2DN(mtWistar), where the acronym T2DN denotes their common nuclear genome (type 2 diabetic nephropathy (T2DN) rats) and mtFHH or mtWistar the origin of their mitochondria, Fawn Hooded Hypertensive (FHH) or Wistar rats, respectively. The T2DN(mtFHH) and T2DN(mtWistar) showed a similar progression of diabetes as determined by HbA1c, cholesterol, and triglycerides with normal blood pressure, thus enabling investigation of the specific role of the mitochondrial genome in cardiac function without the confounding effects of obesity or hypertension found in other models of diabetes. Echocardiographic analysis of 12-week-old animals showed no abnormalities, but at 12 months of age the T2DN(mtFHH) showed left ventricular remodeling that was verified by histology. Decreased complex I and complex IV but not complex II activity within the electron transport chain was found only in T2DN(mtFHH), which was not explained by differences in protein content. Decreased cardiac ATP levels in T2DN(mtFHH) were in agreement with a lower ATP synthetic capacity by isolated mitochondria. Together, our data provide experimental evidence that mtDNA sequence variations have an additional role in energetic heart deficiency. The mitochondrial DNA background may explain the increased susceptibility of certain T2DM patients to develop myocardial dysfunction.	[Sethumadhavan, Savitha; Vasquez-Vivar, Jeannette] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Sethumadhavan, Savitha; Vasquez-Vivar, Jeannette] Med Coll Wisconsin, Redox Biol Program, Milwaukee, WI 53226 USA; [Migrino, Raymond Q.; Harmann, Leanne] Med Coll Wisconsin, Cardiovasc Med Sect, Milwaukee, WI 53226 USA; [Jacob, Howard J.; Lazar, Jozef] Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA; [Jacob, Howard J.] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Jacob, Howard J.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Lazar, Jozef] Med Coll Wisconsin, Dept Dermatol, Milwaukee, WI 53226 USA; [Migrino, Raymond Q.] Phoenix Vet Affairs Hlth Care Syst, Phoenix, AZ 85012 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Vasquez-Vivar, J (corresponding author), Med Coll Wisconsin, Dept Biophys, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jvvivar@mcw.edu			National Institutes of Health [HL-67244]; American Heart Association [11POST5480016]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-67244 (to J. V. V.). This work was also supported by Postdoctoral Fellow Grant 11POST5480016 (to S. S.) from the American Heart Association.	Arbustini E, 1998, AM J PATHOL, V153, P1501, DOI 10.1016/S0002-9440(10)65738-0; Asbun J, 2006, J AM COLL CARDIOL, V47, P693, DOI 10.1016/j.jacc.2005.09.050; Barouch LA, 2006, CIRC RES, V98, P119, DOI 10.1161/01.RES.0000199348.10580.1d; Barrientos Antoni, 2009, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1903s63; Bell DSH, 2003, DIABETES CARE, V26, P2949, DOI 10.2337/diacare.26.10.2949; Boudina S, 2005, CIRCULATION, V112, P2686, DOI 10.1161/CIRCULATIONAHA.105.554360; Boudina S, 2007, DIABETES, V56, P2457, DOI 10.2337/db07-0481; Cai L, 2002, DIABETES, V51, P1938, DOI 10.2337/diabetes.51.6.1938; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Diamant M, 2003, J AM COLL CARDIOL, V42, P328, DOI 10.1016/S0735-1097(03)00625-9; El-Omar MM, 2004, BASIC RES CARDIOL, V99, P133, DOI 10.1007/s00395-004-0440-4; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Ganzera M, 2006, ANAL BIOCHEM, V359, P132, DOI 10.1016/j.ab.2006.09.012; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Holloway GP, 2010, DIABETES, V59, P819, DOI 10.2337/db09-1519; How OJ, 2006, DIABETES, V55, P466, DOI 10.2337/diabetes.55.02.06.db05-1164; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; Kosmala W, 2004, DIABETES CARE, V27, P2736, DOI 10.2337/diacare.27.11.2736; Kwitek AE, 2006, PHYSIOL GENOMICS, V25, P303, DOI 10.1152/physiolgenomics.00288.2005; Mazumder PK, 2004, DIABETES, V53, P2366, DOI 10.2337/diabetes.53.9.2366; Migrino RQ, 2007, J AM SOC ECHOCARDIOG, V20, P342, DOI 10.1016/j.echo.2006.09.011; Migrino RQ, 2008, CARDIOVASC ULTRASOUN, V6, DOI 10.1186/1476-7120-6-17; Nobrega MA, 2004, DIABETES, V53, P735, DOI 10.2337/diabetes.53.3.735; Pieper GM, 2010, J HEART LUNG TRANSPL, V29, P1039, DOI 10.1016/j.healun.2010.04.009; Ryan TD, 2007, J AM COLL CARDIOL, V49, P811, DOI 10.1016/j.jacc.2006.06.083; Schafer E, 2006, J BIOL CHEM, V281, P15370, DOI 10.1074/jbc.M513525200; Schagger H, 2001, J BIOL CHEM, V276, P37861; Schlick NE, 2006, AM J PHYSIOL-CELL PH, V291, pC1183, DOI 10.1152/ajpcell.00234.2006; Shoghi KI, 2009, CIRC-CARDIOVASC IMAG, V2, P373, DOI 10.1161/CIRCIMAGING.108.843227; SILVESTRI G, 1994, HUM MUTAT, V3, P37, DOI 10.1002/humu.1380030107; Suthammarak W, 2009, J BIOL CHEM, V284, P6425, DOI 10.1074/jbc.M805733200; Tan Y, 2011, DIABETES, V60, P625, DOI 10.2337/db10-1164; Ventura-Clapier R, 2011, BBA-MOL CELL RES, V1813, P1360, DOI 10.1016/j.bbamcr.2010.09.006; Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4; Zaragoza MV, 2011, EUR J HUM GENET, V19, P200, DOI 10.1038/ejhg.2010.169; zur Nedden S, 2009, ANAL BIOCHEM, V388, P108, DOI 10.1016/j.ab.2009.02.017	36	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22174	22182		10.1074/jbc.M111.327866	http://dx.doi.org/10.1074/jbc.M111.327866			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22544750	Green Published, hybrid			2022-12-25	WOS:000306418600056
J	David, M; Macias, A; Moreno, C; Prieto, A; Martinez-Marmol, R; Vicente, R; Gonzalez, T; Felipe, A; Tamkun, MM; Valenzuela, C				David, Miren; Macias, Alvaro; Moreno, Cristina; Prieto, Angela; Martinez-Marmol, Ramon; Vicente, Ruben; Gonzalez, Teresa; Felipe, Antonio; Tamkun, Michael M.; Valenzuela, Carmen			Protein Kinase C (PKC) Activity Regulates Functional Effects of K-v beta 1.3 Subunit on K(V)1.5 Channels IDENTIFICATION OF A CARDIAC K(v)1.5 CHANNELOSOME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K+ CHANNEL; BETA-SUBUNIT; HUMAN HEART; BINDING; ALPHA; RACK1; RECEPTOR; INACTIVATION; MODULATION; INHIBITOR	K(v)1.5 channels are the primary channels contributing to the ultrarapid outward potassium current (I-Kur). The regulatory K-v beta 1.3 subunit converts K(v)1.5 channels from delayed rectifiers with a modest degree of slow inactivation to channels with both fast and slow inactivation components. Previous studies have shown that inhibition of PKC with calphostin C abolishes the fast inactivation induced by K-v beta 1.3. In this study, we investigated the mechanisms underlying this phenomenon using electrophysiological, biochemical, and confocal microscopy approaches. To achieve this, we used HEK293 cells (which lack K-v beta subunits) transiently cotransfected with with K(v)1.5+K-v beta 1.3 and also rat ventricular and atrial tissue to study native alpha-beta subunit interactions. Immunocytochemistry assays demonstrated that these channel subunits colocalize in control conditions and after calphostin C treatment. Moreover, coimmunoprecipitation studies showed that Kv1.5 and K-v beta 1.3 remain associated after PKC inhibition. After knocking down all PKC isoforms by siRNA or inhibiting PKC with calphostin C, K-v beta 1.3-induced fast inactivation at +60mV was abolished. However, depolarization to +100 mV revealed K-v beta 1.3-induced inactivation, indicating that PKC inhibition causes a dramatic positive shift of the inactivation curve. Our results demonstrate that calphostin C-mediated abolishment of fast inactivation is not due to the dissociation of Kv1.5 and K-v beta 1.3. Finally, immunoprecipitation and immunocytochemistry experiments revealed an association between K(v)1.5, K-v beta 1.3, the receptor for activated C kinase (RACK1), PKC beta I, PKC beta II, and PKC theta in HEK293 cells. A very similar K(v)1.5 channelosome was found in rat ventricular tissue but not in atrial tissue.	[Gonzalez, Teresa; Valenzuela, Carmen] Univ Autonoma Madrid, Madrid Consejo Super Invest Cient, Inst Invest Biomed, Madrid 28029, Spain; [Martinez-Marmol, Ramon; Felipe, Antonio] Univ Barcelona, Mol Physiol Lab, Dept Bioquim & Biol Mol, Inst Biomed IBUB, E-08028 Barcelona, Spain; [Vicente, Ruben] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Lab Mol Physiol & Channelopathies, Barcelona 08003, Spain; [Tamkun, Michael M.] Colorado State Univ, Dept Biomed Sci, Program Mol Cellular & Dev Neurosci, Ft Collins, CO 80523 USA; [Tamkun, Michael M.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Autonomous University of Madrid; University of Barcelona; Pompeu Fabra University; Colorado State University; Colorado State University	Valenzuela, C (corresponding author), UAM, CSIC, Inst Invest Biomed Alberto Sols, Lab 1 13, C Arturo Duperier 4, Madrid 28029, Spain.	cvalenzuela@iib.uam.es	Gonzalez, Teresa/K-9305-2015; García, Rubén Vicente/L-1097-2014; Felipe, Antonio/M-8297-2015; Macias, Alvaro/N-7267-2015; Valenzuela, Carmen/L-3219-2015; Martínez-Mármol, Ramón/D-2821-2018	Gonzalez, Teresa/0000-0002-0930-0021; García, Rubén Vicente/0000-0003-0401-4808; Felipe, Antonio/0000-0002-7294-6431; Macias, Alvaro/0000-0002-9952-6947; Valenzuela, Carmen/0000-0003-3929-1960; Martínez-Mármol, Ramón/0000-0003-0929-8627	Ministerio de Ciencia e Innovacion (MICINN) [SAF2010-14916]; Ministerio de Educacion y Ciencia [PR2003-0056]; Red Cooperativa de Enfermedades Cardiovasculares RECAVA FIS [RD06/0014/0006, BFU2011-23268, CSD2008-00005]; RECAVA; JAE;  [MEC-PR2003-0056]	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Educacion y Ciencia(Spanish Government); Red Cooperativa de Enfermedades Cardiovasculares RECAVA FIS; RECAVA; JAE; 	This work was supported by Ministerio de Ciencia e Innovacion (MICINN) Grants SAF2010-14916, Ministerio de Educacion y Ciencia-PR2003-0056, and Red Cooperativa de Enfermedades Cardiovasculares RECAVA FIS RD06/0014/0006 (to C. V.) and BFU2011-23268 and CSD2008-00005 (to A. F.).; Recipient of an RECAVA grant.; Recipient of a JAE predoctoral grant.; Recipient of Grant MEC-PR2003-0056. addressed: Instituto de Investigaciones Biomedicas 'Alberto Sols' (CSICUAM), Laboratory 1.13, C/Arturo Duperier 4, 28029 Madrid, Spain. Tel.: 34-91-585-4493; Fax.: 34-91-585-4401; E-mail: cvalenzuela@iib.uam.es.	Arias C, 2007, ANESTHESIOLOGY, V107, P641, DOI 10.1097/01.anes.0000282100.32923.5c; Braz JC, 2002, J CELL BIOL, V156, P905, DOI 10.1083/jcb.200108062; Brechet A, 2008, J CELL BIOL, V183, P1101, DOI 10.1083/jcb.200805169; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; CARPENTER D, 1987, NATURE, V325, P107, DOI 10.1038/325107a0; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; Csukai M, 1997, J BIOL CHEM, V272, P29200, DOI 10.1074/jbc.272.46.29200; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Decher N, 2005, MOL PHARMACOL, V68, P995, DOI 10.1124/mol.105.011668; Decher N, 2008, EMBO J, V27, P3164, DOI 10.1038/emboj.2008.231; Dell EJ, 2002, J BIOL CHEM, V277, P49888, DOI 10.1074/jbc.M202755200; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; DISATNIK MH, 1994, P NATL ACAD SCI USA, V91, P559, DOI 10.1073/pnas.91.2.559; Dorn GW, 2002, ANNU REV PHYSIOL, V64, P407, DOI 10.1146/annurev.physiol.64.081501.155903; ENGLAND SK, 1995, J BIOL CHEM, V270, P28531, DOI 10.1074/jbc.270.48.28531; ENGLAND SK, 1995, P NATL ACAD SCI USA, V92, P6309, DOI 10.1073/pnas.92.14.6309; FEDIDA D, 1993, CIRC RES, V73, P210, DOI 10.1161/01.RES.73.1.210; Gonzalez T, 2002, MOL PHARMACOL, V62, P1456, DOI 10.1124/mol.62.6.1456; Gonzalez T, 2001, J PHARMACOL EXP THER, V296, P573; Hahn HS, 2003, CIRC RES, V93, P1111, DOI 10.1161/01.RES.0000105087.79373.17; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; Isacson CK, 2007, AM J PHYSIOL-CELL PH, V292, pC1459, DOI 10.1152/ajpcell.00322.2006; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; Kerkela R, 2002, MOL PHARMACOL, V62, P1482, DOI 10.1124/mol.62.6.1482; KOBAYASHI E, 1989, BIOCHEM BIOPH RES CO, V159, P548, DOI 10.1016/0006-291X(89)90028-4; Kuhlkamp V, 2000, J AM COLL CARDIOL, V36, P139, DOI 10.1016/S0735-1097(00)00693-8; Kwak YG, 1999, J BIOL CHEM, V274, P13928, DOI 10.1074/jbc.274.20.13928; Kwak YG, 1999, J BIOL CHEM, V274, P25355, DOI 10.1074/jbc.274.36.25355; Leicher T, 1996, NEUROPHARMACOLOGY, V35, P787, DOI 10.1016/0028-3908(96)00133-5; Li GR, 1996, CIRC RES, V78, P903, DOI 10.1161/01.RES.78.5.903; MAYS DJ, 1995, J CLIN INVEST, V96, P282, DOI 10.1172/JCI118032; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; MURRAY KT, 1994, CIRC RES, V75, P999, DOI 10.1161/01.RES.75.6.999; Nagaya N, 1997, J BIOL CHEM, V272, P3022, DOI 10.1074/jbc.272.5.3022; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; O'Connell KMS, 2005, J CELL SCI, V118, P2155, DOI 10.1242/jcs.02348; PARKER PJ, 1989, MOL CELL ENDOCRINOL, V65, P1, DOI 10.1016/0303-7207(89)90159-7; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; QATSHA KA, 1993, P NATL ACAD SCI USA, V90, P4674, DOI 10.1073/pnas.90.10.4674; RHODES KJ, 1995, J NEUROSCI, V15, P5360; Rodriguez MM, 1999, BIOCHEMISTRY-US, V38, P13787, DOI 10.1021/bi991055k; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Schlaich MP, 2005, J HYPERTENS, V23, P1077, DOI 10.1097/01.hjh.0000166850.80344.cf; Schlaich MP, 2003, CIRCULATION, V108, P560, DOI 10.1161/01.CIR.0000081775.72651.B6; SNYDERS DJ, 1993, J GEN PHYSIOL, V101, P513, DOI 10.1085/jgp.101.4.513; Sossin WS, 1997, LEARN MEMORY, V3, P389, DOI 10.1101/lm.3.5.389; Souroujon MC, 1998, NAT BIOTECHNOL, V16, P919, DOI 10.1038/nbt1098-919; Takeishi Y, 1999, CIRC RES, V85, P264, DOI 10.1161/01.RES.85.3.264; Tessier S, 1999, CIRC RES, V85, P810, DOI 10.1161/01.RES.85.9.810; Uebele VN, 1996, J BIOL CHEM, V271, P2406, DOI 10.1074/jbc.271.5.2406; Uebele VN, 1998, AM J PHYSIOL-CELL PH, V274, pC1485, DOI 10.1152/ajpcell.1998.274.6.C1485; Valenzuela C, 2003, CARDIOVASC RES, V58, P498, DOI 10.1016/S0008-6363(03)00370-5; Wadsworth SJ, 2002, INFECT IMMUN, V70, P4650, DOI 10.1128/IAI.70.8.4650-4660.2002; Wang HZ, 2002, CANCER RES, V62, P4843; Williams CP, 2002, J PHARMACOL EXP THER, V302, P545, DOI 10.1124/jpet.102.033357; Woodard GE, 2010, J BIOL CHEM, V285, P8045, DOI 10.1074/jbc.M109.033605; Workman AJ, 2003, CARDIOVASC RES, V58, P518, DOI 10.1016/S0008-6363(03)00263-3; Yaka R, 2002, P NATL ACAD SCI USA, V99, P5710, DOI 10.1073/pnas.062046299; Young LH, 2005, CARDIOVASC DRUG REV, V23, P255	63	17	17	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21416	21428		10.1074/jbc.M111.328278	http://dx.doi.org/10.1074/jbc.M111.328278			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22547057	Green Published, hybrid			2022-12-25	WOS:000306416800059
J	Tanimoto, Y; Veistinen, L; Alakurtti, K; Takatalo, M; Rice, DPC				Tanimoto, Yukiho; Veistinen, Lotta; Alakurtti, Kirsi; Takatalo, Maarit; Rice, David P. C.			Prevention of Premature Fusion of Calvarial Suture in GLI-Kruppel Family Member 3 (Gli3)-deficient Mice by Removing One Allele of Runt-related Transcription Factor 2 (Runx2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLAST DIFFERENTIATION; BONE-DEVELOPMENT; EXPRESSION PATTERNS; DLX5; CRANIOSYNOSTOSIS; MORPHOGENESIS; MUTATIONS; BMP; FGF; CBFA1	Mutations in the gene encoding the zinc finger transcription factor GLI3 (GLI-Kruppel family member 3) have been identified in patients with Grieg cephalopolysyndactyly syndrome in which premature fusion of calvarial suture (craniosynostosis) is an infrequent but important feature. Here, we show that Gli3 acts as a repressor in the developing murine calvaria and that Dlx5, Runx2 type II isoform (Runx2-II), and Bmp2 are expressed ectopically in the calvarial mesenchyme, which results in aberrant osteoblastic differentiation in Gli3-deficient mouse (Gli3(Xt-J/Xt-J)) and resulted in craniosynostosis. At the same time, enhanced activation of phospho-Smad1/5/8 (pSmad1/5/8), which is a downstream mediator of canonical Bmp signaling, was observed in Gli3(Xt-J/Xt-J) embryonic calvaria. Therefore, we generated Gli3; Runx2 compound mutant mice to study the effects of decreasing Runx2 dosage in a Gli3(Xt-J/Xt-J) background. Gli3(Xt-J/Xt-J) Runx2(+/-) mice have neither craniosynostosis nor additional ossification centers in interfrontal suture and displayed a normalization of Dlx5, Runx2-II, and pSmad1/5/8 expression as well as sutural mesenchymal cell proliferation. These findings suggest a novel role for Gli3 in regulating calvarial suture development by controlling canonical Bmp-Smad signaling, which integrates a Dlx5/Runx2-II cascade. We propose that targeting Runx2 might provide an attractive way of preventing craniosynostosis in patients.	[Tanimoto, Yukiho; Veistinen, Lotta; Alakurtti, Kirsi; Takatalo, Maarit; Rice, David P. C.] Univ Helsinki, Dept Orthodont, Inst Dent, FIN-00014 Helsinki, Finland; [Rice, David P. C.] Univ Helsinki, Cent Hosp, Dept Oral & Maxillofacial Dis, Helsinki 00029, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Rice, DPC (corresponding author), Univ Helsinki, Dept Orthodont, Inst Dent, POB 63,Haart Maninkatu 8, Helsinki 00014, Finland.	david.rice@helsinki.fi		Rice, David/0000-0001-9301-3078; Takatalo, Maarit/0000-0003-4825-6358	Academy of Finland; Biocentrum Helsinki; University of Helsinki; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Biocentrum Helsinki; University of Helsinki; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by the Academy of Finland, Biocentrum Helsinki, The University of Helsinki, and the Sigrid Juselius Foundation.	Aberg T, 2004, DEV BIOL, V270, P76, DOI 10.1016/j.ydbio.2004.02.012; Bastida MF, 2004, DEV DYNAM, V231, P148, DOI 10.1002/dvdy.20121; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Choi KY, 2005, DEV DYNAM, V233, P115, DOI 10.1002/dvdy.20323; D'Souza RN, 1999, DEVELOPMENT, V126, P2911; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Hajihosseini MK, 2009, DEV DYNAM, V238, P376, DOI 10.1002/dvdy.21648; Han J, 2009, DEVELOPMENT, V136, P4225, DOI 10.1242/dev.036723; Hartmann C, 2009, CURR OPIN GENET DEV, V19, P437, DOI 10.1016/j.gde.2009.09.001; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; Holleville N, 2003, DEV BIOL, V257, P177, DOI 10.1016/S0012-1606(03)00059-9; Hurst JA, 2011, EUR J HUM GENET, V19, P757, DOI 10.1038/ejhg.2011.13; Iseki S, 1999, DEVELOPMENT, V126, P5611; Kim HJ, 1998, DEVELOPMENT, V125, P1241; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; Liu YH, 1999, DEV BIOL, V205, P260, DOI 10.1006/dbio.1998.9114; Maynard TM, 2002, MAMM GENOME, V13, P58, DOI 10.1007/s00335-001-2115-X; McDonald-McGinn DM, 2010, AM J MED GENET A, V152A, P1654, DOI 10.1002/ajmg.a.33495; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Ohba S, 2008, DEV CELL, V14, P689, DOI 10.1016/j.devcel.2008.03.007; Park MH, 2001, J BONE MINER RES, V16, P885, DOI 10.1359/jbmr.2001.16.5.885; Passos-Bueno Maria Rita, 2008, V12, P107, DOI 10.1159/000115035; Riccomagno MM, 2005, GENE DEV, V19, P1612, DOI 10.1101/gad.1303905; Rice DPC, 2010, HUM MOL GENET, V19, P3457, DOI 10.1093/hmg/ddq258; Rice DPC, 2000, DEVELOPMENT, V127, P1845; Rice R, 2005, DEV DYNAM, V233, P847, DOI 10.1002/dvdy.20430; Rice R, 2003, DEV BIOL, V262, P75, DOI 10.1016/S0012-1606(03)00355-5; Shimoyama A, 2007, MOL BIOL CELL, V18, P2411, DOI 10.1091/mbc.E06-08-0743; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Warren SM, 2003, NATURE, V422, P625, DOI 10.1038/nature01545; Xiao ZS, 2005, DEV BIOL, V283, P345, DOI 10.1016/j.ydbio.2005.04.028; Young DW, 2007, P NATL ACAD SCI USA, V104, P3189, DOI 10.1073/pnas.0611419104; Young DW, 2007, NATURE, V445, P442, DOI 10.1038/nature05473	36	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21429	21438		10.1074/jbc.M112.362145	http://dx.doi.org/10.1074/jbc.M112.362145			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22547067	Green Published, hybrid			2022-12-25	WOS:000306416800060
J	Xiao, QL; Gil, SC; Yan, P; Wang, Y; Han, SR; Gonzales, E; Perez, R; Cirrito, JR; Lee, JM				Xiao, Qingli; Gil, So-Chon; Yan, Ping; Wang, Yan; Han, Sharon; Gonzales, Ernie; Perez, Ronaldo; Cirrito, John R.; Lee, Jin-Moo			Role of Phosphatidylinositol Clathrin Assembly Lymphoid-Myeloid Leukemia (PICALM) in Intracellular Amyloid Precursor Protein (APP) Processing and Amyloid Plaque Pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONSET ALZHEIMERS-DISEASE; GENOME-WIDE ASSOCIATION; A-BETA-PP; DEPENDENT ENDOCYTOSIS; IDENTIFIES VARIANTS; COMMON VARIANTS; COATED VESICLES; IN-VIVO; CALM; CLU	One of the pathological hallmarks of Alzheimer disease is the accumulation of amyloid plaques in the extracellular space in the brain. Amyloid plaques are primarily composed of aggregated amyloid beta peptide (A beta), a proteolytic fragment of the transmembrane amyloid precursor protein (APP). For APP to be proteolytically cleaved into A beta, it must be internalized into the cell and trafficked to endosomes where specific protease complexes can cleave APP. Several recent genome-wide association studies have reported that several single nucleotide polymorphisms (SNPs) in the phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) gene were significantly associated with Alzheimer disease, suggesting a role in APP endocytosis and A beta generation. Here, we show that PICALM co-localizes with APP in intracellular vesicles of N2a-APP cells after endocytosis is initiated. PICALM knockdown resulted in reduced APP internalization and A beta generation. Conversely, PICALM overexpression increased APP internalization and A beta production. In vivo, PICALM was found to be expressed in neurons and co-localized with APP throughout the cortex and hippocampus in APP/PS1 mice. PICALM expression was altered using AAV8 gene transfer of PICALM shRNA or PICALM cDNA into the hippocampus of 6-month-old APP/PS1 mice. PICALM knockdown decreased soluble and insoluble A beta levels and amyloid plaque load in the hippocampus. Conversely, PICALM overexpression increased A beta levels and amyloid plaque load. These data indicate that PICALM, an adaptor protein involved in clathrin-mediated endocytosis, regulates APP internalization and subsequent A beta generation. PICALM con-tributes to amyloid plaque load in brain likely via its effect on A beta metabolism.	[Lee, Jin-Moo] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Lee, JM (corresponding author), Washington Univ, Sch Med, Dept Neurol, 660 S Euclid Ave,Campus Box 8111, St Louis, MO 63110 USA.	leejm@neuro.wustl.edu	Lee, Jin-Moo/K-2024-2015	Lee, Jin-Moo/0000-0002-3979-0906	National Institutes of Health [R01 NS67905, P01 NS32636, K01 AG029524]; Charles F. and Joanne Knight Alzheimer's Disease Research Center at Washington University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067905, P01NS032636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG029524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles F. and Joanne Knight Alzheimer's Disease Research Center at Washington University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS67905, P01 NS32636 (to J. M. L.), and K01 AG029524 (to J. R. C). This work was also supported by a grant from the Charles F. and Joanne Knight Alzheimer's Disease Research Center at Washington University (to J. R. C).	Baig S, 2010, J NEUROPATH EXP NEUR, V69, P1071, DOI 10.1097/NEN.0b013e3181f52e01; Bushlin I, 2008, J NEUROSCI, V28, P10257, DOI 10.1523/JNEUROSCI.2471-08.2008; Carey RM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-30; Carrasquillo MM, 2010, ARCH NEUROL-CHICAGO, V67, P961, DOI 10.1001/archneurol.2010.147; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Corneveaux JJ, 2010, HUM MOL GENET, V19, P3295, DOI 10.1093/hmg/ddq221; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Harel A, 2008, TRAFFIC, V9, P417, DOI 10.1111/j.1600-0854.2007.00694.x; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jun G, 2010, ARCH NEUROL-CHICAGO, V67, P1473, DOI 10.1001/archneurol.2010.201; Kauwe JSK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015918; Klein RL, 2008, MOL THER, V16, P89, DOI 10.1038/sj.mt.6300331; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lakshmana MK, 2009, J BIOL CHEM, V284, P11863, DOI 10.1074/jbc.M807345200; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; LeBlanc AC, 1997, J NEUROCHEM, V68, P1183; Lomakin A, 1997, P NATL ACAD SCI USA, V94, P7942, DOI 10.1073/pnas.94.15.7942; MarquezSterling NR, 1997, J NEUROSCI, V17, P140, DOI 10.1523/JNEUROSCI.17-01-00140.1997; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; Matsuda S, 2003, J BIOL CHEM, V278, P38601, DOI 10.1074/jbc.M304379200; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; Meyerholz A, 2005, TRAFFIC, V6, P1225, DOI 10.1111/j.1600-0854.2005.00355.x; Miller SE, 2011, CELL, V147, P1118, DOI 10.1016/j.cell.2011.10.038; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; NORDSTEDT C, 1993, J BIOL CHEM, V268, P608; Perez RG, 1996, J BIOL CHEM, V271, P9100, DOI 10.1074/jbc.271.15.9100; Pietrzik CU, 2004, J NEUROSCI, V24, P4259, DOI 10.1523/JNEUROSCI.5451-03.2004; Rudinskiy N, 2009, J BIOL CHEM, V284, P12447, DOI 10.1074/jbc.M804740200; Schjeide BMM, 2011, ARCH GEN PSYCHIAT, V68, P207, DOI 10.1001/archgenpsychiatry.2010.196; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Sodhi CP, 2004, MOL BRAIN RES, V128, P201, DOI 10.1016/j.molbrainres.2004.06.012; Sorkina T, 1999, J CELL SCI, V112, P317; Taru H, 2009, J ALZHEIMERS DIS, V18, P253, DOI 10.3233/JAD-2009-1148; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Vetrivel KS, 2006, NEUROLOGY, V66, pS69, DOI 10.1212/01.wnl.0000192107.17175.39; Wendland B, 1998, J CELL BIOL, V141, P71, DOI 10.1083/jcb.141.1.71; Wu FB, 2009, BIOCHEM BIOPH RES CO, V385, P247, DOI 10.1016/j.bbrc.2009.05.050; Yan P, 1999, J NEUROSCI, V19, P9355; Yao PJ, 2003, NEUROSCIENCE, V121, P25, DOI 10.1016/S0306-4522(03)00431-7; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9	48	122	127	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21279	21289		10.1074/jbc.M111.338376	http://dx.doi.org/10.1074/jbc.M111.338376			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22539346	Green Published, hybrid			2022-12-25	WOS:000306416800047
J	Yi, X; Hong, M; Gui, B; Chen, Z; Li, L; Xie, GJ; Liang, J; Wang, XC; Shang, YF				Yi, Xia; Hong, Mei; Gui, Bin; Chen, Zhe; Li, Lei; Xie, Guojia; Liang, Jing; Wang, Xiaocheng; Shang, Yongfeng			RNA Processing and Modification Protein, Carbon Catabolite Repression 4 (Ccr4), Arrests the Cell Cycle through p21-dependent and p53-independent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P21 MESSENGER-RNA; GENE-EXPRESSION; BINDING PROTEIN; 3'-UNTRANSLATED REGION; DEADENYLASE SUBUNITS; HUR; COMPLEX; STABILITY; TARGET; IDENTIFICATION	Ccr4d is a new member of the Ccr4 (carbon catabolite repression 4) family of proteins that are implicated in the regulation of mRNA stability and translation through mRNA deadenylation. However, Ccr4d is not believed to be involved in mRNA deadenylation. Thus, its biological function and mechanistic activity remain to be determined. Here, we report that Ccr4d is broadly expressed in various normal tissues, and the expression of Ccr4d is markedly down-regulated during cell cycle progression. We showed that Ccr4d inhibits cell proliferation and induces cell cycle arrest at G(1) phase. Our experiments further revealed that Ccr4d regulates the expression of p21 in a p53-independent manner. Mechanistic studies indicated that Ccr4d strongly bound to the 3'-UTR of p21 mRNA, leading to the stabilization of p21 mRNA. Interestingly, we found that the expression of Ccr4d is down-regulated in various tumor tissues. Collectively, our data indicate that Ccr4d functions as an anti-proliferating protein through the induction of cell cycle arrest via a p21-dependent and p53-independent pathway and suggest that Ccr4d might have an important role in carcinogenesis.	[Yi, Xia; Hong, Mei; Gui, Bin; Chen, Zhe; Li, Lei; Xie, Guojia; Liang, Jing; Wang, Xiaocheng; Shang, Yongfeng] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100191, Peoples R China; [Shang, Yongfeng] Tianjin Med Univ, Dept Biochem & Mol Biol, Tianjin Key Lab Med Epigenet, Tianjin 300070, Peoples R China	Peking University; Tianjin Medical University	Shang, YF (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minist Educ, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	yshang@hsc.pku.edu.cn	Chen, Zhe/AAA-3235-2020	Chen, Zhe/0000-0002-5303-9879; Xie, Guojia/0000-0002-8250-6157	Natural Science Foundation of China [81130048, 30921062, 30871252]; Ministry of Science and Technology of China 973 Program [2011CB504204]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China 973 Program(Ministry of Science and Technology, ChinaNational Basic Research Program of China)	This work was supported by Natural Science Foundation of China Grants 81130048 and 30921062 (to Y. S.) and 30871252 (to X. Y.) and Ministry of Science and Technology of China 973 Program Grant 2011CB504204 (to Y. S.).	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Aslam A, 2009, MOL BIOL CELL, V20, P3840, DOI 10.1091/mbc.E09-02-0146; Baggs JE, 2003, CURR BIOL, V13, P189, DOI 10.1016/S0960-9822(03)00014-9; Cho SJ, 2010, NUCLEIC ACIDS RES, V38, P2256, DOI 10.1093/nar/gkp1229; Collart MA, 2004, PROG NUCLEIC ACID RE, V77, P289, DOI 10.1016/S0079-6603(04)77008-7; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Denis CL, 2003, PROG NUCLEIC ACID RE, V73, P221, DOI 10.1016/S0079-6603(03)01007-9; Duale N, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-53; Dupressoir A, 2001, BMC Genomics, V2, P9, DOI 10.1186/1471-2164-2-9; Fukuda T, 2009, GENES CELLS, V14, P113, DOI 10.1111/j.1365-2443.2008.01256.x; Giles KM, 2003, J BIOL CHEM, V278, P2937, DOI 10.1074/jbc.M208439200; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; HEIN J, 1990, METHOD ENZYMOL, V183, P626; Hollams EM, 2002, NEUROCHEM RES, V27, P957, DOI 10.1023/A:1020992418511; Joseph B, 1998, J BIOL CHEM, V273, P20511, DOI 10.1074/jbc.273.32.20511; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; KAO PN, 1994, J BIOL CHEM, V269, P20691; KING PH, 1994, J NEUROSCI, V14, P1943; Kruk JA, 2011, GENE DEV, V25, P581, DOI 10.1101/gad.2020911; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Lau NC, 2009, BIOCHEM J, V422, P443, DOI 10.1042/BJ20090500; Li RF, 2009, EMBO J, V28, P2763, DOI 10.1038/emboj.2009.211; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Mittal S, 2011, MOL BIOL CELL, V22, P748, DOI 10.1091/mbc.E10-11-0898; Myer VE, 1997, EMBO J, V16, P2130, DOI 10.1093/emboj/16.8.2130; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Shi L, 2011, P NATL ACAD SCI USA, V108, P7541, DOI 10.1073/pnas.1017374108; Shu LM, 2006, GENE DEV, V20, P2961, DOI 10.1101/gad.1463306; Su AI, 2001, CANCER RES, V61, P7388; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wagner E, 2007, MOL CELL BIOL, V27, P1686, DOI 10.1128/MCB.01483-06; Wang LJ, 2006, NUCLEIC ACIDS RES, V34, pW243, DOI 10.1093/nar/gkl298; Wang WG, 2005, EMBO REP, V6, P158, DOI 10.1038/sj.embor.7400346; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Yang XH, 2011, MOL CELL, V44, P39, DOI 10.1016/j.molcel.2011.07.032; Yang XL, 2004, J BIOL CHEM, V279, P49298, DOI 10.1074/jbc.M407535200; Yano M, 2005, J BIOL CHEM, V280, P12690, DOI 10.1074/jbc.M411119200; Yi X, 2008, CYTOM PART A, V73A, P637, DOI 10.1002/cyto.a.20579; Yi X, 2009, MOL BIOL CELL, V20, P983, DOI 10.1091/mbc.E08-06-0639; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zhang Y, 2007, EMBO J, V26, P2645, DOI 10.1038/sj.emboj.7601710	50	9	10	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21045	21057		10.1074/jbc.M112.355321	http://dx.doi.org/10.1074/jbc.M112.355321			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22547059	Green Published, hybrid			2022-12-25	WOS:000306416800026
J	Newton, PK; Mason, J; Bethel, K; Bazhenova, LA; Nieva, J; Kuhn, P				Newton, Paul K.; Mason, Jeremy; Bethel, Kelly; Bazhenova, Lyudmila A.; Nieva, Jorge; Kuhn, Peter			A Stochastic Markov Chain Model to Describe Lung Cancer Growth and Metastasis	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; DISEASE; PROGRESSION; NETWORKS; BLOOD	A stochastic Markov chain model for metastatic progression is developed for primary lung cancer based on a network construction of metastatic sites with dynamics modeled as an ensemble of random walkers on the network. We calculate a transition matrix, with entries (transition probabilities) interpreted as random variables, and use it to construct a circular bidirectional network of primary and metastatic locations based on postmortem tissue analysis of 3827 autopsies on untreated patients documenting all primary tumor locations and metastatic sites from this population. The resulting 50 potential metastatic sites are connected by directed edges with distributed weightings, where the site connections and weightings are obtained by calculating the entries of an ensemble of transition matrices so that the steady-state distribution obtained from the long-time limit of the Markov chain dynamical system corresponds to the ensemble metastatic distribution obtained from the autopsy data set. We condition our search for a transition matrix on an initial distribution of metastatic tumors obtained from the data set. Through an iterative numerical search procedure, we adjust the entries of a sequence of approximations until a transition matrix with the correct steady-state is found (up to a numerical threshold). Since this constrained linear optimization problem is underdetermined, we characterize the statistical variance of the ensemble of transition matrices calculated using the means and variances of their singular value distributions as a diagnostic tool. We interpret the ensemble averaged transition probabilities as (approximately) normally distributed random variables. The model allows us to simulate and quantify disease progression pathways and timescales of progression from the lung position to other sites and we highlight several key findings based on the model.	[Newton, Paul K.; Mason, Jeremy] Univ So Calif, Dept Aerosp & Mech Engn, Los Angeles, CA 90089 USA; [Newton, Paul K.; Mason, Jeremy] Univ So Calif, Dept Math, Los Angeles, CA 90089 USA; [Bethel, Kelly] Scripps Clin Torrey Pines, La Jolla, CA USA; [Bazhenova, Lyudmila A.] UCSD Moores Canc Ctr, La Jolla, CA USA; [Nieva, Jorge] Billings Clin, Billings, MT USA; [Kuhn, Peter] Scripps Res Inst, La Jolla, CA 92037 USA	University of Southern California; University of Southern California; Scripps Research Institute; Scripps Research Institute	Newton, PK (corresponding author), Univ So Calif, Dept Aerosp & Mech Engn, Los Angeles, CA 90089 USA.	newton@usc.edu	Nieva, Jorge/AAE-3634-2022	Nieva, Jorge/0000-0003-1605-4719; Mason, Jeremy/0000-0002-5933-5003; Bethel, Kelly/0000-0002-7005-8641; Bazhenova, Lyudmila/0000-0001-8764-4359	National Cancer Institute [U54CA143906]; NATIONAL CANCER INSTITUTE [U54CA143906] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This manuscript was supported by National Cancer Institute Award No. U54CA143906. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashworth T. R, 1869, AUST MED J, V14, P146, DOI DOI 10.1038/SJ.BJC.6604218; Balthrop J, 2004, SCIENCE, V304, P527, DOI 10.1126/science.1095845; BUTLER TP, 1975, CANCER RES, V35, P512; Chen LL, 2009, BRIT J CANCER, V101, P749, DOI 10.1038/sj.bjc.6605214; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; CSISZAR I, 1991, ANN STAT, V19, P2032, DOI 10.1214/aos/1176348385; Diaconis P, 2009, B AM MATH SOC, V46, P179; Disibio G, 2008, ARCH PATHOL LAB MED, V132, P931, DOI 10.1043/1543-2165(2008)132[931:MPOCRF]2.0.CO;2; Doucet A, 2001, STAT ENG IN, P3; Ewing J, 1929, NEOPLASTIC DIS TXB T; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gamerman D, 2006, MARKOV CHAIN MONTE C; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Golub GH., 2013, MATRIX COMPUTATIONS; Grinstead C, 2011, INTRO PROBABILITY; Gzyl H., 2003, AIP Conference Proceedings, P361, DOI 10.1063/1.1570553; Gzyl H, 2003, BAY INF MAX ENTR MET, pCP617; Hsieh HB, 2006, BIOSENS BIOELECTRON, V21, P1893, DOI 10.1016/j.bios.2005.12.024; Kalnay E., 2003, ATMOSPHERIC MODELING, DOI DOI 10.1017/CBO9780511802270; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Marrinucci D, 2007, HUM PATHOL, V38, P1468; Marrinucci D, 2009, ARCH PATHOL LAB MED, V133, P1468, DOI 10.1043/1543-2165-133.9.1468; Newman M.E.J., 2010, NETWORKS INTRO; Newman M, 2008, PHYS TODAY, V61, P33, DOI 10.1063/1.3027989; Newman MEJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.108701; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, P NATL ACAD SCI USA, V99, P2566, DOI 10.1073/pnas.012582999; NORTON L, 1988, CANCER RES, V48, P7067; Norton L, 2006, NAT MED, V12, P875, DOI 10.1038/nm0806-875; Okumura Y, 2009, ANN THORAC SURG, V87, P1669, DOI 10.1016/j.athoracsur.2009.03.073; Paget S, 1889, LANCET, V133, P571, DOI [DOI 10.1016/S0140-6736(00)49915-0, 10.1016/S0140-6736(00)49915-0]; Paterlini-Brechot P, 2007, CANCER LETT, V253, P180, DOI 10.1016/j.canlet.2006.12.014; Redner S, 2001, GUIDE 1 PASSAGE TIME; SALSBURY AJ, 1975, CANCER TREAT REV, V2, P55, DOI 10.1016/S0305-7372(75)80015-6; Smerage JB, 2006, BRIT J CANCER, V94, P8, DOI 10.1038/sj.bjc.6602871; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Weinberg RA, 2006, BIOL CANC; WEISS L, 1983, CANCER METAST REV, V2, P111, DOI 10.1007/BF00048965; Wojtkiewicz S., 2001, 19 AIAA APPL AER C, P1455	40	45	45	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e34637	10.1371/journal.pone.0034637	http://dx.doi.org/10.1371/journal.pone.0034637			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558094	gold, Green Submitted, Green Published			2022-12-25	WOS:000305336000015
J	Hu, J; Xie, CQ; Ma, HY; Yang, B; Ma, PX; Chen, YE				Hu, Jiang; Xie, Changqing; Ma, Haiyun; Yang, Bo; Ma, Peter X.; Chen, Y. Eugene			Construction of Vascular Tissues with Macro-Porous Nano-Fibrous Scaffolds and Smooth Muscle Cells Enriched from Differentiated Embryonic Stem Cells	PLOS ONE			English	Article							GROWTH-FACTOR; TRANSGENIC MICE; SM22 ALPHA; BETA; CONTRIBUTES; EXPRESSION; PROMOTER; PDGF	Vascular smooth muscle cells (SMCs) have been broadly used for constructing tissue-engineered blood vessels. However, the availability of mature SMCs from donors or patients is very limited. Derivation of SMCs by differentiating embryonic stem cells (ESCs) has been reported, but not widely utilized in vascular tissue engineering due to low induction efficiency and, hence, low SMC purity. To address these problems, SMCs were enriched from retinoic acid induced mouse ESCs with LacZ genetic labeling under the control of SM22 alpha promoter as the positive sorting marker in the present study. The sorted SMCs were characterized and then cultured on three-dimensional macro-porous nano-fibrous scaffolds in vitro or implanted subcutaneously into nude mice after being seeded on the scaffolds. Our data showed that the LacZ staining, which reflected the corresponding SMC marker SM22 alpha expression level, was efficient as a positive selection marker to dramatically enrich SMCs and eliminate other cell types. After the sorted cells were seeded into the three-dimensional nano-fibrous scaffolds, continuous retinoic acid treatment further enhanced the SMC marker gene expression level while inhibited pluripotent maker gene expression level during the in vitro culture. Meanwhile, after being implanted subcutaneously into nude mice, the implanted cells maintained the positive LacZ staining within the constructs and no teratoma formation was observed. In conclusion, our results demonstrated the potential of SMCs derived from ESCs as a promising cell source for therapeutic vascular tissue engineering and disease model applications.	[Hu, Jiang; Ma, Haiyun; Ma, Peter X.] Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Xie, Changqing; Chen, Y. Eugene] Univ Michigan, Dept Internal Med, Ctr Cardiovasc, Ann Arbor, MI 48109 USA; [Yang, Bo] Univ Michigan, Dept Cardiac Surg, Ctr Cardiovasc, Ann Arbor, MI 48109 USA; [Ma, Peter X.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Ma, Peter X.] Univ Michigan, Ctr Macromol Sci & Engn, Ann Arbor, MI 48109 USA; [Ma, Peter X.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hu, J (corresponding author), Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.	mapx@umich.edu; echenum@umich.edu	X, Peter/E-4895-2011; Hu, Jiang/D-7904-2012	Yang, Bo/0000-0002-2158-9155	Cardiovascular Center at University of Michigan; National Institutes of Health [HL092421, HL068878, DE015384, DE017689]; AHA National Scientific Development Grant [09SDG2260023]; Richard H. Kingery Endowed Collegiate; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL092421, R01HL068878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015384, R01DE017689] Funding Source: NIH RePORTER	Cardiovascular Center at University of Michigan; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA National Scientific Development Grant; Richard H. Kingery Endowed Collegiate; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work is partially funded by an Inaugural Grant (YEC and PXM) from the Cardiovascular Center at University of Michigan and by the National Institutes of Health (HL092421 and HL068878: YEC; DE015384 and DE017689: PXM). CX is supported by an AHA National Scientific Development Grant (09SDG2260023). YEC is an AHA established investigator (0840025N). PXM is partially supported by the Richard H. Kingery Endowed Collegiate Professorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Hishikawa K, 1999, EUR J PHARMACOL, V385, P287, DOI 10.1016/S0014-2999(99)00763-3; Hu JA, 2010, BIOMATERIALS, V31, P7971, DOI 10.1016/j.biomaterials.2010.07.028; Huang HR, 2006, BIOCHEM BIOPH RES CO, V351, P321, DOI 10.1016/j.bbrc.2006.09.171; Huang HR, 2010, J BIOL CHEM, V285, P9383, DOI [10.1074/jbc.M110.101543, 10.1074/jbc.M109.095612]; Kim S, 1997, MOL CELL BIOL, V17, P2266, DOI 10.1128/MCB.17.4.2266; Li L, 1996, CIRC RES, V78, P188, DOI 10.1161/01.RES.78.2.188; Li L, 1996, J CELL BIOL, V132, P849, DOI 10.1083/jcb.132.5.849; Moessler H, 1996, DEVELOPMENT, V122, P2415; Niklason LE, 2001, J VASC SURG, V33, P628, DOI 10.1067/mva.2001.111747; Oishi K, 2002, J PHYSIOL-LONDON, V540, P139, DOI 10.1113/jphysiol.2001.013278; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pera MF, 2010, NATURE, V465, P713, DOI 10.1038/nature09228; Poot M, 1997, CYTOMETRY, V28, P36, DOI 10.1002/(SICI)1097-0320(19970501)28:1<36::AID-CYTO4>3.0.CO;2-F; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; Shen JB, 2010, CIRC RES, V106, P1351, DOI 10.1161/CIRCRESAHA.109.213900; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; Sinha S, 2006, STEM CELLS, V24, P1678, DOI 10.1634/stemcells.2006-0002; Srivastava S, 2003, AM J PHYSIOL-HEART C, V285, pH1190, DOI 10.1152/ajpheart.00280.2003; Wei GB, 2006, J CONTROL RELEASE, V112, P103, DOI 10.1016/j.jconrel.2006.01.011; Xie CQ, 2009, STEM CELLS DEV, V18, P741, DOI 10.1089/scd.2008.0179; Xie CQ, 2011, BIOMATERIALS, V32, P4369, DOI 10.1016/j.biomaterials.2011.02.049; Xie CQ, 2011, STEM CELLS DEV, V20, P205, DOI 10.1089/scd.2010.0283; Xu ZC, 2008, BIOMATERIALS, V29, P1464, DOI 10.1016/j.biomaterials.2007.11.037; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yang Maozhou, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P12; Zhang JCL, 2001, MOL CELL BIOL, V21, P1336, DOI 10.1128/MCB.2001.21.4.1336-1344.2001	29	15	15	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35580	10.1371/journal.pone.0035580	http://dx.doi.org/10.1371/journal.pone.0035580			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545119	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343200039
J	Bruetto, RG; Rodrigues, FB; Torres, US; Otaviano, AP; Zanetta, DMT; Burdmann, EA				Bruetto, Rosana G.; Rodrigues, Fernando B.; Torres, Ulysses S.; Otaviano, Ana P.; Zanetta, Dirce M. T.; Burdmann, Emmanuel A.			Renal Function at Hospital Admission and Mortality Due to Acute Kidney Injury after Myocardial Infarction	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; LONG-TERM PROGNOSIS; SERUM CREATININE; CARDIAC-SURGERY; RISK-FACTOR; OUTCOMES; DISEASE; FAILURE; ASSOCIATION; DEFINITION	Background: The role of an impaired estimated glomerular filtration rate (eGFR) at hospital admission in the outcome of acute kidney injury (AKI) after acute myocardial infarction (AMI) has been underreported. The aim of this study was to assess the influence of an admission eGFR<60 mL/min/1.73 m(2) on the incidence and early and late mortality of AMI-associated AKI. Methods: A prospective study of 828 AMI patients was performed. AKI was defined as a serum creatinine increase of >= 50% from the time of admission (RIFLE criteria) in the first 7 days of hospitalization. Patients were divided into subgroups according to their eGFR upon hospital admission (MDRD formula, mL/min/1.73 m(2)) and the development of AKI: eGFR >= 60 without AKI, eGFR<60 without AKI, eGFR >= 60 with AKI and eGFR<60 with AKI. Results: Overall, 14.6% of the patients in this study developed AKI. The admission eGFR had no impact on the incidence of AKI. However, the admission eGFR was associated with the outcome of AMI-associated AKI. The adjusted hazard ratios (AHR, Cox multivariate analysis) for 30-day mortality were 2.00 (95% CI 1.11-3.61) for eGFR, 60 without AKI, 4.76 (95% CI 2.45-9.26) for eGFR >= 60 with AKI and 6.27 (95% CI 3.20-12.29) for eGFR, 60 with AKI. Only an admission eGFR of <60 with AKI was significantly associated with a 30-day to 1-year mortality hazard (AHR 3.05, 95% CI 1.50-6.19). Conclusions: AKI development was associated with an increased early mortality hazard in AMI patients with either preserved or impaired admission eGFR. Only the association of impaired admission eGFR and AKI was associated with an increased hazard for late mortality among these patients.	[Bruetto, Rosana G.; Torres, Ulysses S.; Burdmann, Emmanuel A.] Hosp Base, Div Nephrol, Sao Jose do Rio Preto Med Sch FAMERP, Sao Paulo, Brazil; [Rodrigues, Fernando B.] Hosp Base, Dept Internal Med, Sao Jose do Rio Preto Med Sch FAMERP, Div Emergency, Sao Paulo, Brazil; [Rodrigues, Fernando B.] Hosp Base, Chest Pain Ctr, Sao Jose do Rio Preto Med Sch FAMERP, Sao Paulo, Brazil; [Otaviano, Ana P.] Hosp Base, Div Cardiol, Sao Jose do Rio Preto Med Sch FAMERP, Sao Paulo, Brazil; [Zanetta, Dirce M. T.] Univ Sao Paulo, Sch Publ Hlth, Sao Paulo, Brazil	Universidade de Sao Paulo	Bruetto, RG (corresponding author), Hosp Base, Div Nephrol, Sao Jose do Rio Preto Med Sch FAMERP, Sao Paulo, Brazil.	burdmann@usp.br	Zanetta, Dirce M T/G-4950-2013; Burdmann, Emmanuel/AAY-1966-2020; Torres, Ulysses S./E-6034-2011; Burdmann, Emmanuel/B-7023-2009; Otaviano, Ana Paula/D-6505-2018	Torres, Ulysses S./0000-0002-1911-9090; Burdmann, Emmanuel/0000-0002-7644-8579; Otaviano, Ana Paula/0000-0002-3745-0297; Zanetta, Dirce Maria/0000-0002-7273-5087	Foundation for the Support of Research in the State of Sao Paulo (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP), Brazil; National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq), Brazil; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil [0076/2007]; Foundation for the Support of Research in the State of Sao Paulo (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP) [2008/57115-6]	Foundation for the Support of Research in the State of Sao Paulo (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Foundation for the Support of Research in the State of Sao Paulo (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	EAB is partially supported by grants from Foundation for the Support of Research in the State of Sao Paulo (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP), Brazil, and from the National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq), Brazil. RGB received a master's degree grant from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil (process 0076/2007). UST received a young investigator award (process 2008/57115-6) from Foundation for the Support of Research in the State of Sao Paulo (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Amin AP, 2010, AM HEART J, V160, P1065, DOI 10.1016/j.ahj.2010.08.007; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bouzas-Mosquera A, 2009, ARCH INTERN MED, V169, P87, DOI 10.1001/archinternmed.2008.554; Cheitlin MD, 1997, J AM COLL CARDIOL, V29, P862, DOI 10.1016/S0735-1097(96)90000-5; CHERTOW GM, 1995, ARCH INTERN MED, V155, P1505, DOI 10.1001/archinte.155.14.1505; Coca SG, 2012, J THORAC CARDIOV SUR, V143, P495, DOI 10.1016/j.jtcvs.2011.09.023; Collins AJ, 2009, AM J KIDNEY DIS, V53, pS1, DOI 10.1053/j.ajkd.2008.10.005; Doi K, 2011, CRIT CARE MED, V39, P2464, DOI 10.1097/CCM.0b013e318225761a; Goldberg A, 2005, AM HEART J, V150, P330, DOI 10.1016/j.ahj.2004.09.055; Goldberg A, 2009, KIDNEY INT, V76, P900, DOI 10.1038/ki.2009.295; Goldenberg I, 2010, ARCH INTERN MED, V170, P888, DOI 10.1001/archinternmed.2010.95; Grams ME, 2010, J AM SOC NEPHROL, V21, P1757, DOI 10.1681/ASN.2010010128; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Huang TM, 2011, J AM SOC NEPHROL, V22, P156, DOI 10.1681/ASN.2010050553; Inrig JK, 2008, NEPHROL DIAL TRANSPL, V23, P934, DOI 10.1093/ndt/gfm689; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; James MT, 2010, LANCET, V376, P2096, DOI 10.1016/S0140-6736(10)61271-8; Khosla N, 2009, CLIN J AM SOC NEPHRO, V4, P1914, DOI 10.2215/CJN.01690309; Kolli H, 2010, RENAL FAILURE, V32, P1066, DOI 10.3109/0886022X.2010.510616; Lazaros G, 2012, INT J CARDIOL, V155, P97, DOI 10.1016/j.ijcard.2010.10.024; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lombardi R, 2008, RENAL FAILURE, V30, P155, DOI 10.1080/08860220701808129; Marenzi G, 2010, CRIT CARE MED, V38, P438, DOI 10.1097/CCM.0b013e3181b9eb3b; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Newsome BB, 2008, ARCH INTERN MED, V168, P609, DOI 10.1001/archinte.168.6.609; Parikh CR, 2008, ARCH INTERN MED, V168, P987, DOI 10.1001/archinte.168.9.987; Reddan DN, 2005, NEPHROL DIAL TRANSPL, V20, P2105, DOI 10.1093/ndt/gfh981; Rodrigues FB, 2010, CLIN J AM SOC NEPHRO, V5, P1530, DOI 10.2215/CJN.01260210; Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Shlipak MG, 2002, ANN INTERN MED, V137, P555, DOI 10.7326/0003-4819-137-7-200210010-00006; Singh P, 2010, CLIN J AM SOC NEPHRO, V5, P1690, DOI 10.2215/CJN.00830110; Skott M, 2010, NEPHROL DIAL TRANSPL, V25, P3509, DOI 10.1093/ndt/gfq281; Szummer K, 2010, J INTERN MED, V268, P40, DOI 10.1111/j.1365-2796.2009.02204.x; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Waikar SS, 2008, CLIN J AM SOC NEPHRO, V3, P844, DOI 10.2215/CJN.05191107; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1143, DOI 10.1681/ASN.2005091017; Wu VC, 2011, KIDNEY INT, V80, P1222, DOI 10.1038/ki.2011.259	40	35	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35496	10.1371/journal.pone.0035496	http://dx.doi.org/10.1371/journal.pone.0035496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539974	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341000040
J	Lichtenfels, R; Rappl, G; Hombach, AA; Recktenwald, CV; Dressler, SP; Abken, H; Seliger, B				Lichtenfels, Rudolf; Rappl, Gunter; Hombach, Andreas A.; Recktenwald, Christian V.; Dressler, Sven P.; Abken, Hinrich; Seliger, Barbara			A Proteomic View at T Cell Costimulation	PLOS ONE			English	Article							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; CD28 COSTIMULATION; B7/CD28 COSTIMULATION; MASS-SPECTROMETRY; PROTEIN; ACTIVATION; IDENTIFICATION; MICROTUBULES; EXPRESSION; BLOCKADE	The "two-signal paradigm" in T cell activation predicts that the cooperation of "signal 1," provided by the T cell receptor (TCR) through engagement of major histocompatility complex (MHC)-presented peptide, with "signal 2" provided by costimulatory molecules, the prototype of which is CD28, is required to induce T cell effector functions. While the individual signalling pathways are well understood, little is known about global changes in the proteome pattern during TCR/CD28-mediated activation. Therefore, comparative 2-DE-based proteome analyses of CD3(+) CD69(-) resting T cells versus cells incubated with (i) the agonistic anti-CD3 antibody OKT3 mimicking signal 1 in absence or presence of IL-2 and/or with (ii) the agonistic antibody 15E8 triggering CD28-mediated signaling were performed. Differentially regulated spots were defined leading to the identification of proteins involved in the regulation of the metabolism, shaping and maintenance of the cytoskeleton and signal transduction. Representative members of the differentially expressed protein families, such as calmodulin (CALM), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), L-lactate dehydrogenase (LDH), Rho GDP-dissociation inhibitor 2 (GDIR2), and platelet basic protein (CXCL7), were independently verified by flow cytometry. Data provide a detailed map of individual protein alterations at the global proteome level in response to TCR/CD28-mediated T cell activation.	[Lichtenfels, Rudolf; Recktenwald, Christian V.; Dressler, Sven P.; Seliger, Barbara] Univ Halle Wittenberg, Inst Med Immunol, Halle, Germany; [Rappl, Gunter; Hombach, Andreas A.; Abken, Hinrich] Univ Cologne, Clin Internal Med 1, CMMC, D-50931 Cologne, Germany; [Rappl, Gunter; Hombach, Andreas A.; Abken, Hinrich] Univ Cologne, Clin Internal Med 1, Tumor Genet Sect, D-50931 Cologne, Germany	Martin Luther University Halle Wittenberg; University of Cologne; University of Cologne	Lichtenfels, R (corresponding author), Univ Halle Wittenberg, Inst Med Immunol, Halle, Germany.	Barbara.Seliger@medizin.uni-halle.de		Seliger, Barbara/0000-0002-5544-4958; Recktenwald, Christian Viktor/0000-0003-1710-1863; Hombach, Andreas/0000-0001-9328-8442	Dr. Mildred Scheel Foundation [107967]; intramural Wilhelm-Roux-Program [18/05]	Dr. Mildred Scheel Foundation(Deutsche Krebshilfe); intramural Wilhelm-Roux-Program	The work presented in this report was in part supported by the Dr. Mildred Scheel Foundation, grant 107967 (B.S.) and the intramural Wilhelm-Roux-Program, grant 18/05 (B.S.). The funders had no role in the study design, the data collection and analysis, decision to publish and preparation of the manuscript.	Bhatia S, 2010, J IMMUNOL, V184, P1821, DOI 10.4049/jimmunol.0902869; Bini L, 2003, BIOCHEM J, V369, P301, DOI 10.1042/BJ20020503; Boesteanu AC, 2009, SEMIN IMMUNOL, V21, P69, DOI 10.1016/j.smim.2009.02.005; Boise LH, 2010, J IMMUNOL, V185, P3788; Borowski AB, 2007, J IMMUNOL, V179, P6494, DOI 10.4049/jimmunol.179.10.6494; Bour-Jordan H, 2009, IMMUNOL REV, V229, P41, DOI 10.1111/j.1600-065X.2009.00775.x; Brockmeyer C, 2011, J BIOL CHEM, V286, P7535, DOI 10.1074/jbc.M110.201236; Carujo S, 2006, ONCOGENE, V25, P4033, DOI 10.1038/sj.onc.1209433; Chmielewski M, 2011, GENE THER, V18, P62, DOI 10.1038/gt.2010.127; Croci S, 2010, PROTEOMICS, V10, P3835, DOI 10.1002/pmic.200900643; de Wet B, 2011, J BIOL CHEM, V286, P4072, DOI 10.1074/jbc.M110.165415; DURRIEU C, 1987, ARCH BIOCHEM BIOPHYS, V252, P32, DOI 10.1016/0003-9861(87)90005-1; Duttagupta PA, 2009, CRIT REV IMMUNOL, V29, P469, DOI 10.1615/CritRevImmunol.v29.i6.20; Fathman CG, 2007, NAT REV IMMUNOL, V7, P599, DOI 10.1038/nri2131; Ford ML, 2009, IMMUNOL REV, V229, P294, DOI 10.1111/j.1600-065X.2009.00776.x; Fuse S, 2008, J IMMUNOL, V180, P1148, DOI 10.4049/jimmunol.180.2.1148; Fuse S, 2011, CELL IMMUNOL, V266, P130, DOI 10.1016/j.cellimm.2010.09.008; Garcon F, 2008, BLOOD, V111, P1464, DOI 10.1182/blood-2007-08-108050; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Heller M, 2000, ELECTROPHORESIS, V21, P2180, DOI 10.1002/1522-2683(20000601)21:11<2180::AID-ELPS2180>3.0.CO;2-#; Hombach AA, 2007, J IMMUNOL, V179, P7924, DOI 10.4049/jimmunol.179.11.7924; Iida N, 1996, FASEB J, V10, P1336, DOI 10.1096/fasebj.10.11.8836048; Iwai LK, 2010, J PROTEOME RES, V9, P3135, DOI 10.1021/pr100035b; JENKINS MK, 1990, J IMMUNOL, V144, P16; Jindra PT, 2010, J IMMUNOL, V185, P990, DOI 10.4049/jimmunol.1000793; Kobayashi M, 2007, ELECTROPHORESIS, V28, P2035, DOI 10.1002/elps.200600675; Kronfeld K, 2005, MOL CELL PROTEOMICS, V4, P1876, DOI 10.1074/mcp.M500194-MCP200; KUMAGAI H, 1983, J BIOCHEM-TOKYO, V93, P1259, DOI 10.1093/oxfordjournals.jbchem.a134260; LAFFERTY KJ, 1983, ANNU REV IMMUNOL, V1, P143, DOI 10.1146/annurev.iy.01.040183.001043; Lange S, 2010, J PROTEOME RES, V9, P4113, DOI 10.1021/pr1003054; Lichtenfels R, 2009, MOL CELL PROTEOMICS, V8, P2827, DOI 10.1074/mcp.M900168-MCP200; Lin SL, 2010, J PROTEOME RES, V9, P283, DOI 10.1021/pr9006156; Linsley PS, 2009, IMMUNOL REV, V229, P307, DOI 10.1111/j.1600-065X.2009.00780.x; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Michalek RD, 2007, J IMMUNOL, V179, P6456, DOI 10.4049/jimmunol.179.10.6456; Nguyen V, 2009, MOL CELL PROTEOMICS, V8, P2418, DOI 10.1074/mcp.M800307-MCP200; Nguyen VH, 2008, BLOOD, V111, P945, DOI 10.1182/blood-2007-07-103895; Nyman TA, 2001, ELECTROPHORESIS, V22, P4375, DOI 10.1002/1522-2683(200112)22:20<4375::AID-ELPS4375>3.0.CO;2-P; Park J, 2009, BBA-PROTEINS PROTEOM, V1794, P254, DOI 10.1016/j.bbapap.2008.10.003; Paterson AM, 2009, CELL, V137, P974, DOI 10.1016/j.cell.2009.05.015; Patterson RL, 2005, P NATL ACAD SCI USA, V102, P1357, DOI 10.1073/pnas.0409657102; Poirier N, 2011, TRANSPL INT, V24, P2, DOI 10.1111/j.1432-2277.2010.01176.x; Reiss N, 1996, BIOCHEM MOL BIOL INT, V40, P1191; Rosenblatt J, 2010, J IMMUNOTHER, V33, P155, DOI 10.1097/CJI.0b013e3181bed253; SCHWARTZ RH, 1989, COLD SPRING HARB SYM, V54, P605; Seliger B, 2005, PROTEOMICS, V5, P2631, DOI 10.1002/pmic.200401264; Sharpe AH, 2009, IMMUNOL REV, V229, P5, DOI 10.1111/j.1600-065X.2009.00784.x; Shen K, 2008, P NATL ACAD SCI USA, V105, P7791, DOI 10.1073/pnas.0710295105; Sheng WY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006322; Thiel M, 2010, IMMUNOLOGY, V129, P28, DOI 10.1111/j.1365-2567.2009.03155.x; Tisdale EJ, 2009, J BIOL CHEM, V284, P5876, DOI 10.1074/jbc.M807756200; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Verbinnen B, 2008, J IMMUNOL, V181, P1034, DOI 10.4049/jimmunol.181.2.1034; Vinh A, 2010, CIRCULATION, V122, P2529, DOI 10.1161/CIRCULATIONAHA.109.930446; von Hundelshausen P, 2007, THROMB HAEMOSTASIS, V97, P704, DOI 10.1160/TH07-01-0066; Waibler Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001708; Yang J, 2009, AM J TRANSPLANT, V9, P2837, DOI 10.1111/j.1600-6143.2009.02839.x; Yokosuka T, 2009, IMMUNOL REV, V229, P27, DOI 10.1111/j.1600-065X.2009.00779.x	58	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e32994	10.1371/journal.pone.0032994	http://dx.doi.org/10.1371/journal.pone.0032994			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539942	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341000005
J	Sezaki, T; Inada, K; Sogabe, T; Kakuda, K; Tomiyama, L; Matsuno, Y; Ichikawa, T; Matsuo, M; Ueda, K; Kioka, N				Sezaki, Takuhito; Inada, Kohki; Sogabe, Takayuki; Kakuda, Kumiyo; Tomiyama, Lucia; Matsuno, Yohsuke; Ichikawa, Takafumi; Matsuo, Michinori; Ueda, Kazumitsu; Kioka, Noriyuki			Role of Dlg5/lp-dlg, a Membrane-Associated Guanylate Kinase Family Protein, in Epithelial-Mesenchymal Transition in LLc-PK1 Renal Epithelial Cells	PLOS ONE			English	Article							TGF-BETA RECEPTOR; DLG5 R30Q; SMAD7; VINEXIN; ACTIVATION; EXPRESSION; MECHANISM; GROWTH; TRAF6; IDENTIFICATION	Discs large homolog 5 (Dlg5) is a member of the membrane-associated guanylate kinase adaptor family of proteins, some of which are involved in the regulation of epithelial-to-mesenchymal transition (EMT). Dlg5 has been described as a susceptibility gene for Crohn's disease; however, the physiological function of Dlg5 is unknown. We show here that transforming growth factor-beta (TGF-beta)-induced EMT suppresses Dlg5 expression in LLc-PK1 cells. Depletion of Dlg5 expression by knockdown promoted the expression of the mesenchymal marker proteins, fibronectin and alpha-smooth muscle actin, and suppressed the expression of E-cadherin. In addition, activation of JNK and p38, which are stimulated by TGF-beta, was enhanced by Dlg5 depletion. Furthermore, inhibition of the TGF-beta receptor suppressed the effects of Dlg5 depletion. These observations suggest that Dlg5 is involved in the regulation of TGF-beta receptor-dependent signals and EMT.	[Sezaki, Takuhito; Inada, Kohki; Sogabe, Takayuki; Kakuda, Kumiyo; Tomiyama, Lucia; Matsuno, Yohsuke; Ichikawa, Takafumi; Matsuo, Michinori; Ueda, Kazumitsu; Kioka, Noriyuki] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto, Japan; [Ueda, Kazumitsu] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Sakyo Ku, Kyoto, Japan	Kyoto University; Kyoto University	Sezaki, T (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto, Japan.	nkioka@kais.kyoto-u.ac.jp		Ichikawa, Takafumi/0000-0002-0490-4176; Ueda, Kazumitsu/0000-0003-2980-6078; Kioka, Noriyuki/0000-0002-2708-537X	Mishima Kaiun Memorial Foundation; Asahi Glass Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Bio-oriented Technology Research Advancement Institution; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [09J02878] Funding Source: KAKEN	Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Asahi Glass Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bio-oriented Technology Research Advancement Institution; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Mishima Kaiun Memorial Foundation; the Asahi Glass Foundation; a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; a grant from the Bio-oriented Technology Research Advancement Institution; and Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Biank V, 2007, AM J GASTROENTEROL, V102, P391, DOI 10.1111/j.1572-0241.2006.01011.x; Boirivant M, 2006, GASTROENTEROLOGY, V131, P1786, DOI 10.1053/j.gastro.2006.09.016; Browning BL, 2008, J MED GENET, V45, P36, DOI 10.1136/jmg.2007.050773; Chang YJ, 2010, CELL CYCLE, V9, P1990, DOI 10.4161/cc.9.10.11730; Chen CL, 2010, EXP CELL RES, V316, P1109, DOI 10.1016/j.yexcr.2010.02.022; Cullen G, 2007, INFLAMM BOWEL DIS, V13, P1369, DOI 10.1002/ibd.20220; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Friedrichs F, 2008, J MOL MED, V86, P423, DOI 10.1007/s00109-008-0307-5; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kioka N, 1999, J CELL BIOL, V144, P59, DOI 10.1083/jcb.144.1.59; Kioka N, 2002, CELL STRUCT FUNCT, V27, P1, DOI 10.1247/csf.27.1; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Li Y, 2010, J DERMATOL SCI, V60, P105, DOI 10.1016/j.jdermsci.2010.08.003; Lin Z, 2009, DIS MARKERS, V27, P193, DOI [10.1155/2009/167534, 10.3233/DMA-2009-0662]; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Lv ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022806; Masszi A, 2003, AM J PHYSIOL-RENAL, V284, pF911, DOI 10.1152/ajprenal.00183.2002; Medici D, 2011, BIOCHEM J, V437, P515, DOI 10.1042/BJ20101500; Mitsushima M, 2006, GENES CELLS, V11, P971, DOI 10.1111/j.1365-2443.2006.00995.x; Monteleone G, 2001, J CLIN INVEST, V108, P601, DOI 10.1172/JCI200112821; Mu Y, 2011, CELL TISSUE RES; Mu YB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1332; Nakamura H, 1998, FEBS LETT, V433, P63, DOI 10.1016/S0014-5793(98)00882-5; Nakamura T, 2004, ONCOGENE, V23, P2385, DOI 10.1038/sj.onc.1207392; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nechiporuk T, 2007, DEV CELL, V13, P338, DOI 10.1016/j.devcel.2007.07.017; Neurath MF, 1996, J EXP MED, V183, P2605, DOI 10.1084/jem.183.6.2605; Pallet N, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/348604; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; Reichert M, 2000, J BIOL CHEM, V275, P9492, DOI 10.1074/jbc.275.13.9492; Ryeom SW, 2000, MOL BIOL CELL, V11, P1687, DOI 10.1091/mbc.11.5.1687; Smolen GA, 2010, GENE DEV, V24, P2654, DOI 10.1101/gad.1989110; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Stoll M, 2004, NAT GENET, V36, P476, DOI 10.1038/ng1345; Taniuchi K, 2005, CANCER RES, V65, P105; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Torok P, 2009, AM J GASTROENTEROL, V104, P1723, DOI 10.1038/ajg.2009.184; Umemoto T, 2009, CANCER LETT, V279, P22, DOI 10.1016/j.canlet.2009.01.017; Ura S, 2001, GENES CELLS, V6, P519, DOI 10.1046/j.1365-2443.2001.00439.x; Van Limbergen J, 2009, ANNU REV GENOM HUM G, V10, P89, DOI 10.1146/annurev-genom-082908-150013; Wakabayashi M, 2003, J BIOL CHEM, V278, P21709, DOI 10.1074/jbc.M211004200; Wang H, 2001, FEBS LETT, V503, P91, DOI 10.1016/S0014-5793(01)02699-0; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Yamashita H, 2011, J BIOL CHEM, V286, P3907, DOI 10.1074/jbc.M110.145409; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zuo W, 2009, MOL BIOL CELL, V20, P1020, DOI 10.1091/mbc.E08-09-0898	54	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35519	10.1371/journal.pone.0035519	http://dx.doi.org/10.1371/journal.pone.0035519			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539977	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341000043
J	Teotonio, H; Carvalho, S; Manoel, D; Roque, M; Chelo, IM				Teotonio, Henrique; Carvalho, Sara; Manoel, Diogo; Roque, Miguel; Chelo, Ivo M.			Evolution of Outcrossing in Experimental Populations of Caenorhabditis elegans	PLOS ONE			English	Article							INBREEDING DEPRESSION; C. ELEGANS; LINKAGE DISEQUILIBRIUM; DELETERIOUS MUTATION; NATURAL-POPULATIONS; SELF-FERTILIZATION; GENETIC DIVERSITY; LINKED SITES; LIFE-SPAN; SELECTION	Caenorhabditis elegans can reproduce exclusively by self-fertilization. Yet, males can be maintained in laboratory populations, a phenomenon that continues to puzzle biologists. In this study we evaluated the role of males in facilitating adaptation to novel environments. For this, we contrasted the evolution of a fitness component exclusive to outcrossing in experimental populations of different mating systems. We introgressed a modifier of outcrossing into a hybrid population derived from several wild isolates to transform the wild-type androdioecious mating system into a dioecious mating system. By genotyping 375 single-nucleotide polymorphisms we show that the two populations had similar standing genetic diversity available for adaptation, despite the occurrence of selection during their derivation. We then performed replicated experimental evolution under the two mating systems from starting conditions of either high or low levels of diversity, under defined environmental conditions of discrete non-overlapping generations, constant density at high population sizes (N = 10(4)), no obvious spatial structure and abundant food resources. During 100 generations measurements of sex ratios and male competitive performance showed: 1) adaptation to the novel environment; 2) directional selection on male frequency under androdioecy; 3) optimal outcrossing rates of 0.5 under androdioecy; 4) the existence of initial inbreeding depression; and finally 5) that the strength of directional selection on male competitive performance does not depend on male frequencies. Taken together, these results suggest that androdioecious males are maintained at intermediate frequencies because outcrossing is adaptive.	[Teotonio, Henrique; Carvalho, Sara; Manoel, Diogo; Roque, Miguel; Chelo, Ivo M.] Inst Gulbenkian Ciencias, Oeiras, Portugal	Instituto Gulbenkian de Ciencia	Teotonio, H (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	teotonio@igc.gulbenkian.pt	Chelo, Ivo M/I-3080-2012; Carvalho, Sara/H-9826-2013	Chelo, Ivo M/0000-0002-5414-6625; Teotonio, Henrique/0000-0003-1057-6882; Carvalho, Sara/0000-0001-7788-8309; Manoel, Diogo/0000-0002-0353-1742	Fundacao para a Ciencia e a Tecnologia [PPCDT/BIA-BDE/61127/2004]; European Research Council [stERC/2009-243285]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); European Research Council(European Research Council (ERC)European Commission)	Fundacao para a Ciencia e a Tecnologia (PPCDT/BIA-BDE/61127/2004); European Research Council (stERC/2009-243285). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2011, J GERONTOL A-BIOL, V66, P1300, DOI 10.1093/gerona/glr143; Anderson JL, 2010, J HERED, V101, pS62, DOI 10.1093/jhered/esq003; Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; Bendesky A, 2011, NATURE, V472, P313, DOI 10.1038/nature09821; Bradic M., 2011, MOL METHODS EVOLUTIO; Burt A, 2000, EVOLUTION, V54, P337; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.ecolsys.18.1.237; CHARLESWORTH D, 1990, EVOLUTION, V44, P870, DOI 10.1111/j.1558-5646.1990.tb03811.x; Chasnov JR, 2007, P NATL ACAD SCI USA, V104, P6730, DOI 10.1073/pnas.0608050104; Chasnov JR, 2002, GENETICS, V160, P983; CHRISTIANSEN FB, 1989, THEOR POPUL BIOL, V35, P307, DOI 10.1016/0040-5809(89)90003-8; Christiansen FB, 1998, THEOR POPUL BIOL, V53, P199, DOI 10.1006/tpbi.1997.1358; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Cutter AD, 2005, J EVOLUTION BIOL, V18, P27, DOI 10.1111/j.1420-9101.2004.00804.x; Cutter AD, 2003, J EVOLUTION BIOL, V16, P812, DOI 10.1046/j.1420-9101.2003.00596.x; Cutter AD, 2003, GENET RES, V81, P91, DOI 10.1017/S001667230300613X; Cutter AD, 2003, MOL BIOL EVOL, V20, P665, DOI 10.1093/molbev/msg072; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Denver DR, 2010, GENOME RES, V20, P1663, DOI 10.1101/gr.108191.110; Dolgin ES, 2007, EVOLUTION, V61, P1339, DOI 10.1111/j.1558-5646.2007.00118.x; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fisher R.A., 1930, GENETICAL THEORY NAT; Garcia LR, 2007, GENETICS, V175, P1761, DOI 10.1534/genetics.106.068304; Gems D, 1996, NATURE, V379, P723, DOI 10.1038/379723a0; Gloria-Soria A, 2008, CURR BIOL, V18, P1694, DOI 10.1016/j.cub.2008.09.043; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; HILL WG, 1981, GENET RES, V38, P209, DOI 10.1017/S0016672300020553; HODGKIN J, 1983, GENETICS, V103, P43; JOHNSON TE, 1993, GENETICS, V134, P465; LaMunyon CW, 2007, J HERED, V98, P67, DOI 10.1093/jhered/esl052; LaMunyon CW, 2002, P ROY SOC B-BIOL SCI, V269, P1125, DOI 10.1098/rspb.2002.1996; LANDE R, 1985, EVOLUTION, V39, P24, DOI [10.2307/2408514, 10.1111/j.1558-5646.1985.tb04077.x]; LANDE R, 1994, EVOLUTION, V48, P965, DOI 10.1111/j.1558-5646.1994.tb05286.x; LANDE R, 1977, GENETICS, V86, P485; Lipton J, 2004, J NEUROSCI, V24, P7427, DOI 10.1523/JNEUROSCI.1746-04.2004; Lynch M., 1998, GENETICS ANAL QUANTI; Manoel D, 2007, P ROY SOC B-BIOL SCI, V274, P417, DOI 10.1098/rspb.2006.3739; Morran LT, 2011, SCIENCE, V333, P216, DOI 10.1126/science.1206360; Morran LT, 2009, NATURE, V462, P350, DOI 10.1038/nature08496; Morran LT, 2009, EVOLUTION, V63, P1473, DOI 10.1111/j.1558-5646.2009.00652.x; Murray RL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-99; Murray RL, 2011, J EXP BIOL, V214, P1740, DOI 10.1242/jeb.053181; Nordborg M, 2000, GENETICS, V154, P923; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; R Development Core Team, 2006, R LANG ENV STAT COMP; Rockman MV, 2010, SCIENCE, V330, P372, DOI 10.1126/science.1194208; Rockman MV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000419; SCHEDL T, 1988, GENETICS, V119, P43; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Seidel HS, 2008, SCIENCE, V319, P589, DOI 10.1126/science.1151107; Simon JM, 2002, P NATL ACAD SCI USA, V99, P1598, DOI 10.1073/pnas.032225799; Sivasundar A, 2005, CURR BIOL, V15, P1598, DOI 10.1016/j.cub.2005.08.034; Stewart AD, 2002, GENETICS, V160, P975; Stiernagle T., 1999, MAINTENANCE C ELEGAN; Teotonio H, 2006, EVOLUTION, V60, P1300, DOI 10.1111/j.0014-3820.2006.tb01207.x; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Wegewitz Viktoria, 2008, BMC Ecology, V8, P12, DOI 10.1186/1472-6785-8-12; Weir BS., 1996, GENETIC DATA ANAL; ZIEHE M, 1989, GENETICS, V121, P861	60	59	59	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35811	10.1371/journal.pone.0035811	http://dx.doi.org/10.1371/journal.pone.0035811			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540006	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341000072
J	Firn, J; Prober, SM; Buckley, YM				Firn, Jennifer; Prober, Suzanne M.; Buckley, Yvonne M.			Plastic Traits of an Exotic Grass Contribute to Its Abundance but Are Not Always Favourable	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; INVASIVE PLANTS; RESOURCE-USE; LEAF-AREA; FRAMEWORK; ECOSYSTEMS; COMMUNITIES; DISTURBANCE; PASSENGERS; DIVERSITY	In herbaceous ecosystems worldwide, biodiversity has been negatively impacted by changed grazing regimes and nutrient enrichment. Altered disturbance regimes are thought to favour invasive species that have a high phenotypic plasticity, although most studies measure plasticity under controlled conditions in the greenhouse and then assume plasticity is an advantage in the field. Here, we compare trait plasticity between three co-occurring, C-4 perennial grass species, an invader Eragrostis curvula, and natives Eragrostis sororia and Aristida personata to grazing and fertilizer in a three-year field trial. We measured abundances and several leaf traits known to correlate with strategies used by plants to fix carbon and acquire resources, i.e. specific leaf area (SLA), leaf dry matter content (LDMC), leaf nutrient concentrations (N, C:N, P), assimilation rates (Amax) and photosynthetic nitrogen use efficiency (PNUE). In the control treatment (grazed only), trait values for SLA, leaf C:N ratios, Amax and PNUE differed significantly between the three grass species. When trait values were compared across treatments, E. curvula showed higher trait plasticity than the native grasses, and this correlated with an increase in abundance across all but the grazed/fertilized treatment. The native grasses showed little trait plasticity in response to the treatments. Aristida personata decreased significantly in the treatments where E. curvula increased, and E. sororia abundance increased possibly due to increased rainfall and not in response to treatments or invader abundance. Overall, we found that plasticity did not favour an increase in abundance of E. curvula under the grazed/fertilized treatment likely because leaf nutrient contents increased and subsequently its' palatability to consumers. E. curvula also displayed a higher resource use efficiency than the native grasses. These findings suggest resource conditions and disturbance regimes can be manipulated to disadvantage the success of even plastic exotic species.	[Firn, Jennifer] Queensland Univ Technol, Sch Earth Environm & Biol Sci, Brisbane, Qld 4001, Australia; [Prober, Suzanne M.] CSIRO, Ecosyst Sci, Wembley, WA, Australia; [Buckley, Yvonne M.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Buckley, Yvonne M.] Ecosyst Sci CSIRO, Dutton Pk, Qld, Australia	Queensland University of Technology (QUT); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Firn, J (corresponding author), Queensland Univ Technol, Sch Earth Environm & Biol Sci, Brisbane, Qld 4001, Australia.	jennifer.firn@qut.edu.au	Prober, Suzanne/G-6465-2010; Buckley, Yvonne/B-1281-2008	Prober, Suzanne/0000-0002-6518-239X; Buckley, Yvonne/0000-0001-7599-3201; Firn, Jennifer/0000-0001-6026-8912	Australian Research Council [DP0771387]; CSIRO Ecosystem Sciences	Australian Research Council(Australian Research Council); CSIRO Ecosystem Sciences	Thank you to CSIRO Ecosystem Sciences and Australian Research Council (YB, DP0771387) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CH, 2011, PERSPECT PLANT ECOL, V13, P217, DOI 10.1016/j.ppees.2011.04.003; Albert CH, 2010, J ECOL, V98, P604, DOI 10.1111/j.1365-2745.2010.01651.x; Anderson E, 2003, PLANTS CENTRAL QUEEN; [Anonymous], 1986, ECOLOGY BIOL INVASIO; Baker HG, 1964, GENETICS COLONIZING, P147; Baruch Z, 1999, OECOLOGIA, V121, P183, DOI 10.1007/s004420050920; Biggs A, 1999, CENTRAL DARLING LAND; Burns JH, 2006, BIOL INVASIONS, V8, P797, DOI 10.1007/s10530-005-3838-5; Chesson P, 2004, OECOLOGIA, V141, P236, DOI 10.1007/s00442-004-1551-1; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Durand LZ, 2001, AM FERN J, V91, P25, DOI 10.1640/0002-8444(2001)091[0025:GLCASP]2.0.CO;2; Elton C. S., 1958, ECOLOGY INVASIONS AN; EVERSON CS, 1987, VEGETATIO, V73, P47, DOI 10.1007/BF00031850; Firn J, 2008, J APPL ECOL, V45, P1143, DOI 10.1111/j.1365-2664.2008.01510.x; Firn J, 2010, J APPL ECOL, V47, P96, DOI 10.1111/j.1365-2664.2009.01741.x; Firn J, 2009, TROP GRASSLANDS, V43, P86; Funk JL, 2008, J ECOL, V96, P1162, DOI 10.1111/j.1365-2745.2008.01435.x; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; Garnier E, 2001, FUNCT ECOL, V15, P688, DOI 10.1046/j.0269-8463.2001.00563.x; Godoy O, 2011, FUNCTIONAL ECOLOGY, V25, P1428; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Grotkopp E, 2002, AM NAT, V159, P396, DOI 10.1086/338995; Gulias J, 2003, ANN BOT-LONDON, V92, P215, DOI 10.1093/aob/mcg123; HENRY DR, 1995, PASTURE PLANTS SO IN; HilleRisLambers J, 2010, J ECOL, V98, P1147, DOI 10.1111/j.1365-2745.2010.01706.x; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; HOBBS RJ, 1988, AUST J ECOL, V13, P171, DOI 10.1111/j.1442-9993.1988.tb00966.x; Hulme PE, 2008, FUNCT ECOL, V22, P3, DOI 10.1111/j.1365-2435.2007.01369.x; Ives AR, 2006, ECOL APPL, V16, P20, DOI 10.1890/04-0702; LEIGH J. H., 1968, Plant Introduction Review, C.S.I.R.O., V5, P21; Leishman MR, 2007, NEW PHYTOL, V176, P635, DOI 10.1111/j.1469-8137.2007.02189.x; Leishman MR, 2010, J ECOL, V98, P28, DOI 10.1111/j.1365-2745.2009.01608.x; MacDougall AS, 2005, ECOLOGY, V86, P42, DOI 10.1890/04-0669; McIntyre S, 2005, AUST J BOT, V53, P757, DOI 10.1071/BT05088; McIntyre S., 2006, AGR ECOSYST ENVIRON, V2007, P11; Melbourne BA, 2007, ECOL LETT, V10, P77, DOI 10.1111/j.1461-0248.2006.00987.x; Mitchell M, 2002, NATIVE GRASSES IDENT; Moles AT, 2008, J ECOL, V96, P13, DOI 10.1111/j.1365-2745.2007.01332.x; Muth NZ, 2007, J ECOL, V95, P1001, DOI 10.1111/j.1365-2745.2007.01268.x; Pickett STA, 2009, APPL VEG SCI, V12, P9, DOI 10.1111/j.1654-109X.2009.01019.x; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pysek P., 2007, BIOL INVASIONS; Rasband W., 2006, IMAGEJ; Raymont GE, 1992, AUSTR HDB SOIL WATER; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Reuter DJ, 1986, PLANT ANAL INTERPRET; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Rout ME, 2009, SCIENCE, V324, P734, DOI 10.1126/science.1173651; Sax DF, 2000, GLOBAL ECOL BIOGEOGR, V9, P363, DOI 10.1046/j.1365-2699.2000.00217.x; Seabloom EW, 2003, P NATL ACAD SCI USA, V100, P13384, DOI 10.1073/pnas.1835728100; Sharp D, 2002, AUSGRASS GRASSES AUS; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Suding KN, 2001, ECOLOGY, V82, P2133, DOI 10.2307/2680221; Thompson K, 2011, TRENDS ECOL EVOL, V26, P155, DOI 10.1016/j.tree.2011.01.007; Voight PW, 1968, AGRON J, V62, P673; Westoby M, 2006, TRENDS ECOL EVOL, V21, P261, DOI 10.1016/j.tree.2006.02.004; Wright IJ, 2005, NEW PHYTOL, V166, P485, DOI 10.1111/j.1469-8137.2005.01349.x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Zavaleta ES, 2001, TRENDS ECOL EVOL, V16, P454, DOI 10.1016/S0169-5347(01)02194-2; Zou J, 2007, FUNCT ECOL, V21, P721, DOI 10.1111/j.1365-2435.2007.01298.x	65	20	20	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35870	10.1371/journal.pone.0035870	http://dx.doi.org/10.1371/journal.pone.0035870			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536448	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200121
J	Gomez, CE; Perdiguero, B; Jimenez, V; Filali-Mouhim, A; Ghneim, K; Haddad, EK; Quakkerlaar, ED; Delaloye, J; Harari, A; Roger, T; Dunhen, T; Sekaly, RP; Melief, CJM; Calandra, T; Sallusto, F; Lanzavecchia, A; Wagner, R; Pantaleo, G; Esteban, M				Elena Gomez, Carmen; Perdiguero, Beatriz; Jimenez, Victoria; Filali-Mouhim, Abdelali; Ghneim, Khader; Haddad, Elias K.; Quakkerlaar, Esther D.; Delaloye, Julie; Harari, Alexandre; Roger, Thierry; Dunhen, Thomas; Sekaly, Rafick P.; Melief, Cornelis J. M.; Calandra, Thierry; Sallusto, Federica; Lanzavecchia, Antonio; Wagner, Ralf; Pantaleo, Giuseppe; Esteban, Mariano			Systems Analysis of MVA-C Induced Immune Response Reveals Its Significance as a Vaccine Candidate against HIV/AIDS of Clade C	PLOS ONE			English	Article							T-CELL RESPONSES; POXVIRUS VECTORS MVA; VIRUS ANKARA; DENDRITIC CELLS; HIV-1 INFECTION; PHASE-1 SAFETY; DNA PRIME; IMMUNOGENICITY; NYVAC; ANTIGENS	Based on the partial efficacy of the HIV/AIDS Thai trial (RV144) with a canarypox vector prime and protein boost, attenuated poxvirus recombinants expressing HIV-1 antigens are increasingly sought as vaccine candidates against HIV/AIDS. Here we describe using systems analysis the biological and immunological characteristics of the attenuated vaccinia virus Ankara strain expressing the HIV-1 antigens Env/Gag-Pol-Nef of HIV-1 of clade C (referred as MVA-C). MVA-C infection of human monocyte derived dendritic cells (moDCs) induced the expression of HIV-1 antigens at high levels from 2 to 8 hpi and triggered moDCs maturation as revealed by enhanced expression of HLA-DR, CD86, CD40, HLA-A2, and CD80 molecules. Infection ex vivo of purified mDC and pDC with MVA-C induced the expression of immunoregulatory pathways associated with antiviral responses, antigen presentation, T cell and B cell responses. Similarly, human whole blood or primary macrophages infected with MVA-C express high levels of proinflammatory cytokines and chemokines involved with T cell activation. The vector MVA-C has the ability to cross-present antigens to HIV-specific CD8 T cells in vitro and to increase CD8 T cell proliferation in a dose-dependent manner. The immunogenic profiling in mice after DNA-C prime/MVA-C boost combination revealed activation of HIV-1-specific CD4 and CD8 T cell memory responses that are polyfunctional and with effector memory phenotype. Env-specific IgG binding antibodies were also produced in animals receiving DNA-C prime/MVA-C boost. Our systems analysis of profiling immune response to MVA-C infection highlights the potential benefit of MVA-C as vaccine candidate against HIV/AIDS for clade C, the prevalent subtype virus in the most affected areas of the world.	[Elena Gomez, Carmen; Perdiguero, Beatriz; Jimenez, Victoria; Esteban, Mariano] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain; [Filali-Mouhim, Abdelali; Ghneim, Khader; Haddad, Elias K.; Sekaly, Rafick P.] Vaccine & Gene Therapy Inst Florida, Port St Lucie, FL USA; [Quakkerlaar, Esther D.; Melief, Cornelis J. M.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Delaloye, Julie; Roger, Thierry; Calandra, Thierry] CHU Vaudois, Dept Med, Infect Dis Serv, CH-1011 Lausanne, Switzerland; [Delaloye, Julie; Roger, Thierry; Calandra, Thierry] Univ Lausanne, Lausanne, Switzerland; [Harari, Alexandre; Pantaleo, Giuseppe] CHU Vaudois, Div Immunol & Allergy, CH-1011 Lausanne, Switzerland; [Dunhen, Thomas; Sallusto, Federica; Lanzavecchia, Antonio] Biomed Res Inst, Bellinzona, Switzerland; [Wagner, Ralf] Univ Regensburg, Regensburg, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Vaccine & Gene Therapy Institute of Florida; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Universita della Svizzera Italiana; University of Regensburg	Gomez, CE (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain.	mesteban@cnb.csic.es	Gomez, Carmen Elena/K-1940-2014; Perdiguero, Beatriz/K-6587-2017; Roger, Thierry/G-2007-2012; Esteban, Mariano/ABG-5375-2020; Calandra, Thierry/D-9017-2015; Pantaleo, Giuseppe/K-6163-2016	Gomez, Carmen Elena/0000-0002-5414-7935; Perdiguero, Beatriz/0000-0001-6276-7766; Roger, Thierry/0000-0002-9358-0109; Esteban, Mariano/0000-0003-0846-2827; Calandra, Thierry/0000-0003-3051-1285; Harari, Alexandre/0000-0002-1055-2090	Bill & Melinda Gates Foundation; SAF [2008-02036]; Swiss National Science Foundation [313600-115680]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); SAF; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was conducted as part of the Poxvirus T Cell Vaccine Discovery Consortium (PTVDC) under the Collaboration for AIDS Vaccine Discovery with support from the Bill & Melinda Gates Foundation and by Spanish grant SAF 2008-02036. JD was supported by a grant from the Swiss National Science Foundation (number 313600-115680). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 1995, J ROY STAT SOC, V57, P289; Clark RH, 2006, J GEN VIROL, V87, P29, DOI 10.1099/vir.0.81417-0; Climent N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019644; Currier JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013983; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; Gomez CE, 2007, VACCINE, V25, P1969, DOI 10.1016/j.vaccine.2006.11.051; Gomez CE, 2011, J VIROL, V85, P11468, DOI 10.1128/JVI.05165-11; Flynn BJ, 2011, P NATL ACAD SCI USA, V108, P7131, DOI 10.1073/pnas.1103869108; Garcia F, 2011, VACCINE, V29, P8309, DOI 10.1016/j.vaccine.2011.08.098; Garcia-Arriaza J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024244; Garcia-Arriaza J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012395; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goepfert PA, 2011, J INFECT DIS, V203, P610, DOI 10.1093/infdis/jiq105; Gomez CE, 2011, CURR GENE THER, V11, P189; Gomez CE, 2009, VACCINE, V27, P3165, DOI 10.1016/j.vaccine.2009.03.049; Gomez CE, 2007, VACCINE, V25, P2863, DOI 10.1016/j.vaccine.2006.09.090; Guerra S, 2007, J VIROL, V81, P8707, DOI 10.1128/JVI.00444-07; Guerra S, 2010, J VIROL, V84, P8141, DOI 10.1128/JVI.00749-10; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Harari A, 2007, P NATL ACAD SCI USA, V104, P16233, DOI 10.1073/pnas.0707570104; Keefer MC, 2011, VACCINE, V29, P1948, DOI 10.1016/j.vaccine.2010.12.104; Kibler KV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025674; Kresge KJ, 2011, IAVI REP, V15, P4; Najera JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011406; McCormack S, 2008, VACCINE, V26, P3162, DOI 10.1016/j.vaccine.2008.02.072; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; Mooij P, 2008, J VIROL, V82, P2975, DOI 10.1128/JVI.02216-07; Pantaleo G, 2010, CURR OPIN HIV AIDS, V5, P391, DOI 10.1097/COH.0b013e32833d1e87; Pascutti MF, 2011, J VIROL, V85, P5532, DOI 10.1128/JVI.02267-10; Quakkelaar ED, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016819; Ramanathan VD, 2009, AIDS RES HUM RETROV, V25, P1107, DOI 10.1089/aid.2009.0096; Ramirez JC, 2000, J VIROL, V74, P923, DOI 10.1128/JVI.74.2.923-933.2000; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Sandstrom E, 2008, J INFECT DIS, V198, P1482, DOI 10.1086/592507; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Staib C, 2005, J GEN VIROL, V86, P1997, DOI 10.1099/vir.0.80646-0; Vasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008816; Zhu YP, 2011, P NATL ACAD SCI USA, V108, P15834, DOI 10.1073/pnas.1101676108	40	21	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35485	10.1371/journal.pone.0035485	http://dx.doi.org/10.1371/journal.pone.0035485			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536391	Green Published, gold			2022-12-25	WOS:000305336200045
J	Guntas, G; Kanwar, M; Ostermeier, M				Guntas, Gurkan; Kanwar, Manu; Ostermeier, Marc			Circular Permutation in the Omega-Loop of TEM-1 beta-Lactamase Results in Improved Activity and Altered Substrate Specificity	PLOS ONE			English	Article							LIPASE-B; CANDIDA-ANTARCTICA; PROTEIN SWITCHES; MUTAGENESIS; INSERTION; EVOLUTION	Generating diverse protein libraries that contain improved variants at a sufficiently high frequency is critical for improving the properties of proteins using directed evolution. Many studies have illustrated how random mutagenesis, cassette mutagenesis, DNA shuffling and similar approaches are effective diversity generating methods for directed evolution. Very few studies have explored random circular permutation, the intramolecular relocation of the N- and C-termini of a protein, as a diversity-generating step for directed evolution. We subjected a library of random circular permutations of TEM-1 beta-lactamase to selections on increasing concentrations of a variety of beta-lactam antibiotics including cefotaxime. We identified two circularly permuted variants that conferred elevated resistance to cefotaxime but decreased resistance to other antibiotics. These variants were circularly permuted in the Omega-loop proximal to the active site. Remarkably, one variant was circularly permuted such that the key catalytic residue Glu166 was located at the N- terminus of the mature protein.	[Guntas, Gurkan; Kanwar, Manu; Ostermeier, Marc] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA	Johns Hopkins University	Guntas, G (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA.	oster@jhu.edu	Ostermeier, Marc/A-2697-2010	Ostermeier, Marc/0000-0003-0900-3665	National Institute of General Medicine at the National Institutes of Health [R01 GM066972]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066972] Funding Source: NIH RePORTER	National Institute of General Medicine at the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institute of General Medicine at the National Institutes of Health (R01 GM066972). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Bosley AD, 2005, BIOMOL ENG, V22, P57, DOI 10.1016/j.bioeng.2004.11.002; Cheltsov AV, 2001, J BIOL CHEM, V276, P19141, DOI 10.1074/jbc.M100329200; Fisher JF, 2009, CURR PROTEIN PEPT SC, V10, P401, DOI 10.2174/138920309789351967; Graf R, 1996, P NATL ACAD SCI USA, V93, P11591, DOI 10.1073/pnas.93.21.11591; Guntas G, 2005, P NATL ACAD SCI USA, V102, P11224, DOI 10.1073/pnas.0502673102; Guntas G, 2004, CHEM BIOL, V11, P1483, DOI 10.1016/j.chembiol.2004.08.020; Hayes F, 1997, J BIOL CHEM, V272, P28833, DOI 10.1074/jbc.272.46.28833; Iwakura M, 2000, NAT STRUCT BIOL, V7, P580, DOI 10.1038/76811; MEISTER GE, 2009, PROTEIN ENG HDB; Minasov G, 2002, J AM CHEM SOC, V124, P5333, DOI 10.1021/ja0259640; Ostermeier M, 1999, NAT BIOTECHNOL, V17, P1205, DOI 10.1038/70754; Ostermeier M, 2005, PROTEIN ENG DES SEL, V18, P359, DOI 10.1093/protein/gzi048; Ostermeier M, 1999, P NATL ACAD SCI USA, V96, P3562, DOI 10.1073/pnas.96.7.3562; Osuna J, 2002, PROTEIN ENG, V15, P463, DOI 10.1093/protein/15.6.463; Petrosino JF, 1996, J BACTERIOL, V178, P1821, DOI 10.1128/jb.178.7.1821-1828.1996; Qian Z, 2005, J AM CHEM SOC, V127, P13466, DOI 10.1021/ja053932h; Qian Z, 2007, CHEMBIOCHEM, V8, P1989, DOI 10.1002/cbic.200700373; Qian Z, 2009, J MOL BIOL, V393, P191, DOI 10.1016/j.jmb.2009.08.008; Reitinger S, 2010, BIOCHEMISTRY-US, V49, P2464, DOI 10.1021/bi100036f; Salverda MLM, 2010, FEMS MICROBIOL REV, V34, P1015, DOI 10.1111/j.1574-6976.2010.00222.x; Topell S, 1999, FEBS LETT, V457, P283, DOI 10.1016/S0014-5793(99)01044-3; Yu Y, 2010, BIOTECHNOL BIOENG, V105, P44, DOI 10.1002/bit.22471	23	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35998	10.1371/journal.pone.0035998	http://dx.doi.org/10.1371/journal.pone.0035998			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536452	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336200071
J	Pempe, EH; Xu, YM; Gopalakrishnan, S; Liu, J; Harris, EN				Pempe, Elizabeth H.; Xu, Yongmei; Gopalakrishnan, Sandhya; Liu, Jian; Harris, Edward N.			Probing Structural Selectivity of Synthetic Heparin Binding to Stabilin Protein Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATIVELY ACTIVATED MACROPHAGES; MOLECULAR-WEIGHT HEPARINS; HYALURONAN RECEPTOR; DERMATAN SULFATE; EXPRESSION; CLEARANCE; 3-O-SULFOTRANSFERASE; SPECIFICITY; SITES	As one of the most widely used drugs worldwide, heparin is an essential anticoagulant required for surgery, dialysis, treatment of thrombosis, cancer, and general circulatory management. Stabilin-2 is a scavenger clearance receptor with high expression in the sinusoidal endothelium of liver. It is believed that Stabilin-2 is the primary receptor for the clearance of unfractionated and low molecular weight heparins in the liver. Here, we identify the modifications and length of the heparin polymer that are required for binding and endocytosis by both human Stabilin receptors: Stabilin-2 and its homolog Stabilin-1 (also found in liver endothelium). Using enzymatically synthesized S-35-labeled heparan sulfate oligomers, we identified that sulfation of the 3-OH position of N-sulfated glucosamine (GlcNS) is the most beneficial modification for binding and endocytosis via both Stabilin receptors. In addition, our data suggest that a decasaccharide is the minimal size for binding to the Stabilin receptors. These findings define the physical parameters of the heparin structure required for efficient clearance from blood circulation. These results will also aid in the design of synthetic heparins with desired clearance rates.	[Gopalakrishnan, Sandhya; Harris, Edward N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Pempe, Elizabeth H.; Xu, Yongmei; Liu, Jian] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA	University of Nebraska System; University of Nebraska Lincoln; University of North Carolina; University of North Carolina Chapel Hill	Harris, EN (corresponding author), Univ Nebraska, Dept Biochem, 1901 Vine St, Lincoln, NE 68588 USA.	eharris5@unl.edu		Chappell, Elizabeth/0000-0003-4491-0631	National Institutes of Health [1R01HL094463, F31AG040927-01]; University of Nebraska; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG040927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Nebraska; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01HL094463 (to J. L.). This work was also supported by funds from the University of Nebraska (to E. N. H.).; A recipient of the Ruth L. Kirschstein National Research Service Award for Individuals Predoctoral Fellowships from the National Institutes of Health (F31AG040927-01).	ATHA DH, 1985, BIOCHEMISTRY-US, V24, P6723, DOI 10.1021/bi00344a063; Chen JH, 2005, J BIOL CHEM, V280, P42817, DOI 10.1074/jbc.M504338200; Chen J, 2007, CHEM BIOL, V14, P986, DOI 10.1016/j.chembiol.2007.07.015; Dinwoodey DL, 2006, CLIN GERIATR MED, V22, P1, DOI 10.1016/j.cger.2005.09.007; Falkowski M, 2003, HISTOCHEM CELL BIOL, V120, P361, DOI 10.1007/s00418-003-0585-5; GOERDT S, 1993, AM J PATHOL, V142, P1409; Hansen B, 2005, EXP CELL RES, V303, P160, DOI 10.1016/j.yexcr.2004.09.017; Harris EN, 2008, GLYCOBIOLOGY, V18, P638, DOI 10.1093/glycob/cwn045; Harris EN, 2008, J BIOL CHEM, V283, P17341, DOI 10.1074/jbc.M710360200; Harris EN, 2007, J BIOL CHEM, V282, P2785, DOI 10.1074/jbc.M607787200; Harris EN, 2004, J BIOL CHEM, V279, P36201, DOI 10.1074/jbc.M405322200; Hirsh J, 2007, CIRCULATION, V116, P552, DOI 10.1161/CIRCULATIONAHA.106.685974; Jacobs LG, 2003, J AM GERIATR SOC, V51, P1472, DOI 10.1046/j.1532-5415.2003.51469.x; Kzhyshkowska J, 2005, IMMUNOBIOLOGY, V210, P161, DOI 10.1016/j.imbio.2005.05.022; Kzhyshkowska J, 2008, J IMMUNOL, V180, P3028, DOI 10.4049/jimmunol.180.5.3028; Kzhyshkowska J, 2006, J CELL MOL MED, V10, P635, DOI 10.1111/j.1582-4934.2006.tb00425.x; Kzhyshkowska J, 2006, J IMMUNOL, V176, P5825, DOI 10.4049/jimmunol.176.10.5825; Lee SJ, 2011, BLOOD, V117, P5215, DOI 10.1182/blood-2010-10-313239; Liu J, 1996, J BIOL CHEM, V271, P27072, DOI 10.1074/jbc.271.43.27072; Liu J, 2007, APPL MICROBIOL BIOT, V74, P263, DOI 10.1007/s00253-006-0722-x; Liu RP, 2010, J BIOL CHEM, V285, P34240, DOI 10.1074/jbc.M110.159152; Moon AF, 2012, P NATL ACAD SCI USA, V109, P5265, DOI 10.1073/pnas.1117923109; Oie CI, 2008, AM J PHYSIOL-GASTR L, V294, pG520, DOI 10.1152/ajpgi.00489.2007; Olson ST, 2002, TRENDS CARDIOVAS MED, V12, P331, DOI 10.1016/S1050-1738(02)00183-4; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Park SY, 2009, J CELL SCI, V122, P3365, DOI 10.1242/jcs.049569; Penc SF, 1998, J BIOL CHEM, V273, P28116, DOI 10.1074/jbc.273.43.28116; Peterson S, 2009, NAT PROD REP, V26, P610, DOI 10.1039/b803795g; Prevo R, 2004, J BIOL CHEM, V279, P52580, DOI 10.1074/jbc.M406897200; Richard B, 2009, J BIOL CHEM, V284, P27054, DOI 10.1074/jbc.M109.029892; Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377; Schledzewski K, 2011, J CLIN INVEST, V121, P703, DOI 10.1172/JCI44740; Tamura Y, 2003, J BIOL CHEM, V278, P12613, DOI 10.1074/jbc.M210211200; Taylor KR, 2005, J BIOL CHEM, V280, P5300, DOI 10.1074/jbc.m410412200; Tobu M, 2004, CLIN APPL THROMB-HEM, V10, P301, DOI 10.1177/107602960401000402; Verhaeghe R, 1998, ACTA CARDIOL, V53, P15; Wary Kishore K, 2003, Mol Cancer, V2, P25, DOI 10.1186/1476-4598-2-25; Weitz JI, 2010, THROMB RES, V125, pS30, DOI 10.1016/S0049-3848(10)70009-8; Xia GQ, 2002, J BIOL CHEM, V277, P37912, DOI 10.1074/jbc.M204209200; Xu YM, 2011, SCIENCE, V334, P498, DOI 10.1126/science.1207478; Zhou B, 2000, J BIOL CHEM, V275, P37733, DOI 10.1074/jbc.M003030200; Zhou XX, 2011, GLYCOBIOLOGY, V21, P771, DOI 10.1093/glycob/cwr001	42	30	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20774	20783		10.1074/jbc.M111.320069	http://dx.doi.org/10.1074/jbc.M111.320069			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22547069	Green Published, hybrid			2022-12-25	WOS:000306416800002
J	Fernandes, H; Franklin, E; Jollivet, F; Bliedtner, K; Khan, AR				Fernandes, Humberto; Franklin, Edward; Jollivet, Florence; Bliedtner, Katharina; Khan, Amir R.			Mapping the Interactions between a RUN Domain from DENND5/Rab6IP1 and Sorting Nexin 1	PLOS ONE			English	Article							TRANS-GOLGI NETWORK; RAB6-INTERACTING PROTEIN-1; RAB PROTEINS; BINDING; RETROMER; IDENTIFICATION; GTPASES; MECHANISMS; CURVATURE; APPARATUS	Eukaryotic cells have developed a diverse repertoire of Rab GTPases to regulate vesicle trafficking pathways. Together with their effector proteins, Rabs mediate various aspects of vesicle formation, tethering, docking and fusion, but details of the biological roles elicited by effectors are largely unknown. Human Rab6 is involved in the trafficking of vesicles at the level of Golgi via interactions with numerous effector proteins. We have previously determined the crystal structure of Rab6 in complex with DENND5, alternatively called Rab6IP1, which comprises two RUN domains (RUN1 and RUN2) separated by a PLAT domain. The structure of Rab6/RUN1-PLAT (Rab6/R1P) revealed the molecular basis for Golgi recruitment of DENND5 via the RUN1 domain, but the functional role of the RUN2 domain has not been well characterized. Here we show that a soluble DENND5 construct encompassing the RUN2 domain binds to the N-terminal region of sorting nexin 1 by surface plasmon resonance analyses.	[Fernandes, Humberto; Franklin, Edward; Jollivet, Florence; Bliedtner, Katharina; Khan, Amir R.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland	Trinity College Dublin	Fernandes, H (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland.	Amir.Khan@tcd.ie		Khan, Amir/0000-0003-1176-6952; Franklin, Edward/0000-0003-0843-9635	Science Foundation Ireland [07.IN1.B975]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Science Foundation Ireland grant number 07.IN1.B975 to ARK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleem AM, 2008, J MOL BIOL, V376, P193, DOI 10.1016/j.jmb.2007.11.086; Angers CG, 2011, SEMIN CELL DEV BIOL, V22, P18, DOI 10.1016/j.semcdb.2010.07.003; Bateman A, 1999, CURR BIOL, V9, pR588, DOI 10.1016/S0960-9822(99)80380-7; Bergbrede T, 2009, J BIOL CHEM, V284, P2628, DOI 10.1074/jbc.M806003200; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Bujny MV, 2007, J CELL SCI, V120, P2010, DOI 10.1242/jcs.003111; Bycroft M, 1999, EMBO J, V18, P297, DOI 10.1093/emboj/18.2.297; Callebaut I, 2001, TRENDS BIOCHEM SCI, V26, P79, DOI 10.1016/S0968-0004(00)01730-8; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Collins BM, 2008, TRAFFIC, V9, P366, DOI 10.1111/j.1600-0854.2007.00688.x; Fernandes H, 2011, ACTA CRYSTALLOGR F, V67, P556, DOI 10.1107/S174430911100724X; Fernandes H, 2009, BIOCHEM SOC T, V37, P1037, DOI 10.1042/BST0371037; Fukuda M, 2011, CELL STRUCT FUNCT, V36, P155, DOI 10.1247/csf.11001; Goody RS, 2005, CELL MOL LIFE SCI, V62, P1657, DOI 10.1007/s00018-005-4486-8; Gullapalli A, 2004, MOL BIOL CELL, V15, P2143, DOI 10.1091/mbc.E03-09-0711; Janoueix-Lerosey I, 1998, EUR J BIOCHEM, V252, P290, DOI 10.1046/j.1432-1327.1998.2520290.x; JANOUEIXLEROSEY I, 1995, J BIOL CHEM, V270, P14801, DOI 10.1074/jbc.270.24.14801; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kukimoto-Niino M, 2006, J BIOL CHEM, V281, P31843, DOI 10.1074/jbc.M604960200; Kurten RC, 2001, J CELL SCI, V114, P1743; Lee MTG, 2009, TRAFFIC, V10, P1377, DOI 10.1111/j.1600-0854.2009.00942.x; Leung KF, 2006, J LIPID RES, V47, P467, DOI 10.1194/jlr.R500017-JLR200; Levivier E, 2001, BIOCHEM BIOPH RES CO, V287, P688, DOI 10.1006/bbrc.2001.5652; Miserey-Lenkei S, 2007, TRAFFIC, V8, P1385, DOI 10.1111/j.1600-0854.2007.00612.x; Opdam FJM, 2000, J CELL SCI, V113, P2725; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pylypenko O, 2007, EMBO J, V26, P4788, DOI 10.1038/sj.emboj.7601889; Recacha R, 2009, STRUCTURE, V17, P21, DOI 10.1016/j.str.2008.10.014; Seaman MNJ, 2002, MOL BIOL CELL, V13, P2826, DOI 10.1091/mbc.02-05-0064; Seet LF, 2006, BBA-MOL CELL BIOL L, V1761, P878, DOI 10.1016/j.bbalip.2006.04.011; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; VANWEERING JR, 2009, SEMIN CELL DEV BIOL; Wang SR, 2003, BRAIN RES REV, V41, P13, DOI 10.1016/S0165-0173(02)00217-5; Wassmer T, 2009, DEV CELL, V17, P110, DOI 10.1016/j.devcel.2009.04.016; Willenborg C, 2011, J CELL BIOL, V195, P71, DOI 10.1083/jcb.201011112; Yoshida H, 2011, FEBS LETT, V585, P1707, DOI 10.1016/j.febslet.2011.05.011; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; Young J, 2010, J MOL BIOL, V397, P69, DOI 10.1016/j.jmb.2010.01.009; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	41	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35637	10.1371/journal.pone.0035637	http://dx.doi.org/10.1371/journal.pone.0035637			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558185	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345200058
J	Ivliev, AE; 't Hoen, PAC; van Roon-Mom, WMC; Peters, DJM; Sergeeva, MG				Ivliev, Alexander E.; 't Hoen, Peter A. C.; van Roon-Mom, Willeke M. C.; Peters, Dorien J. M.; Sergeeva, Marina G.			Exploring the Transcriptome of Ciliated Cells Using In Silico Dissection of Human Tissues	PLOS ONE			English	Article							NETWORK ANALYSIS; MICROARRAY DATA; GENE; DISEASE; COEXPRESSION; EXPRESSION; CILIUM; ROLES; CONSERVATION; ORGANIZATION	Cilia are cell organelles that play important roles in cell motility, sensory and developmental functions and are involved in a range of human diseases, known as ciliopathies. Here, we search for novel human genes related to cilia using a strategy that exploits the previously reported tendency of cell type-specific genes to be coexpressed in the transcriptome of complex tissues. Gene coexpression networks were constructed using the noise-resistant WGCNA algorithm in 12 publicly available microarray datasets from human tissues rich in motile cilia: airways, fallopian tubes and brain. A cilia-related coexpression module was detected in 10 out of the 12 datasets. A consensus analysis of this module's gene composition recapitulated 297 known and predicted 74 novel cilia-related genes. 82% of the novel candidates were supported by tissue-specificity expression data from GEO and/or proteomic data from the Human Protein Atlas. The novel findings included a set of genes (DCDC2, DYX1C1, KIAA0319) related to a neurological disease dyslexia suggesting their potential involvement in ciliary functions. Furthermore, we searched for differences in gene composition of the ciliary module between the tissues. A multidrug-and-toxin extrusion transporter MATE2 (SLC47A2) was found as a brain-specific central gene in the ciliary module. We confirm the localization of MATE2 in cilia by immunofluorescence staining using MDCK cells as a model. While MATE2 has previously gained attention as a pharmacologically relevant transporter, its potential relation to cilia is suggested for the first time. Taken together, our large-scale analysis of gene coexpression networks identifies novel genes related to human cell cilia.	[Ivliev, Alexander E.; Sergeeva, Marina G.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia; ['t Hoen, Peter A. C.; van Roon-Mom, Willeke M. C.; Peters, Dorien J. M.] Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Leiden, Netherlands	Lomonosov Moscow State University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Ivliev, AE (corresponding author), Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia.	sergeeva@genebee.msu.ru	van Roon-Mom, Willeke/Y-3039-2018; Hoen, Peter A 't/D-3950-2018; Sergeeva, Marina/G-3439-2012; Peters, Dorien/AFH-8507-2022	van Roon-Mom, Willeke/0000-0002-3035-0533; Hoen, Peter A 't/0000-0003-4450-3112; Peters, Dorien/0000-0001-6974-7143; Sergeeva, Marina/0000-0003-3424-6431	Russian Foundation for Basic Research [RFBR-10-04-01385-a]; European Community's Seventh Framework Programme; ENGAGE project [HEALTH-F4-2007-201413]; Centre for Medical Systems Biology	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); European Community's Seventh Framework Programme(European Commission); ENGAGE project(General Electric); Centre for Medical Systems Biology	This research was supported by the Russian Foundation for Basic Research (grant RFBR-10-04-01385-a). Dr.'t Hoen was funded through the European Community's Seventh Framework Programme (FP7/2007-2013), ENGAGE project, grant agreement HEALTH-F4-2007-201413, and the Centre for Medical Systems Biology within the framework of The Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Arnaiz O, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-547; Arnaiz O, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap022; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Barrera NP, 2004, AM J PHYSIOL-CELL PH, V287, pC1114, DOI 10.1152/ajpcell.00343.2003; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Christensen ST, 2007, TRAFFIC, V8, P97, DOI 10.1111/j.1600-0854.2006.00516.x; Davis EE, 2006, DEV CELL, V11, P9, DOI 10.1016/j.devcel.2006.06.009; de la Fuente A, 2010, TRENDS GENET, V26, P326, DOI 10.1016/j.tig.2010.05.001; Del Bigio MR, 2010, ACTA NEUROPATHOL, V119, P55, DOI 10.1007/s00401-009-0624-y; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Efimenko E, 2005, DEVELOPMENT, V132, P1923, DOI 10.1242/dev.01775; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Geschwind DH, 2009, NATURE, V461, P908, DOI 10.1038/nature08537; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Glazer AM, 2010, DEV BIOL, V337, P148, DOI 10.1016/j.ydbio.2009.10.025; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Ibanez-Tallon I, 2003, HUM MOL GENET, V12, pR27, DOI 10.1093/hmg/ddg061; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Ivliev AE, 2008, NUCLEIC ACIDS RES, V36, pW327, DOI 10.1093/nar/gkn213; Ivliev AE, 2010, CANCER RES, V70, P10060, DOI 10.1158/0008-5472.CAN-10-2465; Jelier R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r96; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Lim WK, 2007, BIOINFORMATICS, V23, pI282, DOI 10.1093/bioinformatics/btm201; Marshall WF, 2008, J CELL BIOL, V180, P17, DOI 10.1083/jcb.200710085; Massinen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020580; Masuda S, 2006, J AM SOC NEPHROL, V17, P2127, DOI 10.1681/ASN.2006030205; McClintock TS, 2008, PHYSIOL GENOMICS, V32, P198, DOI 10.1152/physiolgenomics.00128.2007; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Naik MU, 2011, INT J BIOCHEM CELL B, V43, P120, DOI 10.1016/j.biocel.2010.10.003; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Palmer RE, 2002, CANCER CELL, V2, P497, DOI 10.1016/S1535-6108(02)00205-2; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Petryshen TL, 2009, CURR PSYCHIAT REP, V11, P149, DOI 10.1007/s11920-009-0023-z; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; Stewart AJ, 2007, NEUROENDOCRINOLOGY, V86, P243, DOI 10.1159/000107795; Stolc V, 2005, P NATL ACAD SCI USA, V102, P3703, DOI 10.1073/pnas.0408358102; Torkko JM, 2008, J CELL SCI, V121, P1193, DOI 10.1242/jcs.015495; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Yonezawa A, 2011, BRIT J PHARMACOL, V164, P1817, DOI 10.1111/j.1476-5381.2011.01394.x; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang JH, 2005, GENOMICS, V85, P297, DOI 10.1016/j.ygeno.2004.11.004	55	61	62	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35618	10.1371/journal.pone.0035618	http://dx.doi.org/10.1371/journal.pone.0035618			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558177	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345200054
J	Saldana, A; Pineda, V; Martinez, I; Santamaria, G; Santamaria, AM; Miranda, A; Calzada, JE				Saldana, Azael; Pineda, Vanessa; Martinez, Inri; Santamaria, Giovanna; Maria Santamaria, Ana; Miranda, Aracelis; Calzada, Jose E.			A New Endemic Focus of Chagas Disease in the Northern Region of Veraguas Province, Western Half Panama, Central America	PLOS ONE			English	Article							TRIATOMA-DIMIDIATA LATREILLE; TRYPANOSOMA-CRUZI; RHODNIUS-PALLESCENS; ECOLOGICAL ASPECTS; LATIN-AMERICA; COSTA-RICA; REDUVIIDAE; EPIDEMIOLOGY; CHALLENGES; INFECTION	Background: Chagas disease was originally reported in Panama in 1931. Currently, the best knowledge of this zoonosis is restricted to studies done in historically endemic regions. However, little is known about the distribution and epidemiology of Chagas disease in other rural areas of the country. Methods and Findings: A cross-sectional descriptive study was carried out between May 2005 - July 2008 in four rural communities of the Santa Fe District, Veraguas Province. The study included an entomologic search to collect triatomines, bloodmeal type identification and infection rate with trypanosomes in collected vectors using a dot-blot and PCR analysis, genotyping of circulating Trypanosoma cruzi (mini-exon gene PCR analysis) and the detection of chagasic antibodies among inhabitants. The vector Rhodnius pallescens was more frequently found in La Culaca and El Pantano communities (788 specimens), where it was a sporadic household visitor. These triatomines presented darker coloration and larger sizescompared with typical specimens collected in Central Panama. Triatoma dimidiata was more common in Sabaneta de El Macho (162 specimens). In one small sub-region (El Macho), 60% of the houses were colonized by this vector. Of the examined R. pallescens, 54.7.0% (88/161) had fed on Didelphis marsupialis, and 24.6% (34/138) of T. dimidiata specimens collected inside houses were positive for human blood. R. pallescens presented an infection index with T. cruzi of 17.7% (24/136), with T. rangeli of 12.5% (17/136) and 50.7% (69/136) were mixed infections. In 117 T. dimidiata domestic specimens the infection index with T. cruzi was 21.4%. Lineage I of T. cruzi was confirmed circulating in these vectors. A T. cruzi infection seroprevalence of 2.3% (24/1,056) was found in this population. Conclusions: This is the first report of Chagas disease endemicity in Santa Fe District, and it should be considered a neglected public health problem in this area of Panama.	[Saldana, Azael; Pineda, Vanessa; Maria Santamaria, Ana; Miranda, Aracelis; Calzada, Jose E.] ICGES, Secc Parasitol, Panama City, Panama; [Saldana, Azael] Univ Panama, Fac Med, CIDEP, Panama City, Panama; [Martinez, Inri] Minist Salud MINSA, Ctr Salud Santa Fe, Santiago, Veraguas, Panama; [Santamaria, Giovanna] Hosp Dr Luis Fabrega, Minist Salud Panama MINSA, Santiago, Veraguas, Panama	Universidad de Panama	Saldana, A (corresponding author), ICGES, Secc Parasitol, Panama City, Panama.	jcalzada@gorgas.gob.pa		Saldana, Azael/0000-0002-5653-1332	UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) [A304558]; Network for Research and Training of Tropical Diseases in Central America (NeTropica) [7-R-2008]; Instituto Conmemorativo Gorgas de Estudios de la Salud (ICGES); Sistema Nacional de Investigacion (SNI), SENACYT (Secretaria Nacional de Ciencia y Tecnologia), Panama	UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR); Network for Research and Training of Tropical Diseases in Central America (NeTropica); Instituto Conmemorativo Gorgas de Estudios de la Salud (ICGES); Sistema Nacional de Investigacion (SNI), SENACYT (Secretaria Nacional de Ciencia y Tecnologia), Panama	This investigation received financial support from UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) (A304558), Network for Research and Training of Tropical Diseases in Central America (NeTropica) (7-R-2008), Instituto Conmemorativo Gorgas de Estudios de la Salud (ICGES) and from the Sistema Nacional de Investigacion (SNI), SENACYT (Secretaria Nacional de Ciencia y Tecnologia), Panama. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bacigalupo A, 2010, MEM I OSWALDO CRUZ, V105, P633, DOI 10.1590/S0074-02762010000500006; Calzada JE, 2006, AM J TROP MED HYG, V74, P762, DOI 10.4269/ajtmh.2006.74.762; Calzada JE, 2010, AM J TROP MED HYG, V82, P580, DOI 10.4269/ajtmh.2010.09-0397; Vasquez Ana Maria de, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P217, DOI 10.1590/S0036-46652004000400008; Dias JCP, 2002, MEM I OSWALDO CRUZ, V97, P603, DOI 10.1590/S0074-02762002000500002; Gaunt M, 2000, MEM I OSWALDO CRUZ, V95, P557, DOI 10.1590/S0074-02762000000400019; Moreno ML, 2010, ACTA TROP, V113, P257, DOI 10.1016/j.actatropica.2009.11.007; Mendez E, 1979, REV MED PANAMA, V4, P258; Moncayo A, 2009, MEM I OSWALDO CRUZ, V104, P17, DOI 10.1590/S0074-02762009000900005; Noireau F, 1997, MEM I OSWALDO CRUZ, V92, P583, DOI 10.1590/S0074-02761997000500003; Pineda V, 2008, REV INST MED TROP SP, V50, P113, DOI 10.1590/S0036-46652008000200009; PIPKIN AC, 1968, J MED ENTOMOL, V5, P107, DOI 10.1093/jmedent/5.1.107; Ponce C, 2007, MEM I OSWALDO CRUZ, V102, P41, DOI 10.1590/S0074-02762007005000082; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Roellig DM, 2008, EMERG INFECT DIS, V14, P1123, DOI 10.3201/eid1407.080175; Rojas ME, 2008, CAD SAUDE PUBLICA, V24, P2323, DOI 10.1590/S0102-311X2008001000013; Saldana A, 1995, SCAND J IMMUNOL, V42, P644, DOI 10.1111/j.1365-3083.1995.tb03707.x; Samudio F, 2007, ACTA TROP, V101, P178, DOI 10.1016/j.actatropica.2006.12.008; Sousa OE, 2006, MEM I OSWALDO CRUZ, V101, P455, DOI 10.1590/S0074-02762006000400018; SOUSA OE, 1973, AM J TROP MED HYG, V22, P18, DOI 10.4269/ajtmh.1973.22.18; SOUSA OE, 1971, AM J TROP MED HYG, V20, P405, DOI 10.4269/ajtmh.1971.20.405; Souto RP, 1996, MOL BIOCHEM PARASIT, V83, P141, DOI 10.1016/S0166-6851(96)02755-7; Dias FBS, 2008, MEM I OSWALDO CRUZ, V103, P824, DOI 10.1590/S0074-02762008000800014; Tarleton RL, 2007, PLOS MED, V4, P1852, DOI 10.1371/journal.pmed.0040332; WHITLAW JT, 1978, AM J TROP MED HYG, V27, P873, DOI 10.4269/ajtmh.1978.27.873; Zeledon R, 2006, MEM I OSWALDO CRUZ, V101, P75, DOI 10.1590/S0074-02762006000100014; Zeledon R, 2008, MEM I OSWALDO CRUZ, V103, P619, DOI 10.1590/S0074-02762008000600020; Zeledon R, 2006, MEM I OSWALDO CRUZ, V101, P379, DOI 10.1590/S0074-02762006000400006	28	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e34657	10.1371/journal.pone.0034657	http://dx.doi.org/10.1371/journal.pone.0034657			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558095	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345200012
J	Purdy, MA; Lara, J; Khudyakov, YE				Purdy, Michael A.; Lara, James; Khudyakov, Yury E.			The Hepatitis E Virus Polyproline Region Is Involved in Viral Adaptation	PLOS ONE			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; MOLECULAR RECOGNITION FEATURES; WEB SERVER; HYPERVARIABLE REGION; SECONDARY STRUCTURE; PREDICTION; DISORDER; BINDING; DISCOVERY; ALIGNMENT	Genomes of hepatitis E virus (HEV), rubivirus and cutthroat virus (CTV) contain a region of high proline density and low amino acid (aa) complexity, named the polyproline region (PPR). In HEV genotypes 1, 3 and 4, it is the only region within the non-structural open reading frame (ORF1) with positive selection (4-10 codons with dN/dS>1). This region has the highest density of sites with homoplasy values >0.5. Genotypes 3 and 4 show similar to 3-fold increase in homoplastic density (HD) in the PPR compared to any other region in ORF1, genotype 1 does not exhibit significant HD (p>0.0001). PPR sequence divergence was found to be 2-fold greater for HEV genotypes 3 and 4 than for genotype 1. The data suggest the PPR plays an important role in host-range adaptation. Although the PPR appears to be hypervariable and homoplastic, it retains as much phylogenetic signal as any other similar sized region in the ORF1, indicating that convergent evolution operates within the major HEV phylogenetic lineages. Analyses of sequence-based secondary structure and the tertiary structure identify PPR as an intrinsically disordered region (IDR), implicating its role in regulation of replication. The identified propensity for the disorder-to-order state transitions indicates the PPR is involved in protein-protein interactions. Furthermore, the PPR of all four HEV genotypes contains seven putative linear binding motifs for ligands involved in the regulation of a wide number of cellular signaling processes. Structure-based analysis of possible molecular functions of these motifs showed the PPR is prone to bind a wide variety of ligands. Collectively, these data suggest a role for the PPR in HEV adaptation. Particularly as an IDR, the PPR likely contributes to fine tuning of viral replication through protein-protein interactions and should be considered as a target for development of novel anti-viral drugs.	[Purdy, Michael A.; Lara, James; Khudyakov, Yury E.] Ctr Dis Control & Prevent, Natl Ctr HIV Hepatitis STD TB Prevent, Div Viral Hepatitis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Purdy, MA (corresponding author), Ctr Dis Control & Prevent, Natl Ctr HIV Hepatitis STD TB Prevent, Div Viral Hepatitis, Atlanta, GA 30333 USA.	mup3@cdc.gov			Division of Viral Hepatitis, Center for Disease Control	Division of Viral Hepatitis, Center for Disease Control	This research was funded completely with programmatic funds from the Division of Viral Hepatitis, Center for Disease Control. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors conceived of this project, conducted experiments as conceived and analyzed the data. No outside influence was used to modify our data or conclusions in any way.	Arankalle VA, 2006, J VIRAL HEPATITIS, V13, P742, DOI 10.1111/j.1365-2893.2006.00759.x; Arankalle VA, 1999, J GEN VIROL, V80, P1691, DOI 10.1099/0022-1317-80-7-1691; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Batts W, 2011, VIRUS RES, V158, P116, DOI 10.1016/j.virusres.2011.03.019; Chatterjee R, 1997, AFRICAN STRAINS HEPA; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dosztanyi Z, 2006, J PROTEOME RES, V5, P2985, DOI 10.1021/pr060171o; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; EMERSON SU, 2004, VIRUS TAXONOMY, P853; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; Khuroo MS, 2011, VIRUS RES, V161, P3, DOI 10.1016/j.virusres.2011.02.007; KOONIN EV, 1992, P NATL ACAD SCI USA, V89, P8259, DOI 10.1073/pnas.89.17.8259; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Legrand-Abravanel F, 2009, EMERG INFECT DIS, V15, P110, DOI 10.3201/eid1501.080296; Li X, 2011, MUTAT RES; Liu HQ, 2009, J VIROL, V83, P1981, DOI 10.1128/JVI.01897-08; Meng XJ, 2011, VIRUS RES, V161, P23, DOI 10.1016/j.virusres.2011.01.016; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; NCBI, 2011, PFAM12526 DUF3729 CO; Nguyen HT, 2011, J GEN VIROL, DOI [10.1099/vir.1090.037259-037250, DOI 10.1099/VIR.1090.037259-037250]; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Pudupakam RS, 2011, J VIROL, V85, P10031, DOI 10.1128/JVI.00763-11; Pudupakam RS, 2009, J VIROL, V83, P384, DOI 10.1128/JVI.01854-08; Puigbo P, 2007, BIOINFORMATICS, V23, P1556, DOI 10.1093/bioinformatics/btm135; Purcell Robert H, 2010, J Infect Dis, V202, P819, DOI 10.1086/655900; Purdy MA, 2011, VIRUS RES, V161, P31, DOI 10.1016/j.virusres.2011.04.030; Ren S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S26; Ropp SL, 2000, ARCH VIROL, V145, P1321, DOI 10.1007/s007050070093; Roy A, 2011, RECOGNIZING PR UNPUB; Roy A, 2011, JOVE-J VIS EXP, DOI 10.3791/3259; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schlessinger A, 2007, BIOINFORMATICS, V23, P2376, DOI 10.1093/bioinformatics/btm349; Shukla P, 2011, P NATL ACAD SCI USA, V108, P2438, DOI 10.1073/pnas.1018878108; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Takahashi M, 2011, J GEN VIROL, V92, P902, DOI 10.1099/vir.0.029470-0; Teshale EH, 2010, CLIN INFECT DIS, V51, P328, DOI 10.1086/653943; Tettamanzi MC, 2006, PROTEIN SCI, V15, P498, DOI 10.1110/ps.051901806; Tompa P, 2003, BIOESSAYS, V25, P847, DOI 10.1002/bies.10324; Tsai CJ, 2001, PROTEINS, V44, P418, DOI 10.1002/prot.1107; TSAREV SA, 1992, P NATL ACAD SCI USA, V89, P559, DOI 10.1073/pnas.89.2.559; Tzeng WP, 2001, VIROLOGY, V289, P63, DOI 10.1006/viro.2001.1088; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Vucetic S, 2003, PROTEINS, V52, P573, DOI 10.1002/prot.10437; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	66	60	61	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35974	10.1371/journal.pone.0035974	http://dx.doi.org/10.1371/journal.pone.0035974			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545153	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343200073
J	Yurchenko, E; Shio, MT; Huang, TC; Martins, MD; Szyf, M; Levings, MK; Olivier, M; Piccirillo, CA				Yurchenko, Ekaterina; Shio, Marina T.; Huang, Tony C.; Martins, Maria Da Silva; Szyf, Moshe; Levings, Megan K.; Olivier, Martin; Piccirillo, Ciriaco A.			Inflammation-Driven Reprogramming of CD4(+)Foxp3(+) Regulatory T Cells into Pathogenic Th1/Th17 T Effectors Is Abrogated by mTOR Inhibition in vivo	PLOS ONE			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; TRANSCRIPTION FACTOR FOXP3; LEISHMANIA-MAJOR; CUTTING EDGE; TH17 CELLS; LINEAGE; T(H)17; DIFFERENTIATION; GENERATION; EXPRESSION	While natural CD4(+)Foxp3(+) regulatory T (nT(REG)) cells have long been viewed as a stable and distinct lineage that is committed to suppressive functions in vivo, recent evidence supporting this notion remains highly controversial. We sought to determine whether Foxp3 expression and the nT(REG) cell phenotype are stable in vivo and modulated by the inflammatory microenvironment. Here, we show that Foxp3(+) nT(REG) cells from thymic or peripheral lymphoid organs reveal extensive functional plasticity in vivo. We show that nT(REG) cells readily lose Foxp3 expression, destabilizing their phenotype, in turn, enabling them to reprogram into Th1 and Th17 effector cells. nT(REG) cell reprogramming is a characteristic of the entire Foxp3(+) nT(REG) population and the stable Foxp3(NEG) T-REG cell phenotype is associated with a methylated foxp3 promoter. The extent of nT(REG) cell reprogramming is modulated by the presence of effector T cell-mediated signals, and occurs independently of variation in IL-2 production in vivo. Moreover, the gut microenvironment or parasitic infection favours the reprogramming of Foxp3(+) T-REG cells into effector T cells and promotes host immunity. IL-17 is predominantly produced by reprogrammed Foxp3(+) nT(REG) cells, and precedes Foxp3 down-regulation, a process accentuated in mesenteric sites. Lastly, mTOR inhibition with the immunosuppressive drug, rapamycin, stabilizes Foxp3 expression in T-REG cells and strongly inhibits IL-17 but not ROR gamma t expression in reprogrammed Foxp3(-) T-REG cells. Overall, inflammatory signals modulate mTOR signalling and influence the stability of the Foxp3(+) nT(REG) cell phenotype.	[Yurchenko, Ekaterina; Shio, Marina T.; Martins, Maria Da Silva; Olivier, Martin; Piccirillo, Ciriaco A.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Yurchenko, Ekaterina; Shio, Marina T.; Martins, Maria Da Silva; Olivier, Martin; Piccirillo, Ciriaco A.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Huang, Tony C.; Szyf, Moshe; Olivier, Martin] McGill Univ, Dept Pharmacol, Montreal, PQ H3A 2T5, Canada; [Levings, Megan K.] Univ British Columbia, Dept Surg, Child & Family Res Inst, Vancouver, BC V6T 1W5, Canada; [Piccirillo, Ciriaco A.] McGill Univ, Res Inst, Ctr Hlth, FOCIS Ctr Excellence, Montreal, PQ, Canada	McGill University; McGill University; McGill University; Child & Family Research Institute; University of British Columbia; McGill University	Yurchenko, E (corresponding author), McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada.	Ciro.piccirillo@mcgill.ca	Shio, Marina Tiemi/E-6466-2019	Shio, Marina Tiemi/0000-0002-2494-6816; Levings, Megan/0000-0002-0305-5790	Canadian Institutes for Health Research [MOP 67211, MOP 84037]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	The authors acknowledge the financial support of the Canadian Institutes for Health Research (MOP 67211 and MOP 84037 to C. A. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Allan SE, 2008, MOL THER, V16, P194, DOI 10.1038/sj.mt.6300341; Ayyoub M, 2009, P NATL ACAD SCI USA, V106, P8635, DOI 10.1073/pnas.0900621106; Battaglia M, 2006, J IMMUNOL, V177, P8338, DOI 10.4049/jimmunol.177.12.8338; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Beriou G, 2009, BLOOD, V113, P4240, DOI 10.1182/blood-2008-10-183251; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Contreras I, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001148; d'Hennezel E, 2009, NEW ENGL J MED, V361, P1710, DOI 10.1056/NEJMc0907093; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Duarte JH, 2009, EUROPEAN J IMMUNOLOG, V9999; Ehrchen JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000871; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Horwitz DA, 2008, TRENDS IMMUNOL, V29, P429, DOI 10.1016/j.it.2008.06.005; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Joshi PB, 2002, MOL BIOCHEM PARASIT, V120, P33, DOI 10.1016/S0166-6851(01)00432-7; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Kopf H, 2007, INT IMMUNOPHARMACOL, V7, P1819, DOI 10.1016/j.intimp.2007.08.027; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Piccirillo CA, 2001, J IMMUNOL, V167, P1137, DOI 10.4049/jimmunol.167.3.1137; Piccirillo CA, 2008, CURR OPIN IMMUNOL, V20, P655, DOI 10.1016/j.coi.2008.09.006; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Sgouroudis E, 2008, J IMMUNOL, V181, P6283, DOI 10.4049/jimmunol.181.9.6283; Strauss L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005994; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Wu WH, 2006, EUR J IMMUNOL, V36, P3238, DOI 10.1002/eji.200636472; Wu WH, 2009, CAN J MICROBIOL, V55, P705, DOI [10.1139/W09-017, 10.1139/w09-017]; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	51	89	94	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35572	10.1371/journal.pone.0035572	http://dx.doi.org/10.1371/journal.pone.0035572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545118	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343200038
J	Brassart-Pasco, S; Senechal, K; Thevenard, J; Ramont, L; Devy, J; Di Stefano, L; Dupont-Deshorgue, A; Brezillon, S; Feru, J; Jazeron, JF; Diebold, MD; Ricard-Blum, S; Maquart, FX; Monboisse, JC				Brassart-Pasco, Sylvie; Senechal, Karine; Thevenard, Jessica; Ramont, Laurent; Devy, Jerome; Di Stefano, Ludivine; Dupont-Deshorgue, Aurelie; Brezillon, Stephane; Feru, Jezabel; Jazeron, Jean-Francois; Diebold, Marie-Daniele; Ricard-Blum, Sylvie; Maquart, Francois-Xavier; Monboisse, Jean Claude			Tetrastatin, the NC1 Domain of the alpha 4(IV) Collagen Chain: A Novel Potent Anti-Tumor Matrikine	PLOS ONE			English	Article							IV COLLAGEN; ALPHA(V)BETA(3) INTEGRIN; NONCOLLAGENOUS DOMAIN; EXTRACELLULAR-MATRIX; ALPHA-3(IV) CHAIN; CELL-SURFACE; TUMOR-CELLS; ANGIOGENESIS; TUMSTATIN; METALLOPROTEINASE	Background: NC1 domains from alpha 1, alpha 2, alpha 3 and alpha 6(IV) collagen chains were shown to exert anti-tumor or anti-angiogenic activities, whereas the NC1 domain of the alpha 4(IV) chain did not show such activities so far. Methodology/Principal Findings: We demonstrate in the present paper that the NC1 alpha 4(IV) domain exerts a potent antitumor activity both in vitro and in an experimental human melanoma model in vivo. The overexpression of NC1 alpha 4(IV) in human UACC-903 melanoma cells strongly inhibited their in vitro proliferative (-38%) and invasive (-52%) properties. MT1-MMP activation was largely decreased and its cellular distribution was modified, resulting in a loss of expression at the migration front associated with a loss of migratory phenotype. In an in vivo xenograft model in athymic nude mice, the subcutaneous injection of NC1 alpha 4(IV)-overexpressing melanoma cells induced significantly smaller tumors (-80% tumor volume) than the Mock cells, due to a strong inhibition of tumor growth. Exogenously added recombinant human NC1 alpha 4(IV) reproduced the inhibitory effects of NC1 alpha 4(IV) overexpression in UACC-903 cells but not in dermal fibroblasts. An anti-alpha v beta 3 integrin blocking antibody inhibited cell adhesion on recombinant human NC1 alpha 4(IV) substratum. The involvement of alpha v beta 3 integrin in mediating NC1 alpha 4(IV) effect was confirmed by surface plasmon resonance (SPR) binding assays showing that recombinant human NC1 alpha 4(IV) binds to alpha v beta 3 integrin (K-D = 148 +/- 9.54 nM). Conclusion/Significance: Collectively, our results demonstrate that the NC1 alpha 4(IV) domain, named tetrastatin, is a new endogenous anti-tumor matrikine.	[Brassart-Pasco, Sylvie; Senechal, Karine; Thevenard, Jessica; Ramont, Laurent; Devy, Jerome; Di Stefano, Ludivine; Dupont-Deshorgue, Aurelie; Brezillon, Stephane; Feru, Jezabel; Maquart, Francois-Xavier; Monboisse, Jean Claude] Univ Reims, CNRS, UMR 6237, Reims, France; [Ramont, Laurent; Maquart, Francois-Xavier; Monboisse, Jean Claude] CHU Reims, Cent Biochim Lab, Reims, France; [Jazeron, Jean-Francois; Diebold, Marie-Daniele] CHU Reims, Lab Anat & Cytol Pathol, Reims, France; [Ricard-Blum, Sylvie] Univ Lyon 1, IBCP, CNRS, UMR 5086, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); Universite de Reims Champagne-Ardenne; CHU de Reims; Universite de Reims Champagne-Ardenne; CHU de Reims; Universite de Reims Champagne-Ardenne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Brassart-Pasco, S (corresponding author), Univ Reims, CNRS, UMR 6237, Reims, France.	sylvie.brassart-pasco@univ-reims.fr		Brassart-Pasco, Sylvie/0000-0002-1340-7868; BREZILLON, stephane/0000-0001-7954-8340	Centre National de la Recherche Scientifique [UMR 6237]; University of Reims Champagne-Ardenne; Ligue Nationale Contre le Cancer (Comites de l'Aisne et de la Haute-Marne); Region Champagne-Ardenne; FEDER (Contrat de Plan Etat-Region); ANR [07-NANO-050SEEC]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University of Reims Champagne-Ardenne; Ligue Nationale Contre le Cancer (Comites de l'Aisne et de la Haute-Marne); Region Champagne-Ardenne(Region Grand-Est); FEDER (Contrat de Plan Etat-Region); ANR(French National Research Agency (ANR))	This work was supported by grants from the Centre National de la Recherche Scientifique (UMR 6237), the University of Reims Champagne-Ardenne, the Ligue Nationale Contre le Cancer (Comites de l'Aisne et de la Haute-Marne), the Region Champagne-Ardenne, the FEDER (Contrat de Plan Etat-Region 2007-2013) and the ANR (07-NANO-050SEEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbolina MV, 2008, SEMIN CELL DEV BIOL, V19, P24, DOI 10.1016/j.semcdb.2007.06.008; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; CHELBERG MK, 1989, CANCER RES, V49, P4796; Colorado PC, 2000, CANCER RES, V60, P2520; Faye C, 2009, J BIOL CHEM, V284, P22029, DOI 10.1074/jbc.M109.002840; Floquet N, 2004, J BIOL CHEM, V279, P2091, DOI 10.1074/jbc.M307736200; Hamano Y, 2003, CANCER CELL, V3, P589, DOI 10.1016/S1535-6108(03)00133-8; Hofmann UB, 2005, BIOCHIMIE, V87, P307, DOI 10.1016/j.biochi.2005.01.013; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kamphaus GD, 2000, J BIOL CHEM, V275, P1209, DOI 10.1074/jbc.275.2.1209; Karagiannis ED, 2007, BIOCHEM BIOPH RES CO, V354, P434, DOI 10.1016/j.bbrc.2006.12.231; Labrecque L, 2004, J BIOL CHEM, V279, P52132, DOI 10.1074/jbc.M409617200; Maeshima Y, 2000, J BIOL CHEM, V275, P23745, DOI 10.1074/jbc.C000186200; Maeshima Y, 2000, J BIOL CHEM, V275, P21340, DOI 10.1074/jbc.M001956200; Maeshima Y, 2002, SCIENCE, V295, P140, DOI 10.1126/science.1065298; Maeshima Y, 2001, J BIOL CHEM, V276, P31959, DOI 10.1074/jbc.M103024200; Maeshima Y, 2001, J BIOL CHEM, V276, P15240, DOI 10.1074/jbc.M007764200; Magnon C, 2005, CANCER RES, V65, P4353, DOI 10.1158/0008-5472.CAN-04-3536; Maquoi E, 2000, EXP CELL RES, V261, P348, DOI 10.1006/excr.2000.5063; MEISSAUER A, 1992, EXP CELL RES, V199, P179, DOI 10.1016/0014-4827(92)90423-6; MONTGOMERY AMP, 1993, CANCER RES, V53, P693; Mundel TM, 2008, INT J CANCER, V122, P1738, DOI 10.1002/ijc.23269; Mundel TM, 2007, MICROVASC RES, V74, P85, DOI 10.1016/j.mvr.2007.05.005; Pasco S, 2000, CANCER RES, V60, P467; Pasco S, 2000, J BIOL CHEM, V275, P32999, DOI 10.1074/jbc.M005235200; Pasco S, 2004, EXP CELL RES, V301, P251, DOI 10.1016/j.yexcr.2004.07.036; Pasco S, 2004, CRIT REV ONCOL HEMAT, V49, P221, DOI 10.1016/j.critrevonc.2003.09.006; Pedchenko V, 2004, J BIOL CHEM, V279, P2772, DOI 10.1074/jbc.M311901200; Petitclerc E, 2000, J BIOL CHEM, V275, P8051, DOI 10.1074/jbc.275.11.8051; Seiki M, 2003, CANCER LETT, V194, P1, DOI 10.1016/S0304-3835(02)00699-7; Seiki M, 2002, CURR OPIN CELL BIOL, V14, P624, DOI 10.1016/S0955-0674(02)00363-0; Shahan TA, 1999, CANCER RES, V59, P4584; Sudhakar A, 2005, J CLIN INVEST, V115, P2801, DOI 10.1172/JCI24813; Thevenard J, 2006, CHEM BIOL, V13, P1307, DOI 10.1016/j.chembiol.2006.10.007; Thevenard J, 2010, INT J CANCER, V126, P1055, DOI 10.1002/ijc.24688; TRENT JM, 1990, SCIENCE, V247, P568, DOI 10.1126/science.2300817; Wald M, 2001, CANCER CHEMOTH PHARM, V47, pS16, DOI 10.1007/s002800170004; Yamaguchi H, 2009, CANCER RES, V69, P8594, DOI 10.1158/0008-5472.CAN-09-2305; ZHOU J, 1994, J BIOL CHEM, V269, P13193	41	40	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e29587	10.1371/journal.pone.0029587	http://dx.doi.org/10.1371/journal.pone.0029587			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539938	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341000001
J	Najbauer, J; Huszthy, PC; Barish, ME; Garcia, E; Metz, MZ; Myers, SM; Gutova, M; Frank, RT; Miletic, H; Kendall, SE; Glackin, CA; Bjerkvig, R; Aboody, KS				Najbauer, Joseph; Huszthy, Peter C.; Barish, Michael E.; Garcia, Elizabeth; Metz, Marianne Z.; Myers, Sarah M.; Gutova, Margarita; Frank, Richard T.; Miletic, Hrvoje; Kendall, Stephen E.; Glackin, Carlotta A.; Bjerkvig, Rolf; Aboody, Karen S.			Cellular Host Responses to Gliomas	PLOS ONE			English	Article							NEURAL STEM-CELLS; CHEMOKINE RECEPTORS; ADJUVANT TEMOZOLOMIDE; NESTIN EXPRESSION; MALIGNANT GLIOMAS; BRAIN-TUMORS; GLIOBLASTOMA; ANGIOGENESIS; MIGRATION; GROWTH	Background: Glioblastoma multiforme (GBM) is the most aggressive type of malignant primary brain tumors in adults. Molecular and genetic analysis has advanced our understanding of glioma biology, however mapping the cellular composition of the tumor microenvironment is crucial for understanding the pathology of this dreaded brain cancer. In this study we identified major cell populations attracted by glioma using orthotopic rodent models of human glioma xenografts. Marker-specific, anatomical and morphological analyses revealed a robust influx of host cells into the main tumor bed and tumor satellites. Methodology/Principal Findings: Human glioma cell lines and glioma spheroid orthotopic implants were used in rodents. In both models, the xenografts recruited large numbers of host nestin-expressing cells, which formed a 'network' with glioma. The host nestin-expressing cells appeared to originate in the subventricular zone ipsilateral to the tumor, and were clearly distinguishable from pericytes that expressed smooth muscle actin. These distinct cell populations established close physical contact in a 'pair-wise' manner and migrated together to the deeper layers of tumor satellites and gave rise to tumor vasculature. The GBM biopsy xenografts displayed two different phenotypes: (a) low-generation tumors (first in vivo passage in rats) were highly invasive and non-angiogenic, and host nestin-positive cells that infiltrated into these tumors displayed astrocytic or elongated bipolar morphology; (b) high-generation xenografts (fifth passage) had pronounced cellularity, were angiogenic with 'glomerulus-like' microvascular proliferations that contained host nestin-positive cells. Stromal cell-derived factor-1 and its receptor CXCR4 were highly expressed in and around glioma xenografts, suggesting their role in glioma progression and invasion. Conclusions/Significance: Our data demonstrate a robust migration of nestin-expressing host cells to glioma, which together with pericytes give rise to tumor vasculature. Mapping the cellular composition of glioma microenvironment and deciphering the complex 'crosstalk' between tumor and host may ultimately aid the development of novel anti-glioma therapies.	[Najbauer, Joseph; Barish, Michael E.; Garcia, Elizabeth; Metz, Marianne Z.; Myers, Sarah M.; Gutova, Margarita; Frank, Richard T.; Kendall, Stephen E.; Glackin, Carlotta A.; Aboody, Karen S.] City Hope Natl Med Ctr, Dept Neurosci, Duarte, CA 91010 USA; [Najbauer, Joseph; Barish, Michael E.; Garcia, Elizabeth; Metz, Marianne Z.; Myers, Sarah M.; Gutova, Margarita; Frank, Richard T.; Kendall, Stephen E.; Glackin, Carlotta A.; Aboody, Karen S.] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA; [Aboody, Karen S.] City Hope Natl Med Ctr, Div Neurosurg, Duarte, CA 91010 USA; [Huszthy, Peter C.; Miletic, Hrvoje; Bjerkvig, Rolf] Univ Bergen, Dept Biomed, NorLux Neurooncol, Bergen, Norway; [Bjerkvig, Rolf] NorLux Neurooncol, Ctr Rech Publ Sante, Luxembourg, Luxembourg	City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; University of Bergen; Luxembourg Institute of Health	Najbauer, J (corresponding author), City Hope Natl Med Ctr, Dept Neurosci, 1500 E Duarte Rd, Duarte, CA 91010 USA.	jnajbauer@coh.org; Peter.Huszthy@biomed.uib.no	Huszthy, Peter Csaba/H-1414-2016	Huszthy, Peter Csaba/0000-0003-0184-8989	Rosalinde and Arthur Gilbert Foundation; STOP CANCER; California Institute for Regenerative Medicine (CIRM) [DR1-01421]	Rosalinde and Arthur Gilbert Foundation; STOP CANCER; California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine)	The authors acknowledge the generous financial support by the Rosalinde and Arthur Gilbert Foundation, STOP CANCER, and the California Institute for Regenerative Medicine (CIRM, DR1-01421). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboody KS, 2008, GENE THER, V15, P739, DOI 10.1038/gt.2008.41; Aboody K, 2011, NEURON, V70, P597, DOI 10.1016/j.neuron.2011.05.007; Aboody KS, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000023; Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Aghi M, 2006, CANCER RES, V66, P9054, DOI 10.1158/0008-5472.CAN-05-3759; Amoh Y, 2005, CANCER RES, V65, P5352, DOI 10.1158/0008-5472.CAN-05-0821; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Bababeygy SR, 2008, STEM CELLS DEV, V17, P11, DOI 10.1089/scd.2007.0117; Bello L, 2002, CLIN CANCER RES, V8, P3539; Benedetti S, 2000, NAT MED, V6, P447, DOI 10.1038/74710; BJERKVIG R, 1990, J NEUROSURG, V72, P463, DOI 10.3171/jns.1990.72.3.0463; Bjerkvig R, 2005, NAT REV CANCER, V5, P899, DOI 10.1038/nrc1740; Brat DJ, 2004, CANCER RES, V64, P920, DOI 10.1158/0008-5472.CAN-03-2073; Cabioglu N, 2009, ANN ONCOL, V20, P1013, DOI 10.1093/annonc/mdn740; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; Charles NA, 2011, GLIA, V59, P1169, DOI 10.1002/glia.21136; Christensen K, 2010, NEUROSURGERY, V66, P933, DOI 10.1227/01.NEU.0000368393.45935.46; Curtis MA, 2007, NAT REV NEUROSCI, V8, P712, DOI 10.1038/nrn2216; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Dziembowska M, 2005, GLIA, V50, P258, DOI 10.1002/glia.20170; Engebraaten O, 1999, J NEUROSURG, V90, P125, DOI 10.3171/jns.1999.90.1.0125; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Gilyarov A V, 2008, Neurosci Behav Physiol, V38, P165, DOI 10.1007/s11055-008-0025-z; Glass R, 2005, J NEUROSCI, V25, P2637, DOI 10.1523/JNEUROSCI.5118-04.2005; Goings GE, 2004, BRAIN RES, V996, P213, DOI 10.1016/j.brainres.2003.10.034; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Hamer PCDW, 2008, ONCOGENE, V27, P2091, DOI 10.1038/sj.onc.1210850; Huszthy PC, 2005, HUM GENE THER, V16, P381, DOI 10.1089/hum.2005.16.381; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Lin D, 2007, NEUROIMAGE, V37, pS18, DOI 10.1016/j.neuroimage.2007.03.076; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Magnon C, 2011, METHODS MOL BIOL, V750, P3, DOI 10.1007/978-1-61779-145-1_1; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Najbauer J, 2007, PROGR GENE THERAPY A, P335; Niclou SP, 2008, FASEB J, V22, P3120, DOI 10.1096/fj.08-109611; Polajeva J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025222; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Rempel SA, 2000, CLIN CANCER RES, V6, P102; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Rong Y, 2006, J NEUROPATH EXP NEUR, V65, P529, DOI 10.1097/00005072-200606000-00001; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Sakariassen PO, 2006, P NATL ACAD SCI USA, V103, P16466, DOI 10.1073/pnas.0607668103; Santarelli JG, 2006, NEUROSURGERY, V59, P374, DOI 10.1227/01.NEU.0000222658.66878.CC; Schulte A, 2011, GLIA, V59, P590, DOI 10.1002/glia.21127; Sica G, 2011, INT J ONCOL, V38, P41, DOI 10.3892/ijo_00000822; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sontheimer H, 2003, TRENDS NEUROSCI, V26, P543, DOI 10.1016/j.tins.2003.08.007; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tran PB, 2004, J NEUROSCI RES, V76, P20, DOI 10.1002/jnr.20001; Tran PB, 2003, NAT REV NEUROSCI, V4, P444, DOI 10.1038/nrn1116; Tran PB, 2007, J COMP NEUROL, V500, P1007, DOI 10.1002/cne.21229; Ubiali F, 2007, INT IMMUNOL, V19, P1063, DOI 10.1093/intimm/dxm079; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; VanMeter TE, 2001, J NEURO-ONCOL, V53, P213, DOI 10.1023/A:1012280925031; Walzlein JH, 2008, STEM CELLS, V26, P2945, DOI 10.1634/stemcells.2008-0307; Wang J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-465; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wesseling P, 1997, J NEURO-ONCOL, V32, P253, DOI 10.1023/A:1005746320099; Westphal M, 2011, NAT REV NEUROSCI, V12, P495, DOI 10.1038/nrn3060; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Zagzag D, 2006, LAB INVEST, V86, P1221, DOI 10.1038/labinvest.3700482; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao DH, 2008, MOL CANCER RES, V6, P1819, DOI 10.1158/1541-7786.MCR-08-0146	74	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35150	10.1371/journal.pone.0035150	http://dx.doi.org/10.1371/journal.pone.0035150			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539956	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341000020
J	Sepuri, NBV; Gorla, M; King, MP				Sepuri, Naresh Babu V.; Gorla, Madhavi; King, Michael P.			Mitochondrial Lysyl-tRNA Synthetase Independent Import of tRNA Lysine into Yeast Mitochondria	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN IMPORT; MECHANISM; TRANSLOCATION; REQUIREMENTS; TRANSLATION; EXPRESSION; TRNA(LYS); MEMBRANE; CONTAINS	Aminoacyl tRNA synthetases play a central role in protein synthesis by charging tRNAs with amino acids. Yeast mitochondrial lysyl tRNA synthetase (Msk1), in addition to the aminoacylation of mitochondrial tRNA, also functions as a chaperone to facilitate the import of cytosolic lysyl tRNA. In this report, we show that human mitochondrial Kars (lysyl tRNA synthetase) can complement the growth defect associated with the loss of yeast Msk1 and can additionally facilitate the in vitro import of tRNA into mitochondria. Surprisingly, the import of lysyl tRNA can occur independent of Msk1 in vivo. This suggests that an alternative mechanism is present for the import of lysyl tRNA in yeast.	[Sepuri, Naresh Babu V.; Gorla, Madhavi] Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India; [Sepuri, Naresh Babu V.; King, Michael P.] Thomas Jefferson Univ, Dept Biochem & Mol Pharmacol, Philadelphia, PA 19107 USA	University of Hyderabad; Jefferson University	Sepuri, NBV (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India.	nareshuohyd@gmail.com; Michael.King@jefferson.edu	Sepuri, Naresh/AAF-2704-2020		Department of Biotechnology, India; Department of Science and Technology; National Institutes of Health (NIH); American Heart Association; CSIR (Council of Scientific and Industrial Research)	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Department of Science and Technology(Department of Science & Technology (India)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); CSIR (Council of Scientific and Industrial Research)(Council of Scientific & Industrial Research (CSIR) - India)	The Department of Biotechnology, India provided funding for school facility in terms of DBT-Center for Research Excellence in Biotechnology, and Department of Science and Technology has provided funding to the Department of Biochemistry. DBT, India has provided funding for studying the tRNA import to Naresh Babu V. Sepuri. Also, the National Institutes of Health (NIH) provided funding to Michael P. King. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Debkumar Pain for providing antibodies for Tim23, put2, CCPO. We thank members of NBVS's and MK's labs for giving valuable suggestions throughout the study. NBVS acknowledges post-doctoral fellowship from American Heart Association (2001-2003). GM is supported by a JRF fellowship from CSIR (Council of Scientific and Industrial Research).	Anandatheerthavarada HK, 2009, J BIOL CHEM, V284, P17352, DOI 10.1074/jbc.M109.007492; Brandina I, 2007, FEBS LETT, V581, P4248, DOI 10.1016/j.febslet.2007.08.013; Diaz-Lazcoz Y, 1998, MOL BIOL EVOL, V15, P1548, DOI 10.1093/oxfordjournals.molbev.a025882; Dietmeier K, 1997, NATURE, V388, P195, DOI 10.1038/40663; Dietrich A, 1996, BIOCHIMIE, V78, P518, DOI 10.1016/0300-9084(96)84758-4; Entelis N, 2006, GENE DEV, V20, P1609, DOI 10.1101/gad.385706; Entelis NS, 1998, P NATL ACAD SCI USA, V95, P2838, DOI 10.1073/pnas.95.6.2838; Entelis NS, 2001, J BIOL CHEM, V276, P45642, DOI 10.1074/jbc.M103906200; HONLINGER A, 1995, BIOL CHEM H-S, V376, P515; Kamenski P, 2007, MOL CELL, V26, P625, DOI 10.1016/j.molcel.2007.04.019; Kazakova HA, 1999, FEBS LETT, V442, P193, DOI 10.1016/S0014-5793(98)01653-6; Kolesnikova OA, 2000, SCIENCE, V289, P1931, DOI 10.1126/science.289.5486.1931; MARTIN RP, 1979, BIOCHEMISTRY-US, V18, P4600, DOI 10.1021/bi00588a021; Mireau H, 2000, J BIOL CHEM, V275, P13291, DOI 10.1074/jbc.275.18.13291; Mukherjee S, 1999, J BIOL CHEM, V274, P31249, DOI 10.1074/jbc.274.44.31249; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Park H, 2003, BIOCHEMISTRY-US, V42, P958, DOI 10.1021/bi026882r; Puranam RS, 2001, MOL CELL BIOL, V21, P548, DOI 10.1128/MCB.21.2.548-561.2001; Rinehart J, 2005, GENE DEV, V19, P583, DOI 10.1101/gad.1269305; Rose M, 1990, LAB COURSE MANUAL ME; Rubio MAT, 2008, P NATL ACAD SCI USA, V105, P9186, DOI 10.1073/pnas.0804283105; Rusconi CP, 1996, EMBO J, V15, P3286, DOI 10.1002/j.1460-2075.1996.tb00693.x; RYAN KR, 1995, CELL, V83, P517, DOI 10.1016/0092-8674(95)90089-6; Schneider A, 2011, ANNU REV BIOCHEM, V80, P1033, DOI 10.1146/annurev-biochem-060109-092838; Sepuri NBV, 1998, J BIOL CHEM, V273, P20941, DOI 10.1074/jbc.273.33.20941; Sepuri NBV, 1998, J BIOL CHEM, V273, P1420, DOI 10.1074/jbc.273.3.1420; TARASSOV I, 1995, EMBO J, V14, P3461, DOI 10.1002/j.1460-2075.1995.tb07352.x; TARASSOV I, 1995, J MOL BIOL, V245, P315, DOI 10.1006/jmbi.1994.0026; Tolkunova E, 2000, J BIOL CHEM, V275, P35063, DOI 10.1074/jbc.M006265200; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Yermovsky-Kammerer AE, 1999, MOL CELL BIOL, V19, P6253	31	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35321	10.1371/journal.pone.0035321	http://dx.doi.org/10.1371/journal.pone.0035321			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539966	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341000031
J	Ye, SD; Tan, L; Yang, RQ; Fang, B; Qu, S; Schulze, EN; Song, HY; Ying, QL; Li, P				Ye, Shoudong; Tan, Li; Yang, Rongqing; Fang, Bo; Qu, Su; Schulze, Eric N.; Song, Houyan; Ying, Qilong; Li, Ping			Pleiotropy of Glycogen Synthase Kinase-3 Inhibition by CHIR99021 Promotes Self-Renewal of Embryonic Stem Cells from Refractory Mouse Strains	PLOS ONE			English	Article							BETA-CATENIN; C-MYC; TYROSINE PHOSPHORYLATION; PREVENT DIFFERENTIATION; EFFICIENT DERIVATION; TUMOR-SUPPRESSOR; PLURIPOTENCY; ESTABLISHMENT; LOCALIZATION; ACTIVATION	Background: Inhibition of glycogen synthase kinase-3 (GSK-3) improves the efficiency of embryonic stem (ES) cell derivation from various strains of mice and rats, as well as dramatically promotes ES cell self-renewal potential. beta-catenin has been reported to be involved in the maintenance of self-renewal of ES cells through TCF dependent and independent pathway. But the intrinsic difference between ES cell lines from different species and strains has not been characterized. Here, we dissect the mechanism of GSK-3 inhibition by CHIR99021 in mouse ES cells from refractory mouse strains. Methodology/Principal Findings: We found that CHIR99021, a GSK-3 specific inhibitor, promotes self-renewal of ES cells from recalcitrant C57BL/6 (B6) and BALB/c mouse strains through stabilization of beta-catenin and c-Myc protein levels. Stabilized beta-catenin promoted ES self-renewal through two mechanisms. First, beta-catenin translocated into the nucleus to maintain stem cell pluripotency in a lymphoid-enhancing factor/T-cell factor-independent manner. Second, beta-catenin binds plasma membrane-localized E-cadherin, which ensures a compact, spherical morphology, a hallmark of ES cells. Further, elevated c-Myc protein levels did not contribute significantly to CH-mediated ES cell self-renewal. Instead, the role of c-Myc is dependent on its transformation activity and can be replaced by N-Myc but not L-Myc. beta-catenin and c-Myc have similar effects on ES cells derived from both B6 and BALB/c mice. Conclusions/Significance: Our data demonstrated that GSK-3 inhibition by CH promotes self-renewal of mouse ES cells with non-permissive genetic backgrounds by regulation of multiple signaling pathways. These findings would be useful to improve the availability of normally non-permissive mouse strains as research tools.	[Ye, Shoudong; Yang, Rongqing; Fang, Bo; Qu, Su; Song, Houyan; Li, Ping] Shanghai Med Coll, Minist Educ, Key Lab Mol Med, Shanghai, Peoples R China; [Tan, Li] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Schulze, Eric N.; Ying, Qilong] Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA	Fudan University; University of Southern California	Ye, SD (corresponding author), Shanghai Med Coll, Minist Educ, Key Lab Mol Med, Shanghai, Peoples R China.	lp0030@hotmail.com	Tan, Li/AAN-2456-2021	Tan, Li/0000-0001-5961-0450	National Key Basic Research Program [2011CBA01100]; Shanghai Municipal Natural Science Foundation [09ZR1404000]	National Key Basic Research Program(National Basic Research Program of China); Shanghai Municipal Natural Science Foundation	This work was supported in part by the National Key Basic Research Program 2011CBA01100 and the Shanghai Municipal Natural Science Foundation 09ZR1404000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Batlle-Morera L, 2008, GENESIS, V46, P758, DOI 10.1002/dvg.20442; Bechard M, 2009, MOL CELL BIOL, V29, P2092, DOI 10.1128/MCB.01405-08; Bijur GN, 2003, NEUROREPORT, V14, P2415, DOI 10.1097/00001756-200312190-00025; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Evans PM, 2010, MOL CELL BIOL, V30, P372, DOI 10.1128/MCB.00063-09; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; GARLAND LG, 1981, N-S ARCH PHARMACOL, V318, P88; Gertsenstein M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011260; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; Iijima S, 2010, CELL REPROGRAM, V12, P679, DOI 10.1089/cell.2010.0018; KAWASE E, 1994, INT J DEV BIOL, V38, P385; Kelly KF, 2011, CELL STEM CELL, V8, P214, DOI 10.1016/j.stem.2010.12.010; Kiyonari H, 2010, GENESIS, V48, P317, DOI 10.1002/dvg.20614; Larue L, 1996, DEVELOPMENT, V122, P3185; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Lluis F, 2008, CELL STEM CELL, V3, P493, DOI 10.1016/j.stem.2008.08.017; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; NAU MM, 1985, NATURE, V318, P69, DOI 10.1038/318069a0; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Piedra J, 2001, J BIOL CHEM, V276, P20436, DOI 10.1074/jbc.M100194200; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Sato H, 2009, GENESIS, V47, P414, DOI 10.1002/dvg.20514; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; SCHWAB M, 1984, NATURE, V308, P288, DOI 10.1038/308288a0; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sineva GS, 2010, BIOL CELL, V102, P549, DOI 10.1042/BC20100016; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Sokol SY, 2011, DEVELOPMENT, V138, P4341, DOI 10.1242/dev.066209; Soncin F, 2009, STEM CELLS, V27, P2069, DOI 10.1002/stem.134; Stepniak E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002949; Sumi T, 2007, ONCOGENE, V26, P5564, DOI 10.1038/sj.onc.1210353; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takao Y, 2007, BIOCHEM BIOPH RES CO, V353, P699, DOI 10.1016/j.bbrc.2006.12.072; Tam WL, 2008, STEM CELLS, V26, P2019, DOI 10.1634/stemcells.2007-1115; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Umehara H, 2007, STEM CELLS, V25, P2705, DOI 10.1634/stemcells.2007-0086; Varlakhanova NV, 2010, DIFFERENTIATION, V80, P9, DOI 10.1016/j.diff.2010.05.001; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	54	58	60	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35892	10.1371/journal.pone.0035892	http://dx.doi.org/10.1371/journal.pone.0035892			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540008	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341000074
J	Amado, GM; Moura, RL; Bastos, AC; Salgado, LT; Sumida, PY; Guth, AZ; Francini, RB; Pereira, GH; Abrantes, DP; Brasileiro, PS; Bahia, RG; Leal, RN; Kaufman, L; Kleypas, JA; Farina, M; Thompson, FL				Amado-Filho, Gilberto M.; Moura, Rodrigo L.; Bastos, Alex C.; Salgado, Leonardo T.; Sumida, Paulo Y.; Guth, Arthur Z.; Francini-Filho, Ronaldo B.; Pereira-Filho, Guilherme H.; Abrantes, Douglas P.; Brasileiro, Poliana S.; Bahia, Ricardo G.; Leal, Rachel N.; Kaufman, Les; Kleypas, Joanie A.; Farina, Marcos; Thompson, Fabiano L.			Rhodolith Beds Are Major CaCO3 Bio-Factories in the Tropical South West Atlantic	PLOS ONE			English	Article							ESPIRITO-SANTO STATE; CARBONATE PRODUCTION; OCEAN ACIDIFICATION; CORALLINE ALGAE; RHODOPHYTA; COMMUNITY; MAERL; DIVERSITY; REEFS; COAST	Rhodoliths are nodules of non-geniculate coralline algae that occur in shallow waters (<150 m depth) subjected to episodic disturbance. Rhodolith beds stand with kelp beds, seagrass meadows, and coralline algal reefs as one of the world's four largest macrophyte-dominated benthic communities. Geographic distribution of rhodolith beds is discontinuous, with large concentrations off Japan, Australia and the Gulf of California, as well as in the Mediterranean, North Atlantic, eastern Caribbean and Brazil. Although there are major gaps in terms of seabed habitat mapping, the largest rhodolith beds are purported to occur off Brazil, where these communities are recorded across a wide latitudinal range (2 degrees N - 27 degrees S). To quantify their extent, we carried out an inter-reefal seabed habitat survey on the Abrolhos Shelf (16 degrees 50' - 19 degrees 45'S) off eastern Brazil, and confirmed the most expansive and contiguous rhodolith bed in the world, covering about 20,900 km(2). Distribution, extent, composition and structure of this bed were assessed with side scan sonar, remotely operated vehicles, and SCUBA. The mean rate of CaCO3 production was estimated from in situ growth assays at 1.07 kg m(-2) yr(-1), with a total production rate of 0.025 Gt yr(-1), comparable to those of the world's largest biogenic CaCO3 deposits. These gigantic rhodolith beds, of areal extent equivalent to the Great Barrier Reef, Australia, are a critical, yet poorly understood component of the tropical South Atlantic Ocean. Based on the relatively high vulnerability of coralline algae to ocean acidification, these beds are likely to experience a profound restructuring in the coming decades.	[Moura, Rodrigo L.; Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, RJ, Brazil; [Amado-Filho, Gilberto M.; Salgado, Leonardo T.; Abrantes, Douglas P.; Brasileiro, Poliana S.; Bahia, Ricardo G.; Leal, Rachel N.] Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, RJ, Brazil; [Bastos, Alex C.] Univ Fed Espirito Santo, Dept Ecol & Recursos Nat, Vitoria, ES, Brazil; [Sumida, Paulo Y.; Guth, Arthur Z.] Univ Sao Paulo, Inst Oceanog, Sao Paulo, Brazil; [Francini-Filho, Ronaldo B.] Univ Fed Paraiba, Ctr Ciencias Aplicadas & Educ, Rio Tinto, PB, Brazil; [Pereira-Filho, Guilherme H.] Univ Fed Rural Rio de Janeiro, Dept Bot, Seropedica, RJ, Brazil; [Kaufman, Les] Boston Univ, Marine Program, Boston, MA 02215 USA; [Kleypas, Joanie A.] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Farina, Marcos] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Jardim Botanico do Rio de Janeiro; Universidade Federal do Espirito Santo; Universidade de Sao Paulo; Universidade Federal da Paraiba; Universidade Federal Rural do Rio de Janeiro (UFRRJ); Boston University; National Center Atmospheric Research (NCAR) - USA; Universidade Federal do Rio de Janeiro	Moura, RL (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, RJ, Brazil.	moura@biologia.ufrj.br	Sumida, Paulo Y G/F-2561-2011; Pereira-Filho, Guilherme-Henrique/I-2946-2013; FILHO, GILBERTO M AMADO/I-1324-2012; Salgado, Leonardo T/F-1123-2013; Bahia, Ricardo/J-8724-2015; Francini-Filho, Ronaldo/I-5708-2012; Farina, Marcos/I-3744-2014; Güth, Arthur Z/F-2559-2011; de Moura, Rodrigo Leao/AAL-5781-2020; Bastos, Alex/H-3674-2014	Sumida, Paulo Y G/0000-0001-7549-4541; Pereira-Filho, Guilherme-Henrique/0000-0001-6078-2241; Francini-Filho, Ronaldo/0000-0002-7678-6797; Güth, Arthur Z/0000-0001-8388-4187; de Moura, Rodrigo Leao/0000-0002-5597-6196; Bastos, Alex/0000-0002-1272-1134; Thompson, Fabiano/0000-0002-7562-1683	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brazil; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - Brazil; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Brazil; Conservation International, USA; Gordon and Betty Moore Foundation, USA	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conservation International, USA; Gordon and Betty Moore Foundation, USA(Gordon and Betty Moore Foundation)	Funders are the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brazil, the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil, the Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - Brazil, the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Brazil, Conservation International, USA, and The Gordon and Betty Moore Foundation, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado GM, 2007, CIENC MAR, V33, P399, DOI 10.7773/cm.v33i4.1148; Amado GM, 2010, CIENC MAR, V36, P371, DOI 10.7773/cm.v36i4.1782; Andersson AJ, 2005, AM J SCI, V305, P875, DOI 10.2475/ajs.305.9.875; [Anonymous], ANN 28 BRAZ C GEOL; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Bahia RG, 2010, BRAZ J OCEANOGR, V58, P323, DOI 10.1590/S1679-87592010000400007; Blake C, 2003, PHYCOLOGIA, V42, P606, DOI 10.2216/i0031-8884-42-6-606.1; BOHM L, 1978, J PHYCOL, V14, P486, DOI 10.1111/j.1529-8817.1978.tb02474.x; Bosence D, 2003, AQUAT CONSERV, V13, pS21, DOI 10.1002/aqc.565; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Foster MS, 2007, CIENC MAR, V33, P367, DOI 10.7773/cm.v33i4.1174; Foster MS, 2001, J PHYCOL, V37, P659, DOI 10.1046/j.1529-8817.2001.00195.x; Frantz BR, 2005, J PHYCOL, V41, P770, DOI 10.1111/j.1529-8817.2005.00107.x; FREIWALD A, 1994, SEDIMENTOLOGY, V41, P963, DOI 10.1111/j.1365-3091.1994.tb01435.x; Guimaraes SMPB, 2008, BOT MAR, V51, P378, DOI 10.1515/BOT.2008.048; Harvey AS, 2006, AUST SYST BOT, V19, P387, DOI 10.1071/SB05029; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; KEMPF M, 1970, MAR BIOL, V5, P213, DOI 10.1007/BF00346909; KINSEY DW, 1991, GLOBAL PLANET CHANGE, V89, P363, DOI 10.1016/0921-8181(91)90117-F; Kleypas JA, 1997, PALEOCEANOGRAPHY, V12, P533, DOI 10.1029/97PA01134; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Leao Z, 1997, P 8 INT COR REEF S, V2, P1767; Leao Z.M.A.N., 1996, ANAIS ACAD BRAS CIEN, V68, P339; Martin S, 2007, MAR ECOL PROG SER, V335, P19, DOI 10.3354/meps335019; Martin S, 2009, GLOBAL CHANGE BIOL, V15, P2089, DOI 10.1111/j.1365-2486.2009.01874.x; MELO U, 1975, CONTRIB SEDIMENTOL, V4, P78; Milliman JD, 1996, GEOL RUNDSCH, V85, P496, DOI 10.1007/s005310050090; MILLIMAN JD, 1993, GLOBAL BIOGEOCHEM CY, V7, P927, DOI 10.1029/93GB02524; Nelson WA, 2009, MAR FRESHWATER RES, V60, P787, DOI 10.1071/MF08335; PAYRI CE, 1995, B SOC GEOL FR, V166, P77; Pena V, 2008, AQUAT CONSERV, V18, P339, DOI 10.1002/aqc.847; POTIN P, 1990, HYDROBIOLOGIA, V204, P263, DOI 10.1007/BF00040243; Riul P, 2009, AQUAT BOT, V90, P315, DOI 10.1016/j.aquabot.2008.12.002; RODRIGUEZ-RAMIREZ A, 2008, STATUS CORAL REEFS W, P281; Spalding MD, 1997, CORAL REEFS, V16, P225, DOI 10.1007/s003380050078; STEARN CW, 1977, B MAR SCI, V27, P479; Vecsei A, 2000, FACIES, V43, P205, DOI 10.1007/BF02536991; Vecsei A, 2004, PALAEOGEOGR PALAEOCL, V214, P3, DOI 10.1016/j.palaeo.2004.06.009; Vecsei A, 2004, GLOBAL PLANET CHANGE, V43, P1, DOI 10.1016/j.gloplacha.2003.12.002; VERHEIJ E, 1993, PHYCOLOGIA, V32, P184, DOI 10.2216/i0031-8884-32-3-184.1; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Villas-Boas AB, 2009, PHYCOLOGIA, V48, P237, DOI 10.2216/08-35.1; Wilson S, 2004, BIOL CONSERV, V120, P279, DOI 10.1016/j.biocon.2004.03.001	43	195	197	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35171	10.1371/journal.pone.0035171	http://dx.doi.org/10.1371/journal.pone.0035171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536356	gold, Green Submitted, Green Published			2022-12-25	WOS:000305339200041
J	Chi, F; Bo, T; Wu, CH; Jong, A; Huang, SH				Chi, Feng; Bo, Tao; Wu, Chun-Hua; Jong, Ambrose; Huang, Sheng-He			Vimentin and PSF Act in Concert to Regulate IbeA plus E-coli K1 Induced Activation and Nuclear Translocation of NF-kappa B in Human Brain Endothelial Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; SIGNALING PATHWAY; BINDING PROTEIN; BREAST-CANCER; IN-VITRO; INVASION; VIRULENCE; EXPRESSION; SYSTEM; IDENTIFICATION	Background: IbeA-induced NF-kappa B signaling through its primary receptor vimentin as well as its co-receptor PSF is required for meningitic E. coli K1 penetration and leukocyte transmigration across the blood-brain barrier (BBB), which are the hallmarks of bacterial meningitis. However, it is unknown how vimentin and PSF cooperatively contribute to IbeA-induced cytoplasmic activation and nuclear translocation of NF-kappa B, which are required for bacteria-mediated pathogenicities. Methodology/Principal Findings: IbeA-induced E. coli K1 invasion, polymorphonuclear leukocyte (PMN) transmigration and IKK/NF-kappa B activation are blocked by Caffeic acid phenethyl ester (CAPE), an inhibitor of NF-kappa B. IKK alpha/beta phosphorylation is blocked by ERK inhibitors. Co-immunoprecipitation analysis shows that vimentin forms a complex with I kappa B, NF-kappa B and tubulins in the resting cells. A dissociation of this complex and a simultaneous association of PSF with NF-kappa B could be induced by IbeA in a time-dependent manner. The head domain of vimentin is required for the complex formation. Two cytoskeletal components, vimentin filaments and microtubules, contribute to the regulation of NF-kappa B. SiRNA-mediated knockdown studies demonstrate that IKK alpha/beta phosphorylation is completely abolished in HBMECs lacking vimentin and PSF. Phosphorylation of ERK and nuclear translocation of NF-kappa B are entirely dependent on PSF. These findings suggest that vimentin and PSF cooperatively contribute to IbeA-induced cytoplasmic activation and nuclear translocation of NF-kappa B activation. PSF is essential for translocation of NF-kappa B and ERK to the nucleus. Conclusion/Significance: These findings reveal previously unappreciated facets of the IbeA-binding proteins. Cooperative contributions of vimentin and PSF to IbeA-induced cytoplasmic activation and nuclear translocation of NF-kappa B may represent a new paradigm in pathogen-induced signal transduction and lead to the development of novel strategies for the prevention and treatment of bacterial meningitis.	[Chi, Feng; Bo, Tao; Wu, Chun-Hua; Jong, Ambrose; Huang, Sheng-He] Univ So Calif, Dept Pediat, Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90089 USA; [Bo, Tao] Cent S Univ, Xiangya Hosp 2, Dept Pediat, Div Neonatol, Changsha, Hunan, Peoples R China	Children's Hospital Los Angeles; University of Southern California; Central South University	Huang, SH (corresponding author), Univ So Calif, Dept Pediat, Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90089 USA.	shhuang@hsc.usc.edu	Chi, Feng/H-5895-2012		Public Health Service [R56-AI40635, R01-NS047599]; Saban Research Institute Research Career Development Fellowship (RCDF); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI040635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047599] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Saban Research Institute Research Career Development Fellowship (RCDF); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was financially supported by Public Health Service grants R56-AI40635 (Dr. Huang) and R01-NS047599 (Dr. Jong), and a Saban Research Institute Research Career Development Fellowship (RCDF) (Dr. Chi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif MMM, 2005, BRIT J PHARMACOL, V146, P1139, DOI 10.1038/sj.bjp.0706421; Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; BENNETT V, 1981, P NATL ACAD SCI-BIOL, V78, P7550, DOI 10.1073/pnas.78.12.7550; Bingen E, 1998, J INFECT DIS, V177, P642, DOI 10.1086/514217; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Che XJ, 2011, BRAIN PATHOL, V21, P389, DOI 10.1111/j.1750-3639.2010.00463.x; Chen M, 2003, CLIN EXP DERMATOL, V28, P193, DOI 10.1046/j.1365-2230.2003.01191.x; Chen YH, 2002, CELL MICROBIOL, V4, P503, DOI 10.1046/j.1462-5822.2002.00209.x; Chi F, 2005, APPL ENVIRON MICROB, V71, P7271, DOI 10.1128/AEM.71.11.7271-7278.2005; Chi F, 2011, FUTURE MICROBIOL, V6, P953, DOI 10.2217/FMB.11.65; Chi F, 2010, BIOCHEM J, V427, P79, DOI 10.1042/BJ20091097; Chi F, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/520283; Cortes MAM, 2008, INFECT IMMUN, V76, P4129, DOI 10.1128/IAI.00334-08; David E, 2010, BLOOD, V116, P5285, DOI 10.1182/blood-2010-03-272393; Dawson S, 1997, MOL BIOL REP, V24, P39, DOI 10.1023/A:1006800522814; Denner L, 2010, ENDOCRINOLOGY, V151, P2819, DOI 10.1210/en.2009-1439; Dev A, 2011, CURR TOP MICROBIOL, V349, P115, DOI 10.1007/82_2010_102; Dong XS, 2005, J BIOL CHEM, V280, P13329, DOI 10.1074/jbc.M409187200; Dziva F, 2008, AVIAN PATHOL, V37, P355, DOI 10.1080/03079450802216652; GEORGATOS SD, 1985, J CELL BIOL, V100, P1955, DOI 10.1083/jcb.100.6.1955; GEORGATOS SD, 1985, J CELL BIOL, V100, P1962, DOI 10.1083/jcb.100.6.1962; Ghoda L, 1997, J BIOL CHEM, V272, P21281, DOI 10.1074/jbc.272.34.21281; Griffiths NJ, 2007, CELL MICROBIOL, V9, P2968, DOI 10.1111/j.1462-5822.2007.01038.x; He L, OJAPPS IN PRESS; Higuero AM, 2010, J BIOL CHEM, V285, P1343, DOI 10.1074/jbc.M109.024703; Huang SH, 2000, MICROBES INFECT, V2, P1237, DOI 10.1016/S1286-4579(00)01277-6; HUANG SH, 1995, INFECT IMMUN, V63, P4470, DOI 10.1128/IAI.63.11.4470-4475.1995; Huang SH, 2001, J INFECT DIS, V183, P1071, DOI 10.1086/319290; Huang Sheng-he, 2001, Functional and Integrative Genomics, V1, P312, DOI 10.1007/s101420100039; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Ichiyama T, 2002, NEUROL RES, V24, P709, DOI 10.1179/016164102101200627; Jackman RW, 2009, EXP CELL RES, V315, P3242, DOI 10.1016/j.yexcr.2009.08.020; Johnson TJ, 2012, FOODBORNE PATHOG DIS, V9, P37, DOI 10.1089/fpd.2011.0961; Johnson TJ, 2012, INFECT IMMUN    0206, V6; Khan M, 2007, J NEUROCHEM, V102, P365, DOI 10.1111/j.1471-4159.2007.04526.x; Koedel U, 2000, J INFECT DIS, V182, P1437, DOI 10.1086/315877; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; Koudelka KJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000417; Lukong KE, 2009, CELL SIGNAL, V21, P1415, DOI 10.1016/j.cellsig.2009.04.008; Luna GM, 2010, APPL ENVIRON MICROB, V76, P5659, DOI 10.1128/AEM.03138-09; Mackenzie GG, 2006, J NEUROCHEM, V99, P402, DOI 10.1111/j.1471-4159.2006.04005.x; Mankan AK, 2009, J CELL MOL MED, V13, P631, DOI 10.1111/j.1582-4934.2009.00632.x; Mikenberg I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000589; Mikenberg I, 2006, EUR J CELL BIOL, V85, P529, DOI 10.1016/j.ejcb.2006.02.007; Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb898; Mora A, 2010, APPL ENVIRON MICROB, V76, P6991, DOI 10.1128/AEM.01112-10; Moreland JG, 2006, AM J PHYSIOL-LUNG C, V290, pL833, DOI 10.1152/ajplung.00333.2005; Moreland JG, 2004, J IMMUNOL, V172, P426, DOI 10.4049/jimmunol.172.1.426; MouraNeto V, 1996, GENE, V168, P261, DOI 10.1016/0378-1119(95)00789-X; Negrini B, 2000, PEDIATRICS, V105, P316, DOI 10.1542/peds.105.2.316; Nemeth ZH, 2004, J CELL PHYSIOL, V200, P71, DOI 10.1002/jcp.10477; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; Panta GR, 2004, MOL CELL BIOL, V24, P1823, DOI 10.1128/MCB.24.5.1823-1835.2004; Perlson E, 2006, J MOL BIOL, V364, P938, DOI 10.1016/j.jmb.2006.09.056; Phua DCY, 2009, MOL BIOL CELL, V20, P2841, DOI 10.1091/mbc.E08-02-0199; Rosenberger U, 2002, J CELL BIOCHEM, V86, P394, DOI 10.1002/jcb.10233; Saegusa M, 2007, J PATHOL, V213, P35, DOI 10.1002/path.2198; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; Shin SR, 2006, CANCER RES, V66, P2570, DOI 10.1158/0008-5472.CAN-05-3056; Soto SM, 2008, J CLIN MICROBIOL, V46, P1123, DOI 10.1128/JCM.01682-07; Stins MF, 1999, INFECT IMMUN, V67, P5522, DOI 10.1128/IAI.67.10.5522-5525.1999; van der Flier M, 2003, CLIN MICROBIOL REV, V16, P415, DOI 10.1128/CMR.16.3.415-429.2003; Wang SH, 2011, INFECT IMMUN, V79, P279, DOI 10.1128/IAI.00821-10; Watt S, 2003, J CLIN MICROBIOL, V41, P1929, DOI 10.1128/JCM.41.5.1929-1935.2003; Xu B, 2004, MOL CELL BIOL, V24, P9198, DOI 10.1128/MCB.24.20.9198-9206.2004; Yang HJ, 2007, MOL PHARMACOL, V71, P426, DOI 10.1124/mol.106.030015; Zhang Q, 2009, CLIN CANCER RES, V15, P3557, DOI 10.1158/1078-0432.CCR-08-1656; Zhao J, 2012, J NEUROTRAUMA   0130, V30; Zolotukhin AS, 2003, MOL CELL BIOL, V23, P6618, DOI 10.1128/MCB.23.18.6618-6630.2003; Zou YM, 2007, MED MICROBIOL IMMUN, V196, P135, DOI 10.1007/s00430-006-0034-x; Zou YM, 2006, BIOCHEM BIOPH RES CO, V351, P625, DOI 10.1016/j.bbrc.2006.10.091	71	24	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35862	10.1371/journal.pone.0035862	http://dx.doi.org/10.1371/journal.pone.0035862			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536447	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339200120
J	Jain, S; Chen, ST; Chang, KC; Lin, YJ; Hu, CT; Boldbaatar, B; Hamilton, JP; Lin, SY; Chang, TT; Chen, SH; Song, W; Meltzer, SJ; Block, TM; Su, YH				Jain, Surbhi; Chen, Sitong; Chang, Kung-Chao; Lin, Yih-Jyh; Hu, Chi-Tan; Boldbaatar, Batbold; Hamilton, James P.; Lin, Selena Y.; Chang, Ting-Tsung; Chen, Shun-Hua; Song, Wei; Meltzer, Stephen J.; Block, Timothy M.; Su, Ying-Hsiu			Impact of the Location of CpG Methylation within the GSTP1 Gene on Its Specificity as a DNA Marker for Hepatocellular Carcinoma	PLOS ONE			English	Article							ABERRANT PROMOTER METHYLATION; TUMOR-SUPPRESSOR GENES; ISLAND HYPERMETHYLATION; MULTIPLE GENES; GLUTATHIONE TRANSFERASES; QUANTITATIVE-ANALYSIS; CANCER; LIVER; HEPATITIS; HEPATOCARCINOGENESIS	Hypermethylation of the glutathione S-transferase pi 1 (GSTP1) gene promoter region has been reported to be a potential biomarker to distinguish hepatocellular carcinoma (HCC) from other liver diseases. However, reports regarding how specific a marker it is have ranged from 100% to 0%. We hypothesized that, to a large extent, the variation of specificity depends on the location of the CpG sites analyzed. To test this hypothesis, we compared the methylation status of the GSTP1 promoter region of the DNA isolated from HCC, cirrhosis, hepatitis, and normal liver tissues by bisulfite-PCR sequencing. We found that the 5' region of the position -48 nt from the transcription start site of the GSTP1 gene is selectively methylated in HCC, whereas the 3' region is methylated in all liver tissues examined, including normal liver and the HCC tissue. Interestingly, when DNA derived from fetal liver and 11 nonhepatic normal tissue was also examined by bisulfite-PCR sequencing, we found that methylation of the 3' region of the promoter appeared to be liver-specific. A methylation-specific PCR assay targeting the 5' region of the promoter was developed and used to quantify the methylated GSTP1 gene in various diseased liver tissues including HCC. When we used an assay targeting the 3' region, we found that the methylation of the 5'-end of the GSTP1 promoter was significantly more specific than that of the 3'-end (97.1% vs. 60%, p < 0.0001 by Fisher's exact test) for distinguishing HCC (n = 120) from hepatitis (n = 35) and cirrhosis (n = 35). Encouragingly, 33.8% of the AFP-negative HCC contained the methylated GSTP1 gene. This study clearly demonstrates the importance of the location of CpG site methylation for HCC specificity and how liver-specific DNA methylation should be considered when an epigenetic DNA marker is studied for detection of HCC.	[Jain, Surbhi; Chen, Sitong; Boldbaatar, Batbold; Lin, Selena Y.; Block, Timothy M.; Su, Ying-Hsiu] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA; [Chang, Kung-Chao] Natl Cheng Kung Univ, Coll Med, Dept Pathol, Tainan 70101, Taiwan; [Lin, Yih-Jyh] Natl Cheng Kung Univ Hosp, Dept Surg, Tainan 70428, Taiwan; [Hu, Chi-Tan] Buddhist Tzu Chi Gen Hosp, Dept Med, Hualien, Taiwan; [Hu, Chi-Tan] Tzu Chi Univ, Hualien, Taiwan; [Hamilton, James P.; Meltzer, Stephen J.] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Baltimore, MD 21205 USA; [Chang, Ting-Tsung] Natl Cheng Kung Univ, Coll Med, Dept Med, Tainan 70101, Taiwan; [Chen, Shun-Hua] Natl Cheng Kung Univ, Coll Med, Dept Microbiol, Tainan 70101, Taiwan; [Song, Wei] JBS Sci Inc, Doylestown, PA USA; [Meltzer, Stephen J.] Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD USA	Drexel University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Johns Hopkins University; National Cheng Kung University; National Cheng Kung University; Johns Hopkins University; Johns Hopkins Medicine	Su, YH (corresponding author), Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA.	Ying-hsiu.Su@drexelmed.edu	CHEN, SI/GZL-4800-2022		National Institute of Health [R01 CA125642, CA146799, CA133012, CA085069, DK087454, K08]; Johns Hopkins University School of Medicine; Prevent Cancer Foundation Postdoctoral Fellowship Award; Early Detection Research Network grant of The National Cancer Institute; Hepatitis B Foundation of America; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE [R01CA133012, R01CA146799, R01CA125642, U01CA085069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087454] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University School of Medicine(Johns Hopkins University); Prevent Cancer Foundation Postdoctoral Fellowship Award; Early Detection Research Network grant of The National Cancer Institute; Hepatitis B Foundation of America; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Health R01 CA125642 (YHS), CA146799(SJM), CA133012 (SJM), CA085069 (SJM), DK087454 (SJM), and K08 (JPH). a Clinician-Scientist Award from Johns Hopkins University School of Medicine (JPH); Prevent Cancer Foundation Postdoctoral Fellowship Award (SJ); The Early Detection Research Network grant of The National Cancer Institute (TMB); The Hepatitis B Foundation of America (TMB); and an appropriation from The Commonwealth of Pennsylvania (TMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	American Cancer Society, 2010, CANC FACTS FIG 2010; Bakker J, 2002, J BIOL CHEM, V277, P22573, DOI 10.1074/jbc.M203009200; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Chai H, 2009, ANN CLIN LAB SCI, V39, P331; Chan KCA, 2008, CLIN CHEM, V54, P1528, DOI 10.1373/clinchem.2008.104653; Chang H, 2008, EXP MOL PATHOL, V85, P96, DOI 10.1016/j.yexmp.2008.07.001; COLES B, 1990, CRIT REV BIOCHEM MOL, V25, P47, DOI 10.3109/10409239009090605; Esteller M, 2001, CANCER RES, V61, P3225; Feng QH, 2010, EXP MOL PATHOL, V88, P287, DOI 10.1016/j.yexmp.2010.01.002; Formeister EJ, 2010, MUTAT RES-FUND MOL M, V692, P26, DOI 10.1016/j.mrfmmm.2010.07.013; Giovannucci E, 2005, JNCI-J NATL CANCER I, V97, P1317, DOI 10.1093/jnci/dji305; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harder J, 2008, INT J CANCER, V122, P2800, DOI 10.1002/ijc.23433; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Hernandez-Vargas H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009749; Hoshida Yujin, 2009, Expert Rev Gastroenterol Hepatol, V3, P101, DOI 10.1586/egh.09.5; Hua D, 2011, EXP MOL PATHOL, V91, P455, DOI 10.1016/j.yexmp.2011.05.001; Huang ZH, 2011, EXP MOL PATHOL, V91, P702, DOI 10.1016/j.yexmp.2011.08.004; Jain S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026799; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Katoh H, 2006, AM J PATHOL, V168, P1375, DOI 10.2353/ajpath.2006.050989; Lambert MP, 2011, J HEPATOL, V54, P705, DOI 10.1016/j.jhep.2010.07.027; Lee S, 2003, AM J PATHOL, V163, P1371, DOI 10.1016/S0002-9440(10)63495-5; Lehmann U, 2005, CLIN CANCER RES, V11, P3654, DOI 10.1158/1078-0432.CCR-04-2462; Millar DS, 2000, J BIOL CHEM, V275, P24893, DOI 10.1074/jbc.M906538199; Millar DS, 1999, ONCOGENE, V18, P1313, DOI 10.1038/sj.onc.1202415; Moribe T, 2009, INT J CANCER, V125, P388, DOI 10.1002/ijc.24394; Nishida N, 2008, HEPATOLOGY, V47, P908, DOI 10.1002/hep.22110; Nomoto S, 2007, BRIT J CANCER, V97, P1260, DOI 10.1038/sj.bjc.6604016; Park IY, 2007, GASTROENTEROLOGY, V132, P1476, DOI 10.1053/j.gastro.2007.01.034; RUSHMORE TH, 1993, J BIOL CHEM, V268, P11475; Sherman M, 2008, NEW ENGL J MED, V359, P2045, DOI 10.1056/NEJMe0807581; Su PF, 2007, INT J CANCER, V121, P1257, DOI 10.1002/ijc.22849; Tchou JC, 2000, INT J ONCOL, V16, P663; TSUCHIDA S, 1992, CRIT REV BIOCHEM MOL, V27, P337, DOI 10.3109/10409239209082566; van Vlodrop IJH, 2011, CLIN CANCER RES, V17, P4225, DOI 10.1158/1078-0432.CCR-10-3394; van Vlodrop IJH, 2010, AM J PATHOL, V176, P575, DOI 10.2353/ajpath.2010.090442; Wang JH, 2006, CLIN BIOCHEM, V39, P344, DOI 10.1016/j.clinbiochem.2006.01.008; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Yang B, 2003, AM J PATHOL, V163, P1101, DOI 10.1016/S0002-9440(10)63469-4; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007; Zhong S, 2002, CLIN CANCER RES, V8, P1087	42	33	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35789	10.1371/journal.pone.0035789	http://dx.doi.org/10.1371/journal.pone.0035789			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536438	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200112
J	Lovly, CM; Dahlman, KB; Fohn, LE; Su, ZL; Dias-Santagata, D; Hicks, DJ; Hucks, D; Berry, E; Terry, C; Duke, M; Su, YJ; Sobolik-Delmaire, T; Richmond, A; Kelley, MC; Vnencak-Jones, CL; Iafrate, AJ; Sosman, J; Pao, W				Lovly, Christine M.; Dahlman, Kimberly Brown; Fohn, Laurel E.; Su, Zengliu; Dias-Santagata, Dora; Hicks, Donna J.; Hucks, Donald; Berry, Elizabeth; Terry, Charles; Duke, MarKeesa; Su, Yingjun; Sobolik-Delmaire, Tammy; Richmond, Ann; Kelley, Mark C.; Vnencak-Jones, Cindy L.; Iafrate, A. John; Sosman, Jeffrey; Pao, William			Routine Multiplex Mutational Profiling of Melanomas Enables Enrollment in Genotype-Driven Therapeutic Trials	PLOS ONE			English	Article							METASTATIC MALIGNANT-MELANOMA; PHASE-III TRIAL; BRAF MUTATIONS; BETA-CATENIN; TUMOR PROGRESSION; UVEAL MELANOMA; COPY NUMBER; N-RAS; KIT; GENE	Purpose: Knowledge of tumor mutation status is becoming increasingly important for the treatment of cancer, as mutation-specific inhibitors are being developed for clinical use that target only sub-populations of patients with particular tumor genotypes. Melanoma provides a recent example of this paradigm. We report here development, validation, and implementation of an assay designed to simultaneously detect 43 common somatic point mutations in 6 genes (BRAF, NRAS, KIT, GNAQ, GNA11, and CTNNB1) potentially relevant to existing and emerging targeted therapies specifically in melanoma. Methods: The test utilizes the SNaPshot method (multiplex PCR, multiplex primer extension, and capillary electrophoresis) and can be performed rapidly with high sensitivity (requiring 5-10% mutant allele frequency) and minimal amounts of DNA (10-20 nanograms). The assay was validated using cell lines, fresh-frozen tissue, and formalin-fixed paraffin embedded tissue. Clinical characteristics and the impact on clinical trial enrollment were then assessed for the first 150 melanoma patients whose tumors were genotyped in the Vanderbilt molecular diagnostics lab. Results: Directing this test to a single disease, 90 of 150 (60%) melanomas from sites throughout the body harbored a mutation tested, including 57, 23, 6, 3, and 2 mutations in BRAF, NRAS, GNAQ, KIT, and CTNNB1, respectively. Among BRAF V600 mutations, 79%, 12%, 5%, and 4% were V600E, V600K, V600R, and V600M, respectively. 23 of 54 (43%) patients with mutation harboring metastatic disease were subsequently enrolled in genotype-driven trials. Conclusion: We present development of a simple mutational profiling screen for clinically relevant mutations in melanoma. Adoption of this genetically-informed approach to the treatment of melanoma has already had an impact on clinical trial enrollment and prioritization of therapy for patients with the disease.	[Lovly, Christine M.; Fohn, Laurel E.; Su, Zengliu; Berry, Elizabeth; Terry, Charles; Duke, MarKeesa; Sosman, Jeffrey; Pao, William] Vanderbilt Univ, Sch Med, Div Hematol Oncol, Dept Med,Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Dahlman, Kimberly Brown; Su, Yingjun; Sobolik-Delmaire, Tammy] Vanderbilt Univ, Sch Med, Dept Canc Biol, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Dias-Santagata, Dora; Iafrate, A. John] Massachusetts Gen Hosp, Dept Pathol, Translat Res Lab, Boston, MA 02114 USA; [Dias-Santagata, Dora; Iafrate, A. John] Harvard Univ, Sch Med, Boston, MA USA; [Hicks, Donna J.; Hucks, Donald] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Med Ctr, Nashville, TN 37212 USA; [Richmond, Ann] Vanderbilt Univ, Sch Med, Dept Canc Biol, Dept Vet Affairs,Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Kelley, Mark C.] Vanderbilt Univ, Sch Med, Div Surg Oncol, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Vnencak-Jones, Cindy L.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37212 USA; [Vnencak-Jones, Cindy L.] Vanderbilt Univ, Med Ctr, Dept Microbiol, Nashville, TN 37212 USA; [Vnencak-Jones, Cindy L.] Vanderbilt Univ, Med Ctr, Dept Immunol & Pediat, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Pao, W (corresponding author), Vanderbilt Univ, Sch Med, Div Hematol Oncol, Dept Med,Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA.	william.pao@vanderbilt.edu	Richmond, Ann/A-3048-2014	RICHMOND, ANN/0000-0002-9580-900X; Berry, Elizabeth/0000-0002-7574-6718; Lovly, Christine/0000-0002-3641-6361	VICC Cancer Center [CA68485]; TJ Martell Foundation; Kleberg Foundation; National Institutes of Health / National Cancer Institute [5K24 CA97588-06]; American Cancer Society; Department of Veterans Affairs; Valvano Foundation; Vanderbilt Institute for Clinical and Translational Research (VICTR) CTSA [UL1 RR024975-01]; AstraZeneca; NATIONAL CANCER INSTITUTE [K24CA097588, P30CA068485, R01CA116021, U54CA163072] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975, TL1RR024978, KL2RR024977] Funding Source: NIH RePORTER	VICC Cancer Center; TJ Martell Foundation; Kleberg Foundation; National Institutes of Health / National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Department of Veterans Affairs(US Department of Veterans Affairs); Valvano Foundation; Vanderbilt Institute for Clinical and Translational Research (VICTR) CTSA; AstraZeneca(AstraZeneca); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a VICC Cancer Center Core Grant (CA68485), the TJ Martell Foundation, the Kleberg Foundation, the National Institutes of Health / National Cancer Institute 5K24 CA97588-06 (JS), the American Cancer Society (Mary Hendrickson-Johnson Melanoma Professorship to JS), the Department of Veterans Affairs (Senior Research Career Scientist Award to AR), the Valvano Foundation (to JS and AR), the Vanderbilt Institute for Clinical and Translational Research (VICTR) CTSA grant (UL1 RR024975-01), and an anonymous donor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Please note: WP has done consulting for Bristol-Myers Squibb and has received research funding from AstraZeneca. However, this is NOT related to the current study.	Andre F, 2011, J CLIN ONCOL, V29, P1236, DOI 10.1200/JCO.2010.31.6877; Antonescu CR, 2007, INT J CANCER, V121, P257, DOI 10.1002/ijc.22681; Atkins MB, 2008, J CLIN ONCOL, V26, P5748, DOI 10.1200/JCO.2008.17.5448; Bauer J, 2009, BRIT J CANCER, V101, P813, DOI 10.1038/sj.bjc.6605226; Beadling C, 2008, CLIN CANCER RES, V14, P6821, DOI 10.1158/1078-0432.CCR-08-0575; CARVAJAL RD, 2009, J CLIN ONCOL, V27; Carvajal RD, 2011, JAMA-J AM MED ASSOC, V305, P2327, DOI 10.1001/jama.2011.746; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chapman PB, 1999, J CLIN ONCOL, V17, P2745, DOI 10.1200/JCO.1999.17.9.2745; Chattopadhyay C, 2011, INT J CANC; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107; Demunter A, 2002, MODERN PATHOL, V15, P454, DOI 10.1038/modpathol.3880546; Dias-Santagata D, 2010, EMBO MOL MED, V2, P146, DOI 10.1002/emmm.201000070; Dunn EF, 2011, ONCOGENE, V30, P561, DOI 10.1038/onc.2010.430; Falkson CI, 1998, J CLIN ONCOL, V16, P1743, DOI 10.1200/JCO.1998.16.5.1743; Fisher D E, 2010, Pigment Cell Melanoma Res, V23, P14, DOI 10.1111/j.1755-148X.2009.00655.x; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Guo J, 2011, J CLIN ONCOL; Handolias D, 2010, BRIT J CANCER, V102, P1219, DOI 10.1038/sj.bjc.6605635; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hodi FS, 2008, J CLIN ONCOL, V26, P2046, DOI 10.1200/JCO.2007.14.0707; Infante JR, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.2503; Jaiswal BS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005717; Jiang XF, 2008, CLIN CANCER RES, V14, P7726, DOI 10.1158/1078-0432.CCR-08-1144; Kefford R. F., 2010, J CLIN ONCOL, V28; King AJ, 2006, CANCER RES, V66, P11100, DOI 10.1158/0008-5472.CAN-06-2554; Levy C, 2010, MOL CELL, V40, P841, DOI 10.1016/j.molcel.2010.11.020; Long GV, 2011, J CLIN ONCOL, V29, P1239, DOI 10.1200/JCO.2010.32.4327; Lutzky J, 2008, PIGM CELL MELANOMA R, V21, P492, DOI 10.1111/j.1755-148X.2008.00475.x; Maldonado JL, 2003, J NATL CANCER I, V95, P1878, DOI 10.1093/jnci/djg123; McGuinness C, 2008, FRONT BIOSCI-LANDMRK, V13, P2435, DOI 10.2741/2856; Middleton MR, 2000, J CLIN ONCOL, V18, P158, DOI 10.1200/JCO.2000.18.1.158; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Omholt K, 2001, INT J CANCER, V92, P839, DOI 10.1002/ijc.1270; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Reifenberger J, 2002, INT J CANCER, V100, P549, DOI 10.1002/ijc.10512; Rubinstein JC, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-67; Sequist LV, 2011, ANN ONCOL, V22, P2616, DOI 10.1093/annonc/mdr489; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; SOSMAN J, 2010, PIGMENT CELL MELANOM, V23; Sosman J, 2012, NEW ENGLAND IN PRESS; Spittle C, 2007, J MOL DIAGN, V9, P464, DOI 10.2353/jmoldx.2007.060191; Su ZL, 2011, J MOL DIAGN, V13, P74, DOI 10.1016/j.jmoldx.2010.11.010; Terheyden P, 2010, J INVEST DERMATOL, V130, P314, DOI 10.1038/jid.2009.197; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Tsao H, 2004, J INVEST DERMATOL, V122, P337, DOI 10.1046/j.0022-202X.2004.22243.x; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Woodman SE, 2009, MOL CANCER THER, V8, P2079, DOI 10.1158/1535-7163.MCT-09-0459; Xing F, 2011, ONCOGENE; Yang H, 2010, CANCER RES, V70, P5518, DOI 10.1158/0008-5472.CAN-10-0646; Zuidervaart W, 2003, BRIT J CANCER, V89, P1914, DOI 10.1038/sj.bjc.6601374	56	151	157	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35309	10.1371/journal.pone.0035309	http://dx.doi.org/10.1371/journal.pone.0035309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536370	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339200052
J	Stauber, EJ; Kuczka, P; van Ohlen, M; Vogt, B; Janowitz, T; Piotrowski, M; Beuerle, T; Wittstock, U				Stauber, Einar J.; Kuczka, Petrissa; van Ohlen, Maike; Vogt, Birgit; Janowitz, Tim; Piotrowski, Markus; Beuerle, Till; Wittstock, Ute			Turning the 'Mustard Oil Bomb' into a 'Cyanide Bomb': Aromatic Glucosinolate Metabolism in a Specialist Insect Herbivore	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; CYANOGENIC GLYCOSIDES; NITRILE FORMATION; GENETIC-BASIS; PIERIS-RAPAE; EVOLUTION; DEFENSE; PLANTS; L.; ISOTHIOCYANATES	Plants have evolved a variety of mechanisms for dealing with insect herbivory among which chemical defense through secondary metabolites plays a prominent role. Physiological, behavioural and sensorical adaptations to these chemicals provide herbivores with selective advantages allowing them to diversify within the newly occupied ecological niche. In turn, this may influence the evolution of plant metabolism giving rise to e. g. new chemical defenses. The association of Pierid butterflies and plants of the Brassicales has been cited as an illustrative example of this adaptive process known as 'coevolutionary armsrace'. All plants of the Brassicales are defended by the glucosinolate-myrosinase system to which larvae of cabbage white butterflies and related species are biochemically adapted through a gut nitrile-specifier protein. Here, we provide evidence by metabolite profiling and enzyme assays that metabolism of benzylglucosinolate in Pieris rapae results in release of equimolar amounts of cyanide, a potent inhibitor of cellular respiration. We further demonstrate that P. rapae larvae develop on transgenic Arabidopsis plants with ectopic production of the cyanogenic glucoside dhurrin without ill effects. Metabolite analyses and fumigation experiments indicate that cyanide is detoxified by beta-cyanoalanine synthase and rhodanese in the larvae. Based on these results as well as on the facts that benzylglucosinolate was one of the predominant glucosinolates in ancient Brassicales and that ancient Brassicales lack nitrilases involved in alternative pathways, we propose that the ability of Pierid species to safely handle cyanide contributed to the primary host shift from Fabales to Brassicales that occured about 75 million years ago and was followed by Pierid species diversification.	[Stauber, Einar J.; Kuczka, Petrissa; van Ohlen, Maike; Vogt, Birgit; Beuerle, Till; Wittstock, Ute] Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmaceut Biol, D-38106 Braunschweig, Germany; [Janowitz, Tim; Piotrowski, Markus] Ruhr Univ Bochum, Dept Plant Physiol, Bochum, Germany	Braunschweig University of Technology; Ruhr University Bochum	Wittstock, U (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmaceut Biol, D-38106 Braunschweig, Germany.	u.wittstock@tu-bs.de	Piotrowski, Markus/F-5419-2010	Piotrowski, Markus/0000-0002-6347-3337; Wittstock, Ute/0000-0002-0914-8453; Beuerle, Till/0000-0001-5037-6653	German Research Foundation [WI 2668/4-1]	German Research Foundation(German Research Foundation (DFG))	Funding provided by the German Research Foundation (http://www.dfg.de/en/index.jsp) grant number: WI 2668/4-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerbirk N, 2008, PHYTOCHEMISTRY, V69, P2937, DOI 10.1016/j.phytochem.2008.08.014; Agerbirk N, 2007, INSECT BIOCHEM MOLEC, V37, P1119, DOI 10.1016/j.ibmb.2007.06.009; Agerbirk N, 2010, INSECT BIOCHEM MOLEC, V40, P126, DOI 10.1016/j.ibmb.2010.01.003; Bak Soren, 2006, Phytochemistry Reviews, V5, P309, DOI 10.1007/s11101-006-9033-1; Ballhorn DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005450; Becerra JX, 1997, SCIENCE, V276, P253, DOI 10.1126/science.276.5310.253; BEESLEY SG, 1985, J CHEM ECOL, V11, P45, DOI 10.1007/BF00987603; Biesgen C, 1999, PLANTA, V208, P155, DOI 10.1007/s004250050545; Bottcher C, 2009, PLANT CELL, V21, P1830, DOI 10.1105/tpc.109.066670; Braby MF, 2006, J EVOLUTION BIOL, V19, P1677, DOI 10.1111/j.1420-9101.2006.01109.x; Braby MF, 2006, ZOOL J LINN SOC-LOND, V147, P238; Burow M, 2009, PLANT PHYSIOL, V149, P561, DOI 10.1104/pp.108.130732; Burow M, 2006, J CHEM ECOL, V32, P2333, DOI 10.1007/s10886-006-9149-1; Cipollone R, 2007, IUBMB LIFE, V59, P51, DOI 10.1080/15216540701206859; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; CONN EE, 1980, ANNU REV PLANT PHYS, V31, P433, DOI 10.1146/annurev.pp.31.060180.002245; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Engelen-Eigles G, 2006, J AGR FOOD CHEM, V54, P328, DOI 10.1021/jf051857o; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Gleadow RM, 2002, J CHEM ECOL, V28, P1301, DOI 10.1023/A:1016298100201; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hall JC, 2002, AM J BOT, V89, P1826, DOI 10.3732/ajb.89.11.1826; Hansen CH, 2001, J BIOL CHEM, V276, P24790, DOI 10.1074/jbc.M102637200; Hartmann T, 2007, PHYTOCHEMISTRY, V68, P2831, DOI 10.1016/j.phytochem.2007.09.017; Hatzfeld Y, 2000, PLANT PHYSIOL, V123, P1163, DOI 10.1104/pp.123.3.1163; Hopkins RJ, 2009, ANNU REV ENTOMOL, V54, P57, DOI 10.1146/annurev.ento.54.110807.090623; Janowitz T, 2009, PHYTOCHEMISTRY, V70, P1680, DOI 10.1016/j.phytochem.2009.07.028; Jensen NB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1271; Kessler A, 2007, CURR OPIN PLANT BIOL, V10, P409, DOI 10.1016/j.pbi.2007.06.001; Kleinwachter M, 2008, J AGR FOOD CHEM, V56, P11165, DOI 10.1021/jf802053n; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; MATILE P, 1980, BIOCHEM PHYSIOL PFL, V175, P722, DOI 10.1016/S0015-3796(80)80059-X; Mesaik MA, 2004, BIOORGAN MED CHEM, V12, P2049, DOI 10.1016/j.bmc.2004.02.034; MEYERS DM, 1991, BIOCHIM BIOPHYS ACTA, V1075, P195, DOI 10.1016/0304-4165(91)90252-C; Mithen R, 2010, PHYTOCHEMISTRY, V71, P2074, DOI 10.1016/j.phytochem.2010.09.017; Piotrowski M, 2001, J BIOL CHEM, V276, P2616, DOI 10.1074/jbc.M007890200; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Takos AM, 2011, PLANT J, V68, P273, DOI 10.1111/j.1365-313X.2011.04685.x; Tattersall DB, 2001, SCIENCE, V293, P1826, DOI 10.1126/science.1062249; THIES W, 1988, FETT WISS TECHNOL, V90, P311, DOI 10.1002/lipi.19880900806; Traka M, 2009, PHYTOCHEM REV, V8, P269, DOI 10.1007/s11101-008-9103-7; Vergara F, 2007, CHEMBIOCHEM, V8, P1757, DOI 10.1002/cbic.200790053; Vergara F, 2006, CHEMBIOCHEM, V7, P1982, DOI 10.1002/cbic.200600280; Vorwerk S, 2001, PLANTA, V212, P508, DOI 10.1007/s004250000420; Wheat CW, 2007, P NATL ACAD SCI USA, V104, P20427, DOI 10.1073/pnas.0706229104; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; WILKINSON CF, 1972, DRUG METAB REV, V1, P153, DOI 10.3109/03602537208993912; Wittstock U, 2004, P NATL ACAD SCI USA, V101, P4859, DOI 10.1073/pnas.0308007101; Wittstock U, 2000, J BIOL CHEM, V275, P14659, DOI 10.1074/jbc.275.19.14659; Wittstock U, 2002, CURR OPIN PLANT BIOL, V5, P300, DOI 10.1016/S1369-5266(02)00264-9; Wittstock U, 2003, RECENT ADV PHYTOCHEM, V37, P101; Zagrobelny M, 2004, PHYTOCHEMISTRY, V65, P293, DOI 10.1016/j.phytochem.2003.10.016; Zagrobelny M, 2011, PHYTOCHEMISTRY, V72, P1585, DOI 10.1016/j.phytochem.2011.02.023	53	51	52	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35545	10.1371/journal.pone.0035545	http://dx.doi.org/10.1371/journal.pone.0035545			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536404	gold, Green Published, Green Submitted			2022-12-25	WOS:000305339200077
J	Ingham, CJ; Schneeberger, PM				Ingham, Colin J.; Schneeberger, Peter M.			Microcolony Imaging of Aspergillus fumigatus Treated with Echinocandins Reveals Both Fungistatic and Fungicidal Activities	PLOS ONE			English	Article							CASPOFUNGIN; MICAFUNGIN	Background: The echinocandins are lipopeptides that can be employed as antifungal drugs that inhibit the synthesis of 1,3-beta-glucans within the fungal cell wall. Anidulafungin and caspofungin are echinocandins used in the treatment of Candida infections and have activity against other fungi including Aspergillus fumigatus. The echinocandins are generally considered fungistatic against Aspergillus species. Methods: Culture of A. fumigatus from conidia to microcolonies on a support of porous aluminium oxide (PAO), combined with fluorescence microscopy and scanning electron microscopy, was used to investigate the effects of anidulafungin and caspofungin. The PAO was an effective matrix for conidial germination and microcolony growth. Additionally, PAO supports could be moved between agar plates containing different concentrations of echinocandins to change dosage and to investigate the recovery of fungal microcolonies from these drugs. Culture on PAO combined with microscopy and image analysis permits quantitative studies on microcolony growth with the flexibility of adding or removing antifungal agents, dyes, fixatives or osmotic stresses during growth with minimal disturbance of fungal microcolonies. Significance: Anidulafungin and caspofungin reduced but did not halt growth at the microcony level; additionally both drugs killed individual cells, particularly at concentrations around the MIC. Intact but not lysed cells showed rapid recovery when the drugs were removed. The classification of these drugs as either fungistatic or fungicidal is simplistic. Microcolony analysis on PAO appears to be a valuable tool to investigate the action of antifungal agents.	[Ingham, Colin J.; Schneeberger, Peter M.] Jeroen Bosch Hosp, Dept Med Microbiol & Infect Control, Shertogenbosch, Netherlands; [Ingham, Colin J.] Wageningen Univ, Microbiol Lab, Wageningen, Netherlands; [Ingham, Colin J.] MicroDish BV, Wageningen, Netherlands	Jeroen Bosch Ziekenhuis; Wageningen University & Research	Ingham, CJ (corresponding author), Jeroen Bosch Hosp, Dept Med Microbiol & Infect Control, Shertogenbosch, Netherlands.	colinutrecht@gmail.com			JBZ Hospital	JBZ Hospital	This work was funded by the JBZ Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antachopoulos C, 2008, ANTIMICROB AGENTS CH, V52, P321, DOI 10.1128/AAC.00699-07; Bowman JC, 2002, ANTIMICROB AGENTS CH, V46, P3001, DOI 10.1128/AAC.46.9.3001-3012.2002; Chiou CC, 2001, ANTIMICROB AGENTS CH, V45, P3310, DOI 10.1128/AAC.45.12.3310-3321.2001; den Besten HM, 2008, APPL ENVIRON MICROB, V73, P4797; Denning DW, 2002, J ANTIMICROB CHEMOTH, V49, P889, DOI 10.1093/jac/dkf045; Douglas CM, 1997, ANTIMICROB AGENTS CH, V41, P2471, DOI 10.1128/AAC.41.11.2471; Hiemenz JW, 2010, EUR J CLIN MICROBIOL, V29, P1387, DOI 10.1007/s10096-010-1013-0; Hill TW, 2006, MYCOLOGIA, V98, P399, DOI 10.3852/mycologia.98.3.399; Ingham CJ, 2005, APPL ENVIRON MICROB, V71, P8978, DOI 10.1128/AEM.71.12.8978-8981.2005; Ingham CJ, 2012, ROLE NEW TECHNOLOGIE, P86; Ingham CJ, 2007, P NATL ACAD SCI USA, V104, P18217, DOI 10.1073/pnas.0701693104; Ingham CJ, 2006, J MED MICROBIOL, V55, P1511, DOI 10.1099/jmm.0.46585-0; Ingham CJ, 2012, BIOTECHNOL ADV, V30, P1089, DOI 10.1016/j.biotechadv.2011.08.005; Jones BV, 2004, INFECT IMMUN, V72, P3941, DOI 10.1128/IAI.72.7.3941-3950.2004; Perlin DS, 2011, FUTURE MICROBIOL, V6, P441, DOI [10.2217/fmb.11.19, 10.2217/FMB.11.19]; Steinbach WJ, 2004, ANTIMICROB AGENTS CH, V48, P1664, DOI 10.1128/AAC.48.5.1664-1669.2004; Templeton SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018777; Walker LA, 2010, FUNGAL GENET BIOL, V47, P117, DOI 10.1016/j.fgb.2009.09.003; Watabe E, 2003, ANTIMICROB AGENTS CH, V47, P1995, DOI 10.1128/AAC.47.6.1995-1998.2003	19	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35478	10.1371/journal.pone.0035478	http://dx.doi.org/10.1371/journal.pone.0035478			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536390	gold, Green Submitted, Green Published			2022-12-25	WOS:000305336200044
J	Khatabi, B; Molitor, A; Lindermayr, C; Pfiffi, S; Durner, J; von Wettstein, D; Kogel, KH; Schafer, P				Khatabi, Behnam; Molitor, Alexandra; Lindermayr, Christian; Pfiffi, Stefanie; Durner, Joerg; von Wettstein, Diter; Kogel, Karl-Heinz; Schaefer, Patrick			Ethylene Supports Colonization of Plant Roots by the Mutualistic Fungus Piriformospora indica	PLOS ONE			English	Article							1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; EXPRESSION PATTERNS; BACTERIAL FLAGELLIN; SYSTEMIC RESISTANCE; DISEASE RESISTANCE; NEGATIVE REGULATOR; SIGNALING PATHWAY; INNATE IMMUNITY	The mutualistic basidiomycete Piriformospora indica colonizes roots of mono- and dicotyledonous plants, and thereby improves plant health and yield. Given the capability of P. indica to colonize a broad range of hosts, it must be anticipated that the fungus has evolved efficient strategies to overcome plant immunity and to establish a proper environment for nutrient acquisition and reproduction. Global gene expression studies in barley identified various ethylene synthesis and signaling components that were differentially regulated in P. indica-colonized roots. Based on these findings we examined the impact of ethylene in the symbiotic association. The data presented here suggest that P. indica induces ethylene synthesis in barley and Arabidopsis roots during colonization. Moreover, impaired ethylene signaling resulted in reduced root colonization, Arabidopsis mutants exhibiting constitutive ethylene signaling, -synthesis or ethylene-related defense were hyper-susceptible to P. indica. Our data suggest that ethylene signaling is required for symbiotic root colonization by P. indica.	[Khatabi, Behnam; Molitor, Alexandra; Pfiffi, Stefanie; von Wettstein, Diter; Kogel, Karl-Heinz; Schaefer, Patrick] Univ Giessen, Inst Phytopathol & Appl Zool, Res Ctr Biosyst Land Use & Nutr, Giessen, Germany; [Lindermayr, Christian; Durner, Joerg] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Biochem Plant Pathol, Oberschleissheim, Germany; [von Wettstein, Diter] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [von Wettstein, Diter] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Justus Liebig University Giessen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Washington State University; Washington State University	Khatabi, B (corresponding author), Univ Giessen, Inst Phytopathol & Appl Zool, Res Ctr Biosyst Land Use & Nutr, Giessen, Germany.	Patrick.schaefer@agrar.uni-giessen.de	Kogel, KH/K-1626-2019; Schäfer, Patrick/I-2681-2013; ALSUDAYS, IBTISAM/H-9378-2012; Lindermayr, Christian/M-7338-2014; Kogel, Karl-Heinz/N-4016-2014	Kogel, KH/0000-0003-1226-003X; Schäfer, Patrick/0000-0002-0366-6858; Lindermayr, Christian/0000-0002-9343-4996; Kogel, Karl-Heinz/0000-0003-1226-003X	Deutsche Forschungsgemeinschaft (DFG) [FOR666]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (DFG)-FOR666 grant to PS and KHK and a Mercator professorship from the DFG to DvW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie B, 2007, J PLANT GROWTH REGUL, V26, P160, DOI 10.1007/s00344-007-0012-6; Berrocal-Lobo M, 2004, MOL PLANT MICROBE IN, V17, P763, DOI 10.1094/MPMI.2004.17.7.763; Berrocal-Lobo M, 2002, PLANT J, V29, P23, DOI 10.1046/j.1365-313x.2002.01191.x; Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Boutrot F, 2010, P NATL ACAD SCI USA, V107, P14502, DOI 10.1073/pnas.1003347107; BRADFORD KJ, 1980, PLANT PHYSIOL, V65, P322, DOI 10.1104/pp.65.2.322; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Broekaert WF, 2006, ANNU REV PHYTOPATHOL, V44, P393, DOI 10.1146/annurev.phyto.44.070505.143440; Camehl I, 2010, NEW PHYTOL, V185, P1062, DOI 10.1111/j.1469-8137.2009.03149.x; Cartwright DA, 2009, BIOINFORMATICS, V25, P2581, DOI 10.1093/bioinformatics/btp437; Chae HS, 2005, TRENDS PLANT SCI, V10, P291, DOI 10.1016/j.tplants.2005.04.006; Chae HS, 2003, PLANT CELL, V15, P545, DOI 10.1105/tpc.006882; Deshmukh S, 2006, P NATL ACAD SCI USA, V103, P18450, DOI 10.1073/pnas.0605697103; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; FINLAYSON SA, 1991, PLANT PHYSIOL, V96, P1360, DOI 10.1104/pp.96.4.1360; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Guinel FC, 2002, CAN J BOT, V80, P695, DOI [10.1139/b02-066, 10.1139/B02-066]; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; Jacobs S, 2011, PLANT PHYSIOL, V156, P726, DOI 10.1104/pp.111.176446; Kendrick MD, 2008, CURR OPIN PLANT BIOL, V11, P479, DOI 10.1016/j.pbi.2008.06.011; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; LANGEBARTELS C, 1991, PLANT PHYSIOL, V95, P882, DOI 10.1104/pp.95.3.882; Leon-Reyes A, 2010, MOL PLANT MICROBE IN, V23, P187, DOI 10.1094/MPMI-23-2-0187; Liu YD, 2004, PLANT CELL, V16, P3386, DOI 10.1105/tpc.104.026609; LIZADA MCC, 1979, ANAL BIOCHEM, V100, P140, DOI 10.1016/0003-2697(79)90123-4; Mersmann S, 2010, PLANT PHYSIOL, V154, P391, DOI 10.1104/pp.110.154567; Penmetsa RV, 2008, PLANT J, V55, P580, DOI 10.1111/j.1365-313X.2008.03531.x; Penmetsa RV, 1997, SCIENCE, V275, P527, DOI 10.1126/science.275.5299.527; Peskan-Berghofer T, 2004, PHYSIOL PLANTARUM, V122, P465, DOI 10.1111/j.1399-3054.2004.00424.x; Pieterse CMJ, 1998, PLANT CELL, V10, P1571, DOI 10.1105/tpc.10.9.1571; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Qiang XY, 2012, PLANT CELL, V24, P794, DOI 10.1105/tpc.111.093260; Riedel T, 2008, PLANT CELL ENVIRON, V31, P1203, DOI 10.1111/j.1365-3040.2008.01827.x; Ruzicka K, 2007, PLANT CELL, V19, P2197, DOI 10.1105/tpc.107.052126; Schafer P, 2009, PLANT J, V59, P461, DOI 10.1111/j.1365-313X.2009.03887.x; Schafer P, 2009, PLANT RELATIONSHIPS, V5, P99; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sirrenberg A, 2007, PHYSIOL PLANTARUM, V131, P581, DOI 10.1111/j.1399-3054.2007.00983.x; Sisler EC, 2003, PLANT BIOLOGY, V5, P473, DOI 10.1055/s-2003-44782; Stein E, 2008, PLANT CELL PHYSIOL, V49, P1747, DOI 10.1093/pcp/pcn147; Stepanova AN, 2007, PLANT CELL, V19, P2169, DOI 10.1105/tpc.107.052068; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; Tamaoki M, 2003, PLANTA, V216, P552, DOI 10.1007/s00425-002-0894-2; Tsuchisaka A, 2004, PLANT PHYSIOL, V136, P2982, DOI 10.1104/pp.104.049999; Tsuda K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000772; TUDELA D, 1992, PLANT PHYSIOL, V100, P131, DOI 10.1104/pp.100.1.131; Van der Ent S, 2009, PHYTOCHEMISTRY, V70, P1581, DOI 10.1016/j.phytochem.2009.06.009; van Loon LC, 2006, TRENDS PLANT SCI, V11, P184, DOI 10.1016/j.tplants.2006.02.005; Varma A, 1999, APPL ENVIRON MICROB, V65, P2741; Verma S, 1998, MYCOLOGIA, V90, P896, DOI 10.2307/3761331; Waller F, 2005, P NATL ACAD SCI USA, V102, P13386, DOI 10.1073/pnas.0504423102; Wang KLC, 2004, NATURE, V428, P945, DOI 10.1038/nature02516; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Yoo SD, 2008, NATURE, V451, P789, DOI 10.1038/nature06543; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367; Zuccaro A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002290	57	58	63	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35502	10.1371/journal.pone.0035502	http://dx.doi.org/10.1371/journal.pone.0035502			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536394	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336200047
J	Altamirano, F; Lopez, JR; Henriquez, C; Molinski, T; Allen, PD; Jaimovich, E				Altamirano, Francisco; Lopez, Jose R.; Henriquez, Carlos; Molinski, Tadeusz; Allen, Paul D.; Jaimovich, Enrique			Increased Resting Intracellular Calcium Modulates NF-kappa B-dependent Inducible Nitric-oxide Synthase Gene Expression in Dystrophic mdx Skeletal Myotubes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; DUCHENNE MUSCULAR-DYSTROPHY; OPERATED CA2+ ENTRY; MOUSE MUSCLE-FIBERS; KNOCKOUT MICE; CELLS; CONTRACTION; PATHWAY; DAMAGE; INVOLVEMENT	Duchenne muscular dystrophy (DMD) is a genetic disorder caused by dystrophin mutations, characterized by chronic inflammation and severe muscle wasting. Dystrophic muscles exhibit activated immune cell infiltrates, up-regulated inflammatory gene expression, and increased NF-kappa B activity, but the contribution of the skeletal muscle cell to this process has been unclear. The aim of this work was to study the pathways that contribute to the increased resting calcium ([Ca2+](rest)) observed in mdx myotubes and its possible link with up-regulation of NF-kappa B and pro-inflammatory gene expression in dystrophic muscle cells. [Ca2+](rest) was higher in mdx than in WT myotubes (308 +/- 6 versus 113 +/- 2 nM, p < 0.001). In mdx myotubes, both the inhibition of Ca2+ entry (low Ca2+ solution, Ca2+-free solution, and Gd3+) and blockade of either ryanodine receptors or inositol 1,4,5-trisphosphate receptors reduced [Ca2+](rest). Basal activity of NF-kappa B was significantly up-regulated in mdx versus WT myotubes. There was an increased transcriptional activity and p65 nuclear localization, which could be reversed when [Ca2+](rest) was reduced. Levels of mRNA for TNF alpha, IL-1 beta, and IL-6 were similar in WT and mdx myotubes, whereas inducible nitric-oxide synthase (iNOS) expression was increased 5-fold. Reducing [Ca2+](rest) using different strategies reduced iNOS gene expression presumably as a result of decreased activation of NF-kappa B. We propose that NF-kappa B, modulated by increased [Ca2+](rest), is constitutively active in mdx myotubes, and this mechanism can account for iNOS overexpression and the increase in reactive nitrogen species that promote damage in dystrophic skeletal muscle cells.	[Altamirano, Francisco; Henriquez, Carlos; Jaimovich, Enrique] Univ Chile, Fac Med, Inst Ciencias Biomed, Ctr Estudios Mol Celula, Santiago 8389100, Chile; [Lopez, Jose R.; Allen, Paul D.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Molinski, Tadeusz] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Molinski, Tadeusz] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	Universidad de Chile; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of California System; University of California San Diego; University of California System; University of California San Diego	Jaimovich, E (corresponding author), Univ Chile, Fac Med, Inst Ciencias Biomed, Casilla 70005, Santiago 7, Chile.	ejaimovi@med.uchile.cl	Henríquez-Olguín, Carlos/K-7671-2012; Altamirano, Francisco/I-1928-2013; Jaimovich, Enrique/AAY-7632-2020; Molinski, Tadeusz F/P-2125-2018; Henríquez-Olguín, Carlos/ABB-6846-2021	Henríquez-Olguín, Carlos/0000-0002-9315-9365; Altamirano, Francisco/0000-0002-1612-2729; Henríquez-Olguín, Carlos/0000-0002-9315-9365	National Institutes of Health [AR43140, AR052354]; Fondo Nacional de Investigacion Cientifica y Tecnologica [1110467]; Fondo de Financiamiento de Centros de Excelencia en Investigacion [15010006]; Asotiation Francaise Contre les Myopathies [14562]; Comision Nacional de Investigacion Cientifica y Tecnologica [AT-24100066]; Vicerrectoria de Asuntos Academicos; Universidad de Chile; Programa de Mejoramiento de lo Calidad y Equidad de la Educacion [UCH 0714]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR052354, R01AR043140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondo Nacional de Investigacion Cientifica y Tecnologica(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondo de Financiamiento de Centros de Excelencia en Investigacion; Asotiation Francaise Contre les Myopathies; Comision Nacional de Investigacion Cientifica y Tecnologica; Vicerrectoria de Asuntos Academicos; Universidad de Chile; Programa de Mejoramiento de lo Calidad y Equidad de la Educacion; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR43140 and AR052354 (to P. D. A. and J. R. L.). This work was also supported by Grants Fondo Nacional de Investigacion Cientifica y Tecnologica 1110467, Fondo de Financiamiento de Centros de Excelencia en Investigacion 15010006, and Asotiation Francaise Contre les Myopathies 14562 (to E. J.), Grant AT-24100066 from Comision Nacional de Investigacion Cientifica y Tecnologica, Vicerrectoria de Asuntos Academicos, Universidad de Chile, and Programa de Mejoramiento de lo Calidad y Equidad de la Educacion travel support UCH 0714, Universidad de Chile (to F. A.).	Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Allen DG, 2010, CAN J PHYSIOL PHARM, V88, P83, DOI 10.1139/Y09-058; Badger AM, 1998, J IMMUNOL, V161, P467; BAKKER AJ, 1993, J PHYSIOL-LONDON, V460, P1; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Boittin FX, 2006, J CELL SCI, V119, P3733, DOI 10.1242/jcs.03184; Buvinic S, 2009, J BIOL CHEM, V284, P34490, DOI 10.1074/jbc.M109.057315; Capote J, 2010, AM J PHYSIOL-CELL PH, V298, pC1077, DOI 10.1152/ajpcell.00428.2009; Carlson CG, 2005, NEUROBIOL DIS, V20, P719, DOI 10.1016/j.nbd.2005.05.003; Casas M, 2010, J GEN PHYSIOL, V136, P455, DOI 10.1085/jgp.200910397; Cases M, 2012, METHODS MOL BIOL, V798, P383, DOI 10.1007/978-1-61779-343-1_22; Culligan K, 2002, J APPL PHYSIOL, V92, P435, DOI 10.1152/japplphysiol.00903.2001; Dogra C, 2008, MOL CELL BIOCHEM, V312, P17, DOI 10.1007/s11010-008-9716-6; Durham WJ, 2006, MUSCLE NERVE, V34, P298, DOI 10.1002/mus.20579; Edwards JN, 2010, AM J PHYSIOL-CELL PH, V299, pC42, DOI 10.1152/ajpcell.00524.2009; Eltit JM, 2010, J BIOL CHEM, V285, P13781, DOI 10.1074/jbc.M110.107300; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Evans NP, 2009, PM&R, V1, P755, DOI 10.1016/j.pmrj.2009.04.010; Falvo JV, 2010, CURR DIR AUTOIMMUN, V11, P27, DOI 10.1159/000289196; GAILLY P, 1993, CELL CALCIUM, V14, P473, DOI 10.1016/0143-4160(93)90006-R; Gervasio OL, 2008, J CELL SCI, V121, P2246, DOI 10.1242/jcs.032003; Goonasekera SA, 2011, J CLIN INVEST, V121, P1044, DOI 10.1172/JCI43844; Henry MD, 1996, CURR OPIN CELL BIOL, V8, P625, DOI 10.1016/S0955-0674(96)80103-7; Hnia K, 2008, AM J PATHOL, V172, P1509, DOI 10.2353/ajpath.2008.071009; Ho RC, 2005, AM J PHYSIOL-CELL PH, V289, pC794, DOI 10.1152/ajpcell.00632.2004; Hollingworth S, 2008, J PHYSIOL-LONDON, V586, P5063, DOI 10.1113/jphysiol.2008.160507; Jaimovich E, 2005, FEBS LETT, V579, P2051, DOI 10.1016/j.febslet.2005.02.053; Ji LL, 2008, FREE RADICAL BIO MED, V44, P142, DOI 10.1016/j.freeradbiomed.2007.02.031; Kargacin ME, 1996, BBA-GEN SUBJECTS, V1290, P4, DOI 10.1016/0304-4165(95)00180-8; Kawasaki H, 1997, J BIOL CHEM, V272, P18518, DOI 10.1074/jbc.272.30.18518; Kleinert H, 2003, BIOL CHEM, V384, P1343, DOI 10.1515/BC.2003.152; Kruger J, 2008, NEUROMUSCULAR DISORD, V18, P501, DOI 10.1016/j.nmd.2008.04.003; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Kumar S, 1999, BIOCHEM BIOPH RES CO, V263, P825, DOI 10.1006/bbrc.1999.1454; Liberona JL, 1998, MUSCLE NERVE, V21, P902, DOI 10.1002/(SICI)1097-4598(199807)21:7<902::AID-MUS8>3.0.CO;2-A; Lilienbaum A, 2003, MOL CELL BIOL, V23, P2680, DOI 10.1128/MCB.23.8.2680-2698.2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljubicic V, 2012, AM J PHYSIOL-CELL PH, V302, pC110, DOI 10.1152/ajpcell.00183.2011; LOPEZ JR, 1987, ACTA CIENT VENEZ, V38, P503; Louboutin JP, 2001, MOL MED, V7, P355, DOI 10.1007/BF03402218; MACK MM, 1994, J BIOL CHEM, V269, P23236; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; Messina S, 2006, EXP NEUROL, V198, P234, DOI 10.1016/j.expneurol.2005.11.021; Miles MT, 2011, J NEUROL SCI, V303, P53, DOI 10.1016/j.jns.2011.01.015; Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736; Millay DP, 2009, P NATL ACAD SCI USA, V106, P19023, DOI 10.1073/pnas.0906591106; Mokri B, 1998, NEUROLOGY, V51, pA1; Morine KJ, 2010, HUM GENE THER, V21, P1735, DOI 10.1089/hum.2010.077; Nakamura A, 2001, NEUROMUSCULAR DISORD, V11, P251, DOI 10.1016/S0960-8966(00)00201-7; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pan Y, 2008, MOL CELLS, V25, P531; PASTERNAK C, 1995, J CELL BIOL, V128, P355, DOI 10.1083/jcb.128.3.355; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Porreca E, 1999, THROMB HAEMOSTASIS, V81, P543; Porter JD, 2002, HUM MOL GENET, V11, P263, DOI 10.1093/hmg/11.3.263; PRESSMAR J, 1994, PFLUG ARCH EUR J PHY, V426, P499, DOI 10.1007/BF00378527; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Riquelme D, 2011, ANTIOXID REDOX SIGN, V14, P1245, DOI 10.1089/ars.2010.3238; Robert V, 2001, J BIOL CHEM, V276, P4647, DOI 10.1074/jbc.M006337200; Robin G, 2012, J GEN PHYSIOL, V139, P209, DOI 10.1085/jgp.201110738; Rockl KSC, 2008, IUBMB LIFE, V60, P145, DOI 10.1002/iub.21; See V, 2004, J CELL BIOL, V166, P661, DOI 10.1083/jcb.200402136; Semenova MM, 2007, NAT NEUROSCI, V10, P436, DOI 10.1038/nn1869; Siegel AL, 2009, NEUROMUSCULAR DISORD, V19, P131, DOI 10.1016/j.nmd.2008.10.006; Singh R, 2009, J NEUROL SCI, V285, P159, DOI 10.1016/j.jns.2009.06.030; SPENCER MJ, 1995, J BIOL CHEM, V270, P10909, DOI 10.1074/jbc.270.18.10909; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tang Y, 2010, GENE THER, V17, P1476, DOI 10.1038/gt.2010.110; TURNER PR, 1988, NATURE, V335, P735, DOI 10.1038/335735a0; Valdes JA, 2007, AM J PHYSIOL-CELL PH, V292, pC1960, DOI 10.1152/ajpcell.00320.2006; Vandebrouck A, 2005, FASEB J, V19, P136, DOI 10.1096/fj.04-3633fje; Vandebrouck C, 2002, J CELL BIOL, V158, P1089, DOI 10.1083/jcb.200203091; Varnai P, 2009, TRENDS PHARMACOL SCI, V30, P118, DOI 10.1016/j.tips.2008.11.005; Westerman KA, 2010, EXP CELL RES, V316, P1966, DOI 10.1016/j.yexcr.2010.03.022; Whitehead NP, 2006, CLIN EXP PHARMACOL P, V33, P657, DOI 10.1111/j.1440-1681.2006.04394.x; Won JS, 2001, MOL BRAIN RES, V89, P1, DOI 10.1016/S0169-328X(01)00047-X; Woods CE, 2004, J PHYSIOL-LONDON, V557, P59, DOI 10.1113/jphysiol.2004.061291; Wright DC, 2007, J BIOL CHEM, V282, P18793, DOI 10.1074/jbc.M611252200; Yeung EW, 2005, J PHYSIOL-LONDON, V562, P367, DOI 10.1113/jphysiol.2004.075275; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821	82	67	67	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20876	20887		10.1074/jbc.M112.344929	http://dx.doi.org/10.1074/jbc.M112.344929			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22549782	hybrid, Green Published			2022-12-25	WOS:000306416800009
J	Stieglitz, B; Haire, LF; Dikic, I; Rittinger, K				Stieglitz, Benjamin; Haire, Lesley F.; Dikic, Ivan; Rittinger, Katrin			Structural Analysis of SHARPIN, a Subunit of a Large Multi-protein E3 Ubiquitin Ligase, Reveals a Novel Dimerization Function for the Pleckstrin Homology Superfold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINEAR UBIQUITINATION; INFLAMMATION; DIVERSITY; DOMAINS; DYNAMIN; SYSTEM	SHARPIN (SHANK-associated RH domain interacting protein) is part of a large multi-protein E3 ubiquitin ligase complex called LUBAC(linear ubiquitin chain assembly complex), which catalyzes the formation of linear ubiquitin chains and regulates immune and apoptopic signaling pathways. The C-terminal half of SHARPIN contains ubiquitin-like domain and Npl4-zinc finger domains that mediate the interaction with the LUBAC subunit HOIP and ubiquitin, respectively. In contrast, the N-terminal region does not show any homology with known protein interaction domains but has been suggested to be responsible for self-association of SHARPIN, presumably via a coiled-coil region. We have determined the crystal structure of the N-terminal portion of SHARPIN, which adopts the highly conserved pleckstrin homology superfold that is often used as a scaffold to create protein interaction modules. We show that in SHARPIN, this domain does not appear to be used as a ligand recognition domain because it lacks many of the surface properties that are present in other pleckstrin homology fold-based interaction modules. Instead, it acts as a dimerization module extending the functional applications of this superfold.	[Stieglitz, Benjamin; Haire, Lesley F.; Rittinger, Katrin] Natl Inst Med Res, MRC, Div Mol Struct, London NW7 1AA, England; [Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Buchmann Inst Mol Life Sci, D-60590 Frankfurt, Germany; [Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Germany	MRC National Institute for Medical Research; Goethe University Frankfurt; Goethe University Frankfurt	Rittinger, K (corresponding author), Natl Inst Med Res, MRC, Div Mol Struct, London NW7 1AA, England.	katrin.rittinger@nimr.mrc.ac.uk	Stieglitz, Benjamin/AAY-4140-2020; Rittinger, Katrin/N-3344-2019; Rittinger, Katrin/D-2586-2014; Dikic, Ivan/O-4650-2015	Stieglitz, Benjamin/0000-0003-3634-6997; Rittinger, Katrin/0000-0002-7698-4435; Rittinger, Katrin/0000-0002-7698-4435; Dikic, Ivan/0000-0001-8156-9511	Medical Research Council UK [U117565398]; MRC [MC_U117565398] Funding Source: UKRI; Medical Research Council [MC_U117565398] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council UK Grant U117565398.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ball LJ, 2002, FEBS LETT, V513, P45, DOI 10.1016/S0014-5793(01)03291-4; Beneken J, 2000, NEURON, V26, P143, DOI 10.1016/S0896-6273(00)81145-9; Blomberg N, 1999, TRENDS BIOCHEM SCI, V24, P441, DOI 10.1016/S0968-0004(99)01472-3; Eisenhaber B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-209; Emmerich CH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002187; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FUSHMAN D, 1995, P NATL ACAD SCI USA, V92, P816, DOI 10.1073/pnas.92.3.816; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Iwai K, 2009, EMBO REP, V10, P706, DOI 10.1038/embor.2009.144; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Jung J, 2010, MOL CELL BIOCHEM, V340, P161, DOI 10.1007/s11010-010-0413-x; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Klein DE, 1998, J BIOL CHEM, V273, P27725, DOI 10.1074/jbc.273.42.27725; Landgraf K, 2010, MOL CELL BIOL, V30, P5764, DOI 10.1128/MCB.01645-09; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Lim S, 2001, MOL CELL NEUROSCI, V17, P385, DOI 10.1006/mcne.2000.0940; Masters TA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000738; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peterson FC, 2009, FRONT BIOSCI-LANDMRK, V14, P833, DOI 10.2741/3281; Rantala JK, 2011, NAT CELL BIOL, V13, P1315, DOI 10.1038/ncb2340; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821	33	21	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20823	20829		10.1074/jbc.M112.359547	http://dx.doi.org/10.1074/jbc.M112.359547			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22549881	Green Published, hybrid			2022-12-25	WOS:000306416800004
J	Hawksworth, JS; Graybill, JC; Brown, TS; Wallace, SM; Davis, TA; Tadaki, DK; Elster, EA				Hawksworth, Jason S.; Graybill, J. Christopher; Brown, Trevor S.; Wallace, Shannon M.; Davis, Thomas A.; Tadaki, Doug K.; Elster, Eric A.			Lymphocyte Modulation with FTY720 Improves Hemorrhagic Shock Survival in Swine	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; T-LYMPHOCYTES; SPHINGOSINE 1-PHOSPHATE; CELL; NEUTROPHIL; SPHINGOSINE-1-PHOSPHATE; TRAUMA; RECEPTORS; ADHESION; ANERGY	The inflammatory response to severe traumatic injury results in significant morbidity and mortality. Lymphocytes have recently been identified as critical mediators of the early innate immune response to ischemia-reperfusion injury. Experimental manipulation of lymphocytes following hemorrhagic shock may prevent secondary immunologic injury in surgical and trauma patients. The objective of this study is to evaluate the lymphocyte sequestration agent FTY720 as an immunomodulator following experimental hemorrhagic shock in a swine liver injury model. Yorkshire swine were anesthetized and underwent a grade III liver injury with uncontrolled hemorrhage to induce hemorrhagic shock. Experimental groups were treated with a lymphocyte sequestration agent, FTY720, (n = 9) and compared to a vehicle control group (n = 9). Animals were observed over a 3 day survival period after hemorrhage. Circulating total leukocyte and neutrophil counts were measured. Central lymphocytes were evaluated with mesenteric lymph node and spleen immunohistochemistry (IHC) staining for CD3. Lung tissue infiltrating neutrophils were analyzed with myeloperoxidase (MPO) IHC staining. Relevant immune-related gene expression from liver tissue was quantified using RT-PCR. The overall survival was 22.2% in the vehicle control and 66.7% in the FTY720 groups (p = 0.081), and reperfusion survival (period after hemorrhage) was 25% in the vehicle control and 75% in the FTY720 groups (p = 0.047). CD3(+) lymphocytes were significantly increased in mesenteric lymph nodes and spleen in the FTY720 group compared to vehicle control, indicating central lymphocyte sequestration. Lymphocyte disruption significantly decreased circulating and lung tissue infiltrating neutrophils, and decreased expression of liver immune-related gene expression in the FTY720 treated group. There were no observed infectious or wound healing complications. Lymphocyte sequestration with FTY720 improves survival in experimental hemorrhagic shock using a porcine liver injury model. These results support a novel and clinically relevant lymphocyte immunomodulation strategy to ameliorate secondary immune injury in hemorrhagic shock.	[Hawksworth, Jason S.; Graybill, J. Christopher; Brown, Trevor S.; Davis, Thomas A.; Tadaki, Doug K.; Elster, Eric A.] USN, Regenerat Med Dept, Operat & Undersea Med Directorate, Med Res Ctr, Silver Spring, MD 20910 USA; [Hawksworth, Jason S.; Graybill, J. Christopher; Elster, Eric A.] Walter Reed Natl Mil Med Ctr, Dept Surg, Bethesda, MD USA; [Tadaki, Doug K.; Elster, Eric A.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Wallace, Shannon M.] Walter Reed Army Inst Res, Dept Diagnost Pathol, Silver Spring, MD USA	United States Department of Defense; United States Navy; Walter Reed National Military Medical Center; Uniformed Services University of the Health Sciences - USA; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Hawksworth, JS (corresponding author), USN, Regenerat Med Dept, Operat & Undersea Med Directorate, Med Res Ctr, Silver Spring, MD 20910 USA.	doug.tadaki@med.navy.mil; eric.elster1@med.navy.mil	Brown, Trevor/K-4703-2012; Elster, Eric/ABG-6091-2021; Brown, Trevor/F-7392-2015	Brown, Trevor/0000-0001-7042-785X; Brown, Trevor/0000-0001-7042-785X; Elster, Eric/0000-0002-0981-2748	Office of Naval Research (work unit number 603729N.02914.W280.A0515)	Office of Naval Research (work unit number 603729N.02914.W280.A0515)(Office of Naval Research)	This work was supported by the Office of Naval Research (work unit number 603729N.02914.W280.A0515). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud F, 2006, TRANSFUSION MED, V16, P290, DOI 10.1111/j.1365-3148.2006.00678.x; Bandyopadhyay G, 2007, CRIT CARE MED, V35, P794, DOI 10.1097/01.CCM.0000256847.61085.A5; BOTHA AJ, 1995, J TRAUMA, V39, P411; Brinkmann V, 2004, AM J TRANSPLANT, V4, P1019, DOI 10.1111/j.1600-6143.2004.00476.x; Brinkmann V, 2002, CURR OPIN IMMUNOL, V14, P569, DOI 10.1016/S0952-7915(02)00374-6; Brinkmann V, 2001, TRANSPLANTATION, V72, P764, DOI 10.1097/00007890-200109150-00002; Burne MJ, 2001, J CLIN INVEST, V108, P1283, DOI 10.1172/JCI200112080; Caldwell CC, 2007, J LEUKOCYTE BIOL, V82, P457, DOI 10.1189/jlb.0107062; Cohen JA, N ENGL J MED, V362, P402; De AK, 2000, CLIN IMMUNOL, V96, P52, DOI 10.1006/clim.2000.4879; Dragun D, 2004, KIDNEY INT, V65, P1076, DOI 10.1111/j.1523-1755.2004.00478.x; Harlan JM, 2002, CRIT CARE MED, V30, pS214, DOI 10.1097/00003246-200205001-00007; Hawksworth JS, 2009, J THROMB HAEMOST, V7, P1663, DOI 10.1111/j.1538-7836.2009.03562.x; Hawksworth JS, 2009, J SURG RES, V151, P267; Horie Y, 1999, MICROCIRCULATION, V6, P267; Huang YF, 2007, CELL IMMUNOL, V248, P4, DOI 10.1016/j.cellimm.2007.03.009; Kappos L, N ENGL J MED, V362, P387; Kokura S, 2000, CIRC RES, V86, P1237, DOI 10.1161/01.RES.86.12.1237; Kokura S, 2000, MICROCIRCULATION, V7, P13, DOI 10.1038/sj.mn.7300088; Koyrakh L, 2005, AM J TRANSPLANT, V5, P529, DOI 10.1111/j.1600-6143.2005.00754.x; Le Moine O, 2000, HEPATOLOGY, V31, P1266, DOI 10.1053/jhep.2000.7881; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Matzinger P, 1998, SEMIN IMMUNOL, V10, P399, DOI 10.1006/smim.1998.0143; Moore FA, 2004, POSTINJURY MULTIPLE; Nugent D, 2000, PLATELETS, V11, P226; Pallister I, 2002, CRIT CARE MED, V30, P1717, DOI 10.1097/00003246-200208000-00007; Peters SLM, 2007, CURR OPIN PHARMACOL, V7, P186, DOI 10.1016/j.coph.2006.09.008; Rabb H, 1997, KIDNEY INT, V51, P1463, DOI 10.1038/ki.1997.200; Rabb H, 2000, AM J PHYSIOL-RENAL, V279, pF525, DOI 10.1152/ajprenal.2000.279.3.F525; Rhee P, 2000, J TRAUMA, V49, P611, DOI 10.1097/00005373-200010000-00007; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Spolarics Z, 2003, CRIT CARE MED, V31, P1722, DOI 10.1097/01.CCM.0000063579.43470.AA; Takada M, 1997, J CLIN INVEST, V100, P1199, DOI 10.1172/JCI119632; Weaver TA, 2007, TRANSPLANTATION, V84, P1545, DOI 10.1097/01.tp.0000296680.75175.67; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; WINDSOR ACJ, 1993, BRIT J SURG, V80, P10, DOI 10.1002/bjs.1800800106; Yonekawa K, 2005, J LEUKOCYTE BIOL, V77, P129, DOI 10.1189/jlb.0804460; Zhao Y, 2004, AM J TRANSPLANT, V4, P1399, DOI 10.1111/j.1600-6143.2004.00527.x; Zwacka RM, 1997, J CLIN INVEST, V100, P279, DOI 10.1172/JCI119533	39	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e34224	10.1371/journal.pone.0034224	http://dx.doi.org/10.1371/journal.pone.0034224			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558085	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340200004
J	Magland, JF; Zhang, N; Rajapakse, CS; Wehrli, FW				Magland, Jeremy F.; Zhang, Ning; Rajapakse, Chamith S.; Wehrli, Felix W.			Computationally-Optimized Bone Mechanical Modeling from High-Resolution Structural Images	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; TRABECULAR BONE; COMPUTED-TOMOGRAPHY; ELASTIC PROPERTIES; DISTAL RADIUS; MR-IMAGES; VOLUME; STRENGTH; FRACTURE; MEN	Image-based mechanical modeling of the complex micro-structure of human bone has shown promise as a non-invasive method for characterizing bone strength and fracture risk in vivo. In particular, elastic moduli obtained from image-derived micro-finite element (mu FE) simulations have been shown to correlate well with results obtained by mechanical testing of cadaveric bone. However, most existing large-scale finite-element simulation programs require significant computing resources, which hamper their use in common laboratory and clinical environments. In this work, we theoretically derive and computationally evaluate the resources needed to perform such simulations (in terms of computer memory and computation time), which are dependent on the number of finite elements in the image-derived bone model. A detailed description of our approach is provided, which is specifically optimized for mu FE modeling of the complex three-dimensional architecture of trabecular bone. Our implementation includes domain decomposition for parallel computing, a novel stopping criterion, and a system for speeding up convergence by pre-iterating on coarser grids. The performance of the system is demonstrated on a dual quad-core Xeon 3.16 GHz CPUs equipped with 40 GB of RAM. Models of distal tibia derived from 3D in-vivo MR images in a patient comprising 200,000 elements required less than 30 seconds to converge (and 40 MB RAM). To illustrate the system's potential for large-scale mu FE simulations, axial stiffness was estimated from high-resolution micro-CT images of a voxel array of 90 million elements comprising the human proximal femur in seven hours CPU time. In conclusion, the system described should enable image-based finite-element bone simulations in practical computation times on high-end desktop computers with applications to laboratory studies and clinical imaging.	[Magland, Jeremy F.; Zhang, Ning; Rajapakse, Chamith S.; Wehrli, Felix W.] Univ Penn, Dept Radiol, Lab Struct NMR Imaging, Med Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania	Magland, JF (corresponding author), Univ Penn, Dept Radiol, Lab Struct NMR Imaging, Med Ctr, Philadelphia, PA 19104 USA.	Jeremy.Magland@gmail.com			National Institutes of Health [R01 AR55647, R01 AR55356, K25 AR 060283]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K25AR060283, R01AR055647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health grants R01 AR55647, R01 AR55356 and K25 AR 060283. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MF, 2004, ACM IEEE P SC2004 HI; Arbenz P, 2008, SCALABLE MULTILEVEL; Arbenz P, 2007, LECT NOTES COMPUT SC, V4699, P240; Bekas C, 2010, CONCURR COMP-PRACT E, V22, P2282, DOI 10.1002/cpe.1591; Bern M., 1992, COMPUT EUCLIDEAN GEO, V1, P23, DOI DOI 10.1142/9789814355858; Bevill G, 2006, BONE, V39, P1218, DOI 10.1016/j.bone.2006.06.016; Bevill G, 2009, BONE, V44, P579, DOI 10.1016/j.bone.2008.11.020; Boutroy S, 2008, J BONE MINER RES, V23, P392, DOI 10.1359/JBMR.071108; Boutry N, 2003, RADIOLOGY, V227, P708, DOI 10.1148/radiol.2273020420; Dalzell N, 2009, OSTEOPOROSIS INT, V20, P1683, DOI 10.1007/s00198-008-0833-6; Danilov S, 2004, OCEAN MODEL, V6, P125, DOI 10.1016/S1463-5003(02)00063-X; DEMPSTER WT, 1952, AM J ANAT, V91, P331, DOI 10.1002/aja.1000910302; GOULET RW, 1994, J BIOMECH, V27, P375, DOI 10.1016/0021-9290(94)90014-0; Hendrickson B, 1993, SAND922765 SAND NAT; Hou TY, 1997, J COMPUT PHYS, V134, P169, DOI 10.1006/jcph.1997.5682; HUGHES TJR, 1983, COMPUT METHOD APPL M, V36, P241, DOI 10.1016/0045-7825(83)90115-9; HUGHES TJR, 1987, COMPUT METHOD APPL M, V61, P215, DOI 10.1016/0045-7825(87)90005-3; Hwang SN, 2002, MAGN RESON MED, V47, P948, DOI 10.1002/mrm.10138; JAWORSKI ZFG, 1981, ORTHOP CLIN N AM, V12, P485; Kabel J, 1999, J BIOMECH, V32, P673, DOI 10.1016/S0021-9290(99)00045-7; Ladd AJC, 1998, J ORTHOP RES, V16, P622, DOI 10.1002/jor.1100160516; MacNeil JA, 2008, BONE, V42, P1203, DOI 10.1016/j.bone.2008.01.017; Magland JF, 2010, MAGN RESON MED, V63, P719, DOI 10.1002/mrm.22213; Magland JF, 2009, J MAGN RESON IMAGING, V29, P118, DOI 10.1002/jmri.21551; Magland JF, 2008, ACAD RADIOL, V15, P1482, DOI 10.1016/j.acra.2008.05.015; MCCULLOCH A, 1992, CRIT REV BIOMED ENG, V20, P427; Muller R, 2004, OSTEOPOROS INT; Podshivalov L, 2011, BONE, V48, P693, DOI 10.1016/j.bone.2010.12.022; Rajapakse CS, 2010, BONE, V47, P556, DOI 10.1016/j.bone.2010.05.039; Recker R, 2004, J BONE MINER RES, V19, P1628, DOI 10.1359/JBMR.040710; Saad Y., 1996, ITERATIVE METHODS SP, DOI 10.1137/1.9780898718003; Saha PK, 2005, P SOC PHOTO-OPT INS, V5746, P12; Silva MJ, 1998, J ORTHOPAED RES, V16, P300, DOI 10.1002/jor.1100160305; Teng S.-H., 1999, ALGORITHMS PARALLEL, V105, P247; Ulrich D, 1997, ST HEAL T, V40, P97; Van Rietbergen B, 1999, J BIOMECH, V32, P443; Van Rietbergen B, 2003, J BONE MINER RES, V18, P1781, DOI 10.1359/jbmr.2003.18.10.1781; VanRietbergen B, 1996, INT J NUMER METH ENG, V39, P2743, DOI 10.1002/(SICI)1097-0207(19960830)39:16<2743::AID-NME974>3.0.CO;2-A; VANRIETBERGEN B, 1995, J BIOMECH, V28, P69, DOI 10.1016/0021-9290(95)80008-5; VICO L, 1988, AM J PHYSIOL, V255, pR243, DOI 10.1152/ajpregu.1988.255.2.R243; Vilayphiou N, 2011, J BONE MINER RES, V26, P965, DOI 10.1002/jbmr.297; Vilayphiou N, 2010, BONE, V46, P1030, DOI 10.1016/j.bone.2009.12.015; Wehrli FW, 2007, J MAGN RESON IMAGING, V25, P390, DOI 10.1002/jmri.20807; Wehrli FW, 2010, J BONE MINER RES, V25, P1406, DOI 10.1002/jbmr.33; Wehrli FW, 1998, RADIOLOGY, V206, P347, DOI 10.1148/radiology.206.2.9457185; Zhang XH, 2008, J BONE MINER RES, V23, P1426, DOI [10.1359/jbmr.080405, 10.1359/JBMR.080405]; Zienkiewicz OC, FINITE ELEMENT METHO, VSixth; Zikan V, 2011, OSTEOPOROSIS INT, V22, P391	48	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35525	10.1371/journal.pone.0035525	http://dx.doi.org/10.1371/journal.pone.0035525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558164	gold, Green Published, Green Submitted			2022-12-25	WOS:000305345200045
J	Riley, ED; Neilands, TB; Moore, K; Cohen, J; Bangsberg, DR; Havlir, D				Riley, Elise D.; Neilands, Torsten B.; Moore, Kelly; Cohen, Jennifer; Bangsberg, David R.; Havlir, Diane			Social, Structural and Behavioral Determinants of Overall Health Status in a Cohort of Homeless and Unstably Housed HIV-Infected Men	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; SELF-RATED HEALTH; QUALITY-OF-LIFE; UNITED-STATES; LOS-ANGELES; ALCOHOL-PROBLEMS; MEDICAL-CARE; PREVENTION; WOMEN; RISK	Background: Previous studies indicate multiple influences on the overall health of HIV-infected persons; however, few assess and rank longitudinal changes in social and structural barriers that are disproportionately found in impoverished populations. We empirically ranked factors that longitudinally impact the overall health status of HIV-infected homeless and unstably housed men. Methods and Findings: Between 2002 and 2008, a cohort of 288 HIV+ homeless and unstably housed men was recruited and followed over time. The population was 60% non-Caucasian and the median age was 41 years; 67% of study participants reported recent drug use and 20% reported recent homelessness. At baseline, the median CD4 cell count was 349 cells/mu l and 18% of eligible persons (CD4<350) took antiretroviral therapy (ART). Marginal structural models were used to estimate the population-level effects of behavioral, social, and structural factors on overall physical and mental health status (measured by the SF-36), and targeted variable importance (tVIM) was used to empirically rank factors by their influence. After adjusting for confounding, and in order of their influence, the three factors with the strongest negative effects on physical health were unmet subsistence needs, Caucasian race, and no reported source of instrumental support. The three factors with the strongest negative effects on mental health were unmet subsistence needs, not having a close friend/confidant, and drug use. ART adherence >90% ranked 5th for its positive influence on mental health, and viral load ranked 4th for its negative influence on physical health. Conclusions: The inability to meet food, hygiene, and housing needs was the most powerful predictor of poor physical and mental health among homeless and unstably housed HIV-infected men in an urban setting. Impoverished persons will not fully benefit from progress in HIV medicine until these barriers are overcome, a situation that is likely to continue fueling the US HIV epidemic.	[Riley, Elise D.; Neilands, Torsten B.; Cohen, Jennifer; Havlir, Diane] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Moore, Kelly] Univ Calif Berkeley, Dept Biostat, Berkeley, CA 94720 USA; [Bangsberg, David R.] Harvard Univ, Ragon Inst, Boston, MA 02115 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Riley, ED (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	eriley@epi-center.ucsf.edu			National Institutes of Health [DA15605, MH54907, UL1 RR024131]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH087227, R01MH054907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health DA15605, MH54907, and UL1 RR024131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidala AA, 2007, AIDS BEHAV, V11, pS1, DOI 10.1007/s10461-007-9302-z; [Anonymous], 2002, INT J DRUG POLICY, DOI DOI 10.1016/S0955-3959(02)00082-8; Armstrong D G, 1995, J Foot Ankle Surg, V34, P563; Bamberger JD, 2000, AM J PUBLIC HEALTH, V90, P699, DOI 10.2105/AJPH.90.5.699; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Beckles Gloria L., 2011, Morbidity and Mortality Weekly Report, V60, P13; Bembom O, 2009, STAT MED, V28, P152, DOI 10.1002/sim.3414; Bobashev GV, 2009, J URBAN HEALTH, V86, pS32, DOI 10.1007/s11524-009-9368-1; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082; Buchanan David, 2009, Am J Public Health, V99 Suppl 3, pS675, DOI 10.2105/AJPH.2008.137810; BURNAM MA, 1988, EVALUATION REV, V12, P117, DOI 10.1177/0193841X8801200202; Cheng WS, 2010, J PSYCHOACTIVE DRUGS, V42, P11, DOI 10.1080/02791072.2010.10399781; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Culhane DP, 2008, EUROPEAN J HOMELESSN, V2, P97; Das-Douglas M, 2009, AIDS BEHAV, V13, P1, DOI 10.1007/s10461-008-9401-5; DeNavas-Walt C, 2011, INCOME POVERTY HLTH; Denning P. H., 2010, COMMUNITIES CRISIS I; Este JA, 2010, ANTIVIR RES, V85, P25, DOI 10.1016/j.antiviral.2009.10.007; Friedman MS, 2009, AIDS CARE, V21, P692, DOI 10.1080/09540120802513709; Gelberg L, 2000, HEALTH SERV RES, V34, P1273; Gelberg L, 1997, AM J PUBLIC HEALTH, V87, P217, DOI 10.2105/AJPH.87.2.217; Gielen AC, 2001, SOC SCI MED, V52, P315, DOI 10.1016/S0277-9536(00)00135-0; Gorbach PM, 2009, J URBAN HEALTH, V86, pS63, DOI 10.1007/s11524-009-9370-7; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Holtgrave DR, 2010, INT J CLIN PRACT, V64, P678, DOI 10.1111/j.1742-1241.2010.02381.x; Hwang SW, 2009, J URBAN HEALTH, V86, P791, DOI 10.1007/s11524-009-9388-x; Idler EL, 2000, AM J EPIDEMIOL, V152, P874, DOI 10.1093/aje/152.9.874; Jenness SM, 2011, AM J PUBLIC HEALTH, V101, P745, DOI 10.2105/AJPH.2009.181883; Kidder DP, 2007, AM J PUBLIC HEALTH, V97, P2238, DOI 10.2105/AJPH.2006.090209; Kidder DP, 2007, AIDS BEHAV, V11, pS149, DOI 10.1007/s10461-007-9249-0; Kim TW, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-19; Kipke MD, 2007, AIDS BEHAV, V11, pS56, DOI 10.1007/s10461-006-9204-5; La Fleur F, 2010, HEALTH, V15, P491; Larimer ME, 2009, JAMA-J AM MED ASSOC, V301, P1349, DOI 10.1001/jama.2009.414; Leaver CA, 2007, AIDS BEHAV, V11, pS85, DOI 10.1007/s10461-007-9246-3; Marshall BDL, 2011, PREV SCI, V12, P173, DOI 10.1007/s11121-010-0197-y; Moore KL, 2009, STAT MED, V28, P39, DOI 10.1002/sim.3445; MOSSEY JM, 1982, AM J PUBLIC HEALTH, V72, P800, DOI 10.2105/AJPH.72.8.800; Nelson KM, 2010, J URBAN HEALTH, V87, P642, DOI 10.1007/s11524-010-9434-8; *NIAAA, 1995, NIH PUBL; Nord M, 2011, PUBLIC HEALTH NUTR, P1; Parker RG, 2000, AIDS, V14, pS22, DOI 10.1097/00002030-200006001-00004; Rajgopal R, 2002, J NUTR EDUC BEHAV, V34, P26, DOI 10.1016/S1499-4046(06)60225-X; Riley ED, 2003, QUAL LIFE RES, V12, P1051, DOI 10.1023/A:1026166021386; Riley ED, 2011, AM J EPIDEMIOL, V174, P526, DOI 10.1093/aje/kwr208; Riley ED, 2011, AM J EPIDEMIOL, V174, P515, DOI 10.1093/aje/kwr209; Riley ED, 2011, AIDS CARE, V23, P822, DOI 10.1080/09540121.2010.538660; Riley ED, 2010, J URBAN HEALTH, V87, P534, DOI 10.1007/s11524-010-9468-y; Riley Elise D, 2007, Curr HIV/AIDS Rep, V4, P181, DOI 10.1007/s11904-007-0026-5; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Sadowski LS, 2009, JAMA-J AM MED ASSOC, V301, P1771, DOI 10.1001/jama.2009.561; Schneider E., 2006, Morbidity and Mortality Weekly Report, V55, P589; Sinisi SE, 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1069; Sterk CE, 2007, AM J PREV MED, V32, pS177, DOI 10.1016/j.amepre.2007.02.020; Sumartojo E, 2000, AIDS, V14, pS3, DOI 10.1097/00002030-200006001-00002; Tsui JI, 2007, AIDS BEHAV, V11, P603, DOI 10.1007/s10461-006-9157-8; van der Laan MJ, 2006, INT J BIOSTAT, V2, P11, DOI [10.2202/1557-4679.1043, DOI 10.2202/1557-4679.1043]; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WHO, 2010, ANT THER HIV INF AD; Wolitski RJ, 2010, AIDS BEHAV, V14, P493, DOI 10.1007/s10461-009-9643-x; Wong YL, 2005, ADMIN SOC WORK, V30, P67; ZIMMERMAN M, 1988, ARCH GEN PSYCHIAT, V45, P738	64	35	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35207	10.1371/journal.pone.0035207	http://dx.doi.org/10.1371/journal.pone.0035207			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VP	22558128	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345200029
J	Hou, HL; Zhang, YY; Huang, Y; Yi, QY; Lv, L; Zhang, TW; Chen, DW; Hao, QM; Shi, QH				Hou, Heli; Zhang, Yingyin; Huang, Yun; Yi, Qiyi; Lv, Lei; Zhang, Tianwei; Chen, Dawei; Hao, Qiaomei; Shi, Qinghua			Inhibitors of Phosphatidylinositol 3 '-Kinases Promote Mitotic Cell Death in HeLa Cells	PLOS ONE			English	Article							INDUCED APOPTOSIS; OVARIAN-CANCER; AUTOPHAGY; PACLITAXEL; KINASE; PHOSPHORYLATION; CATASTROPHE; MECHANISMS; PATHWAY; 3-METHYLADENINE	The phosphatidylinositol 3-kinase (PI3K) pathway plays an important role in many biological processes, including cell cycle progression, cell growth, survival, actin rearrangement and migration, and intracellular vesicular transport. However, the involvement of the PI3K pathway in the regulation of mitotic cell death remains unclear. In this study, we treated HeLa cells with the PI3K inhibitors, 3-methyladenine (3-MA, as well as a widely used autophagy inhibitor) and wortmannin to examine their effects on cell fates using live cell imaging. Treatment with 3-MA decreased cell viability in a time-and dose-dependent manner and was associated with caspase-3 activation. Interestingly, 3-MA-induced cell death was not affected by RNA interference-mediated knockdown (KD) of beclin1 (an essential protein for autophagy) in HeLa cells, or by deletion of atg5 (an essential autophagy gene) in mouse embryonic fibroblasts (MEFs). These data indicate that cell death induced by 3-MA occurs independently of its ability to inhibit autophagy. The results from live cell imaging studies showed that the inhibition of PI3Ks increased the occurrence of lagging chromosomes and cell cycle arrest and cell death in prometaphase. Furthermore, PI3K inhibitors promoted nocodazole-induced mitotic cell death and reduced mitotic slippage. Overexpression of Akt (the downstream target of PI3K) antagonized PI3K inhibitor-induced mitotic cell death and promoted nocodazole-induced mitotic slippage. These results suggest a novel role for the PI3K pathway in regulating mitotic progression and preventing mitotic cell death and provide justification for the use of PI3K inhibitors in combination with anti-mitotic drugs to combat cancer.	[Hou, Heli; Zhang, Yingyin; Huang, Yun; Yi, Qiyi; Lv, Lei; Zhang, Tianwei; Chen, Dawei; Hao, Qiaomei; Shi, Qinghua] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Zhang, Yingyin; Zhang, Tianwei; Shi, Qinghua] Hefei Natl Lab Phys Sci Microscale, Hefei, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Hou, HL (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China.	qshi@ustc.edu.cn	Shi, Qinghua/N-2950-2013; Huang, Yun/AGX-8953-2022; Chen, Dawei/V-4296-2019	Huang, Yun/0000-0001-5987-1319; Chen, Dawei/0000-0002-8201-0549; Yi, Qiyi/0000-0001-5143-8828; Lv, Lei/0000-0002-1889-7018; Lv, Lei/0000-0001-8132-1073	National Natural Science Foundation of China [30711120571, 30725013]; National High Technology Research and Development Program of China [2006AA02Z4B4]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by grants from National Natural Science Foundation of China (Grants 30711120571 and 30725013), and National High Technology Research and Development Program of China (2006AA02Z4B4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan LA, 2007, MOL CELL, V26, P301, DOI 10.1016/j.molcel.2007.03.019; Bacus SS, 2001, ONCOGENE, V20, P147, DOI 10.1038/sj.onc.1204062; BAGULEY BC, 1995, EUR J CANCER, V31A, P230, DOI 10.1016/0959-8049(94)00472-H; Basu A, 2003, FEBS LETT, V538, P41, DOI 10.1016/S0014-5793(03)00131-5; Bowles DW, 2011, EXPERT OPIN INV DRUG, V20, P507, DOI 10.1517/13543784.2011.562192; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Castedo M, 2004, ONCOGENE, V23, P4362, DOI 10.1038/sj.onc.1207572; Cimini D, 2002, J CELL SCI, V115, P507; Cogswell JP, 2000, CELL GROWTH DIFFER, V11, P615; Deacon K, 2003, MOL BIOL CELL, V14, P2071, DOI 10.1091/mbc.e02-10-0653; DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159; Elis W, 2008, MOL CANCER RES, V6, P614, DOI 10.1158/1541-7786.MCR-07-0262; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Ito S, 2007, INT J ONCOL, V31, P261; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim SH, 2007, ANN NY ACAD SCI, V1095, P82, DOI 10.1196/annals.1397.012; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Mhaidat NM, 2007, CLIN CANCER RES, V13, P1308, DOI 10.1158/1078-0432.CCR-06-2216; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Niikura Y, 2007, J CELL BIOL, V178, P283, DOI 10.1083/jcb.200702134; Orth JD, 2008, MOL CANCER THER, V7, P3480, DOI 10.1158/1535-7163.MCT-08-0684; Park SJ, 2004, J BIOL CHEM, V279, P51057, DOI 10.1074/jbc.M406543200; Rao XT, 2008, MUTAT RES-FUND MOL M, V646, P41, DOI 10.1016/j.mrfmmm.2008.09.004; Reagan-Shaw S, 2006, CANCER RES, V66, P1062, DOI 10.1158/0008-5472.CAN-05-1018; Salah-Eldin AE, 2003, INT J CANCER, V103, P53, DOI 10.1002/ijc.10782; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Xu R, 2011, CANCER LETT, V306, P151, DOI 10.1016/j.canlet.2011.02.042; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	38	47	52	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35665	10.1371/journal.pone.0035665	http://dx.doi.org/10.1371/journal.pone.0035665			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545128	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343200048
J	Ramos-Mejia, V; Montes, R; Bueno, C; Ayllon, V; Real, PJ; Rodriguez, R; Menendez, P				Ramos-Mejia, Veronica; Montes, Rosa; Bueno, Clara; Ayllon, Veronica; Real, Pedro J.; Rodriguez, Rene; Menendez, Pablo			Residual Expression of the Reprogramming Factors Prevents Differentiation of iPSC Generated from Human Fibroblasts and Cord Blood CD34+Progenitors	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; LEUKAPHERESIS PRODUCTS; HEMATOPOIETIC-CELLS; PERIPHERAL-BLOOD; INDUCTION; CD34(+); TRANSPLANTATION; TRANSDUCTION; DERIVATION; EFFICIENCY	Human induced pluripotent stem cells (hiPSC) have been generated from different tissues, with the age of the donor, tissue source and specific cell type influencing the reprogramming process. Reprogramming hematopoietic progenitors to hiPSC may provide a very useful cellular system for modelling blood diseases. We report the generation and complete characterization of hiPSCs from human neonatal fibroblasts and cord blood (CB)-derived CD34+ hematopoietic progenitors using a single polycistronic lentiviral vector containing an excisable cassette encoding the four reprogramming factors Oct4, Klf4, Sox2 and c-myc (OKSM). The ectopic expression of OKSM was fully silenced upon reprogramming in some hiPSC clones and was not reactivated upon differentiation, whereas other hiPSC clones failed to silence the transgene expression, independently of the cell type/tissue origin. When hiPSC were induced to differentiate towards hematopoietic and neural lineages those hiPSC which had silenced OKSM ectopic expression displayed good hematopoietic and early neuroectoderm differentiation potential. In contrast, those hiPSC which failed to switch off OKSM expression were unable to differentiate towards either lineage, suggesting that the residual expression of the reprogramming factors functions as a developmental brake impairing hiPSC differentiation. Successful adenovirus-based Cre-mediated excision of the provirus OKSM cassette in CB-derived CD34+ hiPSC with residual transgene expression resulted in transgene-free hiPSC clones with significantly improved differentiation capacity. Overall, our findings confirm that residual expression of reprogramming factors impairs hiPSC differentiation.	[Ramos-Mejia, Veronica; Montes, Rosa; Bueno, Clara; Ayllon, Veronica; Real, Pedro J.; Rodriguez, Rene; Menendez, Pablo] Univ Granada Junta de Andalucia Genom, Ctr Pfizer, Oncol Res GENyO, Granada, Spain	Pfizer; University of Granada	Ramos-Mejia, V (corresponding author), Univ Granada Junta de Andalucia Genom, Ctr Pfizer, Oncol Res GENyO, Granada, Spain.	veronica.ramos@genyo.es; pablo.menendez@genyo.es	Bujan, Pablo Menendez/W-3736-2017; Ayllon, Veronica/L-7069-2014; Ramos-Mejia, Veronica/C-4338-2017; Rodriguez, Rene/P-2168-2018; Real, Pedro J./ABH-3493-2021; Real, Pedro J./K-2994-2014	Bujan, Pablo Menendez/0000-0001-9372-1007; Ayllon, Veronica/0000-0002-7322-9282; Ramos-Mejia, Veronica/0000-0002-8013-4273; Rodriguez, Rene/0000-0002-0768-7306; Real, Pedro J./0000-0001-7968-5353	Junta de Andalucia/Fondo Europeo de Desarrollo Regional [P08-CTS-3678]; Fondo de Investigaciones Sanitarias/Fondo Europeo de Desarrollo Regional [PI10/00449, CP07/00059, PI11/00119, CP09/0063]; Ministerio Espanol de Innovacion y Ciencia [PLE-2009-0111]; Spanish Association Against Cancer [CI110023]; Incoming International Marie Curie Fellowship [PIIF-GA-2009-236430]	Junta de Andalucia/Fondo Europeo de Desarrollo Regional; Fondo de Investigaciones Sanitarias/Fondo Europeo de Desarrollo Regional; Ministerio Espanol de Innovacion y Ciencia; Spanish Association Against Cancer; Incoming International Marie Curie Fellowship	P.M. was supported The Junta de Andalucia/Fondo Europeo de Desarrollo Regional (P08-CTS-3678), The Fondo de Investigaciones Sanitarias/Fondo Europeo de Desarrollo Regional (PI10/00449), The Ministerio Espanol de Innovacion y Ciencia (PLE-2009-0111) and The Spanish Association Against Cancer (CI110023). V. R-M: was supported by Incoming International Marie Curie Fellowship (PIIF-GA-2009-236430). C. B & P.J.R. were supported by the The Fondo de Investigaciones Sanitarias/Fondo Europeo de Desarrollo Regional (CP07/00059 and PI11/00119 and CP09/0063, respectively). R. R. was supported by The Spanish Association Against Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barroso-delJesus A, 2008, MOL CELL BIOL, V28, P6609, DOI 10.1128/MCB.00398-08; Broxmeyer HE, 2010, CELL STEM CELL, V6, P21, DOI 10.1016/j.stem.2009.12.008; Bueno C, 2008, LEUKEMIA, V22, P1475, DOI 10.1038/leu.2008.134; Bueno C, 2012, CELL RES IN PRESS; Bueno C, 2010, STEM CELL REV REP, V6, P215, DOI 10.1007/s12015-010-9118-5; Bueno C, 2009, CARCINOGENESIS, V30, P1628, DOI 10.1093/carcin/bgp169; Calvanese V, 2012, NUCLEIC ACIDS RES, V40, P116, DOI 10.1093/nar/gkr685; Calvanese V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003294; Catalina P, 2009, LEUKEMIA RES, V33, P980, DOI 10.1016/j.leukres.2008.08.028; Catalina P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-76; Catalina P, 2007, CELL BIOL INT, V31, P861, DOI 10.1016/j.cellbi.2007.03.012; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Cortes JL, 2008, STEM CELLS DEV, V17, P255, DOI 10.1089/scd.2007.0157; Cortes JL, 2009, HUM REPROD, V24, P1844, DOI 10.1093/humrep/dep107; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Fussner E, 2011, EMBO J, V30, P1778, DOI 10.1038/emboj.2011.96; Giorgetti A, 2009, CELL STEM CELL, V5, P353, DOI 10.1016/j.stem.2009.09.008; Gutierrez-Aranda I, 2010, STEM CELLS, V28, P1568, DOI 10.1002/stem.471; Haase A, 2009, CELL STEM CELL, V5, P434, DOI 10.1016/j.stem.2009.08.021; Hanley PJ, 2010, CYTOTHERAPY, V12, P713, DOI 10.3109/14653249.2010.517518; Hasegawa K, 2010, STEM CELLS, V28, P1338, DOI 10.1002/stem.466; Hotta A, 2008, J CELL BIOCHEM, V105, P940, DOI 10.1002/jcb.21912; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim PG, 2009, CYTOTHERAPY, V11, P980, DOI 10.3109/14653240903348319; Liang GY, 2010, J BIOL CHEM, V285, P25516, DOI 10.1074/jbc.M110.142059; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Menendez P, 2004, MOL THER, V10, P1109, DOI 10.1016/j.ymthe.2004.08.016; Menendez P, 2006, CYTOTHERAPY, V8, P530, DOI 10.1080/14653240601026654; Menendez P, 2005, CURR GENE THER, V5, P375, DOI 10.2174/1566523054546198; Menendez P, 2002, BRIT J HAEMATOL, V119, P135, DOI 10.1046/j.1365-2141.2002.03794.x; Menendez P, 2002, TRANSFUSION, V42, P1159, DOI 10.1046/j.1537-2995.2002.00190.x; Menendez P, 2001, LEUKEMIA, V15, P430, DOI 10.1038/sj.leu.2402051; Menendez P, 2001, J BIOL REG HOMEOS AG, V15, P53; Menendez P, 2009, J EXP MED, V206, P3131, DOI 10.1084/jem.20091050; Montes R, 2011, BLOOD, V117, P4746, DOI 10.1182/blood-2010-12-322230; Montes R, 2009, CELL RES, V19, P698, DOI 10.1038/cr.2009.35; Muller LUW, 2009, MOL THER, V17, P947, DOI 10.1038/mt.2009.72; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Ramos-Mejia V, 2012, STEM CELLS IN PRESS; Ramos-Mejia V, 2010, MOL THER, V18, P2173, DOI 10.1038/mt.2010.179; RAMOSMEJIA V, 2011, STEM CELLS DEV; Rastegar M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006810; Rubio R, 2010, CANCER RES, V70, P4185, DOI 10.1158/0008-5472.CAN-09-4640; Sanchez L, 2012, TISSUE EN C IN PRESS; Shojaei F, 2008, EXP HEMATOL, V36, P1436, DOI 10.1016/j.exphem.2008.06.001; Sommer CA, 2010, STEM CELLS, V28, P64, DOI 10.1002/stem.255; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Subramanyam D, 2009, NAT BIOTECHNOL, V27, P997, DOI 10.1038/nbt1109-997; Suhr ST, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008124, 10.1371/journal.pone.0014095]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takenaka C, 2010, EXP HEMATOL, V38, P154, DOI 10.1016/j.exphem.2009.11.003; Wang L, 2005, EXP HEMATOL, V33, P987, DOI 10.1016/j.exphem.2005.06.002; Wang LS, 2005, J EXP MED, V201, P1603, DOI 10.1084/jem.20041888; Wang LS, 2004, IMMUNITY, V21, P31, DOI 10.1016/j.immuni.2004.06.006; Ye ZH, 2009, BLOOD, V114, P5473, DOI 10.1182/blood-2009-04-217406; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	62	52	55	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35824	10.1371/journal.pone.0035824	http://dx.doi.org/10.1371/journal.pone.0035824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545141	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343200061
J	Chen, HF; Lin, LN; Chen, YX; Wan, JX; Luo, J; Zhang, CZ; Li, XJ; Hu, YM; Mai, JR; Chen, W; Lin, ZN; Lin, YC				Chen, Hui-Feng; Lin, Li-Na; Chen, Yu-Xi; Wan, Jian-Xin; Luo, Jie; Zhang, Chen-Zi; Li, Xiao-Jie; Hu, Yao-Ming; Mai, Jian-Rong; Chen, Wen; Lin, Zhong-Ning; Lin, Yu-Chun			Identification and Functional Analysis of Variant Haplotypes in the 5 '-Flanking Region of Protein Phosphatase 2A-B delta Gene	PLOS ONE			English	Article							REGULATORY SUBUNIT; GREATWALL KINASE; PP2A COMPLEXES; HAN CHINESE; B-SUBUNITS; 2A; FAMILY; TRANSCRIPTION; APOPTOSIS; CLONING	Serine-threonine protein phosphatase 2A (PP2A) is a trimeric holoenzyme that plays an integral role in the regulation of cell growth, differentiation, and apoptosis. The substrate specificity and (sub) cellular localization of the PP2A holoenzymes are highly regulated by interaction with a family of regulatory B subunits (PP2A-Bs). The regulatory subunit PP2A-B/PR55 delta (PP2A-B delta) is involving in the dephosphorylation of PP2A substrates and is crucial for controlling entry into and exit from mitosis. The molecular mechanisms involved in the regulation of expression of PP2A-B delta gene (PPP2R2D) remain largely unknown. To explore genetic variations in the 5'-flanking region of PPP2R2D gene as well as their frequent haplotypes in the Han Chinese population and determine whether such variations have an impact on transcriptional activity, DNA samples were collected from 70 healthy Chinese donors and sequenced for identifying genetic variants in the 5'-flanking region of PPP2R2D. Four genetic variants were identified in the 1836 bp 5'-flanking region of PPP2R2D. Linkage disequilibrium (LD) patterns and haplotype profiles were constructed for the genetic variants. Using serially truncated human PPP2R2D promoter luciferase constructs, we found that a 601 bp (-540 nt to +61 nt) fragment constitutes the core promoter region. The subcloning of individual 5'-flanking fragment revealed the existence of three haplotypes in the distal promoter of PPP2R2D. The luciferase reporter assay showed that different haplotypes exhibited distinct promoter activities. The EMSA revealed that the -462 G>A variant influences DNA-protein interactions involving the nuclear factor 1 (NF1). In vitro reporter gene assay indicated that cotransfection of NF1/B expression plasmid could positively regulate the activity of PPP2R2D proximal promoter. Introduction of exogenous NF1/B expression plasmid further confirmed that the NF1 involves in the regulation of PPP2R2D gene expression. Our findings suggest that functional genetic variants and their haplotypes in the 5'-flanking region of PPP2R2D are critical for transcriptional regulation of PP2A-B delta.	[Chen, Hui-Feng; Lin, Li-Na; Chen, Yu-Xi; Luo, Jie; Zhang, Chen-Zi; Li, Xiao-Jie; Hu, Yao-Ming; Mai, Jian-Rong; Chen, Wen; Lin, Zhong-Ning; Lin, Yu-Chun] Sun Yat Sen Univ, Sch Publ Hlth, Fac Prevent Med, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Wan, Jian-Xin] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Med Inspect, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Chen, HF (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Fac Prevent Med, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510275, Guangdong, Peoples R China.	linzhn@mail.sysu.edu.cn; linych@mail.sysu.edu.cn			National Natural Science Foundation of China [NSFC 81172705, 81072334, 30771832]; Chinese Ministry of Education [109126]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20090171110052]; Natural Science Foundation of Guangdong Province [S2011020002769]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by National Natural Science Foundation of China (NSFC 81172705, 81072334, 30771832), the Key Project of Chinese Ministry of Education (No. 109126), the Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20090171110052) and the Key Project of Natural Science Foundation of Guangdong Province (S2011020002769). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA N, 1995, EUR J BIOCHEM, V230, P766, DOI 10.1111/j.1432-1033.1995.tb20619.x; Chen CM, 2009, AM J MED GENET B, V150B, P124, DOI 10.1002/ajmg.b.30785; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chen W, 2005, CANCER RES, V65, P8183, DOI 10.1158/0008-5472.CAN-05-1103; Clifford RJ, 2004, ANN NY ACAD SCI, V1020, P101, DOI 10.1196/annals.1310.011; Dagda RK, 2005, J BIOL CHEM, V280, P27375, DOI 10.1074/jbc.M503693200; Dagda RK, 2003, J BIOL CHEM, V278, P24976, DOI 10.1074/jbc.M302832200; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Dupont WD, 2010, CANCER, V116, P8, DOI 10.1002/cncr.24702; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Gharbi-Ayachi A, 2010, SCIENCE, V330, P1673, DOI 10.1126/science.1197048; Grochola LF, 2009, CLIN CANCER RES, V15, P6301, DOI 10.1158/1078-0432.CCR-09-0797; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Hagedorn C, 2009, ARTERIOSCL THROM VAS, V29, P1638, DOI 10.1161/ATVBAHA.109.193532; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Kimura R, 2011, NEUROSCI LETT, V487, P354, DOI 10.1016/j.neulet.2010.10.055; KRUSE U, 1994, J MOL BIOL, V238, P860, DOI 10.1006/jmbi.1994.1343; Lazarus R, 2002, IMMUNOL REV, V190, P9, DOI 10.1034/j.1600-065X.2002.19002.x; Lechward K, 2001, ACTA BIOCHIM POL, V48, P921; Lin CH, 2010, HUM GENET, V128, P205, DOI 10.1007/s00439-010-0843-2; Lin ZN, 2008, HUM MUTAT, V29, P113, DOI 10.1002/humu.20610; MAYER RE, 1991, BIOCHEMISTRY-US, V30, P3589, DOI 10.1021/bi00229a001; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; Mochida S, 2010, SCIENCE, V330, P1670, DOI 10.1126/science.1195689; Mochida S, 2009, EMBO J, V28, P2777, DOI 10.1038/emboj.2009.238; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Plasari G, 2009, MOL CELL BIOL, V29, P6006, DOI 10.1128/MCB.01921-08; Ruediger R, 2001, ONCOGENE, V20, P10, DOI 10.1038/sj.onc.1204059; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Sablina AA, 2010, CANCER RES, V70, P10474, DOI 10.1158/0008-5472.CAN-10-2855; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; Schonthal AH, 2001, CANCER LETT, V170, P1, DOI 10.1016/S0304-3835(01)00561-4; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; Strack S, 1999, FEBS LETT, V460, P462, DOI 10.1016/S0014-5793(99)01377-0; Strack S, 2002, J BIOL CHEM, V277, P20750, DOI 10.1074/jbc.M202992200; Strack S, 1998, J COMP NEUROL, V392, P515; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Turowski P, 1999, MOL BIOL CELL, V10, P1997, DOI 10.1091/mbc.10.6.1997; Van Kanegan MJ, 2005, J BIOL CHEM, V280, P36029, DOI 10.1074/jbc.M506986200; Vazquez A, 2011, INT J CANCER, V128, P2335, DOI 10.1002/ijc.25582; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Voets E, 2010, CELL CYCLE, V9, P3591, DOI 10.4161/cc.9.17.12832; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Zhao Y, 1997, J BIOL CHEM, V272, P8256, DOI 10.1074/jbc.272.13.8256; ZOLNIEROWICZ S, 1994, BIOCHEMISTRY-US, V33, P11858, DOI 10.1021/bi00205a023	49	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35524	10.1371/journal.pone.0035524	http://dx.doi.org/10.1371/journal.pone.0035524			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539979	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341000045
J	Krober, W; Bohnke, M; Welk, E; Wirth, C; Bruelheide, H				Kroeber, Wenzel; Boehnke, Martin; Welk, Erik; Wirth, Christian; Bruelheide, Helge			Leaf Trait-Environment Relationships in a Subtropical Broadleaved Forest in South-East China	PLOS ONE			English	Article							BROAD-LEAVED FOREST; FUNCTIONAL TRAITS; RAIN-FOREST; LIMITING SIMILARITY; PLANT-COMMUNITIES; TRADE-OFF; LIFE-SPAN; GROWTH; DIVERSITY; DECOMPOSABILITY	Although trait analyses have become more important in community ecology, trait-environment correlations have rarely been studied along successional gradients. We asked which environmental variables had the strongest impact on intraspecific and interspecific trait variation in the community and which traits were most responsive to the environment. We established a series of plots in a secondary forest in the Chinese subtropics, stratified by successional stages that were defined by the time elapsed since the last logging activities. On a total of 27 plots all woody plants were recorded and a set of individuals of every species was analysed for leaf traits, resulting in a trait matrix of 26 leaf traits for 122 species. A Fourth Corner Analysis revealed that the mean values of many leaf traits were tightly related to the successional gradient. Most shifts in traits followed the leaf economics spectrum with decreasing specific leaf area and leaf nutrient contents with successional time. Beside succession, few additional environmental variables resulted in significant trait relationships, such as soil moisture and soil C and N content as well as topographical variables. Not all traits were related to the leaf economics spectrum, and thus, to the successional gradient, such as stomata size and density. By comparing different permutation models in the Fourth Corner Analysis, we found that the trait-environment link was based more on the association of species with the environment than of the communities with species traits. The strong species-environment association was brought about by a clear gradient in species composition along the succession series, while communities were not well differentiated in mean trait composition. In contrast, intraspecific trait variation did not show close environmental relationships. The study confirmed the role of environmental trait filtering in subtropical forests, with traits associated with the leaf economics spectrum being the most responsive ones.	[Kroeber, Wenzel; Boehnke, Martin; Welk, Erik; Bruelheide, Helge] Univ Halle Wittenberg, Inst Biol Geobot, Halle, Germany; [Kroeber, Wenzel; Boehnke, Martin; Welk, Erik; Bruelheide, Helge] Univ Halle Wittenberg, Bot Garden, Halle, Germany; [Wirth, Christian] Univ Leipzig, Inst Biol Special Bot & Funct Biodivers Res 1, Leipzig, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Leipzig University	Krober, W (corresponding author), Univ Halle Wittenberg, Inst Biol Geobot, Halle, Germany.	helge.bruelheide@botanik.uni-halle.de	Bruelheide, Helge/G-3907-2013; WELK, Erik/AGL-4971-2022; Wirth, Christian/A-4446-2016	Bruelheide, Helge/0000-0003-3135-0356; Welk, Erik/0000-0002-2685-3795	German Science Foundation (DFG) [FOR 891/1, BR 1698/9-1]; Sino-German Centre for Research Promotion in Beijing [GZ 524, 592, 698, 699]	German Science Foundation (DFG)(German Research Foundation (DFG)); Sino-German Centre for Research Promotion in Beijing	The study was funded by the German Science Foundation (DFG FOR 891/1, BR 1698/9-1, www.dfg.de) and by travel grants by the Sino-German Centre for Research Promotion in Beijing (GZ 524, 592, 698 and 699, http://www.sinogermanscience.org.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2007, ECOL LETT, V10, P135, DOI 10.1111/j.1461-0248.2006.01006.x; Aiba S, 2001, FOREST ECOL MANAG, V140, P163, DOI 10.1016/S0378-1127(00)00325-X; Alexander RM, 1997, NATURE, V386, P327, DOI 10.1038/386327a0; Alonso D, 2006, TRENDS ECOL EVOL, V21, P451, DOI 10.1016/j.tree.2006.03.019; [Anonymous], 1954, VEGETATIO; BEERLING DJ, 1993, BIOL J LINN SOC, V48, P343, DOI 10.1111/j.1095-8312.1993.tb02096.x; Belyea LR, 1999, OIKOS, V86, P402, DOI 10.2307/3546646; Bohnke M, 2012, TREES-STRUCT FUNCT, V26, P641, DOI 10.1007/s00468-011-0632-0; Bohnke M, 2012, ECOSPHERE UNPUB; Bruelheide H, 2011, ECOL MONOGR, V81, P25, DOI 10.1890/09-2172.1; Canas MS, 1997, J ENVIRON MANAGE, V49, P167, DOI 10.1006/jema.1995.0090; CARPENTER SB, 1975, CAN J BOT, V53, P1153, DOI 10.1139/b75-137; Cavender-Bares J, 2005, NEW PHYTOL, V168, P597, DOI 10.1111/j.1469-8137.2005.01555.x; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Deng F, 2008, FOREST ECOL MANAG, V255, P1820, DOI 10.1016/j.foreco.2007.12.004; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Dray S, 2008, ECOLOGY, V89, P3400, DOI 10.1890/08-0349.1; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; FANG J-Y, 1988, Ecological Research, V3, P37, DOI 10.1007/BF02348693; Fortunel C, 2009, ECOLOGY, V90, P598, DOI 10.1890/08-0418.1; Fyllas NM, 2009, BIOGEOSCIENCES, V6, P2677, DOI 10.5194/bg-6-2677-2009; GINDEL I, 1969, ECOLOGY, V50, P263, DOI 10.2307/1934854; Grime JP, 2006, J VEG SCI, V17, P255, DOI 10.1111/j.1654-1103.2006.tb02444.x; Guariguata MR, 2001, FOREST ECOL MANAG, V148, P185, DOI 10.1016/S0378-1127(00)00535-1; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hu Z, 2008, FRONT BIOL CHINA, V3, P45, DOI DOI 10.1007/S11515-008-0011-4; Hubbell Stephen P., 2001, V32, pi; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; INOUYE RS, 1987, ECOLOGY, V68, P12, DOI 10.2307/1938801; Kitao M, 1999, PHOTOSYNTHETICA, V36, P31, DOI 10.1023/A:1007058418199; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Kouwenberg LLR, 2007, REV MINERAL GEOCHEM, V66, P215, DOI 10.2138/rmg.2007.66.9; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Kurokawa H, 2008, ECOLOGY, V89, P2645, DOI 10.1890/07-1352.1; Lambers H., 2008, PLANT PHYSL ECOLOGY; Lang AC, 2010, FOREST ECOL MANAG, V260, P1708, DOI 10.1016/j.foreco.2010.08.015; Lebrija-Trejos E, 2010, ECOLOGY, V91, P386, DOI 10.1890/08-1449.1; Legendre P, 1997, ECOLOGY, V78, P547; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; Leps J, 2011, ECOGRAPHY, V34, P856, DOI 10.1111/j.1600-0587.2010.06904.x; Lusk CH, 2011, J ECOL, V99, P491, DOI 10.1111/j.1365-2745.2010.01766.x; Lusk CH, 2007, NEW PHYTOL, V176, P764, DOI 10.1111/j.1469-8137.2007.02264.x; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Mason NWH, 2011, J VEG SCI, V22, P6, DOI 10.1111/j.1654-1103.2010.01223.x; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; McGlone MS, 2004, NEW ZEAL J BOT, V42, P1, DOI 10.1080/0028825X.2004.9512887; MOORE P, 1980, NATURE, V285, P535, DOI 10.1038/285535a0; Mutke J., 2005, Plant diversity and complexity patterns: local, regional and global dimensions. Proceedings of an International Symposium held at the Royal Danish Academy of Sciences and Letters in Copenhagen, Denmark, 25-28 May, 2003, P521; Oksanen JF, 2010, VEGAN COMMUNITY ECOL; Ordonez JC, 2009, GLOBAL ECOL BIOGEOGR, V18, P137, DOI 10.1111/j.1466-8238.2008.00441.x; PACALA SW, 1994, AM NAT, V143, P222, DOI 10.1086/285602; Pavoine S, 2011, J ECOL, V99, P165, DOI 10.1111/j.1365-2745.2010.01743.x; Peppe DJ, 2011, NEW PHYTOL, V190, P724, DOI 10.1111/j.1469-8137.2010.03615.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Poorter L, 2008, ECOLOGY, V89, P1908, DOI 10.1890/07-0207.1; Poorter L, 2004, PLANT BIOLOGY, V6, P746, DOI 10.1055/s-2004-821269; POPMA J, 1988, OECOLOGIA, V75, P625, DOI 10.1007/BF00776429; Reich PB, 1999, ECOLOGY, V80, P1955, DOI 10.1890/0012-9658(1999)080[1955:GOLTRA]2.0.CO;2; REICH PB, 1992, ECOL MONOGR, V62, P365, DOI 10.2307/2937116; Sasaki T, 2009, ECOLOGY, V90, P2598, DOI 10.1890/08-1850.1; Sterck FJ, 2006, AM NAT, V167, P758, DOI 10.1086/503056; Tomasevic M, 2011, ECOL INDIC, V11, P1689, DOI 10.1016/j.ecolind.2011.04.017; Valiente-Banuet A, 2007, ECOL LETT, V10, P1029, DOI 10.1111/j.1461-0248.2007.01100.x; Violle C, 2009, J PLANT ECOL-UK, V2, P87, DOI 10.1093/jpe/rtp007; von Oheimb G, 2011, FOREST ECOL MANAG, V261, P499, DOI 10.1016/j.foreco.2010.10.035; Wang XH, 2007, FOREST ECOL MANAG, V245, P76, DOI 10.1016/j.foreco.2007.03.043; Webb CT, 2010, ECOL LETT, V13, P267, DOI 10.1111/j.1461-0248.2010.01444.x; Weiher E, 1999, J VEG SCI, V10, P609, DOI 10.2307/3237076; Weiher E., 1999, ECOLOGICAL ASSEMBLY; Wilson PJ, 1999, NEW PHYTOL, V143, P155, DOI 10.1046/j.1469-8137.1999.00427.x; Wirth C, 2009, ECOL STUD-ANAL SYNTH, V207, P465, DOI 10.1007/978-3-540-92706-8_21; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2002, NEW PHYTOL, V155, P403, DOI 10.1046/j.1469-8137.2002.00479.x; Wright SJ, 2011, ECOLOGY, V92, P1616, DOI 10.1890/10-1558.1; Wright S Joseph, 2010, Ecology, V91, P3664, DOI 10.1890/09-2335.1; Yu MingJian, 2001, Journal of Zhejiang University (Agriculture and Life Sciences), V27, P375; Yuan ZYY, 2009, GLOBAL ECOL BIOGEOGR, V18, P532, DOI 10.1111/j.1466-8238.2009.00474.x	78	58	61	6	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35742	10.1371/journal.pone.0035742	http://dx.doi.org/10.1371/journal.pone.0035742			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539999	gold, Green Submitted, Green Published			2022-12-25	WOS:000305341000065
J	Hess, K; Ajjan, R; Phoenix, F; Dobo, J; Gal, P; Schroeder, V				Hess, Katharina; Ajjan, Ramzi; Phoenix, Fladia; Dobo, Jozsef; Gal, Peter; Schroeder, Verena			Effects of MASP-1 of the Complement System on Activation of Coagulation Factors and Plasma Clot Formation	PLOS ONE			English	Article							FACTOR-XIII; SERINE PROTEASE-1; FIBRIN CLOT; GENERATION; PATHWAY; POLYMORPHISM; INFARCTION; PHENOTYPE; PEPTIDES; MUTANTS	Background: Numerous interactions between the coagulation and complement systems have been shown. Recently, links between coagulation and mannan-binding lectin-associated serine protease-1 (MASP-1) of the complement lectin pathway have been proposed. Our aim was to investigate MASP-1 activation of factor XIII (FXIII), fibrinogen, prothrombin, and thrombin-activatable fibrinolysis inhibitor (TAFI) in plasma-based systems, and to analyse effects of MASP-1 on plasma clot formation, structure and lysis. Methodology/Principal Findings: We used a FXIII incorporation assay and specific assays to measure the activation products prothrombin fragment F1+2, fibrinopeptide A (FPA), and activated TAFI (TAFIa). Clot formation and lysis were assessed by turbidimetric assay. Clot structure was studied by scanning electron microscopy. MASP-1 activated FXIII and, contrary to thrombin, induced FXIII activity faster in the Val34 than the Leu34 variant. MASP-1-dependent generation of F1+2, FPA and TAFIa showed a dose-dependent response in normal citrated plasma (NCP), albeit MASP-1 was much less efficient than FXa or thrombin. MASP-1 activation of prothrombin and TAFI cleavage were confirmed in purified systems. No FPA generation was observed in prothrombin-depleted plasma. MASP-1 induced clot formation in NCP, affected clot structure, and prolonged clot lysis. Conclusions/Significance: We show that MASP-1 interacts with plasma clot formation on different levels and influences fibrin structure. Although MASP-1-induced fibrin formation is thrombin-dependent, MASP-1 directly activates prothrombin, FXIII and TAFI. We suggest that MASP-1, in concerted action with other complement and coagulation proteins, may play a role in fibrin clot formation.	[Hess, Katharina; Ajjan, Ramzi; Phoenix, Fladia; Schroeder, Verena] Univ Leeds, Div Cardiovasc & Diabet Res, LIGHT Labs, Multidisciplinary Cardiovasc Res Ctr, Leeds, W Yorkshire, England; [Hess, Katharina] Univ Hosp Aachen, Dept Internal Med, Aachen, Germany; [Dobo, Jozsef; Gal, Peter] Hungarian Acad Sci, Inst Enzymol, Biol Res Ctr, Budapest, Hungary; [Schroeder, Verena] Univ Bern, Bern, Switzerland; [Schroeder, Verena] Univ Hosp Bern, Univ Clin Hematol & Cent Hematol Lab, Hemostasis Res Lab, CH-3010 Bern, Switzerland	University of Leeds; RWTH Aachen University; RWTH Aachen University Hospital; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences; University of Bern; University of Bern; University Hospital of Bern	Schroeder, V (corresponding author), Univ Leeds, Div Cardiovasc & Diabet Res, LIGHT Labs, Multidisciplinary Cardiovasc Res Ctr, Leeds, W Yorkshire, England.	verena.schroeder@insel.ch	Gal, Peter/B-5886-2011; Dobo, Jozsef/C-7331-2014	Schroeder, Verena/0000-0001-6508-3271; Dobo, Jozsef/0000-0001-9187-8502	Rosetrees Trust (UK); Betty and Charles Stilwell Fund (UK); OPO Foundation (Switzerland); Deutsche Forschungsgemeinschaft; Swiss National Science Foundation/Swiss Foundation for Medical-Biological; Novartis Foundation	Rosetrees Trust (UK)(Rosetrees Trust); Betty and Charles Stilwell Fund (UK); OPO Foundation (Switzerland); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swiss National Science Foundation/Swiss Foundation for Medical-Biological; Novartis Foundation(Novartis)	This work was supported by grants awarded to VS by the Rosetrees Trust (UK), The Betty and Charles Stilwell Fund (UK), and OPO Foundation (Switzerland). At the University of Leeds, KH was supported by a grant from the Deutsche Forschungsgemeinschaft and VS was supported by fellowships from the Swiss National Science Foundation/Swiss Foundation for Medical-Biological Grants and the Novartis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajjan R, 2008, BLOOD, V111, P643, DOI 10.1182/blood-2007-05-091231; Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; Ambrus G, 2003, J IMMUNOL, V170, P1374, DOI 10.4049/jimmunol.170.3.1374; Ariens RAS, 2002, BLOOD, V100, P743, DOI 10.1182/blood.V100.3.743; Bajzar L, 1996, J BIOL CHEM, V271, P16603, DOI 10.1074/jbc.271.28.16603; Banda NK, 2010, J IMMUNOL, V185, P5598, DOI 10.4049/jimmunol.1001564; Bereczky Z, 2007, THROMB RES, V120, P567, DOI 10.1016/j.thromres.2006.12.013; BLOMBACK B, 1978, NATURE, V275, P501, DOI 10.1038/275501a0; Carter AM, 2007, ARTERIOSCL THROM VAS, V27, P2783, DOI 10.1161/ATVBAHA.107.153221; Collet JP, 2006, ARTERIOSCL THROM VAS, V26, P2567, DOI 10.1161/01.ATV.0000241589.52950.4c; Collet JP, 2000, ARTERIOSCL THROM VAS, V20, P1354, DOI 10.1161/01.ATV.20.5.1354; Dobo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020036; Dobo J, 2009, J IMMUNOL, V183, P1207, DOI 10.4049/jimmunol.0901141; Fatah K, 1996, THROMB HAEMOSTASIS, V76, P535; Gal P, 2007, IMMUNOBIOLOGY, V212, P267, DOI 10.1016/j.imbio.2006.11.002; Gulla KC, 2010, IMMUNOLOGY, V129, P482, DOI 10.1111/j.1365-2567.2009.03200.x; Hajela K, 2002, IMMUNOBIOLOGY, V205, P467, DOI 10.1078/0171-2985-00147; Hess K, 2012, DIABETOLOGI IN PRESS; Howes JM, 2012, DIAB VASC D IN PRESS; Jadhav MA, 2011, BBA-PROTEINS PROTEOM, V1814, P1955, DOI 10.1016/j.bbapap.2011.07.012; Kocsis A, 2010, J IMMUNOL, V185, P4169, DOI 10.4049/jimmunol.1001819; Kohler HP, 1998, THROMB HAEMOSTASIS, V80, P704; Krarup A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000623; Krarup A, 2008, BBA-PROTEINS PROTEOM, V1784, P1294, DOI 10.1016/j.bbapap.2008.03.020; La Bonte LR, 2012, J IMMUNOL, V188, P885, DOI 10.4049/jimmunol.1102916; Lim BCB, 2003, LANCET, V361, P1424, DOI 10.1016/S0140-6736(03)13135-2; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; Megyeri M, 2009, J IMMUNOL, V183, P3409, DOI 10.4049/jimmunol.0900879; Mikkola H, 1997, BLOOD, V89, P1279, DOI 10.1182/blood.V89.4.1279; Moller-Kristensen M, 2007, INT IMMUNOL, V19, P141, DOI 10.1093/intimm/dxl131; Muszbek L, 2010, SEMIN THROMB HEMOST, V36, P18, DOI 10.1055/s-0030-1248721; Opal SM, 2000, CRIT CARE MED, V28, pS77, DOI 10.1097/00003246-200009001-00017; Presanis JS, 2004, MOL IMMUNOL, V40, P921, DOI 10.1016/j.molimm.2003.10.013; Ryan EA, 1999, BIOPHYS J, V77, P2813, DOI 10.1016/S0006-3495(99)77113-4; Schroeder V, 2010, J THROMB HAEMOST, V8, P2080, DOI 10.1111/j.1538-7836.2010.03966.x; Schwaeble WJ, 2011, P NATL ACAD SCI USA, V108, P7523, DOI 10.1073/pnas.1101748108; Speidl WS, 2011, J THROMB HAEMOST, V9, P428, DOI 10.1111/j.1538-7836.2010.04172.x; Takahashi K, 2011, IMMUNOBIOLOGY, V216, P96, DOI 10.1016/j.imbio.2010.02.005; Takahashi M, 2008, J IMMUNOL, V180, P6132, DOI 10.4049/jimmunol.180.9.6132; Takahashi M, 2010, J EXP MED, V207, P29, DOI 10.1084/jem.20090633; Terai I, 1997, CLIN EXP IMMUNOL, V110, P317; Thiel S, 2011, MOL IMMUNOL, V48, P1710, DOI 10.1016/j.molimm.2011.06.361; Trumbo TA, 2002, BIOCHEMISTRY-US, V41, P2859, DOI 10.1021/bi0157823; Weisel JW, 2004, BIOPHYS CHEM, V112, P267, DOI 10.1016/j.bpc.2004.07.029; Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001	45	81	81	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35690	10.1371/journal.pone.0035690	http://dx.doi.org/10.1371/journal.pone.0035690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536427	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339200099
J	Machida, RJ; Kweskin, M; Knowlton, N				Machida, Ryuji J.; Kweskin, Matthew; Knowlton, Nancy			PCR Primers for Metazoan Mitochondrial 12S Ribosomal DNA Sequences	PLOS ONE			English	Article							RNA GENE; DIVERSITY	Background: Assessment of the biodiversity of communities of small organisms is most readily done using PCR-based analysis of environmental samples consisting of mixtures of individuals. Known as metagenetics, this approach has transformed understanding of microbial communities and is beginning to be applied to metazoans as well. Unlike microbial studies, where analysis of the 16S ribosomal DNA sequence is standard, the best gene for metazoan metagenetics is less clear. In this study we designed a set of PCR primers for the mitochondrial 12S ribosomal DNA sequence based on 64 complete mitochondrial genomes and then tested their efficacy. Methodology/Principal Findings: A total of the 64 complete mitochondrial genome sequences representing all metazoan classes available in GenBank were downloaded using the NCBI Taxonomy Browser. Alignment of sequences was performed for the excised mitochondrial 12S ribosomal DNA sequences, and conserved regions were identified for all 64 mitochondrial genomes. These regions were used to design a primer pair that flanks a more variable region in the gene. Then all of the complete metazoan mitochondrial genomes available in NCBI's Organelle Genome Resources database were used to determine the percentage of taxa that would likely be amplified using these primers. Results suggest that these primers will amplify target sequences for many metazoans. Conclusions/Significance: Newly designed 12S ribosomal DNA primers have considerable potential for metazoan metagenetic analysis because of their ability to amplify sequences from many metazoans.	[Machida, Ryuji J.; Kweskin, Matthew; Knowlton, Nancy] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA	Smithsonian Institution; Smithsonian National Museum of Natural History	Machida, RJ (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan.	ryujimachida@gate.sinica.edu.tw		Kweskin, Matthew/0000-0002-1885-0930	Alfred P. Sloan Foundation; Sant Chair of Marine Science	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Sant Chair of Marine Science	Financial support was provided by the Alfred P. Sloan Foundation and the Sant Chair of Marine Science discretionary funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Bottger-Schnack R, 2011, HYDROBIOLOGIA, V666, P111, DOI 10.1007/s10750-010-0094-1; Bru D, 2008, APPL ENVIRON MICROB, V74, P1660, DOI 10.1128/AEM.02403-07; Committee on Metagenomics National Research Council, 2007, CHALL FUNCT APPL NEW, P170; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Gibson JF, 2010, MOL PHYLOGENET EVOL, V56, P91, DOI 10.1016/j.ympev.2010.03.026; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li J, 2010, PARASITOL RES, V107, P561, DOI 10.1007/s00436-010-1895-x; Machida RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010278; Maddison D. R., 2000, MACCLADE 4 ANAL PHYL; Makowsky R, 2010, MOL PHYLOGENET EVOL, V57, P485, DOI 10.1016/j.ympev.2010.05.009; McIntyre AD, 2010, LIFE WORLDS OCEANS D; Mueller RL, 2006, SYST BIOL, V55, P289, DOI 10.1080/10635150500541672; Pawlowski DR, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018169, 10.1371/journal.pone.0017585]; Schindel DE, 2005, NATURE, V435, P17, DOI 10.1038/435017b; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Snelgrove PVR, 2010, DISCOVERIES CENSUS M, P286; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; van der Kuyl AC, 2002, MOL PHYLOGENET EVOL, V22, P174, DOI 10.1006/mpev.2001.1052	24	19	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35887	10.1371/journal.pone.0035887	http://dx.doi.org/10.1371/journal.pone.0035887			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22536450	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336200070
J	Pan, LL; Li, YL; Jia, LX; Qin, YW; Qi, GM; Cheng, JZ; Qi, YF; Li, HH; Du, J				Pan, Lili; Li, Yulin; Jia, Lixin; Qin, Yanwen; Qi, Guanming; Cheng, Jizhong; Qi, Yongfen; Li, Huihua; Du, Jie			Cathepsin S Deficiency Results in Abnormal Accumulation of Autophagosomes in Macrophages and Enhances Ang II-Induced Cardiac Inflammation	PLOS ONE			English	Article							NF-KAPPA-B; HEART-DISEASE; CYSTEINE CATHEPSINS; HEMODYNAMIC STRESS; CELL-DEATH; EXPRESSION; MECHANISMS; FIBROSIS; MICE; METALLOPROTEINASES	Background: Cathepsin S (Cat S) is overexpressed in human atherosclerotic and aneurysmal tissues and may contributes to degradation of extracellular matrix, especially elastin, in inflammatory diseases. We aimed to define the role of Cat S in cardiac inflammation and fibrosis induced by angiotensin II (Ang II) in mice. Methods and Results: Cat S-knockout (Cat S-/-) and littermate wild-type (WT) C57BL/6J mice were infused continuously with Ang II (750 ng/kg/min) or saline for 7 days. Cat S-/- mice showed severe cardiac fibrosis, including elevated expression of collagen I and alpha-smooth muscle actin (alpha-SMA), as compared with WT mice. Moreover, macrophage infiltration and expression of inflammatory cytokines (tumor necrosis factor alpha, transforming growth factor beta and interleukin 1 beta) were significantly greater in Cat S-/- than WT hearts. These Ang II-induced effects in Cat S-/- mouse hearts was associated with abnormal accumulation of autophagosomes and reduced clearance of damaged mitochondria, which led to increased levels of reactive oxygen species (ROS) and activation of nuclear factor-kappa B (NF-kappa B) in macrophages. Conclusion: Cat S in lysosomes is essential for mitophagy processing in macrophages, deficiency in Cat S can increase damaged mitochondria and elevate ROS levels and NF-kappa B activity in hypertensive mice, so it regulates cardiac inflammation and fibrosis.	[Pan, Lili; Li, Yulin; Jia, Lixin; Qin, Yanwen; Qi, Guanming; Cheng, Jizhong; Qi, Yongfen; Du, Jie] Capital Med Univ, Beijing An Zhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis Beijin, Beijing, Peoples R China; [Du, Jie] Minist Educ, Key Lab Remodeling Related Cardiovasc Dis, Beijing, Peoples R China; [Li, Huihua] Capital Med Univ, Dept Pathol, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Pan, LL (corresponding author), Capital Med Univ, Beijing An Zhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis Beijin, Beijing, Peoples R China.	jdu@bcm.edu	Qin, Yanwen/AAM-6961-2020; Li, yulin/AGZ-5611-2022	Qin, Yanwen/0000-0002-5185-9726; 	Chinese Ministry of Science and Technology [2012CB517802, 2012CB945104]; National Science Foundation of China [30888004, 31090363]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by grants from the Chinese Ministry of Science and Technology (2012CB517802 and 2012CB945104) and from the National Science Foundation of China (30888004 and 31090363). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badenhorst D, 2003, CARDIOVASC RES, V57, P632, DOI 10.1016/S0008-6363(02)00733-2; Blyszczuk P, 2009, CIRC RES, V105, P912, DOI 10.1161/CIRCRESAHA.109.199802; Bruckner AL, 2004, SEMIN CUTAN MED SURG, V23, P116, DOI 10.1016/j.sder.2004.01.005; Burns-Kurtis CL, 2004, CARDIOVASC RES, V62, P610, DOI 10.1016/j.cardiores.2004.02.002; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Dada LA, 2011, J CLIN INVEST, V121, P1683, DOI 10.1172/JCI57748; De Meyer GRY, 2009, BBA-MOL CELL RES, V1793, P1485, DOI 10.1016/j.bbamcr.2008.12.011; de Nooijer R, 2009, ARTERIOSCL THROM VAS, V29, P188, DOI 10.1161/ATVBAHA.108.181578; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Gustafsson AB, 2009, CIRC RES, V104, P150, DOI 10.1161/CIRCRESAHA.108.187427; Huang CY, 2001, J CEREBR BLOOD F MET, V21, P163, DOI 10.1097/00004647-200102000-00008; Huang XR, 2010, HYPERTENSION, V55, P1165, DOI 10.1161/HYPERTENSIONAHA.109.147611; Kania G, 2009, TRENDS CARDIOVAS MED, V19, P247, DOI 10.1016/j.tcm.2010.02.005; Karioti A, 2008, PHYTOMEDICINE, V15, P1125, DOI 10.1016/j.phymed.2008.02.018; Knaapen MWM, 2001, CARDIOVASC RES, V51, P304, DOI 10.1016/S0008-6363(01)00290-5; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Koike M, 2000, J NEUROSCI, V20, P6898, DOI 10.1523/JNEUROSCI.20-18-06898.2000; Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liu J, 2006, ATHEROSCLEROSIS, V184, P302, DOI 10.1016/j.atherosclerosis.2005.05.012; Lutgens SPM, 2006, J PATHOL, V210, P334, DOI 10.1002/path.2054; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Nishida K, 2009, CELL DEATH DIFFER, V16, P31, DOI 10.1038/cdd.2008.163; Pieper GM, 2001, ANTIOXID REDOX SIGN, V3, P81, DOI 10.1089/152308601750100542; Porrello ER, 2009, HYPERTENSION, V53, P1032, DOI 10.1161/HYPERTENSIONAHA.108.128488; Pozgan U, 2010, BIOL CHEM, V391, P571, DOI 10.1515/BC.2010.035; Rothermel BA, 2008, CIRC RES, V103, P1363, DOI 10.1161/CIRCRESAHA.108.186551; Ryter Stefan W, 2010, Proc Am Thorac Soc, V7, P40, DOI 10.1513/pats.200909-100JS; Sasaki T, 2010, ATHEROSCLEROSIS, V210, P430, DOI 10.1016/j.atherosclerosis.2009.12.031; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Shacka JJ, 2007, J NEUROSCI, V27, P2081, DOI 10.1523/JNEUROSCI.5577-06.2007; SHAH PK, 1995, CIRCULATION, V92, P1565; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Stahl S, 2007, BBA-PROTEINS PROTEOM, V1774, P1237, DOI 10.1016/j.bbapap.2007.07.004; Sukhova GK, 2003, J CLIN INVEST, V111, P897, DOI 10.1172/JCI200314915; Sukhova GK, 1998, J CLIN INVEST, V102, P576, DOI 10.1172/JCI181; Usher MG, 2010, J CLIN INVEST, V120, P3350, DOI 10.1172/JCI41080; Wang WS, 2005, J AM SOC NEPHROL, V16, P1371, DOI 10.1681/ASN.2004121070; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yadav A, AM J PHYSL CELL PHYS, V299, pC488; Yang CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021971; Zheng T, 2005, J IMMUNOL, V174, P8106, DOI 10.4049/jimmunol.174.12.8106; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523; Zhu JH, 2011, METHODS MOL BIOL, V793, P325, DOI 10.1007/978-1-61779-328-8_21	49	72	76	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35315	10.1371/journal.pone.0035315	http://dx.doi.org/10.1371/journal.pone.0035315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558139	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340200014
J	Alkire, BC; Vincent, JR; Burns, CT; Metzler, IS; Farmer, PE; Meara, JG				Alkire, Blake C.; Vincent, Jeffrey R.; Burns, Christy Turlington; Metzler, Ian S.; Farmer, Paul E.; Meara, John G.			Obstructed Labor and Caesarean Delivery: The Cost and Benefit of Surgical Intervention	PLOS ONE			English	Article							MATERNAL MORTALITY; STATISTICAL LIFE; HEALTH; RISK; AVAILABILITY; SERVICES; DEATH; EMOC; AGE	Background: Although advances in the reduction of maternal mortality have been made, up to 273,000 women will die this year from obstetric etiologies. Obstructed labor (OL), most commonly treated with Caesarean delivery, has been identified as a major contributor to global maternal morbidity and mortality. We used economic and epidemiological modeling to estimate the cost per disability-adjusted life-year (DALY) averted and benefit-cost ratio of treating OL with Caesarean delivery for 49 countries identified as providing an insufficient number of Caesarean deliveries to meet demand. Methods and Findings: Using publicly available data and explicit economic assumptions, we estimated that the cost per DALY (3,0,0) averted for providing Caesarean delivery for OL ranged widely, from $251 per DALY averted in Madagascar to $3,462 in Oman. The median cost per DALY averted was $304. Benefit-cost ratios also varied, from 0.6 in Zimbabwe to 69.9 in Gabon. The median benefit-cost ratio calculated was 6.0. The main limitation of this study is an assumption that lack of surgical capacity is the main factor responsible for DALYs from OL. Conclusions: Using the World Health Organization's cost-effectiveness standards, investing in Caesarean delivery can be considered "highly cost-effective" for 48 of the 49 countries included in this study. Furthermore, in 46 of the 49 included countries, the benefit-cost ratio was greater than 1.0, implying that investment in Caesarean delivery is a viable economic proposition. While Caesarean delivery alone is not sufficient for combating OL, it is necessary, cost-effective by WHO standards, and ultimately economically favorable in the vast majority of countries included in this study.	[Alkire, Blake C.] Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA; [Alkire, Blake C.; Metzler, Ian S.; Meara, John G.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Program Global Surg & Social Change, Boston, MA USA; [Vincent, Jeffrey R.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Vincent, Jeffrey R.] Duke Univ, Sanford Sch Publ Policy, Durham, NC USA; [Burns, Christy Turlington] Columbia Univ, Dept Populat & Family Hlth, Mailman Sch Publ Hlth, New York, NY USA; [Meara, John G.] Childrens Hosp, Dept Plast & Oral Surg, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Duke University; Duke University; Columbia University; Harvard University; Boston Children's Hospital	Alkire, BC (corresponding author), Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA.	john.meara@childrens.harvard.edu	Alkire, Blake/AAY-6463-2020	Meara, John G./0000-0003-4369-3209				AbouZahr C, 2003, BRIT MED BULL, V67, P1, DOI 10.1093/bmb/ldg015; AbouZhar, 2003, GLOBAL BURDEN OBSTRU; Aldy JE, 2008, REV ECON STAT, V90, P573, DOI 10.1162/rest.90.3.573; Alkire B, 2011, WORLD J SURG, V35, P1194, DOI 10.1007/s00268-011-1055-1; Anand S, 1997, J HEALTH ECON, V16, P685, DOI 10.1016/S0167-6296(97)00005-2; Chhabra S., 2000, Journal of Obstetrics and Gynaecology (Abingdon), V20, P151; Farmer PE, 2008, WORLD J SURG, V32, P533, DOI 10.1007/s00268-008-9525-9; Fournier P, 2009, B WORLD HEALTH ORGAN, V87, P30, DOI 10.2471/BLT.07.047076; Government of Australia Access Economics, 2008, HLTH NAT VAL STAT LI; Graham WJ, 2006, MATERNAL PERINATAL C, P499; Hammitt JK, 2007, REV ENV ECON POLICY, V1, P228, DOI 10.1093/reep/rem015; Hammitt JK, 2011, J BENEFIT-COST ANAL, V2, DOI 10.2202/2152-2812.1009; Hofmeyr GJ, 2004, INT J GYNECOL OBSTET, V85, pS62, DOI 10.1016/j.ijgo.2004.01.011; Islam MT, 2005, INT J GYNECOL OBSTET, V91, P298, DOI 10.1016/j.ijgo.2005.06.029; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P3, DOI 10.1596/978-0-8213-6179-5/Chpt-1; Jamison DT, 2008, CHALLENGE DIS; Jamisse L, 2004, INT J GYNECOL OBSTET, V85, P203, DOI 10.1016/j.ijgo.2004.01.005; Kayongo M, 2006, INT J GYNECOL OBSTET, V92, P308, DOI 10.1016/j.ijgo.2005.12.003; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Lerberghe WV, 2005, WORLD HLTH REPORT 20; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Maine D, 2007, LANCET, V370, P1380, DOI 10.1016/S0140-6736(07)61580-3; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; MATHERS CSC, GLOBAL BURDEN DIS 20; Melah G S, 2003, J Obstet Gynaecol, V23, P369, DOI 10.1080/01443610310001119510; Murray C.J, 1996, GLOBAL BURDEN DIS CO; Murray CJL, 1997, J HEALTH ECON, V16, P703, DOI 10.1016/S0167-6296(97)00004-0; NAVOT D, 1991, LANCET, V337, P1375, DOI 10.1016/0140-6736(91)93060-M; Neilson JP, 2003, BRIT MED BULL, V67, P191, DOI 10.1093/bmb/ldg018; Nyamtema AS, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-30; Paxton A, 2006, INT J GYNECOL OBSTET, V93, P300, DOI 10.1016/j.ijgo.2006.01.030; Pearson L, 2005, INT J GYNECOL OBSTET, V88, P208, DOI 10.1016/j.ijgo.2004.09.027; Pitt C, 2010, LANCET, V376, P1485, DOI 10.1016/S0140-6736(10)61302-5; Robinson LA, 2007, REV ENV ECON POLICY, V1, P283, DOI 10.1093/reep/rem018; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Sachs J., 2001, MACROECONOMICS HLTH; Shek KL, 2010, J UROLOGY, V184, P629, DOI 10.1016/j.juro.2010.03.135; Souza JP, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-71; United Nations Statistics Division, 2011, UN DAT WORLD INF; Viscusi WK, 2003, J RISK UNCERTAINTY, V27, P5, DOI 10.1023/A:1025598106257; Viscusi WK, 2006, QUANTIFYING VALUING, P1029; Wall LL, 2006, LANCET, V368, P1201, DOI 10.1016/S0140-6736(06)69476-2; Warf BC, 2011, J NEUROSURG-PEDIATR, V8, P509, DOI 10.3171/2011.8.PEDS11163; WHO, 2010, WOR HEALT REP, P1; WHO, 2010, TRENDS MAT MORT 1990; WHO, 2002, RED RISKS PROM HLTH; Wilhelmson K., 2006, IMPACT EC GROWTH INV; World Bank, 2011, WORLD BANK OP DAT	49	63	64	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e34595	10.1371/journal.pone.0034595	http://dx.doi.org/10.1371/journal.pone.0034595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558089	gold, Green Published			2022-12-25	WOS:000305345200009
J	Brown, WD; Muntz, GA; Ladowski, AJ				Brown, William D.; Muntz, Gregory A.; Ladowski, Alexander J.			Low Mate Encounter Rate Increases Male Risk Taking in a Sexually Cannibalistic Praying Mantis	PLOS ONE			English	Article							MATING-BEHAVIOR; COURTSHIP; SACRIFICE; SELECTION; STRATEGY	Male praying mantises are forced into the ultimate trade-off of mating versus complete loss of future reproduction if they fall prey to a female. The balance of this trade-off will depend both on (1) the level of predatory risk imposed by females and (2) the frequency of mating opportunities for males. We report the results of a set of experiments that examine the effects of these two variables on male risk-taking behavior and the frequency of sexual cannibalism in the praying mantis Tenodera sinensis. We experimentally altered the rate at which males encountered females and measured male approach and courtship behavior under conditions of high and low risk of being attacked by females. We show that male risk taking depends on prior access to females. Males with restricted access to females showed greater risk-taking behavior. When males were given daily female encounters, they responded to greater female-imposed risk by slowing their rate of approach and remained a greater distance from a potential mate. In contrast, males without recent access to mates were greater risk-takers; they approached females more rapidly and to closer proximity, regardless of risk. In a second experiment, we altered male encounter rate with females and measured rates of sexual cannibalism when paired with hungry or well-fed females. Greater risk-taking behavior by males with low mate encounter rates resulted in high rates of sexual cannibalism when these males were paired with hungry females.	[Brown, William D.; Muntz, Gregory A.; Ladowski, Alexander J.] SUNY Coll Fredonia, Dept Biol, Fredonia, NY 14063 USA	State University of New York (SUNY) System; SUNY Fredonia	Brown, WD (corresponding author), SUNY Coll Fredonia, Dept Biol, Fredonia, NY 14063 USA.	William.Brown@fredonia.edu	Brown, William/GXN-2777-2022		Holmberg Foundation; Department of Biology, SUNY Fredonia	Holmberg Foundation; Department of Biology, SUNY Fredonia	This work was supported by funding from the Holmberg Foundation to GAM and by the Department of Biology, SUNY Fredonia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MCB, 1996, SCIENCE, V271, P70, DOI 10.1126/science.271.5245.70; Andrade MCB, 2003, BEHAV ECOL, V14, P531, DOI 10.1093/beheco/arg015; Barry KL, 2008, BEHAV ECOL, V19, P710, DOI 10.1093/beheco/arm156; Barry KL, 2010, ANIM BEHAV, V80, P163, DOI 10.1016/j.anbehav.2010.04.020; Barry KL, 2010, ANIM BEHAV, V79, P1165, DOI 10.1016/j.anbehav.2010.02.025; Barry KL, 2009, J ETHOL, V27, P377, DOI 10.1007/s10164-008-0130-z; BIRKHEAD TR, 1988, BEHAVIOUR, V106, P112, DOI 10.1163/156853988X00115; BUSKIRK RE, 1984, AM NAT, V123, P612, DOI 10.1086/284227; CORRETTE BJ, 1990, J EXP BIOL, V148, P147; GOULD SJ, 1984, NAT HIST, V93, P10; Holwell GI, 2007, J ZOOL, V271, P255, DOI 10.1111/j.1469-7998.2006.00263.x; Hurd LE, 2004, J CHEM ECOL, V30, P155, DOI 10.1023/B:JOEC.0000013188.79411.18; HURD LE, 1994, OIKOS, V69, P193, DOI 10.2307/3546137; Jensen D, 2009, INVERTEBR SYST, V23, P409, DOI 10.1071/IS09004; KYNASTON SE, 1994, ANIM BEHAV, V47, P739, DOI 10.1006/anbe.1994.1103; Lelito JP, 2006, AM NAT, V168, P263, DOI 10.1086/505757; Lelito JP, 2008, BEHAV ECOL SOCIOBIOL, V63, P313, DOI 10.1007/s00265-008-0663-8; LISKE E, 1987, ANIM BEHAV, V35, P1524, DOI 10.1016/S0003-3472(87)80024-6; Maxwell MR, 2010, ANN ENTOMOL SOC AM, V103, P120, DOI 10.1603/008.103.0115; Maxwell MR, 1999, PRAYING MANTIDS, P69; Roeder KD, 1935, BIOL BULL-US, V69, P203, DOI 10.2307/1537420; West B. T., 2007, LINEAR MIXED MODELS	22	16	18	0	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35377	10.1371/journal.pone.0035377	http://dx.doi.org/10.1371/journal.pone.0035377			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558146	gold, Green Published, Green Submitted			2022-12-25	WOS:000305345200036
J	Flachner, B; Lorincz, Z; Carotti, A; Nicolotti, O; Kuchipudi, P; Remez, N; Sanz, F; Tovari, J; Szabo, MJ; Bertok, B; Cseh, S; Mestres, J; Dorma, G				Flachner, Beata; Loerincz, Zsolt; Carotti, Angelo; Nicolotti, Orazio; Kuchipudi, Praveena; Remez, Nikita; Sanz, Ferran; Tovari, Jozsef; Szabo, Miklos J.; Bertok, Bela; Cseh, Sandor; Mestres, Jordi; Dorma, Gyoergy			A Chemocentric Approach to the Identification of Cancer Targets	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; PROTEIN-COUPLED RECEPTORS; IN-SILICO PHARMACOLOGY; DRUG DISCOVERY; COLORECTAL-CANCER; COLON-CANCER; ACCESSIBLE DATABASE; THERAPY; EXPRESSION; FAMILY	A novel chemocentric approach to identifying cancer-relevant targets is introduced. Starting with a large chemical collection, the strategy uses the list of small molecule hits arising from a differential cytotoxicity screening on tumor HCT116 and normal MRC-5 cell lines to identify proteins associated with cancer emerging from a differential virtual target profiling of the most selective compounds detected in both cell lines. It is shown that this smart combination of differential in vitro and in silico screenings (DIVISS) is capable of detecting a list of proteins that are already well accepted cancer drug targets, while complementing it with additional proteins that, targeted selectively or in combination with others, could lead to synergistic benefits for cancer therapeutics. The complete list of 115 proteins identified as being hit uniquely by compounds showing selective antiproliferative effects for tumor cell lines is provided.	[Flachner, Beata; Loerincz, Zsolt; Cseh, Sandor; Dorma, Gyoergy] TargetEx, Dunakeszi, Hungary; [Carotti, Angelo; Nicolotti, Orazio] Univ Bari Aldo Moro, Dept Med Chem, Bari, Italy; [Kuchipudi, Praveena; Remez, Nikita; Sanz, Ferran; Mestres, Jordi] Univ Pompeu Fabra, Barcelona, Catalonia, Spain; [Kuchipudi, Praveena; Remez, Nikita; Sanz, Ferran; Mestres, Jordi] IMIM Hosp Mar Res Inst, Barcelona, Catalonia, Spain; [Tovari, Jozsef] Natl Inst Oncol, Budapest, Hungary; [Szabo, Miklos J.; Bertok, Bela] AMRI Hungary Zrt, Budapest, Hungary	Universita degli Studi di Bari Aldo Moro; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); National Institute of Oncology Hungary	Flachner, B (corresponding author), TargetEx, Dunakeszi, Hungary.	jmestres@imim.es; dorman@target-ex.com	Remez, Nikita/N-9804-2015; Mestres, Jordi/B-3673-2009; Sanz, Ferran/B-3852-2009; Gasull, Martina/J-4076-2019; Nicolotti, Orazio/F-3209-2012	Remez, Nikita/0000-0002-6033-7137; Mestres, Jordi/0000-0002-5202-4501; Sanz, Ferran/0000-0002-7534-7661; Dorman, Gyorgy/0000-0001-7702-2206; Nicolotti, Orazio/0000-0001-6533-5539	European Comission (CancerGrid) [FP-6 LCHC-CT-2006-037559]	European Comission (CancerGrid)	This work was supported by a grant from the European Comission (CancerGrid, FP-6 LCHC-CT-2006-037559), http://ec.europa.eu/research/fp6/index_en.cfm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Areias FM, 2010, BIOORGAN MED CHEM, V18, P3043, DOI 10.1016/j.bmc.2010.03.048; Baurin N, 2004, J CHEM INF COMP SCI, V44, P643, DOI 10.1021/ci034260m; Beck HC, 2010, ELECTROPHORESIS, V31, P2714, DOI 10.1002/elps.201000033; Benson ML, 2008, NUCLEIC ACIDS RES, V36, pD674, DOI 10.1093/nar/gkm911; Block P, 2006, NUCLEIC ACIDS RES, V34, pD522, DOI 10.1093/nar/gkj039; Caldwell JS, 2007, ADV CANCER RES, V96, P145, DOI 10.1016/S0065-230X(06)96006-0; Cases M, 2005, CURR TOP MED CHEM, V5, P763, DOI 10.2174/1568026054637665; Clark RD, 1997, J CHEM INF COMP SCI, V37, P1181, DOI 10.1021/ci970282v; Cleveland AG, 2009, CARCINOGENESIS, V30, P1581, DOI 10.1093/carcin/bgp132; D'Errico I, 2008, CELL MOL LIFE SCI, V65, P1523, DOI 10.1007/s00018-008-7552-1; de Bono JS, 2003, BREAST CANCER RES, V5, P154, DOI 10.1186/bcr597; Ekins S, 2007, BRIT J PHARMACOL, V152, P9, DOI 10.1038/sj.bjp.0707305; Furney SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn482; Gleeson MP, 2011, NAT REV DRUG DISCOV, V10, P197, DOI 10.1038/nrd3367; Gregori-Puigjane E, 2006, J CHEM INF MODEL, V46, P1615, DOI 10.1021/ci0600509; Gundem G, 2010, NAT METHODS, V7, P92, DOI 10.1038/nmeth0210-92; Harmar AJ, 2009, NUCLEIC ACIDS RES, V37, pD680, DOI 10.1093/nar/gkn728; Heijink DM, 2011, ONCOGENE, V30, P2026, DOI 10.1038/onc.2010.578; Heng HH, 2010, CURR DRUG TARGETS, V11, P1304; Iorns E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005120; Janakiram NB, 2009, CANCER PREV RES, V2, P52, DOI 10.1158/1940-6207.CAPR-08-0140; Jensen NH, 2008, COMB CHEM HIGH T SCR, V11, P420, DOI 10.2174/138620708784911483; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kamb A, 2007, NAT REV DRUG DISCOV, V6, P115, DOI 10.1038/nrd2155; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Khelwatty SA, 2011, INT J ONCOL, V39, P483, DOI 10.3892/ijo.2011.1054; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Le Tourneau C, 2008, CANCER TREAT REV, V34, P37, DOI 10.1016/j.ctrv.2007.09.003; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; Liu W, 2009, CURR OPIN DRUG DISC, V12, P98; Lou JR, 2006, CANCER EPIDEM BIOMAR, V15, P1598, DOI 10.1158/1055-9965.EPI-06-0216; Macarulla Teresa, 2009, Eur J Cancer, V45 Suppl 1, P79, DOI 10.1016/S0959-8049(09)70019-X; Manning BD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.263pe15; Marks PA, 2004, CELL CYCLE, V3, P534; Melnick JS, 2006, P NATL ACAD SCI USA, V103, P3153, DOI 10.1073/pnas.0511292103; Menashe I, 2010, CANCER RES, V70, P4453, DOI 10.1158/0008-5472.CAN-09-4502; Mestres J, 2011, CLIN PHARMACOL THER, V90, P662, DOI 10.1038/clpt.2011.177; Molnar L, 2006, BIOORG MED CHEM LETT, V16, P1037, DOI 10.1016/j.bmcl.2005.10.079; PAGE B, 1993, INT J ONCOL, V3, P473; Papp A, 2006, J CHEM INF MODEL, V46, P1898, DOI 10.1021/ci060074f; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; Poroikov VV, 2003, J CHEM INF COMP SCI, V43, P228, DOI 10.1021/ci020048r; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Slater K, 2001, CURR OPIN BIOTECH, V12, P70, DOI 10.1016/S0958-1669(00)00177-4; Slattery ML, 2006, INT J CANCER, V118, P3140, DOI 10.1002/ijc.21791; Vecchione L, 2011, EXP CELL RES, V317, P2765, DOI 10.1016/j.yexcr.2011.08.021; Vidal D, 2011, METHODS MOL BIOL, V672, P489, DOI 10.1007/978-1-60761-839-3_19; Vidal D, 2010, MOL INFORM, V29, P543, DOI 10.1002/minf.201000055; Wang YL, 2010, NUCLEIC ACIDS RES, V38, pD255, DOI 10.1093/nar/gkp965; Wehler TC, 2008, ONCOL REP, V19, P697; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Yde CW, 2009, ANTI-CANCER DRUG, V20, P723, DOI 10.1097/CAD.0b013e32832ec041	56	16	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35582	10.1371/journal.pone.0035582	http://dx.doi.org/10.1371/journal.pone.0035582			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558171	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345200050
J	Egami, Y; Araki, N				Egami, Youhei; Araki, Nobukazu			Rab20 Regulates Phagosome Maturation in RAW264 Macrophages during Fc Gamma Receptor-Mediated Phagocytosis	PLOS ONE			English	Article							PROTEINS; GTPASES; CELLS; MACROPINOCYTOSIS; LOCALIZATION; 3-KINASE; FUSION	Rab20, a member of the Rab GTPase family, is known to be involved in membrane trafficking, however its implication in Fc gamma R-mediated phagocytosis is unclear. We examined the spatiotemporal localization of Rab20 during phagocytosis of IgG-opsonized erythrocytes (IgG-Es) in RAW264 macrophages. By the live-cell imaging of fluorescent protein-fused Rab20, it was shown that Rab20 was transiently associated with the phagosomal membranes. During the early stage of phagosome formation, Rab20 was not localized on the membranes of phagocytic cups, but was gradually recruited to the newly formed phagosomes. Although Rab20 was colocalized with Rab5 to some extent, the association of Rab20 with the phagosomes persisted even after the loss of Rab5 from the phagosomal membranes. Then, Rab20 was colocalized with Rab7 and Lamp1, late endosomal/lysosomal markers, on the internalized phagosomes. Moreover, our analysis of Rab20 mutant expression revealed that the maturation of phagosomes was significantly delayed in cells expressing the GDP-bound mutant Rab20-T19N. These data suggest that Rab20 is an important component of phagosome and regulates the phagosome maturation during Fc gamma R-mediated phagocytosis.	[Egami, Youhei; Araki, Nobukazu] Kagawa Univ, Sch Med, Dept Histol & Cell Biol, Miki, Kagawa, Japan	Kagawa University	Egami, Y (corresponding author), Kagawa Univ, Sch Med, Dept Histol & Cell Biol, Miki, Kagawa, Japan.	naraki@med.kagawa-u.ac.jp		Araki, Nobukazu/0000-0001-6160-210X	Japan Society for the Promotion of Science [22790188, 23390039]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid for Young Scientists (B) #22790188 and partially by a Grant-in-Aid for Scientific Research (B) #23390039 from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amillet JM, 2006, HUM PATHOL, V37, P256, DOI 10.1016/j.humpath.2005.10.017; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Araki N, 2007, EXP CELL RES, V313, P1496, DOI 10.1016/j.yexcr.2007.02.012; Brighouse A, 2010, CELL MOL LIFE SCI, V67, P3449, DOI 10.1007/s00018-010-0436-1; Cardoso CMP, 2010, TRAFFIC, V11, P221, DOI 10.1111/j.1600-0854.2009.01013.x; Curtis Lisa M., 2005, Nephron Physiology, V100, P31; Das Sarma J, 2008, CELL COMMUN ADHES, V15, P65, DOI 10.1080/15419060802014305; Downey GP, 1999, J BIOL CHEM, V274, P28436, DOI 10.1074/jbc.274.40.28436; Egami Y, 2011, J CELL SCI; Egami Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006689; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Henry RM, 2004, J CELL BIOL, V164, P185, DOI 10.1083/jcb.200307080; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; LUTCKE A, 1994, J CELL SCI, V107, P3437; May RC, 2001, J CELL SCI, V114, P1061; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Rogers LD, 2007, P NATL ACAD SCI USA, V104, P18520, DOI 10.1073/pnas.0705801104; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; Seto S, 2011, TRAFFIC, V12, P407, DOI 10.1111/j.1600-0854.2011.01165.x; Smith AC, 2007, J CELL BIOL, V176, P263, DOI 10.1083/jcb.200611056; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stuart LM, 2007, NATURE, V445, P95, DOI 10.1038/nature05380; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Vieira OV, 2003, MOL CELL BIOL, V23, P2501, DOI 10.1128/MCB.23.7.2501-2514.2003; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	29	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35663	10.1371/journal.pone.0035663	http://dx.doi.org/10.1371/journal.pone.0035663			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545127	Green Submitted, gold, Green Published			2022-12-25	WOS:000305343200047
J	Padmanabhan, P; Dixit, NM				Padmanabhan, Pranesh; Dixit, Narendra M.			Viral Kinetics Suggests a Reconciliation of the Disparate Observations of the Modulation of Claudin-1 Expression on Cells Exposed to Hepatitis C Virus	PLOS ONE			English	Article							IN-VITRO; SUPERINFECTION EXCLUSION; ANTIVIRAL THERAPY; INFECTION; ENTRY; INTERFERON; CD81; ASSOCIATION; CORECEPTOR; ANTIBODIES	The tight junction protein claudin-1 (CLDN1) is necessary for hepatitis C virus (HCV) entry into target cells. Recent studies have made disparate observations of the modulation of the expression of CLDN1 on cells following infection by HCV. In one study, the mean CLDN1 expression on cells exposed to HCV declined, whereas in another study HCV infected cells showed increased CLDN1 expression compared to uninfected cells. Consequently, the role of HCV in modulating CLDN1 expression, and hence the frequency of cellular superinfection, remains unclear. Here, we present a possible reconciliation of these disparate observations. We hypothesized that viral kinetics and not necessarily HCV-induced receptor modulation underlies these disparate observations. To test this hypothesis, we constructed a mathematical model of viral kinetics in vitro that mimicked the above experiments. Model predictions provided good fits to the observed evolution of the distribution of CLDN1 expression on cells following exposure to HCV. Cells with higher CLDN1 expression were preferentially infected and outgrown by cells with lower CLDN1 expression, resulting in a decline of the mean CLDN1 expression with time. At the same time, because the susceptibility of cells to infection increased with CLDN1 expression, infected cells tended to have higher CLDN1 expression on average than uninfected cells. Our study thus presents an explanation of the disparate observations of CLDN1 expression following HCV infection and points to the importance of considering viral kinetics in future studies of receptor expression on cells exposed to HCV.	[Padmanabhan, Pranesh; Dixit, Narendra M.] Indian Inst Sci, Dept Chem Engn, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Padmanabhan, P (corresponding author), Indian Inst Sci, Dept Chem Engn, Bangalore 560012, Karnataka, India.	narendra@chemeng.iisc.ernet.in	Padmanabhan, Pranesh/AAQ-2286-2020	Padmanabhan, Pranesh/0000-0001-5569-8731	Department of Biotechnology Centre of Excellence for Research on Hepatitis C Virus, India	Department of Biotechnology Centre of Excellence for Research on Hepatitis C Virus, India	This work was supported by the Department of Biotechnology Centre of Excellence for Research on Hepatitis C Virus, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiwijaya BS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000745; Beauchemin CAA, 2008, J THEOR BIOL, V254, P439, DOI 10.1016/j.jtbi.2008.05.031; Brimacombe CL, 2011, J VIROL, V85, P596, DOI 10.1128/JVI.01592-10; Colombatto P, 2008, CLIN PHARMACOL THER, V84, P212, DOI 10.1038/clpt.2008.21; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P7270, DOI 10.1073/pnas.0402253101; Dahari H, 2007, HEPATOLOGY, V46, P16, DOI 10.1002/hep.21657; Dahari H, 2007, J VIROL, V81, P750, DOI 10.1128/JVI.01304-06; Dahari H, 2009, J VIROL, V83, P6383, DOI 10.1128/JVI.02612-08; DebRoy S, 2010, MATH BIOSCI, V225, P141, DOI 10.1016/j.mbs.2010.02.005; Dixit N. M., 2008, FUTURE HIV THER, V2, P375; Dixit NM, 2004, NATURE, V432, P922, DOI 10.1038/nature03153; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Farquhar MJ, 2012, J VIROL, V86, P4305, DOI 10.1128/JVI.06996-11; Fofana I, 2010, GASTROENTEROLOGY, V139, P953, DOI 10.1053/j.gastro.2010.05.073; Guedj J, 2011, HEPATOLOGY, V53, P1801, DOI 10.1002/hep.24272; Harris HJ, 2008, J VIROL, V82, P5007, DOI 10.1128/JVI.02286-07; Harris HJ, 2010, J BIOL CHEM, V285, P21092, DOI 10.1074/jbc.M110.104836; Herrmann E, 2003, HEPATOLOGY, V37, P1351, DOI 10.1053/jhep.2003.50218; Hsu CS, 2011, P NATL ACAD SCI USA, V108, P3719, DOI 10.1073/pnas.1100349108; Kannan RP, 2011, J VIROL, V85, P7989, DOI 10.1128/JVI.00280-11; KELLAM P, 1995, J VIROL, V69, P669, DOI 10.1128/JVI.69.2.669-674.1995; Krieger SE, 2010, HEPATOLOGY, V51, P1144, DOI 10.1002/hep.23445; Krishnan SM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001072; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Moutouh L, 1996, P NATL ACAD SCI USA, V93, P6106, DOI 10.1073/pnas.93.12.6106; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Padmanabhan P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002307; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Reynolds GM, 2008, HEPATOLOGY, V47, P418, DOI 10.1002/hep.22028; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; Rong L, 2010, CRIT REV IMMUNOL, V30, P131, DOI 10.1615/CritRevImmunol.v30.i2.30; Sabahi A, 2010, VIROLOGY, V407, P110, DOI 10.1016/j.virol.2010.07.026; Sainz B, 2006, J VIROL, V80, P10253, DOI 10.1128/JVI.01059-06; Sainz Jr. B, NAT MED, V18, P281; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schaller T, 2007, J VIROL, V81, P4591, DOI 10.1128/JVI.02144-06; Timpe JM, 2008, HEPATOLOGY, V47, P17, DOI 10.1002/hep.21959; Tscherne DM, 2007, J VIROL, V81, P3693, DOI 10.1128/JVI.01748-06; Walters KA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000269; Yu XM, 2009, ANTIMICROB AGENTS CH, V53, P4311, DOI 10.1128/AAC.00495-09; Zeisel MB, 2011, J HEPATOL, V54, P566, DOI 10.1016/j.jhep.2010.10.014; Zeuzem S, 2001, GASTROENTEROLOGY, V120, P1438, DOI 10.1053/gast.2001.24006; Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06	45	6	6	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e36107	10.1371/journal.pone.0036107	http://dx.doi.org/10.1371/journal.pone.0036107			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545157	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343200078
J	Purcell, J; Vasconcellos-Neto, J; Gonzaga, MO; Fletcher, JA; Aviles, L				Purcell, Jessica; Vasconcellos-Neto, Joao; Gonzaga, Marcelo O.; Fletcher, Jeffrey A.; Aviles, Leticia			Spatio-Temporal Differentiation and Sociality in Spiders	PLOS ONE			English	Article							ANELOSIMUS-JABAQUARA ARANEAE; PHYLOGENETIC ANALYSIS; LINYPHIID SPIDERS; EVOLUTION; SOLITARY; INSIGHTS; THERIDIIDAE; HYMENOPTERA; COMMUNITY; ANTS	Species that differ in their social system, and thus in traits such as group size and dispersal timing, may differ in their use of resources along spatial, temporal, or dietary dimensions. The role of sociality in creating differences in habitat use is best explored by studying closely related species or socially polymorphic species that differ in their social system, but share a common environment. Here we investigate whether five sympatric Anelosimus spider species that range from nearly solitary to highly social differ in their use of space and in their phenology as a function of their social system. By studying these species in Serra do Japi, Brazil, we find that the more social species, which form larger, longer-lived colonies, tend to live inside the forest, where sturdier, longer lasting vegetation is likely to offer better support for their nests. The less social species, which form single-family groups, in contrast, tend to occur on the forest edge where the vegetation is less robust. Within these two microhabitats, species with longer-lived colonies tend to occupy the potentially more stable positions closer to the core of the plants, while those with smaller and shorter-lived colonies build their nests towards the branch tips. The species further separate in their use of common habitat due to differences in the timing of their reproductive season. These patterns of habitat use suggest that the degree of sociality can enable otherwise similar species to differ from one another in ways that may facilitate their co-occurrence in a shared environment, a possibility that deserves further consideration.	[Purcell, Jessica; Fletcher, Jeffrey A.; Aviles, Leticia] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Purcell, Jessica] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Vasconcellos-Neto, Joao] Univ Estadual Campinas, Inst Biol, Dept Zool, Sao Paulo, Brazil; [Gonzaga, Marcelo O.] Univ Fed Uberlandia, Inst Biol, BR-38400 Uberlandia, MG, Brazil	University of British Columbia; University of Lausanne; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Federal de Uberlandia	Purcell, J (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.	Jessica.Purcell@unil.ch	Aviles, Leticia/AAL-8190-2020; Hymenoptera, Inct/I-2210-2013; Gonzaga, Marcelo O/A-4805-2013; Purcell, Jessica/A-2445-2013; Neto, João Vasconcellos/I-6258-2017	Gonzaga, Marcelo O/0000-0003-0093-1801; Purcell, Jessica/0000-0001-8568-4162; Neto, João Vasconcellos/0000-0001-9306-7594	Natural Sciences and Engineering Research Council of Canada Discovery Grant; Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico grant; INCT/HYMPAR-Sudeste grant; USA National Science Foundation Post-Doctoral fellowship; USA National Science Foundation (NSF) Graduate Research Fellowship; Swiss National Science Foundation [31003A-125306]	Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico grant; INCT/HYMPAR-Sudeste grant; USA National Science Foundation Post-Doctoral fellowship(National Science Foundation (NSF)); USA National Science Foundation (NSF) Graduate Research Fellowship(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This project was funded by a Natural Sciences and Engineering Research Council of Canada Discovery Grant to LA: http://www.nserc-crsng.gc.ca/; a Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico grant to JV: http://agencia.fapesp.br/25; a INCT/HYMPAR-Sudeste grant to MOG and JV: http://www.hympar.ufscar.br/. JF was supported by an USA National Science Foundation Post-Doctoral fellowship, and JP was supported by an USA National Science Foundation (NSF) Graduate Research Fellowship. http://www.nsf.gov/. JP was also supported by grant 31003A-125306 from the Swiss National Science Foundation: http://www.snf.ch/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2006, J NAT HIST, V40, P2681, DOI 10.1080/00222930601110752; Agnarsson I, 2006, ZOOL J LINN SOC-LOND, V146, P453, DOI 10.1111/j.1096-3642.2006.00213.x; Agnarsson I, 2005, ZOOL SCR, V34, P389, DOI 10.1111/j.1463-6409.2005.00189.x; Agnarsson I, 2007, MOL PHYLOGENET EVOL, V43, P833, DOI 10.1016/j.ympev.2006.09.011; Agnarsson I, 2006, EVOLUTION, V60, P2342; Anderson C, 2001, BIOL REV, V76, P211, DOI 10.1017/S1464793101005656; Aviles L, 2007, AM NAT, V170, P783, DOI 10.1086/521965; Aviles Leticia, 1997, P476; Campon FF, 2008, ANIM BEHAV, V75, P1063, DOI 10.1016/j.anbehav.2007.08.021; Chapman Thomas W., 2008, P57, DOI 10.1007/978-3-540-75957-7_3; Eickwort GC, 1996, BEHAV ECOL SOCIOBIOL, V38, P227, DOI 10.1007/s002650050236; Fernandez-Marin H, 2006, NATURWISSENSCHAFTEN, V93, P17, DOI 10.1007/s00114-005-0048-z; Fischer ML, 2005, J MED ENTOMOL, V42, P756, DOI 10.1603/0022-2585(2005)042[0756:MOBLIA]2.0.CO;2; Furey FE, 1998, ANIM BEHAV, V55, P727, DOI 10.1006/anbe.1997.0648; Gause G. F., 1934, STRUGGLE EXISTENCE; Gonzaga MD, 1999, J ARACHNOL, V27, P432; Gonzaga MO, 2001, INSECT SOC, V48, P94, DOI 10.1007/PL00001765; Guevara J, 2007, ECOLOGY, V88, P2015, DOI 10.1890/06-0995.1; Guevara J, 2011, BEHAV ECOL, V22, P630, DOI 10.1093/beheco/arr022; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Harwood JD, 2003, J ANIM ECOL, V72, P745, DOI 10.1046/j.1365-2656.2003.00746.x; Henschel JR, 1998, J ARACHNOL, V26, P61; Herberstein ME, 1998, ACTA OECOL, V19, P67, DOI 10.1016/S1146-609X(98)80009-X; JARVIS JUM, 1994, TRENDS ECOL EVOL, V9, P47, DOI 10.1016/0169-5347(94)90267-4; Jeanne R.L., 1991, P191; Jones TC, 2007, ANIM BEHAV, V73, P195, DOI 10.1016/j.anbehav.2006.06.006; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Krebs C. J., 1999, ECOLOGICAL METHODOLO; LeBrun EG, 2005, OECOLOGIA, V142, P643, DOI 10.1007/s00442-004-1763-4; LIN N, 1972, Q REV BIOL, V47, P131, DOI 10.1086/407216; Lubin Y, 2007, ADV STUD BEHAV, V37, P83, DOI 10.1016/S0065-3454(07)37003-4; Marques ESA, 1998, J ARACHNOL, V26, P227; Masuko K, 2010, ENTOMOL SCI, V13, P191, DOI 10.1111/j.1479-8298.2010.00383.x; Mitri S, 2011, P NATL ACAD SCI USA, V108, P10839, DOI 10.1073/pnas.1100292108; MORELLATO L P C, 1989, Revista Brasileira de Botanica, V12, P85; MORELLATO LPC, 1992, HIST NATURAL SERRA J, P112; Pike Nathan, 2008, P37, DOI 10.1007/978-3-540-75957-7_2; Pinto HS, 1992, HIST NATURAL SERRA J, P30; Plateaux-Quenu C, 2000, INSECT SOC, V47, P263, DOI 10.1007/PL00001713; Powers KS, 2007, J ANIM ECOL, V76, P995, DOI 10.1111/j.1365-2656.2007.01267.x; Purcell J, 2008, P ROY SOC B-BIOL SCI, V275, P2617, DOI 10.1098/rspb.2008.0582; Purcell J, 2007, J ANIM ECOL, V76, P590, DOI 10.1111/j.1365-2656.2007.01228.x; Purcell J, 2011, BIOL REV, V86, P475, DOI 10.1111/j.1469-185X.2010.00156.x; SAVOLAINEN R, 1988, OIKOS, V51, P135, DOI 10.2307/3565636; Schluter D, 1996, PHILOS T R SOC B, V351, P807, DOI 10.1098/rstb.1996.0075; Schwarz MP, 2007, ANNU REV ENTOMOL, V52, P127, DOI 10.1146/annurev.ento.51.110104.150950; Siepielski AM, 2010, ECOLOGY, V91, P3153, DOI 10.1890/10-0154.1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wcislo WT, 1997, TRENDS ECOL EVOL, V12, P468, DOI 10.1016/S0169-5347(97)01198-1; WCISLO WT, 1984, BEHAV ECOL SOCIOBIOL, V15, P157, DOI 10.1007/BF00299384; Wise DH, 1993, SPIDERS ECOLOGICAL W; Yip EC, 2008, P NATL ACAD SCI USA, V105, P11818, DOI 10.1073/pnas.0710603105; Zammit J, 2008, INSECT SOC, V55, P74, DOI 10.1007/s00040-007-0972-3	53	13	15	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e34592	10.1371/journal.pone.0034592	http://dx.doi.org/10.1371/journal.pone.0034592			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545086	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343200009
J	Belaguli, NS; Zhang, M; Garcia, AH; Berger, DH				Belaguli, Narasimhaswamy S.; Zhang, Mao; Garcia, Andres-Hernandez; Berger, David H.			PIAS1 Is a GATA4 SUMO Ligase That Regulates GATA4-Dependent Intestinal Promoters Independent of SUMO Ligase Activity and GATA4 Sumoylation	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-4; CARDIAC GENE-EXPRESSION; MOUSE SMALL-INTESTINE; BINDING PROTEIN GENE; MUTUAL COFACTORS; DIFFERENTIATION; REPRESSION; HNF-1-ALPHA; MAINTENANCE; ACTIVATE	GATA4 confers cell type-specific gene expression on genes expressed in cardiovascular, gastro-intestinal, endocrine and neuronal tissues by interacting with various ubiquitous and cell-type-restricted transcriptional regulators. By using yeast two-hybrid screening approach, we have identified PIAS1 as an intestine-expressed GATA4 interacting protein. The physical interaction between GATA4 and PIAS1 was confirmed in mammalian cells by coimmunoprecipitation and two-hybrid analysis. The interacting domains were mapped to the second zinc finger and the adjacent C-terminal basic region of GATA4 and the RING finger and the adjoining C-terminal 60 amino acids of PIAS1. PIAS1 and GATA4 synergistically activated IFABP and SI promoters but not LPH promoters suggesting that PIAS1 differentially activates GATA4 targeted promoters. In primary murine enterocytes PIAS1 was recruited to the GATA4-regulated IFABP promoter. PIAS1 promoted SUMO-1 modification of GATA4 on lysine 366. However, sumoylation was not required for the nuclear localization and stability of GATA4. Further, neither GATA4 sumoylation nor the SUMO ligase activity of PIAS1 was required for coactivation of IFABP promoter by GATA4 and PIAS1. Together, our results demonstrate that PIAS1 is a SUMO ligase for GATA4 that differentially regulates GATA4 transcriptional activity independent of SUMO ligase activity and GATA4 sumoylation.	[Belaguli, Narasimhaswamy S.; Zhang, Mao; Garcia, Andres-Hernandez; Berger, David H.] Baylor Coll Med, Michael E DeBakey Dept Surg, Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA	Baylor College of Medicine	Belaguli, NS (corresponding author), Baylor Coll Med, Michael E DeBakey Dept Surg, Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA.	elaguli@bcm.edu; dhb@bcm.edu	HERNANDEZ-GARCIA, ANDRES/B-9051-2014; HERNANDEZ-GARCIA, ANDRES/B-6346-2008	HERNANDEZ-GARCIA, ANDRES/0000-0002-5343-5513; 	Veterans Affairs	Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Veterans Affairs Merit Review Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri S, 2009, ONCOGENE, V28, P3033, DOI 10.1038/onc.2009.159; Agnihotri S, 2011, J EXP MED, V208, P689, DOI 10.1084/jem.20102099; Battle MA, 2008, GASTROENTEROLOGY, V135, P1676, DOI 10.1053/j.gastro.2008.07.074; Belaguli NS, 2007, AM J PHYSIOL-GASTR L, V292, pG1520, DOI 10.1152/ajpgi.00236.2006; Belaguli NS, 2010, NEOPLASIA, V12, P856, DOI 10.1593/neo.10224; Belaguli NS, 2000, MOL CELL BIOL, V20, P7550, DOI 10.1128/MCB.20.20.7550-7558.2000; Benoit YD, 2010, AM J PHYSIOL-GASTR L, V298, pG504, DOI 10.1152/ajpgi.00265.2009; Beuling E, 2008, DEV BIOL, V322, P179, DOI 10.1016/j.ydbio.2008.07.022; Beuling E, 2011, GASTROENTEROLOGY, V140, P1219, DOI 10.1053/j.gastro.2011.01.033; Bosse T, 2006, MOL CELL BIOL, V26, P9060, DOI 10.1128/MCB.00124-06; Boudreau F, 2002, J BIOL CHEM, V277, P31909, DOI 10.1074/jbc.M204622200; Brown CO, 2004, J BIOL CHEM, V279, P10659, DOI 10.1074/jbc.M301648200; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; Dai YS, 2002, J BIOL CHEM, V277, P24390, DOI 10.1074/jbc.M202490200; Demarque MD, 2011, GASTROENTEROLOGY, V140, P286, DOI 10.1053/j.gastro.2010.10.002; Divine JK, 2004, AM J PHYSIOL-GASTR L, V287, pG1086, DOI 10.1152/ajpgi.00421.2003; Divine JK, 2006, AM J PHYSIOL-GASTR L, V291, pG297, DOI 10.1152/ajpgi.00422.2003; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Escaffit F, 2005, J CELL PHYSIOL, V203, P15, DOI 10.1002/jcp.20189; Fang RX, 2006, GENE EXPR PATTERNS, V6, P426, DOI 10.1016/j.modgep.2005.09.003; Fang RX, 2001, AM J PHYSIOL-GASTR L, V280, pG58, DOI 10.1152/ajpgi.2001.280.1.G58; Fluck CE, 2004, MOL ENDOCRINOL, V18, P1144, DOI 10.1210/me.2003-0342; Gao XP, 1998, MOL CELL BIOL, V18, P2901, DOI 10.1128/MCB.18.5.2901; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Guo J, 2009, J BIOL CHEM, V284, P134, DOI 10.1074/jbc.M806133200; Holmstrom S, 2003, P NATL ACAD SCI USA, V100, P15758, DOI 10.1073/pnas.2136933100; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Komatsu T, 2004, MOL ENDOCRINOL, V18, P2451, DOI 10.1210/me.2004-0173; Krasinski SD, 2001, AM J PHYSIOL-GASTR L, V281, pG69, DOI 10.1152/ajpgi.2001.281.1.G69; Liang QR, 2001, MOL CELL BIOL, V21, P7460, DOI 10.1128/MCB.21.21.7460-7469.2001; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Peterkin T, 2005, SEMIN CELL DEV BIOL, V16, P83, DOI 10.1016/j.semcdb.2004.10.003; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Snow JW, 2010, J BIOL CHEM, V285, P28064, DOI 10.1074/jbc.M109.096909; Stielow B, 2008, MOL CELL, V29, P742, DOI 10.1016/j.molcel.2007.12.032; Suda N, 2011, ENDOCRINOLOGY, V152, P2266, DOI 10.1210/en.2010-1232; Sumi K, 2007, MOL CELL BIOL, V27, P4248, DOI 10.1128/MCB.01894-06; Svensson EC, 1999, P NATL ACAD SCI USA, V96, P956, DOI 10.1073/pnas.96.3.956; Takahashi H, 2005, J BIOL CHEM, V280, P5611, DOI 10.1074/jbc.M408130200; Takaya T, 2008, J BIOL CHEM, V283, P9828, DOI 10.1074/jbc.M707391200; Tan JA, 2002, J BIOL CHEM, V277, P16993, DOI 10.1074/jbc.M109217200; Tremblay JJ, 1999, MOL ENDOCRINOL, V13, P1388, DOI 10.1210/me.13.8.1388; Tremblay JJ, 2003, J BIOL CHEM, V278, P22128, DOI 10.1074/jbc.M213149200; Trivedi CM, 2010, DEV CELL, V19, P450, DOI 10.1016/j.devcel.2010.08.012; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Valin A, 2007, BIOCHEM SOC T, V35, P1393, DOI 10.1042/BST0351393; van Wering HM, 2004, AM J PHYSIOL-GASTR L, V287, pG899, DOI 10.1152/ajpgi.00150.2004; Viger RS, 2008, MOL ENDOCRINOL, V22, P781, DOI 10.1210/me.2007-0513; Wang J, 2005, MOL CELL BIOL, V25, P9829, DOI 10.1128/MCB.25.22.9829-9844.2005; Wang J, 2004, J BIOL CHEM, V279, P49091, DOI 10.1074/jbc.M407494200; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7	56	9	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35717	10.1371/journal.pone.0035717	http://dx.doi.org/10.1371/journal.pone.0035717			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539995	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341000061
J	Bethge, A; Schumacher, U; Wree, A; Wedemann, G				Bethge, Anja; Schumacher, Udo; Wree, Andreas; Wedemann, Gero			Are Metastases from Metastases Clinical Relevant? Computer Modelling of Cancer Spread in a Case of Hepatocellular Carcinoma	PLOS ONE			English	Article							BREAST-CANCER; PRIMARY TUMORS; CELLS; SURVIVAL; GROWTH; PERSPECTIVES; PROGNOSIS; PATTERNS	Background: Metastasis formation remains an enigmatic process and one of the main questions recently asked is whether metastases are able to generate further metastases. Different models have been proposed to answer this question; however, their clinical significance remains unclear. Therefore a computer model was developed that permits comparison of the different models quantitatively with clinical data and that additionally predicts the outcome of treatment interventions. Methods: The computer model is based on discrete events simulation approach. On the basis of a case from an untreated patient with hepatocellular carcinoma and its multiple metastases in the liver, it was evaluated whether metastases are able to metastasise and in particular if late disseminated tumour cells are still capable to form metastases. Additionally, the resection of the primary tumour was simulated. The simulation results were compared with clinical data. Results: The simulation results reveal that the number of metastases varies significantly between scenarios where metastases metastasise and scenarios where they do not. In contrast, the total tumour mass is nearly unaffected by the two different modes of metastasis formation. Furthermore, the results provide evidence that metastasis formation is an early event and that late disseminated tumour cells are still capable of forming metastases. Simulations also allow estimating how the resection of the primary tumour delays the patient's death. Conclusion: The simulation results indicate that for this particular case of a hepatocellular carcinoma late metastases, i.e., metastases from metastases, are irrelevant in terms of total tumour mass. Hence metastases seeded from metastases are clinically irrelevant in our model system. Only the first metastases seeded from the primary tumour contribute significantly to the tumour burden and thus cause the patient's death.	[Bethge, Anja; Wedemann, Gero] Univ Appl Sci Stralsund, Inst Appl Comp Sci, Competence Ctr Bioinformat, Stralsund, Germany; [Schumacher, Udo] Univ Med Ctr Hamburg Eppendorf, Inst Anat & Expt Morphol, Hamburg, Germany; [Wree, Andreas] Univ Rostock, Inst Anat, Rostock, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Rostock	Bethge, A (corresponding author), Univ Appl Sci Stralsund, Inst Appl Comp Sci, Competence Ctr Bioinformat, Stralsund, Germany.	gero.wedemann@fh-stralsund.de	Wedemann, Gero/A-6384-2009	Wedemann, Gero/0000-0001-7869-774X	Institute for Applied Computer Science, University of Applied Sciences Stralsund	Institute for Applied Computer Science, University of Applied Sciences Stralsund	The work was funded by the Institute for Applied Computer Science, University of Applied Sciences Stralsund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ARA, 2008, NAT REV CANCER, V8, P227, DOI 10.1038/nrc2329; Barbolosi D, 2009, MATH BIOSCI, V218, P1, DOI 10.1016/j.mbs.2008.11.008; Bernhardt P, 2003, MED PHYS, V30, P3227, DOI 10.1118/1.1628851; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chen LL, 2008, PHYSICA A, V387, P3162, DOI 10.1016/j.physa.2008.01.116; Cormio G, 2003, INT J GYNECOL CANCER, V13, P125, DOI 10.1046/j.1525-1438.2003.13054.x; Engel J, 2010, EUR UROL, V57, P754, DOI 10.1016/j.eururo.2009.12.034; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Greten TF, 2005, BRIT J CANCER, V92, P1862, DOI 10.1038/sj.bjc.6602590; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Huang Sui, 2006, Breast Dis, V26, P27; Iwasaki H, 2009, CANCER SCI, V100, P1166, DOI 10.1111/j.1349-7006.2009.01177.x; Iwata K, 2000, J THEOR BIOL, V203, P177, DOI 10.1006/jtbi.2000.1075; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kesmodel SB, 2006, SURG REV INTEGRATED, P61; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Koch G, 2009, J PHARMACOKINET PHAR, V36, P179, DOI 10.1007/s10928-009-9117-9; Meng SD, 2004, CLIN CANCER RES, V10, P8152, DOI 10.1158/1078-0432.CCR-04-1110; Michaelson JS, 2009, CANCER-AM CANCER SOC, V115, P5095, DOI 10.1002/cncr.24592; Monteiro J, 2010, EUR J CANCER, V46, P1198, DOI 10.1016/j.ejca.2010.02.030; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; OKUDA K, 1985, CANCER, V56, P918, DOI 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E; PAGET S, 1989, CANCER METAST REV, V8, P98; PATANAPHAN V, 1988, SOUTHERN MED J, V81, P1109, DOI 10.1097/00007611-198809000-00011; Pavelic SK, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-22; Pons Fernando, 2005, HPB (Oxford), V7, P35, DOI 10.1080/13651820410024058; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Sinek JP, 2009, J MATH BIOL, V58, P485, DOI 10.1007/s00285-008-0214-y; Stoecklein NH, 2010, INT J CANCER, V126, P589, DOI 10.1002/ijc.24916; Stuart KE, 1996, CANCER, V77, P2217, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2217::AID-CNCR6>3.0.CO;2-M; Wedemann G, METHODS MOL IN PRESS; Weinberg RA, 2006, BIOL CANC	33	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35689	10.1371/journal.pone.0035689	http://dx.doi.org/10.1371/journal.pone.0035689			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539992	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341000058
J	Ling, HY; Edwards, AM; Gantier, MP; DeBoer, KD; Neale, AD; Hamill, JD; Walmsley, AM				Ling, Huai-Yian; Edwards, Aaron M.; Gantier, Michael P.; DeBoer, Kathleen D.; Neale, Alan D.; Hamill, John D.; Walmsley, Amanda M.			An Interspecific Nicotiana Hybrid as a Useful and Cost-Effective Platform for Production of Animal Vaccines	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; PLANT-MADE VACCINES; IMMUNE-RESPONSE; TRANSIENT EXPRESSION; PROTECTIVE IMMUNITY; CHALLENGE INFECTION; PANDEMIC INFLUENZA; INNATE IMMUNITY; TABACUM L.; TOBACCO	The use of transgenic plants to produce novel products has great biotechnological potential as the relatively inexpensive inputs of light, water, and nutrients are utilised in return for potentially valuable bioactive metabolites, diagnostic proteins and vaccines. Extensive research is ongoing in this area internationally with the aim of producing plant-made vaccines of importance for both animals and humans. Vaccine purification is generally regarded as being integral to the preparation of safe and effective vaccines for use in humans. However, the use of crude plant extracts for animal immunisation may enable plant-made vaccines to become a cost-effective and efficacious approach to safely immunise large numbers of farm animals against diseases such as avian influenza. Since the technology associated with genetic transformation and large-scale propagation is very well established in Nicotiana, the genus has attributes well-suited for the production of plant-made vaccines. However the presence of potentially toxic alkaloids in Nicotiana extracts impedes their use as crude vaccine preparations. In the current study we describe a Nicotiana tabacum and N. glauca hybrid that expresses the HA glycoprotein of influenza A in its leaves but does not synthesize alkaloids. We demonstrate that injection with crude leaf extracts from these interspecific hybrid plants is a safe and effective approach for immunising mice. Moreover, this antigen-producing alkaloid-free, transgenic interspecific hybrid is vigorous, with a high capacity for vegetative shoot regeneration after harvesting. These plants are easily propagated by vegetative cuttings and have the added benefit of not producing viable pollen, thus reducing potential problems associated with bio-containment. Hence, these Nicotiana hybrids provide an advantageous production platform for partially purified, plant-made vaccines which may be particularly well suited for use in veterinary immunization programs.	[Ling, Huai-Yian; Edwards, Aaron M.; Neale, Alan D.; Walmsley, Amanda M.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia; [Gantier, Michael P.] Ctr Canc Res, Monash Inst Med Res, Melbourne, Vic, Australia; [DeBoer, Kathleen D.] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic 3004, Australia; [Hamill, John D.] Univ Melbourne, Dept Forest & Ecosyst Sci, Creswick, Vic, Australia	Monash University; Monash University; University of Melbourne	Ling, HY (corresponding author), Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia.	john.hamill@unimelb.edu.au; Amanda.Walmsley@monash.edu.au	Gantier, Michael/B-7512-2011; Gantier, Michael/H-7954-2019	Gantier, Michael/0000-0003-3740-698X; Gantier, Michael/0000-0003-3740-698X	Australian Research Council; Faculty of Science from Monash University; Dow AgroScience, LLC	Australian Research Council(Australian Research Council); Faculty of Science from Monash University; Dow AgroScience, LLC	H-YL received an International Post Graduate Award from the Australian Research Council and scholarship fees and a Faculty of Science Postgraduate Publication Award from Monash University. This research was supported by a Linkage Grant from the Australian Research Council and Dow AgroScience, LLC to JDH and AMW. www.monash.edu.au, www.arc.gov.au/, www.dowagro.com/au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: This research was supported by a linkage grant from the Australina Research Council and Dow AgroScience LLC. The constructs and antibody reagents were obtained from Dow AgroScience LLC under a material transfer agreement. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Allen GC, 2006, NAT PROTOC, V1, P2320, DOI 10.1038/nprot.2006.384; BALDWIN IT, 1989, J CHEM ECOL, V15, P1661, DOI 10.1007/BF01012392; Beclin C, 2002, CURR BIOL, V12, P684, DOI 10.1016/S0960-9822(02)00792-3; Boyce TG, 2000, BIOMED PHARMACOTHER, V54, P210, DOI 10.1016/S0753-3322(00)89027-7; Cane KA, 2005, FUNCT PLANT BIOL, V32, P305, DOI 10.1071/FP04008; CHAPLIN JF, 1975, CROP SCI, V15, P282, DOI 10.2135/cropsci1975.0011183X001500020048x; Chen J, 2007, AM J PHYSIOL-GASTR L, V293, pG568, DOI 10.1152/ajpgi.00201.2007; Chintapakorn Y, 2003, PLANT MOL BIOL, V53, P87, DOI 10.1023/B:PLAN.0000009268.45851.95; Collins GB, 1979, NICOTIANA PROCEDURES; D'Aoust MA, 2008, PLANT BIOTECHNOL J, V6, P930, DOI 10.1111/j.1467-7652.2008.00384.x; D'Aoust MA, 2010, PLANT BIOTECHNOL J, V8, P607, DOI 10.1111/j.1467-7652.2009.00496.x; DeBoer K.D., 2010, THESIS MONASH U MELB; DeBoer KD, 2009, PLANT MOL BIOL, V69, P299, DOI 10.1007/s11103-008-9425-2; Driscoll P, 1972, SOZIAL PRAVENTIVMEDI, V17, P211; Gantier MP, 2010, MONITORING INNATE IM, P21; Gleba Y, 2007, CURR OPIN BIOTECH, V18, P134, DOI 10.1016/j.copbio.2007.03.002; HAMILL JD, 1985, THEOR APPL GENET, V71, P486, DOI 10.1007/BF00251193; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; Huber VC, 2006, CLIN VACCINE IMMUNOL, V13, P981, DOI 10.1128/CVI.00156-06; Janssens S, 2003, CLIN MICROBIOL REV, V16, P637, DOI 10.1128/CMR.16.4.637-646.2003; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kilbourne ED, 2004, VIRAL IMMUNOL, V17, P350, DOI 10.1089/0882824041857076; Kirk DD, 2004, EXPERT OPIN BIOL TH, V4, P947, DOI 10.1517/14712598.4.6.947; Lee ST, 2006, NEUROTOXICOL TERATOL, V28, P220, DOI 10.1016/j.ntt.2005.12.010; Ling HY, 2010, EXPERT REV VACCINES, V9, P971, DOI [10.1586/erv.10.87, 10.1586/ERV.10.87]; Marillonnet S, 2005, NAT BIOTECHNOL, V23, P718, DOI 10.1038/nbt1094; Marillonnet S, 2004, P NATL ACAD SCI USA, V101, P6852, DOI 10.1073/pnas.0400149101; MASON HS, 1992, P NATL ACAD SCI USA, V89, P11745, DOI 10.1073/pnas.89.24.11745; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Menassa R, 2001, MOL BREEDING, V8, P177, DOI 10.1023/A:1013376407362; Menassa R, 2007, PLANT BIOTECHNOL J, V5, P50, DOI 10.1111/j.1467-7652.2006.00214.x; Mett V, 2008, INFLUENZA OTHER RESP, V2, P33, DOI 10.1111/j.1750-2659.2008.00037.x; Musiychuk K, 2007, INFLUENZA OTHER RESP, V1, P19, DOI 10.1111/j.1750-2659.2006.00005.x; NI M, 1995, PLANT J, V7, P661, DOI 10.1046/j.1365-313X.1995.7040661.x; Noah DL, 2009, CLIN VACCINE IMMUNOL, V16, P558, DOI 10.1128/CVI.00368-08; OKAMOTO M, 1994, PHARMACOL TOXICOL, V75, P1, DOI 10.1111/j.1600-0773.1994.tb00316.x; Pelosi A, 2011, CURR DRUG DELIV, V8, P612, DOI 10.2174/156720111797635513; PENTAL D, 1984, HEREDITY, V53, P79, DOI 10.1038/hdy.1984.64; Rigano MM, 2009, VACCINE, V27, P3463, DOI 10.1016/j.vaccine.2009.01.120; Rivera E, 2003, VACCINE, V21, P1149, DOI 10.1016/S0264-410X(02)00518-2; SAITOH F, 1985, PHYTOCHEMISTRY, V24, P477, DOI 10.1016/S0031-9422(00)80751-7; Sambrook J, 2001, MOL CLONING LAB MANU; SAUNDERS JW, 1979, PLANT PHYSIOL, V64, P236, DOI 10.1104/pp.64.2.236; SCHLUPMANN H, 1993, PLANTA, V191, P470, DOI 10.1007/BF00195748; Shoji T, 2010, PLANT CELL, V22, P3390, DOI 10.1105/tpc.110.078543; Shoji Y, 2009, VACCINE, V27, P1087, DOI 10.1016/j.vaccine.2008.11.108; Shoji Y, 2008, VACCINE, V26, P2930, DOI 10.1016/j.vaccine.2008.03.045; Shoji Y, 2009, VACCINE, V27, P3467, DOI 10.1016/j.vaccine.2009.01.051; Sinclair SJ, 2004, FUNCT PLANT BIOL, V31, P721, DOI 10.1071/FP03242; Sinclair SJ, 2000, PLANT MOL BIOL, V44, P603, DOI 10.1023/A:1026590521318; SISSON VA, 1990, BEITR TABAKFORSCH, V14, P327, DOI 10.2478/cttr-2013-0610; Song XM, 2009, VACCINE, V27, P51, DOI 10.1016/j.vaccine.2008.10.030; Soulet D, 2003, J CELL BIOL, V162, P257, DOI 10.1083/jcb.200301097; Spitsin S, 2009, VACCINE, V27, P1289, DOI 10.1016/j.vaccine.2008.12.050; Stanekova Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-351; Steppuhn A, 2004, PLOS BIOL, V2, P1074, DOI 10.1371/journal.pbio.0020217; Tremblay R, 2010, BIOTECHNOL ADV, V28, P214, DOI 10.1016/j.biotechadv.2009.11.008; Trojak-Goluch A, 2007, PLANT BREEDING, V126, P201, DOI 10.1111/j.1439-0523.2007.01341.x; Trojak-Goluch A, 2003, J APPL GENET, V44, P45; Vermij P, 2006, NAT BIOTECHNOL, V24, P1301, DOI 10.1038/nbt1106-1301; Walmsley AM, 2000, CURR OPIN BIOTECH, V11, P126, DOI 10.1016/S0958-1669(00)00070-7; Walmsley AM, 2003, CURR OPIN BIOTECH, V14, P145, DOI 10.1016/S0958-1669(03)00026-0; Zimmermann S, 1998, J IMMUNOL, V160, P3627	64	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35688	10.1371/journal.pone.0035688	http://dx.doi.org/10.1371/journal.pone.0035688			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539991	Green Published, gold			2022-12-25	WOS:000305341000057
J	Pfeuty, B				Pfeuty, Benjamin			Strategic Cell-Cycle Regulatory Features That Provide Mammalian Cells with Tunable G1 Length and Reversible G1 Arrest	PLOS ONE			English	Article							RESTRICTION POINT; CDK INHIBITORS; G(1) PHASE; FATE DETERMINATION; DEPENDENT KINASES; SENESCENCE; PROTEIN; PROGRESSION; ROLES; P53	Transitions between consecutive phases of the eukaryotic cell cycle are driven by the catalytic activity of selected sets of cyclin-dependent kinases (Cdks). Yet, their occurrence and precise timing is tightly scheduled by a variety of means including Cdk association with inhibitory/adaptor proteins (CKIs). Here we focus on the regulation of G1-phase duration by the end of which cells of multicelled organisms must decide whether to enter S phase or halt, and eventually then, differentiate, senesce or die to obey the homeostatic rules of their host. In mammalian cells, entry in and progression through G1 phase involve sequential phosphorylation and inactivation of the retinoblastoma Rb proteins, first, by cyclin D-Cdk4,6 with the help of CKIs of the Cip/Kip family and, next, by the cyclin E-Cdk2 complexes that are negatively regulated by Cip/Kip proteins. Using a dynamical modeling approach, we show that the very way how the Rb and Cip/Kip regulatory modules interact differentially with cyclin D-Cdk4,6 and cyclin E-Cdk2 provides to mammalian cells a powerful means to achieve an exquisitely-sensitive control of G1-phase duration and fully reversible G1 arrests. Consistently, corruption of either one of these two modules precludes G1 phase elongation and is able to convert G1 arrests from reversible to irreversible. This study unveils fundamental design principles of mammalian G1-phase regulation that are likely to confer to mammalian cells the ability to faithfully control the occurrence and timing of their division process in various conditions.	Univ Lille 1 Sci & Technol, Lab Phys Lasers Atomes & Mol, CNRS, UMR8523, Villeneuve, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Lille - ISITE; Universite de Lille	Pfeuty, B (corresponding author), Univ Lille 1 Sci & Technol, Lab Phys Lasers Atomes & Mol, CNRS, UMR8523, Villeneuve, France.	benjamin.pfeuty@univ-lille1.fr	pfeuty, benjamin/R-6825-2018		Ministry of Higher Education and Research; Nord-Pas de Calais Regional Council; FEDER (European fund for regional development) through the Contrat de Projets Etat-Region (CPER)	Ministry of Higher Education and Research(Ministry of Higher Education & Scientific Research (MHESR)); Nord-Pas de Calais Regional Council(Region Hauts-de-France); FEDER (European fund for regional development) through the Contrat de Projets Etat-Region (CPER)	This work was supported by Ministry of Higher Education and Research, Nord-Pas de Calais Regional Council and FEDER (European fund for regional development) through the Contrat de Projets Etat-Region (CPER). 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afraimovich VS, 2008, PLOS COMPUT BIOL, V4, P05; Aguda BD, 2003, CELL CYCLE, V2, P538, DOI 10.4161/cc.2.6.550; Aguda BD, 1999, CELL PROLIFERAT, V32, P321, DOI 10.1046/j.1365-2184.1999.3250321.x; Baghdassarian N, 1999, BLOOD, V36, P689; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Blagosklonny MV, 2003, EMBO REP, V4, P358, DOI 10.1038/sj.embor.embor806; Blain SW, 2008, CELL CYCLE, V7, P892, DOI 10.4161/cc.7.7.5637; Blomen VA, 2007, CELL MOL LIFE SCI, V64, P3084, DOI 10.1007/s00018-007-7271-z; Busse D, 2000, J BIOL CHEM, V275, P6987, DOI 10.1074/jbc.275.10.6987; CAVANAUGH AH, 1995, NATURE, V374, P177, DOI 10.1038/374177a0; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Coverley D, 2002, NAT CELL BIOL, V4, P523, DOI 10.1038/ncb813; Csikasz-Nagy A, 2006, BIOPHYS J, V90, P4361, DOI 10.1529/biophysj.106.081240; David-Pfeuty T, 2006, BBA-REV CANCER, V1765, P38, DOI 10.1016/j.bbcan.2005.08.008; David-Pfeuty T, 2001, ONCOGENE, V20, P5951, DOI 10.1038/sj.onc.1204741; Escote X, 2004, NAT CELL BIOL, V6, P997, DOI 10.1038/ncb1174; Ezhevsky SA, 2001, MOL CELL BIOL, V21, P4773, DOI 10.1128/MCB.21.14.4773-4784.2001; Fuse T, 1996, BIOCHEM BIOPH RES CO, V225, P759, DOI 10.1006/bbrc.1996.1247; Gerard C, 2009, P NATL ACAD SCI USA, V106, P21643, DOI 10.1073/pnas.0903827106; Gros C, 2009, COGN COMPUT, V1, P77, DOI 10.1007/s12559-008-9000-9; Guantes R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000235; Guckenheimer J, 2013, APPL MATH SCI, V42; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; HARPER JW, 1993, CELL, V75, P805; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46; HOFFMAN BD, 1991, CYTOMETRY, V12, P26, DOI 10.1002/cyto.990120105; Izhikevich M, 2006, DYNAMICAL SYSTEMS NE; James MK, 2008, MOL CELL BIOL, V28, P498, DOI 10.1128/MCB.02171-06; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Khan SH, 2008, CANCER RES, V58, P396; Kuchina A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002273; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; Lange C, 2010, CELL CYCLE, V9, P1893, DOI 10.4161/cc.9.10.11598; Lefresne J, 1998, DEV GROWTH DIFFER, V40, P497; Linke SP, 1996, GENE DEV, V10, P934, DOI 10.1101/gad.10.8.934; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; MCKINNEY JD, 1995, MOL CELL BIOL, V15, P2509; Mitsuhashi T, 2001, P NATL ACAD SCI USA, V98, P6435, DOI 10.1073/pnas.111051398; Novak M, 2004, J THEOR BIOL, V230, P563, DOI 10.1016/j.jtbi.2004.04.039; OUHIBI N, 1994, INT J DEV BIOL, V38, P731; Pajalunga D, 2007, J CELL BIOL, V176, P807, DOI 10.1083/jcb.200608109; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; Pfeuty B, 2008, CELL CYCLE, V7, P3246, DOI 10.4161/cc.7.20.6853; Pfeuty B, 2007, PHYS BIOL, V4, P194, DOI 10.1088/1478-3975/4/3/006; Pfeuty B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002329; Salomoni P, 2010, TRENDS CELL BIOL, V20, P233, DOI 10.1016/j.tcb.2010.01.006; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; STEINMAN RA, 1994, ONCOGENE, V9, P3389; Swat M, 2004, BIOINFORMATICS, V20, P1506, DOI 10.1093/bioinformatics/bth110; Toettcher JE, 2009, P NATL ACAD SCI USA, V106, P785, DOI 10.1073/pnas.0806196106; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Tyson JJ, 2002, BIOESSAYS, V24, P1095, DOI 10.1002/bies.10191; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Yao G, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.19; Zhang HS, 2001, ONCOGENE, V20, P3134, DOI 10.1038/sj.onc.1204338; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	61	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35291	10.1371/journal.pone.0035291	http://dx.doi.org/10.1371/journal.pone.0035291			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22558136	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341000030
J	Liu, YC; Lin, IH; Chung, WJ; Hu, WS; Ng, WV; Lu, CY; Huang, TY; Shu, HW; Hsiao, KJ; Tsai, SF; Chang, CH; Lin, CH				Liu, Yi-Chang; Lin, I-Hsuan; Chung, Wei-Jen; Hu, Wensi S.; Ng, Wailap Victor; Lu, Chi-Yu; Huang, Tsung-Yen; Shu, Hung-Wei; Hsiao, Kwang-Jen; Tsai, Shih-Feng; Chang, Chuan-Hsiung; Lin, Chao-Hsiung			Proteomics Characterization of Cytoplasmic and Lipid-Associated Membrane Proteins of Human Pathogen Mycoplasma fermentans M64	PLOS ONE			English	Article							FREQUENCY PHASE VARIATION; TOLL-LIKE RECEPTORS; NF-KAPPA-B; SURFACE LIPOPROTEIN; 2-DIMENSIONAL ELECTROPHORESIS; PHYLOGENETIC ANALYSIS; COMPLETE GENOME; PNEUMONIAE; CELL; IDENTIFICATION	Mycoplasma fermentans is a potent human pathogen which has been implicated in several diseases. Notably, its lipid-associated membrane proteins (LAMPs) play a role in immunomodulation and development of infection-associated inflammatory diseases. However, the systematic protein identification of pathogenic M. fermentans has not been reported. From our recent sequencing results of M. fermentans M64 isolated from human respiratory tract, its genome is around 1.1 Mb and encodes 1050 predicted protein-coding genes. In the present study, soluble proteome of M. fermentans was resolved and analyzed using two-dimensional gel electrophoresis. In addition, Triton X-114 extraction was carried out to enrich amphiphilic proteins including putative lipoproteins and membrane proteins. Subsequent mass spectrometric analyses of these proteins had identified a total of 181 M. fermentans ORFs. Further bioinformatics analysis of these ORFs encoding proteins with known or so far unknown orthologues among bacteria revealed that a total of 131 proteins are homologous to known proteins, 11 proteins are conserved hypothetical proteins, and the remaining 39 proteins are likely M. fermentans-specific proteins. Moreover, Triton X-114-enriched fraction was shown to activate NF-kB activity of raw264.7 macrophage and a total of 21 lipoproteins with predicted signal peptide were identified therefrom. Together, our work provides the first proteome reference map of M. fermentans as well as several putative virulence-associated proteins as diagnostic markers or vaccine candidates for further functional study of this human pathogen.	[Lin, I-Hsuan; Chung, Wei-Jen; Ng, Wailap Victor; Tsai, Shih-Feng; Chang, Chuan-Hsiung; Lin, Chao-Hsiung] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Liu, Yi-Chang; Lin, Chao-Hsiung] Natl Yang Ming Univ, Inst Biopharmaceut Res, Taipei 112, Taiwan; [Lin, I-Hsuan] Acad Sinica, Bioinformat Program, Taiwan Int Grad Program, Taipei 115, Taiwan; [Hu, Wensi S.; Ng, Wailap Victor; Shu, Hung-Wei] Natl Yang Ming Univ, Inst Biotechnol Med, Taipei 112, Taiwan; [Ng, Wailap Victor; Lu, Chi-Yu; Lin, Chao-Hsiung] Natl Yang Ming Univ, Prote Res Ctr, Taipei 112, Taiwan; [Huang, Tsung-Yen; Tsai, Shih-Feng; Lin, Chao-Hsiung] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Huang, Tsung-Yen; Tsai, Shih-Feng; Lin, Chao-Hsiung] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Hsiao, Kwang-Jen; Lin, Chao-Hsiung] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Tsai, Shih-Feng] Natl Hlth Res Inst, Div Mol & Genom Med, Zhunan, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Health Research Institutes - Taiwan	Chang, CH (corresponding author), Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan.	cchang@ym.edu.tw; chlin2@ym.edu.tw	Tsai, Shih-Feng/E-3997-2010; Lin, I-Hsuan/N-6501-2013	LIN, CHAO-HSIUNG/0000-0001-6344-271X; Lin, I-Hsuan/0000-0002-6207-1299	National Science Council, Taiwan [NSC 98-2311-B-010-MY3, NSC 99-3112-B-010-018]; "Aim for the Top University Plan" from the Ministry of Education, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); "Aim for the Top University Plan" from the Ministry of Education, Taiwan	This work was supported by grant NSC 98-2311-B-010-MY3 (to CHL) and NSC 99-3112-B-010-018 (to CHC) from the National Science Council, Taiwan, as well as a funding of "Aim for the Top University Plan" from the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ansai T, 2003, ORAL MICROBIOL IMMUN, V18, P398, DOI 10.1046/j.0902-0055.2003.00080.x; Ashton PD, 2001, TRENDS PARASITOL, V17, P198, DOI 10.1016/S1471-4922(00)01947-4; Bizarro CV, 2007, GENET MOL BIOL, V30, P190, DOI 10.1590/S1415-47572007000200005; BLANCHARD A, 1994, ANNU REV MICROBIOL, V48, P687, DOI 10.1146/annurev.mi.48.100194.003351; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Cacciotto C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-225; Calcutt MJ, 1999, INFECT IMMUN, V67, P760, DOI 10.1128/IAI.67.2.760-771.1999; Calcutt MJ, 2002, J BACTERIOL, V184, P6929, DOI 10.1128/JB.184.24.6929-6941.2002; Carvalho FM, 2005, GENE, V360, P111, DOI 10.1016/j.gene.2005.06.012; Catrein I, 2011, PROTEOMICS, V11, P3614, DOI 10.1002/pmic.201100076; Chang AH, 2010, CLIN MICROBIOL REV, V23, P837, DOI 10.1128/CMR.00012-10; DUDLER R, 1988, EMBO J, V7, P3963, DOI 10.1002/j.1460-2075.1988.tb03283.x; FENG SH, 1994, INFECT IMMUN, V62, P3916, DOI 10.1128/IAI.62.9.3916-3921.1994; Ferrer-Navarro M, 2006, J PROTEOME RES, V5, P688, DOI 10.1021/pr050340p; Fisunov GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021964; Fu SL, 2006, BIOCHEM BIOPH RES CO, V339, P137, DOI 10.1016/j.bbrc.2005.11.005; Fuchs TM, 1996, J BACTERIOL, V178, P4445, DOI 10.1128/jb.178.15.4445-4452.1996; Garnier M, 2001, CR ACAD SCI III-VIE, V324, P923, DOI 10.1016/S0764-4469(01)01372-5; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Havlis J, 2003, ANAL CHEM, V75, P1300, DOI 10.1021/ac026136s; He X, 2006, MICROB PATHOGENESIS, V41, P199, DOI 10.1016/j.micpath.2006.07.001; Herrmann R, 1998, CURR OPIN MICROBIOL, V1, P572, DOI 10.1016/S1369-5274(98)80091-X; Hopfe M, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-46; Hopfe M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-55; Hu WS, 1998, CURR MICROBIOL, V37, P1, DOI 10.1007/s002849900327; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Jaffe JD, 2004, GENOME RES, V14, P1447, DOI 10.1101/gr.2674004; Jaffe JD, 2004, PROTEOMICS, V4, P59, DOI 10.1002/pmic.200300511; Johnson SJ, 2008, J MOL BIOL, V377, P1460, DOI 10.1016/j.jmb.2008.01.096; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Jungblut PR, 2001, MICROBES INFECT, V3, P831, DOI 10.1016/S1286-4579(01)01441-1; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kitzerow A, 2001, MOL MICROBIOL, V41, P279, DOI 10.1046/j.1365-2958.2001.02524.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Leigh SA, 2002, INFECT IMMUN, V70, P4925, DOI 10.1128/IAI.70.9.4925-4935.2002; Lenz LL, 1996, IMMUNITY, V5, P63, DOI 10.1016/S1074-7613(00)80310-6; LO SC, 1989, AM J TROP MED HYG, V41, P586, DOI 10.4269/ajtmh.1989.41.586; Lu T, 2009, CHARACTERIZATION STR; Magnan CN, 2010, BIOINFORMATICS, V26, P2936, DOI 10.1093/bioinformatics/btq551; Matsuda K, 2009, MYCOPLASMA FERMENTAN; McGowin CL, 2009, INFECT IMMUN, V77, P1175, DOI 10.1128/IAI.00845-08; Menegatti ACO, 2010, VET MICROBIOL, V145, P134, DOI 10.1016/j.vetmic.2010.03.006; MITCHELL A, 1977, J BACTERIOL, V130, P1047, DOI 10.1128/JB.130.3.1047-1054.1977; Nouvel LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-86; OLSON LD, 1993, FEMS MICROBIOL LETT, V108, P47; Pinto PM, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-45; Pinto PM, 2007, VET MICROBIOL, V121, P83, DOI 10.1016/j.vetmic.2006.11.018; Pollack J. Dennis, 2002, OMICS A Journal of Integrative Biology, V6, P247, DOI 10.1089/15362310260256909; Rawadi G, 2000, MICROBES INFECT, V2, P955, DOI 10.1016/S1286-4579(00)00395-6; RAZIN S, 1978, MICROBIOL REV, V42, P414, DOI 10.1128/MMBR.42.2.414-470.1978; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Regula JT, 2000, ELECTROPHORESIS, V21, P3765, DOI 10.1002/1522-2683(200011)21:17<3765::AID-ELPS3765>3.0.CO;2-6; Regula JT, 2001, MICROBIOL-UK, V147, P1045, DOI 10.1099/00221287-147-4-1045; Romero F, 2004, CURR MICROBIOL, V48, P237, DOI 10.1007/s00284-003-4134-1; Seya T, 2002, INT J BIOCHEM CELL B, V34, P901, DOI 10.1016/S1357-2725(01)00164-9; Sharma A, 1998, INFECT IMMUN, V66, P5703, DOI 10.1128/IAI.66.12.5703-5710.1998; Shimizu T, 2004, IMMUNOLOGY, V113, P121, DOI 10.1111/j.1365-2567.2004.01937.x; Shimizu T, 2008, INFECT IMMUN, V76, P3672, DOI 10.1128/IAI.00257-08; Shu H-W, 2011, J BACTERIOLJB, P05228; Sippel KH, 2009, J BACTERIOL, V191, P2585, DOI 10.1128/JB.01680-08; Sirand-Pugnet P, 2007, PLOS GENET, V3, P744, DOI 10.1371/journal.pgen.0030075; Strittmatter A, MYCOPLASMA FERMENTAN; Sweredoski MJ, 2009, PROTEIN ENG DES SEL, V22, P113, DOI 10.1093/protein/gzn075; Tamura K, 2011, MOL BIOL EVOL; Theiss P, 1997, J BACTERIOL, V179, P4013, DOI 10.1128/jb.179.12.4013-4022.1997; Theiss P, 1996, INFECT IMMUN, V64, P1800, DOI 10.1128/IAI.64.5.1800-1809.1996; Tola S, 2001, FEMS MICROBIOL LETT, V202, P45, DOI 10.1111/j.1574-6968.2001.tb10778.x; Ueberle B, 2002, PROTEOMICS, V2, P754, DOI 10.1002/1615-9861(200206)2:6<754::AID-PROT754>3.0.CO;2-2; Vasconcelos ATR, 2005, J BACTERIOL, V187, P5568, DOI 10.1128/JB.187.16.5568-5577.2005; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wang LY, 2001, MOL MICROBIOL, V42, P1065, DOI 10.1046/j.1365-2958.2001.02700.x; Wasinger VC, 2000, EUR J BIOCHEM, V267, P1571, DOI 10.1046/j.1432-1327.2000.01183.x; WEISBURG WG, 1989, J BACTERIOL, V171, P6455, DOI 10.1128/jb.171.12.6455-6467.1989; WOESE CR, 1980, P NATL ACAD SCI-BIOL, V77, P494, DOI 10.1073/pnas.77.1.494; Wright SH, 2011, ADV NPS PAS, V2, P32; Wright Sonja Huebner, 2011, Adv NPs PAs, V2, P29; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263	83	16	22	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35304	10.1371/journal.pone.0035304	http://dx.doi.org/10.1371/journal.pone.0035304			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536369	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200051
J	Masuda, K; Koizumi, A; Nakajima, K; Tanaka, T; Abe, K; Misaka, T; Ishiguro, M				Masuda, Katsuyoshi; Koizumi, Ayako; Nakajima, Ken-ichiro; Tanaka, Takaharu; Abe, Keiko; Misaka, Takumi; Ishiguro, Masaji			Characterization of the Modes of Binding between Human Sweet Taste Receptor and Low-Molecular-Weight Sweet Compounds	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; PROTEIN-COUPLED RECEPTORS; AMINO-TERMINAL DOMAIN; LIGAND-BINDING; UMAMI TASTE; EXTRACELLULAR DOMAIN; T1R2-T1R3 RECEPTOR; MAMMALIAN SWEET; MECHANISM; T1R3	One of the most distinctive features of human sweet taste perception is its broad tuning to chemically diverse compounds ranging from low-molecular-weight sweeteners to sweet-tasting proteins. Many reports suggest that the human sweet taste receptor (hT1R2-hT1R3), a heteromeric complex composed of T1R2 and T1R3 subunits belonging to the class C G protein-coupled receptor family, has multiple binding sites for these sweeteners. However, it remains unclear how the same receptor recognizes such diverse structures. Here we aim to characterize the modes of binding between hT1R2-hT1R3 and low-molecular-weight sweet compounds by functional analysis of a series of site-directed mutants and by molecular modeling-based docking simulation at the binding pocket formed on the large extracellular amino-terminal domain (ATD) of hT1R2. We successfully determined the amino acid residues responsible for binding to sweeteners in the cleft of hT1R2 ATD. Our results suggest that individual ligands have sets of specific residues for binding in correspondence with the chemical structures and other residues responsible for interacting with multiple ligands.	[Koizumi, Ayako; Nakajima, Ken-ichiro; Abe, Keiko; Misaka, Takumi] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Masuda, Katsuyoshi; Tanaka, Takaharu; Ishiguro, Masaji] Suntory Inst Bioorgan Res, Osaka, Japan; [Abe, Keiko] Kanagawa Acad Sci & Technol, Food Safety & Reliabil Project, Kawasaki, Kanagawa, Japan; [Ishiguro, Masaji] Niigata Univ Pharm & Appl Life Sci, Akiha Ku, Niigata, Japan	University of Tokyo; Suntory Holdings Ltd; Kanagawa Academy Science & Technology; Niigata University	Misaka, T (corresponding author), Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan.	amisaka@mail.ecc.u-tokyo.ac.jp; ishiguro@nupals.ac.jp		Nakajima, Ken-ichiro/0000-0003-1932-418X; Misaka, Takumi/0000-0002-9547-5767	Research and Development Program for New Bio-industry Initiatives of the Bio-oriented Technology Research Advancement Institution; Japan Society for the Promotion of Science Research Fellowship for Young Scientists; Ministry of Education, Culture, Sports, Science and Technology of Japan [21880015, 20688015, 21658046, 20380183]	Research and Development Program for New Bio-industry Initiatives of the Bio-oriented Technology Research Advancement Institution; Japan Society for the Promotion of Science Research Fellowship for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was performed with a grant from the Research and Development Program for New Bio-industry Initiatives of the Bio-oriented Technology Research Advancement Institution. This work was also supported by the Japan Society for the Promotion of Science Research Fellowship for Young Scientists (to AK) and by Grants-in-aid for Scientific Research 21880015 (to KN), 20688015 and 21658046 (to TM) and 20380183 (to KA) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assadi-Porter FM, 2010, J MOL BIOL, V398, P584, DOI 10.1016/j.jmb.2010.03.017; Brauner-Osborne H, 1999, J BIOL CHEM, V274, P18382, DOI 10.1074/jbc.274.26.18382; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Cui M, 2006, CURR PHARM DESIGN, V12, P4591, DOI 10.2174/138161206779010350; Galindo-Cuspinera V, 2006, NATURE, V441, P354, DOI 10.1038/nature04765; Galvez T, 2000, J BIOL CHEM, V275, P41166, DOI 10.1074/jbc.M007848200; Galvez T, 1999, J BIOL CHEM, V274, P13362, DOI 10.1074/jbc.274.19.13362; Hammerland LG, 1999, MOL PHARMACOL, V55, P642; Imada T, 2010, BIOCHEM BIOPH RES CO, V397, P220, DOI 10.1016/j.bbrc.2010.05.088; Jiang PH, 2005, J BIOL CHEM, V280, P34296, DOI 10.1074/jbc.M505255200; Jiang PH, 2004, J BIOL CHEM, V279, P45068, DOI 10.1074/jbc.M406779200; Koizumi A, 2007, BIOCHEM BIOPH RES CO, V358, P585, DOI 10.1016/j.bbrc.2007.04.171; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Liu B, 2011, J NEUROSCI, V31, P11070, DOI 10.1523/JNEUROSCI.0791-11.2011; Morini G, 2005, J MED CHEM, V48, P5520, DOI 10.1021/jm0503345; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Nakajima K, 2006, NEUROREPORT, V17, P1241, DOI 10.1097/01.wnr.0000230513.01339.3b; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Temussi PA, 2002, FEBS LETT, V526, P1, DOI 10.1016/S0014-5793(02)03155-1; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Ueda T, 2003, J NEUROSCI, V23, P7376; Walters DE, 2006, J AGR FOOD CHEM, V54, P10129, DOI 10.1021/jf062359y; Walters DE, 2002, PURE APPL CHEM, V74, P1117, DOI 10.1351/pac200274071117; Wellendorph P, 2009, BRIT J PHARMACOL, V156, P869, DOI 10.1111/j.1476-5381.2008.00078.x; Winnig M, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-66; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101; Zhang F, 2010, P NATL ACAD SCI USA, V107, P4752, DOI 10.1073/pnas.0911660107; Zhang F, 2008, P NATL ACAD SCI USA, V105, P20930, DOI 10.1073/pnas.0810174106; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	31	96	96	5	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35380	10.1371/journal.pone.0035380	http://dx.doi.org/10.1371/journal.pone.0035380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536376	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200061
J	Ucher, AJ; Linehan, EK; Teebor, GW; Schrader, CE; Stavnezer, J				Ucher, Anna J.; Linehan, Erin K.; Teebor, George W.; Schrader, Carol E.; Stavnezer, Janet			The DNA Glycosylases Ogg1 and Nth1 Do Not Contribute to Ig Class Switching in Activated Mouse Splenic B Cells	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; SOMATIC HYPERMUTATION; TARGETED DELETION; RECOMBINATION; AID; DEFICIENCY; GENES; TRANSLOCATIONS; LYMPHOCYTES; REVEALS	During activation of B cells to undergo class switching, B cell metabolism is increased, and levels of reactive oxygen species (ROS) are increased. ROS can oxidize DNA bases resulting in substrates for the DNA glycosylases Ogg1 and Nth1. Ogg1 and Nth1 excise oxidized bases, and nick the resulting abasic sites, forming single-strand DNA breaks (SSBs) as intermediates during the repair process. In this study, we asked whether splenic B cells from mice deficient in these two enzymes would show altered class switching and decreased DNA breaks in comparison with wild-type mice. As the c-myc gene frequently recombines with the IgH S region in B cells induced to undergo class switching, we also analyzed the effect of deletion of these two glycosylases on DSBs in the c-myc gene. We did not detect a reduction in S region or c-myc DSBs or in class switching in splenic B cells from Ogg1- or Nth1-deficient mice or from mice deficient in both enzymes.	[Ucher, Anna J.; Linehan, Erin K.; Schrader, Carol E.; Stavnezer, Janet] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01605 USA; [Teebor, George W.] NYU, Med Ctr, Kaplan Comprehens Canc Ctr, Dept Pathol, New York, NY 10016 USA	University of Massachusetts System; University of Massachusetts Worcester; New York University	Stavnezer, J (corresponding author), Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01605 USA.	janet.stavnezer@umassmed.edu		Schrader, Carol/0000-0001-8920-6803; Teebor, George/0000-0002-7397-2500	National Institutes of Health (NIH) [AI-RO1-023283, AI-R21-088578]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088578, R01AI023283] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) AI-RO1-023283 and AI-R21-088578. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Catalan N, 2003, J IMMUNOL, V171, P2504, DOI 10.4049/jimmunol.171.5.2504; Chan MK, 2009, DNA REPAIR, V8, P786, DOI 10.1016/j.dnarep.2009.03.001; FEDYK ER, 1994, INT J IMMUNOPHARMACO, V16, P533, DOI 10.1016/0192-0561(94)90105-8; Guikema JEJ, 2007, J EXP MED, V204, P3017, DOI 10.1084/jem.20071289; Guikema JEJ, 2010, J IMMUNOL, V184, P6177, DOI 10.4049/jimmunol.0904085; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Ito K, 2007, J IMMUNOL, V178, P103, DOI 10.4049/jimmunol.178.1.103; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Longerich S, 2007, DNA REPAIR AMST; Ocampo MTA, 2002, MOL CELL BIOL, V22, P6111, DOI 10.1128/MCB.22.17.6111-6121.2002; Peron S, 2008, J EXP MED, V205, P2465, DOI 10.1084/jem.20080789; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Schrader CE, 2007, J IMMUNOL, V179, P6064, DOI 10.4049/jimmunol.179.9.6064; Schrader CE, 2005, J EXP MED, V202, P561, DOI 10.1084/jem.20050872; Staszewski O, 2011, MOL CELL, V41, P232, DOI 10.1016/j.molcel.2011.01.007; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Tokuyama H, 1999, CELL IMMUNOL, V192, P41, DOI 10.1006/cimm.1998.1438; Winter DB, 2003, J IMMUNOL, V170, P5558, DOI 10.4049/jimmunol.170.11.5558; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964	21	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e36061	10.1371/journal.pone.0036061	http://dx.doi.org/10.1371/journal.pone.0036061			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536455	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339200127
J	Malek, A; Nunez, LE; Magistri, M; Brambilla, L; Jovic, S; Carbone, GM; Moris, F; Catapano, CV				Malek, Anastasia; Nunez, Luz-Elena; Magistri, Marco; Brambilla, Lara; Jovic, Sandra; Carbone, Giuseppina M.; Moris, Francisco; Catapano, Carlo V.			Modulation of the Activity of Sp Transcription Factors by Mithramycin Analogues as a New Strategy for Treatment of Metastatic Prostate Cancer	PLOS ONE			English	Article							PRODUCER STREPTOMYCES-ARGILLACEUS; ACCELERATES TUMOR-FORMATION; ENDOTHELIAL GROWTH-FACTOR; CELL-CYCLE PROGRESSION; PANCREATIC-CANCER; COMBINATORIAL BIOSYNTHESIS; TOLFENAMIC ACID; ANTITUMOR-ACTIVITY; ANDROGEN RECEPTOR; DRUG MITHRAMYCIN	Deregulated activity of transcription factors (TFs) of the Sp/KLF family, like Sp1, Sp3 and Sp4, and consequent overexpression of Sp-regulated genes occur frequently in human cancers. This provides the rationale for development of inhibitors of Sp TFs as cancer therapeutics. Mithramycin A (MTM-A) is a natural polyketide that binds GC-rich DNA sequences, inhibits activity of Sp TFs and exhibits potent antitumor activity in experimental systems. However, clinical use of MTM-A is limited by the severe toxicity of the compound. Here, we studied two MTM-A analogues, which had been generated by genetically engineering of the MTM-A biosynthetic pathway, and evaluated their activity in human prostate cancer in cell cultures and mouse models. The compounds, named MTM-SDK and MTM-SK, were highly effective in vitro inhibiting proliferation of prostate cancer cells and transcription of Sp-regulated genes by blocking binding of Sp proteins to the gene promoters When administered to mice, both compounds were well tolerated with maximum tolerated doses of MTM-SDK and MTM-SK, respectively, 4- and 32- fold higher than MTM-A. After systemic administration, both compounds were cleared rapidly from the bloodstream but maintained plasma levels well above the active concentrations required in vitro for inhibition of Sp TF activity and cell proliferation. Consistently, MTM-SDK and MTM-SK inhibited transcription of Sp regulated genes in prostate tumor xenografts and exhibited potent antitumor activity in subcutaneous and metastatic tumor xenograft models with no or minimal toxicity. Taken together, these data indicate that MTM-SDK and MTM-SK possess significantly improved pharmacological and toxicological properties compared to MTM-A and represent promising drugs for treatment of advanced prostate cancer.	[Malek, Anastasia; Magistri, Marco; Brambilla, Lara; Jovic, Sandra; Carbone, Giuseppina M.; Catapano, Carlo V.] Oncol Res Inst, Bellinzona, Switzerland; [Malek, Anastasia; Magistri, Marco; Brambilla, Lara; Jovic, Sandra; Carbone, Giuseppina M.; Catapano, Carlo V.] Oncol Inst So Switzerland IOSI, Bellinzona, Switzerland; [Nunez, Luz-Elena; Moris, Francisco] EntreChem SL, Oviedo, Spain	Institute of Oncology Research (IOR); Institute of Oncology Research (IOR)	Malek, A (corresponding author), Oncol Res Inst, Bellinzona, Switzerland.	carlo.catapano@irb.unisi.ch	Malek, Anastasia V/R-8804-2016	Malek, Anastasia V/0000-0001-5334-7292; Brambilla, Lara/0000-0003-0054-4297; Catapano, Carlo V./0000-0002-7079-557X	Fondazione Ticinese per la Ricerca sul Cancro; Swiss National Science Foundation; Swiss Cancer League	Fondazione Ticinese per la Ricerca sul Cancro; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League	This work was supported by the Fondazione Ticinese per la Ricerca sul Cancro, Swiss National Science Foundation and Swiss Cancer League to CVC and GMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahim M, 2002, J BIOL CHEM, V277, P28815, DOI 10.1074/jbc.M203828200; Abdelrahim M, 2007, CANCER RES, V67, P3286, DOI 10.1158/0008-5472.CAN-06-3831; Abdelrahim M, 2006, J NATL CANCER I, V98, P855, DOI 10.1093/jnci/djj232; Albertini V, 2006, NUCLEIC ACIDS RES, V34, P1721, DOI 10.1093/nar/gkl063; Barcelo F, 2007, NUCLEIC ACIDS RES, V35, P2215, DOI 10.1093/nar/gkm037; Barcelo F, 2010, BIOCHEMISTRY-US, V49, P10543, DOI 10.1021/bi101398s; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Bond GL, 2006, CANCER RES, V66, P5104, DOI 10.1158/0008-5472.CAN-06-0180; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Calabresi P., 1991, PHARM BASIS THERAPEU; Chadalapaka G, 2008, CANCER RES, V68, P5345, DOI 10.1158/0008-5472.CAN-07-6805; Chintharlapalli S, 2007, CANCER RES, V67, P2816, DOI 10.1158/0008-5472.CAN-06-3735; Chun JY, 2007, MOL CANCER THER, V6, P2572, DOI 10.1158/1535-7163.MCT-07-0172; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Frank DA, 2009, IDRUGS, V12, P29; Gao Y, 2011, CANCER RES, V71, P5182, DOI 10.1158/0008-5472.CAN-10-2016; Gibson M, 2005, J AM CHEM SOC, V127, P17594, DOI 10.1021/ja055750t; Grohar PJ, 2011, JNCI-J NATL CANCER I, V103, P962, DOI 10.1093/jnci/djr156; Husbeck B, 2006, MOL CANCER THER, V5, P2078, DOI 10.1158/1535-7163.MCT-06-0056; Ishibashi H, 2000, CANCER RES, V60, P6531; Jemal A, 2011, CA CANC J CLIN; Jia ZL, 2007, CANCER RES, V67, P4878, DOI 10.1158/0008-5472.CAN-06-3494; Jia ZL, 2010, CANCER RES, V70, P1111, DOI 10.1158/0008-5472.CAN-09-3282; Jutooru I, 2010, J BIOL CHEM, V285, P25332, DOI 10.1074/jbc.M109.095240; Jutooru I, 2010, MOL PHARMACOL, V78, P226, DOI 10.1124/mol.110.064451; Kunderfranco P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010547; Lombo F, 2006, APPL MICROBIOL BIOT, V73, P1, DOI 10.1007/s00253-006-0511-6; Lou Z, 2005, CANCER RES, V65, P1007; Malek A, 2010, CLIN EXP METASTAS, V27, P261, DOI 10.1007/s10585-010-9324-1; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; MILLER DM, 1987, AM J MED SCI, V294, P388, DOI 10.1097/00000441-198711000-00015; Napoli S, 2009, EMBO J, V28, P1708, DOI 10.1038/emboj.2009.139; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Papineni S, 2009, CARCINOGENESIS, V30, P1193, DOI 10.1093/carcin/bgp092; Perez M, 2008, CHEMBIOCHEM, V9, P2295, DOI 10.1002/cbic.200800299; Post SM, 2010, CANCER CELL, V18, P220, DOI 10.1016/j.ccr.2010.07.010; Previdi S, 2010, GYNECOL ONCOL, V118, P182, DOI 10.1016/j.ygyno.2010.03.020; Remsing LL, 2003, BIOCHEMISTRY-US, V42, P8313, DOI 10.1021/bi034091z; Remsing LL, 2003, J AM CHEM SOC, V125, P5745, DOI 10.1021/ja034162h; Remsing LL, 2002, J AM CHEM SOC, V124, P1606, DOI 10.1021/ja0105156; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; SASTRY M, 1993, BIOCHEMISTRY-US, V32, P6588, DOI 10.1021/bi00077a012; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; SNYDER RC, 1991, BIOCHEMISTRY-US, V30, P4290, DOI 10.1021/bi00231a027; Trefzer A, 2002, J AM CHEM SOC, V124, P6056, DOI 10.1021/ja017385l; Vignati S, 2006, NEOPLASIA, V8, P851, DOI 10.1593/neo.06433; Willoughby JA, 2009, J BIOL CHEM, V284, P2203, DOI 10.1074/jbc.M804491200; Yuan HQ, 2008, BIOCHEM PHARMACOL, V75, P2112, DOI 10.1016/j.bcp.2008.03.005	49	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35130	10.1371/journal.pone.0035130	http://dx.doi.org/10.1371/journal.pone.0035130			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22545098	Green Submitted, gold, Green Published			2022-12-25	WOS:000305336200024
J	Culver, BP; Savas, JN; Park, SK; Choi, JH; Zheng, SQ; Zeitlin, SO; Yates, JR; Tanese, N				Culver, Brady P.; Savas, Jeffrey N.; Park, Sung K.; Choi, Jeong H.; Zheng, Shuqiu; Zeitlin, Scott O.; Yates, John R., III; Tanese, Naoko			Proteomic Analysis of Wild-type and Mutant Huntingtin-associated Proteins in Mouse Brains Identifies Unique Interactions and Involvement in Protein Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE PROTEIN; SHOTGUN PROTEOMICS; RAT-BRAIN; STRESS GRANULES; MESSENGER-RNAS; YEAST PROTEOME; EARLY MOTOR; COMPLEX; DOMAIN; LOCALIZATION	Huntington disease is a neurodegenerative disorder caused by a CAG repeat amplification in the gene huntingtin (HTT) that is reflected by a polyglutamine expansion in the Htt protein. Nearly 20 years of research have uncovered roles for Htt in a wide range of cellular processes, and many of these discoveries stemmed from the identification of Htt-interacting proteins. However, no study has employed an impartial and comprehensive strategy to identify proteins that differentially associate with full-length wild-type and mutant Htt in brain tissue, the most relevant sample source to the disease condition. We analyzed Htt affinity-purified complexes from wild-type and HTT mutant juvenile mouse brain from two different biochemical fractions by tandem mass spectrometry. We compared variations in protein spectral counts relative to Htt to identify those proteins that are the most significantly contrasted between wild-type and mutant Htt purifications. Previously unreported Htt interactions with Myo5a, Prkra (PACT), Gnb2l1 (RACK1), Rps6, and Syt2 were confirmed by Western blot analysis. Gene Ontology analysis of these and other Htt-associated proteins revealed a statistically significant enrichment for proteins involved in translation among other categories. Furthermore, Htt co-sedimentation with polysomes in cytoplasmic mouse brain extracts is dependent upon the presence of intact ribosomes. Finally, wild-type or mutant Htt overexpression inhibits cap-dependent translation of a reporter mRNA in an in vitro system. Cumulatively, these data support a new role for Htt in translation and provide impetus for further study into the link between protein synthesis and Huntington disease pathogenesis.	[Culver, Brady P.; Savas, Jeffrey N.; Tanese, Naoko] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Savas, Jeffrey N.; Park, Sung K.; Choi, Jeong H.; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Zheng, Shuqiu; Zeitlin, Scott O.] Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA	New York University; Scripps Research Institute; University of Virginia	Tanese, N (corresponding author), NYU, Sch Med, Dept Microbiol, 550 1st Ave, New York, NY 10016 USA.	tanesn01@med.nyu.edu	Zeitlin, Scott/P-5787-2019	Tanese, Naoko/0000-0002-1946-3211	National Institutes of Health [R01 NS061917, R01 MH067880-09, P01 AG031097-03, P41 RR011823-14]; Shared Instrumentation Grant [S10 RR017970]; CHDI Foundation, Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017970, P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043466, R01NS061917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031097, F32AG039127] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shared Instrumentation Grant; CHDI Foundation, Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS061917 (to N. T.) and R01 MH067880-09, P01 AG031097-03, and P41 RR011823-14 (to J. R. Y.), and Shared Instrumentation Grant S10 RR017970. This work was also supported by the CHDI Foundation, Inc. (to N. T.).	Angenstein F, 2002, J NEUROSCI, V22, P8827; Antar LN, 2003, NEURON, V37, P555, DOI 10.1016/S0896-6273(03)00090-4; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Bai Fengju, 2007, V43, P77, DOI 10.1007/978-1-4020-5943-8_6; Bano D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.112; Bern M, 2004, BIOINFORMATICS, V20, P49, DOI 10.1093/bioinformatics/bth947; BROUILLET E, 1995, P NATL ACAD SCI USA, V92, P7105, DOI 10.1073/pnas.92.15.7105; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Caviston JP, 2009, TRENDS CELL BIOL, V19, P147, DOI 10.1016/j.tcb.2009.01.005; Choi H, 2008, MOL CELL PROTEOMICS, V7, P2373, DOI 10.1074/mcp.M800203-MCP200; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; Coles LS, 2004, EUR J BIOCHEM, V271, P648, DOI 10.1111/j.1432-1033.2003.03968.x; COLTHURST DR, 1987, EUR J BIOCHEM, V166, P357, DOI 10.1111/j.1432-1033.1987.tb13523.x; Couthouis J, 2011, P NATL ACAD SCI USA, V108, P20881, DOI 10.1073/pnas.1109434108; Crook ZR, 2011, NEURON, V69, P423, DOI 10.1016/j.neuron.2010.12.035; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; deHaro C, 1996, FASEB J, V10, P1378, DOI 10.1096/fasebj.10.12.8903508; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; Faber PW, 2002, P NATL ACAD SCI USA, V99, P17131, DOI 10.1073/pnas.262544899; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Gu M, 1996, ANN NEUROL, V39, P385, DOI 10.1002/ana.410390317; Hallett Penelope J, 2008, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0116s42; Hickey MA, 2008, NEUROSCIENCE, V157, P280, DOI 10.1016/j.neuroscience.2008.08.041; Holbert S, 2001, P NATL ACAD SCI USA, V98, P1811, DOI 10.1073/pnas.041566798; HOOGEVEEN AT, 1993, HUM MOL GENET, V2, P2069, DOI 10.1093/hmg/2.12.2069; IIZUKA N, 1994, MOL CELL BIOL, V14, P7322, DOI 10.1128/MCB.14.11.7322; Imarisio S, 2008, BIOCHEM J, V412, P191, DOI 10.1042/BJ20071619; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Lee JA, 2009, GENE DEV, V23, P2284, DOI 10.1101/gad.1837009; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lundgren DH, 2010, EXPERT REV PROTEOMIC, V7, P39, DOI 10.1586/EPR.09.69; Ma B, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-22; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; McClatchy DB, 2007, GENOME RES, V17, P1378, DOI 10.1101/gr.6375007; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Mitsui K, 2002, J NEUROSCI, V22, P9267; Park SK, 2008, NAT METHODS, V5, P319, DOI [10.1038/NMETH.1195, 10.1038/nmeth.1195]; Passani LA, 2000, HUM MOL GENET, V9, P2175, DOI 10.1093/hmg/9.14.2175; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; Peel AL, 2001, HUM MOL GENET, V10, P1531, DOI 10.1093/hmg/10.15.1531; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Rakotondrafara AM, 2011, NAT PROTOC, V6, P563, DOI 10.1038/nprot.2011.314; Roland JT, 2011, P NATL ACAD SCI USA, V108, P2789, DOI 10.1073/pnas.1010754108; Roos RAC, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-40; Sadygov RG, 2002, J PROTEOME RES, V1, P211, DOI 10.1021/pr015514r; Savas JN, 2008, P NATL ACAD SCI USA, V105, P10820, DOI 10.1073/pnas.0800658105; Savas JN, 2012, SCIENCE, V335, P942, DOI 10.1126/science.1217421; Savas JN, 2010, J BIOL CHEM, V285, P13142, DOI 10.1074/jbc.M110.114561; SILMAN N, 1965, BIOCHIM BIOPHYS ACTA, V103, P231, DOI 10.1016/0005-2787(65)90164-4; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tauber E, 2011, J BIOL CHEM, V286, P410, DOI 10.1074/jbc.M110.101527; Teuling E, 2011, PLOS CURR, V3; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; Velier J, 1998, EXP NEUROL, V152, P34, DOI 10.1006/exnr.1998.6832; Wanker EE, 1997, HUM MOL GENET, V6, P487, DOI 10.1093/hmg/6.3.487; Washburn MP, 2011, TRENDS BIOCHEM SCI, V36, P170, DOI 10.1016/j.tibs.2010.09.001; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yano H, 2006, NAT NEUROSCI, V9, P1009, DOI 10.1038/nn1730; Yoshimura A, 2006, CURR BIOL, V16, P2345, DOI 10.1016/j.cub.2006.10.024; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155	70	87	89	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21599	21614		10.1074/jbc.M112.359307	http://dx.doi.org/10.1074/jbc.M112.359307			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22556411	Green Published, hybrid			2022-12-25	WOS:000306418600004
J	Hoang, B; Benavides, A; Shi, YJ; Yang, YH; Frost, P; Gera, J; Lichtenstein, A				Hoang, Bao; Benavides, Angelica; Shi, Yijiang; Yang, Yonghui; Frost, Patrick; Gera, Joseph; Lichtenstein, Alan			The PP242 Mammalian Target of Rapamycin (mTOR) Inhibitor Activates Extracellular Signal-regulated Kinase (ERK) in Multiple Myeloma Cells via a Target of Rapamycin Complex 1 (TORC1)/Eukaryotic Translation Initiation Factor 4E (eIF-4E)/RAF Pathway and Activation Is a Mechanism of Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASCADE INHIBITORS; TUMOR PROGRESSION; EIF4E; BRAF; PHOSPHORYLATION; SENSITIVITY; RAF-1; AKT	Activation of PI3-K-AKT and ERK pathways is a complication of mTOR inhibitor therapy. Newer mTOR inhibitors (like pp242) can overcome feedback activation of AKT in multiple myeloma (MM) cells. We, thus, studied if feedback activation of ERK is still a complication of therapy with such drugs in this tumor model. PP242 induced ERK activation in MM cell lines as well as primary cells. Surprisingly, equimolar concentrations of rapamycin were relatively ineffective at ERK activation. Activation was not correlated with P70S6kinase inhibition nor was it prevented by PI3-kinase inhibition. ERK activation was prevented by MEK inhibitors and was associated with concurrent stimulation of RAF kinase activity but not RAS activation. RAF activation correlated with decreased phosphorylation of RAF at Ser-289, Ser-296, and Ser-301 inhibitory residues. Knockdown studies confirmed TORC1 inhibition was the key proximal event that resulted in ERK activation. Furthermore, ectopic expression of eIF-4E blunted pp242-induced ERK phosphorylation. Since pp242 was more potent than rapamycin in causing sequestering of eIF-4E, a TORC1/4E-BP1/eIF-4E-mediated mechanism of ERK activation could explain the greater effectiveness of pp242. Use of MEK inhibitors confirmed ERK activation served as a mechanism of resistance to the lethal effects of pp242. Thus, although active site mTOR inhibitors overcome AKT activation often seen with rapalog therapy, feedback ERK activation is still a problem of resistance, is more severe than that seen with use of first generation rapalogs and is mediated by a TORC1-and eIF-4E-dependent mechanism ultimately signaling to RAF.	UCLA GLA VA Healthcare Syst, Div Hematol Oncol, Los Angeles, CA 90073 USA; Jonsson Comprehens Canc Ctr, Los Angeles, CA 90073 USA	UCLA Jonsson Comprehensive Cancer Center	Lichtenstein, A (corresponding author), VA W Hosp, W111H,11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	Alan.lichtenstein@med.va.gov		Frost, Patrick/0000-0003-3348-5983; Gera, Joseph/0000-0002-2908-6894	National Institutes of Health [R01 CA109312, R01 CA111448]; Veteran's Administration; Dept. of Defense; Multiple Myeloma Research Foundation;  [JCCC/P30 CA016042];  [CURE/P30 DK041301]; NATIONAL CANCER INSTITUTE [P30CA016042, R01CA111448, R01CA168700, R01CA109312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran's Administration(US Department of Veterans Affairs); Dept. of Defense(United States Department of Defense); Multiple Myeloma Research Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA109312 and R01 CA111448, research funds of the Veteran's Administration and Dept. of Defense and the Multiple Myeloma Research Foundation. The UCLA Vector Core is supported by JCCC/P30 CA016042 and CURE/P30 DK041301.	Annunziata CM, 2011, BLOOD, V117, P2396, DOI 10.1182/blood-2010-04-278788; Bondzi C, 2000, ONCOGENE, V19, P5030, DOI 10.1038/sj.onc.1203862; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Chang FM, 2003, INT J ONCOL, V22, P469; Chong H, 2003, CELL SIGNAL, V15, P463, DOI 10.1016/S0898-6568(02)00139-0; Depoil D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.263pt1; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Hay N, 2010, P NATL ACAD SCI USA, V107, P13975, DOI 10.1073/pnas.1008908107; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hoang B, 2010, BLOOD, V116, P4560, DOI 10.1182/blood-2010-05-285726; Hoang B, 2009, MOL CANCER THER, V8, P1974, DOI 10.1158/1535-7163.MCT-08-1177; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; McMillin DW, 2009, CANCER RES, V69, P5835, DOI 10.1158/0008-5472.CAN-08-4285; Mody N, 2001, FEBS LETT, V502, P21, DOI 10.1016/S0014-5793(01)02651-5; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Reynolds LF, 2004, J BIOL CHEM, V279, P18239, DOI 10.1074/jbc.M400257200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scheid MP, 1999, J BIOL CHEM, V274, P31108, DOI 10.1074/jbc.274.43.31108; Sharma S, 2008, CLIN CANCER RES, V14, P3262, DOI 10.1158/1078-0432.CCR-07-4153; Shelton JG, 2003, LEUKEMIA, V17, P1765, DOI 10.1038/sj.leu.2403052; Shi Y, 2005, INT J INF TECH DECIS, V4, P1; Shi YJ, 2005, J BIOL CHEM, V280, P10964, DOI 10.1074/jbc.M407874200; Shi YJ, 2002, CANCER RES, V62, P5027; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	31	60	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21796	21805		10.1074/jbc.M111.304626	http://dx.doi.org/10.1074/jbc.M111.304626			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22556409	Green Published, hybrid			2022-12-25	WOS:000306418600021
J	Zhong, Q; Congdon, EE; Nagaraja, HN; Kuret, J				Zhong, Qi; Congdon, Erin E.; Nagaraja, Haikady N.; Kuret, Jeff			Tau Isoform Composition Influences Rate and Extent of Filament Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; HAPLOTYPE-SPECIFIC EXPRESSION; MILD COGNITIVE IMPAIRMENT; CORTICOBASAL DEGENERATION; MICROTUBULE-BINDING; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; GENE-EXPRESSION; MESSENGER-RNAS; PICKS-DISEASE	The risk of developing tauopathic neurodegenerative disease depends in part on the levels and composition of six naturally occurring Tau isoforms in human brain. These proteins, which form filamentous aggregates in disease, vary only by the presence or absence of three inserts encoded by alternatively spliced exons 2, 3, and 10 of the Tau gene (MAPT). To determine the contribution of alternatively spliced segments to Tau aggregation propensity, the aggregation kinetics of six unmodified, recombinant human Tau isoforms were examined in vitro using electron microscopy assay methods. Aggregation propensity was then compared at the level of elementary rate constants for nucleation and extension phases. We found that all three alternatively spliced segments modulated Tau aggregation but through differing kinetic mechanisms that could synergize or compete depending on sequence context. Overall, segments encoded by exons 2 and 10 promoted aggregation, whereas the segment encoded by exon 3 depressed it with its efficacy dependent on the presence or absence of a fourth microtubule binding repeat. In general, aggregation propensity correlated with genetic risk reported for multiple tauopathies, implicating aggregation as one candidate mechanism rationalizing the correlation between Tau expression patterns and disease.	[Zhong, Qi; Congdon, Erin E.; Kuret, Jeff] Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Nagaraja, Haikady N.] Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Kuret, J (corresponding author), Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, 1060 Carmack Rd, Columbus, OH 43210 USA.	kuret.3@osu.edu		Congdon, Erin/0000-0001-8322-6176	National Institutes of Health [AG14452]; Alzheimer's Association [IIRG-05-14288]; NATIONAL INSTITUTE ON AGING [R01AG014452] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG14452. This work was also supported by Alzheimer's Association Grant IIRG-05-14288.	Adams SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010810; Andreadis A, 2012, J CELL PHYSIOL, V227, P1220, DOI 10.1002/jcp.22842; Armstrong RA, 1999, ACTA NEUROPATHOL, V97, P456, DOI 10.1007/s004010051014; Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Boutajangout A, 2004, FEBS LETT, V576, P183, DOI 10.1016/j.febslet.2004.09.011; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; Bullmann T, 2007, HIPPOCAMPUS, V17, P98, DOI 10.1002/hipo.20255; Caffrey TM, 2008, NEUROBIOL AGING, V29, P1923, DOI 10.1016/j.neurobiolaging.2007.05.002; Caffrey TM, 2006, HUM MOL GENET, V15, P3529, DOI 10.1093/hmg/ddl429; CARMEL G, 1994, J BIOL CHEM, V269, P7304; Chang E, 2008, J NEUROCHEM, V107, P1113, DOI 10.1111/j.1471-4159.2008.05692.x; Chang E, 2011, BBA-PROTEINS PROTEOM, V1814, P388, DOI 10.1016/j.bbapap.2010.10.005; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; Chirita CN, 2005, BIOCHEMISTRY-US, V44, P5862, DOI 10.1021/bi0500123; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Combs B, 2011, BIOCHEMISTRY-US, V50, P9446, DOI 10.1021/bi2010569; Congdon EE, 2008, J BIOL CHEM, V283, P13806, DOI 10.1074/jbc.M800247200; Conrad C, 2007, J NEUROCHEM, V103, P1228, DOI 10.1111/j.1471-4159.2007.04857.x; DEANCOS JG, 1993, J BIOL CHEM, V268, P7976; Delacourte A, 1998, ANN NEUROL, V43, P193, DOI 10.1002/ana.410430209; EVANS KC, 1995, P NATL ACAD SCI USA, V92, P763, DOI 10.1073/pnas.92.3.763; FEANY MB, 1995, ACTA NEUROPATHOL, V90, P37; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; FESCE R, 1992, J BIOL CHEM, V267, P11289; GEARING M, 1994, P NATL ACAD SCI USA, V91, P9382, DOI 10.1073/pnas.91.20.9382; Ghoshal N, 2002, EXP NEUROL, V177, P475, DOI 10.1006/exnr.2002.8014; Ginsberg SD, 2006, J NEUROCHEM, V96, P1401, DOI 10.1111/j.1471-4159.2005.03641.x; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Goode BL, 2000, J BIOL CHEM, V275, P38182, DOI 10.1074/jbc.M007489200; HOF PR, 1994, ACTA NEUROPATHOL, V87, P115; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Houlden H, 2001, NEUROLOGY, V56, P1702, DOI 10.1212/WNL.56.12.1702; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; KENESSEY A, 1993, BRAIN RES, V629, P40, DOI 10.1016/0006-8993(93)90478-6; King ME, 2000, J NEUROCHEM, V74, P1749, DOI 10.1046/j.1471-4159.2000.0741749.x; KRISTOFFERSON D, 1980, J BIOL CHEM, V255, P8567; KSIEZAKREDING H, 1994, AM J PATHOL, V145, P1496; Kuret J, 2005, MICROSC RES TECHNIQ, V67, P141, DOI 10.1002/jemt.20187; LEE G, 1989, NEURON, V2, P1615, DOI 10.1016/0896-6273(89)90050-0; Levy SF, 2005, J BIOL CHEM, V280, P13520, DOI 10.1074/jbc.M413490200; Muller R, 1997, CELL TISSUE RES, V288, P239, DOI 10.1007/s004410050809; Necula M, 2005, FEBS LETT, V579, P1453, DOI 10.1016/j.febslet.2005.01.047; Necula M, 2004, ANAL BIOCHEM, V333, P205, DOI 10.1016/j.ab.2004.05.044; Necula M, 2004, ANAL BIOCHEM, V329, P238, DOI 10.1016/j.ab.2004.02.023; NOVAK M, 1993, EMBO J, V12, P365, DOI 10.1002/j.1460-2075.1993.tb05665.x; Pittman AM, 2005, J MED GENET, V42, P837, DOI 10.1136/jmg.2005.031377; Rademakers R, 2004, HUM MUTAT, V24, P277, DOI 10.1002/humu.20086; Rademakers R, 2005, HUM MOL GENET, V14, P3281, DOI 10.1093/hmg/ddi361; Reynolds MR, 2005, BIOCHEMISTRY-US, V44, P1690, DOI 10.1021/bi047982v; Rice J. A., 2007, MATH STAT DATA ANAL, P165; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sergeant N, 2001, HUM MOL GENET, V10, P2143, DOI 10.1093/hmg/10.19.2143; Sergeant N, 2008, EXPERT REV PROTEOMIC, V5, P207, DOI 10.1586/14789450.5.2.207; Siddiqua A, 2010, J BIOL CHEM, V285, P37920, DOI 10.1074/jbc.M110.185728; Singleton A, 2004, HUM MOL GENET, V13, pR123, DOI 10.1093/hmg/ddh093; Spillantini MG, 1997, P NATL ACAD SCI USA, V94, P4113, DOI 10.1073/pnas.94.8.4113; Spittaels K, 1999, AM J PATHOL, V155, P2153, DOI 10.1016/S0002-9440(10)65533-2; Terada S, 2005, ACTA NEUROPATHOL, V110, P12, DOI 10.1007/s00401-005-1012-x; Voss K, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-18; Yasojima K, 1999, BRAIN RES, V831, P301, DOI 10.1016/S0006-8993(99)01486-9; Zody MC, 2008, NAT GENET, V40, P1076, DOI 10.1038/ng.193	64	69	72	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					20711	20719		10.1074/jbc.M112.364067	http://dx.doi.org/10.1074/jbc.M112.364067			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22539343	Green Published, hybrid			2022-12-25	WOS:000306414500089
J	Siegel, AJ; Freedman, C; Page, RE				Siegel, Adam J.; Freedman, Colin; Page, Robert E., Jr.			Ovarian Control of Nectar Collection in the Honey Bee (Apis mellifera)	PLOS ONE			English	Article							DIVISION-OF-LABOR; SUCROSE RESPONSE THRESHOLDS; REPRODUCTIVE GROUND-PLAN; FORAGING BEHAVIOR; GENOTYPE; RESPONSIVENESS; L.; TACTILE	Honey bees are a model system for the study of division of labor. Worker bees demonstrate a foraging division of labor (DOL) by biasing collection towards carbohydrates (nectar) or protein (pollen). The Reproductive ground-plan hypothesis of Amdam et al. proposes that foraging DOL is regulated by the networks that controlled foraging behavior during the reproductive life cycle of honey bee ancestors. Here we test a proposed mechanism through which the ovary of the facultatively sterile worker impacts foraging bias. The proposed mechanism suggests that the ovary has a regulatory effect on sucrose sensitivity, and sucrose sensitivity impacts nectar loading. We tested this mechanism by measuring worker ovary size (ovariole number), sucrose sensitivity, and sucrose solution load size collected from a rate-controlled artificial feeder. We found a significant interaction between ovariole number and sucrose sensitivity on sucrose solution load size when using low concentration nectar. This supports our proposed mechanism. As nectar and pollen loading are not independent, a mechanism impacting nectar load size would also impact pollen load size.	[Siegel, Adam J.; Freedman, Colin; Page, Robert E., Jr.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Siegel, Adam J.] Hebrew Univ Jerusalem, Dept Ecol Evolut & Behav, Alexander Silberman Inst Life Sci, Jerusalem, Israel; [Page, Robert E., Jr.] Arizona State Univ, Coll Liberal Arts & Sci, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Hebrew University of Jerusalem; Arizona State University; Arizona State University-Tempe	Siegel, AJ (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	adam.siegel@mail.huji.ac.il			The National Institute of Aging (NIA) [P01 AG22500]; NATIONAL INSTITUTE ON AGING [P01AG022500] Funding Source: NIH RePORTER	The National Institute of Aging (NIA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was funded by a grant from The National Institute of Aging (NIA P01 AG22500) to REP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2006, NATURE, V439, P76, DOI 10.1038/nature04340; Amdam GV, 2005, EXP GERONTOL, V40, P939, DOI 10.1016/j.exger.2005.08.004; Amdam GV, 2004, P NATL ACAD SCI USA, V101, P11350, DOI 10.1073/pnas.0403073101; Curtis KS, 2005, PHYSIOL BEHAV, V86, P281, DOI 10.1016/j.physbeh.2005.08.002; Mujagic S, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00046; Mujagic S, 2009, J COMP PHYSIOL A, V195, P325, DOI 10.1007/s00359-008-0409-0; NUNEZ JA, 1971, ACTA CIENT VENEZ, V22, P101; Nunez JA, 1996, BEE WORLD, V77, P182, DOI 10.1080/0005772X.1996.11099313; NUNEZ JA, 1982, J APICULT RES, V21, P139, DOI 10.1080/00218839.1982.11100531; Oster G.F., 1978, Monographs in Population Biology, pi; Pacini E, 2003, PLANT SYST EVOL, V238, P7, DOI 10.1007/s00606-002-0277-y; Page RE, 1998, J COMP PHYSIOL A, V182, P489, DOI 10.1007/s003590050196; Page RE, 2000, J HERED, V91, P474, DOI 10.1093/jhered/91.6.474; Page RE, 2006, CURR TOP DEV BIOL, V74, P253, DOI 10.1016/S0070-2153(06)74008-X; Pankiw T, 1999, J COMP PHYSIOL A, V185, P207, DOI 10.1007/s003590050379; Pankiw T, 2000, BEHAV ECOL SOCIOBIOL, V47, P265, DOI 10.1007/s002650050664; Pankiw T, 2003, J COMP PHYSIOL A, V189, P675, DOI 10.1007/s00359-003-0442-y; Pankiw T, 2001, J COMP PHYSIOL A, V187, P293, DOI 10.1007/s003590100201; Rueppell O, 2008, J INSECT BEHAV, V21, P317, DOI 10.1007/s10905-008-9135-2; Scheiner R, 2004, APIDOLOGIE, V35, P133, DOI 10.1051/apido:2004001; Scheiner R, 2001, NEUROBIOL LEARN MEM, V76, P138, DOI 10.1006/nlme.2000.3996; Scheiner R, 2001, BEHAV BRAIN RES, V120, P67, DOI 10.1016/S0166-4328(00)00359-4; Seeley T., 1995, WISDOM HIVE SOCIAL P; Siegel AJ, 2012, ANIM BEHAV, V83, P653, DOI 10.1016/j.anbehav.2011.12.009; THAN TT, 1994, PHYSIOL BEHAV, V56, P237, DOI 10.1016/0031-9384(94)90189-9; Tsuruda JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003397; Winston M.L., 1991, BIOL HONEY BEE	27	10	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e33465	10.1371/journal.pone.0033465	http://dx.doi.org/10.1371/journal.pone.0033465			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558073	gold, Green Published, Green Submitted			2022-12-25	WOS:000305340200003
J	Cantsilieris, S; White, SJ; Richardson, AJ; Guymer, RH; Baird, PN				Cantsilieris, Stuart; White, Stefan J.; Richardson, Andrea J.; Guymer, Robyn H.; Baird, Paul N.			Comprehensive Analysis of Copy Number Variation of Genes at Chromosome 1 and 10 Loci Associated with Late Age Related Macular Degeneration	PLOS ONE			English	Article							C-REACTIVE PROTEIN; FACTOR-H CFH; SEGMENTAL DUPLICATIONS; CFHR1-CFHR3 DELETION; POLYMORPHISM; RISK; REARRANGEMENTS; SUSCEPTIBILITY; PREDISPOSES; HAPLOTYPE	Copy Number Variants (CNVs) are now recognized as playing a significant role in complex disease etiology. Age-related macular degeneration (AMD) is the most common cause of irreversible vision loss in the western world. While a number of genes and environmental factors have been associated with both risk and protection in AMD, the role of CNVs has remained largely unexplored. We analyzed the two major AMD risk-associated regions on chromosome 1q32 and 10q26 for CNVs using Multiplex Ligation-dependant Probe Amplification. The analysis targeted nine genes in these two key regions, including the Complement Factor H (CFH) gene, the 5 CFH-related (CFHR) genes representing a known copy number "hotspot", the F13B gene as well as the ARMS2 and HTRA1 genes in 387 cases of late AMD and 327 controls. No copy number variation was detected at the ARMS2 and HTRA1 genes in the chromosome 10 region, nor for the CFH and F13B genes at the chromosome 1 region. However, significant association was identified for the CFHR3-1 deletion in AMD cases (p = 2.38x10(-12)) OR = 0.31, CI-0.95 (0.23-0.44), for both neovascular disease (nAMD) (p = 8.3x10(-9)) OR = 0.36 CI-0.95 (0.25-0.52) and geographic atrophy (GA) (p = 1.5x10(-6)) OR = 0.36 CI-0.95 (0.25-0.52) compared to controls. In addition, a significant association with deletion of CFHR1-4 was identified only in patients who presented with bilateral GA (p = 0.02) (OR = 7.6 CI-0.95 1.38-41.8). This is the first report of a phenotype specific association of a CNV for a major subtype of AMD and potentially allows for pre-diagnostic identification of individuals most likely to proceed to this end stage of disease.	[Cantsilieris, Stuart; Richardson, Andrea J.; Guymer, Robyn H.; Baird, Paul N.] Univ Melbourne, Ctr Eye Res Australia, Royal Victorian Eye & Ear Hosp, Melbourne, Vic, Australia; [Cantsilieris, Stuart; White, Stefan J.] Monash Inst Med Res, Ctr Reprod & Dev, Melbourne, Vic, Australia	Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Monash University	Cantsilieris, S (corresponding author), Univ Melbourne, Ctr Eye Res Australia, Royal Victorian Eye & Ear Hosp, Melbourne, Vic, Australia.	pnb@unimelb.edu.au		Guymer, Robyn/0000-0002-9441-4356; Baird, Paul/0000-0002-1305-3502	National Health and Medical Research Council (NHMRC) Centre for Clinical Research Excellence [529923]; NHMRC [1008979]	National Health and Medical Research Council (NHMRC) Centre for Clinical Research Excellence(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the National Health and Medical Research Council (NHMRC) Centre for Clinical Research Excellence #529923-Translational Clinical Research in Major Eye Diseases and NHMRC Project Grant #1008979 and NHMRC practitioner fellowship (RHG). CERA and MIMR receives Operational Infrastructure Support from the Victorian Government. The information contained in this manuscript has not been published before. The authors have no financial interests or involvements with companies regarding this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrera-Abeleda MA, 2006, J MED GENET, V43, P582, DOI 10.1136/jmg.2005.038315; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Bhattacharya T, 2009, NAT MED, V15, P1112, DOI 10.1038/nm1009-1112; Campbell CD, 2011, AM J HUM GENET, V88, P317, DOI 10.1016/j.ajhg.2011.02.004; Casilli F, 2002, HUM MUTAT, V20, P218, DOI 10.1002/humu.10108; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Field SF, 2009, NAT MED, V15, P1115, DOI 10.1038/nm1009-1115; Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170; Fritsche LG, 2010, HUM MOL GENET, V19, P4694, DOI 10.1093/hmg/ddq399; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Guymer RH, 2006, MED J AUST, V184; Hageman GS, 2006, ANN MED, V38, P592, DOI 10.1080/07853890601097030; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Hebecker M, 2010, MOL IMMUNOL, V47, P1347, DOI 10.1016/j.molimm.2009.12.005; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Hughes AE, 2010, NAT GENET, V42, P555, DOI 10.1038/ng0710-555; Janssen B, 2005, NEUROGENETICS, V6, P29, DOI 10.1007/s10048-004-0204-1; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Klein R, 2011, ARCH OPHTHALMOL-CHIC, V129, P75, DOI 10.1001/archophthalmol.2010.318; Kubista KE, 2011, MOL VIS, V17, P2080; Laine M, 2007, J IMMUNOL, V178, P3831, DOI 10.4049/jimmunol.178.6.3831; Mamtani M, 2010, GENES IMMUN, V11, P155, DOI 10.1038/gene.2009.71; Marques RB, 2010, PLOS ONE, V5; McKinney C, 2010, ANN RHEUM DIS, V69, P1711, DOI 10.1136/ard.2009.123588; Mihlan M, 2009, MOL IMMUNOL, V46, P335, DOI 10.1016/j.molimm.2008.10.029; Moore I, 2010, BLOOD, V115, P379, DOI 10.1182/blood-2009-05-221549; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Notini AJ, 2008, CYTOGENET GENOME RES, V123, P270, DOI 10.1159/000184717; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2010, NAT GENET, V42, P553, DOI 10.1038/ng0710-553; Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210; Richardson AJ, 2010, INVEST OPHTH VIS SCI, V51, P4932, DOI 10.1167/iovs.09-5114; Robman L, 2010, OPHTHALMOLOGY, V117, P1982, DOI 10.1016/j.ophtha.2010.02.003; Saugier-Veber P, 2006, EUR J HUM GENET, V14, P1009, DOI 10.1038/sj.ejhg.5201661; Sawitzke J, 2011, OPHTHALMOLO IN PRESS; Schmid-Kubista KE, 2009, INVEST OPHTH VIS SCI, V50, P5070, DOI 10.1167/iovs.09-3975; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sivakumaran TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025598; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; White S, 2002, AM J HUM GENET, V71, P365, DOI 10.1086/341942; White SJ, 2007, CYTOGENET GENOME RES, V118, P19, DOI 10.1159/000106437; White SJ, 2004, METHOD CELL BIOL, V75, P751; White SJ, 2004, HUM MUTAT, V24, P86, DOI 10.1002/humu.20054; Zhao J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002079; Zipfel PF, 2007, PLOS GENET, V3, P387, DOI 10.1371/journal.pgen.0030041	51	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35255	10.1371/journal.pone.0035255	http://dx.doi.org/10.1371/journal.pone.0035255			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558131	gold, Green Published, Green Submitted			2022-12-25	WOS:000305345200031
J	Comin, A; Stegeman, A; Marangon, S; Klinkenberg, D				Comin, Arianna; Stegeman, Arjan; Marangon, Stefano; Klinkenberg, Don			Evaluating Surveillance Strategies for the Early Detection of Low Pathogenicity Avian Influenza Infections	PLOS ONE			English	Article							CHICKENS; POULTRY; PROGRAM; VACCINATION; OUTBREAK; VIRUSES; AFRICA; SPREAD; EUROPE; ASIA	In recent years, the early detection of low pathogenicity avian influenza (LPAI) viruses in poultry has become increasingly important, given their potential to mutate into highly pathogenic viruses. However, evaluations of LPAI surveillance have mainly focused on prevalence and not on the ability to act as an early warning system. We used a simulation model based on data from Italian LPAI epidemics in turkeys to evaluate different surveillance strategies in terms of their performance as early warning systems. The strategies differed in terms of sample size, sampling frequency, diagnostic tests, and whether or not active surveillance (i.e., routine laboratory testing of farms) was performed, and were also tested under different epidemiological scenarios. We compared surveillance strategies by simulating within-farm outbreaks. The output measures were the proportion of infected farms that are detected and the farm reproduction number (Rh). The first one provides an indication of the sensitivity of the surveillance system to detect within-farm infections, whereas Rh reflects the effectiveness of outbreak detection (i.e., if detection occurs soon enough to bring an epidemic under control). Increasing the sampling frequency was the most effective means of improving the timeliness of detection (i.e., it occurs earlier), whereas increasing the sample size increased the likelihood of detection. Surveillance was only effective in preventing an epidemic if actions were taken within two days of sampling. The strategies were not affected by the quality of the diagnostic test, although performing both serological and virological assays increased the sensitivity of active surveillance. Early detection of LPAI outbreaks in turkeys can be achieved by increasing the sampling frequency for active surveillance, though very frequent sampling may not be sustainable in the long term. We suggest that, when no LPAI virus is circulating yet and there is a low risk of virus introduction, a less frequent sampling approach might be admitted, provided that the surveillance is intensified as soon as the first outbreak is detected.	[Comin, Arianna; Marangon, Stefano] Ist Zooprofilatt Sperimentale Venezie, Padua, Italy; [Stegeman, Arjan; Klinkenberg, Don] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands	IZS delle Venezie; Utrecht University	Comin, A (corresponding author), Ist Zooprofilatt Sperimentale Venezie, Padua, Italy.	acomin@izsvenezie.it		Klinkenberg, Don/0000-0002-9449-6873; Comin, Arianna/0000-0002-1765-1825; Marangon, Stefano/0000-0002-3158-4243	EU Commission [SSPE-CT-2007-044429]; Italian Ministry of Health	EU Commission(European CommissionEuropean Commission Joint Research Centre); Italian Ministry of Health(Ministry of Health, Italy)	This study has been performed with support from the EU Commission (grant SSPE-CT-2007-044429: Improved diagnosis and early warning systems for avian influenza outbreak management - FLUTEST) and the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey BL, 2003, AVIAN DIS, V47, P1099, DOI 10.1637/0005-2086-47.s3.1099; Alba A, 2010, PREV VET MED, V97, P107, DOI 10.1016/j.prevetmed.2010.09.002; Alexander DJ, 2007, AVIAN DIS, V51, P161, DOI 10.1637/7602-041306R.1; Brown IH, 2010, AVIAN DIS, V54, P187, DOI 10.1637/8949-053109-Reg.1; Capua I, 2007, VACCINE, V25, P4987, DOI 10.1016/j.vaccine.2007.01.113; Comin A, 2011, ZOONOSES PUBLIC HLTH, V58, P244, DOI 10.1111/j.1863-2378.2010.01343.x; Comin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026935; DEFRA, 2008, LOW PATH AV INFL GER; Elbers ARW, COMMUNICATION; European Commission, 2010, OFFICIAL J EUROPEA L, VL 166, P22; European Commission, 2005, OFF J EUR UNION L, VL 274, P105; European Commission, 2006, OFFICIAL J EUROPEAN, V10, P16; Fischer EAJ, 2005, PREV VET MED, V67, P283, DOI 10.1016/j.prevetmed.2004.12.002; Food and Agriculture Organization of the United Nations, 2008, BIOS HIGHL PATH AV I; Gonzales JL, 2010, INFLUENZA OTHER RESP, V4, P91, DOI 10.1111/j.1750-2659.2009.00126.x; Gonzales JL, 2011, VET MICROBIOLOGY; Graat EAM, 2001, VET MICROBIOL, V79, P193, DOI 10.1016/S0378-1135(00)00356-4; Klinkenberg D, 2011, RISK ANAL, V31, P1260, DOI 10.1111/j.1539-6924.2011.01582.x; Marangon S, 2005, WAG UR FRON, V8, P33; Mulatti P, 2010, EPIDEMIOL INFECT, V138, P813, DOI 10.1017/S0950268809991038; R Core Team, 2022, R LANG ENV STAT COMP; Spackman E, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-331; Spickler AR, 2008, AVIAN PATHOL, V37, P555, DOI 10.1080/03079450802499118; Suarez DL, 2004, EMERG INFECT DIS, V10, P693, DOI 10.3201/eid1004.030396; Tumpey TM, 2004, AVIAN DIS, V48, P167, DOI 10.1637/7103; Van der Goot JA, 2003, EPIDEMIOL INFECT, V131, P1003, DOI 10.1017/S0950268803001067; van der Goot JA, 2010, VACCINE, V28, P1771, DOI 10.1016/j.vaccine.2009.12.009; Welby S, 2010, AVIAN DIS, V54, P597, DOI 10.1637/8749-033009-Reg.1	28	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35956	10.1371/journal.pone.0035956	http://dx.doi.org/10.1371/journal.pone.0035956			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545151	gold, Green Published			2022-12-25	WOS:000305343200071
J	Lu, N; Liu, JX; Liu, J; Zhang, CY; Jiang, FQ; Wu, H; Chen, LQ; Zeng, WJ; Cao, XH; Yan, TD; Wang, GH; Zhou, H; Lin, BZ; Yan, XM; Zhang, XK; Zeng, JZ				Lu, Na; Liu, Jinxing; Liu, Jie; Zhang, Chunyun; Jiang, Fuquan; Wu, Hua; Chen, Liqun; Zeng, Wenjun; Cao, Xihua; Yan, Tingdong; Wang, Guanghui; Zhou, Hu; Lin, Bingzhen; Yan, Xiaomei; Zhang, Xiao-kun; Zeng, Jin-Zhang			Antagonist Effect of Triptolide on AKT Activation by Truncated Retinoid X Receptor-alpha	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; KAPPA-B ACTIVATION; L-TYPE PROTEASE; RXR-ALPHA; CANCER-CELLS; INDUCED APOPTOSIS; TRIPTERYGIUM-WILFORDII; 9-CIS-RETINOIC ACID; SERINE-260 IMPAIRS; EPITHELIAL-CELLS	Background: Retinoid X receptor-alpha (RXR alpha) is a key member of the nuclear receptor superfamily. We recently demonstrated that proteolytic cleavage of RXR alpha resulted in production of a truncated product, tRXR alpha, which promotes cancer cell survival by activating phosphatidylinositol-3-OH kinase (PI3K)/AKT pathway. However, how the tRXR alpha-mediated signaling pathway in cancer cells is regulated remains elusive. Methodology/Principal Findings: We screened a natural product library for tRXR alpha targeting leads and identified that triptolide, an active component isolated from traditional Chinese herb Trypterygium wilfordii Hook F, could modulate tRXR alpha-mediated cancer cell survival pathway in vitro and in animals. Our results reveal that triptolide strongly induces cancer cell apoptosis dependent on intracellular tRXR alpha expression levels, demonstrating that tRXR alpha serves as an important intracellular target of triptolide. We show that triptolide selectively induces tRXR alpha degradation and inhibits tRXR alpha-dependent AKT activity without affecting the full-length RXR alpha. Interestingly, such effects of triptolide are due to its activation of p38. Although triptolide also activates Erk1/2 and MAPK pathways, the effects of triptolide on tRXR alpha degradation and AKT activity are only reversed by p38 siRNA and p38 inhibitor. In addition, the p38 inhibitor potently inhibits tRXR alpha interaction with p85 alpha leading to AKT inactivation. Our results demonstrate an interesting novel signaling interplay between p38 and AKT through tRXR alpha mediation. We finally show that targeting tRXR alpha by triptolide strongly activates TNF alpha death signaling and enhances the anticancer activity of other chemotherapies Conclusions/Significance: Our results identify triptolide as a new xenobiotic regulator of the tRXR alpha-dependent survival pathway and provide new insight into the mechanism by which triptolide acts to induce apoptosis of cancer cells. Triptolide represents one of the most promising therapeutic leads of natural products of traditional Chinese medicine with unfortunate side-effects. Our findings will offer new strategies to develop improved triptolide analogs for cancer therapy.	[Lu, Na; Liu, Jinxing; Liu, Jie; Zhang, Chunyun; Jiang, Fuquan; Wu, Hua; Chen, Liqun; Zeng, Wenjun; Yan, Tingdong; Wang, Guanghui; Zhang, Xiao-kun; Zeng, Jin-Zhang] Xiamen Univ, Sch Pharmaceut Sci, Xiamen, Peoples R China; [Lu, Na; Liu, Jinxing; Liu, Jie; Zhang, Chunyun; Jiang, Fuquan; Wu, Hua; Chen, Liqun; Zeng, Wenjun; Yan, Tingdong; Wang, Guanghui; Zhang, Xiao-kun; Zeng, Jin-Zhang] Xiamen Univ, Inst Biomed Res, Xiamen, Peoples R China; [Cao, Xihua; Zhou, Hu; Lin, Bingzhen; Zhang, Xiao-kun] Sanford Burnham Med Res Inst, Ctr Canc, La Jolla, CA USA; [Yan, Xiaomei] Xiamen Univ, Coll Chem & Chem Engn, Dept Biol Chem, Key Lab Analyt Sci,Key Lab Chem Biol Fujian Prov, Xiamen, Peoples R China	Xiamen University; Xiamen University; Sanford Burnham Prebys Medical Discovery Institute; Xiamen University	Lu, N (corresponding author), Xiamen Univ, Sch Pharmaceut Sci, Xiamen, Peoples R China.	xzhang@burnham.org; jzzeng@xmu.edu.cn	Wu, Hua/W-4204-2019; Zeng, JZ/G-3377-2010		National Natural Science Foundation of China [NSFC: 30971445, 90913015, 91129302]; NSFC/Hong Kong Research Grants Council [NSFC/RGC: 30931160431/N_HKU 735/09]; Natural Science Foundation of Fujian Province [2009J01198]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC/Hong Kong Research Grants Council(Hong Kong Research Grants CouncilNational Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province)	This work was supported by National Natural Science Foundation of China (NSFC: 30971445, 90913015 and 91129302), NSFC/Hong Kong Research Grants Council (NSFC/RGC: 30931160431/N_HKU 735/09) and Natural Science Foundation of Fujian Province (2009J01198). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2002, HEPATOLOGY, V35, P332, DOI 10.1053/jhep.2002.31164; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Carter BZ, 2008, BLOOD, V111, P3742, DOI 10.1182/blood-2007-05-091504; Carter BZ, 2006, BLOOD, V108, P630, DOI 10.1182/blood-2005-09-3898; Chang WT, 2001, J BIOL CHEM, V276, P2221, DOI 10.1074/jbc.M009713200; Chen BJ, 2001, LEUKEMIA LYMPHOMA, V42, P253, DOI 10.3109/10428190109064582; Corson TW, 2007, CELL, V130, P769, DOI 10.1016/j.cell.2007.08.021; Dawson MI, 2002, CURR MED CHEM, V9, P623, DOI 10.2174/0929867023370789; Fidler JM, 2003, MOL CANCER THER, V2, P855; Fidler JM, 2002, TRANSPLANTATION, V74, P445, DOI 10.1097/00007890-200208270-00004; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; HSIANG YH, 1988, CANCER RES, V48, P1722; Huang JP, 2002, CANCER RES, V62, P4812; Jiang XH, 2001, ONCOGENE, V20, P8009, DOI 10.1038/sj.onc.1204981; Kiviharju TM, 2002, CLIN CANCER RES, V8, P2666; Kunz C, 2009, PLOS BIOL, V7, P967, DOI 10.1371/journal.pbio.1000091; Lee KY, 2002, EXP MOL MED, V34, P462, DOI 10.1038/emm.2002.64; Lee KY, 1999, J BIOL CHEM, V274, P13451, DOI 10.1074/jbc.274.19.13451; Lefebvre P, 2010, TRENDS ENDOCRIN MET, V21, P676, DOI 10.1016/j.tem.2010.06.009; Leuenroth SJ, 2008, CANCER RES, V68, P5257, DOI 10.1158/0008-5472.CAN-07-6207; Li M, 2001, DEVELOPMENT, V128, P675; Liu J, 2008, CANCER RES, V68, P8871, DOI 10.1158/0008-5472.CAN-08-1972; Macoritto M, 2008, J BIOL CHEM, V283, P4943, DOI 10.1074/jbc.M707517200; Matsushima-Nishiwaki R, 2001, CANCER RES, V61, P7675; MatsushimaNishiwaki R, 1996, BIOCHEM BIOPH RES CO, V225, P946, DOI 10.1006/bbrc.1996.1276; Nagaya T, 1998, J BIOL CHEM, V273, P33166, DOI 10.1074/jbc.273.50.33166; Nakamura M, 2007, J HEPATOL, V46, P77, DOI 10.1016/j.jhep.2006.07.032; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Nomura Y, 1999, BIOCHEM BIOPH RES CO, V254, P388, DOI 10.1006/bbrc.1998.9941; Olson JM, 2004, TRENDS MOL MED, V10, P125, DOI 10.1016/j.molmed.2004.01.007; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Phillips PA, 2007, CANCER RES, V67, P9407, DOI 10.1158/0008-5472.CAN-07-1077; Picard E, 1999, J NATL CANCER I, V91, P1059, DOI 10.1093/jnci/91.12.1059; Qiu Daoming, 2003, Drugs R D, V4, P1, DOI 10.2165/00126839-200304010-00001; Takiyama Y, 2004, J CLIN ENDOCR METAB, V89, P5851, DOI 10.1210/jc.2003-032036; Tillman DM, 1999, CLIN CANCER RES, V5, P425; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wan CK, 2006, CANCER LETT, V241, P31, DOI 10.1016/j.canlet.2005.10.001; Westerheide SD, 2006, J BIOL CHEM, V281, P9616, DOI 10.1074/jbc.M512044200; Yamazaki K, 2007, GUT, V56, P1557, DOI 10.1136/gut.2007.129858; Yan TD, 2010, CANCER RES, V70, P2285, DOI 10.1158/0008-5472.CAN-09-2968; Yang SM, 2003, MOL CANCER THER, V2, P65; Zeisig BB, 2007, CANCER CELL, V12, P36, DOI 10.1016/j.ccr.2007.06.006; Zhao GH, 2000, AM J PHYSIOL-LUNG C, V279, pL958, DOI 10.1152/ajplung.2000.279.5.L958; Zhong C, 2003, CANCER BIOL THER, V2, P179, DOI 10.4161/cbt.2.2.281; Zhou H, 2010, CANCER CELL, V17, P560, DOI 10.1016/j.ccr.2010.04.023; Zhu J, 2007, CANCER CELL, V12, P23, DOI 10.1016/j.ccr.2007.06.004	48	17	20	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35722	10.1371/journal.pone.0035722	http://dx.doi.org/10.1371/journal.pone.0035722			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545132	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343200052
J	Zhuang, PW; Zhang, YJ; Cui, GZ; Bian, YH; Zhang, MX; Zhang, JB; Liu, Y; Yang, XP; Isaiah, AO; Lin, YX; Jiang, YB				Zhuang, Pengwei; Zhang, Yanjun; Cui, Guangzhi; Bian, Yuhong; Zhang, Mixia; Zhang, Jinbao; Liu, Yang; Yang, Xinpeng; Isaiah, Adejobi Oluwaniyi; Lin, Yingxue; Jiang, Yongbo			Direct Stimulation of Adult Neural Stem/Progenitor Cells In Vitro and Neurogenesis In Vivo by Salvianolic Acid B	PLOS ONE			English	Article							TRANSIENT GLOBAL-ISCHEMIA; CEREBRAL-ISCHEMIA; STEM-CELLS; CHINESE MEDICINE; PROGENITOR CELLS; SPATIAL MEMORY; DENTATE GYRUS; BRAIN-INJURY; EXERCISE; NEURONS	Background: Small molecules have been shown to modulate the neurogenesis processes. In search for new therapeutic drugs, the herbs used in traditional medicines for neurogenesis are promising candidates. Methodology and Principal Findings: We selected a total of 45 natural compounds from Traditional Chinese herbal medicines which are extensively used in China to treat stroke clinically, and tested their proliferation-inducing activities on neural stem/progenitor cells (NSPCs). The screening results showed that salvianolic acid B (Sal B) displayed marked effects on the induction of proliferation of NSPCs. We further demonstrated that Sal B promoted NSPCs proliferation in dose-and time-dependent manners. To explore the molecular mechanism, PI3K/Akt, MEK/ERK and Notch signaling pathways were investigated. Cell proliferation assay demonstrated that Ly294002 (PI3K/Akt inhibitor), but neither U0126 (ERK inhibitor) nor DAPT (Notch inhibitor) inhibited the Sal B-induced proliferation of cells. Western Blotting results showed that stimulation of NSPCs with Sal B enhanced the phosphorylation of Akt, and Ly294002 abolished this effect, confirming the role of Akt in Sal B mediated proliferation of NSPCs. Rats exposed to transient cerebral ischemia were treated for 4 weeks with Sal B from the 7th day after stroke. BrdU incorporation assay results showed that exposure Sal B could maintain the proliferation of NSPCs after cerebral ischemia. Morris water maze test showed that delayed post-ischemic treatment with Sal B improved cognitive impairment after stroke in rats. Significance: Sal B could maintain the NSPCs self-renew and promote proliferation, which was mediated by PI3K/Akt signal pathway. And delayed post-ischemic treatment with Sal B improved cognitive impairment after stroke in rats. These findings suggested that Sal B may act as a potential drug in treatment of brain injury or neurodegenerative diseases.	[Zhuang, Pengwei; Zhang, Yanjun; Cui, Guangzhi; Zhang, Mixia; Zhang, Jinbao; Liu, Yang; Yang, Xinpeng; Isaiah, Adejobi Oluwaniyi; Lin, Yingxue; Jiang, Yongbo] Tianjin Univ Tradit Chinese Med, Chinese Mat Med Coll, Key Lab Tradit Chinese Med Pharmacol, Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China; [Bian, Yuhong] Tianjin Univ Tradit Chinese Med, Chinese Med Coll, Tianjin, Peoples R China	Tianjin University of Traditional Chinese Medicine; China Medical University; Tianjin University of Traditional Chinese Medicine	Zhuang, PW (corresponding author), Tianjin Univ Tradit Chinese Med, Chinese Mat Med Coll, Key Lab Tradit Chinese Med Pharmacol, Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China.	zyjsunye@163.com			National Natural Science Foundation of China [30873395, 30472177]; National Basic Research Program of China [2011CB505302]; National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" [2012ZX09101202]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0973]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program"; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Natural Science Foundation of China (nos. 30873395 and 30472177), National Basic Research Program of China (no. 2011CB505302), National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" (2012ZX09101202) and the Program for Changjiang Scholars and Innovative Research Team in University (no. IRT0973). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruel-Jungerman E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007901; Canales JJ, 2010, BEHAV PHARMACOL, V21, P379, DOI 10.1097/FBP.0b013e32833e16b6; Chan CB, 2011, J NEUROSCI, V31, P8083, DOI 10.1523/JNEUROSCI.1129-11.2011; Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Choi YS, 2008, GLIA, V56, P791, DOI 10.1002/glia.20653; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI 10.1016/j.neuropharm.2008.01.005; Du GH, 2000, J ASIAN NAT PROD RES, V2, P145, DOI 10.1080/10286020008039903; Duncan P, 2003, STROKE, V34, P2173, DOI 10.1161/01.STR.0000083699.95351.F2; Feigin VL, 2007, STROKE, V38, P1734, DOI 10.1161/STROKEAHA.107.487132; Heurteaux C, 2010, NEUROPHARMACOLOGY, V58, P987, DOI 10.1016/j.neuropharm.2010.01.001; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Jacobs S, 2006, P NATL ACAD SCI USA, V103, P3902, DOI 10.1073/pnas.0511294103; Ji XY, 2000, ACTA PHARMACOL SIN, V21, P1089; Jiang M, 2011, AM J CHINESE MED, V39, P111, DOI 10.1142/S0192415X11008683; Johnson MA, 2009, BMB REP, V42, P245, DOI 10.5483/BMBRep.2009.42.5.245; Kee NJ, 2001, EXP BRAIN RES, V136, P313, DOI 10.1007/s002210000591; Khodosevich K, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-18; Kim DH, 2011, NEUROPHARMACOLOGY, V61, P1432, DOI 10.1016/j.neuropharm.2011.08.038; Kim H, 2005, NEUROL RES, V27, P287, DOI 10.1179/016164105X25234; Kim SJ, 2008, J BIOL CHEM, V283, P14497, DOI 10.1074/jbc.M708373200; Kwakkel G, 2004, STROKE, V35, P2529, DOI 10.1161/01.STR.0000143153.76460.7d; Lavenex PB, 2009, HIPPOCAMPUS, V19, P8, DOI 10.1002/hipo.20485; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Leker RR, 2009, J NEURAL TRANSM, V116, P1397, DOI 10.1007/s00702-009-0329-3; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Liu JL, 1998, J NEUROSCI, V18, P7768; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mook-Jung I, 2001, J NEUROSCI RES, V63, P509, DOI 10.1002/jnr.1045; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; NITATORI T, 1995, J NEUROSCI, V15, P1001; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Quintard H, 2011, NEUROPHARMACOLOGY, V61, P622, DOI 10.1016/j.neuropharm.2011.05.003; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Shioda N, 2009, INT REV NEUROBIOL, V85, P375, DOI 10.1016/S0074-7742(09)85026-5; Takagi Y, 1999, BRAIN RES, V831, P283, DOI 10.1016/S0006-8993(99)01411-0; Tang MK, 2006, BEHAV PHARMACOL, V17, P493, DOI 10.1097/00008877-200609000-00015; Tang MK, 2002, PHYTOMEDICINE, V9, P405, DOI 10.1078/09447110260571634; Wang CM, 2011, NEUROSCI LETT, V488, P70, DOI 10.1016/j.neulet.2010.10.079; Weiss S, 1996, TRENDS NEUROSCI, V19, P387, DOI 10.1016/S0166-2236(96)10035-7; Wu B, 2007, STROKE, V38, P1973, DOI 10.1161/STROKEAHA.106.473165; Xu M, 2007, BIOMED CHROMATOGR, V21, P1052, DOI 10.1002/bmc.852; Yabe T, 2010, NEUROSCIENCE, V165, P515, DOI 10.1016/j.neuroscience.2009.10.023; Yagita Y, 2001, STROKE, V32, P1890, DOI 10.1161/01.STR.32.8.1890; Yonemori F, 1996, J CEREBR BLOOD F MET, V16, P973, DOI 10.1097/00004647-199609000-00022; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	49	72	84	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35636	10.1371/journal.pone.0035636	http://dx.doi.org/10.1371/journal.pone.0035636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545124	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343200044
J	Cheng, FY; Huang, X; Sarangi, A; Ketova, T; Cooper, MK; Ying, LTT; Chiang, C				Cheng, Frances Y.; Huang, Xi; Sarangi, Anuraag; Ketova, Tatiana; Cooper, Michael K.; Ying Litingtung; Chiang, Chin			Widespread Contribution of Gdf7 Lineage to Cerebellar Cell Types and Implications for Hedgehog-Driven Medulloblastoma Formation	PLOS ONE			English	Article							EXPRESSING NEURAL PROGENITORS; SONIC HEDGEHOG; ROOF PLATE; CHOROID-PLEXUS; RHOMBIC-LIP; N-MYC; MOUSE CEREBELLUM; VERTEBRATE CNS; CREST CELLS; STEM-CELLS	The roof plate is a specialized embryonic midline tissue of the central nervous system that functions as a signaling center regulating dorsal neural patterning. In the developing hindbrain, roof plate cells express Gdf7 and previous genetic fate mapping studies showed that these cells contribute mostly to non-neural choroid plexus epithelium. We demonstrate here that constitutive activation of the Sonic hedgehog signaling pathway in the Gdf7 lineage invariably leads to medulloblastoma. Lineage tracing analysis reveals that Gdf7-lineage cells not only are a source of choroid plexus epithelial cells, but are also present in the cerebellar rhombic lip and contribute to a subset of cerebellar granule neuron precursors, the presumed cell-of-origin for Sonic hedgehog-driven medulloblastoma. We further show that Gdf7-lineage cells also contribute to multiple neuronal and glial cell types in the cerebellum, including glutamatergic granule neurons, unipolar brush cells, Purkinje neurons, GABAergic interneurons, Bergmann glial cells, and white matter astrocytes. These findings establish hindbrain roof plate as a novel source of diverse neural cell types in the cerebellum that is also susceptible to oncogenic transformation by deregulated Sonic hedgehog signaling.	[Cheng, Frances Y.; Huang, Xi; Ketova, Tatiana; Ying Litingtung; Chiang, Chin] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37235 USA; [Sarangi, Anuraag; Cooper, Michael K.] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN USA; [Chiang, Chin] Vanderbilt Univ, Neurosci Program, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Cheng, FY (corresponding author), Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37235 USA.	chin.chiang@vanderbilt.edu	Huang, Xi/C-2409-2017	Huang, Xi/0000-0002-7177-7525	National Institutes of Health (NIH) [T32 GM007347, NS 042205]; Children's Brain Tumor Foundation; Vanderbilt-Ingram Cancer Center [P30 CA068485]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS074638, R01NS042205] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Brain Tumor Foundation; Vanderbilt-Ingram Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) T32 GM007347, the Children's Brain Tumor Foundation, Vanderbilt-Ingram Cancer Center Support Grant P30 CA068485, and NIH NS 042205. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder J, 1999, NAT NEUROSCI, V2, P535, DOI 10.1038/9189; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Banka S, 2007, CHILD NERV SYST, V23, P587, DOI 10.1007/s00381-006-0249-6; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Chizhikov VV, 2006, DEVELOPMENT, V133, P2793, DOI 10.1242/dev.02441; Chizhikov VV, 2010, P NATL ACAD SCI USA, V107, P10725, DOI 10.1073/pnas.0910786107; Chizhikov VV, 2004, NAT REV NEUROSCI, V5, P808, DOI 10.1038/nrn1520; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Currle DS, 2005, DEVELOPMENT, V132, P3549, DOI 10.1242/dev.01915; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dang L, 2006, ONCOGENE, V25, P487, DOI 10.1038/sj.onc.1209074; Due-Tonnessen BJ, 2007, PEDIATR NEUROSURG, V43, P92, DOI 10.1159/000098379; Dymecki SM, 1998, DEV BIOL, V201, P57, DOI 10.1006/dbio.1998.8971; Englund C, 2006, J NEUROSCI, V26, P9184, DOI 10.1523/JNEUROSCI.1610-06.2006; Filippidis AS, 2011, CHILD NERV SYST, V27, P27, DOI 10.1007/s00381-010-1227-6; Fujimura M, 2004, CHILDS NERVOUS SYSTE, P20; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Gilbertson R, 2008, ORIGINS MEDULLOBLAST; Hatton BA, 2006, CANCER RES, V66, P8655, DOI 10.1158/0008-5472.CAN-06-1621; Huang X, 2010, J VISUALIZED EXPT; Huang X, 2009, DEVELOPMENT, V136, P2535, DOI 10.1242/dev.033795; Hunter NL, 2007, DEVELOPMENT, V134, P3449, DOI 10.1242/dev.003095; INOUYE M, 1980, J COMP NEUROL, V194, P499, DOI 10.1002/cne.901940302; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kenney AM, 2004, DEVELOPMENT, V131, P217, DOI 10.1242/dev.00891; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Kessler JD, 2009, GENE DEV, V23, P157, DOI 10.1101/gad.1759909; Kool M, 2012, ACTA NEUROPATHOLOGIC; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Landsberg RL, 2005, NEURON, V48, P933, DOI 10.1016/j.neuron.2005.11.031; Lang S-S, 2011, WORLD NEUROSURGERY; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Lo LC, 2005, P NATL ACAD SCI USA, V102, P7192, DOI 10.1073/pnas.0502581102; Machold R, 2005, NEURON, V48, P17, DOI 10.1016/j.neuron.2005.08.028; Millonig JH, 2000, NATURE, V403, P764, DOI 10.1038/35001573; Monuki ES, 2001, NEURON, V32, P591, DOI 10.1016/S0896-6273(01)00504-9; Northcott PA, 2011, ACTA NEUROPATHOLOGIC; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Rao G, 2004, ONCOGENE, V23, P6156, DOI 10.1038/sj.onc.1207818; Rao G, 2003, NEOPLASIA, V5, P198, DOI 10.1016/S1476-5586(03)80052-0; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Sillitoe RV, 2007, ANNU REV CELL DEV BI, V23, P549, DOI 10.1146/annurev.cellbio.23.090506.123237; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Taylor MD, 2011, ACTA NEUROPATHOLOGIC; Thomas WD, 2009, ONCOGENE, V28, P1605, DOI 10.1038/onc.2009.3; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; Wang VY, 2005, NEURON, V48, P31, DOI 10.1016/j.neuron.2005.08.024; Ward RJ, 2009, CANCER RES, V69, P4682, DOI 10.1158/0008-5472.CAN-09-0342; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; Zhang Y, 2010, BRAIN STRUCT FUNCT, V215, P115, DOI 10.1007/s00429-010-0278-5	58	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35541	10.1371/journal.pone.0035541	http://dx.doi.org/10.1371/journal.pone.0035541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539980	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341000046
J	Regev-Yochay, G; Abullaish, I; Malley, R; Shainberg, B; Varon, M; Roytman, Y; Ziv, A; Goral, A; Elhamdany, A; Rahav, G; Raz, M				Regev-Yochay, Gili; Abullaish, Izzeldin; Malley, Richard; Shainberg, Bracha; Varon, Miriam; Roytman, Yulia; Ziv, Arnona; Goral, Aviva; Elhamdany, Abedallah; Rahav, Galia; Raz, Meir		Palestinian-Israeli Collaborative	Streptococcus pneumoniae Carriage in the Gaza Strip	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; NASOPHARYNGEAL CARRIAGE; CHILDREN; DISEASE; SEROTYPE; IMPACT; SURVEILLANCE; RESISTANCE; REDUCTION; PROGRAM	Background: Pneumococcal infections cause major morbidity and mortality in developing countries. We report the epidemiology of S. pneumoniae carriage in a developing region, the Gaza strip, and evaluate the theoretical coverage of carriage strains by pneumococcal conjugate vaccines (PCVs). Methodology: In 2009 we conducted a cross-sectional survey of S. pneumoniae carriage in healthy children and their parents, living throughout the Gaza strip. Data were collected and nasopharyngeal swabs were obtained. Antibiotic susceptibilities were determined by Vitek-2 and serotypes by the Quellung reaction. Principal Findings: S. pneumoniae carriage was detected in 189/379 (50%) of children and 30/376 (8%) of parents. Carriage prevalence was highest in children <6 months of age (63%). Significant predictors for child carriage were number of household members and DCC attendance. The proportion of pediatric and adults isolates with serotypes included in PCV7 were 32% and 20% respectively, and 46% and 33% in PCV13 respectively. The most prominent non-vaccine serotypes (NVT) were 35B, 15B/C and 23B. Penicillin-nonsusceptible strains were carried by70% of carriers, penicillin-resistant strains (PRSP) by 13% and Multi-drug-resistant (MDR) by 30%. Of all PRSP isolates 54% belonged to serotypes included in PCV7 and 71% in the PCV13. Similarly, 59% and 73% of MDR-SP isolates, would theoretically be covered by PCV7 and PCV13, respectively. Conclusions: This study demonstrates that, PCV13-included strains were carried by 46% and 33% of pediatric and adult subjects respectively. In the absence of definitive data regarding the virulence of the NVT strains, it is difficult to predict the effect of PCVs on IPD in this region.	[Regev-Yochay, Gili; Roytman, Yulia; Goral, Aviva; Rahav, Galia] Chaim Sheba Med Ctr, Infect Dis Unit, IL-52621 Tel Hashomer, Israel; [Regev-Yochay, Gili; Roytman, Yulia; Goral, Aviva; Rahav, Galia] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Regev-Yochay, Gili; Abullaish, Izzeldin; Ziv, Arnona; Goral, Aviva] Gertner Inst Epidemiol Res, Ramat Gan, Israel; [Malley, Richard] Childrens Hosp Boston, Div Infect Dis, Boston, MA USA; [Malley, Richard] Harvard Univ, Sch Med, Boston, MA USA; [Shainberg, Bracha] Macabbi Healthcare Serv, Cent Lab, Rehovot, Israel; [Varon, Miriam; Raz, Meir] Macabbi Healthcare Serv, Modiin, Israel; [Abullaish, Izzeldin] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, BC, Canada; [Elhamdany, Abedallah] Keystone Consulting Agcy, Gaza City, Gaza Strip, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Toronto	Regev-Yochay, G (corresponding author), Chaim Sheba Med Ctr, Infect Dis Unit, IL-52621 Tel Hashomer, Israel.	gregev@hsph.harvard.edu	Goral, Aviva/K-8254-2016	Goral, Aviva/0000-0002-0784-0569; Regev-Yochay, Gili/0000-0001-7163-4607	Gertner Institute; Maccabi Healthcare Services Research Institute [RC-24010]; NIH [R01 AI066013]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066013] Funding Source: NIH RePORTER	Gertner Institute; Maccabi Healthcare Services Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Gertner Institute grant 2009, Maccabi Healthcare Services Research Institute grant RC-24010 and NIH grant R01 AI066013. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. No additional external funding was received for this study.	Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Dagan R, 2008, LANCET INFECT DIS, V8, P785, DOI 10.1016/S1473-3099(08)70281-0; Dagan R, 2010, J INFECT DIS, V201, P1570, DOI 10.1086/652006; ElAstal Z, 1997, PEDIATR INFECT DIS J, V16, P905, DOI 10.1097/00006454-199709000-00016; Falade AG, 2009, CLIN INFECT DIS, V48, pS190, DOI 10.1086/596500; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Granat SM, 2007, PEDIATR INFECT DIS J, V26, P319, DOI 10.1097/01.inf.0000257425.24492.11; Hanage WP, 2005, INFECT IMMUN, V73, P431, DOI 10.1128/IAI.73.1.431-435.2005; Hill PC, 2006, CLIN INFECT DIS, V43, P673, DOI 10.1086/506941; Hsu KK, 2010, PEDIATR INFECT DIS J, V29, P289, DOI 10.1097/INF.0b013e3181c15471; Huang SS, 2005, PEDIATRICS, V116, pE408, DOI 10.1542/peds.2004-2338; Huang SS, 2009, PEDIATRICS, V124, pE1, DOI 10.1542/peds.2008-3099; Jacoby P, 2011, PEDIATR INFECT DIS J, V30, P480, DOI 10.1097/INF.0b013e318217dc6e; Kaplan SL, 2004, PEDIATRICS, V113, P443, DOI 10.1542/peds.113.3.443; Kim SY, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-260; Kisakye A, 2009, CLIN INFECT DIS, V48, pS153, DOI 10.1086/596495; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Labout JAM, 2008, J PEDIATR-US, V153, P771, DOI 10.1016/j.jpeds.2008.05.061; Lagos R, 2008, J INFECT DIS, V198, P1809, DOI 10.1086/593334; Levine OS, 2006, LANCET, V367, P1880, DOI 10.1016/S0140-6736(06)68703-5; Millar EV, 2009, PEDIATR INFECT DIS J, V28, P711, DOI 10.1097/INF.0b013e3181a06303; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Regev-Yochay G, 2003, SCAND J INFECT DIS, V35, P219, DOI 10.1080/00365540310000319; Regev-Yochay G, 2004, CLIN INFECT DIS, V38, P632, DOI 10.1086/381547; Simoes AS, 2011, J CLIN MICROBIOL, V49, P2810, DOI 10.1128/JCM.00517-11; Spijkerman J, 2011, EMERG INFECT DIS, V17, P584, DOI 10.3201/eid1704.101115; Stamboulidis K, 2011, PEDIATR INFECT DIS J, V30, P551, DOI 10.1097/INF.0b013e31821038d9; Talbot TR, 2004, CLIN INFECT DIS, V39, P641, DOI 10.1086/422653; Tyrrell GJ, 2009, VACCINE, V27, P3553, DOI 10.1016/j.vaccine.2009.03.063; Vestrheim DF, 2010, CLIN VACCINE IMMUNOL, V17, P325, DOI 10.1128/CVI.00435-09; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828; Yildirim I, 2010, VACCINE, V29, P283, DOI 10.1016/j.vaccine.2010.10.032	36	13	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35061	10.1371/journal.pone.0035061	http://dx.doi.org/10.1371/journal.pone.0035061			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539955	gold, Green Submitted, Green Published			2022-12-25	WOS:000305341000019
J	Esposito, R; D'Aniello, S; Squarzoni, P; Pezzotti, MR; Ristoratore, F; Spagnuolo, A				Esposito, Rosaria; D'Aniello, Salvatore; Squarzoni, Paola; Pezzotti, Maria Rosa; Ristoratore, Filomena; Spagnuolo, Antonietta			New Insights into the Evolution of Metazoan Tyrosinase Gene Family	PLOS ONE			English	Article							ASCIDIAN EMBRYOS; PIGMENT-CELLS; CIONA-INTESTINALIS; AMPHIOXUS GENOME; SIMPLE CHORDATE; EXPRESSION; PROTEINS; MELANIN; MECHANISM; TYRP1	Tyrosinases, widely distributed among animals, plants and fungi, are involved in the biosynthesis of melanin, a pigment that has been exploited, in the course of evolution, to serve different functions. We conducted a deep evolutionary analysis of tyrosinase family amongst metazoa, thanks to the availability of new sequenced genomes, assessing that tyrosinases (tyr) represent a distinctive feature of all the organisms included in our study and, interestingly, they show an independent expansion in most of the analyzed phyla. Tyrosinase-related proteins (tyrp), which derive from tyr but show distinct key residues in the catalytic domain, constitute an invention of chordate lineage. In addition we here reported a detailed study of the expression territories of the ascidian Ciona intestinalis tyr and tyrps. Furthermore, we put efforts in the identification of the regulatory sequences responsible for their expression in pigment cell lineage. Collectively, the results reported here enlarge our knowledge about the tyrosinase gene family as valuable resource for understanding the genetic components involved in pigment cells evolution and development.	[Esposito, Rosaria; D'Aniello, Salvatore; Squarzoni, Paola; Pezzotti, Maria Rosa; Ristoratore, Filomena; Spagnuolo, Antonietta] Stn Zool Anton Dohrn, Cellular & Dev Biol Dept, Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli	Spagnuolo, A (corresponding author), Ecole Normale Super, Inst Biol, IBENS, INSERM,U1024,Avenir Team, 24 Rue Lhomond, F-75231 Paris, France.	nietta.spagnuolo@szn.it	Esposito, Rosaria/M-8422-2016	Spagnuolo, Antonietta/0000-0001-6660-071X				AROCA P, 1990, BIOCHIM BIOPHYS ACTA, V1035, P266, DOI 10.1016/0304-4165(90)90088-E; Beh J, 2007, DEVELOPMENT, V134, P3297, DOI 10.1242/dev.010140; Bertrand V, 2003, CELL, V115, P615, DOI 10.1016/S0092-8674(03)00928-0; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Camacho-Hubner A, 2002, GENE, V285, P59, DOI 10.1016/S0378-1119(02)00411-0; Caracciolo A, 1997, DEV GROWTH DIFFER, V39, P437; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Corbo JC, 1997, DEVELOPMENT, V124, P589; Davidson B, 2005, DEVELOPMENT, V132, P4811, DOI 10.1242/dev.02051; Davidson B, 2006, GENE DEV, V20, P2728, DOI 10.1101/gad.1467706; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Di Gregorio A, 2002, DIFFERENTIATION, V70, P132; EAKIN RM, 1973, 3 EYE; Garcia-Borron JC, 2002, PIGM CELL RES, V15, P162, DOI 10.1034/j.1600-0749.2002.02012.x; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Goding CR, 2007, INT J BIOCHEM CELL B, V39, P275, DOI 10.1016/j.biocel.2006.10.003; Hearing VJ, 2000, PIGM CELL RES, V13, P23, DOI 10.1034/j.1600-0749.13.s8.7.x; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Huang GH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000206; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; JACKSON IJ, 1994, PIGM CELL RES, V7, P241, DOI 10.1111/j.1600-0749.1994.tb00056.x; JIMENEZ M, 1991, J BIOL CHEM, V266, P1147; JIMENEZCERVANTES C, 1993, EUR J BIOCHEM, V217, P549, DOI 10.1111/j.1432-1033.1993.tb18276.x; JIMENEZCERVANTES C, 1994, J BIOL CHEM, V269, P17993; Johnson DS, 2004, GENOME RES, V14, P2448, DOI 10.1101/gr.2964504; KOBAYASHI T, 1994, EMBO J, V13, P5818, DOI 10.1002/j.1460-2075.1994.tb06925.x; Kobayashi T, 1998, J BIOL CHEM, V273, P31801, DOI 10.1074/jbc.273.48.31801; Lacalli TC, 2004, BRAIN BEHAV EVOLUT, V64, P148, DOI 10.1159/000079744; Le Douarin N.M., 1982, NEURAL CREST; LUO D, 1994, EXP CELL RES, V213, P231, DOI 10.1006/excr.1994.1195; Manga P, 2000, PIGM CELL RES, V13, P364, DOI 10.1034/j.1600-0749.2000.130510.x; Martinez-Morales JR, 2004, BIOESSAYS, V26, P766, DOI 10.1002/bies.20064; Murisier F, 2006, HISTOL HISTOPATHOL, V21, P567, DOI 10.14670/HH-21.567; NISHIDA H, 1987, DEV BIOL, V121, P526, DOI 10.1016/0012-1606(87)90188-6; Olivares C, 2009, PIGM CELL MELANOMA R, V22, P750, DOI 10.1111/j.1755-148X.2009.00636.x; PORCHETHENNERE E, 1992, CELL TISSUE RES, V269, P167, DOI 10.1007/BF00384737; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Ristoratore F, 1999, DEVELOPMENT, V126, P5149; Sarangarajan R, 2001, PIGM CELL RES, V14, P437, DOI 10.1034/j.1600-0749.2001.140603.x; Sato S, 1997, DEV DYNAM, V208, P363; Sato S, 2001, PIGM CELL RES, V14, P428, DOI 10.1034/j.1600-0749.2001.140602.x; Sato S, 1999, DEV DYNAM, V215, P225, DOI 10.1002/(SICI)1097-0177(199907)215:3<225::AID-AJA5>3.0.CO;2-S; Satoh N, 2001, DIFFERENTIATION, V68, P1, DOI 10.1046/j.1432-0436.2001.068001001.x; SILVERS WK (ED), 1979, COAT COLORS MICE MOD; Squarzoni P, 2011, DEVELOPMENT, V138, P1421, DOI 10.1242/dev.057323; STEEL KP, 1992, DEVELOPMENT, V115, P1111; STURM RA, 1995, GENOMICS, V29, P24, DOI 10.1006/geno.1995.1211; Sugumaran H, 2002, PIGM CELL RES, V15, P2, DOI 10.1034/j.1600-0749.2002.00056.x; Sugumaran M, 1998, ADV INSECT PHYSIOL, V27, P229, DOI 10.1016/S0065-2806(08)60014-4; Takeuchi K, 2005, ZOOL SCI, V22, P723, DOI 10.2108/zsj.22.723; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toyoda R, 2004, GENE, V332, P61, DOI 10.1016/j.gene.2004.01.030; Toyoda R, 2000, GENE, V259, P159, DOI 10.1016/S0378-1119(00)00433-9; Tsuda M, 2003, J EXP BIOL, V206, P1409, DOI 10.1242/jeb.00235; TSUKAMOTO K, 1992, EMBO J, V11, P519, DOI 10.1002/j.1460-2075.1992.tb05082.x; Vinson JP, 2005, GENOME RES, V15, P1127, DOI 10.1101/gr.3722605; Wang TT, 2009, FISH SHELLFISH IMMUN, V27, P757, DOI 10.1016/j.fsi.2009.09.002; WHITTAKER JR, 1973, DEV BIOL, V30, P441, DOI 10.1016/0012-1606(73)90101-2; WINDER A, 1994, CELL MOL BIOL RES, V40, P613; Xiang ZX, 2006, CURR PROTEIN PEPT SC, V7, P217, DOI 10.2174/138920306777452312; Yajima I, 2003, MECH DEVELOP, V120, P1489, DOI 10.1016/j.mod.2003.08.009; Yu JK, 2008, GENOME RES, V18, P1127, DOI 10.1101/gr.076208.108; Zhang SC, 2009, PROG NAT SCI-MATER, V19, P923, DOI 10.1016/j.pnsc.2008.07.025	66	27	34	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35731	10.1371/journal.pone.0035731	http://dx.doi.org/10.1371/journal.pone.0035731			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536431	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339200103
J	Gong, YB; Zheng, JL; Jin, B; Zhuo, DX; Huang, ZQ; Qi, H; Zhang, W; Duan, W; Fu, JT; Wang, CJ; Mao, ZB				Gong, Yan-Bing; Zheng, Jian-Ling; Jin, Bo; Zhuo, De-Xiang; Huang, Zhu-Qing; Qi, He; Zhang, Wei; Duan, Wei; Fu, Ji-Ting; Wang, Chui-Jie; Mao, Ze-Bin			Particular Candida albicans Strains in the Digestive Tract of Dyspeptic Patients, Identified by Multilocus Sequence Typing	PLOS ONE			English	Article							UPPER GASTROINTESTINAL-TRACT; MOLECULAR PHYLOGENETICS; AUTOIMMUNE PANCREATITIS; HELICOBACTER-PYLORI; EPITHELIAL-CELLS; COLONIZATION; POPULATION; INFECTIONS; PREVALENCE; DIVERSITY	Background: Candida albicans is a human commensal that is also responsible for chronic gastritis and peptic ulcerous disease. Little is known about the genetic profiles of the C. albicans strains in the digestive tract of dyspeptic patients. The aim of this study was to evaluate the prevalence, diversity, and genetic profiles among C. albicans isolates recovered from natural colonization of the digestive tract in the dyspeptic patients. Methods and Findings: Oral swab samples (n = 111) and gastric mucosa samples (n = 102) were obtained from a group of patients who presented dyspeptic symptoms or ulcer complaints. Oral swab samples (n = 162) were also obtained from healthy volunteers. C. albicans isolates were characterized and analyzed by multilocus sequence typing. The prevalence of Candida spp. in the oral samples was not significantly different between the dyspeptic group and the healthy group (36.0%, 40/111 vs. 29.6%, 48/162; P > 0.05). However, there were significant differences between the groups in the distribution of species isolated and the genotypes of the C. albicans isolates. C. albicans was isolated from 97.8% of the Candida-positive subjects in the dyspeptic group, but from only 56.3% in the healthy group (P < 0.001). DST1593 was the dominant C. albicans genotype from the digestive tract of the dyspeptic group (60%, 27/45), but not the healthy group (14.8%, 4/27) (P < 0.001). Conclusions: Our data suggest a possible link between particular C. albicans strain genotypes and the host microenvironment. Positivity for particular C. albicans genotypes could signify susceptibility to dyspepsia.	[Gong, Yan-Bing; Jin, Bo; Zhuo, De-Xiang; Mao, Ze-Bin] Peking Univ, Lab Ze Bin Mao, Dept Biochem & Mol Biol, Sch Basic Med Sci,Hlth Sci Ctr, Beijing 100871, Peoples R China; [Zheng, Jian-Ling; Huang, Zhu-Qing; Qi, He; Zhang, Wei; Duan, Wei] Med Sci Inst Liaoning, Dept Microbiol, Shenyang, Peoples R China; [Fu, Ji-Ting; Wang, Chui-Jie] Liaoning Univ Tradit Chinese Med, Div Gastroenterol, Hosp 1, Shenyang, Peoples R China	Peking University; Liaoning University of Traditional Chinese Medicine	Gong, YB (corresponding author), Peking Univ, Lab Ze Bin Mao, Dept Biochem & Mol Biol, Sch Basic Med Sci,Hlth Sci Ctr, Beijing 100871, Peoples R China.	gongyanbing@bjmu.edu.cn; shenyangzheng@hotmail.com; zbmao@bjmu.edu.cn		GONG, Yan-Bing/0000-0001-8896-3765				Asherson RA, 2008, NAT CLIN PRACT RHEUM, V4, P439, DOI 10.1038/ncprheum0839; Borman AM, 2009, J CLIN MICROBIOL, V47, P2307, DOI 10.1128/JCM.00240-09; Bougnoux ME, 2008, INTENS CARE MED, V34, P292, DOI 10.1007/s00134-007-0865-y; Bougnoux ME, 2004, INFECT GENET EVOL, V4, P243, DOI 10.1016/j.meegid.2004.06.002; Bougnoux ME, 2006, J CLIN MICROBIOL, V44, P1810, DOI 10.1128/JCM.44.5.1810-1820.2006; Bougnoux ME, 2003, J CLIN MICROBIOL, V41, P5265, DOI 10.1128/JCM.41.11.5265-5266.2003; Bougnoux ME, 2002, J CLIN MICROBIOL, V40, P1290, DOI 10.1128/JCM.40.4.1290-1297.2002; Chang MC, 2009, PANCREAS, V38, P442, DOI 10.1097/MPA.0b013e31819b5f3c; Chavez-Galarza J, 2010, INFECT GENET EVOL, V10, P697, DOI 10.1016/j.meegid.2010.03.007; Chen KW, 2006, J CLIN MICROBIOL, V44, P2172, DOI 10.1128/JCM.00320-06; Chen YC, 2010, DIAGN MICR INFEC DIS, V68, P284, DOI 10.1016/j.diagmicrobio.2010.07.004; Cliff PR, 2008, J HOSP INFECT, V69, P24, DOI 10.1016/j.jhin.2008.02.006; d'Enfert C, 2009, CURR OPIN MICROBIOL, V12, P358, DOI 10.1016/j.mib.2009.05.008; Da Matta DA, 2010, J CLIN MICROBIOL, V48, P3062, DOI 10.1128/JCM.00262-10; Dalle F, 2010, CELL MICROBIOL, V12, P248, DOI 10.1111/j.1462-5822.2009.01394.x; Davis DA, 2009, CURR OPIN MICROBIOL, V12, P365, DOI 10.1016/j.mib.2009.05.006; Ge SH, 2012, FUNGAL GENET BIOL, V49, P86, DOI 10.1016/j.fgb.2011.10.006; Grubb SEW, 2008, INFECT IMMUN, V76, P4370, DOI 10.1128/IAI.00332-08; Hirasaki S, 1999, J GASTROENTEROL, V34, P688, DOI 10.1007/s005350050320; Jacobsen MD, 2008, FEMS YEAST RES, V8, P1334, DOI 10.1111/j.1567-1364.2008.00438.x; Jacobsen MD, 2008, RES MICROBIOL, V159, P436, DOI 10.1016/j.resmic.2008.05.003; KALOGEROPOULOS NK, 1988, J CLIN PATHOL, V41, P1093, DOI 10.1136/jcp.41.10.1093; Karczewska E, 2009, J PHYSIOL PHARMACOL, V60, P33; Karkowska-Kuleta J, 2009, ACTA BIOCHIM POL, V56, P211; Laverdiere M, 2006, J ANTIMICROB CHEMOTH, V57, P705, DOI 10.1093/jac/dkl022; MacCallum DM, 2009, EUKARYOT CELL, V8, P373, DOI 10.1128/EC.00387-08; Mansueto P, 2012, CLIN EXP MED, V12, P201, DOI 10.1007/s10238-011-0158-1; McManus BA, 2011, J CLIN MICROBIOL, V49, P1879, DOI 10.1128/JCM.00026-11; MIRHENDI H, 2006, JPN J MED MYCOL, V47, P225; Moreno-Ruiz E, 2009, CELL MICROBIOL, V11, P1179, DOI 10.1111/j.1462-5822.2009.01319.x; Odds FC, 2006, J CLIN MICROBIOL, V44, P3647, DOI 10.1128/JCM.00934-06; Odds FC, 2008, EUKARYOT CELL, V7, P1075, DOI 10.1128/EC.00062-08; Odds FC, 2007, J MED MICROBIOL, V56, P1066, DOI 10.1099/jmm.0.47239-0; Odds FC, 2007, EUKARYOT CELL, V6, P1041, DOI 10.1128/EC.00041-07; Odds FC, 2010, FUTURE MICROBIOL, V5, P67, DOI 10.2217/FMB.09.113; Odds FC, 2009, FEMS YEAST RES, V9, P1091, DOI 10.1111/j.1567-1364.2009.00577.x; Parnanen P, 2010, J ORAL PATHOL MED, V39, P275, DOI 10.1111/j.1600-0714.2009.00866.x; Ramaswamy K, 2007, Indian J Med Microbiol, V25, P57; Robles JC, 2004, J CLIN MICROBIOL, V42, P2480, DOI 10.1128/JCM.42.6.2480-2488.2004; Rollenhagen C, 2009, CELL MICROBIOL, V11, P946, DOI 10.1111/j.1462-5822.2009.01303.x; Sampaio P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010155; Selmecki A, 2010, EUKARYOT CELL, V9, P991, DOI 10.1128/EC.00060-10; Shin JH, 2011, J CLIN MICROBIOL, V49, P2572, DOI 10.1128/JCM.02153-10; Shinji A, 2004, GASTROINTEST ENDOSC, V59, P506, DOI 10.1016/S0016-5107(03)02874-8; Takakura S, 2008, INT J MED MICROBIOL, V298, P663, DOI 10.1016/j.ijmm.2007.11.002; Tavanti A, 2005, J CLIN MICROBIOL, V43, P5601, DOI 10.1128/JCM.43.11.5601-5613.2005; Tavanti A, 2004, FUNGAL GENET BIOL, V41, P553, DOI 10.1016/j.fgb.2003.12.008; Tavanti A, 2003, J CLIN MICROBIOL, V41, P3765, DOI 10.1128/JCM.41.8.3765-3776.2003; Wrobel L, 2008, EUKARYOT CELL, V7, P1475, DOI 10.1128/EC.00162-08; Zhu WD, 2010, CELL MICROBIOL, V12, P273, DOI 10.1111/j.1462-5822.2009.01412.x; Zwolinska-Wcislo M, 2006, J PHYSIOL PHARMACOL, V57, P35; Zwolinska-Wcislo M, 2001, MED SCI MONITOR, V7, P266	53	26	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35311	10.1371/journal.pone.0035311	http://dx.doi.org/10.1371/journal.pone.0035311			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536371	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200053
J	Yamashita, H; Chen, SL; Komagata, S; Hishida, R; Iwasato, T; Itohara, S; Yagi, T; Endo, N; Shibata, M; Shibuki, K				Yamashita, Haruyoshi; Chen, Shanlin; Komagata, Seiji; Hishida, Ryuichi; Iwasato, Takuji; Itohara, Shigeyoshi; Yagi, Takeshi; Endo, Naoto; Shibata, Minoru; Shibuki, Katsuei			Restoration of Contralateral Representation in the Mouse Somatosensory Cortex after Crossing Nerve Transfer	PLOS ONE			English	Article							PROTOCADHERIN-ALPHA FAMILY; VISUAL-CORTEX; FLAVOPROTEIN AUTOFLUORESCENCE; HAND REPRESENTATION; CORPUS-CALLOSUM; AUDITORY-CORTEX; SENSORY NEURONS; INJURED ARM; PLASTICITY; MICE	Avulsion of spinal nerve roots in the brachial plexus (BP) can be repaired by crossing nerve transfer via a nerve graft to connect injured nerve ends to the BP contralateral to the lesioned side. Sensory recovery in these patients suggests that the contralateral primary somatosensory cortex (S1) is activated by afferent inputs that bypassed to the contralateral BP. To confirm this hypothesis, the present study visualized cortical activity after crossing nerve transfer in mice through the use of transcranial flavoprotein fluorescence imaging. In naive mice, vibratory stimuli applied to the forepaw elicited localized fluorescence responses in the S1 contralateral to the stimulated side, with almost no activity in the ipsilateral S1. Four weeks after crossing nerve transfer, forepaw stimulation in the injured and repaired side resulted in cortical responses only in the S1 ipsilateral to the stimulated side. At eight weeks after crossing nerve transfer, forepaw stimulation resulted in S1 cortical responses of both hemispheres. These cortical responses were abolished by cutting the nerve graft used for repair. Exposure of the ipsilateral S1 to blue laser light suppressed cortical responses in the ipsilateral S1, as well as in the contralateral S1, suggesting that ipsilateral responses propagated to the contralateral S1 via cortico-cortical pathways. Direct high-frequency stimulation of the ipsilateral S1 in combination with forepaw stimulation acutely induced S1 bilateral cortical representation of the forepaw area in naive mice. Cortical responses in the contralateral S1 after crossing nerve transfer were reduced in cortex-restricted heterotypic GluN1 (NMDAR1) knockout mice. Functional bilateral cortical representation was not clearly observed in genetically manipulated mice with impaired cortico-cortical pathways between S1 of both hemispheres. Taken together, these findings strongly suggest that activity-dependent potentiation of cortico-cortical pathways has a critical role for sensory recovery in patients after crossing nerve transfer.	[Yamashita, Haruyoshi; Chen, Shanlin; Komagata, Seiji; Hishida, Ryuichi; Shibuki, Katsuei] Niigata Univ, Brain Res Inst, Dept Neurophysiol, Niigata, Japan; [Yamashita, Haruyoshi; Chen, Shanlin; Shibata, Minoru] Niigata Univ, Fac Med, Dept Plast Surg, Niigata, Japan; [Yamashita, Haruyoshi; Endo, Naoto] Niigata Univ, Fac Med, Dept Orthoped Surg, Niigata, Japan; [Chen, Shanlin] Beijing Jishuitan Hosp, Beijing, Peoples R China; [Iwasato, Takuji] Natl Inst Genet, Div Neurogenet, Mishima, Shizuoka 411, Japan; [Itohara, Shigeyoshi] RIKEN Brain Sci Inst, Lab Behav Genet, Wako, Saitama, Japan; [Yagi, Takeshi] Osaka Univ, KOKORO Biol Grp, Labs Integrated Biol, Grad Sch Frontier Biosci, Osaka, Japan	Niigata University; Niigata University; Niigata University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; RIKEN; Osaka University	Shibuki, K (corresponding author), Niigata Univ, Brain Res Inst, Dept Neurophysiol, Niigata, Japan.	shibuki@bri.niigata-u.ac.jp	Itohara, Shigeyoshi/I-8769-2012	Itohara, Shigeyoshi/0000-0002-2410-9989	Japanese Government;  [22115011];  [22240044]; Grants-in-Aid for Scientific Research [23500383, 19100006] Funding Source: KAKEN	Japanese Government; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (Nos. 22115011 and 22240044) and Core Research for Evolutional Science and Technology program from the Japanese Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addas BMJ, 2009, NEUROSURG CLIN N AM, V20, P27, DOI 10.1016/j.nec.2008.07.018; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CHANCE B, 1962, SCIENCE, V137, P499, DOI 10.1126/science.137.3529.499; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; Donnerer J, 2003, PHARMACOLOGY, V67, P169, DOI 10.1159/000068405; Fabri M, 2006, EUR J NEUROSCI, V23, P3139, DOI 10.1111/j.1460-9568.2006.04823.x; Fabri M, 2005, COGNITIVE BRAIN RES, V24, P73, DOI 10.1016/j.cogbrainres.2004.12.003; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; GU YD, 1994, J HAND SURG-BRIT EUR, V19B, P69, DOI 10.1016/0266-7681(94)90053-1; GU YD, 1992, J HAND SURG-BRIT EUR, V17B, P518, DOI 10.1016/S0266-7681(05)80235-9; Hasegawa S, 2008, MOL CELL NEUROSCI, V38, P66, DOI 10.1016/j.mcn.2008.01.016; Hishida R, 2011, J NEUROSCI METH, V201, P315, DOI 10.1016/j.jneumeth.2011.08.007; Iwamura Y, 2002, BEHAV BRAIN RES, V135, P185, DOI 10.1016/S0166-4328(02)00164-X; IWAMURA Y, 1994, NATURE, V369, P554, DOI 10.1038/369554a0; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Jain N, 2008, J NEUROSCI, V28, P11042, DOI 10.1523/JNEUROSCI.2334-08.2008; Kamatani D, 2007, NEUROIMAGE, V35, P47, DOI 10.1016/j.neuroimage.2006.08.049; Katori S, 2009, J NEUROSCI, V29, P9137, DOI 10.1523/JNEUROSCI.5478-08.2009; Kitaura H, 2010, BRAIN RES, V1319, P54, DOI 10.1016/j.brainres.2010.01.020; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Komagata S, 2011, J NEUROSCI, V31, P4896, DOI 10.1523/JNEUROSCI.6753-10.2011; Kubota Y, 2008, NEUROSCI RES, V60, P422, DOI 10.1016/j.neures.2007.12.013; Lou L, 2006, NEUROSCIENCE, V138, P1225, DOI 10.1016/j.neuroscience.2005.11.062; Lundborg G, 2007, ACTA PHYSIOL, V189, P207, DOI 10.1111/j.1748-1716.2006.01653.x; MERZENICH MM, 1983, NEUROSCIENCE, V8, P33, DOI 10.1016/0306-4522(83)90024-6; Murakami H, 2004, EUR J NEUROSCI, V19, P1352, DOI 10.1111/j.1460-9568.2004.03237.x; Romo R, 2001, ANNU REV NEUROSCI, V24, P107, DOI 10.1146/annurev.neuro.24.1.107; Schreiner D, 2010, P NATL ACAD SCI USA, V107, P14893, DOI 10.1073/pnas.1004526107; Schuett S, 2002, J NEUROSCI, V22, P6549; Shibuki K, 2003, J PHYSIOL-LONDON, V549, P919, DOI 10.1113/jphysiol.2003.040709; SHIMOJO S, 1981, PERCEPTION, V10, P391, DOI 10.1068/p100391; Sugita Y, 1996, NATURE, V380, P523, DOI 10.1038/380523a0; Takahashi K, 2006, EUR J NEUROSCI, V23, P1365, DOI 10.1111/j.1460-9568.2006.04662.x; Tanaka Y, 2007, VISION RES, V47, P1350, DOI 10.1016/j.visres.2006.10.028; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tohmi M, 2006, J NEUROSCI, V26, P11775, DOI 10.1523/JNEUROSCI.1643-06.2006; VITERBO F, 1994, BRIT J PLAST SURG, V47, P75, DOI 10.1016/0007-1226(94)90162-7; Wang M, 2010, NEUROSURGERY, V67, P136, DOI 10.1227/01.NEU.0000370603.45342.6B; WANG XQ, 1995, NATURE, V378, P71, DOI 10.1038/378071a0; Watanabe K, 2007, BRAIN RES, V1166, P20, DOI 10.1016/j.brainres.2007.06.049; Wiest MC, 2010, J NEUROPHYSIOL, V104, P300, DOI 10.1152/jn.00194.2010; Zuo CT, 2010, J NEUROSURG, V113, P133, DOI 10.3171/2010.1.JNS09448	42	16	17	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35676	10.1371/journal.pone.0035676	http://dx.doi.org/10.1371/journal.pone.0035676			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22536423	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200095
J	Savory, EA; Zou, C; Adhikari, BN; Hamilton, JP; Buell, CR; Shiu, SH; Day, B				Savory, Elizabeth A.; Zou, Cheng; Adhikari, Bishwo N.; Hamilton, John P.; Buell, C. Robin; Shiu, Shin-Han; Day, Brad			Alternative Splicing of a Multi-Drug Transporter from Pseudoperonospora cubensis Generates an RXLR Effector Protein That Elicits a Rapid Cell Death	PLOS ONE			English	Review							PHYTOPHTHORA-SOJAE; GENOME SEQUENCE; AVIRULENCE; ARABIDOPSIS; EXPRESSION; EVOLUTION; GENES; LOCUS; POLYMORPHISMS; MECHANISMS	Pseudoperonospora cubensis, an obligate oomycete pathogen, is the causal agent of cucurbit downy mildew, a foliar disease of global economic importance. Similar to other oomycete plant pathogens, Ps. cubensis has a suite of RXLR and RXLR-like effector proteins, which likely function as virulence or avirulence determinants during the course of host infection. Using in silico analyses, we identified 271 candidate effector proteins within the Ps. cubensis genome with variable RXLR motifs. In extending this analysis, we present the functional characterization of one Ps. cubensis effector protein, RXLR protein 1 (PscRXLR1), and its closest Phytophthora infestans ortholog, PITG_17484, a member of the Drug/Metabolite Transporter (DMT) superfamily. To assess if such effector-non-effector pairs are common among oomycete plant pathogens, we examined the relationship(s) among putative ortholog pairs in Ps. cubensis and P. infestans. Of 271 predicted Ps. cubensis effector proteins, only 109 (41%) had a putative ortholog in P. infestans and evolutionary rate analysis of these orthologs shows that they are evolving significantly faster than most other genes. We found that PscRXLR1 was up-regulated during the early stages of infection of plants, and, moreover, that heterologous expression of PscRXLR1 in Nicotiana benthamiana elicits a rapid necrosis. More interestingly, we also demonstrate that PscRXLR1 arises as a product of alternative splicing, making this the first example of an alternative splicing event in plant pathogenic oomycetes transforming a non-effector gene to a functional effector protein. Taken together, these data suggest a role for PscRXLR1 in pathogenicity, and, in total, our data provide a basis for comparative analysis of candidate effector proteins and their non-effector orthologs as a means of understanding function and evolutionary history of pathogen effectors.	[Savory, Elizabeth A.; Day, Brad] Michigan State Univ, Dept Plant Pathol, E Lansing, MI 48824 USA; [Zou, Cheng; Adhikari, Bishwo N.; Hamilton, John P.; Buell, C. Robin; Shiu, Shin-Han] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Savory, EA (corresponding author), Michigan State Univ, Dept Plant Pathol, E Lansing, MI 48824 USA.	bday@msu.edu	Shiu, Shin-Han/R-6117-2016; Hamilton, John P/G-1379-2016	Shiu, Shin-Han/0000-0001-6470-235X; Hamilton, John P/0000-0002-8682-5526; Buell, C Robin/0000-0002-6727-4677; Adhikari, Bishwo/0000-0003-4840-9609; Savory, Elizabeth/0000-0002-6016-9962; zou, cheng/0000-0001-9325-9465; Day, Brad/0000-0002-9880-4319; Vaillancourt, Brieanne/0000-0002-6795-5173	National Science Foundation [IOS-0641319]; United States Department of Agriculture Agriculture and Food Research Initiative (AFRI)	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture Agriculture and Food Research Initiative (AFRI)	Work in the laboratory of BD is supported by a grant from the National Science Foundation (IOS-0641319). EAS is supported by a United States Department of Agriculture Agriculture and Food Research Initiative (AFRI) pre-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Chandran D, 2009, PLANT PHYSIOL, V149, P1435, DOI 10.1104/pp.108.132985; Chaparro-Garcia A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016608; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Costanzo S, 2007, CURR GENET, V52, P115, DOI 10.1007/s00294-007-0144-z; de Wit PJGM, 2009, MOL PLANT PATHOL, V10, P735, DOI 10.1111/j.1364-3703.2009.00591.x; Dong SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005556; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Franke I, 2003, J BACTERIOL, V185, P1161, DOI 10.1128/JB.185.4.1161-1166.2003; Gurlebeck D, 2009, MOL PLANT PATHOL, V10, P175, DOI 10.1111/j.1364-3703.2008.00519.x; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Halterman DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010536; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Jack DL, 2001, EUR J BIOCHEM, V268, P3620, DOI 10.1046/j.1432-1327.2001.02265.x; Jacobs KA, 1997, GENE, V198, P289, DOI 10.1016/S0378-1119(97)00330-2; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; Jin P, 2003, PLANT PHYSIOL, V133, P1072, DOI 10.1104/pp.103.025999; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Knepper C, 2011, PLANT PHYSIOL, V156, P286, DOI 10.1104/pp.110.169656; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levesque CA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r73; Liu TL, 2011, PLANT PHYSIOL, V155, P490, DOI 10.1104/pp.110.166470; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mansfield JW, 2009, MOL PLANT PATHOL, V10, P721, DOI 10.1111/j.1364-3703.2009.00576.x; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Qutob D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005066; Rafiqi M, 2010, PLANT CELL, V22, P2017, DOI 10.1105/tpc.109.072983; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Savory EA, 2011, MOL PLANT PATHOL, V12, P217, DOI 10.1111/j.1364-3703.2010.00670.x; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Schornack S, 2009, MOL PLANT PATHOL, V10, P795, DOI 10.1111/j.1364-3703.2009.00593.x; Shan LB, 2000, PLANT CELL, V12, P2323, DOI 10.1105/tpc.12.12.2323; Shan WX, 2004, MOL PLANT MICROBE IN, V17, P394, DOI 10.1094/MPMI.2004.17.4.394; Shen DY, 2011, CAN J MICROBIOL, V57, P84, DOI [10.1139/W10-103, 10.1139/w10-103]; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Tian MY, 2011, MOL PLANT MICROBE IN, V24, P543, DOI 10.1094/MPMI-08-10-0185; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Win J, 2006, FUNGAL GENET BIOL, V43, P20, DOI 10.1016/j.fgb.2005.10.003; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Win J, 2011, METHODS MOL BIOL, V712, P181, DOI 10.1007/978-1-61737-998-7_15; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	60	45	46	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34701	10.1371/journal.pone.0034701	http://dx.doi.org/10.1371/journal.pone.0034701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22545137	Green Published, gold, Green Submitted			2022-12-25	WOS:000305010500024
J	Kelleher, RJ; Geigenmuller, U; Hovhannisyan, H; Trautman, E; Pinard, R; Rathmell, B; Carpenter, R; Margulies, D				Kelleher, Raymond J., III; Geigenmueller, Ute; Hovhannisyan, Hayk; Trautman, Edwin; Pinard, Robert; Rathmell, Barbara; Carpenter, Randall; Margulies, David			High-Throughput Sequencing of mGluR Signaling Pathway Genes Reveals Enrichment of Rare Variants in Autism	PLOS ONE			English	Article							COPY-NUMBER VARIATION; ACTIVATED PROTEIN-KINASES; LONG-TERM DEPRESSION; DE-NOVO; SYNAPTIC PLASTICITY; LEARNING-DEFICITS; MOUSE MODEL; MUTATIONS; HOMER; DISEASE	Identification of common molecular pathways affected by genetic variation in autism is important for understanding disease pathogenesis and devising effective therapies. Here, we test the hypothesis that rare genetic variation in the metabotropic glutamate-receptor (mGluR) signaling pathway contributes to autism susceptibility. Single-nucleotide variants in genes encoding components of the mGluR signaling pathway were identified by high-throughput multiplex sequencing of pooled samples from 290 non-syndromic autism cases and 300 ethnically matched controls on two independent next-generation platforms. This analysis revealed significant enrichment of rare functional variants in the mGluR pathway in autism cases. Higher burdens of rare, potentially deleterious variants were identified in autism cases for three pathway genes previously implicated in syndromic autism spectrum disorder, TSC1, TSC2, and SHANK3, suggesting that genetic variation in these genes also contributes to risk for non-syndromic autism. In addition, our analysis identified HOMER1, which encodes a postsynaptic density-localized scaffolding protein that interacts with Shank3 to regulate mGluR activity, as a novel autism-risk gene. Rare, potentially deleterious HOMER1 variants identified uniquely in the autism population affected functionally important protein regions or regulatory sequences and co-segregated closely with autism among children of affected families. We also identified rare ASD-associated coding variants predicted to have damaging effects on components of the Ras/MAPK cascade. Collectively, these findings suggest that altered signaling downstream of mGluRs contributes to the pathogenesis of non-syndromic autism.	[Kelleher, Raymond J., III] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Kelleher, Raymond J., III] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Kelleher, Raymond J., III] Harvard Univ, Sch Med, Program Neurosci, Boston, MA USA; [Geigenmueller, Ute; Hovhannisyan, Hayk; Trautman, Edwin; Pinard, Robert; Margulies, David] Correlagen Diagnost Inc, Waltham, MA USA; [Rathmell, Barbara; Carpenter, Randall] Seaside Therapeut, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Kelleher, RJ (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	kelleher@helix.mgh.harvard.edu	Sala, Carlo/A-2493-2009	Sala, Carlo/0000-0003-0662-9523; Crater, Glenn/0000-0002-1159-1323	Pew Scholars Program in Biomedical Sciences; John Merck Scholars Fund; NIMH [K02 MH087796]; Simons Foundation Autism Research Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH [U24MH081810, K02MH087796] Funding Source: NIH RePORTER	Pew Scholars Program in Biomedical Sciences; John Merck Scholars Fund; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation Autism Research Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	RJK was supported by awards from the Pew Scholars Program in Biomedical Sciences, the John Merck Scholars Fund, the NIMH (K02 MH087796), and the Simons Foundation Autism Research Initiative. These funding institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Seaside Therapeutics and Correlagen Diagnostics contributed funding for this study. These companies had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript due to their employment of one or more of the authors of the study.	Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aoki Y, 2008, HUM MUTAT, V29, P992, DOI 10.1002/humu.20748; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Chen JM, 2006, HUM GENET, V120, P1, DOI 10.1007/s00439-006-0180-7; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Costa RM, 2002, NATURE, V415, P526, DOI 10.1038/nature711; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; El-Fishawy P, 2010, PSYCHIAT CLIN N AM, V33, P83, DOI 10.1016/j.psc.2009.12.002; Gai X, 2011, MOL PSYCHIATR; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hamdan FF, 2009, NEW ENGL J MED, V360, P599, DOI 10.1056/NEJMoa0805392; Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Krueger DD, ANN REV MED; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Nava C, 2007, J MED GENET, V44, P763, DOI 10.1136/jmg.2007.050450; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Ronesi JA, 2008, J NEUROSCI, V28, P543, DOI 10.1523/JNEUROSCI.5019-07.2008; Ronesi JA, 2012, NAT NEUROSCI, V15, P431, DOI 10.1038/nn.3033; Rumbaugh G, 2006, P NATL ACAD SCI USA, V103, P4344, DOI 10.1073/pnas.0600084103; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Schaaf CP, 2011, HUM MOL GENET, V20, P3366, DOI 10.1093/hmg/ddr243; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; Toro R, 2010, TRENDS GENET, V26, P363, DOI 10.1016/j.tig.2010.05.007; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Wiznitzer M, 2004, J CHILD NEUROL, V19, P675, DOI 10.1177/08830738040190090701; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104	53	114	116	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35003	10.1371/journal.pone.0035003	http://dx.doi.org/10.1371/journal.pone.0035003			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558107	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000020
J	Zhang, XN; Jaramillo, M; Singh, S; Kumta, P; Banerjee, I				Zhang, Xinan; Jaramillo, Maria; Singh, Satish; Kumta, Prashant; Banerjee, Ipsita			Analysis of Regulatory Network Involved in Mechanical Induction of Embryonic Stem Cell Differentiation	PLOS ONE			English	Article							HEPATOCYTE NUCLEAR FACTOR-3-BETA; ENRICHED TRANSCRIPTION FACTORS; GENE-EXPRESSION DATA; LIVER DEVELOPMENT; HOMEOBOX GENE; ENDODERM; COMMITMENT; BINDING	Embryonic stem cells are conventionally differentiated by modulating specific growth factors in the cell culture media. Recently the effect of cellular mechanical microenvironment in inducing phenotype specific differentiation has attracted considerable attention. We have shown the possibility of inducing endoderm differentiation by culturing the stem cells on fibrin substrates of specific stiffness [1]. Here, we analyze the regulatory network involved in such mechanically induced endoderm differentiation under two different experimental configurations of 2-dimensional and 3-dimensional culture, respectively. Mouse embryonic stem cells are differentiated on an array of substrates of varying mechanical properties and analyzed for relevant endoderm markers. The experimental data set is further analyzed for identification of co-regulated transcription factors across different substrate conditions using the technique of bi-clustering. Overlapped bi-clusters are identified following an optimization formulation, which is solved using an evolutionary algorithm. While typically such analysis is performed at the mean value of expression data across experimental repeats, the variability of stem cell systems reduces the confidence on such analysis of mean data. Bootstrapping technique is thus integrated with the bi-clustering algorithm to determine sets of robust bi-clusters, which is found to differ significantly from corresponding bi-clusters at the mean data value. Analysis of robust bi-clusters reveals an overall similar network interaction as has been reported for chemically induced endoderm or endodermal organs but with differences in patterning between 2-dimensional and 3-dimensional culture. Such analysis sheds light on the pathway of stem cell differentiation indicating the prospect of the two culture configurations for further maturation.	[Zhang, Xinan] Cent China Normal Univ, Sch Math & Stat, Wuhan, Peoples R China; [Zhang, Xinan; Singh, Satish; Kumta, Prashant; Banerjee, Ipsita] Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA; [Jaramillo, Maria; Kumta, Prashant; Banerjee, Ipsita] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Kumta, Prashant] Univ Pittsburgh, Dept Mech Engn & Mat Sci, Pittsburgh, PA USA; [Kumta, Prashant] Univ Pittsburgh, Ctr Complex Engn Multifunct Mat, Pittsburgh, PA USA	Central China Normal University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhang, XN (corresponding author), Cent China Normal Univ, Sch Math & Stat, Wuhan, Peoples R China.	ipb1@pitt.edu			National Institutes of Health [DP2 116520]; Oak Ridge Associated Universities; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oak Ridge Associated Universities; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors acknowledge support from National Institutes of Health New Innovator Award DP2 116520 and Oak Ridge Associated Universities Ralph Powe Junior Faculty Enhancement Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah A, 2006, NEUROCOMPUTING, V69, P1882, DOI 10.1016/j.neucom.2006.02.018; Anderson WJ, 2008, DEV DYNAM, V237, P504, DOI 10.1002/dvdy.21437; Banerjee I, 2006, COMBUST FLAME, V144, P619, DOI 10.1016/j.combustflame.2005.10.001; Banerjee I, 2003, CHEM ENG SCI, V58, P4537, DOI 10.1016/S0009-2509(03)00343-9; Banerjee I, 2010, BIOINFORMATICS, V26, P1332, DOI 10.1093/bioinformatics/btq139; Barbera JPM, 2000, DEVELOPMENT, V127, P2433; Bieniasz LK, 2006, ANAL CHEM, V78, P8430, DOI 10.1021/ac061167z; Cao L, 2011, DIFFERENTIATION, V81, P1, DOI 10.1016/j.diff.2010.09.182; Cheng Y, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P93; COCKELL M, 1995, MOL CELL BIOL, V15, P1933; Costa RH, 2003, HEPATOLOGY, V38, P1331, DOI 10.1016/j.hep.2003.09.034; Denson LA, 2000, GENE, V246, P311, DOI 10.1016/S0378-1119(00)00082-2; Denton AM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-294; Divina F, 2006, IEEE T KNOWL DATA EN, V18, P590, DOI 10.1109/TKDE.2006.74; Efron B., 1994, INTRO BOOTSTRAP; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Getz G, 2000, P NATL ACAD SCI USA, V97, P12079, DOI 10.1073/pnas.210134797; Goldberg D. E., 1989, GENETIC ALGORITHMS S; HARTIGAN JA, 1972, J AM STAT ASSOC, V67, P123, DOI 10.2307/2284710; HERBST RS, 1991, NEW BIOL, V3, P289; Hochreiter S, 2010, BIOINFORMATICS, V26, P1520, DOI 10.1093/bioinformatics/btq227; Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]; Jaramillo M, 2011, INDUCING ENDODERM DI; Lehner F, 2010, WORLD J GASTROENTERO, V16, P3919, DOI 10.3748/wjg.v16.i31.3919; Lopez-Sanchez C, 2009, INT J DEV BIOL, V53, P1445, DOI 10.1387/ijdb.072417cl; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Morrison GM, 2008, CELL STEM CELL, V3, P402, DOI 10.1016/j.stem.2008.07.021; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; NAGY P, 1994, J CELL BIOL, V126, P223, DOI 10.1083/jcb.126.1.223; Orling J, 1977, NEDERL AKAD WETENSCH, V39, P8; PANI L, 1992, MOL CELL BIOL, V12, P3723, DOI 10.1128/MCB.12.9.3723; POLITIS DN, 1994, J AM STAT ASSOC, V89, P1303, DOI 10.2307/2290993; Reiss DJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-280; Rojas A, 2010, DEV BIOL, V346, P346, DOI 10.1016/j.ydbio.2010.07.032; Sill M, 2011, BIOINFORMATICS, V27, P2089, DOI 10.1093/bioinformatics/btr322; STINE R, 1989, SOCIOL METHOD RES, V18, P243, DOI 10.1177/0049124189018002003; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang H, 2002, P 2002 ACM SIGMOD IN, P418; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Yang E, 2007, BIOINFORMATICS, V23, P2306, DOI 10.1093/bioinformatics/btm335	40	308	314	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35700	10.1371/journal.pone.0035700	http://dx.doi.org/10.1371/journal.pone.0035700			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558203	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000305336000049
J	Zhang, YG; Li, F; Liu, S; Wang, H; Mahavadi, S; Murthy, KS; Khalili, K; Hu, WH				Zhang, Yonggang; Li, Fang; Liu, Shu; Wang, Hong; Mahavadi, Sunila; Murthy, Karnam S.; Khalili, Kamel; Hu, Wenhui			MEKK1-MKK4-JNK-AP1 Pathway Negatively Regulates Rgs4 Expression in Colonic Smooth Muscle Cells	PLOS ONE			English	Article							NF-KAPPA-B; MESSENGER-RNA EXPRESSION; PROTEIN-KINASE PATHWAYS; JUN NH2-TERMINAL KINASE; NECROSIS-FACTOR-ALPHA; P38 MAPK; SIGNAL-TRANSDUCTION; TERMINAL KINASE; JNK ACTIVATION; ANGIOTENSIN-II	Background: Regulator of G-protein Signaling 4 (RGS4) plays an important role in regulating smooth muscle contraction, cardiac development, neural plasticity and psychiatric disorder. However, the underlying regulatory mechanisms remain elusive. Our recent studies have shown that upregulation of Rgs4 by interleukin (IL)-1 beta is mediated by the activation of NFkB signaling and modulated by extracellular signal-regulated kinases, p38 mitogen-activated protein kinase, and phosphoinositide-3 kinase. Here we investigate the effect of the c-Jun N-terminal kinase (JNK) pathway on Rgs4 expression in rabbit colonic smooth muscle cells. Methodology/Principal Findings: Cultured cells at first passage were treated with or without IL-1 beta (10 ng/ml) in the presence or absence of the selective JNK inhibitor (SP600125) or JNK small hairpin RNA (shRNA). The expression levels of Rgs4 mRNA and protein were determined by real-time RT-PCR and Western blot respectively. SP600125 or JNK shRNA increased Rgs4 expression in the absence or presence of IL-1 beta stimulation. Overexpression of MEKK1, the key upstream kinase of JNK, inhibited Rgs4 expression, which was reversed by co-expression of JNK shRNA or dominant-negative mutants for MKK4 or JNK. Both constitutive and inducible upregulation of Rgs4 expression by SP600125 was significantly inhibited by pretreatment with the transcription inhibitor, actinomycin D. Dual reporter assay showed that pretreatment with SP600125 sensitized the promoter activity of Rgs4 in response to IL-1 beta. Mutation of the AP1-binding site within Rgs4 promoter increased the promoter activity. Western blot analysis confirmed that IL-1 beta treatment increased the phosphorylation of JNK, ATF-2 and c-Jun. Gel shift and chromatin immunoprecipitation assays validated that IL-1 beta increased the in vitro and ex vivo binding activities of AP1 within rabbit Rgs4 promoter. Conclusion/Significance: Activation of MEKK1-MKK4-JNK-AP1 signal pathway plays a tonic inhibitory role in regulating Rgs4 transcription in rabbit colonic smooth muscle cells. This negative regulation may aid in maintaining the transient level of RGS4 expression.	[Zhang, Yonggang; Li, Fang; Liu, Shu; Wang, Hong; Khalili, Kamel; Hu, Wenhui] Temple Univ, Dept Neurosci, Sch Med, Philadelphia, PA 19122 USA; [Mahavadi, Sunila; Murthy, Karnam S.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Virginia Commonwealth University	Zhang, YG (corresponding author), Temple Univ, Dept Neurosci, Sch Med, Philadelphia, PA 19122 USA.	whu@temple.edu	Song, Yajun/GQQ-0476-2022; Song, Yajun/F-3714-2011; Yang, Ruifu/A-2273-2011	Song, Yajun/0000-0002-6628-2747; Song, Yajun/0000-0002-6628-2747; Yang, Ruifu/0000-0003-3219-7269	National Institutes of Diabetes and Digestive and Kidney Diseases [DK075964, DK015564]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK015564, R01DK075964, R37DK015564] Funding Source: NIH RePORTER	National Institutes of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by grant DK075964 (WH) and DK015564 (KM) from the National Institutes of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Bachar O, 2004, EUR J IMMUNOL, V34, P1196, DOI 10.1002/eji.200324569; Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; Barona I, 2011, J PHARM PHARMACOL, V63, P657, DOI 10.1111/j.2042-7158.2011.01253.x; Bashari D, 2011, CELL SIGNAL, V23, P65, DOI 10.1016/j.cellsig.2010.08.004; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Bodenstein J, 2007, MOL PHARMACOL, V71, P1040, DOI 10.1124/mol.106.029397; Bongalon S, 2004, J VASC RES, V41, P412, DOI 10.1159/000081247; Bowden NA, 2007, SCHIZOPHR RES, V89, P165, DOI 10.1016/j.schres.2006.09.003; Cao WB, 2004, J PHARMACOL EXP THER, V311, P60, DOI 10.1124/jpet.104.068023; Cao WB, 2003, AM J PHYSIOL-GASTR L, V285, pG86, DOI 10.1152/ajpgi.00156.2002; Cho H, 2003, BIOCHEM J, V371, P973, DOI 10.1042/BJ20021769; Chowdari KV, 2008, SCHIZOPHRENIA BULL, V34, P118, DOI 10.1093/schbul/sbm042; Chung FY, 2008, ARCH PHARM RES, V31, P1437, DOI 10.1007/s12272-001-2128-8; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Cook AK, 2000, AM J PHYSIOL-GASTR L, V278, pG429, DOI 10.1152/ajpgi.2000.278.3.G429; Costigan M, 2003, MOL CELL NEUROSCI, V24, P106, DOI 10.1016/S1044-7431(03)00135-0; Davies JS, 2011, J BIOL CHEM, V286, P15227, DOI 10.1074/jbc.M110.201996; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Ding GX, 2010, WORLD J PEDIATR, V6, P169, DOI 10.1007/s12519-010-0033-2; Ding L, 2007, GENE, V401, P46, DOI 10.1016/j.gene.2007.07.002; Erdely HA, 2006, SYNAPSE, V59, P472, DOI 10.1002/syn.20265; Gerthoffer WT, 2005, AM J PHYSIOL-GASTR L, V288, pG849, DOI 10.1152/ajpgi.00530.2004; Ginnan R, 2006, AM J PHYSIOL-CELL PH, V290, pC1583, DOI 10.1152/ajpcell.00390.2005; Gold SJ, 2003, EUR J NEUROSCI, V17, P971, DOI 10.1046/j.1460-9568.2003.02529.x; Gonzalo S, 2011, NEUROGASTROENT MOTIL, V23, pe80, DOI 10.1111/j.1365-2982.2010.01632.x; Gonzalo S, 2010, NEUROGASTROENT MOTIL, V22, P564, DOI 10.1111/j.1365-2982.2009.01439.x; Grillet N, 2003, J NEUROSCI, V23, P10613; Guikema BJ, 2005, FREE RADICAL BIO MED, V38, P597, DOI 10.1016/j.freeradbiomed.2004.11.022; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Hallsworth MP, 2001, AM J RESP CRIT CARE, V164, P688, DOI 10.1164/ajrccm.164.4.2011004; Hao JM, 2006, J MOL CELL CARDIOL, V41, P51, DOI 10.1016/j.yjmcc.2006.04.003; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Hendriks-Balk MC, 2008, EUR J PHARMACOL, V600, P1, DOI 10.1016/j.ejphar.2008.09.041; Hirst SJ, 2002, AM J RESP CRIT CARE, V165, P1161, DOI 10.1164/ajrccm.165.8.2107158; Hu W, 2006, BIOCHEM BIOPH RES CO, V343, P1038, DOI 10.1016/j.bbrc.2006.03.079; Hu WH, 2008, BIOCHEM J, V412, P35, DOI 10.1042/BJ20080042; Hu WH, 2007, AM J PHYSIOL-CELL PH, V293, pC1991, DOI 10.1152/ajpcell.00300.2007; Hu WH, 2009, AM J PHYSIOL-CELL PH, V296, pC1310, DOI 10.1152/ajpcell.00573.2008; Hu WH, 1999, J BIOL CHEM, V274, P30603, DOI 10.1074/jbc.274.43.30603; Hu YH, 1997, ARTERIOSCL THROM VAS, V17, P2808, DOI 10.1161/01.ATV.17.11.2808; Huang CF, 1997, P NATL ACAD SCI USA, V94, P6159, DOI 10.1073/pnas.94.12.6159; Huang J, 2005, AM J PHYSIOL-GASTR L, V288, pG23, DOI 10.1152/ajpgi.00305.2004; Huang J, 2007, AM J PHYSIOL-CELL PH, V292, pC200, DOI 10.1152/ajpcell.00103.2006; Ihara E, 2007, AM J PHYSIOL-GASTR L, V293, pG699, DOI 10.1152/ajpgi.00214.2007; Ihara E, 2009, MOL PHARMACOL, V75, P1031, DOI 10.1124/mol.108.049858; Il Jeong S, 2011, J PHARM PHARMACOL, V63, P245, DOI 10.1111/j.2042-7158.2010.01212.x; Je HD, 2001, J PHYSIOL-LONDON, V537, P567, DOI 10.1111/j.1469-7793.2001.00567.x; Jiang SN, 2011, AM J PHYSIOL-GASTR L, V301, pG454, DOI 10.1152/ajpgi.00148.2011; Jung YD, 2002, CYTOKINE, V18, P206, DOI 10.1006/cyto.2002.1034; Jung Young D., 2001, Angiogenesis, V4, P155, DOI 10.1023/A:1012291524723; Kattoulas E, 2011, PSYCHOL MED, P1; Khan I., 2006, Inflammopharmacology, V14, P28, DOI 10.1007/s10787-006-1507-7; Kim J, 2005, EUR J PHARMACOL, V514, P209, DOI 10.1016/j.ejphar.2005.03.030; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Kloss S, 2004, MOL PHARMACOL, V65, P1440, DOI 10.1124/mol.65.6.1440; Kordowska J, 2006, J BIOMED SCI, V13, P159, DOI 10.1007/s11373-005-9060-8; Krumins AM, 2004, J BIOL CHEM, V279, P2593, DOI 10.1074/jbc.M311600200; Lawler S, 1998, CURR BIOL, V8, P1387, DOI 10.1016/S0960-9822(98)00019-0; Lee CW, 2006, J CELL PHYSIOL, V207, P174, DOI 10.1002/jcp.20549; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Lee PCW, 2011, MOL CELL, V43, P392, DOI 10.1016/j.molcel.2011.05.034; Lee TS, 2002, CELL SIGNAL, V14, P989, DOI 10.1016/S0898-6568(02)00032-3; Lee YR, 2006, J PHARMACOL SCI, V100, P119, DOI 10.1254/jphs.FP0050777; Levitt P, 2006, BIOL PSYCHIAT, V60, P534, DOI 10.1016/j.biopsych.2006.04.028; Li F, 2010, AM J PHYSIOL-CELL PH, V299, pC1418, DOI 10.1152/ajpcell.00093.2010; Li F, 2010, GENE, V451, P45, DOI 10.1016/j.gene.2009.11.010; Liang D, 2001, MOL BRAIN RES, V96, P94, DOI 10.1016/S0169-328X(01)00287-X; Liang KC, 2007, J CELL PHYSIOL, V211, P759, DOI 10.1002/jcp.20992; Lin TC, 2009, EPILEPSY BEHAV, V14, P316, DOI 10.1016/j.yebeh.2008.12.005; Lipska BK, 2006, HUM MOL GENET, V15, P2804, DOI 10.1093/hmg/ddl222; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Luo SF, 2008, TOXICOL APPL PHARM, V232, P396, DOI 10.1016/j.taap.2008.07.019; Mittmann C, 2002, CARDIOVASC RES, V55, P778, DOI 10.1016/S0008-6363(02)00459-5; Mittmann C, 2001, N-S ARCH PHARMACOL, V363, P456; Ni YG, 1999, J NEUROSCI, V19, P3674; Oltmanns U, 2003, BRIT J PHARMACOL, V139, P1228, DOI 10.1038/sj.bjp.0705345; Ortega-Perez I, 2005, J BIOL CHEM, V280, P20867, DOI 10.1074/jbc.M501898200; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Park SU, 2006, WORLD J GASTROENTERO, V12, P2259, DOI 10.3748/wjg.v12.i14.2259; Patten M, 2003, N-S ARCH PHARMACOL, V368, P360, DOI 10.1007/s00210-003-0798-0; Patten M, 2002, CARDIOVASC RES, V53, P156, DOI 10.1016/S0008-6363(01)00443-6; Pepperl DJ, 1998, BIOCHEM BIOPH RES CO, V243, P52, DOI 10.1006/bbrc.1997.8056; Ray RM, 2011, AM J PHYSIOL-GASTR L, V300, pG761, DOI 10.1152/ajpgi.00405.2010; Reusch HP, 1997, BIOCHEM BIOPH RES CO, V237, P239, DOI 10.1006/bbrc.1997.7121; Rivero G, 2012, NEUROPHARMACOLOGY, V62, P1044, DOI 10.1016/j.neuropharm.2011.10.015; Romero DG, 2007, J ENDOCRINOL, V194, P429, DOI 10.1677/JOE-07-0153; Salinthone S, 2004, AM J PHYSIOL-GASTR L, V287, pG627, DOI 10.1152/ajpgi.00462.2003; Singer CA, 2003, AM J PHYSIOL-LUNG C, V285, pL1087, DOI 10.1152/ajplung.00409.2002; Somara S, 2010, AM J PHYSIOL-GASTR L, V299, pG1164, DOI 10.1152/ajpgi.00479.2009; Song HJ, 2006, MOL CELLS, V21, P42; Sze KL, 2008, BIOCHEM J, V410, P575, DOI 10.1042/BJ20070901; Takata Y, 2008, P NATL ACAD SCI USA, V105, P4277, DOI 10.1073/pnas.0708647105; Taniyama Y, 2004, AM J PHYSIOL-CELL PH, V287, pC494, DOI 10.1152/ajpcell.00439.2003; van Gemert NG, 2006, BRAIN RES, V1093, P161, DOI 10.1016/j.brainres.2006.03.083; Van Gemert NG, 2006, STRESS, V9, P165, DOI 10.1080/10253890600966169; Wang CC, 2005, AM J PHYSIOL-LUNG C, V288, pL227, DOI 10.1152/ajplung.00224.2004; Wang JC, 2010, FEBS LETT, V584, P4570, DOI 10.1016/j.febslet.2010.10.052; Wang Q, 2011, J BIOL CHEM, V286, P7854, DOI 10.1074/jbc.M110.160911; Weston CR, 2002, SCIENCE, V296, P2345, DOI 10.1126/science.1073344; Wullaert A, 2006, BIOCHEM PHARMACOL, V72, P1090, DOI 10.1016/j.bcp.2006.07.003; Xie GX, 2007, J MOL BIOL, V366, P349, DOI 10.1016/j.jmb.2006.11.045; Yamboliev IA, 2000, AM J PHYSIOL-HEART C, V278, pH1899, DOI 10.1152/ajpheart.2000.278.6.H1899; Yang CM, 2002, CELL SIGNAL, V14, P899, DOI 10.1016/S0898-6568(02)00037-2; Yang JQ, 2010, J BIOL CHEM, V285, P29760, DOI 10.1074/jbc.M110.121459; Zarnegar P, 2006, NEUROSCI LETT, V396, P197, DOI 10.1016/j.neulet.2005.11.040; Zhang Y, 2004, CLIN EXP ALLERGY, V34, P1480, DOI 10.1111/j.1365-2222.2004.02040.x; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814	110	23	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35646	10.1371/journal.pone.0035646	http://dx.doi.org/10.1371/journal.pone.0035646			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545125	Green Published, gold			2022-12-25	WOS:000305343200045
J	Liao, MZ; Nie, XJ; Pan, RJ; Wang, CX; Ruan, SM; Zhang, CQ; Kang, DM; Fu, JH; Qian, YS; Tao, XR; Zhao, JK				Liao, Meizhen; Nie, Xijuan; Pan, Rongjian; Wang, Chuangxin; Ruan, Shiman; Zhang, Changqing; Kang, Dianming; Fu, Jihua; Qian, Yuesheng; Tao, Xiaorun; Zhao, Jinkou			Consistently Low Prevalence of Syphilis among Female Sex Workers in Jinan, China: Findings from Two Consecutive Respondent Driven Sampling Surveys	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; HUMAN-IMMUNODEFICIENCY-VIRUS; METHAMPHETAMINE USE; HIV PREVALENCE; RISK; MEN; INFECTION; PROVINCE; TRIAL	Background: Routine surveillance using convenient sampling found low prevalence of HIV and syphilis among female sex workers in China. Two consecutive surveys using respondent driven sampling were conducted in 2008 and 2009 to examine the prevalence of HIV and syphilis among female sex workers in Jinan, China. Methods: A face-to-face interview was conducted to collect demographic, behavioral and service utilization information using a structured questionnaire. Blood samples were drawn for serological tests of HIV-1 antibody and syphilis antibody. Respondent Driven Sampling Analysis Tool was used to generate population level estimates. Results: In 2008 and in 2009, 363 and 432 subjects were recruited and surveyed respectively. Prevalence of syphilis was 2.8% in 2008 and 2.2% in 2009, while no HIV case was found in both years. Results are comparable to those from routine sentinel surveillance system in the city. Only 60.8% subjects in 2008 and 48.3% in 2009 reported a consistent condom use with clients during the past month. Over 50% subjects had not been covered by any HIV-related services in the past year, with only 15.6% subjects in 2008 and 13.1% in 2009 ever tested for HIV. Conclusions: Despite the low prevalence of syphilis and HIV, risk behaviors are common. Targeted interventions to promote the safe sex and utilization of existing intervention services are still needed to keep the epidemic from growing.	[Liao, Meizhen; Kang, Dianming; Fu, Jihua; Qian, Yuesheng; Tao, Xiaorun] Shandong Prov Ctr Dis Control & Prevent, Inst AIDS STD Control & Prevent, Jinan, Shandong Provin, Peoples R China; [Nie, Xijuan; Pan, Rongjian; Wang, Chuangxin] Licheng Dist Ctr Dis Control & Prevent, Inst AIDS STD Control & Prevent, Jinan, Shandong Provin, Peoples R China; [Ruan, Shiman; Zhang, Changqing] Jinan Municipal Ctr Dis Control & Prevent, Inst AIDS STD Control & Prevent, Jinan, Shandong Provin, Peoples R China; [Zhao, Jinkou] Global Fund Fight AIDS TB & Malaria, Monitoring & Evaluat Unit, Geneva, Switzerland		Liao, MZ (corresponding author), Shandong Prov Ctr Dis Control & Prevent, Inst AIDS STD Control & Prevent, Jinan, Shandong Provin, Peoples R China.	jinkou.zhao@theglobalfund.org	Yang, Xiaobo/G-3854-2016; Zhang, Youjie/F-7346-2016	Zhang, Youjie/0000-0002-6035-8536; mo, zengnan/0000-0002-3047-3138; Zhao, Jinkou/0000-0001-9184-3385	China-US cooperation on HIV prevention and care	China-US cooperation on HIV prevention and care	This work was supported by the China-US cooperation on HIV prevention and care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, 2011 EST HIV AIDS EP; Brown T, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010165; Chapman J, 2008, SEX HEALTH, V5, P291, DOI 10.1071/SH07057; China CDC, 2011, NAT BEH BIOL SURV RE; China-CDC, 2009, NAT GUID DET HIV AID; Chow EPF, 2011, SEX TRANSM DIS, V38, P845, DOI 10.1097/OLQ.0b013e31821a4f43; Cohen J, 2004, SCIENCE, V304, P1934, DOI 10.1126/science.304.5679.1934; Colfax G, 2006, CLIN INFECT DIS, V42, P1463, DOI 10.1086/503259; Fu JH, 2009, CHIN J PUBLIC HLTH, V25, P1004; Goel S, 2009, STAT MED, V28, P2202, DOI 10.1002/sim.3613; Heimer R, 2005, AIDS BEHAV, V9, P403, DOI 10.1007/s10461-005-9030-1; Johnston LG, 2006, J URBAN HEALTH, V83, pI16, DOI 10.1007/s11524-006-9099-5; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Kang DM, 2011, AIDS CARE, V23, P26, DOI 10.1080/09540121.2011.560930; Li Y, 2010, JAIDS-J ACQ IMM DEF, V53, pS48, DOI 10.1097/QAI.0b013e3181c7d72f; Liao MZ, 2011, SEX TRANSM DIS, V38, P57, DOI 10.1097/OLQ.0b013e3181ebb475; Liu HJ, 2009, AIDS BEHAV, V13, P652, DOI 10.1007/s10461-008-9475-0; Ma X, 2007, J ACQ IMMUN DEF SYND, V45, P581; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Pascom AR, 2010, BRAZ J INFECT DIS, V14, P385, DOI 10.1590/S1413-86702010000400014; Potula R, 2008, AM J PATHOL, V172, P1467, DOI 10.2353/ajpath.2008.080130; Rou KM, 2007, AIDS, V21, pS95, DOI 10.1097/01.aids.0000304703.77755.c7; Ruan SM, 2008, AIDS BEHAV, V12, P469, DOI 10.1007/s10461-008-9361-9; Ruan SM, 2009, AIDS BEHAV, V13, P671, DOI 10.1007/s10461-009-9567-5; Scorgie F, 2011, AIDS BEHAV IN PRESS; Shandong Provincial CDC, 2010, COMPR REP HIV AIDS S; Shandong Provincial CDC, 2011, COMPR REP HIV AIDS S; Stormer A, 2006, J URBAN HEALTH, V83, pI73, DOI 10.1007/s11524-006-9105-y; Tabet S, 2002, AIDS, V16, P1271, DOI 10.1097/00002030-200206140-00010; UNODC, 2008, 2008 WORLD DRUG REP; van den Hoek A, 2001, AIDS, V15, P753, DOI 10.1097/00002030-200104130-00011; Wang Lan, 2009, Zhonghua Yu Fang Yi Xue Za Zhi, V43, P1009; Wang Y, 2009, AIDS BEHAV, V13, P866, DOI 10.1007/s10461-008-9446-5; World Health Organization, 2000, 2 GEN SURV HIV NEXT; Wu ZY, 2006, SCIENCE, V312, P1475, DOI 10.1126/science.1120682; Yang HM, 2005, SEX TRANSM DIS, V32, P270, DOI 10.1097/01.olq.0000162360.11910.5a; Yang XS, 2006, AIDS EDUC PREV, V18, P333, DOI 10.1521/aeap.2006.18.4.333	37	30	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e34085	10.1371/journal.pone.0034085	http://dx.doi.org/10.1371/journal.pone.0034085			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UP	22737230	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341000007
J	Lee, MS; Jung, JI; Kwon, SH; Lee, SM; Morita, K; Her, S				Lee, Mi-Sook; Jung, Jae-In; Kwon, Seung-Hae; Lee, Sang-Mok; Morita, Kyoji; Her, Song			TIMP-2 Fusion Protein with Human Serum Albumin Potentiates Anti-Angiogenesis-Mediated Inhibition of Tumor Growth by Suppressing MMP-2 Expression	PLOS ONE			English	Article							TISSUE INHIBITOR; IN-VIVO; MATRIX-METALLOPROTEINASE; CELL-PROLIFERATION; ESCHERICHIA-COLI; DOWN-REGULATION; APOPTOSIS; ACTIVATION; CANCER; THERAPY	TIMP-2 protein has been intensively studied as a promising anticancer candidate agent, but the in vivo mechanism underlying its anticancer effect has not been clearly elucidated by previous works. In this study, we investigated the mechanism underlying the anti-tumor effects of a TIMP-2 fusion protein conjugated with human serum albumin (HSA/TIMP-2). Systemic administration of HSA/TIMP-2 effectively inhibited tumor growth at a minimum effective dose of 60 mg/kg. The suppressive effect of HSA/TIMP-2 was accompanied by a marked reduction of in vivo vascularization. The anti-angiogenic activity of HSA/TIMP-2 was directly confirmed by CAM assays. In HSA/TIMP-2-treated tumor tissues, MMP-2 expression was profoundly decreased without a change in MT1-MMP expression of PECAM-1-positive cells. MMP-2 mRNA was also decreased by HSA/TIMP-2 treatment of human umbilical vein endothelial cells. Zymographic analysis showed that HSA/TIMP-2 substantially decreased extracellular pro-MMP-2 activity (94-99% reduction) and moderately decreased active MMP-2 activity (10-24% reduction), suggesting MT1-MMP-independent MMP-2 modulation. Furthermore, HSA/TIMP-2 had no effect on in vitro active MMP-2 activity and in vivo MMP-2 activity. These studies show that HSA/TIMP-2 potentiates anti-angiogenic activity by modulating MMP-2 expression, but not MMP-2 activity, to subsequently suppress tumor growth, suggesting an important role for MMP-2 expression rather than MMP-2 activity in anti-angiogenesis.	[Lee, Mi-Sook; Jung, Jae-In; Kwon, Seung-Hae; Her, Song] Korea Basic Sci Inst, Chuncheon Ctr, Div Bioimaging, Chunchon, South Korea; [Lee, Sang-Mok] BiocurePharm, Daejeon Bio Venture Town, Taejon, South Korea; [Morita, Kyoji] Shikoku Univ, Sch Hlth Sci, Dept Nursing, Neuropharmacol Lab, Tokushima, Japan	Korea Basic Science Institute (KBSI)	Lee, MS (corresponding author), Kyung Hee Univ, Coll Oriental Med, Dept Basic Oriental Med Sci, Seoul, South Korea.	swher@kbsi.re.kr		CORBETTA, MAURIZIO/0000-0001-8295-3304	Korea Basic Science Institute grant [T31901]	Korea Basic Science Institute grant	This study was supported by a Korea Basic Science Institute grant (T31901) to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG JS, 1992, J CLIN PATHOL, V45, P1116, DOI 10.1136/jcp.45.12.1116; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Bourboulia D, 2011, AM J PATHOL, V179, P2589, DOI 10.1016/j.ajpath.2011.07.035; Bremer C, 2001, NAT MED, V7, P743, DOI 10.1038/89126; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Chetty C, 2010, INT J CANCER, V127, P1081, DOI 10.1002/ijc.25134; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fassina G, 2000, CLIN EXP METASTAS, V18, P111, DOI 10.1023/A:1006797522521; Fernandez CA, 2010, J BIOL CHEM, V285, P41886, DOI 10.1074/jbc.M110.166439; Ferrara N, 2004, ONCOLOGIST, V9, P2, DOI 10.1634/theoncologist.9-suppl_1-2; Folkman J, 2003, SEMIN CANCER BIOL, V13, P159, DOI 10.1016/S1044-579X(02)00133-5; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; Hajitou A, 2001, CANCER RES, V61, P3450; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Higashi S, 1999, J BIOL CHEM, V274, P10497, DOI 10.1074/jbc.274.15.10497; Hoegy SE, 2001, J BIOL CHEM, V276, P3203, DOI 10.1074/jbc.M008157200; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Imren S, 1996, CANCER RES, V56, P2891; Itoh T, 1998, CANCER RES, V58, P1048; Jiang YF, 2002, ONCOGENE, V21, P2245, DOI 10.1038/sj.onc.1205291; Kang WK, 2007, PROTEIN EXPRES PURIF, V53, P331, DOI 10.1016/j.pep.2007.02.001; Kargiotis O, 2008, ONCOGENE, V27, P4830, DOI 10.1038/onc.2008.122; Kim JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009364; Kwon GT, 2011, J NUTR BIOCH; Laemmel E, 2004, J VASC RES, V41, P400, DOI 10.1159/000081209; Lafleur Marc A, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006628; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lee Mi-Sook, 2010, [Journal of Life Science, 생명과학회지], V20, P1738; Lee MS, 2011, J PHARM PHARM SCI, V14, P368, DOI 10.18433/J3H88D; Lee MS, 2010, BIOCHEM BIOPH RES CO, V394, P348, DOI 10.1016/j.bbrc.2010.03.009; Lee S, 2008, ANGEW CHEM INT EDIT, V47, P2804, DOI 10.1002/anie.200705240; Li H, 2001, HUM GENE THER, V12, P515, DOI 10.1089/104303401300042429; Lovelock JD, 2005, AM J PHYSIOL-HEART C, V288, pH461, DOI 10.1152/ajpheart.00402.2004; Morita K, 2009, J MOL NEUROSCI, V38, P31, DOI 10.1007/s12031-008-9156-5; MURPHY AN, 1993, J CELL PHYSIOL, V157, P351, DOI 10.1002/jcp.1041570219; Murphy FR, 2002, J BIOL CHEM, V277, P11069, DOI 10.1074/jbc.M111490200; NEGRO A, 1995, FEBS LETT, V360, P52, DOI 10.1016/0014-5793(95)00073-I; Nishida Y, 2008, CANCER RES, V68, P9096, DOI 10.1158/0008-5472.CAN-08-2522; Park JY, 2009, ANAL BIOCHEM, V394, P217, DOI 10.1016/j.ab.2009.07.040; Preaux AM, 2002, HEPATOLOGY, V36, P615, DOI 10.1053/jhep.2002.35279; Rho SB, 2007, J CELL BIOCHEM, V101, P57, DOI 10.1002/jcb.21127; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Shapiro S, 2010, AM J PHYSIOL-CELL PH, V298, pC942, DOI 10.1152/ajpcell.00305.2009; Steinbrenner H, 2003, BIOCHEM BIOPH RES CO, V308, P486, DOI 10.1016/S0006-291X(03)01430-X; STETLERSTEVENSON WG, 1990, J BIOL CHEM, V265, P13933; Storgard Chris, 2004, V294, P123; Streit M, 1999, P NATL ACAD SCI USA, V96, P14888, DOI 10.1073/pnas.96.26.14888; Sun Jun, 2009, J Mol Signal, V4, P4, DOI 10.1186/1750-2187-4-4; Uemura S, 2001, CIRC RES, V88, P1291, DOI 10.1161/hh1201.092042; VARMUS H, 1988, SCIENCE, V240, P1427, DOI 10.1126/science.3287617; VAUPEL P, 1989, CANCER RES, V49, P6449; Williamson RA, 2000, METH MOL B, V151, P257, DOI 10.1385/1-59259-046-2:257; Wingfield PT, 1999, J BIOL CHEM, V274, P21362, DOI 10.1074/jbc.274.30.21362; Yi Y, 2005, CURR GENE THER, V5, P25, DOI 10.2174/1566523052997514	57	152	154	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35710	10.1371/journal.pone.0035710	http://dx.doi.org/10.1371/journal.pone.0035710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22792291	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343200051
J	Liao, M; Huang, XH; Gao, Y; Tan, AH; Lu, Z; Wu, CL; Zhang, YJ; Yang, XB; Zhang, HY; Qin, X; Mo, ZN				Liao, Ming; Huang, Xianghua; Gao, Yong; Tan, Aihua; Lu, Zheng; Wu, Chunlei; Zhang, Youjie; Yang, Xiaobo; Zhang, Haiying; Qin, Xue; Mo, Zengnan			Testosterone Is Associated with Erectile Dysfunction: A Cross-Sectional Study in Chinese Men	PLOS ONE			English	Article							AGE-RELATED DECLINE; SEX-HORMONE LEVELS; AREA MALE HEALTH; RISK-FACTORS; INTERNATIONAL INDEX; ANDROGEN DEFICIENCY; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; PREVALENCE; SYMPTOMS	Background: Testosterone is essential for the regulation of erectile physiology, but the relationship between low testosterone and erectile dysfunction (ED) has not been firmly established. Purpose: To examine the association between serum total, free and bio-available testosterone and ED in a population-based sample. Methods: A consecutive series of 1776 men aged 20-77 participated in the routine physical examination from September 2009 to December 2009 in Guangxi, China. ED was assessed using the five-item International Index of Erectile Function (IIEF-5) questionnaire. Total testosterone (TT), sex hormone binding globulin (SHBG) and other biochemical profiles were measured. Free testosterone (FT) and bio-available testosterone (BT) were calculated based on Vermeulen's formula. Data were collected with regard to smoking, alcoholic drinking, physical activity and metabolic syndrome. Results: The prevalence of ED (IIEF-5<22) was 47.6%. Men with ED were significantly older, and more prone to smoke cigarettes (>= 20 cigarettes/day) or drink alcohol (>= 3 drinks/week), and more likely to have elevated blood pressure (P = 0.036) or hyperglycemia (P < 0.001) compared with those without ED. The significant increase in SHBG with age was parallel to its increase with increasing severity of ED (P < 0.001). The obscure increase in TT across the ED status was detected without significance (P = 0.418), but TT was positively associated with ED after adjustment for age [odds ratio (OR) = 1.02, 95% CI (confidence internal): 1.00-1.04]. FT and BT were inversely associated with ED (OR = 0.14, 95% CI: 0.06-0.33; OR = 0.92 (95% CI: 0.89-0.96, respectively) in the univariate analysis, and this inverse association appeared to be independent of smoking status, alcoholic drinking, physical activity, hyper-triglyceridemia and hyperglycemia. Conclusions: FT and BT are inversely related to worsening ED, whereas the positive association between TT and ED is most likely due to the increase in SHBG.	[Liao, Ming; Gao, Yong; Lu, Zheng; Wu, Chunlei; Zhang, Youjie; Mo, Zengnan] Guangxi Med Univ, Affiliated Hosp 1, Inst Urol & Nephrol, Nanning, Guangxi Zhuang, Peoples R China; [Liao, Ming; Huang, Xianghua; Gao, Yong; Tan, Aihua; Lu, Zheng; Wu, Chunlei; Zhang, Youjie; Yang, Xiaobo; Zhang, Haiying; Qin, Xue; Mo, Zengnan] Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi Zhuang, Peoples R China; [Tan, Aihua] Guangxi Med Univ, Affiliated Hosp 1, Ctr Metab Dis & Diabet, Nanning, Guangxi Zhuang, Peoples R China; [Yang, Xiaobo; Zhang, Haiying] Guangxi Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Environm Hlth, Nanning, Guangxi Zhuang, Peoples R China; [Qin, Xue] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi Zhuang, Peoples R China; [Gao, Yong] Fudan Univ, Sch Life Sci, Fudan VARI Ctr Genet Epidemiol, Shanghai 200433, Peoples R China; [Huang, Xianghua] Guigang Peoples Hosp, Dept Urol, Guigang, Guangxi Zhuang, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Fudan University	Liao, M (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Inst Urol & Nephrol, Nanning, Guangxi Zhuang, Peoples R China.	zengnanmo@hotmail.com	Yang, Xiaobo/G-3854-2016; Zhang, Youjie/F-7346-2016	Zhang, Youjie/0000-0002-6035-8536; mo, zengnan/0000-0002-3047-3138; Zhao, Jinkou/0000-0001-9184-3385	National Natural Science Foundation of China [30945204]; Provincial departments of Finance and Education, Guangxi Zhuang Autonomous Region, China [2009GJCJ150]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial departments of Finance and Education, Guangxi Zhuang Autonomous Region, China	The work described in this article is supported by grants from the National Natural Science Foundation of China (Grant No. 30945204) and the Provincial departments of Finance and Education, Guangxi Zhuang Autonomous Region, China (Grant No. 2009GJCJ150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HS, 2002, BJU INT, V89, P526, DOI 10.1046/j.1464-410X.2002.02650.x; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Araujo AB, 2007, J CLIN ENDOCR METAB, V92, P4241, DOI 10.1210/jc.2007-1245; Armagan A, 2006, J ANDROL, V27, P517, DOI 10.2164/jandrol.05157; Bai Q, 2004, ASIAN J ANDROL, V6, P343; Basar MM, 2005, UROLOGY, V66, P597, DOI 10.1016/j.urology.2005.03.060; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Christensen BS, 2011, J SEX MED, V8, P1903, DOI 10.1111/j.1743-6109.2011.02291.x; Chughtai B, 2011, CURR OPIN UROL, V21, P514, DOI 10.1097/MOU.0b013e32834b8681; Corona G, 2004, INT J IMPOT RES, V16, P395, DOI 10.1038/sj.ijir.3901225; Corona G, 2009, INT J ANDROL, V32, P720, DOI 10.1111/j.1365-2605.2009.00952.x; Corona G, 2010, J SEX MED, V7, P1362, DOI 10.1111/j.1743-6109.2009.01601.x; Corona G, 2010, J SEX MED, V7, P182, DOI 10.1111/j.1743-6109.2009.01497.x; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; DAMASSA DA, 1977, HORM BEHAV, V8, P275, DOI 10.1016/0018-506X(77)90002-2; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; Fisher AD, 2009, J SEX MED, V6, P866, DOI 10.1111/j.1743-6109.2008.01140.x; Gades NM, 2008, J SEX MED, V5, P2209, DOI 10.1111/j.1743-6109.2008.00924.x; Golden SH, 2009, J CLIN ENDOCR METAB, V94, P1853, DOI 10.1210/jc.2008-2291; Gooren LJG, 1996, BRIT J UROL, V78, P763, DOI 10.1046/j.1464-410X.1996.05918.x; Grover SA, 2006, ARCH INTERN MED, V166, P213, DOI 10.1001/archinte.166.2.213; Hao ZY, 2011, J ANDROL, V32, P496, DOI 10.2164/jandrol.110.012138; Isidori AM, 2005, CLIN ENDOCRINOL, V63, P381, DOI 10.1111/j.1365-2265.2005.02350.x; Kocoglu H, 2011, AGING MALE, V14, P207, DOI 10.3109/13685538.2011.617798; Kupelian V, 2007, EUR UROL, V52, P416, DOI 10.1016/j.eururo.2007.03.015; Kupelian V, 2010, PREV MED, V50, P19, DOI 10.1016/j.ypmed.2009.11.006; Lee ACK, 2010, INT J IMPOT RES, V22, P272, DOI 10.1038/ijir.2010.15; Lee JC, 2011, BJU INT, V107, P956, DOI 10.1111/j.1464-410X.2010.09691.x; Lu Z, 2012, PROSTATE, V72, P193, DOI 10.1002/pros.21421; Ly LP, 2010, CLIN ENDOCRINOL, V73, P382, DOI 10.1111/j.1365-2265.2010.03804.x; Muezzinoglu T, 2007, YONSEI MED J, V48, P1015, DOI 10.3349/ymj.2007.48.6.1015; O'Connor DB, 2011, J CLIN ENDOCR METAB, V96, pE1577, DOI 10.1210/jc.2010-2216; Ohlsson C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002313; Rhoden EL, 2002, INT J IMPOT RES, V14, P167, DOI 10.1038/sj.ijir.3900852; Rhoden EL, 2002, J UROLOGY, V167, P1745, DOI 10.1016/S0022-5347(05)65191-9; Rosen RC, 1999, INT J IMPOT RES, V11, P319, DOI 10.1038/sj.ijir.3900472; Rosner W, 2007, J CLIN ENDOCR METAB, V92, P405, DOI 10.1210/jc.2006-1864; Shiels MS, 2009, CANCER CAUSE CONTROL, V20, P877, DOI 10.1007/s10552-009-9318-y; Tan AH, 2011, METABOLISM, V60, P1186, DOI 10.1016/j.metabol.2011.01.002; Traish AM, 2007, EUR UROL, V52, P54, DOI 10.1016/j.eururo.2007.02.034; Traish AM, 2006, J SEX MED, V3, P382, DOI 10.1111/j.1743-6109.2006.00245.x; Tsujimura A, 2003, J UROLOGY, V170, P2345, DOI 10.1097/01.ju.0000089768.17091.c0; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; VERMEULEN A, 1993, ANN MED, V25, P531; Wu CL, 2011, J ANDROL, V33, P59, DOI 10.2164/jandrol.110.012542; Wu FCW, 2010, NEW ENGL J MED, V363, P123, DOI 10.1056/NEJMoa0911101	46	30	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39234	10.1371/journal.pone.0039234	http://dx.doi.org/10.1371/journal.pone.0039234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737230	Green Published, gold, Green Submitted			2022-12-25	WOS:000305695100028
J	Zhang, X; Tiewsiri, K; Kain, W; Huang, LH; Wang, P				Zhang, Xin; Tiewsiri, Kasorn; Kain, Wendy; Huang, Lihua; Wang, Ping			Resistance of Trichoplusia ni to Bacillus thuringiensis Toxin Cry1Ac Is Independent of Alteration of the Cadherin-Like Receptor for Cry Toxins	PLOS ONE			English	Article							DIAMONDBACK MOTH LEPIDOPTERA; HELIOTHIS-VIRESCENS; INSECT RESISTANCE; CABBAGE-LOOPER; MANDUCA-SEXTA; BT TOXINS; BINDING; MEMBRANE; PROTEIN; MECHANISM	Alteration of binding sites for Bacillus thuringiensis (Bt) toxins in insect midgut is the major mechanism of high-level resistance to Bt toxins in insects. The midgut cadherin is known to be a major binding protein for Bt Cry1A toxins and linkage of Bt-resistance to cadherin gene mutations has been identified in lepidopterans. The resistance to Bt toxin Cry1Ac evolved in greenhouse populations of Trichoplusia ni has been identified to be associated with the down-regulation of an aminopeptidase N (APN1) gene by a trans-regulatory mechanism and the resistance gene has been mapped to the locus of an ABC transporter (ABCC2) gene. However, whether cadherin is also involved with Cry1Ac-resistance in T. ni requires to be understood. Here we report that the Cry1Ac-resistance in T. ni is independent of alteration of the cadherin. The T. ni cadherin cDNA was cloned and the cadherin sequence showed characteristic features known to cadherins from Lepidoptera. Various T. ni cadherin gene alleles were identified and genetic linkage analysis of the cadherin alleles with Cry1Ac-resistance showed no association of the cadherin gene with the Cry1Ac-resistance in T. ni. Analysis of cadherin transcripts showed no quantitative difference between the susceptible and Cry1Ac-resistant T. ni larvae. Quantitative proteomic analysis of midgut BBMV proteins by iTRAQ-2D-LC-MS/MS determined that there was no quantitative difference in cadherin content between the susceptible and the resistant larvae and the cadherin only accounted for 0.0014% (mol%) of the midgut BBMV proteins, which is 1/300 of APN1 in molar ratio. The cadherin from both the susceptible and resistant larvae showed as a 200-kDa Cry1Ac-binding protein by toxin overlay binding analysis, and nano-LC-MS/MS analysis of the 200-kDa cadherin determined that there is no quantitative difference between the susceptible and resistant larvae. Results from this study indicate that the Cry1Ac-resistance in T. ni is independent of cadherin alteration.	[Zhang, Xin; Tiewsiri, Kasorn; Kain, Wendy; Huang, Lihua; Wang, Ping] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA	Cornell University	Zhang, X (corresponding author), Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA.	pingwang@cornell.edu			Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture [2008-35302-18806]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by Agriculture and Food Research Initiative Competitive Grant no. 2008-35302-18806 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Bagla P, 2010, SCIENCE, V327, P1439, DOI 10.1126/science.327.5972.1439; Baxter SW, 2011, GENETICS, V189, P675, DOI 10.1534/genetics.111.130971; Baxter SW, 2005, INSECT MOL BIOL, V14, P327, DOI 10.1111/j.1365-2583.2005.00563.x; Bell RA., 1981, USDA TECH B, P599; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; Bravo A, 2002, BBA-BIOMEMBRANES, V1562, P63, DOI 10.1016/S0005-2736(02)00360-7; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Caccia S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009975; Dorsch JA, 2002, INSECT BIOCHEM MOLEC, V32, P1025, DOI 10.1016/S0965-1748(02)00040-1; Federici BA, 2005, J INVERTEBR PATHOL, V89, P30, DOI 10.1016/j.jip.2005.06.007; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Flannagan RD, 2005, INSECT BIOCHEM MOLEC, V35, P33, DOI 10.1016/j.ibmb.2004.10.001; Gahan LJ, 2007, J ECON ENTOMOL, V100, P187, DOI 10.1603/0022-0493(2007)100[187:APCRSO]2.0.CO;2; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gomez I, 2001, J BIOL CHEM, V276, P28906, DOI 10.1074/jbc.M103007200; Gonzalez-Cabrera J, 2003, INSECT BIOCHEM MOLEC, V33, P929, DOI 10.1016/S0965-1748(03)00099-7; Griffitts JS, 2005, BIOESSAYS, V27, P614, DOI 10.1002/bies.20239; Gunning RV, 2005, APPL ENVIRON MICROB, V71, P2558, DOI 10.1128/AEM.71.5.2558-2563.2005; Hayakawa T, 2004, FEBS LETT, V576, P331, DOI 10.1016/j.febslet.2004.09.029; Heckel DG, 2007, J INVERTEBR PATHOL, V95, P192, DOI 10.1016/j.jip.2007.03.008; Hua G, 2004, J BIOL CHEM, V279, P28051, DOI 10.1074/jbc.M400237200; Huang FN, 2007, J ECON ENTOMOL, V100, P164, DOI 10.1603/0022-0493(2007)100[164:SBLCRT]2.0.CO;2; Ibrahim Mohamed A, 2010, Bioeng Bugs, V1, P31, DOI 10.4161/bbug.1.1.10519; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Janmaat AF, 2003, P ROY SOC B-BIOL SCI, V270, P2263, DOI 10.1098/rspb.2003.2497; Jimenez CR, 2001, CURR PROTOC PROTEIN, DOI [DOI 10.1002/0471140864.PS1604S14, 10.1002/0471140864.ps1604s14]; Jurat-Fuentes JL, 2004, BIOCHEMISTRY-US, V43, P14299, DOI 10.1021/bi048500i; Jurat-Fuentes JL, 2004, EUR J BIOCHEM, V271, P3127, DOI 10.1111/j.1432-1033.2004.04238.x; Jurat-Fuentes JL, 2006, J INVERTEBR PATHOL, V92, P166, DOI 10.1016/j.jip.2006.01.010; Jurat-Fuentes JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017606; Kain WC, 2004, J ECON ENTOMOL, V97, P2073, DOI 10.1603/0022-0493-97.6.2073; Ma G, 2005, INSECT BIOCHEM MOLEC, V35, P729, DOI 10.1016/j.ibmb.2005.02.011; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Nagamatsu Y, 1999, FEBS LETT, V460, P385, DOI 10.1016/S0014-5793(99)01327-7; Oppert B, 1999, ARCH INSECT BIOCHEM, V42, P1, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;1::AID-ARCH2&gt;3.0.CO;2-#; Pacheco S, 2009, J BIOL CHEM, V284, P32750, DOI 10.1074/jbc.M109.024968; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Rahman MM, 2004, P NATL ACAD SCI USA, V101, P2696, DOI 10.1073/pnas.0306669101; Redding Alyssa M., 2006, Briefings in Functional Genomics & Proteomics, V5, P133, DOI 10.1093/bfgp/ell025; RINALDINI L M, 1954, J Physiol, V123, P20; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; SHELTON AM, 1993, J ECON ENTOMOL, V86, P697, DOI 10.1093/jee/86.3.697; Soberon M, 2007, SCIENCE, V318, P1640, DOI 10.1126/science.1146453; Tabashnik BE, 2003, J ECON ENTOMOL, V96, P1031, DOI 10.1603/0022-0493-96.4.1031; TABASHNIK BE, 1990, J ECON ENTOMOL, V83, P1671, DOI 10.1093/jee/83.5.1671; Tabashnik BE, 1998, PHILOS T R SOC B, V353, P1751, DOI 10.1098/rstb.1998.0327; Tabashnik BE, 2006, J ECON ENTOMOL, V99, P1525, DOI 10.1603/0022-0493-99.5.1525; Tabashnik Bruce E, 2011, Nat Biotechnol, V29, P1128, DOI 10.1038/nbt.1988; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Tiewsiri K, 2011, P NATL ACAD SCI USA, V108, P14037, DOI 10.1073/pnas.1102555108; Wang P, 1997, J BIOL CHEM, V272, P16663, DOI 10.1074/jbc.272.26.16663; Wang P, 2007, APPL ENVIRON MICROB, V73, P1199, DOI 10.1128/AEM.01834-06; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; Xie RY, 2005, J BIOL CHEM, V280, P8416, DOI 10.1074/jbc.M408403200; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; Yang YJ, 2007, APPL ENVIRON MICROB, V73, P6939, DOI 10.1128/AEM.01703-07; Zhang X, 2005, CELL DEATH DIFFER, V12, P1407, DOI 10.1038/sj.cdd.4401675; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103	62	308	314	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e35991	10.1371/journal.pone.0035991	http://dx.doi.org/10.1371/journal.pone.0035991			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22558203	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339400010
J	Zhang, YJ; Dai, X; Wang, XH; Maituohuti, A; Cui, YJ; Rehemu, A; Wang, QG; Meng, WW; Luo, T; Guo, R; Li, B; Abudurexiti, A; Song, YJ; Yang, RF; Cao, HL				Zhang, Yujiang; Dai, Xiang; Wang, Xinhui; Maituohuti, Abulimiti; Cui, Yujun; Rehemu, Azhati; Wang, Qiguo; Meng, Weiwei; Luo, Tao; Guo, Rong; Li, Bing; Abudurexiti, Abulikemu; Song, Yajun; Yang, Ruifu; Cao, Hanli			Dynamics of Yersinia pestis and Its Antibody Response in Great Gerbils (Rhombomys opimus) by Subcutaneous Infection	PLOS ONE			English	Article							EXPERIMENTAL PLAGUE; RODENTS; HISTORY; SYSTEM; AGENT; MODEL	Background: Rhombomys opimus (great gerbil) is a reservoir of Yersinia pestis in the natural plague foci of Central Asia. Great gerbils are highly resistant to Y. pestis infection. The coevolution of great gerbils and Y. pestis is believed to play an important role in the plague epidemics in Central Asia plague foci. However, the dynamics of Y. pestis infection and the corresponding antibody response in great gerbils have not been evaluated. In this report, animal experiments were employed to investigate the bacterial load in both the liver and spleen of infected great gerbils. The dynamics of the antibody response to the F1 capsule antigen of Y. pestis was also determined. Methodology: Captured great gerbils that tested negative for both anti-F1 antibodies and bacterial isolation were infected subcutaneously with different doses (10(5) to 10(11) CFU) of a Y. pestis strain isolated from a live great gerbil during routine plague surveillance in the Junggar Basin, Xinjiang, China. The clinical manifestations, changes in body weight, anal temperature, and gross anatomy of the infected animals were observed. The blood cell count, bacterial load, and anti-F1 antibody titers were determined at different time points after infection using a blood analyzer, plate counts, and an indirect hemagglutination assay, respectively. Conclusions/Significance: The dynamics of bacterial load and the anti-F1 antibody concentration in great gerbils are highly variable among individuals. The Y. pestis infection in great gerbils could persist as long as 15 days. They act as an appropriate reservoir for plague in the Junggar Basin, which is part of the natural plague foci in Central Asia. The dynamics of the Y. pestis susceptibility of great gerbil will improve the understanding of its variable resistance, which would facilitate the development of more effective countermeasures for controlling plague epidemics in this focus.	[Cui, Yujun; Song, Yajun; Yang, Ruifu] Beijing Inst Microbiol & Epidemiol, Lab Analyt Microbiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Zhang, Yujiang; Dai, Xiang; Wang, Xinhui; Maituohuti, Abulimiti; Rehemu, Azhati; Wang, Qiguo; Meng, Weiwei; Luo, Tao; Guo, Rong; Li, Bing; Abudurexiti, Abulikemu; Cao, Hanli] Ctr Dis Control & Prevent Xinjiang Uygur Autonomo, Urumqi, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Yang, RF (corresponding author), Beijing Inst Microbiol & Epidemiol, Lab Analyt Microbiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	ruifuyang@gmail.com; chl2621215@126.com	Song, Yajun/GQQ-0476-2022; Song, Yajun/F-3714-2011; Yang, Ruifu/A-2273-2011	Song, Yajun/0000-0002-6628-2747; Song, Yajun/0000-0002-6628-2747; Yang, Ruifu/0000-0003-3219-7269	National Natural Science Foundation of China [30960348]; Science and Technology of Xinjiang Uygur Autonomous Region; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK015564, R01DK075964, R37DK015564] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology of Xinjiang Uygur Autonomous Region; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Natural Science Foundation of China (contract no. 30960348) and Science and Technology of Xinjiang Uygur Autonomous Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimov AP, 2004, CLIN MICROBIOL REV, V17, P434, DOI 10.1128/CMR.17.2.434-464.2004; Begon M, 2006, EMERG INFECT DIS, V12, P268; Biggins DE, 2001, J MAMMAL, V82, P906, DOI 10.1644/1545-1542(2001)082&lt;0906:IOIPON&gt;2.0.CO;2; Bizanov G, 2007, J INFECTION, V54, P198, DOI 10.1016/j.jinf.2006.02.012; CHRISTIE A B, 1982, Ecology of Disease, V1, P111; Cully JF, 2001, J MAMMAL, V82, P894, DOI 10.1644/1545-1542(2001)082&lt;0894:ICOSPI&gt;2.0.CO;2; Davis S, 2007, EPIDEMIOL INFECT, V135, P740, DOI 10.1017/S095026880600759X; Davis S, 2007, J R SOC INTERFACE, V4, P649, DOI 10.1098/rsif.2006.0208; Davis S, 2004, SCIENCE, V304, P736, DOI 10.1126/science.1095854; Dennis DT., 1999, PLAGUE MANUAL EPIDEM; DUNAEV GS, 1982, ZH MIKROB EPID IMMUN, P50; EIDSON M, 1991, J AM VET MED ASSOC, V199, P1191; Ergaliev K Kh, 1990, Genetika, V26, P103; Fang X, 1990, NATURAL PLAGUE FOCI; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; Guryev V, 2009, FEBS LETT, V583, P1668, DOI 10.1016/j.febslet.2009.04.020; Isin Zh.M., 1986, Journal of Hygiene Epidemiology Microbiology and Immunology (Prague), V31, P307; ISIN ZM, 1987, ZH MIKROB EPID IMMUN, P84; Kagramanov V S, 1999, Zh Mikrobiol Epidemiol Immunobiol, P13; Kausrud KL, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-112; MENKENS GE, 1991, J MAMMAL, V72, P328, DOI 10.2307/1382103; Nham T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034714; Park S, 2007, J R SOC INTERFACE, V4, P57, DOI 10.1098/rsif.2006.0160; Randall JA, 2005, BEHAV ECOL, V16, P961, DOI 10.1093/beheco/ari078; Rena TRD, 2006, CHI J ZOONOSIS, V22, P1086; Watson RP, 2001, VET PATHOL, V38, P165, DOI 10.1354/vp.38-2-165; WILLIAMS JE, 1983, EXPERIENTIA, V39, P408, DOI 10.1007/BF01963151; Zhang Yu-Jiang, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P136; Zhao XN, 2011, J GEN VIROL, V92, P216, DOI 10.1099/vir.0.026328-0; ZYKIN LF, 1989, ZH MIKROB EPID IMMUN, P36	30	23	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46820	10.1371/journal.pone.0046820	http://dx.doi.org/10.1371/journal.pone.0046820			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	22545125	Green Submitted, Green Published, gold			2022-12-25	WOS:000309827300064
J	Li, Y; Farooq, M; Sheng, DL; Chandramouli, C; Lan, T; Mahajan, NK; Kini, RM; Hong, YH; Lisowsky, T; Ge, RW				Li, Yan; Farooq, Muhammad; Sheng, Donglai; Chandramouli, Chanchal; Lan, Tian; Mahajan, Nilesh K.; Kini, R. Manjunatha; Hong, Yunhan; Lisowsky, Thomas; Ge, Ruowen			Augmenter of Liver Regeneration (alr) Promotes Liver Outgrowth during Zebrafish Hepatogenesis	PLOS ONE			English	Article							HEPATIC STIMULATOR SUBSTANCE; DISULFIDE RELAY SYSTEM; MITOCHONDRIAL SULFHYDRYL OXIDASE; INTERMEMBRANE SPACE; RESPIRATORY-CHAIN; PROTEIN IMPORT; CYTOCHROME-C; GENE; HEPATOPOIETIN; YEAST	Augmenter of Liver Regeneration (ALR) is a sulfhydryl oxidase carrying out fundamental functions facilitating protein disulfide bond formation. In mammals, it also functions as a hepatotrophic growth factor that specifically stimulates hepatocyte proliferation and promotes liver regeneration after liver damage or partial hepatectomy. Whether ALR also plays a role during vertebrate hepatogenesis is unknown. In this work, we investigated the function of alr in liver organogenesis in zebrafish model. We showed that alr is expressed in liver throughout hepatogenesis. Knockdown of alr through morpholino antisense oligonucleotide (MO) leads to suppression of liver outgrowth while overexpression of alr promotes liver growth. The small-liver phenotype in alr morphants results from a reduction of hepatocyte proliferation without affecting apoptosis. When expressed in cultured cells, zebrafish Alr exists as dimer and is localized in mitochondria as well as cytosol but not in nucleus or secreted outside of the cell. Similar to mammalian ALR, zebrafish Alr is a flavin-linked sulfhydryl oxidase and mutation of the conserved cysteine in the CxxC motif abolishes its enzymatic activity. Interestingly, overexpression of either wild type Alr or enzyme-inactive Alr(C131S) mutant promoted liver growth and rescued the liver growth defect of alr morphants. Nevertheless, alr(C131S) is less efficacious in both functions. Meantime, high doses of alr MOs lead to widespread developmental defects and early embryonic death in an alr sequence-dependent manner. These results suggest that alr promotes zebrafish liver outgrowth using mechanisms that are dependent as well as independent of its sulfhydryl oxidase activity. This is the first demonstration of a developmental role of alr in vertebrate. It exemplifies that a low-level sulfhydryl oxidase activity of Alr is essential for embryonic development and cellular survival. The dose-dependent and partial suppression of alr expression through MO-mediated knockdown allows the identification of its late developmental role in vertebrate liver organogenesis.	[Li, Yan; Farooq, Muhammad; Sheng, Donglai; Chandramouli, Chanchal; Lan, Tian; Mahajan, Nilesh K.; Kini, R. Manjunatha; Hong, Yunhan; Ge, Ruowen] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Farooq, Muhammad] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia; [Kini, R. Manjunatha] Virginia Commonwealth Univ, Med Coll Virginia, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Lisowsky, Thomas] MultiBIND Biotec GmbH, Cologne, Germany	National University of Singapore; King Saud University; Virginia Commonwealth University	Li, Y (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsgerw@nus.edu.sg	He, Zheng-Guo/P-3647-2014; Ge, Ruowen/D-8352-2012; Kini, Manjunatha/H-8029-2012; Chandramouli, Chanchal/AAF-2848-2020; Hong, Yunhan/D-4197-2009; Farooq, Muhammad/G-9838-2013; Li, Zhi-Yong/G-9701-2011; Li, Zhi-Yong/G-9701-2011	Ge, Ruowen/0000-0002-0750-7336; Farooq, Muhammad/0000-0001-9891-2443; Kini, Manjunatha/0000-0002-6100-3251; Zhang, Yuesheng/0000-0002-0976-2875; Li, Zhi-Yong/0000-0003-3039-8833; Li, Zhi-Yong/0000-0002-6814-9165	Singapore Biomedical Research Council [BMRC/01/1/21/18/068]; Ministry of Education [R-154-000-475-112]; NCI NIH HHS [CA120533, R01 CA124627, R01 CA120533, P30 CA016056] Funding Source: Medline	Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Ministry of Education; NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by the Singapore Biomedical Research Council grant BMRC/01/1/21/18/068 and Ministry of Education grant R-154-000-475-112 to Dr. Ge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123; Cao Y, 2009, FREE RADICAL BIO MED, V47, P1057, DOI 10.1016/j.freeradbiomed.2009.07.017; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Chen XX, 2003, J BIOL CHEM, V278, P49022, DOI 10.1074/jbc.M304057200; Chu J, 2009, HEPATOLOGY, V50, P1656, DOI 10.1002/hep.23157; Daithankar VN, 2010, BIOCHEMISTRY-US, V49, P6737, DOI 10.1021/bi100912m; Daithankar VN, 2009, BIOCHEMISTRY-US, V48, P4828, DOI 10.1021/bi900347v; Di Fonzo A, 2009, AM J HUM GENET, V84, P594, DOI 10.1016/j.ajhg.2009.04.004; Farooq M, 2008, DEV BIOL, V317, P336, DOI 10.1016/j.ydbio.2008.02.034; Farrell SR, 2005, BIOCHEMISTRY-US, V44, P1532, DOI 10.1021/bi0479555; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Gandhi CR, 1999, HEPATOLOGY, V29, P1435, DOI 10.1002/hep.510290522; Gandhi CR, 2009, J CELL PHYSL; Gatzidou E, 2006, WORLD J GASTROENTERO, V12, P4951, DOI 10.3748/wjg.v12.i31.4951; GHOSH C, 1994, CELL BIOL TOXICOL, V10, P167, DOI 10.1007/BF00757560; HAGIYA M, 1994, P NATL ACAD SCI USA, V91, P8142, DOI 10.1073/pnas.91.17.8142; HE FH, 1993, HEPATOLOGY, V17, P225, DOI 10.1016/0270-9139(93)90081-W; Hofhaus G, 1999, EUR J CELL BIOL, V78, P349, DOI 10.1016/S0171-9335(99)80069-7; Ilowski M, 2011, BIOCHEM BIOPH RES CO, V404, P148, DOI 10.1016/j.bbrc.2010.11.083; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kondili VG, 2005, DIGEST DIS SCI, V50, P297, DOI 10.1007/s10620-005-1598-9; Korzh S, 2001, MECH DEVELOP, V103, P137, DOI 10.1016/S0925-4773(01)00330-6; LABRECQUE DR, 1975, J PHYSIOL-LONDON, V248, P273, DOI 10.1113/jphysiol.1975.sp010973; Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161; Lee JE, 2000, FEBS LETT, V477, P62, DOI 10.1016/S0014-5793(00)01767-1; Levitan A, 2004, J BIOL CHEM, V279, P20002, DOI 10.1074/jbc.M312877200; Li Y, 2002, EUR J BIOCHEM, V269, P3888, DOI 10.1046/j.1432-1033.2002.03054.x; Li Y, 2000, J BIOL CHEM, V275, P37443, DOI 10.1074/jbc.M004373200; Liatsos GD, 2003, DIGEST DIS SCI, V48, P1929, DOI 10.1023/A:1026157901805; LISOWSKY T, 1995, GENOMICS, V29, P690, DOI 10.1006/geno.1995.9950; LISOWSKY T, 1992, MOL GEN GENET, V232, P58, DOI 10.1007/BF00299137; Lisowsky T, 2001, DIGEST LIVER DIS, V33, P173, DOI 10.1016/S1590-8658(01)80074-8; Lu CR, 2002, FASEB J, V16, P90, DOI 10.1096/fj.01-0506fje; Lu J, 2002, WORLD J GASTROENTERO, V8, P353; McClure KD, 2008, DEV BIOL, V319, P68, DOI 10.1016/j.ydbio.2008.04.004; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Passeri MJ, 2009, HEPATOLOGY, V49, P443, DOI 10.1002/hep.22667; Sadler KC, 2007, P NATL ACAD SCI USA, V104, P1570, DOI 10.1073/pnas.0610774104; Shin D, 2007, DEVELOPMENT, V134, P2041, DOI 10.1242/dev.000281; Tanigawa K, 2000, J GASTROENTEROL, V35, P112, DOI 10.1007/s005350050023; Thasler WE, 2005, HISTOPATHOLOGY, V47, P57, DOI 10.1111/j.1365-2559.2005.02172.x; Thirunavukkarasu C, 2008, J HEPATOL, V48, P578, DOI 10.1016/j.jhep.2007.12.010; Tokatlidis K, 2005, CELL, V121, P965, DOI 10.1016/j.cell.2005.06.019; Wang CP, 2006, WORLD J GASTROENTERO, V12, P4859; Wang G, 1999, J BIOL CHEM, V274, P11469, DOI 10.1074/jbc.274.17.11469; Wang WZ, 2007, BIOCHEMISTRY-US, V46, P3246, DOI 10.1021/bi602499t; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Wiedenmann J, 2009, IUBMB LIFE, V61, P1029, DOI 10.1002/iub.256; Yabu T, 2001, FISHERIES SCI, V67, P333, DOI 10.1046/j.1444-2906.2001.00233.x; Yang XM, 1997, SCI CHINA SER C, V40, P642, DOI 10.1007/BF02882695	52	150	169	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30835	10.1371/journal.pone.0030835	http://dx.doi.org/10.1371/journal.pone.0030835			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22905149	gold, Green Published			2022-12-25	WOS:000301703800034
J	Li, YY; Zhu, RN; Qian, Y; Deng, J				Li, Yuyun; Zhu, Runan; Qian, Yuan; Deng, Jie			The Characteristics of Blood Glucose and WBC Counts in Peripheral Blood of Cases of Hand Foot and Mouth Disease in China: A Systematic Review	PLOS ONE			English	Review							ENTEROVIRUS 71; OUTBREAK; INFECTIONS; MALAYSIA; TAIWAN; MANIFESTATIONS	Background: Outbreaks of Hand Foot and Mouth Disease (HFMD) have occurred in many parts of the world especially in China. We aimed to summarize the characteristics of the levels of blood glucose and white blood cell (WBC) counts in cases of HFMD in Mainland China and Taiwan, using meta-analysis based on systematic review of published articles. Methods: We systematically reviewed published studies, from the MEDLINE and WANFANG Data, about the levels of blood glucose and WBC counts in cases of HFMD until 15(th) June 2011, and quantitatively summarized the characteristics of them using meta-analysis. Results: In total, 37 studies were included in this review. In Mainland China and Taiwan, generally, the average level of blood glucose, the prevalence of hyperglycemia, WBC counts and the prevalence of leukocytosis increased with the severity of the illness. There was no significant difference in the prevalence of leukocytosis between ANS (autonomic nervous system dysregulation)/PE (pulmonary edema) group and CNS (central nervous system) group, and in the average level of blood glucose between healthy controls and mild cases of HFMD. WBC counts in cases infected by EV71 were less than those in cases infected by CA16. Conclusions: our analyses indicated that blood glucose and WBC counts increased with the severity of HFMD disease, which would help doctors to manage patients efficiently.	[Li, Yuyun; Zhu, Runan; Qian, Yuan; Deng, Jie] Capital Inst Pediat, Virol Lab, Beijing, Peoples R China	Capital Institute of Pediatrics (CIP)	Li, YY (corresponding author), Capital Inst Pediat, Virol Lab, Beijing, Peoples R China.	qybds1129@163.com	He, Zheng-Guo/P-3647-2014; Ge, Ruowen/D-8352-2012; Kini, Manjunatha/H-8029-2012; Chandramouli, Chanchal/AAF-2848-2020; Hong, Yunhan/D-4197-2009; Farooq, Muhammad/G-9838-2013; Li, Zhi-Yong/G-9701-2011; Li, Zhi-Yong/G-9701-2011	Ge, Ruowen/0000-0002-0750-7336; Farooq, Muhammad/0000-0001-9891-2443; Kini, Manjunatha/0000-0002-6100-3251; Zhang, Yuesheng/0000-0002-0976-2875; Li, Zhi-Yong/0000-0003-3039-8833; Li, Zhi-Yong/0000-0002-6814-9165	NCI NIH HHS [CA120533, R01 CA124627, R01 CA120533, P30 CA016056] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abubakar S, 1999, SCAND J INFECT DIS, V31, P331, DOI 10.1080/00365549950163734; AbuBakar S, 2009, EMERG INFECT DIS, V15, P79, DOI 10.3201/eid1501.080264; Ahmad K, 2000, LANCET, V356, P1338, DOI 10.1016/S0140-6736(05)74253-7; ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Chen JH, 2010, ACTA ACAD MEDICINAE, V32, P363; Chen WB, 2000, 5 DIAGNOSTICS; Chu PY, 2001, ARCH VIROL, V146, P589, DOI 10.1007/s007050170164; Cui LD, 2011, CHINA PRAC MED, V6, P50; Dai W, 2011, CHINESE COMMUNITY DO, V13, P88; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ding NZ, 2009, VIRUS RES, V145, P157, DOI 10.1016/j.virusres.2009.06.006; Fan XC, 2009, ANHUI MED J, V30, P253; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hsia SH, 2005, PEDIATR INFECT DIS J, V24, P331, DOI 10.1097/01.inf.0000157219.19674.98; Huang S, 2008, ANHUI MED J, V29, P361; Huang YF, 2003, J INFECTION, V46, P238, DOI 10.1053/jinf.2002.1117; Jiang J, 2010, J QILU NURSING, V16, P119; Kehle J, 2003, J NEUROVIROL, V9, P126, DOI 10.1080/13550280390173364; Li CC, 2002, SCAND J INFECT DIS, V34, P104, DOI 10.1080/00365540110077119; Li JM, 2009, CHIN PEDIAT EMERG ME, V16, P142; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li Q., 2010, ANHUI MED J, V31, P1410; Li SH, 2010, CHIN PECIATR EMERG M, V17, P49; Li SH, 2010, CHIN J CLIN INFECT D, V3, P337; [李玉芬 Li Yufen], 2010, [临床儿科杂志, Journal of Chinical Pediatrics], V28, P1011; Liao Y, 2010, JILIN MED J, P4075; Lin TY, 2003, EMERG INFECT DIS, V9, P291, DOI 10.3201/eid0903.020285; Lin TY, 2003, CLIN INFECT DIS, V36, P269, DOI 10.1086/345905; Lin TY, 2002, ACTA PAEDIATR, V91, P632, DOI 10.1080/080352502760069016; Liu J, 2009, ANHUI MED J, V30, P261; Liu X, 2010, CHIN J MED ULTRASOUN, V7, P1844; Liu Ying-xia, 2008, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V22, P475; Lu CY, 2002, J MED VIROL, V67, P217, DOI 10.1002/jmv.2210; Luo LP, 2010, J N CHINA COAL MED U, V12, P356; Mai LL, 2011, CHINESE J NEW CLIN M, V4, P356; MANTEL N, 1959, J NATL CANCER I, V22, P719; [毛国顺 MAO Guoshun], 2008, [中华传染病杂志, Chinese Journal of Infections Diseases], V26, P387; [毛月燕 MAO Yue-yan], 2009, [中华传染病杂志, Chinese Journal of Infections Diseases], V27, P35; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Qian N, 2010, THESIS QINGDAO U, P17; Shen Q, 2011, J MED RES, V40, P93; Shimizu H, 1999, JPN J INFECT DIS, V52, P12; Tang LP, 2009, CHIN J M ISDIAGN, V9, P6840; Verbruggen SCAT, 2007, CLIN NUTR, V26, P677, DOI 10.1016/j.clnu.2007.08.012; Wang HC, 2010, CHINA CLIN PRAC MED, V4, P155; Wang JR, 2002, J CLIN MICROBIOL, V40, P10, DOI 10.1128/JCM.40.1.10-15.2002; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Wei XL, 2010, SHANDONG MED J, V50, P70; World Health Organization, 2017, GUID DRINK WAT QUAL, VFourth, DOI 10.1016/S1462-0758(00)00006-6; Yan ZW, 2011, CHIN J GEN PRACT, V10, P343; Yang T, 2010, ACTA MEDCINAE SINICA, V23, P68; Yu LX, 2011, CHIN PEDIAT EMERG ME, V18, P57; [岳保珠 Yue Baozhu], 2010, [中国全科医学, Chinese General Practice], V13, P2239; Zhang GH, 2010, CHINA CLIN PRAC MED, V4, P132; Zhang JH, 2010, CHINESE FOREIGN MED, V8, P12; Zhang Shou-Bin, 2008, Zhongguo Dang Dai Er Ke Za Zhi, V10, P38; Zhao H., 2008, J CLIN PEDIAT, V26, P467; Zheng NH, 2011, CHINA MODERN DOCTOR, V49, P126; Zhou AR, 2000, 5 BIOCH; [周大明 Zhou Daming], 2010, [重庆医科大学学报, Acta Universitatis Scientiae Medicinae Chongqing], V35, P1724	63	150	169	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29003	10.1371/journal.pone.0029003	http://dx.doi.org/10.1371/journal.pone.0029003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22905149	Green Published, Green Submitted, gold			2022-12-25	WOS:000301123400018
J	Li, YQ; He, ZG				Li, Yuqing; He, Zheng-Guo			The Mycobacterial LysR-Type Regulator OxyS Responds to Oxidative Stress and Negatively Regulates Expression of the Catalase-Peroxidase Gene	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATOR; PATHOGENIC MYCOBACTERIA; TUBERCULOSIS; KATG; FURA; SENSITIVITY; SMEGMATIS; MACROPHAGES; RESISTANCE; PROTEINS	Protection against oxidative stress is one of the primary defense mechanisms contributing to the survival of Mycobacterium tuberculosis in the host. In this study, we provide evidence that OxyS, a LysR-type transcriptional regulator functions as an oxidative stress response regulator in mycobacteria. Overexpression of OxyS lowers expression of the catalase-peroxidase (KatG) gene in M. smegmatis. OxyS binds directly with the katG promoter region and a conserved, GC-rich T-N-11-A motif for OxyS binding was successfully characterized in the core binding site. Interestingly, the DNA-binding activity of OxyS was inhibited by H2O2, but not by dithiothreitol. Cys25, which is situated at the DNA-binding domain of OxyS, was found to have a regulatory role for the DNA-binding ability of OxyS in response to oxidative stress. In contrast, the other three cysteine residues in OxyS do not appear to have this function. Furthermore, the mycobacterial strain over-expressing OxyS had a higher sensitivity to H2O2. Thus, OxyS responds to oxidative stress through a unique cysteine residue situated in its DNA-binding domain and negatively regulates expression of the katG gene. These findings uncover a specific regulatory mechanism for mycobacterial adaptation to oxidative stress.	[Li, Yuqing; He, Zheng-Guo] Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Ctr Prote Res, Coll Life Sci & Technol, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	He, ZG (corresponding author), Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Ctr Prote Res, Coll Life Sci & Technol, Wuhan, Hubei, Peoples R China.	hezhengguo@mail.hzau.edu.cn	He, Zheng-Guo/P-3647-2014; Ge, Ruowen/D-8352-2012; Kini, Manjunatha/H-8029-2012; Chandramouli, Chanchal/AAF-2848-2020; Hong, Yunhan/D-4197-2009; Farooq, Muhammad/G-9838-2013; Li, Zhi-Yong/G-9701-2011; Li, Zhi-Yong/G-9701-2011	Ge, Ruowen/0000-0002-0750-7336; Farooq, Muhammad/0000-0001-9891-2443; Kini, Manjunatha/0000-0002-6100-3251; Zhang, Yuesheng/0000-0002-0976-2875; Li, Zhi-Yong/0000-0003-3039-8833; Li, Zhi-Yong/0000-0002-6814-9165	National Natural Science Foundation of China [31025002, 30930003]; Fundamental Research Funds for the Central Universities [2011PY140]; Hubei Chutian Scholar Program; NCI NIH HHS [CA120533, R01 CA124627, R01 CA120533, P30 CA016056] Funding Source: Medline	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Hubei Chutian Scholar Program; NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Natural Science Foundation of China (31025002, 30930003), the Fundamental Research Funds for the Central Universities (2011PY140) and Hubei Chutian Scholar Program (to Z-GH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Chen H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001602; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; DERETIC V, 1995, MOL MICROBIOL, V17, P889, DOI 10.1111/j.1365-2958.1995.mmi_17050889.x; Dhandayuthapani S, 1996, J BACTERIOL, V178, P3641, DOI 10.1128/jb.178.12.3641-3649.1996; Domenech P, 2001, MICROBES INFECT, V3, P713, DOI 10.1016/S1286-4579(01)01422-8; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Guo MM, 2009, GENOME RES, V19, P1301, DOI 10.1101/gr.086595.108; He ZG, 2003, J BIOL CHEM, V278, P29538, DOI 10.1074/jbc.M304318200; Italiani VCS, 2011, J BACTERIOL, V193, P1734, DOI 10.1128/JB.01339-10; Jittawuttipoka T, 2009, J BACTERIOL, V191, P7372, DOI 10.1128/JB.00788-09; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Lee HI, 2010, J BIOCHEM, V147, P511, DOI 10.1093/jb/mvp197; Li YQ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-242; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Manca C, 1999, INFECT IMMUN, V67, P74, DOI 10.1128/IAI.67.1.74-79.1999; Master S, 2001, J BACTERIOL, V183, P4033, DOI 10.1128/JB.183.13.4033-4039.2001; Milano A, 2001, J BACTERIOL, V183, P6801, DOI 10.1128/JB.183.23.6801-6806.2001; Muraoka S, 2003, J MOL BIOL, V328, P555, DOI 10.1016/S0022-2836(03)00312-7; Nguyen L, 2005, TRENDS CELL BIOL, V15, P269, DOI 10.1016/j.tcb.2005.03.009; Pagan-Ramos E, 1998, J BACTERIOL, V180, P4856; Pym AS, 2001, MOL MICROBIOL, V40, P879, DOI 10.1046/j.1365-2958.2001.02427.x; Sala C, 2003, J BACTERIOL, V185, P5357, DOI 10.1128/JB.185.18.5357-5362.2003; Sala C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-33; SHERMAN DR, 1995, P NATL ACAD SCI USA, V92, P6625, DOI 10.1073/pnas.92.14.6625; Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104; Sreevatsan S, 1996, J CLIN MICROBIOL, V34, P2007, DOI 10.1128/JCM.34.8.2007-2010.1996; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Yu K., 1999, Tubercle and Lung Disease, V79, P191, DOI 10.1054/tuld.1998.0203; Zahrt TC, 2001, MOL MICROBIOL, V39, P1174, DOI 10.1046/j.1365-2958.2001.02321.x; Zhang H, 2008, FEBS J, V275, P753, DOI 10.1111/j.1742-4658.2007.06241.x; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	36	150	169	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30186	10.1371/journal.pone.0030186	http://dx.doi.org/10.1371/journal.pone.0030186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22905149	Green Published, gold, Green Submitted			2022-12-25	WOS:000301454400077
